Citrus Sinensis ID: 002899

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------87
Protein Sequence
MPKKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIYWS
Secondary Structure (PSIPRED)
cHHHHHHHHHHHHcccccccccccccccccccccccccccccccEEEcccccEEEEEEEEEEcccccccccHHHcccccccEEEcccccccccccHHHHccccEEEEEccccccccccHHccccccccccccccccccccccccccccccccEEEEEEcccEEcccccccccccccEEEcccccccccccccccccccccEEEEEcccccccccccccccccccEEEEEcccccccccccccccccccEEcccccccccccHHHHccccccEEEcccccccccccccccccccccEEEEccccccccccccccccccEEEEEEEcccccccccccccccccEEEEEcccccccccccccccccccccccccccccccEEEEcccccEEEcccEEcccccccccccEEEcccEEEEccccccccccccccccEEEccccccccccccHHHHHHHccccccccccccccccccEEEEEccccEEEccccccccccEEEEEEEEcccEEccccccHHHcccccccEEEcccEEEccccEEEEEEEcccccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHcccccccccHHHHcccccccccccHHHHHHHHccccccccccccccccEEEEEcccccEEEEEEccccccccHHHHHHHHHHHHHcccccccccccEEEcccEEEEEEEEEcccccHHHHcccccccccccccHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccEEccccccEEEEEEEEccccccHHHHccccccEEccccEEEEEEEEEEccccccccccccccccHHHHHHHHHHcccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEEEEEEEccccccccccHHHHccccccEEEcccccccccccHHHccccEEEEEcccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEEccccccccccHHHHHcccccEEEEccccccccccHHHcccccccEEEEcccccccccccHHcccccccEEEEccccccccccccHcccccEEEEEEcccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHcccccEEEEEEcccccccccccHHccccccEEEEEEcccccccccccccHccccccccccccccEEEEEcccccccccccEEccccccccccccccccccccEcccccccccccccccccccccccccccccccHHHHHccccccccHHHHcccccccccccEHHHHHEEEEccccHcHcccccccHHHcccEEEEEccHHHHccccccEEEEEEcccccccEEEEEEEEcccccccccccccccccEcEccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHcccccccccEcHHHHHHHHccccHHccccccccccEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHHccccHHEEEEEEccccccEEEEEEcccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHccHcccEcccccHHHEEEcccccEEEccccccEEcccccEEccccccccHHHccHHHHHHcEEcHHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHcccccc
Coil and Loop (DISEMBL)
MPKKALKQIGRKlgkkdwnfgvdpcsqkgnwelssddkkgfesnvtcdcssatCHVVTIALKaqnltgtlpteLSKLRYlkqldlsrncltgsfspqwaSLQLVELSVMgnrlsgpfpkvltnittlknlsiegnlftgsippdIRKLINLQKLilssnsftgelpaeltkltnlndlrisdnnfsgkipeFIGKWKKIQKLHIqgsslegpipasISALTSLtdlrisdlkgsesafpkldkmnlktLILTKClihgeipdyigdmtKLKNIDlsfnnltggiptTFEKLAKTNFMyltgnkltgpvpkyifnsnknvdislnnftwessdpiecprgsvnlvesyssprnkldkvhpclrqnfpcsapadqyhytlhincggakintghtkyeADMEARGASmfyssgqywafsstgkfmdddtdldnyirtntstlskvsaVDLELYRTARVSPLSLTYYGlclgngnytVRLHFAEIIFkndstfnslgkrIFDIYIQEKlvkkdfniedeaggtgipivknfpaevtshTLKIHLYwagrgttgiplrgtygplISAIsvksnfkppvvhskkNHVMIMAAIVGASVLLVLLILFIMRWKgclggkvsadkelrgldlqTGLYTLRQIKAatnnfdpankvgeggfgsVYKGILSDGTVIAVKQLSsksrqgnrefVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNClsraifgkdteyrlkldwptrkKICIGIARGlaylhedsrikIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIStriagtigymapeyamrgYLTSKADVYSFGVVTLEIVsgksntnyrpnedFVYLLDWAYVLQEEEIYWS
Flexible Loop (DISEMBL)
mpkkalkqigrklgkkdwnfgvdpcsqkgnwelssddKKGFESNVTCDCSSATCHVVTIALKaqnltgtlpTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKltnlndlrisdnnfsgkiPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKgsesafpkldkmNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRtntstlskvsavdlELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGkvsadkelrgLDLQTGLYTLRQIKAAtnnfdpankvGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRaifgkdteyrlkldwptrkKICIGIARGLAYLHEDSRIKIVHrdiktsnvlldkdlnAKISDFGLAKlyeedkthistriagtigyMAPEYAMRGYLTSKADVYSFGVVTLEIvsgksntnyrpnEDFVYLLDWAYVLQEEEIYWS
Low Complexity Region (SEG)
MPKKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIYWS
Disordered region (IsUnstruct)
***************KDWNFGVDPCS***NW*********FESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDL*****AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLV*********LDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQL*********EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIYW*
Disordered Region (DISOPRED)
MPKKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSK**AVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGP*************************MAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS******NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEI***
Disordered Region (DISEMBL)
*********GRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIYWS
Disordered Region (DISPRO)
MPKKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE*****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPKKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIYWS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	869	2.2.26 [Sep-21-2011]
C0LGE0	1014	Probable LRR receptor-lik	yes	no	0.987	0.846	0.657	0.0
C0LGG8	1038	Probable LRR receptor-lik	no	no	0.975	0.816	0.556	0.0
C0LGG9	1035	Probable LRR receptor-lik	no	no	0.975	0.819	0.552	0.0
C0LGN2	1020	Probable leucine-rich rep	no	no	0.981	0.836	0.539	0.0
C0LGG7	953	Probable LRR receptor-lik	no	no	0.922	0.841	0.523	0.0
Q9FXF2	1021	Probable LRR receptor-lik	no	no	0.960	0.817	0.489	0.0
Q9ASQ6	1019	Probable LRR receptor-lik	no	no	0.964	0.822	0.497	0.0
C0LGH2	1032	Probable LRR receptor-lik	no	no	0.964	0.812	0.430	0.0
C0LGH3	1033	Probable LRR receptor-lik	no	no	0.967	0.814	0.430	0.0
O23081	665	Cysteine-rich receptor-li	no	no	0.310	0.406	0.463	3e-69

>sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1

 Score = 1117 bits (2888), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 572/870 (65%), Positives = 682/870 (78%), Gaps = 12/870 (1%)

Query: 4   KALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS----SATCHVVTI 59
           +ALK+IG+KLGKKDW+F  DPCS +G W +++   KGFESN+TCDCS    +++CHV+ I
Sbjct: 36  RALKEIGKKLGKKDWDFNKDPCSGEGTWIVTTYTTKGFESNITCDCSFLPQNSSCHVIRI 95

Query: 60  ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPK 119
           ALK+QNLTG +P E SKLR+LK LDLSRN LTGS   +WAS++L +LS MGNRLSGPFPK
Sbjct: 96  ALKSQNLTGIVPPEFSKLRHLKVLDLSRNSLTGSIPKEWASMRLEDLSFMGNRLSGPFPK 155

Query: 120 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 179
           VLT +T L+NLS+EGN F+G IPPDI +L++L+KL L SN+FTG L  +L  L NL D+R
Sbjct: 156 VLTRLTMLRNLSLEGNQFSGPIPPDIGQLVHLEKLHLPSNAFTGPLTEKLGLLKNLTDMR 215

Query: 180 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 239
           ISDNNF+G IP+FI  W +I KL + G  L+GPIP+SIS+LTSLTDLRISDL G  S+FP
Sbjct: 216 ISDNNFTGPIPDFISNWTRILKLQMHGCGLDGPIPSSISSLTSLTDLRISDLGGKPSSFP 275

Query: 240 KLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 298
            L  + ++KTLIL KC I G IP YIGD+ KLK +DLSFN L+G IP++FE + K +F+Y
Sbjct: 276 PLKNLESIKTLILRKCKIIGPIPKYIGDLKKLKTLDLSFNLLSGEIPSSFENMKKADFIY 335

Query: 299 LTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPI-ECPRGSVNLVESYSSPRNKLDKV 357
           LTGNKLTG VP Y    NKNVD+S NNFT ESS P  +C R + NLVES++   NK  K 
Sbjct: 336 LTGNKLTGGVPNYFVERNKNVDVSFNNFTDESSIPSHDCNRVTSNLVESFALG-NKSHKG 394

Query: 358 HPCLRQNFPCSAPADQYHYTLHINCGGAKINTG-HTKYEADMEARGASMFY-SSGQYWAF 415
             C  Q  PC  P   + Y L+INCGG ++       Y+AD E +GASM+   + + WA 
Sbjct: 395 STCFLQRMPCVHPKRYHLYKLYINCGGGEVKVDKEITYQADDEPKGASMYVLGANKRWAL 454

Query: 416 SSTGKFMDDDTDLDNYIRTNTSTLS-KVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTV 474
           SSTG FMD+D D D Y   NTS LS   S+    LYRTARVSPLSLTYYG+CLGNGNYTV
Sbjct: 455 SSTGNFMDNDDDADEYTVQNTSRLSVNASSPSFGLYRTARVSPLSLTYYGICLGNGNYTV 514

Query: 475 RLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSH 534
            LHFAEIIF +D+T  SLGKR+FDIY+Q++LV K+FNI++ A G+G PI+K+F   VT H
Sbjct: 515 NLHFAEIIFTDDNTLYSLGKRLFDIYVQDQLVIKNFNIQEAARGSGKPIIKSFLVNVTDH 574

Query: 535 TLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLL 594
           TLKI L WAG+GTTGIP+RG YGP+ISAISV+ NFKPPV +  K+ ++ +   V A+ LL
Sbjct: 575 TLKIGLRWAGKGTTGIPIRGVYGPMISAISVEPNFKPPVYYDTKDIILKVGVPVAAATLL 634

Query: 595 VLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSV 654
           + +I+ +  WK     K   DKELRGLDLQTG +TLRQIKAAT+NFD   K+GEGGFGSV
Sbjct: 635 LFIIVGVF-WKK-RRDKNDIDKELRGLDLQTGTFTLRQIKAATDNFDVTRKIGEGGFGSV 692

Query: 655 YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 714
           YKG LS+G +IAVKQLS+KSRQGNREFVNEIGMISA QHPNLVKLYGCCVEGNQL+LVYE
Sbjct: 693 YKGELSEGKLIAVKQLSAKSRQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLILVYE 752

Query: 715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 774
           Y++NNCLSRA+FGKD   RLKLDW TRKKI +GIA+GL +LHE+SRIKIVHRDIK SNVL
Sbjct: 753 YLENNCLSRALFGKDESSRLKLDWSTRKKIFLGIAKGLTFLHEESRIKIVHRDIKASNVL 812

Query: 775 LDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTL 834
           LDKDLNAKISDFGLAKL ++  THISTRIAGTIGYMAPEYAMRGYLT KADVYSFGVV L
Sbjct: 813 LDKDLNAKISDFGLAKLNDDGNTHISTRIAGTIGYMAPEYAMRGYLTEKADVYSFGVVAL 872

Query: 835 EIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 864
           EIVSGKSNTN+RP EDFVYLLDWAYVLQE 
Sbjct: 873 EIVSGKSNTNFRPTEDFVYLLDWAYVLQER 902

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1

 Score =  948 bits (2451), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 484/869 (55%), Positives = 619/869 (71%), Gaps = 21/869 (2%)

Query: 4   KALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFE-SNVTCDC---SSATCHVVTI 59
           + L+ I RKL  +  N     CS + NW    +       SN+TCDC   +S+ C V  I
Sbjct: 37  QTLRTIFRKLQNQTVNIERTSCSDQ-NWNFVVESASNSPTSNITCDCTFNASSVCRVTNI 95

Query: 60  ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPK 119
            LK+ +L G  P E   L  L+++DLSRN L G+     + + L  LSV+GNRLSGPFP 
Sbjct: 96  QLKSFSLPGIFPPEFGNLTRLREIDLSRNFLNGTIPTTLSQIPLEILSVIGNRLSGPFPP 155

Query: 120 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 179
            L +ITTL ++++E NLFTG +P ++  L +L++L+LS+N+FTG++P  L+ L NL + R
Sbjct: 156 QLGDITTLTDVNLETNLFTGPLPRNLGNLRSLKELLLSANNFTGQIPESLSNLKNLTEFR 215

Query: 180 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES-AF 238
           I  N+ SGKIP+FIG W  +++L +QG+S+EGPIP SIS LT+LT+LRI+DL+G  + +F
Sbjct: 216 IDGNSLSGKIPDFIGNWTLLERLDLQGTSMEGPIPPSISNLTNLTELRITDLRGQAAFSF 275

Query: 239 PKL-DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 297
           P L + M +K L+L  CLI G IP+YIG M++LK +DLS N LTG IP TF  L   NFM
Sbjct: 276 PDLRNLMKMKRLVLRNCLIRGPIPEYIGSMSELKTLDLSSNMLTGVIPDTFRNLDAFNFM 335

Query: 298 YLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKV 357
           +L  N LTGPVP++I NS +N+D+S NNFT   +  + C +  VNL+ SY S  +  + V
Sbjct: 336 FLNNNSLTGPVPQFIINSKENLDLSDNNFTQPPT--LSCNQLDVNLISSYPSVTD--NSV 391

Query: 358 HPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSS 417
             CLR+  PC  P D    +L INCGG+++  G   Y  D+ +RG S F S  + W +SS
Sbjct: 392 QWCLREGLPC--PEDAKQSSLFINCGGSRLKIGKDTYTDDLNSRGQSTFSSVSERWGYSS 449

Query: 418 TGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLH 477
           +G ++  +     Y+ T+   L  ++    E Y+TAR+SP SL YYGLCL  G+Y ++LH
Sbjct: 450 SGVWLGKEDA--GYLATDRFNL--INGSTPEYYKTARLSPQSLKYYGLCLRRGSYKLQLH 505

Query: 478 FAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPA-EVTSHTL 536
           FAEI+F ND TFNSLG+RIFDIY+Q  L+++DFNI + AGG G P ++     +V   TL
Sbjct: 506 FAEIMFSNDQTFNSLGRRIFDIYVQGNLLERDFNIAERAGGVGKPFIRQIDGVQVNGSTL 565

Query: 537 KIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVL 596
           +IHL W G+GT  IP RG YGPLISAI++  NFK        N   +   ++ A  +  L
Sbjct: 566 EIHLQWTGKGTNVIPTRGVYGPLISAITITPNFKVDTGKPLSNGA-VAGIVIAACAVFGL 624

Query: 597 LILFIMRWKGCLGGK-VSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY 655
           L+L I+R  G LGGK V  ++ELRGLDLQTG +TL+QIK ATNNFDP NK+GEGGFG VY
Sbjct: 625 LVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVY 684

Query: 656 KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 715
           KG+L+DG  IAVKQLSSKS+QGNREFV EIGMISA QHPNLVKLYGCC+EG +LLLVYEY
Sbjct: 685 KGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEY 744

Query: 716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 775
           ++NN L+RA+FG + + RL LDW TR KICIGIA+GLAYLHE+SR+KIVHRDIK +NVLL
Sbjct: 745 LENNSLARALFGTEKQ-RLHLDWSTRNKICIGIAKGLAYLHEESRLKIVHRDIKATNVLL 803

Query: 776 DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLE 835
           D  LNAKISDFGLAKL +++ THISTRIAGTIGYMAPEYAMRGYLT KADVYSFGVV LE
Sbjct: 804 DLSLNAKISDFGLAKLNDDENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLE 863

Query: 836 IVSGKSNTNYRPNEDFVYLLDWAYVLQEE 864
           IVSGKSNTNYRP E+FVYLLDWAYVLQE+
Sbjct: 864 IVSGKSNTNYRPKEEFVYLLDWAYVLQEQ 892

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2

 Score =  937 bits (2423), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 480/869 (55%), Positives = 611/869 (70%), Gaps = 21/869 (2%)

Query: 4   KALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFE-SNVTCDC---SSATCHVVTI 59
           + L+ I RKL  +  N     C  +  W   ++       SN+TCDC   +S+ C V  I
Sbjct: 35  QTLRTIFRKLQNQTVNIERTSCLDR-KWNFVAESTSKLPTSNITCDCTFNASSVCRVTNI 93

Query: 60  ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPK 119
            L+  NL G +P E   L  L ++DL  N L+G+     + + L  L+V GNRLSGPFP 
Sbjct: 94  QLRGFNLRGIIPPEFGNLTRLTEIDLVLNFLSGTIPTTLSQIPLEILAVTGNRLSGPFPP 153

Query: 120 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 179
            L  ITTL ++ +E NLFTG +PP++  L +L++L++SSN+ TG +P  L+ L NL + R
Sbjct: 154 QLGQITTLTDVIMESNLFTGQLPPNLGNLRSLKRLLISSNNITGRIPESLSNLKNLTNFR 213

Query: 180 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 239
           I  N+ SGKIP+FIG W ++ +L +QG+S+EGPIPASIS L +LT+LRI+DL+G  S FP
Sbjct: 214 IDGNSLSGKIPDFIGNWTRLVRLDLQGTSMEGPIPASISNLKNLTELRITDLRGPTSPFP 273

Query: 240 KLDKM-NLKTLILTKCLIHGEIPDYIG-DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 297
            L  M N++ L+L  CLI   IP+YIG  MT LK +DLS N L G IP TF  L   NFM
Sbjct: 274 DLQNMTNMERLVLRNCLIREPIPEYIGTSMTMLKLLDLSSNMLNGTIPDTFRSLNAFNFM 333

Query: 298 YLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKV 357
           YL  N LTGPVP++I +S +N+D+S NNFT   +  + C +  VNL+ SY S  N  + V
Sbjct: 334 YLNNNSLTGPVPQFILDSKQNIDLSYNNFTQPPT--LSCNQLDVNLISSYPSVTN--NSV 389

Query: 358 HPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSS 417
             CLR++ PC  P D +H +L INCGG ++     +Y  D+  RGAS F S  + W +SS
Sbjct: 390 QWCLRKDLPC--PGDAHHSSLFINCGGNRLKVDKDEYADDLNKRGASTFSSVSERWGYSS 447

Query: 418 TGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLH 477
           +G ++ +D     Y+ T+T  L  ++    E Y+TAR++  SL YYGLC+  G+Y V+L+
Sbjct: 448 SGAWLGNDGA--TYLATDTFNL--INESTPEYYKTARLASQSLKYYGLCMRRGSYKVQLY 503

Query: 478 FAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNF-PAEVTSHTL 536
           FAEI+F ND T++SLG+R+FDIY+Q  L+++DFNI   AGG G P ++     +V   TL
Sbjct: 504 FAEIMFSNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKPFLRQVDEVQVNGSTL 563

Query: 537 KIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVL 596
           +IHL W G+GT  IP RG YGPLISAI+V  NFK        N V +   ++ A V   L
Sbjct: 564 EIHLKWTGKGTNVIPTRGVYGPLISAITVTPNFKVDTGKPLSNGV-VAGIVIAACVAFGL 622

Query: 597 LILFIMRWKGCLGGK-VSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY 655
           L+L I+R  G LGGK V  ++ELRGLDLQTG +TL+QIK ATNNFDP NK+GEGGFG VY
Sbjct: 623 LVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVY 682

Query: 656 KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 715
           KG+L+DG  IAVKQLSSKS+QGNREFV EIGMISA QHPNLVKLYGCC+EG +LLLVYEY
Sbjct: 683 KGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEY 742

Query: 716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 775
           ++NN L+RA+FG + + RL LDW TR K+CIGIA+GLAYLHE+SR+KIVHRDIK +NVLL
Sbjct: 743 LENNSLARALFGTEKQ-RLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLL 801

Query: 776 DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLE 835
           D  LNAKISDFGLAKL EE+ THISTRIAGTIGYMAPEYAMRGYLT KADVYSFGVV LE
Sbjct: 802 DLSLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLE 861

Query: 836 IVSGKSNTNYRPNEDFVYLLDWAYVLQEE 864
           IVSGKSNTNYRP E+F+YLLDWAYVLQE+
Sbjct: 862 IVSGKSNTNYRPKEEFIYLLDWAYVLQEQ 890

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1

 Score =  934 bits (2414), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 474/878 (53%), Positives = 617/878 (70%), Gaps = 25/878 (2%)

Query: 1   MPKK---ALKQIGRKLGKKDWNFGVDPCSQ---KGNWELSSDDKKGFESNVTCDCSSATC 54
           +PK+   AL+ +   L K +WNF VDPC +   +G W  + +  KGFE  VTC+CSS  C
Sbjct: 29  LPKEEVDALQSVATALKKSNWNFSVDPCDETLSEGGWR-NPNAAKGFEDAVTCNCSSVIC 87

Query: 55  HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 114
           HV  I LKAQ+L G+LPT+LS L +L++LDL+RN L GS  P+W +  L+ +S++GNR+S
Sbjct: 88  HVTNIVLKAQDLQGSLPTDLSGLPFLQELDLTRNYLNGSIPPEWGASSLLNISLLGNRIS 147

Query: 115 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 174
           G  PK L N+TTL  L +E N  +G IPP++  L NL++L+LSSN+ +GE+P+   KLT 
Sbjct: 148 GSIPKELGNLTTLSGLVLEYNQLSGKIPPELGNLPNLKRLLLSSNNLSGEIPSTFAKLTT 207

Query: 175 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 234
           L DLRISDN F+G IP+FI  WK ++KL IQ S L GPIP++I  L +LTDLRI+DL G 
Sbjct: 208 LTDLRISDNQFTGAIPDFIQNWKGLEKLVIQASGLVGPIPSAIGLLGTLTDLRITDLSGP 267

Query: 235 ESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 293
           ES FP L  M ++K LIL  C + G++P Y+G   KLKN+DLSFN L+G IP T+  L+ 
Sbjct: 268 ESPFPPLRNMTSMKYLILRNCNLTGDLPAYLGQNRKLKNLDLSFNKLSGPIPATYSGLSD 327

Query: 294 TNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNK 353
            +F+Y T N L G VP ++ +    +DI+ NNF+ + ++  EC + SVN   S S     
Sbjct: 328 VDFIYFTSNMLNGQVPSWMVDQGDTIDITYNNFSKDKTE--ECQQKSVNTFSSTSPLVAN 385

Query: 354 LDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYW 413
                 CL + + C     +  Y LHINCGG +I +  TKY+AD        +Y S   W
Sbjct: 386 NSSNVSCLSK-YTCP----KTFYGLHINCGGNEITSNETKYDAD--TWDTPGYYDSKNGW 438

Query: 414 AFSSTGKFMDDDTDLDNYIRTNTSTLSKV--SAVDLELYRTARVSPLSLTYYGLCLGNGN 471
             S+TG F+DDD   +   + + S+  K+  S++D  LY  AR+S +SLTY  LCLG GN
Sbjct: 439 VSSNTGNFLDDDRTNNGKSKWSNSSELKITNSSIDFRLYTQARLSAISLTYQALCLGKGN 498

Query: 472 YTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEV 531
           YTV LHFAEI+F   + +++LG+R FDIY+Q K   KDFNI DEA G G  +VK FP  V
Sbjct: 499 YTVNLHFAEIMFNEKNMYSNLGRRYFDIYVQGKREVKDFNIVDEAKGVGKAVVKKFPVMV 558

Query: 532 TSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPP-----VVHSKKNHVMIMAA 586
           T+  L+I L WAG+GT  IP+RG YGPLISA+SV  +F PP           +   ++ +
Sbjct: 559 TNGKLEIRLQWAGKGTQAIPVRGVYGPLISAVSVDPDFIPPKEPGTGTGGGSSVGTVVGS 618

Query: 587 IVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKV 646
           ++ ++V LVLLI  I+ W+GCL  K   +K+ + LD Q   ++LRQIK AT+NFDPANK+
Sbjct: 619 VIASTVFLVLLIGGILWWRGCLRPKSQMEKDFKNLDFQISSFSLRQIKVATDNFDPANKI 678

Query: 647 GEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG 706
           GEGGFG V+KGI++DGTVIAVKQLS+KS+QGNREF+NEI MISA QHP+LVKLYGCCVEG
Sbjct: 679 GEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNREFLNEIAMISALQHPHLVKLYGCCVEG 738

Query: 707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHR 766
           +QLLLVYEY++NN L+RA+FG   E ++ L+WP R+KIC+GIARGLAYLHE+SR+KIVHR
Sbjct: 739 DQLLLVYEYLENNSLARALFGPQ-ETQIPLNWPMRQKICVGIARGLAYLHEESRLKIVHR 797

Query: 767 DIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADV 826
           DIK +NVLLDK+LN KISDFGLAKL EE+ THISTR+AGT GYMAPEYAMRG+LT KADV
Sbjct: 798 DIKATNVLLDKELNPKISDFGLAKLDEEENTHISTRVAGTYGYMAPEYAMRGHLTDKADV 857

Query: 827 YSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 864
           YSFGVV LEIV GKSNT+ R   D  YLLDW +VL+E+
Sbjct: 858 YSFGVVALEIVHGKSNTSSRSKADTFYLLDWVHVLREQ 895

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2

 Score =  833 bits (2153), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 439/839 (52%), Positives = 564/839 (67%), Gaps = 37/839 (4%)

Query: 33  LSSDDKKGFESNVT-CDCSSATCHVVTIA--LKAQNLTGTLPTELSKLRYLKQLDLSRNC 89
           L++  K   + NV  C+ SS      TI+  LK +NL G+LP EL  L  L+++DLSRN 
Sbjct: 39  LTTLKKTNIDLNVDPCEVSSTGNEWSTISRNLKRENLQGSLPKELVGLPLLQEIDLSRNY 98

Query: 90  LTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI 149
           L GS  P+W  L LV + ++GNRL+GP PK   NITTL +L +E N  +G +P ++  L 
Sbjct: 99  LNGSIPPEWGVLPLVNIWLLGNRLTGPIPKEFGNITTLTSLVLEANQLSGELPLELGNLP 158

Query: 150 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 209
           N+Q++ILSSN+F GE+P+   KLT L D R+SDN  SG IP+FI KW K+++L IQ S L
Sbjct: 159 NIQQMILSSNNFNGEIPSTFAKLTTLRDFRVSDNQLSGTIPDFIQKWTKLERLFIQASGL 218

Query: 210 EGPIPASISALTSLTDLRISDLKGSESAFPKLDKMN-LKTLILTKCLIHGEIPDYIGDMT 268
            GPIP +I++L  L DLRISDL G ES FP+L  +  ++TLIL  C + G++PDY+G +T
Sbjct: 219 VGPIPIAIASLVELKDLRISDLNGPESPFPQLRNIKKMETLILRNCNLTGDLPDYLGKIT 278

Query: 269 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW 328
             K +DLSFN L+G IP T+  L    ++Y TGN L G VP ++ N    +D+S NNF+ 
Sbjct: 279 SFKFLDLSFNKLSGAIPNTYINLRDGGYIYFTGNMLNGSVPDWMVNKGYKIDLSYNNFSV 338

Query: 329 ESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKIN 388
           + ++ + C                K + V  C+R N+ C    +     LHINCGG +++
Sbjct: 339 DPTNAV-C----------------KYNNVLSCMR-NYQCPKTFN----ALHINCGGDEMS 376

Query: 389 TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLE 448
              T YE+D   R  S +Y S   W  ++ G F+DD    +    T  S  S+++ VD  
Sbjct: 377 INGTIYESDKYDRLES-WYESRNGWFSNNVGVFVDDKHVPERV--TIESNSSELNVVDFG 433

Query: 449 LYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKK 508
           LY  AR+S +SLTYY LCL NGNY V LHFAEI+F  ++ + SLG+R FDIYIQ KL  K
Sbjct: 434 LYTQARISAISLTYYALCLENGNYNVNLHFAEIMFNGNNNYQSLGRRFFDIYIQRKLEVK 493

Query: 509 DFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSN 568
           DFNI  EA   G  ++K FP E+    L+I LYWAGRGTT IP    YGPLISAISV S+
Sbjct: 494 DFNIAKEAKDVGNVVIKTFPVEIKDGKLEIRLYWAGRGTTVIPKERVYGPLISAISVDSS 553

Query: 569 FKPPVVHSKKNHV---MIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQT 625
             P    S +N +    +   +V  S+ +V L+   +  KG L  K   +K+ + L+L  
Sbjct: 554 VNP----SPRNGMSTGTLHTLVVILSIFIVFLVFGTLWKKGYLRSKSQMEKDFKSLELMI 609

Query: 626 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEI 685
             ++LRQIK ATNNFD AN++GEGGFG VYKG L DGT+IAVKQLS+ S+QGNREF+NEI
Sbjct: 610 ASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEI 669

Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
           GMISA  HPNLVKLYGCCVEG QLLLVYE+++NN L+RA+FG   E +L+LDWPTR+KIC
Sbjct: 670 GMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQ-ETQLRLDWPTRRKIC 728

Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
           IG+ARGLAYLHE+SR+KIVHRDIK +NVLLDK LN KISDFGLAKL EED THISTRIAG
Sbjct: 729 IGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAG 788

Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 864
           T GYMAPEYAMRG+LT KADVYSFG+V LEIV G+SN   R   +  YL+DW  VL+E+
Sbjct: 789 TFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREK 847

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1

 Score =  783 bits (2023), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 425/869 (48%), Positives = 563/869 (64%), Gaps = 34/869 (3%)

Query: 5   ALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSAT---CHVVTIAL 61
           AL+QI   LG K W F  + C  +    L+       +  + C+CS      CHVV  A 
Sbjct: 49  ALQQIATTLGSKFWKFDAENCKIE-MVGLTETPPPTAKQEIECECSPTNDTDCHVVKFAF 107

Query: 62  KAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVL 121
           K  NL GTLP ++ KL YL+++DL+ N + G+   +WAS  L  +S++ NRLSG  PK  
Sbjct: 108 KDHNLPGTLP-QIVKLPYLREIDLAYNYINGTLPREWASSNLTFISLLVNRLSGEIPKEF 166

Query: 122 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 181
            N ++L  L +E N F+G+IP ++  L++L+KL+LSSN  TG LPA L +L N+ D RI+
Sbjct: 167 GN-SSLTYLDLESNAFSGTIPQELGNLVHLKKLLLSSNKLTGTLPASLARLQNMTDFRIN 225

Query: 182 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 241
           D   SG IP +I  WK++++L +  S L GPIP+ IS L++L +LRISD++G    FP L
Sbjct: 226 DLQLSGTIPSYIQNWKQLERLEMIASGLTGPIPSVISVLSNLVNLRISDIRGPVQPFPSL 285

Query: 242 DKMN-LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLT 300
             +  L  +IL  C I G+IP Y+  + +L+ +DLSFN L GGIP+ F +     F+ L 
Sbjct: 286 KNVTGLTKIILKNCNISGQIPTYLSHLKELETLDLSFNKLVGGIPS-FAQAENLRFIILA 344

Query: 301 GNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIEC-PRGSVNLVESYSSPRNKLDKVHP 359
           GN L G  P  +      VD+S NN  W+S +   C P  ++NL    S+   K  K  P
Sbjct: 345 GNMLEGDAPDELLRDGITVDLSYNNLKWQSPESRACRPNMNLNLNLFQSTSTKKSSKFLP 404

Query: 360 CLRQNFPCSAPADQYHYTLHINCGGAKINTGHTK----YEAD--MEARGASMFYSSGQYW 413
           C++ +F C     +Y   LH+NCGG+ +     K    YE D  +E   A  F      W
Sbjct: 405 CIK-DFKCP----RYSSCLHVNCGGSDMYVKEKKTKELYEGDGNVEGGAAKYFLKPDANW 459

Query: 414 AFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYT 473
            FSSTG FMDD     N  +    T+   ++   +LY++AR++P+SLTY+  CL NGNYT
Sbjct: 460 GFSSTGDFMDD-----NNFQNTRFTMFVPASNQSDLYKSARIAPVSLTYFHACLENGNYT 514

Query: 474 VRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTS 533
           + L FAEI F ND  +N LG+R+FDIYIQEKLV KDFNI DEA G   PI+K   A VT+
Sbjct: 515 INLDFAEIRFTNDENYNRLGRRLFDIYIQEKLVAKDFNIMDEAKGAQTPIIKPLTAYVTN 574

Query: 534 HTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAI---VGA 590
           H L I L WAG+GTT IP RG YGP+ISAIS+ S+ KP      K  +   A I   +GA
Sbjct: 575 HFLTIRLSWAGKGTTRIPTRGVYGPIISAISIVSDSKP--CERPKTGMSPGAYIAIGIGA 632

Query: 591 SVLLVLLILFIMRW-KGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEG 649
             L++ ++ F+  W  GCL       K+    +L +G +TLRQIK AT++F+P NK+GEG
Sbjct: 633 PCLIIFILGFL--WICGCLPRCGRQRKDPYEEELPSGTFTLRQIKFATDDFNPTNKIGEG 690

Query: 650 GFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 709
           GFG+V+KG+L+DG V+AVKQLSSKSRQGNREF+NEIG IS  QHPNLVKL+G CVE  QL
Sbjct: 691 GFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAISCLQHPNLVKLHGFCVERAQL 750

Query: 710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK 769
           LL YEYM+NN LS A+F    + ++ +DWPTR KIC GIA+GLA+LHE+S +K VHRDIK
Sbjct: 751 LLAYEYMENNSLSSALFSPKHK-QIPMDWPTRFKICCGIAKGLAFLHEESPLKFVHRDIK 809

Query: 770 TSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSF 829
            +N+LLDKDL  KISDFGLA+L EE+KTHIST++AGTIGYMAPEYA+ GYLT KADVYSF
Sbjct: 810 ATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAPEYALWGYLTFKADVYSF 869

Query: 830 GVVTLEIVSGKSNTNYRPNEDFVYLLDWA 858
           GV+ LEIV+G +N+N+    D V LL++A
Sbjct: 870 GVLVLEIVAGITNSNFMGAGDSVCLLEFA 898

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3

 Score =  769 bits (1986), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 436/877 (49%), Positives = 557/877 (63%), Gaps = 39/877 (4%)

Query: 5   ALKQIGRKLGKKDWNF-GVDPCSQKGNWELSSDD---KKGFESNVTCDCS---SATCHVV 57
           ALK+I   LG K  N    DPCS K    +   D        + + CDCS   +  C + 
Sbjct: 38  ALKEIATTLGIKRLNLRDEDPCSSKTLKIIQEVDFVPNLDINNTIGCDCSFNNNTICRIT 97

Query: 58  TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGP 116
            +ALK  +L G LP EL+KL YLK ++L RN L+G+   +WA +  L  +SV  N LSG 
Sbjct: 98  ELALKTMSLRGKLPPELTKLPYLKSIELCRNYLSGTIPMEWAKMAYLTSISVCANNLSGN 157

Query: 117 FPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLN 176
            P  L N   L  L +EGN F+G IP ++  L +L  L L+SN FTG LP  L +L NL 
Sbjct: 158 LPAGLQNFKNLTFLGVEGNQFSGPIPDELGNLTSLTGLELASNKFTGILPGTLARLVNLE 217

Query: 177 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES 236
            +RI DNNF+G IP +IG W ++QKLH+  S L GPIP ++  L +L +L +SD  G +S
Sbjct: 218 RVRICDNNFTGIIPAYIGNWTRLQKLHLYASGLTGPIPDAVVRLENLLELSLSDTTGIKS 277

Query: 237 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNF 296
            FP L    LK LIL    + G IP YI ++T LK +DLSFN L G I    +   K   
Sbjct: 278 -FPNLSSKGLKRLILRNVGLSGPIPSYIWNLTDLKILDLSFNKLNG-IVQGVQNPPKN-- 333

Query: 297 MYLTGNKLTGPVPKY-IFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLD 355
           +YLTGN L+G +    + NS   +D+S NNF+W SS    C +GS       S  +N L 
Sbjct: 334 IYLTGNLLSGNIESGGLLNSQSYIDLSYNNFSWSSS----CQKGSTINTYQSSYSKNNLT 389

Query: 356 KVHPCLRQNFPCSAPAD--QYHYTLHINCGGAKINT----GHTKYEADMEARGASMFYSS 409
            + PC       + PA+  +Y   LHINCGG +++     G   Y+ D   +  +     
Sbjct: 390 GLPPC-------AVPANCKKYQRFLHINCGGEEVSIRNSLGKITYQTDNSRQTNAASNQQ 442

Query: 410 GQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGN 469
             YW  S+TG F DD++D D Y  +   TLS       +LY+TAR S LSL YY  CL N
Sbjct: 443 FDYWGVSNTGDFTDDNSDHDEYYTSTNLTLSGDYP---DLYKTARRSALSLVYYAFCLEN 499

Query: 470 GNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPA 529
           GNY V+LHF EI F +   ++ LG+RIFD+Y+Q KL  +DFNI  EA G   P++K   A
Sbjct: 500 GNYNVKLHFMEIQFSDKEVYSRLGRRIFDVYVQGKLFLRDFNINKEANGNMKPVIKEINA 559

Query: 530 EVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVG 589
            VT+H L+I LYWAG+GTT IP RG YGPLISAIS+  + +P     K  H +    I+G
Sbjct: 560 TVTNHMLEIRLYWAGKGTTLIPKRGNYGPLISAISLCHSQEPLCGVEKTKHHIKYPLILG 619

Query: 590 AS---VLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKV 646
           AS   V +VLL + I             +++LR   LQT  ++ RQ++ ATNNFD ANK+
Sbjct: 620 ASGALVTIVLLAVGIYARGIYRRDNNRRERDLRAQGLQTVCFSWRQLQTATNNFDQANKL 679

Query: 647 GEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG 706
           GEGGFGSV+KG LSDGT+IAVKQLSSKS QGNREFVNEIGMIS   HPNLVKLYGCCVE 
Sbjct: 680 GEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIGMISGLNHPNLVKLYGCCVER 739

Query: 707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHR 766
           +QLLLVYEYM+NN L+ A+FG+++   LKLDW  R+KIC+GIARGL +LH+ S +++VHR
Sbjct: 740 DQLLLVYEYMENNSLALALFGQNS---LKLDWAARQKICVGIARGLEFLHDGSAMRMVHR 796

Query: 767 DIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADV 826
           DIKT+NVLLD DLNAKISDFGLA+L+E + THIST++AGTIGYMAPEYA+ G LT KADV
Sbjct: 797 DIKTTNVLLDTDLNAKISDFGLARLHEAEHTHISTKVAGTIGYMAPEYALWGQLTEKADV 856

Query: 827 YSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQE 863
           YSFGVV +EIVSGKSNT  + N D V L++WA  LQ+
Sbjct: 857 YSFGVVAMEIVSGKSNTKQQGNADSVSLINWALTLQQ 893

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2

 Score =  675 bits (1742), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 374/869 (43%), Positives = 529/869 (60%), Gaps = 31/869 (3%)

Query: 16  KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPT 72
           ++WN   + CS         D    +   + CDCS   S  C +  I + A ++ G +P 
Sbjct: 58  REWNISGELCSGAAIDASVLDSNPAYNPLIKCDCSFQNSTICRITNIKVYAIDVVGPIPP 117

Query: 73  ELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMG-NRLSGPFPKVLTNITTLKNLS 131
           EL  L YL  L+L +N LTGS  P   +L  ++    G N LSGP PK +  +T L+ L 
Sbjct: 118 ELWTLTYLTNLNLGQNVLTGSLPPAIGNLTRMQWMTFGINALSGPVPKEIGLLTDLRLLG 177

Query: 132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 191
           I  N F+GSIP +I +   LQ++ + S+  +G +P     L  L    I+D   + +IP+
Sbjct: 178 ISSNNFSGSIPDEIGRCTKLQQMYIDSSGLSGRIPLSFANLVQLEQAWIADLEVTDQIPD 237

Query: 192 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLI 250
           FIG W K+  L I G+ L GPIP+S S LTSLT+LR+ D+    S+   +  M +L  L+
Sbjct: 238 FIGDWTKLTTLRIIGTGLSGPIPSSFSNLTSLTELRLGDISSGSSSLDFIKDMKSLSVLV 297

Query: 251 LTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK 310
           L    + G IP  IG+ + L+ +DLSFN L G IP +   L++   ++L  N L G  P 
Sbjct: 298 LRNNNLTGTIPSTIGEHSSLRQVDLSFNKLHGPIPASLFNLSQLTHLFLGNNTLNGSFPT 357

Query: 311 YIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP---CLRQNFPC 367
               S +NVD+S N+ +      +  P   +NLV +  +     ++V P   CL++NFPC
Sbjct: 358 QKTQSLRNVDVSYNDLSGSLPSWVSLPSLKLNLVANNFTLEGLDNRVLPGLNCLQKNFPC 417

Query: 368 SAPADQYHYTLHINCGGAKIN--TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDD 425
           +     Y     INCGG +    TG      D +   AS F S+GQ WA SS G F    
Sbjct: 418 NRGKGIYS-DFSINCGGPEKRSVTGALFEREDEDFGPASFFVSAGQRWAASSVGLFAGSS 476

Query: 426 TDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEI--IF 483
            ++  YI T+ S    V+ +D EL+++AR+S  S+ YYGL L NG YTV L FAEI  + 
Sbjct: 477 NNI--YIATSQSQF--VNTLDSELFQSARLSASSVRYYGLGLENGGYTVTLQFAEIQILG 532

Query: 484 KNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKN-FPAEVTSHTLKIHLYW 542
              +T+  LG+R FDIY+Q +LV+KDF++   AG + +  V+  + A V+ + L++HL+W
Sbjct: 533 STSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQRVYKANVSENHLEVHLFW 592

Query: 543 AGRGTTGIPLRGTYGPLISAISVKSNFKPPVVH-----SKKNHVMIMAAIVGASVLLVL- 596
           AG+GT  IP++G YGPLISA+S   +F P V +      K     I+  IVG  +L +L 
Sbjct: 593 AGKGTCCIPIQGAYGPLISAVSATPDFTPTVANKPPSKGKNRTGTIVGVIVGVGLLSILA 652

Query: 597 -LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY 655
            +++F +R +     + + D+EL G+D++  ++T  ++K+AT +FDP+NK+GEGGFG VY
Sbjct: 653 GVVMFTIRKRR---KRYTDDEELLGMDVKPYIFTYSELKSATQDFDPSNKLGEGGFGPVY 709

Query: 656 KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 715
           KG L+DG V+AVK LS  SRQG  +FV EI  IS+  H NLVKLYGCC EG   +LVYEY
Sbjct: 710 KGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEY 769

Query: 716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 775
           + N  L +A+FG  T   L LDW TR +IC+G+ARGL YLHE++ ++IVHRD+K SN+LL
Sbjct: 770 LPNGSLDQALFGDKT---LHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILL 826

Query: 776 DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLE 835
           D  L  +ISDFGLAKLY++ KTHISTR+AGTIGY+APEYAMRG+LT K DVY+FGVV LE
Sbjct: 827 DSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALE 886

Query: 836 IVSGKSNTNYRPNEDFVYLLDWAYVLQEE 864
           +VSG+ N++    E+  YLL+WA+ L E+
Sbjct: 887 LVSGRPNSDENLEEEKKYLLEWAWNLHEK 915

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2

 Score =  669 bits (1726), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/876 (43%), Positives = 528/876 (60%), Gaps = 35/876 (3%)

Query: 11  RKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS---SATCHVVTIALKAQNLT 67
           R    ++WN   + CS         D    +   + CDCS   S  C +  I + A  + 
Sbjct: 52  RIRAPREWNISGELCSGAAIDASVLDSNPAYNPLIKCDCSFENSTICRITNIKVYAMEVV 111

Query: 68  GTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMG-NRLSGPFPKVLTNITT 126
           G++P +L  L YL  L+L +N LTGS  P   +L  +     G N LSGP PK +  +T 
Sbjct: 112 GSIPQQLWTLEYLTNLNLGQNVLTGSLPPALGNLTRMRWMTFGINALSGPIPKEIGLLTD 171

Query: 127 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS 186
           L+ LSI  N F+GSIP +I +   LQ++ + S+  +G LP     L  L    I+D   +
Sbjct: 172 LRLLSISSNNFSGSIPDEIGRCTKLQQIYIDSSGLSGGLPVSFANLVELEQAWIADMELT 231

Query: 187 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-N 245
           G+IP+FIG W K+  L I G+ L GPIPAS S LTSLT+LR+ D+    S+   +  M +
Sbjct: 232 GQIPDFIGDWTKLTTLRILGTGLSGPIPASFSNLTSLTELRLGDISNGNSSLEFIKDMKS 291

Query: 246 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 305
           L  L+L    + G IP  IG+ + L+ +DLSFN L G IP +   L +   ++L  N L 
Sbjct: 292 LSILVLRNNNLTGTIPSNIGEYSSLRQLDLSFNKLHGTIPASLFNLRQLTHLFLGNNTLN 351

Query: 306 GPVPKYIFNSNKNVDISLNNFT-----WESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 360
           G +P     S  NVD+S N+ +     W S   +     + N   +     N++     C
Sbjct: 352 GSLPTQKGQSLSNVDVSYNDLSGSLPSWVSLPNLNLNLVANNF--TLEGLDNRVLSGLNC 409

Query: 361 LRQNFPCSAPADQYHYTLHINCGGAKINT-GHTKYEADMEARG-ASMFYSSGQYWAFSST 418
           L++NFPC+     Y     INCGG +I +     +E + E  G AS   S+GQ WA SS 
Sbjct: 410 LQKNFPCNRGKGIYS-DFSINCGGPEIRSVTEAVFEREDEDLGPASFVVSAGQRWAASSV 468

Query: 419 GKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHF 478
           G F     ++  YI T+ S    V+ +D EL+++AR+S  SL YYGL L NG YTV L F
Sbjct: 469 GLFAGSSNNI--YISTSQSQF--VNTLDSELFQSARLSASSLRYYGLGLENGGYTVTLQF 524

Query: 479 AEI--IFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIV-KNFPAEVTSHT 535
           AEI  +    +T+  LG+R FDIY+Q +LV+KDF++   AG + +  V + + A V+ + 
Sbjct: 525 AEIQILGSTSNTWRGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQREYKANVSQNH 584

Query: 536 LKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKP-----PVVHSKKNHVMIMAAIVGA 590
           L+IHL+WAG+GT  IP++G YGPLISA+    +F P     P    K     I+  IVG 
Sbjct: 585 LEIHLFWAGKGTCCIPIQGAYGPLISAVGATPDFTPTVGNRPPSKGKSMTGTIVGVIVGV 644

Query: 591 SVLLVL--LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGE 648
            +L ++  +++FI+R +     + + D+E+  +D++   +T  ++K+AT +FDP+NK+GE
Sbjct: 645 GLLSIISGVVIFIIRKRR---KRYTDDEEILSMDVKPYTFTYSELKSATQDFDPSNKLGE 701

Query: 649 GGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 708
           GGFG VYKG L+DG  +AVK LS  SRQG  +FV EI  ISA QH NLVKLYGCC EG  
Sbjct: 702 GGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQHRNLVKLYGCCYEGEH 761

Query: 709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI 768
            LLVYEY+ N  L +A+FG+ T   L LDW TR +IC+G+ARGL YLHE++R++IVHRD+
Sbjct: 762 RLLVYEYLPNGSLDQALFGEKT---LHLDWSTRYEICLGVARGLVYLHEEARLRIVHRDV 818

Query: 769 KTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYS 828
           K SN+LLD  L  K+SDFGLAKLY++ KTHISTR+AGTIGY+APEYAMRG+LT K DVY+
Sbjct: 819 KASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYA 878

Query: 829 FGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 864
           FGVV LE+VSG+ N++    ++  YLL+WA+ L E+
Sbjct: 879 FGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHEK 914

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O23081|CRK41_ARATH Cysteine-rich receptor-like protein kinase 41 OS=Arabidopsis thaliana GN=CRK41 PE=3 SV=2

 Score =  263 bits (673), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 135/291 (46%), Positives = 193/291 (66%), Gaps = 21/291 (7%)

Query: 581 VMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQ-------- 632
           +  + +++G +++ V L  F+ R       + +A +   G DL+  +    Q        
Sbjct: 283 IATVCSVIGFAIIAVFLYFFMTR------NRRTAKQRHEGKDLEELMIKDAQLLQLDFDT 336

Query: 633 IKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ 692
           I+ ATN+F   N++GEGGFG+VYKG+L  G  IAVK+LS KS QG+ EF+NE+ +++  Q
Sbjct: 337 IRLATNDFSRDNQLGEGGFGAVYKGVLDYGEEIAVKRLSMKSGQGDNEFINEVSLVAKLQ 396

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           H NLV+L G C++G + +L+YE+ KN  L   IF  D+  R+ LDW TR +I  G+ARGL
Sbjct: 397 HRNLVRLLGFCLQGEERILIYEFFKNTSLDHYIF--DSNRRMILDWETRYRIISGVARGL 454

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED---KTHISTRIAGTIGY 809
            YLHEDSR KIVHRD+K SNVLLD  +N KI+DFG+AKL++ D   +T  ++++AGT GY
Sbjct: 455 LYLHEDSRFKIVHRDMKASNVLLDDAMNPKIADFGMAKLFDTDQTSQTRFTSKVAGTYGY 514

Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED-FVYLLDWAY 859
           MAPEYAM G  + K DV+SFGV+ LEI+ GK N N+ P ED  ++LL + +
Sbjct: 515 MAPEYAMSGEFSVKTDVFSFGVLVLEIIKGKKN-NWSPEEDSSLFLLSYVW 564

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	869
302143484	1011	unnamed protein product [Vitis vinifera]	0.986	0.847	0.744	0.0
224080095	977	predicted protein [Populus trichocarpa]	0.988	0.879	0.717	0.0
449444971	1028	PREDICTED: probable LRR receptor-like se	0.986	0.833	0.723	0.0
255584521	941	conserved hypothetical protein [Ricinus	0.921	0.851	0.769	0.0
359485473	999	PREDICTED: probable LRR receptor-like se	0.965	0.839	0.727	0.0
356501491	1025	PREDICTED: probable LRR receptor-like se	0.987	0.837	0.690	0.0
317106662	927	JHL10I11.12 [Jatropha curcas]	0.903	0.846	0.759	0.0
357494365	1039	BED finger-nbs resistance protein [Medic	0.988	0.826	0.677	0.0
345651730	1027	rfls6 protein [Glycine max]	0.988	0.836	0.680	0.0
297849060	1012	hypothetical protein ARALYDRAFT_470791 [	0.983	0.844	0.669	0.0

>gi|302143484|emb|CBI22045.3| unnamed protein product [Vitis vinifera]

 Score = 1298 bits (3359), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 644/865 (74%), Positives = 737/865 (85%), Gaps = 8/865 (0%)

Query: 4   KALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS---SATCHVVTIA 60
           KALK IG +LGK+DW+FG DPCS +GNW  S ++KKG ES+VTCDC+   +A+CHVVTIA
Sbjct: 31  KALKVIGTRLGKRDWDFGKDPCSGEGNWS-SVNEKKGVESSVTCDCTFHHNASCHVVTIA 89

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 120
           LKAQNL+G+LP ELSKL +LK LDLSRN  +GS   QWA+++LVELS+MGNRLSGPFPKV
Sbjct: 90  LKAQNLSGSLPPELSKLYHLKHLDLSRNLFSGSIPSQWATMRLVELSLMGNRLSGPFPKV 149

Query: 121 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 180
           LTNITTL+NLSIEGNLF+G IPP+I KLI ++K++LSSN+FTGELP  L KLTNL D+RI
Sbjct: 150 LTNITTLRNLSIEGNLFSGPIPPEIGKLIRIEKMVLSSNAFTGELPVALAKLTNLTDMRI 209

Query: 181 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK 240
           +DN+FSG+IPEFIG W  +QKLHIQGSSLEGPIP+SISALTSL+DLRISDLKG  S FP 
Sbjct: 210 NDNHFSGRIPEFIGNWTHVQKLHIQGSSLEGPIPSSISALTSLSDLRISDLKGRGSTFPP 269

Query: 241 LDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 299
           L  + +LKTL+L KCLIHGEIP+YIGDM KLK++DLSFN L G IPT+F++LAKT+FMYL
Sbjct: 270 LSTIESLKTLVLRKCLIHGEIPEYIGDMKKLKHLDLSFNELAGEIPTSFQELAKTDFMYL 329

Query: 300 TGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP 359
           TGN LTG +P +I  +NKN D+S NNFTW+SS P+ECPRGSVNLVESYSS   +      
Sbjct: 330 TGNMLTGHIPDWILGTNKNFDLSYNNFTWDSSSPVECPRGSVNLVESYSSSSVRRSIHS- 388

Query: 360 CLRQNFPCSAPADQYHYTLHINCGGAKIN-TGHTKYEADMEARGASMFYSSGQYWAFSST 418
           CL+QNFPCSA ++QYHY+LHINCGG + +  G TKYEAD+E  GASMFY  GQ WAFSST
Sbjct: 389 CLKQNFPCSASSNQYHYSLHINCGGKETSINGSTKYEADLEPTGASMFYL-GQNWAFSST 447

Query: 419 GKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHF 478
           G FMD+D D D YI  NTS+LS VS +D+ELY+ ARVSPLSLTYYGLCLGNGNYTV+LHF
Sbjct: 448 GNFMDNDVDGDAYIEANTSSLSNVSVLDVELYKKARVSPLSLTYYGLCLGNGNYTVKLHF 507

Query: 479 AEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKI 538
           AEIIF ND +FNSLG+RIFD+YIQ KLV KDFNIE EAGGTG PI+KNF AEVTSHTLK+
Sbjct: 508 AEIIFINDKSFNSLGERIFDVYIQGKLVLKDFNIEKEAGGTGKPIIKNFTAEVTSHTLKV 567

Query: 539 HLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLI 598
             YWAGRGTTGIPLRG YGPLISAISV  NF+PP    K   + I+      +V+LVLL 
Sbjct: 568 QFYWAGRGTTGIPLRGFYGPLISAISVDPNFEPPSPPGKNWDIKIVVGAAAVAVVLVLLT 627

Query: 599 LFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI 658
           L I+  KG LGGK S DKELRGLDLQTGL+TLRQIKAAT NFD  NK+GEGGFG+V+KG 
Sbjct: 628 LGILWRKGWLGGKTSEDKELRGLDLQTGLFTLRQIKAATKNFDAENKLGEGGFGAVFKGT 687

Query: 659 LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 718
           LSDGTVIAVKQLSSKS+QGNREFVNE+GMISA QHPNLVKLYGCC+EGNQL LVYEYM+N
Sbjct: 688 LSDGTVIAVKQLSSKSKQGNREFVNEVGMISALQHPNLVKLYGCCIEGNQLSLVYEYMEN 747

Query: 719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD 778
           N LSRA+FG+D  Y+LKL+W TR+ IC+GIARGLAYLHE+S +KIVHRDIKTSNVLLDKD
Sbjct: 748 NSLSRALFGRDATYKLKLNWSTRQNICVGIARGLAYLHEESTLKIVHRDIKTSNVLLDKD 807

Query: 779 LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +NAKISDFGLAKL E+D THISTRIAGTIGYMAPEYAMRGYLT KADVYSFGVV LEIVS
Sbjct: 808 MNAKISDFGLAKLDEDDNTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVALEIVS 867

Query: 839 GKSNTNYRPNEDFVYLLDWAYVLQE 863
           GKSNTNYRP E+FVYLLDWAYVLQE
Sbjct: 868 GKSNTNYRPKEEFVYLLDWAYVLQE 892

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224080095|ref|XP_002306015.1| predicted protein [Populus trichocarpa] gi|222848979|gb|EEE86526.1| predicted protein [Populus trichocarpa]

 Score = 1289 bits (3336), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 622/867 (71%), Positives = 725/867 (83%), Gaps = 8/867 (0%)

Query: 4   KALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS---SATCHVVTIA 60
           + L++IG+KLGKKDW+F  DPCS +GNW +  D++KGFE++VTCDCS   +++CH+V+IA
Sbjct: 2   RVLREIGKKLGKKDWDFNKDPCSGEGNWSIL-DERKGFENSVTCDCSFNNNSSCHLVSIA 60

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 120
           LK+QNL+G +P E SK RYLKQLDLSRN  TG   PQW +L+L E SVMGNRLSGPFPKV
Sbjct: 61  LKSQNLSGIIPPEFSKFRYLKQLDLSRNLFTGVIPPQWGTLRLEEFSVMGNRLSGPFPKV 120

Query: 121 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 180
           LTN+TTL+NLSIEGN F+G IPP+I +LINLQKL+ SSN+ TG LPAEL KL NL D+RI
Sbjct: 121 LTNMTTLRNLSIEGNHFSGPIPPEIGRLINLQKLVFSSNALTGNLPAELGKLVNLTDVRI 180

Query: 181 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK 240
           +DNNFSGK+P FI KW K+QKLH+QG+SL+GPIP+SI++LT L+DLRISDL G  S FP 
Sbjct: 181 NDNNFSGKLPTFISKWTKVQKLHLQGTSLKGPIPSSIASLTKLSDLRISDLTGRGSPFPP 240

Query: 241 LDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 299
           L  M ++KTLIL  CLI+GEIP+Y+G M KLK++D+SFNNL G IP+TF +LA+ +F+YL
Sbjct: 241 LSDMESMKTLILRNCLIYGEIPEYVGQMEKLKHLDVSFNNLRGEIPSTFIQLARIDFLYL 300

Query: 300 TGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP 359
           TGNKLTG VP ++   NKNVD+S NNFTW+SS P EC RGSVN+VES+S P     K H 
Sbjct: 301 TGNKLTGSVPPWLLERNKNVDLSYNNFTWQSSSPDECARGSVNIVESFS-PSTIKSKAHS 359

Query: 360 CLRQNFPCSAPADQYHYTLHINCGGAKINT-GHTKYEADMEARGASMFYSS-GQYWAFSS 417
           CL+QNFPCSA  +Q HYTLHINCGG +I   G+T Y+ D E RGASMFYS   Q WAFSS
Sbjct: 360 CLKQNFPCSASRNQQHYTLHINCGGNEITVDGNTTYQDDKEPRGASMFYSHPSQEWAFSS 419

Query: 418 TGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLH 477
           TG FMDDD++ D Y +TN S +S VSA   +LY TARVSPLSLTYYGLCL NGNYTV+LH
Sbjct: 420 TGNFMDDDSEADAYTKTNKSAISNVSATIAQLYTTARVSPLSLTYYGLCLMNGNYTVKLH 479

Query: 478 FAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLK 537
           FAEIIF NDS+  SLGKRIFD+YIQ KLV KDFNIEDEAGG  IP+VK F A VT +TLK
Sbjct: 480 FAEIIFTNDSSLTSLGKRIFDVYIQGKLVLKDFNIEDEAGGVAIPLVKTFIAAVTHNTLK 539

Query: 538 IHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLL 597
           I LYWAGRGTTGIPLRG YGPLISAISV  NFKPP   SK+N V+I+   V  ++ L  L
Sbjct: 540 IRLYWAGRGTTGIPLRGIYGPLISAISVDPNFKPPSNGSKRNVVIIVTGAVAGAIFLAFL 599

Query: 598 ILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKG 657
           +L +M   G L GK +ADKEL+GLDLQTGL+TLRQ+KAATNNFD  NKVGEGGFGSVYKG
Sbjct: 600 VLGVMWRNGWLCGKAAADKELKGLDLQTGLFTLRQMKAATNNFDAENKVGEGGFGSVYKG 659

Query: 658 ILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 717
            LSDGTVIAVK LSSKS+QGNREFVNEIGMISA QHPNLVKLYGCCVEGNQL++VYEYM+
Sbjct: 660 SLSDGTVIAVKLLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLMIVYEYME 719

Query: 718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 777
           NNCLSRA+ GK++++R+KLDWPTR+KIC+G+A+GL YLHE+S IKIVHRDIKTSNVLLDK
Sbjct: 720 NNCLSRALLGKESKFRMKLDWPTRQKICLGVAKGLMYLHEESIIKIVHRDIKTSNVLLDK 779

Query: 778 DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV 837
           +LNAKISDFGLAKL E+D THISTRIAGTIGYMAPEYAMRGYLT+KADVYSFGVV LEIV
Sbjct: 780 ELNAKISDFGLAKLNEDDDTHISTRIAGTIGYMAPEYAMRGYLTNKADVYSFGVVALEIV 839

Query: 838 SGKSNTNYRPNEDFVYLLDWAYVLQEE 864
           SGKSNTNYRP E+FVYLLDWAYVLQE 
Sbjct: 840 SGKSNTNYRPKEEFVYLLDWAYVLQER 866

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449444971|ref|XP_004140247.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650-like [Cucumis sativus] gi|449481221|ref|XP_004156118.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650-like [Cucumis sativus]

 Score = 1280 bits (3313), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 626/865 (72%), Positives = 725/865 (83%), Gaps = 8/865 (0%)

Query: 4   KALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS---SATCHVVTIA 60
           KALK+I +KLGK DW+F +DPCS +G W +  + +KGFES+VTCDCS   ++TCH+V IA
Sbjct: 44  KALKEIEKKLGKNDWDFNIDPCSGEGKWHVV-NGRKGFESSVTCDCSFNHNSTCHIVAIA 102

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 120
           LK+QNL+G +P E SKLR+LKQLDLSRNCLTG    QWA+++LVELS MGN+LSGPFPKV
Sbjct: 103 LKSQNLSGIVPPEFSKLRFLKQLDLSRNCLTGFVPSQWATMRLVELSFMGNKLSGPFPKV 162

Query: 121 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 180
           LTNITTL+NLSIEGN F+G IPP+I KL+NL+KL+LSSN  TGELP  L KL+NL D+RI
Sbjct: 163 LTNITTLRNLSIEGNQFSGRIPPEIGKLVNLEKLVLSSNGLTGELPKGLAKLSNLTDMRI 222

Query: 181 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK 240
           SDNNFSGKIPEFI  W +I+KLHIQG SLEGPIP SIS +TSLTDLRISDLKG  S FP 
Sbjct: 223 SDNNFSGKIPEFISNWAQIEKLHIQGCSLEGPIPLSISTMTSLTDLRISDLKGGRSPFPP 282

Query: 241 LDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 299
           L  + ++KTLIL KC I GEIP YIGDM KLKN+DLS+N+LTG +P TFE+L K ++++L
Sbjct: 283 LSNIKSMKTLILRKCFIFGEIPKYIGDMKKLKNLDLSYNDLTGEVPATFERLDKIDYIFL 342

Query: 300 TGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP 359
           T NKL G +P +I  SNKNVD+S NNFTWE+S P ECPRGSVNLVE+YS    KL ++HP
Sbjct: 343 TANKLNGIIPGWILGSNKNVDLSNNNFTWENSSPAECPRGSVNLVETYSPSAEKLTRIHP 402

Query: 360 CLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTG 419
           CL++NFPCSA  +++HY+L INCGG + +    +YEAD E  GASMFY+ GQ WAFSSTG
Sbjct: 403 CLKRNFPCSASREEHHYSLRINCGGKETSIRGERYEADRE--GASMFYT-GQNWAFSSTG 459

Query: 420 KFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFA 479
            FMD+D D DNYI TNTS LS VSA   ELY  AR SP SLTYYGLCL NGNYTV+LHFA
Sbjct: 460 SFMDNDVDADNYIVTNTSALSNVSATYSELYTKARNSPQSLTYYGLCLINGNYTVKLHFA 519

Query: 480 EIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIH 539
           EI+F NDS+FNSLG+R+FD+YIQEKLV KDF+IE EAGGTG PI+K     VTSHTLKIH
Sbjct: 520 EIVFINDSSFNSLGRRVFDVYIQEKLVLKDFDIEHEAGGTGKPIIKKITVAVTSHTLKIH 579

Query: 540 LYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLIL 599
            YWAGRGTTGIPLRG YGPLISAISV  NF PP  H KK+  +I+     A+ +L+LL+L
Sbjct: 580 FYWAGRGTTGIPLRGNYGPLISAISVDPNFTPPKNHGKKDFTIIIIGTAAAAFVLLLLVL 639

Query: 600 FIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGIL 659
            IMR KG LGGK S  KELRG+DLQTGL+T+RQIKAAT NFD ANKVGEGGFG+VYKG+L
Sbjct: 640 CIMRRKGWLGGKASVYKELRGIDLQTGLFTIRQIKAATKNFDAANKVGEGGFGAVYKGLL 699

Query: 660 SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 719
           SDGT+IAVKQLSSKS+QGNREFVNEIGMISA QHPNLVKLYGCC++GNQL+L+YEYM+NN
Sbjct: 700 SDGTIIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIDGNQLMLIYEYMENN 759

Query: 720 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 779
           CLSRA+F  D   +LKLDWPTR+KIC+GIARGLAYLHE+SR+KIVHRDIKTSNVLLDKD 
Sbjct: 760 CLSRALFRNDPGSKLKLDWPTRQKICLGIARGLAYLHEESRLKIVHRDIKTSNVLLDKDF 819

Query: 780 NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           +AKISDFGLAKL+E+D THISTR+AGTIGYMAPEYAMRG LTSKADVYSFGVV LEIVSG
Sbjct: 820 SAKISDFGLAKLHEDDNTHISTRVAGTIGYMAPEYAMRGCLTSKADVYSFGVVALEIVSG 879

Query: 840 KSNTNYRPNEDFVYLLDWAYVLQEE 864
           KSNTNY P EDFVYLLDWA VLQE+
Sbjct: 880 KSNTNYMPKEDFVYLLDWASVLQEK 904

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255584521|ref|XP_002532988.1| conserved hypothetical protein [Ricinus communis] gi|223527234|gb|EEF29396.1| conserved hypothetical protein [Ricinus communis]

 Score = 1277 bits (3304), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 621/807 (76%), Positives = 702/807 (86%), Gaps = 6/807 (0%)

Query: 60  ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPK 119
           ALK+QNL+G +P + SKL Y++ LDLSRNCLTGS   QWA+++LV+LS MGN+LSGPFPK
Sbjct: 6   ALKSQNLSGIVPPDFSKLHYIELLDLSRNCLTGSIPSQWATMRLVDLSFMGNQLSGPFPK 65

Query: 120 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 179
            LTNITTLKNLSIEGN F+G IPP+I KLINL+KL LSSN+FTG+LP EL KL NL D+R
Sbjct: 66  ALTNITTLKNLSIEGNNFSGPIPPEIGKLINLEKLTLSSNAFTGKLPRELAKLVNLTDMR 125

Query: 180 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 239
           ISD NFSG+IP+FI +WK+IQKLHIQGSSLEGPIP+SIS LT L+DLRISDLKG  S+FP
Sbjct: 126 ISDANFSGQIPDFISRWKQIQKLHIQGSSLEGPIPSSISGLTRLSDLRISDLKGQSSSFP 185

Query: 240 KLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 298
            LD M ++KTLIL KCL+ G+IP+YIG M KLKN+DLSFNNLTG IP TF  LAK +FMY
Sbjct: 186 HLDNMESMKTLILRKCLLSGKIPEYIGHMKKLKNLDLSFNNLTGEIPATFSHLAKVDFMY 245

Query: 299 LTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 358
           LTGNKLTGP+P+++   NKNVDIS NNFTW+SS  IECPRGSVNLVESYSS  NKL KVH
Sbjct: 246 LTGNKLTGPIPEWVLERNKNVDISDNNFTWDSSSQIECPRGSVNLVESYSSSTNKLSKVH 305

Query: 359 PCLRQNFPCSAPADQYHYTLHINCGGAKINTG-HTKYEADMEARGASMFYSSGQYWAFSS 417
            CL+QNFPCS+  +  +Y LHINCGG +I  G +  Y AD+EARGASM+YSS Q WAFSS
Sbjct: 306 SCLKQNFPCSSKPN--NYALHINCGGKEIIAGSNITYNADLEARGASMYYSS-QNWAFSS 362

Query: 418 TGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLH 477
           TG FMD+D D D YI+ NTS +S VSA+D +LY+TARVSPLSL+YYGLCL NGNYTV+LH
Sbjct: 363 TGNFMDNDIDADPYIQINTSAISNVSALDAQLYKTARVSPLSLSYYGLCLINGNYTVKLH 422

Query: 478 FAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLK 537
           FAEI+F +D+TFNSLGKRIFD+YIQEKLV KDFNI +EAGGTG PIVK F   VTSHTLK
Sbjct: 423 FAEIVFTDDNTFNSLGKRIFDVYIQEKLVLKDFNIAEEAGGTGRPIVKMFTVAVTSHTLK 482

Query: 538 IHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLL 597
           IH YWAGRGTTGIP+RG YGPLISAISV  NFKPP  + KKN V+I+A  V A+V LVLL
Sbjct: 483 IHFYWAGRGTTGIPVRGIYGPLISAISVDPNFKPPSDNDKKN-VIIVATTVSAAVFLVLL 541

Query: 598 ILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKG 657
           IL IM  KGCLG  VSADKELRGLDLQTG++TLRQIKAAT NFDPANK+GEGGFGSVYKG
Sbjct: 542 ILGIMWRKGCLGDNVSADKELRGLDLQTGIFTLRQIKAATKNFDPANKLGEGGFGSVYKG 601

Query: 658 ILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 717
           +LSDGT+IAVKQLSSKS+QGNREFVNEIGMIS  QHPNLVKLYGCCVEGNQLLL+YEYM+
Sbjct: 602 LLSDGTIIAVKQLSSKSKQGNREFVNEIGMISGLQHPNLVKLYGCCVEGNQLLLIYEYME 661

Query: 718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 777
           NNCLSRA+FGK++  RLKLDWPTR+KIC+G+ARGLAYLHE+S IKIVHRDIKTSNVLLDK
Sbjct: 662 NNCLSRALFGKNSTSRLKLDWPTRQKICLGVARGLAYLHEESIIKIVHRDIKTSNVLLDK 721

Query: 778 DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV 837
           DLNAKISDFGLAKL E++ THISTRIAGTIGYMAPEYAMRGYLT+KADVYSFGVV LEIV
Sbjct: 722 DLNAKISDFGLAKLNEDENTHISTRIAGTIGYMAPEYAMRGYLTNKADVYSFGVVALEIV 781

Query: 838 SGKSNTNYRPNEDFVYLLDWAYVLQEE 864
           SGKSNTNYRP E+FVYLLDWAYVLQE 
Sbjct: 782 SGKSNTNYRPKEEFVYLLDWAYVLQER 808

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485473|ref|XP_002278131.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650 [Vitis vinifera]

 Score = 1269 bits (3284), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 634/871 (72%), Positives = 726/871 (83%), Gaps = 32/871 (3%)

Query: 4   KALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS---SATCHVVTI- 59
           KALK IG +LGK+DW+FG DPCS +GNW  S ++KKG ES+VTCDC+   +A+CHVVT+ 
Sbjct: 31  KALKVIGTRLGKRDWDFGKDPCSGEGNWS-SVNEKKGVESSVTCDCTFHHNASCHVVTMV 89

Query: 60  -----ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 114
                ALKAQNL+G+LP ELSKL +LK LDLSRN  +GS   QWA+++LVELS+MGNRLS
Sbjct: 90  YVNCRALKAQNLSGSLPPELSKLYHLKHLDLSRNLFSGSIPSQWATMRLVELSLMGNRLS 149

Query: 115 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 174
           GPFPKVLTNITTL+NLSIEGNLF+G IPP+I KLI ++K++LSSN+FTGELP  L KLTN
Sbjct: 150 GPFPKVLTNITTLRNLSIEGNLFSGPIPPEIGKLIRIEKMVLSSNAFTGELPVALAKLTN 209

Query: 175 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 234
           L D+RI+DN+FSG+IPEFIG W  +QKLHIQGSSLEGPIP+SISALTSL+DLRISDLKG 
Sbjct: 210 LTDMRINDNHFSGRIPEFIGNWTHVQKLHIQGSSLEGPIPSSISALTSLSDLRISDLKGR 269

Query: 235 ESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 293
            S FP L  + +LKTL+L KCLIHGEIP+YIGDM KLK++DLSFN L G IPT+F++LAK
Sbjct: 270 GSTFPPLSTIESLKTLVLRKCLIHGEIPEYIGDMKKLKHLDLSFNELAGEIPTSFQELAK 329

Query: 294 TNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNK 353
           T+FMYLTGN LTG +P +I  +NKN D+S NNFTW+SS P+ECPRGSVNLVESYSS    
Sbjct: 330 TDFMYLTGNMLTGHIPDWILGTNKNFDLSYNNFTWDSSSPVECPRGSVNLVESYSSS--- 386

Query: 354 LDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKIN-TGHTKYEADMEARGASMFYSSGQY 412
                  +R+N          HY+LHINCGG + +  G TKYEAD+E  GASMFY  GQ 
Sbjct: 387 ------SVRRN----------HYSLHINCGGKETSINGSTKYEADLEPTGASMFYL-GQN 429

Query: 413 WAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNY 472
           WAFSSTG FMD+D D D YI  NTS+LS VS +D+ELY+ ARVSPLSLTYYGLCLGNGNY
Sbjct: 430 WAFSSTGNFMDNDVDGDAYIEANTSSLSNVSVLDVELYKKARVSPLSLTYYGLCLGNGNY 489

Query: 473 TVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVT 532
           TV+LHFAEIIF ND +FNSLG+RIFD+YIQ KLV KDFNIE EAGGTG PI+KNF AEVT
Sbjct: 490 TVKLHFAEIIFINDKSFNSLGERIFDVYIQGKLVLKDFNIEKEAGGTGKPIIKNFTAEVT 549

Query: 533 SHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASV 592
           SHTLK+  YWAGRGTTGIPLRG YGPLISAISV  NF+PP    K   + I+      +V
Sbjct: 550 SHTLKVQFYWAGRGTTGIPLRGFYGPLISAISVDPNFEPPSPPGKNWDIKIVVGAAAVAV 609

Query: 593 LLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFG 652
           +LVLL L I+  KG LGGK S DKELRGLDLQTGL+TLRQIKAAT NFD  NK+GEGGFG
Sbjct: 610 VLVLLTLGILWRKGWLGGKTSEDKELRGLDLQTGLFTLRQIKAATKNFDAENKLGEGGFG 669

Query: 653 SVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 712
           +V+KG LSDGTVIAVKQLSSKS+QGNREFVNE+GMISA QHPNLVKLYGCC+EGNQL LV
Sbjct: 670 AVFKGTLSDGTVIAVKQLSSKSKQGNREFVNEVGMISALQHPNLVKLYGCCIEGNQLSLV 729

Query: 713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 772
           YEYM+NN LSRA+FG+D  Y+LKL+W TR+ IC+GIARGLAYLHE+S +KIVHRDIKTSN
Sbjct: 730 YEYMENNSLSRALFGRDATYKLKLNWSTRQNICVGIARGLAYLHEESTLKIVHRDIKTSN 789

Query: 773 VLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVV 832
           VLLDKD+NAKISDFGLAKL E+D THISTRIAGTIGYMAPEYAMRGYLT KADVYSFGVV
Sbjct: 790 VLLDKDMNAKISDFGLAKLDEDDNTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVV 849

Query: 833 TLEIVSGKSNTNYRPNEDFVYLLDWAYVLQE 863
            LEIVSGKSNTNYRP E+FVYLLDWAYVLQE
Sbjct: 850 ALEIVSGKSNTNYRPKEEFVYLLDWAYVLQE 880

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356501491|ref|XP_003519558.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650-like [Glycine max]

 Score = 1231 bits (3184), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 598/866 (69%), Positives = 716/866 (82%), Gaps = 8/866 (0%)

Query: 4   KALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS---SATCHVVTIA 60
           KALK+IG K+GKKDW+FGVDPCS KGNW +S D +KGFES+V CDCS   +++CHVV+I+
Sbjct: 42  KALKEIGSKIGKKDWDFGVDPCSGKGNWNVS-DARKGFESSVICDCSFDHNSSCHVVSIS 100

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 120
           LKAQNL+G+L  + SKL +L++LDLSRN +TG+  PQW +++LVELS MGN+LSGPFPKV
Sbjct: 101 LKAQNLSGSLSPDFSKLHHLQELDLSRNIITGAIPPQWGTMRLVELSFMGNKLSGPFPKV 160

Query: 121 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 180
           LTNITTL+NLSIEGN F+G IP +I KL NL+KLILSSN FTG LP  L+KLT L DLRI
Sbjct: 161 LTNITTLRNLSIEGNQFSGHIPTEIGKLTNLEKLILSSNGFTGALPPTLSKLTKLIDLRI 220

Query: 181 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES-AFP 239
           SDNNF GKIP+FI  W  I+KLH+ G SLEGPIP+SISALT L+DLRI+DLKGS+S AFP
Sbjct: 221 SDNNFFGKIPDFISNWTLIEKLHMHGCSLEGPIPSSISALTRLSDLRIADLKGSKSSAFP 280

Query: 240 KLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 298
            L+ + ++KTL+L KC+I GEIP YIG M KLK +DLS+N L+G IP +F +L K +FMY
Sbjct: 281 PLNNLKSMKTLVLRKCMIKGEIPAYIGRMEKLKILDLSYNGLSGEIPESFAQLDKVDFMY 340

Query: 299 LTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 358
           LTGNKL+G +P ++  +NKN+DIS NNF+W+SS P ECPRGS+NLVESYSS  N  +K+H
Sbjct: 341 LTGNKLSGIIPGWVLANNKNIDISDNNFSWDSSSPTECPRGSINLVESYSSSVNTQNKIH 400

Query: 359 PCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSST 418
            CL++NFPC++  ++YHY+++INCGG + N     YEAD E +GA+M Y +GQ WA SST
Sbjct: 401 SCLKRNFPCTSSVNKYHYSMNINCGGNEANISGQIYEADREQKGAAMLYYTGQDWALSST 460

Query: 419 GKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHF 478
           G FMD+D D D Y+  NTS L+ VSA++ +LY TARVSPL+LTYYGLCL NGNYTV+LHF
Sbjct: 461 GNFMDNDIDSDPYVVANTSRLN-VSALNSQLYTTARVSPLALTYYGLCLINGNYTVKLHF 519

Query: 479 AEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKI 538
           AEIIF ND +  SLG+R+FD+YIQ  LV KDF+I+ EAGGTG PIVK   A VT HTL+I
Sbjct: 520 AEIIFINDRSLYSLGRRVFDVYIQGNLVLKDFDIQREAGGTGKPIVKTLNASVTQHTLEI 579

Query: 539 HLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLI 598
           H YWAG+GTTGIP RG YGPLISAISV  NFKPP    K+ + M+   IV   +++VLL+
Sbjct: 580 HFYWAGKGTTGIPTRGVYGPLISAISVNPNFKPPSGDGKRTYFMLAIGIVAGVLVVVLLV 639

Query: 599 LFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI 658
           L +MR  G LGGK    KELRG+DLQTGL+TLRQIKAAT NFD  NK+GEGGFG V+KG+
Sbjct: 640 LVLMRRMGWLGGKDPVYKELRGIDLQTGLFTLRQIKAATKNFDAENKIGEGGFGCVFKGL 699

Query: 659 LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 718
           LSDGT+IAVKQLSSKS+QGNREFVNE+G+IS  QHPNLVKLYGCCVEGNQL+L+YEYM+N
Sbjct: 700 LSDGTIIAVKQLSSKSKQGNREFVNEMGLISGLQHPNLVKLYGCCVEGNQLILIYEYMEN 759

Query: 719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD 778
           NCLSR +FG+D   + KLDWPTRKKIC+GIA+ LAYLHE+SRIKI+HRDIK SNVLLDKD
Sbjct: 760 NCLSRILFGRDPN-KTKLDWPTRKKICLGIAKALAYLHEESRIKIIHRDIKASNVLLDKD 818

Query: 779 LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            NAK+SDFGLAKL E+DKTHISTR+AGTIGYMAPEYAMRGYLT KADVYSFGVV LE VS
Sbjct: 819 FNAKVSDFGLAKLIEDDKTHISTRVAGTIGYMAPEYAMRGYLTDKADVYSFGVVALETVS 878

Query: 839 GKSNTNYRPNEDFVYLLDWAYVLQEE 864
           GKSNTN+RPNEDF YLLDWAYVLQE 
Sbjct: 879 GKSNTNFRPNEDFFYLLDWAYVLQER 904

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|317106662|dbj|BAJ53166.1| JHL10I11.12 [Jatropha curcas]

 Score = 1229 bits (3181), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 601/791 (75%), Positives = 678/791 (85%), Gaps = 6/791 (0%)

Query: 76  KLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 135
           KLR+L+ LDLSRNC TGS   QWA+L+LV LS MGNRLSG FPKVLTNITTL NLS+EGN
Sbjct: 1   KLRHLQLLDLSRNCFTGSIPSQWATLRLVNLSFMGNRLSGSFPKVLTNITTLTNLSVEGN 60

Query: 136 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGK 195
            F+GSIP +I KLINLQK ILSSN+FTG+LP EL+KLTNL D+RISDNNFSG IP FI K
Sbjct: 61  RFSGSIPREIGKLINLQKFILSSNAFTGKLPTELSKLTNLTDMRISDNNFSGTIPTFINK 120

Query: 196 WKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKC 254
           W  IQKLHIQGS LEGPIP+SISAL +L+DLRISDLKG  S FP L  M ++K LIL  C
Sbjct: 121 WTHIQKLHIQGSGLEGPIPSSISALKNLSDLRISDLKGKGSTFPPLSNMESIKALILRNC 180

Query: 255 LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN 314
           L+  EIP+YIG M KLKN+DLSFNNLTG IPT+F  L K +FMYLTGNKLTG VP+++  
Sbjct: 181 LLSDEIPEYIGHMKKLKNLDLSFNNLTGEIPTSFSYLGKADFMYLTGNKLTGSVPEWVLE 240

Query: 315 SNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQY 374
            NKNVDIS NNF+WESS PIECPRGSVNLVESYSS   KL KVH CL+QNFPCS+  ++ 
Sbjct: 241 RNKNVDISDNNFSWESSSPIECPRGSVNLVESYSSSTEKLSKVHSCLKQNFPCSS--NKK 298

Query: 375 HYTLHINCGGAK-INTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIR 433
           +Y+L+INCGG + I  G+T Y+AD+E RGASMFY+S Q WAFSSTG FMD++ D D YI+
Sbjct: 299 YYSLYINCGGEEMIAGGNTTYQADLEPRGASMFYTS-QSWAFSSTGNFMDNNIDSDPYIQ 357

Query: 434 TNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLG 493
            NTS +S VS+ D +LY TARVSP+SLTYYGLCL NGNYTV LHFAEI+F NDS+FNSLG
Sbjct: 358 INTSAISNVSSPDAQLYTTARVSPISLTYYGLCLINGNYTVNLHFAEIVFINDSSFNSLG 417

Query: 494 KRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLR 553
           +RIFD+YIQEKLV KDFNI +EAGGTG PIVK F   VTSHTLKIH YWAG+GTTGIP+R
Sbjct: 418 RRIFDVYIQEKLVLKDFNIVEEAGGTGRPIVKKFTVTVTSHTLKIHFYWAGKGTTGIPVR 477

Query: 554 GTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVS 613
           GTYGPLISAISV  NFKPP  + +K  +++ + + GA V LVLL+L IM  KGCLGGKV 
Sbjct: 478 GTYGPLISAISVDPNFKPPSDNDEKEKIIVSSTVAGA-VFLVLLVLCIMWRKGCLGGKVY 536

Query: 614 ADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK 673
           ADKELRGLDLQTG++TL+QIKAAT NFD ANKVGEGGFGSVYKG LSDGT+IAVKQLSSK
Sbjct: 537 ADKELRGLDLQTGIFTLKQIKAATKNFDAANKVGEGGFGSVYKGQLSDGTIIAVKQLSSK 596

Query: 674 SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR 733
           S+QGNREFVNEIGMISA QHPNLVKLYGCCVEGNQLLL+YEYM+NNCLSRA+FGK+   R
Sbjct: 597 SKQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLLLIYEYMENNCLSRALFGKNPTSR 656

Query: 734 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 793
           LKLDWPTR+KIC+G+ARGLAYLHE+S IKIVHRDIKTSNVL+DKDLNAKISDFGLAKL E
Sbjct: 657 LKLDWPTRQKICLGVARGLAYLHEESIIKIVHRDIKTSNVLIDKDLNAKISDFGLAKLNE 716

Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 853
           +D THISTR+AGTIGYMAPEYAMRGYLT+KADVYSFGVV LEIVSGKSNTNYRP E+FVY
Sbjct: 717 DDNTHISTRVAGTIGYMAPEYAMRGYLTNKADVYSFGVVALEIVSGKSNTNYRPKEEFVY 776

Query: 854 LLDWAYVLQEE 864
           LLDWAYVLQE 
Sbjct: 777 LLDWAYVLQER 787

Source: Jatropha curcas

Species: Jatropha curcas

Genus: Jatropha

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357494365|ref|XP_003617471.1| BED finger-nbs resistance protein [Medicago truncatula] gi|355518806|gb|AET00430.1| BED finger-nbs resistance protein [Medicago truncatula]

 Score = 1220 bits (3156), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 599/884 (67%), Positives = 704/884 (79%), Gaps = 25/884 (2%)

Query: 4   KALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS---SATCHVVTIA 60
           KALK+IG K+GKKDW+FGVDPCS KG W +S D +KGFES V C+CS   +++CHVV+I 
Sbjct: 37  KALKEIGNKIGKKDWDFGVDPCSGKGKWNVS-DSRKGFESAVICNCSFNHNSSCHVVSIF 95

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 120
           LKAQNL+GTL  E SKL +LK LDLSRN +TGS   QWA + LV+LS MGNR SGPFP V
Sbjct: 96  LKAQNLSGTLSPEFSKLPHLKILDLSRNIITGSIPQQWAKMNLVDLSFMGNRFSGPFPTV 155

Query: 121 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 180
           LTNITTLKNLSIEGN F+G IP DI KLINL+KL+L SN FTG LP+  +KLT LNDLRI
Sbjct: 156 LTNITTLKNLSIEGNQFSGFIPEDIGKLINLEKLVLQSNRFTGALPSAFSKLTKLNDLRI 215

Query: 181 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA-FP 239
           SDN+FSGKIP+FI KW  I+KLHI+G SLEGPIP+SISALT L+DLRI+DL+GS S+ FP
Sbjct: 216 SDNDFSGKIPDFISKWTLIEKLHIEGCSLEGPIPSSISALTVLSDLRITDLRGSRSSTFP 275

Query: 240 KLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 298
            L  M ++KTL+L KCLI GEIP+YIG+M KLK +DLSFN+L+G IP +F  L K +FMY
Sbjct: 276 PLSNMKSMKTLVLRKCLIKGEIPEYIGEMAKLKVLDLSFNSLSGKIPESFRDLDKVDFMY 335

Query: 299 LTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 358
           LT N L+G +P ++  +NKN+D+S NNF WESS P EC RGSVNLVESYS    K   +H
Sbjct: 336 LTRNNLSGTIPDWVLKNNKNIDVSYNNFEWESSSPTECQRGSVNLVESYSLSATKKSNIH 395

Query: 359 PCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSST 418
            CL++NFPC++  +  HY+L INCGG + N     Y AD+E +GASM Y S + WA SST
Sbjct: 396 SCLKRNFPCTS-KNPRHYSLRINCGGNEANVSGNIYTADIERKGASMLYISAEDWALSST 454

Query: 419 GKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHF 478
           G FMD+D D D YI TNTS+L  VS ++ +LY TARVSPLSLTYYGLC+ NGNYTV+LHF
Sbjct: 455 GSFMDNDIDSDPYIVTNTSSLQNVSVINSKLYTTARVSPLSLTYYGLCMINGNYTVQLHF 514

Query: 479 AEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKI 538
           AEIIF ND + NSLG+RIFD+YIQ KLV +DF+IE EAGG   PIVK F A VT +TLKI
Sbjct: 515 AEIIFINDRSLNSLGRRIFDVYIQGKLVLRDFDIEREAGGAEKPIVKKFNATVTENTLKI 574

Query: 539 HLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMA-AIVGASVLLVLL 597
             YWAG+GTTGIP RG YGPL+SAISV  NFKPP  H  +  V+++A  IV   + +VL+
Sbjct: 575 QFYWAGKGTTGIPTRGVYGPLVSAISVDPNFKPPSEHGNRTRVILLAVGIVCGFLAVVLI 634

Query: 598 ILFIMRWKGCLGGKVSADK-----------------ELRGLDLQTGLYTLRQIKAATNNF 640
           ++ +MR KG LGGK    K                 ELRG+DLQTGL+TLRQIK AT NF
Sbjct: 635 MVAVMRRKGLLGGKDPVYKGKVINFVIESKFPFFFSELRGIDLQTGLFTLRQIKVATKNF 694

Query: 641 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           D ANK+GEGGFGSVYKG LSDGTVIAVKQLSSKS+QGNREFVNEIGMIS  QHPNLVKL+
Sbjct: 695 DAANKLGEGGFGSVYKGQLSDGTVIAVKQLSSKSKQGNREFVNEIGMISGLQHPNLVKLH 754

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           GCCVEGNQL+L+YEYM+NNCLSR +FGK +E + KLDW TRKKIC+GIA+ LAYLHE+SR
Sbjct: 755 GCCVEGNQLILIYEYMENNCLSRILFGKGSESKKKLDWLTRKKICLGIAKALAYLHEESR 814

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
           IKI+HRDIK SNVLLDKD NAK+SDFGLAKL E+DKTH+STRIAGT+GYMAPEYAMRGYL
Sbjct: 815 IKIIHRDIKASNVLLDKDFNAKVSDFGLAKLIEDDKTHVSTRIAGTVGYMAPEYAMRGYL 874

Query: 821 TSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 864
           T KADVYSFGVV LEI+SGKSNTNYRP+++F YLLDWAYVLQE 
Sbjct: 875 TDKADVYSFGVVALEIISGKSNTNYRPDDEFFYLLDWAYVLQER 918

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|345651730|gb|AEO14875.1| rfls6 protein [Glycine max]

 Score = 1199 bits (3101), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 589/866 (68%), Positives = 703/866 (81%), Gaps = 7/866 (0%)

Query: 4   KALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS---SATCHVVTIA 60
           KALK+IG K+GKKDWNFGVDPCS KGNW +    K    S+V CDCS   +++CHVV+I 
Sbjct: 41  KALKEIGSKIGKKDWNFGVDPCSGKGNWNVPDARKAFVMSSVICDCSFNHNSSCHVVSIY 100

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 120
            KAQNL+G+L  E SKL YL++LDLSRN +TGS  PQW +++LVELS+MGN+LSGPFPKV
Sbjct: 101 WKAQNLSGSLSPEFSKLHYLQKLDLSRNIITGSIPPQWGTMRLVELSLMGNKLSGPFPKV 160

Query: 121 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 180
           LTNITTL+NLSIEGN F+G IP +I KL NL+KL+LSSN FTG LP  L+KLT L DLRI
Sbjct: 161 LTNITTLRNLSIEGNQFSGHIPTEIGKLTNLEKLVLSSNGFTGALPPVLSKLTKLIDLRI 220

Query: 181 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES-AFP 239
           SDNNF GKIP+FI  W  I+KLH+ G SLEGPIP+SISALT L+DLRI+DLKGS+S AFP
Sbjct: 221 SDNNFLGKIPDFISNWTLIEKLHMHGCSLEGPIPSSISALTRLSDLRITDLKGSKSSAFP 280

Query: 240 KLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 298
            L+ + ++KTL+L KC+I GEIP+YIG M KLK +DLS+N L+G IP +F +L K +FMY
Sbjct: 281 PLNNLKSMKTLVLRKCMIKGEIPEYIGRMEKLKILDLSYNGLSGEIPESFAQLDKVDFMY 340

Query: 299 LTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 358
           LTGNKL+G +P+++  +N+N+DIS NNF+W+SS P EC RGSVNLVESYSS  N   K++
Sbjct: 341 LTGNKLSGIIPRWVLANNENIDISDNNFSWDSSSPTECQRGSVNLVESYSSSVNTQTKIN 400

Query: 359 PCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSST 418
            CL++NF C+A   QY Y+L+INCGG + N     YEAD E +GA+M Y + Q WA SST
Sbjct: 401 SCLKKNFLCTASPSQYRYSLNINCGGNEANVSGNIYEADREQKGAAMLYYTSQDWALSST 460

Query: 419 GKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHF 478
           G F D+D D D YI  NTS L+ VSA++ +LY TARVSPL+LTYYGLCL NGNYTV+LHF
Sbjct: 461 GNFTDNDIDSDPYIVANTSRLN-VSALNSKLYTTARVSPLALTYYGLCLINGNYTVKLHF 519

Query: 479 AEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKI 538
           AEIIF ND + NSLG+R+FD+YIQ  LV KDF+I  EAGGTG  I K F A VT HTLKI
Sbjct: 520 AEIIFINDRSLNSLGRRVFDVYIQGNLVLKDFDIRREAGGTGKSIEKTFNASVTQHTLKI 579

Query: 539 HLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLI 598
           H YWAG+GTTGIP RG YGPL+SAISV  NFKPP    K+ ++++   IV   +++VLL+
Sbjct: 580 HFYWAGKGTTGIPTRGVYGPLVSAISVNPNFKPPSGEGKRTYLILAIIIVAGVLVVVLLV 639

Query: 599 LFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI 658
           L ++R  G LGGK    KELRG+DLQTGL+TLRQIKAAT NFD  NK+GEGGFG VYKG 
Sbjct: 640 LVLLRRMGWLGGKDPVYKELRGIDLQTGLFTLRQIKAATKNFDALNKIGEGGFGCVYKGQ 699

Query: 659 LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 718
            SDGT+IAVKQLSSKS+QGNREFVNE+G+IS  QHPNLVKLYGCCVEGNQL+L+YEYM+N
Sbjct: 700 QSDGTMIAVKQLSSKSKQGNREFVNEMGLISGLQHPNLVKLYGCCVEGNQLILIYEYMEN 759

Query: 719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD 778
           NCLSR +FG+D   + KLDWPTRKKIC+GIA+ LAYLHE+SRIKI+HRD+K SNVLLDKD
Sbjct: 760 NCLSRILFGRDPN-KTKLDWPTRKKICLGIAKALAYLHEESRIKIIHRDVKASNVLLDKD 818

Query: 779 LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            NAK+SDFGLAKL E++KTHISTR+AGTIGYMAPEYAMRGYLT KADVYSFGVV LE VS
Sbjct: 819 FNAKVSDFGLAKLIEDEKTHISTRVAGTIGYMAPEYAMRGYLTDKADVYSFGVVALETVS 878

Query: 839 GKSNTNYRPNEDFVYLLDWAYVLQEE 864
           GKSNT++RPNEDFVYLLDWAYVLQE 
Sbjct: 879 GKSNTDFRPNEDFVYLLDWAYVLQER 904

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297849060|ref|XP_002892411.1| hypothetical protein ARALYDRAFT_470791 [Arabidopsis lyrata subsp. lyrata] gi|297338253|gb|EFH68670.1| hypothetical protein ARALYDRAFT_470791 [Arabidopsis lyrata subsp. lyrata]

 Score = 1148 bits (2970), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 583/871 (66%), Positives = 693/871 (79%), Gaps = 16/871 (1%)

Query: 4   KALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS----SATCHVVTI 59
           +ALK+IG KLGKKDWNF  DPCS +GNW +++   K FESN+TCDCS    +++CHV+ I
Sbjct: 36  RALKEIGEKLGKKDWNFNKDPCSGEGNWVVTTYTTKEFESNITCDCSFLPPNSSCHVIRI 95

Query: 60  ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPK 119
           ALK+QNLTG +P+E SKLR+LK LDLSRN LTGS   +WAS++L +LS MGNRLSGPFPK
Sbjct: 96  ALKSQNLTGIVPSEFSKLRHLKVLDLSRNSLTGSIPKEWASMRLEDLSFMGNRLSGPFPK 155

Query: 120 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 179
           VLT ITTL+NLS+EGN F+G IPPDI KL++L+KL L SN+FTG L  +L  L NL D+R
Sbjct: 156 VLTRITTLRNLSLEGNQFSGPIPPDIGKLVHLEKLHLPSNAFTGPLTEKLGLLKNLTDMR 215

Query: 180 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 239
           ISDNNF+G IP+FIG W ++ KL + G  L+GPIP+SIS LTSLTDLRISDL G  S+FP
Sbjct: 216 ISDNNFTGPIPDFIGNWTRVMKLQMHGCGLDGPIPSSISTLTSLTDLRISDLGGKPSSFP 275

Query: 240 KLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 298
           +L  + ++KTLIL KC ++G IP YIGD+ KLK +DLSFN L+G IP++FEK+ K +F+Y
Sbjct: 276 QLKNLESIKTLILRKCNLNGPIPKYIGDLMKLKTLDLSFNLLSGEIPSSFEKMKKADFIY 335

Query: 299 LTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPI--ECPRGSVNLVESYSSPRNKLDK 356
           LTGNKLTG VP Y    NKNVD+S NNFT ESS P   +C R S N+VE ++   NK  K
Sbjct: 336 LTGNKLTGGVPNYFVERNKNVDVSYNNFTDESSIPKNGDCNRVSFNMVEGFA--LNKSHK 393

Query: 357 VHPCLRQNFPCSAPADQYHYTLHINCGGA--KINTGHTKYEADMEARGASMFYSSGQYWA 414
              C  Q+FPC+ P   + Y L+INCGG   K++ G T Y+ D E +GASM Y  G++WA
Sbjct: 394 NSTCFLQHFPCAHPKRHHTYKLYINCGGGEVKVDKGIT-YQTDDEPKGASM-YVLGKHWA 451

Query: 415 FSSTGKFMDDDTDLDNYIRTNTSTLS-KVSAVDLELYRTARVSPLSLTYYGLCLGNGNYT 473
            SSTG FMD+D D D+Y   NTS LS   S+   ELYRTARVSPLSLTYYGLCLGNGNYT
Sbjct: 452 LSSTGNFMDNDDDADDYTVQNTSRLSVNASSPSFELYRTARVSPLSLTYYGLCLGNGNYT 511

Query: 474 VRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTS 533
           V LHFAEIIF +D+T  SLGKR+FDIY+Q++LV K+FNI++ A G+G PI+K+F   VT 
Sbjct: 512 VNLHFAEIIFTDDNTLYSLGKRLFDIYVQDQLVIKNFNIQEAARGSGKPIIKSFMVNVTD 571

Query: 534 HTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVL 593
           HTLKI L WAG+GTTGIP+RG YGP+ISAISV+ NFKPPV +  K  ++     V A+ L
Sbjct: 572 HTLKIGLRWAGKGTTGIPIRGVYGPMISAISVEPNFKPPVYYDIKGIILKAGVPVAAATL 631

Query: 594 LVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGS 653
           L+ +I+ +  WK     K + DKELRGLDLQTG +TLRQIKAAT+NFD A K+GEGGFGS
Sbjct: 632 LLFIIVGVF-WKK-RRDKNAIDKELRGLDLQTGTFTLRQIKAATDNFDVAKKIGEGGFGS 689

Query: 654 VYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 713
           VYKG LS+G +IAVKQLS+KSRQGNREFVNEIGMISA QHPNLVKLYGCCVEGNQL+LVY
Sbjct: 690 VYKGELSEGKLIAVKQLSAKSRQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLILVY 749

Query: 714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV 773
           EY++NNCLSRA+FGKD   RLKLDW TRKKI +GIA+GL +LHE+SRIKIVHRDIK SNV
Sbjct: 750 EYLENNCLSRALFGKDESSRLKLDWSTRKKIFLGIAKGLTFLHEESRIKIVHRDIKASNV 809

Query: 774 LLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 833
           LLDKDLNAKISDFGLAKL ++  THISTRIAGTIGYMAPEYAMRGYLT KADVYSFGVV 
Sbjct: 810 LLDKDLNAKISDFGLAKLNDDGNTHISTRIAGTIGYMAPEYAMRGYLTEKADVYSFGVVA 869

Query: 834 LEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 864
           LEIVSGKSNTN+RP EDFVYLLDWAYVLQE 
Sbjct: 870 LEIVSGKSNTNFRPTEDFVYLLDWAYVLQER 900

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	869
TAIR|locus:2203718	1035	AT1G53440 [Arabidopsis thalian	0.975	0.819	0.556	9.3e-249
TAIR|locus:2019367	1078	AT1G29740 [Arabidopsis thalian	0.956	0.770	0.500	4e-209
TAIR|locus:2203847	1021	RKF1 "receptor-like kinase in	0.960	0.817	0.492	1.1e-208
TAIR|locus:2019317	969	AT1G29730 [Arabidopsis thalian	0.627	0.562	0.436	4.7e-207
TAIR|locus:2205250	1032	AT1G56130 [Arabidopsis thalian	0.964	0.812	0.434	9e-180
TAIR|locus:2009630	953	AT1G53420 [Arabidopsis thalian	0.929	0.847	0.459	1.4e-172
TAIR|locus:2205260	1047	AT1G56120 [Arabidopsis thalian	0.899	0.746	0.389	2.8e-137
UNIPROTKB|Q8RZV7	1294	P0413C03.22 "Putative extra sp	0.262	0.176	0.447	8.8e-83
TAIR|locus:2092810	1164	BRL3 "BRI1-like 3" [Arabidopsi	0.272	0.203	0.457	4.2e-80
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.261	0.190	0.467	5.7e-79

TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)]

 Score = 2396 (848.5 bits), Expect = 9.3e-249, P = 9.3e-249
 Identities = 484/869 (55%), Positives = 612/869 (70%)

Query:     4 KALKQIGRKLGKKDWNFGVDPC-SQKGNWELSSDDKKGFESNVTCDCS---SATCHVVTI 59
             + L+ I RKL  +  N     C  +K N+   S  K    SN+TCDC+   S+ C V  I
Sbjct:    35 QTLRTIFRKLQNQTVNIERTSCLDRKWNFVAESTSKLP-TSNITCDCTFNASSVCRVTNI 93

Query:    60 ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPK 119
              L+  NL G +P E   L  L ++DL  N L+G+     + + L  L+V GNRLSGPFP 
Sbjct:    94 QLRGFNLRGIIPPEFGNLTRLTEIDLVLNFLSGTIPTTLSQIPLEILAVTGNRLSGPFPP 153

Query:   120 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 179
              L  ITTL ++ +E NLFTG +PP++  L +L++L++SSN+ TG +P  L+ L NL + R
Sbjct:   154 QLGQITTLTDVIMESNLFTGQLPPNLGNLRSLKRLLISSNNITGRIPESLSNLKNLTNFR 213

Query:   180 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 239
             I  N+ SGKIP+FIG W ++ +L +QG+S+EGPIPASIS L +LT+LRI+DL+G  S FP
Sbjct:   214 IDGNSLSGKIPDFIGNWTRLVRLDLQGTSMEGPIPASISNLKNLTELRITDLRGPTSPFP 273

Query:   240 KLDKM-NLKTLILTKCLIHGEIPDYIG-DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 297
              L  M N++ L+L  CLI   IP+YIG  MT LK +DLS N L G IP TF  L   NFM
Sbjct:   274 DLQNMTNMERLVLRNCLIREPIPEYIGTSMTMLKLLDLSSNMLNGTIPDTFRSLNAFNFM 333

Query:   298 YLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKV 357
             YL  N LTGPVP++I +S +N+D+S NNFT   +  + C +  VNL+ SY S  N  + V
Sbjct:   334 YLNNNSLTGPVPQFILDSKQNIDLSYNNFTQPPT--LSCNQLDVNLISSYPSVTN--NSV 389

Query:   358 HPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSS 417
               CLR++ PC  P D +H +L INCGG ++     +Y  D+  RGAS F S  + W +SS
Sbjct:   390 QWCLRKDLPC--PGDAHHSSLFINCGGNRLKVDKDEYADDLNKRGASTFSSVSERWGYSS 447

Query:   418 TGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLH 477
             +G ++ +D     Y+ T+T  L   S    E Y+TAR++  SL YYGLC+  G+Y V+L+
Sbjct:   448 SGAWLGNDGA--TYLATDTFNLINESTP--EYYKTARLASQSLKYYGLCMRRGSYKVQLY 503

Query:   478 FAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFP-AEVTSHTL 536
             FAEI+F ND T++SLG+R+FDIY+Q  L+++DFNI   AGG G P ++     +V   TL
Sbjct:   504 FAEIMFSNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKPFLRQVDEVQVNGSTL 563

Query:   537 KIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVL 596
             +IHL W G+GT  IP RG YGPLISAI+V  NFK        N V +   ++ A V   L
Sbjct:   564 EIHLKWTGKGTNVIPTRGVYGPLISAITVTPNFKVDTGKPLSNGV-VAGIVIAACVAFGL 622

Query:   597 LILFIMRWKGCLGGK-VSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY 655
             L+L I+R  G LGGK V  ++ELRGLDLQTG +TL+QIK ATNNFDP NK+GEGGFG VY
Sbjct:   623 LVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVY 682

Query:   656 KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 715
             KG+L+DG  IAVKQLSSKS+QGNREFV EIGMISA QHPNLVKLYGCC+EG +LLLVYEY
Sbjct:   683 KGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEY 742

Query:   716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 775
             ++NN L+RA+FG + + RL LDW TR K+CIGIA+GLAYLHE+SR+KIVHRDIK +NVLL
Sbjct:   743 LENNSLARALFGTEKQ-RLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLL 801

Query:   776 DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLE 835
             D  LNAKISDFGLAKL EE+ THISTRIAGTIGYMAPEYAMRGYLT KADVYSFGVV LE
Sbjct:   802 DLSLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLE 861

Query:   836 IVSGKSNTNYRPNEDFVYLLDWAYVLQEE 864
             IVSGKSNTNYRP E+F+YLLDWAYVLQE+
Sbjct:   862 IVSGKSNTNYRPKEEFIYLLDWAYVLQEQ 890

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)]

 Score = 2022 (716.8 bits), Expect = 4.0e-209, P = 4.0e-209
 Identities = 443/885 (50%), Positives = 570/885 (64%)

Query:     4 KALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDD-KKGFESNVTCDC---SSATCHVVTI 59
             +ALK I   LG K  N   DPC  K    ++ D  K+G  S + CDC   ++ TCH+   
Sbjct:    45 EALKDIALTLGVKHLNLSEDPCLTK-TLVITQDVLKEGQNSTIRCDCHFNNNNTCHITHF 103

Query:    60 ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFP 118
              LK  +L G LP E SKLRYL+ +DL RN L GS   +WASL  L  +SV  NRL+G  P
Sbjct:   104 VLKTFSLPGRLPPEFSKLRYLEFIDLCRNYLYGSIPMEWASLPYLKSISVCANRLTGDIP 163

Query:   119 KVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDL 178
             K L     L  L +E N F+G+IP ++  L+NL+ L  SSN   G +P  L +L  L +L
Sbjct:   164 KGLGKFINLTQLGLEANQFSGTIPKELGNLVNLEGLAFSSNQLVGGVPKTLARLKKLTNL 223

Query:   179 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF 238
             R SDN  +G IPEFIG   K+Q+L +  S L+ PIP SI  L +L DLRISD        
Sbjct:   224 RFSDNRLNGSIPEFIGNLSKLQRLELYASGLKDPIPYSIFRLENLIDLRISDTAAGLGQV 283

Query:   239 PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 298
             P +   +LK L+L    + G IP  + D+  L  +DLSFN LTG +P      +   + Y
Sbjct:   284 PLITSKSLKFLVLRNMNLTGPIPTSLWDLPNLMTLDLSFNRLTGEVPAD---ASAPKYTY 340

Query:   299 LTGNKLTGPVPKYIF-NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPR--NKLD 355
             L GN L+G V    F  ++ N+D+S NNFTW  S    C     N + +Y+S R  N L 
Sbjct:   341 LAGNMLSGKVESGPFLTASTNIDLSYNNFTWSQS----CKER--NNINTYASSRSTNSLT 394

Query:   356 KVHPCLRQNFPCSAPADQYHYTLHINCGGAKI---NT-GHTKYEADMEARGASMFYSSGQ 411
             ++ PC   N  C      Y+ +LHINCGG  +   N+ G   YE D      S     G+
Sbjct:   395 RLLPCSAINL-CQ----NYNRSLHINCGGPDVTIENSRGRFLYEGDNYGLTGSATNYYGK 449

Query:   412 YWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGN 471
              W FS+TG FMDD    D Y     S+ S VSA   +LY+ AR SPLSL Y+ +C  NG+
Sbjct:   450 NWGFSNTGDFMDDAITEDTY---TVSSESAVSAKYPDLYQNARRSPLSLAYFAICFENGS 506

Query:   472 YTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEV 531
             Y V+LHFAEI F ++  F+ L KR+F+IY+Q KL+ +DF+I +EA GT   ++K     V
Sbjct:   507 YNVKLHFAEIQFSDEEPFSRLAKRVFNIYVQGKLIWEDFSIREEANGTHKEVIKEVNTTV 566

Query:   532 TSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISV----KSNFKPPV-VH--SKKNHVMIM 584
             T +TL+I LYWAG+GTT IP RG YG LISAISV    +S    PV +H  +K+ H    
Sbjct:   567 TDNTLEIRLYWAGKGTTIIPKRGNYGSLISAISVCPSSESECGVPVQIHPVTKQQHKQRK 626

Query:   585 A-AIVGASVLLV---LLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNF 640
                I+G + L+V    LIL  + W+ C+    +AD E RG       ++LRQ+K AT++F
Sbjct:   627 YHLILGIAALIVSLSFLILGALYWRICVS---NADGEKRGS------FSLRQLKVATDDF 677

Query:   641 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLY 700
             +P NK+GEGGFGSVYKG L +GT+IAVK+LSSKS QGN+EF+NEIG+I+  QHPNLVKLY
Sbjct:   678 NPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGIIACLQHPNLVKLY 737

Query:   701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
             GCCVE  QLLLVYEY++NNCL+ A+FG+     LKLDW TR KIC+GIARGLA+LHEDS 
Sbjct:   738 GCCVEKTQLLLVYEYLENNCLADALFGRSG---LKLDWRTRHKICLGIARGLAFLHEDSA 794

Query:   761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
             +KI+HRDIK +N+LLDKDLN+KISDFGLA+L+E+D++HI+TR+AGTIGYMAPEYAMRG+L
Sbjct:   795 VKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVAGTIGYMAPEYAMRGHL 854

Query:   821 TSKADVYSFGVVTLEIVSGKSNTNYRP-NEDFVYLLDWAYVLQEE 864
             T KADVYSFGVV +EIVSGKSN NY P NE  V LLDWA+VLQ++
Sbjct:   855 TEKADVYSFGVVAMEIVSGKSNANYTPDNECCVGLLDWAFVLQKK 899

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2203847 RKF1 "receptor-like kinase in flowers 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 2018 (715.4 bits), Expect = 1.1e-208, P = 1.1e-208
 Identities = 428/869 (49%), Positives = 567/869 (65%)

Query:     5 ALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSAT---CHVVTIAL 61
             AL+QI   LG K W F  + C  +    L+       +  + C+CS      CHVV  A 
Sbjct:    49 ALQQIATTLGSKFWKFDAENCKIE-MVGLTETPPPTAKQEIECECSPTNDTDCHVVKFAF 107

Query:    62 KAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVL 121
             K  NL GTLP ++ KL YL+++DL+ N + G+   +WAS  L  +S++ NRLSG  PK  
Sbjct:   108 KDHNLPGTLP-QIVKLPYLREIDLAYNYINGTLPREWASSNLTFISLLVNRLSGEIPKEF 166

Query:   122 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 181
              N ++L  L +E N F+G+IP ++  L++L+KL+LSSN  TG LPA L +L N+ D RI+
Sbjct:   167 GN-SSLTYLDLESNAFSGTIPQELGNLVHLKKLLLSSNKLTGTLPASLARLQNMTDFRIN 225

Query:   182 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 241
             D   SG IP +I  WK++++L +  S L GPIP+ IS L++L +LRISD++G    FP L
Sbjct:   226 DLQLSGTIPSYIQNWKQLERLEMIASGLTGPIPSVISVLSNLVNLRISDIRGPVQPFPSL 285

Query:   242 DKMN-LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLT 300
               +  L  +IL  C I G+IP Y+  + +L+ +DLSFN L GGIP+ F +     F+ L 
Sbjct:   286 KNVTGLTKIILKNCNISGQIPTYLSHLKELETLDLSFNKLVGGIPS-FAQAENLRFIILA 344

Query:   301 GNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIEC-PRGSVNLVESYSSPRNKLDKVHP 359
             GN L G  P  +      VD+S NN  W+S +   C P  ++NL    S+   K  K  P
Sbjct:   345 GNMLEGDAPDELLRDGITVDLSYNNLKWQSPESRACRPNMNLNLNLFQSTSTKKSSKFLP 404

Query:   360 CLRQNFPCSAPADQYHYTLHINCGGAK--INTGHTK--YEAD--MEARGASMFYSSGQYW 413
             C++ +F C  P  +Y   LH+NCGG+   +    TK  YE D  +E   A  F      W
Sbjct:   405 CIK-DFKC--P--RYSSCLHVNCGGSDMYVKEKKTKELYEGDGNVEGGAAKYFLKPDANW 459

Query:   414 AFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYT 473
              FSSTG FMDD+    N+  T   T+   ++   +LY++AR++P+SLTY+  CL NGNYT
Sbjct:   460 GFSSTGDFMDDN----NFQNTRF-TMFVPASNQSDLYKSARIAPVSLTYFHACLENGNYT 514

Query:   474 VRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTS 533
             + L FAEI F ND  +N LG+R+FDIYIQEKLV KDFNI DEA G   PI+K   A VT+
Sbjct:   515 INLDFAEIRFTNDENYNRLGRRLFDIYIQEKLVAKDFNIMDEAKGAQTPIIKPLTAYVTN 574

Query:   534 HTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAI---VGA 590
             H L I L WAG+GTT IP RG YGP+ISAIS+ S+ KP      K  +   A I   +GA
Sbjct:   575 HFLTIRLSWAGKGTTRIPTRGVYGPIISAISIVSDSKP--CERPKTGMSPGAYIAIGIGA 632

Query:   591 SVLLVLLILFIMRWK-GCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEG 649
               L++ ++ F+  W  GCL       K+    +L +G +TLRQIK AT++F+P NK+GEG
Sbjct:   633 PCLIIFILGFL--WICGCLPRCGRQRKDPYEEELPSGTFTLRQIKFATDDFNPTNKIGEG 690

Query:   650 GFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 709
             GFG+V+KG+L+DG V+AVKQLSSKSRQGNREF+NEIG IS  QHPNLVKL+G CVE  QL
Sbjct:   691 GFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAISCLQHPNLVKLHGFCVERAQL 750

Query:   710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK 769
             LL YEYM+NN LS A+F    + ++ +DWPTR KIC GIA+GLA+LHE+S +K VHRDIK
Sbjct:   751 LLAYEYMENNSLSSALFSPKHK-QIPMDWPTRFKICCGIAKGLAFLHEESPLKFVHRDIK 809

Query:   770 TSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSF 829
              +N+LLDKDL  KISDFGLA+L EE+KTHIST++AGTIGYMAPEYA+ GYLT KADVYSF
Sbjct:   810 ATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAPEYALWGYLTFKADVYSF 869

Query:   830 GVVTLEIVSGKSNTNYRPNEDFVYLLDWA 858
             GV+ LEIV+G +N+N+    D V LL++A
Sbjct:   870 GVLVLEIVAGITNSNFMGAGDSVCLLEFA 898

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)]

 Score = 1060 (378.2 bits), Expect = 4.7e-207, Sum P(2) = 4.7e-207
 Identities = 250/573 (43%), Positives = 325/573 (56%)

Query:     4 KALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDC---SSATCHVVTIA 60
             +ALK I   LG K  N   DPC  K         K+G  S + CDC   + +TCH+    
Sbjct:    45 EALKDITETLGVKHLNLSEDPCLTKTLVISQGVLKEGQNSTIRCDCHFNNYSTCHIKHFV 104

Query:    61 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPK 119
             L+  NL G LP  L K R+L+ +DL  N L GS   +WASL  L  +SV  NRLSG  PK
Sbjct:   105 LQKFNLPGRLPPMLYKFRHLESIDLYNNYLYGSIPMEWASLPYLKSISVCANRLSGDIPK 164

Query:   120 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 179
              L     L  L +E N F+G+IP ++  L+NLQ L LSSN   G LP  L KLT L +L 
Sbjct:   165 GLGKFINLTLLVLEANQFSGTIPKELGNLVNLQGLGLSSNQLVGGLPKTLAKLTKLTNLH 224

Query:   180 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 239
             +SDN  +G IPEFIGK  K+Q+L +  S L GPIP SI  L +L D+RISD        P
Sbjct:   225 LSDNRLNGSIPEFIGKLPKLQRLELYASGLRGPIPDSIFHLENLIDVRISDTVAGLGHVP 284

Query:   240 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 299
             ++   +LK L+L    + G IP  I D+  L  +DLSFN LTG IP  +    K  + YL
Sbjct:   285 QITSTSLKYLVLRNINLSGPIPTSIWDLPSLMTLDLSFNRLTGEIPA-YATAPK--YTYL 341

Query:   300 TGNKLTGPVPKYIF-NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 358
              GN L+G V    F  ++ N+D+S NNFTW    P+   R ++N  ES S  +N+L ++ 
Sbjct:   342 AGNMLSGKVETGAFLTASTNIDLSYNNFTWS---PMCKERKNINTYES-SHSKNRLTRLL 397

Query:   359 PC--LRQNFPCSAPADQYHYTLHINCGGAKI---NT-GHTKYEADMEARGASMFYSSGQY 412
             PC  ++Q   C      Y  +LHINCGG  +   N+ G   YE D      S      + 
Sbjct:   398 PCSAIKQ---CQ----NYSRSLHINCGGPDVTIENSRGRFLYEGDNYGLTGSATNYYRKN 450

Query:   413 WAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNY 472
             W +S+TG FMDD    D Y     S+ S VSA   +LY+ AR SPLSL YY  C  NG+Y
Sbjct:   451 WGYSNTGDFMDDAITEDTY---TVSSESAVSAKYPDLYQNARRSPLSLAYYAFCFENGSY 507

Query:   473 TVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVT 532
              V+LHFAEI F +   +  L KR+F+IYIQ KL+ +DF+I +EA GT   +++     VT
Sbjct:   508 NVKLHFAEIQFSDVEPYTKLAKRVFNIYIQGKLIWEDFSIREEANGTHKEVIREVNTTVT 567

Query:   533 SHTLKIHLYWAGRGTTGIPLRGTYGPLISAISV 565
              +TL+I LYWAG+GT  IP RG YG LISA+SV
Sbjct:   568 DNTLEIRLYWAGKGTMIIPQRGYYGSLISAVSV 600

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)]

 Score = 1745 (619.3 bits), Expect = 9.0e-180, P = 9.0e-180
 Identities = 378/869 (43%), Positives = 534/869 (61%)

Query:    16 KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPT 72
             ++WN   + CS         D    +   + CDCS   S  C +  I + A ++ G +P 
Sbjct:    58 REWNISGELCSGAAIDASVLDSNPAYNPLIKCDCSFQNSTICRITNIKVYAIDVVGPIPP 117

Query:    73 ELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMG-NRLSGPFPKVLTNITTLKNLS 131
             EL  L YL  L+L +N LTGS  P   +L  ++    G N LSGP PK +  +T L+ L 
Sbjct:   118 ELWTLTYLTNLNLGQNVLTGSLPPAIGNLTRMQWMTFGINALSGPVPKEIGLLTDLRLLG 177

Query:   132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 191
             I  N F+GSIP +I +   LQ++ + S+  +G +P     L  L    I+D   + +IP+
Sbjct:   178 ISSNNFSGSIPDEIGRCTKLQQMYIDSSGLSGRIPLSFANLVQLEQAWIADLEVTDQIPD 237

Query:   192 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL-DKMNLKTLI 250
             FIG W K+  L I G+ L GPIP+S S LTSLT+LR+ D+    S+   + D  +L  L+
Sbjct:   238 FIGDWTKLTTLRIIGTGLSGPIPSSFSNLTSLTELRLGDISSGSSSLDFIKDMKSLSVLV 297

Query:   251 LTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK 310
             L    + G IP  IG+ + L+ +DLSFN L G IP +   L++   ++L  N L G  P 
Sbjct:   298 LRNNNLTGTIPSTIGEHSSLRQVDLSFNKLHGPIPASLFNLSQLTHLFLGNNTLNGSFPT 357

Query:   311 YIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP---CLRQNFPC 367
                 S +NVD+S N+ +      +  P   +NLV +  +     ++V P   CL++NFPC
Sbjct:   358 QKTQSLRNVDVSYNDLSGSLPSWVSLPSLKLNLVANNFTLEGLDNRVLPGLNCLQKNFPC 417

Query:   368 SAPADQYHYTLHINCGGA-KINTGHTKYEADMEARG-ASMFYSSGQYWAFSSTGKFMDDD 425
             +     Y     INCGG  K +     +E + E  G AS F S+GQ WA SS G F    
Sbjct:   418 NRGKGIYS-DFSINCGGPEKRSVTGALFEREDEDFGPASFFVSAGQRWAASSVGLFAGSS 476

Query:   426 TDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEI--IF 483
              ++  YI T+ S    V+ +D EL+++AR+S  S+ YYGL L NG YTV L FAEI  + 
Sbjct:   477 NNI--YIATSQSQF--VNTLDSELFQSARLSASSVRYYGLGLENGGYTVTLQFAEIQILG 532

Query:   484 KNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKN-FPAEVTSHTLKIHLYW 542
                +T+  LG+R FDIY+Q +LV+KDF++   AG + +  V+  + A V+ + L++HL+W
Sbjct:   533 STSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQRVYKANVSENHLEVHLFW 592

Query:   543 AGRGTTGIPLRGTYGPLISAISVKSNFKPPVVH---SK-KNHV-MIMAAIVGASVLLVL- 596
             AG+GT  IP++G YGPLISA+S   +F P V +   SK KN    I+  IVG  +L +L 
Sbjct:   593 AGKGTCCIPIQGAYGPLISAVSATPDFTPTVANKPPSKGKNRTGTIVGVIVGVGLLSILA 652

Query:   597 -LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY 655
              +++F +R +     + + D+EL G+D++  ++T  ++K+AT +FDP+NK+GEGGFG VY
Sbjct:   653 GVVMFTIRKRR---KRYTDDEELLGMDVKPYIFTYSELKSATQDFDPSNKLGEGGFGPVY 709

Query:   656 KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 715
             KG L+DG V+AVK LS  SRQG  +FV EI  IS+  H NLVKLYGCC EG   +LVYEY
Sbjct:   710 KGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEY 769

Query:   716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 775
             + N  L +A+FG  T   L LDW TR +IC+G+ARGL YLHE++ ++IVHRD+K SN+LL
Sbjct:   770 LPNGSLDQALFGDKT---LHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILL 826

Query:   776 DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLE 835
             D  L  +ISDFGLAKLY++ KTHISTR+AGTIGY+APEYAMRG+LT K DVY+FGVV LE
Sbjct:   827 DSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALE 886

Query:   836 IVSGKSNTNYRPNEDFVYLLDWAYVLQEE 864
             +VSG+ N++    E+  YLL+WA+ L E+
Sbjct:   887 LVSGRPNSDENLEEEKKYLLEWAWNLHEK 915

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=ISS

TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)]

 Score = 1677 (595.4 bits), Expect = 1.4e-172, P = 1.4e-172
 Identities = 387/843 (45%), Positives = 502/843 (59%)

Query:    41 FESNVTCDCSSATCH-VVTIALKAQNLTGTL-PTELSKLRYLKQLDLSRNC----LTGSF 94
             F S+ T          VV   LK  N+   + P E+S     +   +SRN     L GS 
Sbjct:    21 FASSATLPTQEGEAFKVVLTTLKKTNIDLNVDPCEVSSTGN-EWSTISRNLKRENLQGSL 79

Query:    95 SPQWASLQLV-ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 153
               +   L L+ E+ +  N L+G  P     +  L N+ + GN  TG IP +   +  L  
Sbjct:    80 PKELVGLPLLQEIDLSRNYLNGSIPPEW-GVLPLVNIWLLGNRLTGPIPKEFGNITTLTS 138

Query:   154 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 213
             L+L +N  +GELP EL  L N+  + +S NNF+G+IP    K   ++   +  + L G I
Sbjct:   139 LVLEANQLSGELPLELGNLPNIQQMILSSNNFNGEIPSTFAKLTTLRDFRVSDNQLSGTI 198

Query:   214 PASISALTSLTDLRI--SDLKGS-ESAFPKLDKMNLKTLILTKCLIHG-EIP-DYIGDMT 268
             P  I   T L  L I  S L G    A   L  + LK L ++   ++G E P   + ++ 
Sbjct:   199 PDFIQKWTKLERLFIQASGLVGPIPIAIASL--VELKDLRISD--LNGPESPFPQLRNIK 254

Query:   269 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW 328
             K++ + L   NLTG +P    K+    F+ L+ NKL+G +P    N      I       
Sbjct:   255 KMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYINLRDGGYIYFTGNML 314

Query:   329 ESSDPIECPRGSVNLVESYSS----PRN---KLDKVHPCLRQNFPCSAPADQYHYTLHIN 381
               S P         +  SY++    P N   K + V  C+R N+ C    +     LHIN
Sbjct:   315 NGSVPDWMVNKGYKIDLSYNNFSVDPTNAVCKYNNVLSCMR-NYQCPKTFN----ALHIN 369

Query:   382 CGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSK 441
             CGG +++   T YE+D   R  S +Y S   W  ++ G F+DD    +    T  S  S+
Sbjct:   370 CGGDEMSINGTIYESDKYDRLES-WYESRNGWFSNNVGVFVDDKHVPERV--TIESNSSE 426

Query:   442 VSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYI 501
             ++ VD  LY  AR+S +SLTYY LCL NGNY V LHFAEI+F  ++ + SLG+R FDIYI
Sbjct:   427 LNVVDFGLYTQARISAISLTYYALCLENGNYNVNLHFAEIMFNGNNNYQSLGRRFFDIYI 486

Query:   502 QEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLIS 561
             Q KL  KDFNI  EA   G  ++K FP E+    L+I LYWAGRGTT IP    YGPLIS
Sbjct:   487 QRKLEVKDFNIAKEAKDVGNVVIKTFPVEIKDGKLEIRLYWAGRGTTVIPKERVYGPLIS 546

Query:   562 AISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGL 621
             AISV S+  P   +      +    ++  S+ +V L+   +  KG L  K   +K+ + L
Sbjct:   547 AISVDSSVNPSPRNGMSTGTLHTLVVI-LSIFIVFLVFGTLWKKGYLRSKSQMEKDFKSL 605

Query:   622 DLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREF 681
             +L    ++LRQIK ATNNFD AN++GEGGFG VYKG L DGT+IAVKQLS+ S+QGNREF
Sbjct:   606 ELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREF 665

Query:   682 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 741
             +NEIGMISA  HPNLVKLYGCCVEG QLLLVYE+++NN L+RA+FG   E +L+LDWPTR
Sbjct:   666 LNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQ-ETQLRLDWPTR 724

Query:   742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
             +KICIG+ARGLAYLHE+SR+KIVHRDIK +NVLLDK LN KISDFGLAKL EED THIST
Sbjct:   725 RKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHIST 784

Query:   802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVL 861
             RIAGT GYMAPEYAMRG+LT KADVYSFG+V LEIV G+SN   R   +  YL+DW  VL
Sbjct:   785 RIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVL 844

Query:   862 QEE 864
             +E+
Sbjct:   845 REK 847

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)]

 Score = 1344 (478.2 bits), Expect = 2.8e-137, P = 2.8e-137
 Identities = 324/831 (38%), Positives = 480/831 (57%)

Query:    57 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSG 115
             +T  + A  L+G +P E+  L  L+ L +S N  +GS   +  S  +L ++ +  + LSG
Sbjct:   127 MTFGINA--LSGPIPKEIGLLTDLRLLGISSNNFSGSLPAEIGSCTKLQQMYIDSSGLSG 184

Query:   116 PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNL 175
               P    N   L+   I     TG IP  I     L  L +     +G +P+  + L  L
Sbjct:   185 GIPLSFANFVELEVAWIMDVELTGRIPDFIGFWTKLTTLRILGTGLSGPIPSSFSNLIAL 244

Query:   176 NDLRISD-NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL--TDLRISDLK 232
              +LR+ D +N S  + +FI   K +  L ++ ++L G IP++I   TSL   DL  + L 
Sbjct:   245 TELRLGDISNGSSSL-DFIKDMKSLSVLVLRNNNLTGTIPSTIGGYTSLQQVDLSFNKLH 303

Query:   233 GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE--- 289
             G   A    +   L  L L    ++G +P   G    L N+D+S+N+L+G +P+      
Sbjct:   304 GPIPA-SLFNLSRLTHLFLGNNTLNGSLPTLKGQ--SLSNLDVSYNDLSGSLPSWVSLPD 360

Query:   290 ---KLAKTNFMY--LTGNKLTG-PVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNL 343
                 L   NF    L    L+G    +  F  N+   I   N       P +     +N 
Sbjct:   361 LKLNLVANNFTLEGLDNRVLSGLHCLQKNFPCNRGEGICKCN----KKIPSQIMFSMLN- 415

Query:   344 VESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINT--GHTKYEADMEAR 401
             V++Y    N L + + C +  F      D   Y   INCGG +I +  G    + D +  
Sbjct:   416 VQTYGQGSNVLLEKN-CFK-TFAIDWCLD---YNFSINCGGPEIRSVSGALFEKEDADLG 470

Query:   402 GASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLT 461
              AS   S+ + WA SS G F     ++  YI T+ +    ++ +D EL+++AR+S  SL 
Sbjct:   471 PASFVVSAAKRWAASSVGNFAGSSNNI--YIATSLAQF--INTMDSELFQSARLSASSLR 526

Query:   462 YYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGI 521
             YYGL L NG YTV L FAE+  +  +++  +G+R F+IY+Q +LV+KDF+I   AGG+ +
Sbjct:   527 YYGLGLENGGYTVTLQFAEVQIEGSNSWKGIGRRRFNIYVQGRLVEKDFDIRRTAGGSSV 586

Query:   522 PIV-KNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVH---SK 577
               V + +   V+ + L++HL+WAG+GT  IP++G YGPLI+A+S   +F P V +   SK
Sbjct:   587 RAVQREYKTNVSENHLEVHLFWAGKGTCCIPIQGAYGPLIAAVSATPDFTPTVANRPPSK 646

Query:   578 -KNHV-MIMAAIVGASVLLVL--LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQI 633
              K+    I+  IVG  +L +   +++ ++R +       + D+E+  +D++   +T  ++
Sbjct:   647 GKSRTGTIVGVIVGVGLLSIFAGVVILVIRKRR---KPYTDDEEILSMDVKPYTFTYSEL 703

Query:   634 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH 693
             K AT +FD +NK+GEGGFG+VYKG L+DG  +AVKQLS  SRQG  +FV EI  IS+  H
Sbjct:   704 KNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQFVAEIIAISSVLH 763

Query:   694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
              NLVKLYGCC EG+  LLVYEY+ N  L +A+FG  +   L LDW TR +IC+G+ARGL 
Sbjct:   764 RNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKS---LHLDWSTRYEICLGVARGLV 820

Query:   754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
             YLHE++ ++I+HRD+K SN+LLD +L  K+SDFGLAKLY++ KTHISTR+AGTIGY+APE
Sbjct:   821 YLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPE 880

Query:   814 YAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 864
             YAMRG+LT K DVY+FGVV LE+VSG+ N++    E   YLL+WA+ L E+
Sbjct:   881 YAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHEK 931

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 509 (184.2 bits), Expect = 8.8e-83, Sum P(2) = 8.8e-83
 Identities = 103/230 (44%), Positives = 145/230 (63%)

Query:   629 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-QGNREFVNEIGM 687
             T   I  AT NF   + +G+GGFG+VYK  L +G  +A+K+L    + QG+REF+ E+  
Sbjct:   991 TADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQFQGDREFLAEMET 1050

Query:   688 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 747
             I   +HPNLV L G CV G++  L+YEYM+N  L   +  +       L WP R KIC+G
Sbjct:  1051 IGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEA-LGWPDRLKICLG 1109

Query:   748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
              ARGLA+LH      I+HRD+K+SN+LLD++   ++SDFGLA++    +TH+ST IAGT 
Sbjct:  1110 SARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACETHVSTDIAGTF 1169

Query:   808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDW 857
             GY+ PEY +    T+K DVYSFGVV LE+++G+  T     +    L+ W
Sbjct:  1170 GYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQEEVQGGGNLVGW 1219

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0009554 "megasporogenesis" evidence=IMP

GO:0009556 "microsporogenesis" evidence=IMP

GO:0048658 "tapetal layer development" evidence=IMP

TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 516 (186.7 bits), Expect = 4.2e-80, Sum P(2) = 4.2e-80
 Identities = 109/238 (45%), Positives = 148/238 (62%)

Query:   629 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 688
             T   +  ATN F   + +G GGFG VYK  L+DG+V+A+K+L   + QG+REF+ E+  I
Sbjct:   847 TFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEMETI 906

Query:   689 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 748
                +H NLV L G C  G + LLVYEYMK   L   +  K  +  + LDW  RKKI IG 
Sbjct:   907 GKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIGA 966

Query:   749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS-TRIAGTI 807
             ARGLA+LH      I+HRD+K+SNVLLD+D  A++SDFG+A+L     TH+S + +AGT 
Sbjct:   967 ARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGTP 1026

Query:   808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEE 865
             GY+ PEY      T+K DVYS+GV+ LE++SGK   +     +   L+ WA  L  E+
Sbjct:  1027 GYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWAKQLYREK 1084

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 513 (185.6 bits), Expect = 5.7e-79, Sum P(2) = 5.7e-79
 Identities = 108/231 (46%), Positives = 143/231 (61%)

Query:   630 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMIS 689
             L  I  AT++F   N +G+GGFG+VYK  L     +AVK+LS    QGNREF+ E+  + 
Sbjct:   907 LGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLG 966

Query:   690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
               +HPNLV L G C    + LLVYEYM N  L   +  +     + LDW  R KI +G A
Sbjct:   967 KVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEV-LDWSKRLKIAVGAA 1025

Query:   750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
             RGLA+LH      I+HRDIK SN+LLD D   K++DFGLA+L    ++H+ST IAGT GY
Sbjct:  1026 RGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGY 1085

Query:   810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT--NYRPNEDFVYLLDWA 858
             + PEY      T+K DVYSFGV+ LE+V+GK  T  +++ +E    L+ WA
Sbjct:  1086 IPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGG-NLVGWA 1135

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGE0	Y1765_ARATH	2, ., 7, ., 1, 1, ., 1	0.6574	0.9873	0.8461	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00018818001 SubName- Full=Chromosome chr12 scaffold_18, whole genome shotgun sequence; (1010 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	869
pfam11721	164	pfam11721, Malectin, Di-glucose binding within end	2e-58
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-51
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-50
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-50
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-50
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-50
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-47
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-46
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-40
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-36
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-35
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-35
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-35
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-34
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-34
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-33
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-33
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-33
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-32
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-32
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-32
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-31
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-30
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-30
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-30
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-30
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-30
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-29
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-29
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-29
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-28
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-28
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-28
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-27
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-27
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-27
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-27
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-27
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-27
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-27
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-26
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-25
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-25
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-25
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-25
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-24
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-24
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-24
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-24
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-24
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-23
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-23
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-23
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-23
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-23
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-23
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-23
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-22
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-22
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-22
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-22
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-22
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-22
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-22
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-22
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-21
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-21
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-21
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-21
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-21
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-21
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-20
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-20
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-20
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-20
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-20
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-20
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-20
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-20
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-19
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-19
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-18
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-18
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-18
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-18
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-17
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-15
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-15
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-13
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-13
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-13
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-09
pfam12819	335	pfam12819, Malectin_like, Carbohydrate-binding pro	8e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	6e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-04
PLN03210	1153	PLN03210, PLN03210, Resistant to P	0.001
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.002
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.003
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.003
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.004

>gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum

 Score =  196 bits (500), Expect = 2e-58
 Identities = 86/192 (44%), Positives = 101/192 (52%), Gaps = 32/192 (16%)

Query: 376 YTLHINCGGAKINTGH-TKYEAD-MEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIR 433
             L INCGG +        YEAD     G++ +Y S    + S  G    D         
Sbjct: 1   VVLAINCGGPEHTDSDGITYEADTYFTGGSADYYVSDTNGSSSIAG--TTDP-------- 50

Query: 434 TNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLG 493
                         ELY+T R SP S +YY  CL NGNYTV LHFAEI F  D     LG
Sbjct: 51  --------------ELYQTERYSPSSFSYYIPCLENGNYTVILHFAEIYFGED----GLG 92

Query: 494 KRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNF-PAEVTSHTLKIHLYWAGRGTTGIPL 552
           +R+FD+Y+Q KLV KDF+I  EAGG G    K + P  VT  TL+IH YWAG+GT  IP 
Sbjct: 93  RRVFDVYVQGKLVLKDFDIVAEAGGKGKTAHKEYIPVTVTDGTLEIHFYWAGKGTLLIPF 152

Query: 553 RGTYG-PLISAI 563
           RG YG P ISAI
Sbjct: 153 RGVYGNPKISAI 164

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  177 bits (451), Expect = 8e-51
 Identities = 74/195 (37%), Positives = 103/195 (52%), Gaps = 12/195 (6%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGCC 703
           +GEGGFG+VY       G  +A+K +  +      E  + EI ++    HPN+VKLYG  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
            + N L LV EY +   L   +     E   KL      +I + I  GL YLH      I
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK----ENEGKLSEDEILRILLQILEGLEYLHS---NGI 113

Query: 764 VHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYLT 821
           +HRD+K  N+LLD D    K++DFGL+KL   DK  +   I GT  YMAPE    +GY +
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTPAYMAPEVLLGKGYYS 172

Query: 822 SKADVYSFGVVTLEI 836
            K+D++S GV+  E+
Sbjct: 173 EKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  178 bits (454), Expect = 1e-50
 Identities = 79/207 (38%), Positives = 106/207 (51%), Gaps = 17/207 (8%)

Query: 644 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 698
            K+GEG FG VYKG L       T +AVK L    S +  ++F+ E  ++    HPN+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 699 LYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           L G C E   L LV EYM+   L      SR +F    +  L L         I IA+G+
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKD--LLSFAIQIAKGM 118

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMA 811
            YL      K VHRD+   N L+ +DL  KISDFGL++   +D  +         I +MA
Sbjct: 119 EYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175

Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVS 838
           PE    G  TSK+DV+SFGV+  EI +
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  177 bits (452), Expect = 2e-50
 Identities = 75/200 (37%), Positives = 101/200 (50%), Gaps = 13/200 (6%)

Query: 645 KVGEGGFGSVYKGILSD-----GTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 698
           K+GEG FG VYKG L          +AVK L    S Q   EF+ E  ++    HPN+VK
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
           L G C E   L +V EYM+   L   +     + R KL         + IARG+ YL   
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYLE-- 119

Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 818
                +HRD+   N L+ ++L  KISDFGL++   +D  +        I +MAPE    G
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178

Query: 819 YLTSKADVYSFGVVTLEIVS 838
             TSK+DV+SFGV+  EI +
Sbjct: 179 KFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  176 bits (448), Expect = 8e-50
 Identities = 74/206 (35%), Positives = 104/206 (50%), Gaps = 22/206 (10%)

Query: 645 KVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVK 698
           K+GEG FG VYKG L        T +AVK L   + +  R EF+ E  ++    HPN+V+
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLAY 754
           L G C +G  L +V EYM    L         ++      KL      ++ + IA+G+ Y
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLL--------DFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPE 813
           L        VHRD+   N L+ ++L  KISDFGL++   ED  +         I +MAPE
Sbjct: 118 LES---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSG 839
               G  TSK+DV+SFGV+  EI + 
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  176 bits (448), Expect = 8e-50
 Identities = 73/200 (36%), Positives = 101/200 (50%), Gaps = 12/200 (6%)

Query: 645 KVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 698
           K+GEG FG VYKG L          +AVK L    S Q   EF+ E  ++    HPN+VK
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
           L G C E   L++V EYM    L   +  +    + +L         + IARG+ YL   
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPK-ELSLSDLLSFALQIARGMEYLE-- 120

Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 818
                +HRD+   N L+ ++L  KISDFGL++   +D  +        I +MAPE    G
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 819 YLTSKADVYSFGVVTLEIVS 838
             TSK+DV+SFGV+  EI +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  169 bits (430), Expect = 2e-47
 Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 16/206 (7%)

Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 697
           ++   K+GEG FG VY       G ++A+K +  K  + +RE  + EI ++   +HPN+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           +LY    + ++L LV EY +   L   +   G+ +E   +            I   L YL
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR-------FYLRQILSALEYL 113

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
           H      IVHRD+K  N+LLD+D + K++DFGLA+  +  +    T   GT  YMAPE  
Sbjct: 114 HS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVL 168

Query: 816 MRGYLTSKADVYSFGVVTLEIVSGKS 841
           +        D++S GV+  E+++GK 
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKP 194

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  168 bits (428), Expect = 4e-47
 Identities = 72/200 (36%), Positives = 105/200 (52%), Gaps = 13/200 (6%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYG 701
           K+G G FG+VYK      G ++AVK L  +S   + ++    EI ++    HPN+V+L  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              + + L LV EY +   L   +          L     KKI + I RGL YLH +   
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLHSNG-- 118

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYL 820
            I+HRD+K  N+LLD++   KI+DFGLAK   +  + ++T   GT  YMAPE        
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGY 176

Query: 821 TSKADVYSFGVVTLEIVSGK 840
             K DV+S GV+  E+++GK
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  164 bits (418), Expect = 8e-46
 Identities = 77/205 (37%), Positives = 106/205 (51%), Gaps = 18/205 (8%)

Query: 644 NKVGEGGFGSVYKGILSD-GTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLY 700
             +G G FGSVY  +  D G ++AVK   LS  S +       EI ++S+ QHPN+V+ Y
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           G     E N L +  EY+    LS  +  FGK  E       P  +K    I  GLAYLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLAYLH 118

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIGYMAPEYA 815
            +    IVHRDIK +N+L+D D   K++DFG AK   + +T   T  + GT  +MAPE  
Sbjct: 119 SN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175

Query: 816 MRGYLTSKADVYSFGVVTLEIVSGK 840
                   AD++S G   +E+ +GK
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  148 bits (375), Expect = 4e-40
 Identities = 67/202 (33%), Positives = 104/202 (51%), Gaps = 10/202 (4%)

Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
           F+   K+G+GGFG VYK      G  +A+K +  +S++   + +NEI ++   +HPN+VK
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
            YG  ++ ++L +V E+     L   +  K T   L         +C  + +GL YLH  
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIA--YVCKELLKGLEYLHS- 116

Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 818
               I+HRDIK +N+LL  D   K+ DFGL+       T     + GT  +MAPE     
Sbjct: 117 --NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVINGK 172

Query: 819 YLTSKADVYSFGVVTLEIVSGK 840
               KAD++S G+  +E+  GK
Sbjct: 173 PYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  149 bits (377), Expect = 1e-36
 Identities = 101/293 (34%), Positives = 150/293 (51%), Gaps = 29/293 (9%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 123
           NLTG +P+ L  L+ L+ L L +N L+G   P   SLQ L+ L +  N LSG  P+++  
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306

Query: 124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 183
           +  L+ L +  N FTG IP  +  L  LQ L L SN F+GE+P  L K  NL  L +S N
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366

Query: 184 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS-ESAFPK 240
           N +G+IPE +     + KL +  +SLEG IP S+ A  SL  +R+ D    G   S F K
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426

Query: 241 L----------------------DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN 278
           L                      D  +L+ L L +    G +PD  G   +L+N+DLS N
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRN 485

Query: 279 NLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK--NVDISLNNFTWE 329
             +G +P     L++   + L+ NKL+G +P  + +  K  ++D+S N  + +
Sbjct: 486 QFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538

Length = 968

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  134 bits (339), Expect = 3e-35
 Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 24/208 (11%)

Query: 644 NKVGEGGFGSVYKG-ILSDGTVIAVKQLS-SKSRQGNREFV-NEIGMISAQQHPNLVKLY 700
            ++G+G FG VY     SDG +  +K++  S   +  RE   NE+ ++    HPN++K Y
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-------LDWPTRKKICIGIARGLA 753
               E  +L +V EY     LS+ I  K  +   K       LDW       + +   L 
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDW------FVQLCLALK 117

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YLH     KI+HRDIK  N+ L  +   K+ DFG++K+         T + GT  Y++PE
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE 173

Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               + Y   K+D++S G V  E+ + K
Sbjct: 174 LCQNKPY-NYKSDIWSLGCVLYELCTLK 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  134 bits (339), Expect = 6e-35
 Identities = 73/213 (34%), Positives = 112/213 (52%), Gaps = 21/213 (9%)

Query: 646 VGEGGFGSVYKGILS------DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVK 698
           +GEG FG V+ G         D  ++AVK L  + S    ++F  E  +++  QH N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRK-------KICIGIA 749
            YG C EG+  ++V+EYM++  L++ +   G D  +    D P  +       +I + IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIG 808
            G+ YL   +    VHRD+ T N L+  DL  KI DFG+++ +Y  D   +       I 
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189

Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GK 840
           +M PE  M    T+++DV+SFGVV  EI + GK
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  134 bits (339), Expect = 8e-35
 Identities = 66/206 (32%), Positives = 113/206 (54%), Gaps = 14/206 (6%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQH 693
              +    K+GEG  G VYK    + G  +A+K+  L  ++++     +NEI ++   +H
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKH 74

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           PN+V  Y   + G++L +V EYM    L+  I    T+  ++++ P    +C  + +GL 
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTDII----TQNFVRMNEPQIAYVCREVLQGLE 130

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YLH  + I   HRDIK+ N+LL KD + K++DFG A    ++K+  ++ + GT  +MAPE
Sbjct: 131 YLHSQNVI---HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPE 186

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSG 839
              R     K D++S G++ +E+  G
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  131 bits (331), Expect = 3e-34
 Identities = 69/200 (34%), Positives = 99/200 (49%), Gaps = 26/200 (13%)

Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 705
           +G+G FG V  G      V AVK L   S      F+ E  +++  +HPNLV+L G  ++
Sbjct: 14  IGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 706 GNQLLLVYEYMKNNCL-------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
           GN L +V EYM    L        RA+     +    LD          +  G+ YL E 
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD----------VCEGMEYLEEK 121

Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 818
                VHRD+   NVL+ +DL AK+SDFGLAK  E  +   S ++   + + APE     
Sbjct: 122 ---NFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREK 174

Query: 819 YLTSKADVYSFGVVTLEIVS 838
             ++K+DV+SFG++  EI S
Sbjct: 175 KFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  130 bits (329), Expect = 8e-34
 Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 17/206 (8%)

Query: 644 NKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           NK+G G FG VY  + L  G ++AVK++    +     +E  +E+ ++   +HPNLVK Y
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G  V   ++ +  EY     L   +     E+   LD    +   + +  GLAYLH    
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELL-----EHGRILDEHVIRVYTLQLLEGLAYLHSH-- 118

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG---YMAPEYAMR 817
             IVHRDIK +N+ LD +   K+ DFG A   + + T +   +    G   YMAPE    
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 818 GYLTSK---ADVYSFGVVTLEIVSGK 840
           G        AD++S G V LE+ +GK
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGK 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  139 bits (351), Expect = 1e-33
 Identities = 109/350 (31%), Positives = 165/350 (47%), Gaps = 65/350 (18%)

Query: 17  DWNFGVDPCSQKG-----NWELSSDDKKGFESNVTCDCSSATCH---VVTIALKAQNLTG 68
           +WN   D C  +G     +  + S D  G   N++   SSA      + TI L    L+G
Sbjct: 50  NWNSSADVCLWQGITCNNSSRVVSIDLSG--KNISGKISSAIFRLPYIQTINLSNNQLSG 107

Query: 69  TLPTEL----SKLRYL-------------------KQLDLSRNCLTGSFSPQ----WASL 101
            +P ++    S LRYL                   + LDLS N L+G   P     ++SL
Sbjct: 108 PIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEI-PNDIGSFSSL 166

Query: 102 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSF 161
           ++++L   GN L G  P  LTN+T+L+ L++  N   G IP ++ ++ +L+ + L  N+ 
Sbjct: 167 KVLDLG--GNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224

Query: 162 TGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALT 221
           +GE+P E+  LT+LN L +  NN +G IP  +G  K +Q L +  + L GPIP SI +L 
Sbjct: 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQ 284

Query: 222 SLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 281
            L  L +SD   S                       GEIP+ +  +  L+ + L  NN T
Sbjct: 285 KLISLDLSDNSLS-----------------------GEIPELVIQLQNLEILHLFSNNFT 321

Query: 282 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK--NVDISLNNFTWE 329
           G IP     L +   + L  NK +G +PK +   N    +D+S NN T E
Sbjct: 322 GKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371

Length = 968

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  128 bits (325), Expect = 2e-33
 Identities = 70/212 (33%), Positives = 112/212 (52%), Gaps = 26/212 (12%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQHPN 695
           N+   + +G G FG VYKG+ L  G  +A+KQ+S      +  +  + EI ++   +HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA---R 750
           +VK  G     + L ++ EY +N  L + I  FG   E  L         + + +    +
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE-SL---------VAVYVYQVLQ 110

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGY 809
           GLAYLHE     ++HRDIK +N+L  KD   K++DFG+A KL +  K      + GT  +
Sbjct: 111 GLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYW 165

Query: 810 MAPE-YAMRGYLTSKADVYSFGVVTLEIVSGK 840
           MAPE   M G  ++ +D++S G   +E+++G 
Sbjct: 166 MAPEVIEMSG-ASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  128 bits (323), Expect = 8e-33
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)

Query: 644 NKVGEGGFGSVYKG---ILSDGT--VIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLV 697
            ++GEG FG V       L D T   +AVK L+ S   Q   +F  EI ++    H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 698 KLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           K  G C +  G  L L+ EY+ +  L   +      +R +++          I +G+ YL
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL----QRHRDQINLKRLLLFSSQICKGMDYL 125

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPE 813
                 + +HRD+   N+L++ +   KISDFGLAK+  EDK +   +  G   I + APE
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVS 838
                  +S +DV+SFGV   E+ +
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  128 bits (323), Expect = 8e-33
 Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 23/217 (10%)

Query: 646 VGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVK 698
           +G+G FG VY+G+          T +A+K ++  +    R EF+NE  ++      ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGK--DTEYRLKLDWPTRKKI---CIGIARGLA 753
           L G    G   L+V E M    L   +  +  + E    L  PT +K       IA G+A
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YL      K VHRD+   N ++ +DL  KI DFG+ + +YE D      +    + +MAP
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVS-------GKSN 842
           E    G  T+K+DV+SFGVV  E+ +       G SN
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  135 bits (342), Expect = 1e-32
 Identities = 94/311 (30%), Positives = 153/311 (49%), Gaps = 58/311 (18%)

Query: 23  DPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQ 82
           DP     NW  S+D        +TC+ SS    VV+I L  +N++G + + + +L Y++ 
Sbjct: 43  DPLKYLSNWNSSADVCLW--QGITCNNSS---RVVSIDLSGKNISGKISSAIFRLPYIQT 97

Query: 83  LDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPK-VLTNITTLKNLSIEGNLFTGSI 141
           ++LS                        N+LSGP P  + T  ++L+ L++  N FTGSI
Sbjct: 98  INLS-----------------------NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSI 134

Query: 142 PPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 201
           P     + NL+ L LS+N  +GE+P ++   ++L  L +  N   GKIP  +     ++ 
Sbjct: 135 PRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEF 192

Query: 202 LHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEI 260
           L +  + L G IP                         +L +M +LK + L    + GEI
Sbjct: 193 LTLASNQLVGQIPR------------------------ELGQMKSLKWIYLGYNNLSGEI 228

Query: 261 PDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK--N 318
           P  IG +T L ++DL +NNLTG IP++   L    +++L  NKL+GP+P  IF+  K  +
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS 288

Query: 319 VDISLNNFTWE 329
           +D+S N+ + E
Sbjct: 289 LDLSDNSLSGE 299

Length = 968

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  126 bits (319), Expect = 1e-32
 Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 19/206 (9%)

Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
           FD   K+GEG +GSVYK I    G V+A+K +  +     +E + EI ++     P +VK
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI---CIGIARGLAYL 755
            YG   +   L +V EY     +S  +  K T   L     T ++I        +GL YL
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTL-----TEEEIAAILYQTLKGLEYL 115

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
           H     K +HRDIK  N+LL+++  AK++DFG++    +     +T I GT  +MAPE  
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVI 171

Query: 816 MR-GYLTSKADVYSFGVVTLEIVSGK 840
              GY  +KAD++S G+  +E+  GK
Sbjct: 172 QEIGY-NNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  124 bits (314), Expect = 8e-32
 Identities = 71/199 (35%), Positives = 103/199 (51%), Gaps = 17/199 (8%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKLYG 701
           K+G G FG V+ G  +  T +AVK L    + G      F+ E  ++   +H  LV+LY 
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
            C E   + +V EYM    L    F K  E + KL  P    +   IA G+AYL      
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLD--FLKSGEGK-KLRLPQLVDMAAQIAEGMAYLE---SR 122

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK--THISTRIAGTIGYMAPEYAMRGY 819
             +HRD+   N+L+ ++L  KI+DFGLA+L E+D+       +    I + APE A  G 
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGR 180

Query: 820 LTSKADVYSFGVVTLEIVS 838
            T K+DV+SFG++  EIV+
Sbjct: 181 FTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  122 bits (308), Expect = 4e-31
 Identities = 70/204 (34%), Positives = 109/204 (53%), Gaps = 21/204 (10%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLS-----SKSRQGNREFVNEIGMISAQQHPNLVKL 699
           +G G FGSVY+G+ L DG   AVK++S        ++  ++   EI ++S  QHPN+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
            G   E + L +  E +    L++ +  +G   E  ++L   TR+     I  GL YLH+
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL--YTRQ-----ILLGLEYLHD 120

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
                 VHRDIK +N+L+D +   K++DFG+AK   E     S +  G+  +MAPE   +
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK--GSPYWMAPEVIAQ 175

Query: 818 -GYLTSKADVYSFGVVTLEIVSGK 840
            G     AD++S G   LE+ +GK
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  122 bits (307), Expect = 6e-31
 Identities = 71/207 (34%), Positives = 109/207 (52%), Gaps = 14/207 (6%)

Query: 639 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPN 695
           +F+  NK+G+G FG V+K +  +D  V A+KQ  LS  +R+   E ++E  +++      
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD--WPTRKKICIGIARGLA 753
           +++ Y   ++  +L +V EY +N  L   +        L  D  W    +  I I  GLA
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDL-HKLLKMQRGRPLPEDQVW----RFFIQILLGLA 115

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           +LH     KI+HRDIK+ N+ LD   N KI D G+AKL   D T+ +  I GT  Y++PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLSPE 171

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                    K+DV++ GVV  E  +GK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  120 bits (302), Expect = 3e-30
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 22/204 (10%)

Query: 645 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGC 702
            +G+G  G VYK      G + A+K++     +  R + + E+  + + + P +VK YG 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +  ++ +V EYM    L+  +     +   K+  P    I   I +GL YLH      
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYLHTKR--H 120

Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA------GTIGYMAPEYAM 816
           I+HRDIK SN+L++     KI+DFG++K        +   +       GT+ YM+PE   
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISK-------VLENTLDQCNTFVGTVTYMSPERIQ 173

Query: 817 RGYLTSKADVYSFGVVTLEIVSGK 840
               +  AD++S G+  LE   GK
Sbjct: 174 GESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  119 bits (299), Expect = 6e-30
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 9/200 (4%)

Query: 640 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL 699
           F    K+G G FG V++G+  +   +A+K L S      ++F  E+  +   +H +L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
           +  C  G  + ++ E M+   L    F +  E ++ L   +   +   +A G+AYL E  
Sbjct: 68  FAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ- 123

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED-KTHISTRIAGTIGYMAPEYAMRG 818
               +HRD+   N+L+ +DL  K++DFGLA+L +ED       +I     + APE A  G
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHG 179

Query: 819 YLTSKADVYSFGVVTLEIVS 838
             ++K+DV+SFG++  E+ +
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  119 bits (300), Expect = 6e-30
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 20/211 (9%)

Query: 645 KVGEGGFGSVY----KGIL--SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
           ++GEG FG V+      +L   D  ++AVK L   S    ++F  E  +++  QH ++V+
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----------KLDWPTRKKICIGI 748
            YG C EG  LL+V+EYM++  L+R +     + ++          +L       I   I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTI 807
           A G+ YL   + +  VHRD+ T N L+ + L  KI DFG+++ +Y  D   +  R    I
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            +M PE  +    T+++D++SFGVV  EI +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  119 bits (301), Expect = 8e-30
 Identities = 74/226 (32%), Positives = 110/226 (48%), Gaps = 28/226 (12%)

Query: 638 NNFDPANKVGEGGFGSVYK----GILS--DGTVIAVKQLSSK-SRQGNREFVNEIGMISA 690
           NN +    +G+G FG V++    G+L     T++AVK L  + S     +F  E  +++ 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMK----NNCL-------------SRAIFGKDTEYR 733
             HPN+VKL G C  G  + L++EYM     N  L             S +   K     
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 734 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLY 792
           L L    +  I   +A G+AYL E    K VHRD+ T N L+ +++  KI+DFGL+  +Y
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             D    S   A  I +M PE       T+++DV+++GVV  EI S
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  119 bits (299), Expect = 9e-30
 Identities = 66/201 (32%), Positives = 109/201 (54%), Gaps = 19/201 (9%)

Query: 647 GEGGFGSVYKGI---LSDGTVI--AVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           G G FG+VYKG+     +   I  A+K L    S + N+E ++E  ++++  HP++V+L 
Sbjct: 16  GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY--RLKLDWPTRKKICIGIARGLAYLHED 758
           G C+  +Q+ L+ + M   CL   +         +  L+W      C+ IA+G++YL E+
Sbjct: 76  GICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL-EE 127

Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAMR 817
            R+  VHRD+   NVL+    + KI+DFGLAKL + D+           I +MA E  + 
Sbjct: 128 KRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185

Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              T K+DV+S+GV   E+++
Sbjct: 186 RIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  118 bits (296), Expect = 1e-29
 Identities = 66/212 (31%), Positives = 113/212 (53%), Gaps = 15/212 (7%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYG 701
           ++G G FG V+ G   +   +A+K +    R+G     +F+ E  ++    HP LV+LYG
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
            C E + + LV+E+M++ CLS  +  +    R K    T   +C+ +  G+AYL   +  
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLESSN-- 120

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
            ++HRD+   N L+ ++   K+SDFG+ +   +D+   ST     + + +PE       +
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179

Query: 822 SKADVYSFGVVTLEIVS-GKSNTNYRPNEDFV 852
           SK+DV+SFGV+  E+ S GK+    R N + V
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  115 bits (291), Expect = 8e-29
 Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 21/203 (10%)

Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 700
           +G G FG V +G L         +A+K L + S    R +F+ E  ++    HPN+++L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDT---EYRLKLDWPTRKKICIGIARGLAYLHE 757
           G   +   ++++ EYM+N  L       D    E   K        +  GIA G+ YL  
Sbjct: 72  GVVTKSRPVMIITEYMENGSL-------DKFLRENDGKFTVGQLVGMLRGIASGMKYL-- 122

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYA 815
            S +  VHRD+   N+L++ +L  K+SDFGL++  E+ +   +T+  G I   + APE  
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAPEAI 180

Query: 816 MRGYLTSKADVYSFGVVTLEIVS 838
                TS +DV+SFG+V  E++S
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  123 bits (311), Expect = 9e-29
 Identities = 88/272 (32%), Positives = 141/272 (51%), Gaps = 9/272 (3%)

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWA---SLQLVELSVMGNRLSGPF 117
           L + N TG +P  L+ L  L+ L L  N  +G          +L +++LS   N L+G  
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLST--NNLTGEI 372

Query: 118 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLND 177
           P+ L +   L  L +  N   G IP  +    +L+++ L  NSF+GELP+E TKL  +  
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432

Query: 178 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA 237
           L IS+NN  G+I         +Q L +  +   G +P S  +   L +L +S  + S + 
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAV 491

Query: 238 FPKLDKMN-LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNF 296
             KL  ++ L  L L++  + GEIPD +    KL ++DLS N L+G IP +F ++   + 
Sbjct: 492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ 551

Query: 297 MYLTGNKLTGPVPKYIFN--SNKNVDISLNNF 326
           + L+ N+L+G +PK + N  S   V+IS N+ 
Sbjct: 552 LDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583

Length = 968

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  115 bits (290), Expect = 1e-28
 Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 7/194 (3%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G G FG V++G+ ++ T +AVK L   +     +F+ E  ++   +HP L++LY  C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
               + +V E MK   L   +        LKL  P    +   +A G+AYL   + I   
Sbjct: 72  LEEPIYIVTELMKYGSLLEYL-QGGAGRALKL--PQLIDMAAQVASGMAYLEAQNYI--- 125

Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD+   NVL+ ++   K++DFGLA++ +ED           I + APE A+    + K+
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  EIV+
Sbjct: 186 DVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  118 bits (296), Expect = 1e-28
 Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 20/210 (9%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISA-QQHPNLVKLY 700
           K+GEG FG VY     D  ++A+K L+ K     +    F+ EI ++++    PN+VKLY
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
               +   L LV EY+    L   +  K    +  L       I   I   L YLH    
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALEYLHS--- 119

Query: 761 IKIVHRDIKTSNVLLDKDLN-AKISDFGLAKLYEEDKTHISTR-----IAGTIGYMAPEY 814
             I+HRDIK  N+LLD+D    K+ DFGLAKL  +  +  S         GT GYMAPE 
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179

Query: 815 AM---RGYLTSKADVYSFGVVTLEIVSGKS 841
            +     Y +S +D++S G+   E+++G  
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLP 209

Length = 384

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  114 bits (287), Expect = 4e-28
 Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 22/212 (10%)

Query: 646 VGEGGFGSVYKGIL------SDGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVK 698
           +GEG FG VYKG L         T +A+K L      +  +EF  E  ++S  QHPN+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIF-----------GKDTEYRLKLDWPTRKKICIG 747
           L G C +     +++EY+ +  L   +              D   +  LD      I I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL-YEEDKTHISTRIAGT 806
           IA G+ YL   S    VHRD+   N L+ + L  KISDFGL++  Y  D   + ++    
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           + +M PE  + G  T+++D++SFGVV  EI S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  113 bits (284), Expect = 6e-28
 Identities = 76/221 (34%), Positives = 121/221 (54%), Gaps = 16/221 (7%)

Query: 639 NFDPANKVGEGGFGSVYK-GILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPN 695
           +F    K+G+G +GSVYK   LSD    A+K+  L S S++   + VNEI ++++  HPN
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL---KLDWPTRKKICIGIARGL 752
           ++      ++GN+L +V EY     LS+AI  +  + +L   +  W    +I I + RGL
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGL 116

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
             LHE    KI+HRD+K++N+LL  +   KI D G++K+ +  K    T+I GT  YMAP
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQI-GTPHYMAP 170

Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 853
           E       + K+D++S G +  E+ +       R  +D  Y
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY 211

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 7e-28
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 26/213 (12%)

Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS-RQG-NREFVNEIGMISAQQHPNL 696
           ++   ++GEG +G VYK      G ++A+K++  ++ ++G     + EI ++   +HPN+
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 697 VKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           V+L           + +V+EYM ++ L+  +        +K      K     +  GL Y
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHD-LTGLL----DSPEVKFTESQIKCYMKQLLEGLQY 115

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE- 813
           LH      I+HRDIK SN+L++ D   K++DFGLA+ Y +  +   T    T+ Y  PE 
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172

Query: 814 ------YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                 Y        + D++S G +  E+  GK
Sbjct: 173 LLGATRY------GPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  113 bits (284), Expect = 9e-28
 Identities = 69/223 (30%), Positives = 114/223 (51%), Gaps = 20/223 (8%)

Query: 644 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLYG 701
             +G G    VY  I L +   +A+K++  +  Q + + +  E+  +S   HPN+VK Y 
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 702 CCVEGNQLLLVYEYMK-NNCLS--RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
             V G++L LV  Y+   + L   ++ + +       LD      +   + +GL YLH +
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-----LDEAIIATVLKEVLKGLEYLHSN 121

Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGL-AKLYEE-DKTHIS-TRIAGTIGYMAPE-- 813
            +I   HRDIK  N+LL +D + KI+DFG+ A L +  D+T        GT  +MAPE  
Sbjct: 122 GQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGKSN-TNYRPNEDFVYLL 855
             + GY   KAD++SFG+  +E+ +G +  + Y P +  +  L
Sbjct: 179 EQVHGY-DFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL 220

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  112 bits (282), Expect = 1e-27
 Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 8/194 (4%)

Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 705
           +G G FG V+ G       +A+K +   +     +F+ E  ++    HPNLV+LYG C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVH 765
              + +V EYM N CL    + ++ + +L  +W     +C  +   + YL  +  I   H
Sbjct: 71  QRPIFIVTEYMANGCLLN--YLRERKGKLGTEWLL--DMCSDVCEAMEYLESNGFI---H 123

Query: 766 RDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKAD 825
           RD+   N L+ +D   K+SDFGLA+   +D+   S      + +  PE       +SK+D
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183

Query: 826 VYSFGVVTLEIVSG 839
           V+SFGV+  E+ S 
Sbjct: 184 VWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 3e-27
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 19/203 (9%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF----VNEIGMISAQQHPNLVKL 699
           K+GEG +G VYK      G ++A+K++  +            + EI ++   +HPN+VKL
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
                   +L LV+EY   + L + +   D      L     K I   + RGLAY H   
Sbjct: 64  LDVIHTERKLYLVFEYCDMD-LKKYL---DK-RPGPLSPNLIKSIMYQLLRGLAYCH--- 115

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMR 817
             +I+HRD+K  N+L+++D   K++DFGLA+ +       +  +  T+ Y APE     +
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSK 174

Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
            Y T+  D++S G +  E+++GK
Sbjct: 175 HYSTA-VDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  111 bits (281), Expect = 4e-27
 Identities = 62/200 (31%), Positives = 106/200 (53%), Gaps = 14/200 (7%)

Query: 645 KVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 701
           ++GEG  G V+K      G  +A+K+++ +  +G    + + EI  + A QHP +VKL  
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
               G+  +LV EYM ++ LS  +     +    L     K     + +G+AY+H +   
Sbjct: 67  VFPHGSGFVLVMEYMPSD-LSEVL----RDEERPLPEAQVKSYMRMLLKGVAYMHAN--- 118

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMRGY 819
            I+HRD+K +N+L+  D   KI+DFGLA+L+ E++  + +    T  Y APE  Y  R Y
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178

Query: 820 LTSKADVYSFGVVTLEIVSG 839
                D+++ G +  E+++G
Sbjct: 179 -DPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 4e-27
 Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 20/202 (9%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLVKLYGC 702
            +G+G FG VYK I      V+A+K +  +  +   E +  EI  +S  + P + K YG 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 703 CVEGNQLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
            ++G++L ++ EY    +CL     GK  E            I      +  GL YLHE+
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKPGKLDE----------TYIAFILREVLLGLEYLHEE 117

Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 818
            +I   HRDIK +N+LL ++ + K++DFG++       +  +T   GT  +MAPE   + 
Sbjct: 118 GKI---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPEVIKQS 173

Query: 819 YLTSKADVYSFGVVTLEIVSGK 840
               KAD++S G+  +E+  G+
Sbjct: 174 GYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  111 bits (278), Expect = 6e-27
 Identities = 74/220 (33%), Positives = 112/220 (50%), Gaps = 30/220 (13%)

Query: 646 VGEGGFGSVYKGI------LSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVK 698
           +GEG FG V K         +  T +AVK L   +     R+ ++E  ++    HP+++K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 699 LYGCCVEGNQLLLVYEYMKNNCL------SRAI----FGKD-TEYRLKLDWPTRKKICIG 747
           LYG C +   LLL+ EY K   L      SR +     G D       LD P  + + +G
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 748 --------IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTH 798
                   I+RG+ YL E   +K+VHRD+   NVL+ +    KISDFGL++ +YEED   
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             ++    + +MA E       T+++DV+SFGV+  EIV+
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  111 bits (278), Expect = 6e-27
 Identities = 77/244 (31%), Positives = 120/244 (49%), Gaps = 24/244 (9%)

Query: 645 KVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
           ++GEG FG V+           D  ++AVK L   S    ++F  E  +++  QH ++VK
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKK------ICIGIAR 750
            YG CVEG+ L++V+EYMK+  L++ +   G D     + + P          I   IA 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGY 809
           G+ YL        VHRD+ T N L+ ++L  KI DFG+++ +Y  D   +       I +
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQE----- 863
           M PE  M    T+++DV+S GVV  EI + GK       N + +  +    VLQ      
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCP 248

Query: 864 EEIY 867
           +E+Y
Sbjct: 249 KEVY 252

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  110 bits (277), Expect = 9e-27
 Identities = 60/204 (29%), Positives = 109/204 (53%), Gaps = 13/204 (6%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
             D   K+GEG  G V      S G  +AVK++  + +Q      NE+ ++   QHPN+V
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           ++Y   + G++L +V E+++   L+      D     +++      +C+ + + L++LH 
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLAVLKALSFLHA 133

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGL-AKLYEEDKTHISTRIAGTIGYMAPEYAM 816
                ++HRDIK+ ++LL  D   K+SDFG  A++ +E     S  + GT  +MAPE   
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVIS 188

Query: 817 RGYLTSKADVYSFGVVTLEIVSGK 840
           R    ++ D++S G++ +E+V G+
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  109 bits (274), Expect = 1e-26
 Identities = 66/197 (33%), Positives = 105/197 (53%), Gaps = 14/197 (7%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYG 701
           K+G G FG V+ G  +  T +A+K L    +QG+     F+ E  ++   QHP LV+LY 
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
             V    + ++ EYM+N  L   +    T   +KL       +   IA G+A++   + I
Sbjct: 69  V-VTQEPIYIITEYMENGSLVDFL---KTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
              HRD++ +N+L+ + L  KI+DFGLA+L E+++          I + APE    G  T
Sbjct: 125 ---HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 181

Query: 822 SKADVYSFGVVTLEIVS 838
            K+DV+SFG++  EIV+
Sbjct: 182 IKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  107 bits (268), Expect = 1e-25
 Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 21/212 (9%)

Query: 645 KVGEGGFGSVYKG------ILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
           ++GEG FG V+           D  ++AVK L   +    ++F  E  +++  QH ++VK
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK-----------ICIG 747
            YG C +G+ L++V+EYMK+  L++ +     +  + +D   R+            I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT 806
           IA G+ YL        VHRD+ T N L+  +L  KI DFG+++ +Y  D   +       
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           I +M PE  M    T+++DV+SFGV+  EI +
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  106 bits (265), Expect = 2e-25
 Identities = 65/201 (32%), Positives = 106/201 (52%), Gaps = 16/201 (7%)

Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 700
           +G G FG V++GIL         +A+K L     +  R +F++E  ++    H N+++L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +    +++ EYM+N  L + +   D E+   +L    R     GIA G+ YL   S
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGMKYL---S 124

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGL+++ E+D     T   G I   + APE    
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              TS +DV+SFG+V  E++S
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  106 bits (266), Expect = 2e-25
 Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 25/236 (10%)

Query: 638 NNFDPANKVGEGGFGSVYKG-ILSDGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 694
           ++ +   ++G G  G V K      G ++AVK  +L        ++ + E+ ++     P
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSP 59

Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW-PTR--KKICIGIARG 751
            +V  YG       + +  EYM    L       D   +      P R   KI + + +G
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGSL-------DKILKEVQGRIPERILGKIAVAVLKG 112

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L YLHE    KI+HRD+K SN+L++     K+ DFG++         ++    GT  YMA
Sbjct: 113 LTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYMA 167

Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK---SNTNYRPNEDFVYLLDWAYVLQEE 864
           PE       + K+D++S G+  +E+ +G+      N  P+  F  LL   Y++ E 
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-ELLQ--YIVNEP 220

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  105 bits (264), Expect = 3e-25
 Identities = 69/195 (35%), Positives = 106/195 (54%), Gaps = 10/195 (5%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G G FG V+ G  +  T +AVK L   +      F+ E  ++   +H  LV+LY    
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           E   + +V EYM    L    F KD E R LKL  P    +   +A G+AY+    R+  
Sbjct: 72  E-EPIYIVTEYMSKGSL--LDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNY 123

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRD++++N+L+   L  KI+DFGLA+L E+++          I + APE A+ G  T K
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 824 ADVYSFGVVTLEIVS 838
           +DV+SFG++  E+V+
Sbjct: 184 SDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 4e-25
 Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 11/200 (5%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGCC 703
           K+G+G FG VYKG+L   T +AVK   S      +  F+ E  ++    HPN+VKL G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           V+   + +V E +    L   +  K     +K       ++ +  A G+ YL   + I  
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK----KLLQMSLDAAAGMEYLESKNCI-- 115

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI--GYMAPEYAMRGYLT 821
            HRD+   N L+ ++   KISDFG+++  EE   +  +     I   + APE    G  T
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173

Query: 822 SKADVYSFGVVTLEIVSGKS 841
           S++DV+S+G++  E  S   
Sbjct: 174 SESDVWSYGILLWETFSLGD 193

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 5e-25
 Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 27/218 (12%)

Query: 645 KVGEGGFGSVY----KGILS-----------DGTVIAVKQLSSKSRQGNR-EFVNEIGMI 688
           K+GEG FG V+    +G+                ++AVK L +   +  R +F+ EI ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 689 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKL--DWPTRKK--- 743
           S  ++PN+++L G CV  + L ++ EYM+N  L++ +  ++ E       + P+      
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 744 --ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIS 800
             + + IA G+ YL   + +  VHRD+ T N L+      KI+DFG+++ LY  D   I 
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            R    I +MA E  + G  T+ +DV++FGV   E+ +
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 6e-25
 Identities = 67/211 (31%), Positives = 97/211 (45%), Gaps = 34/211 (16%)

Query: 644 NKVGEGGFGSVYKGI--LSDGTVI--AVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G G FGSV KG+  +  G  +  AVK L       G +EF+ E  +++   HP +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 699 LYGCCVEGNQLLLVYE---------YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           L G C +G  L+LV E         Y+K          +     LK     +      +A
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKR-------REIPVSDLKE-LAHQ------VA 105

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--I 807
            G+AYL        VHRD+   NVLL     AKISDFG+++       +     AG   +
Sbjct: 106 MGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPL 162

Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            + APE    G  +SK+DV+S+GV   E  S
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  104 bits (261), Expect = 9e-25
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 15/212 (7%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ------LSSKSRQGNREFVNEIGMIS 689
             NF    K+G+G F  VYK I L DG V+A+K+      + +K+RQ   + + EI ++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57

Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
              HPN++K     +E N+L +V E      LSR I     + RL +   T  K  + + 
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFVQLC 116

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
             L ++H     +I+HRDIK +NV +      K+ D GL + +   KT  +  + GT  Y
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYY 172

Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           M+PE         K+D++S G +  E+ + +S
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  104 bits (262), Expect = 1e-24
 Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 34/228 (14%)

Query: 638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVN---EIGMISAQ 691
           ++F     +GEG F +V            A+K L  +   ++   ++V    E+ +    
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLN 59

Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
            HP ++KLY    +   L  V EY  N  L + I          LD    +     I   
Sbjct: 60  GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-----RKYGSLDEKCTRFYAAEILLA 114

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA------- 804
           L YLH      I+HRD+K  N+LLDKD++ KI+DFG AK+ + + +  S +         
Sbjct: 115 LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 805 ------------GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
                       GT  Y++PE          +D+++ G +  ++++GK
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  103 bits (259), Expect = 1e-24
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 72  E-EPIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 124

Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 185 DVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 2e-24
 Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 30/214 (14%)

Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
           ++   ++G G +G VYK   ++ G ++A+K +  +          EI M+   +HPN+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
            +G  +  ++L +V EY     L    +   G  +E ++         +C    +GLAYL
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-------VCRETLKGLAYL 117

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA------GTIGY 809
           HE  +I   HRDIK +N+LL +D + K++DFG++         ++  IA      GT  +
Sbjct: 118 HETGKI---HRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYW 167

Query: 810 MAPEYA---MRGYLTSKADVYSFGVVTLEIVSGK 840
           MAPE A    +G    K D+++ G+  +E+   +
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  103 bits (257), Expect = 2e-24
 Identities = 72/222 (32%), Positives = 110/222 (49%), Gaps = 8/222 (3%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G G FG V+ G  ++ T +AVK L   +    + F+ E  ++   QH  LV+LY    
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           +   + ++ EYM    L    F K  E   K+  P        IA G+AY+   + I   
Sbjct: 72  KEEPIYIITEYMAKGSLLD--FLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERKNYI--- 125

Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +NVL+ + L  KI+DFGLA++ E+++          I + APE    G  T K+
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185

Query: 825 DVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEE 865
           DV+SFG++  EIV+ GK       N D +  L   Y +   E
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRME 227

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  103 bits (260), Expect = 3e-24
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 18/210 (8%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIGMISAQQ 692
            ++   K+GEG +  VYK      G ++A+K++    R+  ++ +N     EI ++   +
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++ L       + + LV+E+M+ + L + I  KD    L       K   +   RGL
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETD-LEKVI--KDKSIVLTP--ADIKSYMLMTLRGL 115

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
            YLH +    I+HRD+K +N+L+  D   K++DFGLA+ +      ++ ++  T  Y AP
Sbjct: 116 EYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAP 171

Query: 813 E--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
           E  +  R Y     D++S G +  E++   
Sbjct: 172 ELLFGARHY-GVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  103 bits (258), Expect = 3e-24
 Identities = 73/216 (33%), Positives = 107/216 (49%), Gaps = 17/216 (7%)

Query: 646 VGEGGFGSVYK---GILSDGT--VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           +G+G FGSV       L D T  V+AVK+L   + +  R+F  EI ++ + QH N+VK  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 701 GCCVEG--NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
           G C       L LV EY+    L R    K  E   +LD          I +G+ YL   
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSL-RDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSK 127

Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAM 816
              + VHRD+ T N+L++ +   KI DFGL K+  +DK +   R  G   I + APE   
Sbjct: 128 ---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184

Query: 817 RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFV 852
               +  +DV+SFGVV  E+ +  S+ +  P  +F+
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT-YSDKSCSPPAEFM 219

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 3e-24
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 23/205 (11%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYG 701
           K+GEG +G VYK      G ++A+K++  +       +  + EI ++    HPN++KL  
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
                  L LV+E+M  +        KD   +  L     K     + +GLA+ H     
Sbjct: 66  VFRHKGDLYLVFEFMDTDLYK---LIKD--RQRGLPESLIKSYLYQLLQGLAFCH---SH 117

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK---TH-ISTRIAGTIGYMAPE--YA 815
            I+HRD+K  N+L++ +   K++DFGLA+ +       TH + TR      Y APE    
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPELLLG 172

Query: 816 MRGYLTSKADVYSFGVVTLEIVSGK 840
            +GY ++  D++S G +  E++S +
Sbjct: 173 DKGY-STPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  102 bits (256), Expect = 4e-24
 Identities = 68/210 (32%), Positives = 111/210 (52%), Gaps = 23/210 (10%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQL-----SSKSRQGNREFVN----EIGMISAQQHPN 695
           +G G FGSVY G+  S G ++AVKQ+     S+ S+   R  ++    EI ++   QH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           +V+  G  ++ + L +  EY+    ++  +      Y    +    +     I +GL YL
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL----NNYG-AFEETLVRNFVRQILKGLNYL 122

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA-----GTIGYM 810
           H  +R  I+HRDIK +N+L+D     KISDFG++K  E +     T  A     G++ +M
Sbjct: 123 H--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 811 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           APE   +   T KAD++S G + +E+++GK
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  102 bits (256), Expect = 5e-24
 Identities = 72/225 (32%), Positives = 102/225 (45%), Gaps = 25/225 (11%)

Query: 644 NKVGEGGFGSVYKGILS--DGTV----IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNL 696
             +G G FG VY+G+    DG      +AVK L  S S Q   +F+ E  ++S   H N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK------KICIGIAR 750
           V+L G   E     ++ E M    L   +     E R + + P+             +A+
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFL----RENRPRPERPSSLTMKDLLFCARDVAK 127

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGT 806
           G  YL E+     +HRDI   N LL        AKI+DFG+A+ +Y         R    
Sbjct: 128 GCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNED 850
           I +M PE  + G  TSK DV+SFGV+  EI S G      R N++
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 1e-23
 Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 13/200 (6%)

Query: 646 VGEGGFGSVYK-GILSDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYG 701
           +G+G FG V        G + A+K L  K    R+     + E  ++S   HP +VKL+ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
                 +L LV EY     L   +         +      +     I   L YLH    +
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHL-----SKEGRFSEERARFYAAEIVLALEYLH---SL 112

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
            I++RD+K  N+LLD D + K++DFGLAK    + +  +T   GT  Y+APE  +     
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYG 171

Query: 822 SKADVYSFGVVTLEIVSGKS 841
              D +S GV+  E+++GK 
Sbjct: 172 KAVDWWSLGVLLYEMLTGKP 191

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  101 bits (253), Expect = 1e-23
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 9/204 (4%)

Query: 644 NKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQHPNLVKLY 700
             +G+G FG+V K    SDG ++  K++   + + +  ++ V+E+ ++   +HPN+V+ Y
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 701 GCCV-EGNQLL-LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH-- 756
              +   NQ L +V EY +   L++ I  K  + R  ++     +I   +   L   H  
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLI-QKCKKERKYIEEEFIWRILTQLLLALYECHNR 124

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
            D    ++HRD+K +N+ LD + N K+ DFGLAK+   D +   T   GT  YM+PE   
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYMSPEQLN 183

Query: 817 RGYLTSKADVYSFGVVTLEIVSGK 840
                 K+D++S G +  E+ +  
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  100 bits (251), Expect = 2e-23
 Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 22/203 (10%)

Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 701
           +G+G FG V      D   + A+K ++ +    +   R  +NE  ++    HP LV L+ 
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIARGLAYLHE 757
              +   + LV + +          G D  Y L    K      K     I   L YLH 
Sbjct: 68  SFQDEENMYLVVDLL---------LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS 118

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
                I+HRDIK  N+LLD+  +  I+DF +A     D   ++T  +GT GYMAPE   R
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCR 173

Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
              +   D +S GV   E + GK
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  100 bits (251), Expect = 2e-23
 Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 19/209 (9%)

Query: 646 VGEGGFGSVYKG----ILSDGT---VIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLV 697
           +G G FG VY+G    IL  G+    +AVK L   +  Q  +EF+ E  ++S   HPN+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFG--KDTEYRLKLDWPTRKKICIGIARGLAYL 755
           KL G C+      ++ E M+   L   +     +      L       IC+ +A+G  YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 756 HEDSRIKIVHRDIKTSNVLL-----DKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGY 809
               ++  +HRD+   N L+     D D   KI DFGLA+ +Y+ D           + +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179

Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           MAPE  + G  T+++DV+SFGV+  EI++
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 2e-23
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 37/212 (17%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF--------VNEIGMISA-QQHP 694
           ++G+G FGSVY       G ++A+K++        ++F        + E+  +    +HP
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHP 58

Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG--KDTEYRLKLDWPTRKKICIGIARGL 752
           N+VKL     E ++L  V+EYM+ N     ++   KD + +        + I   I +GL
Sbjct: 59  NIVKLKEVFRENDELYFVFEYMEGN-----LYQLMKDRKGKP-FSESVIRSIIYQILQGL 112

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH---ISTRIAGTIGY 809
           A++H   +    HRD+K  N+L+      KI+DFGLA+       +   +STR      Y
Sbjct: 113 AHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WY 164

Query: 810 MAPEYAMR-GYLTSKADVYSFGVVTLEIVSGK 840
            APE  +R    +S  D+++ G +  E+ + +
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 99.4 bits (247), Expect = 4e-23
 Identities = 65/194 (33%), Positives = 105/194 (54%), Gaps = 8/194 (4%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV LY    
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V E+M    L   +   D +Y LKL  P    +   IA G+AY+    R+  +
Sbjct: 72  E-EPIYIVTEFMGKGSLLDFLKEGDGKY-LKL--PQLVDMAAQIADGMAYIE---RMNYI 124

Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+  +L  KI+DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+V+
Sbjct: 185 DVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 99.6 bits (248), Expect = 4e-23
 Identities = 62/203 (30%), Positives = 109/203 (53%), Gaps = 18/203 (8%)

Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 700
           +G G FG V +G L         +A+K L S  + +  R+F++E  ++    HPN++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   ++++ E+M+N  L   +   D ++  ++L    R     GIA G+ YL E  
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLSE-- 124

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH--ISTRIAGTIG--YMAPEYA 815
            +  VHRD+   N+L++ +L  K+SDFGL++  E+D +    ++ + G I   + APE  
Sbjct: 125 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 816 MRGYLTSKADVYSFGVVTLEIVS 838
                TS +DV+S+G+V  E++S
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 99.5 bits (248), Expect = 5e-23
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 34/215 (15%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQL------SSKSRQGNREFV----NEIGMISAQQHP 694
           +G+G +G VY  + ++ G ++AVKQ+      + +     ++ V    +EI  +    H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGL 752
           N+V+  G       L +  EY+    +   +  +G+  E          +     +  GL
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-------QLVRFFTEQVLEGL 121

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK----LYEEDKTHISTRIAGTIG 808
           AYLH      I+HRD+K  N+L+D D   KISDFG++K    +Y+ D+      + G++ 
Sbjct: 122 AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN---MSMQGSVF 175

Query: 809 YMAPEY---AMRGYLTSKADVYSFGVVTLEIVSGK 840
           +MAPE      +GY ++K D++S G V LE+ +G+
Sbjct: 176 WMAPEVIHSYSQGY-SAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 99.6 bits (248), Expect = 6e-23
 Identities = 59/197 (29%), Positives = 106/197 (53%), Gaps = 11/197 (5%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+G+G  G+VY  I ++ G  +A+KQ++ + +      +NEI ++   +HPN+V      
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V EY+    L+      D      +D      +C    + L +LH +   ++
Sbjct: 86  LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 136

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRDIK+ N+LL  D + K++DFG       +++  ST + GT  +MAPE   R     K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195

Query: 824 ADVYSFGVVTLEIVSGK 840
            D++S G++ +E+V G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 99.6 bits (248), Expect = 7e-23
 Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 28/219 (12%)

Query: 645 KVGEGGFGSVY----KGIL-------------SDGTVIAVKQLSSKSRQGNR-EFVNEIG 686
           K+GEG FG V+    +G+              +   ++AVK L   + +  R +F+ EI 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLK--LDWPT 740
           ++S  + PN+++L   C+  + L ++ EYM+    N  LSR    +  E      + + T
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 741 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHI 799
              +   IA G+ YL   S +  VHRD+ T N L+ K+   KI+DFG+++ LY  D   I
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 800 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             R    I +M+ E  + G  T+ +DV++FGV   EI++
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  104 bits (261), Expect = 9e-23
 Identities = 74/245 (30%), Positives = 121/245 (49%), Gaps = 27/245 (11%)

Query: 49  CSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVE-LS 107
           CSS   ++  + L + +L G +P  L   R L+++ L  N  +G    ++  L LV  L 
Sbjct: 377 CSSG--NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD 434

Query: 108 VMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA 167
           +  N L G       ++ +L+ LS+  N F G + PD      L+ L LS N F+G +P 
Sbjct: 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL-PDSFGSKRLENLDLSRNQFSGAVPR 493

Query: 168 ELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR 227
           +L  L+ L  L++S+N  SG+IP+ +   KK+  L +  + L G IPAS S +  L+ L 
Sbjct: 494 KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQL- 552

Query: 228 ISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 287
             DL  ++                    + GEIP  +G++  L  +++S N+L G +P+T
Sbjct: 553 --DLSQNQ--------------------LSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590

Query: 288 FEKLA 292
              LA
Sbjct: 591 GAFLA 595

Length = 968

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 99.3 bits (248), Expect = 9e-23
 Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 34/222 (15%)

Query: 645 KVGEGGFGSVY----------------KGILSDGTV-IAVKQL----SSKSRQGNREFVN 683
           K+GEG FG V+                +   +D  V +AVK L    S  +R+   +F+ 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE---DFLK 68

Query: 684 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDT--EYRLKLD 737
           E+ ++S    PN+ +L G C     L ++ EYM+    N  L + +            L 
Sbjct: 69  EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128

Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDK 796
           + T   +   IA G+ YL     +  VHRD+ T N L+ K+   KI+DFG+++ LY  D 
Sbjct: 129 FSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185

Query: 797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             +  R    I +MA E  + G  T+K+DV++FGV   EI++
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 9e-23
 Identities = 67/222 (30%), Positives = 101/222 (45%), Gaps = 31/222 (13%)

Query: 641 DPANK------VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISA-QQ 692
           DP         +GEG +G VYK      G ++A+K +     +   E   E  ++     
Sbjct: 3   DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61

Query: 693 HPNLVKLYGC------CVEGNQLLLVYEYMKNNCLSRAIFG-KDTEYRLKLDWPTRKKIC 745
           HPN+   YG           +QL LV E      ++  + G +    RLK +W     I 
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--IL 119

Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL-AKL-YEEDKTHISTRI 803
               RGLAYLHE+   K++HRDIK  N+LL K+   K+ DFG+ A+L     + +     
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-- 174

Query: 804 AGTIGYMAPE-----YAMRGYLTSKADVYSFGVVTLEIVSGK 840
            GT  +MAPE             +++DV+S G+  +E+  GK
Sbjct: 175 -GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 98.4 bits (245), Expect = 1e-22
 Identities = 67/203 (33%), Positives = 98/203 (48%), Gaps = 18/203 (8%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           +G+G +G VY    LS    IA+K++  +  +  +    EI + S  +H N+V+  G   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 705 EGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
           E     +  E +    LS   R+ +G      LK +  T       I  GL YLH++   
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGP-----LKDNEQTIIFYTKQILEGLKYLHDN--- 127

Query: 762 KIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPE---YAMR 817
           +IVHRDIK  NVL++      KISDFG +K          T   GT+ YMAPE      R
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPR 186

Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
           GY  + AD++S G   +E+ +GK
Sbjct: 187 GY-GAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 99.0 bits (246), Expect = 1e-22
 Identities = 67/202 (33%), Positives = 112/202 (55%), Gaps = 19/202 (9%)

Query: 646 VGEGGFGSVYKGI-LSDGTVI----AVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 699
           +G G FG+VYKGI + +G  +    A+K L+  +  + N EF++E  ++++  HP+LV+L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
            G C+    + LV + M + CL   +     +   +L L+W      C+ IA+G+ YL E
Sbjct: 75  LGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAM 816
               ++VHRD+   NVL+    + KI+DFGLA+L E D+   +       I +MA E   
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 817 RGYLTSKADVYSFGVVTLEIVS 838
               T ++DV+S+GV   E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 98.6 bits (245), Expect = 1e-22
 Identities = 58/197 (29%), Positives = 106/197 (53%), Gaps = 11/197 (5%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+G+G  G+VY  I ++ G  +A+KQ++ + +      +NEI ++   ++PN+V      
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V EY+    L+      D      +D      +C    + L +LH +   ++
Sbjct: 86  LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALDFLHSN---QV 136

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRDIK+ N+LL  D + K++DFG       +++  ST + GT  +MAPE   R     K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195

Query: 824 ADVYSFGVVTLEIVSGK 840
            D++S G++ +E+V G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 23/213 (10%)

Query: 646 VGEGGFGSVYKGILSD------GTVIAVKQL-SSKSRQGNREFVNEIGMI-SAQQHPNLV 697
           +GEG FG V K            + +AVK L    + +   + V+E+ M+    +H N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKI--------CI 746
            L G C +   L +V EY  +  L    RA              P  + +          
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAG 805
            +ARG+ +L   S+ K +HRD+   NVL+ +D   KI+DFGLA+ ++  D    +T    
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196

Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            + +MAPE       T ++DV+SFGV+  EI +
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 98.3 bits (245), Expect = 2e-22
 Identities = 69/217 (31%), Positives = 120/217 (55%), Gaps = 14/217 (6%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNL 696
           NF    K+GEG + +VYKG   + G ++A+K++   + +G     + EI ++   +H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTE-YRLKLDWPTRKKICIGIARGLAYL 755
           V+L+      N+L+LV+EYM  + L + +   DT   R  LD  T K     + +G+A+ 
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKD-LKKYM---DTHGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
           HE+   +++HRD+K  N+L++K    K++DFGLA+ +       S  +  T+ Y AP+  
Sbjct: 117 HEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVL 172

Query: 816 M--RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 850
           +  R Y TS  D++S G +  E+++G+       NED
Sbjct: 173 LGSRTYSTS-IDIWSVGCIMAEMITGRPLFPGTNNED 208

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 97.7 bits (243), Expect = 2e-22
 Identities = 67/203 (33%), Positives = 106/203 (52%), Gaps = 21/203 (10%)

Query: 646 VGEGGFGSVYKGI-LSDGTVI----AVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 699
           +G G FG+V+KGI + +G  I    A+K +  +S RQ  +E  + +  + +  H  +V+L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 700 YGCCVEGNQLLLVYEYMKNNCL---SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
            G C  G  L LV +      L    R         RL L+W      C+ IA+G+ YL 
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRL-LNW------CVQIAKGMYYLE 126

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYA 815
           E    ++VHR++   N+LL  D   +I+DFG+A  LY +DK +  +     I +MA E  
Sbjct: 127 EH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183

Query: 816 MRGYLTSKADVYSFGVVTLEIVS 838
           + G  T ++DV+S+GV   E++S
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 97.3 bits (242), Expect = 3e-22
 Identities = 69/225 (30%), Positives = 116/225 (51%), Gaps = 17/225 (7%)

Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 700
           +G G FG V  G L         +A+K L +  + +  R+F++E  ++    HPN++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   +++V EYM+N  L   +   D ++  ++L    R     GIA G+ YL   S
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR-----GIASGMKYL---S 123

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGL+++ E+D     T   G I   + APE    
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  ++  Y L
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL 228

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 96.9 bits (241), Expect = 4e-22
 Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 31/212 (14%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGN--REFVNEIGMISAQQHPNLVK 698
           +G G F S Y+   +  GT++AVKQ++    + S Q         EI +++   HP++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           + G   E +   L  E+M    +S  +  +G   E  +             + RGL+YLH
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-------INYTEQLLRGLSYLH 120

Query: 757 EDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKT---HISTRIAGTIGYM 810
           E+   +I+HRD+K +N+L+D   + L  +I+DFG A       T       ++ GTI +M
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 811 APEYAMRG--YLTSKADVYSFGVVTLEIVSGK 840
           APE  +RG  Y  S  DV+S G V +E+ + K
Sbjct: 176 APE-VLRGEQYGRS-CDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 97.0 bits (241), Expect = 5e-22
 Identities = 58/198 (29%), Positives = 107/198 (54%), Gaps = 13/198 (6%)

Query: 645 KVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+GEG  G V    + S G ++AVK++  + +Q      NE+ ++   QH N+V++Y   
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V E+++   L+      D     +++      +C+ + + L+ LH      +
Sbjct: 87  LVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---V 137

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGL-AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
           +HRDIK+ ++LL  D   K+SDFG  A++ +E     S  + GT  +MAPE   R     
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGP 195

Query: 823 KADVYSFGVVTLEIVSGK 840
           + D++S G++ +E+V G+
Sbjct: 196 EVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 96.4 bits (240), Expect = 5e-22
 Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 25/211 (11%)

Query: 646 VGEGGFGSVYKGILS--DGTV--IAVK--QLSSKSRQGNREFVNEIGMISAQQHPNLVKL 699
           +GEG FGSV +G LS  DG+   +AVK  +L   +     EF++E   +    HPN++KL
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 700 YGCCVEGNQL------LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK--KICIGIARG 751
            G C E + L      +++  +MK+  L   +        L    P +   K  + IA G
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIALG 125

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED---KTHISTRIAGTI 807
           + YL   S    +HRD+   N +L +D+   ++DFGL+ K+Y  D   +  I+      +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM---PV 179

Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            ++A E       TSK+DV++FGV   EI +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 96.1 bits (239), Expect = 6e-22
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 23/210 (10%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQL---SSKSRQGNREFVN---EIGMISAQQHPNLV 697
             +G+G +G+VY G+ + G +IAVKQ+   +S      +E+     E+ ++ + +H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           +  G C++ N + +  E++    +S  +  FG   E       P   K    I  G+AYL
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE-------PVFCKYTKQILDGVAYL 118

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-----EEDKTHISTRIAGTIGYM 810
           H +    +VHRDIK +NV+L  +   K+ DFG A+           +++   + GT  +M
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 811 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           APE         K+D++S G    E+ +GK
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 96.3 bits (240), Expect = 9e-22
 Identities = 79/253 (31%), Positives = 118/253 (46%), Gaps = 44/253 (17%)

Query: 631 RQIKAATNNFDPANKVGEGGFGSVYKG-ILSDGTVIAVKQLSSKSRQGNREFVNEIGM-- 687
           ++  A  N+ +   ++G G  G VYK      G V+AVKQ+    R GN+E    I M  
Sbjct: 8   QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDL 64

Query: 688 -ISAQQH--PNLVKLYGCCVEGNQLLLVYEYMKNNC--LSRAIFGKDTEYRLKLDWPTRK 742
            +  + H  P +VK YG  +  + + +  E M      L + I G   E  L        
Sbjct: 65  DVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG------- 117

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
           K+ + I + L YL E     ++HRD+K SN+LLD   N K+ DFG++    + K    TR
Sbjct: 118 KMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TR 173

Query: 803 IAGTIGYMAPE----------YAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE-DF 851
            AG   YMAPE          Y +R      ADV+S G+  +E+ +G+    Y+  + +F
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIR------ADVWSLGISLVELATGQF--PYKNCKTEF 225

Query: 852 VYLLDWAYVLQEE 864
             L     +LQEE
Sbjct: 226 EVL---TKILQEE 235

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 96.0 bits (239), Expect = 9e-22
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 11/207 (5%)

Query: 638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPN 695
                 +++GEG  GSV K  L + G + A+K +++       ++ + E+ +  + + P 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 696 LVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           +VK YG  ++   + + +  EY +   L  +I+ K  +   ++      KI   + +GL+
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YLH     KI+HRDIK SN+LL +    K+ DFG++    E    ++    GT  YMAPE
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFTGTSFYMAPE 173

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                  +  +DV+S G+  LE+   +
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 95.9 bits (238), Expect = 1e-21
 Identities = 65/204 (31%), Positives = 113/204 (55%), Gaps = 23/204 (11%)

Query: 646 VGEGGFGSVYKGI-LSDGTVI----AVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 699
           +G G FG+VYKGI + DG  +    A+K L  + S + N+E ++E  +++    P + +L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTRKKICIGIARGLAYL 755
            G C+  + + LV + M   CL   +  ++ + R+     L+W      C+ IA+G++YL
Sbjct: 75  LGICLT-STVQLVTQLMPYGCLLDYV--RENKDRIGSQDLLNW------CVQIAKGMSYL 125

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEY 814
            E   +++VHRD+   NVL+    + KI+DFGLA+L + D+T          I +MA E 
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182

Query: 815 AMRGYLTSKADVYSFGVVTLEIVS 838
            +    T ++DV+S+GV   E+++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 94.9 bits (236), Expect = 1e-21
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 9/197 (4%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           ++G G FG V  G       +A+K +   S   + EF+ E  ++    H  LV+LYG C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           +   + +V EYM N CL   +     E+  +       ++C  +  G+AYL      + +
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEGMAYLESK---QFI 122

Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD+   N L+D     K+SDFGL++   +D+   S      + +  PE  +    +SK+
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182

Query: 825 DVYSFGVVTLEIVS-GK 840
           DV++FGV+  E+ S GK
Sbjct: 183 DVWAFGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 18/209 (8%)

Query: 639 NFDPANKVGEGGFGS--VYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 694
           ++ P   +G+G FG   +Y+    D +++  K+  L+  S +  R+ +NEI ++S  QHP
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59

Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT---EYRLKLDWPTRKKICIGIARG 751
           N++  Y   ++ N LL+  EY     L   I  +     E  + L +         I   
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY------LFQIVSA 113

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           ++Y+H+     I+HRDIKT N+ L K    K+ DFG++K+   + +   T + GT  YM+
Sbjct: 114 VSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMS 169

Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K+D+++ G V  E+++ K
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 95.9 bits (238), Expect = 1e-21
 Identities = 61/220 (27%), Positives = 113/220 (51%), Gaps = 11/220 (5%)

Query: 622 DLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE 680
           ++   L T+  I      +    K+G+G  G+V+  I ++ G  +A+KQ++ + +     
Sbjct: 3   EIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL 62

Query: 681 FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 740
            +NEI ++   ++PN+V      + G++L +V EY+    L+      D      +D   
Sbjct: 63  IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT------DVVTETCMDEAQ 116

Query: 741 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 800
              +C    + L +LH +   +++HRDIK+ NVLL  D + K++DFG       +++  S
Sbjct: 117 IAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173

Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           T + GT  +MAPE   R     K D++S G++ +E+V G+
Sbjct: 174 TMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 95.2 bits (237), Expect = 2e-21
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 16/212 (7%)

Query: 639 NFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQG-NREFVNEIGMISAQ 691
           N      +G G FG V+    KGI  +G  T++ VK L     +    EF  E+ M    
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLK-LDWPTRKKICIG 747
            H N+V+L G C E     ++ EY     L    RA   KD + +   L    +  +C  
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT 806
           IA G+ +L   S  + VHRD+   N L+      K+S   L+K +Y  +   +   +   
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-P 181

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           + ++APE       ++K+DV+SFGV+  E+ +
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 2e-21
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 36/216 (16%)

Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREF-VNEIGM---ISAQQH 693
           ++   ++GEG +G+VYK   L+ G  +A+K++    S +G     + EI +   + + +H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 694 PNLVKLYGCCV-----EGNQLLLVYEYMK-------NNCLSRAIFGKDTEYRLKLDWPTR 741
           PN+V+L   C         +L LV+E++        + C               L   T 
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-----------LPPETI 109

Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS- 800
           K +   + RG+ +LH     +IVHRD+K  N+L+  D   KI+DFGLA++Y      ++ 
Sbjct: 110 KDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF---EMAL 163

Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEI 836
           T +  T+ Y APE  ++    +  D++S G +  E+
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 30/207 (14%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQH---PNLVKLY 700
           +G G +G+VY+G  +  G V+A+K ++  +   +   +  E+ ++S  +    PN+ K Y
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 701 GCCVEGNQLLLVYEYMKNN---CLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----GLA 753
           G  ++G +L ++ EY +      L +A              P  +K    I R     L 
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKA-------------GPIAEKYISVIIREVLVALK 115

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           Y+H+     ++HRDIK +N+L+    N K+ DFG+A L  ++ +  ST   GT  +MAPE
Sbjct: 116 YIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPE 171

Query: 814 YAMRG-YLTSKADVYSFGVVTLEIVSG 839
               G Y  +KAD++S G+   E+ +G
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 95.2 bits (236), Expect = 2e-21
 Identities = 54/197 (27%), Positives = 105/197 (53%), Gaps = 11/197 (5%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+G+G  G+VY  + ++ G  +A++Q++ + +      +NEI ++   ++PN+V      
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V EY+    L+      D      +D      +C    + L +LH +   ++
Sbjct: 87  LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 137

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRDIK+ N+LL  D + K++DFG       +++  S  + GT  +MAPE   R     K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAYGPK 196

Query: 824 ADVYSFGVVTLEIVSGK 840
            D++S G++ +E++ G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 94.3 bits (234), Expect = 3e-21
 Identities = 68/216 (31%), Positives = 113/216 (52%), Gaps = 23/216 (10%)

Query: 640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLV 697
           F    ++G+G FG V+KGI +    V+A+K +  +  +   E +  EI ++S    P + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 698 KLYGCCVEGNQLLLVYEYMKNNC---LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           K YG  ++G +L ++ EY+       L RA  G   E+++         +   I +GL Y
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIA-------TMLKEILKGLDY 116

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
           LH + +I   HRDIK +NVLL +  + K++DFG+A    + +   +T + GT  +MAPE 
Sbjct: 117 LHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEV 172

Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 850
             +    SKAD++S G+  +E+  G+      PN D
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEP-----PNSD 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 14/212 (6%)

Query: 645 KVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKL 699
            +GEG FG VY+G+     ++   +AVK   + +    RE F+ E  ++    HP++VKL
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
            G   E N + +V E      L   +       +  LD  +       ++  LAYL    
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYL----QVNKYSLDLASLILYSYQLSTALAYLES-- 125

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY 819
             + VHRDI   NVL+      K+ DFGL++  E++  + +++    I +MAPE      
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184

Query: 820 LTSKADVYSFGVVTLEIVS-GKSNTNYRPNED 850
            TS +DV+ FGV   EI+  G        N D
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 93.1 bits (231), Expect = 6e-21
 Identities = 60/194 (30%), Positives = 100/194 (51%), Gaps = 14/194 (7%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
            +GEG FG+V +G  + G  +AVK +  K     + F+ E  +++   H NLV+L G  +
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
             N L +V E M    L   +    T  R  +      +  + +A G+ YL      K+V
Sbjct: 70  H-NGLYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLV 122

Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD+   N+L+ +D  AK+SDFGLA++        ++++   + + APE       +SK+
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLP--VKWTAPEALKHKKFSSKS 178

Query: 825 DVYSFGVVTLEIVS 838
           DV+S+GV+  E+ S
Sbjct: 179 DVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 93.6 bits (232), Expect = 8e-21
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 15/199 (7%)

Query: 645 KVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+GEG  G V        G  +AVK +  + +Q      NE+ ++   QH N+V++Y   
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G +L ++ E+++   L+      D   + +L+      +C  + + L YLH      +
Sbjct: 88  LVGEELWVLMEFLQGGALT------DIVSQTRLNEEQIATVCESVLQALCYLHSQG---V 138

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--IAGTIGYMAPEYAMRGYLT 821
           +HRDIK+ ++LL  D   K+SDFG      +D   +  R  + GT  +MAPE   R    
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKSLVGTPYWMAPEVISRTPYG 195

Query: 822 SKADVYSFGVVTLEIVSGK 840
           ++ D++S G++ +E+V G+
Sbjct: 196 TEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 93.5 bits (232), Expect = 1e-20
 Identities = 66/230 (28%), Positives = 113/230 (49%), Gaps = 42/230 (18%)

Query: 645 KVGEGGFGSVY--------------------KGILSDGTVIAVKQLSSKSRQGNR-EFVN 683
           K+GEG FG V+                    KG      ++AVK L   + +  R +F+ 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG---RPLLVAVKILRPDANKNARNDFLK 68

Query: 684 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR---------- 733
           E+ ++S  + PN+++L G CV+ + L ++ EYM+N  L++ +     + +          
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 734 ----LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 789
                 + + +   + + IA G+ YL   S +  VHRD+ T N L+ ++L  KI+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 790 K-LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           + LY  D   I  R    I +MA E  + G  T+ +DV++FGV   EI+ 
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 94.1 bits (234), Expect = 1e-20
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 36/212 (16%)

Query: 644 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN------REFVNEIGMISAQQHPNL 696
           N++G G  G+VYK I    G + A+K +      GN      R+   EI ++    HPN+
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVI-----YGNHEDTVRRQICREIEILRDVNHPNV 134

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           VK +       ++ ++ E+M    L       +      L    R+     I  G+AYLH
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF----LADVARQ-----ILSGIAYLH 185

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY-- 814
              R  IVHRDIK SN+L++   N KI+DFG++++  +     ++ + GTI YM+PE   
Sbjct: 186 ---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERIN 241

Query: 815 ------AMRGYLTSKADVYSFGVVTLEIVSGK 840
                 A  GY     D++S GV  LE   G+
Sbjct: 242 TDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 9/222 (4%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G G FG V+    +  T +AVK +   S      F+ E  ++   QH  LVKL+   V
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV-V 70

Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
               + ++ E+M    L    F K  E   K   P        IA G+A++ + + I   
Sbjct: 71  TKEPIYIITEFMAKGSLLD--FLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNYI--- 124

Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+   L  KI+DFGLA++ E+++          I + APE    G  T K+
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184

Query: 825 DVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEE 865
           DV+SFG++ +EIV+ G+       N + +  L+  Y +   E
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE 226

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 92.8 bits (230), Expect = 1e-20
 Identities = 57/198 (28%), Positives = 104/198 (52%), Gaps = 13/198 (6%)

Query: 645 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+GEG  G V        G  +AVK++  + +Q      NE+ ++    H N+V +Y   
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V E+++   L+      D     +++      +C+ + R L+YLH      +
Sbjct: 89  LVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---V 139

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGL-AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
           +HRDIK+ ++LL  D   K+SDFG  A++ +E     S  + GT  +MAPE   R    +
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGT 197

Query: 823 KADVYSFGVVTLEIVSGK 840
           + D++S G++ +E++ G+
Sbjct: 198 EVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 16/200 (8%)

Query: 644 NKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+       +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 703 CVEGNQLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
           C       ++ E+M   N L    + ++   R +++      +   I+  + YL + + I
Sbjct: 71  CTREPPFYIITEFMTYGNLLD---YLRECN-RQEVNAVVLLYMATQISSAMEYLEKKNFI 126

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT---IGYMAPEYAMRG 818
              HRD+   N L+ ++   K++DFGL++L   D     T  AG    I + APE     
Sbjct: 127 ---HRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYN 180

Query: 819 YLTSKADVYSFGVVTLEIVS 838
             + K+DV++FGV+  EI +
Sbjct: 181 KFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 22/214 (10%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQ-----LSSKSRQGNREFVNEIGMISAQ 691
            N+     +G+G FG VY     D G  +AVKQ      S ++++       EI ++   
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
           QH  +V+ YGC  +   L +  EYM    +   +  +G  TE          +K    I 
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTE-------TVTRKYTRQIL 114

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTI 807
            G+ YLH +    IVHRDIK +N+L D   N K+ DFG +K  +   +  +    + GT 
Sbjct: 115 EGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171

Query: 808 GYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK 840
            +M+PE     GY   KADV+S G   +E+++ K
Sbjct: 172 YWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 92.9 bits (231), Expect = 2e-20
 Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 20/203 (9%)

Query: 645 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKLY 700
           ++G G FG+VY         V+A+K++S   +Q N   ++ + E+  +   +HPN ++  
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           GC +  +   LV EY    CL  A    +  ++  L       IC G  +GLAYLH   R
Sbjct: 82  GCYLREHTAWLVMEY----CLGSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSHER 136

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAM-R 817
           I   HRDIK  N+LL +    K++DFG A L     + +     GT  +MAPE   AM  
Sbjct: 137 I---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDE 188

Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
           G    K DV+S G+  +E+   K
Sbjct: 189 GQYDGKVDVWSLGITCIELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 28/201 (13%)

Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 705
           +G+G FG V  G    G  +AVK +  K+    + F+ E  +++  +H NLV+L G  VE
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 706 GN-QLLLVYEYMKNNCL-------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
               L +V EYM    L        R++ G D   +  LD          +   + YL  
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD----------VCEAMEYLEA 120

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
           ++    VHRD+   NVL+ +D  AK+SDFGL K  E   T  + ++   + + APE    
Sbjct: 121 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALRE 173

Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              ++K+DV+SFG++  EI S
Sbjct: 174 KKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 92.0 bits (228), Expect = 2e-20
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 22/213 (10%)

Query: 645 KVGEGGFGSVYKGIL-----SDGTVIAVKQLSS-KSRQGNREFVNEIGMISAQQHPNLVK 698
           ++GE  FG +YKG L         ++A+K L    + Q   EF  E  +++   HPN+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIF------------GKDTEYRLKLDWPTRKKICI 746
           L G   +   + +++EY+    L   +              +D   +  LD      I I
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAG 805
            IA G+ YL   S    VH+D+   N+L+ + L+ KISD GL++ +Y  D   +  +   
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            I +M PE  M G  +S +D++SFGVV  EI S
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 36/212 (16%)

Query: 645 KVGEGGFGSVYKG--ILSDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKL 699
           K+G+G FG V +G    S G VI  AVK L S        +F+ E  ++ +  H NL++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 700 YGCCVEGNQLLLV---------YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 750
           YG  V  + L++V          + ++ + L   +     +Y             + IA 
Sbjct: 62  YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY------------AVQIAN 108

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIST---RIAGT 806
           G+ YL      + +HRD+   N+LL  D   KI DFGL + L + +  ++     ++   
Sbjct: 109 GMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP-- 163

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             + APE       +  +DV+ FGV   E+ +
Sbjct: 164 FAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 31/215 (14%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYG 701
           ++G G FG V+ G       +A+K +     +G     +F+ E  ++    HP LV+LYG
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 702 CCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
            C +   L +V E+M+N CL       +    KD              +C  +  G+ YL
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL----------SMCQDVCEGMEYL 116

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
             +S I   HRD+   N L+      K+SDFG+ +   +D+   S+     + +  PE  
Sbjct: 117 ERNSFI---HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVF 173

Query: 816 MRGYLTSKADVYSFGVVTLEIVS-GK----SNTNY 845
                +SK+DV+SFGV+  E+ + GK      +NY
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 21/213 (9%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ------LSSKSRQGNREFVNEIGMISAQ 691
           NF    K+G G F  VY+   L DG  +A+K+      + +K+R    + + EI ++   
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 59

Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL---KLDWPTRKKICIGI 748
            HPN++K Y   +E N+L +V E      LSR I     + RL   K  W    ++C   
Sbjct: 60  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC--- 116

Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
              L ++H  SR +++HRDIK +NV +      K+ D GL + +   KT  +  + GT  
Sbjct: 117 -SALEHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPY 171

Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           YM+PE         K+D++S G +  E+ + +S
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 91.4 bits (227), Expect = 3e-20
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 30/212 (14%)

Query: 646 VGEGGFGSVYKGILSDG--TVIAVKQLS---------SKSRQGN-REFVNEIGMISAQ-Q 692
           +G G FG VYK    +    ++A+K+++          + R  +  + V+E+ +I  Q +
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF------GKDTEYRLKLDWPTRKKICI 746
           HPN+V+ Y   +E ++L +V + ++   L            + TE R+   W     I +
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI---W----NIFV 120

Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 806
            +   L YLH++ RI  VHRD+  +N++L +D    I+DFGLAK  + +     T + GT
Sbjct: 121 QMVLALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGT 176

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           I Y  PE         KADV++FG +  ++ +
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 91.6 bits (227), Expect = 3e-20
 Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 16/207 (7%)

Query: 645 KVGEGGFGSVYKGILSD------GTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLV 697
           ++G+G FG VY+G   D       T +AVK ++ S S +   EF+NE  ++      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKI---CIGIARGL 752
           +L G   +G   L+V E M +  L   +     + E       PT +++      IA G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMA 811
           AYL+     K VHRD+   N ++  D   KI DFG+ + +YE D      +    + +MA
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVS 838
           PE    G  T+ +D++SFGVV  EI S
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 91.2 bits (226), Expect = 3e-20
 Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 16/207 (7%)

Query: 645 KVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLV 697
           ++G+G FG VY    KG++ D   T +A+K ++  +    R EF+NE  ++      ++V
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICI---GIARGL 752
           +L G   +G   L++ E M    L   +     + E       P+ KK+      IA G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMA 811
           AYL+ +   K VHRD+   N ++ +D   KI DFG+ + +YE D      +    + +M+
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVS 838
           PE    G  T+ +DV+SFGVV  EI +
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 91.7 bits (228), Expect = 4e-20
 Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 19/210 (9%)

Query: 639 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLS-SKSRQG-NREFVNEIGMISAQQHPN 695
            F+  N++GEG +G VY+   +  G ++A+K++     R G     + EI ++   +HPN
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 696 LVKLYGCCVEGNQL---LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           +V+L    V G  L    LV EY + + L+  +    T +         K + + + RGL
Sbjct: 68  IVELKEV-VVGKHLDSIFLVMEYCEQD-LASLLDNMPTPFSE----SQVKCLMLQLLRGL 121

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
            YLHE+    I+HRD+K SN+LL      KI+DFGLA+ Y      ++ ++  T+ Y AP
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177

Query: 813 E--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
           E       Y T+  D+++ G +  E+++ K
Sbjct: 178 ELLLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 90.4 bits (224), Expect = 4e-20
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 10/195 (5%)

Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGCCV 704
           +G+G FG V+KG L D T +AVK       Q  + +F++E  ++    HPN+VKL G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           +   + +V E +        +  K  E + K       K  +  A G+AYL   +    +
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKKKDELKTK----QLVKFALDAAAGMAYLESKN---CI 115

Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAMRGYLTSK 823
           HRD+   N L+ ++   KISDFG+++  E+D  + S+ +    I + APE    G  +S+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174

Query: 824 ADVYSFGVVTLEIVS 838
           +DV+S+G++  E  S
Sbjct: 175 SDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 91.1 bits (226), Expect = 4e-20
 Identities = 71/231 (30%), Positives = 102/231 (44%), Gaps = 42/231 (18%)

Query: 646 VGEGGFGSVYKGIL------SDGT--VIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNL 696
           +GEG FG V    L      +DGT  ++AVK L  +  Q N   +  EI ++    H N+
Sbjct: 12  LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68

Query: 697 VKLYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG------- 747
           VK  GCC E     L L+ EY+    L               D+  + K+ +        
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSL--------------RDYLPKHKLNLAQLLLFAQ 114

Query: 748 -IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 806
            I  G+AYLH    I   HRD+   NVLLD D   KI DFGLAK   E   +   R  G 
Sbjct: 115 QICEGMAYLHSQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171

Query: 807 --IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 855
             + + A E       +  +DV+SFGV   E+++   ++   P + F  ++
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMI 221

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 91.6 bits (227), Expect = 5e-20
 Identities = 61/204 (29%), Positives = 115/204 (56%), Gaps = 23/204 (11%)

Query: 646 VGEGGFGSVYKGI-LSDGTVI----AVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 699
           +G G FG+VYKG+ + +G  +    A+K+L  + S + N+E ++E  ++++  +P++ +L
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTRKKICIGIARGLAYL 755
            G C+  + + L+ + M   CL   +  ++ +  +     L+W      C+ IA+G+ YL
Sbjct: 75  LGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIAKGMNYL 125

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIGYMAPEY 814
            E    ++VHRD+   NVL+    + KI+DFGLAKL   ++K + +      I +MA E 
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182

Query: 815 AMRGYLTSKADVYSFGVVTLEIVS 838
            +    T ++DV+S+GV   E+++
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 91.6 bits (228), Expect = 5e-20
 Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 46/235 (19%)

Query: 636 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ-LSSKSRQGNREF----VNEIGMIS 689
              +++   K+GEG FG VYK   +  G V+A+K+ L    + G   F    + EI ++ 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62

Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY------------RLKLD 737
             +HPN+V L         + +  E    +   R      T Y             +KL 
Sbjct: 63  KLKHPNVVPL---------IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT 113

Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK- 796
               K   + +  G+ YLHE+    I+HRDIK +N+L+D     KI+DFGLA+ Y+    
Sbjct: 114 ESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170

Query: 797 ---------THISTRIAGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 840
                    T   T +  T  Y  PE  +  R Y T+  D++  G V  E+ + +
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 90.8 bits (225), Expect = 6e-20
 Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 20/201 (9%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAV-KQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           ++G+G FG VYK    +  V+A  K + +KS +   +++ EI ++++  HPN+VKL    
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
              N L ++ E+    C   A+     E    L  P  + +C      L YLHE+   KI
Sbjct: 72  YYENNLWILIEF----CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KI 124

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--IAGTIGYMAPEYAM----- 816
           +HRD+K  N+L   D + K++DFG++    ++   I  R    GT  +MAPE  M     
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181

Query: 817 -RGYLTSKADVYSFGVVTLEI 836
            R Y   KADV+S G+  +E+
Sbjct: 182 DRPY-DYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 89.8 bits (223), Expect = 7e-20
 Identities = 81/235 (34%), Positives = 117/235 (49%), Gaps = 28/235 (11%)

Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
           +G+G FG VY G L  SDG  I  AVK L+  +     E F+ E  ++    HPN++ L 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 701 GCCVEGNQL-LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG----IARGLAYL 755
           G C+      L+V  YMK+  L   I       R +   PT K + IG    +A+G+ YL
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFI-------RSETHNPTVKDL-IGFGLQVAKGMEYL 114

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LY--EEDKTHISTRIAGTIGYMAP 812
                 K VHRD+   N +LD+    K++DFGLA+ +Y  E    H  T     + +MA 
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171

Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y   + F   VYLL    +LQ E
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITVYLLQGRRLLQPE 225

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 61/201 (30%), Positives = 87/201 (43%), Gaps = 14/201 (6%)

Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 701
           +G+GGFG V    +   G + A K+L  K    R+G +  +NE  ++       +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
                + L LV   M    L   I+                     I  GL +LH+    
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEP---GFPEARAIFYAAQIICGLEHLHQR--- 114

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
           +IV+RD+K  NVLLD   N +ISD GLA +L    K       AGT GYMAPE       
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEVY 171

Query: 821 TSKADVYSFGVVTLEIVSGKS 841
               D ++ G    E+++G+S
Sbjct: 172 DFSVDWFALGCTLYEMIAGRS 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 22/211 (10%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREF----VNEIGMISAQQ 692
           N ++    VGEG +G V K      G ++A+K+   K  + + +     + E+ ++   +
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLR 58

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           H N+V L        +L LV+EY++   L              L     +     + + +
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEYVERTLLELL-----EASPGGLPPDAVRSYIWQLLQAI 113

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           AY H      I+HRDIK  N+L+ +    K+ DFG A+          T    T  Y AP
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170

Query: 813 E----YAMRGYLTSKADVYSFGVVTLEIVSG 839
           E        G      DV++ G +  E++ G
Sbjct: 171 ELLVGDTNYG---KPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 89.0 bits (220), Expect = 2e-19
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 25/218 (11%)

Query: 640 FDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLV 697
           F    ++G+G FG VYKGI +    V+A+K +  +  +   E +  EI ++S    P + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----GLA 753
           + YG  ++G +L ++ EY+          G  +   L    P  +     I R    GL 
Sbjct: 66  RYYGSYLKGTKLWIIMEYL----------GGGSALDLLKPGPLEETYIATILREILKGLD 115

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YLH + +I   HRDIK +NVLL +  + K++DFG+A    + +   +T + GT  +MAPE
Sbjct: 116 YLHSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 171

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF 851
              +     KAD++S G+  +E+  G+      PN D 
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEP-----PNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 88.6 bits (220), Expect = 3e-19
 Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 18/198 (9%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 705
           G+G FG VYK      G   A K +  +S +   +F+ EI ++S  +HPN+V LY     
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73

Query: 706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVH 765
            N+L ++ E+    C   A+     E    L  P  + +C  +   L +LH     K++H
Sbjct: 74  ENKLWILIEF----CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126

Query: 766 RDIKTSNVLLDKDLNAKISDFGL-AKLYEEDKTHISTRIAGTIGYMAPEYAM------RG 818
           RD+K  N+LL  D + K++DFG+ AK     +    T I GT  +MAPE           
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACETFKDNP 184

Query: 819 YLTSKADVYSFGVVTLEI 836
           Y   KAD++S G+  +E+
Sbjct: 185 Y-DYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 88.6 bits (219), Expect = 4e-19
 Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 22/202 (10%)

Query: 645 KVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           ++G+G FG VYK    + G + A K + +KS +   +++ EI +++   HP +VKL G  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
               +L ++ E+    C   A+     E    L  P  + IC  +   L YLH    +KI
Sbjct: 79  YWDGKLWIMIEF----CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKI 131

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLA----KLYEEDKTHISTRIAGTIGYMAPEYAMRGY 819
           +HRD+K  NVLL  D + K++DFG++    K  +   + I     GT  +MAPE  M   
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186

Query: 820 LTS-----KADVYSFGVVTLEI 836
           +       KAD++S G+  +E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 28/208 (13%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR-QGNREFV-----NEIGMISAQQHPNLV 697
           K+GEG +G VYK      G ++A+K    K R +   E V      EI ++    HPN+V
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALK----KIRLETEDEGVPSTAIREISLLKELNHPNIV 61

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           +L       N+L LV+E++  + L + +   D+     LD P  K     + +G+AY H 
Sbjct: 62  RLLDVVHSENKLYLVFEFLDLD-LKKYM---DSSPLTGLDPPLIKSYLYQLLQGIAYCH- 116

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE---EDKTHISTRIAGTIGYMAPEY 814
            S  +++HRD+K  N+L+D++   K++DFGLA+ +       TH       T+ Y APE 
Sbjct: 117 -SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEI 170

Query: 815 AM--RGYLTSKADVYSFGVVTLEIVSGK 840
            +  R Y T   D++S G +  E+V+ +
Sbjct: 171 LLGSRQYSTP-VDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 87.4 bits (217), Expect = 8e-19
 Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 47/219 (21%)

Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNRE---FVNEIGMI-SAQQHPNLVKLY 700
           +G G FG+V K +    GT++AVK++ S      +E    + ++ ++  +   P +VK Y
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DEKEQKRLLMDLDVVMRSSDCPYIVKFY 69

Query: 701 G-------C--CVE------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
           G       C  C+E            VYE +  + +   I GK               I 
Sbjct: 70  GALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGK---------------IA 113

Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
           +   + L YL E+  +KI+HRD+K SN+LLD++ N K+ DFG++    +  +   TR AG
Sbjct: 114 VATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--SIAKTRDAG 169

Query: 806 TIGYMAPE----YAMRGYLTSKADVYSFGVVTLEIVSGK 840
              YMAPE     A  GY   ++DV+S G+   E+ +GK
Sbjct: 170 CRPYMAPERIDPSARDGY-DVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 87.1 bits (215), Expect = 8e-19
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 12/203 (5%)

Query: 640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLV 697
           F    K+G+G FG V+KGI +    V+A+K +  +  +   E +  EI ++S    P + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           K YG  ++  +L ++ EY+            D      LD      I   I +GL YLH 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGS------ALDLLEPGPLDETQIATILREILKGLDYLHS 119

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
           + +I   HRDIK +NVLL +    K++DFG+A    + +        GT  +MAPE   +
Sbjct: 120 EKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQ 175

Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
               SKAD++S G+  +E+  G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 22/213 (10%)

Query: 645 KVGEGGFGSVYKGILSDGT------VIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 697
           ++GE  FG VYKG L           +A+K L  K+    RE F +E  M S  QHPN+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK-----------DTEYRLKLDWPTRKKICI 746
            L G   +   L +++ Y  ++ L   +  +           D   +  L+      I  
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAG 805
            IA G+ +L   S   +VH+D+ T NVL+   LN KISD GL + +Y  D   +      
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            I +M+PE  M G  +  +D++S+GVV  E+ S
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)

Query: 639 NFDPANKVGEGGFGSVY--KGILSDGTVI----AVKQLSSKSRQGNREFVNEIGMISAQQ 692
            ++    VG G FG V+  +       VI     V+Q++   R   +   NE  ++    
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLS 57

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+++ Y   +E   L++V EY     L+  I  +       LD  T     + I   L
Sbjct: 58  HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL---LDEDTILHFFVQILLAL 114

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLN-AKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
            ++H      I+HRD+KT N+LLDK     KI DFG++K+    K+   T + GT  Y++
Sbjct: 115 HHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYT-VVGTPCYIS 169

Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K+D+++ G V  E+ S K
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 23/212 (10%)

Query: 639 NFDPANKVGEGGFGSVY--KG-ILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 695
            ++   K+GEG FG +Y  K    S+  VI    L+    +       E+ +++  +HPN
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 696 LVKLYGCCVEGNQLLLVYEY------MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           +V  +    E  +L +V EY      MK     R +   + +    L W       + I+
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI---LSW------FVQIS 111

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            GL ++H+    KI+HRDIK+ N+ L K+ + AK+ DFG+A+    D   ++    GT  
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPY 167

Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           Y++PE        +K D++S G V  E+ + K
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 19/235 (8%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIA---VKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 699
           +++G G FG V  G    G   A   VK+L +S +      F+ E+       HPN+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
            G C+E    LLV E+     L   +                +++   +A GL +LH   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAPEYA--- 815
           +   +H D+   N  L  DL+ KI D+GLA + Y ED        A  + ++APE     
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 816 ----MRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEI 866
               +    T K++++S GV   E+         +P  D         V++E++I
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL----FTAADQPYPDLSDEQVLKQVVREQDI 228

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 60/211 (28%), Positives = 110/211 (52%), Gaps = 21/211 (9%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREF----VNEIGMISAQQ 692
            ++  N++ EG +G VY+      G ++A+K+L   K ++G   F    + EI ++   Q
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQ 62

Query: 693 HPNLVKLYGCCVEGN--QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 750
           HPN+V +    V  N  ++ +V EY++++ L   +      +         K + + +  
Sbjct: 63  HPNIVTVKEVVVGSNLDKIYMVMEYVEHD-LKSLMETMKQPFLQ----SEVKCLMLQLLS 117

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 810
           G+A+LH++    I+HRD+KTSN+LL+     KI DFGLA+ Y        T++  T+ Y 
Sbjct: 118 GVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVVTLWYR 173

Query: 811 APEYAM-RGYLTSKADVYSFGVVTLEIVSGK 840
           APE  +     ++  D++S G +  E+++ K
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 86.6 bits (214), Expect = 2e-18
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 20/204 (9%)

Query: 644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKL 699
           +++G G FG+VY    S    V+AVK++S   +Q N   ++ + E+  +   +HPN ++ 
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
            GC ++ +   LV EY    CL  A    +  ++  L       I  G  +GLAYLH  +
Sbjct: 87  KGCYLKEHTAWLVMEY----CLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN 141

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM--- 816
            I   HRDIK  N+LL +    K++DFG A      K+  +    GT  +MAPE  +   
Sbjct: 142 MI---HRDIKAGNILLTEPGQVKLADFGSAS-----KSSPANSFVGTPYWMAPEVILAMD 193

Query: 817 RGYLTSKADVYSFGVVTLEIVSGK 840
            G    K DV+S G+  +E+   K
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERK 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 86.3 bits (213), Expect = 3e-18
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 20/208 (9%)

Query: 640 FDPANKVGEGGFGSVY-KGILSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 695
           F    ++G G FG+VY    +    V+A+K++S   +Q N   ++ + E+  +   +HPN
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
            ++  GC +  +   LV EY    CL  A    +  ++  L       I  G  +GLAYL
Sbjct: 87  SIEYKGCYLREHTAWLVMEY----CLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYL 141

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
           H  +   ++HRDIK  N+LL +    K++DFG A +     + +     GT  +MAPE  
Sbjct: 142 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193

Query: 816 M---RGYLTSKADVYSFGVVTLEIVSGK 840
           +    G    K DV+S G+  +E+   K
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERK 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 85.5 bits (211), Expect = 5e-18
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 20/208 (9%)

Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 695
           F    ++G G FG+VY    + +  V+A+K++S   +Q N   ++ + E+  +   +HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
            ++  GC +  +   LV EY    CL  A    +  ++  L       +  G  +GLAYL
Sbjct: 77  TIQYRGCYLREHTAWLVMEY----CLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYL 131

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
           H  +   ++HRD+K  N+LL +    K+ DFG A +       +     GT  +MAPE  
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183

Query: 816 M---RGYLTSKADVYSFGVVTLEIVSGK 840
           +    G    K DV+S G+  +E+   K
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 16/206 (7%)

Query: 646 VGEGGFGSVYKGILS-DGTV--IAVK--QLSSKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           +GEG FGSV +G L+ D ++  +AVK  +++  +R    +F++E   +    HPN+++L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 701 GCCVEGNQL------LLVYEYMKNNCL-SRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           G C++  +       +++  +MK+  L S  ++ +  +    L      K    IA G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAP 812
           YL   S    +HRD+   N +L++++N  ++DFGL+K       +   RIA   + ++A 
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVS 838
           E       T+K+DV+SFGV   EI +
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 84.3 bits (208), Expect = 6e-18
 Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 19/212 (8%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ------LSSKSRQGNREFVNEIGMISAQ 691
           NF    K+G G F  VY+   L D   +A+K+      + +K+RQ   + V EI ++   
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQL 59

Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK--KICIGIA 749
            HPN++K     +E N+L +V E      LS+ I     + RL    P R   K  + + 
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL---IPERTVWKYFVQLC 116

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
             + ++H  SR +++HRDIK +NV +      K+ D GL + +   KT  +  + GT  Y
Sbjct: 117 SAVEHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYY 172

Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           M+PE         K+D++S G +  E+ + +S
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 84.1 bits (208), Expect = 2e-17
 Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 41/223 (18%)

Query: 638 NNFDPANKVGEGGFGSVYK----GILSDGTVI--AVKQLSSKSRQGNRE-FVNEIGMIS- 689
           NN      +G G FG V +    G+     V+  AVK L   +    RE  ++E+ ++S 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK------ 743
              H N+V L G C  G  +L++ EY    C           Y   L++  RK+      
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEY----CC----------YGDLLNFLRRKRESFLTL 140

Query: 744 ---ICIG--IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 798
              +     +A+G+A+L   +    +HRD+   NVLL      KI DFGLA+    D  +
Sbjct: 141 EDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY 197

Query: 799 I---STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +   + R+   + +MAPE       T ++DV+S+G++  EI S
Sbjct: 198 VVKGNARLP--VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 45/217 (20%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQL-SSKSRQGNREFVNE--IGMISAQQHPNLVKLYGC 702
           G G +G V K   +  GT++AVK++ ++ + Q  +  + +  I M S    P  V  YG 
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVD-CPYTVTFYGA 68

Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR------KKICIGIARGLAYLH 756
                 + +  E M    L       D  Y+   D           KI + I + L YLH
Sbjct: 69  LFREGDVWICMEVMDT-SL-------DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFG--------LAKLYEEDKTHISTRIAGTIG 808
              ++ ++HRD+K SNVL++++   K+ DFG        +AK          T  AG   
Sbjct: 121 S--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK----------TIDAGCKP 168

Query: 809 YMAPE-----YAMRGYLTSKADVYSFGVVTLEIVSGK 840
           YMAPE        +GY   K+DV+S G+  +E+ +G+
Sbjct: 169 YMAPERINPELNQKGY-DVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 83.5 bits (206), Expect = 2e-17
 Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 21/209 (10%)

Query: 646 VGEGGFGSVYKGILS-DGTVI--AVKQLSS-KSRQGNREFVNEIGMISA-QQHPNLVKLY 700
           +GEG FG V + ++  DG  +  A+K L    S   +R+F  E+ ++     HPN++ L 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 701 GCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWPTRKKICIGIA 749
           G C     L +  EY     L      SR +     F K+      L      +    +A
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ YL E    + +HRD+   NVL+ ++L +KI+DFGL++  E        R+   + +
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP--VRW 184

Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           MA E       T+K+DV+SFGV+  EIVS
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 82.3 bits (203), Expect = 3e-17
 Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 14/200 (7%)

Query: 645 KVGEGGFGSVYKGIL---SDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 700
           ++G G FG V KG+         +A+K L +++ +  R E + E  ++    +P +V++ 
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G C E   L+LV E      L++ + GK  E  +        ++   ++ G+ YL   + 
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVS----NVVELMHQVSMGMKYLEGKN- 115

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAMRG 818
              VHRD+   NVLL     AKISDFGL+K    D ++   R AG   + + APE     
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173

Query: 819 YLTSKADVYSFGVVTLEIVS 838
             +S++DV+S+G+   E  S
Sbjct: 174 KFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 82.4 bits (203), Expect = 5e-17
 Identities = 57/228 (25%), Positives = 110/228 (48%), Gaps = 33/228 (14%)

Query: 640 FDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNREF--VNEIGMI---SAQQ 692
           ++   ++GEG +G V+K   + + G  +A+K++  ++ +       + E+ ++      +
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62

Query: 693 HPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWP-----TRK 742
           HPN+V+L+  C         +L LV+E++  +          T Y  K+  P     T K
Sbjct: 63  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL---------TTYLDKVPEPGVPTETIK 113

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
            +   + RGL +LH     ++VHRD+K  N+L+      K++DFGLA++Y        T 
Sbjct: 114 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTS 168

Query: 803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 850
           +  T+ Y APE  ++    +  D++S G +  E+   +    +R + D
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSD 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 81.8 bits (202), Expect = 6e-17
 Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 18/210 (8%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPN 695
           NF    K+GEG +G VYK      G V+A+K+  L +++       + EI ++    HPN
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           +VKL       N+L LV+E++ +  L + +   D      +  P  K     + +GLA+ 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASPLSGIPLPLIKSYLFQLLQGLAFC 116

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE---EDKTHISTRIAGTIGYMAP 812
           H     +++HRD+K  N+L++ +   K++DFGLA+ +       TH       T+ Y AP
Sbjct: 117 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 169

Query: 813 EYAM-RGYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.8 bits (202), Expect = 6e-17
 Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 12/197 (6%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGCC 703
           +G G  GSV K   +  GTV+A K +   ++   R + + E+ ++   + P +V  YG  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           +  N + +  E+M    L R I+ K     +++      KI + +  GL YL+   RI  
Sbjct: 73  LNENNICMCMEFMDCGSLDR-IYKKGGPIPVEI----LGKIAVAVVEGLTYLYNVHRI-- 125

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRDIK SN+L++     K+ DFG++    E    I+    GT  YM+PE    G  T K
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFVGTSTYMSPERIQGGKYTVK 182

Query: 824 ADVYSFGVVTLEIVSGK 840
           +DV+S G+  +E+  GK
Sbjct: 183 SDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 67/234 (28%), Positives = 110/234 (47%), Gaps = 19/234 (8%)

Query: 645 KVGEGGFGSVYKGILSDG---TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           ++G G FG V  G ++ G     + VK+L  S S Q   +F+ E     + QH NL++  
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G C E    LLV E+     L   +        +  D  T +++   IA GL +LH+++ 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKL-YEEDKTHISTRIAGTIGYMAPEYA--MR 817
              +H D+   N LL  DL  KI D+GL+   Y+ED      ++   + ++APE    + 
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 818 GYL-----TSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEI 866
           G L     T +++V+S GV   E+     +  YR   D   L    Y ++E+++
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFE-LGSQPYRHLSDEQVL---TYTVREQQL 228

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 23/214 (10%)

Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLV 697
           F+    VG G +G VYKG  +  G + A+K +     +   E   EI M+     H N+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66

Query: 698 KLYGCCVEGN------QLLLVYEYMKNNCLSRAIFGKDTE-YRLKLDWPTRKKICIGIAR 750
             YG  ++ N      QL LV E+     ++  I  K+T+   LK +W     IC  I R
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAY--ICREILR 122

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 810
           GL++LH+    K++HRDIK  NVLL ++   K+ DFG++   +      +T I GT  +M
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWM 178

Query: 811 APEYAM-----RGYLTSKADVYSFGVVTLEIVSG 839
           APE              K+D++S G+  +E+  G
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 81.1 bits (201), Expect = 1e-16
 Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 50/223 (22%)

Query: 638 NNFDPANKVGEGGFGSV----YKG--------ILSDGTVIAVKQLSSKSRQGNREFVNEI 685
           ++F+    +G G FG V    +KG        ILS   ++ +KQ+           +NE 
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE--------HVLNEK 52

Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            ++ + +HP LV LYG   + + L LV EY         + G +    L+       +  
Sbjct: 53  RILQSIRHPFLVNLYGSFQDDSNLYLVMEY---------VPGGELFSHLR----KSGRFP 99

Query: 746 IGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
             +AR         L YLH    + IV+RD+K  N+LLD D   KI+DFG AK   + +T
Sbjct: 100 EPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRT 155

Query: 798 HISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSG 839
           +    + GT  Y+APE  + +GY     D ++ G++  E+++G
Sbjct: 156 YT---LCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 37/214 (17%)

Query: 646 VGEGGFGSVY--KGILSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHPNLVKL 699
           + +G FGSVY  K   + G   A+K L         +  N       M+   + P + KL
Sbjct: 4   ISKGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK------LDWPTRKKICIGIARGLA 753
           Y      + L LV EY+          G D    +K       DW   K+    +  G+ 
Sbjct: 63  YYSFQSKDYLYLVMEYLN---------GGDCASLIKTLGGLPEDWA--KQYIAEVVLGVE 111

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
            LH+     I+HRDIK  N+L+D+  + K++DFGL++   E+K     +  GT  Y+APE
Sbjct: 112 DLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPE 163

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 847
             +       +D +S G V  E + G     Y P
Sbjct: 164 TILGVGDDKMSDWWSLGCVIFEFLFG-----YPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 16/200 (8%)

Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           +G G FG + +G L         +A+  L +  S +  R F+ E   +    H N+V+L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G    GN +++V EYM N  L    F +  E +L         +  G+A G+ YL E   
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDS--FLRKHEGQLVAG--QLMGMLPGLASGMKYLSE--- 125

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG--TIGYMAPEYAMRG 818
           +  VH+ +    VL++ DL  KIS F   +L E+    I T ++G   + + APE     
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 819 YLTSKADVYSFGVVTLEIVS 838
           + +S +DV+SFG+V  E++S
Sbjct: 184 HFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 17/197 (8%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           +G G  G+VYK   L    ++AVK +    + +  ++ ++E+ ++     P ++  YG  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
              N++ +  E+M    L   ++ K  E+ L        +I + + +GL YL     +KI
Sbjct: 69  FVENRISICTEFMDGGSLD--VYRKIPEHVLG-------RIAVAVVKGLTYLWS---LKI 116

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRD+K SN+L++     K+ DFG++    +    I+    GT  YMAPE          
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQYGIH 173

Query: 824 ADVYSFGVVTLEIVSGK 840
           +DV+S G+  +E+  G+
Sbjct: 174 SDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 33/221 (14%)

Query: 640 FDPANKVGEGGFGSVYKGIL---SDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQH 693
           ++    +G G +G VYK       DG   A+K+      Q    ++    EI ++   +H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 694 PNLVKLYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
            N+V L    +E     + L+++Y +++      F +  + R+ +     K +   I  G
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNG 120

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNA----KISDFGLAK--------LYEEDKTHI 799
           + YLH +    ++HRD+K +N+L+  +       KI D GLA+        L + D   +
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177

Query: 800 STRIAGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVS 838
                 TI Y APE  +  R Y T   D+++ G +  E+++
Sbjct: 178 ------TIWYRAPELLLGARHY-TKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 26/205 (12%)

Query: 645 KVGEGGFGSVYKGIL-SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           ++G G FG V+ G L +D T +AVK    +       +F+ E  ++    HPN+V+L G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK-----KICIGIARGLAYLHE 757
           C +   + +V E ++         G D    L+ + P  K     ++    A G+ YL  
Sbjct: 62  CTQKQPIYIVMELVQ---------GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES 112

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT----IGYMAPE 813
              I   HRD+   N L+ +    KISDFG+++  EED  + ST   G     + + APE
Sbjct: 113 KHCI---HRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYAST--GGMKQIPVKWTAPE 166

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVS 838
               G  +S++DV+SFG++  E  S
Sbjct: 167 ALNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 57/204 (27%), Positives = 86/204 (42%), Gaps = 23/204 (11%)

Query: 649 GGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF---VNEIGMISAQQHPNLVKLYGCCV 704
           G +G V+     S G + A+K +         +    + E  ++S  Q P +VKLY    
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 705 EGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
               L LV EY+    L+  +   G        LD    +     I   L YLH      
Sbjct: 64  GKKNLYLVMEYLPGGDLASLLENVGS-------LDEDVARIYIAEIVLALEYLH---SNG 113

Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHIST-----RIAGTIGYMAPEYA 815
           I+HRD+K  N+L+D + + K++DFGL+K  L               RI GT  Y+APE  
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 816 MRGYLTSKADVYSFGVVTLEIVSG 839
           +    +   D +S G +  E + G
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 79.2 bits (195), Expect = 5e-16
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 22/213 (10%)

Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF--VNEIGMI---SAQQH 693
           ++P  ++G G +G+VYK      G  +A+K +  ++ +       V E+ ++    A  H
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 694 PNLVKLYGCCVEGN-----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 748
           PN+V+L   C         ++ LV+E++  +   R    K     L  +  T K +    
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHVDQDL--RTYLDKVPPPGLPAE--TIKDLMRQF 117

Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS-TRIAGTI 807
            RGL +LH +    IVHRD+K  N+L+      K++DFGLA++Y      ++ T +  T+
Sbjct: 118 LRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTL 171

Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            Y APE  ++    +  D++S G +  E+   K
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.0 bits (194), Expect = 5e-16
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 21/209 (10%)

Query: 646 VGEGGFGSVYKGILS-DGTVI--AVKQLSS-KSRQGNREFVNEIGMISA-QQHPNLVKLY 700
           +GEG FG V K  +  DG  +  A+K++    S+  +R+F  E+ ++     HPN++ L 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 701 GCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWPTRKKICIGIA 749
           G C     L L  EY  +  L      SR +     F         L           +A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
           RG+ YL +    + +HRD+   N+L+ ++  AKI+DFGL++  E        R+   + +
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 177

Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           MA E       T+ +DV+S+GV+  EIVS
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.4 bits (194), Expect = 6e-16
 Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 18/201 (8%)

Query: 646 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQHPNLVKLYG 701
           +G GGFG V    + S     A+K +  +     G +E + +E  ++    HP +VKLY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              +   + ++ EY     L   +  +D   R   D  T +     +     YLH     
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTIL--RD---RGLFDEYTARFYIACVVLAFEYLHNRG-- 113

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYAM-RGY 819
            I++RD+K  N+LLD +   K+ DFG AK L    KT       GT  Y+APE  + +GY
Sbjct: 114 -IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGY 169

Query: 820 LTSKADVYSFGVVTLEIVSGK 840
             S  D +S G++  E+++G+
Sbjct: 170 DFS-VDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 78.8 bits (194), Expect = 6e-16
 Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 20/221 (9%)

Query: 646 VGEGGFGSVY------KGILSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVK 698
           +GEG FG V       +G  + G  +AVK L  +S   +  +   EI ++    H N+VK
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 699 LYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C E  GN + L+ E++ +  L   +     +  LK     + K  + I +G+ YL 
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK----QQLKYAVQICKGMDYL- 125

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--IAGTIGYMAPEY 814
             SR + VHRD+   NVL++ +   KI DFGL K  E DK + + +  +   + + APE 
Sbjct: 126 -GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 855
            ++      +DV+SFGV   E+++   ++   P   F+ ++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT-YCDSESSPMTLFLKMI 223

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 78.6 bits (194), Expect = 6e-16
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 23/210 (10%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHPN 695
            ++   K+GEG +G+V+K        ++A+K  +L           + EI ++   +H N
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 696 LVKLYGCCVEGNQLLLVYEY----MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +V+LY       +L LV+EY    +K    S             +D    K     + +G
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDS---------CNGDIDPEIVKSFMFQLLKG 111

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           LA+ H      ++HRD+K  N+L++K+   K++DFGLA+ +       S  +  T+ Y  
Sbjct: 112 LAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRP 167

Query: 812 PEYAM--RGYLTSKADVYSFGVVTLEIVSG 839
           P+     + Y TS  D++S G +  E+ + 
Sbjct: 168 PDVLFGAKLYSTS-IDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 78.5 bits (193), Expect = 7e-16
 Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 29/217 (13%)

Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLV 697
           F+    VG G +G VYKG  +  G + A+K +     +   E   EI M+     H N+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76

Query: 698 KLYGCCVE------GNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIAR 750
             YG  ++       +QL LV E+     ++  +  K+T+   LK DW     IC  I R
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAY--ICREILR 132

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 810
           GLA+LH     K++HRDIK  NVLL ++   K+ DFG++   +      +T I GT  +M
Sbjct: 133 GLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWM 188

Query: 811 APEY--------AMRGYLTSKADVYSFGVVTLEIVSG 839
           APE         A   Y   ++D++S G+  +E+  G
Sbjct: 189 APEVIACDENPDATYDY---RSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 77.9 bits (192), Expect = 9e-16
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 36/212 (16%)

Query: 645 KVGEGGFGSVYKGIL----SDGTVIAVKQ-----LSSKSRQGNREFVNEIGMISAQQHPN 695
           K+GEG FG   K IL     DG    +K+     +S K R+ +R+   E+ ++S  +HPN
Sbjct: 7   KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKHPN 60

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-------FGKDTEYRLKLDWPTRKKICIGI 748
           +V+      E   L +V +Y +   L + I       F +D      LDW    +IC+  
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ----ILDWFV--QICLA- 113

Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
              L ++H+    KI+HRDIK+ N+ L KD   K+ DFG+A++         T I GT  
Sbjct: 114 ---LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPY 166

Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           Y++PE        +K+D+++ G V  E+ + K
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 21/158 (13%)

Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKIC 745
           A +HP L +L+ C    ++L  V EY+          G D  + +    + D P  +   
Sbjct: 52  AGKHPFLTQLHSCFQTKDRLFFVMEYVN---------GGDLMFHIQRSGRFDEPRARFYA 102

Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRI 803
             I  GL +LHE     I++RD+K  NVLLD + + KI+DFG+ K  +     T   +  
Sbjct: 103 AEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STF 156

Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
            GT  Y+APE           D ++ GV+  E+++G+S
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS 194

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 21/205 (10%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
           K+GEG +G VYKG     G ++A+K+  L S+        + EI ++   QHPN+V L  
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-LDWPTRKKICIGIARGLAYLHEDSR 760
             ++ ++L L++E++  + L + +   D+  + + +D    K     I +G+ + H    
Sbjct: 67  VLMQESRLYLIFEFLSMD-LKKYL---DSLPKGQYMDAELVKSYLYQILQGILFCH---S 119

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI----AGTIGYMAPEYAM 816
            +++HRD+K  N+L+D     K++DFGLA+ +      I  R+      T+ Y APE  +
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-----GIPVRVYTHEVVTLWYRAPEVLL 174

Query: 817 RGYLTS-KADVYSFGVVTLEIVSGK 840
                S   D++S G +  E+ + K
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 18/222 (8%)

Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMI 688
           L  +   T+ ++    +G+G +G VYK     DG++ AVK L       + E   E  ++
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP-ISDVDEEIEAEYNIL 72

Query: 689 -SAQQHPNLVKLYGCCVE-----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
            S   HPN+VK YG   +     G QL LV E      ++  + G       +LD     
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL-LICGQRLDEAMIS 131

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
            I  G   GL +LH +   +I+HRD+K +N+LL  +   K+ DFG++      +   +T 
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188

Query: 803 IAGTIGYMAPEYAM--RGYLTS---KADVYSFGVVTLEIVSG 839
           + GT  +MAPE     + Y  S   + DV+S G+  +E+  G
Sbjct: 189 V-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 22/204 (10%)

Query: 645 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKL 699
           ++G G FG+V KG+         +AVK L + +       E + E  ++    +P +V++
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI---CIGIARGLAYLH 756
            G C E    +LV E         A  G   ++  K    T K I      ++ G+ YL 
Sbjct: 62  IGIC-EAESWMLVMEL--------AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
           E +    VHRD+   NVLL     AKISDFGL+K    D+ +   +  G   + + APE 
Sbjct: 113 ETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169

Query: 815 AMRGYLTSKADVYSFGVVTLEIVS 838
                 +SK+DV+SFGV+  E  S
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 31/208 (14%)

Query: 646 VGEGGFGSVY---KGILSD-GTVIAVKQL---SSKSRQGNREFVNEIGMISAQQHPNLVK 698
           +G+G FG V+   K    D G + A+K L   + K R   R    E  +++   HP +VK
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVK 62

Query: 699 L-YGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           L Y    EG +L L+ ++++       LS+ +   + + +  L           +A  L 
Sbjct: 63  LHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL---------AELALALD 112

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMA 811
           +LH    + I++RD+K  N+LLD++ + K++DFGL+K  +  E K +      GT+ YMA
Sbjct: 113 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMA 166

Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           PE   R   T  AD +SFGV+  E+++G
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 76.8 bits (189), Expect = 3e-15
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 27/213 (12%)

Query: 640 FDPANKVGEGGFGSVYKGILSD---GTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 694
           ++   K+GEG +G VYK    D      IA+K+  L  +        + EI ++   QH 
Sbjct: 4   YEKVEKIGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 695 NLVKLYGCCVEGNQLLLVYEY----MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 750
           N+V+L        +L LV+EY    +K +  S   F K+   RL       K     I R
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKN--PRLI------KTYLYQILR 113

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGY 809
           G+AY H     +++HRD+K  N+L+D+  NA K++DFGLA+ +       +  +  T+ Y
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWY 169

Query: 810 MAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 840
            APE  +  R Y T   D++S G +  E+V+ K
Sbjct: 170 RAPEILLGSRHYSTP-VDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.0 bits (189), Expect = 4e-15
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)

Query: 646 VGEGGFGSVYKG-ILSDGTVI--AVKQLSS-KSRQGNREFVNEIGMISA-QQHPNLVKLY 700
           +GEG FG V K  I  DG  +  A+K++    S+  +R+F  E+ ++     HPN++ L 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 701 GCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWPTRKKICIGIA 749
           G C     L L  EY  +  L      SR +     F         L           +A
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
           RG+ YL   S+ + +HRD+   N+L+ ++  AKI+DFGL++  E        R+   + +
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 189

Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           MA E       T+ +DV+S+GV+  EIVS
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 76.7 bits (189), Expect = 4e-15
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 645 KVGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
            VGEG +G V K    + G ++A+K+   S   +   +  + EI M+   +H NLV L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTE-YRLKLDWPTRKKICIGIARGLAYLHEDSR 760
                 +L LV+E++ +  L       D E Y   LD    +K    I RG+ + H  + 
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLD------DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN- 120

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE---EDKT-HISTRIAGTIGYMAPEYAM 816
             I+HRDIK  N+L+ +    K+ DFG A+      E  T +++TR      Y APE  +
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPELLV 173

Query: 817 RGYLTSKA-DVYSFGVVTLEIVSG 839
                 +A D+++ G +  E+++G
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 77.1 bits (190), Expect = 5e-15
 Identities = 58/235 (24%), Positives = 105/235 (44%), Gaps = 41/235 (17%)

Query: 637 TNNFDPANK-VGEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGM--- 687
           +  +      +GEG +G V K      G ++A+K++     S     +R+ V   G+   
Sbjct: 7   SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66

Query: 688 -------ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 740
                  ++  +H N++ L    VEG+ + LV + M ++ L + +     + +++L    
Sbjct: 67  TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV-----DRKIRLTESQ 120

Query: 741 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-------- 792
            K I + I  GL  LH+      +HRD+  +N+ ++     KI+DFGLA+ Y        
Sbjct: 121 VKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177

Query: 793 -EEDKTHISTRIAG----TIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 840
             +D+T            T+ Y APE  M    Y     D++S G +  E+++GK
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKY-HFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 77.0 bits (189), Expect = 5e-15
 Identities = 72/233 (30%), Positives = 110/233 (47%), Gaps = 26/233 (11%)

Query: 646 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V      GI  D       +AVK L   +   +  + V+E+ M+    +H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEY---RLKLDWPTRKKI--- 744
           ++ L G C +   L ++ EY     L     +R   G D  +   +L  +  T K +   
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 745 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL      K +HRD+   NVL+ +D   KI+DFGLA+ ++  D    +T  
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 69/216 (31%), Positives = 104/216 (48%), Gaps = 19/216 (8%)

Query: 646 VGEGGFGSV----YKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKL 699
           VG+G +G V    ++   +DG    +K+L+ +  SR+  +    E  ++S  +HPN+V  
Sbjct: 8   VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-A 63

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI--CIGIARGLAYLHE 757
           Y    EG   LL Y  M   C    ++ K  E + KL  P  + +   + IA  L YLHE
Sbjct: 64  YRESWEGEDGLL-YIVM-GFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHE 120

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
                I+HRD+KT NV L +    K+ D G+A++ E      ST I GT  YM+PE    
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSN 176

Query: 818 GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 853
                K+DV++ G    E+ + K   N +     VY
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 76.2 bits (187), Expect = 6e-15
 Identities = 71/233 (30%), Positives = 107/233 (45%), Gaps = 26/233 (11%)

Query: 646 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V      GI  D       +AVK L   + + +  + V+E+ M+    +H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKL----DWPTRKKICIG- 747
           ++ L G C +   L ++ EY     L    RA      EY   +    D     K  +  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 748 ---IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL      K +HRD+   NVL+ ++   KI+DFGLA+ +   D    +T  
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.1 bits (184), Expect = 9e-15
 Identities = 68/210 (32%), Positives = 107/210 (50%), Gaps = 28/210 (13%)

Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVN----EIGMISAQQHPNLVK 698
           +G G FG VY    +D G  +AVKQ+     S++ ++E VN    EI ++   +H  +V+
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68

Query: 699 LYGCCV--EGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAY 754
            YGC    E  +L +  EYM    +   +  +G  TE          ++    I +G++Y
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE-------NVTRRYTRQILQGVSY 121

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE---DKTHISTRIAGTIGYMA 811
           LH +    IVHRDIK +N+L D   N K+ DFG +K  +      T I + + GT  +M+
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMS 177

Query: 812 PEY-AMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE  +  GY   KADV+S     +E+++ K
Sbjct: 178 PEVISGEGY-GRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 75.8 bits (186), Expect = 9e-15
 Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 26/233 (11%)

Query: 646 VGEGGFGSVYK----GILSDG----TVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V      G+  +     T +AVK L S + + +  + ++E+ M+    +H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIG----- 747
           ++ L G C +   L ++ EY     L    RA      EY         +++        
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 748 ---IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL   +  K +HRD+   NVL+ +D   KI+DFGLA+ ++  D    +T  
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 66/209 (31%), Positives = 95/209 (45%), Gaps = 33/209 (15%)

Query: 644 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA----QQHPNLVK 698
            K+GEG F  V K      G   A+K +  K    + E VN +  I A      HPN+++
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 699 LYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           L     +    +L LV+E M  N L   I G+    +  L     K     + + L ++H
Sbjct: 63  LIEVLFDRKTGRLALVFELMDMN-LYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMH 117

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL------YEEDKTHISTRIAGTIGYM 810
              R  I HRDIK  N+L+  D+  K++DFG  +       Y E   +ISTR      Y 
Sbjct: 118 ---RNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTE---YISTR-----WYR 165

Query: 811 APEYAMR-GYLTSKADVYSFGVVTLEIVS 838
           APE  +  GY   K D+++ G V  EI+S
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 26/209 (12%)

Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLS--SKSRQGNREFVN---EIGMISAQQHPNLVKL 699
           +G+G FG VY     D G  +A KQ+    +S + ++E      EI ++   QH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 700 YGCCVE-GNQLLLVY-EYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           YGC  +   + L ++ EYM    +   +  +G  TE          +K    I  G++YL
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE-------SVTRKYTRQILEGMSYL 122

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE---DKTHISTRIAGTIGYMAP 812
           H +    IVHRDIK +N+L D   N K+ DFG +K  +      T I + + GT  +M+P
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSP 178

Query: 813 EY-AMRGYLTSKADVYSFGVVTLEIVSGK 840
           E  +  GY   KADV+S G   +E+++ K
Sbjct: 179 EVISGEGY-GRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 27/208 (12%)

Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNE---IGMISAQQHPNLVK 698
           +G GGFG VY    +D G + A+K L  K    +QG    +NE   + ++S    P +V 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTRKKICIGIARGLAY 754
           +       ++L  + + M          G D  Y L           +     I  GL +
Sbjct: 62  MSYAFHTPDKLSFILDLMN---------GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEH 112

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
           +H      +V+RD+K +N+LLD+  + +ISD GLA  + + K H S    GT GYMAPE 
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166

Query: 815 AMRGY-LTSKADVYSFGVVTLEIVSGKS 841
             +G    S AD +S G +  +++ G S
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHS 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 77.2 bits (190), Expect = 2e-14
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 19/202 (9%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           N +  G  G+ YKG      +  V +  +         + ++G +   QHPN+VKL G C
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKL---QHPNIVKLIGLC 752

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
                  L++EY++   LS  +          L W  R+KI IGIA+ L +LH      +
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAV 804

Query: 764 VHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
           V  ++    +++D KD         L  L   D     +       Y+APE      +T 
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLR--LSLPGLLCTDTKCFISS-----AYVAPETRETKDITE 857

Query: 823 KADVYSFGVVTLEIVSGKSNTN 844
           K+D+Y FG++ +E+++GKS  +
Sbjct: 858 KSDIYGFGLILIELLTGKSPAD 879

Length = 968

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 14/201 (6%)

Query: 646 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 701
           +G+GGFG V    + + G + A K+L  K    R+G    +NE  ++       +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGK-DTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
                + L LV   M    L   I+   +  +          +IC G    L  LH++  
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQE-- 121

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
            +IV+RD+K  N+LLD   + +ISD GLA    E +T I  R+ GT+GYMAPE       
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERY 178

Query: 821 TSKADVYSFGVVTLEIVSGKS 841
           T   D ++ G +  E+++G+S
Sbjct: 179 TFSPDWWALGCLLYEMIAGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 75.6 bits (186), Expect = 2e-14
 Identities = 39/95 (41%), Positives = 55/95 (57%), Gaps = 6/95 (6%)

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I RGL YLH      I+HRDIK  N+L++ +   KI DFGLA++ E D++   T+   T 
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 808 GYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 840
            Y APE  M  R Y TS  D++S G +  E++  +
Sbjct: 169 YYRAPEILMGSRHY-TSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 27/208 (12%)

Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNE---IGMISAQQHPNLVK 698
           +G GGFG VY    +D G + A+K L  K    +QG    +NE   + ++S    P +V 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK----ICIGIARGLAY 754
           +       ++L  + + M          G D  Y L       +K        I  GL +
Sbjct: 62  MTYAFHTPDKLCFILDLMN---------GGDLHYHLSQHGVFSEKEMRFYATEIILGLEH 112

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
           +H  +R  +V+RD+K +N+LLD+  + +ISD GLA  + + K H S    GT GYMAPE 
Sbjct: 113 MH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166

Query: 815 AMRGY-LTSKADVYSFGVVTLEIVSGKS 841
             +G    S AD +S G +  +++ G S
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHS 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 74.9 bits (185), Expect = 3e-14
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 54/223 (24%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIGMISAQQHPN 695
           +G G +G V   +    G  +A+K++       +  F +         EI ++   +H N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 696 LVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IG 747
           ++ L          + N + +V E M+ + L + I     +    L   T   I      
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETD-LHKVI-----KSPQPL---TDDHIQYFLYQ 111

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS------- 800
           I RGL YLH      ++HRD+K SN+L++ + + KI DFGLA+  + D+           
Sbjct: 112 ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168

Query: 801 TRIAGTIGYMAPE--YAMRGYLTSKA-DVYSFGVVTLEIVSGK 840
           TR      Y APE   +   Y  +KA D++S G +  E+++ K
Sbjct: 169 TRW-----YRAPELLLSSSRY--TKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 26/205 (12%)

Query: 645 KVGEGGFGSVYKGILSDGTVIA------VKQLSSKSRQGNREFVN---EIGMISAQQHPN 695
           ++G+G FG+VY  ++ D   +A      +K++       N E V    E  ++S   HP 
Sbjct: 7   RLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPN-ETVQANQEAQLLSKLDHPA 63

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGL 752
           +VK +   +E +   ++ EY    C  R +  K  E +      +  ++C   I +  G+
Sbjct: 64  IVKFHASFLERDAFCIITEY----CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
            Y+H+    +I+HRD+K  N+ L  +L  KI DFG+++L       ++T   GT  YM+P
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDLATTFTGTPYYMSP 174

Query: 813 E-YAMRGYLTSKADVYSFGVVTLEI 836
           E    +GY  SK+D++S G +  E+
Sbjct: 175 EALKHQGY-DSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 74.2 bits (182), Expect = 3e-14
 Identities = 66/233 (28%), Positives = 112/233 (48%), Gaps = 26/233 (11%)

Query: 646 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V +    GI          +AVK L   +   +  + ++E+ ++    +H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRL------KLDWPTRKKI 744
           ++ L G C +   L ++ EY     L     +R   G D  + +      +L +      
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 745 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL  +SR + +HRD+   NVL+ +D   KI+DFGLA+ +++ D    ++  
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFG++  EI + G S     P E+   LL
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 74.3 bits (182), Expect = 4e-14
 Identities = 52/206 (25%), Positives = 105/206 (50%), Gaps = 14/206 (6%)

Query: 638 NNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 695
           ++F+  +++G G  G V K      G ++A K +  + +   R + + E+ ++     P 
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           +V  YG      ++ +  E+M    L + +     E + ++      K+ I + RGLAYL
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAK-RIPEEILGKVSIAVLRGLAYL 119

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAPEY 814
            E  + +I+HRD+K SN+L++     K+ DFG++ +L +     ++    GT  YM+PE 
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPER 173

Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
               + + ++D++S G+  +E+  G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 73.4 bits (180), Expect = 4e-14
 Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 12/200 (6%)

Query: 646 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 701
           +G+GGFG V    + + G + A K+L  K    + G +  + E  ++     P +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
                  L LV   M    L   I+         L+          I  G+ +LH    +
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGER---GLEMERVIHYSAQITCGILHLHS---M 114

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
            IV+RD+K  NVLLD   N ++SD GLA   ++ KT   T+ AGT GYMAPE       +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYS 172

Query: 822 SKADVYSFGVVTLEIVSGKS 841
              D ++ G    E+V+G++
Sbjct: 173 YPVDWFAMGCSIYEMVAGRT 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 73.9 bits (182), Expect = 4e-14
 Identities = 67/215 (31%), Positives = 96/215 (44%), Gaps = 43/215 (20%)

Query: 647 GEGGFGSV----YKG--------ILSDGTVIA---VKQLSSKSRQGNREFVNEIGMISAQ 691
           G G FG V    YK          L  G +IA   V+ L  + R      + E    +++
Sbjct: 8   GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKR------IFET--ANSE 59

Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR- 750
           +HP LV L+ C    + +  V EY           G D    +  D  +  +     A  
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAA---------GGDLMMHIHTDVFSEPRAVFYAACV 110

Query: 751 --GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGT 806
             GL YLHE+   KIV+RD+K  N+LLD +   KI+DFGL K  +   D+T  ST   GT
Sbjct: 111 VLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGT 164

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
             ++APE       T   D +  GV+  E++ G+S
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 72.8 bits (179), Expect = 5e-14
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 22/206 (10%)

Query: 648 EGGFGSVYKGILSDGT--------VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL 699
           EG FG ++ GIL D          V  VK  +S+  Q     + E  ++    H N++ +
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEI-QVTL-LLQESCLLYGLSHQNILPI 73

Query: 700 YGCCVEGNQLLLV-YEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIG--IARGLA 753
              C+E  +   V Y YM    L   +F    +  E        T++ + +   IA G++
Sbjct: 74  LHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH   +  ++H+DI   N ++D++L  KI+D  L++ L+  D   +       + +MA 
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188

Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVS 838
           E  +    +S +DV+SFGV+  E+++
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 72.7 bits (178), Expect = 6e-14
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)

Query: 646 VGEGGFGSVYKGIL--SDGTV--IAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKL 699
           +G+G FGSV +  L   DG+   +AVK L +   S     EF+ E   +    HPN++KL
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 700 YGCCVEGNQL------LLVYEYMKNNCL-SRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
            G  +           +++  +MK+  L +  +  +  E    L   T  +  I IA G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMA 811
            YL   S    +HRD+   N +L++++   ++DFGL+ K+Y  D           + ++A
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183

Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVS 838
            E       T+ +DV++FGV   EI++
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 33/209 (15%)

Query: 645 KVGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
           K+GEG +G V+K    + G ++A+K+   S       +  + EI M+   +HPNLV L  
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
                 +L LV+EY  +  L+        +    +     KKI     + + + H+    
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNEL-----EKNPRGVPEHLIKKIIWQTLQAVNFCHKH--- 119

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKL---YEEDKT-HISTRIAGTIGYMAPE---- 813
             +HRD+K  N+L+ K    K+ DFG A++     +D T +++TR      Y APE    
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPELLVG 174

Query: 814 ---YAMRGYLTSKADVYSFGVVTLEIVSG 839
              Y          DV++ G V  E+++G
Sbjct: 175 DTQYG------PPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 25/208 (12%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
           +F+   ++G G +G VYK   ++ G + A+K +  +  +       EI M+   +H N+V
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
             +G  +  ++L +  E+     L             ++ + +R+ +     +GL YLH 
Sbjct: 70  AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHS 124

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA------GTIGYMA 811
             ++   HRDIK +N+LL  + + K++DFG++         I+  IA      GT  +MA
Sbjct: 125 KGKM---HRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMA 174

Query: 812 PEYAM---RGYLTSKADVYSFGVVTLEI 836
           PE A    +G      D+++ G+  +E+
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)

Query: 639 NFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ--- 691
           NF+    +G G +G V+     G    G + A+K L  K+    +    E      Q   
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLK-KATIVQKAKTAEHTRTERQVLE 59

Query: 692 ---QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG- 747
              + P LV L+       +L L+ +Y+    L   ++ ++             ++ I  
Sbjct: 60  AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HFTES---EVRVYIAE 113

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I   L +LH+   + I++RDIK  N+LLD + +  ++DFGL+K +  ++   +    GTI
Sbjct: 114 IVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTI 170

Query: 808 GYMAPEYAMRGYLT-SKA-DVYSFGVVTLEIVSGKS 841
            YMAPE    G     KA D +S GV+T E+++G S
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 29/211 (13%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 696
           ++++   +VG G +G VYK   L  G + AVK +  +          EI M+   +H N+
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRA--IFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           V  +G  +   +L +  EY     L     + G  +E ++         +C    +GLAY
Sbjct: 69  VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-------VCRETLQGLAY 121

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA------GTIG 808
           LH   ++   HRDIK +N+LL  + + K++DFG+A         I+  IA      GT  
Sbjct: 122 LHSKGKM---HRDIKGANILLTDNGDVKLADFGVA-------AKITATIAKRKSFIGTPY 171

Query: 809 YMAPEYAM---RGYLTSKADVYSFGVVTLEI 836
           +MAPE A     G      D+++ G+  +E+
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 54/158 (34%), Positives = 76/158 (48%), Gaps = 15/158 (9%)

Query: 687 MISAQQHPNLVKLYGCCVEGNQ-LLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKK 743
           +  A +HP L  L+ C  +  + L  V EY+    L   I   G+  E R       R  
Sbjct: 49  LALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR------ARFY 101

Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 803
               I  GL +LH+     I++RD+K  NVLLDKD + KI+DFG+ K     +   ST  
Sbjct: 102 AA-EIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-F 156

Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
            GT  Y+APE           D +SFGV+  E++ G+S
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 11/200 (5%)

Query: 646 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 701
           +G+GGFG V    + + G + A K+L+ K    R+G    + E   I A+ H   +    
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVE-KRILAKVHSRFIVSLA 59

Query: 702 CCVEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
              +    L LV   M    L   I+  D E       P        I  GL +LH+   
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEE-NPGFPEPRACFYTAQIISGLEHLHQR-- 116

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
            +I++RD+K  NVLLD D N +ISD GLA   ++ ++  +   AGT G+MAPE       
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEY 174

Query: 821 TSKADVYSFGVVTLEIVSGK 840
               D ++ GV   E+++ +
Sbjct: 175 DFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 63/209 (30%), Positives = 91/209 (43%), Gaps = 30/209 (14%)

Query: 646 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMIS------AQQHPNLVK 698
           +G+G FG V+   L       A+K L       + +   E  M+       A +HP L  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFLTH 60

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIARGLAY 754
           LY        L  V EY+          G D  + +    K D P        I  GL +
Sbjct: 61  LYCTFQTKENLFFVMEYLN---------GGDLMFHIQSCHKFDLPRATFYAAEIICGLQF 111

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMAP 812
           LH      IV+RD+K  N+LLD D + KI+DFG+ K  +  + KT       GT  Y+AP
Sbjct: 112 LHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAP 165

Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           E  +     +  D +SFGV+  E++ G+S
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 16/201 (7%)

Query: 645 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGC 702
           K+GEG + +VYKGI   +G ++A+K +S K+ +G     + E  ++   +H N+V L+  
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 703 CVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
                 L  V+EYM  +     I   G    Y ++L           + RGLAY+H    
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIH---G 121

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY- 819
             I+HRD+K  N+L+      K++DFGLA+         S+ +  T+ Y  P+  +    
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATD 180

Query: 820 LTSKADVYSFGVVTLEIVSGK 840
            +S  D++  G + +E++ G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 54/218 (24%), Positives = 102/218 (46%), Gaps = 26/218 (11%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN------REFVNEIGMISA 690
           + ++   K+GEG +G VYK    + G ++A+K+   +  +        RE ++ + M+S 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALRE-ISLLQMLS- 58

Query: 691 QQHPNLVKLYGCCVEGN-------QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 743
            +   +V+L    VE          L LV+EY+ ++ L + +          L   T K 
Sbjct: 59  -ESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIKS 114

Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTR 802
               + +G+A+ H+     ++HRD+K  N+L+DK     KI+D GL + +       +  
Sbjct: 115 FMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171

Query: 803 IAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSG 839
           I  T+ Y APE  +   + ++  D++S G +  E+   
Sbjct: 172 IV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 71.2 bits (174), Expect = 4e-13
 Identities = 54/210 (25%), Positives = 106/210 (50%), Gaps = 22/210 (10%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 695
           ++F+  +++G G  G V+K      G ++A K +  + +   R + + E+ ++     P 
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 696 LVKLYGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +V  YG      ++ +  E+M     +  L +A  G+  E  L        K+ I + +G
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILG-------KVSIAVIKG 115

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYM 810
           L YL E  + KI+HRD+K SN+L++     K+ DFG++ +L +     ++    GT  YM
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYM 169

Query: 811 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           +PE     + + ++D++S G+  +E+  G+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 32/195 (16%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE--F----VNEIGMISA 690
           + ++   K+G+G FG V+K        ++A+K    K    N +  F    + EI ++  
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALK----KVLMENEKEGFPITALREIKILQL 67

Query: 691 QQHPNLVKLYGCC----VEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
            +H N+V L   C       N       LV+E+ +++ L+  +  K+ ++ L       K
Sbjct: 68  LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLLSNKNVKFTL----SEIK 122

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY----EEDKTH 798
           K+   +  GL Y+H   R KI+HRD+K +N+L+ KD   K++DFGLA+ +          
Sbjct: 123 KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179

Query: 799 ISTRIAGTIGYMAPE 813
            + R+  T+ Y  PE
Sbjct: 180 YTNRVV-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 69.9 bits (171), Expect = 5e-13
 Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 16/204 (7%)

Query: 645 KVGEGGFGSVYKGILSDGTVIA---VKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           ++G G FG V    +   T +A   VK+L ++ S +   EF+ +       QHPN+++  
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G CVE    LLV+EY +   L ++   ++  +R        +++   IA G+ ++H   +
Sbjct: 62  GQCVEAIPYLLVFEYCELGDL-KSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAPEYAMR-- 817
              +H D+   N  L  DL  K+ D+G+    Y+ED           + ++APE      
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177

Query: 818 -GYLTSK----ADVYSFGVVTLEI 836
            G +T++    ++V++ GV   E+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 71.1 bits (175), Expect = 5e-13
 Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 39/221 (17%)

Query: 640 FDPANKVGEGGFGSVYKGILSD---GTVIAVK------QLSSKSRQGNRE--FVNEIGMI 688
           ++   K+G+G +G V+K I  D     V+A+K      + ++ +++  RE  F+ E+G  
Sbjct: 9   YEILQKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-- 64

Query: 689 SAQQHPNLVKLYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK-IC 745
               HPN+VKL       N   + LV+EYM+ + L   I       R  +     K+ I 
Sbjct: 65  ---DHPNIVKLLNVIKAENDKDIYLVFEYMETD-LHAVI-------RANILEDVHKRYIM 113

Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK----LYEEDKTHIST 801
             + + L Y+H  S   ++HRD+K SN+LL+ D   K++DFGLA+    L E  +  + T
Sbjct: 114 YQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170

Query: 802 RIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               T  Y APE       Y T   D++S G +  E++ GK
Sbjct: 171 DYVATRWYRAPEILLGSTRY-TKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 28/210 (13%)

Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVN----EIGMISAQQHPNLVK 698
           +G+G FG VY    +D G  +AVKQ+    +S + ++E VN    EI ++    H  +V+
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VNALECEIQLLKNLLHERIVQ 68

Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAY 754
            YGC  +  +  L +  E+M    +   +  +G  TE          +K    I  G++Y
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-------NVTRKYTRQILEGVSY 121

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE---DKTHISTRIAGTIGYMA 811
           LH +    IVHRDIK +N+L D   N K+ DFG +K  +      T + + + GT  +M+
Sbjct: 122 LHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMS 177

Query: 812 PEY-AMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE  +  GY   KAD++S G   +E+++ K
Sbjct: 178 PEVISGEGY-GRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 69.9 bits (171), Expect = 6e-13
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 27/211 (12%)

Query: 644 NKVGEGGFGSVYKGILS-DGTVIAVKQL-----SSKSRQGNREFVNEIGMISAQQHPNLV 697
           +++G+G +GSVYK +    G  +A+K++      SK  Q     + E+ ++     P +V
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ----IIMELDILHKAVSPYIV 62

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
             YG       + +  EYM    L +   G      +       ++I   + +GL +L E
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGI--PEDVLRRITYAVVKGLKFLKE 120

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGYMAPEY- 814
           +    I+HRD+K +NVL++ +   K+ DFG++        KT+I     G   YMAPE  
Sbjct: 121 E--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERI 173

Query: 815 -----AMRGYLTSKADVYSFGVVTLEIVSGK 840
                      T ++DV+S G+  LE+  G+
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 71.2 bits (174), Expect = 7e-13
 Identities = 62/251 (24%), Positives = 112/251 (44%), Gaps = 32/251 (12%)

Query: 80  LKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNIT-TLKNLSIEGNLFT 138
           L  LDL+ N L  + S       L  L +  N ++   P ++  +   LK L +  N   
Sbjct: 95  LPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE 153

Query: 139 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 198
            S+P  +R L NL+ L LS N  + +LP  L+ L+NLN+L +S N  S  +P  I     
Sbjct: 154 -SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSA 210

Query: 199 IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHG 258
           +++L +  +S+   + +S+S L +L+ L +S+ K                          
Sbjct: 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE------------------------ 245

Query: 259 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 318
           ++P+ IG+++ L+ +DLS N ++    ++   L     + L+GN L+  +P         
Sbjct: 246 DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLL 303

Query: 319 VDISLNNFTWE 329
             +     T +
Sbjct: 304 ELLLNLLLTLK 314

Length = 394

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.8 bits (176), Expect = 8e-13
 Identities = 34/82 (41%), Positives = 52/82 (63%)

Query: 139 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 198
           G IP DI KL +LQ + LS NS  G +P  L  +T+L  L +S N+F+G IPE +G+   
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 199 IQKLHIQGSSLEGPIPASISAL 220
           ++ L++ G+SL G +PA++   
Sbjct: 492 LRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 30/219 (13%)

Query: 640 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGN-RE-----FVNEIGMISAQQ 692
           FD   ++GEG +G VYK    D G ++A+K    K R  N +E      + EI ++    
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALK----KVRLDNEKEGFPITAIREIKILRQLN 64

Query: 693 HPNLVKLYGCCVEGNQLL----------LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
           H N+V L     +    L          LV+EYM ++     + G      +       K
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIK 119

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
                +  GL Y H+ +    +HRDIK SN+LL+     K++DFGLA+LY  +++   T 
Sbjct: 120 SFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176

Query: 803 IAGTIGYMAPEYAMRGYLTSKA-DVYSFGVVTLEIVSGK 840
              T+ Y  PE  +       A DV+S G +  E+ + K
Sbjct: 177 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 71.0 bits (174), Expect = 2e-12
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 36/229 (15%)

Query: 640 FDPANKVGEGGFGSVYKGILSD---GTVIAVKQ----LSSKSRQGNREFVNEIGMISAQQ 692
           +D    +G+GG G VY     D      +A+K+    LS       R F+ E  + +   
Sbjct: 4   YDIIRLIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKR-FLREAKIAADLI 60

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDT---EYRLKLDWPTRKKICI 746
           HP +V +Y  C +G+ +     Y++   L    ++++ K++   E   K        I  
Sbjct: 61  HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK---LYEEDKTHIST-- 801
            I   + Y+H  S+  ++HRD+K  N+LL       I D+G A    L EED   I    
Sbjct: 121 KICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 802 ------------RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
                       +I GT  YMAPE  +    +   D+Y+ GV+  ++++
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 68.7 bits (168), Expect = 3e-12
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 37/212 (17%)

Query: 646 VGEGGFGSVYKGILSDGT----VIAVKQLSS----KSRQGNREFVNEIGMISAQQHPNLV 697
           +G+GG+G V++     G     + A+K L      ++++       E  ++ A +HP +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRLKLDWPTRKKICI---GIA 749
            L      G +L L+ EY+    L        IF +DT              C     I+
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA-------------CFYLSEIS 110

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTI 807
             L +LH+     I++RD+K  N+LLD   + K++DFGL K  ++E   TH      GTI
Sbjct: 111 LALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTI 164

Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            YMAPE  MR       D +S G +  ++++G
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 68.4 bits (167), Expect = 3e-12
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 21/228 (9%)

Query: 646 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREF---VNEIGMIS-AQQHPNLVKLY 700
           +G+G FG V    L   G + AVK L       + +    + E  ++S A+ HP L +LY
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
            C    ++L  V E++    L   I     +   + D    +     I   L +LH+   
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHI-----QKSRRFDEARARFYAAEITSALMFLHDKG- 116

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIGYMAPEYAMRGY 819
             I++RD+K  NVLLD + + K++DFG+ K  E      +T    GT  Y+APE      
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEML 172

Query: 820 LTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIY 867
                D ++ GV+  E++ G +      NED ++      +L +E +Y
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAE-NEDDLF----EAILNDEVVY 215

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 68.7 bits (168), Expect = 3e-12
 Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 30/162 (18%)

Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLV--------YEYMKNNCLSRAIFGKDTEYRLKLDW 738
           ++    HP+++++    V G    +V        Y Y+     SR +             
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKR--SRPL------------- 154

Query: 739 PTRKKICI--GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 796
           P  + + I   I  GL YLH     +I+HRD+KT N+ ++      I D G A+      
Sbjct: 155 PIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211

Query: 797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             +   +AGT+   APE   R    SKAD++S G+V  E+++
Sbjct: 212 AFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 24/206 (11%)

Query: 644 NKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 700
            K+GEG + +V+KG   L++  ++A+K++  +  +G     + E+ ++   +H N+V L+
Sbjct: 12  EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-----LDWPTRKKICIGIARGLAYL 755
                   L LV+EY+           KD +  +      +     K     I RGLAY 
Sbjct: 71  DIVHTDKSLTLVFEYLD----------KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
           H   R K++HRD+K  N+L+++    K++DFGLA+         S  +  T+ Y  P+  
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVL 176

Query: 816 M-RGYLTSKADVYSFGVVTLEIVSGK 840
           +     +++ D++  G +  E+ SG+
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 69/233 (29%), Positives = 104/233 (44%), Gaps = 23/233 (9%)

Query: 646 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 701
           +G+GGFG V    + + G + A K+L  K    R+G    +NE  ++       +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDT----EYRLKLDWPTRKKICIGIARGLAYLHE 757
                + L LV   M    L   I+        E R         +I  G    L  LH 
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF---YAAEILCG----LEDLHR 120

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAPEYAM 816
           ++    V+RD+K  N+LLD   + +ISD GLA K+ E +   I  R+ GT+GYMAPE   
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVLN 174

Query: 817 RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIYWS 869
               T   D +  G +  E++ G+S    R  +     +D   VL+ EE+Y +
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD-RRVLETEEVYSA 226

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 65/204 (31%), Positives = 92/204 (45%), Gaps = 20/204 (9%)

Query: 646 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 701
           +G+GGFG V    + + G + A K+L  K    R+G    +NE  ++       +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIF----GKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
                + L LV   M    L   I+        E R         +I  G    L  LH 
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF---YAAEITCG----LEDLH- 119

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
             R +IV+RD+K  N+LLD   + +ISD GLA    E +T I  R+ GT+GYMAPE    
Sbjct: 120 --RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKN 175

Query: 818 GYLTSKADVYSFGVVTLEIVSGKS 841
              T   D +  G +  E++ GKS
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 70.3 bits (172), Expect = 4e-12
 Identities = 53/193 (27%), Positives = 91/193 (47%), Gaps = 23/193 (11%)

Query: 662 GTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYGCCVEGNQLLL-VYEYMK 717
           G  +A+K L + + +   +   F  E  + +   HPN+V L         LL  V+EY+ 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-- 775
              L R +   D      L      ++ + +   LA  H      IVHRD+K  N+++  
Sbjct: 63  GRTL-REVLAADG----ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQ 114

Query: 776 -DKDLNAKISDFGLAKL----YEEDKTHIS--TRIAGTIGYMAPEYAMRGY-LTSKADVY 827
                +AK+ DFG+  L     + D   ++  T + GT  Y APE  +RG  +T  +D+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLY 173

Query: 828 SFGVVTLEIVSGK 840
           ++G++ LE ++G+
Sbjct: 174 AWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 67.3 bits (164), Expect = 5e-12
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 37/223 (16%)

Query: 639 NFDPANKVGEGGFGSVY---------------KGILSDGTVIAVKQLSSKSRQGNREFVN 683
           NF+    +G G +G V+                 +L   T++   + +  +R   R+ + 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT-ERQVLE 59

Query: 684 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTR 741
            I     +Q P LV L+       +L L+ +Y+    L   +  ++   E  ++      
Sbjct: 60  HI-----RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQ------ 108

Query: 742 KKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 800
             I  G I   L +LH   ++ I++RDIK  N+LLD + +  ++DFGL+K + ED+   +
Sbjct: 109 --IYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA 163

Query: 801 TRIAGTIGYMAPEYAMRGYL--TSKADVYSFGVVTLEIVSGKS 841
               GTI YMAP+    G        D +S GV+  E+++G S
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 5e-12
 Identities = 63/249 (25%), Positives = 99/249 (39%), Gaps = 55/249 (22%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 693
            +F    +VG+GG+G V+     D G ++A+K++           R  + E  +++  + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
             LVKL     +   L L  EY+          G D  +R  L              G+ 
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVP---------GGD--FRTLL-----------NNLGV- 97

Query: 754 YLHEDS----------------RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            L ED                  +  +HRD+K  N L+D   + K++DFGL+K       
Sbjct: 98  -LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIV 152

Query: 798 HISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK---SNTNYRPNEDFVY 853
             +  + G+  YMAPE    +GY     D +S G +  E + G    S +   PNE +  
Sbjct: 153 TYANSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGST--PNETWEN 209

Query: 854 LLDWAYVLQ 862
           L  W   LQ
Sbjct: 210 LKYWKETLQ 218

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 67.9 bits (166), Expect = 6e-12
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 33/216 (15%)

Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLY---- 700
           +G G  G V+  + SD    +AVK++     Q  +  + EI +I    H N+VK+Y    
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 701 ----------GCCVEGNQLLLVYEYMKNNCLSRAI-FGKDTEYRLKLDWPTRKKICIGIA 749
                     G   E N + +V EYM+ + L+  +  G  +E   +L           + 
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVLEQGPLSEEHARL-------FMYQLL 124

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
           RGL Y+H  +   ++HRD+K +NV ++ +DL  KI DFGLA++ +   +H      G + 
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 809 --YMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 840
             Y +P   +    Y T   D+++ G +  E+++GK
Sbjct: 182 KWYRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 66.9 bits (163), Expect = 6e-12
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)

Query: 646 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 701
           +G+GGFG V    + + G + A K+L  K    R+G    +NE  ++       +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIF-----GKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
                + L LV   M    L   I+     G D +  +        ++C G       L 
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY----AAELCCG-------LE 116

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
           +  R +IV+RD+K  N+LLD   + +ISD GLA    E +T +  R+ GT+GYMAPE   
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVIN 174

Query: 817 RGYLTSKADVYSFGVVTLEIVSGKS 841
               T   D +  G +  E++ G+S
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 67.0 bits (163), Expect = 6e-12
 Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 24/206 (11%)

Query: 644 NKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 700
           +K+GEG + +VYKG   L+D  ++A+K++  +  +G     + E+ ++   +H N+V L+
Sbjct: 12  DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-----LDWPTRKKICIGIARGLAYL 755
                   L LV+EY+           KD +  L      ++    K     + RGL Y 
Sbjct: 71  DIIHTEKSLTLVFEYLD----------KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
           H   R K++HRD+K  N+L+++    K++DFGLA+         S  +  T+ Y  P+  
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDIL 176

Query: 816 MRGY-LTSKADVYSFGVVTLEIVSGK 840
           +     +++ D++  G +  E+ +G+
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.9 bits (166), Expect = 1e-11
 Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 42/171 (24%)

Query: 5   ALKQIGRKLG---KKDWNFGVDPCS-QKGNWELSSDDKKGFESNVTC--DCSSATCHVVT 58
           AL+ +   LG   +  WN   DPC  Q+  W           S   C  D +     +  
Sbjct: 376 ALQTLKSSLGLPLRFGWNG--DPCVPQQHPW-----------SGADCQFDSTKGKWFIDG 422

Query: 59  IALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFP 118
           + L  Q L G +P ++SKLR+L+ ++LS                       GN + G  P
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLS-----------------------GNSIRGNIP 459

Query: 119 KVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL 169
             L +IT+L+ L +  N F GSIP  + +L +L+ L L+ NS +G +PA L
Sbjct: 460 PSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 1e-11
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 32/218 (14%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPN 695
            +   + +GEG +G V        G  +A+K++S    Q    R  + EI ++   +H N
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHEN 64

Query: 696 LVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---G 747
           ++ +            N + +V E M+ + L + I  +               I      
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMETD-LYKLIKTQHLSN---------DHIQYFLYQ 114

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY--EEDKTHISTRIAG 805
           I RGL Y+H  +   ++HRD+K SN+LL+ + + KI DFGLA++   E D T   T    
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171

Query: 806 TIGYMAPEYAM--RGYLTSKA-DVYSFGVVTLEIVSGK 840
           T  Y APE  +  +GY  +KA D++S G +  E++S +
Sbjct: 172 TRWYRAPEIMLNSKGY--TKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 27/206 (13%)

Query: 646 VGEGGFGS--VYKGILSDGTVIAVKQL----SSKSRQGNREFVNEIGMISAQQHPNLVKL 699
           VGEG FG   + + + SD    A+K++    SS + + +R+   E  +++  +HPN+V  
Sbjct: 8   VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAF 63

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-----KLDWPTRKKICIGIARGLAY 754
                    L +V EY     L + I  K    +L      L W    ++C+G+     +
Sbjct: 64  KESFEADGHLYIVMEYCDGGDLMQKI--KLQRGKLFPEDTILQWFV--QMCLGVQ----H 115

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
           +HE    +++HRDIK+ N+ L ++   K+ DFG A+L      +  T + GT  Y+ PE 
Sbjct: 116 IHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEI 171

Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
                  +K+D++S G +  E+ + K
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 54/223 (24%)

Query: 647 GEGGFGSVYKGIL---SDG--------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 695
           G+G F ++YKG+L   SD           + +K L S  R  +  F     ++S   H +
Sbjct: 4   GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKH 62

Query: 696 LVKLYGCCV-EGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 750
           LVKLYG CV + N   +V EY+K    +  L R        ++L +           +A 
Sbjct: 63  LVKLYGVCVRDENI--MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAK--------QLAS 112

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKD-------LNAKISDFG-----LAKLYEEDKTH 798
            L YL +    K+VH ++   N+L+ +           K+SD G     L++    ++  
Sbjct: 113 ALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER-- 167

Query: 799 ISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSG 839
                   I ++APE    G   LT  AD +SFG   LEI S 
Sbjct: 168 --------IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 66.5 bits (163), Expect = 1e-11
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 46/216 (21%)

Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN---------EIGMISAQQHPN 695
           VG G +G V     +  G  +A+K+LS       R F +         E+ ++    H N
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75

Query: 696 LVKLYGCCVEG------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI--- 746
           ++ L               + LV   M          G D    +K    +   I     
Sbjct: 76  VIGLLDVFTPASSLEDFQDVYLVTHLM----------GADLNNIVKCQKLSDDHIQFLVY 125

Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAG 805
            I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++TR   
Sbjct: 126 QILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR--- 179

Query: 806 TIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK 840
              Y APE  +   +     D++S G +  E+++GK
Sbjct: 180 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 16/150 (10%)

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARG 751
           P +V  YG      ++ +  E+M    L + +   G+  E  L        KI I + RG
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-------KISIAVLRG 111

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYM 810
           L YL E  + KI+HRD+K SN+L++     K+ DFG++ +L +     ++    GT  YM
Sbjct: 112 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYM 165

Query: 811 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           +PE     + T ++D++S G+  +E+  G+
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 65.9 bits (160), Expect = 2e-11
 Identities = 51/205 (24%), Positives = 99/205 (48%), Gaps = 12/205 (5%)

Query: 638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 695
           ++++   K+GEG + +VYKG    +G ++A+K +  +  +G     + E  ++   +H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           +V L+        L LV+EY+  +           ++   L     K     + RGL+Y+
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYM-----DKHPGGLHPENVKLFLFQLLRGLSYI 119

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
           H+     I+HRD+K  N+L+      K++DFGLA+  +   +H  +    T+ Y  P+  
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVL 175

Query: 816 MRGYLTSKA-DVYSFGVVTLEIVSG 839
           +     S   D++  G + +E++ G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 22/208 (10%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGC- 702
           +G+G +G V+K +   +G+  AVK L       + E   E  ++ A   HPN+VK YG  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 703 ----CVEGNQLLLVYEYMKNNCLSRAIFG--KDTEYRLKLDWPTRKKICIGIARGLAYLH 756
                  G+QL LV E      ++  + G  K  E   +++ P    I      GL +LH
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE---RMEEPIIAYILHEALMGLQHLH 141

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY-A 815
            +   K +HRD+K +N+LL  +   K+ DFG++      +   +T + GT  +MAPE  A
Sbjct: 142 VN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 197

Query: 816 MRGYLTS----KADVYSFGVVTLEIVSG 839
               L S    + DV+S G+  +E+  G
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 18/203 (8%)

Query: 646 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNRE----FVNEIGMISAQQHPNLVKLY 700
           +G+G FG V    L   G   AVK L       + +     V +  +  A ++P L  LY
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
                   L  V E++    L   I  K      +  +   + +C     GL +LH    
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC-----GLQFLHSKG- 116

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMAPEYAMRG 818
             I++RD+K  NV+LD+D + KI+DFG+ K  ++ +++   ++   GT  Y+APE     
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR---ASTFCGTPDYIAPEILQGL 171

Query: 819 YLTSKADVYSFGVVTLEIVSGKS 841
             T   D +SFGV+  E++ G+S
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.8 bits (160), Expect = 3e-11
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)

Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 11  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 67

Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 68  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 123

Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 124 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 180

Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 181 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 65.6 bits (160), Expect = 3e-11
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 31/221 (14%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSRQGNRE----FVNEIGMISA 690
            +FD  + VG G FG V   ++ +   G + A+K +  KS    +E    F  E  ++S 
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMK-KSVLLAQETVSFFEEERDILSI 57

Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKICI 746
              P + +L     + + L LV EY       + L+R        Y  + D    +    
Sbjct: 58  SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR--------YEDQFDEDMAQFYLA 109

Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 806
            +   +  +H+   +  VHRDIK  NVL+D+  + K++DFG A     +K   S    GT
Sbjct: 110 ELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGT 166

Query: 807 IGYMAPEY--AMRGYLTSKADV----YSFGVVTLEIVSGKS 841
             Y+APE    M G       V    +S GV+  E++ G+S
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 25/212 (11%)

Query: 637 TNNFDPANKVGEGGFGSV--YKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQ 692
           TN +     VG G FG V   +  L+ G  +A+K++     +    +    E+ ++   +
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67

Query: 693 HPNLVKLYGCCVEGNQ-LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           H N++ L    +   + +  V E +  + L R +  +  E +        +     I RG
Sbjct: 68  HENIISLSDIFISPLEDIYFVTELLGTD-LHRLLTSRPLEKQFI------QYFLYQILRG 120

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYM 810
           L Y+H      +VHRD+K SN+L++++ + KI DFGLA++ +   T ++STR      Y 
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YR 172

Query: 811 APEYAM--RGYLTSKADVYSFGVVTLEIVSGK 840
           APE  +  + Y   + D++S G +  E++ GK
Sbjct: 173 APEIMLTWQKY-DVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (158), Expect = 4e-11
 Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 25/208 (12%)

Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIG------MISAQQHPNLVK 698
           +G+G FG VY+    D   + A+K LS K     +E  + IG           + P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG-IARGLAYLHE 757
           L       + L LV +YM         +    E R   D   R K  I  +   L +LH+
Sbjct: 61  LKFSFQTDSDLYLVTDYM---SGGELFWHLQKEGRFSED---RAKFYIAELVLALEHLHK 114

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMAPEYA 815
                IV+RD+K  N+LLD   +  + DFGL+K  L +   T+      GT  Y+APE  
Sbjct: 115 YD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT---FCGTTEYLAPEVL 168

Query: 816 M--RGYLTSKADVYSFGVVTLEIVSGKS 841
           +  +GY T   D +S GV+  E+  G S
Sbjct: 169 LDEKGY-TKHVDFWSLGVLVFEMCCGWS 195

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 4e-11
 Identities = 63/238 (26%), Positives = 92/238 (38%), Gaps = 48/238 (20%)

Query: 638 NNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS---RQGNREFVNEIGMISA 690
           ++F+    +G G FG V+   L      G V A+K L  KS   ++     V     I A
Sbjct: 1   DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDILA 56

Query: 691 QQH-PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
               P +VKLY    +   L LV EYM    L   +  KD       +   R      IA
Sbjct: 57  DADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV---FPEET-AR----FYIA 108

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT------------ 797
             +  L    ++  +HRDIK  N+L+D D + K++DFGL K   + K             
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 798 ----------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                             +    GT  Y+APE         + D +S GV+  E++ G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 64.3 bits (157), Expect = 6e-11
 Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 30/215 (13%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPN 695
            + P   +G G +G V   I    G  +A+K++          +  + E+ ++   +H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 696 LVKLYGCCV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GI 748
           ++ +         +   + +V + M+++ L   I        L  +      I      +
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMDLMESD-LHHIIHSDQP---LTEE-----HIRYFLYQL 116

Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY----EEDKTHISTRIA 804
            RGL Y+H      ++HRD+K SN+L+++D   +I DFG+A+       E K  ++  +A
Sbjct: 117 LRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173

Query: 805 GTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIV 837
            T  Y APE   ++  Y T+  D++S G +  E++
Sbjct: 174 -TRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 63.5 bits (154), Expect = 9e-11
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 21/211 (9%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREF----VNEIGMISAQQ 692
           N F+    VGEG +G V K    +   ++A+K+   K  + N E     + E+ M+   +
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT---RKKICIGIA 749
             N+V+L        +L LV+EY++ N L            L  + P     +K+   I 
Sbjct: 59  QENIVELKEAFRRRGKLYLVFEYVEKNML-----------ELLEEMPNGVPPEKVRSYIY 107

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
           + +  +H   +  IVHRDIK  N+L+  +   K+ DFG A+   E      T    T  Y
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167

Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            +PE  +        D++S G +  E+  G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 49/154 (31%), Positives = 76/154 (49%), Gaps = 13/154 (8%)

Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           A  HP LV L+ C    ++L  V EY+    L   +F    + +L  +        I +A
Sbjct: 52  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA 108

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTI 807
             L YLHE     I++RD+K  NVLLD + + K++D+G+ K  L   D T   +   GT 
Sbjct: 109 --LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTP 160

Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
            Y+APE           D ++ GV+  E+++G+S
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 51/207 (24%), Positives = 99/207 (47%), Gaps = 26/207 (12%)

Query: 644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYG 701
           +K+GEG + +V+KG       ++A+K++  +  +G     + E+ ++   +H N+V L+ 
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD-------WPTRKKICIGIARGLAY 754
                  L LV+EY+            D++ +  LD           K     + RGL+Y
Sbjct: 71  IIHTERCLTLVFEYL------------DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H+    KI+HRD+K  N+L+++    K++DFGLA+         S  +  T+ Y  P+ 
Sbjct: 119 CHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDV 174

Query: 815 AMRGY-LTSKADVYSFGVVTLEIVSGK 840
            +     ++  D++  G +  E+ +G+
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 26/211 (12%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQHP 694
           + +    VG G FG V+           A+K ++     R    + V NE  ++    HP
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRLKLDWPTRKKICIGIA 749
            +++L+    +   L ++ EY+    L     +   F   T       +   + +C    
Sbjct: 62  FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL-----FYASEIVC---- 112

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
             L YLH      IV+RD+K  N+LLDK+ + K++DFG AK    D+T     + GT  Y
Sbjct: 113 -ALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT---LCGTPEY 164

Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           +APE           D ++ G++  E++ G 
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 50/156 (32%), Positives = 78/156 (50%), Gaps = 17/156 (10%)

Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT--RKKICIG 747
           A  +P LV L+ C    ++L LV EY+    L   +F    + +L  +       +ICI 
Sbjct: 52  ASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIA 108

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAG 805
               L +LHE     I++RD+K  NVLLD D + K++D+G+ K  L   D T   +   G
Sbjct: 109 ----LNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCG 158

Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           T  Y+APE           D ++ GV+  E+++G+S
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 21/153 (13%)

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIA 749
           P L +L+ C    ++L  V EY+          G D  Y +    K   P        IA
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVN---------GGDLMYHIQQVGKFKEPHAVFYAAEIA 111

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTI 807
            GL +LH      I++RD+K  NV+LD + + KI+DFG+ K  ++    T       GT 
Sbjct: 112 IGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---FCGTP 165

Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            Y+APE           D ++FGV+  E+++G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 63.0 bits (153), Expect = 2e-10
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 27/207 (13%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKL--- 699
           VG G +GSV   I    G  +A+K+LS   +S    +    E+ ++   QH N++ L   
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 700 YGCCVEGNQL---LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           +   V G++     LV  YM+ + L + +    +E   K+ +   + +C     GL Y+H
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTD-LQKIMGHPLSED--KVQYLVYQMLC-----GLKYIH 134

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYA 815
                 I+HRD+K  N+ +++D   KI DFGLA+  + + T ++ TR      Y APE  
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVI 186

Query: 816 MRG-YLTSKADVYSFGVVTLEIVSGKS 841
           +   +     D++S G +  E+++GK+
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKT 213

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 14/199 (7%)

Query: 646 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIG----MISAQQHPNLVKLY 700
           +G+G FG V      SDG+  AVK L  K+    +E  + +     ++   +HP LV L+
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
                  +L  V +Y+    L    F    E       P  +     +A  + YLH    
Sbjct: 63  YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFL--EPRARFYAAEVASAIGYLHS--- 114

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
           + I++RD+K  N+LLD   +  ++DFGL K   E +   ST   GT  Y+APE   +   
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPY 173

Query: 821 TSKADVYSFGVVTLEIVSG 839
               D +  G V  E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 62.4 bits (151), Expect = 3e-10
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 33/220 (15%)

Query: 646 VGEGGFGSV---YKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G +GSV   Y   L     +AVK+LS   +S    R    E+ ++   +H N++ L 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 701 GCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
                       N++ LV   M  +  +     K ++  ++        +   + RGL Y
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-------LIYQLLRGLKY 133

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPE 813
           +H      I+HRD+K SNV +++D   +I DFGLA+  +++ T +++TR      Y APE
Sbjct: 134 IHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPE 185

Query: 814 YAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFV 852
             +   +     D++S G +  E++ GK+     P  D++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKA---LFPGNDYI 222

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 42/109 (38%), Positives = 64/109 (58%), Gaps = 10/109 (9%)

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIA 804
           +ARG+ +L   SR K +HRD+   N+LL ++   KI DFGLA+   +D  ++   S R+ 
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 805 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSN-TNYRPNEDF 851
             + +MAPE       T+++DV+SFGV+  EI S G S     + NE+F
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF 286

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 50/155 (32%), Positives = 80/155 (51%), Gaps = 13/155 (8%)

Query: 689 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 748
           +A  HP LV L+ C    ++L  V E++    L   +F    + +L  +        I +
Sbjct: 51  TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISL 107

Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
           A  L +LHE     I++RD+K  NVLLD + + K++D+G+ K         ST   GT  
Sbjct: 108 A--LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPN 161

Query: 809 YMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKS 841
           Y+APE  +RG  Y  S  D ++ GV+  E+++G+S
Sbjct: 162 YIAPE-ILRGEDYGFS-VDWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.9 bits (150), Expect = 4e-10
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 19/152 (12%)

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIA 749
           P L +L+ C    ++L  V EY+          G D  Y +    K   P        I+
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVN---------GGDLMYHIQQVGKFKEPQAVFYAAEIS 111

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIG 808
            GL +LH      I++RD+K  NV+LD + + KI+DFG+ K  E     ++TR   GT  
Sbjct: 112 VGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPD 166

Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           Y+APE           D +++GV+  E+++G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 61.9 bits (150), Expect = 4e-10
 Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 4/95 (4%)

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I   L +LH   ++ IV+RDIK  N+LLD + +  ++DFGL+K +  ++   +    GTI
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170

Query: 808 GYMAPEYAMRGYLTSKA-DVYSFGVVTLEIVSGKS 841
            YMAPE         KA D +S G++  E+++G S
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS 205

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 62.3 bits (151), Expect = 5e-10
 Identities = 51/170 (30%), Positives = 88/170 (51%), Gaps = 18/170 (10%)

Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
           +E+  ++A  H  +VK +      ++LLL+ EY     L++ I     + RLK   P ++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-----KQRLKEHLPFQE 168

Query: 743 K----ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT- 797
                +   I   L  +H  SR K++HRD+K++N+ L      K+ DFG +K Y +  + 
Sbjct: 169 YEVGLLFYQIVLALDEVH--SR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225

Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 847
            +++   GT  Y+APE   R   + KAD++S GV+  E++     T +RP
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL-----TLHRP 270

Length = 478

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 62.0 bits (150), Expect = 5e-10
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 25/224 (11%)

Query: 630 LRQIKAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSS---KSRQGNREFV 682
           +R+++    ++D    +G G FG V    +K   S   V A+K LS      R  +  F 
Sbjct: 35  IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFW 91

Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
            E  +++    P +V+L+    +   L +V EYM    L   +    + Y +   W   K
Sbjct: 92  EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM----SNYDVPEKWA--K 145

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIST 801
                +   L  +H    + ++HRD+K  N+LLDK  + K++DFG   K+ E       T
Sbjct: 146 FYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT 202

Query: 802 RIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKS 841
            + GT  Y++PE        GY   + D +S GV   E++ G +
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT 245

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.3 bits (149), Expect = 6e-10
 Identities = 60/203 (29%), Positives = 85/203 (41%), Gaps = 22/203 (10%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ--------QHPNL 696
           +G+G FG V      +DG   AVK L  K+         E   I A+        +HP L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK----KEQKHIMAERNVLLKNVKHPFL 58

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           V L+      ++L  V +Y+    L    F    E       P  +     IA  L YLH
Sbjct: 59  VGLHYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFP--EPRARFYAAEIASALGYLH 113

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
               + I++RD+K  N+LLD   +  ++DFGL K   E     ST   GT  Y+APE   
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLR 169

Query: 817 RGYLTSKADVYSFGVVTLEIVSG 839
           +       D +  G V  E++ G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 61.2 bits (148), Expect = 7e-10
 Identities = 60/201 (29%), Positives = 89/201 (44%), Gaps = 18/201 (8%)

Query: 646 VGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIG-MISAQQHPNLVKLY 700
           +G+G FG V       DG   AVK L  K   +R+  +  + E   ++   +HP LV L+
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
                  +L  V +++    L    F    E       P  +     IA  L YLH    
Sbjct: 63  YSFQTTEKLYFVLDFVNGGEL---FFHLQRER--SFPEPRARFYAAEIASALGYLHS--- 114

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMAPEYAMRG 818
           I IV+RD+K  N+LLD   +  ++DFGL K  + + D T   T   GT  Y+APE   + 
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRKQ 171

Query: 819 YLTSKADVYSFGVVTLEIVSG 839
              +  D +  G V  E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.1 bits (151), Expect = 8e-10
 Identities = 29/82 (35%), Positives = 51/82 (62%)

Query: 113 LSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL 172
           L G  P  ++ +  L+++++ GN   G+IPP +  + +L+ L LS NSF G +P  L +L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 173 TNLNDLRISDNNFSGKIPEFIG 194
           T+L  L ++ N+ SG++P  +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 60.6 bits (147), Expect = 9e-10
 Identities = 36/94 (38%), Positives = 56/94 (59%), Gaps = 8/94 (8%)

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIA 804
           +ARG+ +L   SR K +HRD+   N+LL ++   KI DFGLA+   +D  ++     R+ 
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 805 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             + +MAPE       T+++DV+SFGV+  EI S
Sbjct: 239 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 19/156 (12%)

Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKIC 745
           A +HP L  L+ C    ++L  V EY+          G D  +++    K D P  +   
Sbjct: 52  AAKHPFLTALHCCFQTKDRLFFVMEYVN---------GGDLMFQIQRSRKFDEPRSRFYA 102

Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL-YEEDKTHISTRIA 804
             +   L +LH   R  +++RD+K  N+LLD + + K++DFG+ K       T  +T   
Sbjct: 103 AEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFC 157

Query: 805 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           GT  Y+APE           D ++ GV+  E+++G+
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 22/203 (10%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLY 700
           +G+G FG V      ++    AVK L  K+   ++  +  ++E   ++   +HP LV L+
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW----PTRKKICIGIARGLAYLH 756
                 ++L  V +Y         I G +  Y L+ +     P  +     IA  L YLH
Sbjct: 63  FSFQTADKLYFVLDY---------INGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 113

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
               + IV+RD+K  N+LLD   +  ++DFGL K   E     ST   GT  Y+APE   
Sbjct: 114 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLH 169

Query: 817 RGYLTSKADVYSFGVVTLEIVSG 839
           +       D +  G V  E++ G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 19/217 (8%)

Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTV--IAVKQLSS----KSRQGNREFV 682
             R+ K    +F+    +G G FG V      +     +A+K+       K +Q +  F 
Sbjct: 21  PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF- 79

Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
           +E  +++   HP  V LYG   + + L LV E++    +    F   T  R    +P   
Sbjct: 80  SERKILNYINHPFCVNLYGSFKDESYLYLVLEFV----IGGEFF---TFLRRNKRFPNDV 132

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
             C   A+ +        + IV+RD+K  N+LLDKD   K++DFG AK+ +  +T+    
Sbjct: 133 G-CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYT--- 187

Query: 803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           + GT  Y+APE  +       AD ++ G+   EI+ G
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.0 bits (148), Expect = 2e-09
 Identities = 36/117 (30%), Positives = 49/117 (41%), Gaps = 24/117 (20%)

Query: 193 IGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILT 252
            GKW  I  L +    L G IP  IS L  L  + +S                       
Sbjct: 415 KGKWF-IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNS-------------------- 453

Query: 253 KCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 309
              I G IP  +G +T L+ +DLS+N+  G IP +  +L     + L GN L+G VP
Sbjct: 454 ---IRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 35/93 (37%), Positives = 48/93 (51%), Gaps = 4/93 (4%)

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I   L YLH      +V+RD+K  N++LDKD + KI+DFGL K    D   + T   GT 
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 159

Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            Y+APE           D +  GVV  E++ G+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 44/212 (20%), Positives = 81/212 (38%), Gaps = 39/212 (18%)

Query: 649 GGFGSVYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG 706
                + K      T++AVK+  L S S++  +    EI      QHPN++      +  
Sbjct: 13  LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71

Query: 707 NQLLLVYEYM---------KNNCLSRAIFG-KDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L +V   M         K +       G  +              I   +   L Y+H
Sbjct: 72  SELYVVSPLMAYGSCEDLLKTHFPE----GLPELAIAF---------ILKDVLNALDYIH 118

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDK----THISTR-IAGTIGYM 810
                  +HR +K S++LL  D    +S    +  + +  K     H   +     + ++
Sbjct: 119 ---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175

Query: 811 APEY---AMRGYLTSKADVYSFGVVTLEIVSG 839
           +PE     ++GY   K+D+YS G+   E+ +G
Sbjct: 176 SPEVLQQNLQGY-NEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 19/153 (12%)

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIA 749
           P L +L+ C    ++L  V EY+          G D  Y++    +   P        IA
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVN---------GGDLMYQIQQVGRFKEPHAVFYAAEIA 111

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIG 808
            GL +LH      I++RD+K  NV+LD + + KI+DFG+ K  E     ++T+   GT  
Sbjct: 112 IGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPD 166

Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           Y+APE           D ++FGV+  E+++G++
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 60.3 bits (146), Expect = 3e-09
 Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 2/90 (2%)

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYM 810
           LA  H  S+  ++HRDIK++N+LL  +   K+ DFG +K+Y    +  +     GT  Y+
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 811 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           APE   R   + KAD++S GV+  E+++ K
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLK 242

Length = 496

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 63/207 (30%), Positives = 90/207 (43%), Gaps = 29/207 (14%)

Query: 646 VGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREF---VNEIGMISAQQHPNLVK 698
           +G+G FG V   IL    + G   A+K L  +      E    + E  ++   +HP L  
Sbjct: 3   LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 699 LYGCCVEGNQLLLVYEYMKNN----CLSRA-IFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           L       ++L  V EY+        LSR  +F +D       +          I   L 
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAE----------IVSALD 109

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YLH     KIV+RD+K  N++LDKD + KI+DFGL K    D   + T   GT  Y+APE
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPE 165

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                      D +  GVV  E++ G+
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 3/93 (3%)

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I   L YLH +    +V+RD+K  N++LDKD + KI+DFGL K   +D   + T   GT 
Sbjct: 104 IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTP 160

Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            Y+APE           D +  GVV  E++ G+
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 4/93 (4%)

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I   L YLH      +V+RDIK  N++LDKD + KI+DFGL K    D   + T   GT 
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 159

Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            Y+APE           D +  GVV  E++ G+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 21/207 (10%)

Query: 646 VGEGGFGSVYKGI---LSDG-----TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
           +G+G F  ++KGI   + D      T + +K L    R  +  F     M+S   H +LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY-LH 756
             YG CV G++ ++V EY+K   L    + K  +  + + W       + +A+ LA+ LH
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLD--TYLKKNKNLINISWK------LEVAKQLAWALH 114

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE--DKTHISTRI-AGTIGYMAPE 813
                 + H ++   NVLL ++ + K  +    KL +     T +   I    I ++ PE
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174

Query: 814 YAMRG-YLTSKADVYSFGVVTLEIVSG 839
                  L+  AD +SFG    EI SG
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.2 bits (141), Expect = 5e-09
 Identities = 43/155 (27%), Positives = 79/155 (50%), Gaps = 24/155 (15%)

Query: 645 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGC 702
           K+GEG + +VYKG     G ++A+K++  +  +G     + E  ++   +H N+V L+  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW------PTRKKICI-GIARGLAYL 755
                 L LV+EY+            DT+ +  +D           ++ +  + RGLAY 
Sbjct: 72  IHTKKTLTLVFEYL------------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 790
           H   + +++HRD+K  N+L+ +    K++DFGLA+
Sbjct: 120 H---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 58.3 bits (141), Expect = 6e-09
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 30/212 (14%)

Query: 639 NFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSSKS--RQGNREFVN-EIGMISAQ 691
           +F+    +G G FG V    +KG    G   A+K L  +   +    + V  E  ++   
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75

Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT--RKKICIGIA 749
            HP +V +     + N++  + E++    +   +F   T  R    +P    K     + 
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLLEFV----VGGELF---THLRKAGRFPNDVAKFYHAELV 128

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
               YLH      I++RD+K  N+LLD   + K++DFG AK    D+T     + GT  Y
Sbjct: 129 LAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTFT---LCGTPEY 181

Query: 810 MAPEYAM-RGYLTSKA-DVYSFGVVTLEIVSG 839
           +APE    +G+   KA D ++ GV+  E ++G
Sbjct: 182 LAPEVIQSKGH--GKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.5 bits (142), Expect = 6e-09
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 7/95 (7%)

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           + RGL Y+H  +   ++HRD+K SN+LL+ + + KI DFGLA+    +K    T    T 
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTR 172

Query: 808 GYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGK 840
            Y APE  +    Y T+  DV+S G +  E++  K
Sbjct: 173 WYRAPELLLNCSEY-TTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER

 Score = 58.1 bits (141), Expect = 8e-09
 Identities = 43/177 (24%), Positives = 60/177 (33%), Gaps = 47/177 (26%)

Query: 413 WAFSSTGKFM--DDDT-------DLDNYIRTNTSTLSKVSAVD--------LELYRTARV 455
             F  +   +   DD           +   +  ST   V              + +TA  
Sbjct: 175 LNFGGSEGTIRYPDDVYDRIWEPFFSSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAVT 234

Query: 456 -----SPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDF 510
                +PL+ T+  L   N  Y V LHFAEI         SL  R FDIYI  K V  D 
Sbjct: 235 PTNASAPLNFTW-DLVDPNFEYYVYLHFAEI--------QSLETREFDIYINGKTVYGDV 285

Query: 511 NIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLR----GTYGPLISAI 563
           +     G     +  +FP           +  +G G   I L      T  PL++A+
Sbjct: 286 SP-KYLGTDTGALYLDFP-----------VNVSGGGLLNISLVPTSGSTLPPLLNAL 330

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.1 bits (140), Expect = 8e-09
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 4/92 (4%)

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG-T 806
           +A+G+ +L   SR K +HRD+   N+LL ++   KI DFGLA+   +D  ++    A   
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 57.8 bits (140), Expect = 8e-09
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 11/99 (11%)

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT----HISTRI 803
           I  GL Y+H  +   ++HRD+K  N+L++ D   KI DFGLA+ + E+       ++  +
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 804 AGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 840
           A T  Y APE  +  + Y T   DV+S G +  E++  K
Sbjct: 171 A-TRWYRAPEIMLSFQSY-TKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 9/98 (9%)

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIA 804
           +A+G+ +L   + I   HRD+   NVLL     AKI DFGLA+    D  ++   + R+ 
Sbjct: 221 VAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277

Query: 805 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKS 841
             + +MAPE       T ++DV+S+G++  EI S GKS
Sbjct: 278 --VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 10/97 (10%)

Query: 746 IGIARGL----AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIS 800
           I I R L    AYLH      I+HRD+KT N+ LD+  NA + DFG A KL     T   
Sbjct: 188 ITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244

Query: 801 TRIAGTIGYMAPEY-AMRGYLTSKADVYSFGVVTLEI 836
              +GT+   +PE  A+  Y   K D++S G+V  E+
Sbjct: 245 YGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 57.3 bits (138), Expect = 2e-08
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 26/206 (12%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           VG G +G+V   +    G  +A+K+L    +S    +    E+ ++   +H N++ L   
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 703 CV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
                     +   LV  +M  +        K +E R++        +   + +GL Y+H
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGLKYIH 135

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYA 815
                 I+HRD+K  N+ +++D   KI DFGLA+  + + T ++ TR      Y APE  
Sbjct: 136 AAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVI 187

Query: 816 MRG-YLTSKADVYSFGVVTLEIVSGK 840
           +   + T   D++S G +  E+++GK
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 57.3 bits (138), Expect = 2e-08
 Identities = 45/176 (25%), Positives = 72/176 (40%), Gaps = 28/176 (15%)

Query: 675 RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL 734
           R G      E  ++ A  HP++++L G           + Y K  CL    +  D    L
Sbjct: 127 RGGT---ATEAHILRAINHPSIIQLKG----------TFTYNKFTCLILPRYKTDLYCYL 173

Query: 735 KLDWPTRKKICI--------GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 786
                 ++ I I         + R + YLHE+    I+HRDIK  N+ ++   +  + DF
Sbjct: 174 A----AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDF 226

Query: 787 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN 842
           G A    +   +     AGTI   APE   R       D++S G+V  E+ +   +
Sbjct: 227 GAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282

Length = 391

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 20/211 (9%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYG 701
           KVG G +G VYK    DG     K+ + K  +G   +     EI ++   +HPN++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65

Query: 702 CCVEGN--QLLLVYEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             +  +  ++ L+++Y +++      F    K  +  ++L     K +   I  G+ YLH
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 757 EDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYM 810
            +    ++HRD+K +N+L+     +    KI+D G A+L+      ++    +  T  Y 
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 811 APEYAMRGYLTSKA-DVYSFGVVTLEIVSGK 840
           APE  +     +KA D+++ G +  E+++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 55.8 bits (134), Expect = 4e-08
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 29/190 (15%)

Query: 662 GTVIAVKQLS------SKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV------EGNQL 709
           G  +AVK+LS      + +++  RE V    ++    H N++ L           E   +
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELV----LLKCVNHKNIISLLNVFTPQKSLEEFQDV 101

Query: 710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK 769
            LV E M  N L + I        ++LD      +   +  G+ +LH      I+HRD+K
Sbjct: 102 YLVMELMDAN-LCQVI-------HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 150

Query: 770 TSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSF 829
            SN+++  D   KI DFGLA+        + T    T  Y APE  +        D++S 
Sbjct: 151 PSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 208

Query: 830 GVVTLEIVSG 839
           G +  E+V G
Sbjct: 209 GCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 55.5 bits (133), Expect = 5e-08
 Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 36/237 (15%)

Query: 639 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS------SKSRQGNREFVNEIGMISAQQ 692
           N  P     +G   + Y  +L     +A+K+LS      + +++  RE V    ++    
Sbjct: 21  NLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV----LMKCVN 74

Query: 693 HPNLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 746
           H N++ L           E   + LV E M  N L + I       +++LD      +  
Sbjct: 75  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-LCQVI-------QMELDHERMSYLLY 126

Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 806
            +  G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVT 181

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQE 863
             Y APE  +        D++S G +  E+V  K      P  D  Y+  W  V+++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI---LFPGRD--YIDQWNKVIEQ 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 55.1 bits (132), Expect = 6e-08
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 20/211 (9%)

Query: 645 KVGEGGFGSVYKGILSDG---TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
           KVG G +G VYK    DG      A+KQ+       +     EI ++   +HPN++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 65

Query: 702 CCVE--GNQLLLVYEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             +     ++ L+++Y +++      F    K  +  ++L     K +   I  G+ YLH
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 757 EDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYM 810
            +    ++HRD+K +N+L+     +    KI+D G A+L+      ++    +  T  Y 
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 811 APEYAMRGYLTSKA-DVYSFGVVTLEIVSGK 840
           APE  +     +KA D+++ G +  E+++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 55.2 bits (133), Expect = 6e-08
 Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 34/228 (14%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQ-------LSSKSRQGNREFVNEIGMISAQQHPNLV 697
           +G+G +G V   I    G  +A+K+       +S  +R      + EI ++   +HP++V
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-----ILREIKLLRLLRHPDIV 62

Query: 698 KLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           ++    +     E   + +V+E M+++ L + I   D      L     +     + R L
Sbjct: 63  EIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKAND-----DLTPEHHQFFLYQLLRAL 116

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGYM 810
            Y+H  +   + HRD+K  N+L + D   KI DFGLA++   D       T    T  Y 
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 811 APEY--AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLD 856
           APE   +     T   D++S G +  E+++GK      P ++ V+ LD
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP---LFPGKNVVHQLD 218

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 55.2 bits (133), Expect = 7e-08
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 25/222 (11%)

Query: 630 LRQIKAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSS---KSRQGNREFV 682
           + +++    +FD    +G G FG V    +K   S   V A+K LS      R  +  F 
Sbjct: 35  ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFW 91

Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
            E  +++      +V+L+    +   L +V EYM    L   +    + Y +   W    
Sbjct: 92  EERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWARFY 147

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIST 801
              + +A  L  +H    +  +HRD+K  N+LLDK  + K++DFG   K+         T
Sbjct: 148 TAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT 202

Query: 802 RIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSG 839
            + GT  Y++PE        GY   + D +S GV   E++ G
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 55.6 bits (134), Expect = 8e-08
 Identities = 43/121 (35%), Positives = 60/121 (49%), Gaps = 19/121 (15%)

Query: 449 LYRTARVS----PLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEK 504
           LY++A VS    P  L+Y      N NY+V LHFAEI    D++  + GKR+FD+ I   
Sbjct: 254 LYQSALVSTDTQP-DLSYTMDVDPNRNYSVWLHFAEI----DNSITAEGKRVFDVLINGD 308

Query: 505 LVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAIS 564
              KD +I   +G     +V N    V+  TL I L          P +GT+  +I+AI 
Sbjct: 309 TAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQ---------PKKGTHA-IINAIE 358

Query: 565 V 565
           V
Sbjct: 359 V 359

Length = 623

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.4 bits (133), Expect = 8e-08
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 10/95 (10%)

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT- 806
           +ARG+ +L   +    VHRD+   NVLL +    KI DFGLA+    D  ++S    G+ 
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK---GST 299

Query: 807 ---IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
              + +MAPE       T+ +DV+S+G++  EI S
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 54.7 bits (131), Expect = 1e-07
 Identities = 60/247 (24%), Positives = 98/247 (39%), Gaps = 56/247 (22%)

Query: 639 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS------SKSRQGNREFVNEIGMISAQQ 692
           N  P     +G   + Y  IL     +A+K+LS      + +++  RE V    ++    
Sbjct: 28  NLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV----LMKCVN 81

Query: 693 HPNLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 746
           H N++ L           E   + +V E M  N L + I       +++LD      +  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI-------QMELDHERMSYLLY 133

Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 806
            +  G+ +LH      I+HRD+K SN+++  D   KI DFGLA            R AGT
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGT 178

Query: 807 IGYMAPEYAMRGY----------LTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLD 856
              M P    R Y               D++S G +  E++ G       P  D  ++  
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV---LFPGTD--HIDQ 233

Query: 857 WAYVLQE 863
           W  V+++
Sbjct: 234 WNKVIEQ 240

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 25/224 (11%)

Query: 630 LRQIKAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSS---KSRQGNREFV 682
           +R ++    +++    +G G FG V    +K   S   V A+K LS      R  +  F 
Sbjct: 35  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFW 91

Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
            E  +++    P +V+L+    +   L +V EYM    L   +    + Y +   W   +
Sbjct: 92  EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWA--R 145

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIST 801
                +   L  +H    +  +HRD+K  N+LLDK  + K++DFG   K+ +E      T
Sbjct: 146 FYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202

Query: 802 RIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKS 841
            + GT  Y++PE        GY   + D +S GV   E++ G +
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 54.7 bits (131), Expect = 1e-07
 Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 8/158 (5%)

Query: 683 NEIGMISAQQHPNLVKLYGCC-VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-LDWPT 740
           NEI  +    H N++K+      E N  ++  +Y  +  L   ++ +  +++ + L   T
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFMYDEAFDWKDRPLLKQT 269

Query: 741 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 800
           R  I   +   + Y+H+    K++HRDIK  N+ L+ D    + DFG A  +E+++    
Sbjct: 270 RA-IMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325

Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
               GT+   +PE           D++S G++ L+++S
Sbjct: 326 YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 54.0 bits (130), Expect = 2e-07
 Identities = 51/198 (25%), Positives = 80/198 (40%), Gaps = 49/198 (24%)

Query: 665 IAVKQLS------SKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV------EGNQLLLV 712
           +A+K+LS      + +++  RE V    ++    H N++ L           E   + LV
Sbjct: 44  VAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99

Query: 713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 772
            E M  N L + I       ++ LD      +   +  G+ +LH      I+HRD+K SN
Sbjct: 100 MELMDAN-LCQVI-------QMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 148

Query: 773 VLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY----------LTS 822
           +++  D   KI DFGLA            R AGT   M P    R Y             
Sbjct: 149 IVVKSDCTLKILDFGLA------------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 196

Query: 823 KADVYSFGVVTLEIVSGK 840
             D++S G +  E++ G 
Sbjct: 197 NVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 60/266 (22%), Positives = 107/266 (40%), Gaps = 55/266 (20%)

Query: 639 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL- 696
           +F+    +G G FG V      D G V A+K L    R+ +     ++G I A++   + 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKIL----RKADMLEKEQVGHIRAERDILVE 57

Query: 697 ------VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 750
                 VK++    +   L L+ E++    +   +  KDT         T ++    IA 
Sbjct: 58  ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTL--------TEEETQFYIAE 109

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL---------------------- 788
            +  +    ++  +HRDIK  N+LLD   + K+SDFGL                      
Sbjct: 110 TVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169

Query: 789 ------------AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEI 836
                       A+ ++ ++  ++    GT  Y+APE  M+       D +S GV+  E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 837 VSGKSN-TNYRPNEDFVYLLDWAYVL 861
           + G     +  P E +  +++W   L
Sbjct: 230 LIGYPPFCSETPQETYKKVMNWKETL 255

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 52/232 (22%)

Query: 634 KAATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQGNREFVNEIGMISAQQ 692
           ++   ++   N +G G FG VY+ I  D +  +A+K++    +  NRE +    ++    
Sbjct: 62  RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLN 117

Query: 693 HPNLVKL----YGCCVEGNQ--LLL----------VYEYMK----NNCLSRAIFGKDTEY 732
           H N++ L    Y  C + N+  + L          V++YMK    NN        K   Y
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177

Query: 733 RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKL 791
           +L               R LAY+H      I HRD+K  N+L+D + +  K+ DFG AK 
Sbjct: 178 QL--------------CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220

Query: 792 Y---EEDKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSG 839
               +   ++I +R      Y APE  +     T+  D++S G +  E++ G
Sbjct: 221 LLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 64/246 (26%), Positives = 104/246 (42%), Gaps = 55/246 (22%)

Query: 638 NNFDPANKVGEGGFGSV--YKGILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQ 691
           ++F+    +G G FG V   +   + G + A+K+L  KS    +E V     E  +++  
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDT-GHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEA 58

Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
            +P +VKLY    + N L L+ EY+    +   +  KDT         T ++    IA  
Sbjct: 59  DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTF--------TEEETRFYIAET 110

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--------LYEEDKTHI---- 799
           +  +    ++  +HRDIK  N+LLD   + K+SDFGL           +    +H     
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170

Query: 800 ----------STRIA---------------GTIGYMAPEYAMR-GYLTSKADVYSFGVVT 833
                     S R A               GT  Y+APE  ++ GY   + D +S GV+ 
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIM 229

Query: 834 LEIVSG 839
            E++ G
Sbjct: 230 YEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 3e-07
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 5/87 (5%)

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY--AM- 816
           ++  VHRDIK  NVLLDK+ + +++DFG       D T  S    GT  Y++PE   AM 
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179

Query: 817 --RGYLTSKADVYSFGVVTLEIVSGKS 841
             +G    + D +S GV   E++ G++
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 52.6 bits (127), Expect = 3e-07
 Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 18/151 (11%)

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARG 751
           +PN +KLY         +L+ +Y+K+  L    F  D  +   KL     KKI   +   
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----F--DLLKKEGKLSEAEVKKIIRQLVEA 121

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLN-AKISDFGLAKLYEEDKTHISTRIAGTIGYM 810
           L  LH   +  I+H DIK  NVL D+  +   + D+GL K+      +      GT+ Y 
Sbjct: 122 LNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYF 173

Query: 811 APE-YAMRGYLTSKADVYSFGVVTLEIVSGK 840
           +PE      Y  S  D ++ GV+T E+++GK
Sbjct: 174 SPEKIKGHNYDVS-FDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 46/230 (20%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSDG-TVIAVKQLSSKS----RQGNREFVNEIGMISAQQ 692
            +F+    +  G +G+VY     +     A+K+++ ++     Q  + FV E  +++  +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAE 59

Query: 693 HPNLVKLYGCCVEGNQ-LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR- 750
           +P +V ++ C  E  + L +V EY++         G D    LK        + + +AR 
Sbjct: 60  NPFVVSMF-CSFETKRHLCMVMEYVE---------GGDCATLLKNIGA----LPVDMARM 105

Query: 751 -------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK---------LYE- 793
                   L YLH      IVHRD+K  N+L+    + K++DFGL+K         LYE 
Sbjct: 106 YFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG 162

Query: 794 ----EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
               + +  +  ++ GT  Y+APE  +R       D ++ G++  E + G
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 52.7 bits (126), Expect = 5e-07
 Identities = 41/131 (31%), Positives = 63/131 (48%), Gaps = 17/131 (12%)

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT- 806
           +A G+ +L   +    VHRD+   NVL+ +    KI DFGLA+    D  +IS    G+ 
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK---GST 301

Query: 807 ---IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSNTNYRPNEDFVYLLDWAYVL 861
              + +MAPE       T+ +DV+SFG++  EI +  G        NE F   +   Y +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM 361

Query: 862 QE-----EEIY 867
            +     +EIY
Sbjct: 362 AKPAHASDEIY 372

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 52.6 bits (126), Expect = 5e-07
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIA 804
           +A+G+++L   + I   HRD+   N+LL      KI DFGLA+    D  ++   + R+ 
Sbjct: 223 VAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 805 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             + +MAPE       T ++DV+S+G++  EI S
Sbjct: 280 --VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (123), Expect = 8e-07
 Identities = 30/88 (34%), Positives = 48/88 (54%), Gaps = 4/88 (4%)

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L  LH+     +++RD+K  N+LLD   +  + DFGL KL  +D    +T   GT  Y+A
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLA 161

Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           PE  +    T   D ++ GV+  E+++G
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.6 bits (123), Expect = 9e-07
 Identities = 55/263 (20%), Positives = 103/263 (39%), Gaps = 47/263 (17%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEI----GMISAQQH 693
           ++F+    +G G FG V      D   I   ++  K+    +E V  I     ++     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
             +VK++    +   L L+ E++    +   +  KDT         + +     IA  + 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTL--------SEEATQFYIAETVL 112

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL------------------------- 788
            +    ++  +HRDIK  N+LLD   + K+SDFGL                         
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172

Query: 789 ---------AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                    A+ +++++  ++    GT  Y+APE  M+       D +S GV+  E++ G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Query: 840 KSN-TNYRPNEDFVYLLDWAYVL 861
                +  P E +  +++W   L
Sbjct: 233 YPPFCSETPQETYRKVMNWKETL 255

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 5/99 (5%)

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           IA  +  +H   ++  VHRDIK  NVLLD + + +++DFG      +D T  S+   GT 
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167

Query: 808 GYMAPEY--AMR---GYLTSKADVYSFGVVTLEIVSGKS 841
            Y++PE   AM    G    + D +S GV   E++ G++
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.8 bits (124), Expect = 1e-06
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 646 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEI----GMISAQQHPNLVKLY 700
           +  G FG VY G   ++  + AVK +  K+   N+  V+++      ++  + P +V LY
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70

Query: 701 GCCVEGNQLLLVYEYMKNNCLSR--AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
                 N + LV EY+    +     I+G         D     K    +A  L YLH  
Sbjct: 71  YSLQSANNVYLVMEYLIGGDVKSLLHIYGY-------FDEEMAVKYISEVALALDYLH-- 121

Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 791
            R  I+HRD+K  N+L+  + + K++DFGL+K+
Sbjct: 122 -RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 50.7 bits (121), Expect = 2e-06
 Identities = 45/192 (23%), Positives = 88/192 (45%), Gaps = 22/192 (11%)

Query: 662 GTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 719
           GT++ V+   L + + +  +   NE+ +    +HPN++  +     G+ L ++  +M   
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84

Query: 720 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 779
             +  +    T +   +       I  G  RGL YLH++  I   HR+IK S++L+  D 
Sbjct: 85  SANSLL---KTYFPEGMSEALIGNILFGALRGLNYLHQNGYI---HRNIKASHILISGDG 138

Query: 780 NAKISDFGLAKLYEEDKTHISTRIA--------GTIGYMAPEYA---MRGYLTSKADVYS 828
              +S  GL+ LY   +     ++           + +++PE     + GY   K+D+YS
Sbjct: 139 LVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGY-NVKSDIYS 195

Query: 829 FGVVTLEIVSGK 840
            G+   E+ +G+
Sbjct: 196 VGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 48/201 (23%), Positives = 83/201 (41%), Gaps = 29/201 (14%)

Query: 653 SVYKGILSDGTVI--AVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG----CCVEG 706
           S+YKGI ++  VI    K+     +       NEI  +      N++K+YG       + 
Sbjct: 35  SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHR 766
            +L L+ EY     L   +     +    L + T+  + I   +GL  L+        ++
Sbjct: 95  PRLSLILEYCTRGYLREVL-----DKEKDLSFKTKLDMAIDCCKGLYNLY--KYTNKPYK 147

Query: 767 DIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL------ 820
           ++ + + L+ ++   KI   GL K+       +S+     + +M   Y     L      
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKI-------LSSPPFKNVNFMV--YFSYKMLNDIFSE 198

Query: 821 -TSKADVYSFGVVTLEIVSGK 840
            T K D+YS GVV  EI +GK
Sbjct: 199 YTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 50.2 bits (120), Expect = 4e-06
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 23/99 (23%)

Query: 187 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNL 246
           G IP  I K + +Q +++ G+S+ G IP S+ ++TSL  L   DL  +            
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL---DLSYNS----------- 477

Query: 247 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 285
                     +G IP+ +G +T L+ ++L+ N+L+G +P
Sbjct: 478 ---------FNGSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 49.7 bits (118), Expect = 4e-06
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 5/87 (5%)

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY--AM- 816
           ++  VHRDIK  N+L+D + + +++DFG      ED T  S+   GT  Y++PE   AM 
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179

Query: 817 --RGYLTSKADVYSFGVVTLEIVSGKS 841
             +G    + D +S GV   E++ G++
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.5 bits (106), Expect = 4e-06
 Identities = 21/60 (35%), Positives = 28/60 (46%)

Query: 245 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 304
           NLK+L L+   +          +  LK +DLS NNLT   P  F  L     + L+GN L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.4 bits (115), Expect = 1e-05
 Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 4/83 (4%)

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK-THISTRIAGTIGYMAP 812
           Y+H +    I+HRDIKT NVL++   +  + DFG A        T     IAGT+   AP
Sbjct: 275 YIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331

Query: 813 EYAMRGYLTSKADVYSFGVVTLE 835
           E       T   D++S G+V  E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 31/123 (25%), Positives = 53/123 (43%), Gaps = 42/123 (34%)

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGL---------AKLYEEDKTH------------ 798
           ++  +HRDIK  N+L+D+D + K++DFGL         +K Y++   H            
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 799 ---------------------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV 837
                                ++  + GT  Y+APE  +R   T   D +S GV+  E++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238

Query: 838 SGK 840
            G+
Sbjct: 239 VGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 47.4 bits (112), Expect = 3e-05
 Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 49/241 (20%)

Query: 638 NNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH 693
           N ++   K+G G FG V+    K         A+     K R+ + + V E+ ++   +H
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS-QLVIEVNVMRELKH 71

Query: 694 PNLVKLYGCCV-EGNQ-LLLVYEYMKNNCLSRAI------FGKDTEYRLKLDWPTRKKIC 745
            N+V+     + + NQ L ++ E+     LSR I      FGK  E+ +         I 
Sbjct: 72  KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV-------DIT 124

Query: 746 IGIARGLAYLHE----DSRIKIVHRDIKTSNVLLD-------------KDLN----AKIS 784
             +   LAY H      +  +++HRD+K  N+ L               +LN    AKI 
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184

Query: 785 DFGLAK-LYEEDKTHISTRIAGTIGYMAPE---YAMRGYLTSKADVYSFGVVTLEIVSGK 840
           DFGL+K +  E   H      GT  Y +PE   +  + Y   K+D+++ G +  E+ SGK
Sbjct: 185 DFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSY-DDKSDMWALGCIIYELCSGK 240

Query: 841 S 841
           +
Sbjct: 241 T 241

Length = 1021

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 3e-05
 Identities = 60/242 (24%), Positives = 90/242 (37%), Gaps = 58/242 (23%)

Query: 640 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHP 694
           F     +G+G  G V+   L   G + A+K L  K     R  V     E  +++   HP
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHP 61

Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR---- 750
            L  LY        L LV +Y     L R            L     K +   +AR    
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRL-----------LQRQPGKCLSEEVARFYAA 110

Query: 751 ----GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK---------------- 790
                L YLH    + IV+RD+K  N+LL +  +  +SDF L+K                
Sbjct: 111 EVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167

Query: 791 ------------LYEEDKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIV 837
                        + E+ +  S    GT  Y+APE  + G    S  D ++ G++  E++
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEML 226

Query: 838 SG 839
            G
Sbjct: 227 YG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 45.7 bits (108), Expect = 6e-05
 Identities = 48/184 (26%), Positives = 86/184 (46%), Gaps = 28/184 (15%)

Query: 665 IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRA 724
           + +K L    R     F     ++S   H +L  ++G CV G++ ++V E++++  L   
Sbjct: 47  VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD-- 104

Query: 725 IFGKDTEYRLKLDWPTRKKICIG--IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA- 781
           +  +  + R+ + W    KI +   +A  L+YL + +   +VH ++   N+LL +   A 
Sbjct: 105 VCLRKEKGRVPVAW----KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE 157

Query: 782 ------KISDFG--LAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVV 832
                 K+SD G     L  E++          I ++APE    G  L++ AD +SFG  
Sbjct: 158 GTSPFIKLSDPGVSFTALSREERVE-------RIPWIAPECVPGGNSLSTAADKWSFGTT 210

Query: 833 TLEI 836
            LEI
Sbjct: 211 LLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 32/127 (25%), Positives = 52/127 (40%), Gaps = 46/127 (36%)

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGL---------AKLYE------EDKTHISTR-- 802
           ++  +HRDIK  N+L+D+D + K++DFGL         +K Y+      +D    S    
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 803 -----------------------------IAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 833
                                        + GT  Y+APE  +R   T   D +S GV+ 
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238

Query: 834 LEIVSGK 840
            E++ G+
Sbjct: 239 YEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 36/150 (24%), Positives = 61/150 (40%), Gaps = 47/150 (31%)

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGL---------AKLYEE---------------- 794
           ++  +HRDIK  N+L+D D + K++DFGL         +K Y++                
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 795 ------------------DKTH---ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 833
                              K H   ++  + GT  Y+APE  +R   T   D +S GV+ 
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 834 LEIVSGKSN-TNYRPNEDFVYLLDWAYVLQ 862
            E++ G+       P E  + +++W   L 
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLH 268

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.1 bits (104), Expect = 3e-04
 Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 30/175 (17%)

Query: 638 NNFDPANKVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQ 692
            +F     +G+G FG V        G + A+K L  KS    ++ +     E  +++   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLL-KSEMFKKDQLAHVKAERDVLAESD 59

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRLKLDWPTRKKI--C 745
            P +V LY    +   L L+ E++    L         F +D          TR  +  C
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---------TRFYMAEC 110

Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 800
           +     +  +H   ++  +HRDIK  N+L+D+  + K+SDFGL+  +   K H S
Sbjct: 111 V---LAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH--KQHDS 157

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 37/214 (17%)

Query: 646 VGEGGFGSVYKGIL-------SDGTV------IAVKQLSSKSRQGNREFVNEIGMISAQQ 692
           +G G    +Y GIL        DG        + +K L    R  +  F     M+    
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           H ++V LYG CV   + ++V E+++   L   +  K       L  P + K+   +A  L
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD----VLTTPWKFKVAKQLASAL 118

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKD-LNA------KISDFG--LAKLYEEDKTHISTRI 803
           +YL ED    +VH ++ T N+LL ++ ++       K+SD G  +  L  ++        
Sbjct: 119 SYL-EDK--DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE----- 170

Query: 804 AGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEI 836
              I ++APE       L+  AD +SFG    EI
Sbjct: 171 --RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 27/150 (18%), Positives = 55/150 (36%), Gaps = 17/150 (11%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLV-KLYGC 702
            +  G    VY  + +      +K   S+ +  +RE   E+ ++    +    V K+   
Sbjct: 5   LLKGGLTNRVYL-LGTKDEDYVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61

Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
                   L+ E+++         G+  +   + +      I   +A  LA LH+   + 
Sbjct: 62  GESDGWSYLLMEWIE---------GETLDEVSEEEKE---DIAEQLAELLAKLHQLPLLV 109

Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLY 792
           + H D+   N+L+D      I D+  A   
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYG 139

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 42.6 bits (100), Expect = 0.001
 Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 6/107 (5%)

Query: 75  SKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 134
            KLR L+       C+  +F P+     LV+L + G++L   +  V  ++T L+N+ + G
Sbjct: 589 PKLRLLRWDKYPLRCMPSNFRPE----NLVKLQMQGSKLEKLWDGV-HSLTGLRNIDLRG 643

Query: 135 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 181
           +     IP D+    NL+ L LS  S   ELP+ +  L  L DL +S
Sbjct: 644 SKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689

syringae 6; Provisional. Length = 1153

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 41.6 bits (97), Expect = 0.002
 Identities = 54/223 (24%), Positives = 88/223 (39%), Gaps = 68/223 (30%)

Query: 631 RQIKAATNNFDPANKVGEGGFGSVYKGI---LSDGTVIAVKQLSSKS------------- 674
              + ++++F   +K+G G FG  ++G+     D  V    +L+++              
Sbjct: 138 ANSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMD 197

Query: 675 RQGNR-EFVNEIGMISAQQHPNLVKLYGC------------CVE---------------- 705
           RQG R +F+    +        +V+ Y C            C E                
Sbjct: 198 RQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTK 257

Query: 706 GNQLLLVYEYMKNNCLSRAIFGKDTEY------------RLKLDWPTRKK---ICIGIAR 750
           G+Q L V+++  +  L  A+ GK   +            ++  + P  K+   +  G+ R
Sbjct: 258 GSQWL-VWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMR 316

Query: 751 ----GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 789
               GL  LH   RI IVHRDIK  N+L+  D   KI DFG A
Sbjct: 317 QVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 39.6 bits (93), Expect = 0.003
 Identities = 26/95 (27%), Positives = 40/95 (42%), Gaps = 18/95 (18%)

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           V+ +  L+V EY++   L  A+               R  +   + R +  LH   +  I
Sbjct: 69  VDPDNGLIVMEYIEGELLKDAL------------EEARPDLLREVGRLVGKLH---KAGI 113

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKL--YEEDK 796
           VH D+ TSN++L         DFGL +     EDK
Sbjct: 114 VHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVEDK 147

Length = 204

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.0 bits (97), Expect = 0.003
 Identities = 17/58 (29%), Positives = 27/58 (46%), Gaps = 4/58 (6%)

Query: 741 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 798
             ++   +   +A LH+     IVH D+ TSN ++  D    I DFGL K  +  +  
Sbjct: 430 NPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIVRDDRLYLI-DFGLGKYSDLIEDK 483

Length = 535

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.0 bits (84), Expect = 0.004
 Identities = 22/60 (36%), Positives = 30/60 (50%), Gaps = 2/60 (3%)

Query: 127 LKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 185
           LK+L +  N  T  IP    + L NL+ L LS N+ T   P   + L +L  L +S NN 
Sbjct: 2   LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	869
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.98
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.98
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.98
KOG0589	426	consensus Serine/threonine protein kinase [General	99.98
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.98
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.98
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.98
KOG0610	459	consensus Putative serine/threonine protein kinase	99.98
PHA02988	283	hypothetical protein; Provisional	99.98
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.98
PHA03212	391	serine/threonine kinase US3; Provisional	99.98
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.98
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.98
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.98
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.98
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.98
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.98
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.98
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.98
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.98
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.98
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.98
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.97
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.97
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.97
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.97
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.97
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.97
PTZ00283	496	serine/threonine protein kinase; Provisional	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.97
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.97
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.97
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.97
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.96
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.96
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.96
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.96
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.96
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.96
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.96
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.96
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.96
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.96
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.96
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.96
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.96
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.96
KOG0586	596	consensus Serine/threonine protein kinase [General	99.96
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.96
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.96
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.96
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.96
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.96
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.96
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.96
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.96
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.96
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.96
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.96
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.96
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.96
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.96
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.96
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.96
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.96
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.96
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.96
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.96
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.96
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.96
PLN00009	294	cyclin-dependent kinase A; Provisional	99.96
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.96
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.96
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.96
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.96
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.96
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.96
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.96
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.96
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.96
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.96
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.96
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.96
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.95
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.95
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.95
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.95
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.95
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.95
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.95
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.95
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.95
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.95
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.95
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.95
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.95
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.95
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.95
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.95
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.95
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.95
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.95
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.95
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.95
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.95
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.95
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.94
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.94
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.94
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.93
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.93
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.93
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.92
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.92
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.91
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.91
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.91
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.9
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.89
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.89
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.89
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.88
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	99.87
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.87
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.86
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.85
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.83
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.82
PLN00181	793	protein SPA1-RELATED; Provisional	99.81
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.81
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.8
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.79
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.79
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.78
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.77
PRK12274	218	serine/threonine protein kinase; Provisional	99.77
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.77
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.76
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.75
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.75
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.75
PRK10345	210	hypothetical protein; Provisional	99.74
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.73
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.72
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.71
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.71
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.71
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.71
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
smart00090	237	RIO RIO-like kinase.	99.68
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.66
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.66
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.61
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.59
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.57
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.56
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.54
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.52
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.5
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.5
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.47
PLN03150	623	hypothetical protein; Provisional	99.45
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.43
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.37
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.36
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.34
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.34
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.32
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.22
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.22
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.19
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.15
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.14
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.14
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.14
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.09
KOG1243	690	consensus Protein kinase [General function predict	99.09
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.06
PLN03150	623	hypothetical protein; Provisional	99.06
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.04
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.03
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.01
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.0
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.99
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.95
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.91
KOG3087	229	consensus Serine/threonine protein kinase [General	98.9
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.76
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.75
KOG2120	419	consensus SCF ubiquitin ligase, Skp2 component [Po	98.74
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.74
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.73
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.73
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.72
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.7
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.7
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.7
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.64
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.64
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.62
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.57
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.51
COG4248	637	Uncharacterized protein with protein kinase and he	98.48
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.41
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.35
KOG2120	419	consensus SCF ubiquitin ligase, Skp2 component [Po	98.35

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.4e-66  Score=649.42  Aligned_cols=206  Identities=29%  Similarity=0.500  Sum_probs=171.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ....|+..++||+|+||.||+|+. .+++.||||++.....    ...+|++++++++|||||+++++|.+++..++|||
T Consensus       688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            345678889999999999999997 4789999999864332    12346888999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++|+|.++++        .++|.++.+|+.|+|+||+|||+...++|+||||||+||+++.++.+++. ||.......
T Consensus       764 y~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        764 YIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             CCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            999999999984        37899999999999999999997655679999999999999999988876 665443321


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHHH
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYV  860 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~~  860 (869)
                      .     ....+++.|+|||++.+..++.++|||||||++|||++|+.||... ......+++|++.
T Consensus       835 ~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~-~~~~~~~~~~~~~  894 (968)
T PLN00113        835 D-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE-FGVHGSIVEWARY  894 (968)
T ss_pred             C-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc-cCCCCcHHHHHHH
Confidence            1     1235789999999999999999999999999999999999999542 2234567777754

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=413.81  Aligned_cols=238  Identities=56%  Similarity=0.921  Sum_probs=208.8

Q ss_pred             cCCcccHHHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEE
Q 002899          624 QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC  703 (869)
Q Consensus       624 ~~~~~~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~  703 (869)
                      ....|++.++..||++|...+.||+|+||.||+|.+++|+.||||++.....+..++|..|++++++++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34679999999999999999999999999999999999999999988765433256799999999999999999999999


Q ss_pred             eeCc-eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEE
Q 002899          704 VEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK  782 (869)
Q Consensus       704 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~k  782 (869)
                      .+.+ +.+||||||++|+|.++|++....   +++|.+|++||.++|+||+|||+..+++||||||||+|||||+++++|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            9998 599999999999999999986543   789999999999999999999999888999999999999999999999


Q ss_pred             EeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHHHhh
Q 002899          783 ISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQ  862 (869)
Q Consensus       783 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~~~~  862 (869)
                      |+|||+|+..........+...||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+.....+...+++|+....
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999996554311111111179999999999999999999999999999999999999987655455666999987665


Q ss_pred             cc
Q 002899          863 EE  864 (869)
Q Consensus       863 ~~  864 (869)
                      ++
T Consensus       298 ~~  299 (361)
T KOG1187|consen  298 EE  299 (361)
T ss_pred             HC
Confidence            54

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-42  Score=358.56  Aligned_cols=199  Identities=31%  Similarity=0.567  Sum_probs=179.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+...  .+...+-...|+++|+.++|||||++++++..++.+||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            356778888999999999999986 5789999998766  4455566789999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC------CcEEEeecC
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD------LNAKISDFG  787 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~------~~~kl~DFG  787 (869)
                      |||.+|+|.++++..+     .+++..++.++.|+|.||++||+++   ||||||||.||||+..      -.+||+|||
T Consensus        89 EyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            9999999999998775     6899999999999999999999998   9999999999999764      468999999


Q ss_pred             CceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +|+.+...  ......+|+|-|||||++...+|+.|+|+||.|+|+|||++|+.||+.
T Consensus       161 fAR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  161 FARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hhhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            99988743  344567999999999999999999999999999999999999999974

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=341.78  Aligned_cols=201  Identities=28%  Similarity=0.445  Sum_probs=180.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .++|++.++||+|+||+||.++.+ +++.+|+|++++..   ..+.+...+|..+|.+++||.||+++..|++.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            568999999999999999999965 58899999987653   23456678899999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      +||+.||.|..+|..++     .+++..++-++..|+.||.|||+.+   ||||||||+|||||++|+++|+|||+++..
T Consensus       104 ld~~~GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EeccCCccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            99999999999997654     6899999999999999999999998   999999999999999999999999999855


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ..... ....++||+.|||||++.+..++..+|+||+||++|||++|.+||...
T Consensus       176 ~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~  228 (357)
T KOG0598|consen  176 LKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE  228 (357)
T ss_pred             ccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence            43322 233479999999999999999999999999999999999999999653

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=354.56  Aligned_cols=200  Identities=38%  Similarity=0.616  Sum_probs=174.8

Q ss_pred             CCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchh--hHHHHHHHHHHHhcCCCceeeEEeEEeeCc-eEEEEEEecc
Q 002899          641 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYGCCVEGN-QLLLVYEYMK  717 (869)
Q Consensus       641 ~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~--~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~E~~~  717 (869)
                      .+.+.||+|+||+||+|.++....||||++.......  .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            3456699999999999999755559999997654322  568999999999999999999999999887 7999999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-cEEEeecCCceeecCCC
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLYEEDK  796 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~~~  796 (869)
                      +|+|.++++..   ....+++..+++++.|||+||.|||++++  ||||||||+|||++.++ ++||+|||+++......
T Consensus       124 ~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  124 GGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            99999999874   12379999999999999999999999874  99999999999999997 99999999998776432


Q ss_pred             ccccccccccccccchhhcc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~--~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                       ...+...||+.|||||++.  ...++.|+|||||||++|||+||+.||...
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~  249 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL  249 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC
Confidence             2223367999999999999  669999999999999999999999999653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=337.58  Aligned_cols=207  Identities=30%  Similarity=0.484  Sum_probs=180.2

Q ss_pred             CCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc-eEEEEEEeccC
Q 002899          642 PANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-QLLLVYEYMKN  718 (869)
Q Consensus       642 ~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~E~~~~  718 (869)
                      ..+.||+|..|+|||++++ +++.+|+|.+.... ....+++.+|++++++.+||+||+++|.|+..+ ++.++||||++
T Consensus        83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg  162 (364)
T KOG0581|consen   83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG  162 (364)
T ss_pred             hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence            3578999999999999987 68899999996553 344678999999999999999999999999998 59999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |||++.+...+     .+++...-+|+.+|++||.|||+..  +||||||||+|||++..|++||||||.+..+...   
T Consensus       163 GSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  163 GSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            99999886543     6899999999999999999999632  4999999999999999999999999999877644   


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--CCcchhhHHHHH
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR--PNEDFVYLLDWA  858 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~--~~~~~~~l~~w~  858 (869)
                      .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+...  ...+..+|..++
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I  294 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI  294 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH
Confidence            344578999999999999999999999999999999999999999663  233444555444

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-39  Score=351.82  Aligned_cols=200  Identities=30%  Similarity=0.520  Sum_probs=181.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ..|...+.||+|||+.||+++. ..|+.||+|++.+.   ..........||+|.+.++|||||+++++|++.+.+|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688899999999999999997 78999999999764   3334567889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      |+|++++|..++...+     ++++..++.++.||+.||.|||+++   |+|||||..|++|+++.++||+|||+|....
T Consensus        98 ELC~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLE  169 (592)
T ss_pred             EecCCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeec
Confidence            9999999999987443     7999999999999999999999998   9999999999999999999999999999887


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .+.. ....++|||.|+|||++.+...+..+||||+||+||.||.|++||+..
T Consensus       170 ~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk  221 (592)
T KOG0575|consen  170 YDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK  221 (592)
T ss_pred             Cccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence            5432 234579999999999999999999999999999999999999999754

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-38  Score=339.10  Aligned_cols=213  Identities=29%  Similarity=0.450  Sum_probs=180.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLV  712 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV  712 (869)
                      +.|+..++||+|.||.||||+. .+|+.||+|++....  ....+-..+||.+|++++||||+++.+...+.  +.+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            3455667899999999999994 579999999987654  33345567999999999999999999998876  689999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      +|||++ +|.-++....    ..++..++..++.|++.||+|+|.++   |+|||||.+|||||.+|.+||+|||+|+++
T Consensus       197 FeYMdh-DL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             Eecccc-hhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence            999997 5766665433    36899999999999999999999998   999999999999999999999999999998


Q ss_pred             cCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHH
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA  858 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~  858 (869)
                      ........+..+-|..|.|||++.+. .|+..+|+||.||||.||+.|++.|..+.+-++...+--+
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl  335 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL  335 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH
Confidence            87665555666779999999998875 7999999999999999999999999876544444444433

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-38  Score=332.36  Aligned_cols=200  Identities=29%  Similarity=0.445  Sum_probs=172.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCch-------hhHHHHHHHHHHHhcCCCceeeEEeEEeeCc
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQ-------GNREFVNEIGMISAQQHPNLVKLYGCCVEGN  707 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~-------~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~  707 (869)
                      ..+.|-+.+.||+|+||.|-+|.- ++|+.||||+++.....       ......+|+++|++++|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456678899999999999999985 47999999999754211       1233569999999999999999999999999


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC---CcEEEe
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKIS  784 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~---~~~kl~  784 (869)
                      ..|||||||++|.|.+.+-++.     .+.+..-+-++.|++.|+.|||++|   |+||||||+|||+..+   ..+||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEec
Confidence            9999999999999999987765     4677778999999999999999998   9999999999999765   789999


Q ss_pred             ecCCceeecCCCccccccccccccccchhhcccCC---CCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          785 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY---LTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       785 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |||+|+..+.  .......+|||.|.|||++....   +..++|+||+||+||-+++|.+||..
T Consensus       322 DFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~  383 (475)
T KOG0615|consen  322 DFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE  383 (475)
T ss_pred             ccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence            9999998873  33455689999999999997542   34489999999999999999999954

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-39  Score=322.66  Aligned_cols=206  Identities=29%  Similarity=0.446  Sum_probs=177.1

Q ss_pred             CCCCCCeeeccCceEEEEEE-EcCCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEe-EEeeCce-EEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYG-CCVEGNQ-LLLVY  713 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~-~~~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~-~~~~~~~-~~lV~  713 (869)
                      +|.+.++||+|.||+|||+. +.+|..||.|.++-.  ..+..+....|+.+|+.++|||||++++ -+.++.+ ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            46677899999999999999 468999999987533  4555678899999999999999999998 4555555 89999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR-IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      ||+..|+|.+++...+. ....+++..+++++.|+++||.++|..-+ ..|+||||||.||+++.+|.+||+|||+++++
T Consensus       100 E~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999975432 23478999999999999999999998421 13889999999999999999999999999988


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ..... .....+|||.||+||.+....|+.|+||||+||++|||..-++||..+
T Consensus       179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~  231 (375)
T KOG0591|consen  179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD  231 (375)
T ss_pred             cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence            76543 334578999999999999999999999999999999999999999754

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=310.07  Aligned_cols=216  Identities=27%  Similarity=0.368  Sum_probs=184.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch---hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~---~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|+..+.||.|+||.|..++.+ +|..+|+|+++...-.   ..+....|.++|+.+.||.++++++.+.+.+.+||||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46778899999999999999976 6889999999765322   2334567999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|-|..+++..+     +++++.++-++.+|+.||+|||+.+   |++|||||+|||+|.+|.+||+|||+|+...
T Consensus       124 eyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             eccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            9999999999997754     6899999999999999999999998   9999999999999999999999999998775


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHHHhhccccc
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIY  867 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~~~~~~~~~  867 (869)
                      ..    ....+|||.|+|||++....++..+|.|||||++|||+.|.+||.....  +.-.-+.+...++-+-|
T Consensus       196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~iY~KI~~~~v~fP~~  263 (355)
T KOG0616|consen  196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQIYEKILEGKVKFPSY  263 (355)
T ss_pred             Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HHHHHHHHhCcccCCcc
Confidence            43    3357999999999999999999999999999999999999999964322  44444444444444333

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-38  Score=342.23  Aligned_cols=200  Identities=34%  Similarity=0.538  Sum_probs=176.0

Q ss_pred             CCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCc
Q 002899          641 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC  720 (869)
Q Consensus       641 ~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs  720 (869)
                      ...+.||+|.||.||.|.++....||+|.++.. ......|.+|+++|++++|+|||+++|+|..++.++||||||+.|+
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs  287 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS  287 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence            346789999999999999988779999999865 3345789999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcccc
Q 002899          721 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS  800 (869)
Q Consensus       721 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  800 (869)
                      |.++|....   +..+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+|||+|+...++.....
T Consensus       288 Ll~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~  361 (468)
T KOG0197|consen  288 LLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS  361 (468)
T ss_pred             HHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence            999997632   336899999999999999999999997   99999999999999999999999999996555444344


Q ss_pred             ccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 002899          801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP  847 (869)
Q Consensus       801 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~  847 (869)
                      ....-+..|.|||.+..+.++.|+|||||||+||||+| |+.|+....
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms  409 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS  409 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC
Confidence            33445679999999999999999999999999999999 888875443

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=320.93  Aligned_cols=193  Identities=34%  Similarity=0.534  Sum_probs=164.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHh--cCCCceeeEEeEEeeCc----eEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVEGN----QLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~~l  711 (869)
                      +..+..++||+|.||.||||++. ++.||||++..   +..+.|+.|-++.+.  ++|+||++++++-....    +++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            34556788999999999999996 48999999964   345678888887764  68999999999987665    8999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED------SRIKIVHRDIKTSNVLLDKDLNAKISD  785 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~iiH~Dlk~~NILl~~~~~~kl~D  785 (869)
                      |+||.+.|||.++|..+      .++|....+|+..|++||+|||+.      .+++|+|||||++||||..|+++.|+|
T Consensus       286 Vt~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             EeeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            99999999999999876      689999999999999999999974      457799999999999999999999999


Q ss_pred             cCCceeecCCCccc-cccccccccccchhhcccCC------CCchhHHHHHHHHHHHHHcCC
Q 002899          786 FGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGY------LTSKADVYSFGVVTLEIVSGK  840 (869)
Q Consensus       786 FGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~------~~~k~DvwSlGvil~elltG~  840 (869)
                      ||+|..+....... ....+||.+|||||++.+..      .-.+.||||+|.+||||++.-
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC  421 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC  421 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence            99999887543221 12268999999999998653      234689999999999999853

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.4e-37  Score=330.67  Aligned_cols=215  Identities=27%  Similarity=0.437  Sum_probs=187.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+..  ..+.+...+|+++++.++|||||.++++|+...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            56788899999999999999965 67899999986543  3345678899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+.+ +|..++....     .++++.+..|+.+++.||.|||+..   |+|||+||.|||++..+.+|++|||+|+.+..
T Consensus        82 ~a~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             hhhh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc
Confidence            9987 9999996654     6899999999999999999999997   99999999999999999999999999998876


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHHHhhcccccC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIYW  868 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~~~~~~~~~~  868 (869)
                      . ..+-+.+.|||-|||||++.+..|+..+|+||+|||+|||++|++||-.      ..+.+-|+....++.-|
T Consensus       153 ~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~v~~  219 (808)
T KOG0597|consen  153 N-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDPVKP  219 (808)
T ss_pred             C-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCCCCC
Confidence            3 4455678999999999999999999999999999999999999999943      23444455555555444

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.5e-36  Score=327.01  Aligned_cols=219  Identities=24%  Similarity=0.379  Sum_probs=187.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .++|+++++||+|+||.||.|+-+ +|..+|+|++++..   ....+....|-.+|...++|+||+++..|++.+.+|||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            578999999999999999999965 69999999997653   33455678899999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||++||++-.+|...+     .|++..++.++.+++-|++.||+.|   +|||||||+|+|||..|++||+|||++..+
T Consensus       220 MEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence            99999999999998765     6899999999999999999999998   999999999999999999999999998543


Q ss_pred             cCC-----------------------Ccc----c-------------------cccccccccccchhhcccCCCCchhHH
Q 002899          793 EED-----------------------KTH----I-------------------STRIAGTIGYMAPEYAMRGYLTSKADV  826 (869)
Q Consensus       793 ~~~-----------------------~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~k~Dv  826 (869)
                      ...                       ...    .                   ....+|||.|||||++.+..|+..+|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            210                       000    0                   012569999999999999999999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCC-CcchhhHHHHHHHhhc
Q 002899          827 YSFGVVTLEIVSGKSNTNYRP-NEDFVYLLDWAYVLQE  863 (869)
Q Consensus       827 wSlGvil~elltG~~p~~~~~-~~~~~~l~~w~~~~~~  863 (869)
                      ||+||||||||.|-+||.... .+--..++.|...++.
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f  409 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF  409 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC
Confidence            999999999999999997654 4445568888765543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.7e-37  Score=309.68  Aligned_cols=210  Identities=26%  Similarity=0.408  Sum_probs=177.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      +.|+...++|+|+||+|||++.+ +|+.||||++.....  ...+-.++|+++|+.++|||+|.++++|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35667788999999999999976 599999999976533  234456899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |++.--| +-|....    ..++...+.+++.|+++|+.|+|+++   +|||||||+|||++.++.+||||||+|+.+..
T Consensus        82 ~~dhTvL-~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   82 YCDHTVL-HELERYP----NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             ecchHHH-HHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            9997544 3343322    25789999999999999999999998   99999999999999999999999999998875


Q ss_pred             CCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHH
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLD  856 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~  856 (869)
                      . ....+..+.|..|.|||.+.+ ..|++.+||||.||++.||++|.+-|..+++-|+.-+++
T Consensus       154 p-gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~  215 (396)
T KOG0593|consen  154 P-GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIR  215 (396)
T ss_pred             C-cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHH
Confidence            3 233455678999999999887 689999999999999999999999887766555444433

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.7e-36  Score=298.06  Aligned_cols=221  Identities=27%  Similarity=0.408  Sum_probs=182.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchh--hHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~--~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ++|...+.+|+|.||.||+|+. .+|+.||||+++.....+  .....+|+++|+.++|+||+.++++|...+.+-||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4566778999999999999995 579999999997664333  4567899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      ||+. +|...+....    ..+...++..++.++++|++|||++.   |+||||||.|+|++++|.+||+|||+|+.+..
T Consensus        82 fm~t-dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             eccc-cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            9985 7888886553    36899999999999999999999998   99999999999999999999999999999876


Q ss_pred             CCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHHHhhccccc
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIY  867 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~~~~~~~~~  867 (869)
                      ...... ..+-|..|.|||.+.+. .|+..+||||.|||+.||+-|.+-|....+-|+...+--+-...+++.|
T Consensus       154 p~~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~W  226 (318)
T KOG0659|consen  154 PNRIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQW  226 (318)
T ss_pred             CCcccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccC
Confidence            543322 23568899999998865 6999999999999999999999777655444444444333344444443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=324.72  Aligned_cols=204  Identities=28%  Similarity=0.446  Sum_probs=178.7

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCce
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~  708 (869)
                      .+-..+|.+.+.||+|+|++|++|+.. .++.+|||++.+.-   ....+-...|-++|.++ .||.||+|+..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            344568999999999999999999954 68999999986541   12234456788888888 89999999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      +|+|+||+++|.|.++|+..+     .+++...+.++.+|+.||+|||++|   ||||||||+|||||.|+++||+|||.
T Consensus       149 LYFvLe~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGs  220 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGS  220 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccc
Confidence            999999999999999998764     6899999999999999999999998   99999999999999999999999999


Q ss_pred             ceeecCCCcc---------c-c--ccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          789 AKLYEEDKTH---------I-S--TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       789 a~~~~~~~~~---------~-~--~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |+.+.+....         . +  ..++||..|.+||++.....++.+|+||||||+|.|+.|++||..
T Consensus       221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra  289 (604)
T KOG0592|consen  221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA  289 (604)
T ss_pred             cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence            9988643221         1 1  347899999999999999999999999999999999999999964

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-36  Score=344.20  Aligned_cols=209  Identities=34%  Similarity=0.544  Sum_probs=179.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~  709 (869)
                      +.+....+.||+|+||+||+|+..      +...||||.+++.+.. ...+|.+|++++..++|||||+++|.|.+++.+
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            455667889999999999999853      3467999999988766 788999999999999999999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCccc---------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEY---------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN  780 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~  780 (869)
                      ++|+|||..|+|.++|.......         ..+++..+.+.||.|||.||+||-++.   +|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            99999999999999986432221         335899999999999999999999987   999999999999999999


Q ss_pred             EEEeecCCceeecC-CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCC
Q 002899          781 AKISDFGLAKLYEE-DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPN  848 (869)
Q Consensus       781 ~kl~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~  848 (869)
                      +||+|||+++..-. +..+......-..+|||||.+..++++.++|||||||+|||+++ |+.|+....+
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn  711 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN  711 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence            99999999986533 32332223344679999999999999999999999999999998 8889865444

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.2e-36  Score=305.02  Aligned_cols=221  Identities=27%  Similarity=0.393  Sum_probs=186.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchh--hHHHHHHHHHHHhcCCCceeeEEeEEee--CceEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLV  712 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~--~~~f~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV  712 (869)
                      ++|+..+.|++|.||.||+|+.+ +++.||+|+++......  -.--++||.+|.+.+|||||.+.++...  -+.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45667889999999999999965 68899999997654322  2345799999999999999999998765  4579999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      ||||+. +|..++..-.    .++...++..++.|+++|++|||.+.   |+|||||++|+|+...|.+||+|||+|+.+
T Consensus       156 Me~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             HHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence            999986 6888886543    37899999999999999999999998   999999999999999999999999999999


Q ss_pred             cCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHHHhhccccc
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIY  867 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~~~~~~~~~  867 (869)
                      +.... ..++.+-|..|.|||.+.+. .|+..+|+||+|||+.||+++++-|.....-++.+.+--+....+|.||
T Consensus       228 gsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw  302 (419)
T KOG0663|consen  228 GSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW  302 (419)
T ss_pred             cCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence            86543 34556779999999998865 6999999999999999999999999877666666666666666777776

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-36  Score=326.32  Aligned_cols=198  Identities=30%  Similarity=0.553  Sum_probs=178.8

Q ss_pred             cCCCCCCeeeccCceEEEEEE-EcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~-~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      ..|+..++||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.+..++++|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            346667889999999999998 4578899999998766665666789999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++|+|.+.+...      .+++.++..|++.+++||+|||.++   |+|||||++|||++.+|.+||+|||++..+....
T Consensus       353 ~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  353 EGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             CCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            999999988554      5899999999999999999999998   9999999999999999999999999998887655


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ... ..++|||.|||||++....|++|+||||||++++||+-|.+||-.
T Consensus       424 ~KR-~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln  471 (550)
T KOG0578|consen  424 SKR-STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN  471 (550)
T ss_pred             Ccc-ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence            433 347899999999999999999999999999999999999999954

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=327.38  Aligned_cols=202  Identities=28%  Similarity=0.447  Sum_probs=175.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~  710 (869)
                      .-++|.+.++||+|.||+|++|..+ +++.+|||.+++..   ..+....+.|.+++... +||.++.++.+|+..+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3467899999999999999999976 57899999998764   33445567788888766 5999999999999999999


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      .||||+.||++..+.+..      .+++..++-++..|+.||+|||+++   ||+||||.+|||||.+|++||+|||+++
T Consensus       446 fvmey~~Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEecCCCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence            999999999965554433      6899999999999999999999998   9999999999999999999999999997


Q ss_pred             eecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          791 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      ..--.. .....++|||.|||||++.+..|+..+|+|||||+|||||.|.+||...+
T Consensus       517 e~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd  572 (694)
T KOG0694|consen  517 EGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD  572 (694)
T ss_pred             ccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            543222 23456899999999999999999999999999999999999999997543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6e-36  Score=332.12  Aligned_cols=200  Identities=30%  Similarity=0.517  Sum_probs=175.8

Q ss_pred             CCCCCCeeeccCceEEEEEEEcC----CcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~~----g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ...+.++||.|.||.||+|+++-    ...||||.++.... ...++|+.|+.||.++.||||++|.|+......+++|+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            34678899999999999999862    35799999987644 45678999999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      |||++|+|..+|..++.    ++.+.+...+.++||.||+||.+.+   +|||||.++|||++.+..+||+|||+++.+.
T Consensus       710 EyMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             hhhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence            99999999999987764    5899999999999999999999887   9999999999999999999999999999887


Q ss_pred             CCCcccccccc--ccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          794 EDKTHISTRIA--GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ++.....+..-  -+.+|.|||.+...+++..+|||||||+|||+++ |..|+..
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd  837 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD  837 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc
Confidence            65533222222  2569999999999999999999999999999876 8888754

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=319.27  Aligned_cols=202  Identities=27%  Similarity=0.446  Sum_probs=175.5

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc----Cc-hhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCc
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK----SR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN  707 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~----~~-~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~  707 (869)
                      ...++|.+.+.||+|+||+|+.|... ++..||+|++...    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34568889999999999999999864 6899999976553    11 22445567999999999 999999999999999


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-CcEEEeec
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDF  786 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~-~~~kl~DF  786 (869)
                      .+++||||+.+|.|.+++...+     ++.+..+..+++|+++|++|||+++   |+||||||+|||++.+ +.+||+||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF  165 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF  165 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence            9999999999999999997633     6888999999999999999999998   9999999999999999 99999999


Q ss_pred             CCceeecCCCccccccccccccccchhhcccCC-C-CchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          787 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY-L-TSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       787 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |++.... .........+||+.|+|||++.+.. | +.++||||+||+||.|++|+.||+.
T Consensus       166 G~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d  225 (370)
T KOG0583|consen  166 GLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD  225 (370)
T ss_pred             ccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence            9998874 1222334578999999999998765 5 5789999999999999999999975

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-35  Score=310.14  Aligned_cols=201  Identities=34%  Similarity=0.553  Sum_probs=171.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc--eEEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QLLLVYE  714 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~E  714 (869)
                      .++...+.||+|+||+||++... +|...|||.+........+.+.+|+.+|++++|||||+++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            34566789999999999999975 48999999987654333566889999999999999999999855444  6899999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCcEEEeecCCceeec
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYE  793 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~-~~~~kl~DFGla~~~~  793 (869)
                      |+++|+|.+++...+.    .+++..++.+++||++||+|||+++   ||||||||+|||++. ++.+||+|||++....
T Consensus        97 y~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             ccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            9999999999976542    5899999999999999999999998   999999999999999 7999999999998776


Q ss_pred             C--CCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 E--DKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .  ..........||+.|||||++..+ ...+++||||+||++.||+||++||..
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence            3  122223357899999999999854 344699999999999999999999864

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=315.15  Aligned_cols=212  Identities=26%  Similarity=0.406  Sum_probs=179.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchhh-HHHHHHHHHHHhcC-CCceeeEEeEEeeCc-eEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQ-HPNLVKLYGCCVEGN-QLLL  711 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~~-~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~-~~~l  711 (869)
                      ..++|...++||.|.||.||+|+. .++..||||+++.+..... --=.+|++.|++++ |||||++.+.+.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            346788889999999999999995 4789999999876643322 22368999999999 999999999999988 9999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      |||||+. +|.+++..++    ..++++.++.|+.||++||+|+|.+|   +.|||+||+|||+.....+||+|||+|+.
T Consensus        88 VfE~Md~-NLYqLmK~R~----r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eHHhhhh-hHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence            9999985 7999987653    37999999999999999999999998   99999999999999989999999999998


Q ss_pred             ecCCCccccccccccccccchhhcc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHH
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAY  859 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~  859 (869)
                      ......  .+..+.|..|+|||++. .+.|+.+.||||+|||++|+.+-++-|....  |.+++-+.-.
T Consensus       160 v~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s--E~Dqi~KIc~  224 (538)
T KOG0661|consen  160 VRSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS--EIDQIYKICE  224 (538)
T ss_pred             cccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc--HHHHHHHHHH
Confidence            765443  34567899999999875 5689999999999999999999999886543  4444544433

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=303.06  Aligned_cols=203  Identities=26%  Similarity=0.398  Sum_probs=177.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchh-hHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~-~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .+.|++.++||.|..++||+|+. +.+..||||++.-+.... .+.+.+|+..++.++||||++++..|..+.++|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            46788999999999999999995 467999999997654333 4788899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      ||.+||+.+.+...-   ...+++..+..|.+++++||.|||++|   .||||||+.||||+.+|.+||+|||.+..+..
T Consensus       105 fMa~GS~ldIik~~~---~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYY---PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             hhcCCcHHHHHHHHc---cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            999999999997653   335899999999999999999999998   99999999999999999999999998876654


Q ss_pred             CCcccc---ccccccccccchhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHIS---TRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......   ...+||+.|||||++..  ..|+.|+|||||||...||.+|..||..
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k  234 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK  234 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence            332221   34689999999999653  4699999999999999999999999964

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-35  Score=318.25  Aligned_cols=206  Identities=29%  Similarity=0.532  Sum_probs=175.8

Q ss_pred             cHHHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC
Q 002899          629 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG  706 (869)
Q Consensus       629 ~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~  706 (869)
                      +.++++...+.+.+.+.||+|.||+||+|.|.  ..||||++....  .+..+.|..|+.++++-||.||+-+.|||...
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            33556666667778899999999999999986  348999987653  44567899999999999999999999999988


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                      .. .+|+.+|++.+|..++|-.+.    .++..+.+.|++|||+||.|||.++   |||||||+.||+++++++|||+||
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~et----kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQET----KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhh----hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecc
Confidence            76 999999999999999987653    6899999999999999999999998   999999999999999999999999


Q ss_pred             CCceeecCCC-ccccccccccccccchhhcccC---CCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          787 GLAKLYEEDK-THISTRIAGTIGYMAPEYAMRG---YLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       787 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      |++..-..-. .......-|...|||||+++..   +|++.+||||||+++|||++|..||.
T Consensus       533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys  594 (678)
T KOG0193|consen  533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS  594 (678)
T ss_pred             cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence            9987543211 1111123467799999999743   78999999999999999999999996

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.4e-34  Score=319.26  Aligned_cols=201  Identities=24%  Similarity=0.366  Sum_probs=174.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||+||+|... +++.||+|++....   ......+..|++++.+++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999865 58899999986532   223456788999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            9999999999986543     5899999999999999999999998   9999999999999999999999999987543


Q ss_pred             CCCc----------------------------------cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcC
Q 002899          794 EDKT----------------------------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG  839 (869)
Q Consensus       794 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG  839 (869)
                      ....                                  ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G  232 (363)
T cd05628         153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG  232 (363)
T ss_pred             ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence            2110                                  001234799999999999988999999999999999999999


Q ss_pred             CCCCCCC
Q 002899          840 KSNTNYR  846 (869)
Q Consensus       840 ~~p~~~~  846 (869)
                      +.||...
T Consensus       233 ~~Pf~~~  239 (363)
T cd05628         233 YPPFCSE  239 (363)
T ss_pred             CCCCCCC
Confidence            9999653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-34  Score=299.54  Aligned_cols=198  Identities=26%  Similarity=0.463  Sum_probs=177.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      -+|++.+.||+|.||.|-+|.. ..|+.||||.+++...   ++.-.+.+|++||+.++||||+.++++|+..+.+.+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            3577788999999999999984 6899999998876543   33445778999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||..+|.|.+++...+     .+++..++.+++||.+|+.|+|.+.   ++|||||.+|||||.++.+||+|||++..+.
T Consensus       133 EYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  133 EYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence            9999999999997764     6899999999999999999999987   9999999999999999999999999998876


Q ss_pred             CCCccccccccccccccchhhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..  ..-+.++|+|-|.+||++.+.+| ++.+|-|||||+||.|+.|..||+.
T Consensus       205 ~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG  255 (668)
T KOG0611|consen  205 DK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG  255 (668)
T ss_pred             cc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence            43  34456899999999999998765 6789999999999999999999963

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.6e-33  Score=303.01  Aligned_cols=200  Identities=30%  Similarity=0.410  Sum_probs=173.1

Q ss_pred             CCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+....   ......+.+|++++.+++|+||+++++++.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367788999999999999996 478999999886432   2233467889999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++|+|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.....
T Consensus        81 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          81 IMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             ecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            9999999888754321   25899999999999999999999987   99999999999999999999999999987543


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ...  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  204 (285)
T cd05631         155 GET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR  204 (285)
T ss_pred             CCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence            221  22346899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.3e-34  Score=318.83  Aligned_cols=204  Identities=25%  Similarity=0.371  Sum_probs=175.1

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002899          633 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       633 i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~  708 (869)
                      +....++|++.+.||+|+||.||+|+.. +++.||+|++...   .....+.+.+|+++++.++||||+++++++.+++.
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3444578999999999999999999976 5789999998642   22234567889999999999999999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .++||||+++|+|.+++...      .+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccc
Confidence            99999999999999988543      4788899999999999999999997   99999999999999999999999999


Q ss_pred             ceeecCCCccccccccccccccchhhcccC----CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMRG----YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +...............||+.|+|||++...    .++.++||||+||++|||++|+.||..
T Consensus       189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~  249 (370)
T cd05621         189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA  249 (370)
T ss_pred             ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence            987654332222345799999999998754    378899999999999999999999964

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-34  Score=282.11  Aligned_cols=204  Identities=26%  Similarity=0.423  Sum_probs=179.4

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEE
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  710 (869)
                      .+-++|++.+.||+|-||.||.|+.+ ++-.||+|++.+..   .+..+++.+|+++-+.++||||+++++||.+....|
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy   98 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY   98 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence            44578999999999999999999965 67789999886542   233567889999999999999999999999999999


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      |++||.+.|++...|.+...   .++++.....+..|+|.|+.|+|...   ||||||||+|+|++.++..|++|||.+.
T Consensus        99 LilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen   99 LILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             EEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCcee
Confidence            99999999999999985543   36888899999999999999999887   9999999999999999999999999976


Q ss_pred             eecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          791 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      ...   .......+||..|.|||+..+...+.++|+|++|++.||++.|.+||....
T Consensus       173 ~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~  226 (281)
T KOG0580|consen  173 HAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS  226 (281)
T ss_pred             ecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence            543   222345789999999999999999999999999999999999999996543

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=297.91  Aligned_cols=201  Identities=30%  Similarity=0.465  Sum_probs=167.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch--------------hhHHHHHHHHHHHhcCCCceeeEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--------------GNREFVNEIGMISAQQHPNLVKLY  700 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~--------------~~~~f~~E~~~l~~l~H~nIv~l~  700 (869)
                      .-++|.+.+.||+|.||.|-+|+.. +++.||||++.+....              ..+...+||.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3478999999999999999999965 7899999998654211              124678999999999999999999


Q ss_pred             eEEee--CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC
Q 002899          701 GCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD  778 (869)
Q Consensus       701 ~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~  778 (869)
                      ++..+  .+.+|||+|||..|.+...-   .  ....++..++++++++++.||+|||.++   ||||||||+|+||+++
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p---~--d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP---P--DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC---C--CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence            99876  46799999999998774321   1  1113899999999999999999999998   9999999999999999


Q ss_pred             CcEEEeecCCceeecCCCc----cccccccccccccchhhcccC----CCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          779 LNAKISDFGLAKLYEEDKT----HISTRIAGTIGYMAPEYAMRG----YLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       779 ~~~kl~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      |++||+|||.+........    ..-...+|||.|+|||....+    ..+.+.||||+||+||-|+.|+.||.
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            9999999999887633211    112236899999999998763    35678999999999999999999995

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=295.21  Aligned_cols=193  Identities=31%  Similarity=0.463  Sum_probs=162.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHh--cCCCceeeEEeEEeeCc----eE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVEGN----QL  709 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~  709 (869)
                      ...+..+.+.||+|.||.||+|.|+ |+.||||++..   .+++.+.+|.++.+.  ++|+||+.+++.-..+.    ++
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            3467788999999999999999996 78899999954   335667778888775  69999999999866543    68


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEEcCCCCCCEEEcCCCcEEEe
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-----DSRIKIVHRDIKTSNVLLDKDLNAKIS  784 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~iiH~Dlk~~NILl~~~~~~kl~  784 (869)
                      +||+||++.|||.++|..+      .++-...++++..+|.||++||-     +|+|.|.|||||++|||+..++.+.|+
T Consensus       285 wLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            9999999999999999664      68999999999999999999994     588899999999999999999999999


Q ss_pred             ecCCceeecCCCcc---ccccccccccccchhhcccC------CCCchhHHHHHHHHHHHHHc
Q 002899          785 DFGLAKLYEEDKTH---ISTRIAGTIGYMAPEYAMRG------YLTSKADVYSFGVVTLEIVS  838 (869)
Q Consensus       785 DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlGvil~ellt  838 (869)
                      |+|+|.........   .....+||.+|||||++...      ..-..+||||||+++||+..
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            99999877654322   23346899999999998643      23346999999999999875

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-34  Score=318.24  Aligned_cols=200  Identities=26%  Similarity=0.411  Sum_probs=173.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999975 68899999986532   233456788999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+.
T Consensus        81 E~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            9999999999986543     5899999999999999999999998   9999999999999999999999999987653


Q ss_pred             CCCcc-------------------------------------ccccccccccccchhhcccCCCCchhHHHHHHHHHHHH
Q 002899          794 EDKTH-------------------------------------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEI  836 (869)
Q Consensus       794 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~el  836 (869)
                      .....                                     .....+||+.|+|||++....++.++|||||||++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el  232 (364)
T cd05599         153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM  232 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence            21100                                     01124689999999999988999999999999999999


Q ss_pred             HcCCCCCCC
Q 002899          837 VSGKSNTNY  845 (869)
Q Consensus       837 ltG~~p~~~  845 (869)
                      ++|+.||..
T Consensus       233 ~~G~~Pf~~  241 (364)
T cd05599         233 LVGYPPFCS  241 (364)
T ss_pred             hcCCCCCCC
Confidence            999999964

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-33  Score=318.16  Aligned_cols=200  Identities=24%  Similarity=0.372  Sum_probs=172.1

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .|...+.||+|+||+||+|+.. +++.||+|++....   ......+..|++++.+++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5778899999999999999864 67899999986532   2334578899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++|+|.+++....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~  153 (381)
T cd05626          82 YIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW  153 (381)
T ss_pred             cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence            999999999986543     5789999999999999999999987   99999999999999999999999999754311


Q ss_pred             CCc----------------------------------------------cccccccccccccchhhcccCCCCchhHHHH
Q 002899          795 DKT----------------------------------------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYS  828 (869)
Q Consensus       795 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwS  828 (869)
                      ...                                              .......||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (381)
T cd05626         154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence            000                                              0012346999999999999888999999999


Q ss_pred             HHHHHHHHHcCCCCCCCC
Q 002899          829 FGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       829 lGvil~elltG~~p~~~~  846 (869)
                      |||++|||++|+.||...
T Consensus       234 lG~il~elltG~~Pf~~~  251 (381)
T cd05626         234 VGVILFEMLVGQPPFLAP  251 (381)
T ss_pred             hhhHHHHHHhCCCCCcCC
Confidence            999999999999999653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=312.76  Aligned_cols=197  Identities=24%  Similarity=0.371  Sum_probs=174.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|++++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46889999999999999999976 58899999987542   223457889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        81 e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~  152 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV  152 (333)
T ss_pred             eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence            9999999999986543     5789999999999999999999998   9999999999999999999999999987654


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .    ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  201 (333)
T cd05600         153 T----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS  201 (333)
T ss_pred             c----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence            3    122356899999999999889999999999999999999999999654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=305.84  Aligned_cols=196  Identities=25%  Similarity=0.365  Sum_probs=173.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999975 68899999986432   223456888999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~  152 (291)
T cd05612          81 EYVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR  152 (291)
T ss_pred             eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence            9999999999986543     5789999999999999999999998   9999999999999999999999999987654


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...    ....|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  200 (291)
T cd05612         153 DRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD  200 (291)
T ss_pred             CCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            321    234689999999999988899999999999999999999999964

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.2e-34  Score=298.33  Aligned_cols=209  Identities=31%  Similarity=0.428  Sum_probs=168.6

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc-----eEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLLLV  712 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lV  712 (869)
                      .|...+++|.|+||.||+|.+. +++.||||++-...+    .-.+|+++|+++.|||||+++-+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4556789999999999999975 578999998754432    2346889999999999999999887532     23579


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-CcEEEeecCCcee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKL  791 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~-~~~kl~DFGla~~  791 (869)
                      ||||+. +|.+.+... ......++.-.++-++.||++||+|||+.+   |+||||||.|+|+|.+ |.+||||||.|+.
T Consensus       101 leymP~-tL~~~~r~~-~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHY-TRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHhchH-HHHHHHHHH-hhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence            999986 788888642 112236777788999999999999999987   9999999999999976 8999999999999


Q ss_pred             ecCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHHH
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYV  860 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~~  860 (869)
                      +......  .....|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|...+.  ..+|+..++.
T Consensus       176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~  241 (364)
T KOG0658|consen  176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKV  241 (364)
T ss_pred             eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHH
Confidence            8765544  334678899999998865 799999999999999999999998876443  3345544443

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-33  Score=311.84  Aligned_cols=197  Identities=26%  Similarity=0.371  Sum_probs=173.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC--CcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD--GTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~--g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      -++|++.+.||+|+||.||+|....  +..||+|++....   ......+.+|++++..++||||+++++++.+++..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3568899999999999999998643  3689999886432   2334568889999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       109 v~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            999999999999986543     5889999999999999999999998   99999999999999999999999999986


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .....    ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       181 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~  230 (340)
T PTZ00426        181 VDTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA  230 (340)
T ss_pred             cCCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence            64321    235689999999999988899999999999999999999999964

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=319.97  Aligned_cols=320  Identities=19%  Similarity=0.238  Sum_probs=218.3

Q ss_pred             CcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhcc-ccceEEEeecccCCCCCchhhcCccccccc
Q 002899           52 ATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS-LQLVELSVMGNRLSGPFPKVLTNITTLKNL  130 (869)
Q Consensus        52 ~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~-l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  130 (869)
                      ..+|++.|+|.+|-|+..-.+++..++.|+.||||.|.|+.+....|.. .++++|+|++|+|+....+.|.++.+|..|
T Consensus       123 ~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tl  202 (873)
T KOG4194|consen  123 ESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTL  202 (873)
T ss_pred             cccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheee
Confidence            3567889999999888777788888888888888888888888777776 488888888888887777778888888888


Q ss_pred             cccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCC------------------------CeEeccCCcCC
Q 002899          131 SIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNL------------------------NDLRISDNNFS  186 (869)
Q Consensus       131 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L------------------------~~L~Ls~N~l~  186 (869)
                      .|+.|+++...+..|.+|++|+.|+|..|+|.-..-..|.+|++|                        ++|+|+.|+++
T Consensus       203 kLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~  282 (873)
T KOG4194|consen  203 KLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ  282 (873)
T ss_pred             ecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh
Confidence            888888886666677778888888888777763223344555544                        45555555554


Q ss_pred             CCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccc-cceEEEcccccCccCCCcccC
Q 002899          187 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIG  265 (869)
Q Consensus       187 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~-~L~~L~Ls~N~i~~~~p~~~~  265 (869)
                      .....++.++++|+.|+|+.|.|....++..+..++|++|+|+.|+++..+...+... .|++|.|++|+|+.+-...|.
T Consensus       283 ~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~  362 (873)
T KOG4194|consen  283 AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFV  362 (873)
T ss_pred             hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHH
Confidence            4444455555555555555555555555555556666666666666655555544443 466666666666655555666


Q ss_pred             CCCCcCEEeccCCCCCCCCc---hhhhcCCCCCEEEeeCCcCCCCCchhh---hccCCceeeeccCccCCC---------
Q 002899          266 DMTKLKNIDLSFNNLTGGIP---TTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISLNNFTWES---------  330 (869)
Q Consensus       266 ~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~~l~~l~ls~N~~~~~~---------  330 (869)
                      .+++|+.|||++|.|+..+.   ..|.+|++|+.|+|.||+|. .+|+-.   ++.|+.|||.+|.+....         
T Consensus       363 ~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~L  441 (873)
T KOG4194|consen  363 GLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMEL  441 (873)
T ss_pred             HhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCCcceeecccccccchh
Confidence            66666666777666664333   34666777777777777776 344333   456677888888775333         


Q ss_pred             ------CCCCCCCCCCccceeccCCCCCCCCCCcCccCCCCCCCCCcccccceee
Q 002899          331 ------SDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLH  379 (869)
Q Consensus       331 ------~~p~~C~c~~~~~~~~l~~~~~~~~~~~~~~~~~~~C~~p~~~~~~~~~  379 (869)
                            +..+.|||++.|+..|+....-.       ......|+-|+.+++++..
T Consensus       442 k~Lv~nSssflCDCql~Wl~qWl~~~~lq-------~sv~a~CayPe~Lad~~i~  489 (873)
T KOG4194|consen  442 KELVMNSSSFLCDCQLKWLAQWLYRRKLQ-------SSVIAKCAYPEPLADQSIV  489 (873)
T ss_pred             hhhhhcccceEEeccHHHHHHHHHhcccc-------cceeeeccCCcccccceeE
Confidence                  34588999999999999754322       2234579999999998765

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.6e-33  Score=315.80  Aligned_cols=207  Identities=24%  Similarity=0.364  Sum_probs=177.8

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEee
Q 002899          630 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE  705 (869)
Q Consensus       630 ~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~  705 (869)
                      ++++....++|++.+.||+|+||.||+|... +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4455566789999999999999999999976 5789999998642   22234567889999999999999999999999


Q ss_pred             CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002899          706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD  785 (869)
Q Consensus       706 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~D  785 (869)
                      ++..++||||+++|+|.+++...      .++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~D  185 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD  185 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEe
Confidence            99999999999999999988543      4788889999999999999999998   99999999999999999999999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcccC----CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG----YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ||++...............||+.|+|||++...    .++.++|||||||++|||++|+.||..
T Consensus       186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  249 (371)
T cd05622         186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (371)
T ss_pred             CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence            999987654332223345799999999998753    378899999999999999999999964

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=317.42  Aligned_cols=201  Identities=23%  Similarity=0.381  Sum_probs=172.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|... +++.||||++....   ....+.+.+|++++..++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888999999999999999865 68899999886432   223456788999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  152 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFH  152 (377)
T ss_pred             eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccc
Confidence            9999999999986543     5789999999999999999999998   9999999999999999999999999986432


Q ss_pred             CCCc------------c----------------------------------ccccccccccccchhhcccCCCCchhHHH
Q 002899          794 EDKT------------H----------------------------------ISTRIAGTIGYMAPEYAMRGYLTSKADVY  827 (869)
Q Consensus       794 ~~~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dvw  827 (869)
                      ....            .                                  .....+||+.|+|||++.+..++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  232 (377)
T cd05629         153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW  232 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence            1000            0                                  00124689999999999988899999999


Q ss_pred             HHHHHHHHHHcCCCCCCCC
Q 002899          828 SFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       828 SlGvil~elltG~~p~~~~  846 (869)
                      ||||++|||++|+.||...
T Consensus       233 SlGvil~elltG~~Pf~~~  251 (377)
T cd05629         233 SLGAIMFECLIGWPPFCSE  251 (377)
T ss_pred             ecchhhhhhhcCCCCCCCC
Confidence            9999999999999999653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.5e-33  Score=291.45  Aligned_cols=224  Identities=25%  Similarity=0.384  Sum_probs=179.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch--hhHHHHHHHHHHHhcCCCc-eeeEEeEEeeCc------
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPN-LVKLYGCCVEGN------  707 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~--~~~~f~~E~~~l~~l~H~n-Iv~l~~~~~~~~------  707 (869)
                      ..|...++||+|+||+||+|+.. +|+.||+|++......  .-....+|+.+++.++|+| ||++++++....      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34555677999999999999954 7899999998765442  2334578999999999999 999999999877      


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                      .+++||||++. +|..++....... ..++...++.++.||++||+|||+++   |+||||||.|||++++|.+||+|||
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence            78999999975 6888876543211 24666889999999999999999998   9999999999999999999999999


Q ss_pred             CceeecCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHHHhhcccc
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEI  866 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~~~~~~~~  866 (869)
                      +|+...-... ..++-++|..|.|||++.+. .|+..+||||+|||++||+++++-|....+.++...+--+.....++.
T Consensus       166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9997653222 23345678899999999876 799999999999999999999988876555444444444444444444


Q ss_pred             c
Q 002899          867 Y  867 (869)
Q Consensus       867 ~  867 (869)
                      |
T Consensus       245 W  245 (323)
T KOG0594|consen  245 W  245 (323)
T ss_pred             C
Confidence            4

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.3e-33  Score=308.99  Aligned_cols=193  Identities=27%  Similarity=0.351  Sum_probs=168.5

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN  719 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g  719 (869)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ......+..|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999965 68899999987542   233456788999999999999999999999999999999999999


Q ss_pred             chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccc
Q 002899          720 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI  799 (869)
Q Consensus       720 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  799 (869)
                      +|.+++....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~  151 (323)
T cd05571          81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-T  151 (323)
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-c
Confidence            9998886543     5899999999999999999999998   99999999999999999999999999875432221 1


Q ss_pred             cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          800 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       800 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  197 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (323)
T ss_pred             ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence            2235689999999999988999999999999999999999999954

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.8e-33  Score=317.44  Aligned_cols=200  Identities=24%  Similarity=0.372  Sum_probs=171.6

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .|+..++||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++|||||++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788999999999999999964 67899999986532   2334578889999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++|+|.+++....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+..
T Consensus        82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~  153 (382)
T cd05625          82 YIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (382)
T ss_pred             CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence            999999999886542     5788999999999999999999997   99999999999999999999999999753310


Q ss_pred             CC----------------------------------------------ccccccccccccccchhhcccCCCCchhHHHH
Q 002899          795 DK----------------------------------------------THISTRIAGTIGYMAPEYAMRGYLTSKADVYS  828 (869)
Q Consensus       795 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwS  828 (869)
                      ..                                              ........||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (382)
T cd05625         154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence            00                                              00011246899999999999889999999999


Q ss_pred             HHHHHHHHHcCCCCCCCC
Q 002899          829 FGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       829 lGvil~elltG~~p~~~~  846 (869)
                      +||++|||++|+.||...
T Consensus       234 lGvil~elltG~~Pf~~~  251 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             chHHHHHHHhCCCCCCCC
Confidence            999999999999999653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.2e-33  Score=309.95  Aligned_cols=196  Identities=23%  Similarity=0.381  Sum_probs=173.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888999999999999999976 58899999986532   223456889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        98 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             cCCCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            9999999999886543     5788999999999999999999998   9999999999999999999999999998664


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...    ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  217 (329)
T PTZ00263        170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD  217 (329)
T ss_pred             CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence            322    234689999999999988899999999999999999999999954

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=302.25  Aligned_cols=203  Identities=31%  Similarity=0.516  Sum_probs=177.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchh-hHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~-~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      .....+.++||+|.||.|..++...+..||||+++..+... .++|.+|+++|.+++|||||+++|+|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            34567889999999999999999888999999999876554 48999999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      |++|+|.+++..+....   ++-+...+|+.|||.||+||.+..   +|||||.++|+|++.++++||+|||+++-+-..
T Consensus       617 mEnGDLnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPT---AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HhcCcHHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence            99999999998775432   456677889999999999999987   999999999999999999999999999855443


Q ss_pred             C-ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc--CCCCCCC
Q 002899          796 K-THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSNTNY  845 (869)
Q Consensus       796 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt--G~~p~~~  845 (869)
                      . .+...+.+-+.+|||||.+.-++++.++|||+||+.+||+++  ...||..
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~  743 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQ  743 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhh
Confidence            3 333444556789999999999999999999999999999876  5567643

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-33  Score=316.49  Aligned_cols=200  Identities=24%  Similarity=0.371  Sum_probs=171.8

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      +|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|++++.+++||||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6889999999999999999965 58899999986432   2234567889999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++|+|.+++....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|..+..
T Consensus        82 ~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          82 YIPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            999999999986543     5788899999999999999999998   99999999999999999999999999753210


Q ss_pred             CC------------------------------------------ccccccccccccccchhhcccCCCCchhHHHHHHHH
Q 002899          795 DK------------------------------------------THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVV  832 (869)
Q Consensus       795 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvi  832 (869)
                      ..                                          ........||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            00                                          000112469999999999999899999999999999


Q ss_pred             HHHHHcCCCCCCCC
Q 002899          833 TLEIVSGKSNTNYR  846 (869)
Q Consensus       833 l~elltG~~p~~~~  846 (869)
                      +|||++|+.||...
T Consensus       234 lyell~G~~Pf~~~  247 (376)
T cd05598         234 LYEMLVGQPPFLAD  247 (376)
T ss_pred             eeehhhCCCCCCCC
Confidence            99999999999654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.1e-33  Score=306.24  Aligned_cols=193  Identities=28%  Similarity=0.359  Sum_probs=168.0

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN  719 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g  719 (869)
                      +.||+|+||.||++... +|+.||+|++....   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999965 68999999987542   233456788999999999999999999999999999999999999


Q ss_pred             chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccc
Q 002899          720 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI  799 (869)
Q Consensus       720 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  799 (869)
                      +|..++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~  151 (323)
T cd05595          81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T  151 (323)
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-c
Confidence            9988886543     5899999999999999999999997   99999999999999999999999999875322221 1


Q ss_pred             cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          800 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       800 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  197 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (323)
T ss_pred             cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence            2235689999999999988999999999999999999999999964

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.2e-33  Score=309.07  Aligned_cols=208  Identities=28%  Similarity=0.442  Sum_probs=171.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEE------cCCcEEEEEEecccCc-hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC-
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG-  706 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~------~~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~-  706 (869)
                      ..++|++.++||+|+||.||+|..      .+++.||||++..... ...+.+..|++++.++ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            346788999999999999999974      2356899999875432 3346789999999999 899999999988764 


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcc-------------------------------------------------------
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTE-------------------------------------------------------  731 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------  731 (869)
                      +..++||||+++|+|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            4689999999999999988653210                                                       


Q ss_pred             --cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccc-ccccccccc
Q 002899          732 --YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIG  808 (869)
Q Consensus       732 --~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~  808 (869)
                        ...++++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......... .....+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence              0135888999999999999999999987   9999999999999999999999999998654322211 122345678


Q ss_pred             ccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       809 y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      |+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~  280 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV  280 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999998889999999999999999997 99998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=311.91  Aligned_cols=211  Identities=32%  Similarity=0.488  Sum_probs=176.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC--C--cE-EEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD--G--TV-IAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~--g--~~-VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~  708 (869)
                      -++....++||+|+||.||+|.+..  +  .. ||||..+..   .....++|..|+++|+.++|||||+++|++..+..
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3445566899999999999999753  2  23 899998853   35667899999999999999999999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      +++|||+|++|+|.++|.....    .++..++.+++.++|+||+|||+.+   +|||||.++|+|++.++.+||+|||+
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccc
Confidence            9999999999999999977643    5899999999999999999999997   99999999999999999999999999


Q ss_pred             ceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcchhhHHHHH
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWA  858 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~w~  858 (869)
                      ++.-....... ....-+.+|+|||.+..+.++.++|||||||++||+++ |..|+...   ...++..|+
T Consensus       309 s~~~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~---~~~~v~~kI  375 (474)
T KOG0194|consen  309 SRAGSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM---KNYEVKAKI  375 (474)
T ss_pred             ccCCcceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC---CHHHHHHHH
Confidence            87543111110 01123569999999999999999999999999999999 88888543   233444554

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.6e-33  Score=306.50  Aligned_cols=193  Identities=28%  Similarity=0.363  Sum_probs=168.7

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN  719 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g  719 (869)
                      ++||+|+||.||++... +++.||+|++....   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999965 68999999987542   234567888999999999999999999999999999999999999


Q ss_pred             chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccc
Q 002899          720 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI  799 (869)
Q Consensus       720 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  799 (869)
                      +|..++....     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~  151 (328)
T cd05593          81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-T  151 (328)
T ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-c
Confidence            9988886543     5899999999999999999999997   99999999999999999999999999875432221 1


Q ss_pred             cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          800 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       800 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  197 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (328)
T ss_pred             cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence            2235689999999999988899999999999999999999999964

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7.6e-33  Score=299.50  Aligned_cols=201  Identities=24%  Similarity=0.364  Sum_probs=172.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...  ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999986 57889999986542  2234568899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |++++++..+....     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          81 YVEKNMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            99998776544322     25889999999999999999999987   99999999999999999999999999987644


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ..........|++.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~  204 (287)
T cd07848         153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE  204 (287)
T ss_pred             cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence            3322223456899999999999888999999999999999999999999653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=290.45  Aligned_cols=216  Identities=25%  Similarity=0.384  Sum_probs=180.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecc--cCchhhHHHHHHHHHHHhcCCCceeeEEeEEee-----Cc
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-----GN  707 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~-----~~  707 (869)
                      ....|...+.||+|+||.|.+|... +|+.||||++..  .+....++-.+|+++|+.++|+||+.+.+.+..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3455666789999999999999965 789999999873  345557788999999999999999999998865     34


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                      .+|+|+|+|+ -+|.+.++.+.     .+......-++.|+++||+|+|+.+   |+||||||+|+|++.+..+||+|||
T Consensus       100 DvYiV~elMe-tDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen  100 DVYLVFELME-TDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             eeEEehhHHh-hHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence            6899999995 57888887653     4889999999999999999999998   9999999999999999999999999


Q ss_pred             CceeecCCC-ccccccccccccccchhhcc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHHH
Q 002899          788 LAKLYEEDK-THISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYV  860 (869)
Q Consensus       788 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~~  860 (869)
                      +|+...... ....+..+.|..|.|||++. ...|+...||||.|||+.||++|++-|.+.+.-++..++.-+-.
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG  245 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG  245 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence            999885431 12234567799999999875 56899999999999999999999999987665555555544433

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.6e-33  Score=314.17  Aligned_cols=201  Identities=25%  Similarity=0.340  Sum_probs=172.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++...   .......+.+|+++++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3567889999999999999999975 6889999998643   22234457789999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+++...      .++...+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       121 v~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            99999999999988543      4678889999999999999999987   99999999999999999999999999987


Q ss_pred             ecCCCccccccccccccccchhhcccC----CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRG----YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .............||+.|+|||++...    .++.++|||||||++|||++|+.||..
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  249 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence            654332222345799999999998643    478899999999999999999999964

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.4e-32  Score=303.98  Aligned_cols=200  Identities=25%  Similarity=0.441  Sum_probs=175.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++|++.+.||+|+||.||+++.. ++..||+|.+..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            467899999999999999999976 678899999875432 335678999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++|+|.+++....     .+++..+..++.|++.||.|||+.+  .|+||||||+|||++.++.+||+|||++.....
T Consensus        84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          84 HMDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            999999999986543     5789999999999999999999864  399999999999999999999999999876543


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ..   .....|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       157 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             cc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            22   22356899999999999889999999999999999999999999643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-33  Score=306.04  Aligned_cols=201  Identities=26%  Similarity=0.345  Sum_probs=172.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .....+.|.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47889999999999999999975 5889999998642   2223456888999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  153 (331)
T cd05597          81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLL  153 (331)
T ss_pred             ecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence            9999999999986432    25789999999999999999999998   9999999999999999999999999987665


Q ss_pred             CCCccccccccccccccchhhccc-----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...........||+.|+|||++..     ..++.++|||||||++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            433322233468999999999863     4578899999999999999999999964

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-34  Score=306.30  Aligned_cols=184  Identities=30%  Similarity=0.518  Sum_probs=164.7

Q ss_pred             CCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCchh
Q 002899          643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS  722 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~  722 (869)
                      .+=||.|+.|.||.|+++ ++.||||+++...       ..+|+-|++++||||+.+.|+|.....++||||||..|-|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            456899999999999996 5779999885322       24688899999999999999999999999999999999999


Q ss_pred             hhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcccccc
Q 002899          723 RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR  802 (869)
Q Consensus       723 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  802 (869)
                      ..|....     .+.-.....+..+||.||.|||.+.   |||||||+-|||+..+..+||+|||-++...+....+  .
T Consensus       201 ~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkM--S  270 (904)
T KOG4721|consen  201 EVLKAGR-----PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKM--S  270 (904)
T ss_pred             HHHhccC-----ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhhh--h
Confidence            9997764     5778888999999999999999986   9999999999999999999999999998876553333  4


Q ss_pred             ccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       803 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      ++||..|||||+++..+.+.|+|||||||+|||||||..||.
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYk  312 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYK  312 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcc
Confidence            689999999999999999999999999999999999999985

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.5e-33  Score=307.05  Aligned_cols=201  Identities=25%  Similarity=0.328  Sum_probs=173.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++...   .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999975 5788999998642   1223445788999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        81 Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~  153 (331)
T cd05624          81 DYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMN  153 (331)
T ss_pred             eCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999996532    25789999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCccccccccccccccchhhccc-----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...........||+.|+|||++..     ..++.++|||||||++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence            433322233568999999999875     4678899999999999999999999954

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.7e-32  Score=297.10  Aligned_cols=200  Identities=23%  Similarity=0.402  Sum_probs=170.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|.+.++||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999975 688999999865432 2345678999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++ +|.+++....    ..+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus        85 ~~~-~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          85 LDS-DLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             CCc-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            985 8888775432    24789999999999999999999987   999999999999999999999999998765432


Q ss_pred             Cccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .. ......+++.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~  207 (288)
T cd07871         157 TK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS  207 (288)
T ss_pred             Cc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            21 1223467899999998865 56899999999999999999999999653

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-33  Score=305.54  Aligned_cols=207  Identities=29%  Similarity=0.419  Sum_probs=180.5

Q ss_pred             CCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      -|+..+.||+|+-|.|-.|++ .+|+.+|||++.+..   ......+.+|+-+|+.+.|||++++++.++...++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            366788999999999999996 489999999987652   2234567889999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++|-|.+++..++     ++++.++.+++.||+.|+.|+|..+   |+|||+||+|+|||..+.+||+|||+|....+
T Consensus        93 yv~gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             ecCCchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            999999999997765     6899999999999999999999987   99999999999999999999999999987654


Q ss_pred             CCccccccccccccccchhhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHH
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA  858 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~  858 (869)
                      +.  .-..-+|+|.|.|||++.+.+| +.++||||+|||||.||+|+.||+   +++...|..-|
T Consensus       165 gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV  224 (786)
T KOG0588|consen  165 GK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKV  224 (786)
T ss_pred             Cc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHH
Confidence            32  3334689999999999998765 668999999999999999999996   34555666655

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-33  Score=302.99  Aligned_cols=191  Identities=25%  Similarity=0.370  Sum_probs=167.5

Q ss_pred             eeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCch
Q 002899          646 VGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL  721 (869)
Q Consensus       646 IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL  721 (869)
                      ||+|+||.||+|... +++.||+|++...   .......+..|++++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999975 5789999998643   233456788899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccccc
Q 002899          722 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST  801 (869)
Q Consensus       722 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  801 (869)
                      .+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~  151 (312)
T cd05585          81 FHHLQREG-----RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTN  151 (312)
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccc
Confidence            99886543     5899999999999999999999988   99999999999999999999999999875432221 223


Q ss_pred             cccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       802 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~  195 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD  195 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence            45789999999999998999999999999999999999999964

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1e-32  Score=305.11  Aligned_cols=199  Identities=27%  Similarity=0.391  Sum_probs=170.8

Q ss_pred             CCCCCCeeeccCceEEEEEEE----cCCcEEEEEEecccC----chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceE
Q 002899          639 NFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~----~~g~~VAvK~~~~~~----~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~  709 (869)
                      +|++.+.||+|+||.||+++.    .+++.||+|++....    ....+.+..|++++..+ +||||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999885    357899999986432    22245678899999999 599999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||+++|+|.+++....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~  152 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLS  152 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCC
Confidence            99999999999999886543     5889999999999999999999998   999999999999999999999999999


Q ss_pred             eeecCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +..............||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  209 (332)
T cd05614         153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL  209 (332)
T ss_pred             ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence            86543333233345799999999998764 478899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5e-33  Score=311.17  Aligned_cols=201  Identities=24%  Similarity=0.378  Sum_probs=173.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+..|++++..++||||+++++++.+++..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999975 68899999986432   233456788999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        81 E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             eCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            9999999999986543     5889999999999999999999998   9999999999999999999999999987543


Q ss_pred             CCCc----------------------------------cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcC
Q 002899          794 EDKT----------------------------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG  839 (869)
Q Consensus       794 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG  839 (869)
                      ....                                  ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG  232 (360)
T cd05627         153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG  232 (360)
T ss_pred             cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence            2100                                  001134699999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 002899          840 KSNTNYR  846 (869)
Q Consensus       840 ~~p~~~~  846 (869)
                      +.||...
T Consensus       233 ~~Pf~~~  239 (360)
T cd05627         233 YPPFCSE  239 (360)
T ss_pred             CCCCCCC
Confidence            9999653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-34  Score=300.08  Aligned_cols=199  Identities=28%  Similarity=0.488  Sum_probs=176.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ..|+..+.||+|.||.||||... .++.||+|++..... ....++++|+.++..++|+||.++++.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            34666789999999999999964 688999999976643 3456788999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      |.+|++.+.+....     .+++..+..|++++..|+.|||.++   .+|||||+.|||+..+|.+||+|||.+..+...
T Consensus        93 ~~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             hcCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence            99999999997653     3477788889999999999999997   999999999999999999999999999877665


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .... ..++|||.|||||++....|+.|+|||||||+.+||.+|.+|+..
T Consensus       165 ~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~  213 (467)
T KOG0201|consen  165 VKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSK  213 (467)
T ss_pred             hhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcc
Confidence            4443 567899999999999988999999999999999999999999853

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=9.9e-33  Score=305.19  Aligned_cols=201  Identities=25%  Similarity=0.340  Sum_probs=172.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.++||+|+||.||+++.. +++.||+|++...   .......|.+|+.++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999976 4788999998642   1222345788999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        81 ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~  153 (332)
T cd05623          81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLM  153 (332)
T ss_pred             eccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecc
Confidence            9999999999996532    25889999999999999999999987   9999999999999999999999999987654


Q ss_pred             CCCccccccccccccccchhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...........||+.|+|||++.     ...++.++|||||||++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~  210 (332)
T cd05623         154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (332)
T ss_pred             cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence            33322233357999999999986     34678899999999999999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.9e-32  Score=301.74  Aligned_cols=199  Identities=27%  Similarity=0.394  Sum_probs=169.7

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....   ......+..|.+++... +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999976 57899999987542   22234566777777776 5899999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+.+....     .+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             cCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            9999999998886543     5789999999999999999999987   9999999999999999999999999987543


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~  204 (323)
T cd05616         153 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  204 (323)
T ss_pred             CCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence            2221 123456899999999999999999999999999999999999999653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.7e-33  Score=304.36  Aligned_cols=193  Identities=27%  Similarity=0.357  Sum_probs=167.3

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN  719 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g  719 (869)
                      +.||+|+||.||++... +++.||+|+++...   .....++..|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 68899999987542   233456788999999999999999999999999999999999999


Q ss_pred             chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          720 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       720 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      +|..++....     .+++..+..++.||+.||+|||+ .+   |+||||||+|||++.++.+||+|||+++........
T Consensus        81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  152 (325)
T cd05594          81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT  152 (325)
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence            9998886543     58999999999999999999997 56   999999999999999999999999998754322221


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                       .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~  198 (325)
T cd05594         153 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  198 (325)
T ss_pred             -cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC
Confidence             2235689999999999988999999999999999999999999964

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.7e-32  Score=300.73  Aligned_cols=198  Identities=27%  Similarity=0.385  Sum_probs=169.5

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCC-ceeeEEeEEeeCceEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHP-NLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lV~  713 (869)
                      +|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+..|++++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999975 57889999986532   23345678899999988765 5888999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENI  152 (324)
T ss_pred             cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence            9999999998886543     5789999999999999999999987   9999999999999999999999999987532


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~  203 (324)
T cd05587         153 FGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG  203 (324)
T ss_pred             CCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence            2111 12235689999999999998899999999999999999999999964

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-32  Score=301.87  Aligned_cols=193  Identities=28%  Similarity=0.438  Sum_probs=167.0

Q ss_pred             CeeeccCceEEEEEEE----cCCcEEEEEEecccC----chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          644 NKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~----~~g~~VAvK~~~~~~----~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +.||+|+||.||++..    .+++.||+|+++...    ......+..|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    357899999986532    22345677899999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++|+|.+++....     .+.+..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            99999999886543     5788899999999999999999998   999999999999999999999999998754322


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~  202 (323)
T cd05584         154 GT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA  202 (323)
T ss_pred             CC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence            22 22335689999999999988899999999999999999999999964

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-34  Score=278.94  Aligned_cols=200  Identities=27%  Similarity=0.406  Sum_probs=173.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .+++|++.++||+|.|+.||+.... +|+.+|+|++...  ...+.+++.+|++|.+.++|||||++.....+....|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            3567888899999999999998854 6888998876433  333567888999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCcEEEeecCCc
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLA  789 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~---~~~~kl~DFGla  789 (869)
                      +|+|.++.|..-+-..     ..+++..+-..++||+++|.|+|.++   |||||+||+|+|+-.   ..-+||+|||+|
T Consensus        89 Fe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvA  160 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLA  160 (355)
T ss_pred             EecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceE
Confidence            9999999997666443     25688889999999999999999998   999999999999953   345899999999


Q ss_pred             eeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...+  ...+....+|||+|||||++++.+++..+|||+.|||||-|+.|.+||..
T Consensus       161 i~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~  214 (355)
T KOG0033|consen  161 IEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  214 (355)
T ss_pred             EEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence            8887  33344457899999999999999999999999999999999999999965

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.6e-32  Score=299.58  Aligned_cols=193  Identities=30%  Similarity=0.435  Sum_probs=164.5

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHh-cCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      ++||+|+||.||+|... +++.||+|+++...   ....+.+..|.+++.. .+||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 57889999987542   2223445566666664 5899999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....... .
T Consensus        81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~  151 (316)
T cd05592          81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G  151 (316)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence            99998886543     5889999999999999999999987   9999999999999999999999999997653322 2


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~  198 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence            22345789999999999988899999999999999999999999964

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-33  Score=309.08  Aligned_cols=201  Identities=29%  Similarity=0.412  Sum_probs=176.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|.+.+.||+|+||.||+|... +++.||||+++...   ......+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999976 68999999987542   234567889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++++|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  152 (350)
T cd05573          81 EYMPGGDLMNLLIRKD-----VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMN  152 (350)
T ss_pred             cCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence            9999999999987652     6899999999999999999999987   9999999999999999999999999998665


Q ss_pred             CCC----------------------------ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDK----------------------------THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...                            ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence            432                            1112235689999999999999999999999999999999999999965


Q ss_pred             C
Q 002899          846 R  846 (869)
Q Consensus       846 ~  846 (869)
                      .
T Consensus       233 ~  233 (350)
T cd05573         233 D  233 (350)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.3e-32  Score=291.25  Aligned_cols=202  Identities=27%  Similarity=0.406  Sum_probs=171.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~----~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++.... ...+.|.+|+.++.+++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888999999999999999863    356899999876533 334678999999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+++....    ..+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+|++|||.+..
T Consensus        84 v~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          84 VTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccc
Confidence            999999999999986542    26899999999999999999999987   99999999999999999999999998765


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .............++..|+|||.+.+..++.++|||||||++||+++ |+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~  211 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD  211 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence            43222111112234678999999998999999999999999999875 9999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.1e-32  Score=294.60  Aligned_cols=204  Identities=29%  Similarity=0.501  Sum_probs=169.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcC-----------------CcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSD-----------------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL  699 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~-----------------g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l  699 (869)
                      ++|.+.++||+|+||.||+|.+.+                 +..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            568889999999999999998532                 3369999987653 3335679999999999999999999


Q ss_pred             EeEEeeCceEEEEEEeccCCchhhhhhcCCc--------------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 002899          700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT--------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVH  765 (869)
Q Consensus       700 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH  765 (869)
                      ++++.+.+..++||||+++|+|.+++.....              .....++|..+.+++.||+.||+|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            9999999999999999999999998854321              11235788999999999999999999987   999


Q ss_pred             cCCCCCCEEEcCCCcEEEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcC--CCC
Q 002899          766 RDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG--KSN  842 (869)
Q Consensus       766 ~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG--~~p  842 (869)
                      |||||+|||++.++.+||+|||+++....... .......++..|+|||++....++.++||||||+++|||+++  ..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986543322 112233457899999999888899999999999999999974  455


Q ss_pred             CC
Q 002899          843 TN  844 (869)
Q Consensus       843 ~~  844 (869)
                      |.
T Consensus       242 ~~  243 (304)
T cd05096         242 YG  243 (304)
T ss_pred             CC
Confidence            54

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7e-33  Score=306.22  Aligned_cols=201  Identities=27%  Similarity=0.370  Sum_probs=174.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|... +++.||+|+++...   ....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999965 68899999987542   233456888999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  153 (330)
T cd05601          81 EYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLT  153 (330)
T ss_pred             CCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECC
Confidence            9999999999986642    26899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccccccchhhcc------cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAM------RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...........||+.|+|||++.      ...++.++|||||||++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  211 (330)
T cd05601         154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE  211 (330)
T ss_pred             CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence            44333333356899999999986      45678999999999999999999999954

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.4e-32  Score=300.43  Aligned_cols=193  Identities=25%  Similarity=0.379  Sum_probs=167.1

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      ++||+|+||.||+|... +++.||+|+++...   ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999975 68899999987542   22345678899999888 799999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-  151 (329)
T cd05588          81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-  151 (329)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC-
Confidence            99988885442     6899999999999999999999998   99999999999999999999999999874322111 


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            22345789999999999998999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.5e-32  Score=300.92  Aligned_cols=197  Identities=29%  Similarity=0.433  Sum_probs=167.5

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHH---HhcCCCceeeEEeEEeeCceEEEE
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMI---SAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      |++.+.||+|+||.||+|... +++.||||+++...   ....+.+..|++++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999965 68899999987542   22234566666554   567899999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++|+|...+...      .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        81 ~E~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          81 MEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             EcCCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence            9999999998887542      5899999999999999999999987   999999999999999999999999998754


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ..... ......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       152 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~  204 (324)
T cd05589         152 MGFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD  204 (324)
T ss_pred             CCCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence            32221 123457899999999999889999999999999999999999999653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.8e-32  Score=299.01  Aligned_cols=193  Identities=26%  Similarity=0.383  Sum_probs=166.9

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      ++||+|+||.||+|... +++.||+|+++...   ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 57899999997542   22345678899988887 699999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|..++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++........ 
T Consensus        81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  151 (327)
T cd05617          81 GDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-  151 (327)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-
Confidence            99988875442     5899999999999999999999998   99999999999999999999999999875322111 


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~  198 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence            12235689999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.3e-32  Score=299.32  Aligned_cols=193  Identities=28%  Similarity=0.446  Sum_probs=166.5

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      ++||+|+||.||+|+.. +++.||||++....   ......+..|.+++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 57899999986532   23345677888888776 799999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++........ 
T Consensus        81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-  151 (320)
T cd05590          81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-  151 (320)
T ss_pred             chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence            99998886543     5889999999999999999999987   99999999999999999999999999875432221 


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA  198 (320)
T ss_pred             cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence            22335689999999999988899999999999999999999999964

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.8e-32  Score=293.72  Aligned_cols=200  Identities=25%  Similarity=0.412  Sum_probs=169.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999976 688999999865432 223467889999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |++ ++|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        84 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          84 YVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             CCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            996 56777665432    25788999999999999999999998   99999999999999999999999999875533


Q ss_pred             CCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ... ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  206 (303)
T cd07869         156 PSH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG  206 (303)
T ss_pred             CCc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            221 1223467899999998865 4688999999999999999999999965

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.2e-32  Score=298.31  Aligned_cols=200  Identities=24%  Similarity=0.449  Sum_probs=174.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++|++.+.||+|+||.||+|... ++..+|+|.+..... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999976 678899998875432 334678999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++|+|.+++....     .+++..+..++.|++.||.|||+.+  +++||||||+|||++.++.+||+|||++.....
T Consensus        84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          84 HMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            999999999986542     5789999999999999999999753  399999999999999999999999999875533


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ..   .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       157 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            21   12346889999999999888999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.9e-32  Score=300.04  Aligned_cols=193  Identities=27%  Similarity=0.424  Sum_probs=166.5

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      ++||+|+||.||+|+.. +++.||+|+++...   ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999975 57899999987542   23345677888888865 899999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|...+....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++........ 
T Consensus        81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-  151 (321)
T cd05591          81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-  151 (321)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence            99998886543     5789999999999999999999998   99999999999999999999999999875432222 


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~  198 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA  198 (321)
T ss_pred             cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence            22335689999999999988999999999999999999999999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.9e-32  Score=313.03  Aligned_cols=203  Identities=23%  Similarity=0.314  Sum_probs=175.1

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-C-CcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-D-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~-g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+..........+..|+++++.++|||||++++++..++..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3888999999999999999854 3 5778888776555555567888999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++|+|.+++.... ....++++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       148 ~gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        148 SGGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999998886432 12236889999999999999999999987   9999999999999999999999999998765432


Q ss_pred             c-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 T-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~  273 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG  273 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            2 123345699999999999988999999999999999999999999964

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-33  Score=324.80  Aligned_cols=206  Identities=34%  Similarity=0.533  Sum_probs=174.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcC--Cc----EEEEEEeccc-CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSD--GT----VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~--g~----~VAvK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  710 (869)
                      ++.+..+.||+|+||.||.|...+  |.    .||||.++.. +.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            345667889999999999999753  43    4899988766 3455778999999999999999999999999999999


Q ss_pred             EEEEeccCCchhhhhhcCCcc--cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          711 LVYEYMKNNCLSRAIFGKDTE--YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      +++|||++|+|..+|...+..  ....+...+.+.++.|||+|+.||++++   +|||||..+|+||++...+||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999765221  2346899999999999999999999987   99999999999999999999999999


Q ss_pred             ceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          789 AKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       789 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      |+.+.....+ ......-...|||||.+..+.++.|+|||||||++||++| |..||...
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~  908 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR  908 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc
Confidence            9954333222 2222123469999999999999999999999999999999 77888544

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.7e-32  Score=296.29  Aligned_cols=194  Identities=31%  Similarity=0.456  Sum_probs=165.5

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHh-cCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      +.||+|+||.||+|+.. +++.||||+++...   ......+..|.+++.. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 57899999987542   2234456677777775 5999999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++........ 
T Consensus        81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  151 (316)
T cd05619          81 GDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-  151 (316)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence            99999886532     5789999999999999999999987   99999999999999999999999999875322221 


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~  199 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH  199 (316)
T ss_pred             ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence            122356899999999999888999999999999999999999999653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.98  E-value=4.2e-32  Score=299.65  Aligned_cols=193  Identities=26%  Similarity=0.388  Sum_probs=166.1

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      +.||+|+||.||+|... +++.||+|+++...   ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 57899999987542   23345677888888766 899999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|..++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-  151 (329)
T cd05618          81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-  151 (329)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence            99988875542     5899999999999999999999998   99999999999999999999999999875432221 


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence            12235789999999999999999999999999999999999999953

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.98  E-value=5.3e-32  Score=298.15  Aligned_cols=199  Identities=27%  Similarity=0.396  Sum_probs=169.6

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      +|+..+.||+|+||.||+|... +++.||+|++....   ....+.+..|.+++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4678899999999999999965 68899999986532   223456778888888875 567888999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            9999999999886543     5899999999999999999999987   9999999999999999999999999987543


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~  204 (323)
T cd05615         153 VDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE  204 (323)
T ss_pred             CCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence            2221 122356899999999999888999999999999999999999999653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.98  E-value=9.4e-32  Score=291.41  Aligned_cols=200  Identities=27%  Similarity=0.465  Sum_probs=165.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc--CCcEEEEEEecccCc--hhhHHHHHHHHHHHhc---CCCceeeEEeEEee-----
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQ---QHPNLVKLYGCCVE-----  705 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~--~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l---~H~nIv~l~~~~~~-----  705 (869)
                      ++|++.+.||+|+||.||+|+..  +++.||+|+++....  .....+.+|+++++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  467899998865432  2234566677766655   79999999998853     


Q ss_pred             CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002899          706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD  785 (869)
Q Consensus       706 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~D  785 (869)
                      ....++||||++ ++|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcc
Confidence            456899999997 588888865422   25899999999999999999999998   99999999999999999999999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ||++.......  ......||+.|+|||++....++.++|||||||++|||++|++||...
T Consensus       154 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  212 (290)
T cd07862         154 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  212 (290)
T ss_pred             ccceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence            99998765331  223356899999999998888999999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=7.1e-33  Score=300.35  Aligned_cols=209  Identities=28%  Similarity=0.447  Sum_probs=182.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce-EEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ-LLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~lV~  713 (869)
                      ++|...+++|+|+||.++..+++ +++.+++|++....  ....+....|+.++++++|||||.+.+.+++++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56888999999999999988865 57789999876543  3334567889999999999999999999999998 99999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      +|++||++.+.+...+   ...++++++..++.|++.|+.|||++.   |+|||||+.||+++.+..+||+|||+|+.+.
T Consensus        84 ~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             eecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence            9999999999997765   346899999999999999999999876   9999999999999999999999999999998


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHH
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLD  856 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~  856 (869)
                      ..... ....+||+.||+||++.+.+|+.|+|||||||++|||.+-+++|..   .+...|+.
T Consensus       158 ~~~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a---~~m~~Li~  216 (426)
T KOG0589|consen  158 PEDSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA---SNMSELIL  216 (426)
T ss_pred             Cchhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc---cchHHHHH
Confidence            76533 3347899999999999999999999999999999999999999964   34555544

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.98  E-value=8.6e-32  Score=286.13  Aligned_cols=200  Identities=29%  Similarity=0.507  Sum_probs=172.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEecc
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      ++|++.+.||+|+||.||+|.+.++..+|+|.+... .....+|..|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            457788999999999999999988888999987643 2335678999999999999999999999999999999999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      +|+|.++++...    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||.++.......
T Consensus        83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          83 NGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            999999886543    25899999999999999999999987   99999999999999999999999999876543222


Q ss_pred             cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .......++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~  204 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK  204 (256)
T ss_pred             eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence            21222335668999999988889999999999999999999 8999854

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=7.7e-32  Score=298.81  Aligned_cols=198  Identities=26%  Similarity=0.442  Sum_probs=166.8

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC-----ceEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQLL  710 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~  710 (869)
                      +|++.++||+|+||.||+|+.. +++.||||++...  ......++.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999965 6899999998643  223345788999999999999999999988643     2479


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      +||||++ ++|.+++....     .+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        81 lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~  151 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR  151 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccc
Confidence            9999996 67888875442     5899999999999999999999998   9999999999999999999999999997


Q ss_pred             eecCCCc--cccccccccccccchhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          791 LYEEDKT--HISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       791 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .......  .......||+.|+|||++..  ..++.++|||||||++|||++|++||..
T Consensus       152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~  210 (338)
T cd07859         152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG  210 (338)
T ss_pred             ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            6532221  11233568999999999865  6789999999999999999999999964

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.98  E-value=7.2e-32  Score=296.14  Aligned_cols=194  Identities=30%  Similarity=0.420  Sum_probs=165.5

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHh-cCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      ++||+|+||.||+|+.. +++.||+|.++...   ......+..|.+++.. .+||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 68899999987542   2234456677777765 5899999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|..++....     .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... .
T Consensus        81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  151 (316)
T cd05620          81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-N  151 (316)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-C
Confidence            99998886542     5789999999999999999999998   9999999999999999999999999987432211 1


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~  199 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD  199 (316)
T ss_pred             ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            223457899999999999989999999999999999999999999643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=4e-32  Score=284.08  Aligned_cols=211  Identities=25%  Similarity=0.317  Sum_probs=177.6

Q ss_pred             CCCCCeeeccCceEEEEEEEcC-CcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          640 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~~-g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      |+..+.||+|.-|+||.+++.+ +..+|+|++.+..   +....+.+.|-+||+.++||.++.||+.++.++..++||||
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey  158 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY  158 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence            4456789999999999999874 5889999997653   33345678899999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      |+||+|..+.+.+...   .+++..++-++..++-||+|||-.|   ||+|||||+||||.+||++-|+||.++......
T Consensus       159 CpGGdL~~LrqkQp~~---~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  159 CPGGDLHSLRQKQPGK---RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             CCCccHHHHHhhCCCC---ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999999877543   7899999999999999999999998   999999999999999999999999986432110


Q ss_pred             --------------------------------C-c----------------------cccccccccccccchhhcccCCC
Q 002899          796 --------------------------------K-T----------------------HISTRIAGTIGYMAPEYAMRGYL  820 (869)
Q Consensus       796 --------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~  820 (869)
                                                      . .                      ..+...+||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                      01112679999999999999999


Q ss_pred             CchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHH
Q 002899          821 TSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA  858 (869)
Q Consensus       821 ~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~  858 (869)
                      +.++|+|+|||++||||.|+.||....  ..+.+.+-|
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~--~~~Tl~NIv  348 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSN--NKETLRNIV  348 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCC--chhhHHHHh
Confidence            999999999999999999999997543  344444443

>PHA02988 hypothetical protein; Provisional

Probab=99.98  E-value=1.1e-31  Score=289.78  Aligned_cols=191  Identities=23%  Similarity=0.333  Sum_probs=165.0

Q ss_pred             CCeeeccCceEEEEEEEcCCcEEEEEEecccCchh---hHHHHHHHHHHHhcCCCceeeEEeEEee----CceEEEEEEe
Q 002899          643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVYEY  715 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~---~~~f~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~E~  715 (869)
                      ...||+|++|.||+|.. +|+.||||+++......   .+.|.+|++++.+++|||||+++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 68899999987653332   4678899999999999999999999877    3468999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      +++|+|.+++....     .+++.....++.|++.||+|||+. +   ++||||||+|||+++++.+||+|||+++....
T Consensus       104 ~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988        104 CTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSS  175 (283)
T ss_pred             CCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence            99999999996543     588999999999999999999985 5   77999999999999999999999999876543


Q ss_pred             CCccccccccccccccchhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ..    ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       176 ~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~  225 (283)
T PHA02988        176 PP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL  225 (283)
T ss_pred             cc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence            22    12357889999999976  67899999999999999999999999653

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.98  E-value=1.4e-31  Score=288.69  Aligned_cols=196  Identities=30%  Similarity=0.419  Sum_probs=168.0

Q ss_pred             eeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCch
Q 002899          646 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL  721 (869)
Q Consensus       646 IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL  721 (869)
                      ||+|+||+||++... +++.||+|++.....   .....+..|+++++.++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999965 688999999865322   2235678899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccccc
Q 002899          722 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST  801 (869)
Q Consensus       722 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  801 (869)
                      ..++.... .....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++......... ..
T Consensus        81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~  155 (280)
T cd05608          81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TK  155 (280)
T ss_pred             HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-cc
Confidence            88875432 12236899999999999999999999997   999999999999999999999999999766443221 22


Q ss_pred             cccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       802 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  200 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR  200 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            346899999999999999999999999999999999999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=7.5e-32  Score=303.81  Aligned_cols=192  Identities=23%  Similarity=0.308  Sum_probs=166.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      ++|.+.+.||+|+||.||+|... +++.||+|...      ...+.+|++++++++|||||++++++...+..++|||++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            57899999999999999999964 68899999653      235678999999999999999999999999999999998


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      . ++|..++....     .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       166 ~-~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        166 K-TDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             C-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            6 67877775432     5789999999999999999999987   9999999999999999999999999997543322


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+.
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            222234579999999999998899999999999999999999998864

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.4e-31  Score=289.43  Aligned_cols=200  Identities=32%  Similarity=0.419  Sum_probs=172.7

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      +|++.++||+|+||.||++... +++.||+|++....   ......+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999965 68899999986532   2223457889999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++|+|.+++....   ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.....
T Consensus        81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05605          81 LMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE  154 (285)
T ss_pred             ccCCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            999999998876432   125899999999999999999999987   99999999999999999999999999876543


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ...  .....|++.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus       155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~  204 (285)
T cd05605         155 GET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR  204 (285)
T ss_pred             CCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence            221  12346889999999999888999999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.98  E-value=4.6e-32  Score=298.99  Aligned_cols=194  Identities=29%  Similarity=0.420  Sum_probs=164.8

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHH-HHHhcCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      ++||+|+||.||+|... +|+.||+|++....   .....++..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999965 68999999986542   223345555654 56779999999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|..++....     .+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  151 (325)
T cd05604          81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-  151 (325)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-
Confidence            99988886542     5899999999999999999999998   99999999999999999999999999875322211 


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~  199 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR  199 (325)
T ss_pred             CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence            223456899999999999989999999999999999999999999653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.98  E-value=6e-32  Score=297.82  Aligned_cols=193  Identities=28%  Similarity=0.425  Sum_probs=164.3

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHH-HHHhcCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      ++||+|+||.||+|... +|+.||+|++....   ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 68999999986532   222344555544 56789999999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|..++....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....... .
T Consensus        81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~  151 (323)
T cd05575          81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-K  151 (323)
T ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-C
Confidence            99998886543     5789999999999999999999998   9999999999999999999999999987543222 1


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  198 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (323)
T ss_pred             ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence            22345689999999999988999999999999999999999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.6e-32  Score=288.57  Aligned_cols=214  Identities=30%  Similarity=0.395  Sum_probs=183.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .+.|..-++||+|+||.||-++.+ +|+.+|.|++.++   .++...-.+.|-.||.+++.+.||.+-..|+.++.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356778899999999999998865 6899999988654   334455667899999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      +..|.||+|.-+|+..+.   ..+++..++-++.+|+-||++||.+.   ||.||+||+|||||+.|+++|+|+|+|..+
T Consensus       264 LtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence            999999999999987654   36899999999999999999999997   999999999999999999999999999988


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-CcchhhHHHHH
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP-NEDFVYLLDWA  858 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~-~~~~~~l~~w~  858 (869)
                      .......  ..+||.+|||||++..+.|+...|.||+||++|||+.|+.||.... ....+++-+.+
T Consensus       338 ~~g~~~~--~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~  402 (591)
T KOG0986|consen  338 PEGKPIR--GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT  402 (591)
T ss_pred             CCCCccc--cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH
Confidence            7654432  2389999999999999999999999999999999999999997643 33333444333

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.98  E-value=1.1e-31  Score=299.49  Aligned_cols=194  Identities=31%  Similarity=0.497  Sum_probs=163.9

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      +|+..+.||+|+||.||+|... +++.||||++..... .....+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3456788999999999999965 689999999865433 33567889999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++|+|.+..         ...+..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||++.......
T Consensus       155 ~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        155 DGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             CCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            999985432         3466788899999999999999998   9999999999999999999999999998764322


Q ss_pred             ccccccccccccccchhhccc-----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      . ......||..|+|||++..     ...+.++|||||||++|||++|+.||..
T Consensus       223 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  275 (353)
T PLN00034        223 D-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV  275 (353)
T ss_pred             c-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            1 1223568999999998743     2345689999999999999999999974

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.4e-33  Score=321.77  Aligned_cols=207  Identities=28%  Similarity=0.354  Sum_probs=185.9

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEee
Q 002899          630 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE  705 (869)
Q Consensus       630 ~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~  705 (869)
                      .+++....++|.+.++||+|+||.|..++++ +++++|+|++.+.   .+....-|.+|-.+|.-.+.+-||.++..|++
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            4556666789999999999999999999976 6889999998762   34556679999999999999999999999999


Q ss_pred             CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002899          706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD  785 (869)
Q Consensus       706 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~D  785 (869)
                      +..+|+|||||+||+|-.++...+     ++++.-++-++..|+-||.-||+.|   +|||||||+|||+|..|++||+|
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLAD  218 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLAD  218 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeecc
Confidence            999999999999999999996653     5889999999999999999999998   99999999999999999999999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcc----c-CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAM----R-GYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      ||.+-.+..++.-.+...+|||.|++||++.    + +.|++.+|+||+||++|||+.|..||.
T Consensus       219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY  282 (1317)
T KOG0612|consen  219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY  282 (1317)
T ss_pred             chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence            9999888877666666788999999999986    2 579999999999999999999999995

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.98  E-value=1.3e-31  Score=285.62  Aligned_cols=202  Identities=31%  Similarity=0.522  Sum_probs=174.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            35788899999999999999998888899999886533 33568899999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++....   ...+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          84 AKGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             CCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            9999999986542   236789999999999999999999987   9999999999999999999999999998765432


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ........++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~  207 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG  207 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence            222222345678999999988889999999999999999998 9999854

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.98  E-value=9.6e-32  Score=302.05  Aligned_cols=206  Identities=28%  Similarity=0.438  Sum_probs=171.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE------cCCcEEEEEEecccC-chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCce
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~------~~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~  708 (869)
                      .++|++.++||+|+||.||+|.+      .++..||||+++... ....+.+.+|++++..+ +||||+++++++.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45788899999999999999974      235689999987543 33345788999999999 89999999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcc---------------------------------------------------------
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTE---------------------------------------------------------  731 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~---------------------------------------------------------  731 (869)
                      .++||||+++|+|.+++......                                                         
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            99999999999999988653210                                                         


Q ss_pred             -------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          732 -------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       732 -------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                                   ....++|..+.+++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         0125789999999999999999999987   999999999999999999999999999866433221


Q ss_pred             c-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          799 I-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       799 ~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      . .....++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~  319 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG  319 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            1 112234568999999999999999999999999999998 8888854

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.98  E-value=7.7e-34  Score=283.40  Aligned_cols=195  Identities=31%  Similarity=0.511  Sum_probs=174.6

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      |+++++||+|+||.||||.++ .|+++|+|++...  .+.++++.|+.++++.+.|++|++||.+.....+++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            567889999999999999976 6999999998654  4568999999999999999999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      ||..+.+..++    .++.+..+..+.+.-++||+|||...   -||||||+.||||+.+|.+||+|||.|-.+.+.-..
T Consensus       113 GSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  113 GSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             CcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            99999986653    37999999999999999999999875   799999999999999999999999999776543322


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      . ..+.|||.|||||++..-.|..++||||+|+...||..|++|+.
T Consensus       186 R-NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYs  230 (502)
T KOG0574|consen  186 R-NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYS  230 (502)
T ss_pred             h-CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcc
Confidence            2 34679999999999999999999999999999999999999874

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.98  E-value=1.7e-31  Score=317.02  Aligned_cols=205  Identities=24%  Similarity=0.395  Sum_probs=174.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.++||+|+||.||+|... +++.||+|++....   ....++|.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47889999999999999999975 58899999986542   223567999999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCC------cccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          714 EYMKNNCLSRAIFGKD------TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                      ||+++|+|.+++....      .......++..+++++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999886421      111235678889999999999999999987   9999999999999999999999999


Q ss_pred             CceeecCCCc-----------------cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          788 LAKLYEEDKT-----------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       788 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ++........                 .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9987621110                 011124689999999999999999999999999999999999999964

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.98  E-value=1.7e-31  Score=300.16  Aligned_cols=200  Identities=29%  Similarity=0.434  Sum_probs=169.7

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc-----eEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLL  710 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~  710 (869)
                      +|++.+.||+|+||.||+|... +++.||||++...  .....+++.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999964 7899999998653  2234567889999999999999999999998776     789


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      +||||+. ++|.+.+....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        81 lv~e~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~  151 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLAR  151 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecccccee
Confidence            9999997 46777664432     6899999999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          791 LYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      ..............+++.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  209 (372)
T cd07853         152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS  209 (372)
T ss_pred             ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence            7654333333334678899999998764 57899999999999999999999996543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.98  E-value=9.3e-32  Score=296.54  Aligned_cols=193  Identities=27%  Similarity=0.398  Sum_probs=163.0

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHH-HHHHhcCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEI-GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~-~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      +.||+|+||.||+|+.. +++.||+|++....   .....++..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 57889999986532   12233444444 456789999999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|.+.+....     .+.+..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-  151 (325)
T cd05602          81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-  151 (325)
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-
Confidence            99999886543     5778889999999999999999998   99999999999999999999999999875432221 


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  198 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (325)
T ss_pred             CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence            22345689999999999998999999999999999999999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.98  E-value=8.7e-32  Score=296.27  Aligned_cols=193  Identities=27%  Similarity=0.401  Sum_probs=163.4

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHH-HHHHhcCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEI-GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~-~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      ++||+|+||.||+|+.. +++.||+|++....   .....++..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 67899999986532   12234455554 467889999999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|...+....     .+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++...... .
T Consensus        81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~  151 (321)
T cd05603          81 GELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-E  151 (321)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-C
Confidence            99988875432     5788899999999999999999987   9999999999999999999999999987532222 1


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  198 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (321)
T ss_pred             ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence            22345689999999999988899999999999999999999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.97  E-value=9.5e-32  Score=301.84  Aligned_cols=207  Identities=30%  Similarity=0.461  Sum_probs=171.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCc-hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCc
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN  707 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~  707 (869)
                      ..++|++.+.||+|+||.||+|+..      +++.||||+++.... .....+.+|+++++.+ +|+|||++++++...+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3457889999999999999998842      235799999975433 3345688999999999 8999999999999999


Q ss_pred             eEEEEEEeccCCchhhhhhcCCc---------------------------------------------------------
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDT---------------------------------------------------------  730 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  730 (869)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            99999999999999998854311                                                         


Q ss_pred             --------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc-ccc
Q 002899          731 --------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH-IST  801 (869)
Q Consensus       731 --------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~  801 (869)
                              ....++++..+.+++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++........ ...
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                    01125789999999999999999999987   999999999999999999999999999765432211 111


Q ss_pred             cccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       802 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ...++..|+|||++....++.++|||||||++|||++ |+.||..
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~  317 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG  317 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence            2234568999999998899999999999999999997 9999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.97  E-value=1.8e-31  Score=293.21  Aligned_cols=193  Identities=30%  Similarity=0.440  Sum_probs=166.4

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      +.||+|+||.||+|... +++.||||+++...   ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 57899999987542   23345677888888877 799999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|.+.+....     .+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++....... 
T Consensus        81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  151 (318)
T cd05570          81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-  151 (318)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence            99998886543     5899999999999999999999987   99999999999999999999999999875322221 


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~  198 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG  198 (318)
T ss_pred             cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence            12234689999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=4.6e-32  Score=298.04  Aligned_cols=193  Identities=28%  Similarity=0.393  Sum_probs=167.7

Q ss_pred             CeeeccCceEEEEEEE----cCCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEecc
Q 002899          644 NKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~----~~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      +.||+|+||.||++..    .+|+.||+|+++....  .....+..|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    3578999999875422  234457789999999999999999999999999999999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      +|+|.+.+....     .+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  153 (318)
T cd05582          82 GGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  153 (318)
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence            999999886542     5899999999999999999999998   99999999999999999999999999876543322


Q ss_pred             cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                       ......|++.|+|||++....++.++|||||||++|||++|+.||..
T Consensus       154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  200 (318)
T cd05582         154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG  200 (318)
T ss_pred             -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence             22235689999999999988889999999999999999999999964

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=293.77  Aligned_cols=201  Identities=27%  Similarity=0.401  Sum_probs=178.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch---hhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~---~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~  710 (869)
                      ....|++.+.||+|.||.||+++.+ +|+.+|+|.+.+....   ....+.+|+.+|+++. |||||.+.+.+++...++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            4567888899999999999999976 4999999999766443   3457889999999998 999999999999999999


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC----CcEEEeec
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD----LNAKISDF  786 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~----~~~kl~DF  786 (869)
                      +|||++.+|.|.+.+...      .+++..+..++.|++.+++|||+.+   |+||||||+|+|+...    +.+|++||
T Consensus       113 lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             EEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            999999999999988665      2799999999999999999999988   9999999999999643    57999999


Q ss_pred             CCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          787 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       787 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      |++.....  ......++||+.|+|||++....++..+||||+||++|.|++|.+||....
T Consensus       184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~  242 (382)
T KOG0032|consen  184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET  242 (382)
T ss_pred             CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence            99998876  333445789999999999999999999999999999999999999997643

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.97  E-value=6.7e-31  Score=282.93  Aligned_cols=192  Identities=31%  Similarity=0.437  Sum_probs=165.7

Q ss_pred             eeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCch
Q 002899          646 VGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL  721 (869)
Q Consensus       646 IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL  721 (869)
                      ||+|+||.||++... +|+.||+|.+....   ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999965 68999999986432   12234556799999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccccc
Q 002899          722 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST  801 (869)
Q Consensus       722 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  801 (869)
                      .+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++........  ..
T Consensus        81 ~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~  152 (277)
T cd05607          81 KYHIYNVGE---RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--IT  152 (277)
T ss_pred             HHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--ee
Confidence            988865432   25899999999999999999999987   99999999999999999999999999876653321  22


Q ss_pred             cccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       802 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...|++.|+|||++....++.++||||+||++|||++|+.||..
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~  196 (277)
T cd05607         153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD  196 (277)
T ss_pred             ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence            34688999999999888899999999999999999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.97  E-value=3.2e-31  Score=281.96  Aligned_cols=201  Identities=29%  Similarity=0.506  Sum_probs=172.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEecc
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      ++|++.+.||+|+||.||+|...++..||+|.+.... ....+|.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            3577889999999999999998777789999887543 234679999999999999999999999999999999999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      +|+|.+++.....    .+++..++.++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||.++.......
T Consensus        83 ~~~l~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          83 NGCLLNYLREHGK----RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             CCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            9999998865422    5899999999999999999999987   99999999999999999999999999876644322


Q ss_pred             cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      .......++..|+|||+.....++.++||||||+++|||++ |+.||...
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~  205 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF  205 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence            21122235678999999988889999999999999999998 99998643

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-32  Score=268.97  Aligned_cols=207  Identities=27%  Similarity=0.314  Sum_probs=176.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEE-EcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc-----eEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLL  710 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~-~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~  710 (869)
                      .++|.+.+++|+|||+.||.++ ..+++.+|+|++.-.+.++....++|++..++++|||+++++++...+.     +.|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            5679999999999999999999 5678999999988777777888999999999999999999998876433     589


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      ++++|...|||.+.+..... .+..+++.+.++|+.++++||++||+.. ++++||||||.|||+.+++.+++.|||.++
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999998876543 2346899999999999999999999986 479999999999999999999999999987


Q ss_pred             eecCCCccc--------cccccccccccchhhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          791 LYEEDKTHI--------STRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       791 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...-.....        ...-..|..|.|||.+.   +...+.++|||||||++|+|+.|..||++
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~  243 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER  243 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence            653211110        11124688999999875   45789999999999999999999999964

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=3.7e-31  Score=289.66  Aligned_cols=201  Identities=24%  Similarity=0.408  Sum_probs=169.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999975 678899999875432 2344678899999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++ +|.+++....    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        86 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          86 LDK-DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             CCC-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            985 7777775432    25789999999999999999999987   999999999999999999999999998765432


Q ss_pred             Cccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      ... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus       158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  209 (309)
T cd07872         158 TKT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST  209 (309)
T ss_pred             ccc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            221 123457889999998865 468899999999999999999999996543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=2.9e-31  Score=291.47  Aligned_cols=200  Identities=30%  Similarity=0.552  Sum_probs=169.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~----~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      .+|+..+.||+|+||.||+|++. +++    .||+|.++... ....++|.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46889999999999999999864 333    48999987543 34467899999999999999999999999865 5779


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      |+||+++|+|.+++....    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        86 v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence            999999999999987643    25789999999999999999999987   99999999999999999999999999987


Q ss_pred             ecCCCcccc-ccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          792 YEEDKTHIS-TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ......... ....++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~  214 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG  214 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            654332211 11234668999999999999999999999999999998 9999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.97  E-value=2.9e-31  Score=285.89  Aligned_cols=205  Identities=32%  Similarity=0.534  Sum_probs=174.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~------g~~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  710 (869)
                      ++|.+.+.||+|+||.||+|...+      ++.||||.++..... ..+.|.+|++++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457788999999999999998643      478999998765444 4578999999999999999999999999999999


Q ss_pred             EEEEeccCCchhhhhhcCCc---------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcE
Q 002899          711 LVYEYMKNNCLSRAIFGKDT---------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA  781 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~  781 (869)
                      +||||+++++|.+++.....         .....+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            99999999999999976432         12235889999999999999999999997   9999999999999999999


Q ss_pred             EEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          782 KISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       782 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ||+|||++........ .......+++.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~  227 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG  227 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence            9999999876533221 11223345788999999999999999999999999999998 9999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=5e-31  Score=280.33  Aligned_cols=199  Identities=30%  Similarity=0.521  Sum_probs=170.9

Q ss_pred             CCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          639 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      +|++.+.||+|+||.||+|.++++..+|+|.+.... ....+|.+|++++++++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            477889999999999999998877789999886432 2345788999999999999999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      ++|.+++.....    .+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||+++........
T Consensus        84 ~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          84 GCLLNYLRERKG----KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            999999865432    5899999999999999999999998   999999999999999999999999998765432221


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  204 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER  204 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence            1111223457999999998889999999999999999999 8888864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=5.3e-31  Score=280.94  Aligned_cols=202  Identities=31%  Similarity=0.535  Sum_probs=174.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .++|++.+.||+|++|.||+|...+++.||+|.++... ...++|.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688899999999999999998778889999987543 33567899999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++....   ...+++..+..++.|++.|+.|||+.+   ++||||||+||++++++.+||+|||++.......
T Consensus        84 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          84 KYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             cCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999999986543   236899999999999999999999987   9999999999999999999999999998765332


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .........+..|+|||+.....++.++||||||+++|||++ |+.||..
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  207 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG  207 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence            211111223458999999988889999999999999999999 9988854

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.97  E-value=1.4e-31  Score=296.94  Aligned_cols=207  Identities=24%  Similarity=0.353  Sum_probs=173.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcC-C-----CceeeEEeEEeeCceEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-H-----PNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~-H-----~nIv~l~~~~~~~~~~~  710 (869)
                      -+|.+.+.||+|+||.|-||... +++.||||+++... .-.++-..|+++|..++ |     -|+|++++||...++++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            37889999999999999999854 68999999997643 33456678999999987 4     37999999999999999


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC--CcEEEeecCC
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD--LNAKISDFGL  788 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~--~~~kl~DFGl  788 (869)
                      ||+|.++ -+|.+++..+...   .++...++.|+.||+.||..||+.+   |||+||||+||||.+-  ..+||+|||.
T Consensus       265 iVfELL~-~NLYellK~n~f~---Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  265 IVFELLS-TNLYELLKNNKFR---GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eeehhhh-hhHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccc
Confidence            9999876 4899999877543   6899999999999999999999998   9999999999999653  4799999999


Q ss_pred             ceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHH
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA  858 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~  858 (869)
                      ++.......    ...-+..|+|||++.+.+|+.+.||||||||++||++|.+-|...  .+.+.+...+
T Consensus       338 Sc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~--ne~DQl~~I~  401 (586)
T KOG0667|consen  338 SCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD--NEYDQLARII  401 (586)
T ss_pred             ccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC--CHHHHHHHHH
Confidence            987654332    345677999999999999999999999999999999998777543  3344444443

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.97  E-value=2.9e-31  Score=282.77  Aligned_cols=198  Identities=38%  Similarity=0.630  Sum_probs=165.6

Q ss_pred             CCCeeeccCceEEEEEEEc-----CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          642 PANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       642 ~~~~IG~G~fG~Vyka~~~-----~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ..+.||.|+||.||+|.+.     .+..|+||.++.... ...++|.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999987     256899999966433 3478899999999999999999999999988889999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++|+|.+++....   ...+++..+.+|+.||++||+|||+++   ++|+||+++||+++.++.+||+|||++......
T Consensus        83 ~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             -TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            99999999998762   236899999999999999999999987   999999999999999999999999999876322


Q ss_pred             Cc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          796 KT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       796 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .. ...........|+|||.+....++.++||||||+++|||++ |+.|+..
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~  208 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD  208 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            21 12222346779999999998889999999999999999999 7788754

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2.6e-31  Score=307.84  Aligned_cols=208  Identities=24%  Similarity=0.336  Sum_probs=175.4

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc---
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN---  707 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~---  707 (869)
                      ....++|.+.+.||+|+||+||+|... +++.||||++...  .......+.+|+.++..++|+||+++++.+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            344578999999999999999999854 7899999998654  2334567889999999999999999988775432   


Q ss_pred             -----eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEE
Q 002899          708 -----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK  782 (869)
Q Consensus       708 -----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~k  782 (869)
                           .+++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence                 36899999999999998865422 2246899999999999999999999987   99999999999999999999


Q ss_pred             EeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          783 ISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       783 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~  247 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG  247 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            999999987643221 122345799999999999998999999999999999999999999964

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=1.1e-30  Score=282.60  Aligned_cols=198  Identities=30%  Similarity=0.406  Sum_probs=171.5

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      |+..+.||+|+||.||++... +++.||||.+.....   .....+..|+.++++++|++++++++.+.+++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999975 688999998865422   2234577899999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++.....   ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++......
T Consensus        82 ~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          82 MNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             cCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            999999988864322   25899999999999999999999987   999999999999999999999999998765432


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..  .....|+..|+|||++.+..++.++||||+|+++|||++|+.||..
T Consensus       156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~  203 (285)
T cd05630         156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ  203 (285)
T ss_pred             cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence            22  1234689999999999988999999999999999999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=2.5e-31  Score=283.23  Aligned_cols=204  Identities=29%  Similarity=0.516  Sum_probs=178.4

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      +...+|++.++||+|+||.||+|...+++.+|+|.+.........++..|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34567888999999999999999988899999999987666566789999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++++|.+++.....   ..+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+||+|||.+.....
T Consensus        83 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          83 LMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             ecccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            9999999999976432   35899999999999999999999987   99999999999999999999999999976643


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .... .....++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus       157 ~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~  207 (261)
T cd05148         157 DVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG  207 (261)
T ss_pred             cccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Confidence            3221 112345678999999988889999999999999999998 8999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=4e-32  Score=268.27  Aligned_cols=198  Identities=28%  Similarity=0.445  Sum_probs=170.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc----hhh----HHHHHHHHHHHhc-CCCceeeEEeEEeeC
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR----QGN----REFVNEIGMISAQ-QHPNLVKLYGCCVEG  706 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~----~~~----~~f~~E~~~l~~l-~H~nIv~l~~~~~~~  706 (869)
                      -++|...+.+|+|..++|-+..++ +|+..|+|++.....    ...    ..-..|+.+|+++ .||+|+++.+.++.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            346788899999999999888765 688899998754321    112    2345688999886 799999999999999


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                      ..+++|+|.|+.|-|.++|...     ..++++..++|++|+..|++|||.++   ||||||||+|||++++.++||+||
T Consensus        96 sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence            9999999999999999999654     36899999999999999999999997   999999999999999999999999


Q ss_pred             CCceeecCCCccccccccccccccchhhccc------CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          787 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMR------GYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       787 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      |+++.+.++..  -...+|||+|+|||.+..      ..|+..+|+||+|||||.|+.|.+||.
T Consensus       168 GFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw  229 (411)
T KOG0599|consen  168 GFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW  229 (411)
T ss_pred             ceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence            99998875443  335799999999999863      358889999999999999999999984

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=8.1e-31  Score=283.49  Aligned_cols=199  Identities=29%  Similarity=0.391  Sum_probs=171.7

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      |+..+.||+|+||+||+|... +++.||+|.+.....   .....+.+|++++++++|+||+++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999975 688999999865422   2234578899999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++.....   ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++......
T Consensus        82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          82 MNGGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             ccCccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            999999988865321   25899999999999999999999987   999999999999999999999999998765432


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ..  .....|+..|+|||++.+..++.++|+||||+++|||++|+.||...
T Consensus       156 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~  204 (285)
T cd05632         156 ES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR  204 (285)
T ss_pred             Cc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            21  12346899999999998888999999999999999999999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.97  E-value=6.9e-31  Score=283.50  Aligned_cols=205  Identities=33%  Similarity=0.549  Sum_probs=172.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~------g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  710 (869)
                      ++|++.+.||+|+||.||+|....      ...||+|.+..... ....+|.+|++++.+++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            367888999999999999998643      25799998875433 33467899999999999999999999999999999


Q ss_pred             EEEEeccCCchhhhhhcCCccc-----------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEY-----------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL  779 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~  779 (869)
                      ++|||+++|+|.+++.......           ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            9999999999999886542211           136889999999999999999999997   99999999999999999


Q ss_pred             cEEEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          780 NAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       780 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .+||+|||++........ .......+++.|+|||.+....++.++|||||||++|||++ |+.||..
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~  229 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG  229 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence            999999999876543221 12223456789999999988889999999999999999998 9999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.97  E-value=6.2e-31  Score=296.65  Aligned_cols=207  Identities=27%  Similarity=0.409  Sum_probs=172.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCc
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN  707 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~  707 (869)
                      ..++|.+.++||+|+||.||+|...      .+..||||+++.... .....|..|+++++++. |||||++++++.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3567889999999999999999853      134699999975433 33457899999999996 999999999999999


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcc--------------------------------------------------------
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTE--------------------------------------------------------  731 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------  731 (869)
                      ..++||||+++|+|.++++.....                                                        
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            999999999999999988653210                                                        


Q ss_pred             -----------------------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc
Q 002899          732 -----------------------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD  776 (869)
Q Consensus       732 -----------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~  776 (869)
                                                         ....+++..+..++.|+++||+|||+.+   |+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence                                               0124788999999999999999999987   99999999999999


Q ss_pred             CCCcEEEeecCCceeecCCCccc-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          777 KDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       777 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .++.+||+|||+++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~  342 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG  342 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence            99999999999998664322211 122346788999999988889999999999999999997 8888854

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=8.7e-32  Score=298.74  Aligned_cols=212  Identities=28%  Similarity=0.458  Sum_probs=175.7

Q ss_pred             CCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------ceEEEE
Q 002899          641 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQLLLV  712 (869)
Q Consensus       641 ~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lV  712 (869)
                      ...+.||+||||.||+|+.+ .|+.||||.+..... ...+...+|++++++++|+|||++.+.-++.      +...+|
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            34577999999999999954 799999999877543 3355678999999999999999999876553      356899


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc--CCCc--EEEeecCC
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLN--AKISDFGL  788 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~--~~~~--~kl~DFGl  788 (869)
                      ||||.+|||...+..-.  ....+++...+.+..+++.||.|||+++   |+||||||.||++-  ++|+  -||+|||.
T Consensus        96 mEyC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EeecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999996543  4457999999999999999999999998   99999999999994  3343  59999999


Q ss_pred             ceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHH
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAY  859 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~  859 (869)
                      |+.+.++.  ..+.++||..|.+||+... +.++..+|.|||||++||..||..||..........-+.|+.
T Consensus       171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~  240 (732)
T KOG4250|consen  171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI  240 (732)
T ss_pred             cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh
Confidence            99887654  4556789999999999984 889999999999999999999999997644333222234443

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=7.2e-31  Score=280.31  Aligned_cols=201  Identities=27%  Similarity=0.462  Sum_probs=172.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .+|.+.+.||+|+||.||+|... .++.||+|.+... .....++.+|++++.+++||||+++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            35778889999999999999975 5788999998754 334567899999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++.....   ..+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||++.......
T Consensus        85 ~~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          85 TYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             CCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            99999998865432   35899999999999999999999987   9999999999999999999999999998765432


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~  208 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG  208 (263)
T ss_pred             eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            221112234568999999988889999999999999999998 9988854

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.97  E-value=5.6e-31  Score=283.42  Aligned_cols=207  Identities=28%  Similarity=0.443  Sum_probs=172.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~  708 (869)
                      .+++|++.+.||+|+||.||+|...      .+..||+|++.... .....+|.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999999853      24679999886433 2345678999999999999999999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEE
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTE-----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI  783 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl  783 (869)
                      .++||||+++|+|.+++......     ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            99999999999999988653211     1234688999999999999999999987   999999999999999999999


Q ss_pred             eecCCceeecCCCccc-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          784 SDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       784 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      +|||++.......... .....+++.|+|||++....++.++|||||||++|||++ |+.||..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~  224 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG  224 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            9999987654322211 112345678999999998889999999999999999999 6888854

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=1.1e-30  Score=278.33  Aligned_cols=201  Identities=30%  Similarity=0.527  Sum_probs=171.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .++|++.++||+|+||.||+|...++..||+|.+..... ....|.+|++++++++|+|++++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            356888999999999999999988888899999875433 3467899999999999999999999875 45689999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++.....   ..+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++..+....
T Consensus        83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          83 SKGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            99999999875432   25899999999999999999999987   9999999999999999999999999998765432


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ........++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~  206 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG  206 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence            222222335668999999988889999999999999999999 8888854

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.97  E-value=1e-30  Score=282.36  Aligned_cols=205  Identities=30%  Similarity=0.505  Sum_probs=171.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEE-----cCCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~-----~~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ++|++.+.||+|+||.||+|..     .+++.||+|.+.... .....+|.+|++++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577889999999999999985     245789999987543 3334678899999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCc------------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC
Q 002899          712 VYEYMKNNCLSRAIFGKDT------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL  779 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~  779 (869)
                      ||||+++++|.+++.....            .....+++.++..++.|++.||+|||+++   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999998853321            11235789999999999999999999997   99999999999999999


Q ss_pred             cEEEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          780 NAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       780 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~  229 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG  229 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            999999999976543221 11222345678999999988889999999999999999998 9888854

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.97  E-value=1e-30  Score=283.12  Aligned_cols=205  Identities=33%  Similarity=0.545  Sum_probs=174.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+..........+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56888999999999999999852      345689999876665566789999999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCc--------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEE
Q 002899          712 VYEYMKNNCLSRAIFGKDT--------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI  783 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl  783 (869)
                      ||||+++++|.+++.....        .....+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            9999999999998865431        12235899999999999999999999987   999999999999999999999


Q ss_pred             eecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          784 SDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       784 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      +|||++........ .......+++.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~  225 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ  225 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999876543221 11222345678999999998889999999999999999998 8988854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-32  Score=273.66  Aligned_cols=202  Identities=28%  Similarity=0.355  Sum_probs=177.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhh---HHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~---~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .++|+..++||+|.||.|-.++-+ +++.+|+|++++....+.   ..-..|-++|+..+||.+..+...|+..+.++.|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            467889999999999999998854 689999999987644333   3346788999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+.+|.|.-+|...+     .+++...+-+...|+.||.|||+++   ||.||||.+|.|+|.||++||+|||+++.-
T Consensus       247 MeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence            99999999998886643     5788888899999999999999987   999999999999999999999999999754


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      -.... ....++|||.|+|||++....|+..+|+|.+||+||||++|+.||...+
T Consensus       319 I~~g~-t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d  372 (516)
T KOG0690|consen  319 IKYGD-TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD  372 (516)
T ss_pred             ccccc-eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence            43332 2345899999999999999999999999999999999999999996543

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=1.4e-30  Score=278.49  Aligned_cols=198  Identities=27%  Similarity=0.439  Sum_probs=171.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++..++..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            4688999999999999999996 468899999987655455567888999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++....     .+++..+..++.|++.||+|||+.+   |+||||+|+||+++.++.+||+|||++.......
T Consensus        89 ~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          89 GGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            9999999886432     5789999999999999999999987   9999999999999999999999999998664322


Q ss_pred             ccccccccccccccchhhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      . ......+++.|+|||.+.   ...++.++||||||+++|||++|+.||.
T Consensus       161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~  210 (267)
T cd06646         161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF  210 (267)
T ss_pred             c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence            1 112346788999999874   3457889999999999999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=2.2e-30  Score=279.15  Aligned_cols=193  Identities=25%  Similarity=0.431  Sum_probs=169.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccc-CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|++.++||+|+||.||+|.. .+++.||+|.+... .....++|..|++++.+++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3677889999999999999986 46889999998654 233456789999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|..+.         .+++..+..++.|++.||+|||+.+   |+|+||||+|||++.++.++|+|||++......
T Consensus        81 ~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          81 MDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             CCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            9999986432         4678899999999999999999997   999999999999999999999999998765432


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .   .....|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       149 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         149 I---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             c---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence            2   2234688999999999988899999999999999999999999964

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.6e-30  Score=277.31  Aligned_cols=200  Identities=30%  Similarity=0.454  Sum_probs=172.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-----chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ++|++.+.||+|++|.||+|... +++.||+|.+....     ....+.+.+|++++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57889999999999999999864 68999999876432     1223568889999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++++|.+++....     .+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||++..
T Consensus        82 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~  153 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  153 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            999999999999886542     5788999999999999999999998   99999999999999999999999999876


Q ss_pred             ecCCCcccc--ccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHIS--TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .........  ....++..|+|||++.+..++.++||||+|+++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  209 (263)
T cd06625         154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE  209 (263)
T ss_pred             ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            543221111  234577899999999988899999999999999999999999854

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.97  E-value=1.3e-30  Score=278.64  Aligned_cols=202  Identities=30%  Similarity=0.498  Sum_probs=172.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC----CcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~----g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      .++|++.+.||+|+||.||+|.+..    ...||||.++... .....+|.+|+.++.+++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3578899999999999999999752    3579999887543 3335678999999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++++|.+++.....    .+++..+..++.|++.|++|||+.+   |+||||||+||++++++.++|+|||++..
T Consensus        83 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          83 ITEYMENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             EEEcCCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhc
Confidence            9999999999999865432    6899999999999999999999987   99999999999999999999999999987


Q ss_pred             ecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          792 YEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ....... ......++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~  211 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD  211 (266)
T ss_pred             ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence            7522211 1112234678999999998889999999999999999998 9999853

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=7.4e-31  Score=300.42  Aligned_cols=199  Identities=25%  Similarity=0.354  Sum_probs=161.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--------c
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--------N  707 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~--------~  707 (869)
                      .++|++.++||+|+||.||+|... +++.||||++....    ....+|+.+++.++|||||++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999975 68899999885432    2345799999999999999999887532        2


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-cEEEeec
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDF  786 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~-~~kl~DF  786 (869)
                      .+++||||+++ ++.+++.... .....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++ .+||+||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            46789999985 5666554321 12236899999999999999999999998   99999999999999664 7999999


Q ss_pred             CCceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          787 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       787 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |+++.+.....  .....||+.|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus       216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  274 (440)
T PTZ00036        216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ  274 (440)
T ss_pred             ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99986643222  223468999999998865 46899999999999999999999999654

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=1.7e-30  Score=284.24  Aligned_cols=198  Identities=26%  Similarity=0.454  Sum_probs=172.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|++.+.||+|+||.||+|... ++..+|+|.++.... ....++.+|++++.+++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46889999999999999999965 578899998865432 3345688999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++....     .+++..+..++.|+++||+|||+..  +++||||||+|||++.++.+||+|||++......
T Consensus        81 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          81 MDGGSLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            99999999986542     5789999999999999999999742  3999999999999999999999999998755322


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .   .....+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       154 ~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         154 M---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             c---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            1   1234688999999999888899999999999999999999999854

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=1.4e-30  Score=278.01  Aligned_cols=201  Identities=30%  Similarity=0.513  Sum_probs=170.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .++|++.++||+|+||.||+|...++..||+|+++.... ...+|.+|++++++++||||+++++.+. .+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            356889999999999999999987777899999875332 3467899999999999999999999875 45689999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++|+|.+++....   ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||.+.......
T Consensus        83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          83 SKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             CCCcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            9999999996532   125799999999999999999999987   9999999999999999999999999998765433


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ........++..|+|||+..+..++.++||||||+++|||++ |+.||..
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~  206 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  206 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            222222345678999999988889999999999999999999 8888854

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=1.6e-30  Score=280.17  Aligned_cols=201  Identities=30%  Similarity=0.465  Sum_probs=167.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~----~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ++|++.+.||+|+||.||+|.+. +++    .|++|.+..... ....++..|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46778899999999999999964 344    477887754322 234577788889999999999999998764 56788


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ++||+++|+|.+++....    ..+++..+..++.||+.||+|||+.+   ++||||||+|||+++++.+||+|||+++.
T Consensus        86 i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcccee
Confidence            999999999999997543    25899999999999999999999987   99999999999999999999999999987


Q ss_pred             ecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          792 YEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       792 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      ....... ......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~  215 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM  215 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            6433221 1223456779999999988889999999999999999998 99998653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=303.11  Aligned_cols=203  Identities=24%  Similarity=0.292  Sum_probs=170.6

Q ss_pred             CCCCCCeeeccCceEEEEEEEcCC-cEEEEEEecccCchhhHHHHHHHHHHHhcC-CCceeeEEeEEe-e------CceE
Q 002899          639 NFDPANKVGEGGFGSVYKGILSDG-TVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCV-E------GNQL  709 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~~g-~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~-~------~~~~  709 (869)
                      +.++.+.|.+|||+.||.|+...+ ..||+|++-.....+.+...+|+++|+.+. |+|||.+++... .      .-++
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            345788999999999999998765 999999987777778889999999999997 999999999322 1      2478


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      +|.||||.+|+|.+++..+..   ..|.+.++++|+.|+++|+++||... +||||||||-+||||+.+++.||||||.|
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence            999999999999999865432   25999999999999999999999884 67999999999999999999999999998


Q ss_pred             eeecCCCcccc--------ccccccccccchhhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKTHIS--------TRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .-.........        -....|+.|+|||++.   +..+++|+|||||||+||-|.....||+.
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~  260 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE  260 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc
Confidence            64322221100        0134689999999874   66899999999999999999999999964

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=1.7e-30  Score=276.78  Aligned_cols=201  Identities=31%  Similarity=0.538  Sum_probs=172.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .++|++.++||+|+||.||+|...+++.||+|.+..... ...+|.+|++++++++|+||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            467888999999999999999988899999999875433 3567899999999999999999999864 55789999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++.....   ..+++.++..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        83 ~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          83 ENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            99999998865432   36899999999999999999999987   9999999999999999999999999997765332


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ........++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  206 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG  206 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            222222345678999999988889999999999999999999 9999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.97  E-value=2e-30  Score=281.99  Aligned_cols=198  Identities=26%  Similarity=0.529  Sum_probs=174.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .+|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+++++.++||||+++++++..++..++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            47888899999999999999864 68899999987665555677889999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++...      .+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus       100 ~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654         100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             CCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            999999988543      4789999999999999999999997   9999999999999999999999999987654322


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .. .....+++.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~  218 (296)
T cd06654         171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN  218 (296)
T ss_pred             cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            21 1234688899999999888889999999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=2.2e-30  Score=274.96  Aligned_cols=200  Identities=32%  Similarity=0.496  Sum_probs=175.0

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +|++.+.||+|++|.||+|... +++.|++|.+...  ......++..|+++++.++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4777899999999999999975 6889999988643  334567889999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++....   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          81 AENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             CCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            99999999987642   236899999999999999999999987   999999999999999999999999998876543


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ... .....|++.|+|||+..+..++.++||||||++++||++|+.||..
T Consensus       155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  203 (256)
T cd08529         155 TNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA  203 (256)
T ss_pred             cch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence            222 2234678899999999988899999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=1.4e-30  Score=291.35  Aligned_cols=198  Identities=26%  Similarity=0.368  Sum_probs=167.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc-----
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----  707 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~-----  707 (869)
                      ..++|.+.+.||+|+||.||+|... +++.||||++...  ......++.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3578999999999999999999865 5889999998643  2334567889999999999999999999986543     


Q ss_pred             -eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          708 -QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       708 -~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                       ..++||||+++ ++.+.++.       .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecC
Confidence             47999999986 45555532       4788899999999999999999998   999999999999999999999999


Q ss_pred             CCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          787 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       787 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       168 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         168 GLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             CCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            9997543221  223356899999999999889999999999999999999999999653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=3.3e-30  Score=272.74  Aligned_cols=195  Identities=30%  Similarity=0.461  Sum_probs=167.3

Q ss_pred             CeeeccCceEEEEEEEcCCcEEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCchh
Q 002899          644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS  722 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~  722 (869)
                      ++||+|+||.||+|...+++.||+|.+...... ....|.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            468999999999999888899999998765432 3456889999999999999999999999999999999999999999


Q ss_pred             hhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcccccc
Q 002899          723 RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR  802 (869)
Q Consensus       723 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  802 (869)
                      +++....    ..+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++.............
T Consensus        81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            9886543    25789999999999999999999987   9999999999999999999999999987544322211112


Q ss_pred             ccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       803 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ..+++.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~  197 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG  197 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence            234568999999988889999999999999999998 9999854

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.97  E-value=2.1e-30  Score=281.19  Aligned_cols=205  Identities=31%  Similarity=0.531  Sum_probs=174.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      .+|.+.+.||+|+||.||+|+..      ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35777889999999999999842      345689999876665556789999999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 002899          712 VYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN  780 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~  780 (869)
                      ||||+++++|.+++.....           .....+++..++.++.|++.|++|||+++   ++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            9999999999999865432           11235899999999999999999999998   999999999999999999


Q ss_pred             EEEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          781 AKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       781 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ++|+|||++........ .......++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  228 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ  228 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999976543221 11223456788999999998889999999999999999999 9999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.8e-30  Score=275.14  Aligned_cols=202  Identities=34%  Similarity=0.552  Sum_probs=174.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .++|.+.++||+|+||.||+|...+++.||||.+.... ....++.+|++++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            46788999999999999999998888899999987543 33567999999999999999999999999889999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++.....   ..+++..+..++.|++.|++|||+++   ++|+||||+||++++++.+||+|||++.......
T Consensus        84 ~~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          84 SKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             CCCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            99999999976432   25899999999999999999999997   9999999999999999999999999988765322


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ........++..|+|||.+.+..++.++||||+|++++||++ |+.||..
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  207 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG  207 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            111112234568999999998889999999999999999998 9999854

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=298.76  Aligned_cols=208  Identities=34%  Similarity=0.538  Sum_probs=178.4

Q ss_pred             CCCCeeeccCceEEEEEEE-cCC----cEEEEEEeccc-CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          641 DPANKVGEGGFGSVYKGIL-SDG----TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       641 ~~~~~IG~G~fG~Vyka~~-~~g----~~VAvK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ...++||+|+||+||||.+ ..|    -+||+|++... ..+..+++.+|+-+|.+++|||+++++|+|.... +.||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            4568999999999999996 344    36899987654 4556789999999999999999999999999876 889999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      ||+.|+|.++++.++.    .+.-...+.+..|||+||.|||++.   ++||||.++||||.+-..+||.|||+++.+..
T Consensus       778 ~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             hcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            9999999999977543    6888899999999999999999886   99999999999999999999999999998876


Q ss_pred             CCcccccc-ccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcchhhHHH
Q 002899          795 DKTHISTR-IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLD  856 (869)
Q Consensus       795 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~  856 (869)
                      +....... ..-.+.|||-|.+....++.++|||||||.+||++| |..|+...+.++..++.+
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle  914 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE  914 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh
Confidence            65544332 233568999999999999999999999999999998 889998777666666554

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=293.23  Aligned_cols=192  Identities=32%  Similarity=0.461  Sum_probs=170.7

Q ss_pred             eeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCchhh
Q 002899          645 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSR  723 (869)
Q Consensus       645 ~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  723 (869)
                      +||+|.||+||-|+.. +...+|||.+........+...+|+...+.++|.|||+++|.+.+++.+-+.||-++||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            7999999999999965 456799999988887778889999999999999999999999999999999999999999999


Q ss_pred             hhhcCCcccccCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-CCCcEEEeecCCceeecCCCcccc
Q 002899          724 AIFGKDTEYRLKL--DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHIS  800 (869)
Q Consensus       724 ~l~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~  800 (869)
                      +|....+    ++  .+.++--+.+||++||.|||++.   |||||||-.|||++ -.|.+||+|||-++.+..-+ ...
T Consensus       662 LLrskWG----PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~T  733 (1226)
T KOG4279|consen  662 LLRSKWG----PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCT  733 (1226)
T ss_pred             HHHhccC----CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC-ccc
Confidence            9977654    34  77788889999999999999997   99999999999996 57999999999998765332 233


Q ss_pred             ccccccccccchhhcccC--CCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          801 TRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       801 ~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      ..+-||..|||||++..+  .|+..+|||||||.+.||.|||+||.
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~  779 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV  779 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence            456799999999999865  58999999999999999999999994

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4e-31  Score=292.20  Aligned_cols=191  Identities=28%  Similarity=0.387  Sum_probs=160.4

Q ss_pred             eeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHHHHhc---CCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          646 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQ---QHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       646 IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      ||+|+||+||+|+.. +++.||||++.....   .....+..|..++...   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999975 589999999864321   2233455666666654   799999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|.+++....     .+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||++........ 
T Consensus        81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-  151 (330)
T cd05586          81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-  151 (330)
T ss_pred             ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence            99998886542     5899999999999999999999998   99999999999999999999999999875432221 


Q ss_pred             ccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~  199 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA  199 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence            12345689999999998754 478999999999999999999999854

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=2.2e-30  Score=275.47  Aligned_cols=198  Identities=33%  Similarity=0.522  Sum_probs=171.3

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhH--HHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR--EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~--~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      |++.+.||+|+||+||++... +++.||+|++.........  ....|+.++++++||||+++++++.+.+..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456789999999999999976 4678999999876543322  3456999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++...     ..+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.++|+|||.+...... 
T Consensus        81 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-  151 (260)
T PF00069_consen   81 PGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-  151 (260)
T ss_dssp             TTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST-
T ss_pred             cccccccccccc-----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-
Confidence            999999999722     26799999999999999999999997   999999999999999999999999999865222 


Q ss_pred             ccccccccccccccchhhcc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ........++..|+|||++. ....+.++||||+|+++++|++|+.||...
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            22233456899999999998 788999999999999999999999999754

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=2.8e-30  Score=276.67  Aligned_cols=200  Identities=27%  Similarity=0.396  Sum_probs=164.7

Q ss_pred             CeeeccCceEEEEEEEcC---CcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCC
Q 002899          644 NKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN  719 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~---g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g  719 (869)
                      +.||+|+||.||+|...+   +..+|+|.++.... .....|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998643   45799998865532 33457889999999999999999999999999999999999999


Q ss_pred             chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccc
Q 002899          720 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI  799 (869)
Q Consensus       720 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  799 (869)
                      +|.+++...........++..+..++.|+++|++|||+.+   ++||||||+||+++.++++||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999997643322335678888999999999999999987   9999999999999999999999999987543322211


Q ss_pred             -cccccccccccchhhcccC-------CCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          800 -STRIAGTIGYMAPEYAMRG-------YLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       800 -~~~~~gt~~y~aPE~~~~~-------~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                       .....++..|+|||++...       .++.++||||||+++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  213 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL  213 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence             1234567889999988642       35789999999999999996 99999653

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=1.4e-30  Score=288.43  Aligned_cols=206  Identities=29%  Similarity=0.466  Sum_probs=170.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCc-hhhHHHHHHHHHHHhc-CCCceeeEEeEEee-Cc
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVE-GN  707 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~-~~  707 (869)
                      .++|++.++||+|+||.||+|...      +++.||+|++..... ...+.+..|++++.++ +|+||++++++|.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357889999999999999999742      347899999875432 2345678899999999 89999999998865 45


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcc--------------------------------------------------------
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTE--------------------------------------------------------  731 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------  731 (869)
                      ..+++|||+++++|.+++......                                                        
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            688999999999999888643211                                                        


Q ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccc-ccccccccccc
Q 002899          732 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYM  810 (869)
Q Consensus       732 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~  810 (869)
                      ...+++|..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||++..+....... .....++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence            0136899999999999999999999987   9999999999999999999999999998764332221 12234567899


Q ss_pred             chhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          811 APEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       811 aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      |||++.+..++.++|||||||++|||++ |+.||..
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~  278 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG  278 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999999998 9999865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=3.7e-30  Score=280.09  Aligned_cols=199  Identities=28%  Similarity=0.534  Sum_probs=175.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36788999999999999999996 47899999999766555567788999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++...      .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++......
T Consensus        98 ~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          98 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             cCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            9999999988543      4788999999999999999999987   999999999999999999999999998765433


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       169 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~  217 (297)
T cd06656         169 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (297)
T ss_pred             ccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            221 2234678899999999988899999999999999999999999954

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=2.4e-30  Score=277.14  Aligned_cols=198  Identities=25%  Similarity=0.371  Sum_probs=161.7

Q ss_pred             eeeccCceEEEEEEEcC---CcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCc
Q 002899          645 KVGEGGFGSVYKGILSD---GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC  720 (869)
Q Consensus       645 ~IG~G~fG~Vyka~~~~---g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs  720 (869)
                      .||+|+||.||+|...+   ...+|+|.+.... ......|.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   3568888876443 2335678899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc-c
Q 002899          721 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH-I  799 (869)
Q Consensus       721 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~  799 (869)
                      |.+++...........++.....++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++......... .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999997654332334578889999999999999999997   999999999999999999999999998654332211 1


Q ss_pred             cccccccccccchhhccc-------CCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          800 STRIAGTIGYMAPEYAMR-------GYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       800 ~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .....+++.|+|||++..       ..++.++|||||||++|||++ |+.||..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~  212 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD  212 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence            122345678999998743       356889999999999999999 7778754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=1.5e-30  Score=301.03  Aligned_cols=201  Identities=22%  Similarity=0.310  Sum_probs=163.7

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCC------CceeeEEeEEee
Q 002899          633 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH------PNLVKLYGCCVE  705 (869)
Q Consensus       633 i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H------~nIv~l~~~~~~  705 (869)
                      +...+++|++.++||+|+||+||+|... .++.||||+++... ...+++..|++++..++|      .+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3445788999999999999999999965 57889999986432 223455667777776654      458899998876


Q ss_pred             C-ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEcCCCCCCEEEcCCC----
Q 002899          706 G-NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDL----  779 (869)
Q Consensus       706 ~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NILl~~~~----  779 (869)
                      + +..++|||++ +++|.+++....     .+++..+..|+.||+.||+|||++ +   ||||||||+|||++.++    
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence            4 5788999987 567888776542     689999999999999999999974 6   99999999999998765    


Q ss_pred             ------------cEEEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          780 ------------NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       780 ------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                                  .+||+|||.+.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                        499999998754322    1234679999999999999999999999999999999999999997543

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=3.3e-30  Score=277.47  Aligned_cols=208  Identities=31%  Similarity=0.431  Sum_probs=172.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~~------g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~  708 (869)
                      .+++|.+.+.||+|+||.||+|.+.+      +..||+|.+.... ......|..|+.++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35678899999999999999999753      5678999886543 3335679999999999999999999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCc--ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC---cEEE
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDT--EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKI  783 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~---~~kl  783 (869)
                      .++||||+++++|.+++.....  .....+++..+++++.||+.||+|||+.+   ++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            9999999999999999866432  12235899999999999999999999987   99999999999998654   5899


Q ss_pred             eecCCceeecCCCccc-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          784 SDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       784 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      +|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~  225 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR  225 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999998663322111 112233568999999998889999999999999999997 99998643

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=4.7e-30  Score=273.55  Aligned_cols=200  Identities=31%  Similarity=0.506  Sum_probs=169.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEecc
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      ++|.+.+.||+|+||.||+|...++..||+|.+.... ...+.|.+|++++++++|||++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4577889999999999999998777789999876543 23467889999999999999999999875 456889999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      +++|.+++.....   ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++........
T Consensus        84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          84 KGSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            9999999975432   25799999999999999999999987   99999999999999999999999999987643322


Q ss_pred             cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .......++..|+|||...+..++.++||||||+++|||++ |+.||..
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  206 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG  206 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            22222345678999999988889999999999999999999 8988854

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3e-30  Score=291.88  Aligned_cols=196  Identities=22%  Similarity=0.274  Sum_probs=168.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc---CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~---~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ..+|.+.+.||+|+||.||++...   .++.||+|.+...     +.+.+|++++++++|||||++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357889999999999999999753   3578999987543     34567999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      |++. ++|.+++...     ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       166 e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        166 PKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             hhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence            9986 5777777332     26899999999999999999999998   9999999999999999999999999997665


Q ss_pred             CCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          794 EDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       794 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ..... ......||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            43221 222457999999999999889999999999999999999999999653

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=2.3e-31  Score=267.63  Aligned_cols=204  Identities=25%  Similarity=0.417  Sum_probs=171.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcC-----CcEEEEEEecccCchh--hHHHHHHHHHHHhcCCCceeeEEeEEee-CceE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYGCCVE-GNQL  709 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~-----g~~VAvK~~~~~~~~~--~~~f~~E~~~l~~l~H~nIv~l~~~~~~-~~~~  709 (869)
                      ..|+....||+|.||.||||+-.+     .+.+|+|+++.+....  .....+|+..++.++||||+.+..++.. +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            468888999999999999996432     2368999998764322  3456789999999999999999998877 7889


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC----CcEEEee
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD----LNAKISD  785 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~----~~~kl~D  785 (869)
                      ++++||.+. +|.+.++-++......++-..+..|+.||+.|+.|||++-   |+||||||.|||+..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 6777776555444568999999999999999999999998   9999999999999877    8999999


Q ss_pred             cCCceeecCCCcc--ccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          786 FGLAKLYEEDKTH--ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       786 FGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ||+++.+...-..  ....++-|..|.|||.+.+. .|+++.||||.|||+.||++-++-|..
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            9999988754322  23346679999999998875 699999999999999999999987754

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=3.5e-30  Score=282.95  Aligned_cols=197  Identities=25%  Similarity=0.417  Sum_probs=159.9

Q ss_pred             CCeeeccCceEEEEEEEc---CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEee--CceEEEEEEecc
Q 002899          643 ANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLVYEYMK  717 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~---~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~E~~~  717 (869)
                      .++||+|+||.||+|+..   +++.||+|.+....  ....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            467999999999999864   45789999986542  23467889999999999999999998864  456899999987


Q ss_pred             CCchhhhhhcCCc----ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE----cCCCcEEEeecCCc
Q 002899          718 NNCLSRAIFGKDT----EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLA  789 (869)
Q Consensus       718 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl----~~~~~~kl~DFGla  789 (869)
                      + +|.+++.....    .....+++..+..++.||+.||+|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 67766643211    11235899999999999999999999998   9999999999999    45678999999999


Q ss_pred             eeecCCCc--cccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKT--HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +.......  .......||+.|+|||++.+ ..++.++||||+||++|||++|++||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            87653321  11224568999999999876 4589999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=3.3e-30  Score=281.05  Aligned_cols=200  Identities=23%  Similarity=0.408  Sum_probs=169.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888999999999999999875 57899999986543 22345678899999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      ++ ++|.+.+....    ..+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||++......
T Consensus        86 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          86 LD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            98 58888775532    25789999999999999999999987   999999999999999999999999998765432


Q ss_pred             Cccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ... .....+++.|+|||++.+ ..++.++||||||+++|||++|++||...
T Consensus       158 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~  208 (301)
T cd07873         158 TKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS  208 (301)
T ss_pred             CCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            211 122356889999998865 45788999999999999999999999654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.9e-31  Score=292.75  Aligned_cols=207  Identities=26%  Similarity=0.454  Sum_probs=171.7

Q ss_pred             CCCCeeeccCceEEEEEEEc-CCcEEEEEEec--c--cCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce--EEEEE
Q 002899          641 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLS--S--KSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ--LLLVY  713 (869)
Q Consensus       641 ~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~--~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~--~~lV~  713 (869)
                      +..++||+|+|-+||||... +|..||=-.++  .  .+.....+|..|+++|+.++|||||+++.++.+...  .-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            45678999999999999975 46666633222  1  234445889999999999999999999999987654  78899


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCcEEEeecCCceee
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLY  792 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~-~~~~kl~DFGla~~~  792 (869)
                      |.|..|+|..++...+     ..+.+.++++++||++||.|||++. |||||||||-.||+|+. .|.+||+|+|+|..+
T Consensus       123 EL~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             ecccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            9999999999997765     5788899999999999999999986 68999999999999975 599999999999988


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHH
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAY  859 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~  859 (869)
                      .....   ..++|||.|||||+.. ..|+..+||||||++|+||+|+.+||.  .-....++.+-|-
T Consensus       197 r~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs--EC~n~AQIYKKV~  257 (632)
T KOG0584|consen  197 RKSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS--ECTNPAQIYKKVT  257 (632)
T ss_pred             hcccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh--hhCCHHHHHHHHH
Confidence            65432   2378999999999987 779999999999999999999999984  2334455555553

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=3.6e-30  Score=280.02  Aligned_cols=199  Identities=28%  Similarity=0.537  Sum_probs=175.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .+|++.+.||.|+||.||+|.. .+++.||+|.+..........+.+|+++++.++||||+++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4588899999999999999985 468999999987665555678889999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++...      .+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          99 AGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            999999988542      4799999999999999999999997   9999999999999999999999999987654332


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .. .....+++.|+|||.+....++.++|||||||++|||++|+.||...
T Consensus       170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~  218 (296)
T cd06655         170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (296)
T ss_pred             cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            21 22346788999999998888999999999999999999999999653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=2.7e-30  Score=276.44  Aligned_cols=199  Identities=25%  Similarity=0.416  Sum_probs=172.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      ++|.+.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46777888999999999999864 68899999987665555567888999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++....     .+++.++..++.|++.|++|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        89 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          89 GGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            9999999886543     5899999999999999999999997   9999999999999999999999999987654322


Q ss_pred             ccccccccccccccchhhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      . ......|++.|+|||++.   ...++.++|||||||++|||++|+.||..
T Consensus       161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~  211 (267)
T cd06645         161 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD  211 (267)
T ss_pred             c-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence            1 122346899999999874   45688899999999999999999999853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=2.5e-30  Score=289.84  Aligned_cols=198  Identities=24%  Similarity=0.331  Sum_probs=167.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------  706 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~------  706 (869)
                      ..++|.+.+.||+|+||.||+|... .++.||||++....  ....+++.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999965 57889999986532  33356788999999999999999999987643      


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                      ...++||||+++ +|.+.+..       .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeC
Confidence            357999999975 56665532       4788999999999999999999987   999999999999999999999999


Q ss_pred             CCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          787 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       787 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |+++......  ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       171 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  228 (364)
T cd07875         171 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  228 (364)
T ss_pred             CCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence            9997654322  223356899999999999989999999999999999999999999653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=3.5e-30  Score=277.76  Aligned_cols=205  Identities=32%  Similarity=0.532  Sum_probs=174.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ++|...++||+|+||.||++...      ++..+|+|.+..........|.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46778899999999999999742      356899999887666667789999999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcE
Q 002899          712 VYEYMKNNCLSRAIFGKDTE----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA  781 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~  781 (869)
                      ||||+++|+|.+++......          ....+++..++.++.|++.|++|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            99999999999998754311          1135899999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          782 KISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       782 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ||+|||++........ .......+++.|+|||++....++.++|||||||++|||++ |++||..
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  227 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ  227 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence            9999999876543221 11122345678999999998889999999999999999998 8988843

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=4.2e-30  Score=278.11  Aligned_cols=199  Identities=28%  Similarity=0.481  Sum_probs=164.3

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch--hhHHHHHHHHHHHhc---CCCceeeEEeEEee-----Cc
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQ---QHPNLVKLYGCCVE-----GN  707 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~--~~~~f~~E~~~l~~l---~H~nIv~l~~~~~~-----~~  707 (869)
                      +|++.+.||+|+||.||+|... +++.||+|.++.....  ....+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999975 6889999988754222  233556677766654   79999999998864     34


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                      ..++||||+++ +|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccC
Confidence            57999999985 78777754322   25899999999999999999999998   9999999999999999999999999


Q ss_pred             CceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ++........  .....++..|+|||++.+..++.++||||+||++|||++|++||...
T Consensus       154 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         154 LARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             ccccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            9987643221  22346789999999998888999999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=5.3e-30  Score=276.80  Aligned_cols=200  Identities=32%  Similarity=0.485  Sum_probs=169.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-----CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEee--CceEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLL  710 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-----~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~  710 (869)
                      .+|++.+.||+|+||.||+|...     +++.||+|+++.......+.|..|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46788999999999999999753     578999999987666667789999999999999999999998754  34689


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      +||||+++|+|.+++....    ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.
T Consensus        84 lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence            9999999999999986542    25899999999999999999999997   9999999999999999999999999998


Q ss_pred             eecCCCccc--cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          791 LYEEDKTHI--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       791 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      .........  .....++..|+|||++.+..++.++||||||+++|||++|..|+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~  212 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC  212 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence            764432211  111223456999999988889999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=3.2e-30  Score=276.51  Aligned_cols=203  Identities=30%  Similarity=0.483  Sum_probs=170.9

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC------
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG------  706 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~------  706 (869)
                      .+++.|++.+.||+|+||.||+|... +++.||+|++.... ....++..|+.++.++ +||||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35677888899999999999999975 57889999986543 3346788899999988 799999999998753      


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                      ...++||||+++++|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccC
Confidence            46899999999999999886532   125889999999999999999999987   999999999999999999999999


Q ss_pred             CCceeecCCCccccccccccccccchhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          787 GLAKLYEEDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       787 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |++........ ......|++.|+|||++.     ...++.++|||||||++|||++|+.||..
T Consensus       156 g~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~  218 (272)
T cd06637         156 GVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  218 (272)
T ss_pred             CCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            99876543222 223456889999999986     34578899999999999999999999853

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=5e-30  Score=276.78  Aligned_cols=198  Identities=29%  Similarity=0.505  Sum_probs=170.7

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      |++.+.||+|+||.||+|... ++..+++|.+..........+..|+++++.++||||+++++++..++..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            567788999999999999976 5778899998766555667889999999999999999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      ++|..++....    .++++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++........ 
T Consensus        87 ~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-  158 (282)
T cd06643          87 GAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  158 (282)
T ss_pred             CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence            99988876532    26899999999999999999999987   99999999999999999999999999876543221 


Q ss_pred             ccccccccccccchhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......+++.|+|||++.     ...++.++|||||||++|||++|++||..
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~  210 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE  210 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence            122346889999999874     34577899999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-31  Score=264.76  Aligned_cols=205  Identities=24%  Similarity=0.400  Sum_probs=173.3

Q ss_pred             cHHHHHHHhcCCCCCCeeeccCceEEEEEE-EcCCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC
Q 002899          629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG  706 (869)
Q Consensus       629 ~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~-~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~  706 (869)
                      .++++-+.|     .+.||+|+|+.|--++ +.+|..+|||++.+.......+..+|++++... .|+||++++++|+++
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            356666665     3679999999999887 678999999999888766778899999999887 599999999999999


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc---EEE
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKI  783 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~---~kl  783 (869)
                      ..+|||||-|.+|+|..+++.+.     .+++..+.++..+||.||++||.+|   |.|||+||+|||...-..   +||
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceee
Confidence            99999999999999999997764     6899999999999999999999998   999999999999965443   799


Q ss_pred             eecCCceeecCCC--ccccc----cccccccccchhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          784 SDFGLAKLYEEDK--THIST----RIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       784 ~DFGla~~~~~~~--~~~~~----~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +||.+..-+....  +..++    ..+|+..|||||+..     ...|+.++|.||||||+|-|++|.+||...
T Consensus       221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~  294 (463)
T KOG0607|consen  221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH  294 (463)
T ss_pred             eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence            9998876443221  11111    256888999999874     347899999999999999999999999653

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=5.4e-30  Score=277.73  Aligned_cols=204  Identities=32%  Similarity=0.487  Sum_probs=169.8

Q ss_pred             CCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      +|.+.+.||+|+||.||+|...      ....+|+|.+..... ....++..|+.+++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4678899999999999999853      235789998875533 335678899999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCc-------------------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCC
Q 002899          712 VYEYMKNNCLSRAIFGKDT-------------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN  772 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~N  772 (869)
                      ||||+++|+|.+++.....                   .....+++..+..++.|++.||+|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            9999999999998754211                   11235889999999999999999999987   9999999999


Q ss_pred             EEEcCCCcEEEeecCCceeecCCCccc-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          773 VLLDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       773 ILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ||+++++.+||+|||+++......... .....++..|+|||++....++.++||||||++++||++ |+.||..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            999999999999999997654332211 112345678999999988889999999999999999998 9988854

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=5.6e-30  Score=272.02  Aligned_cols=200  Identities=30%  Similarity=0.583  Sum_probs=172.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEecc
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      .+|++.+.||+|+||.||+|.+.+++.+|+|.++... ....+|.+|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4677889999999999999998778899999886432 234678999999999999999999999999999999999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      +++|.+++.....    .++++.+..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        83 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          83 HGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             CCcHHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            9999998865432    5789999999999999999999987   99999999999999999999999999876543222


Q ss_pred             cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .......++.+|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  204 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN  204 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            11222234678999999988889999999999999999998 9999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.97  E-value=4.8e-30  Score=271.95  Aligned_cols=195  Identities=27%  Similarity=0.451  Sum_probs=165.1

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCch
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL  721 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL  721 (869)
                      +.||+|+||.||+|... +++.||+|.+.... ......|.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999975 68899999876543 33356789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccc-c
Q 002899          722 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI-S  800 (869)
Q Consensus       722 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~  800 (869)
                      .+++....    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.......... .
T Consensus        81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            99986532    25789999999999999999999987   9999999999999999999999999987654321111 0


Q ss_pred             ccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       801 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .....+..|+|||.+..+.++.++||||||+++|||++ |..||..
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~  199 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN  199 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence            11123457999999988889999999999999999998 8888854

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=5.3e-30  Score=276.11  Aligned_cols=201  Identities=31%  Similarity=0.547  Sum_probs=168.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~----~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  710 (869)
                      .++|++.++||+|+||.||+|.+. +++    .||+|++.... .....++..|+.++..++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            456888999999999999999853 444    48999886543 33456788999999999999999999998754 578


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      ++|||+++|+|.+++....    ..+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        85 l~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             EEEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCcee
Confidence            9999999999999986543    25899999999999999999999997   9999999999999999999999999998


Q ss_pred             eecCCCccc-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          791 LYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       791 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ......... .....+++.|+|||...+..++.++||||||+++|||++ |+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  214 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG  214 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            765332211 111234678999999988889999999999999999998 8999864

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=5.7e-30  Score=273.60  Aligned_cols=200  Identities=29%  Similarity=0.410  Sum_probs=169.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-----chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL  709 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~--~~~  709 (869)
                      .+|++.+.||+|+||.||+|... +++.||+|.+....     ....+.+.+|++++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57889999999999999999975 58899999875321     12345788899999999999999999998763  467


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||+++++|.+++....     .+++....+++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~  153 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGAS  153 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccc
Confidence            89999999999999886542     4788899999999999999999987   999999999999999999999999998


Q ss_pred             eeecCCCc--cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKT--HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ........  .......++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  211 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE  211 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence            76542211  111224578899999999888899999999999999999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=5.6e-30  Score=274.16  Aligned_cols=207  Identities=29%  Similarity=0.381  Sum_probs=174.8

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          633 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       633 i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ++.+++++.....||+|+||.||+|... +++.||+|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3556777778889999999999999965 578899999887666667789999999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCcEEEeecCCce
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAK  790 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~-~~~~kl~DFGla~  790 (869)
                      ||||+++++|.+++......  ...++..+..++.|+++||+|||+.+   |+||||||+||+++. ++.++|+|||++.
T Consensus        83 v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGP--LKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEecCCCCCHHHHHHHhccc--CCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            99999999999998654211  12278889999999999999999987   999999999999986 6799999999987


Q ss_pred             eecCCCccccccccccccccchhhcccC--CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          791 LYEEDKTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....... ......+++.|+|||++...  .++.++||||||+++|||++|+.||..
T Consensus       158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~  213 (268)
T cd06624         158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE  213 (268)
T ss_pred             ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence            6543222 12234578899999998654  378899999999999999999999853

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=7.8e-30  Score=271.42  Aligned_cols=193  Identities=28%  Similarity=0.476  Sum_probs=161.9

Q ss_pred             eeeccCceEEEEEEEc---CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCc
Q 002899          645 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC  720 (869)
Q Consensus       645 ~IG~G~fG~Vyka~~~---~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs  720 (869)
                      .||+|+||.||+|.+.   .+..||+|++..... ...++|.+|++++++++||||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999864   355799999876543 33467899999999999999999999886 457899999999999


Q ss_pred             hhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcccc
Q 002899          721 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS  800 (869)
Q Consensus       721 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  800 (869)
                      |.+++....    ..+++..+++++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++...........
T Consensus        81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            999886532    26899999999999999999999987   99999999999999999999999999976543322111


Q ss_pred             --ccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          801 --TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       801 --~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                        ....++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  201 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKK  201 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCc
Confidence              11223578999999988889999999999999999996 9999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=8.9e-30  Score=275.11  Aligned_cols=200  Identities=27%  Similarity=0.414  Sum_probs=171.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999976 58899999886442  2234568899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++++|..++....     .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          81 YCDHTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             ccCccHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            999998887764332     5899999999999999999999987   99999999999999999999999999987654


Q ss_pred             CCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus       153 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~  204 (286)
T cd07847         153 PGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK  204 (286)
T ss_pred             Ccc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            322 1123457789999999875 45788999999999999999999999653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.97  E-value=5.3e-30  Score=274.00  Aligned_cols=203  Identities=26%  Similarity=0.408  Sum_probs=173.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|... +++.||||.+...   .......|.+|+++++.++||||+++++++...+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57889999999999999999965 6899999987542   2333457889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++..... ....+++..+..++.|+++||+|||+++   ++||||||+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          82 ELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            99999999988753221 1235788999999999999999999987   9999999999999999999999999988765


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~  208 (267)
T cd08228         158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             chhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence            33221 1224578899999999888889999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=6.7e-30  Score=277.28  Aligned_cols=200  Identities=29%  Similarity=0.483  Sum_probs=172.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      +.|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56888999999999999999975 58899999998766666778999999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|..++....    ..+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        92 ~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          92 PGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             CCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence            9999988775432    25899999999999999999999987   9999999999999999999999999987543321


Q ss_pred             ccccccccccccccchhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      . ......+++.|+|||++.     ...++.++|||||||++|||++|+.||..
T Consensus       165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  217 (292)
T cd06644         165 Q-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE  217 (292)
T ss_pred             c-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence            1 122345788999999884     34568899999999999999999999854

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=5.4e-30  Score=288.84  Aligned_cols=207  Identities=27%  Similarity=0.437  Sum_probs=172.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCc
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN  707 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~  707 (869)
                      ..++|.+.+.||+|+||.||+|++.      .++.||+|+++.... ...+.+..|++++.++. |||||++++++...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3456778899999999999999864      246799999975433 22457889999999997 999999999999999


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcc--------------------------------------------------------
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTE--------------------------------------------------------  731 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------  731 (869)
                      ..++||||+++|+|.++++.....                                                        
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            999999999999999998754210                                                        


Q ss_pred             -------------------------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 002899          732 -------------------------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL  774 (869)
Q Consensus       732 -------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIL  774 (869)
                                                           ....+++..+..++.|++.||+|||+.+   ++||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence                                                 1124788889999999999999999887   999999999999


Q ss_pred             EcCCCcEEEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          775 LDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       775 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      +++++.+||+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |+.||..
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~  344 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE  344 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence            99999999999999986533221 11122356789999999998889999999999999999998 8888854

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=2.8e-30  Score=288.50  Aligned_cols=198  Identities=26%  Similarity=0.337  Sum_probs=167.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------  706 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~------  706 (869)
                      ..++|++.+.||+|+||.||+|... .++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999864 57899999987542  23346778899999999999999999988643      


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                      ...++||||+++ ++.+.+..       .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeC
Confidence            357999999976 56555532       4788999999999999999999998   999999999999999999999999


Q ss_pred             CCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          787 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       787 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       164 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  221 (355)
T cd07874         164 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_pred             cccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9997654322  223356899999999999888999999999999999999999999653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=5.5e-30  Score=277.73  Aligned_cols=196  Identities=30%  Similarity=0.450  Sum_probs=173.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||++... +++.||+|+++...   ......+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999975 58999999986432   233466889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++++|.+++....     .+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||++....
T Consensus        81 e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~  152 (290)
T cd05580          81 EYVPGGELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVK  152 (290)
T ss_pred             ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence            9999999999886542     6889999999999999999999987   9999999999999999999999999988764


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..    .....+++.|+|||.+.....+.++||||||+++|||++|+.||..
T Consensus       153 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  200 (290)
T cd05580         153 GR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD  200 (290)
T ss_pred             CC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            43    2234688999999999888889999999999999999999999854

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=6.9e-30  Score=271.14  Aligned_cols=199  Identities=32%  Similarity=0.528  Sum_probs=175.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~-g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      .++|++.+.||+|+||.||+|...+ ++.+|+|.+.....  ..++.+|++++++++||||+++++++.+++..++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3678899999999999999999864 78999999865432  67899999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++....    ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++......
T Consensus        80 ~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          80 CGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             CCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            99999999986432    26899999999999999999999987   999999999999999999999999998866543


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .. ......++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~  201 (256)
T cd06612         153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD  201 (256)
T ss_pred             cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            21 12234578899999999888999999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.97  E-value=4.7e-30  Score=280.64  Aligned_cols=206  Identities=29%  Similarity=0.435  Sum_probs=171.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc--------CCcEEEEEEecccC-chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG  706 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~--------~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~  706 (869)
                      .++|.+.+.||+|+||.||+|...        +...+|+|.++... .....++..|++++.++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            467889999999999999999853        23569999987543 33456788899999999 799999999999999


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL  775 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  775 (869)
                      +..++||||+++|+|.+++......           ....+++.+++.++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            9999999999999999999764321           1135899999999999999999999987   9999999999999


Q ss_pred             cCCCcEEEeecCCceeecCCCccc-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          776 DKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       776 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      +.++.+||+|||.+.......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~  245 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  245 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            999999999999987654322111 111224568999999988889999999999999999998 8888854

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=5.7e-30  Score=272.86  Aligned_cols=201  Identities=29%  Similarity=0.485  Sum_probs=172.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .++|++.+.||+|+||.||+|...++..+|+|.++... .....|.+|++++++++|+||+++.+++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46788999999999999999998778889999887542 235678899999999999999999999887 7789999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++.....   ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||.+.......
T Consensus        83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          83 AKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             CCCcHHHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            99999999866432   35789999999999999999999987   9999999999999999999999999987664322


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ........++..|+|||++....++.++|+||||+++|||++ |+.||..
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~  206 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG  206 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence            221222335678999999998889999999999999999998 8999854

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=5.6e-30  Score=278.39  Aligned_cols=205  Identities=29%  Similarity=0.475  Sum_probs=168.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcC---------------CcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSD---------------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYG  701 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~---------------g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~  701 (869)
                      ++|++.+.||+|+||.||+++...               ...||+|.++.... .....|.+|++++++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578899999999999999987532               23589999876532 33457899999999999999999999


Q ss_pred             EEeeCceEEEEEEeccCCchhhhhhcCCcc-------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 002899          702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTE-------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL  774 (869)
Q Consensus       702 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIL  774 (869)
                      ++...+..++||||+++++|.+++......       ....+++..++.++.|+++||+|||+.+   ++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            999999999999999999999988643211       1124789999999999999999999987   999999999999


Q ss_pred             EcCCCcEEEeecCCceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc--CCCCCCC
Q 002899          775 LDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSNTNY  845 (869)
Q Consensus       775 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt--G~~p~~~  845 (869)
                      +++++.+||+|||++......... ......++..|+|||++....++.++||||||+++|||++  |..||..
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            999999999999998765432211 1122345678999999988889999999999999999998  5556643

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=3.2e-30  Score=281.41  Aligned_cols=204  Identities=29%  Similarity=0.464  Sum_probs=169.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCc--EEEEEEecccC-chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGT--VIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~--~VAvK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  711 (869)
                      .++|++.+.||+|+||.||+|.+. ++.  .+|+|.++... ....++|.+|++++.++ +||||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357888999999999999999975 444  46778776532 33456788999999999 89999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 002899          712 VYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN  780 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~  780 (869)
                      ||||+++|+|.+++.....           .....+++.+++.++.|++.|++|||+.+   ++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            9999999999999875431           11235899999999999999999999987   999999999999999999


Q ss_pred             EEEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          781 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       781 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      +||+|||++........  .....++..|+|||++....++.++|||||||++|||++ |+.||..
T Consensus       163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  226 (303)
T cd05088         163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  226 (303)
T ss_pred             EEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc
Confidence            99999999864321111  111224568999999988889999999999999999998 9999854

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=5.1e-30  Score=278.97  Aligned_cols=203  Identities=30%  Similarity=0.460  Sum_probs=168.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcC-C--cEEEEEEeccc-CchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSD-G--TVIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~-g--~~VAvK~~~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ++|++.++||+|+||.||+|...+ +  ..+++|.++.. .....+.|..|++++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999998753 3  34788888753 233456789999999999 799999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcE
Q 002899          713 YEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA  781 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~  781 (869)
                      |||+++|+|.+++......           ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            9999999999998654211           1125889999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          782 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       782 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ||+|||++........  ......+..|+|||++....++.++|||||||++|||++ |+.||..
T Consensus       159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~  221 (297)
T cd05089         159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG  221 (297)
T ss_pred             EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            9999999864321111  111123457999999988889999999999999999997 9999854

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=4.4e-30  Score=278.18  Aligned_cols=207  Identities=29%  Similarity=0.439  Sum_probs=171.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~~------g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~  708 (869)
                      .+++|++.+.||+|+||.||+|...+      +..||+|.+.... .....++.+|+.++++++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            46789999999999999999997542      4579999886543 2234568889999999999999999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEE
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTE-----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI  783 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl  783 (869)
                      .++||||+++|+|.+++......     .....++..+..++.|++.||+|||+++   |+||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            99999999999999998653211     1234678889999999999999999987   999999999999999999999


Q ss_pred             eecCCceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          784 SDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       784 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      +|||+++........ ......++..|+|||.+....++.++|||||||++|||++ |+.||..
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~  224 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG  224 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence            999998765432211 1112235678999999988889999999999999999998 7888854

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.3e-30  Score=277.81  Aligned_cols=201  Identities=27%  Similarity=0.492  Sum_probs=174.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      .++|++.+.||+|+||.||+|... +++.||+|.+..........|..|++++++++||||+++++++..++..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            456888999999999999999975 6889999998766666667899999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++...+    ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++......
T Consensus        84 ~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          84 CDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             cCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            99999999886532    25899999999999999999999998   999999999999999999999999988655432


Q ss_pred             Cccccccccccccccchhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .. ......+++.|+|||++.     ...++.++||||||+++|||++|+.||..
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~  210 (280)
T cd06611         157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE  210 (280)
T ss_pred             cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence            22 122346888999999875     34567899999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.97  E-value=6.5e-30  Score=273.58  Aligned_cols=201  Identities=30%  Similarity=0.496  Sum_probs=170.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-C---CcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-D---GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~---g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .+|++.+.||+|+||.||+|+.. +   +..+|+|.++... ....+.|..|+.++.+++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788999999999999999864 2   3479999887543 23356789999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++++|.+++....    ..+++.++..++.|++.|++|||+.+   ++||||||+|||++.++.++++|||++...
T Consensus        84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          84 TEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            99999999999986543    25799999999999999999999987   999999999999999999999999999876


Q ss_pred             cCCCccccc--cccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          793 EEDKTHIST--RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .........  ...++..|+|||++....++.++||||||+++||+++ |+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~  212 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE  212 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence            543322111  1223568999999998889999999999999999886 9999854

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=4.6e-30  Score=292.99  Aligned_cols=193  Identities=24%  Similarity=0.295  Sum_probs=166.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ..+|.+.+.||+|+||.||+|... .++.||||...      ...+.+|++++++++|+|||++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457889999999999999999976 47889999642      23467899999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +. ++|.+++....    ..++|..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       242 ~~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        242 YR-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             cC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            95 67877775432    26899999999999999999999998   999999999999999999999999999876432


Q ss_pred             Cc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 002899          796 KT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       796 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~  843 (869)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            21 1222357999999999999989999999999999999999988765

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=9.3e-30  Score=272.91  Aligned_cols=203  Identities=28%  Similarity=0.455  Sum_probs=165.5

Q ss_pred             CCCCCeeeccCceEEEEEEEcC-Cc--EEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------ce
Q 002899          640 FDPANKVGEGGFGSVYKGILSD-GT--VIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQ  708 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~~-g~--~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~------~~  708 (869)
                      |.+.++||+|+||.||+|...+ +.  .||+|.++..  .....+.|..|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567889999999999999754 32  5899988654  234456788999999999999999999987532      24


Q ss_pred             EEEEEEeccCCchhhhhhcCC-cccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                      .++||||+++|+|.+++.... ......+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            689999999999988774322 112235899999999999999999999987   9999999999999999999999999


Q ss_pred             CceeecCCCccc-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          788 LAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       788 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      +++.+....... .....+++.|+|||+.....++.++||||||+++|||++ |+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  217 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG  217 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            998764332211 122345678999999998899999999999999999999 8888854

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=6.1e-30  Score=279.32  Aligned_cols=208  Identities=27%  Similarity=0.434  Sum_probs=173.2

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc--------CCcEEEEEEecccC-chhhHHHHHHHHHHHhc-CCCceeeEEeEEe
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCV  704 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~--------~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~  704 (869)
                      ...++|.+.+.||+|+||.||+|+..        ++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34567888999999999999999741        24579999887543 34456789999999999 8999999999999


Q ss_pred             eCceEEEEEEeccCCchhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCE
Q 002899          705 EGNQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV  773 (869)
Q Consensus       705 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NI  773 (869)
                      ..+..++||||+++|+|.+++......           ....+++.++..++.||++||+|||+++   ++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence            999999999999999999998754321           1235889999999999999999999997   99999999999


Q ss_pred             EEcCCCcEEEeecCCceeecCCCccc-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          774 LLDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       774 Ll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ++++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  242 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  242 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            99999999999999998765432211 122345678999999988889999999999999999998 7888754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.97  E-value=7.4e-30  Score=271.01  Aligned_cols=200  Identities=24%  Similarity=0.345  Sum_probs=173.3

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc-CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      +|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+..|+.+++.++||||+++++++..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999975 6889999988643 2334567888999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++|+|.+++.....   ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++++|||++.......
T Consensus        81 ~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          81 DGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             CCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            99999988754322   25789999999999999999999987   9999999999999999999999999997665332


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      . ......|++.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus       155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~  202 (255)
T cd08219         155 A-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA  202 (255)
T ss_pred             c-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC
Confidence            2 22235688899999999888899999999999999999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=4.6e-30  Score=276.08  Aligned_cols=206  Identities=28%  Similarity=0.443  Sum_probs=173.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~------g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~  709 (869)
                      .++|.+.+.||+|+||.||+|...+      +..||+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4578889999999999999998642      3689999986543 23456788999999999999999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEe
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTE-----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS  784 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~  784 (869)
                      ++||||+++|+|.+++......     ....++|..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            9999999999999998654321     1224789999999999999999999987   9999999999999999999999


Q ss_pred             ecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          785 DFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       785 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      |||+++....... .......++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  224 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG  224 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc
Confidence            9999876543321 11222346789999999988889999999999999999998 9988854

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=288.92  Aligned_cols=191  Identities=30%  Similarity=0.510  Sum_probs=167.1

Q ss_pred             CCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          640 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      |.-.+.||.|+||.||-|+. .+..+||||++.-..   .....+++.|++.|.+++|||+|.+.|||..+...||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            44467799999999999995 478899999886443   33356889999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      |- ||-.+++.-.+    .++.+-.+..|+.+.+.||+|||+.+   .||||||+.||||++.|.+||+|||.|.++.+.
T Consensus       108 Cl-GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  108 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             Hh-ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence            96 57888775432    37889999999999999999999997   899999999999999999999999999877654


Q ss_pred             Cccccccccccccccchhhcc---cCCCCchhHHHHHHHHHHHHHcCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltG~~p~  843 (869)
                      .     .++|||.|||||++.   .+.|+-|+||||+||...||...++|.
T Consensus       180 n-----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl  225 (948)
T KOG0577|consen  180 N-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL  225 (948)
T ss_pred             h-----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence            3     468999999999985   468999999999999999999999985

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=8.6e-30  Score=272.17  Aligned_cols=199  Identities=29%  Similarity=0.493  Sum_probs=171.7

Q ss_pred             CCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccC------chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS------RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~------~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      +|++.+.||+|+||.||+|...+++.+|+|.+....      ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998889999999886432      12235688899999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++++|.+++....     .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++...
T Consensus        81 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          81 MEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            99999999999986542     5789999999999999999999987   999999999999999999999999998754


Q ss_pred             cCCC-----ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDK-----THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....     ........++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~  210 (265)
T cd06631         153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS  210 (265)
T ss_pred             hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence            3211     1112234588899999999988899999999999999999999999954

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=9.5e-30  Score=272.78  Aligned_cols=203  Identities=30%  Similarity=0.452  Sum_probs=167.9

Q ss_pred             CCCCCeeeccCceEEEEEEEcC----CcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce-----
Q 002899          640 FDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ-----  708 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~~----g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~-----  708 (869)
                      |++.+.||+|+||.||+|....    +..||+|+++...  ......+..|+++++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998642    3679999987542  2334678999999999999999999998876554     


Q ss_pred             -EEEEEEeccCCchhhhhhcCCcc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          709 -LLLVYEYMKNNCLSRAIFGKDTE-YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       709 -~~lV~E~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                       .++||||+++|+|..++...... ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             79999999999999888553211 2236899999999999999999999987   999999999999999999999999


Q ss_pred             CCceeecCCCccc-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          787 GLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       787 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      |+++......... .....++..|+|||.+....++.++||||||+++|||++ |..||..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~  218 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG  218 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            9998765433221 111234678999999988889999999999999999999 8888854

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=9.6e-30  Score=270.61  Aligned_cols=192  Identities=30%  Similarity=0.468  Sum_probs=162.4

Q ss_pred             eeeccCceEEEEEEEc---CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCC
Q 002899          645 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN  719 (869)
Q Consensus       645 ~IG~G~fG~Vyka~~~---~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g  719 (869)
                      +||+|+||.||+|.++   +++.+|+|+++...  ....+++..|+.+++.++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   57889999886543  233567899999999999999999999875 45678999999999


Q ss_pred             chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccc
Q 002899          720 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI  799 (869)
Q Consensus       720 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  799 (869)
                      +|.+++....     .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            9999885432     5889999999999999999999987   9999999999999999999999999998765433211


Q ss_pred             --cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          800 --STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       800 --~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                        .....++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  201 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG  201 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence              112234578999999988889999999999999999998 9999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=9.2e-30  Score=271.72  Aligned_cols=190  Identities=27%  Similarity=0.414  Sum_probs=160.4

Q ss_pred             CeeeccCceEEEEEEEcC-------------CcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEE
Q 002899          644 NKVGEGGFGSVYKGILSD-------------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~-------------g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  710 (869)
                      +.||+|+||.||+|.+..             ...||+|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2358899887665555668889999999999999999999999999999


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc-------EEE
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-------AKI  783 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~-------~kl  783 (869)
                      +||||+++|+|..++....    ..+++..+.+++.||++||+|||+.+   |+||||||+|||++.++.       +++
T Consensus        81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence            9999999999988876532    25899999999999999999999987   999999999999987664       899


Q ss_pred             eecCCceeecCCCccccccccccccccchhhcc-cCCCCchhHHHHHHHHHHHHH-cCCCCCCC
Q 002899          784 SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIV-SGKSNTNY  845 (869)
Q Consensus       784 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvil~ell-tG~~p~~~  845 (869)
                      +|||++.......     ...++..|+|||.+. ...++.++|||||||++|||+ +|+.|+..
T Consensus       154 ~d~g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~  212 (262)
T cd05077         154 SDPGIPITVLSRQ-----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD  212 (262)
T ss_pred             CCCCCCccccCcc-----cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999986553221     235778999999886 467899999999999999998 58888754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=9.7e-30  Score=272.23  Aligned_cols=202  Identities=30%  Similarity=0.522  Sum_probs=171.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CC---cEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DG---TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g---~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      +++|+..+.||+|+||.||+|... ++   ..+|+|.++... ....+++..|++++.+++||||+++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            457888999999999999999975 33   379999886553 3345678999999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++++|.+++....    ..+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        84 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          84 ITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcccee
Confidence            999999999999986542    25899999999999999999999987   99999999999999999999999999876


Q ss_pred             ecCCCccccc--cccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          792 YEEDKTHIST--RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ..........  ....++.|+|||++....++.++|||||||++|||++ |+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~  213 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD  213 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence            6433221111  1223457999999988889999999999999999997 9999854

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=4.8e-30  Score=285.19  Aligned_cols=198  Identities=28%  Similarity=0.407  Sum_probs=167.7

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC----
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG----  706 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~----  706 (869)
                      ....++|.+.+.||+|+||.||+|... +++.||||++....  ....+.+.+|++++++++||||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            345678999999999999999999864 67899999986542  22345678899999999999999999887543    


Q ss_pred             --ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEe
Q 002899          707 --NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS  784 (869)
Q Consensus       707 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~  784 (869)
                        ...++++|++ +++|.+++...      .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEc
Confidence              3578999987 67888777432      5899999999999999999999998   9999999999999999999999


Q ss_pred             ecCCceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          785 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       785 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |||++.......    ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus       161 Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         161 DFGLARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             CCccceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999998654322    23468999999999876 5689999999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=4e-30  Score=279.09  Aligned_cols=209  Identities=28%  Similarity=0.433  Sum_probs=173.9

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEecccC-chhhHHHHHHHHHHHhc-CCCceeeEEeEEee
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE  705 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~~~------g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~  705 (869)
                      ....++|++.+.||+|+||.||+|....      ...+|+|.+.... .....++.+|++++.++ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            3445678889999999999999998642      3679999987543 23346788999999999 89999999999999


Q ss_pred             CceEEEEEEeccCCchhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 002899          706 GNQLLLVYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL  774 (869)
Q Consensus       706 ~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIL  774 (869)
                      ++..++||||+++|+|..++.....           .....+++..++.++.|++.||+|||+.+   |+||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence            9999999999999999999865321           12346899999999999999999999987   999999999999


Q ss_pred             EcCCCcEEEeecCCceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          775 LDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       775 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ++.++.+||+|||+++.+...... ......++..|+|||++....++.++|||||||++|||++ |..||..
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  237 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG  237 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence            999999999999999876543221 1112234568999999988889999999999999999997 8888854

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=7.8e-30  Score=275.42  Aligned_cols=197  Identities=31%  Similarity=0.472  Sum_probs=166.5

Q ss_pred             CCCCCeeeccCceEEEEEEE-----cCCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceEEE
Q 002899          640 FDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLL  711 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~-----~~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l  711 (869)
                      |+..+.||+|+||+||++..     .+++.||+|.++.... .....|.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37889999999999988653     3578899999876532 3456788999999999999999999988753  35789


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++++|.+++...      .+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++..
T Consensus        86 v~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccc
Confidence            99999999999988643      4899999999999999999999997   99999999999999999999999999987


Q ss_pred             ecCCCccc--cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHI--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ........  .....++..|+|||.+....++.++||||||+++|||++|+.|+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  212 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS  212 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence            65432211  1122356679999999888899999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=1.3e-29  Score=271.08  Aligned_cols=200  Identities=30%  Similarity=0.434  Sum_probs=169.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-----chhhHHHHHHHHHHHhcCCCceeeEEeEEee--CceE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQL  709 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~--~~~~  709 (869)
                      .+|+..+.||+|+||.||+|... +++.||+|++....     ......+.+|+.++++++||||+++++++.+  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47889999999999999999975 58899999875432     2234568889999999999999999998875  3577


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      +++|||+++++|.+++....     .+++.....++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||++
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~  153 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS  153 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCc
Confidence            89999999999999886543     4789999999999999999999987   999999999999999999999999998


Q ss_pred             eeecCCCc--cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKT--HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ........  .......++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~  211 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE  211 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence            76532111  111224578899999999888899999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=1.1e-29  Score=279.06  Aligned_cols=197  Identities=25%  Similarity=0.421  Sum_probs=159.4

Q ss_pred             CCeeeccCceEEEEEEEc---CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEee--CceEEEEEEecc
Q 002899          643 ANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLVYEYMK  717 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~---~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~E~~~  717 (869)
                      ..+||+|+||.||+|+..   +++.||+|.+....  ....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999965   35789999886542  23567889999999999999999998854  567899999988


Q ss_pred             CCchhhhhhcCC----cccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE----cCCCcEEEeecCCc
Q 002899          718 NNCLSRAIFGKD----TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLA  789 (869)
Q Consensus       718 ~gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl----~~~~~~kl~DFGla  789 (869)
                      + +|.+.+....    ......+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 6666654221    112235889999999999999999999987   9999999999999    56679999999999


Q ss_pred             eeecCCCcc--ccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKTH--ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +........  ......+|+.|+|||++.+ ..++.++|||||||++|||++|++||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            876543221  1223568999999999876 4579999999999999999999999964

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-30  Score=275.29  Aligned_cols=211  Identities=26%  Similarity=0.382  Sum_probs=178.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ..-|+..+.||+|.|..|-.|++- +|..||||++.+..-  .....+.+|+++|+.++|||||++|++...+-.+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            345677788999999999999853 799999999976533  23456889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-CCCcEEEeecCCceee
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLY  792 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~-~~~~~kl~DFGla~~~  792 (869)
                      |.=++|+|.+++..++.    .+.+..+.+++.||+.|+.|+|+.+   +|||||||+||.+- .-|-+||.|||++..+
T Consensus        97 ELGD~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EecCCchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccC
Confidence            99999999999987653    6899999999999999999999997   99999999998885 4688999999999877


Q ss_pred             cCCCccccccccccccccchhhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHH
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA  858 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~  858 (869)
                      .+...  -+..+|+..|-|||++.+..| .+++||||||||||-|++|++||+..  ++.+.|-..+
T Consensus       170 ~PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA--NDSETLTmIm  232 (864)
T KOG4717|consen  170 QPGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA--NDSETLTMIM  232 (864)
T ss_pred             CCcch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc--cchhhhhhhh
Confidence            65432  234689999999999988755 56899999999999999999999743  3444444433

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=4.9e-30  Score=276.91  Aligned_cols=204  Identities=31%  Similarity=0.448  Sum_probs=169.0

Q ss_pred             CCCCCCeeeccCceEEEEEEEcC------CcEEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~~------g~~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      +|.+.+.||+|+||.||+|...+      ++.||+|+++..... ....|.+|+.++..++||||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            35667889999999999998632      478999998755433 24568899999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 002899          712 VYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN  780 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~  780 (869)
                      ++||+++++|.+++.....           .....+++..+..++.|++.||+|||+.+   |+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            9999999999988853211           11235889999999999999999999987   999999999999999999


Q ss_pred             EEEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          781 AKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       781 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      +||+|||+++....... .......+++.|+|||++....++.++||||||+++|||++ |..||..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  229 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG  229 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999876543221 11122345779999999988889999999999999999998 8878754

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=1.5e-29  Score=270.34  Aligned_cols=203  Identities=29%  Similarity=0.453  Sum_probs=175.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|... +++.||+|.++..   .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999976 7899999988642   2233567889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++.... .....+++.++..++.++++||.|||+.+   ++||||+|+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          82 ELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             ecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            9999999999886432 12235899999999999999999999987   9999999999999999999999999987654


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       158 ~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  208 (267)
T cd08224         158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             CCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence            32221 1234578899999999888899999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=1.3e-29  Score=275.73  Aligned_cols=205  Identities=28%  Similarity=0.484  Sum_probs=170.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-----------------CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-----------------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL  699 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-----------------~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l  699 (869)
                      ++|++.+.||+|+||.||++...                 ++..||+|++.... .....+|.+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56889999999999999998642                 23468999987543 3345678999999999999999999


Q ss_pred             EeEEeeCceEEEEEEeccCCchhhhhhcCCcc------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCE
Q 002899          700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTE------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV  773 (869)
Q Consensus       700 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NI  773 (869)
                      ++++..++..++||||+++|+|.+++......      ....+++.++..++.|++.||+|||+.+   ++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            99999999999999999999999988654321      1235788999999999999999999997   99999999999


Q ss_pred             EEcCCCcEEEeecCCceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc--CCCCCCC
Q 002899          774 LLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSNTNY  845 (869)
Q Consensus       774 Ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt--G~~p~~~  845 (869)
                      |++.++.++|+|||+++.+...... ......+++.|+|||....+.++.++|||||||++|||++  |..||..
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            9999999999999998765432211 1112234678999999888889999999999999999998  6677754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-29  Score=272.34  Aligned_cols=198  Identities=29%  Similarity=0.493  Sum_probs=174.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|++.+.||.|+||.||+|... +++.||+|.+.... ......+..|+++++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36778899999999999999975 68899999986543 33456788999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++...      .+++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          81 CGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             eCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            9999999988653      6899999999999999999999987   999999999999999999999999999877543


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ... .....+++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       152 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~  200 (274)
T cd06609         152 MSK-RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD  200 (274)
T ss_pred             ccc-cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            221 2234678899999999988899999999999999999999999854

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=1.4e-29  Score=270.67  Aligned_cols=199  Identities=31%  Similarity=0.525  Sum_probs=170.5

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch---------hhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ---------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~---------~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~  708 (869)
                      +|.+.+.||+|+||.||+|... +++.||+|.+......         ..+.+.+|++++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677889999999999999864 5789999988654322         12467889999999999999999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .++||||+++++|.+++....     .+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~  152 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGI  152 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCC
Confidence            999999999999999986542     5788999999999999999999987   99999999999999999999999999


Q ss_pred             ceeecCCCc-----cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          789 AKLYEEDKT-----HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       789 a~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ++.......     .......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  214 (267)
T cd06628         153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD  214 (267)
T ss_pred             CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence            887653211     011124578899999999888899999999999999999999999964

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-31  Score=284.20  Aligned_cols=208  Identities=26%  Similarity=0.446  Sum_probs=180.3

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceE
Q 002899          631 RQIKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       631 ~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~~-g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~  709 (869)
                      .+++....+....++||-|.||.||.|+|+. .-.||||.++.. .....+|+.|+.+|+.++|||+|+++|+|..+..+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            4555555567788999999999999999974 567999999864 44578999999999999999999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      |||+|||..|+|.++|...+..   .++--..+.++.||+.||+||..++   +|||||.++|+|+.++..+||+|||++
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchh
Confidence            9999999999999999876533   5666778999999999999999887   999999999999999999999999999


Q ss_pred             eeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          790 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      +++..+.........-.+.|.|||-+....++.|+|||+|||+|||+.| |-.|+..
T Consensus       413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG  469 (1157)
T KOG4278|consen  413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG  469 (1157)
T ss_pred             hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence            9997665433333334679999999999999999999999999999988 7777743

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=1.7e-29  Score=272.88  Aligned_cols=200  Identities=27%  Similarity=0.449  Sum_probs=168.4

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +|++.+.||+|++|.||+|+.. +++.||+|+++...  ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999975 68899999886432  22346788899999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      ++ ++|.+++.....  ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          81 LS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             CC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence            98 578777754321  236899999999999999999999987   999999999999999999999999998765432


Q ss_pred             Cccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .. ......+++.|+|||++.+ ..++.++||||||+++|||++|++||..
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~  204 (285)
T cd07861         155 VR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG  204 (285)
T ss_pred             cc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            21 1122356889999998765 4578899999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.5e-29  Score=268.81  Aligned_cols=198  Identities=32%  Similarity=0.544  Sum_probs=172.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .++|++.+.||+|+||.||+|... ++.||+|.++.... ..+++.+|+.++.+++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357888999999999999999875 78899999976544 5678999999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++.....   ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||.++......
T Consensus        83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          83 AKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            99999999865432   25899999999999999999999998   9999999999999999999999999998664322


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      .    ....+..|+|||++....++.++||||||++++||++ |+.||...
T Consensus       157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  203 (256)
T cd05039         157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  203 (256)
T ss_pred             c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence            1    1234568999999988889999999999999999997 99998543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-29  Score=270.13  Aligned_cols=200  Identities=28%  Similarity=0.464  Sum_probs=175.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      ++|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++...+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888999999999999999975 57889999987665556678999999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++....    ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        83 ~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          83 GGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            9999999886542    25889999999999999999999987   9999999999999999999999999987654322


Q ss_pred             ccccccccccccccchhhcccC---CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRG---YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      . ......++..|+|||.+...   .++.++||||||+++|||++|+.||..
T Consensus       156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~  206 (262)
T cd06613         156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD  206 (262)
T ss_pred             h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            1 12234678899999998776   789999999999999999999999854

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=6.1e-30  Score=304.95  Aligned_cols=208  Identities=25%  Similarity=0.400  Sum_probs=170.5

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEee--CceE
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQL  709 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~--~~~~  709 (869)
                      ...++|.+.+.||+|+||+||+|... +++.||+|.+...  .......|..|+.++..++|||||++++++..  .+.+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34568999999999999999999975 5678999988643  23345678999999999999999999998865  4568


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEEcCCCCCCEEEcCC-------
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR----IKIVHRDIKTSNVLLDKD-------  778 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~iiH~Dlk~~NILl~~~-------  778 (869)
                      |+||||+++|+|.++|..... ....+++..++.|+.||+.||+|||+.+.    .+||||||||+||||+.+       
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            999999999999998865321 12368999999999999999999998542    249999999999999643       


Q ss_pred             ----------CcEEEeecCCceeecCCCccccccccccccccchhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          779 ----------LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       779 ----------~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                                ..+||+|||++..+....  ......||+.|+|||++..  ..++.++|||||||++|||++|+.||..
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                      348999999998664322  1233568999999999854  4588999999999999999999999964

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=8.8e-30  Score=272.81  Aligned_cols=200  Identities=31%  Similarity=0.537  Sum_probs=168.9

Q ss_pred             CCCCCCeeeccCceEEEEEEEcC-C---cEEEEEEeccc-CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILSD-G---TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~~-g---~~VAvK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      .|++.+.||+|+||.||+|.... +   ..||||.++.. ......+|..|+.+++.++||||+++++++..++..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46788999999999999999753 3   36999998765 3334568999999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....    ..+++.+++.++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        85 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          85 EFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             ecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999886543    25899999999999999999999987   9999999999999999999999999987654


Q ss_pred             CCCccc--ccccc--ccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          794 EDKTHI--STRIA--GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       794 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ......  .....  .+..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~  214 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD  214 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence            322211  11111  1357999999998899999999999999999886 9999854

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=1.9e-29  Score=267.96  Aligned_cols=200  Identities=28%  Similarity=0.456  Sum_probs=174.4

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +|+..+.||+|+||.||.+... +++.+++|.+...  .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4788999999999999998854 6888999987644  234456789999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++....   ...+++..+..++.|+++||+|||+.+   ++||||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            99999999986542   236899999999999999999999987   999999999999999999999999999876543


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .. ......+++.|+|||++.+...+.++||||||+++|||++|+.||..
T Consensus       155 ~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08221         155 YS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA  203 (256)
T ss_pred             cc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence            32 22335688999999999888889999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=9.5e-30  Score=273.50  Aligned_cols=190  Identities=25%  Similarity=0.383  Sum_probs=158.9

Q ss_pred             eeeccCceEEEEEEEcC-------------------------CcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeE
Q 002899          645 KVGEGGFGSVYKGILSD-------------------------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL  699 (869)
Q Consensus       645 ~IG~G~fG~Vyka~~~~-------------------------g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l  699 (869)
                      .||+|+||.||+|.+..                         ...||+|++.........+|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997521                         13589999876655556788999999999999999999


Q ss_pred             EeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC
Q 002899          700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL  779 (869)
Q Consensus       700 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~  779 (869)
                      ++++.+....++||||+++|+|..++....    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~  154 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG  154 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence            999999999999999999999998886532    25789999999999999999999987   99999999999997643


Q ss_pred             -------cEEEeecCCceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHH-HcCCCCCCCC
Q 002899          780 -------NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEI-VSGKSNTNYR  846 (869)
Q Consensus       780 -------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~el-ltG~~p~~~~  846 (869)
                             .+|++|||++.......     ...++..|+|||.+.. ..++.++||||||+++||| ++|+.||...
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  225 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER  225 (274)
T ss_pred             cccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence                   37999999876442211     1246778999998865 5689999999999999998 5799998653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.97  E-value=1e-29  Score=277.26  Aligned_cols=203  Identities=29%  Similarity=0.436  Sum_probs=171.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCc-hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCce
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~  708 (869)
                      .++|.+.+.||+|+||.||+|...      .+..||||+++.... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            457889999999999999999742      345799999875532 3346788999999999 79999999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .++||||+++|+|.+++.....   ..+++.++..++.|++.||+|||+.+   ++|+||||+|||++.++.++++|||+
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence            9999999999999999875432   24899999999999999999999987   99999999999999999999999999


Q ss_pred             ceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          789 AKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       789 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      +......... ......++..|+|||++....++.++||||+||++|||++ |+.||..
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~  246 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG  246 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence            8765433221 1112345678999999998889999999999999999998 9999854

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=1.7e-29  Score=275.95  Aligned_cols=200  Identities=23%  Similarity=0.376  Sum_probs=171.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||++... .++.||+|.+....   ......+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999975 57889999886543   233457889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++++|.+++....     .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        81 e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~  152 (305)
T cd05609          81 EYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGL  152 (305)
T ss_pred             ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence            9999999999986542     5899999999999999999999987   9999999999999999999999999986421


Q ss_pred             CCCc--------------cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKT--------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....              .......++..|+|||.+....++.++|+||||+++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~  218 (305)
T cd05609         153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG  218 (305)
T ss_pred             cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            1100              001123578899999999888899999999999999999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=9.3e-30  Score=272.13  Aligned_cols=203  Identities=28%  Similarity=0.442  Sum_probs=174.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|.. .+++.+|||.+...   ......++.+|+++++.++||||+++++++.+++..++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677889999999999999996 47899999987643   2233467889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++++|.+++..... ....+++..+..++.|+++||+|||+++   ++|+||||+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          82 ELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            99999999998864221 2236899999999999999999999988   9999999999999999999999999987664


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..... .....++..|+|||.+....++.++||||||+++|||++|+.||..
T Consensus       158 ~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  208 (267)
T cd08229         158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             cCCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence            33221 1234578899999999888899999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=1.1e-29  Score=274.55  Aligned_cols=198  Identities=28%  Similarity=0.468  Sum_probs=171.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+..|++++..++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46778899999999999999965 68899999876543 33457889999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++...+     .+++..+..++.+++.||.|||+..  .++||||+|+||+++.++.++|+|||++......
T Consensus        85 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          85 MDCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             CCCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            99999998886532     5899999999999999999999742  2999999999999999999999999998654322


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .   .....|+..|+|||++....++.++|||||||++|||++|+.||..
T Consensus       158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~  204 (284)
T cd06620         158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF  204 (284)
T ss_pred             c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence            1   1234688999999999888899999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=1.3e-29  Score=271.67  Aligned_cols=201  Identities=29%  Similarity=0.424  Sum_probs=169.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcC----CcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~----g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ++|.+.+.||+|+||.||+|...+    ...||||...... ....+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788999999999999998643    2468999887654 3445689999999999999999999998875 567899


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++|+|.+++....    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++..
T Consensus        85 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          85 MELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence            99999999999986542    25899999999999999999999987   999999999999999999999999998876


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      ............++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~  212 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV  212 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence            5433222222334568999999988889999999999999999996 99998643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.97  E-value=1.7e-29  Score=268.28  Aligned_cols=197  Identities=32%  Similarity=0.512  Sum_probs=171.6

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-----chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      +|+..+.||+|+||.||+|... +++.|++|.+....     ....+.+..|+++++.++|+||+++++++..++..++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999976 78999999876433     23456788999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++++|.+++....     .+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.+||+|||++...
T Consensus        81 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~  152 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQV  152 (258)
T ss_pred             EEecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceec
Confidence            99999999999986542     5789999999999999999999987   999999999999999999999999998765


Q ss_pred             cCCCccccccccccccccchhhcccCC-CCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....  ......++..|+|||.+.... ++.++|+||||+++|||++|+.||..
T Consensus       153 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~  204 (258)
T cd06632         153 VEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ  204 (258)
T ss_pred             cccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            4332  122345788999999987666 89999999999999999999999854

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-29  Score=277.77  Aligned_cols=202  Identities=26%  Similarity=0.360  Sum_probs=173.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch---hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~---~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|+..+.||+|+||.||+|... +++.||+|.+......   ..+.+..|++++..++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            46888899999999999999976 4899999998754322   4567889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+.+++|.+++....   ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++....
T Consensus        81 e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          81 DYCPGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EecCCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            9999999999886432   236899999999999999999999987   9999999999999999999999999987553


Q ss_pred             CCCcc----------------------------ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTH----------------------------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .....                            ......|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  234 (316)
T cd05574         155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG  234 (316)
T ss_pred             ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence            22110                            01124578899999999988899999999999999999999999864

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=1.5e-29  Score=271.94  Aligned_cols=205  Identities=25%  Similarity=0.395  Sum_probs=172.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  710 (869)
                      ++|++.+.||+|+||.||+|...      +.+.|++|.+...... ...++..|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888999999999999999964      2467999988654433 3567999999999999999999999999999999


Q ss_pred             EEEEeccCCchhhhhhcCCccc----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                      +||||+++|+|.+++.......    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999987543211    125899999999999999999999998   999999999999999999999999


Q ss_pred             CCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          787 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       787 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      |++...............++..|+|||.+.....+.++||||||+++|||++ |..||..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~  221 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG  221 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            9986543322222223356778999999988888999999999999999999 7788853

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=6.7e-30  Score=278.04  Aligned_cols=193  Identities=28%  Similarity=0.508  Sum_probs=168.7

Q ss_pred             CCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCch
Q 002899          643 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL  721 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL  721 (869)
                      ...||+|+||.||+|... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++||||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            456999999999999865 6889999998765555566788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccccc
Q 002899          722 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST  801 (869)
Q Consensus       722 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  801 (869)
                      .+++...      .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++......... ..
T Consensus       106 ~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~  175 (297)
T cd06659         106 TDIVSQT------RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RK  175 (297)
T ss_pred             HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc-cc
Confidence            9877432      4789999999999999999999987   999999999999999999999999998755432211 12


Q ss_pred             cccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       802 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  219 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS  219 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            34688999999999988899999999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=1.6e-29  Score=274.13  Aligned_cols=200  Identities=24%  Similarity=0.414  Sum_probs=168.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999976 688999999865432 2234577899999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++ +|.+++....    ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~~-~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          85 LDT-DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             CCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            985 8988876543    25789999999999999999999987   999999999999999999999999998754322


Q ss_pred             Cccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .. ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||...
T Consensus       157 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  207 (291)
T cd07844         157 SK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS  207 (291)
T ss_pred             Cc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            11 1112346789999998865 45789999999999999999999999643

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=3.5e-29  Score=266.83  Aligned_cols=212  Identities=29%  Similarity=0.468  Sum_probs=181.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|++.+.||+|++|.||+|... +++.||||++..... ....++..|++++.+++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46888999999999999999976 589999999876543 4467899999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      +++++|.+++...     ..+++..+..++.|+++|++|||+ .+   ++||||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999998654     268999999999999999999999 87   99999999999999999999999999987654


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHH
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA  858 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~  858 (869)
                      ..... ....++..|+|||.+....++.++||||||+++|||++|+.||......+..++.+++
T Consensus       153 ~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~  215 (264)
T cd06623         153 TLDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI  215 (264)
T ss_pred             CCCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH
Confidence            33221 2345788999999999888999999999999999999999999654322334444443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=1.5e-29  Score=275.00  Aligned_cols=205  Identities=30%  Similarity=0.485  Sum_probs=172.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC-----------------CcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceee
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD-----------------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVK  698 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~-----------------g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~  698 (869)
                      ..+|++.+.||+|+||.||+|...+                 +..||+|.+.... .....+|.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578899999999999999988642                 2468999987553 334567889999999999999999


Q ss_pred             EEeEEeeCceEEEEEEeccCCchhhhhhcCCccc------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCC
Q 002899          699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN  772 (869)
Q Consensus       699 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~N  772 (869)
                      +++++..++..++||||+++++|.+++.......      ...+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999987654221      226899999999999999999999987   9999999999


Q ss_pred             EEEcCCCcEEEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc--CCCCCC
Q 002899          773 VLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSNTN  844 (869)
Q Consensus       773 ILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt--G~~p~~  844 (869)
                      |+++.++.++|+|||+++....... .......+++.|+|||++....++.++||||||+++|||++  |..||.
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            9999999999999999876543221 11223446779999999988889999999999999999998  666664

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=2e-29  Score=273.30  Aligned_cols=202  Identities=27%  Similarity=0.423  Sum_probs=168.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++++|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|+++++.++|+||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3578999999999999999999864 6889999998654332 2346788999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||++ +++.+.+....    ..+.+..+..++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||+++...
T Consensus        83 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          83 EYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             eccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            9996 56666664432    24788889999999999999999987   9999999999999999999999999987643


Q ss_pred             CCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ..... .....+++.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus       155 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~  207 (291)
T cd07870         155 IPSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV  207 (291)
T ss_pred             CCCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            32211 1223568899999988753 5788999999999999999999999643

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=1.7e-29  Score=278.73  Aligned_cols=198  Identities=19%  Similarity=0.272  Sum_probs=163.9

Q ss_pred             CCCeeecc--CceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          642 PANKVGEG--GFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       642 ~~~~IG~G--~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      +.++||+|  +|++||++... +|+.||+|++.....  ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  67899999864 789999999875432  22345778999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++|+|.+++.....   ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.++++||+.+.......
T Consensus        82 ~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          82 AYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             CCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            99999998865322   25899999999999999999999987   9999999999999999999999998654332111


Q ss_pred             cc------ccccccccccccchhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 TH------ISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~------~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..      ......++..|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            10      0111346678999999875  4588999999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=1.7e-29  Score=268.53  Aligned_cols=195  Identities=29%  Similarity=0.475  Sum_probs=168.3

Q ss_pred             CeeeccCceEEEEEEEcC--C--cEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILSD--G--TVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~--g--~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      ++||+|++|.||+|.+.+  +  ..||+|.+..... ...++|..|++++++++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999743  3  3689999987655 556789999999999999999999999988 889999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      ++|.+.+.....   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            999999876532   36899999999999999999999987   999999999999999999999999999876543221


Q ss_pred             --ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          799 --ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       799 --~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                        ......++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  203 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG  203 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence              1112456789999999988889999999999999999998 9999853

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=3e-29  Score=266.54  Aligned_cols=200  Identities=27%  Similarity=0.394  Sum_probs=171.0

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEee-CceEEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVYE  714 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~E  714 (869)
                      +|++.+.||+|++|.||++... +++.||+|++....  ....+.+..|++++++++|+|++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999965 57889999986432  2345678889999999999999999998764 446789999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++++|.+++....   ...+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          81 FCEGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             ccCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            999999999886532   225899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ... ......+++.|+|||++.+..++.++||||||++++||++|+.||..
T Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~  204 (257)
T cd08223         155 QCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA  204 (257)
T ss_pred             cCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            322 22234678899999999988899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=2e-29  Score=271.70  Aligned_cols=201  Identities=31%  Similarity=0.574  Sum_probs=169.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~----~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      .+|++.+.||+|+||.||+|.+. +|+    .||+|....... ....++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56788899999999999999964 333    589998765543 345678899999999999999999999987 78899


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+++.....    .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        86 v~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEecCCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence            9999999999999876432    4899999999999999999999987   99999999999999999999999999987


Q ss_pred             ecCCCcccc-ccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          792 YEEDKTHIS-TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       792 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      ......... ....++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  215 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI  215 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            653322111 11223568999999988889999999999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=6.9e-30  Score=277.22  Aligned_cols=196  Identities=28%  Similarity=0.530  Sum_probs=170.4

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      |+....||+|+||.||++... +++.||||++........+.+.+|+.+++.++||||+++++.+..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            344567999999999999864 6889999998765555567789999999999999999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      ++|.+++...      .+++..+..++.||+.||+|||+.+   |+||||||+||++++++.++|+|||++.........
T Consensus       104 ~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~  174 (292)
T cd06658         104 GALTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK  174 (292)
T ss_pred             CcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence            9999887432      4789999999999999999999987   999999999999999999999999998755332221


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                       .....|+..|+|||+.....++.++||||||+++|||++|+.||..
T Consensus       175 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~  220 (292)
T cd06658         175 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN  220 (292)
T ss_pred             -CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence             1234688899999999888899999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=1.7e-29  Score=272.22  Aligned_cols=206  Identities=25%  Similarity=0.413  Sum_probs=172.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC-----CcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEee-CceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~-----g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~-~~~~  709 (869)
                      .++|.+.++||+|+||.||+|...+     +..|++|++.... ......+.+|+.++++++||||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            5678899999999999999999765     6889999887543 3335678899999999999999999998776 5678


Q ss_pred             EEEEEeccCCchhhhhhcCCcc---cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTE---YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                      ++++||+++++|.+++......   ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999988654211   1136899999999999999999999987   999999999999999999999999


Q ss_pred             CCceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          787 GLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       787 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      |+++.+...... ......++..|+|||++....++.++||||||+++||+++ |+.||..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  222 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE  222 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence            999866433221 1122345678999999988889999999999999999999 9999854

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.3e-29  Score=283.03  Aligned_cols=193  Identities=24%  Similarity=0.318  Sum_probs=164.3

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ....+|.+.+.||+|+||.||+|... +++.||+|.....      ....|+.++++++||||+++++++...+..++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            33567999999999999999999976 4678999975332      2356899999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+. ++|.+++....    ..+++..+..|+.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       137 e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        137 PHYS-SDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EccC-CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            9986 57877775432    26899999999999999999999997   9999999999999999999999999987543


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~  843 (869)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       209 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        209 VAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            222  122356899999999999889999999999999999999866554

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=1.3e-29  Score=274.08  Aligned_cols=201  Identities=26%  Similarity=0.479  Sum_probs=170.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc-CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|++.+.||+|+||.||+|... +++.||+|.++.. .......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46788899999999999999976 6899999988654 233356788999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++....  ....+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          81 MDAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             cCCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999988886532  1236899999999999999999999742  3999999999999999999999999998765332


Q ss_pred             CccccccccccccccchhhcccC------CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRG------YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..   ....+++.|+|||++.+.      .++.++|||||||++|||++|+.||..
T Consensus       157 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  209 (286)
T cd06622         157 LA---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP  209 (286)
T ss_pred             cc---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence            21   223578899999998554      348899999999999999999999954

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=1.7e-29  Score=272.93  Aligned_cols=199  Identities=29%  Similarity=0.469  Sum_probs=171.5

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999975 68899999987654  23356789999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      + +++|.+++....    ..+++.+++.++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            9 999999886543    36899999999999999999999987   999999999999999999999999998876543


Q ss_pred             CccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .........++..|+|||++... .++.++||||+|++++||++|++||..
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~  203 (286)
T cd07832         153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG  203 (286)
T ss_pred             CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence            32222334688899999988654 468999999999999999999887754

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=1.3e-29  Score=274.11  Aligned_cols=212  Identities=26%  Similarity=0.434  Sum_probs=174.7

Q ss_pred             ccHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEe-
Q 002899          628 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCV-  704 (869)
Q Consensus       628 ~~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~-  704 (869)
                      ..+..+..+.++|++.+.||+|+||.||+|... +++.+|+|++.... ....++..|+.++.++ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            344556678899999999999999999999875 57899999876432 2245678899999998 6999999999884 


Q ss_pred             ----eCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 002899          705 ----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN  780 (869)
Q Consensus       705 ----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~  780 (869)
                          .++..++||||+++++|.+++.... .....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~  162 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCC
Confidence                3456899999999999998876432 12236889999999999999999999987   999999999999999999


Q ss_pred             EEEeecCCceeecCCCccccccccccccccchhhccc-----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          781 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       781 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +||+|||++........ ......|++.|+|||++..     ..++.++||||+||++|||++|+.|+..
T Consensus       163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~  231 (286)
T cd06638         163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD  231 (286)
T ss_pred             EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCC
Confidence            99999999876643221 1223468899999998753     4578899999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=1.6e-29  Score=277.30  Aligned_cols=206  Identities=26%  Similarity=0.434  Sum_probs=170.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc--------CCcEEEEEEecccC-chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG  706 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~--------~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~  706 (869)
                      .++|.+.+.||+|+||.||+|...        ....||+|.++... .....++..|++++.++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            457888999999999999999742        24578999887543 33456788999999999 699999999999999


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL  775 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  775 (869)
                      +..++||||+++|+|.+++.....           .....+++.++..++.|++.||+|||+++   ++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            999999999999999999865421           01235899999999999999999999987   9999999999999


Q ss_pred             cCCCcEEEeecCCceeecCCCccc-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          776 DKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       776 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ++++.+||+|||+++......... .....++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~  239 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG  239 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence            999999999999997664322111 111223467999999988889999999999999999999 8888854

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=2.7e-29  Score=267.01  Aligned_cols=195  Identities=30%  Similarity=0.480  Sum_probs=166.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEe-eCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV-EGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lV~E~~  716 (869)
                      ++|++.+.||+|+||.||+|... |+.||+|.++...  ..+.|.+|+.++++++|+|++++++++. .++..++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46788899999999999999875 7789999886432  3567899999999999999999999765 456789999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++.....   ..+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||+|||++.......
T Consensus        83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          83 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            99999999865432   25889999999999999999999987   9999999999999999999999999987654322


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .    ...++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       157 ~----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~  202 (256)
T cd05082         157 D----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  202 (256)
T ss_pred             C----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            1    2234568999999988889999999999999999997 9998854

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=2.6e-29  Score=267.06  Aligned_cols=200  Identities=38%  Similarity=0.569  Sum_probs=171.5

Q ss_pred             CeeeccCceEEEEEEEcC----CcEEEEEEecccCchh-hHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~----g~~VAvK~~~~~~~~~-~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      +.||+|+||.||+|....    +..||+|.++...... .+.+.+|++++..++|+||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999764    7889999987654433 67889999999999999999999999999999999999999


Q ss_pred             CchhhhhhcCCcc----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          719 NCLSRAIFGKDTE----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       719 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      ++|.+++......    ....+++..+..++.|+++||+|||+++   ++||||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999998764211    1246899999999999999999999987   99999999999999999999999999987754


Q ss_pred             CCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          795 DKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       795 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      ... .......+++.|+|||.+....++.++||||+|+++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  211 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL  211 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence            321 11223457889999999988889999999999999999999 69898653

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=1e-29  Score=274.70  Aligned_cols=199  Identities=27%  Similarity=0.426  Sum_probs=170.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ++|++.++||+|+||.||+|... +++.||+|++.....  ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999986 588999998765422  234568899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++++|.++.....     .+++..+..++.|+++||+|||+.+   ++||||+|+||++++++.++|+|||++.....
T Consensus        81 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          81 FVDHTVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             cCCccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            999998887764432     4799999999999999999999987   99999999999999999999999999876544


Q ss_pred             CCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ... ......++..|+|||++.+ ..++.++||||||+++|||++|++||..
T Consensus       153 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~  203 (286)
T cd07846         153 PGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG  203 (286)
T ss_pred             Ccc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence            322 2223457889999998865 4578899999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.1e-29  Score=295.16  Aligned_cols=203  Identities=19%  Similarity=0.319  Sum_probs=162.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEcC--CcEEEEE------------------EecccCchhhHHHHHHHHHHHhcCCCc
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILSD--GTVIAVK------------------QLSSKSRQGNREFVNEIGMISAQQHPN  695 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~~--g~~VAvK------------------~~~~~~~~~~~~f~~E~~~l~~l~H~n  695 (869)
                      ..++|++.+.||+|+||+||++..+.  +..+++|                  .+. ........+.+|++++++++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            35789999999999999999987542  2222222                  111 11223456889999999999999


Q ss_pred             eeeEEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE
Q 002899          696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL  775 (869)
Q Consensus       696 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  775 (869)
                      ||++++++...+..|+|+|++. +++..++...............+..++.|++.||+|||+++   |+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            9999999999999999999886 46666665443222223446677889999999999999987   9999999999999


Q ss_pred             cCCCcEEEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 002899          776 DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       776 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~  843 (869)
                      +.++.+||+|||+++.+............||+.|+|||++.+..++.++|||||||++|||++|+.++
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999999999877544333333457999999999999989999999999999999999998654

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.96  E-value=3.1e-29  Score=268.78  Aligned_cols=197  Identities=29%  Similarity=0.468  Sum_probs=162.7

Q ss_pred             CeeeccCceEEEEEEEcC-Cc--EEEEEEecccC-chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILSD-GT--VIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~-g~--~VAvK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      +.||+|+||.||+|...+ +.  .+|+|.++... ......+..|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999753 43  47888887543 34456788999999999 899999999999999999999999999


Q ss_pred             CchhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          719 NCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       719 gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                      |+|.+++......           ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            9999998654311           1225789999999999999999999987   9999999999999999999999999


Q ss_pred             CceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ++........  ......+..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~  214 (270)
T cd05047         158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  214 (270)
T ss_pred             Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            9853221111  111223567999999988889999999999999999997 9999853

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.96  E-value=2.3e-29  Score=268.40  Aligned_cols=199  Identities=34%  Similarity=0.565  Sum_probs=173.5

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +|++.+.||+|+||.||+|... +++.||+|.++....  ...+++..|++++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999965 688999999876543  3567899999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++....     .+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          81 CSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             CCCCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            99999999986542     4788999999999999999999988   999999999999999999999999998876543


Q ss_pred             Cccccc---cccccccccchhhcccCC---CCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHIST---RIAGTIGYMAPEYAMRGY---LTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~---~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......   ...+++.|+|||++....   .+.++||||||++++||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~  208 (264)
T cd06626         153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE  208 (264)
T ss_pred             CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence            322111   245788999999988765   88999999999999999999999954

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.8e-29  Score=268.18  Aligned_cols=200  Identities=29%  Similarity=0.424  Sum_probs=169.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc-----CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL  709 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~-----~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~--~~~  709 (869)
                      .+|++.+.||+|+||.||+|... +++.||+|.+...     .......+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57889999999999999999964 6889999987432     123345788999999999999999999998764  468


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||+++++|.+++....     .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~  153 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS  153 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccc
Confidence            89999999999999886542     4788999999999999999999998   999999999999999999999999999


Q ss_pred             eeecCCCc--cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKT--HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +.......  .......++..|+|||++.+...+.++||||||++++||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  211 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE  211 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence            76532111  111234578899999999888889999999999999999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.96  E-value=1.9e-29  Score=272.81  Aligned_cols=201  Identities=25%  Similarity=0.390  Sum_probs=172.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ++|++.+.||+|+||.||+|... +++.||+|+++...  ......+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999976 57899999886542  2334678999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |++++.+..+....     ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||++.....
T Consensus        81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~  152 (288)
T cd07833          81 YVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRA  152 (288)
T ss_pred             cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence            99987776555332     24799999999999999999999987   99999999999999999999999999887654


Q ss_pred             CCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ..........++..|+|||++... .++.++||||||+++|||++|++||...
T Consensus       153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  205 (288)
T cd07833         153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD  205 (288)
T ss_pred             CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            433222335678899999999887 8899999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.96  E-value=2.8e-29  Score=268.50  Aligned_cols=200  Identities=29%  Similarity=0.473  Sum_probs=171.4

Q ss_pred             CCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCc------hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~------~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+.....      ...+.+..|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999985 4688999998864321      124678899999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-cEEEeecCCce
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAK  790 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~-~~kl~DFGla~  790 (869)
                      ||||+++++|.+++....     ++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||.+.
T Consensus        81 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~  152 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAA  152 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccc
Confidence            999999999999886542     5789999999999999999999997   99999999999998776 58999999987


Q ss_pred             eecCCCcc---ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          791 LYEEDKTH---ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       791 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .+......   ......++..|+|||++.+..++.++||||+|++++||++|+.||...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  211 (268)
T cd06630         153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE  211 (268)
T ss_pred             ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            76543211   112346788999999998888899999999999999999999999653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.96  E-value=1.4e-29  Score=281.29  Aligned_cols=206  Identities=29%  Similarity=0.453  Sum_probs=168.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE------cCCcEEEEEEecccCc-hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC-c
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG-N  707 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~------~~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~-~  707 (869)
                      .++|++.+.||+|+||.||+|..      .+++.||||+++.... ...+.+..|++++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46789999999999999999973      3467899999975432 3346788999999999 689999999988654 4


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcc--------------------------------------------------------
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTE--------------------------------------------------------  731 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------  731 (869)
                      ..++||||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            678999999999999988653210                                                        


Q ss_pred             ------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccc-ccccc
Q 002899          732 ------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI-STRIA  804 (869)
Q Consensus       732 ------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~  804 (869)
                            ....+++..+..++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||++.......... .....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                  0124788999999999999999999987   9999999999999999999999999987653322111 11223


Q ss_pred             ccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          805 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       805 gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      +++.|+|||.+....++.++||||||+++|||++ |..||..
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  284 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  284 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            5678999999988889999999999999999997 8988854

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.96  E-value=3.9e-29  Score=269.14  Aligned_cols=197  Identities=29%  Similarity=0.522  Sum_probs=171.7

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .|+..+.||+|+||.||+|... +++.||+|.+.... ......+..|++++++++||||+++++++.++...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4667788999999999999975 58899999987543 344567889999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++|+|.+++...      ++++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        85 ~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          85 GGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            999999988543      4788999999999999999999987   9999999999999999999999999997664332


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      . ......++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  203 (277)
T cd06640         156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD  203 (277)
T ss_pred             c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence            1 12234578899999999888899999999999999999999999853

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=4.5e-29  Score=268.97  Aligned_cols=192  Identities=30%  Similarity=0.415  Sum_probs=158.9

Q ss_pred             eeeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHHH---HhcCCCceeeEEeEEeeCceEEEEEEecc
Q 002899          645 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMI---SAQQHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       645 ~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      .||+|+||.||++... +++.+|+|.+.....   .....+.+|..++   ...+||||+++++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 588999998865321   2223344454433   34579999999999999999999999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.++|+|||++........
T Consensus        81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~  152 (279)
T cd05633          81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  152 (279)
T ss_pred             CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence            999998886543     5899999999999999999999998   99999999999999999999999999875543221


Q ss_pred             cccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          798 HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                         ....|++.|+|||.... ..++.++||||+||++|||++|+.||....
T Consensus       153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  200 (279)
T cd05633         153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (279)
T ss_pred             ---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence               22468999999998864 567899999999999999999999996543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.96  E-value=3.9e-30  Score=278.75  Aligned_cols=207  Identities=31%  Similarity=0.502  Sum_probs=177.3

Q ss_pred             HHHHHhcCCCCCCeeeccCceEEEEEEEcC---Cc--EEEEEEeccc-CchhhHHHHHHHHHHHhcCCCceeeEEeEEee
Q 002899          632 QIKAATNNFDPANKVGEGGFGSVYKGILSD---GT--VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE  705 (869)
Q Consensus       632 ~i~~~t~~f~~~~~IG~G~fG~Vyka~~~~---g~--~VAvK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~  705 (869)
                      +.+...+.....++||+|-||.||+|...+   |.  .||||.-+.. .....+.|+.|+.+|+.++|||||+++|.|.+
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e  462 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE  462 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence            333444455667889999999999999543   33  5888987764 34456789999999999999999999999986


Q ss_pred             CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002899          706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD  785 (869)
Q Consensus       706 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~D  785 (869)
                      . ..++|||.++-|-|..+|..+..    .++......++.||+.||+|||+..   +|||||..+|||+....-+||+|
T Consensus       463 ~-P~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaD  534 (974)
T KOG4257|consen  463 Q-PMWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLAD  534 (974)
T ss_pred             c-ceeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecc
Confidence            5 78999999999999999987653    6888999999999999999999986   99999999999999999999999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      ||+++.+..+..+......-+..|||||.+.-.+++.++|||.|||+|||+++ |..||..-
T Consensus       535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv  596 (974)
T KOG4257|consen  535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV  596 (974)
T ss_pred             cchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence            99999988776555555556779999999999999999999999999999876 89999753

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=2.4e-29  Score=267.43  Aligned_cols=188  Identities=30%  Similarity=0.484  Sum_probs=160.0

Q ss_pred             CeeeccCceEEEEEEEcCCc-----------EEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          644 NKVGEGGFGSVYKGILSDGT-----------VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~g~-----------~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      +.||+|+||.||+|.+.+..           .|++|.+...... ...|.+|+.++++++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999986432           5788877654433 6789999999999999999999999988 778999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-------cEEEee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-------NAKISD  785 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~-------~~kl~D  785 (869)
                      |||+++|+|.+++.....    .+++..+..++.|++.||+|||+++   |+||||||+|||++.++       .+||+|
T Consensus        79 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCC
Confidence            999999999999865432    5889999999999999999999987   99999999999999887       799999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcccC--CCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ||++......     ....++..|+|||++...  .++.++||||||+++|||++ |..|+..
T Consensus       152 fg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~  209 (259)
T cd05037         152 PGIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST  209 (259)
T ss_pred             CCcccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc
Confidence            9998765431     123466789999998876  78999999999999999999 5667754

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.96  E-value=8.9e-30  Score=274.05  Aligned_cols=195  Identities=30%  Similarity=0.534  Sum_probs=169.4

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEecc
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      |+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            455678999999999999865 57889999887443 3345678899999999999999999999999999999999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      +++|.+++...      .+++..+..++.|+++|+.|||+++   ++|+||+|+||++++++.++|+|||++........
T Consensus        86 ~~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          86 GGSALDLLKPG------PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            99999888542      5789999999999999999999987   99999999999999999999999999876543221


Q ss_pred             cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                       ......++..|+|||++.+..++.++||||||+++|||++|+.|+.
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~  202 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS  202 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCc
Confidence             1122457889999999998889999999999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.96  E-value=4.3e-29  Score=264.40  Aligned_cols=195  Identities=32%  Similarity=0.517  Sum_probs=166.9

Q ss_pred             CeeeccCceEEEEEEEcCCcEEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCchh
Q 002899          644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS  722 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~  722 (869)
                      ++||+|+||.||+|...+++.||+|.+...... ....|..|++++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999877999999988765443 4568999999999999999999999999999999999999999999


Q ss_pred             hhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcccc-c
Q 002899          723 RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS-T  801 (869)
Q Consensus       723 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~  801 (869)
                      +++.....    .+++..+..++.+++.|++|||+++   ++||||||+||+++.++.+||+|||++........... .
T Consensus        81 ~~l~~~~~----~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          81 TFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            99865432    5789999999999999999999987   99999999999999999999999999876542221111 1


Q ss_pred             cccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       802 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ....+..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~  198 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG  198 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence            1223567999999988889999999999999999999 8888854

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=4.6e-29  Score=265.29  Aligned_cols=193  Identities=33%  Similarity=0.517  Sum_probs=163.2

Q ss_pred             CeeeccCceEEEEEEEcC----CcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~----g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      ++||+|+||.||+|....    +..||+|.+..... ...+++..|+++++.+.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999998532    26899999876543 34567899999999999999999999876 4568999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|.+++....     .+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++........
T Consensus        80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            99999997543     5799999999999999999999987   999999999999999999999999999876543322


Q ss_pred             cccc--ccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          799 ISTR--IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       799 ~~~~--~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ....  ..++..|+|||......++.++||||||+++|||++ |+.||..
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~  201 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE  201 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc
Confidence            1111  123467999999988889999999999999999998 9999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=1.9e-29  Score=272.54  Aligned_cols=199  Identities=29%  Similarity=0.484  Sum_probs=168.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEE-----cCCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceE
Q 002899          638 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL  709 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~-----~~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~--~~~  709 (869)
                      +.|++.+.||+|+||.||++..     .+++.||+|.++... ......+.+|++++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467889999999999999974     257889999987553 33346789999999999999999999998875  568


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||+++++|.+++....    ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccc
Confidence            99999999999999885442    25899999999999999999999998   999999999999999999999999999


Q ss_pred             eeecCCCcc--ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 002899          790 KLYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       790 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~  843 (869)
                      +........  ......++..|+|||++.+..++.++||||||+++|||++++.|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence            866433221  112244667899999998888999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.96  E-value=2.1e-29  Score=278.99  Aligned_cols=208  Identities=28%  Similarity=0.425  Sum_probs=171.6

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEcC--------CcEEEEEEecccC-chhhHHHHHHHHHHHhc-CCCceeeEEeEEe
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCV  704 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~~--------g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~  704 (869)
                      ....+|++.+.||+|+||.||+|....        +..||+|.++... ....+++.+|++++.++ +||||+++++++.
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            334568899999999999999997421        2368999887543 33456889999999999 8999999999999


Q ss_pred             eCceEEEEEEeccCCchhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCE
Q 002899          705 EGNQLLLVYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV  773 (869)
Q Consensus       705 ~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NI  773 (869)
                      .++..++||||+++|+|.+++.....           .....++|..+..++.|++.||+|||+.+   ++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceE
Confidence            99999999999999999999865321           11235899999999999999999999987   99999999999


Q ss_pred             EEcCCCcEEEeecCCceeecCCCccc-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          774 LLDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       774 Ll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      |+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  239 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG  239 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence            99999999999999998664322111 111234567999999998889999999999999999998 8888854

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.96  E-value=2.5e-29  Score=272.19  Aligned_cols=205  Identities=32%  Similarity=0.518  Sum_probs=171.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~  709 (869)
                      .++|++.+.||+|+||.||+|...      ++..||+|+++... ....++|.+|+.++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467889999999999999999863      46789999987553 33456789999999999999999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCc-----------------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCC
Q 002899          710 LLVYEYMKNNCLSRAIFGKDT-----------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN  772 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~N  772 (869)
                      ++||||+++|+|.+++.....                 .....+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            999999999999999864321                 11235789999999999999999999987   9999999999


Q ss_pred             EEEcCCCcEEEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 002899          773 VLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTN  844 (869)
Q Consensus       773 ILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~  844 (869)
                      |+++.++.++|+|||++........ ........+..|+|||.+....++.++|||||||++|||++ |..||.
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999876543221 11112234668999999988889999999999999999997 888874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.96  E-value=2.7e-29  Score=272.67  Aligned_cols=198  Identities=28%  Similarity=0.541  Sum_probs=174.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+........+.+..|+.++++++||||+++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67889999999999999999864 67899999986555555677899999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++...      .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++.......
T Consensus        99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          99 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             CCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            999999988543      4788999999999999999999997   9999999999999999999999999987654332


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .. .....+++.|+|||.+....++.++||||||+++|||++|+.||..
T Consensus       170 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~  217 (293)
T cd06647         170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (293)
T ss_pred             cc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            21 1234578899999999888889999999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=7.7e-30  Score=279.98  Aligned_cols=199  Identities=27%  Similarity=0.452  Sum_probs=176.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ...|.+...||+|.|+.|..|++. ++..||+|.+++..-  ...+.+.+|+++|..++|||||+++.+.+.+..+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            457889999999999999999965 689999999987633  23355889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+.+|.+.+++..++     ......+..++.|+.+|++|||+++   |+|||||++||||+.+..+||+|||++..+.
T Consensus       135 eya~~ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EeccCchhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence            9999999999998765     3455889999999999999999998   9999999999999999999999999999887


Q ss_pred             CCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..  ......+|++.|.|||+..+. ..++++|+||+|+++|-|+.|..||+.
T Consensus       207 ~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG  257 (596)
T KOG0586|consen  207 YG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG  257 (596)
T ss_pred             cc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence            43  344557899999999998865 567899999999999999999999974

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.96  E-value=8.3e-30  Score=321.33  Aligned_cols=277  Identities=32%  Similarity=0.439  Sum_probs=235.5

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      ..+++.|+|++|.+++.+|..++++++|++|+|++|.+.+..|..+..+ +|++|+|++|++++.+|..++++++|++|+
T Consensus       139 l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~  218 (968)
T PLN00113        139 IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIY  218 (968)
T ss_pred             cCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEE
Confidence            4578899999999999999999999999999999999998888888887 899999999999989999999999999999


Q ss_pred             ccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCC
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG  211 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  211 (869)
                      |++|++++.+|..+.++++|++|+|++|++++.+|..+.++++|++|+|++|++++.+|..+.++++|+.|+|++|.+.+
T Consensus       219 L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~  298 (968)
T PLN00113        219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSG  298 (968)
T ss_pred             CcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeecc
Confidence            99999998899999999999999999999998889899999999999999999988888888889999999999999988


Q ss_pred             CchHhhhcCCCCCEEEcCCCCCCCCcccccc-cccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhc
Q 002899          212 PIPASISALTSLTDLRISDLKGSESAFPKLD-KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK  290 (869)
Q Consensus       212 ~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~-~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  290 (869)
                      .+|..+.++++|+.|++++|.+.......+. ..+|+.|+|++|.+++.+|..++.+++|+.|+|++|++++.+|..+..
T Consensus       299 ~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~  378 (968)
T PLN00113        299 EIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS  378 (968)
T ss_pred             CCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhC
Confidence            8888888899999999988888765544433 336888888888888888888888888888888888888777777777


Q ss_pred             CCCCCEEEeeCCcCCCCCchhh--hccCCceeeeccCccCC
Q 002899          291 LAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWE  329 (869)
Q Consensus       291 l~~L~~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~~  329 (869)
                      +++|+.|++++|++++.+|..+  ...++.|++++|+++..
T Consensus       379 ~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~  419 (968)
T PLN00113        379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGE  419 (968)
T ss_pred             cCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeE
Confidence            7777777777777777777665  44667777777766643

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=1.1e-28  Score=264.15  Aligned_cols=199  Identities=26%  Similarity=0.369  Sum_probs=165.6

Q ss_pred             HHHHHHHhcCCCCCCee--eccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHh-cCCCceeeEEeEEee
Q 002899          630 LRQIKAATNNFDPANKV--GEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGCCVE  705 (869)
Q Consensus       630 ~~~i~~~t~~f~~~~~I--G~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~-l~H~nIv~l~~~~~~  705 (869)
                      ..++....++|++.+.+  |+|+||.||++... +++.+|+|.+.......   .  |+..... .+||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEec
Confidence            34445556778887777  99999999999964 67889999986542211   1  2222222 279999999999999


Q ss_pred             CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-cEEEe
Q 002899          706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKIS  784 (869)
Q Consensus       706 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~-~~kl~  784 (869)
                      .+..++||||+++++|.+++....     .+++..+..++.|+++||+|||+.+   ++||||||+||+++.++ .++|+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~  152 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLC  152 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEe
Confidence            999999999999999999986543     6899999999999999999999988   99999999999999998 99999


Q ss_pred             ecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          785 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       785 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |||++.......     ...++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       153 dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  209 (267)
T PHA03390        153 DYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED  209 (267)
T ss_pred             cCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            999987654322     235788999999999888999999999999999999999999743

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.96  E-value=2.3e-29  Score=271.59  Aligned_cols=201  Identities=27%  Similarity=0.461  Sum_probs=165.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHH-HHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGM-ISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|+++... .....++..|+.. ++..+||||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999975 68999999987543 2334556666654 666799999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      |++ |+|.+++..... ....+++..+..++.|++.||+|||++ +   ++||||||+||+++.++.+||+|||++....
T Consensus        81 ~~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          81 VMD-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhc-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            997 678777654321 124689999999999999999999986 5   9999999999999999999999999987654


Q ss_pred             CCCccccccccccccccchhhccc----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...  ......++..|+|||.+..    ..++.++|+||||+++|||++|+.||..
T Consensus       156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (283)
T cd06617         156 DSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS  209 (283)
T ss_pred             ccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence            322  1123457889999998864    4568899999999999999999999853

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.96  E-value=3e-29  Score=273.79  Aligned_cols=200  Identities=33%  Similarity=0.573  Sum_probs=166.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~----~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ++|+..+.||+|+||.||+|.+. ++.    .||+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            56778899999999999999864 443    578898865432 3345788999999999999999999998754 4679


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ++||+++|+|.+++....    ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++.
T Consensus        86 v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence            999999999999986543    25789999999999999999999987   99999999999999999999999999987


Q ss_pred             ecCCCccc-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          792 YEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ........ .....++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~  214 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG  214 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            64332211 112345678999999988889999999999999999997 8888854

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.96  E-value=5.7e-29  Score=264.13  Aligned_cols=200  Identities=37%  Similarity=0.580  Sum_probs=171.5

Q ss_pred             CCCCCeeeccCceEEEEEEEcC-----CcEEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          640 FDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~~-----g~~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      |++.+.||+|+||.||++...+     +..||+|.+...... ..+.+..|++++..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567899999999999999764     378999999765443 5678999999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++++|.+++......   .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++....
T Consensus        81 e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPK---ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             eccCCCCHHHHHHhhhhc---cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecc
Confidence            999999999998764321   2899999999999999999999997   9999999999999999999999999998765


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ...........+++.|+|||.+....++.++||||+|++++||++ |++||..
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~  207 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG  207 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            442222112236789999999988889999999999999999998 7888754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.96  E-value=5.2e-29  Score=270.00  Aligned_cols=199  Identities=28%  Similarity=0.409  Sum_probs=169.4

Q ss_pred             CCCCCCeeeccCceEEEEEEE----cCCcEEEEEEecccCc----hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceE
Q 002899          639 NFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSR----QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~----~~g~~VAvK~~~~~~~----~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~  709 (869)
                      +|++.+.||+|+||.||+|..    .+|+.||+|++.....    ...+.+..|++++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999986    3688999999865322    2245678899999999 599999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||+++++|.+++....     .+++..+..++.|+++||+|||+.+   ++||||+|+|||++.++.+||+|||++
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~  152 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  152 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccc
Confidence            99999999999999886542     5788999999999999999999987   999999999999999999999999999


Q ss_pred             eeecCCCccccccccccccccchhhcccC--CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...............|+..|+|||.+...  ..+.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence            87644332222235688899999998753  467899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.96  E-value=4.4e-29  Score=265.14  Aligned_cols=200  Identities=26%  Similarity=0.425  Sum_probs=172.9

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +|++.+.||+|+||.||++... +++.||+|.+...  .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788899999999999999864 6889999988643  233456789999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++.....   ..+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          81 CEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            999999998865322   25789999999999999999999987   999999999999999999999999999766432


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .. ......|++.|+|||++.+...+.++||||||++++||++|+.||..
T Consensus       155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08218         155 VE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA  203 (256)
T ss_pred             hh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence            21 12234578899999999888899999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.96  E-value=3.2e-29  Score=271.73  Aligned_cols=213  Identities=29%  Similarity=0.464  Sum_probs=175.7

Q ss_pred             cccHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEe
Q 002899          627 LYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCV  704 (869)
Q Consensus       627 ~~~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~  704 (869)
                      .+.++++..++++|.+.+.||+|+||.||+|... +++.+|+|.+.... ....++.+|+.++.++ +|||++++++++.
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            3455666777899999999999999999999974 68899999886532 2245677899999988 8999999999987


Q ss_pred             eC-----ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC
Q 002899          705 EG-----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL  779 (869)
Q Consensus       705 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~  779 (869)
                      ..     +..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+   ++||||||+||+++.++
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~  165 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEG  165 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCC
Confidence            54     358999999999999988864211 1236899999999999999999999987   99999999999999999


Q ss_pred             cEEEeecCCceeecCCCccccccccccccccchhhcccC-----CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          780 NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-----YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       780 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .+||+|||++......... .....|+..|+|||++...     .++.++|||||||++|||++|+.||..
T Consensus       166 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~  235 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD  235 (291)
T ss_pred             CEEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCC
Confidence            9999999998765432211 1234678899999987643     368899999999999999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.96  E-value=5.5e-29  Score=265.84  Aligned_cols=203  Identities=29%  Similarity=0.493  Sum_probs=175.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|++.+.||+|+||.||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47889999999999999999965 67889999986542 33567889999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++.....  ...+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||++..+...
T Consensus        81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          81 LSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             cCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            999999999865432  135899999999999999999999987   999999999999999999999999998766543


Q ss_pred             Ccc---ccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTH---ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...   ......|+..|+|||++... ..+.++||||||++++||++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~  209 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK  209 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc
Confidence            221   12234688999999998776 789999999999999999999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.96  E-value=1.2e-28  Score=265.26  Aligned_cols=197  Identities=30%  Similarity=0.519  Sum_probs=171.0

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      -|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++.+++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3667889999999999999864 67899999876443 233467889999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++...      .+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        85 ~~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          85 GGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            999999988543      5789999999999999999999987   9999999999999999999999999987664332


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .. .....++..|+|||.+.....+.++|||||||++|||++|+.||..
T Consensus       156 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  203 (277)
T cd06641         156 IK-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE  203 (277)
T ss_pred             hh-hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence            11 2234578899999999888889999999999999999999999853

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.96  E-value=1.9e-29  Score=268.41  Aligned_cols=199  Identities=30%  Similarity=0.442  Sum_probs=174.5

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      +|++.+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999976 58899999986542   2345788999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++++|.+++...     .++++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||.+.....
T Consensus        81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~  152 (258)
T cd05578          81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP  152 (258)
T ss_pred             CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence            99999999988654     26889999999999999999999987   99999999999999999999999999876644


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      ..  ......|+..|+|||.+....++.++|+||||+++|+|++|+.||....
T Consensus       153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  203 (258)
T cd05578         153 DT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS  203 (258)
T ss_pred             Cc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence            32  1223457889999999988889999999999999999999999997643

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.96  E-value=5.8e-29  Score=272.93  Aligned_cols=204  Identities=25%  Similarity=0.400  Sum_probs=168.5

Q ss_pred             CCCCCCeeeccCceEEEEEEEc---CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLL  710 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~---~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~  710 (869)
                      +|++.+.||+|+||.||+|...   +++.||+|.+....   ......+.+|+.++.+++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999975   47899999987633   33345678899999999999999999999988  8899


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC----CCcEEEeec
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK----DLNAKISDF  786 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~----~~~~kl~DF  786 (869)
                      +||||+++ ++.+.+..........+++..+..++.|++.||+|||+.+   ++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999985 5666554332222236889999999999999999999987   999999999999999    999999999


Q ss_pred             CCceeecCCCc--cccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          787 GLAKLYEEDKT--HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       787 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |++........  .......+++.|+|||++.+ ..++.++||||||++++||++|++||...
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  219 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR  219 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence            99886643322  11223467889999998765 45789999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.96  E-value=2.6e-29  Score=271.31  Aligned_cols=197  Identities=24%  Similarity=0.431  Sum_probs=166.0

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +|++.+.||+|+||.||+|... +|+.||+|+++...  ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999975 68899999886532  22235678899999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++ +|.+++....    ..+++..++.++.||++||+|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  152 (284)
T cd07839          81 CDQ-DLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP  152 (284)
T ss_pred             CCC-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence            974 6777665432    25899999999999999999999987   999999999999999999999999998765432


Q ss_pred             CccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      ... .....+++.|+|||++.+. .++.++|||||||++|||++|+.|+.
T Consensus       153 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~  201 (284)
T cd07839         153 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  201 (284)
T ss_pred             CCC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence            221 1234568899999988764 47899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.96  E-value=7e-29  Score=270.03  Aligned_cols=198  Identities=29%  Similarity=0.440  Sum_probs=168.9

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch-----hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-----GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~-----~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      +|++.+.||+|+||.||+|... +++.||||++......     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999975 6889999998755332     244567899999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+ +|+|.+++....    ..+++..+..++.||++||+|||+.+   ++||||+|+||+++.++.++|+|||++...
T Consensus        81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~  152 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF  152 (298)
T ss_pred             Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeec
Confidence            9999 899999986543    25899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...... .....+++.|+|||.+.+ ..++.++|||||||++|||++|.+||..
T Consensus       153 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~  205 (298)
T cd07841         153 GSPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG  205 (298)
T ss_pred             cCCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence            543221 122346778999998854 4678999999999999999999877754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=6.1e-29  Score=266.65  Aligned_cols=199  Identities=27%  Similarity=0.447  Sum_probs=168.2

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch----------hhHHHHHHHHHHHhcCCCceeeEEeEEeeCc
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ----------GNREFVNEIGMISAQQHPNLVKLYGCCVEGN  707 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~----------~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~  707 (869)
                      +|...+.||+|+||.||+|... +++.||+|.++.....          ..+.+..|+++++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667889999999999999864 6889999987532111          1245778999999999999999999999999


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                      ..++||||+++++|.+++....     .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~  153 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFG  153 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecc
Confidence            9999999999999999986542     6889999999999999999999987   9999999999999999999999999


Q ss_pred             CceeecCCCcc-ccccccccccccchhhcccCC--CCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          788 LAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGY--LTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       788 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ++......... ......++..|+|||.+....  ++.++||||||+++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  214 (272)
T cd06629         154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD  214 (272)
T ss_pred             ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence            98765432211 122345788999999987654  78999999999999999999999853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=7.5e-29  Score=266.71  Aligned_cols=197  Identities=27%  Similarity=0.542  Sum_probs=170.3

Q ss_pred             CCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccC-chhhHHHHHHHHHHHhcC---CCceeeEEeEEeeCceEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.... .....++.+|++++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999996 468899999986542 334567888999999986   999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++++|.+++...      .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          82 EYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             ecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            999999999887543      5889999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..... .....|+..|+|||.+..+ .++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  204 (277)
T cd06917         153 QNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD  204 (277)
T ss_pred             CCccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence            43322 2234688899999988654 568899999999999999999999854

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=1.1e-28  Score=267.08  Aligned_cols=215  Identities=26%  Similarity=0.400  Sum_probs=176.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~  713 (869)
                      ++|+..+.||+|++|.||+|... +++.+|+|.+.... .....++.+|++++++++||||+++++++.+.  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46778899999999999999975 57889999887543 23456789999999999999999999998653  4689999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++++|.+++..... ....+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          81 EYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            99999999887653211 2235789999999999999999999987   9999999999999999999999999987553


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--cchhhHHHHHH
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN--EDFVYLLDWAY  859 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~--~~~~~l~~w~~  859 (869)
                      ....   ....++..|+|||.+.+..++.++||||+|+++|||++|+.||.....  ....++..|+.
T Consensus       157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  221 (287)
T cd06621         157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV  221 (287)
T ss_pred             cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh
Confidence            2211   234577899999999988999999999999999999999999975421  23344555544

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.96  E-value=1e-28  Score=263.37  Aligned_cols=194  Identities=30%  Similarity=0.472  Sum_probs=158.7

Q ss_pred             CeeeccCceEEEEEEEc----CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEe-eCceEEEEEEecc
Q 002899          644 NKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCV-EGNQLLLVYEYMK  717 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~----~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lV~E~~~  717 (869)
                      +.||+|+||.||+|.+.    +...||+|++.... ....+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999863    23579999885432 334567889999999999999999999876 4556899999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      +|+|.+++.....    ...+..+..++.|+++||+|||+.+   ++||||||+|||+++++.+||+|||+++.......
T Consensus        81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          81 HGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            9999999865432    4578888999999999999999987   99999999999999999999999999876543211


Q ss_pred             ---cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCC-CCCC
Q 002899          798 ---HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK-SNTN  844 (869)
Q Consensus       798 ---~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~-~p~~  844 (869)
                         .......++..|+|||.+....++.++||||||+++|||++|+ +||.
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~  204 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP  204 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence               1111234567899999998888999999999999999999964 4553

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.96  E-value=6e-29  Score=268.26  Aligned_cols=209  Identities=29%  Similarity=0.480  Sum_probs=173.1

Q ss_pred             cHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEee-
Q 002899          629 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE-  705 (869)
Q Consensus       629 ~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~-  705 (869)
                      ++.++..+.+.|++.+.||+|+||.||+|... +++.||+|.+.... ....++..|+.++.++ +||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            44555566788999999999999999999974 67899999886543 3345678899999888 79999999999853 


Q ss_pred             -----CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 002899          706 -----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN  780 (869)
Q Consensus       706 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~  780 (869)
                           .+..++||||+++|+|.+++.....   ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~  159 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence                 4578999999999999998865432   25788889999999999999999987   999999999999999999


Q ss_pred             EEEeecCCceeecCCCccccccccccccccchhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          781 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       781 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ++|+|||++........ ......|++.|+|||.+.     ...++.++|||||||++|||++|+.||..
T Consensus       160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~  228 (282)
T cd06636         160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD  228 (282)
T ss_pred             EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence            99999999875532221 122356889999999875     34678899999999999999999999853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-30  Score=268.39  Aligned_cols=200  Identities=28%  Similarity=0.392  Sum_probs=168.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhH---HHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR---EFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~---~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .+|....+||+|+||.|..|.-+ +.+.+|||++++....+..   --+.|-++|... +-|.+++++.+|+.-+.+|.|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            47889999999999999999865 4578999999875322211   123455666554 578899999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+.+|+|-.+++.-+     .+.++.+.-+|..||-||-+||+++   ||.||||..|||||.+|++||+|||+++.-
T Consensus       429 MEyvnGGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             EEEecCchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999988886553     5778889999999999999999998   999999999999999999999999998753


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      --+ .......+|||.|+|||++...+|+..+|+|||||+||||+.|++||+..
T Consensus       501 i~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe  553 (683)
T KOG0696|consen  501 IFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE  553 (683)
T ss_pred             ccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence            322 22334589999999999999999999999999999999999999999763

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.96  E-value=5.4e-29  Score=266.70  Aligned_cols=196  Identities=23%  Similarity=0.408  Sum_probs=157.6

Q ss_pred             eeeccCceEEEEEEEcCC---cEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCc
Q 002899          645 KVGEGGFGSVYKGILSDG---TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC  720 (869)
Q Consensus       645 ~IG~G~fG~Vyka~~~~g---~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs  720 (869)
                      .||+|+||.||+|...++   ..+++|.+.... ....+.|.+|+++++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999985443   345677665443 3345789999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC-ccc
Q 002899          721 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK-THI  799 (869)
Q Consensus       721 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~-~~~  799 (869)
                      |.+++...... ....++..+..++.||++||+|||+.+   ++||||||+|||++.++.+||+|||++....... ...
T Consensus        82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99998754321 234677788999999999999999987   9999999999999999999999999976432211 111


Q ss_pred             cccccccccccchhhccc-------CCCCchhHHHHHHHHHHHHHcC-CCCCC
Q 002899          800 STRIAGTIGYMAPEYAMR-------GYLTSKADVYSFGVVTLEIVSG-KSNTN  844 (869)
Q Consensus       800 ~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlGvil~elltG-~~p~~  844 (869)
                      .....++..|+|||++..       ..++.++||||||+++|||+++ +.||.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~  210 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS  210 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence            223457889999998753       2457899999999999999974 66764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.96  E-value=1.1e-28  Score=266.75  Aligned_cols=197  Identities=28%  Similarity=0.533  Sum_probs=171.2

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEecc
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      .|+..+.||+|++|.||+|... +++.|++|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3455678999999999999964 688999999876555556678899999999999999999999999999999999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      +++|.+++...      .+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||.+........
T Consensus       100 ~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648         100 GGALTDIVTHT------RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             CCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence            99999988652      5789999999999999999999998   99999999999999999999999998765543222


Q ss_pred             cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      . .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~  217 (285)
T cd06648         171 R-RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN  217 (285)
T ss_pred             c-cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence            1 1234588999999999888899999999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=5.7e-30  Score=272.46  Aligned_cols=194  Identities=28%  Similarity=0.435  Sum_probs=167.2

Q ss_pred             CCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCC
Q 002899          643 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN  719 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g  719 (869)
                      .++||.|.||+||-|.++ +|+.||||++.+..  ........+|+.||+.++||.||.+-.-|+..+.+++|||-+.+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            578999999999999975 79999999987652  333467889999999999999999999999999999999988765


Q ss_pred             chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC---CcEEEeecCCceeecCCC
Q 002899          720 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       720 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~---~~~kl~DFGla~~~~~~~  796 (869)
                      -|.-.|....    .++++..-.-+..||+.||.|||.++   |+|+||||+||||...   -++||||||+|++..+..
T Consensus       649 MLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  649 MLEMILSSEK----GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             HHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            5544444332    26888888889999999999999998   9999999999999643   479999999999987533


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                        ....++|||.|+|||+++...|...-|+||.|||+|-=++|..||+-
T Consensus       722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE  768 (888)
T KOG4236|consen  722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE  768 (888)
T ss_pred             --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence              34457899999999999999999999999999999999999999963

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.6e-29  Score=272.22  Aligned_cols=199  Identities=28%  Similarity=0.445  Sum_probs=168.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccc--CchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ...|++.++||+||.+.||++...+.+.+|+|++...  ..+...-|..|++.|.++ .|.+||++++|-..++.+||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            4468889999999999999999888889999876543  344467899999999998 4999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      || ...+|.++|......   ..+| .++.+..||+.++.++|+++   |||.||||.|+|+- .|.+||+|||+|..+.
T Consensus       440 E~-Gd~DL~kiL~k~~~~---~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  440 EC-GDIDLNKILKKKKSI---DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             ec-ccccHHHHHHhccCC---CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence            95 557899999765432   3445 78899999999999999998   99999999999996 5789999999999887


Q ss_pred             CCCccc-cccccccccccchhhcccC-----------CCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          794 EDKTHI-STRIAGTIGYMAPEYAMRG-----------YLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       794 ~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      .+.... ....+||+.||+||.+...           ..++++||||+|||||+|+.|++||.
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~  573 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG  573 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence            665443 2346899999999988532           36789999999999999999999995

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.96  E-value=9.9e-29  Score=265.96  Aligned_cols=193  Identities=32%  Similarity=0.418  Sum_probs=166.1

Q ss_pred             eeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCch
Q 002899          646 VGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL  721 (869)
Q Consensus       646 IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL  721 (869)
                      ||+|+||+||+|... +|+.||+|.+....   ......+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 68899999886532   22345677899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccccc
Q 002899          722 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST  801 (869)
Q Consensus       722 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  801 (869)
                      .+++.....   ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||.+........  ..
T Consensus        81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~  152 (277)
T cd05577          81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IK  152 (277)
T ss_pred             HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--cc
Confidence            998865432   25899999999999999999999997   99999999999999999999999999876543211  12


Q ss_pred             cccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       802 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ...++..|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus       153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  197 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR  197 (277)
T ss_pred             cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence            245778999999998888999999999999999999999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=1.3e-28  Score=265.22  Aligned_cols=191  Identities=30%  Similarity=0.430  Sum_probs=158.7

Q ss_pred             eeeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHH---HHHhcCCCceeeEEeEEeeCceEEEEEEecc
Q 002899          645 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIG---MISAQQHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       645 ~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~---~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      +||+|+||.||+|... +++.||+|.+.....   .....+..|..   .++...||+|+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 588999998865421   11223444433   4445689999999999999999999999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      +|+|.+++....     .+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        81 g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~  152 (278)
T cd05606          81 GGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  152 (278)
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence            999998885432     6899999999999999999999987   99999999999999999999999999875543221


Q ss_pred             cccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          798 HISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                         ....|+..|+|||++..+ .++.++||||+|+++|||++|+.||...
T Consensus       153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence               224689999999998754 6889999999999999999999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.96  E-value=6.3e-29  Score=268.35  Aligned_cols=199  Identities=29%  Similarity=0.499  Sum_probs=168.1

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +|+..+.||+|++|.||+|+.. +++.||||++.....  .....+..|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999975 688999998865432  2235788999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +. ++|.+++....   ...+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||++......
T Consensus        81 ~~-~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          81 LH-QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             cc-cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            96 57888775532   236899999999999999999999987   999999999999999999999999998765432


Q ss_pred             CccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ... .....+++.|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus       154 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~  203 (284)
T cd07860         154 VRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  203 (284)
T ss_pred             ccc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            211 1223467899999988654 468899999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=2.4e-29  Score=267.84  Aligned_cols=189  Identities=27%  Similarity=0.443  Sum_probs=160.0

Q ss_pred             CeeeccCceEEEEEEEcC--------CcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          644 NKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~--------g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +.||+|+||.||+|....        ...||+|.+........++|.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998642        234888888665555567889999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc--------EEEeecC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN--------AKISDFG  787 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~--------~kl~DFG  787 (869)
                      +++|+|.+++.....    .+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.        ++++|||
T Consensus        81 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          81 VKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             CCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccc
Confidence            999999999976532    5789999999999999999999987   999999999999987765        5999999


Q ss_pred             CceeecCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCC-CCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGK-SNTN  844 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~-~p~~  844 (869)
                      .+......     ....+++.|+|||++... .++.++||||||+++|||++|. .|+.
T Consensus       154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~  207 (258)
T cd05078         154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS  207 (258)
T ss_pred             cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChh
Confidence            88654321     124578899999998764 5789999999999999999995 5543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.96  E-value=1.1e-28  Score=261.85  Aligned_cols=199  Identities=29%  Similarity=0.452  Sum_probs=171.6

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +|+..+.||+|+||.||+|... +++.+|+|.+...  .......+..|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4778899999999999999964 6788999988654  233456788999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-CcEEEeecCCceeecC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEE  794 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~-~~~kl~DFGla~~~~~  794 (869)
                      +++++|.+++....   ...+++..+.+++.++++||+|||+++   ++||||+|+||+++++ +.+||+|||++.....
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          81 APGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             CCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            99999999986543   225899999999999999999999987   9999999999999855 4689999999987653


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...  .....++..|+|||.+.+...+.++||||||+++|||++|+.||..
T Consensus       155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  203 (256)
T cd08220         155 KSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA  203 (256)
T ss_pred             Ccc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc
Confidence            321  2234678899999999988889999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.96  E-value=7.5e-29  Score=263.21  Aligned_cols=195  Identities=29%  Similarity=0.481  Sum_probs=166.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEecc
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      ++|++.+.||+|+||.||++.. +++.||+|.++...  ....+.+|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4578899999999999999975 57789999986532  346788999999999999999999998765 4799999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      +++|.+++.....   ..+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        82 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~  155 (254)
T cd05083          82 KGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD  155 (254)
T ss_pred             CCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCC
Confidence            9999999865432   25789999999999999999999987   99999999999999999999999999876432211


Q ss_pred             cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                          ....+..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus       156 ----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  201 (254)
T cd05083         156 ----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM  201 (254)
T ss_pred             ----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence                1234568999999988889999999999999999997 99998543

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=8.9e-29  Score=266.89  Aligned_cols=201  Identities=29%  Similarity=0.480  Sum_probs=171.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-----CCcEEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeEEee--CceE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQL  709 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-----~g~~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~~--~~~~  709 (869)
                      +.|+..+.||+|+||.||+|.+.     +++.||||.+...... ..++|..|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45677899999999999999864     3678999998765443 46789999999999999999999999887  5578


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||+++++|.+++.....    .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccc
Confidence            999999999999999976532    5899999999999999999999987   999999999999999999999999999


Q ss_pred             eeecCCCcc--ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .........  ......++..|+|||.+....++.++||||||++++||++|+.|+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  214 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS  214 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence            876532221  11122345679999999888899999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=236.40  Aligned_cols=220  Identities=23%  Similarity=0.383  Sum_probs=179.3

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +|+-.++||+|.||+||||+.. +++.||+|++.....  ..-....+|+-+++.++|.|||++++....+..+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4555678999999999999965 578999998865432  2234678999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +.. .|..+.-...    ..++.+..+.++.|+++||.++|+++   +.|||+||.|.|++.+|+.|++|||+++.++..
T Consensus        83 cdq-dlkkyfdsln----g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             hhH-HHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            974 5655553332    25889999999999999999999997   999999999999999999999999999988654


Q ss_pred             CccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcchhhHHHHHHHhhccccc
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEEIY  867 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~w~~~~~~~~~~  867 (869)
                      -...+ .-+-|..|.+|.++.+. -|+...|+||.|||+.|+.. |++-|...+-+++...+-|+....+|+-|
T Consensus       155 vrcys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~w  227 (292)
T KOG0662|consen  155 VRCYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQW  227 (292)
T ss_pred             eEeee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccC
Confidence            33222 23458899999999876 58889999999999999987 55556555556666777777777777665

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=282.53  Aligned_cols=212  Identities=25%  Similarity=0.447  Sum_probs=176.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCC-cEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDG-TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g-~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      +.|.+...||.|+||.||||+.++. -..|.|++...+.....+|+-||+||....||+||++++.|+.++.+++..|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            3455677899999999999997754 345678887777777889999999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      .||-....+..-+    ..+.+.++.-++.|++.||.|||++.   |||||||+.|||++-||.++|+|||.+...... 
T Consensus       112 ~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-  183 (1187)
T KOG0579|consen  112 GGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-  183 (1187)
T ss_pred             CCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-
Confidence            9999988775543    27899999999999999999999997   999999999999999999999999987544321 


Q ss_pred             ccccccccccccccchhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHH
Q 002899          797 THISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAY  859 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~  859 (869)
                      ......+.|||.|||||+..     ..+|+.++|||||||.|.||..+.+|-..  -.-+..|++.+.
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe--lnpMRVllKiaK  249 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE--LNPMRVLLKIAK  249 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc--cchHHHHHHHhh
Confidence            12223478999999999875     35799999999999999999999988743  123444544443

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.96  E-value=1.1e-28  Score=264.12  Aligned_cols=201  Identities=27%  Similarity=0.480  Sum_probs=168.9

Q ss_pred             CCCCCCeeeccCceEEEEEEEcC--CcEEEEEEecccC----------chhhHHHHHHHHHHHh-cCCCceeeEEeEEee
Q 002899          639 NFDPANKVGEGGFGSVYKGILSD--GTVIAVKQLSSKS----------RQGNREFVNEIGMISA-QQHPNLVKLYGCCVE  705 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~~--g~~VAvK~~~~~~----------~~~~~~f~~E~~~l~~-l~H~nIv~l~~~~~~  705 (869)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+....          .....++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999765  6889999875321          1223457788888765 799999999999999


Q ss_pred             CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCEEEcCCCcEEEe
Q 002899          706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKIS  784 (869)
Q Consensus       706 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NILl~~~~~~kl~  784 (869)
                      ++..++||||+++++|.+++.... .....+++..++.++.|++.||.|||+ .+   ++|+||+|+||+++.++.+||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~  156 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTIT  156 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEe
Confidence            999999999999999998874321 112368999999999999999999996 44   9999999999999999999999


Q ss_pred             ecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          785 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       785 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |||++.......  ......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       157 dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~  215 (269)
T cd08528         157 DFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS  215 (269)
T ss_pred             cccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence            999998765432  22335688899999999988899999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=1.5e-28  Score=262.10  Aligned_cols=192  Identities=25%  Similarity=0.396  Sum_probs=168.0

Q ss_pred             eeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCch
Q 002899          646 VGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL  721 (869)
Q Consensus       646 IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL  721 (869)
                      ||+|+||.||+|... +++.||+|++....   ....+.+..|+++++.++||||+++++++.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999975 48899999986542   23356789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccccc
Q 002899          722 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST  801 (869)
Q Consensus       722 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  801 (869)
                      .+++....     .+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......  ...
T Consensus        81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~  150 (262)
T cd05572          81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW  150 (262)
T ss_pred             HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence            99996643     4789999999999999999999987   9999999999999999999999999998765432  122


Q ss_pred             cccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       802 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      ...+++.|+|||.+....++.++|+||+|+++|||++|+.||....
T Consensus       151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence            3467889999999988889999999999999999999999996543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-31  Score=262.76  Aligned_cols=199  Identities=28%  Similarity=0.442  Sum_probs=162.6

Q ss_pred             CCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHH-HhcCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          642 PANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMI-SAQQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       642 ~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l-~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      ....||.|+||+|+|-.++ .|+..|||++..... .+.+++..|.+.. +.-+.||||+++|.+..++..|+.||.|+-
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~  147 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI  147 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence            3467999999999999976 689999999987654 5577888888754 456899999999999999999999999974


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                       |+..+-..-.......+++.-.-.|+...++||.||-+..  +|||||+||+|||++..|.+||||||++-.+..  +.
T Consensus       148 -SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--Si  222 (361)
T KOG1006|consen  148 -SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SI  222 (361)
T ss_pred             -hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--HH
Confidence             5543221111112336888888899999999999998765  599999999999999999999999999876653  33


Q ss_pred             ccccccccccccchhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..+..+|...|||||.+..  ..++.++|||||||.|||+.||+.|++.
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~  271 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK  271 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence            3455678899999999864  3589999999999999999999999853

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.96  E-value=1.8e-28  Score=266.31  Aligned_cols=201  Identities=28%  Similarity=0.435  Sum_probs=166.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ++|++.+.||+|++|.||+|... +++.||+|.+.....  .....+.+|++++++++||||+++++++..++..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999975 688999998865422  234568899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCcEEEeecCCceeec
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYE  793 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~-~~~~kl~DFGla~~~~  793 (869)
                      |++ ++|.+++.....   ..+++..+..++.||+.||+|||+++   ++||||+|+||+++. ++.+||+|||++....
T Consensus        82 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             ccc-ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            997 477776644321   24688889999999999999999987   999999999999985 5679999999997654


Q ss_pred             CCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .... ......+++.|+|||++.+ ..++.++||||+|+++|||++|++||...
T Consensus       155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~  207 (294)
T PLN00009        155 IPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD  207 (294)
T ss_pred             CCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            3221 1122356889999998865 45789999999999999999999999653

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.96  E-value=1.7e-28  Score=264.87  Aligned_cols=201  Identities=29%  Similarity=0.503  Sum_probs=169.5

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      +|++.+.||+|++|.||+|+.. +|+.||||+++..... ....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5788999999999999999975 6889999998765332 3456778999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++ +|.+++.....  ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          81 DK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             Cc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            85 78887754432  236899999999999999999999987   9999999999999999999999999987554322


Q ss_pred             ccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      . ......+++.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus       155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  204 (284)
T cd07836         155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT  204 (284)
T ss_pred             c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1 11223568899999988653 5788999999999999999999998654

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=1.5e-28  Score=266.99  Aligned_cols=203  Identities=25%  Similarity=0.356  Sum_probs=167.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCce-----
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQ-----  708 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~~-----  708 (869)
                      ++|++.+.||+|+||.||+|... +++.||+|+++....  .....+.+|++++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999975 689999998765432  22457888999999995 6999999999887665     


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCcEEEeecC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFG  787 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~-~~~~kl~DFG  787 (869)
                      .++||||+++ +|.+++..........+++..+..++.||+.||+|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 7888776543322346899999999999999999999987   999999999999998 8899999999


Q ss_pred             CceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ++......... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  214 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG  214 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence            98765432211 122346789999998865 4578999999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.96  E-value=5.8e-29  Score=266.27  Aligned_cols=199  Identities=32%  Similarity=0.519  Sum_probs=165.1

Q ss_pred             CeeeccCceEEEEEEEcC-------CcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          644 NKVGEGGFGSVYKGILSD-------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~-------g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +.||+|+||.||+|...+       ++.+|+|.+.... .....+|.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2578999876543 23466889999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcc--cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-----cEEEeecCC
Q 002899          716 MKNNCLSRAIFGKDTE--YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-----NAKISDFGL  788 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~-----~~kl~DFGl  788 (869)
                      +++++|.+++......  ....+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998653211  1234789999999999999999999987   99999999999999877     899999999


Q ss_pred             ceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          789 AKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       789 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      +........ .......++..|+|||++..+.++.++||||||+++|||++ |+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~  216 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA  216 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence            875533221 11112345678999999998999999999999999999998 9999854

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.96  E-value=1.4e-28  Score=266.05  Aligned_cols=201  Identities=31%  Similarity=0.578  Sum_probs=176.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++.|+..+.||+|+||.||+|... +++.||+|++..... ....+.+|+++++.++|+|++++++++...+..++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999999986 688999999876544 46678899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++++|.+++....    ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        96 ~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          96 YMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             ccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            999999999997643    26899999999999999999999987   99999999999999999999999998865543


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ... ......++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~  218 (286)
T cd06614         169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR  218 (286)
T ss_pred             chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence            221 11224578899999999888899999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=250.43  Aligned_cols=197  Identities=28%  Similarity=0.500  Sum_probs=166.0

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc-CchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEEEec
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .+....||.|..|.|+|++.+ .|..+|||.+... +.+..++++..++++.+- .+|.||+.+|||..+..+++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            344577999999999999975 5899999988655 555677888888877665 4899999999999999999999998


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      .. .+.+++..-.    .++++..+-++...+.+||.||.+++  .|+|||+||+|||+|+.|.+|+||||++-.+.+..
T Consensus       174 s~-C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  174 ST-CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HH-HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            64 4555554332    26888888899999999999998876  59999999999999999999999999998876543


Q ss_pred             ccccccccccccccchhhccc---CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                        ..++.+|.+.|||||.+.-   ..|+.++|||||||.++||.||+.||..
T Consensus       247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~  296 (391)
T KOG0983|consen  247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG  296 (391)
T ss_pred             --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence              3455689999999999863   4789999999999999999999999965

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.96  E-value=5.4e-29  Score=265.82  Aligned_cols=198  Identities=26%  Similarity=0.480  Sum_probs=173.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|+..+.||+|+||.||+|... +++.||+|.+.... ....+++.+|++++++++||||+++++.+..++..++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778889999999999999976 68899999887653 34456789999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      +++++|.+++....    ..+++..+.+++.|++.||+|||+ .+   ++||||||+||++++++.++|+|||.+.....
T Consensus        81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          81 MDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             cCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            99999999886542    368899999999999999999999 76   99999999999999999999999999876543


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....   ...++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       154 ~~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  201 (265)
T cd06605         154 SLAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP  201 (265)
T ss_pred             HHhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence            2211   15678899999999888999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.96  E-value=1.4e-28  Score=262.03  Aligned_cols=206  Identities=27%  Similarity=0.456  Sum_probs=171.7

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEee--CceEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLVY  713 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~  713 (869)
                      +|++.+.||+|+||.||+|... +++.||+|.+...  .....+++..|++++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999864 6789999988643  23345678899999999999999999998764  45679999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS--RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||+++++|.+++.... .....+++..++.++.|++.||+|||..+  ...++|+||+|+||+++.++.+||+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            9999999999886532 12346899999999999999999999332  23499999999999999999999999999987


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ....... .....+++.|+|||++....++.++||||||+++++|++|+.||...
T Consensus       160 ~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  213 (265)
T cd08217         160 LGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR  213 (265)
T ss_pred             ccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence            6543321 22346889999999999888999999999999999999999999653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.96  E-value=1.5e-28  Score=266.82  Aligned_cols=200  Identities=28%  Similarity=0.440  Sum_probs=168.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLV  712 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV  712 (869)
                      ++|++.+.||+|+||.||+|... +++.+|+|.++....  .....+.+|++++.+++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999976 588999999864432  2234567899999999999999999999877  889999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++ +|.+.+.....    .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        85 ~e~~~~-~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             ehhcCc-CHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            999984 88888765432    5899999999999999999999998   999999999999999999999999998876


Q ss_pred             cCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ...... .....+++.|+|||.+.+. ..+.++|+||+|+++|||++|++||...
T Consensus       157 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~  210 (293)
T cd07843         157 GSPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK  210 (293)
T ss_pred             cCCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            543221 1224568899999988654 4689999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=1.2e-28  Score=267.36  Aligned_cols=192  Identities=28%  Similarity=0.527  Sum_probs=168.2

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCchh
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS  722 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~  722 (869)
                      .+||+|+||.||+|... +++.||||++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            56999999999999874 68899999986655555677899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcccccc
Q 002899          723 RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR  802 (869)
Q Consensus       723 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  802 (869)
                      +++...      .+++.....++.|++.|++|||+.+   ++||||+|+||++++++.++|+|||++........ ....
T Consensus       106 ~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~  175 (292)
T cd06657         106 DIVTHT------RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS  175 (292)
T ss_pred             HHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence            877432      4789999999999999999999987   99999999999999999999999999876543221 1223


Q ss_pred             ccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       803 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..+++.|+|||.+....++.++|+||+|+++|||++|+.||..
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~  218 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN  218 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            4678899999999888889999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.96  E-value=1.7e-28  Score=264.92  Aligned_cols=198  Identities=29%  Similarity=0.476  Sum_probs=168.7

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceEEEEEE
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVYE  714 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~E  714 (869)
                      |++.+.||+|+||.||+|... +++.+|+|++....  ....+.+.+|++++++++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999976 57899999997653  33346788999999999999999999999988  88999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++ +|.+++....    ..+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          81 YMDH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             cccc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            9985 7887775442    26899999999999999999999987   99999999999999999999999999987755


Q ss_pred             CCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..........++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~  204 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG  204 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            43222233456788999997764 4678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.96  E-value=3.2e-28  Score=256.89  Aligned_cols=199  Identities=33%  Similarity=0.588  Sum_probs=176.3

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEecc
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      +|+..+.||+|++|.||++... +++.+++|++........+++.+|++++++++|+|++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4677899999999999999976 688999999977655566789999999999999999999999999999999999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      +++|.+++....    ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||.+........
T Consensus        81 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          81 GGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             CCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence            999999886542    36899999999999999999999987   99999999999999999999999999877654332


Q ss_pred             cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                        .....++..|+|||.+.....+.++||||||++++||++|+.||...
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence              22356788999999998888999999999999999999999998643

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.96  E-value=1.9e-28  Score=268.03  Aligned_cols=195  Identities=31%  Similarity=0.511  Sum_probs=166.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      +.|+..+.||+|+||.||+|... +++.||+|++....   ....+++.+|+++++.++||||+++.+++.+++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999975 68899999886432   233457889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||++ |++.+.+....    ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++....
T Consensus        95 e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          95 EYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             HhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            9997 56666664322    25899999999999999999999987   9999999999999999999999999987654


Q ss_pred             CCCccccccccccccccchhhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...     ...+++.|+|||++.   ...++.++||||||+++|||++|+.||..
T Consensus       167 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~  216 (307)
T cd06607         167 PAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (307)
T ss_pred             CCC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence            322     235788999999874   45688899999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=8.8e-30  Score=279.38  Aligned_cols=197  Identities=27%  Similarity=0.428  Sum_probs=170.0

Q ss_pred             CCCeeeccCceEEEEEEEc--CCc--EEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          642 PANKVGEGGFGSVYKGILS--DGT--VIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       642 ~~~~IG~G~fG~Vyka~~~--~g~--~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      ..++||+|.||.|++|.|.  +|+  .||||.+...... ...+|++|+.+|.+++|||++++||...+ ....||||.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            4578999999999999986  343  5899999876544 56899999999999999999999999987 6788999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      +.|||.+.|+..   ....|.......++.|||.||.||..++   +|||||..+|+||-....+||+|||+.+.+....
T Consensus       193 plGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  193 PLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             ccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            999999999772   2346888999999999999999999987   9999999999999999999999999999886544


Q ss_pred             ccc--cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          797 THI--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       797 ~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ...  .....-.+.|+|||.+....++.++|||+|||.+|||+| |..||-.
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G  318 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG  318 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence            322  222334679999999999999999999999999999999 6677754

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=1.6e-28  Score=268.74  Aligned_cols=201  Identities=30%  Similarity=0.470  Sum_probs=167.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch--hhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~--~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l  711 (869)
                      .++|++.+.||+|+||.||+|... +|+.||+|+++.....  ....+.+|++++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467889999999999999999975 6899999998654322  233567899999999999999999998764  56899


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++ +|.+++....    ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++..
T Consensus        86 v~e~~~~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEecCCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeee
Confidence            9999975 7877775432    36899999999999999999999998   99999999999999999999999999987


Q ss_pred             ecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ....... .....+++.|+|||.+.+ ..++.++||||+|+++|||++|++||...
T Consensus       158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~  212 (309)
T cd07845         158 YGLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK  212 (309)
T ss_pred             cCCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            6543221 122345778999998865 45789999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.96  E-value=1.9e-28  Score=267.07  Aligned_cols=203  Identities=28%  Similarity=0.436  Sum_probs=168.7

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc----
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----  707 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~----  707 (869)
                      ...++|++.+.||+|+||.||+|... +++.||+|+++....  .....+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999976 588999999865432  22356778999999999999999999987654    


Q ss_pred             ------eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcE
Q 002899          708 ------QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA  781 (869)
Q Consensus       708 ------~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~  781 (869)
                            ..++|+||+++ ++...+....    ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcE
Confidence                  78999999986 5666664432    26899999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          782 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       782 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ||+|||++...............++..|+|||.+.+ ..++.++|||||||+++||++|++||..
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~  220 (302)
T cd07864         156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA  220 (302)
T ss_pred             EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            999999998765433222222346778999998764 4578899999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.96  E-value=2e-28  Score=262.81  Aligned_cols=203  Identities=27%  Similarity=0.434  Sum_probs=165.5

Q ss_pred             CCCCCeeeccCceEEEEEEEc----CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc------
Q 002899          640 FDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------  707 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~----~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~------  707 (869)
                      |.+.++||+|+||.||+|.+.    +++.||||++....  ....+++.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999864    36789999986542  334567889999999999999999999886532      


Q ss_pred             eEEEEEEeccCCchhhhhhcCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                      ..++++||+++|+|.+++..... .....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            24789999999999887753321 11235789999999999999999999987   999999999999999999999999


Q ss_pred             CCceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          787 GLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       787 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      |+++........ ......+++.|++||.+....++.++||||||+++|||++ |++||..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~  218 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG  218 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC
Confidence            998866432211 1122345678999999988889999999999999999999 8888854

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=9.7e-29  Score=265.00  Aligned_cols=205  Identities=30%  Similarity=0.500  Sum_probs=171.7

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCc-----
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN-----  707 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~-----  707 (869)
                      .++++|++.+.||+|++|.||+|... +++.+++|++..... ...+|.+|+++++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35688999999999999999999975 578899998875433 356789999999998 7999999999997644     


Q ss_pred             -eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          708 -QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       708 -~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                       ..++||||+++++|.+++.... .....+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.+||+||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence             4899999999999998886432 11236899999999999999999999987   999999999999999999999999


Q ss_pred             CCceeecCCCccccccccccccccchhhccc-----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          787 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       787 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |++......... .....++..|+|||++..     ..++.++||||||+++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  220 (275)
T cd06608         158 GVSAQLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD  220 (275)
T ss_pred             ccceecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence            998765432221 223458889999998753     3467899999999999999999999953

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=241.79  Aligned_cols=202  Identities=26%  Similarity=0.410  Sum_probs=163.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc-CchhhHHHHHHHHHHH-hcCCCceeeEEeEEeeCceEEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMIS-AQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~-~~~~~~~f~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      +.....+.||+|++|.|=+-++. +|+..|||++... ..+..++...|+.+.. ...+|.+|.++|...+++..++.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            34444577999999999888864 7999999998765 3455677788887654 4579999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      .|.. ||..+-. +--.....+++..+-+|+..+.+||.|||++-  .+||||+||+|||++.+|++|+||||++-.+.+
T Consensus       126 ~M~t-Sldkfy~-~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  126 LMDT-SLDKFYR-KVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             Hhhh-hHHHHHH-HHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            9974 5654321 11122336899999999999999999999875  599999999999999999999999999987764


Q ss_pred             CCccccccccccccccchhhccc----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .-.  .+..+|...|||||.+..    ..|+.|+||||||+.+.||.+++.|+..
T Consensus       202 SiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  202 SIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             hhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            332  223467889999998863    3689999999999999999999999864

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.96  E-value=1.3e-28  Score=272.81  Aligned_cols=199  Identities=27%  Similarity=0.427  Sum_probs=166.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC-----ceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~  709 (869)
                      +++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            568999999999999999999864 68999999986432 23356788899999999999999999887654     357


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++|+||+++ ++.+.+...      .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        84 ~lv~e~~~~-~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             EEEehhccc-CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccce
Confidence            999999975 777776443      5899999999999999999999997   999999999999999999999999998


Q ss_pred             eeecCCCccc--cccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKTHI--STRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..........  .....|++.|+|||.+.. ..++.++||||+||++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~  212 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG  212 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            7664322211  123467899999998654 5688999999999999999999999954

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-30  Score=301.74  Aligned_cols=201  Identities=32%  Similarity=0.472  Sum_probs=170.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      +-++.....||.|.||.||.|.. ++|...|||.++..  .....+...+|+.++..++|||+|+++|+-.+.++.+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            34567778999999999999994 57888999976543  3334567789999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      |||++|+|++.+...+     ..++.....+..|++.|++|||++|   ||||||||.||+|+.+|.+|++|||.|....
T Consensus      1314 EyC~~GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHhccCcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence            9999999999986543     3567777888999999999999998   9999999999999999999999999998775


Q ss_pred             CCCc---cccccccccccccchhhcccC---CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKT---HISTRIAGTIGYMAPEYAMRG---YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....   ..-...+||+.|||||++.+.   ....++||||+||++.||+||+.||..
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~ 1443 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE 1443 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh
Confidence            4321   112347899999999999754   356689999999999999999999954

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=3e-28  Score=266.42  Aligned_cols=201  Identities=26%  Similarity=0.432  Sum_probs=165.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc-------
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-------  707 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~-------  707 (869)
                      ++|++.+.||+|+||.||+|... +++.||||.+.....  .....+.+|++++++++||||+++++++...+       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            46889999999999999999975 688999998864322  22345678999999999999999999987654       


Q ss_pred             -eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          708 -QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       708 -~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                       ..++||||+++ +|.+.+....    ..+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.+||+||
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence             35999999975 6777765432    25899999999999999999999987   999999999999999999999999


Q ss_pred             CCceeecCCCcc---ccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          787 GLAKLYEEDKTH---ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       787 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |++.........   ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~  227 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN  227 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            999766432211   11224567899999988654 4688999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=1.5e-28  Score=272.41  Aligned_cols=202  Identities=29%  Similarity=0.467  Sum_probs=168.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC--ceE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG--NQL  709 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~--~~~  709 (869)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...  .......+..|+.++.++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4567888999999999999999975 5789999988543  223345677899999999 999999999998653  368


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||++ ++|..++...      .++|..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        85 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~  154 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLA  154 (337)
T ss_pred             EEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccch
Confidence            99999998 5888877543      5789999999999999999999987   999999999999999999999999999


Q ss_pred             eeecCCCc----cccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          790 KLYEEDKT----HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       790 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      ........    .......|++.|+|||++.. ..++.++||||||+++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~  217 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS  217 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence            86643321    12223568889999998754 467889999999999999999999996543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.96  E-value=1.8e-28  Score=261.27  Aligned_cols=192  Identities=28%  Similarity=0.448  Sum_probs=166.7

Q ss_pred             eeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCch
Q 002899          646 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL  721 (869)
Q Consensus       646 IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL  721 (869)
                      ||+|+||.||+++.. +++.+|+|.+.....   .....+.+|++++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999986 489999999865433   3456788899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc----
Q 002899          722 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT----  797 (869)
Q Consensus       722 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~----  797 (869)
                      .+++....     .+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||++........    
T Consensus        81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  152 (265)
T cd05579          81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN  152 (265)
T ss_pred             HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence            99886543     5899999999999999999999987   99999999999999999999999999876533211    


Q ss_pred             ---cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          798 ---HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       798 ---~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                         .......++..|+|||.......+.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~  203 (265)
T cd05579         153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG  203 (265)
T ss_pred             cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence               112234578899999999888889999999999999999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=5.5e-28  Score=255.92  Aligned_cols=198  Identities=30%  Similarity=0.522  Sum_probs=174.3

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +|++.+.||+|++|.||+|... +++.||+|.+.....  .....+.+|++++++++|||++++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999865 578999999876543  4456789999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++...     ..+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            9999999988654     26899999999999999999999987   999999999999999999999999999877543


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ... .....++..|+|||.......+.++||||+|++++||++|+.||..
T Consensus       153 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~  201 (254)
T cd06627         153 SKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD  201 (254)
T ss_pred             ccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            322 2234678899999999887889999999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.96  E-value=1.8e-28  Score=260.38  Aligned_cols=200  Identities=26%  Similarity=0.451  Sum_probs=171.2

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +|++.+.||+|+||.||+|... +|..||+|.+....  ....+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999976 57889999886532  23345788999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-cEEEeecCCceeecC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLYEE  794 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~  794 (869)
                      +++++|.+++.....   ..+++..+..++.|+++||+|||+.+   ++|+||||+||++++++ .+||+|||.+.....
T Consensus        81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          81 CDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            999999998865432   25799999999999999999999987   99999999999999885 469999999876653


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ... ......|++.|+|||+.....++.++||||||++++||++|+.||..
T Consensus       155 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  204 (257)
T cd08225         155 SME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG  204 (257)
T ss_pred             Ccc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            322 12234588899999999888899999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.96  E-value=3.1e-28  Score=262.81  Aligned_cols=198  Identities=28%  Similarity=0.484  Sum_probs=167.5

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      |++.+.||+|++|.||+|... +|+.||+|++....  ......+..|+++++.++|||++++++++.+++..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999965 78999999886543  222357889999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      + ++|.+++.....   ..+++..+..++.|+++||+|||+.+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          81 D-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             C-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            5 689888865432   35899999999999999999999987   9999999999999999999999999987654322


Q ss_pred             ccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .. .....+++.|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus       154 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  202 (283)
T cd07835         154 RT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG  202 (283)
T ss_pred             cc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            11 1223467899999987654 578899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.6e-28  Score=258.02  Aligned_cols=189  Identities=28%  Similarity=0.391  Sum_probs=160.1

Q ss_pred             CeeeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHH-HHhcCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGM-ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      +.||+|+||.||+|... +++.||+|.+.....   .....+..|..+ ....+|+|++++++++..++..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999874 688999999865422   222344455444 4456899999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      ++|.+++....     .+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++.....    
T Consensus        82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----  149 (260)
T cd05611          82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----  149 (260)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence            99999986543     5789999999999999999999987   99999999999999999999999999875432    


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                       .....+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  195 (260)
T cd05611         150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA  195 (260)
T ss_pred             -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC
Confidence             1234578899999999888889999999999999999999999954

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=5.8e-28  Score=260.33  Aligned_cols=195  Identities=28%  Similarity=0.384  Sum_probs=162.5

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcC-CCceeeEEeEEeeC--ceEEEEEE
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEG--NQLLLVYE  714 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~E  714 (869)
                      |++.+.||+|+||.||+|... +++.||+|+++... .........|+.++.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999965 68899999987542 222344567888888885 99999999999987  88999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |++ |++.+.+....    ..+++..+..++.|++.||+|||+.+   ++||||+|+||+++. +.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          81 LMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             cCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            997 57777775432    26899999999999999999999987   999999999999999 9999999999986643


Q ss_pred             CCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....  ....++..|+|||++.. ..++.++||||+||++|||++|+.||..
T Consensus       152 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~  201 (282)
T cd07831         152 KPPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG  201 (282)
T ss_pred             CCCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence            3221  23457889999997654 5678899999999999999999999965

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.96  E-value=3.9e-28  Score=269.94  Aligned_cols=204  Identities=27%  Similarity=0.411  Sum_probs=170.9

Q ss_pred             cHHHHHHHhcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEee
Q 002899          629 TLRQIKAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE  705 (869)
Q Consensus       629 ~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~  705 (869)
                      ..+++..++++|.+.+.||+|+||.||+|.. .+++.||+|+++...  ....+.+.+|++++.+++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            4566777889999999999999999999985 468899999986532  2234567889999999999999999998864


Q ss_pred             C------ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC
Q 002899          706 G------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL  779 (869)
Q Consensus       706 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~  779 (869)
                      .      ...+++++++ +++|.+++...      .+++..+..++.|+++||+|||+.+   |+||||||+||++++++
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~  157 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence            3      3468888876 67888777432      4789999999999999999999998   99999999999999999


Q ss_pred             cEEEeecCCceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          780 NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       780 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .+||+|||++......    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       158 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  221 (345)
T cd07877         158 ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  221 (345)
T ss_pred             CEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999998764322    123457889999998765 56889999999999999999999999643

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=3.2e-28  Score=271.62  Aligned_cols=198  Identities=25%  Similarity=0.345  Sum_probs=168.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------  706 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~------  706 (869)
                      ..++|+..+.||+|+||.||+|... +++.||+|.+...  ......++.+|++++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999965 6899999998643  223345678899999999999999999988643      


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                      ...++||||+++ +|.+.+..       .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Df  162 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  162 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccC
Confidence            346999999974 77776642       2788899999999999999999987   999999999999999999999999


Q ss_pred             CCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          787 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       787 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |+++.......  .....+++.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       163 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  220 (353)
T cd07850         163 GLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT  220 (353)
T ss_pred             ccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence            99987643321  22345788999999999989999999999999999999999999643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=5.3e-28  Score=265.68  Aligned_cols=193  Identities=30%  Similarity=0.501  Sum_probs=164.2

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      |+..+.||+|+||.||+|... ++..||+|++....   .....++..|++++++++|||++++++++.+++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            566788999999999999965 68899999886432   22345788999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      ++ |++.+.+....    ..+++.++..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++......
T Consensus       107 ~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         107 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            97 47777664432    25899999999999999999999987   999999999999999999999999998754322


Q ss_pred             Cccccccccccccccchhhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                           ....+++.|+|||++.   .+.++.++|||||||++|||++|+.||..
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~  226 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  226 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence                 1235788999999874   45688999999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.96  E-value=7e-28  Score=255.44  Aligned_cols=200  Identities=35%  Similarity=0.512  Sum_probs=175.4

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVY  713 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~  713 (869)
                      +|+..+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++++||||+++++.+.+.  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999976 688999999876542  4467889999999999999999999999988  8999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++++|.+++....     .+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||.+....
T Consensus        81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            9999999999986543     6899999999999999999999987   9999999999999999999999999988775


Q ss_pred             CCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          794 EDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       794 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ..... ......++..|+|||.......+.++||||||++++||++|+.||...
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (260)
T cd06606         153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL  206 (260)
T ss_pred             cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            44321 122346788999999998888999999999999999999999998653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=1.8e-28  Score=265.50  Aligned_cols=198  Identities=29%  Similarity=0.500  Sum_probs=163.0

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceEEEEEEe
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +|...+.||+|+||.||++... +++.||+|++.... ......+..|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556678999999999999965 58899999986543 334567889999999986 99999999999999999999999


Q ss_pred             ccCCchhhh---hhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          716 MKNNCLSRA---IFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       716 ~~~gsL~~~---l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ++. ++.++   +....   ...+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.+||+|||++..
T Consensus        85 ~~~-~l~~l~~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          85 MDI-SLDKFYKYVYEVL---KSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             ccC-CHHHHHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            874 44433   22221   13689999999999999999999975 5   99999999999999999999999999876


Q ss_pred             ecCCCccccccccccccccchhhcccC---CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRG---YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......  .....|++.|+|||++...   .++.++||||||+++|||++|+.||..
T Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  212 (288)
T cd06616         158 LVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK  212 (288)
T ss_pred             hccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence            543221  1234578899999998765   689999999999999999999999854

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-28  Score=249.66  Aligned_cols=200  Identities=26%  Similarity=0.378  Sum_probs=173.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHh-cCCCceeeEEeEEeeCceEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      -++|+...+||+|+|.+|..+++. +.+.+|+|+++++.   .++..-.+.|-.+..+ -+||.+|.+..+|+.+..++.
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            357899999999999999999975 67889999987652   2334445667666655 489999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      |.||+++|+|--++..++     .++++.++-+...|.-||.|||++|   ||.||||..|||+|..|++|+.|||+++.
T Consensus       329 vieyv~ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke  400 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE  400 (593)
T ss_pred             EEEEecCcceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence            999999999987776554     6899999999999999999999999   99999999999999999999999999875


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      --.... ....++|||.|+|||++++..|+..+|+|++||+|+||+.|+.||+-
T Consensus       401 ~l~~gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  401 GLGPGD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             CCCCCc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            433222 33458999999999999999999999999999999999999999963

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=4.7e-28  Score=263.12  Aligned_cols=201  Identities=21%  Similarity=0.246  Sum_probs=152.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC----CcEEEEEEecccCchhh-----------HHHHHHHHHHHhcCCCceeeEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQGN-----------REFVNEIGMISAQQHPNLVKLYG  701 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~----g~~VAvK~~~~~~~~~~-----------~~f~~E~~~l~~l~H~nIv~l~~  701 (869)
                      .++|.+.++||+|+||.||+|...+    +..+|+|+.........           .....+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3678999999999999999999754    34566665432221111           11223334456678999999999


Q ss_pred             EEeeCc----eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC
Q 002899          702 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK  777 (869)
Q Consensus       702 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~  777 (869)
                      ++....    ..++++|++.. ++.+.+....     ..++..+..++.|+++||+|||+.+   |+||||||+|||++.
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~  161 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG  161 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence            876543    34677776643 4544443221     3578889999999999999999987   999999999999999


Q ss_pred             CCcEEEeecCCceeecCCCcc------ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          778 DLNAKISDFGLAKLYEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       778 ~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ++.++|+|||+++.+......      ......||+.|+|||+..+..++.++|||||||++|||++|+.||...
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~  236 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF  236 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999876432211      112246899999999999999999999999999999999999999754

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.96  E-value=3.9e-28  Score=262.83  Aligned_cols=199  Identities=28%  Similarity=0.421  Sum_probs=168.3

Q ss_pred             CCCCCCeeeccCceEEEEEEEc----CCcEEEEEEecccC----chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS----RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~----~g~~VAvK~~~~~~----~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~  709 (869)
                      +|++.+.||+|+||.||++...    +++.||||.++...    ....+.+..|++++.++ +||||+++++.+..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4677899999999999999852    56889999886432    12345688899999999 599999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||+++|+|.+++....     .+++..+..++.|+++||+|||+.+   ++||||+|+||+++.++.++|+|||++
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~  152 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLS  152 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccc
Confidence            99999999999998886432     5789999999999999999999987   999999999999999999999999998


Q ss_pred             eeecCCCccccccccccccccchhhcccCC--CCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKTHISTRIAGTIGYMAPEYAMRGY--LTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +..............|+..|+|||.+.+..  .+.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  210 (288)
T cd05583         153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence            765433222222345788999999987654  78899999999999999999999854

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=6.4e-29  Score=269.56  Aligned_cols=214  Identities=23%  Similarity=0.396  Sum_probs=177.4

Q ss_pred             CCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      -|..++.||-|+||.|.++.- ++...+|.|.+.+..   +.......+|-+||.....+.||+|+..|.+++.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            366678899999999999884 446678999886552   3334456788999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec-
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-  793 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~-  793 (869)
                      |++||++-.+|-..+     .+.+..++-++..+..|+++.|..|   +|||||||+|||+|.||++||.|||++.-+. 
T Consensus       710 YIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             ccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence            999999988886554     5788888889999999999999988   9999999999999999999999999975431 


Q ss_pred             --C-----CCcc----------------------------c-----cccccccccccchhhcccCCCCchhHHHHHHHHH
Q 002899          794 --E-----DKTH----------------------------I-----STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT  833 (869)
Q Consensus       794 --~-----~~~~----------------------------~-----~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil  833 (869)
                        +     ...+                            .     ....+||+.|+|||++....++.-+|+||.||||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence              0     0000                            0     0115699999999999999999999999999999


Q ss_pred             HHHHcCCCCCCCC-CCcchhhHHHHHHH
Q 002899          834 LEIVSGKSNTNYR-PNEDFVYLLDWAYV  860 (869)
Q Consensus       834 ~elltG~~p~~~~-~~~~~~~l~~w~~~  860 (869)
                      |||+.|++||... +.+-+..++.|-..
T Consensus       862 ~em~~g~~pf~~~tp~~tq~kv~nw~~~  889 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADTPGETQYKVINWRNF  889 (1034)
T ss_pred             HHHhhCCCCccCCCCCcceeeeeehhhc
Confidence            9999999999764 45566677777543

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.96  E-value=9.1e-28  Score=254.57  Aligned_cols=203  Identities=26%  Similarity=0.450  Sum_probs=176.3

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +|++.+.||+|+||.||++... +++.||+|++.....  ...+++.+|+++++.++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999975 588999999876533  4566788999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+.+..... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+......
T Consensus        81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999998866421 1247899999999999999999999997   999999999999999999999999998776543


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      . .......|++.|+|||......++.++||||+|+++++|++|+.||...
T Consensus       157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  206 (258)
T cd08215         157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE  206 (258)
T ss_pred             c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence            2 1222346888999999998888999999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.95  E-value=4.2e-28  Score=257.28  Aligned_cols=201  Identities=32%  Similarity=0.490  Sum_probs=173.8

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +|++.+.||+|+||.||++... +++.+|+|.+....  .....++.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999865 67899999986542  33456788999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++.... .....+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            99999999886532 12246899999999999999999999987   999999999999999999999999999776543


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .   .....+++.|+|||.+.+..++.++|+||+|++++||++|+.||...
T Consensus       157 ~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~  204 (256)
T cd08530         157 M---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR  204 (256)
T ss_pred             C---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            1   22245788999999999888999999999999999999999999643

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-29  Score=272.34  Aligned_cols=251  Identities=20%  Similarity=0.224  Sum_probs=188.3

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI  132 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  132 (869)
                      ..++.|++++|.|...-+..|.++++|++++|.+|.++.++. ..... +|+.|+|.+|.|+.+-...++.++.|+.|||
T Consensus        78 ~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~-f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDL  156 (873)
T KOG4194|consen   78 SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPR-FGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDL  156 (873)
T ss_pred             cceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhccc-ccccccceeEEeeeccccccccHHHHHhHhhhhhhhh
Confidence            357789999999998888899999999999999999986543 33333 7999999999999888899999999999999


Q ss_pred             cccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCC
Q 002899          133 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP  212 (869)
Q Consensus       133 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  212 (869)
                      |.|.|+.+....|..-.+|++|+|++|+|+......|.++.+|..|.|+.|+++...+..|.++++|+.|+|..|+|.-.
T Consensus       157 SrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv  236 (873)
T KOG4194|consen  157 SRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV  236 (873)
T ss_pred             hhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee
Confidence            99999966666788888999999999999988888899999999999999999988888899999999999999998855


Q ss_pred             chHhhhcCCCCCEEEcCCCCCCCCccccccc-ccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcC
Q 002899          213 IPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL  291 (869)
Q Consensus       213 ~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  291 (869)
                      .-..|.+|++|+.|.|..|.+.......+-. .++++|+|+.|+++.....++-+++.|+.|+||+|.|..+.++++...
T Consensus       237 e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft  316 (873)
T KOG4194|consen  237 EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT  316 (873)
T ss_pred             hhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhc
Confidence            4667777777777777777766554433322 244444444444444444444444444444444444444444444444


Q ss_pred             CCCCEEEeeCCcCC
Q 002899          292 AKTNFMYLTGNKLT  305 (869)
Q Consensus       292 ~~L~~L~Ls~N~l~  305 (869)
                      ++|++|+|++|+|+
T Consensus       317 qkL~~LdLs~N~i~  330 (873)
T KOG4194|consen  317 QKLKELDLSSNRIT  330 (873)
T ss_pred             ccceeEeccccccc
Confidence            44444444444444

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.95  E-value=4e-28  Score=268.70  Aligned_cols=200  Identities=24%  Similarity=0.406  Sum_probs=168.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEee----CceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~----~~~~  709 (869)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            468899999999999999999965 68999999987542  2334667889999999999999999988763    3468


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||+. ++|.+++....     .+++..+..++.||++||+|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~  154 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMA  154 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccc
Confidence            99999996 58888875542     4899999999999999999999987   999999999999999999999999999


Q ss_pred             eeecCCCc---cccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKT---HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ........   .......++..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~  214 (334)
T cd07855         155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG  214 (334)
T ss_pred             eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence            76643221   11123468889999998765 4688999999999999999999999954

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.95  E-value=3.7e-28  Score=261.39  Aligned_cols=201  Identities=28%  Similarity=0.448  Sum_probs=174.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ++|.+.+.||+|+||.||+|... +++.||+|++...   .....+.+.+|++++.+++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999975 6899999998653   2233467888999999998 99999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++++|.+++....     .+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++++|||++...
T Consensus        81 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~  152 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVL  152 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcccccc
Confidence            99999999999886543     6899999999999999999999987   999999999999999999999999998766


Q ss_pred             cCCCc-------------------cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          793 EEDKT-------------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       793 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .....                   .......++..|+|||.......+.++||||||++++||++|+.||...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (280)
T cd05581         153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS  225 (280)
T ss_pred             CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence            43321                   1112245788999999998888999999999999999999999999643

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.95  E-value=9.2e-28  Score=266.73  Aligned_cols=198  Identities=25%  Similarity=0.410  Sum_probs=167.4

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc---
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN---  707 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~---  707 (869)
                      ....++|++.+.||+|+||.||+|... +++.||||++....  ......+..|++++++++||||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            345778999999999999999999854 68999999986432  223456889999999999999999999987643   


Q ss_pred             ---eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEe
Q 002899          708 ---QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS  784 (869)
Q Consensus       708 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~  784 (869)
                         ..++||||+ +++|.+++...      .+++..++.++.|+++||+|||+.+   |+||||||+||+++.++.+||+
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence               458999998 67888777532      5899999999999999999999987   9999999999999999999999


Q ss_pred             ecCCceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          785 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       785 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |||++.......    ....+++.|+|||.+.. ..++.++|+||||+++|+|++|+.||..
T Consensus       161 dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  218 (343)
T cd07880         161 DFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG  218 (343)
T ss_pred             ecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999987654321    22456889999998875 4588999999999999999999999964

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=5.4e-28  Score=267.98  Aligned_cols=200  Identities=28%  Similarity=0.439  Sum_probs=167.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC-----ce
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~-----~~  708 (869)
                      .++|.+.+.||+|+||.||+|... +++.||||.++..  ......++.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457889999999999999999964 6899999998653  233345678899999999999999999987654     34


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .++||||+. ++|.+++....     .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~  154 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGL  154 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcc
Confidence            799999997 67887775432     5899999999999999999999987   99999999999999999999999999


Q ss_pred             ceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +....... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  212 (337)
T cd07858         155 ARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK  212 (337)
T ss_pred             ccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence            98664332 11223457889999998764 46889999999999999999999999653

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.95  E-value=4.9e-28  Score=267.47  Aligned_cols=199  Identities=27%  Similarity=0.428  Sum_probs=171.4

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc-----eEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLL  710 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~  710 (869)
                      +|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999975 48899999987653  344567899999999999999999999988775     789


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      +||||++ ++|.+.+....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||++.
T Consensus        81 lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~  151 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLAR  151 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceE
Confidence            9999998 47888886542     6899999999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCc--cccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          791 LYEEDKT--HISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       791 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .......  .......+++.|+|||++.+. .++.++||||||+++|||++|++||...
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~  210 (330)
T cd07834         152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR  210 (330)
T ss_pred             eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence            7754331  112234578899999999877 8899999999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.95  E-value=1.6e-28  Score=285.82  Aligned_cols=197  Identities=32%  Similarity=0.506  Sum_probs=159.1

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------  706 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~------  706 (869)
                      +-..+|+..++||+||||.|||++.+ ||+.+|||++.... ......+.+|+..+++++|||||+++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34567888999999999999999977 89999999987653 33456788999999999999999998432110      


Q ss_pred             --------------------------------------------------------------------------------
Q 002899          707 --------------------------------------------------------------------------------  706 (869)
Q Consensus       707 --------------------------------------------------------------------------------  706 (869)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHH
Q 002899          707 ---------------------------------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA  753 (869)
Q Consensus       707 ---------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~  753 (869)
                                                       -.+|+-||||+.-++.+.+..+...    -.-....+++++|+.||+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHHHH
Confidence                                             1257888999887777777655321    145677899999999999


Q ss_pred             HHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec------C-----------CCccccccccccccccchhhcc
Q 002899          754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE------E-----------DKTHISTRIAGTIGYMAPEYAM  816 (869)
Q Consensus       754 yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~  816 (869)
                      |+|+.|   ||||||||.||+++++..+||+|||+|....      .           ......+..+||.-|+|||++.
T Consensus       712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            999998   9999999999999999999999999998721      0           0011234578999999999987


Q ss_pred             cC---CCCchhHHHHHHHHHHHHHc
Q 002899          817 RG---YLTSKADVYSFGVVTLEIVS  838 (869)
Q Consensus       817 ~~---~~~~k~DvwSlGvil~ellt  838 (869)
                      +.   .|+.|+|+||+|||++||+.
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc
Confidence            54   49999999999999999985

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.95  E-value=9.5e-28  Score=258.73  Aligned_cols=198  Identities=28%  Similarity=0.452  Sum_probs=169.5

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch--hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~--~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      |++.+.||+|++|.||+|... +++.+++|++......  ....+..|++++++++|+||+++++++..++..++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999975 6889999998765332  3567888999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++ ++.+.+....    ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||.+.......
T Consensus        81 ~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          81 DT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             CC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            85 7877775532    26899999999999999999999987   9999999999999999999999999988775433


Q ss_pred             ccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                       .......++..|+|||.+.+. ..+.++||||+|+++|+|++|+.||...
T Consensus       153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~  202 (283)
T cd05118         153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK  202 (283)
T ss_pred             -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence             112234577899999998766 7899999999999999999999998653

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.95  E-value=9e-28  Score=261.17  Aligned_cols=199  Identities=30%  Similarity=0.538  Sum_probs=164.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEecccC-chhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~-g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      -++|++.+.||+|+||.||+|...+ ++.||||.++... .....++..|++++.+.. ||||+++++++.++...++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3567889999999999999999874 8999999987543 233456777877776664 999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      ||+++ ++.+++....    ..+++..+..++.|++.||+|||+. +   |+||||+|+||++++++.+||+|||++..+
T Consensus        94 e~~~~-~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          94 ELMST-CLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             eccCc-CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            99864 6666554322    2689999999999999999999974 5   999999999999999999999999998765


Q ss_pred             cCCCccccccccccccccchhhcccCC----CCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGY----LTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......  ....++..|+|||++....    ++.++||||||+++|||++|+.||..
T Consensus       166 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  220 (296)
T cd06618         166 VDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN  220 (296)
T ss_pred             cCCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence            432221  2235778999999987543    78899999999999999999999854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.95  E-value=1.7e-27  Score=257.30  Aligned_cols=197  Identities=29%  Similarity=0.473  Sum_probs=164.7

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch--hhHHHHHHHHHHHhc---CCCceeeEEeEEeeCce-----
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQ---QHPNLVKLYGCCVEGNQ-----  708 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~--~~~~f~~E~~~l~~l---~H~nIv~l~~~~~~~~~-----  708 (869)
                      |++.+.||+|+||.||+|+.. +++.||+|+++.....  ....+..|+.++.++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999986 4899999998744222  234566777766655   69999999999998776     


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .+++|||+++ +|.+++.....   ..+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||+
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~  153 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGL  153 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCc
Confidence            8999999974 78887765432   25899999999999999999999987   99999999999999999999999999


Q ss_pred             ceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +..+......  ....++..|+|||++.+..++.++||||||+++|||++|++||..
T Consensus       154 ~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~  208 (287)
T cd07838         154 ARIYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG  208 (287)
T ss_pred             ceeccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence            9876433221  223478899999999988899999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-30  Score=268.26  Aligned_cols=310  Identities=21%  Similarity=0.236  Sum_probs=193.6

Q ss_pred             ceEecCCCCcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhc
Q 002899           44 NVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLT  122 (869)
Q Consensus        44 ~v~C~~~~~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~  122 (869)
                      +..|.|++..  -..+++++-+++ .+|..+.  +.-..|+|..|+|+.+++.+|..+ +|+.|||++|+|+.+.|++|.
T Consensus        38 P~pC~Cs~~~--g~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~  112 (498)
T KOG4237|consen   38 PAPCTCSDVE--GGIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFK  112 (498)
T ss_pred             CCCcccCCCC--CceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhh
Confidence            3445554322  234455555555 4444333  233445555566666666666555 566666666666655566666


Q ss_pred             Cccccccccccc-cccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccE
Q 002899          123 NITTLKNLSIEG-NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK  201 (869)
Q Consensus       123 ~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  201 (869)
                      ++++|..|-+.+ |+|+......|.+|..|+.|.+.-|++.-.....|..+++|..|.|.+|.+..+-...|..+..++.
T Consensus       113 GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~t  192 (498)
T KOG4237|consen  113 GLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKT  192 (498)
T ss_pred             hhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccch
Confidence            665555555444 5555444445555666666666666655555555555666666666666655333335555556666


Q ss_pred             EEccCCc------------------------------------CCCCchHhhhcC-CCCC-EEEcCCCCCCCCccccc-c
Q 002899          202 LHIQGSS------------------------------------LEGPIPASISAL-TSLT-DLRISDLKGSESAFPKL-D  242 (869)
Q Consensus       202 L~L~~N~------------------------------------l~~~~~~~l~~l-~~L~-~L~L~~n~~~~~~~~~~-~  242 (869)
                      +++..|.                                    +..+.+..|... ..+. .+...++....-+...+ .
T Consensus       193 lhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~  272 (498)
T KOG4237|consen  193 LHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKK  272 (498)
T ss_pred             HhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhh
Confidence            6555555                                    322222222211 1111 11111122222222222 2


Q ss_pred             cccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh--hccCCcee
Q 002899          243 KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVD  320 (869)
Q Consensus       243 ~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~l~~l~  320 (869)
                      ..+|++|+|++|+|+.+-+.+|.++..|+.|.|..|+|..+....|.++..|+.|+|.+|+|+...|..+  ..++..|.
T Consensus       273 L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~  352 (498)
T KOG4237|consen  273 LPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLN  352 (498)
T ss_pred             cccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeee
Confidence            3389999999999999999999999999999999999998888899999999999999999998888777  45788899


Q ss_pred             eeccCccCCCCCCCCCCCCCccceeccCCCCCCCCCCcCccCCCCCCCCCccccc
Q 002899          321 ISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYH  375 (869)
Q Consensus       321 ls~N~~~~~~~~p~~C~c~~~~~~~~l~~~~~~~~~~~~~~~~~~~C~~p~~~~~  375 (869)
                      |-.|        ||.|+|.+.|+.+|+++.+  ..+       ..+|+.|...+.
T Consensus       353 l~~N--------p~~CnC~l~wl~~Wlr~~~--~~~-------~~~Cq~p~~~~~  390 (498)
T KOG4237|consen  353 LLSN--------PFNCNCRLAWLGEWLRKKS--VVG-------NPRCQSPGFVRQ  390 (498)
T ss_pred             hccC--------cccCccchHHHHHHHhhCC--CCC-------CCCCCCCchhcc
Confidence            9888        9999999999999999876  223       335666654443

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.95  E-value=6.7e-28  Score=263.75  Aligned_cols=201  Identities=31%  Similarity=0.475  Sum_probs=164.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch--hhHHHHHHHHHHHhcCCCceeeEEeEEeeC-------
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCVEG-------  706 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~--~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~-------  706 (869)
                      .++|++.+.||+|+||.||+|... +++.||+|++......  ....+.+|++++++++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999975 6889999988654322  234677899999999999999999987543       


Q ss_pred             -ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002899          707 -NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD  785 (869)
Q Consensus       707 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~D  785 (869)
                       ...++||||++. ++...+....    ..+++..+..++.|+++||+|||+.+   ++||||||+||++++++.+||+|
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence             346999999975 5666664432    25899999999999999999999998   99999999999999999999999


Q ss_pred             cCCceeecCCCcc----------ccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          786 FGLAKLYEEDKTH----------ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       786 FGla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ||++.........          ......+++.|+|||.+.+. .++.++||||||+++|||++|++||..
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~  229 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG  229 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence            9999765432211          11223567889999987654 578999999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.95  E-value=1.3e-27  Score=263.79  Aligned_cols=200  Identities=27%  Similarity=0.409  Sum_probs=168.6

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEee-Cce
Q 002899          633 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQ  708 (869)
Q Consensus       633 i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~-~~~  708 (869)
                      +..++++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+..|++++.+++||||+++++++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456889999999999999999999865 78999999875432  2334678889999999999999999999876 557


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .++||||+. ++|.+++...      .+++..+..++.|+++||+|||+.+   ++||||+|+||++++++.++|+|||+
T Consensus        85 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~  154 (328)
T cd07856          85 IYFVTELLG-TDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGL  154 (328)
T ss_pred             EEEEeehhc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccc
Confidence            899999985 5888877543      4788889999999999999999987   99999999999999999999999999


Q ss_pred             ceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +.......    ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       155 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~  209 (328)
T cd07856         155 ARIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK  209 (328)
T ss_pred             ccccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            87543221    22356789999998765 56899999999999999999999999653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.3e-27  Score=265.51  Aligned_cols=195  Identities=27%  Similarity=0.428  Sum_probs=163.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc------
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------  707 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~------  707 (869)
                      .++|.+.+.||+|+||.||+|+.. +++.||||+++...  ......+.+|++++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999964 68999999986532  222456889999999999999999999987543      


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                      ..++|+||+.. ++.+...       ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||
T Consensus        94 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             eEEEEeccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCC
Confidence            46999999974 5655441       15789999999999999999999987   9999999999999999999999999


Q ss_pred             CceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +++......    ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       163 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~  218 (342)
T cd07879         163 LARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  218 (342)
T ss_pred             CCcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            987543221    23457889999999876 46889999999999999999999999753

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.95  E-value=2.2e-27  Score=262.94  Aligned_cols=200  Identities=27%  Similarity=0.389  Sum_probs=164.7

Q ss_pred             cCCC-CCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchh--------------hHHHHHHHHHHHhcCCCceeeEEe
Q 002899          638 NNFD-PANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG--------------NREFVNEIGMISAQQHPNLVKLYG  701 (869)
Q Consensus       638 ~~f~-~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~--------------~~~f~~E~~~l~~l~H~nIv~l~~  701 (869)
                      ++|. +.+.||+|+||.||+|... +++.||||++.......              ...+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 4577999999999999965 68899999886542211              125778999999999999999999


Q ss_pred             EEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcE
Q 002899          702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA  781 (869)
Q Consensus       702 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~  781 (869)
                      ++..++..++||||++ |+|.+++....     .+++.....++.|++.||+|||+.+   ++||||+|+||+++.++.+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence            9999999999999997 58888875432     5789999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCceeecCCC-------------ccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          782 KISDFGLAKLYEEDK-------------THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       782 kl~DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +|+|||++.......             ........+++.|+|||.+.+. .++.++||||||+++|||++|++||...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999987665111             0111123467889999988754 4689999999999999999999999653

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.7e-29  Score=259.93  Aligned_cols=213  Identities=28%  Similarity=0.420  Sum_probs=173.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccc--Cchh-----hHHHHHHHHHHHhcCCCceeeEEeEEe-eCc
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQG-----NREFVNEIGMISAQQHPNLVKLYGCCV-EGN  707 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~--~~~~-----~~~f~~E~~~l~~l~H~nIv~l~~~~~-~~~  707 (869)
                      .++|-..++||+|+|+.||||.. ...+.||||+-...  -+..     .+...+|.+|.+.+.||-||++++|+. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            45677788999999999999984 45788999975432  1111     234568899999999999999999986 456


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc---CCCcEEEe
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKIS  784 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~---~~~~~kl~  784 (869)
                      .++-|+||+++.+|.-+|..++     .++++.++.|+.||+.||.||.+.. +||||-||||.||||.   ..|.+||.
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence            7899999999999999997764     5799999999999999999999874 6799999999999995   45889999


Q ss_pred             ecCCceeecCCCcc------ccccccccccccchhhccc----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhH
Q 002899          785 DFGLAKLYEEDKTH------ISTRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYL  854 (869)
Q Consensus       785 DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l  854 (869)
                      |||+++++..+...      .....+||..|++||.+.-    ..++.|+||||.|||+|..+.|+.||..  +..++++
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh--nqsQQdI  693 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH--NQSQQDI  693 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC--chhHHHH
Confidence            99999998754322      2334689999999997643    3688899999999999999999999964  2334444


Q ss_pred             HHH
Q 002899          855 LDW  857 (869)
Q Consensus       855 ~~w  857 (869)
                      ++.
T Consensus       694 Lqe  696 (775)
T KOG1151|consen  694 LQE  696 (775)
T ss_pred             Hhh
Confidence            443

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=1.2e-27  Score=258.16  Aligned_cols=198  Identities=28%  Similarity=0.426  Sum_probs=167.2

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceEEEEEEec
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      |++.+.||+|++|.||+|... +++.||+|++..... .......+|+..+.+++ ||||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999976 478899999865432 22334567899999999 999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                       +|+|.+.+....   ...+++..+..++.|++++|.|||+++   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 -~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          81 -EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             -CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence             788988886543   236899999999999999999999987   9999999999999999999999999987664332


Q ss_pred             ccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .  .....++..|+|||++.. ..++.++|+||||++++||++|++||...
T Consensus       154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~  202 (283)
T cd07830         154 P--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS  202 (283)
T ss_pred             C--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence            2  123457889999998754 45789999999999999999999998654

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.95  E-value=4.4e-27  Score=257.92  Aligned_cols=193  Identities=31%  Similarity=0.507  Sum_probs=163.1

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      |...+.||+|+||.||+|... +++.||+|++.....   ...+.+.+|+++++.++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999964 688999999864322   2345688899999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +. |++.+.+....    .++++..+..++.|++.|++|||+.+   ++||||+|+||+++.++.+||+|||++......
T Consensus       103 ~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~  174 (313)
T cd06633         103 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA  174 (313)
T ss_pred             CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC
Confidence            96 56777664432    25899999999999999999999987   999999999999999999999999998643221


Q ss_pred             Cccccccccccccccchhhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                           ....|+..|+|||++.   ...++.++||||||+++|||++|+.||..
T Consensus       175 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~  222 (313)
T cd06633         175 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  222 (313)
T ss_pred             -----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                 2346788999999974   45688899999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.95  E-value=1.7e-27  Score=261.22  Aligned_cols=195  Identities=19%  Similarity=0.240  Sum_probs=160.1

Q ss_pred             CeeeccCceEEEEEEEcCCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCch
Q 002899          644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL  721 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL  721 (869)
                      +.+|.|+++.||++.. +++.||||++...  .....+.+..|++++++++||||+++++++.+.+..+++|||+++|+|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3344555555555544 6899999998654  344457899999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc---
Q 002899          722 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH---  798 (869)
Q Consensus       722 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~---  798 (869)
                      .+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||.+.........   
T Consensus        87 ~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          87 EDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             HHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999875422   25789999999999999999999987   999999999999999999999999998765422110   


Q ss_pred             ---ccccccccccccchhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ---ISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ---~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                         ......++..|+|||++..  ..++.++|||||||++|||++|+.||..
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~  212 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD  212 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence               1122346778999999875  3578899999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.95  E-value=1.8e-27  Score=262.87  Aligned_cols=196  Identities=21%  Similarity=0.346  Sum_probs=160.6

Q ss_pred             Ceeecc--CceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEG--GFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G--~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      +.||+|  +||+||+|... +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356766  99999999974 78999999986543  22346788899999999999999999999999999999999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      +++.+++.....   ..+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.++++||+.+.........
T Consensus        84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            999998865432   25889999999999999999999987   999999999999999999999999865433211110


Q ss_pred             c------cccccccccccchhhcccC--CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 I------STRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~------~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .      .....++..|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  212 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD  212 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            0      0112345679999998764  478999999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.95  E-value=1.6e-27  Score=264.82  Aligned_cols=198  Identities=27%  Similarity=0.423  Sum_probs=164.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC----------
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG----------  706 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~----------  706 (869)
                      .+|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57889999999999999999975 6889999998766655667788999999999999999999776543          


Q ss_pred             ----ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-CCCcE
Q 002899          707 ----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNA  781 (869)
Q Consensus       707 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~-~~~~~  781 (869)
                          ...++||||++ ++|.+.+...      .+++..++.++.||+.||.|||+.+   ++||||||+||+++ +++.+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~  154 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence                35789999997 5787777432      5789999999999999999999988   99999999999997 45678


Q ss_pred             EEeecCCceeecCCCcc--ccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          782 KISDFGLAKLYEEDKTH--ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       782 kl~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |++|||++.........  ......++..|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~  221 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG  221 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999866432211  1122357889999998654 5678899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.95  E-value=2.4e-27  Score=259.32  Aligned_cols=194  Identities=29%  Similarity=0.498  Sum_probs=164.3

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .|+..+.||+|+||.||+|... +++.||+|.+...   .....+++.+|+++++.++|+|++++++++...+..++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666788999999999999975 5788999988642   22334578899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+. |++.+.+....    ..+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++.....
T Consensus        96 ~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          96 YCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             ccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            997 57777664332    25789999999999999999999987   99999999999999999999999999876543


Q ss_pred             CCccccccccccccccchhhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..     ...+++.|+|||.+.   ...++.++|||||||++|||++|+.||..
T Consensus       168 ~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  216 (308)
T cd06634         168 AN-----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (308)
T ss_pred             cc-----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence            22     245788999999874   35678899999999999999999999843

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.95  E-value=2.8e-27  Score=261.68  Aligned_cols=199  Identities=26%  Similarity=0.399  Sum_probs=163.2

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-C--CcEEEEEEecccC--chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC----ce
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-D--GTVIAVKQLSSKS--RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG----NQ  708 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~--g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~----~~  708 (869)
                      +|++.+.||+|+||.||++... .  ++.||+|++....  ....+.+..|++++.++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999965 3  6789999886432  22345778899999998 599999999875432    45


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .++++||++ ++|.+.+....     .+++..++.++.||+.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCC
Confidence            788999887 57888875432     5899999999999999999999998   99999999999999999999999999


Q ss_pred             ceeecCCCcc---ccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          789 AKLYEEDKTH---ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       789 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +.........   ......|++.|+|||++.+ ..++.++||||+|+++|||++|++||...
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~  213 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK  213 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence            9865432211   1123468899999998765 46899999999999999999999998653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.95  E-value=2e-27  Score=270.75  Aligned_cols=207  Identities=23%  Similarity=0.295  Sum_probs=157.0

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEE-----------------cCCcEEEEEEecccCchhhHHH--------------HH
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGIL-----------------SDGTVIAVKQLSSKSRQGNREF--------------VN  683 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~-----------------~~g~~VAvK~~~~~~~~~~~~f--------------~~  683 (869)
                      ...++|++.++||+|+||.||+|..                 ..++.||||++........++|              ..
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            3578999999999999999999964                 2356799999865433333333              34


Q ss_pred             HHHHHHhcCCCce-----eeEEeEEee--------CceEEEEEEeccCCchhhhhhcCCcc-------------------
Q 002899          684 EIGMISAQQHPNL-----VKLYGCCVE--------GNQLLLVYEYMKNNCLSRAIFGKDTE-------------------  731 (869)
Q Consensus       684 E~~~l~~l~H~nI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~-------------------  731 (869)
                      |+.++.+++|.++     ++++++|..        ++..+|||||+++++|.+++++....                   
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6677777776654     677787753        35689999999999999998753211                   


Q ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccccccccccccccc
Q 002899          732 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA  811 (869)
Q Consensus       732 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~a  811 (869)
                      ....++|..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||++..+............+++.|+|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence            1124578899999999999999999987   9999999999999999999999999997654322211112234789999


Q ss_pred             hhhcccCCC----------------------CchhHHHHHHHHHHHHHcCCC-CCC
Q 002899          812 PEYAMRGYL----------------------TSKADVYSFGVVTLEIVSGKS-NTN  844 (869)
Q Consensus       812 PE~~~~~~~----------------------~~k~DvwSlGvil~elltG~~-p~~  844 (869)
                      ||.+.....                      ..+.||||+||+++||++|.. |+.
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence            998754321                      124799999999999999985 553

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-28  Score=245.38  Aligned_cols=197  Identities=24%  Similarity=0.310  Sum_probs=163.6

Q ss_pred             HhcCCCCC-CeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHh-cCCCceeeEEeEEee----Cce
Q 002899          636 ATNNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGCCVE----GNQ  708 (869)
Q Consensus       636 ~t~~f~~~-~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~-l~H~nIv~l~~~~~~----~~~  708 (869)
                      .|++|.+. ++||-|-.|.|-.+..+ +++.+|+|++...     ....+|++..-. -.|||||.++++++.    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45666654 57999999999998875 6889999988543     234567765443 379999999998764    457


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc---CCCcEEEee
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISD  785 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~---~~~~~kl~D  785 (869)
                      +.+|||.|+||.|.+.+..++.   ..+++.++..|+.||+.|+.|||+.+   |.||||||+|+|..   .|..+||+|
T Consensus       134 LLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             eEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecc
Confidence            8899999999999999977653   36899999999999999999999987   99999999999996   456789999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ||+|+.......  -...+-||.|.|||++...+|+..+|+||+||++|-|+.|-+||..
T Consensus       208 fGFAK~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS  265 (400)
T KOG0604|consen  208 FGFAKETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS  265 (400)
T ss_pred             cccccccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence            999987654222  2234679999999999999999999999999999999999999953

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=6.7e-27  Score=280.23  Aligned_cols=145  Identities=28%  Similarity=0.439  Sum_probs=130.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|.+.++||+|+||.||+|... +++.||||+++...   ......+..|+.++..++||||+++++++...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999976 68899999986542   222467888999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      ||+++++|.+++....     .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999986542     5788999999999999999999987   9999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.95  E-value=5.3e-27  Score=248.04  Aligned_cols=191  Identities=30%  Similarity=0.418  Sum_probs=167.0

Q ss_pred             eeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCch
Q 002899          646 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL  721 (869)
Q Consensus       646 IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL  721 (869)
                      ||+|+||.||++... +++.+|+|.+.....   ....++..|++++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999976 588999998865432   2355788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccccc
Q 002899          722 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST  801 (869)
Q Consensus       722 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  801 (869)
                      .+++....     .+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~  151 (250)
T cd05123          81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTN  151 (250)
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-ccc
Confidence            99986543     5899999999999999999999987   99999999999999999999999999877644321 123


Q ss_pred             cccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       802 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...++..|+|||...+...+.++|+||||+++|||++|+.||..
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~  195 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA  195 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            35678899999999888889999999999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=2.8e-27  Score=254.89  Aligned_cols=197  Identities=30%  Similarity=0.477  Sum_probs=168.6

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      |+..+.||+|+||.||+|... +++.||+|.+....  ....+.+..|++++++++|+||+++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999976 58999999987653  233467788999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      + ++|.+++....    ..+++..+..++.|+++||+|||+++   |+||||+|+||++++++.++|+|||.+.......
T Consensus        81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~  152 (282)
T cd07829          81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL  152 (282)
T ss_pred             C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence            8 58999886542    25899999999999999999999997   9999999999999999999999999987664332


Q ss_pred             ccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .. .....++..|+|||.+... .++.++||||||++++||++|++||..
T Consensus       153 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  201 (282)
T cd07829         153 RT-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG  201 (282)
T ss_pred             cc-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            21 1223456789999998766 789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=9.3e-29  Score=262.89  Aligned_cols=199  Identities=23%  Similarity=0.351  Sum_probs=172.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCc-EEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~-~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      .+++....||-|+||.|=.+...... .+|+|++++.   ..........|-++|...+.|.||++|..|.+...+|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34556678999999999988865433 3788877654   3333455678889999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      |-|-+|.+...+...+     .++....+-++..+++|++|||.++   ||.|||||+|.+|+.+|.+||.|||+|+.+.
T Consensus       500 EaClGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             HhhcCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            9999999999986654     5888899999999999999999998   9999999999999999999999999999887


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ....  ...++|||.|.|||++.....+..+|.|||||++|||++|++||...
T Consensus       572 ~g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~  622 (732)
T KOG0614|consen  572 SGRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV  622 (732)
T ss_pred             cCCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence            5433  34579999999999999888899999999999999999999999754

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=3.5e-29  Score=244.95  Aligned_cols=220  Identities=25%  Similarity=0.429  Sum_probs=172.2

Q ss_pred             CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch--hhHHHHHHHHHHHhcCCCceeeEEeEEee--------Cce
Q 002899          640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCVE--------GNQ  708 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~--~~~~f~~E~~~l~~l~H~nIv~l~~~~~~--------~~~  708 (869)
                      |.-..+||+|.||.||+|+.. .|+.||+|++-.++..  -....++|+++|..++|+|++.+++.|..        ...
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            334567999999999999975 5788899865433222  23456889999999999999999988754        345


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      +|+||++++. +|+-+|....    ..++..++.+++.++..||.|+|...   |+|||+|+.|+|++.++.+||+|||+
T Consensus        99 ~ylVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   99 FYLVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             eeeeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            8999999986 5766664332    36889999999999999999999876   99999999999999999999999999


Q ss_pred             ceeecCCCc---cccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHHHhhcc
Q 002899          789 AKLYEEDKT---HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE  864 (869)
Q Consensus       789 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~~~~~~  864 (869)
                      ++.+.....   ...+..+-|..|.+||.+.+ ..++++.|||..|||+.||++|.+-+....+..+..+++-+-.-.+.
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            987754322   11233455889999998876 47999999999999999999999888765544455555555444555


Q ss_pred             ccc
Q 002899          865 EIY  867 (869)
Q Consensus       865 ~~~  867 (869)
                      ++|
T Consensus       251 evW  253 (376)
T KOG0669|consen  251 EVW  253 (376)
T ss_pred             ccC
Confidence            544

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=4.8e-27  Score=277.31  Aligned_cols=224  Identities=29%  Similarity=0.434  Sum_probs=179.7

Q ss_pred             HHHHHhcCCCCCCeeeccCceEEEEEEEc----C----CcEEEEEEecccCc-hhhHHHHHHHHHHHhc-CCCceeeEEe
Q 002899          632 QIKAATNNFDPANKVGEGGFGSVYKGILS----D----GTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYG  701 (869)
Q Consensus       632 ~i~~~t~~f~~~~~IG~G~fG~Vyka~~~----~----g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~~  701 (869)
                      .++...++..+.+.+|+|+||.|++|...    .    ...||||.++.... .+.+.+..|+++|+.+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34445556667779999999999999853    1    35799999986543 4567899999999987 6999999999


Q ss_pred             EEeeCceEEEEEEeccCCchhhhhhcCC---------cccc--cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCC
Q 002899          702 CCVEGNQLLLVYEYMKNNCLSRAIFGKD---------TEYR--LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKT  770 (869)
Q Consensus       702 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~  770 (869)
                      +|..++..++|+||+..|+|.+++...+         ....  ..+...+...++.|||.||+||++..   +|||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999998765         1111  13899999999999999999999986   99999999


Q ss_pred             CCEEEcCCCcEEEeecCCceeecCCCcccccccc--ccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 002899          771 SNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA--GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP  847 (869)
Q Consensus       771 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~  847 (869)
                      +|||+.++..+||+|||+|+............-.  -...|||||.+....++.|+|||||||+|||++| |..|+..-.
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999865544333222112  2447999999999999999999999999999999 666774311


Q ss_pred             CcchhhHHHHHHH
Q 002899          848 NEDFVYLLDWAYV  860 (869)
Q Consensus       848 ~~~~~~l~~w~~~  860 (869)
                        -..++.++++.
T Consensus       527 --~~~~l~~~l~~  537 (609)
T KOG0200|consen  527 --PTEELLEFLKE  537 (609)
T ss_pred             --cHHHHHHHHhc
Confidence              13445556543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.94  E-value=2.7e-27  Score=263.08  Aligned_cols=197  Identities=27%  Similarity=0.433  Sum_probs=167.2

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce---
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ---  708 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~---  708 (869)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++....  ......+.+|+.++++++||||+++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999975 57899999886532  2234567789999999999999999988776654   


Q ss_pred             ---EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002899          709 ---LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD  785 (869)
Q Consensus       709 ---~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~D  785 (869)
                         .++|+||+ +++|.+++...      .+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcc
Confidence               89999998 56898887542      5899999999999999999999987   99999999999999999999999


Q ss_pred             cCCceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ||++......    .....++..|+|||.+.. ...+.++||||||+++|||++|+.||..
T Consensus       162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~  218 (343)
T cd07851         162 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG  218 (343)
T ss_pred             cccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            9998765432    123457889999998865 4678999999999999999999999964

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=4.6e-27  Score=265.84  Aligned_cols=204  Identities=28%  Similarity=0.490  Sum_probs=174.3

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEee-----
Q 002899          633 IKAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE-----  705 (869)
Q Consensus       633 i~~~t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~-----  705 (869)
                      +...++-|.+.++||+|.+|.||+++. ++++.+|+|+...... ...++..|.+|++.. +|||++.++|++..     
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            334467788999999999999999995 4788899998876533 345677888898876 79999999999874     


Q ss_pred             CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002899          706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD  785 (869)
Q Consensus       706 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~D  785 (869)
                      ++++|||||||.+||..+++.+..   ...+.|+.+..|++.+++|+.+||.+.   ++|||||-.|||++.++.+|+.|
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence            578999999999999999997765   447999999999999999999999886   99999999999999999999999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcccC-----CCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-----YLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      ||.+..+....... ....|||.|||||++...     .|+.++|+|||||+..||--|.+|+.
T Consensus       167 FGvSaQldsT~grR-nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~  229 (953)
T KOG0587|consen  167 FGVSAQLDSTVGRR-NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC  229 (953)
T ss_pred             eeeeeeeecccccc-cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence            99988776543332 235799999999998643     57889999999999999999999974

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.94  E-value=6.1e-27  Score=249.40  Aligned_cols=200  Identities=25%  Similarity=0.361  Sum_probs=164.6

Q ss_pred             CCCCCCeeeccCceEEEEEEEcC-CcEEEEEEeccc-----CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK-----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~~-g~~VAvK~~~~~-----~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      +|.+.+.||+|+||.||++.... +..+++|.++..     ......++..|+.++.+++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999998653 444555555432     122344577889999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++++|.+++.... .....+++..++.++.|++.||+|||+.+   ++|+||+|+||+++. +.++|+|||.+...
T Consensus        81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          81 TEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeec
Confidence            99999999998886432 12236899999999999999999999987   999999999999975 56999999998766


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      ..... ......|++.|+|||......++.++|+||||+++|+|++|+.||.
T Consensus       156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~  206 (260)
T cd08222         156 MGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE  206 (260)
T ss_pred             CCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            43222 2223457889999999988888999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.94  E-value=8.9e-27  Score=244.78  Aligned_cols=179  Identities=24%  Similarity=0.248  Sum_probs=153.0

Q ss_pred             cCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCchhhhhhc
Q 002899          649 GGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG  727 (869)
Q Consensus       649 G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  727 (869)
                      |.||.||++... +++.||+|++....     ++..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999965 68899999986542     234455555566799999999999999999999999999999998865


Q ss_pred             CCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccccccccccc
Q 002899          728 KDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI  807 (869)
Q Consensus       728 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~  807 (869)
                      ..     .+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.++++|||.+.......    ....++.
T Consensus        79 ~~-----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~  146 (237)
T cd05576          79 FL-----NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVEN  146 (237)
T ss_pred             hc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCc
Confidence            42     5899999999999999999999987   9999999999999999999999999876554321    1234567


Q ss_pred             cccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       808 ~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      .|+|||.+....++.++||||+|+++|||++|+.|+.
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~  183 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE  183 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence            8999999988888999999999999999999998764

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1e-28  Score=243.97  Aligned_cols=206  Identities=28%  Similarity=0.406  Sum_probs=168.8

Q ss_pred             CCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC-----ceEEEE
Q 002899          641 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQLLLV  712 (869)
Q Consensus       641 ~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~lV  712 (869)
                      +..+.||-|+||.||.+... +|+.||.|++....  -...+++.+|+++++.++|.|++..++...-.     .++|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            45678999999999999864 79999999886542  23467889999999999999999988876543     357889


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      +|.|.. +|.+.+-.-     ..++-..+.-+..||++||+|||+.+   |.||||||.|.|++.+..+||+|||+++..
T Consensus       136 TELmQS-DLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  136 TELMQS-DLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHh-hhhheeccC-----CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence            998864 677766443     26788889999999999999999997   999999999999999999999999999987


Q ss_pred             cCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHH
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL  855 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~  855 (869)
                      +.+...-.+.-+-|..|.|||++.+. .|+..+||||.|||+.||+..|.-|+....-++.+++
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI  270 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI  270 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH
Confidence            66554433444558899999999875 6899999999999999999999888765544444443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=7.6e-26  Score=234.57  Aligned_cols=199  Identities=34%  Similarity=0.513  Sum_probs=172.4

Q ss_pred             CCCCCeeeccCceEEEEEEEcC-CcEEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEecc
Q 002899          640 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~~-g~~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      |++.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5567899999999999999875 889999999766544 56788999999999999999999999999899999999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      +++|.+++.....    .+++..+..++.++++++.+||+.+   ++|+|++|+||+++.++.++|+|||.+........
T Consensus        81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       81 GGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             CCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            9999999865431    1789999999999999999999987   99999999999999999999999999887754421


Q ss_pred             cccccccccccccchhhc-ccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          798 HISTRIAGTIGYMAPEYA-MRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~-~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            112234577899999998 666788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-26  Score=256.64  Aligned_cols=196  Identities=28%  Similarity=0.401  Sum_probs=164.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHh-cCCCceeeEEeEEeeCceEEEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      .++.|.+...+|.|+|+.|-.+... +++..+||++....    .+-.+|+.++.. -+||||+++.+.+.++.+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3567778888999999999988864 67889999997652    223456655554 47999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE-cCCCcEEEeecCCceee
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-DKDLNAKISDFGLAKLY  792 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl-~~~~~~kl~DFGla~~~  792 (869)
                      |.+.++-+.+.+....      .....+..|+.+|+.++.|||++|   +|||||||+|||+ +..++++|+|||.++..
T Consensus       396 e~l~g~ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             hhccccHHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhC
Confidence            9999998888776553      222677889999999999999998   9999999999999 58999999999999876


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN  848 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~  848 (869)
                      ...    ....+-|..|.|||++....+++++|+||||++|||||+|+.||...+.
T Consensus       467 ~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~  518 (612)
T KOG0603|consen  467 ERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA  518 (612)
T ss_pred             chh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence            654    1122457799999999999999999999999999999999999976543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.93  E-value=5.5e-26  Score=265.75  Aligned_cols=201  Identities=24%  Similarity=0.330  Sum_probs=143.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-C----CcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeE------Ee
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-D----GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC------CV  704 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~----g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~------~~  704 (869)
                      ..++|.+.++||+|+||.||+|++. +    +..||||++......  ..+..|  .+....+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5678999999999999999999975 4    689999987543211  111111  1112222222222111      24


Q ss_pred             eCceEEEEEEeccCCchhhhhhcCCccc---------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCC
Q 002899          705 EGNQLLLVYEYMKNNCLSRAIFGKDTEY---------------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK  769 (869)
Q Consensus       705 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk  769 (869)
                      .++..++||||+++++|.+++.......               ........+..++.|++.||+|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            5678999999999999999886543110               001223456689999999999999987   9999999


Q ss_pred             CCCEEEcC-CCcEEEeecCCceeecCCCccccccccccccccchhhcccC----------------------CCCchhHH
Q 002899          770 TSNVLLDK-DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG----------------------YLTSKADV  826 (869)
Q Consensus       770 ~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~Dv  826 (869)
                      |+|||+++ ++.+||+|||+++.+............+++.|+|||.+...                      .+..++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 57999999999986654433334456789999999965422                      23456799


Q ss_pred             HHHHHHHHHHHcCCCCC
Q 002899          827 YSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       827 wSlGvil~elltG~~p~  843 (869)
                      |||||++|||+++..|+
T Consensus       363 wSlGviL~el~~~~~~~  379 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRS  379 (566)
T ss_pred             HHHHHHHHHHHhCcCCC
Confidence            99999999999976654

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.93  E-value=1.1e-26  Score=224.53  Aligned_cols=214  Identities=23%  Similarity=0.408  Sum_probs=176.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEE-EcCCcEEEEEEecccCchhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCc--eEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN--QLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~-~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~~lV  712 (869)
                      .++|++.+++|+|.|+.||.|. ..+.++++||++++..   .+.+.+|+++|..++ ||||+++++...+..  ...||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4678888999999999999998 4567889999997653   467889999999997 999999999987654  45799


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCcEEEeecCCcee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKL  791 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~-~~~~kl~DFGla~~  791 (869)
                      +||+.+.+...+- .       .+....++..+.+++.||.|+|+.|   |+|||+||+|+++|. ...++|+|+|+|.+
T Consensus       114 FE~v~n~Dfk~ly-~-------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY-P-------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             hhhhccccHHHHh-h-------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence            9999987654432 1       4667788999999999999999998   999999999999985 46789999999999


Q ss_pred             ecCCCccccccccccccccchhhcc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHHHhhccccc
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIY  867 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~~~~~~~~~  867 (869)
                      +.+.....  ..+.+..|.-||.+- ...++..-|+|||||++.+|+..+.||-. ..++..+|++.++.+.+++++
T Consensus       183 YHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh-G~dN~DQLVkIakVLGt~el~  256 (338)
T KOG0668|consen  183 YHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVKIAKVLGTDELY  256 (338)
T ss_pred             cCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC-CCCCHHHHHHHHHHhChHHHH
Confidence            87654321  224566889999875 45688899999999999999999999943 445778899999888887754

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-26  Score=250.85  Aligned_cols=196  Identities=26%  Similarity=0.357  Sum_probs=165.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch--------hhHHHHHHHHHHHhcC---CCceeeEEeEEee
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--------GNREFVNEIGMISAQQ---HPNLVKLYGCCVE  705 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~--------~~~~f~~E~~~l~~l~---H~nIv~l~~~~~~  705 (869)
                      .+|...+.+|+|+||.|+.|.++ +...|+||.+.+..--        .....-.|+.||..++   |+||+|++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46888999999999999999986 4567899988654211        0112446999999987   9999999999999


Q ss_pred             CceEEEEEEecc-CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEe
Q 002899          706 GNQLLLVYEYMK-NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS  784 (869)
Q Consensus       706 ~~~~~lV~E~~~-~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~  784 (869)
                      ++.+||+||-.. +-+|.+++..+.     .+++..+.-|++||+.|+++||+++   |||||||-+||.++.+|-+||+
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence            999999999764 557788885543     6899999999999999999999998   9999999999999999999999


Q ss_pred             ecCCceeecCCCccccccccccccccchhhcccCCC-CchhHHHHHHHHHHHHHcCCCCCC
Q 002899          785 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       785 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      |||.|......+   ...++||.+|.|||++.+..| +..-||||+||+||.++....||.
T Consensus       713 dfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999987654332   335789999999999998765 556899999999999999988874

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.93  E-value=1e-27  Score=259.68  Aligned_cols=278  Identities=25%  Similarity=0.332  Sum_probs=189.8

Q ss_pred             EEEEeccCCCccc-cCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccccc
Q 002899           56 VVTIALKAQNLTG-TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG  134 (869)
Q Consensus        56 v~~L~l~~~~l~~-~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  134 (869)
                      ++++++.+|++.. -+|+.|..+..|+.||||+|+++..+...-...++..|+||+|+|..++...|-+|+.|-.||||+
T Consensus        80 LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~  159 (1255)
T KOG0444|consen   80 LRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSN  159 (1255)
T ss_pred             hHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhcccc
Confidence            4455555665532 467777777888888888888776655544445777788888888766666677778888888888


Q ss_pred             cccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCC-CCCccccCCCCcccEEEccCCcCCCCc
Q 002899          135 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS-GKIPEFIGKWKKIQKLHIQGSSLEGPI  213 (869)
Q Consensus       135 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~  213 (869)
                      |++. .+|+.+..|..|++|+|++|.+...--..+..+++|+.|.+++.+-+ ..+|..+..+.+|..+||+.|.+. .+
T Consensus       160 NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~v  237 (1255)
T KOG0444|consen  160 NRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IV  237 (1255)
T ss_pred             chhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cc
Confidence            8877 66777777777888888877665322333444556666666665533 345666777777777777777776 66


Q ss_pred             hHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCC------------
Q 002899          214 PASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT------------  281 (869)
Q Consensus       214 ~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~------------  281 (869)
                      |..+-++++|+.|+||+|++++.....-.-.+|++|+||.|+++ .+|+++..+++|+.|.+.+|+|+            
T Consensus       238 Pecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~  316 (1255)
T KOG0444|consen  238 PECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLI  316 (1255)
T ss_pred             hHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhh
Confidence            77777777777777777777766555444446667777776666 45555555555555555555443            


Q ss_pred             ------------CCCchhhhcCCCCCEEEeeCCcCCCCCchhh--hccCCceeeeccCccCCCCCCCCCC
Q 002899          282 ------------GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECP  337 (869)
Q Consensus       282 ------------~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~~~~~p~~C~  337 (869)
                                  ...|+.++.+.+|+.|.|+.|+|. .+|+.+  ++.++.||+..|.....++-|-.-.
T Consensus       317 ~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~  385 (1255)
T KOG0444|consen  317 QLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDAR  385 (1255)
T ss_pred             hhHHHHhhccccccCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcchhh
Confidence                        156777777788888888888887 677766  6788899999998888877775543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.93  E-value=1.1e-24  Score=228.31  Aligned_cols=186  Identities=32%  Similarity=0.532  Sum_probs=164.7

Q ss_pred             CceEEEEEEEc-CCcEEEEEEecccCchh-hHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCchhhhhhc
Q 002899          650 GFGSVYKGILS-DGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG  727 (869)
Q Consensus       650 ~fG~Vyka~~~-~g~~VAvK~~~~~~~~~-~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  727 (869)
                      +||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......+++|||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999986 48999999997665544 67899999999999999999999999999999999999999999998865


Q ss_pred             CCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccccccccccc
Q 002899          728 KDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI  807 (869)
Q Consensus       728 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~  807 (869)
                      ..     .+++..+..++.++++++.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......  ......++.
T Consensus        81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~  150 (244)
T smart00220       81 RG-----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTP  150 (244)
T ss_pred             cc-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCc
Confidence            43     2789999999999999999999987   9999999999999999999999999998775432  222346788


Q ss_pred             cccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       808 ~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .|+|||.......+.++||||||++++||++|+.||..
T Consensus       151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999888889999999999999999999999854

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.92  E-value=6e-26  Score=235.80  Aligned_cols=206  Identities=21%  Similarity=0.315  Sum_probs=169.9

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCC--Cc----eeeEEeE
Q 002899          630 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH--PN----LVKLYGC  702 (869)
Q Consensus       630 ~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H--~n----Iv~l~~~  702 (869)
                      ++.-...+++|.+...+|+|.||.|-+.... .+..||||+++.... ....-.-|+++++++.+  |+    +|.+.++
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            3333445889999999999999999998754 468899999875432 23345678999999832  22    7889999


Q ss_pred             EeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-----
Q 002899          703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-----  777 (869)
Q Consensus       703 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~-----  777 (869)
                      |.-.+..++|+|.+ |-|+.+++..+..   .+++..+++.|+.|+++++++||+..   ++|-||||+|||+.+     
T Consensus       160 FdyrghiCivfell-G~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  160 FDYRGHICIVFELL-GLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             hhccCceEEEEecc-ChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEE
Confidence            99999999999976 4589999976542   47899999999999999999999987   999999999999942     


Q ss_pred             ---------------CCcEEEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCC
Q 002899          778 ---------------DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN  842 (869)
Q Consensus       778 ---------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p  842 (869)
                                     +..+||+|||.|....+..    ..++.|..|.|||++.+-.++.++||||+||||+||.+|..-
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L  308 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL  308 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence                           2358999999998766544    346778999999999999999999999999999999999998


Q ss_pred             CCCCC
Q 002899          843 TNYRP  847 (869)
Q Consensus       843 ~~~~~  847 (869)
                      |+.-+
T Consensus       309 FqtHe  313 (415)
T KOG0671|consen  309 FQTHE  313 (415)
T ss_pred             cccCC
Confidence            87544

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.92  E-value=9.3e-25  Score=226.10  Aligned_cols=222  Identities=21%  Similarity=0.339  Sum_probs=177.1

Q ss_pred             HHHHHhcCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEe
Q 002899          632 QIKAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCV  704 (869)
Q Consensus       632 ~i~~~t~~f~~~~~IG~G~fG~Vyka~~~~------g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~  704 (869)
                      ++.....+++...++-+|.||.||.|.|.+      .+.|.||.++.... -....+..|.-++..+.|||+.++.+.+.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            444445678888899999999999997653      35677887765543 34566888888888889999999999887


Q ss_pred             eC-ceEEEEEEeccCCchhhhhh---cCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 002899          705 EG-NQLLLVYEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN  780 (869)
Q Consensus       705 ~~-~~~~lV~E~~~~gsL~~~l~---~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~  780 (869)
                      ++ +..++++.++.-|+|..++.   +.+......+...+...++.|++.|++|||.++   |||.||.++|.++|+.-+
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence            64 45688899999999999886   223334446788889999999999999999998   999999999999999999


Q ss_pred             EEEeecCCceeecCCCccc-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcchhhHHH
Q 002899          781 AKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLD  856 (869)
Q Consensus       781 ~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~  856 (869)
                      +||+|=.+++.+-+.+.+. ...--.+..||+||.+....++..+|||||||+||||+| |+.|+...++.|++..++
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            9999999998776544321 111123558999999999999999999999999999998 888987655556555443

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.91  E-value=4.6e-26  Score=246.90  Aligned_cols=274  Identities=24%  Similarity=0.349  Sum_probs=215.6

Q ss_pred             CcceEEEEeccCCCcc-ccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccc
Q 002899           52 ATCHVVTIALKAQNLT-GTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKN  129 (869)
Q Consensus        52 ~~~~v~~L~l~~~~l~-~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  129 (869)
                      +.+-|+.+|+++|.+. +..|.....++.++.|-|...++..+ |..++.+ +|++|.+++|++. .+.+.++.|+.|+.
T Consensus         5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~v-PeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRs   82 (1255)
T KOG0444|consen    5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQV-PEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRS   82 (1255)
T ss_pred             ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhhC-hHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHH
Confidence            3456888999999998 57788899999999999998888755 4455555 8999999999998 45567888999999


Q ss_pred             ccccccccC-CCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCc
Q 002899          130 LSIEGNLFT-GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSS  208 (869)
Q Consensus       130 L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  208 (869)
                      +++.+|++. .-+|..+..+..|+.||||+|+++ ..|..+..-+++-.|+||+|+|..++...|.+++.|-.|||++|+
T Consensus        83 v~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~Nr  161 (1255)
T KOG0444|consen   83 VIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNR  161 (1255)
T ss_pred             HhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccch
Confidence            999999887 347778888999999999999998 888888888999999999999986666668889999999999999


Q ss_pred             CCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccc-cceEEEcccccCc-cCCCcccCCCCCcCEEeccCCCCCCCCch
Q 002899          209 LEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIH-GEIPDYIGDMTKLKNIDLSFNNLTGGIPT  286 (869)
Q Consensus       209 l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~-~L~~L~Ls~N~i~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  286 (869)
                      +. .+|..+..|..|+.|+|++|++.......+..+ +|+.|.+++.+-+ ..+|..+.++.+|..+|||.|.|. ..|+
T Consensus       162 Le-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPe  239 (1255)
T KOG0444|consen  162 LE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPE  239 (1255)
T ss_pred             hh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchH
Confidence            98 667778889999999999998876555544443 6777777766433 346777777777888888888877 7777


Q ss_pred             hhhcCCCCCEEEeeCCcCCCCC-chhhhccCCceeeeccCccCCC
Q 002899          287 TFEKLAKTNFMYLTGNKLTGPV-PKYIFNSNKNVDISLNNFTWES  330 (869)
Q Consensus       287 ~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~~l~~l~ls~N~~~~~~  330 (869)
                      .+-++++|+.|+||+|+|+... -...+..+++|++|.|+++.++
T Consensus       240 cly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP  284 (1255)
T KOG0444|consen  240 CLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLP  284 (1255)
T ss_pred             HHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccch
Confidence            7777777888888888777422 2233667777777777777654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.91  E-value=9.7e-25  Score=221.76  Aligned_cols=204  Identities=26%  Similarity=0.375  Sum_probs=166.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------ce
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQ  708 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~------~~  708 (869)
                      .+|.-...+|.|+- .|..|... .+++||+|++...  .....++..+|..++..++|+||++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45556677888887 56666533 5788999987543  334467788999999999999999999998643      35


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .|+|||+|. .+|...++-       .++-.++..|..|++.|++|||+.+   |+||||||+||++..+..+||.|||+
T Consensus        96 ~y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             HHHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence            799999997 478777752       4677789999999999999999998   99999999999999999999999999


Q ss_pred             ceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHHH
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYV  860 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~~  860 (869)
                      |+.....  ...+.++.|..|.|||++.+..+.+.+||||.||++.||++|+.-|..     ...+-+|-+.
T Consensus       165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g-----~d~idQ~~ki  229 (369)
T KOG0665|consen  165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG-----KDHIDQWNKI  229 (369)
T ss_pred             hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC-----chHHHHHHHH
Confidence            9865543  455677889999999999988899999999999999999999998863     3344456544

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.91  E-value=6.7e-25  Score=247.33  Aligned_cols=197  Identities=31%  Similarity=0.429  Sum_probs=159.2

Q ss_pred             CCCCCeeeccCce-EEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEEEecc
Q 002899          640 FDPANKVGEGGFG-SVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       640 f~~~~~IG~G~fG-~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      |...+++|.|+-| .||+|... |+.||||++....   ..-..+|+..|+.- +|||||++++.-.++...|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            4455678999998 68999985 7899999985432   34556899988876 69999999999889999999999997


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---C--CcEEEeecCCceee
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---D--LNAKISDFGLAKLY  792 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~---~--~~~kl~DFGla~~~  792 (869)
                       .+|.+++.... .......-...+.+..|+++||++||+.+   ||||||||.|||++.   +  ..++|+|||+++.+
T Consensus       587 -~sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  587 -CSLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             -hhHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence             58999997741 11111121456788999999999999987   999999999999975   3  46899999999988


Q ss_pred             cCCCcccc--ccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcC-CCCCCC
Q 002899          793 EEDKTHIS--TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG-KSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG-~~p~~~  845 (869)
                      ..+.....  ....||-+|+|||++....-+..+||||+||++|+.++| +.||..
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd  717 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD  717 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence            76544332  236799999999999998888899999999999998887 889954

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.2e-24  Score=215.52  Aligned_cols=210  Identities=20%  Similarity=0.340  Sum_probs=164.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEe-EEeeCceEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYG-CCVEGNQLLLVY  713 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~-g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~-~~~~~~~~~lV~  713 (869)
                      .+.|++.+.+|+|.||.+-.++++. .+.+++|-++.. ....++|.+|...--.+ .|.||+.-++ .|+..+.++.++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            4678899999999999999999874 567888987654 23468899997654333 6899997665 567788888999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc--CCCcEEEeecCCcee
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLNAKISDFGLAKL  791 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~--~~~~~kl~DFGla~~  791 (869)
                      ||++.|+|..-+...      .+.+....+++.|+++|+.|||+..   +||||||.+|||+-  +...+||+|||+.+.
T Consensus       102 E~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             ccCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence            999999998877543      4778888999999999999999997   99999999999993  345799999999875


Q ss_pred             ecCCCccccccccccccccchhhccc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHHHh
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVL  861 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~~~  861 (869)
                      .+..-.    ...-+..|.|||....     -...+.+|||.|||+++..+||+.||+. ...+...+.+|.+..
T Consensus       173 ~g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w~  242 (378)
T KOG1345|consen  173 VGTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQWL  242 (378)
T ss_pred             cCceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHHh
Confidence            543211    1223457899997643     2467789999999999999999999984 344555666666543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.89  E-value=9e-24  Score=222.83  Aligned_cols=217  Identities=30%  Similarity=0.454  Sum_probs=175.2

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCc
Q 002899          633 IKAATNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN  707 (869)
Q Consensus       633 i~~~t~~f~~~~~IG~G~fG~Vyka~~~----~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~  707 (869)
                      +....+.|...++||+|.|++||+|.+.    ..+.||+|.+...+..  .+...|+++|..+ .+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            4455677899999999999999999854    3578999988765443  5688999999987 5999999999999999


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCcEEEeec
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDF  786 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~-~~~~kl~DF  786 (869)
                      ...+|+||+++..-.++..        .++...+..+++.+..||+++|.+|   ||||||||+|+|.+. -+.-.|.||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             eeEEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEec
Confidence            9999999999987777663        3567899999999999999999998   999999999999975 466799999


Q ss_pred             CCceeecCCC-------------c------------------------------cccccccccccccchhhccc-CCCCc
Q 002899          787 GLAKLYEEDK-------------T------------------------------HISTRIAGTIGYMAPEYAMR-GYLTS  822 (869)
Q Consensus       787 Gla~~~~~~~-------------~------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~  822 (869)
                      |+|.......             .                              ......+||+||.|||++.. ...++
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            9987221000             0                              00112569999999999865 46788


Q ss_pred             hhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHHHhhc
Q 002899          823 KADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQE  863 (869)
Q Consensus       823 k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~~~~~  863 (869)
                      ++||||.|||++-+++++.||-. ..++...+++.+-.+..
T Consensus       258 aiDiws~GVI~Lslls~~~PFf~-a~dd~~al~ei~tifG~  297 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFFK-AKDDADALAEIATIFGS  297 (418)
T ss_pred             ccceeeccceeehhhcccccccc-CccccchHHHHHHHhCh
Confidence            99999999999999999999954 44566667766655443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.89  E-value=2.9e-22  Score=204.45  Aligned_cols=183  Identities=39%  Similarity=0.668  Sum_probs=159.1

Q ss_pred             eeccCceEEEEEEEcC-CcEEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCchhh
Q 002899          646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSR  723 (869)
Q Consensus       646 IG~G~fG~Vyka~~~~-g~~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  723 (869)
                      ||+|.+|.||++...+ ++.+++|++...... ....+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999864 889999998765443 35678999999999999999999999999999999999999999999


Q ss_pred             hhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCcEEEeecCCceeecCCCcccccc
Q 002899          724 AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYEEDKTHISTR  802 (869)
Q Consensus       724 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~  802 (869)
                      ++....    ..+++..+..++.++++++++||+.+   ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus        81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~  152 (215)
T cd00180          81 LLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT  152 (215)
T ss_pred             HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence            886542    25899999999999999999999997   999999999999999 89999999999987654321 1223


Q ss_pred             ccccccccchhhcccC-CCCchhHHHHHHHHHHHH
Q 002899          803 IAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEI  836 (869)
Q Consensus       803 ~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~el  836 (869)
                      ..+...|++||..... ..+.++|+|++|+++++|
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            4567899999998877 888999999999999998

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.89  E-value=1.4e-24  Score=238.61  Aligned_cols=198  Identities=27%  Similarity=0.484  Sum_probs=173.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      .++|.....+|.|.||.||||+.. .++..|||+++.....+..-.+.|+-+++..+|||||.++|.+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            457888999999999999999964 6889999999988777777888999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +.+|+|.+.-|...     ++++.++..+++..++|++|||+.+   -+|||||-.|||+++.+.+|++|||.+..+...
T Consensus        94 cgggslQdiy~~Tg-----plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             cCCCcccceeeecc-----cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence            99999988766553     7899999999999999999999998   689999999999999999999999998766532


Q ss_pred             Cccccccccccccccchhhcc---cCCCCchhHHHHHHHHHHHHHcCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltG~~p~  843 (869)
                      -. ....+.||+.|||||+..   .+.|..++|||++|+...|+-.-++|.
T Consensus       166 i~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl  215 (829)
T KOG0576|consen  166 IA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL  215 (829)
T ss_pred             hh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence            22 223478999999999863   567899999999999999988777664

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.88  E-value=7.2e-24  Score=226.42  Aligned_cols=225  Identities=21%  Similarity=0.294  Sum_probs=185.9

Q ss_pred             ccccCCcccHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcC------C
Q 002899          621 LDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ------H  693 (869)
Q Consensus       621 ~~~~~~~~~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~------H  693 (869)
                      ++...+.|.+...+....+|.+....|+|-|++|.+|... .|..||||++...... .+.=+.|+++|++++      -
T Consensus       415 WdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk  493 (752)
T KOG0670|consen  415 WDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDK  493 (752)
T ss_pred             cccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhh
Confidence            4555678888888888999999999999999999999864 4789999999754322 334467899999985      3


Q ss_pred             CceeeEEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCE
Q 002899          694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV  773 (869)
Q Consensus       694 ~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NI  773 (869)
                      -|+++++..|....+++||||-+. .+|.+.|...+..  ..+....+..++.|+.-||..|-..+   |+|.||||.||
T Consensus       494 ~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNi  567 (752)
T KOG0670|consen  494 FHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNI  567 (752)
T ss_pred             hHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccce
Confidence            479999999999999999999664 5788888765432  35778899999999999999999887   99999999999


Q ss_pred             EEcCC-CcEEEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchh
Q 002899          774 LLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFV  852 (869)
Q Consensus       774 Ll~~~-~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~  852 (869)
                      |+++. ..+||||||.|........   +++.-+..|.|||++.+-.|+...|+||.||.||||.||+.-|....++.+.
T Consensus       568 LVNE~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML  644 (752)
T KOG0670|consen  568 LVNESKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML  644 (752)
T ss_pred             EeccCcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence            99876 4579999999987754332   3344566899999999999999999999999999999999999887766665


Q ss_pred             hHH
Q 002899          853 YLL  855 (869)
Q Consensus       853 ~l~  855 (869)
                      .|.
T Consensus       645 rl~  647 (752)
T KOG0670|consen  645 RLF  647 (752)
T ss_pred             HHH
Confidence            554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.8e-22  Score=220.95  Aligned_cols=167  Identities=22%  Similarity=0.215  Sum_probs=130.9

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEEc--CCcEEEEEEecccC-----chhhHHHHHHHHHHHhcCCCceee-EEeEEe
Q 002899          633 IKAATNNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVK-LYGCCV  704 (869)
Q Consensus       633 i~~~t~~f~~~~~IG~G~fG~Vyka~~~--~g~~VAvK~~~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~-l~~~~~  704 (869)
                      +....++|++.++||+|+||+||+|.+.  +++.||||++....     ......|.+|++++++++|+|+++ +++   
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---   89 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---   89 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence            3455678999999999999999999875  57788999865331     223456899999999999999985 443   


Q ss_pred             eCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC-CCCCEEEcCCCcEEE
Q 002899          705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI-KTSNVLLDKDLNAKI  783 (869)
Q Consensus       705 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl-k~~NILl~~~~~~kl  783 (869)
                       .+..++||||+++++|.. +..        ..   ...++.+++++|+|||+.+   |+|||| ||+|||++.++.+||
T Consensus        90 -~~~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikL  153 (365)
T PRK09188         90 -TGKDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAV  153 (365)
T ss_pred             -cCCcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEE
Confidence             246899999999999862 211        01   1467889999999999998   999999 999999999999999


Q ss_pred             eecCCceeecCCCccc-------cccccccccccchhhcccC
Q 002899          784 SDFGLAKLYEEDKTHI-------STRIAGTIGYMAPEYAMRG  818 (869)
Q Consensus       784 ~DFGla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~  818 (869)
                      +|||+|+.+.......       -....+++.|+|||++...
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999999775433211       1245688899999988643

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=6.5e-22  Score=210.91  Aligned_cols=132  Identities=26%  Similarity=0.416  Sum_probs=108.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcC-----C---CceeeEEeEEee---
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----H---PNLVKLYGCCVE---  705 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~-----H---~nIv~l~~~~~~---  705 (869)
                      .+|.+.++||-|.|++||+|... +.+.||+|+++... .-....+.||++|++++     |   .+||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            67889999999999999999854 56789999987542 22445678999999873     3   369999999986   


Q ss_pred             -CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc
Q 002899          706 -GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD  776 (869)
Q Consensus       706 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~  776 (869)
                       +.+++||+|++. .+|..+|....-   ..++...+++|++||+.||.|||.++  .|||-||||+|||+.
T Consensus       157 NG~HVCMVfEvLG-dnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  157 NGQHVCMVFEVLG-DNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCcEEEEEehhhh-hHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence             447899999875 577777765432   26889999999999999999999886  599999999999994

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=99.87  E-value=1.5e-22  Score=199.77  Aligned_cols=169  Identities=42%  Similarity=0.688  Sum_probs=112.8

Q ss_pred             eeeeecCCcce-ecCCceeccCccCccccc-ccccCcceeeeeccccccCCCCcccceecccccccccccchhhhhhhcc
Q 002899          377 TLHINCGGAKI-NTGHTKYEADMEARGASM-FYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTAR  454 (869)
Q Consensus       377 ~~~~~c~~~~~-~~~~~~~~~d~~~~~~~~-~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (869)
                      .+.++||++.. ......|..|....+.+. |..+              ++..  .  .+.....+-..+.|..||+|+|
T Consensus         2 ~~~IN~Gg~~~~~~~g~~w~~D~~~~~g~~~y~~~--------------~~~~--~--~~~~~~~~i~~t~d~~Lyqt~R   63 (174)
T PF11721_consen    2 VLRINAGGPAYTDSSGIVWEADQYYTGGSWGYYVS--------------SDNN--G--STSSTNSSIPGTTDDPLYQTER   63 (174)
T ss_dssp             EEEEEETSSSEEETTTEEE-SSSSSTTSS-----------------------------SSTTS--TTS-HHHHHTTT---
T ss_pred             EEEEECCCCcccCCCCCEEcCCCCCCCCCcccccc--------------cccc--c--ccccccccccCCCchhhhHhhc
Confidence            46799999887 567788888876655443 1111              0000  0  0011112223688999999999


Q ss_pred             cccccceeeeeeccCceEEEEEEeEEEEecCCCcccccCceeeEEEecceecccccchhhhcCCCCcceEEee-ceeecc
Q 002899          455 VSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNF-PAEVTS  533 (869)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  533 (869)
                      ..|.+++|...|+.+|.|+|+|||||+.+..+..++..|+|||||+|+|++++++|||.+++|+..+++.+.+ .+.+++
T Consensus        64 ~g~~~f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~d  143 (174)
T PF11721_consen   64 YGPSSFSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTD  143 (174)
T ss_dssp             --SSSEEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEET
T ss_pred             CCCCceEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeC
Confidence            9999999999999999999999999999999999999999999999999999999999999999998888888 889999


Q ss_pred             ceeEEEEEEcCCCccccCCCCCCC-Cccccc
Q 002899          534 HTLKIHLYWAGRGTTGIPLRGTYG-PLISAI  563 (869)
Q Consensus       534 ~~~~~~~~~~g~~~~~~p~~~~~~-pl~s~~  563 (869)
                      ..|.|++.|+++|++++|..+.++ |++++|
T Consensus       144 g~L~i~f~~~~~~~~~i~~~~~~~~p~IsaI  174 (174)
T PF11721_consen  144 GTLNIQFVWAGKGTLCIPFIGSYGNPLISAI  174 (174)
T ss_dssp             TEEETTEEEE--SEEEEEEESSSSSSSEEEE
T ss_pred             CcEEEEEEecCCCcEEeeccccCCCcEEeeC
Confidence            999999999999999999988887 888765

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.87  E-value=3.4e-25  Score=230.16  Aligned_cols=262  Identities=22%  Similarity=0.290  Sum_probs=225.0

Q ss_pred             EEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCcccccccccccc
Q 002899           56 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN  135 (869)
Q Consensus        56 v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  135 (869)
                      ++.+.+++|.++ .+.+.+.++..|.+|++.+|++...+|.+.....++.|+.++|+++ .+|..+..+.+|..|++++|
T Consensus        47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n  124 (565)
T KOG0472|consen   47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSN  124 (565)
T ss_pred             hhhhhhccCchh-hccHhhhcccceeEEEeccchhhhCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccc
Confidence            678899999998 6677789999999999999999988877777779999999999999 77888999999999999999


Q ss_pred             ccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchH
Q 002899          136 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA  215 (869)
Q Consensus       136 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  215 (869)
                      .+. ..|+.++.+..|+.|+..+|+++ ..|..+..+.+|..|++.+|++....|+.+. |+.|++|+...|.+. .+|.
T Consensus       125 ~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~  200 (565)
T KOG0472|consen  125 ELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPP  200 (565)
T ss_pred             cee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCCh
Confidence            999 78889999999999999999999 7888899999999999999999966666665 999999999999998 7888


Q ss_pred             hhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCC
Q 002899          216 SISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN  295 (869)
Q Consensus       216 ~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  295 (869)
                      .++.+.+|..|+|.+|++...+ ..-....|++|++..|+|+-...+...++++|..|||.+|+++ ..|+.+.-+.+|+
T Consensus       201 ~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~  278 (565)
T KOG0472|consen  201 ELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLE  278 (565)
T ss_pred             hhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhh
Confidence            9999999999999999998876 3333446899999999998544455668999999999999999 7899999999999


Q ss_pred             EEEeeCCcCCCCCchhh-hccCCceeeeccCc
Q 002899          296 FMYLTGNKLTGPVPKYI-FNSNKNVDISLNNF  326 (869)
Q Consensus       296 ~L~Ls~N~l~~~~p~~~-~~~l~~l~ls~N~~  326 (869)
                      +||||+|.|++ +|..+ .-.++.|-+.+|.+
T Consensus       279 rLDlSNN~is~-Lp~sLgnlhL~~L~leGNPl  309 (565)
T KOG0472|consen  279 RLDLSNNDISS-LPYSLGNLHLKFLALEGNPL  309 (565)
T ss_pred             hhcccCCcccc-CCcccccceeeehhhcCCch
Confidence            99999999984 45444 22677888888843

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.86  E-value=5.3e-23  Score=213.96  Aligned_cols=263  Identities=19%  Similarity=0.237  Sum_probs=218.8

Q ss_pred             cceEecCC-------CCcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEe-ecccC
Q 002899           43 SNVTCDCS-------SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSV-MGNRL  113 (869)
Q Consensus        43 ~~v~C~~~-------~~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~L-s~N~l  113 (869)
                      +.|.|+..       .-++..+.|+|..|+|+.+.|.+|+.+++|+.||||+|+|+.+.|.+|..+ +|.+|-+ ++|+|
T Consensus        49 ~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI  128 (498)
T KOG4237|consen   49 GIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI  128 (498)
T ss_pred             ceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence            45777653       345678999999999998888899999999999999999999999999999 6666654 55999


Q ss_pred             CCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCC-------
Q 002899          114 SGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS-------  186 (869)
Q Consensus       114 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~-------  186 (869)
                      +.+..+.|.+|..|+.|.|.-|++.-.....|..+++|..|.+.+|.+..+--.+|..+.+++.+.+..|.+-       
T Consensus       129 ~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~w  208 (498)
T KOG4237|consen  129 TDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPW  208 (498)
T ss_pred             hhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccch
Confidence            9998899999999999999999999888889999999999999999999444448999999999999999821       


Q ss_pred             -----CCCccccCCCC----------------------cccEE----EccCCcCCCCchHhhhcCCCCCEEEcCCCCCCC
Q 002899          187 -----GKIPEFIGKWK----------------------KIQKL----HIQGSSLEGPIPASISALTSLTDLRISDLKGSE  235 (869)
Q Consensus       187 -----~~~~~~~~~l~----------------------~L~~L----~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~  235 (869)
                           ...|..++...                      .++.+    ....+.........|..|++|+.|+|++|+++.
T Consensus       209 la~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~  288 (498)
T KOG4237|consen  209 LADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITR  288 (498)
T ss_pred             hhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccch
Confidence                 12222222211                      11222    222233333445679999999999999999999


Q ss_pred             Ccccccccc-cceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCC
Q 002899          236 SAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT  305 (869)
Q Consensus       236 ~~~~~~~~~-~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  305 (869)
                      +....+... .+++|.|..|+|.......|.++..|+.|+|.+|+|+..-|.+|..+.+|..|+|-.|++.
T Consensus       289 i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  289 IEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             hhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence            888777665 7999999999999888899999999999999999999999999999999999999999985

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.85  E-value=2.8e-24  Score=223.44  Aligned_cols=240  Identities=25%  Similarity=0.409  Sum_probs=220.2

Q ss_pred             EEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCcccccccccccc
Q 002899           56 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN  135 (869)
Q Consensus        56 v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  135 (869)
                      +++|++.+|++. .+|++++.+..++.|+.++|++...++......+++.|++++|.+. ..++.++.+..|+.|+..+|
T Consensus        70 l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N  147 (565)
T KOG0472|consen   70 LTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNN  147 (565)
T ss_pred             eeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcccc
Confidence            789999999999 8899999999999999999999988888888889999999999999 66777999999999999999


Q ss_pred             ccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchH
Q 002899          136 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA  215 (869)
Q Consensus       136 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  215 (869)
                      +++ ..|..+..+.+|..|++.+|++.. .|...-.++.|++||+..|-++ .+|..++.+.+|+.|+|.+|+|. ..| 
T Consensus       148 ~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-  222 (565)
T KOG0472|consen  148 QIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-  222 (565)
T ss_pred             ccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-
Confidence            999 788899999999999999999994 4445445999999999999998 78889999999999999999999 556 


Q ss_pred             hhhcCCCCCEEEcCCCCCCCCccccccc-ccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCC
Q 002899          216 SISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT  294 (869)
Q Consensus       216 ~l~~l~~L~~L~L~~n~~~~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  294 (869)
                      .|.+++.|.+|+++.|.++..+...... .+|..|||..|+++ ..|+.+.-+.+|.+||||+|.|+ ..|.+++++ +|
T Consensus       223 ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL  299 (565)
T KOG0472|consen  223 EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HL  299 (565)
T ss_pred             CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-ee
Confidence            8999999999999999999988877744 47999999999999 78999999999999999999999 678889999 99


Q ss_pred             CEEEeeCCcCC
Q 002899          295 NFMYLTGNKLT  305 (869)
Q Consensus       295 ~~L~Ls~N~l~  305 (869)
                      +.|-|.||++.
T Consensus       300 ~~L~leGNPlr  310 (565)
T KOG0472|consen  300 KFLALEGNPLR  310 (565)
T ss_pred             eehhhcCCchH
Confidence            99999999987

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=1.2e-19  Score=199.24  Aligned_cols=201  Identities=22%  Similarity=0.255  Sum_probs=163.1

Q ss_pred             CCCCCCeeeccCceEEEEEEEcCC--cEEEEEEecccCchhhHHHHHHHHHHHhcCC----CceeeEEeEE-eeCceEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILSDG--TVIAVKQLSSKSRQGNREFVNEIGMISAQQH----PNLVKLYGCC-VEGNQLLL  711 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~~g--~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H----~nIv~l~~~~-~~~~~~~l  711 (869)
                      +|.+.+.||+|+||.||++.....  ..+|+|............+..|+.++..+..    +++.++++.. ..++..++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            789999999999999999997543  4788887765433333367788888888763    5888999888 57778899


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-----CcEEEeec
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-----LNAKISDF  786 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~-----~~~kl~DF  786 (869)
                      ||+.. +.+|.++.....   ...++..+..+|+.|++.+|++||+.|   ++||||||.|+++...     ..+.|.||
T Consensus        99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence            99955 678988775443   237899999999999999999999998   9999999999999754     46899999


Q ss_pred             CCce--eecCCCc-----c-c-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          787 GLAK--LYEEDKT-----H-I-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       787 Gla~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |+++  .+.....     . . .....||..|+++....+...+.+.|+||++.++.|++.|..|+...
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~  240 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL  240 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence            9998  3321111     0 1 12355999999999999999999999999999999999999999653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.82  E-value=5.5e-19  Score=193.03  Aligned_cols=200  Identities=35%  Similarity=0.555  Sum_probs=169.2

Q ss_pred             CCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCch---hhHHHHHHHHHHHhcCCC-ceeeEEeEEeeCceEEEEEEe
Q 002899          640 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQHP-NLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~---~~~~f~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      |...+.||.|+||.||++...  ..+++|.+......   ....|.+|+.++..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            567788999999999999976  78899988765333   367899999999999988 799999999877778999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-cEEEeecCCceeecC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLYEE  794 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~  794 (869)
                      +.++++.+.+......  ..+.......++.|++.+++|+|+.+   ++|||+||+||+++... .++++|||.++....
T Consensus        80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence            9999999666543211  25788999999999999999999998   99999999999999988 799999999986654


Q ss_pred             CCcc-----ccccccccccccchhhccc---CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          795 DKTH-----ISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       795 ~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ....     ......|+..|+|||.+..   .......|+||+|++++++++|+.|+...
T Consensus       155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~  214 (384)
T COG0515         155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE  214 (384)
T ss_pred             CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            3321     2345679999999999987   67899999999999999999999996543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.81  E-value=1.1e-20  Score=232.14  Aligned_cols=146  Identities=18%  Similarity=0.200  Sum_probs=112.7

Q ss_pred             cCC-CceeeEEeEE-------eeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 002899          691 QQH-PNLVKLYGCC-------VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK  762 (869)
Q Consensus       691 l~H-~nIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  762 (869)
                      ++| +||++++++|       .+.+.++++|||+ +++|.+++....    ..+++.+++.++.||++||+|||+++   
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g---  100 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQG---  100 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            455 5788888877       2334678889987 459999996432    25899999999999999999999998   


Q ss_pred             eEEcCCCCCCEEEcC-------------------CCcEEEeecCCceeecCCCc---------------ccccccccccc
Q 002899          763 IVHRDIKTSNVLLDK-------------------DLNAKISDFGLAKLYEEDKT---------------HISTRIAGTIG  808 (869)
Q Consensus       763 iiH~Dlk~~NILl~~-------------------~~~~kl~DFGla~~~~~~~~---------------~~~~~~~gt~~  808 (869)
                      |+||||||+||||+.                   ++.+|++|||+++.......               .......||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999964                   44556666666653211000               00111357889


Q ss_pred             ccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       809 y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      |||||++.+..++.++|||||||+||||++|.+|+.
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~  216 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE  216 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence            999999999999999999999999999999998864

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.81  E-value=6.6e-20  Score=217.70  Aligned_cols=243  Identities=24%  Similarity=0.343  Sum_probs=174.1

Q ss_pred             EEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCcccccccccccc
Q 002899           56 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN  135 (869)
Q Consensus        56 v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  135 (869)
                      .+.|++++++++ .+|..+.  ++|+.|+|++|+|+.++...+  .+|+.|+|++|+|+. +|..+.  .+|+.|+|++|
T Consensus       180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N  251 (754)
T PRK15370        180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMELSIN  251 (754)
T ss_pred             ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEECcCC
Confidence            567888888888 5676554  478888999988886655443  278888888888884 454443  47888889888


Q ss_pred             ccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchH
Q 002899          136 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA  215 (869)
Q Consensus       136 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  215 (869)
                      ++. .+|..+.  .+|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|++ +|..+.  ++|+.|+|++|.++. +|.
T Consensus       252 ~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~  321 (754)
T PRK15370        252 RIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPE  321 (754)
T ss_pred             ccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCc
Confidence            888 6666654  47888889888888 5666554  578888898888884 454432  478888888888884 343


Q ss_pred             hhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCC
Q 002899          216 SISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN  295 (869)
Q Consensus       216 ~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  295 (869)
                      .+  .++|+.|++++|.++..+...  ..+|+.|+|++|+|+ .+|..+  .++|+.|+|++|+|+ .+|..+.  ..|+
T Consensus       322 ~l--~~sL~~L~Ls~N~Lt~LP~~l--~~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt-~LP~~l~--~sL~  391 (754)
T PRK15370        322 TL--PPGLKTLEAGENALTSLPASL--PPELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALT-NLPENLP--AALQ  391 (754)
T ss_pred             cc--cccceeccccCCccccCChhh--cCcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCC-CCCHhHH--HHHH
Confidence            33  257888888888887654322  247888888888887 455544  367888888888888 4565554  3688


Q ss_pred             EEEeeCCcCCCCCchhhh------ccCCceeeeccCcc
Q 002899          296 FMYLTGNKLTGPVPKYIF------NSNKNVDISLNNFT  327 (869)
Q Consensus       296 ~L~Ls~N~l~~~~p~~~~------~~l~~l~ls~N~~~  327 (869)
                      .|++++|+|+ .+|..+.      +.+..++|.+|.++
T Consensus       392 ~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        392 IMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             HHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            8888888887 5666542      34567888888443

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.81  E-value=1.7e-19  Score=212.73  Aligned_cols=235  Identities=26%  Similarity=0.327  Sum_probs=138.5

Q ss_pred             EEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCcccccccccccc
Q 002899           56 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN  135 (869)
Q Consensus        56 v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  135 (869)
                      -..|+|++++|+ .+|+.+.  ++|+.|+|++|+|+.++..   ..+|++|+|++|+|+.+ |..   .++|+.|+|++|
T Consensus       203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~LP~l---p~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls~N  272 (788)
T PRK15387        203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPAL---PPELRTLEVSGNQLTSL-PVL---PPGLLELSIFSN  272 (788)
T ss_pred             CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCCCCC---CCCCcEEEecCCccCcc-cCc---ccccceeeccCC
Confidence            346788888888 6777765  4788888888888865431   23788888888888854 432   357778888888


Q ss_pred             ccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchH
Q 002899          136 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA  215 (869)
Q Consensus       136 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  215 (869)
                      .|+ .+|..+   .+|+.|+|++|+|+ .+|..   +++|+.|+|++|+|++ +|..   ..+|+.|++++|.|++ +|.
T Consensus       273 ~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~  339 (788)
T PRK15387        273 PLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LPT  339 (788)
T ss_pred             chh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc-ccc
Confidence            777 344322   45677777777777 44432   3567777777777774 3332   2345566666666653 232


Q ss_pred             hhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCC
Q 002899          216 SISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN  295 (869)
Q Consensus       216 ~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  295 (869)
                      .   ..+|+.|+|++|+++..+..   ..+|+.|++++|+|+. +|..   .++|+.|+|++|+|++ +|..   .++|+
T Consensus       340 l---p~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~  405 (788)
T PRK15387        340 L---PSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELK  405 (788)
T ss_pred             c---ccccceEecCCCccCCCCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCC
Confidence            1   13566666666666654321   1245566666666653 3332   2345666666666653 3322   24555


Q ss_pred             EEEeeCCcCCCCCchhhhccCCceeeeccCccCC
Q 002899          296 FMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWE  329 (869)
Q Consensus       296 ~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~  329 (869)
                      .|+|++|+|++ +|. +...++.|++++|+++.+
T Consensus       406 ~LdLS~N~Lss-IP~-l~~~L~~L~Ls~NqLt~L  437 (788)
T PRK15387        406 ELMVSGNRLTS-LPM-LPSGLLSLSVYRNQLTRL  437 (788)
T ss_pred             EEEccCCcCCC-CCc-chhhhhhhhhccCccccc
Confidence            66666666653 343 223455556666655544

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.81  E-value=1.4e-19  Score=182.40  Aligned_cols=139  Identities=15%  Similarity=0.185  Sum_probs=107.3

Q ss_pred             CCeeeccCceEEEEEEEcCCcEEEEEEecccCch--h-------hHHH-----------------HHHHHHHHhcCCCce
Q 002899          643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--G-------NREF-----------------VNEIGMISAQQHPNL  696 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~--~-------~~~f-----------------~~E~~~l~~l~H~nI  696 (869)
                      ...||+|+||.||+|...+|+.||||+++.....  .       ...|                 ..|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999998654211  1       1122                 348899999988776


Q ss_pred             eeEEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEcCCCCCCEEE
Q 002899          697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL-HEDSRIKIVHRDIKTSNVLL  775 (869)
Q Consensus       697 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiH~Dlk~~NILl  775 (869)
                      .....+..  ...++||||++++++.......     ..++...+..++.|++.+|+|+ |+.+   |+||||||+|||+
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli  151 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY  151 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence            43333222  2348999999988775543222     2578899999999999999999 6777   9999999999999


Q ss_pred             cCCCcEEEeecCCceee
Q 002899          776 DKDLNAKISDFGLAKLY  792 (869)
Q Consensus       776 ~~~~~~kl~DFGla~~~  792 (869)
                      + ++.++|+|||+|...
T Consensus       152 ~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         152 H-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             E-CCcEEEEEccccccC
Confidence            8 478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=9.8e-20  Score=185.47  Aligned_cols=170  Identities=15%  Similarity=0.147  Sum_probs=131.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHH---------HHHHHHHHHhcCCCceeeEEeEEeeC
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE---------FVNEIGMISAQQHPNLVKLYGCCVEG  706 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~---------f~~E~~~l~~l~H~nIv~l~~~~~~~  706 (869)
                      ..++|+..+++|+|+||.||.+.. +++.+|+|.+.+......+.         +.+|++.+.+++||+|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            468899999999999999999766 56789999997654333222         67899999999999999998886643


Q ss_pred             --------ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC
Q 002899          707 --------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD  778 (869)
Q Consensus       707 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~  778 (869)
                              ...++||||++|.+|.+..         .++.    ....+++.++..+|+.+   ++|||++|+||+++++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~---------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~  171 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMP---------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN  171 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhh---------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence                    3578999999999997763         1222    24568999999999998   9999999999999999


Q ss_pred             CcEEEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHH
Q 002899          779 LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEI  836 (869)
Q Consensus       779 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~el  836 (869)
                      + ++|+|||...........             ..+.....+..++|+||||+.+.-.
T Consensus       172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHH
Confidence            8 999999987655322111             1133344466789999999976544

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.80  E-value=2.5e-19  Score=211.37  Aligned_cols=236  Identities=28%  Similarity=0.365  Sum_probs=177.1

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCcccccccccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE  133 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  133 (869)
                      .+++.|++.+|+|+. +|..   .++|++|+|++|+|+.+++ .  ..+|+.|+|++|.++. +|..   ..+|+.|+|+
T Consensus       222 ~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~LtsLP~-l--p~sL~~L~Ls~N~L~~-Lp~l---p~~L~~L~Ls  290 (788)
T PRK15387        222 AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTSLPV-L--PPGLLELSIFSNPLTH-LPAL---PSGLCKLWIF  290 (788)
T ss_pred             cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCcccC-c--ccccceeeccCCchhh-hhhc---hhhcCEEECc
Confidence            468999999999994 6643   5889999999999997643 2  2389999999999984 3432   3578899999


Q ss_pred             ccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCc
Q 002899          134 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI  213 (869)
Q Consensus       134 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  213 (869)
                      +|+|+ .+|.   .+++|+.|+|++|+|++ +|..   ..+|+.|++++|+|++ +|..   ..+|+.|+|++|+|+. +
T Consensus       291 ~N~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-L  357 (788)
T PRK15387        291 GNQLT-SLPV---LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-L  357 (788)
T ss_pred             CCccc-cccc---cccccceeECCCCcccc-CCCC---cccccccccccCcccc-cccc---ccccceEecCCCccCC-C
Confidence            99998 4554   24689999999999984 4542   2468888999999984 4532   2578999999999985 3


Q ss_pred             hHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCC
Q 002899          214 PASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK  293 (869)
Q Consensus       214 ~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  293 (869)
                      |..   .++|+.|++++|++...+.  . ..+|+.|+|++|+|++ +|..   .++|+.|+|++|+|++ +|..   ..+
T Consensus       358 P~l---p~~L~~L~Ls~N~L~~LP~--l-~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~  423 (788)
T PRK15387        358 PTL---PSELYKLWAYNNRLTSLPA--L-PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSG  423 (788)
T ss_pred             CCC---CcccceehhhccccccCcc--c-ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhh
Confidence            432   3578888899998886442  1 2378999999999885 4433   3678899999999984 5643   346


Q ss_pred             CCEEEeeCCcCCCCCchhh--hccCCceeeeccCccC
Q 002899          294 TNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTW  328 (869)
Q Consensus       294 L~~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~  328 (869)
                      |+.|+|++|+|+ .+|..+  +..++.|+|++|+|+.
T Consensus       424 L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~  459 (788)
T PRK15387        424 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE  459 (788)
T ss_pred             hhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCc
Confidence            788899999988 678776  4577889999996653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=3e-19  Score=174.68  Aligned_cols=201  Identities=23%  Similarity=0.316  Sum_probs=164.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEE-EcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCC-CceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~-~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ..+|.++++||.|+||.+|.|. ..+|..||||.-.....  .....-|.++...++| ..|..+..|..+++.-.+|||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4678999999999999999998 56899999998755433  3456778888888875 457777778888888899999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCcEEEeecCCcee
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAKL  791 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~---~~~~kl~DFGla~~  791 (869)
                      .. +-||.++..-..    ..++.++.+-++.|++.-++|+|.++   +|||||||+|+|..-   ...+.++|||+|+.
T Consensus        92 LL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             cc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence            76 458888774432    25888999999999999999999998   999999999999963   35689999999988


Q ss_pred             ecCCCcc------ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          792 YEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       792 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      +.+....      ......||.+|.+-....+...+.+.|+-|+|.+|...--|+.||+.-.
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk  225 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK  225 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence            7543322      1233679999998887777778889999999999999999999998743

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.79  E-value=1.4e-18  Score=175.78  Aligned_cols=141  Identities=16%  Similarity=0.171  Sum_probs=110.7

Q ss_pred             CCeeeccCceEEEEEEEcCCcEEEEEEecccCchh--------------------------hHHHHHHHHHHHhcCCCce
Q 002899          643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG--------------------------NREFVNEIGMISAQQHPNL  696 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~--------------------------~~~f~~E~~~l~~l~H~nI  696 (869)
                      ...||+|+||.||+|...+|+.||||++.......                          ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            56899999999999998789999999987542110                          1123578899999999987


Q ss_pred             eeEEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCEEE
Q 002899          697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLL  775 (869)
Q Consensus       697 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NILl  775 (869)
                      .....+...  ..++||||++++++.......     ..++.....+++.|++.++.++|+ .+   |+||||||+|||+
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence            544443333  248999999988654432221     146788899999999999999999 87   9999999999999


Q ss_pred             cCCCcEEEeecCCceeecC
Q 002899          776 DKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       776 ~~~~~~kl~DFGla~~~~~  794 (869)
                      + ++.++|+|||++.....
T Consensus       152 ~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             E-CCCEEEEEcccceecCC
Confidence            9 88999999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.78  E-value=1.7e-18  Score=176.92  Aligned_cols=197  Identities=24%  Similarity=0.352  Sum_probs=161.9

Q ss_pred             CCCCCCeeeccCceEEEEEE-EcCCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEEEec
Q 002899          639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~-~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      +|.+.++||+|.||.++.|+ +-+++.||||.-...+.  ..++..|.+..+.+ ..+.|...+.+-.++..-.||+|.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            67889999999999999998 44789999997544332  34556677766665 5688888888777887888999976


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-----CCcEEEeecCCcee
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-----DLNAKISDFGLAKL  791 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~-----~~~~kl~DFGla~~  791 (869)
                       +-||.++..-.+    ..++.+++..||.|++.-++|+|++.   +|.|||||+|+||..     ...+.|+|||+|+.
T Consensus       107 -GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  107 -GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             -CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence             458888764443    36899999999999999999999998   999999999999963     34589999999998


Q ss_pred             ecCCCccc------cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHI------STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +.+.....      .....||.+||+-....+.+.+.+.|+-|+|-++.+.|-|..||+.
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG  238 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG  238 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence            86544322      2235699999999988899999999999999999999999999975

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.77  E-value=1.8e-20  Score=213.74  Aligned_cols=262  Identities=25%  Similarity=0.303  Sum_probs=183.6

Q ss_pred             eEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccccc
Q 002899           55 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE  133 (869)
Q Consensus        55 ~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  133 (869)
                      .++.|+..+|-++...+...  -.+|+++++++|+++..+ .....+ +|+.|+..+|+|+ .+|..+..+++|+.|.+.
T Consensus       220 ~l~~L~a~~n~l~~~~~~p~--p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~  295 (1081)
T KOG0618|consen  220 SLTALYADHNPLTTLDVHPV--PLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAA  295 (1081)
T ss_pred             chheeeeccCcceeeccccc--cccceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhh
Confidence            45566666666663322221  246777777777777666 444444 7777777777775 666677777777888887


Q ss_pred             ccccCCCCCccccCCCCccEEEeecccccccCCccc-cCCCC-CCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCC
Q 002899          134 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL-TKLTN-LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG  211 (869)
Q Consensus       134 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~-~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  211 (869)
                      .|.+. .+|.....+..|++|+|..|+|. .+|+.+ .-+.. |+.|+.+.|++.......=..++.|+.|+|.+|.++.
T Consensus       296 ~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd  373 (1081)
T KOG0618|consen  296 YNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTD  373 (1081)
T ss_pred             hhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccc
Confidence            77777 66667777778888888888877 444433 32222 5666666666653322222335678888888888887


Q ss_pred             CchHhhhcCCCCCEEEcCCCCCCCCcccccccc-cceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhc
Q 002899          212 PIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK  290 (869)
Q Consensus       212 ~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~-~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  290 (869)
                      ..-..|.+..+|+.|+|++|++...+...+... .|++|+||+|+++ .+|+....++.|++|...+|+|. ..| .+..
T Consensus       374 ~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~  450 (1081)
T KOG0618|consen  374 SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQ  450 (1081)
T ss_pred             cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhh
Confidence            777778888888888888888887776665554 5888888888888 56677888888888888888888 566 6888


Q ss_pred             CCCCCEEEeeCCcCCC-CCchhhh-ccCCceeeeccC
Q 002899          291 LAKTNFMYLTGNKLTG-PVPKYIF-NSNKNVDISLNN  325 (869)
Q Consensus       291 l~~L~~L~Ls~N~l~~-~~p~~~~-~~l~~l~ls~N~  325 (869)
                      ++.|+.+|||.|+|+. .+|.... +.|+.|||++|.
T Consensus       451 l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  451 LPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             cCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence            8888888888888874 3555554 788888888884

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=5e-18  Score=169.13  Aligned_cols=184  Identities=14%  Similarity=0.055  Sum_probs=139.3

Q ss_pred             CCCCeeeccCceEEEEEEEcCCcEEEEEEecccCch----hhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceEEEEEEe
Q 002899          641 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ----GNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       641 ~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~----~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      .+...|++|+||+||.+.- .+.+++.+.+.....-    ....|.+|+++|+++. |+++.+++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3567899999999997665 6778887777654331    1235889999999995 5789999886    346899999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC-CCCCEEEcCCCcEEEeecCCceeecC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI-KTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl-k~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      +.+.+|.+.+..            ....++.|++++|+++|++|   |+|||| ||.|||+++++.++|+|||+|.....
T Consensus        80 I~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         80 LAGAAMYQRPPR------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             ecCccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            999888653311            11357789999999999998   999999 79999999999999999999986554


Q ss_pred             CCcc----c--------cccccccccccchhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          795 DKTH----I--------STRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       795 ~~~~----~--------~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      ....    .        ......++.|++|+...-  ...-...+.++.|.-+|.++|++.|.-
T Consensus       145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            3210    0        001225778888885432  233367899999999999999998764

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.77  E-value=1.3e-18  Score=206.80  Aligned_cols=228  Identities=25%  Similarity=0.315  Sum_probs=183.7

Q ss_pred             CCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEee
Q 002899           78 RYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILS  157 (869)
Q Consensus        78 ~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  157 (869)
                      .+...|+|+++.++.++...  ..+|+.|+|++|+|+.. |..+.  ++|+.|+|++|+|+ .+|..+.  .+|+.|+|+
T Consensus       178 ~~~~~L~L~~~~LtsLP~~I--p~~L~~L~Ls~N~LtsL-P~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls  249 (754)
T PRK15370        178 NNKTELRLKILGLTTIPACI--PEQITTLILDNNELKSL-PENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS  249 (754)
T ss_pred             cCceEEEeCCCCcCcCCccc--ccCCcEEEecCCCCCcC-Chhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence            56789999999999765432  13799999999999954 54443  58999999999999 5676554  479999999


Q ss_pred             cccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCc
Q 002899          158 SNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA  237 (869)
Q Consensus       158 ~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~  237 (869)
                      +|++. .+|..+.  .+|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+. +|..+.  ++|+.|+|++|.++..+
T Consensus       250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~LP  320 (754)
T PRK15370        250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTALP  320 (754)
T ss_pred             CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccccCC
Confidence            99999 6777664  58999999999999 4676554  589999999999995 444332  47899999999998765


Q ss_pred             ccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCC
Q 002899          238 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK  317 (869)
Q Consensus       238 ~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~  317 (869)
                      ...  ..+|+.|++++|.+++ +|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+...++
T Consensus       321 ~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~~sL~  391 (754)
T PRK15370        321 ETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLPAALQ  391 (754)
T ss_pred             ccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHHHHHH
Confidence            332  2489999999999996 565543  79999999999998 5777663  68999999999999 67888888899


Q ss_pred             ceeeeccCccCCCC
Q 002899          318 NVDISLNNFTWESS  331 (869)
Q Consensus       318 ~l~ls~N~~~~~~~  331 (869)
                      .|++++|+++.++.
T Consensus       392 ~LdLs~N~L~~LP~  405 (754)
T PRK15370        392 IMQASRNNLVRLPE  405 (754)
T ss_pred             HHhhccCCcccCch
Confidence            99999999886643

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.76  E-value=2.7e-18  Score=171.38  Aligned_cols=106  Identities=25%  Similarity=0.271  Sum_probs=93.2

Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|.+++...+    ..++|.++..++.|+++||+|||+++         ||+|||++.++.+|+  ||++.......  
T Consensus         1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--   63 (176)
T smart00750        1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--   63 (176)
T ss_pred             CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc--
Confidence            68888886532    26899999999999999999999875         999999999999999  99988765422  


Q ss_pred             ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       799 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                          ..||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus        64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~  106 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE  106 (176)
T ss_pred             ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence                2578999999999999999999999999999999999999854

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.75  E-value=9.6e-20  Score=200.23  Aligned_cols=267  Identities=19%  Similarity=0.223  Sum_probs=187.5

Q ss_pred             EEeccCCCcc-ccCCccccCCCCCCEEEeecCcCCCCCc----hhhccc-cceEEEeecccCCC------CCchhhcCcc
Q 002899           58 TIALKAQNLT-GTLPTELSKLRYLKQLDLSRNCLTGSFS----PQWASL-QLVELSVMGNRLSG------PFPKVLTNIT  125 (869)
Q Consensus        58 ~L~l~~~~l~-~~~p~~l~~l~~L~~L~Ls~N~i~~~~~----~~~~~l-~L~~L~Ls~N~l~~------~~~~~~~~l~  125 (869)
                      .|+|..+++. ......+..++.|+.|+|+++.++....    ..+... ++++|+++++.+.+      .++..+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            4677777776 3445667777788899999888865322    222222 48888888887762      2345677788


Q ss_pred             ccccccccccccCCCCCccccCCCC---ccEEEeecccccc----cCCccccCC-CCCCeEeccCCcCCCC----Ccccc
Q 002899          126 TLKNLSIEGNLFTGSIPPDIRKLIN---LQKLILSSNSFTG----ELPAELTKL-TNLNDLRISDNNFSGK----IPEFI  193 (869)
Q Consensus       126 ~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~Ls~N~i~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~----~~~~~  193 (869)
                      +|+.|+|++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|+.|+|++|.+++.    ++..+
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~  161 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL  161 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence            9999999999888666666655555   9999999998873    233445666 8899999999998843    33456


Q ss_pred             CCCCcccEEEccCCcCCCC----chHhhhcCCCCCEEEcCCCCCCCCccccc-----ccccceEEEcccccCccCCCccc
Q 002899          194 GKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPKL-----DKMNLKTLILTKCLIHGEIPDYI  264 (869)
Q Consensus       194 ~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~n~~~~~~~~~~-----~~~~L~~L~Ls~N~i~~~~p~~~  264 (869)
                      ..+++|++|+|++|.+++.    ++..+..+++|+.|+|++|.+.......+     ...+|+.|++++|.+++.....+
T Consensus       162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l  241 (319)
T cd00116         162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL  241 (319)
T ss_pred             HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence            6778899999999988852    34456667789999999888875443222     12368999999998876333332


Q ss_pred             C-----CCCCcCEEeccCCCCCC----CCchhhhcCCCCCEEEeeCCcCCCC----Cchhh--h-ccCCceeeecc
Q 002899          265 G-----DMTKLKNIDLSFNNLTG----GIPTTFEKLAKTNFMYLTGNKLTGP----VPKYI--F-NSNKNVDISLN  324 (869)
Q Consensus       265 ~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~--~-~~l~~l~ls~N  324 (869)
                      .     ..+.|+.|++++|.++.    .+...+..+++|++|++++|+++..    +.+.+  + ..++.+++.+|
T Consensus       242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (319)
T cd00116         242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDD  317 (319)
T ss_pred             HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCC
Confidence            2     24789999999999872    3345566778899999999999855    33333  2 46777888877

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PLN03210 Resistant to P

Probab=99.75  E-value=2.4e-17  Score=209.00  Aligned_cols=258  Identities=21%  Similarity=0.281  Sum_probs=151.3

Q ss_pred             eEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccccc
Q 002899           55 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE  133 (869)
Q Consensus        55 ~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  133 (869)
                      +++.|++.++.+. .++..+..+++|+.|+|++|.....+|. +..+ +|+.|+|++|.....+|..+.++++|+.|+|+
T Consensus       612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~  689 (1153)
T PLN03210        612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS  689 (1153)
T ss_pred             CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence            4556666666655 4555566666666666666543333343 3333 66666666665445566666666666666666


Q ss_pred             ccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCcccc--------------------
Q 002899          134 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI--------------------  193 (869)
Q Consensus       134 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~--------------------  193 (869)
                      +|.....+|..+ ++++|++|+|++|.....+|..   .++|+.|+|++|.+.. +|..+                    
T Consensus       690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~~l~~L~~L~l~~~~~~~l~~  764 (1153)
T PLN03210        690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNLRLENLDELILCEMKSEKLWE  764 (1153)
T ss_pred             CCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccccccccccccccccchhhccc
Confidence            653333555444 5666666666666544344432   3456667777776652 33221                    


Q ss_pred             ----------CCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcc
Q 002899          194 ----------GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDY  263 (869)
Q Consensus       194 ----------~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~  263 (869)
                                ...++|+.|+|++|.....+|..++++++|+.|+|++|......+......+|+.|+|++|..-..+|..
T Consensus       765 ~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~~  844 (1153)
T PLN03210        765 RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPDI  844 (1153)
T ss_pred             cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcccccccc
Confidence                      1124566777777766666777777777777777776543222222234446777777776544344433


Q ss_pred             cCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeC-CcCCCCCchhh--hccCCceeeecc
Q 002899          264 IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG-NKLTGPVPKYI--FNSNKNVDISLN  324 (869)
Q Consensus       264 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~--~~~l~~l~ls~N  324 (869)
                         .++|+.|+|++|.|+ .+|..+..+++|+.|+|++ |+|+ .+|..+  +..++.++++++
T Consensus       845 ---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        845 ---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             ---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence               356777777777777 5677777777777777777 4444 344443  334555555544

syringae 6; Provisional

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.75  E-value=6e-20  Score=209.44  Aligned_cols=272  Identities=22%  Similarity=0.240  Sum_probs=218.9

Q ss_pred             CCcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccc
Q 002899           51 SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNL  130 (869)
Q Consensus        51 ~~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  130 (869)
                      ..+..++.+++++|+++ .+|+.+..+.+|+.|+..+|+++..+...+...+|+.|++..|.++ .+|..+..++.|++|
T Consensus       238 p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tL  315 (1081)
T KOG0618|consen  238 PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTL  315 (1081)
T ss_pred             cccccceeeecchhhhh-cchHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeee
Confidence            44567899999999999 5669999999999999999999877777777779999999999999 667778889999999


Q ss_pred             cccccccCCCCCccccCCCC-ccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcC
Q 002899          131 SIEGNLFTGSIPPDIRKLIN-LQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL  209 (869)
Q Consensus       131 ~Ls~N~l~~~~~~~~~~l~~-L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  209 (869)
                      +|..|+|....+..|.-+.. |+.|..+.|.+.....-.=..++.|+.|+|.+|.|+...-..|.++++|+.|+|++|+|
T Consensus       316 dL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL  395 (1081)
T KOG0618|consen  316 DLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRL  395 (1081)
T ss_pred             eehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccc
Confidence            99999999444334444444 88899999998833322223457799999999999988888899999999999999999


Q ss_pred             CCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhh
Q 002899          210 EGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE  289 (869)
Q Consensus       210 ~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  289 (869)
                      .......+.+++.|++|+||+|+++..+........|++|...+|+|. ..| .+..++.|+.+|||.|+|+...-..-.
T Consensus       396 ~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~  473 (1081)
T KOG0618|consen  396 NSFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL  473 (1081)
T ss_pred             ccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhC
Confidence            988888999999999999999999998866666668999999999998 566 788999999999999999854333233


Q ss_pred             cCCCCCEEEeeCCcCCCCCchhh---hccCCceeeeccCcc
Q 002899          290 KLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISLNNFT  327 (869)
Q Consensus       290 ~l~~L~~L~Ls~N~l~~~~p~~~---~~~l~~l~ls~N~~~  327 (869)
                      .-++|++|||+||.-. ......   +..+...+++-|+..
T Consensus       474 p~p~LkyLdlSGN~~l-~~d~~~l~~l~~l~~~~i~~~~~~  513 (1081)
T KOG0618|consen  474 PSPNLKYLDLSGNTRL-VFDHKTLKVLKSLSQMDITLNNTP  513 (1081)
T ss_pred             CCcccceeeccCCccc-ccchhhhHHhhhhhheecccCCCC
Confidence            3389999999999742 222222   445556666666333

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=2.7e-17  Score=167.31  Aligned_cols=138  Identities=14%  Similarity=0.279  Sum_probs=106.8

Q ss_pred             CCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhc-----CCCceeeEEeEEeeCc---eEE-E
Q 002899          641 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-----QHPNLVKLYGCCVEGN---QLL-L  711 (869)
Q Consensus       641 ~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-----~H~nIv~l~~~~~~~~---~~~-l  711 (869)
                      +-.++||+|+||.||.  ++.....+||++........+++.+|++++..+     .||||++++|+++++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4567899999999996  443333478988765444567899999999999     5799999999998863   434 7


Q ss_pred             EEEe--ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEEcCCCCCCEEEcC----CCcEEEe
Q 002899          712 VYEY--MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL-AYLHEDSRIKIVHRDIKTSNVLLDK----DLNAKIS  784 (869)
Q Consensus       712 V~E~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiH~Dlk~~NILl~~----~~~~kl~  784 (869)
                      |+||  +++|+|.+++...      .+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+
T Consensus        83 I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence            8999  5589999999543      24444  35677888777 9999998   999999999999974    3479999


Q ss_pred             e-cCCcee
Q 002899          785 D-FGLAKL  791 (869)
Q Consensus       785 D-FGla~~  791 (869)
                      | ||....
T Consensus       152 Dg~G~~~~  159 (210)
T PRK10345        152 DNIGESTF  159 (210)
T ss_pred             ECCCCcce
Confidence            9 555444

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.73  E-value=2.4e-18  Score=170.81  Aligned_cols=193  Identities=24%  Similarity=0.381  Sum_probs=151.9

Q ss_pred             CCCeeeccCceEEEEEEEcCCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCC
Q 002899          642 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN  719 (869)
Q Consensus       642 ~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g  719 (869)
                      ...+|.+...|..|+|+|.. ..+++|++...  .....++|.+|.-.++-+.||||+.++|.|.......++..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            34568888999999999974 44566665432  3344678999999999999999999999999999999999999999


Q ss_pred             chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccc
Q 002899          720 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI  799 (869)
Q Consensus       720 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  799 (869)
                      ||...+|+...   ...+-.++.+++.+||+|++|||+..+ -|.---|.++.|++|++.+++|+= +-+++.-+...  
T Consensus       273 slynvlhe~t~---vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kfsfqe~g--  345 (448)
T KOG0195|consen  273 SLYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQEVG--  345 (448)
T ss_pred             HHHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-ccceeeeeccc--
Confidence            99999998743   357888999999999999999999863 244557899999999999988761 11111111111  


Q ss_pred             cccccccccccchhhcccCCC---CchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          800 STRIAGTIGYMAPEYAMRGYL---TSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       800 ~~~~~gt~~y~aPE~~~~~~~---~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                         ..-.|.||+||.++..+.   -..+|+|||+|++|||.|...||..
T Consensus       346 ---r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad  391 (448)
T KOG0195|consen  346 ---RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD  391 (448)
T ss_pred             ---cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc
Confidence               123578999999987643   3468999999999999999999964

>PLN03210 Resistant to P

Probab=99.72  E-value=5.6e-17  Score=205.75  Aligned_cols=252  Identities=23%  Similarity=0.284  Sum_probs=136.1

Q ss_pred             cCCccccCCC-CCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccC
Q 002899           69 TLPTELSKLR-YLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRK  147 (869)
Q Consensus        69 ~~p~~l~~l~-~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  147 (869)
                      .+|+.|..++ +|+.|++.++.+... |..|...+|+.|+|++|++. .++..+..+++|+.|+|++|.....+| .+..
T Consensus       579 ~lp~~~~~lp~~Lr~L~~~~~~l~~l-P~~f~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~  655 (1153)
T PLN03210        579 HLPEGFDYLPPKLRLLRWDKYPLRCM-PSNFRPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSM  655 (1153)
T ss_pred             ecCcchhhcCcccEEEEecCCCCCCC-CCcCCccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-cccc
Confidence            3444444443 355555555555433 33344445666666666665 344455566666666666654333444 3555


Q ss_pred             CCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEE
Q 002899          148 LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR  227 (869)
Q Consensus       148 l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~  227 (869)
                      +++|++|+|++|.....+|..+..+++|+.|++++|..-..+|..+ ++++|+.|+|++|......|..   .++|+.|+
T Consensus       656 l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~  731 (1153)
T PLN03210        656 ATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLD  731 (1153)
T ss_pred             CCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeee
Confidence            6666666666655444566666666666666666654333444443 4556666666665443333321   23455555


Q ss_pred             cCCCCCCCCcccc------------------------------cccccceEEEcccccCccCCCcccCCCCCcCEEeccC
Q 002899          228 ISDLKGSESAFPK------------------------------LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSF  277 (869)
Q Consensus       228 L~~n~~~~~~~~~------------------------------~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~  277 (869)
                      |++|.+...+...                              ....+|+.|+|++|.....+|..++++++|+.|+|++
T Consensus       732 L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~  811 (1153)
T PLN03210        732 LDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIEN  811 (1153)
T ss_pred             cCCCccccccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCC
Confidence            5555544332110                              0012466666666665556666666666666666666


Q ss_pred             CCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCC
Q 002899          278 NNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWE  329 (869)
Q Consensus       278 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~  329 (869)
                      |..-+.+|..+ ++++|+.|+|++|.....+|.. ..+++.|+|++|.++..
T Consensus       812 C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~-~~nL~~L~Ls~n~i~~i  861 (1153)
T PLN03210        812 CINLETLPTGI-NLESLESLDLSGCSRLRTFPDI-STNISDLNLSRTGIEEV  861 (1153)
T ss_pred             CCCcCeeCCCC-CccccCEEECCCCCcccccccc-ccccCEeECCCCCCccC
Confidence            54333455444 5666666666665544444432 34566666666666543

syringae 6; Provisional

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=2.6e-18  Score=200.54  Aligned_cols=199  Identities=26%  Similarity=0.373  Sum_probs=157.3

Q ss_pred             CCCeeeccCceEEEEEEEc-CCcEEEEEEec----cc-Cc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          642 PANKVGEGGFGSVYKGILS-DGTVIAVKQLS----SK-SR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       642 ~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~----~~-~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ..+++|.|++|.|+.+... ..+..+.|.+.    .. .. .....+..|.-+-..+.|||++..+..+.+....+-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4678999999988877643 33434444332    11 11 111225567777778999999888887777777767799


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |++. +|...+....     .+....+..++.|+.+|++|||+.|   |.|||+|++|+++..++.+||+|||.+..+..
T Consensus       402 ~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             cccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence            9999 9998887652     4678889999999999999999998   99999999999999999999999999987654


Q ss_pred             CCc---cccccccccccccchhhcccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCc
Q 002899          795 DKT---HISTRIAGTIGYMAPEYAMRGYLTSK-ADVYSFGVVTLEIVSGKSNTNYRPNE  849 (869)
Q Consensus       795 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k-~DvwSlGvil~elltG~~p~~~~~~~  849 (869)
                      ...   .....++|+..|+|||.+....|.++ .||||.||++..|.+|+.||.....+
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~  531 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS  531 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence            332   34445789999999999998888775 79999999999999999999765433

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.71  E-value=1.3e-18  Score=191.32  Aligned_cols=250  Identities=20%  Similarity=0.279  Sum_probs=194.1

Q ss_pred             eEEEEeccCCCccc----cCCccccCCCCCCEEEeecCcCCC------CCchhhccc-cceEEEeecccCCCCCchhhcC
Q 002899           55 HVVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRNCLTG------SFSPQWASL-QLVELSVMGNRLSGPFPKVLTN  123 (869)
Q Consensus        55 ~v~~L~l~~~~l~~----~~p~~l~~l~~L~~L~Ls~N~i~~------~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~  123 (869)
                      +++.|++.++.++.    .++..+...+.|++|+++++.+.+      ..+..+..+ +|+.|+|++|.+....+..+..
T Consensus        24 ~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~  103 (319)
T cd00116          24 CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLES  103 (319)
T ss_pred             hccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHH
Confidence            38899999999854    356778888999999999998873      122344444 8999999999998777777777


Q ss_pred             ccc---cccccccccccCC----CCCccccCC-CCccEEEeecccccc----cCCccccCCCCCCeEeccCCcCCCC---
Q 002899          124 ITT---LKNLSIEGNLFTG----SIPPDIRKL-INLQKLILSSNSFTG----ELPAELTKLTNLNDLRISDNNFSGK---  188 (869)
Q Consensus       124 l~~---L~~L~Ls~N~l~~----~~~~~~~~l-~~L~~L~Ls~N~i~~----~~p~~~~~l~~L~~L~Ls~N~l~~~---  188 (869)
                      +.+   |++|+|++|++++    .+...+..+ ++|+.|+|++|.+++    .++..+..+++|++|+|++|.+++.   
T Consensus       104 l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~  183 (319)
T cd00116         104 LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR  183 (319)
T ss_pred             HhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHH
Confidence            766   9999999999883    223345666 899999999999984    2344567788999999999999843   


Q ss_pred             -CccccCCCCcccEEEccCCcCCCCc----hHhhhcCCCCCEEEcCCCCCCCCcccccc------cccceEEEcccccCc
Q 002899          189 -IPEFIGKWKKIQKLHIQGSSLEGPI----PASISALTSLTDLRISDLKGSESAFPKLD------KMNLKTLILTKCLIH  257 (869)
Q Consensus       189 -~~~~~~~l~~L~~L~L~~N~l~~~~----~~~l~~l~~L~~L~L~~n~~~~~~~~~~~------~~~L~~L~Ls~N~i~  257 (869)
                       ++..+..+++|+.|+|++|.+.+..    +..+..+++|+.|++++|.++......+.      ...|+.|++++|.|+
T Consensus       184 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~  263 (319)
T cd00116         184 ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT  263 (319)
T ss_pred             HHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence             3344566789999999999998543    45667788999999999998864332221      248999999999997


Q ss_pred             c----CCCcccCCCCCcCEEeccCCCCCCC----CchhhhcC-CCCCEEEeeCCcC
Q 002899          258 G----EIPDYIGDMTKLKNIDLSFNNLTGG----IPTTFEKL-AKTNFMYLTGNKL  304 (869)
Q Consensus       258 ~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~l  304 (869)
                      .    .+...+..+++|+.|++++|.++..    ....+... ++|++|++.+|++
T Consensus       264 ~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         264 DDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             cHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            3    2345566779999999999999955    44445555 7899999999864

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=2.2e-17  Score=195.83  Aligned_cols=200  Identities=22%  Similarity=0.229  Sum_probs=160.0

Q ss_pred             HHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcC---CCceeeEEeEEeeCce
Q 002899          632 QIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       632 ~i~~~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~---H~nIv~l~~~~~~~~~  708 (869)
                      +.+.-.+.|.+.+.||+|+||+||+|...+|+.||+|+-++.+.   -+|.--.+++.+++   -+.|..+..++.-.+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            34444567889999999999999999988899999998765432   34444445555555   2344455555555677


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-------CCCcE
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-------KDLNA  781 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~-------~~~~~  781 (869)
                      -+||+||.+.|+|.+++...     ..++|.-.+.++.||++.+++||..+   ||||||||+|.||.       ...-+
T Consensus       769 S~lv~ey~~~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             ceeeeeccccccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence            78999999999999999633     36899999999999999999999988   99999999999994       23458


Q ss_pred             EEeecCCceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCC
Q 002899          782 KISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN  842 (869)
Q Consensus       782 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p  842 (869)
                      +|+|||-+..+..-... .....++|-.+-.+|+..+..++.++|.|.++-+++-||.|+.-
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99999998766432222 23346789999999999999999999999999999999999863

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.71  E-value=3.2e-19  Score=165.81  Aligned_cols=122  Identities=22%  Similarity=0.384  Sum_probs=63.6

Q ss_pred             cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEecc
Q 002899          102 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS  181 (869)
Q Consensus       102 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls  181 (869)
                      +++.|.||+|+++ .+|..++.+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. .+|..|+.++.|+.|||+
T Consensus        34 ~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlt  110 (264)
T KOG0617|consen   34 NITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLT  110 (264)
T ss_pred             hhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcc
Confidence            3444444455554 33334555555555555555555 45555555555555555555555 555555555555555555


Q ss_pred             CCcCC-CCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEE
Q 002899          182 DNNFS-GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR  227 (869)
Q Consensus       182 ~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~  227 (869)
                      +|++. ..+|..|..|+.|+.|+|++|.+. .+|..++++++|+.|.
T Consensus       111 ynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~  156 (264)
T KOG0617|consen  111 YNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILS  156 (264)
T ss_pred             ccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEe
Confidence            55554 234445555555555555555554 3344444444444333

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.71  E-value=1.8e-18  Score=191.88  Aligned_cols=186  Identities=28%  Similarity=0.333  Sum_probs=154.5

Q ss_pred             eeeccCceEEEEEE----EcCCcEEEEEEecccCchh--hHHHHHHHHHHHhcC-CCceeeEEeEEeeCceEEEEEEecc
Q 002899          645 KVGEGGFGSVYKGI----LSDGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       645 ~IG~G~fG~Vyka~----~~~g~~VAvK~~~~~~~~~--~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      ++|+|+||.|+.+.    ...|+.+|+|..++.....  ......|..++...+ ||.+|++...++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999754    3457788888876653221  124456777788876 9999999999999999999999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      +|.+...+....     .++..........+|-+++++|+.+   ++|||+|++||+++.+|++++.|||+++.......
T Consensus        81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI  152 (612)
T ss_pred             cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence            999987775543     4677777788888999999999998   99999999999999999999999999987654432


Q ss_pred             cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .     +||..|||||++.  .....+|.||||++++||++|-.||..
T Consensus       153 ~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 A-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             c-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            2     7899999999998  467789999999999999999999964

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=2.7e-16  Score=161.93  Aligned_cols=135  Identities=22%  Similarity=0.305  Sum_probs=113.6

Q ss_pred             CeeeccCceEEEEEEEcCCcEEEEEEecccCch--------hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~--------~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      +.||+|++|.||+|.. +|..|++|+.......        ....+..|++++..++|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 5677899976543211        124577899999999999988777777777888999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      +++++|.+.+...        .+ .+..++.+++.+|.++|+.+   ++|||++|+|||++ ++.++|+|||.+...
T Consensus        81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            9999999888542        12 78899999999999999987   99999999999999 789999999998754

>smart00090 RIO RIO-like kinase

Probab=99.68  E-value=3e-16  Score=163.60  Aligned_cols=142  Identities=16%  Similarity=0.158  Sum_probs=110.0

Q ss_pred             CCCCCeeeccCceEEEEEE--EcCCcEEEEEEecccCch------------------------hhHHHHHHHHHHHhcCC
Q 002899          640 FDPANKVGEGGFGSVYKGI--LSDGTVIAVKQLSSKSRQ------------------------GNREFVNEIGMISAQQH  693 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~--~~~g~~VAvK~~~~~~~~------------------------~~~~f~~E~~~l~~l~H  693 (869)
                      |.+.+.||+|+||.||+|.  ..+|+.||+|+++.....                        ....+..|++.+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            6678999999999999998  568999999998754210                        01235679999999876


Q ss_pred             Cc--eeeEEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCC
Q 002899          694 PN--LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTS  771 (869)
Q Consensus       694 ~n--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~  771 (869)
                      ..  +.+++++    ...++||||++++++........     .+.......++.|++.++++||+.+  .++||||||+
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~  178 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY  178 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence            33  3444443    23589999999988876542221     3455667899999999999999886  4999999999


Q ss_pred             CEEEcCCCcEEEeecCCceeec
Q 002899          772 NVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       772 NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++ ++.++|+|||.+....
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccC
Confidence            99999 8899999999987544

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=5.4e-16  Score=181.99  Aligned_cols=139  Identities=22%  Similarity=0.297  Sum_probs=112.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEE-ecccCc-------hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQ-LSSKSR-------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~-~~~~~~-------~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~  708 (869)
                      ...|...+.||+|+||+||+|.+.+.. +++|+ +.....       ....++..|++++..++|++++....++...+.
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            445567899999999999999876544 33333 222111       123468899999999999999988888887778


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .++||||+++++|.+++.             ....++.+++++|.|||+.+   ++||||||+|||+ .++.++|+|||+
T Consensus       411 ~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl  473 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL  473 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence            899999999999988773             35678999999999999998   9999999999999 578999999999


Q ss_pred             ceeec
Q 002899          789 AKLYE  793 (869)
Q Consensus       789 a~~~~  793 (869)
                      ++...
T Consensus       474 a~~~~  478 (535)
T PRK09605        474 GKYSD  478 (535)
T ss_pred             cccCC
Confidence            97653

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.67  E-value=1.4e-18  Score=161.65  Aligned_cols=157  Identities=25%  Similarity=0.383  Sum_probs=129.8

Q ss_pred             ccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccE
Q 002899           74 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK  153 (869)
Q Consensus        74 l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  153 (869)
                      +.++.+++.|.||+|.++.++|..-...+|+.|++++|+++ ..|..++.+++|+.|+++-|++. ..|..|+.+|.|+.
T Consensus        29 Lf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev  106 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV  106 (264)
T ss_pred             ccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence            45566777788888888877666655557888888888887 66778899999999999999988 88899999999999


Q ss_pred             EEeecccccc-cCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCC
Q 002899          154 LILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK  232 (869)
Q Consensus       154 L~Ls~N~i~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~  232 (869)
                      |||..|++.. .+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|..++.++.|++|++.+|+
T Consensus       107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr  184 (264)
T KOG0617|consen  107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR  184 (264)
T ss_pred             hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence            9999998875 67888888999999999999998 78888999999999999999988 678888888888877776444


Q ss_pred             CC
Q 002899          233 GS  234 (869)
Q Consensus       233 ~~  234 (869)
                      ++
T Consensus       185 l~  186 (264)
T KOG0617|consen  185 LT  186 (264)
T ss_pred             ee
Confidence            43

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.66  E-value=7.1e-16  Score=157.33  Aligned_cols=132  Identities=25%  Similarity=0.328  Sum_probs=107.3

Q ss_pred             eeeccCceEEEEEEEcCCcEEEEEEecccCc--------hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       645 ~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~--------~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .||+|+||.||+|.+ +++.|++|.......        ....++..|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 567899998654321        11255778999999999988765555666667789999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ++++|.+.+....           . .++.+++.+|.+||+.+   ++|||++|+||+++ ++.++++|||++....
T Consensus        80 ~g~~l~~~~~~~~-----------~-~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        80 EGKPLKDVIEEGN-----------D-ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             CCccHHHHHhhcH-----------H-HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence            9999988774321           0 78999999999999998   99999999999999 8899999999987643

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.66  E-value=6.2e-16  Score=157.62  Aligned_cols=143  Identities=20%  Similarity=0.182  Sum_probs=110.7

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCch----------------------hhHHHHHHHHHHHhc
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ----------------------GNREFVNEIGMISAQ  691 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~----------------------~~~~f~~E~~~l~~l  691 (869)
                      ......|.+.+.||+|+||.||+|...+|+.||||++......                      ....+..|+.++.++
T Consensus        11 ~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   90 (198)
T cd05144          11 VKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL   90 (198)
T ss_pred             HHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence            3333347788999999999999999888999999986543210                      012356788888888


Q ss_pred             CCCc--eeeEEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCC
Q 002899          692 QHPN--LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK  769 (869)
Q Consensus       692 ~H~n--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk  769 (869)
                      .|++  +.+.++    ....++||||+++++|.+....           .....++.+++.++.++|+.+   ++|||||
T Consensus        91 ~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~  152 (198)
T cd05144          91 YEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGDLS  152 (198)
T ss_pred             HHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence            8874  444444    2456899999999988765321           235678899999999999987   9999999


Q ss_pred             CCCEEEcCCCcEEEeecCCceeecC
Q 002899          770 TSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       770 ~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+||++++++.++|+|||++.....
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.61  E-value=4.3e-15  Score=156.11  Aligned_cols=197  Identities=19%  Similarity=0.237  Sum_probs=127.1

Q ss_pred             CCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHHHHhcCC----------CceeeEEeEE---
Q 002899          641 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQH----------PNLVKLYGCC---  703 (869)
Q Consensus       641 ~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l~H----------~nIv~l~~~~---  703 (869)
                      ...+.||.|+++.||.++.. +++.+|||++.....   ...+++.+|.-....+.+          -.++..++..   
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            34678999999999999986 589999998754432   234556666544443222          1222222211   


Q ss_pred             ------eeC---c-----eEEEEEEeccCCchhhhhh---cCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEc
Q 002899          704 ------VEG---N-----QLLLVYEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHR  766 (869)
Q Consensus       704 ------~~~---~-----~~~lV~E~~~~gsL~~~l~---~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~  766 (869)
                            ...   .     ..+++|+-+ .++|.+++.   ..... ...+....++.+..|+++.+++||..|   ++|+
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                  111   1     236677766 467876643   22111 223455667788899999999999998   9999


Q ss_pred             CCCCCCEEEcCCCcEEEeecCCceeecCCCccccccccccccccchhhccc--------CCCCchhHHHHHHHHHHHHHc
Q 002899          767 DIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR--------GYLTSKADVYSFGVVTLEIVS  838 (869)
Q Consensus       767 Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DvwSlGvil~ellt  838 (869)
                      ||+|+|++++++|.++|+||+.....+....   . ...+..|.+||....        ..++.+.|.|++|+++|.|++
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceee---c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            9999999999999999999988765543221   1 223568999997644        257889999999999999999


Q ss_pred             CCCCCCCC
Q 002899          839 GKSNTNYR  846 (869)
Q Consensus       839 G~~p~~~~  846 (869)
                      |+.||...
T Consensus       246 ~~lPf~~~  253 (288)
T PF14531_consen  246 GRLPFGLS  253 (288)
T ss_dssp             SS-STCCC
T ss_pred             ccCCCCCC
Confidence            99999754

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.59  E-value=3.7e-16  Score=181.38  Aligned_cols=196  Identities=23%  Similarity=0.275  Sum_probs=149.7

Q ss_pred             CCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccC-chhhHHHHHHHHH--HHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          639 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS-RQGNREFVNEIGM--ISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~-~~~~~~f~~E~~~--l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++...+.||++.|=+|.+|+.+.|. |+||++-... .-..+.|.++++-  ...++|||.+++.-....+...|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5667788999999999999998887 8899875543 3334555554433  4556999999998887777778899998


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee--c
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY--E  793 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~--~  793 (869)
                      ..+ +|.+.+..+.     -+...+.+.|+.|++.|+.-+|..+   |.|||||.+|||++.-.-+.|+||..-+..  .
T Consensus       103 vkh-nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  103 VKH-NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             Hhh-hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCC
Confidence            865 7888886543     4677788899999999999999998   999999999999999999999999765432  2


Q ss_pred             CCCccccc----cccccccccchhhcccC----------C-CCchhHHHHHHHHHHHHHc-CCCCCC
Q 002899          794 EDKTHIST----RIAGTIGYMAPEYAMRG----------Y-LTSKADVYSFGVVTLEIVS-GKSNTN  844 (869)
Q Consensus       794 ~~~~~~~~----~~~gt~~y~aPE~~~~~----------~-~~~k~DvwSlGvil~ellt-G~~p~~  844 (869)
                      .++.....    .-..-..|+|||..-..          . .+++-||||+||+++||++ |++||.
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            22211111    11122379999976431          1 5778999999999999988 788885

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.57  E-value=1.9e-15  Score=175.66  Aligned_cols=181  Identities=23%  Similarity=0.357  Sum_probs=125.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~-g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ..+|+.+++|..|+||.||..+++. .+.+|+|+=+.+ -     +.+  .++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-l-----ilR--nilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-L-----ILR--NILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc-h-----hhh--ccccccCCccee------------------
Confidence            3578889999999999999998763 566777432211 0     000  022233333333                  


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                         |+-...+..-+     +++.        +++.+++|||+.+   |+|||+||+|.+++.-|++|+.|||+.++....
T Consensus       136 ---gDc~tllk~~g-----~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG-----PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             ---chhhhhcccCC-----CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence               33333343222     2221        2378899999998   999999999999999999999999998764321


Q ss_pred             Cc--------------cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHHHh
Q 002899          796 KT--------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVL  861 (869)
Q Consensus       796 ~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~~~  861 (869)
                      ..              .....++||+.|+|||++....|+..+|+|++|+|+||.+.|..||.....++      -...+
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~v  270 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQV  270 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhh
Confidence            10              01123689999999999999999999999999999999999999997643332      23344


Q ss_pred             hcccccC
Q 002899          862 QEEEIYW  868 (869)
Q Consensus       862 ~~~~~~~  868 (869)
                      +.++++|
T Consensus       271 isd~i~w  277 (1205)
T KOG0606|consen  271 ISDDIEW  277 (1205)
T ss_pred             hhhhccc
Confidence            4555555

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.56  E-value=4.1e-14  Score=136.67  Aligned_cols=136  Identities=18%  Similarity=0.197  Sum_probs=114.2

Q ss_pred             CCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCC--CceeeEEeEEeeCceEEEEEEeccCC
Q 002899          642 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH--PNLVKLYGCCVEGNQLLLVYEYMKNN  719 (869)
Q Consensus       642 ~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~E~~~~g  719 (869)
                      +.+.||+|.++.||++...+ +.+++|.......  ...+..|+.++..++|  .++.+++++...++..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45779999999999999854 7799998865433  4678899999999976  58889999888888899999999987


Q ss_pred             chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          720 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       720 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      .+...            +......++.++++++++||......++|+|++|+||++++.+.++++|||.+...
T Consensus        79 ~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          79 TLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            66432            45677888999999999999864445999999999999999899999999998643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.54  E-value=2.9e-14  Score=143.89  Aligned_cols=137  Identities=20%  Similarity=0.267  Sum_probs=98.3

Q ss_pred             CCeeeccCceEEEEEEEcCCcEEEEEEecccCch--hhHHH----------------------HHHHHHHHhcCCCc--e
Q 002899          643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--GNREF----------------------VNEIGMISAQQHPN--L  696 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~--~~~~f----------------------~~E~~~l~~l~H~n--I  696 (869)
                      .+.||+|+||.||+|...+++.||||++......  ....+                      ..|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999988653211  11111                      24555565554443  3


Q ss_pred             eeEEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCEEE
Q 002899          697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLL  775 (869)
Q Consensus       697 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NILl  775 (869)
                      .+.+++    ...++||||++++.+........     ... .....++.+++.++.++|. .+   |+||||||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence            444443    24589999999965432111110     011 5678899999999999998 76   9999999999999


Q ss_pred             cCCCcEEEeecCCceeec
Q 002899          776 DKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       776 ~~~~~~kl~DFGla~~~~  793 (869)
                      + ++.++++|||.+....
T Consensus       149 ~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             E-CCcEEEEECccccccc
Confidence            9 8999999999987554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.52  E-value=2.2e-14  Score=159.99  Aligned_cols=166  Identities=32%  Similarity=0.479  Sum_probs=133.8

Q ss_pred             HhcCCCceeeEEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC
Q 002899          689 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI  768 (869)
Q Consensus       689 ~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl  768 (869)
                      +.+.|.|+.+++|.+.++...+.|.+|++.|+|.+.+....    ..++|.....+.++++.||+|||... . -.|+.+
T Consensus         2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l   75 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGAL   75 (484)
T ss_pred             cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeee
Confidence            46789999999999999999999999999999999997643    37899999999999999999999763 1 289999


Q ss_pred             CCCCEEEcCCCcEEEeecCCceeecCCC-ccccccccccccccchhhcccC-------CCCchhHHHHHHHHHHHHHcCC
Q 002899          769 KTSNVLLDKDLNAKISDFGLAKLYEEDK-THISTRIAGTIGYMAPEYAMRG-------YLTSKADVYSFGVVTLEIVSGK  840 (869)
Q Consensus       769 k~~NILl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-------~~~~k~DvwSlGvil~elltG~  840 (869)
                      +++|.++|....+|++|||+........ ........-..-|.|||.+...       ..+++.||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            9999999999999999999987764211 1111112234478999998753       1577899999999999999999


Q ss_pred             CCCCCCC-CcchhhHHHHHHH
Q 002899          841 SNTNYRP-NEDFVYLLDWAYV  860 (869)
Q Consensus       841 ~p~~~~~-~~~~~~l~~w~~~  860 (869)
                      .||.... .++..+++.++..
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~  176 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKK  176 (484)
T ss_pred             CccccccccCChHHHHHHHHh
Confidence            9997643 3444567766654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.50  E-value=5.7e-15  Score=161.33  Aligned_cols=146  Identities=25%  Similarity=0.372  Sum_probs=118.9

Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                      ..+|+.|+++...+|.+++.+...  ....++.....++.|++.|++|   ++   .+|+|+||.||+...+..+||.||
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhh
Confidence            357899999999999999975542  3467899999999999999999   55   899999999999999999999999


Q ss_pred             CCceeecCCC-----ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-----------------CCCCCC
Q 002899          787 GLAKLYEEDK-----THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-----------------GKSNTN  844 (869)
Q Consensus       787 Gla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-----------------G~~p~~  844 (869)
                      |+...+....     ....+..+||..||+||.+.+..|+.|+||||||+||+||+.                 |..|..
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~  480 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPE  480 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChH
Confidence            9987765443     222344679999999999999999999999999999999998                 555633


Q ss_pred             C-CCCcchhhHHHHHHH
Q 002899          845 Y-RPNEDFVYLLDWAYV  860 (869)
Q Consensus       845 ~-~~~~~~~~l~~w~~~  860 (869)
                      + ....+..++++|...
T Consensus       481 ~~~d~p~e~~ll~~lls  497 (516)
T KOG1033|consen  481 FLQDYPEEYTLLQQLLS  497 (516)
T ss_pred             HhhcCcHHHHHHHHhcC
Confidence            3 223445567777643

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.50  E-value=2.4e-13  Score=142.16  Aligned_cols=137  Identities=18%  Similarity=0.214  Sum_probs=105.2

Q ss_pred             CCeee-ccCceEEEEEEEcCCcEEEEEEecccC-------------chhhHHHHHHHHHHHhcCCCce--eeEEeEEeeC
Q 002899          643 ANKVG-EGGFGSVYKGILSDGTVIAVKQLSSKS-------------RQGNREFVNEIGMISAQQHPNL--VKLYGCCVEG  706 (869)
Q Consensus       643 ~~~IG-~G~fG~Vyka~~~~g~~VAvK~~~~~~-------------~~~~~~f~~E~~~l~~l~H~nI--v~l~~~~~~~  706 (869)
                      ...|| .|+.|+||++... +..++||.+....             ......+.+|++++..++|++|  ++.+++...+
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45688 8999999999875 6778999875321             1223467889999999999885  6777765443


Q ss_pred             c----eEEEEEEeccC-CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcE
Q 002899          707 N----QLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA  781 (869)
Q Consensus       707 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~  781 (869)
                      .    ..++|||++++ .+|.+++...      .++..    .+.+++.++.+||+.|   |+||||||.|||++.++.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v  181 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKF  181 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCE
Confidence            2    22599999997 6888877432      23433    3578999999999998   9999999999999999999


Q ss_pred             EEeecCCceeec
Q 002899          782 KISDFGLAKLYE  793 (869)
Q Consensus       782 kl~DFGla~~~~  793 (869)
                      +|+|||.+....
T Consensus       182 ~LIDfg~~~~~~  193 (239)
T PRK01723        182 WLIDFDRGELRT  193 (239)
T ss_pred             EEEECCCcccCC
Confidence            999999987543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.47  E-value=1.7e-13  Score=143.51  Aligned_cols=144  Identities=25%  Similarity=0.404  Sum_probs=108.9

Q ss_pred             CCCceeeEEeEEee---------------------------CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHH
Q 002899          692 QHPNLVKLYGCCVE---------------------------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI  744 (869)
Q Consensus       692 ~H~nIv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i  744 (869)
                      +|||||++.++|.+                           ...+|+||.-.+ .+|..++..+.      .+...+.-|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~------~s~r~~~~~  346 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH------RSYRTGRVI  346 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC------CchHHHHHH
Confidence            69999998877643                           235799998776 48888887663      455667778


Q ss_pred             HHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE--cCCC--cEEEeecCCceeecCCC---cc--ccccccccccccchhhc
Q 002899          745 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLL--DKDL--NAKISDFGLAKLYEEDK---TH--ISTRIAGTIGYMAPEYA  815 (869)
Q Consensus       745 ~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl--~~~~--~~kl~DFGla~~~~~~~---~~--~~~~~~gt~~y~aPE~~  815 (869)
                      ..|+++|+.|||.++   |.|||+|++|||+  |+|+  .+.|+|||++-.-....   ..  .....-|...-||||+.
T Consensus       347 laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~  423 (598)
T KOG4158|consen  347 LAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA  423 (598)
T ss_pred             HHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence            899999999999998   9999999999999  3443  46899999875433211   11  11123467788999987


Q ss_pred             ccCC------CCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          816 MRGY------LTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       816 ~~~~------~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...+      .-.|+|.|+.|-+.||+++...||..
T Consensus       424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence            5432      23489999999999999999999964

>PLN03150 hypothetical protein; Provisional

Probab=99.45  E-value=2.8e-13  Score=160.86  Aligned_cols=147  Identities=29%  Similarity=0.532  Sum_probs=98.3

Q ss_pred             cHHHHHHHHHHhCCC---CCCCCCCCCCCCCCccccCCCCCCCCcceEecCCCC--cceEEEEeccCCCccccCCccccC
Q 002899            2 PKKALKQIGRKLGKK---DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSA--TCHVVTIALKAQNLTGTLPTELSK   76 (869)
Q Consensus         2 ~~~~l~~~~~~l~~~---~W~~~~d~C~~~g~w~~~~~~~~~~~~~v~C~~~~~--~~~v~~L~l~~~~l~~~~p~~l~~   76 (869)
                      +.+||+++|+.++..   +|+  .|+|....          ..|.||.|..+..  ...|+.|+|++|+++|.+|..|.+
T Consensus       373 ~~~aL~~~k~~~~~~~~~~W~--g~~C~p~~----------~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~  440 (623)
T PLN03150        373 EVSALQTLKSSLGLPLRFGWN--GDPCVPQQ----------HPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISK  440 (623)
T ss_pred             HHHHHHHHHHhcCCcccCCCC--CCCCCCcc----------cccccceeeccCCCCceEEEEEECCCCCccccCCHHHhC
Confidence            467999999999863   784  46774211          1234799964332  346999999999999999999999


Q ss_pred             CCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCC-CCccEE
Q 002899           77 LRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL-INLQKL  154 (869)
Q Consensus        77 l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L  154 (869)
                      +++|+.|+|++|.+++.+|..+..+ +|+.|+|++|++++.+|..++++++|+.|+|++|++++.+|..+..+ .++..+
T Consensus       441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l  520 (623)
T PLN03150        441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF  520 (623)
T ss_pred             CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceE
Confidence            9999999999888876666555555 56666666666665555555556666666666655555555554432 234444


Q ss_pred             Eeeccc
Q 002899          155 ILSSNS  160 (869)
Q Consensus       155 ~Ls~N~  160 (869)
                      ++.+|.
T Consensus       521 ~~~~N~  526 (623)
T PLN03150        521 NFTDNA  526 (623)
T ss_pred             EecCCc
Confidence            444443

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.43  E-value=1.1e-14  Score=158.78  Aligned_cols=199  Identities=27%  Similarity=0.318  Sum_probs=142.7

Q ss_pred             EEEeecCcCCCCCchhhc-cc-cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecc
Q 002899           82 QLDLSRNCLTGSFSPQWA-SL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN  159 (869)
Q Consensus        82 ~L~Ls~N~i~~~~~~~~~-~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  159 (869)
                      .|.|++-.+...+-..+. .+ --...||+.|++. .+|..+..+..|+.|.|..|.|. .+|..+.++..|+.|+|+.|
T Consensus        54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N  131 (722)
T KOG0532|consen   54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN  131 (722)
T ss_pred             ccccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence            456666666544444333 11 3445788888888 67777888888899999998888 78888888889999999999


Q ss_pred             cccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCccc
Q 002899          160 SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP  239 (869)
Q Consensus       160 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~  239 (869)
                      +++ .+|..+..|+ |+.|-+++|+++ .+|+.++.+..|..|+.+.|.+. .+|..++.+.+|+.|.+..|.+...+..
T Consensus       132 qlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~E  207 (722)
T KOG0532|consen  132 QLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEE  207 (722)
T ss_pred             hhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHH
Confidence            988 7787787776 889999999988 67888888888999999999888 6677888888888888776666655444


Q ss_pred             ccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhh
Q 002899          240 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE  289 (869)
Q Consensus       240 ~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  289 (869)
                      .. ...|..||+|.|+|. .+|-.|.+|+.|++|-|.+|.|+ ..|..+.
T Consensus       208 l~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC  254 (722)
T KOG0532|consen  208 LC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC  254 (722)
T ss_pred             Hh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence            33 335555555555555 45555555555555555555555 4444443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.37  E-value=2.3e-12  Score=146.30  Aligned_cols=142  Identities=22%  Similarity=0.256  Sum_probs=101.5

Q ss_pred             CCeeeccCceEEEEEEEcCCcEEEEEEecccCchh----------------------------------------hHHHH
Q 002899          643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG----------------------------------------NREFV  682 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~----------------------------------------~~~f~  682 (869)
                      .+.||.|++|.||+|++.+|+.||||+.++.....                                        .-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36799999999999999999999999986542111                                        01245


Q ss_pred             HHHHHHHhc----C-CCceeeEEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHH-HHHHHH
Q 002899          683 NEIGMISAQ----Q-HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR-GLAYLH  756 (869)
Q Consensus       683 ~E~~~l~~l----~-H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH  756 (869)
                      .|++.+.++    + ++++.-..-|.......+|||||+++++|.+.......    ..   .+.+++..+++ .+..+|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHH
Confidence            566555554    2 34433222222234467999999999999887643211    12   24557777766 478889


Q ss_pred             hcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       757 ~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      ..+   ++|+|++|.||++++++.++++|||++..+..
T Consensus       275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            887   99999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.36  E-value=6.7e-13  Score=150.49  Aligned_cols=200  Identities=30%  Similarity=0.462  Sum_probs=121.5

Q ss_pred             EEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCC-CccEEEeecccccccCCccccCCCCCCeEeccCC
Q 002899          105 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI-NLQKLILSSNSFTGELPAELTKLTNLNDLRISDN  183 (869)
Q Consensus       105 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N  183 (869)
                      .|+++.|.+... ...+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            355555555322 222344455666666666666 4444444443 6666666666665 44445556666666666666


Q ss_pred             cCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcc
Q 002899          184 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDY  263 (869)
Q Consensus       184 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~  263 (869)
                      +++ .+|.....+++|+.|++++|+++ .+|.....+..|++|.+++|.+...........++..|.+.+|++.. .+..
T Consensus       174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~-~~~~  250 (394)
T COG4886         174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED-LPES  250 (394)
T ss_pred             hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee-ccch
Confidence            665 34444445566666666666666 44444444445666666666543333333333355566666777663 3667


Q ss_pred             cCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh
Q 002899          264 IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI  312 (869)
Q Consensus       264 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  312 (869)
                      ++.+++|+.|++++|+++...+  +..+.+|+.|++++|.++...|...
T Consensus       251 ~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~  297 (394)
T COG4886         251 IGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA  297 (394)
T ss_pred             hccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence            7788889999999999985444  8888999999999999887776655

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.34  E-value=5e-14  Score=153.70  Aligned_cols=199  Identities=22%  Similarity=0.351  Sum_probs=168.7

Q ss_pred             EEEeecccCCCCCchhh-cCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCC
Q 002899          105 ELSVMGNRLSGPFPKVL-TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN  183 (869)
Q Consensus       105 ~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N  183 (869)
                      .|.|++-++....-... -.++--...||+.|++. ++|..+..+..|+.|.|.+|.|. .+|..+.++..|++|+|+.|
T Consensus        54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N  131 (722)
T KOG0532|consen   54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN  131 (722)
T ss_pred             ccccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence            35566666653322222 34666678899999999 89999999999999999999999 88999999999999999999


Q ss_pred             cCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcc
Q 002899          184 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDY  263 (869)
Q Consensus       184 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~  263 (869)
                      +++ .+|..++.++ |+.|.+++|+++ .+|..++.+..|..|+.+.|.+...+.......+|+.|.+..|++. .+|..
T Consensus       132 qlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~E  207 (722)
T KOG0532|consen  132 QLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEE  207 (722)
T ss_pred             hhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHH
Confidence            998 7788887776 999999999999 7788888999999999999999988888777778999999999998 45556


Q ss_pred             cCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh
Q 002899          264 IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI  312 (869)
Q Consensus       264 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  312 (869)
                      +.. -.|..||+|.|+++ .+|..|.+|.+|++|-|.+|+|+ ..|..+
T Consensus       208 l~~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqI  253 (722)
T KOG0532|consen  208 LCS-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQI  253 (722)
T ss_pred             HhC-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHH
Confidence            664 45899999999999 89999999999999999999998 445444

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.34  E-value=1.2e-13  Score=161.54  Aligned_cols=214  Identities=25%  Similarity=0.365  Sum_probs=164.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcC--CcEEEEEEecccC--chhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSD--GTVIAVKQLSSKS--RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~--g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ..|.+.+.||+|+|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++++++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            456677889999999998877533  3456677665443  222233344666666665 99999999999999999999


Q ss_pred             EEeccCCchhhhh-hcCCcccccCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEEcCCCCCCEEEcCCC-cEEEeecCCc
Q 002899          713 YEYMKNNCLSRAI-FGKDTEYRLKLDWPTRKKICIGIARGLAYLH-EDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLA  789 (869)
Q Consensus       713 ~E~~~~gsL~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiH~Dlk~~NILl~~~~-~~kl~DFGla  789 (869)
                      +||..++++.+-+ +...    ...+....-..+.|+..++.|+| +.+   +.|+|+||+|.+++..+ ..+++|||+|
T Consensus       100 ~~~s~g~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             cCcccccccccccccCCc----cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhh
Confidence            9999999998877 3321    13455677889999999999999 777   99999999999999999 9999999999


Q ss_pred             eeecC-CC-ccccccccc-cccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHH
Q 002899          790 KLYEE-DK-THISTRIAG-TIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAY  859 (869)
Q Consensus       790 ~~~~~-~~-~~~~~~~~g-t~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~  859 (869)
                      ..+.. .. .......+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|+..... .......|..
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~-~~~~~~~~~~  245 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR-KDGRYSSWKS  245 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc-ccccceeecc
Confidence            87765 22 233334678 999999998877 5678889999999999999999999976443 2244445543

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.32  E-value=2.1e-12  Score=146.38  Aligned_cols=202  Identities=30%  Similarity=0.425  Sum_probs=165.1

Q ss_pred             EEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCcc-ccccccccccccCCCCCccccCCCCccEEEeeccc
Q 002899           82 QLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNIT-TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS  160 (869)
Q Consensus        82 ~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  160 (869)
                      .|+++.|.+............++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|+
T Consensus        97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~  174 (394)
T COG4886          97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND  174 (394)
T ss_pred             eeeccccccccCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence            588888888656555555558999999999999 4555566664 9999999999999 666788999999999999999


Q ss_pred             ccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccc
Q 002899          161 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK  240 (869)
Q Consensus       161 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~  240 (869)
                      ++ .+|.....+++|+.|++++|+++ .+|.....+..|++|.+++|.+. ..+..+.++.++..|.+.+|++.......
T Consensus       175 l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~  251 (394)
T COG4886         175 LS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESI  251 (394)
T ss_pred             hh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeeccchh
Confidence            99 66666668899999999999998 66776667778999999999755 56778899999999999999988754333


Q ss_pred             cccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhc
Q 002899          241 LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK  290 (869)
Q Consensus       241 ~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  290 (869)
                      -...+|++|++++|+++...+  ++.+.+|+.|++++|.+...+|.....
T Consensus       252 ~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~  299 (394)
T COG4886         252 GNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALL  299 (394)
T ss_pred             ccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhcc
Confidence            444469999999999996555  889999999999999999777765443

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.22  E-value=8.7e-13  Score=136.92  Aligned_cols=232  Identities=16%  Similarity=0.233  Sum_probs=151.6

Q ss_pred             eEEEEeccCCCccc----cCCccccCCCCCCEEEeecC---cCCCCCchhhcc-------c-cceEEEeecccCCCCCch
Q 002899           55 HVVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRN---CLTGSFSPQWAS-------L-QLVELSVMGNRLSGPFPK  119 (869)
Q Consensus        55 ~v~~L~l~~~~l~~----~~p~~l~~l~~L~~L~Ls~N---~i~~~~~~~~~~-------l-~L~~L~Ls~N~l~~~~~~  119 (869)
                      .++.|+|++|.+-.    .+.+.+.+.++|+..++|.-   ++...+|..+..       . +|++|+||+|.+....+.
T Consensus        31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~  110 (382)
T KOG1909|consen   31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIR  110 (382)
T ss_pred             ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchH
Confidence            48899999998753    45667888899999999874   222333333221       2 799999999988755443


Q ss_pred             h----hcCccccccccccccccCCCCCc-------------cccCCCCccEEEeeccccccc----CCccccCCCCCCeE
Q 002899          120 V----LTNITTLKNLSIEGNLFTGSIPP-------------DIRKLINLQKLILSSNSFTGE----LPAELTKLTNLNDL  178 (869)
Q Consensus       120 ~----~~~l~~L~~L~Ls~N~l~~~~~~-------------~~~~l~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L  178 (869)
                      .    +..++.|++|.|.+|.+...-..             ....-++|+++..++|++...    +...|...+.|+.+
T Consensus       111 ~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leev  190 (382)
T KOG1909|consen  111 GLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEV  190 (382)
T ss_pred             HHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceE
Confidence            3    45578899999999988722111             234456788888888887632    22345666788888


Q ss_pred             eccCCcCCCC----CccccCCCCcccEEEccCCcCCCC----chHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEE
Q 002899          179 RISDNNFSGK----IPEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLI  250 (869)
Q Consensus       179 ~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~  250 (869)
                      .++.|.|...    +...|..+++|+.|||++|-++..    +...++.+++|++|+++++.+.......+.        
T Consensus       191 r~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~--------  262 (382)
T KOG1909|consen  191 RLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFV--------  262 (382)
T ss_pred             EEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHH--------
Confidence            8888877521    234567778888888888877642    345566667777777776655543322211        


Q ss_pred             cccccCccCCCccc-CCCCCcCEEeccCCCCCC----CCchhhhcCCCCCEEEeeCCcCC
Q 002899          251 LTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTG----GIPTTFEKLAKTNFMYLTGNKLT  305 (869)
Q Consensus       251 Ls~N~i~~~~p~~~-~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~  305 (869)
                                 +.+ ...|+|+.|.|.+|.|+.    .+...+...+.|..|+|++|++.
T Consensus       263 -----------~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  263 -----------DALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             -----------HHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence                       111 235777888888887762    23344556777888888888873

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.22  E-value=5e-11  Score=118.05  Aligned_cols=131  Identities=19%  Similarity=0.143  Sum_probs=96.9

Q ss_pred             CCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCcee-eEEeEEeeCceEEEEEEeccCCch
Q 002899          643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV-KLYGCCVEGNQLLLVYEYMKNNCL  721 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~E~~~~gsL  721 (869)
                      .+.++.|.++.||++... ++.|++|....... ....+..|++++..+.+.+++ +++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            356899999999999875 77899998765432 234567888999888665554 455443  2345799999999877


Q ss_pred             hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          722 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS--RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       722 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ...-             .....++.+++++|+.||+.+  +..++|||++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~-------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED-------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc-------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5320             012345678999999999876  22369999999999999 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.19  E-value=4.7e-12  Score=128.13  Aligned_cols=222  Identities=21%  Similarity=0.219  Sum_probs=112.5

Q ss_pred             cceEEEEeccCC--------CccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCc
Q 002899           53 TCHVVTIALKAQ--------NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI  124 (869)
Q Consensus        53 ~~~v~~L~l~~~--------~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l  124 (869)
                      +|+++.|..++.        -+...+|-.+.-+++|+.+.+|.+.-..+..-......|++|.+.+..++.. | .+--.
T Consensus       181 ~~~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~~-~-~l~pe  258 (490)
T KOG1259|consen  181 CTQLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQDV-P-SLLPE  258 (490)
T ss_pred             hhheeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchhheeceeecCchhheeeeeccccccc-c-cccch
Confidence            456777776543        2333556667778889999999876543333233334678887776665521 1 11111


Q ss_pred             cccccccccc-cccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEE
Q 002899          125 TTLKNLSIEG-NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLH  203 (869)
Q Consensus       125 ~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  203 (869)
                      ..+..+.-+. .-.+|..-........|++|||++|.|+ .+.++..-+|.++.|++|+|.|.. + +.++.+++|+.||
T Consensus       259 ~~~~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LD  335 (490)
T KOG1259|consen  259 TILADPSGSEPSTSNGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLD  335 (490)
T ss_pred             hhhcCccCCCCCccCCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEee
Confidence            1222111111 1112222223333445666666666666 555555566666666666666652 2 2266666666777


Q ss_pred             ccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCC
Q 002899          204 IQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG  283 (869)
Q Consensus       204 L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~  283 (869)
                      |++|.++ .+...-.++.+++.|.|+.|.+..                         -..+..+-+|..||+++|+|...
T Consensus       336 LS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~-------------------------LSGL~KLYSLvnLDl~~N~Ie~l  389 (490)
T KOG1259|consen  336 LSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET-------------------------LSGLRKLYSLVNLDLSSNQIEEL  389 (490)
T ss_pred             cccchhH-hhhhhHhhhcCEeeeehhhhhHhh-------------------------hhhhHhhhhheeccccccchhhH
Confidence            7766665 222333344444444444333322                         11233344455555555555421


Q ss_pred             Cc-hhhhcCCCCCEEEeeCCcCC
Q 002899          284 IP-TTFEKLAKTNFMYLTGNKLT  305 (869)
Q Consensus       284 ~p-~~~~~l~~L~~L~Ls~N~l~  305 (869)
                      .. ..+++||-|+.|.|.+|+|.
T Consensus       390 deV~~IG~LPCLE~l~L~~NPl~  412 (490)
T KOG1259|consen  390 DEVNHIGNLPCLETLRLTGNPLA  412 (490)
T ss_pred             HHhcccccccHHHHHhhcCCCcc
Confidence            11 23455555555555555555

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.15  E-value=4.2e-11  Score=137.51  Aligned_cols=144  Identities=17%  Similarity=0.216  Sum_probs=94.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEecccCchh---------------------------------------
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQG---------------------------------------  677 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~-g~~VAvK~~~~~~~~~---------------------------------------  677 (869)
                      ..|+. +.||+|++|.||+|++++ |+.||||+.++.....                                       
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35776 789999999999999987 9999999987542110                                       


Q ss_pred             -hHHHHHHHHHHHhc----CCCceeeEEeEEee-CceEEEEEEeccCCchhhhh--hcCCcccccCCCHHHHHHHHHHHH
Q 002899          678 -NREFVNEIGMISAQ----QHPNLVKLYGCCVE-GNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA  749 (869)
Q Consensus       678 -~~~f~~E~~~l~~l----~H~nIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~~~~~l~~~~~~~i~~~ia  749 (869)
                       +-+|..|+..+.++    .+...+.+-..+.+ ....+|||||++|+.+.+.-  ...+      .+   +..++...+
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g------~d---~~~la~~~v  269 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG------TD---MKLLAERGV  269 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC------CC---HHHHHHHHH
Confidence             01244455444444    24443443333322 45678999999999997642  2211      11   112222222


Q ss_pred             HH-HHHHHhcCCCCeEEcCCCCCCEEEcCCC----cEEEeecCCceeecC
Q 002899          750 RG-LAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISDFGLAKLYEE  794 (869)
Q Consensus       750 ~g-L~yLH~~~~~~iiH~Dlk~~NILl~~~~----~~kl~DFGla~~~~~  794 (869)
                      +. +..++..|   ++|+|+||.||+++.++    .+++.|||++..+.+
T Consensus       270 ~~~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        270 EVFFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            21 23344566   99999999999999988    999999999987754

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.14  E-value=9e-12  Score=132.71  Aligned_cols=186  Identities=20%  Similarity=0.221  Sum_probs=79.2

Q ss_pred             hcCccccccccccccccCCCCC--ccccCCCCccEEEeecccccccCCccc-cCCCCCCeEeccCCcCCCC-CccccCCC
Q 002899          121 LTNITTLKNLSIEGNLFTGSIP--PDIRKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLRISDNNFSGK-IPEFIGKW  196 (869)
Q Consensus       121 ~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~Ls~N~i~~~~p~~~-~~l~~L~~L~Ls~N~l~~~-~~~~~~~l  196 (869)
                      ...+++++.|||+.|-|..-.+  .....||+|+.|+|+.|++.....+.. ..+++|+.|.|+.|.|+.. +...+..+
T Consensus       142 ~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~f  221 (505)
T KOG3207|consen  142 SKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTF  221 (505)
T ss_pred             hhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhC
Confidence            3344444444444444442111  122344444444444444432111111 1234444444444444411 11123334


Q ss_pred             CcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcc--cccccccceEEEcccccCccC-CCcc-----cCCCC
Q 002899          197 KKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF--PKLDKMNLKTLILTKCLIHGE-IPDY-----IGDMT  268 (869)
Q Consensus       197 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~--~~~~~~~L~~L~Ls~N~i~~~-~p~~-----~~~l~  268 (869)
                      |+|+.|+|..|............+..|++|+|++|.+...+.  .......|+.|.++.|.|..+ .|+.     ...++
T Consensus       222 Psl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~  301 (505)
T KOG3207|consen  222 PSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFP  301 (505)
T ss_pred             CcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccc
Confidence            444444444443222222333334444445554444433321  111112333444444443322 1111     23567


Q ss_pred             CcCEEeccCCCCCCC-CchhhhcCCCCCEEEeeCCcCCC
Q 002899          269 KLKNIDLSFNNLTGG-IPTTFEKLAKTNFMYLTGNKLTG  306 (869)
Q Consensus       269 ~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~  306 (869)
                      +|++|+++.|+|... .-..+..+++|+.|.+..|.|+.
T Consensus       302 kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  302 KLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             cceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence            788888888887521 11234556666777777777763

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.14  E-value=2.5e-12  Score=133.56  Aligned_cols=246  Identities=18%  Similarity=0.217  Sum_probs=135.7

Q ss_pred             CccccCCCCCCEEEeecCcCCCCCchhhcc----c-cceEEEeecc---cCCCCCch-------hhcCcccccccccccc
Q 002899           71 PTELSKLRYLKQLDLSRNCLTGSFSPQWAS----L-QLVELSVMGN---RLSGPFPK-------VLTNITTLKNLSIEGN  135 (869)
Q Consensus        71 p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~----l-~L~~L~Ls~N---~l~~~~~~-------~~~~l~~L~~L~Ls~N  135 (869)
                      -+.+..+..++.|+||+|.+.......+..    . +|+..++++-   ++...+|.       ++...++|+.||||+|
T Consensus        23 ~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDN  102 (382)
T KOG1909|consen   23 EEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDN  102 (382)
T ss_pred             HHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccc
Confidence            345667788888999998887544333322    2 5666666542   12222232       2333456666666666


Q ss_pred             ccCCCCCcc----ccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCC
Q 002899          136 LFTGSIPPD----IRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG  211 (869)
Q Consensus       136 ~l~~~~~~~----~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  211 (869)
                      -|....+..    +..+..|++|.|.+|.+.-.--..++.  .|..|.         .....+.-++|+++...+|++..
T Consensus       103 A~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~---------~~kk~~~~~~Lrv~i~~rNrlen  171 (382)
T KOG1909|consen  103 AFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA---------VNKKAASKPKLRVFICGRNRLEN  171 (382)
T ss_pred             ccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH---------HHhccCCCcceEEEEeecccccc
Confidence            655333332    233455666666666554111111000  000000         00112233455555555555543


Q ss_pred             C----chHhhhcCCCCCEEEcCCCCCCCCcccc-----cccccceEEEcccccCccC----CCcccCCCCCcCEEeccCC
Q 002899          212 P----IPASISALTSLTDLRISDLKGSESAFPK-----LDKMNLKTLILTKCLIHGE----IPDYIGDMTKLKNIDLSFN  278 (869)
Q Consensus       212 ~----~~~~l~~l~~L~~L~L~~n~~~~~~~~~-----~~~~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~Ls~N  278 (869)
                      .    +...|...+.|+.+.+..|.|.......     ....+|+.|||..|-++..    +...+..+++|+.|++++|
T Consensus       172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dc  251 (382)
T KOG1909|consen  172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDC  251 (382)
T ss_pred             ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccc
Confidence            2    2334445555555555555554433311     1122566666666665533    3456778899999999999


Q ss_pred             CCCCCCchhhh-----cCCCCCEEEeeCCcCCCCCchhh------hccCCceeeeccCcc
Q 002899          279 NLTGGIPTTFE-----KLAKTNFMYLTGNKLTGPVPKYI------FNSNKNVDISLNNFT  327 (869)
Q Consensus       279 ~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~~~------~~~l~~l~ls~N~~~  327 (869)
                      .++.....+|.     ..++|+.|.|.+|.++..--..+      .+.+..|+|++|.+.
T Consensus       252 ll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  252 LLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             ccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            99866555543     36899999999999984332222      457888999999774

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.14  E-value=6e-12  Score=127.40  Aligned_cols=130  Identities=17%  Similarity=0.213  Sum_probs=79.6

Q ss_pred             CCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEe
Q 002899          195 KWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNID  274 (869)
Q Consensus       195 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~  274 (869)
                      .+..|++|||++|.|+ .+..+..-+|.++.|++++|.+..... .-...+|..||||+|.++ .+..+-..+-+++.|.
T Consensus       282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~  358 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK  358 (490)
T ss_pred             hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence            3444555555555554 334444444555555555555444332 111125556666666665 3344445678999999


Q ss_pred             ccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCch-hh--hccCCceeeeccCccCC
Q 002899          275 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK-YI--FNSNKNVDISLNNFTWE  329 (869)
Q Consensus       275 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~--~~~l~~l~ls~N~~~~~  329 (869)
                      |++|.|..  -..+..|-+|..||+++|+|...-.. .+  ++.++.+.|.+|.+...
T Consensus       359 La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  359 LAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             hhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            99999972  23477788899999999999732111 12  56788999999966544

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.09  E-value=5.6e-11  Score=116.50  Aligned_cols=123  Identities=28%  Similarity=0.323  Sum_probs=47.0

Q ss_pred             cceEEEeecccCCCCCchhhc-CccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccc-cCCCCCCeEe
Q 002899          102 QLVELSVMGNRLSGPFPKVLT-NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLR  179 (869)
Q Consensus       102 ~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~-~~l~~L~~L~  179 (869)
                      ++++|+|++|+|+.+ . .++ .+.+|+.|+|++|.|+.. + .+..+++|++|++++|+|+. +...+ ..+++|++|+
T Consensus        20 ~~~~L~L~~n~I~~I-e-~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~   94 (175)
T PF14580_consen   20 KLRELNLRGNQISTI-E-NLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY   94 (175)
T ss_dssp             ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred             ccccccccccccccc-c-chhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence            566666666666633 2 344 467788888888888743 2 46777888888888888873 33334 3577888888


Q ss_pred             ccCCcCCCCC-ccccCCCCcccEEEccCCcCCCCc---hHhhhcCCCCCEEEcC
Q 002899          180 ISDNNFSGKI-PEFIGKWKKIQKLHIQGSSLEGPI---PASISALTSLTDLRIS  229 (869)
Q Consensus       180 Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~l~~L~~L~L~  229 (869)
                      |++|+|.... -..+..+++|+.|+|.+|.+....   ...+..+|+|+.||-.
T Consensus        95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~  148 (175)
T PF14580_consen   95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ  148 (175)
T ss_dssp             -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred             CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence            8888886432 244667788888888888887432   3467788888888643

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.09  E-value=7e-10  Score=125.15  Aligned_cols=166  Identities=16%  Similarity=0.197  Sum_probs=124.9

Q ss_pred             EcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCH
Q 002899          659 LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW  738 (869)
Q Consensus       659 ~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~  738 (869)
                      ..++.+|.|..++...........+-++.|+.+|||||++++...+.++.+|||+|-+..  |...+...        ..
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l--------~~  103 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKEL--------GK  103 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHh--------HH
Confidence            446888889888766553334456678899999999999999999999999999998863  55555332        34


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccccccccccccccchhhcccC
Q 002899          739 PTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG  818 (869)
Q Consensus       739 ~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  818 (869)
                      ....-.+.||+.||.+||+.+  .++|++|.-.-|++++.|+.||++|.++........ ......--..|..|+.+...
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence            556678889999999999776  599999999999999999999999988765432221 00111112256777755433


Q ss_pred             CCCchhHHHHHHHHHHHHHcC
Q 002899          819 YLTSKADVYSFGVVTLEIVSG  839 (869)
Q Consensus       819 ~~~~k~DvwSlGvil~elltG  839 (869)
                      .  -..|.|-||++++|++.|
T Consensus       181 ~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCc
Confidence            3  346999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.06  E-value=2.5e-09  Score=107.05  Aligned_cols=136  Identities=15%  Similarity=0.130  Sum_probs=96.5

Q ss_pred             CeeeccCceEEEEEEEcC-------CcEEEEEEecccCc----------------------hhhHHHH----HHHHHHHh
Q 002899          644 NKVGEGGFGSVYKGILSD-------GTVIAVKQLSSKSR----------------------QGNREFV----NEIGMISA  690 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~-------g~~VAvK~~~~~~~----------------------~~~~~f~----~E~~~l~~  690 (869)
                      ..||.|--+.||.|.-.+       +..+|||+++....                      ...+.+.    +|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543       47899998753210                      0011222    78888888


Q ss_pred             cCCC--ceeeEEeEEeeCceEEEEEEeccCCchhh-hhhcCCcccccCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEc
Q 002899          691 QQHP--NLVKLYGCCVEGNQLLLVYEYMKNNCLSR-AIFGKDTEYRLKLDWPTRKKICIGIARGLAYL-HEDSRIKIVHR  766 (869)
Q Consensus       691 l~H~--nIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiH~  766 (869)
                      +...  ++.+++++    ...++||||+.++.+.. .+..      ..++..+...+..+++.+|..| |..+   ++||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG  149 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA  149 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            7543  44455554    46789999998754422 2211      1244556778889999999999 7777   9999


Q ss_pred             CCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          767 DIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       767 Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||++.|||++ ++.+.|+|||.+....
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            9999999997 4689999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PLN03150 hypothetical protein; Provisional

Probab=99.06  E-value=2e-10  Score=136.53  Aligned_cols=110  Identities=34%  Similarity=0.570  Sum_probs=102.1

Q ss_pred             ccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEcc
Q 002899          126 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQ  205 (869)
Q Consensus       126 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  205 (869)
                      .++.|+|++|.+.+.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++|++++.+|+.++++++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            48899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCCCCchHhhhcC-CCCCEEEcCCCCCCC
Q 002899          206 GSSLEGPIPASISAL-TSLTDLRISDLKGSE  235 (869)
Q Consensus       206 ~N~l~~~~~~~l~~l-~~L~~L~L~~n~~~~  235 (869)
                      +|.+++.+|..+..+ .++..+++.+|....
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc  529 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLC  529 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCcccc
Confidence            999999999998875 477889999887543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.04  E-value=2e-09  Score=111.47  Aligned_cols=142  Identities=20%  Similarity=0.283  Sum_probs=109.3

Q ss_pred             CeeeccCceEEEEEEEcCCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCc--eeeEEeEEeeCc---eEEEEEEecc
Q 002899          644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPN--LVKLYGCCVEGN---QLLLVYEYMK  717 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~n--Iv~l~~~~~~~~---~~~lV~E~~~  717 (869)
                      +.|+.|..+.||++...+|+.+++|....... .....+..|+++++.+++.+  +.+++.+....+   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987778899998754322 13557889999999987644  566777766542   5689999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS--------------------------------------  759 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------  759 (869)
                      +.++.+.+..      ..++..++..++.+++++|.+||+..                                      
T Consensus        84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            9888765431      14677788888888888888888521                                      


Q ss_pred             ---------------CCCeEEcCCCCCCEEEcC--CCcEEEeecCCcee
Q 002899          760 ---------------RIKIVHRDIKTSNVLLDK--DLNAKISDFGLAKL  791 (869)
Q Consensus       760 ---------------~~~iiH~Dlk~~NILl~~--~~~~kl~DFGla~~  791 (869)
                                     +..++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           244789999999999998  66789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.03  E-value=9.4e-11  Score=114.91  Aligned_cols=110  Identities=26%  Similarity=0.335  Sum_probs=38.6

Q ss_pred             hcCccccccccccccccCCCCCcccc-CCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCcccc-CCCCc
Q 002899          121 LTNITTLKNLSIEGNLFTGSIPPDIR-KLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI-GKWKK  198 (869)
Q Consensus       121 ~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~  198 (869)
                      +.+..++++|+|++|.|+. +. .++ .+.+|+.|+|++|+|+. +. .+..+++|++|+|++|+|+.. .+.+ ..+++
T Consensus        15 ~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~   89 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPN   89 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred             ccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCcc-ccchHHhCCc
Confidence            4556678899999999883 33 454 57888999999998884 33 577788889999999988854 3333 46788


Q ss_pred             ccEEEccCCcCCCC-chHhhhcCCCCCEEEcCCCCCCC
Q 002899          199 IQKLHIQGSSLEGP-IPASISALTSLTDLRISDLKGSE  235 (869)
Q Consensus       199 L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~L~~n~~~~  235 (869)
                      |++|+|++|+|... .-..++.+++|+.|+|.+|++..
T Consensus        90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~  127 (175)
T PF14580_consen   90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE  127 (175)
T ss_dssp             --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred             CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence            88888888888752 23566777777777777666653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.01  E-value=2.3e-10  Score=128.06  Aligned_cols=198  Identities=24%  Similarity=0.262  Sum_probs=152.6

Q ss_pred             cCCCCCCeeec--cCceEEEEEEE--c-CCcEEEEEEecccC--chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceE
Q 002899          638 NNFDPANKVGE--GGFGSVYKGIL--S-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       638 ~~f~~~~~IG~--G~fG~Vyka~~--~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~  709 (869)
                      ..|.+.+.+|.  |.+|.||++..  + ++..+|+|+-+..-  ......=.+|+....++ .|+|.++....+.+.+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34567788999  99999999987  3 67889999743322  23333445566666665 499999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEEcCCCCCCEEEcCC-CcEEEe
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----GLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKIS  784 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~iiH~Dlk~~NILl~~~-~~~kl~  784 (869)
                      ++-+|++. .+|..+.+.-..    .++......+..+..+    |+.++|...   ++|-|+||.||+...+ ...+++
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             eeeecccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecC
Confidence            99999776 678777765432    2455666667777777    999999987   9999999999999999 889999


Q ss_pred             ecCCceeecCCCcc----ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          785 DFGLAKLYEEDKTH----ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       785 DFGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      |||+...+....-.    ...+..|...|++||...+ -++...|+|++|.++.|...|..+..
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence            99999888655421    1122356779999997764 46889999999999999998876654

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.00  E-value=7.8e-11  Score=125.65  Aligned_cols=185  Identities=22%  Similarity=0.214  Sum_probs=86.0

Q ss_pred             cccCCCCCCEEEeecCcCCCCCc--hhhccc-cceEEEeecccCCCCCchh-hcCccccccccccccccCCC-CCccccC
Q 002899           73 ELSKLRYLKQLDLSRNCLTGSFS--PQWASL-QLVELSVMGNRLSGPFPKV-LTNITTLKNLSIEGNLFTGS-IPPDIRK  147 (869)
Q Consensus        73 ~l~~l~~L~~L~Ls~N~i~~~~~--~~~~~l-~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~-~~~~~~~  147 (869)
                      ....+++++.||||+|-+..-.+  .....+ +|+.|+|+.|++....... -..+++|+.|.|+.|.|+-. +...+..
T Consensus       141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~  220 (505)
T KOG3207|consen  141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLT  220 (505)
T ss_pred             hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHh
Confidence            34455555555555555543222  122222 5555555555554221111 11345555555655555511 1112344


Q ss_pred             CCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCC-ccccCCCCcccEEEccCCcCCCC-chHh-----hhcC
Q 002899          148 LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKI-PEFIGKWKKIQKLHIQGSSLEGP-IPAS-----ISAL  220 (869)
Q Consensus       148 l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~-~~~~-----l~~l  220 (869)
                      +|+|+.|+|..|...........-+..|+.|+|++|++-... -...+.++.|+.|+++.+.+... .|+.     ...+
T Consensus       221 fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f  300 (505)
T KOG3207|consen  221 FPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTF  300 (505)
T ss_pred             CCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhccc
Confidence            555666666555322222223334455566666655554221 12345555555566665555531 1222     3445


Q ss_pred             CCCCEEEcCCCCCCCCc-ccc-cccccceEEEcccccCc
Q 002899          221 TSLTDLRISDLKGSESA-FPK-LDKMNLKTLILTKCLIH  257 (869)
Q Consensus       221 ~~L~~L~L~~n~~~~~~-~~~-~~~~~L~~L~Ls~N~i~  257 (869)
                      ++|++|+++.|++.+.. +.. ....+|+.|.+..|.|+
T Consensus       301 ~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  301 PKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             ccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence            56666666666653322 111 11225666666666665

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.99  E-value=3.6e-11  Score=136.76  Aligned_cols=194  Identities=25%  Similarity=0.249  Sum_probs=90.6

Q ss_pred             ceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccC
Q 002899          103 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD  182 (869)
Q Consensus       103 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~  182 (869)
                      ++.+++..|.+.. +-..+..+++|+.|+|.+|+|. .+...+..+++|++|+|++|+|+...  .+..++.|+.|++++
T Consensus        74 l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~  149 (414)
T KOG0531|consen   74 LKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSG  149 (414)
T ss_pred             HHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhheecc
Confidence            3444444444442 2222444555555555555555 22222444555555555555555322  233444455555555


Q ss_pred             CcCCCCCccccCCCCcccEEEccCCcCCCCch-HhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCC
Q 002899          183 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP-ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP  261 (869)
Q Consensus       183 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p  261 (869)
                      |.|+.  ...+..++.|+.+++++|++....+ . +..+.+|+.++++.|.+.....-.... .+..+++..|.++..-+
T Consensus       150 N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~~~~~~-~l~~~~l~~n~i~~~~~  225 (414)
T KOG0531|consen  150 NLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEGLDLLK-KLVLLSLLDNKISKLEG  225 (414)
T ss_pred             Ccchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccchHHHH-HHHHhhcccccceeccC
Confidence            55541  2223335555555555555553222 1 344555555555555544332111100 22333555555542222


Q ss_pred             cccCCCC--CcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCC
Q 002899          262 DYIGDMT--KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP  307 (869)
Q Consensus       262 ~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  307 (869)
                      -  ..+.  .|+.+++++|++. ..+..+..+..+..|++.+|++...
T Consensus       226 l--~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~  270 (414)
T KOG0531|consen  226 L--NELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL  270 (414)
T ss_pred             c--ccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc
Confidence            1  1122  2666677777666 3334455666666666666666543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.95  E-value=7.5e-09  Score=99.86  Aligned_cols=133  Identities=23%  Similarity=0.306  Sum_probs=98.5

Q ss_pred             CeeeccCceEEEEEEEcCCcEEEEEEecccC-c-h------hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKS-R-Q------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~-~-~------~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ..+++|+-+.+|.+.+.+ ..+++|.-.++. . .      ...+-..|++++.+++--.|...+=+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            357899999999998754 346666432221 1 1      123456789999888766666556667778888999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      +++-.|.+.+...            +..++..+=+-+.-||..+   |+|+||.++||++..+. +.++|||++..-.
T Consensus        81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             eCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            9998888787543            2445566666677799998   99999999999998765 9999999987543

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.91  E-value=1.1e-10  Score=132.89  Aligned_cols=242  Identities=24%  Similarity=0.282  Sum_probs=171.3

Q ss_pred             cCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccE
Q 002899           75 SKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK  153 (869)
Q Consensus        75 ~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  153 (869)
                      ..+..++.++++.|.|.... ..+..+ +|+.|+|.+|+|..+.. .+..+++|++|+|++|+|+...+  +..++.|+.
T Consensus        69 ~~l~~l~~l~l~~n~i~~~~-~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~  144 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIAKIL-NHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKE  144 (414)
T ss_pred             HHhHhHHhhccchhhhhhhh-cccccccceeeeeccccchhhccc-chhhhhcchheeccccccccccc--hhhccchhh
Confidence            45677788888888887622 223333 79999999999985433 37788999999999999995543  677778999


Q ss_pred             EEeecccccccCCccccCCCCCCeEeccCCcCCCCCc-cccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCC
Q 002899          154 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK  232 (869)
Q Consensus       154 L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~  232 (869)
                      |++++|.|+. + ..+..+++|+.+++++|+++...+ . ...+.+|+.+++.+|.+...  ..+..+..+..+++..|.
T Consensus       145 L~l~~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~  219 (414)
T KOG0531|consen  145 LNLSGNLISD-I-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNK  219 (414)
T ss_pred             heeccCcchh-c-cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhccccc
Confidence            9999999983 2 245668899999999999985444 2 57788999999999998743  334444455555777887


Q ss_pred             CCCCccccc-ccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCC---C
Q 002899          233 GSESAFPKL-DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP---V  308 (869)
Q Consensus       233 ~~~~~~~~~-~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~  308 (869)
                      ++....... ....|+.+++++|.+.. .+..+..+..+..|++++|++...-.  +...+.+..+.+..|++...   .
T Consensus       220 i~~~~~l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  296 (414)
T KOG0531|consen  220 ISKLEGLNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNLEG--LERLPKLSELWLNDNKLALSEAIS  296 (414)
T ss_pred             ceeccCcccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccccccc--ccccchHHHhccCcchhcchhhhh
Confidence            766543222 21148899999999883 33667788999999999999884332  55666777778888887632   1


Q ss_pred             chh---hhccCCceeeeccCccC
Q 002899          309 PKY---IFNSNKNVDISLNNFTW  328 (869)
Q Consensus       309 p~~---~~~~l~~l~ls~N~~~~  328 (869)
                      ...   -...++.+.+.+|....
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
T KOG0531|consen  297 QEYITSAAPTLVTLTLELNPIRK  319 (414)
T ss_pred             ccccccccccccccccccCcccc
Confidence            111   13456677777775543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.90  E-value=1.7e-08  Score=96.73  Aligned_cols=144  Identities=18%  Similarity=0.282  Sum_probs=102.8

Q ss_pred             CCCeeeccCceEEEEEEEcCCcEEEEEE-eccc-------CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          642 PANKVGEGGFGSVYKGILSDGTVIAVKQ-LSSK-------SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       642 ~~~~IG~G~fG~Vyka~~~~g~~VAvK~-~~~~-------~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ....+-||+-+.|+++.+. |+...||. +.+.       ..-..++-..|++.+.+++--.|.-..=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678999999999999885 66666664 3221       1122456778999998876555554444555666667999


Q ss_pred             EeccC-CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC---cEEEeecCCc
Q 002899          714 EYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKISDFGLA  789 (869)
Q Consensus       714 E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~---~~kl~DFGla  789 (869)
                      ||+++ .++.+++......   +...+....++..|=+.+.-||.++   |+||||..+||++..++   .+.++|||++
T Consensus        90 E~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             EeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence            99986 3666666554322   2222333678888888999999998   99999999999997654   3589999998


Q ss_pred             eee
Q 002899          790 KLY  792 (869)
Q Consensus       790 ~~~  792 (869)
                      ..-
T Consensus       164 ~~s  166 (229)
T KOG3087|consen  164 SVS  166 (229)
T ss_pred             hcc
Confidence            654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.76  E-value=2.6e-09  Score=119.81  Aligned_cols=194  Identities=22%  Similarity=0.224  Sum_probs=145.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc--CCcEEEEEEecccCchhhH--HHHHHHHHHHhc-CCCceeeEEeEEeeCceEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSKSRQGNR--EFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~--~g~~VAvK~~~~~~~~~~~--~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~  710 (869)
                      .+.+|..+..||.|.|+.|++...+  ++..+++|.+.........  .-..|+-+...+ .|.++++....+...+..|
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            3457888999999999999987744  5778999987654332222  223455555444 5899999888888888888


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-CcEEEeecCCc
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLA  789 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~-~~~kl~DFGla  789 (869)
                      +--||++++++...+..     ...++...++++..|++.++.++|+..   ++|+|+||+||++..+ +..+++|||.+
T Consensus       343 ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             CchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence            99999999998765521     224677888999999999999999876   9999999999999886 88899999998


Q ss_pred             eeecCCCcccccccccccccc--chhhcccCCCCchhHHHHHHHHHHHHHcCCC
Q 002899          790 KLYEEDKTHISTRIAGTIGYM--APEYAMRGYLTSKADVYSFGVVTLEIVSGKS  841 (869)
Q Consensus       790 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~k~DvwSlGvil~elltG~~  841 (869)
                      ..+....    ......-+++  +|+......+..++|++|||.-+.|.++|..
T Consensus       415 t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  415 TRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             cccceec----ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence            6432111    1112223444  5555666788999999999999999999875

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.75  E-value=8.2e-09  Score=106.59  Aligned_cols=153  Identities=22%  Similarity=0.318  Sum_probs=114.1

Q ss_pred             HHHhcCCCceeeEEeEEeeC-----ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 002899          687 MISAQQHPNLVKLYGCCVEG-----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI  761 (869)
Q Consensus       687 ~l~~l~H~nIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  761 (869)
                      -+-.+.|.|||+++.|+.+.     .+..++.|||..|++..+|.... .....+......+++.||..||.|||+.. |
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~-~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P  197 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK-KNQKALFQKAWKKWCTQILSALSYLHSCD-P  197 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH-HhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence            34456799999999998654     34688999999999999997643 23345777788899999999999999875 6


Q ss_pred             CeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC----CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHH
Q 002899          762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED----KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV  837 (869)
Q Consensus       762 ~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ell  837 (869)
                      +|+|+++.-+-|++..++-+|+.--.-. .....    .......-.+-++|.|||.=.....+..+|||+||...+||.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            7999999999999999988887521110 00000    000011123567999999776666777899999999999999


Q ss_pred             cCCCC
Q 002899          838 SGKSN  842 (869)
Q Consensus       838 tG~~p  842 (869)
                      .|..-
T Consensus       277 ilEiq  281 (458)
T KOG1266|consen  277 ILEIQ  281 (458)
T ss_pred             Hheec
Confidence            88653

>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]

Probab=98.74  E-value=1.8e-10  Score=116.98  Aligned_cols=211  Identities=22%  Similarity=0.279  Sum_probs=127.8

Q ss_pred             CcHHHHHHHHHHhCCCCCCCCCCCCCCCCCccccCCCCCCCCcceEecCCCCcceEEEEeccCCCccccCCccccCCC--
Q 002899            1 MPKKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLR--   78 (869)
Q Consensus         1 ~~~~~l~~~~~~l~~~~W~~~~d~C~~~g~w~~~~~~~~~~~~~v~C~~~~~~~~v~~L~l~~~~l~~~~p~~l~~l~--   78 (869)
                      +|++.|++|++-|-.+.--....+|.   .|+.-+-+               ...=+.+|+.+-+|.   |.++..+-  
T Consensus       101 lpDEill~IFs~L~kk~LL~~~~VC~---Rfyr~~~d---------------e~lW~~lDl~~r~i~---p~~l~~l~~r  159 (419)
T KOG2120|consen  101 LPDEILLGIFSCLCKKELLKVSGVCK---RFYRLASD---------------ESLWQTLDLTGRNIH---PDVLGRLLSR  159 (419)
T ss_pred             CCHHHHHHHHHhccHHHHHHHHHHHH---HHhhcccc---------------ccceeeeccCCCccC---hhHHHHHHhC
Confidence            58999999999999877655566775   34421111               122356777777666   44444442  


Q ss_pred             CCCEEEeecCcCCCC-Cchhhccc--cceEEEeecccCCC-CCchhhcCccccccccccccccCCCCCccccCCCCccEE
Q 002899           79 YLKQLDLSRNCLTGS-FSPQWASL--QLVELSVMGNRLSG-PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKL  154 (869)
Q Consensus        79 ~L~~L~Ls~N~i~~~-~~~~~~~l--~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  154 (869)
                      ....+-|....+.+. ..+.+...  +|+.|||++..|+. .....++.+.+|+.|.|.++++.+.+...+....+|+.|
T Consensus       160 gV~v~Rlar~~~~~prlae~~~~frsRlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~l  239 (419)
T KOG2120|consen  160 GVIVFRLARSFMDQPRLAEHFSPFRSRLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRL  239 (419)
T ss_pred             CeEEEEcchhhhcCchhhhhhhhhhhhhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceee
Confidence            233444443333333 23334333  47888888777762 234556777888888888888887777778888888888


Q ss_pred             Eeecc-cccccCC-ccccCCCCCCeEeccCCcCCCCCccc-cCC-CCcccEEEccCCcC---CCCchHhhhcCCCCCEEE
Q 002899          155 ILSSN-SFTGELP-AELTKLTNLNDLRISDNNFSGKIPEF-IGK-WKKIQKLHIQGSSL---EGPIPASISALTSLTDLR  227 (869)
Q Consensus       155 ~Ls~N-~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~-l~~L~~L~L~~N~l---~~~~~~~l~~l~~L~~L~  227 (869)
                      +|+.+ .|+.... --+.+++.|..|+|+.+.++...-.. +.. -++|..|+|++.+-   ...+..-...+++|..||
T Consensus       240 nlsm~sG~t~n~~~ll~~scs~L~~LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LD  319 (419)
T KOG2120|consen  240 NLSMCSGFTENALQLLLSSCSRLDELNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLD  319 (419)
T ss_pred             ccccccccchhHHHHHHHhhhhHhhcCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeec
Confidence            88776 3432111 12467788888888888776332211 222 24677777776532   122333446677888888


Q ss_pred             cCCCC
Q 002899          228 ISDLK  232 (869)
Q Consensus       228 L~~n~  232 (869)
                      |+++.
T Consensus       320 LSD~v  324 (419)
T KOG2120|consen  320 LSDSV  324 (419)
T ss_pred             ccccc
Confidence            87643

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.74  E-value=5.1e-09  Score=84.43  Aligned_cols=60  Identities=33%  Similarity=0.505  Sum_probs=55.9

Q ss_pred             cceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcC
Q 002899          245 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL  304 (869)
Q Consensus       245 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  304 (869)
                      +|++|+|++|+|+...+..|..+++|++|+|++|+|+...|..|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            688899999999988889999999999999999999988888999999999999999975

...

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.73  E-value=2.3e-09  Score=125.82  Aligned_cols=203  Identities=20%  Similarity=0.265  Sum_probs=145.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ..+.+.+.+-+-+|+++.++.+.-. .|...+.|......   ....+....+-.++-..+||-+++...-+......+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4566777888889999999877633 34444444332221   1112222223333333456777766655666778899


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      |++|..+++|...+|...     ..+..-.+.....+..+.+|||...   +.|+|++|.|++...+++.+++|||....
T Consensus       882 ~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             hhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence            999999999999887754     3444455666667888899999875   89999999999999999999999984322


Q ss_pred             ecCC---------------------C---------ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCC
Q 002899          792 YEED---------------------K---------THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS  841 (869)
Q Consensus       792 ~~~~---------------------~---------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~  841 (869)
                      ....                     .         ........||+.|.+||...+......+|+|+.|++++|.++|.+
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence            2100                     0         001223568999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 002899          842 NTNYR  846 (869)
Q Consensus       842 p~~~~  846 (869)
                      ||+..
T Consensus      1034 p~na~ 1038 (1205)
T KOG0606|consen 1034 PFNAE 1038 (1205)
T ss_pred             CCCCc
Confidence            99753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.73  E-value=1.1e-07  Score=94.94  Aligned_cols=126  Identities=27%  Similarity=0.291  Sum_probs=82.5

Q ss_pred             EEEEEEEcCCcEEEEEEecccC--------------c-------h-----hhHHHHHHHHHHHhcCCCc--eeeEEeEEe
Q 002899          653 SVYKGILSDGTVIAVKQLSSKS--------------R-------Q-----GNREFVNEIGMISAQQHPN--LVKLYGCCV  704 (869)
Q Consensus       653 ~Vyka~~~~g~~VAvK~~~~~~--------------~-------~-----~~~~f~~E~~~l~~l~H~n--Iv~l~~~~~  704 (869)
                      .||.|...+|..+|||..+...              +       .     ......+|.+.|.++..-.  +.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999899999999875321              0       0     0123567999999997764  45565442 


Q ss_pred             eCceEEEEEEecc--CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEEcCCCCCCEEEcCCCcE
Q 002899          705 EGNQLLLVYEYMK--NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY-LHEDSRIKIVHRDIKTSNVLLDKDLNA  781 (869)
Q Consensus       705 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~iiH~Dlk~~NILl~~~~~~  781 (869)
                         ...+||||++  +..+.++....       ++......++.+++..+.. +|..|   |+|||+.+.|||++++ .+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~  145 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV  145 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence               4569999999  55554433221       1134566777888886655 46776   9999999999999988 99


Q ss_pred             EEeecCCceeec
Q 002899          782 KISDFGLAKLYE  793 (869)
Q Consensus       782 kl~DFGla~~~~  793 (869)
                      .++|||.+....
T Consensus       146 ~iIDf~qav~~~  157 (188)
T PF01163_consen  146 YIIDFGQAVDSS  157 (188)
T ss_dssp             EE--GTTEEETT
T ss_pred             EEEecCcceecC
Confidence            999999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.72  E-value=8.9e-09  Score=83.03  Aligned_cols=59  Identities=29%  Similarity=0.472  Sum_probs=29.4

Q ss_pred             CccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCc
Q 002899          150 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSS  208 (869)
Q Consensus       150 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  208 (869)
                      +|++|+|++|+|+...+..|.++++|++|++++|+++...+..|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            44555555555553333444555555555555555554444445555555555555554

...

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.70  E-value=2.2e-07  Score=101.97  Aligned_cols=170  Identities=20%  Similarity=0.296  Sum_probs=128.6

Q ss_pred             eEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEe----eCceEEEEEEeccC-Cchhhhh
Q 002899          652 GSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV----EGNQLLLVYEYMKN-NCLSRAI  725 (869)
Q Consensus       652 G~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~----~~~~~~lV~E~~~~-gsL~~~l  725 (869)
                      .+.||+... ||..|++|+++....+.......-+++++++.|+|+|++.+++.    .+..+++||+|.++ ++|.+.-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            578999854 89999999996543333333445678999999999999998876    35578999999985 4555543


Q ss_pred             hcCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          726 FGKDTE----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       726 ~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +.....          .....++..++.++.|+..||.++|+.|   +.-+-|.+++||++.+.+++|+..|.......+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            332211          1235788899999999999999999998   888999999999999999999888776655443


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN  842 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p  842 (869)
                      ..               |-+   ..-.+-|.-.||.+++.|.+|...
T Consensus       447 ~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  447 PT---------------EPL---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CC---------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            31               111   123467999999999999999754

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.70  E-value=2.5e-08  Score=121.35  Aligned_cols=104  Identities=25%  Similarity=0.331  Sum_probs=57.0

Q ss_pred             CCCEEEeecCc--CCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEE
Q 002899           79 YLKQLDLSRNC--LTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLI  155 (869)
Q Consensus        79 ~L~~L~Ls~N~--i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  155 (869)
                      .|++|-+..|.  +.......|..+ .|+.|||++|.--+.+|..+++|-+|++|+|++..+. .+|..+.+|.+|.+|+
T Consensus       546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln  624 (889)
T KOG4658|consen  546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN  624 (889)
T ss_pred             ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence            45555555554  444444445544 4555666655444455555666666666666666555 5555566666666666


Q ss_pred             eecccccccCCccccCCCCCCeEeccCC
Q 002899          156 LSSNSFTGELPAELTKLTNLNDLRISDN  183 (869)
Q Consensus       156 Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N  183 (869)
                      +..+.....+|.....|++|++|.|..-
T Consensus       625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s  652 (889)
T KOG4658|consen  625 LEVTGRLESIPGILLELQSLRVLRLPRS  652 (889)
T ss_pred             cccccccccccchhhhcccccEEEeecc
Confidence            6555444344444444555666555443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.70  E-value=2.7e-07  Score=97.75  Aligned_cols=141  Identities=16%  Similarity=0.053  Sum_probs=99.5

Q ss_pred             CeeeccCceEEEEEEEcCCcEEEEEEecccCch-----------hhHHHHHHHHHHHhcCCCce--eeEEeEEee-----
Q 002899          644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ-----------GNREFVNEIGMISAQQHPNL--VKLYGCCVE-----  705 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~-----------~~~~f~~E~~~l~~l~H~nI--v~l~~~~~~-----  705 (869)
                      +.+-+-....|++..+ +|+.+.||+.......           ....+.+|.+.+.++...+|  .+++++.+.     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444455777766 5788999977543311           11147788888887754443  344555543     


Q ss_pred             CceEEEEEEeccCC-chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-------
Q 002899          706 GNQLLLVYEYMKNN-CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-------  777 (869)
Q Consensus       706 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~-------  777 (869)
                      ...-++|||++++- +|.+++.....   .+.+...+..++.+++..+.-||+.|   |+|+|++++|||++.       
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~  180 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREE  180 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCC
Confidence            23568999999975 78877642111   13456677899999999999999998   999999999999985       


Q ss_pred             CCcEEEeecCCcee
Q 002899          778 DLNAKISDFGLAKL  791 (869)
Q Consensus       778 ~~~~kl~DFGla~~  791 (869)
                      +..+.++||+.+..
T Consensus       181 ~~~~~LIDl~r~~~  194 (268)
T PRK15123        181 DLKLSVIDLHRAQI  194 (268)
T ss_pred             CceEEEEECCcccc
Confidence            47899999998754

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.64  E-value=1.6e-08  Score=123.11  Aligned_cols=204  Identities=19%  Similarity=0.259  Sum_probs=143.2

Q ss_pred             ccCCCCCCEEEeecCcCCCCCchhhccccceEEEeeccc--CCCCCchhhcCccccccccccccccCCCCCccccCCCCc
Q 002899           74 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNR--LSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINL  151 (869)
Q Consensus        74 l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  151 (869)
                      ..+....+.+.+.+|.+... +......+|++|-+..|.  +..+..+.|..++.|+.|||++|.=.+.+|..++.|-+|
T Consensus       519 ~~~~~~~rr~s~~~~~~~~~-~~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L  597 (889)
T KOG4658|consen  519 VKSWNSVRRMSLMNNKIEHI-AGSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL  597 (889)
T ss_pred             ccchhheeEEEEeccchhhc-cCCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence            34457788999999988644 333344489999999996  666667779999999999999987667999999999999


Q ss_pred             cEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcC--CCCchHhhhcCCCCCEEEcC
Q 002899          152 QKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL--EGPIPASISALTSLTDLRIS  229 (869)
Q Consensus       152 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l--~~~~~~~l~~l~~L~~L~L~  229 (869)
                      ++|+|++..++ .+|..+.+|..|.+|++..+.-...+|..+..|++|++|.|.....  .......+.++.+|+.|...
T Consensus       598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~  676 (889)
T KOG4658|consen  598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT  676 (889)
T ss_pred             hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence            99999999999 8999999999999999999987667788888899999999976653  23444556666666666654


Q ss_pred             CCCCCCCcccccccccc----eEEEcccccCccCCCcccCCCCCcCEEeccCCCCC
Q 002899          230 DLKGSESAFPKLDKMNL----KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT  281 (869)
Q Consensus       230 ~n~~~~~~~~~~~~~~L----~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~  281 (869)
                      .... ...........|    +.+.+..+... ..+..+..+.+|+.|.+.++.+.
T Consensus       677 ~~s~-~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~  730 (889)
T KOG4658|consen  677 ISSV-LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGIS  730 (889)
T ss_pred             cchh-HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCc
Confidence            3222 111111111111    12222222221 23344556666666666666664

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.64  E-value=7.9e-09  Score=105.23  Aligned_cols=166  Identities=19%  Similarity=0.231  Sum_probs=102.4

Q ss_pred             CCccccCCCCCCEEEeecCcCCCCCch-hhccc--cceEEEeecccCCC--CCchhhcCccccccccccccccCCCCCcc
Q 002899           70 LPTELSKLRYLKQLDLSRNCLTGSFSP-QWASL--QLVELSVMGNRLSG--PFPKVLTNITTLKNLSIEGNLFTGSIPPD  144 (869)
Q Consensus        70 ~p~~l~~l~~L~~L~Ls~N~i~~~~~~-~~~~l--~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  144 (869)
                      -+-.+..+..++.|.|.++.|...... .|+..  .++.|||.+|.|+.  .+...+.+||.|+.|+|+.|.+...+...
T Consensus        37 s~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~l  116 (418)
T KOG2982|consen   37 SYLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSL  116 (418)
T ss_pred             ceeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccC
Confidence            344455555677788888888655432 23333  68999999999984  45566788999999999999998554433


Q ss_pred             ccCCCCccEEEeeccccccc-CCccccCCCCCCeEeccCCcCCCC--CccccCCCC-cccEEEccCCcCCC--CchHhhh
Q 002899          145 IRKLINLQKLILSSNSFTGE-LPAELTKLTNLNDLRISDNNFSGK--IPEFIGKWK-KIQKLHIQGSSLEG--PIPASIS  218 (869)
Q Consensus       145 ~~~l~~L~~L~Ls~N~i~~~-~p~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~-~L~~L~L~~N~l~~--~~~~~l~  218 (869)
                      -..+.+|++|.|.+..+.-. .-..+..+|.+++|++|.|.+...  ..+...... .+++|++..|....  .....-.
T Consensus       117 p~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r  196 (418)
T KOG2982|consen  117 PLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSR  196 (418)
T ss_pred             cccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHh
Confidence            24677899999998877632 233457788899999999955422  122222222 45555554443321  1111112


Q ss_pred             cCCCCCEEEcCCCCCCC
Q 002899          219 ALTSLTDLRISDLKGSE  235 (869)
Q Consensus       219 ~l~~L~~L~L~~n~~~~  235 (869)
                      -++++..+.+..+++..
T Consensus       197 ~Fpnv~sv~v~e~PlK~  213 (418)
T KOG2982|consen  197 IFPNVNSVFVCEGPLKT  213 (418)
T ss_pred             hcccchheeeecCcccc
Confidence            33555555555555443

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.62  E-value=1.7e-09  Score=121.51  Aligned_cols=155  Identities=24%  Similarity=0.273  Sum_probs=82.7

Q ss_pred             CccccCCCCCCEEEeecCcCCCCCchhhccc----------------------------------cceEEEeecccCCCC
Q 002899           71 PTELSKLRYLKQLDLSRNCLTGSFSPQWASL----------------------------------QLVELSVMGNRLSGP  116 (869)
Q Consensus        71 p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l----------------------------------~L~~L~Ls~N~l~~~  116 (869)
                      |-.|..+++|++|.|.++.|...  ..+..+                                  .|...+.+.|++. .
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~  178 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-L  178 (1096)
T ss_pred             CceeccccceeeEEecCcchhhh--hhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-h
Confidence            66788889999999999988641  111111                                  2444555555555 3


Q ss_pred             CchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCc-cccCCCCCCeEeccCCcCCCCCccccCC
Q 002899          117 FPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA-ELTKLTNLNDLRISDNNFSGKIPEFIGK  195 (869)
Q Consensus       117 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  195 (869)
                      ...++.-++.|+.|||++|+++...  .+..+++|++|||+.|.++ .+|. ...++. |..|.|++|.++.  -..+.+
T Consensus       179 mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~t--L~gie~  252 (1096)
T KOG1859|consen  179 MDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTT--LRGIEN  252 (1096)
T ss_pred             HHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHh--hhhHHh
Confidence            3444555555666666666555322  4555555666666666555 2221 122222 5555555555541  223455


Q ss_pred             CCcccEEEccCCcCCC-CchHhhhcCCCCCEEEcCCCCCC
Q 002899          196 WKKIQKLHIQGSSLEG-PIPASISALTSLTDLRISDLKGS  234 (869)
Q Consensus       196 l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~n~~~  234 (869)
                      +.+|+.|||+.|-|.+ .....+..|..|+.|+|.+|++-
T Consensus       253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            5555555666555543 22233444555555555555543

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.57  E-value=2.2e-09  Score=120.66  Aligned_cols=195  Identities=18%  Similarity=0.234  Sum_probs=134.8

Q ss_pred             ceEEEeecccCCCCC-chhhcCccccccccccccccCCCCCccccCC-CCccEEEeecccccc---cCCc---ccc---C
Q 002899          103 LVELSVMGNRLSGPF-PKVLTNITTLKNLSIEGNLFTGSIPPDIRKL-INLQKLILSSNSFTG---ELPA---ELT---K  171 (869)
Q Consensus       103 L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~i~~---~~p~---~~~---~  171 (869)
                      ++.|.+-.-.-.+.. |-.+..+..|++|.|.++.|..  ...+..+ .+|++|..++ .+..   .+..   .+.   .
T Consensus        86 t~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~-Sl~Al~~v~ascggd~~ns~~  162 (1096)
T KOG1859|consen   86 TKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHN-SLDALRHVFASCGGDISNSPV  162 (1096)
T ss_pred             heeeeecccCCCCCCCCceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhc-cHHHHHHHHHHhccccccchh
Confidence            444444433222222 4456677888899888888873  2223333 2466664433 2220   1110   111   1


Q ss_pred             CCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEc
Q 002899          172 LTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLIL  251 (869)
Q Consensus       172 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~L  251 (869)
                      ...|...+.+.|.+. ....++.-++.|+.|+|++|+++..  +.+..|+.|+.|||+.|.+...+--......|..|.|
T Consensus       163 Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~L~l  239 (1096)
T KOG1859|consen  163 WNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQLLNL  239 (1096)
T ss_pred             hhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhhheeeee
Confidence            235888899999998 5667788889999999999999854  3889999999999999999888776666667999999


Q ss_pred             ccccCccCCCcccCCCCCcCEEeccCCCCCCCC-chhhhcCCCCCEEEeeCCcCC
Q 002899          252 TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI-PTTFEKLAKTNFMYLTGNKLT  305 (869)
Q Consensus       252 s~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~  305 (869)
                      ++|.++..  ..+.++.+|+.|||++|-|.+.- -..+..|..|+.|+|.||++.
T Consensus       240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            99988733  34668899999999999887522 223566778888999999886

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.51  E-value=6.5e-07  Score=91.72  Aligned_cols=134  Identities=23%  Similarity=0.209  Sum_probs=95.8

Q ss_pred             CCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCc----------------------hhhHHHHHHHHHHHhcCCC--c
Q 002899          640 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR----------------------QGNREFVNEIGMISAQQHP--N  695 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~----------------------~~~~~f~~E~~~l~~l~H~--n  695 (869)
                      ..+.+.||.|--+.||.|..+.|.++|||.-.....                      .......+|.++|.++.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            346788999999999999999999999996432100                      0112346788889888655  5


Q ss_pred             eeeEEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE
Q 002899          696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL  775 (869)
Q Consensus       696 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  775 (869)
                      +.+.+++    +...+||||+++--|.+.-          ++-+....|+..|+.-+.-+-..|   |||||+.+-||++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV  235 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV  235 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence            6666655    4567999999986664322          123334445555555555444566   9999999999999


Q ss_pred             cCCCcEEEeecCCce
Q 002899          776 DKDLNAKISDFGLAK  790 (869)
Q Consensus       776 ~~~~~~kl~DFGla~  790 (869)
                      ++||.+.++||--+.
T Consensus       236 ~~dg~~~vIDwPQ~v  250 (304)
T COG0478         236 TEDGDIVVIDWPQAV  250 (304)
T ss_pred             ecCCCEEEEeCcccc
Confidence            999999999996554

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.48  E-value=1.7e-06  Score=92.75  Aligned_cols=194  Identities=15%  Similarity=0.188  Sum_probs=127.3

Q ss_pred             CCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHh-cCCCceeeEEeE----Ee--e-CceEEEEE
Q 002899          642 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGC----CV--E-GNQLLLVY  713 (869)
Q Consensus       642 ~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~-l~H~nIv~l~~~----~~--~-~~~~~lV~  713 (869)
                      ....||+|+-+.+|-.--  -...+.|+++........+..   ++|.+ -.||-+-.-+.+    ..  + +....+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecch--hhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            456799999999995321  112355776654433333222   22332 356543321111    11  1 22256677


Q ss_pred             EeccCCchhhhhhcC--CcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          714 EYMKNNCLSRAIFGK--DTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       714 E~~~~gsL~~~l~~~--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ..+++.---..++.-  +.......+|...++.++.+|.+.+-||+.|   .+-||+.++|+|+.+++.+.|.|=..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence            776654333333322  1223346899999999999999999999998   88899999999999999999998654433


Q ss_pred             ecCCCccccccccccccccchhhcc-----cCCCCchhHHHHHHHHHHHHHcC-CCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSG-KSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltG-~~p~~~  845 (869)
                      -..+..  ..-.+|...|.+||...     +...+...|-|-+||++++|+.| +.||..
T Consensus       167 ~~ng~~--~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         167 NANGTL--HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             ccCCce--EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence            322222  22246888999999765     33557789999999999999987 999864

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.41  E-value=4.2e-08  Score=98.82  Aligned_cols=224  Identities=17%  Similarity=0.144  Sum_probs=110.0

Q ss_pred             ccCCCCCCEEEeecCcCCCCCchhhccc-----cceEEEeecccCC---CCC-------chhhcCccccccccccccccC
Q 002899           74 LSKLRYLKQLDLSRNCLTGSFSPQWASL-----QLVELSVMGNRLS---GPF-------PKVLTNITTLKNLSIEGNLFT  138 (869)
Q Consensus        74 l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-----~L~~L~Ls~N~l~---~~~-------~~~~~~l~~L~~L~Ls~N~l~  138 (869)
                      +..+..++.++||+|.|.......++..     +|+..+++.--..   ..+       -.++..+++|+..+||+|.|.
T Consensus        26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg  105 (388)
T COG5238          26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFG  105 (388)
T ss_pred             HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccC
Confidence            4446777778888887776554444332     4555555442211   111       123334455555555555555


Q ss_pred             CCCCcc----ccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCc-
Q 002899          139 GSIPPD----IRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI-  213 (869)
Q Consensus       139 ~~~~~~----~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-  213 (869)
                      ...|..    ++.-+.|++|.|++|.+.-..-.-++.  .|.  +|..|       .-..+-|.|+......|++..-. 
T Consensus       106 ~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigk--al~--~la~n-------KKaa~kp~Le~vicgrNRlengs~  174 (388)
T COG5238         106 SEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGK--ALF--HLAYN-------KKAADKPKLEVVICGRNRLENGSK  174 (388)
T ss_pred             cccchHHHHHHhcCCCceeEEeecCCCCccchhHHHH--HHH--HHHHH-------hhhccCCCceEEEeccchhccCcH
Confidence            444432    233344555555555443100000000  000  00000       01123355666666666665321 


Q ss_pred             ---hHhhhcCCCCCEEEcCCCCCCCCcccc------cccccceEEEcccccCccCC----CcccCCCCCcCEEeccCCCC
Q 002899          214 ---PASISALTSLTDLRISDLKGSESAFPK------LDKMNLKTLILTKCLIHGEI----PDYIGDMTKLKNIDLSFNNL  280 (869)
Q Consensus       214 ---~~~l~~l~~L~~L~L~~n~~~~~~~~~------~~~~~L~~L~Ls~N~i~~~~----p~~~~~l~~L~~L~Ls~N~l  280 (869)
                         ...|..-.+|+.+.+..|.|.......      +...+|+.|||..|-++-..    ...+..++.|+.|.+.+|-+
T Consensus       175 ~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDCll  254 (388)
T COG5238         175 ELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLL  254 (388)
T ss_pred             HHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhh
Confidence               112223345666666666665443221      11225777777777665332    34455667788888888888


Q ss_pred             CCCCchhhh------cCCCCCEEEeeCCcCCCCC
Q 002899          281 TGGIPTTFE------KLAKTNFMYLTGNKLTGPV  308 (869)
Q Consensus       281 ~~~~p~~~~------~l~~L~~L~Ls~N~l~~~~  308 (869)
                      +.....++-      ..++|..|-+.+|...+.+
T Consensus       255 s~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~  288 (388)
T COG5238         255 SNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGI  288 (388)
T ss_pred             ccccHHHHHHHhhhhcCCCccccccchhhhcCce
Confidence            755444332      2567788888888776543

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.35  E-value=5.8e-08  Score=97.81  Aligned_cols=182  Identities=16%  Similarity=0.226  Sum_probs=128.3

Q ss_pred             eEEEEeccCCCccc----cCCccccCCCCCCEEEeecCcCC---CCCchh--------hccccceEEEeecccCCCCCch
Q 002899           55 HVVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRNCLT---GSFSPQ--------WASLQLVELSVMGNRLSGPFPK  119 (869)
Q Consensus        55 ~v~~L~l~~~~l~~----~~p~~l~~l~~L~~L~Ls~N~i~---~~~~~~--------~~~l~L~~L~Ls~N~l~~~~~~  119 (869)
                      .++.++|++|-|..    .+...|.+-++|+..+++.-...   ..++..        ....+|+..+||.|.+....|.
T Consensus        31 ~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~~e  110 (388)
T COG5238          31 ELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEFPE  110 (388)
T ss_pred             ceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCcccch
Confidence            58899999998865    34556778899999999875332   222222        2223799999999999876664


Q ss_pred             ----hhcCccccccccccccccCCCCCcc-------------ccCCCCccEEEeecccccccCCcc-----ccCCCCCCe
Q 002899          120 ----VLTNITTLKNLSIEGNLFTGSIPPD-------------IRKLINLQKLILSSNSFTGELPAE-----LTKLTNLND  177 (869)
Q Consensus       120 ----~~~~l~~L~~L~Ls~N~l~~~~~~~-------------~~~l~~L~~L~Ls~N~i~~~~p~~-----~~~l~~L~~  177 (869)
                          .++.-+.|++|.|++|.+...-...             ..+-|.|+++....|++. ..+..     +..-.+|++
T Consensus       111 ~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRle-ngs~~~~a~~l~sh~~lk~  189 (388)
T COG5238         111 ELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLE-NGSKELSAALLESHENLKE  189 (388)
T ss_pred             HHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhc-cCcHHHHHHHHHhhcCcee
Confidence                4566789999999999887322221             234578999999999987 33322     333368999


Q ss_pred             EeccCCcCCCCC-----ccccCCCCcccEEEccCCcCCCC----chHhhhcCCCCCEEEcCCCCCCCCc
Q 002899          178 LRISDNNFSGKI-----PEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESA  237 (869)
Q Consensus       178 L~Ls~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~n~~~~~~  237 (869)
                      +.+..|.|.-.-     -..+..+.+|+.|||++|-++..    +...+...+.|++|.+.+|-++...
T Consensus       190 vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G  258 (388)
T COG5238         190 VKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEG  258 (388)
T ss_pred             EEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhcccc
Confidence            999999886221     11244568999999999998843    3455667778899998887776544

>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]

Probab=98.35  E-value=2.2e-08  Score=102.07  Aligned_cols=175  Identities=17%  Similarity=0.190  Sum_probs=82.8

Q ss_pred             ccccccccccccCCC-CCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCc-CCCCC-ccccCCCCcccEE
Q 002899          126 TLKNLSIEGNLFTGS-IPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN-FSGKI-PEFIGKWKKIQKL  202 (869)
Q Consensus       126 ~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~-~~~~~~l~~L~~L  202 (869)
                      .|++|||++..|+.. .-..+..+.+|+.|.|.++++.+.+...+++-.+|+.|+|+.+. |+... .-.+.+++.|..|
T Consensus       186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L  265 (419)
T KOG2120|consen  186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL  265 (419)
T ss_pred             hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence            356666665555511 11123445555555555555555555555555555555555442 22110 1123445555555


Q ss_pred             EccCCcCCCCch-HhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEccccc--Cc-cCCCcccCCCCCcCEEeccCC
Q 002899          203 HIQGSSLEGPIP-ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCL--IH-GEIPDYIGDMTKLKNIDLSFN  278 (869)
Q Consensus       203 ~L~~N~l~~~~~-~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~--i~-~~~p~~~~~l~~L~~L~Ls~N  278 (869)
                      +|+.+.+..... ..+.+..                      .+|+.|+|+++.  +. ..+...-..+|+|.+||||+|
T Consensus       266 NlsWc~l~~~~Vtv~V~his----------------------e~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~  323 (419)
T KOG2120|consen  266 NLSWCFLFTEKVTVAVAHIS----------------------ETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDS  323 (419)
T ss_pred             CchHhhccchhhhHHHhhhc----------------------hhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccc
Confidence            555555443211 1112211                      134445554432  11 111122235677777777766


Q ss_pred             C-CCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh-----hccCCceeeecc
Q 002899          279 N-LTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI-----FNSNKNVDISLN  324 (869)
Q Consensus       279 ~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~~l~~l~ls~N  324 (869)
                      . |+......|.+++.|++|.|+.+..  .+|..+     .+++.+||+-+.
T Consensus       324 v~l~~~~~~~~~kf~~L~~lSlsRCY~--i~p~~~~~l~s~psl~yLdv~g~  373 (419)
T KOG2120|consen  324 VMLKNDCFQEFFKFNYLQHLSLSRCYD--IIPETLLELNSKPSLVYLDVFGC  373 (419)
T ss_pred             cccCchHHHHHHhcchheeeehhhhcC--CChHHeeeeccCcceEEEEeccc
Confidence            3 4444444566667777777766643  455544     334555655443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	869
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-54
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-52
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-49
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-48
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-42
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-42
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-41
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-39
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-24
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-24
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-24
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-24
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-24
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-23
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-23
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-23
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-23
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-23
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-23
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-23
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-23
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-23
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-23
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-22
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-22
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-22
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-22
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-21
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-21
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-21
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-21
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-21
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-21
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-21
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-21
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-21
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-21
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-21
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-21
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-21
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-21
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-21
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-21
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-21
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-21
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-21
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-21
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-21
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-21
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-21
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-21
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-21
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-21
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-21
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-20
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-20
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-20
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-20
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-20
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-20
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-20
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-20
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-20
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-20
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-20
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-20
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-20
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-20
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-20
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-20
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-20
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-20
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-20
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-20
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-19
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-19
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-19
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-19
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-19
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-19
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-19
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-18
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-18
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-18
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-18
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-18
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-18
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-18
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-18
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-18
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-18
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-18
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-18
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-18
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-18
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-18
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-18
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-18
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-18
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-18
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-18
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-18
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-18
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-18
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-18
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-18
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-18
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-18
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-18
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-18
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-18
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-18
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-18
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-18
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-18
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-18
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-17
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-17
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-17
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-17
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-17
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-17
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-17
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-17
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-17
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-17
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-17
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-17
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-17
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-17
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-17
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-17
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-17
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-17
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-17
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-17
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-17
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-17
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-17
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-17
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-17
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-17
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-17
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-17
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-17
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-17
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-17
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-17
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-17
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-17
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-17
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-17
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-17
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-17
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-17
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-17
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-17
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-17
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-17
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-17
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-17
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-17
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-17
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-17
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-17
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-16
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-16
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-16
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-16
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-16
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-16
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-16
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-16
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-15
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-15
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-15
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-15
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-15
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-15
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-15
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-13
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-13
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-13
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-13
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		9e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-09
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-09
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-09
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-09
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		9e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-08
3soa_A	444	Full-Length Human Camkii Length = 444		1e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-05
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-05
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  209 bits (531), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 105/244 (43%), Positives = 156/244 (63%), Gaps = 4/244 (1%)
Query: 624 QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-EFV 682
           Q   ++LR+++ A++NF   N +G GGFG VYKG L+DGT++AVK+L  +  QG   +F 
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
            E+ MIS   H NL++L G C+   + LLVY YM N  ++  +  +  E +  LDWP R+
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER-PESQPPLDWPKRQ 142
Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
           +I +G ARGLAYLH+    KI+HRD+K +N+LLD++  A + DFGLAKL +    H+   
Sbjct: 143 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA 202
Query: 803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR--PNEDFVYLLDWAYV 860
           + GTIG++APEY   G  + K DV+ +GV+ LE+++G+   +     N+D V LLDW   
Sbjct: 203 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 262
Query: 861 LQEE 864
           L +E
Sbjct: 263 LLKE 266

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  204 bits (519), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 103/244 (42%), Positives = 154/244 (63%), Gaps = 4/244 (1%)
Query: 624 QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-EFV 682
           Q   ++LR+++ A++NF   N +G GGFG VYKG L+DG ++AVK+L  +  QG   +F 
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
            E+ MIS   H NL++L G C+   + LLVY YM N  ++  +  +  E +  LDWP R+
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER-PESQPPLDWPKRQ 134
Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
           +I +G ARGLAYLH+    KI+HRD+K +N+LLD++  A + DFGLAKL +    H+   
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA 194
Query: 803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR--PNEDFVYLLDWAYV 860
           + G IG++APEY   G  + K DV+ +GV+ LE+++G+   +     N+D V LLDW   
Sbjct: 195 VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 861 LQEE 864
           L +E
Sbjct: 255 LLKE 258

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  195 bits (495), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 103/230 (44%), Positives = 149/230 (64%), Gaps = 5/230 (2%)
Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMIS 689
           L  ++ ATNNFD    +G G FG VYKG+L DG  +A+K+ + +S QG  EF  EI  +S
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
             +HP+LV L G C E N+++L+Y+YM+N  L R ++G D    + + W  R +ICIG A
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP-TMSMSWEQRLEICIGAA 149
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE-DKTHISTRIAGTIG 808
           RGL YLH  +   I+HRD+K+ N+LLD++   KI+DFG++K   E D+TH+   + GT+G
Sbjct: 150 RGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLG 206
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA 858
           Y+ PEY ++G LT K+DVYSFGVV  E++  +S        + V L +WA
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  191 bits (486), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 102/230 (44%), Positives = 148/230 (64%), Gaps = 5/230 (2%)
Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMIS 689
           L  ++ ATNNFD    +G G FG VYKG+L DG  +A+K+ + +S QG  EF  EI  +S
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
             +HP+LV L G C E N+++L+Y+YM+N  L R ++G D    + + W  R +ICIG A
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP-TMSMSWEQRLEICIGAA 149
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE-DKTHISTRIAGTIG 808
           RGL YLH  +   I+HRD+K+ N+LLD++   KI+DFG++K   E  +TH+   + GT+G
Sbjct: 150 RGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLG 206
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA 858
           Y+ PEY ++G LT K+DVYSFGVV  E++  +S        + V L +WA
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  170 bits (430), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 103/236 (43%), Positives = 146/236 (61%), Gaps = 18/236 (7%)
Query: 615 DKELRGLDLQTGLYTLRQIKAATNNFDP------ANKVGEGGFGSVYKGILSDGTVIAVK 668
           +K L   D +   ++  ++K  TNNFD        NK+GEGGFG VYKG +++ T +AVK
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVK 60
Query: 669 QLSS----KSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRA 724
           +L++     + +  ++F  EI +++  QH NLV+L G   +G+ L LVY YM N  L   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 725 IFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 784
           +   D      L W  R KI  G A G+ +LHE+  I   HRDIK++N+LLD+   AKIS
Sbjct: 121 LSCLDG--TPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKIS 175
Query: 785 DFGLAKLYEE-DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           DFGLA+  E+  +T + +RI GT  YMAPE A+RG +T K+D+YSFGVV LEI++G
Sbjct: 176 DFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  169 bits (427), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 103/236 (43%), Positives = 145/236 (61%), Gaps = 18/236 (7%)
Query: 615 DKELRGLDLQTGLYTLRQIKAATNNFDP------ANKVGEGGFGSVYKGILSDGTVIAVK 668
           +K L   D +   ++  ++K  TNNFD        NK+GEGGFG VYKG +++ T +AVK
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVK 60
Query: 669 QLSS----KSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRA 724
           +L++     + +  ++F  EI +++  QH NLV+L G   +G+ L LVY YM N  L   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 725 IFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 784
           +   D      L W  R KI  G A G+ +LHE+  I   HRDIK++N+LLD+   AKIS
Sbjct: 121 LSCLDG--TPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKIS 175
Query: 785 DFGLAKLYEE-DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           DFGLA+  E+  +T +  RI GT  YMAPE A+RG +T K+D+YSFGVV LEI++G
Sbjct: 176 DFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  166 bits (420), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 99/223 (44%), Positives = 139/223 (62%), Gaps = 18/223 (8%)
Query: 628 YTLRQIKAATNNFDP------ANKVGEGGFGSVYKGILSDGTVIAVKQLSS----KSRQG 677
           ++  ++K  TNNFD        NK+GEGGFG VYKG +++ T +AVK+L++     + + 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 678 NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD 737
            ++F  EI +++  QH NLV+L G   +G+ L LVY YM N  L   +   D      L 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLS 125
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE-DK 796
           W  R KI  G A G+ +LHE+  I   HRDIK++N+LLD+   AKISDFGLA+  E+  +
Sbjct: 126 WHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  RI GT  YMAPE A+RG +T K+D+YSFGVV LEI++G
Sbjct: 183 XVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  159 bits (401), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 97/223 (43%), Positives = 135/223 (60%), Gaps = 18/223 (8%)
Query: 628 YTLRQIKAATNNFDP------ANKVGEGGFGSVYKGILSDGTVIAVKQLSS----KSRQG 677
           ++  ++K  TNNFD        NK GEGGFG VYKG +++ T +AVK+L++     + + 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 678 NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD 737
            ++F  EI + +  QH NLV+L G   +G+ L LVY Y  N  L   +   D      L 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDG--TPPLS 122
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
           W  R KI  G A G+ +LHE+  I   HRDIK++N+LLD+   AKISDFGLA+  E+   
Sbjct: 123 WHXRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 798 HI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            +  +RI GT  Y APE A+RG +T K+D+YSFGVV LEI++G
Sbjct: 180 XVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  111 bits (278), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/196 (34%), Positives = 104/196 (53%), Gaps = 7/196 (3%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR--EFVNEIGMISAQQHPNLVKLYGC 702
           K+G G FG+V++     G+ +AVK L  +     R  EF+ E+ ++   +HPN+V   G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +   L +V EY+    L R +       R +LD   R  +   +A+G+ YLH +    
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
           IVHRD+K+ N+L+DK    K+ DFGL++L +      S   AGT  +MAPE         
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KASXFLXSKXAAGTPEWMAPEVLRDEPSNE 218
Query: 823 KADVYSFGVVTLEIVS 838
           K+DVYSFGV+  E+ +
Sbjct: 219 KSDVYSFGVILWELAT 234

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 108/197 (54%), Gaps = 9/197 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR--EFVNEIGMISAQQHPNLVKLYGC 702
           K+G G FG+V++     G+ +AVK L  +     R  EF+ E+ ++   +HPN+V   G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +   L +V EY+    L R +       R +LD   R  +   +A+G+ YLH +    
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIGYMAPEYAMRGYLT 821
           IVHR++K+ N+L+DK    K+ DFGL++L  +  T +S++  AGT  +MAPE        
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 822 SKADVYSFGVVTLEIVS 838
            K+DVYSFGV+  E+ +
Sbjct: 218 EKSDVYSFGVILWELAT 234

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 124/251 (49%), Gaps = 24/251 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ 691
           +N     ++GEG FG V+           D  ++AVK L   S    ++F  E  +++  
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTR------KK 743
           QH ++VK YG CVEG+ L++V+EYMK+  L++ +   G D     + + PT         
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTR 802
           I   IA G+ YL   +    VHRD+ T N L+ ++L  KI DFG+++ +Y  D   +   
Sbjct: 133 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 189
Query: 803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
               I +M PE  M    T+++DV+S GVV  EI + GK       N + +  +    VL
Sbjct: 190 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 249
Query: 862 QE-----EEIY 867
           Q      +E+Y
Sbjct: 250 QRPRTCPQEVY 260

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  110 bits (275), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 21/217 (9%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G   +   +A+K +   +     +F+ E  ++    HP LV+LYG 
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 703 CVEGNQLLLVYEYMKNNCLS------RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           C+E   + LV+E+M++ CLS      R +F  +T             +C+ +  G+AYL 
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL----------GMCLDVCEGMAYLE 120
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
           E S   ++HRD+   N L+ ++   K+SDFG+ +   +D+   ST     + + +PE   
Sbjct: 121 EAS---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 177
Query: 817 RGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFV 852
               +SK+DV+SFGV+  E+ S GK     R N + V
Sbjct: 178 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 214

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  109 bits (273), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 115/209 (55%), Gaps = 26/209 (12%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQQHPNLVKLYG 701
           +G GGFG VY+     G  +AVK       +   + +     E  + +  +HPN++ L G
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
            C++   L LV E+ +   L+R + GK     + ++W       + IARG+ YLH+++ +
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNYLHDEAIV 127
Query: 762 KIVHRDIKTSNVLL-----DKDLN---AKISDFGLAKLYEEDKTHISTRI--AGTIGYMA 811
            I+HRD+K+SN+L+     + DL+    KI+DFGLA+ +     H +T++  AG   +MA
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-----HRTTKMSAAGAYAWMA 182
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE       +  +DV+S+GV+  E+++G+
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  108 bits (271), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 21/217 (9%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G   +   +A+K +   S   + +F+ E  ++    HP LV+LYG 
Sbjct: 32  VQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED-DFIEEAEVMMKLSHPKLVQLYGV 90
Query: 703 CVEGNQLLLVYEYMKNNCLS------RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           C+E   + LV+E+M++ CLS      R +F  +T             +C+ +  G+AYL 
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL----------GMCLDVCEGMAYLE 140
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
           E     ++HRD+   N L+ ++   K+SDFG+ +   +D+   ST     + + +PE   
Sbjct: 141 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 197
Query: 817 RGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFV 852
               +SK+DV+SFGV+  E+ S GK     R N + V
Sbjct: 198 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 234

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  108 bits (271), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G   +   +A+K +   +     +F+ E  ++    HP LV+LYG 
Sbjct: 15  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 703 CVEGNQLLLVYEYMKNNCLS------RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           C+E   + LV+E+M++ CLS      R +F  +T             +C+ +  G+AYL 
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAET----------LLGMCLDVCEGMAYLE 123
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
           E     ++HRD+   N L+ ++   K+SDFG+ +   +D+   ST     + + +PE   
Sbjct: 124 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 180
Query: 817 RGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFV 852
               +SK+DV+SFGV+  E+ S GK     R N + V
Sbjct: 181 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 217

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G   +   +A+K +   +     +F+ E  ++    HP LV+LYG 
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 703 CVEGNQLLLVYEYMKNNCLS------RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           C+E   + LV+E+M++ CLS      R +F  +T             +C+ +  G+AYL 
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAET----------LLGMCLDVCEGMAYLE 118
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
           E     ++HRD+   N L+ ++   K+SDFG+ +   +D+   ST     + + +PE   
Sbjct: 119 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 817 RGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFV 852
               +SK+DV+SFGV+  E+ S GK     R N + V
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 212

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G   +   +A+K +   +     +F+ E  ++    HP LV+LYG 
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 703 CVEGNQLLLVYEYMKNNCLS------RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           C+E   + LV+E+M++ CLS      R +F  +T             +C+ +  G+AYL 
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAET----------LLGMCLDVCEGMAYLE 120
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
           E     ++HRD+   N L+ ++   K+SDFG+ +   +D+   ST     + + +PE   
Sbjct: 121 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 177
Query: 817 RGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFV 852
               +SK+DV+SFGV+  E+ S GK     R N + V
Sbjct: 178 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 214

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 109/219 (49%), Gaps = 20/219 (9%)
Query: 645 KVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
           ++GEG FG V+           D  ++AVK L   S    ++F  E  +++  QH ++V+
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----------KLDWPTRKKICIGI 748
            +G C EG  LL+V+EYM++  L+R +     + +L           L       +   +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTI 807
           A G+ YL   + +  VHRD+ T N L+ + L  KI DFG+++ +Y  D   +  R    I
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 846
            +M PE  +    T+++DV+SFGVV  EI +      Y+
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 240

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 109/219 (49%), Gaps = 20/219 (9%)
Query: 645 KVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
           ++GEG FG V+           D  ++AVK L   S    ++F  E  +++  QH ++V+
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----------KLDWPTRKKICIGI 748
            +G C EG  LL+V+EYM++  L+R +     + +L           L       +   +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTI 807
           A G+ YL   + +  VHRD+ T N L+ + L  KI DFG+++ +Y  D   +  R    I
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 846
            +M PE  +    T+++DV+SFGVV  EI +      Y+
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 234

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 20/211 (9%)
Query: 645 KVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
           ++GEG FG V+           D  ++AVK L   S    ++F  E  +++  QH ++V+
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----------KLDWPTRKKICIGI 748
            +G C EG  LL+V+EYM++  L+R +     + +L           L       +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTI 807
           A G+ YL   + +  VHRD+ T N L+ + L  KI DFG+++ +Y  D   +  R    I
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            +M PE  +    T+++DV+SFGVV  EI +
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  107 bits (266), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 21/217 (9%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G   +   +A+K +   +     +F+ E  ++    HP LV+LYG 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 703 CVEGNQLLLVYEYMKNNCLS------RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           C+E   + LV E+M++ CLS      R +F  +T             +C+ +  G+AYL 
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLL----------GMCLDVCEGMAYLE 121
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
           E     ++HRD+   N L+ ++   K+SDFG+ +   +D+   ST     + + +PE   
Sbjct: 122 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 178
Query: 817 RGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFV 852
               +SK+DV+SFGV+  E+ S GK     R N + V
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 215

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  106 bits (264), Expect = 6e-23,   Method: Composition-based stats.
 Identities = 64/194 (32%), Positives = 106/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM   CL   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 84  E-EPIYIVMEYMSKGCLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  106 bits (264), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 111/202 (54%), Gaps = 17/202 (8%)
Query: 646 VGEGGFGSVYKGILSDGT-----VIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKL 699
           +G G FG VYKG+L   +      +A+K L +   +  R +F+ E G++    H N+++L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHED 758
            G   +   ++++ EYM+N  L + +  KD E+  L+L    R     GIA G+ YL   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR-----GIAAGMKYL--- 163
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAM 816
           + +  VHRD+   N+L++ +L  K+SDFGL+++ E+D     T   G I   + APE   
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 817 RGYLTSKADVYSFGVVTLEIVS 838
               TS +DV+SFG+V  E+++
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMT 245

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  106 bits (264), Expect = 7e-23,   Method: Composition-based stats.
 Identities = 64/194 (32%), Positives = 106/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM   CL   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 84  E-EPIYIVTEYMSKGCLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 118/242 (48%), Gaps = 22/242 (9%)
Query: 644 NKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
            ++GEG FG V+           D  ++AVK L   +    ++F  E  +++  QH ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK-----------KICI 746
           K YG C +G+ L++V+EYMK+  L++ +     +  + +D   R+            I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAG 805
            IA G+ YL   +    VHRD+ T N L+  +L  KI DFG+++ +Y  D   +      
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEE 864
            I +M PE  M    T+++DV+SFGV+  EI + GK       N + +  +    VL+  
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP 257
Query: 865 EI 866
            +
Sbjct: 258 RV 259

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  104 bits (259), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 333 E-EPIYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 446 DVWSFGILLTELTT 459

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 250 E-EPIYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 363 DVWSFGILLTELTT 376

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 250 E-EPIYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 363 DVWSFGILLTELTT 376

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 104/194 (53%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           ++G G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L    F KD E R  L  P    +   +A G+AY+    R+  +
Sbjct: 75  E-EPIYIVTEYMNKGSLLD--FLKDGEGR-ALKLPNLVDMAAQVAAGMAYIE---RMNYI 127
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++++N+L+   L  KI+DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+V+
Sbjct: 188 DVWSFGILLTELVT 201

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Composition-based stats.
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 74  E-EPIXIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 126
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 186
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 187 DVWSFGILLTELTT 200

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 250 E-EPIYIVGEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 363 DVWSFGILLTELTT 376

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Composition-based stats.
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 77  E-EPIYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 129
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 189
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 190 DVWSFGILLTELTT 203

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           +G+G FG   K    + G V+ +K+L     +  R F+ E+ ++   +HPN++K  G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           +  +L  + EY+K   L   I   D++Y     W  R      IA G+AYLH    + I+
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQY----PWSQRVSFAKDIASGMAYLHS---MNII 130
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS-------------TRIAGTIGYMA 811
           HRD+ + N L+ ++ N  ++DFGLA+L  ++KT                  + G   +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 844
           PE         K DV+SFG+V  EI+ G+ N +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Composition-based stats.
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 81  E-EPIYIVTEYMNKGSLLDFLKGETGKY---LRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 194 DVWSFGILLTELTT 207

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 8e-22,   Method: Composition-based stats.
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 84  E-EPIYIVIEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 116/213 (54%), Gaps = 19/213 (8%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG+VYKG       + +  +++ + Q  + F NE+G++   +H N++   G 
Sbjct: 17  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK--LDWPTRKKICIGIARGLAYLHEDSR 760
             +  QL +V ++ + + L   +   +T++ +K  +D      I    ARG+ YLH  S 
Sbjct: 77  STK-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLID------IARQTARGMDYLHAKS- 128
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE-DKTHISTRIAGTIGYMAPEYAM--- 816
             I+HRD+K++N+ L +D   KI DFGLA +      +H   +++G+I +MAPE      
Sbjct: 129 --IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 186
Query: 817 RGYLTSKADVYSFGVVTLEIVSGK---SNTNYR 846
               + ++DVY+FG+V  E+++G+   SN N R
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 219

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Composition-based stats.
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 81  E-EPIYIVTEYMNKGSLLDFLKGETGKY---LRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 194 DVWSFGILLTELTT 207

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Composition-based stats.
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 84  E-EPIYIVIEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Composition-based stats.
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 73  E-EPIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 125
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 185
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 186 DVWSFGILLTELTT 199

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Composition-based stats.
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 75  E-EPIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 127
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 188 DVWSFGILLTELTT 201

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Composition-based stats.
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 115/228 (50%), Gaps = 30/228 (13%)
Query: 638 NNFDPANKVGEGGFGSVYK----GIL--SDGTVIAVKQLSSK-SRQGNREFVNEIGMISA 690
           NN +    +GEG FG V++    G+L     T++AVK L  + S     +F  E  +++ 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSR-----------AIFGKDTEYRLKLDWP 739
             +PN+VKL G C  G  + L++EYM    L+            ++   D   R ++  P
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 740 ------TRKKICIG--IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK- 790
                   +++CI   +A G+AYL E    K VHRD+ T N L+ +++  KI+DFGL++ 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 791 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +Y  D        A  I +M PE       T+++DV+++GVV  EI S
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 99/321 (30%), Positives = 153/321 (47%), Gaps = 41/321 (12%)
Query: 48  DCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSP-QWASLQLVEL 106
           DCS+    +  + +    L+G     +S    LK L++S N   G   P    SLQ   L
Sbjct: 218 DCSA----LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQY--L 271
Query: 107 SVMGNRLSGPFPKVLTNIT-TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGEL 165
           S+  N+ +G  P  L+    TL  L + GN F G++PP       L+ L LSSN+F+GEL
Sbjct: 272 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 331
Query: 166 PAE-LTKLTNLNDLRISDNNFSGKIPE------------------FIGKW---------K 197
           P + L K+  L  L +S N FSG++PE                  F G            
Sbjct: 332 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 391
Query: 198 KIQKLHIQGSSLEGPIPASISALTSLTDLRIS--DLKGS-ESAFPKLDKMNLKTLILTKC 254
            +Q+L++Q +   G IP ++S  + L  L +S   L G+  S+   L K  L+ L L   
Sbjct: 392 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSK--LRDLKLWLN 449
Query: 255 LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN 314
           ++ GEIP  +  +  L+ + L FN+LTG IP+        N++ L+ N+LTG +PK+I  
Sbjct: 450 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 509
Query: 315 SNKNVDISLNNFTWESSDPIE 335
                 + L+N ++  + P E
Sbjct: 510 LENLAILKLSNNSFSGNIPAE 530

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Composition-based stats.
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Composition-based stats.
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 84  E-EPIYIVCEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 14/197 (7%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKLYG 701
           K+G+G FG V+ G  +  T +A+K L    + GN     F+ E  ++   +H  LV+LY 
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTL----KPGNMSPEAFLQEAQVMKKLRHEKLVQLYA 247
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+
Sbjct: 248 VVSE-EPIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RM 300
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
             VHRD++ +N+L+ ++L  K++DFGL +L E+++          I + APE A+ G  T
Sbjct: 301 NYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 360
Query: 822 SKADVYSFGVVTLEIVS 838
            K+DV+SFG++  E+ +
Sbjct: 361 IKSDVWSFGILLTELTT 377

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 115/225 (51%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G FG V  G L         +A+K L    + +  R+F+ E  ++    HPN+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   +++V EYM+N  L   +   D ++  ++L    R     GIA G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----GIASGMKYL---S 164
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGLA++ E+D     T   G I   + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  +D  Y L
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 269

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 124/226 (54%), Gaps = 19/226 (8%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG+VYKG       + +  +++ + Q  + F NE+G++   +H N++   G 
Sbjct: 15  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-KLDWPTRKKICIGIARGLAYLHEDSRI 761
             +  QL +V ++ + + L   +   +T++ + KL       I    A+G+ YLH  S  
Sbjct: 75  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAKS-- 126
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE-DKTHISTRIAGTIGYMAPEYAM---R 817
            I+HRD+K++N+ L +DL  KI DFGLA +      +H   +++G+I +MAPE      +
Sbjct: 127 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 185
Query: 818 GYLTSKADVYSFGVVTLEIVSGK---SNTNYRPNEDFVYLLDWAYV 860
              + ++DVY+FG+V  E+++G+   SN N R  +  ++++   Y+
Sbjct: 186 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYL 229

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 124/226 (54%), Gaps = 19/226 (8%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG+VYKG       + +  +++ + Q  + F NE+G++   +H N++   G 
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-KLDWPTRKKICIGIARGLAYLHEDSRI 761
             +  QL +V ++ + + L   +   +T++ + KL       I    A+G+ YLH  S  
Sbjct: 73  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAKS-- 124
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE-DKTHISTRIAGTIGYMAPEYAM---R 817
            I+HRD+K++N+ L +DL  KI DFGLA +      +H   +++G+I +MAPE      +
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 818 GYLTSKADVYSFGVVTLEIVSGK---SNTNYRPNEDFVYLLDWAYV 860
              + ++DVY+FG+V  E+++G+   SN N R  +  ++++   Y+
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYL 227

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 124/226 (54%), Gaps = 19/226 (8%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG+VYKG       + +  +++ + Q  + F NE+G++   +H N++   G 
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-KLDWPTRKKICIGIARGLAYLHEDSRI 761
             +  QL +V ++ + + L   +   +T++ + KL       I    A+G+ YLH  S  
Sbjct: 78  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAKS-- 129
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE-DKTHISTRIAGTIGYMAPEYAM---R 817
            I+HRD+K++N+ L +DL  KI DFGLA +      +H   +++G+I +MAPE      +
Sbjct: 130 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 188
Query: 818 GYLTSKADVYSFGVVTLEIVSGK---SNTNYRPNEDFVYLLDWAYV 860
              + ++DVY+FG+V  E+++G+   SN N R  +  ++++   Y+
Sbjct: 189 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYL 232

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 124/226 (54%), Gaps = 19/226 (8%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG+VYKG       + +  +++ + Q  + F NE+G++   +H N++   G 
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-KLDWPTRKKICIGIARGLAYLHEDSRI 761
             +  QL +V ++ + + L   +   +T++ + KL       I    A+G+ YLH  S  
Sbjct: 78  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAKS-- 129
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE-DKTHISTRIAGTIGYMAPEYAM---R 817
            I+HRD+K++N+ L +DL  KI DFGLA +      +H   +++G+I +MAPE      +
Sbjct: 130 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 188
Query: 818 GYLTSKADVYSFGVVTLEIVSGK---SNTNYRPNEDFVYLLDWAYV 860
              + ++DVY+FG+V  E+++G+   SN N R  +  ++++   Y+
Sbjct: 189 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYL 232

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 99/321 (30%), Positives = 153/321 (47%), Gaps = 41/321 (12%)
Query: 48  DCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSP-QWASLQLVEL 106
           DCS+    +  + +    L+G     +S    LK L++S N   G   P    SLQ   L
Sbjct: 221 DCSA----LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQY--L 274
Query: 107 SVMGNRLSGPFPKVLTNIT-TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGEL 165
           S+  N+ +G  P  L+    TL  L + GN F G++PP       L+ L LSSN+F+GEL
Sbjct: 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334
Query: 166 PAE-LTKLTNLNDLRISDNNFSGKIPE------------------FIGKW---------K 197
           P + L K+  L  L +S N FSG++PE                  F G            
Sbjct: 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 394
Query: 198 KIQKLHIQGSSLEGPIPASISALTSLTDLRIS--DLKGS-ESAFPKLDKMNLKTLILTKC 254
            +Q+L++Q +   G IP ++S  + L  L +S   L G+  S+   L K  L+ L L   
Sbjct: 395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSK--LRDLKLWLN 452
Query: 255 LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN 314
           ++ GEIP  +  +  L+ + L FN+LTG IP+        N++ L+ N+LTG +PK+I  
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 315 SNKNVDISLNNFTWESSDPIE 335
                 + L+N ++  + P E
Sbjct: 513 LENLAILKLSNNSFSGNIPAE 533

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 123/226 (54%), Gaps = 19/226 (8%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG+VYKG       + +  +++ + Q  + F NE+G++   +H N++   G 
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-KLDWPTRKKICIGIARGLAYLHEDSRI 761
                QL +V ++ + + L   +   +T++ + KL       I    A+G+ YLH  S  
Sbjct: 73  ST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAKS-- 124
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE-DKTHISTRIAGTIGYMAPEYAM---R 817
            I+HRD+K++N+ L +DL  KI DFGLA +      +H   +++G+I +MAPE      +
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 818 GYLTSKADVYSFGVVTLEIVSGK---SNTNYRPNEDFVYLLDWAYV 860
              + ++DVY+FG+V  E+++G+   SN N R  +  ++++   Y+
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYL 227

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Composition-based stats.
 Identities = 63/194 (32%), Positives = 104/194 (53%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           E   + +V EYM    L   + G+  +Y   L  P    +   IA G+AY+    R+  V
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD+  +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K+
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++  E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G  +  T +AVK L   S   +  F+ E  ++   QH  LV+LY  
Sbjct: 26  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 84
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +   + ++ EYM+N  L   +    T   +KL       +   IA G+A++ E + I 
Sbjct: 85  VTQ-EPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI- 139
Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
             HRD++ +N+L+   L+ KI+DFGLA+L E+++          I + APE    G  T 
Sbjct: 140 --HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 197
Query: 823 KADVYSFGVVTLEIVS 838
           K+DV+SFG++  EIV+
Sbjct: 198 KSDVWSFGILLTEIVT 213

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 124/226 (54%), Gaps = 19/226 (8%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG+VYKG       + +  +++ + Q  + F NE+G++   +H N++   G 
Sbjct: 41  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-KLDWPTRKKICIGIARGLAYLHEDSRI 761
             +  QL +V ++ + + L   +   +T++ + KL       I    A+G+ YLH  S  
Sbjct: 101 STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAKS-- 152
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE-DKTHISTRIAGTIGYMAPEYAM---R 817
            I+HRD+K++N+ L +DL  KI DFGLA +      +H   +++G+I +MAPE      +
Sbjct: 153 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 211
Query: 818 GYLTSKADVYSFGVVTLEIVSGK---SNTNYRPNEDFVYLLDWAYV 860
              + ++DVY+FG+V  E+++G+   SN N R  +  ++++   Y+
Sbjct: 212 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYL 255

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G  +  T +AVK L   S   +  F+ E  ++   QH  LV+LY  
Sbjct: 27  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 85
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +   + ++ EYM+N  L   +    T   +KL       +   IA G+A++ E + I 
Sbjct: 86  VTQ-EPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI- 140
Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
             HRD++ +N+L+   L+ KI+DFGLA+L E+++          I + APE    G  T 
Sbjct: 141 --HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 198
Query: 823 KADVYSFGVVTLEIVS 838
           K+DV+SFG++  EIV+
Sbjct: 199 KSDVWSFGILLTEIVT 214

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 124/226 (54%), Gaps = 19/226 (8%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG+VYKG       + +  +++ + Q  + F NE+G++   +H N++   G 
Sbjct: 40  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-KLDWPTRKKICIGIARGLAYLHEDSRI 761
             +  QL +V ++ + + L   +   +T++ + KL       I    A+G+ YLH  S  
Sbjct: 100 STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAKS-- 151
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE-DKTHISTRIAGTIGYMAPEYAM---R 817
            I+HRD+K++N+ L +DL  KI DFGLA +      +H   +++G+I +MAPE      +
Sbjct: 152 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 210
Query: 818 GYLTSKADVYSFGVVTLEIVSGK---SNTNYRPNEDFVYLLDWAYV 860
              + ++DVY+FG+V  E+++G+   SN N R  +  ++++   Y+
Sbjct: 211 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYL 254

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 118/215 (54%), Gaps = 23/215 (10%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG+VYKG       + +  +++ + Q  + F NE+G++   +H N++   G 
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK--LDWPTRKKICIGIARGLAYLHEDSR 760
             +  QL +V ++ + + L   +   +T++ +K  +D      I    ARG+ YLH  S 
Sbjct: 89  STK-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLID------IARQTARGMDYLHAKS- 140
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK---THISTRIAGTIGYMAPEYAM- 816
             I+HRD+K++N+ L +D   KI DFGLA   E+ +   +H   +++G+I +MAPE    
Sbjct: 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLAT--EKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK---SNTNYR 846
                 + ++DVY+FG+V  E+++G+   SN N R
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 117/215 (54%), Gaps = 23/215 (10%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG+VYKG       + +  +++ + Q  + F NE+G++   +H N++   G 
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK--LDWPTRKKICIGIARGLAYLHEDSR 760
                QL +V ++ + + L   +   +T++ +K  +D      I    ARG+ YLH  S 
Sbjct: 89  ST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLID------IARQTARGMDYLHAKS- 140
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK---THISTRIAGTIGYMAPEYAM- 816
             I+HRD+K++N+ L +D   KI DFGLA   E+ +   +H   +++G+I +MAPE    
Sbjct: 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLAT--EKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK---SNTNYR 846
                 + ++DVY+FG+V  E+++G+   SN N R
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G  +  T +AVK L   S   +  F+ E  ++   QH  LV+LY  
Sbjct: 20  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 78
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +   + ++ EYM+N  L   +    T   +KL       +   IA G+A++ E + I 
Sbjct: 79  VTQ-EPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI- 133
Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
             HRD++ +N+L+   L+ KI+DFGLA+L E+++          I + APE    G  T 
Sbjct: 134 --HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 191
Query: 823 KADVYSFGVVTLEIVS 838
           K+DV+SFG++  EIV+
Sbjct: 192 KSDVWSFGILLTEIVT 207

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G  +  T +AVK L   S   +  F+ E  ++   QH  LV+LY  
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 82
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +   + ++ EYM+N  L   +    T   +KL       +   IA G+A++ E + I 
Sbjct: 83  VTQ-EPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI- 137
Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
             HRD++ +N+L+   L+ KI+DFGLA+L E+++          I + APE    G  T 
Sbjct: 138 --HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 195
Query: 823 KADVYSFGVVTLEIVS 838
           K+DV+SFG++  EIV+
Sbjct: 196 KSDVWSFGILLTEIVT 211

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G  +  T +AVK L   S   +  F+ E  ++   QH  LV+LY  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 76
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +   + ++ EYM+N  L   +    T   +KL       +   IA G+A++ E + I 
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI- 131
Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
             HRD++ +N+L+   L+ KI+DFGLA+L E+++          I + APE    G  T 
Sbjct: 132 --HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 823 KADVYSFGVVTLEIVS 838
           K+DV+SFG++  EIV+
Sbjct: 190 KSDVWSFGILLTEIVT 205

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G  +  T +AVK L   S   +  F+ E  ++   QH  LV+LY  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 76
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +   + ++ EYM+N  L   +    T   +KL       +   IA G+A++ E + I 
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI- 131
Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
             HRD++ +N+L+   L+ KI+DFGLA+L E+++          I + APE    G  T 
Sbjct: 132 --HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 823 KADVYSFGVVTLEIVS 838
           K+DV+SFG++  EIV+
Sbjct: 190 KSDVWSFGILLTEIVT 205

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 115/225 (51%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G FG V  G L         +A+K L    + +  R+F+ E  ++    HPN+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   +++V EYM+N  L   +   D ++  ++L    R     GIA G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----GIASGMKYL---S 164
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGL+++ E+D     T   G I   + +PE    
Sbjct: 165 DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  +D  Y L
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 269

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 110/223 (49%), Gaps = 8/223 (3%)
Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
            ++G G FG V+ G  ++ T +AVK L   +    + F+ E  ++   QH  LV+LY   
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
                + ++ EYM    L    F K  E   K+  P        IA G+AY+    R   
Sbjct: 78  TREEPIYIITEYMAKGSLLD--FLKSDE-GGKVLLPKLIDFSAQIAEGMAYIE---RKNY 131
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRD++ +NVL+ + L  KI+DFGLA++ E+++          I + APE    G  T K
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191
Query: 824 ADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEE 865
           +DV+SFG++  EIV+ GK     R N D +  L   Y +   E
Sbjct: 192 SDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVE 234

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G  +  T +AVK L   S   +  F+ E  ++   QH  LV+LY  
Sbjct: 19  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 77
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +   + ++ EYM+N  L   +    T   +KL       +   IA G+A++ E + I 
Sbjct: 78  VTQ-EPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI- 132
Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
             HRD++ +N+L+   L+ KI+DFGLA+L E+++          I + APE    G  T 
Sbjct: 133 --HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 190
Query: 823 KADVYSFGVVTLEIVS 838
           K+DV+SFG++  EIV+
Sbjct: 191 KSDVWSFGILLTEIVT 206

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 112/202 (55%), Gaps = 19/202 (9%)
Query: 646 VGEGGFGSVYKGI-LSDGTVI----AVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 699
           +G G FG+VYKGI + +G  +    A+K L+  +  + N EF++E  ++++  HP+LV+L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY--RLKLDWPTRKKICIGIARGLAYLHE 757
            G C+    + LV + M + CL   +         +L L+W      C+ IA+G+ YL E
Sbjct: 106 LGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 158
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED-KTHISTRIAGTIGYMAPEYAM 816
               ++VHRD+   NVL+    + KI+DFGLA+L E D K + +      I +MA E   
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 817 RGYLTSKADVYSFGVVTLEIVS 838
               T ++DV+S+GV   E+++
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMT 237

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 111/202 (54%), Gaps = 19/202 (9%)
Query: 646 VGEGGFGSVYKGI-LSDGTVI----AVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 699
           +G G FG+VYKGI + +G  +    A+K L+  +  + N EF++E  ++++  HP+LV+L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY--RLKLDWPTRKKICIGIARGLAYLHE 757
            G C+    + LV + M + CL   +         +L L+W      C+ IA+G+ YL E
Sbjct: 83  LGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 135
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAM 816
               ++VHRD+   NVL+    + KI+DFGLA+L E D+   +       I +MA E   
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 817 RGYLTSKADVYSFGVVTLEIVS 838
               T ++DV+S+GV   E+++
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMT 214

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G  +  T +AVK L   S   +  F+ E  ++   QH  LV+LY  
Sbjct: 23  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 81
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +   + ++ EYM+N  L   +    T   +KL       +   IA G+A++ E + I 
Sbjct: 82  VTQ-EPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI- 136
Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
             HRD++ +N+L+   L+ KI+DFGLA+L E+++          I + APE    G  T 
Sbjct: 137 --HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 194
Query: 823 KADVYSFGVVTLEIVS 838
           K+DV+SFG++  EIV+
Sbjct: 195 KSDVWSFGILLTEIVT 210

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 107/211 (50%), Gaps = 17/211 (8%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQ 692
           K     FD   K+GEG +GSVYK I  + G ++A+KQ+  +S    +E + EI ++    
Sbjct: 25  KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCD 82
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA--- 749
            P++VK YG   +   L +V EY     +S  I       RL+    T  +I   +    
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII-------RLRNKTLTEDEIATILQSTL 135
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
           +GL YLH    ++ +HRDIK  N+LL+ + +AK++DFG+A     D       + GT  +
Sbjct: 136 KGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL-TDXMAKRNXVIGTPFW 191
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           MAPE          AD++S G+  +E+  GK
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G  +  T +AVK L   S   +  F+ E  ++   QH  LV+LY  
Sbjct: 28  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 86
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +   + ++ EYM+N  L   +    T   +KL       +   IA G+A++ E + I 
Sbjct: 87  VTQ-EPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI- 141
Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
             HRD++ +N+L+   L+ KI+DFGLA+L E+++          I + APE    G  T 
Sbjct: 142 --HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 199
Query: 823 KADVYSFGVVTLEIVS 838
           K+DV+SFG++  EIV+
Sbjct: 200 KSDVWSFGILLTEIVT 215

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 112/231 (48%), Gaps = 21/231 (9%)
Query: 621 LDLQTGLYTLRQIKAATNN----------FDPANKVGEGGFGSV-YKGILSDGTVIAVKQ 669
           L  Q+G+ T  Q KAA              D   K+GEG  G V        G  +AVK 
Sbjct: 18  LYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKM 77
Query: 670 LSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD 729
           +  + +Q      NE+ ++   QH N+V++Y   + G +L ++ E+++   L+      D
Sbjct: 78  MDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT------D 131
Query: 730 TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 789
              +++L+      +C  + + LAYLH      ++HRDIK+ ++LL  D   K+SDFG  
Sbjct: 132 IVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFC 188
Query: 790 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
               +D       + GT  +MAPE   R    ++ D++S G++ +E+V G+
Sbjct: 189 AQISKDVPK-RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G  +  T +AVK L   S   +  F+ E  ++   QH  LV+LY  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 76
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +   + ++ EYM+N  L   +    T   +KL       +   IA G+A++ E + I 
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI- 131
Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
             HRD++ +N+L+   L+ KI+DFGLA+L E+++          I + APE    G  T 
Sbjct: 132 --HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 823 KADVYSFGVVTLEIVS 838
           K+DV+SFG++  EIV+
Sbjct: 190 KSDVWSFGILLTEIVT 205

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G  +  T +AVK L   S   +  F+ E  ++   QH  LV+LY  
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 82
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +   + ++ EYM+N  L   +    T   +KL       +   IA G+A++ E + I 
Sbjct: 83  VTQ-EPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI- 137
Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
             HRD++ +N+L+   L+ KI+DFGLA+L E+++          I + APE    G  T 
Sbjct: 138 --HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 195
Query: 823 KADVYSFGVVTLEIVS 838
           K+DV+SFG++  EIV+
Sbjct: 196 KSDVWSFGILLTEIVT 211

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 126/228 (55%), Gaps = 23/228 (10%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG+VYKG       + +  +++ + Q  + F NE+G++   +H N++   G 
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-KLDWPTRKKICIGIARGLAYLHEDSRI 761
             +  QL +V ++ + + L   +   +T++ + KL       I    A+G+ YLH  S  
Sbjct: 73  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAKS-- 124
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK---THISTRIAGTIGYMAPEYAM-- 816
            I+HRD+K++N+ L +DL  KI DFGLA   E+ +   +H   +++G+I +MAPE     
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLAT--EKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 817 -RGYLTSKADVYSFGVVTLEIVSGK---SNTNYRPNEDFVYLLDWAYV 860
            +   + ++DVY+FG+V  E+++G+   SN N R  +  ++++   Y+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYL 227

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 115/225 (51%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G FG V  G L         +A+K L    + +  R+F+ E  ++    HPN+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   +++V EYM+N  L   +   D ++  ++L    R     GIA G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----GIASGMKYL---S 164
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGL+++ E+D     T   G I   + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  +D  Y L
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 269

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 126/228 (55%), Gaps = 23/228 (10%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG+VYKG       + +  +++ + Q  + F NE+G++   +H N++   G 
Sbjct: 33  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-KLDWPTRKKICIGIARGLAYLHEDSRI 761
             +  QL +V ++ + + L   +   +T++ + KL       I    A+G+ YLH  S  
Sbjct: 93  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAKS-- 144
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK---THISTRIAGTIGYMAPEYAM-- 816
            I+HRD+K++N+ L +DL  KI DFGLA   E+ +   +H   +++G+I +MAPE     
Sbjct: 145 -IIHRDLKSNNIFLHEDLTVKIGDFGLAT--EKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 817 -RGYLTSKADVYSFGVVTLEIVSGK---SNTNYRPNEDFVYLLDWAYV 860
            +   + ++DVY+FG+V  E+++G+   SN N R  +  ++++   Y+
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYL 247

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 115/225 (51%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G FG V  G L         +A+K L    + +  R+F+ E  ++    HPN+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   +++V EYM+N  L   +   D ++  ++L    R     GIA G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----GIASGMKYL---S 164
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGL+++ E+D     T   G I   + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  +D  Y L
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 269

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 115/225 (51%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G FG V  G L         +A+K L    + +  R+F+ E  ++    HPN+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   +++V EYM+N  L   +   D ++  ++L    R     GIA G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----GIASGMKYL---S 164
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGL+++ E+D     T   G I   + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  +D  Y L
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 269

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G  +  T +AVK L   S   +  F+ E  ++   QH  LV+LY  
Sbjct: 13  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 71
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +   + ++ EYM+N  L   +    T   +KL       +   IA G+A++ E + I 
Sbjct: 72  VTQ-EPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI- 126
Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
             HRD++ +N+L+   L+ KI+DFGLA+L E+++          I + APE    G  T 
Sbjct: 127 --HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 184
Query: 823 KADVYSFGVVTLEIVS 838
           K+DV+SFG++  EIV+
Sbjct: 185 KSDVWSFGILLTEIVT 200

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 115/225 (51%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G FG V  G L         +A+K L    + +  R+F+ E  ++    HPN+++L 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   +++V EYM+N  L   +   D ++  ++L    R     GIA G+ YL   S
Sbjct: 84  GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----GIASGMKYL---S 135
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGL+++ E+D     T   G   I + +PE    
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 195
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  +D  Y L
Sbjct: 196 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 240

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G FG V  G L         +A+K L    + +  R+F+ E  ++    HPN+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   +++V EYM+N  L   +   D ++  ++L    R     GIA G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----GIASGMKYL---S 164
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGL ++ E+D     T   G I   + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  +D  Y L
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 269

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 126/228 (55%), Gaps = 23/228 (10%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG+VYKG       + +  +++ + Q  + F NE+G++   +H N++   G 
Sbjct: 41  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-KLDWPTRKKICIGIARGLAYLHEDSRI 761
             +  QL +V ++ + + L   +   +T++ + KL       I    A+G+ YLH  S  
Sbjct: 101 STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLHAKS-- 152
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK---THISTRIAGTIGYMAPEYAM-- 816
            I+HRD+K++N+ L +DL  KI DFGLA   E+ +   +H   +++G+I +MAPE     
Sbjct: 153 -IIHRDLKSNNIFLHEDLTVKIGDFGLAT--EKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 817 -RGYLTSKADVYSFGVVTLEIVSGK---SNTNYRPNEDFVYLLDWAYV 860
            +   + ++DVY+FG+V  E+++G+   SN N R  +  ++++   Y+
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYL 255

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 115/225 (51%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G FG V  G L         +A+K L    + +  R+F+ E  ++    HPN+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   +++V EYM+N  L   +   D ++  ++L    R     GIA G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----GIASGMKYL---S 164
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGL+++ E+D     T   G I   + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  +D  Y L
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 269

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 115/225 (51%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G FG V  G L         +A+K L    + +  R+F+ E  ++    HPN+++L 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 100
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   +++V EYM+N  L   +   D ++  ++L    R     GIA G+ YL   S
Sbjct: 101 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----GIASGMKYL---S 152
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGL+++ E+D     T   G   I + +PE    
Sbjct: 153 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 212
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  +D  Y L
Sbjct: 213 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 257

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 115/225 (51%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G FG V  G L         +A+K L    + +  R+F+ E  ++    HPN+++L 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 110
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   +++V EYM+N  L   +   D ++  ++L    R     GIA G+ YL   S
Sbjct: 111 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----GIASGMKYL---S 162
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGL+++ E+D     T   G I   + +PE    
Sbjct: 163 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 222
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  +D  Y L
Sbjct: 223 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 267

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+G+G  G+VY  + ++ G  +A++Q++ + +      +NEI ++   ++PN+V      
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V EY+    L+      D      +D      +C    + L +LH +   ++
Sbjct: 87  LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRDIK+ N+LL  D + K++DFG       +++  ST + GT  +MAPE   R     K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196
Query: 824 ADVYSFGVVTLEIVSGK 840
            D++S G++ +E++ G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 636 ATNNFDPANKVGEGGFGSVYKG-ILSDGTVIAVKQLSSKSRQGN-------REFVNEIGM 687
           A N  +   ++G+GGFG V+KG ++ D +V+A+K L     +G        +EF  E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 688 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 747
           +S   HPN+VKLYG     N   +V E++    L   +  K       + W  + ++ + 
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLD 130
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLL-----DKDLNAKISDFGLAKLYEEDKTHISTR 802
           IA G+ Y+ ++    IVHRD+++ N+ L     +  + AK++DFGL+    +   H  + 
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVSG 185
Query: 803 IAGTIGYMAPEY--AMRGYLTSKADVYSFGVVTLEIVSGK 840
           + G   +MAPE   A     T KAD YSF ++   I++G+
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 111/220 (50%), Gaps = 30/220 (13%)
Query: 646 VGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVK 698
           +GEG FG V K         +  T +AVK L   +     R+ ++E  ++    HP+++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 699 LYGCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWPTRKKICIG 747
           LYG C +   LLL+ EY K   L      SR +         +     LD P  + + +G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 748 --------IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTH 798
                   I++G+ YL E   +K+VHRD+   N+L+ +    KISDFGL++ +YEED   
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             ++    + +MA E       T+++DV+SFGV+  EIV+
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 111/222 (50%), Gaps = 8/222 (3%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G G FG V+ G  ++ T +AVK L   +    + F+ E  ++   QH  LV+LY    
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           +   + ++ E+M    L    F K  E   K+  P        IA G+AY+    R   +
Sbjct: 78  KEEPIYIITEFMAKGSLLD--FLKSDEGG-KVLLPKLIDFSAQIAEGMAYIE---RKNYI 131
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +NVL+ + L  KI+DFGLA++ E+++          I + APE    G  T K+
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 825 DVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEE 865
           +V+SFG++  EIV+ GK     R N D +  L   Y +   E
Sbjct: 192 NVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRME 233

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 115/225 (51%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           +G G FG V  G L         +A+K L    + +  R+F+ E  ++    HPN+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G    G  +++V E+M+N  L   +   D ++  ++L    R     GIA G+ YL +  
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR-----GIAAGMRYLAD-- 163
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGL+++ E+D   + T   G I   + APE    
Sbjct: 164 -MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  ++  Y L
Sbjct: 223 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRL 267

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 111/220 (50%), Gaps = 30/220 (13%)
Query: 646 VGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVK 698
           +GEG FG V K         +  T +AVK L   +     R+ ++E  ++    HP+++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 699 LYGCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWPTRKKICIG 747
           LYG C +   LLL+ EY K   L      SR +         +     LD P  + + +G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 748 --------IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTH 798
                   I++G+ YL E   +K+VHRD+   N+L+ +    KISDFGL++ +YEED   
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             ++    + +MA E       T+++DV+SFGV+  EIV+
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 115/214 (53%), Gaps = 17/214 (7%)
Query: 635 AATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQ 692
           ++++ F    K+G G + +VYKG+  + G  +A+K++   S +G     + EI ++   +
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCL----SRAIFGKDTEYRLKLDWPTRKKICIGI 748
           H N+V+LY      N+L LV+E+M N+      SR +        L L     K     +
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNL----VKYFQWQL 117
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            +GLA+ HE+   KI+HRD+K  N+L++K    K+ DFGLA+ +       S+ +  T+ 
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLW 173
Query: 809 YMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 840
           Y AP+  M  R Y TS  D++S G +  E+++GK
Sbjct: 174 YRAPDVLMGSRTYSTS-IDIWSCGCILAEMITGK 206

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             ++G G FG V+ G  +  T +AVK L   S   +  F+ E  ++   QH  LV+LY  
Sbjct: 14  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 72
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +   + ++ EYM+N  L   +    T   +KL       +   IA G+A++ E + I 
Sbjct: 73  VTQ-EPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI- 127
Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
             HR+++ +N+L+   L+ KI+DFGLA+L E+++          I + APE    G  T 
Sbjct: 128 --HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 185
Query: 823 KADVYSFGVVTLEIVS 838
           K+DV+SFG++  EIV+
Sbjct: 186 KSDVWSFGILLTEIVT 201

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 645 KVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+GEG  G V    + S G ++AVK++  + +Q      NE+ ++   QH N+V++Y   
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V E+++   L+      D     +++      +C+ + + L+ LH      +
Sbjct: 96  LVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---V 146
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRDIK+ ++LL  D   K+SDFG      ++       + GT  +MAPE   R     +
Sbjct: 147 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPE 205
Query: 824 ADVYSFGVVTLEIVSGK 840
            D++S G++ +E+V G+
Sbjct: 206 VDIWSLGIMVIEMVDGE 222

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 105/197 (53%), Gaps = 11/197 (5%)
Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+G+G  G+VY  + ++ G  +A++Q++ + +      +NEI ++   ++PN+V      
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V EY+    L+      D      +D      +C    + L +LH +   ++
Sbjct: 87  LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRDIK+ N+LL  D + K++DFG       +++  S  + GT  +MAPE   R     K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-EMVGTPYWMAPEVVTRKAYGPK 196
Query: 824 ADVYSFGVVTLEIVSGK 840
            D++S G++ +E++ G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 645 KVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+GEG  G V    + S G ++AVK++  + +Q      NE+ ++   QH N+V++Y   
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V E+++   L+      D     +++      +C+ + + L+ LH      +
Sbjct: 218 LVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---V 268
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRDIK+ ++LL  D   K+SDFG      ++       + GT  +MAPE   R     +
Sbjct: 269 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPE 327
Query: 824 ADVYSFGVVTLEIVSGK 840
            D++S G++ +E+V G+
Sbjct: 328 VDIWSLGIMVIEMVDGE 344

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 645 KVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+GEG  G V    + S G ++AVK++  + +Q      NE+ ++   QH N+V++Y   
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V E+++   L+      D     +++      +C+ + + L+ LH      +
Sbjct: 87  LVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---V 137
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRDIK+ ++LL  D   K+SDFG      ++       + GT  +MAPE   R     +
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPE 196
Query: 824 ADVYSFGVVTLEIVSGK 840
            D++S G++ +E+V G+
Sbjct: 197 VDIWSLGIMVIEMVDGE 213

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 645 KVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+GEG  G V    + S G ++AVK++  + +Q      NE+ ++   QH N+V++Y   
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V E+++   L+      D     +++      +C+ + + L+ LH      +
Sbjct: 91  LVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---V 141
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRDIK+ ++LL  D   K+SDFG      ++       + GT  +MAPE   R     +
Sbjct: 142 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPE 200
Query: 824 ADVYSFGVVTLEIVSGK 840
            D++S G++ +E+V G+
Sbjct: 201 VDIWSLGIMVIEMVDGE 217

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+G+G  G+VY  + ++ G  +A++Q++ + +      +NEI ++   ++PN+V      
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V EY+    L+      D      +D      +C    + L +LH +   ++
Sbjct: 88  LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 138
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HR+IK+ N+LL  D + K++DFG       +++  ST + GT  +MAPE   R     K
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 197
Query: 824 ADVYSFGVVTLEIVSGK 840
            D++S G++ +E++ G+
Sbjct: 198 VDIWSLGIMAIEMIEGE 214

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 645 KVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+GEG  G V    + S G ++AVK++  + +Q      NE+ ++   QH N+V++Y   
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V E+++   L+      D     +++      +C+ + + L+ LH      +
Sbjct: 98  LVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---V 148
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRDIK+ ++LL  D   K+SDFG      ++       + GT  +MAPE   R     +
Sbjct: 149 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPE 207
Query: 824 ADVYSFGVVTLEIVSGK 840
            D++S G++ +E+V G+
Sbjct: 208 VDIWSLGIMVIEMVDGE 224

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G FG V  G L         +A+K L    + +  R+F+ E  ++    HPN+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   +++V E M+N  L   +   D ++  ++L    R     GIA G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR-----GIASGMKYL---S 164
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGL+++ E+D     T   G I   + +PE    
Sbjct: 165 DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  +D  Y L
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 269

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 105/197 (53%), Gaps = 11/197 (5%)
Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+G+G  G+VY  + ++ G  +A++Q++ + +      +NEI ++   ++PN+V      
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V EY+    L+      D      +D      +C    + L +LH +   ++
Sbjct: 88  LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 138
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRDIK+ N+LL  D + K++DFG       +++  S  + GT  +MAPE   R     K
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPK 197
Query: 824 ADVYSFGVVTLEIVSGK 840
            D++S G++ +E++ G+
Sbjct: 198 VDIWSLGIMAIEMIEGE 214

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 105/197 (53%), Gaps = 11/197 (5%)
Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+G+G  G+VY  + ++ G  +A++Q++ + +      +NEI ++   ++PN+V      
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V EY+    L+      D      +D      +C    + L +LH +   ++
Sbjct: 87  LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRDIK+ N+LL  D + K++DFG       +++  S  + GT  +MAPE   R     K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPK 196
Query: 824 ADVYSFGVVTLEIVSGK 840
            D++S G++ +E++ G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 645 KVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+GEG  G V    + S G ++AVK++  + +Q      NE+ ++   QH N+V++Y   
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V E+++   L+      D     +++      +C+ + + L+ LH      +
Sbjct: 141 LVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---V 191
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRDIK+ ++LL  D   K+SDFG      ++       + GT  +MAPE   R     +
Sbjct: 192 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPE 250
Query: 824 ADVYSFGVVTLEIVSGK 840
            D++S G++ +E+V G+
Sbjct: 251 VDIWSLGIMVIEMVDGE 267

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 30/220 (13%)
Query: 646 VGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVK 698
           +GEG FG V K         +  T +AVK L   +     R+ ++E  ++    HP+++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 699 LYGCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWPTRKKICIG 747
           LYG C +   LLL+ EY K   L      SR +         +     LD P  + + +G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 748 --------IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTH 798
                   I++G+ YL E   + +VHRD+   N+L+ +    KISDFGL++ +YEED   
Sbjct: 151 DLISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             ++    + +MA E       T+++DV+SFGV+  EIV+
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 636 ATNNFDPANKVGEGGFGSVYKG-ILSDGTVIAVKQLSSKSRQGN-------REFVNEIGM 687
           A N  +   ++G+GGFG V+KG ++ D +V+A+K L     +G        +EF  E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 688 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 747
           +S   HPN+VKLYG     N   +V E++    L   +  K       + W  + ++ + 
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLD 130
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLL-----DKDLNAKISDFGLAKLYEEDKTHISTR 802
           IA G+ Y+ ++    IVHRD+++ N+ L     +  + AK++DFG +    +   H  + 
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS----QQSVHSVSG 185
Query: 803 IAGTIGYMAPEY--AMRGYLTSKADVYSFGVVTLEIVSGK 840
           + G   +MAPE   A     T KAD YSF ++   I++G+
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 16/222 (7%)
Query: 624 QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSK-SRQGN 678
           + G    R+I+A+  + +    +G G  G V  G L         +A+K L +  + +  
Sbjct: 37  RAGRSFTREIEASRIHIE--KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR 94
Query: 679 REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW 738
           R+F++E  ++    HPN+++L G    G   ++V EYM+N  L   +   D ++ +    
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM--- 151
Query: 739 PTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 798
                +  G+  G+ YL   S +  VHRD+   NVL+D +L  K+SDFGL+++ E+D   
Sbjct: 152 -QLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207
Query: 799 ISTRIAGTIG--YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             T   G I   + APE       +S +DV+SFGVV  E+++
Sbjct: 208 AXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G FG V  G L         +A+K L    + +  R+F+ E  ++    HPN+++L 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   +++V E M+N  L   +   D ++  ++L    R     GIA G+ YL   S
Sbjct: 84  GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR-----GIASGMKYL---S 135
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGL+++ E+D     T   G   I + +PE    
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 195
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  +D  Y L
Sbjct: 196 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 240

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 636 ATNNFDPANKVGEGGFGSVYKG-ILSDGTVIAVKQLSSKSRQGN-------REFVNEIGM 687
           A N  +   ++G+GGFG V+KG ++ D +V+A+K L     +G        +EF  E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 688 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 747
           +S   HPN+VKLYG     N   +V E++    L   +  K       + W  + ++ + 
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLD 130
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLL-----DKDLNAKISDFGLAKLYEEDKTHISTR 802
           IA G+ Y+ ++    IVHRD+++ N+ L     +  + AK++DF L+    +   H  + 
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS----QQSVHSVSG 185
Query: 803 IAGTIGYMAPEY--AMRGYLTSKADVYSFGVVTLEIVSGK 840
           + G   +MAPE   A     T KAD YSF ++   I++G+
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G FG V  G L         +A+K L    + +  R+F+ E  ++    HPN+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   +++V E M+N  L   +   D ++  ++L    R     GIA G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR-----GIASGMKYL---S 164
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGL+++ E+D     T   G I   + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  +D  Y L
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 269

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 103/200 (51%), Gaps = 20/200 (10%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 705
           VG G FG V K       V A+KQ+ S+S +  + F+ E+  +S   HPN+VKLYG C+ 
Sbjct: 17  VGRGAFGVVCKAKWRAKDV-AIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 72
Query: 706 GNQLLLVYEYMKNNCLSRAIFGKDT----EYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
            N + LV EY +   L   + G +          + W      C+  ++G+AYLH     
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPK 125
Query: 762 KIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
            ++HRD+K  N+LL       KI DFG A    + +TH+ T   G+  +MAPE       
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHM-TNNKGSAAWMAPEVFEGSNY 181
Query: 821 TSKADVYSFGVVTLEIVSGK 840
           + K DV+S+G++  E+++ +
Sbjct: 182 SEKCDVFSWGIILWEVITRR 201

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
            ++G G  G V+ G  +  T +AVK L   S   +  F+ E  ++   QH  LV+LY   
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVV 77
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
            +   + ++ EYM+N  L   +    T   +KL       +   IA G+A++ E + I  
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI-- 131
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
            HRD++ +N+L+   L+ KI+DFGLA+L E+ +          I + APE    G  T K
Sbjct: 132 -HRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 824 ADVYSFGVVTLEIVS 838
           +DV+SFG++  EIV+
Sbjct: 191 SDVWSFGILLTEIVT 205

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 103/200 (51%), Gaps = 20/200 (10%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 705
           VG G FG V K       V A+KQ+ S+S +  + F+ E+  +S   HPN+VKLYG C+ 
Sbjct: 16  VGRGAFGVVCKAKWRAKDV-AIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 706 GNQLLLVYEYMKNNCLSRAIFGKDT----EYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
            N + LV EY +   L   + G +          + W      C+  ++G+AYLH     
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPK 124
Query: 762 KIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
            ++HRD+K  N+LL       KI DFG A    + +TH+ T   G+  +MAPE       
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHM-TNNKGSAAWMAPEVFEGSNY 180
Query: 821 TSKADVYSFGVVTLEIVSGK 840
           + K DV+S+G++  E+++ +
Sbjct: 181 SEKCDVFSWGIILWEVITRR 200

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 120/228 (52%), Gaps = 21/228 (9%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 700
           +G G FG V +G L       + +A+K L    + +  REF++E  ++   +HPN+++L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G       ++++ E+M+N  L   +   D ++  ++L    R     GIA G+ YL E  
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR-----GIASGMRYLAE-- 134
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE---DKTHISTRIAGTIG--YMAPEY 814
            +  VHRD+   N+L++ +L  K+SDFGL++  EE   D T+ S+ + G I   + APE 
Sbjct: 135 -MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSS-LGGKIPIRWTAPEA 192
Query: 815 AMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
                 TS +D +S+G+V  E++S G+       N+D +  ++  Y L
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRL 240

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 110/215 (51%), Gaps = 16/215 (7%)
Query: 631 RQIKAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSK-SRQGNREFVNEI 685
           R+I+A+  + +    +G G  G V  G L         +A+K L +  + +  R+F++E 
Sbjct: 44  REIEASRIHIE--KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEA 101
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            ++    HPN+++L G    G   ++V EYM+N  L   +   D ++ +         + 
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM----QLVGML 157
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
            G+  G+ YL   S +  VHRD+   NVL+D +L  K+SDFGL+++ E+D     T   G
Sbjct: 158 RGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG 214
Query: 806 TIG--YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            I   + APE       +S +DV+SFGVV  E+++
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Composition-based stats.
 Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 13/211 (6%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           ++G G FG V  G       +AVK +   S   + EF  E   +    HP LVK YG C 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 705 EGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
           +   + +V EY+ N CL   +   GK  E    L+      +C  +  G+A+L      +
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLE------MCYDVCEGMAFLESH---Q 124
Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
            +HRD+   N L+D+DL  K+SDFG+ +   +D+   S      + + APE       +S
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 823 KADVYSFGVVTLEIVS-GKSNTNYRPNEDFV 852
           K+DV++FG++  E+ S GK   +   N + V
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVV 215

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 119/228 (52%), Gaps = 21/228 (9%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 700
           +G G FG V +G L       + +A+K L    + +  REF++E  ++   +HPN+++L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G       ++++ E+M+N  L   +   D ++  ++L    R     GIA G+ YL E  
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR-----GIASGMRYLAE-- 136
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE---DKTHISTRIAGTIG--YMAPEY 814
            +  VHRD+   N+L++ +L  K+SDFGL++  EE   D T  S+ + G I   + APE 
Sbjct: 137 -MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSS-LGGKIPIRWTAPEA 194
Query: 815 AMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
                 TS +D +S+G+V  E++S G+       N+D +  ++  Y L
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRL 242

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           +G G FG V  G L         +A+K L    + +  R+F+ E  ++    HPN++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   +++V EYM+N  L   +   D ++  ++L    R     GI+ G+ YL   S
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLR-----GISAGMKYL---S 141
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFGL+++ E+D     T   G I   + APE    
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E+VS G+       N+D +  ++  Y L
Sbjct: 202 RKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRL 246

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 112/204 (54%), Gaps = 23/204 (11%)
Query: 646 VGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 699
           +G G FG+VYKGI + DG      +A+K L  + S + N+E ++E  +++    P + +L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTRKKICIGIARGLAYL 755
            G C+    + LV + M   CL   +  ++   RL     L+W      C+ IA+G++YL
Sbjct: 85  LGICLTST-VQLVTQLMPYGCLLDHV--RENRGRLGSQDLLNW------CMQIAKGMSYL 135
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEY 814
            +   +++VHRD+   NVL+    + KI+DFGLA+L + D+T          I +MA E 
Sbjct: 136 ED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 815 AMRGYLTSKADVYSFGVVTLEIVS 838
            +R   T ++DV+S+GV   E+++
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 118/227 (51%), Gaps = 19/227 (8%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 700
           +G G FG V  G L         +A+K L S  + +  R+F++E  ++    HPN++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   ++++ E+M+N  L   +   D ++  ++L    R     GIA G+ YL +  
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLAD-- 153
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH--ISTRIAGTIG--YMAPEYA 815
            +  VHRD+   N+L++ +L  K+SDFGL++  E+D +    ++ + G I   + APE  
Sbjct: 154 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 212
Query: 816 MRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
                TS +DV+S+G+V  E++S G+       N+D +  ++  Y L
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL 259

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 120/237 (50%), Gaps = 29/237 (12%)
Query: 620 GLDLQT-GLY--TLRQIKAATNNFDPAN------KVGEGGFGSVYKGILSDGTVIAV-KQ 669
           G+DL T  LY  +++Q +  T + +P +      ++G+G FG VYK    + +V+A  K 
Sbjct: 10  GVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV 69
Query: 670 LSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD 729
           + +KS +   +++ EI ++++  HPN+VKL       N L ++ E+    C   A+    
Sbjct: 70  IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF----CAGGAVDAVM 125
Query: 730 TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 789
            E    L     + +C      L YLH++   KI+HRD+K  N+L   D + K++DFG++
Sbjct: 126 LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182
Query: 790 KLYEEDKTHISTR--IAGTIGYMAPEYAM------RGYLTSKADVYSFGVVTLEIVS 838
               ++   I  R    GT  +MAPE  M      R Y   KADV+S G+  +E+  
Sbjct: 183 A---KNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAE 235

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 120/237 (50%), Gaps = 29/237 (12%)
Query: 620 GLDLQT-GLY--TLRQIKAATNNFDPAN------KVGEGGFGSVYKGILSDGTVIAV-KQ 669
           G+DL T  LY  +++Q +  T + +P +      ++G+G FG VYK    + +V+A  K 
Sbjct: 10  GVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV 69
Query: 670 LSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD 729
           + +KS +   +++ EI ++++  HPN+VKL       N L ++ E+    C   A+    
Sbjct: 70  IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF----CAGGAVDAVM 125
Query: 730 TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 789
            E    L     + +C      L YLH++   KI+HRD+K  N+L   D + K++DFG++
Sbjct: 126 LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182
Query: 790 KLYEEDKTHISTR--IAGTIGYMAPEYAM------RGYLTSKADVYSFGVVTLEIVS 838
               ++   I  R    GT  +MAPE  M      R Y   KADV+S G+  +E+  
Sbjct: 183 A---KNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAE 235

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 114/221 (51%), Gaps = 17/221 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
           +++G+G FGSV    Y  +  + G ++AVKQL        R+F  EI ++ A     +VK
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 699 LYGCCV-EGNQ-LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G     G Q L LV EY+ + CL   +      +R +LD          I +G+ YL 
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYL- 130
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
             SR + VHRD+   N+L++ + + KI+DFGLAKL   DK +   R  G   I + APE 
Sbjct: 131 -GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 188
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 855
                 + ++DV+SFGVV  E+ +   + +  P+ +F+ ++
Sbjct: 189 LSDNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSAEFLRMM 228

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 120/237 (50%), Gaps = 29/237 (12%)
Query: 620 GLDLQT-GLY--TLRQIKAATNNFDPAN------KVGEGGFGSVYKGILSDGTVIAV-KQ 669
           G+DL T  LY  +++Q +  T + +P +      ++G+G FG VYK    + +V+A  K 
Sbjct: 10  GVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV 69
Query: 670 LSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD 729
           + +KS +   +++ EI ++++  HPN+VKL       N L ++ E+    C   A+    
Sbjct: 70  IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF----CAGGAVDAVM 125
Query: 730 TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 789
            E    L     + +C      L YLH++   KI+HRD+K  N+L   D + K++DFG++
Sbjct: 126 LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182
Query: 790 KLYEEDKTHISTR--IAGTIGYMAPEYAM------RGYLTSKADVYSFGVVTLEIVS 838
               ++   I  R    GT  +MAPE  M      R Y   KADV+S G+  +E+  
Sbjct: 183 A---KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAE 235

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 114/221 (51%), Gaps = 17/221 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
           +++G+G FGSV    Y  +  + G ++AVKQL        R+F  EI ++ A     +VK
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 699 LYGCCV-EGNQ-LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G     G Q L LV EY+ + CL   +      +R +LD          I +G+ YL 
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYL- 131
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
             SR + VHRD+   N+L++ + + KI+DFGLAKL   DK +   R  G   I + APE 
Sbjct: 132 -GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 189
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 855
                 + ++DV+SFGVV  E+ +   + +  P+ +F+ ++
Sbjct: 190 LSDNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSAEFLRMM 229

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 114/221 (51%), Gaps = 17/221 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
           +++G+G FGSV    Y  +  + G ++AVKQL        R+F  EI ++ A     +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 699 LYGCCV-EGNQ-LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G     G Q L LV EY+ + CL   +      +R +LD          I +G+ YL 
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYL- 143
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
             SR + VHRD+   N+L++ + + KI+DFGLAKL   DK +   R  G   I + APE 
Sbjct: 144 -GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 855
                 + ++DV+SFGVV  E+ +   + +  P+ +F+ ++
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSAEFLRMM 241

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 700
           +G G FG V  G L         +A+K L +  + +  R+F++E  ++    HPN++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   ++++ EYM+N  L   +   D  +  ++L    R     GI  G+ YL   S
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR-----GIGSGMKYL---S 148
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFG++++ E+D     T   G I   + APE    
Sbjct: 149 DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 208
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  ++  Y L
Sbjct: 209 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRL 253

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV    Y  +  + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C    +  L L+ EY+    L R    K  E   ++D     +    I +G+ YL 
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSL-RDYLQKHKE---RIDHIKLLQYTSQICKGMEYL- 130
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                + +HRD+ T N+L++ +   KI DFGL K+  +DK     +  G   I + APE 
Sbjct: 131 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 849
                 +  +DV+SFGVV  E+ +    +   P E
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 700
           +G G FG V  G L         +A+K L +  + +  R+F++E  ++    HPN++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   ++++ EYM+N  L   +   D  +  ++L    R     GI  G+ YL   S
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR-----GIGSGMKYL---S 127
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFG++++ E+D     T   G   I + APE    
Sbjct: 128 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  ++  Y L
Sbjct: 188 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRL 232

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 106/228 (46%), Gaps = 24/228 (10%)
Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVN 683
           L++I  +   F    ++GE  FG VYKG L           +A+K L  K+    RE   
Sbjct: 20  LKEISLSAVRF--MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 77
Query: 684 EIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK-----------DTE 731
              M+ A+ QHPN+V L G   +   L +++ Y  +  L   +  +           D  
Sbjct: 78  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 732 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK- 790
            +  L+ P    +   IA G+ YL   S   +VH+D+ T NVL+   LN KISD GL + 
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE 194
Query: 791 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +Y  D   +       I +MAPE  M G  +  +D++S+GVV  E+ S
Sbjct: 195 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 700
           +G G FG V  G L         +A+K L +  + +  R+F++E  ++    HPN++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   ++++ EYM+N  L   +   D  +  ++L    R     GI  G+ YL   S
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR-----GIGSGMKYL---S 133
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAMR 817
            +  VHRD+   N+L++ +L  K+SDFG++++ E+D     T   G   I + APE    
Sbjct: 134 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
              TS +DV+S+G+V  E++S G+       N+D +  ++  Y L
Sbjct: 194 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRL 238

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 79  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 131
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 132 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 188
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV    Y  +  + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C    +  L L+ EY+    L R    K  E   ++D     +    I +G+ YL 
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSL-RDYLQKHKE---RIDHIKLLQYTSQICKGMEYL- 129
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                + +HRD+ T N+L++ +   KI DFGL K+  +DK     +  G   I + APE 
Sbjct: 130 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 187
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 849
                 +  +DV+SFGVV  E+ +    +   P E
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 75  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV    Y  +  + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C    +  L L+ EY+    L R    K  E   ++D     +    I +G+ YL 
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSL-RDYLQKHKE---RIDHIKLLQYTSQICKGMEYL- 134
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                + +HRD+ T N+L++ +   KI DFGL K+  +DK     +  G   I + APE 
Sbjct: 135 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 192
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 849
                 +  +DV+SFGVV  E+ +    +   P E
Sbjct: 193 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 227

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV    Y  +  + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C    +  L L+ EY+    L R    K  E   ++D     +    I +G+ YL 
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSL-RDYLQKHKE---RIDHIKLLQYTSQICKGMEYL- 161
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                + +HRD+ T N+L++ +   KI DFGL K+  +DK     +  G   I + APE 
Sbjct: 162 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 219
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 849
                 +  +DV+SFGVV  E+ +    +   P E
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 254

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV    Y  +  + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C    +  L L+ EY+    L R    K  E   ++D     +    I +G+ YL 
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSL-RDYLQKHKE---RIDHIKLLQYTSQICKGMEYL- 130
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                + +HRD+ T N+L++ +   KI DFGL K+  +DK     +  G   I + APE 
Sbjct: 131 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 849
                 +  +DV+SFGVV  E+ +    +   P E
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 645 KVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+GEG  G V        G  +AVK++  + +Q      NE+ ++    H N+V +Y   
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           + G++L +V E+++   L+      D     +++      +C+ + R L+YLH      +
Sbjct: 112 LVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---V 162
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRDIK+ ++LL  D   K+SDFG      ++       + GT  +MAPE   R    ++
Sbjct: 163 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKXLVGTPYWMAPEVISRLPYGTE 221
Query: 824 ADVYSFGVVTLEIVSGK 840
            D++S G++ +E++ G+
Sbjct: 222 VDIWSLGIMVIEMIDGE 238

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 78  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 130
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 131 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 76  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 128
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 129 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 77  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 130 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV    Y  +  + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C    +  L L+ EY+    L R    K  E   ++D     +    I +G+ YL 
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSL-RDYLQKHKE---RIDHIKLLQYTSQICKGMEYL- 128
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                + +HRD+ T N+L++ +   KI DFGL K+  +DK     +  G   I + APE 
Sbjct: 129 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 186
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 849
                 +  +DV+SFGVV  E+ +    +   P E
Sbjct: 187 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 221

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 85  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 137
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 138 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 194
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 195 WMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV    Y  +  + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C    +  L L+ EY+    L R    K  E   ++D     +    I +G+ YL 
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSL-RDYLQKHKE---RIDHIKLLQYTSQICKGMEYL- 130
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                + +HRD+ T N+L++ +   KI DFGL K+  +DK     +  G   I + APE 
Sbjct: 131 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 849
                 +  +DV+SFGVV  E+ +    +   P E
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV    Y  +  + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C    +  L L+ EY+    L R    K  E   ++D     +    I +G+ YL 
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSL-RDYLQKHKE---RIDHIKLLQYTSQICKGMEYL- 135
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                + +HRD+ T N+L++ +   KI DFGL K+  +DK     +  G   I + APE 
Sbjct: 136 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 193
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 849
                 +  +DV+SFGVV  E+ +    +   P E
Sbjct: 194 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 228

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV    Y  +  + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C    +  L L+ EY+    L R    K  E   ++D     +    I +G+ YL 
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSL-RDYLQKHKE---RIDHIKLLQYTSQICKGMEYL- 148
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                + +HRD+ T N+L++ +   KI DFGL K+  +DK     +  G   I + APE 
Sbjct: 149 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 849
                 +  +DV+SFGVV  E+ +    +   P E
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 241

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV    Y  +  + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C    +  L L+ EY+    L R    K  E   ++D     +    I +G+ YL 
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSL-RDYLQKHKE---RIDHIKLLQYTSQICKGMEYL- 136
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                + +HRD+ T N+L++ +   KI DFGL K+  +DK     +  G   I + APE 
Sbjct: 137 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 194
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 849
                 +  +DV+SFGVV  E+ +    +   P E
Sbjct: 195 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 229

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV    Y  +  + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C    +  L L+ EY+    L R    K  E   ++D     +    I +G+ YL 
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSL-RDYLQKHKE---RIDHIKLLQYTSQICKGMEYL- 133
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                + +HRD+ T N+L++ +   KI DFGL K+  +DK     +  G   I + APE 
Sbjct: 134 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 849
                 +  +DV+SFGVV  E+ +    +   P E
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 226

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 16/215 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV    Y  +  + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C    +  L L+ EY+    L   +     +++ ++D     +    I +G+ YL 
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQICKGMEYL- 137
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                + +HRD+ T N+L++ +   KI DFGL K+  +DK     +  G   I + APE 
Sbjct: 138 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 195
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 849
                 +  +DV+SFGVV  E+ +    +   P E
Sbjct: 196 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 230

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 106/228 (46%), Gaps = 24/228 (10%)
Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVN 683
           L++I  +   F    ++GE  FG VYKG L           +A+K L  K+    RE   
Sbjct: 3   LKEISLSAVRF--MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 684 EIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK-----------DTE 731
              M+ A+ QHPN+V L G   +   L +++ Y  +  L   +  +           D  
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 732 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK- 790
            +  L+ P    +   IA G+ YL   S   +VH+D+ T NVL+   LN KISD GL + 
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 791 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +Y  D   +       I +MAPE  M G  +  +D++S+GVV  E+ S
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 78  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 130
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 131 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 81  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 133
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 134 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 190
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 191 WMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 77  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 130 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 112/221 (50%), Gaps = 17/221 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
           +++G+G FGSV    Y  +  + G ++AVKQL        R+F  EI ++ A     +VK
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 699 LYGCCVEGN--QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G        +L LV EY+ + CL   +      +R +LD          I +G+ YL 
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYL- 127
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
             SR + VHRD+   N+L++ + + KI+DFGLAKL   DK     R  G   I + APE 
Sbjct: 128 -GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPES 185
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 855
                 + ++DV+SFGVV  E+ +   + +  P+ +F+ ++
Sbjct: 186 LSDNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSAEFLRMM 225

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 78  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 130
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 131 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 69  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 121
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 122 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV    Y  +  + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C    +  L L+ EY+    L R    K  E   ++D     +    I +G+ YL 
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSL-RDYLQKHKE---RIDHIKLLQYTSQICKGMEYL- 148
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                + +HRD+ T N+L++ +   KI DFGL K+  +DK     +  G   I + APE 
Sbjct: 149 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 849
                 +  +DV+SFGVV  E+ +    +   P E
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 241

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 78  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 130
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 131 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 100 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 152
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 153 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 209
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 210 WMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 82  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 134
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 135 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 16/214 (7%)
Query: 645 KVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL 699
           ++G+G FGSV    Y  +  + G V+AVK+L   + +  R+F  EI ++ + QH N+VK 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 700 YGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
            G C    +  L L+ E++    L   +     +++ ++D     +    I +G+ YL  
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL----QKHKERIDHIKLLQYTSQICKGMEYL-- 133
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYA 815
               + +HRD+ T N+L++ +   KI DFGL K+  +DK     +  G   I + APE  
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 816 MRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 849
                +  +DV+SFGVV  E+ +    +   P E
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 226

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 16/215 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV    Y  +  + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C    +  L L+ EY+    L R    K  E   ++D     +    I +G+ YL 
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSL-RDYLQKHKE---RIDHIKLLQYTSQICKGMEYL- 131
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                + +HR++ T N+L++ +   KI DFGL K+  +DK +   +  G   I + APE 
Sbjct: 132 --GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 189
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 849
                 +  +DV+SFGVV  E+ +    +   P E
Sbjct: 190 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 224

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 117/227 (51%), Gaps = 19/227 (8%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 700
           +G G FG V  G L         +A+K L S  + +  R+F++E  ++    HPN++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 759
           G   +   ++++ E+M+N  L   +   D ++  ++L    R     GIA G+ YL +  
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLAD-- 127
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH--ISTRIAGTIG--YMAPEYA 815
            +  VHR +   N+L++ +L  K+SDFGL++  E+D +    ++ + G I   + APE  
Sbjct: 128 -MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 816 MRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
                TS +DV+S+G+V  E++S G+       N+D +  ++  Y L
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL 233

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 113/210 (53%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 72  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 124
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
            G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 125 EGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 181
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 182 WMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 93/194 (47%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           ++G G FG V  G       +A+K +   S   + EF+ E  ++    H  LV+LYG C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           +   + ++ EYM N CL   +     E R +       ++C  +   + YL      + +
Sbjct: 90  KQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 142
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD+   N L++     K+SDFGL++   +D+   S      + +  PE  M    +SK+
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 825 DVYSFGVVTLEIVS 838
           D+++FGV+  EI S
Sbjct: 203 DIWAFGVLMWEIYS 216

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 121/235 (51%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ YL
Sbjct: 97  GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT--IGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+ +Y+++   +  +      + +MA 
Sbjct: 149 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMAL 205
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 259

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 13/221 (5%)
Query: 623 LQTGLYTLRQIKAATNN-FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLS-SKSRQGNR 679
           +Q+GL  ++ +KA     F    K+G+G FG V+KGI +    V+A+K +   ++     
Sbjct: 6   VQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE 65
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWP 739
           +   EI ++S    P + K YG  ++  +L ++ EY+            D      LD  
Sbjct: 66  DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS------ALDLLEPGPLDET 119
Query: 740 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 799
               I   I +GL YLH + +I   HRDIK +NVLL +    K++DFG+A    + +   
Sbjct: 120 QIATILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK- 175
Query: 800 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
                GT  +MAPE   +    SKAD++S G+  +E+  G+
Sbjct: 176 RNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/235 (34%), Positives = 120/235 (51%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ +L
Sbjct: 103 GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKFL 154
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LY--EEDKTHISTRIAGTIGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+ +Y  E D  H  T     + +MA 
Sbjct: 155 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 211
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 265

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 16/215 (7%)
Query: 644 NKVGEGGFGSV----YKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV    Y  +  + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C    +  L L+ EY+    L R       E   ++D     +    I +G+ YL 
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSL-RDYLQAHAE---RIDHIKLLQYTSQICKGMEYL- 133
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                + +HRD+ T N+L++ +   KI DFGL K+  +DK     +  G   I + APE 
Sbjct: 134 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 849
                 +  +DV+SFGVV  E+ +    +   P E
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 226

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/235 (34%), Positives = 120/235 (51%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ +L
Sbjct: 98  GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LY--EEDKTHISTRIAGTIGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+ +Y  E D  H  T     + +MA 
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 260

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/235 (34%), Positives = 120/235 (51%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ +L
Sbjct: 157 GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LY--EEDKTHISTRIAGTIGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+ +Y  E D  H  T     + +MA 
Sbjct: 209 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 319

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/235 (34%), Positives = 120/235 (51%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ +L
Sbjct: 98  GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LY--EEDKTHISTRIAGTIGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+ +Y  E D  H  T     + +MA 
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 260

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/235 (34%), Positives = 120/235 (51%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ +L
Sbjct: 96  GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKFL 147
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LY--EEDKTHISTRIAGTIGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+ +Y  E D  H  T     + +MA 
Sbjct: 148 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 204
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 258

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
            ++G G FG V  G       +A+K +   S   + EF+ E  ++    H  LV+LYG C
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
            +   + ++ EYM N CL   +     E R +       ++C  +   + YL      + 
Sbjct: 73  TKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLESK---QF 125
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRD+   N L++     K+SDFGL++   +D+   S      + +  PE  M    +SK
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 185
Query: 824 ADVYSFGVVTLEIVS 838
           +D+++FGV+  EI S
Sbjct: 186 SDIWAFGVLMWEIYS 200

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/235 (34%), Positives = 120/235 (51%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ +L
Sbjct: 99  GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LY--EEDKTHISTRIAGTIGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+ +Y  E D  H  T     + +MA 
Sbjct: 151 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 207
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 261

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 93/194 (47%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           ++G G FG V  G       +A+K +   S   + EF+ E  ++    H  LV+LYG C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           +   + ++ EYM N CL   +     E R +       ++C  +   + YL      + +
Sbjct: 90  KQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 142
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD+   N L++     K+SDFGL++   +D+   S      + +  PE  M    +SK+
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 825 DVYSFGVVTLEIVS 838
           D+++FGV+  EI S
Sbjct: 203 DIWAFGVLMWEIYS 216

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/235 (33%), Positives = 121/235 (51%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ YL
Sbjct: 116 GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKYL 167
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED--KTHISTRIAGTIGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+ +Y+++    H  T     + +MA 
Sbjct: 168 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 224
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 225 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 278

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/235 (33%), Positives = 121/235 (51%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ YL
Sbjct: 117 GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKYL 168
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED--KTHISTRIAGTIGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+ +Y+++    H  T     + +MA 
Sbjct: 169 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 225
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 226 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 279

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 93/194 (47%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           ++G G FG V  G       +A+K +   S   + EF+ E  ++    H  LV+LYG C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           +   + ++ EYM N CL   +     E R +       ++C  +   + YL      + +
Sbjct: 75  KQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 127
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD+   N L++     K+SDFGL++   +D+   S      + +  PE  M    +SK+
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 825 DVYSFGVVTLEIVS 838
           D+++FGV+  EI S
Sbjct: 188 DIWAFGVLMWEIYS 201

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
            ++G G FG V  G       +A+K +   S   + EF+ E  ++    H  LV+LYG C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
            +   + ++ EYM N CL   +     E R +       ++C  +   + YL      + 
Sbjct: 69  TKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLESK---QF 121
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRD+   N L++     K+SDFGL++   +D+   S      + +  PE  M    +SK
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 824 ADVYSFGVVTLEIVS 838
           +D+++FGV+  EI S
Sbjct: 182 SDIWAFGVLMWEIYS 196

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/235 (33%), Positives = 121/235 (51%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ YL
Sbjct: 98  GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED--KTHISTRIAGTIGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+ +Y+++    H  T     + +MA 
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 260

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 113/210 (53%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+ +L  + S + N+E ++E  ++++ 
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 109 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 161
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 162 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 219 WMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 113/210 (53%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 79  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 131
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFG AKL   E+K + +      I 
Sbjct: 132 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 188
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
            ++G G FG V  G       +A+K +   S   + EF+ E  ++    H  LV+LYG C
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
            +   + ++ EYM N CL   +     E R +       ++C  +   + YL      + 
Sbjct: 80  TKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLESK---QF 132
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRD+   N L++     K+SDFGL++   +D+   S      + +  PE  M    +SK
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 192
Query: 824 ADVYSFGVVTLEIVS 838
           +D+++FGV+  EI S
Sbjct: 193 SDIWAFGVLMWEIYS 207

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/235 (33%), Positives = 121/235 (51%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ YL
Sbjct: 90  GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKYL 141
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED--KTHISTRIAGTIGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+ +Y+++    H  T     + +MA 
Sbjct: 142 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 198
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 199 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 252

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 113/210 (53%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 77  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFG AKL   E+K + +      I 
Sbjct: 130 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 113/210 (53%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +  G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 82  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 134
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 135 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
            ++G G FG V  G       +A+K +   S   + EF+ E  ++    H  LV+LYG C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
            +   + ++ EYM N CL   +     E R +       ++C  +   + YL      + 
Sbjct: 74  TKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLESK---QF 126
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRD+   N L++     K+SDFGL++   +D+   S      + +  PE  M    +SK
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSK 186
Query: 824 ADVYSFGVVTLEIVS 838
           +D+++FGV+  EI S
Sbjct: 187 SDIWAFGVLMWEIYS 201

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 113/210 (53%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +  G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 639 NFDPANKVGEGGFGSVYKG-ILSDGTVIAVKQ------LSSKSRQGNREFVNEIGMISAQ 691
           NF    K+G G F  VY+   L DG  +A+K+      + +K+R    + + EI ++   
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 89
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK--KICIGIA 749
            HPN++K Y   +E N+L +V E      LSR I     + RL    P R   K  + + 
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL---IPERTVWKYFVQLC 146
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
             L ++H  SR +++HRDIK +NV +      K+ D GL + +   KT  +  + GT  Y
Sbjct: 147 SALEHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYY 202
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           M+PE         K+D++S G +  E+ + +S
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/235 (33%), Positives = 121/235 (51%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ YL
Sbjct: 97  GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED--KTHISTRIAGTIGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+ +Y+++    H  T     + +MA 
Sbjct: 149 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 205
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 259

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/235 (33%), Positives = 121/235 (51%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ YL
Sbjct: 95  GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKYL 146
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED--KTHISTRIAGTIGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+ +Y+++    H  T     + +MA 
Sbjct: 147 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 203
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 257

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/235 (33%), Positives = 121/235 (51%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ YL
Sbjct: 98  GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED--KTHISTRIAGTIGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+ +Y+++    H  T     + +MA 
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 260

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/235 (33%), Positives = 121/235 (51%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ YL
Sbjct: 96  GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKYL 147
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED--KTHISTRIAGTIGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+ +Y+++    H  T     + +MA 
Sbjct: 148 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 204
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 258

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 113/210 (53%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 77  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFG AKL   E+K + +      I 
Sbjct: 130 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/235 (33%), Positives = 121/235 (51%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ YL
Sbjct: 93  GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED--KTHISTRIAGTIGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+ +Y+++    H  T     + +MA 
Sbjct: 145 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 255

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/235 (33%), Positives = 118/235 (50%), Gaps = 28/235 (11%)
Query: 646 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           +G G FG VY G L  +DG  I  AVK L+  +  G   +F+ E  ++    HPN++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G C+  EG+ L+ V  YMK+  L   I       R +   PT K +    + +A+G+ +L
Sbjct: 99  GICLRSEGSPLV-VLPYMKHGDLRNFI-------RNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY---EEDKTHISTRIAGTIGYMAP 812
              +  K VHRD+   N +LD+    K++DFGLA+     E D  H  T     + +MA 
Sbjct: 151 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMAL 207
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 864
           E       T+K+DV+SFGV+  E+++ +    Y     F   VYLL    +LQ E
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 261

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 12/208 (5%)
Query: 638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 694
            NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    HP
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GLA+
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H     +++HRD+K  N+L++ +   K++DFGLA+ +        T    T+ Y APE 
Sbjct: 126 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEI 181
Query: 815 AM-RGYLTSKADVYSFGVVTLEIVSGKS 841
            +   Y ++  D++S G +  E+V+ ++
Sbjct: 182 LLGXKYYSTAVDIWSLGCIFAEMVTRRA 209

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 113/210 (53%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +  G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 82  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 134
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I 
Sbjct: 135 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 113/210 (53%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 77  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFG AKL   E+K + +      I 
Sbjct: 130 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 113/211 (53%), Gaps = 21/211 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD---TEYRLKLDWPTRKKICIGI 748
            +P++ +L G C+     L++        L      KD   ++Y L  +W      C+ I
Sbjct: 76  DNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLL--NW------CVQI 127
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTI 807
           A+G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I
Sbjct: 128 AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            +MA E  +    T ++DV+S+GV   E+++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 113/210 (53%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFG AKL   E+K + +      I 
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 184
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 98/194 (50%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G G FG V+    +  T +AVK +   S      F+ E  ++   QH  LVKL+   V
Sbjct: 22  KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV-V 79
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
               + ++ E+M    L    F K  E   K   P        IA G+A++ + + I   
Sbjct: 80  TKEPIYIITEFMAKGSLLD--FLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNYI--- 133
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+   L  KI+DFGLA++ E+++          I + APE    G  T K+
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 193
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++ +EIV+
Sbjct: 194 DVWSFGILLMEIVT 207

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 12/208 (5%)
Query: 638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 694
            NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GLA+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H     +++HRD+K  N+L++ +   K++DFGLA+ +        T    T+ Y APE 
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEI 174
Query: 815 AM-RGYLTSKADVYSFGVVTLEIVSGKS 841
            +   Y ++  D++S G +  E+V+ ++
Sbjct: 175 LLGXKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 113/214 (52%), Gaps = 19/214 (8%)
Query: 640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLV 697
           F    ++G+G FG V+KGI +    V+A+K +   ++     +   EI ++S      + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 698 KLYGCCVEGNQLLLVYEYMKNNC---LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           K YG  ++G++L ++ EY+       L RA  G   E+++         +   I +GL Y
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRA--GPFDEFQIA-------TMLKEILKGLDY 135
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
           LH + +I   HRDIK +NVLL +  + K++DFG+A    + +   +T + GT  +MAPE 
Sbjct: 136 LHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEV 191
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK-SNTNYRP 847
             +    SKAD++S G+  +E+  G+  N++  P
Sbjct: 192 IQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP 225

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 111/225 (49%), Gaps = 16/225 (7%)
Query: 627 LYTLRQIKAATNNFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQGNR- 679
           +Y   + + A      + ++G+G FG VY    KG++ D   T +A+K ++  +    R 
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
           EF+NE  ++      ++V+L G   +G   L++ E M    L   +     + E    L 
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 738 WPTRKKICI---GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYE 793
            P+  K+      IA G+AYL+ +   K VHRD+   N ++ +D   KI DFG+ + +YE
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            D      +    + +M+PE    G  T+ +DV+SFGVV  EI +
Sbjct: 191 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 113/210 (53%), Gaps = 19/210 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 749
            +P++ +L G C+    + L+ + M   CL   +     +   +  L+W      C+ IA
Sbjct: 82  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 134
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
           +G+ YL ED R+  VHRD+   NVL+    + KI+DFG AKL   E+K + +      I 
Sbjct: 135 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 191
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MA E  +    T ++DV+S+GV   E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 111/225 (49%), Gaps = 16/225 (7%)
Query: 627 LYTLRQIKAATNNFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQGNR- 679
           +Y   + + A      + ++G+G FG VY    KG++ D   T +A+K ++  +    R 
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
           EF+NE  ++      ++V+L G   +G   L++ E M    L   +     + E    L 
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 738 WPTRKKICI---GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYE 793
            P+  K+      IA G+AYL+ +   K VHRD+   N ++ +D   KI DFG+ + +YE
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            D      +    + +M+PE    G  T+ +DV+SFGVV  EI +
Sbjct: 184 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI + +   H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 66  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 112/211 (53%), Gaps = 21/211 (9%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQ 691
             F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++E  ++++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD---TEYRLKLDWPTRKKICIGI 748
            +P++ +L G C+     L+         L      KD   ++Y L  +W      C+ I
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLL--NW------CVQI 126
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTI 807
           A+G+ YL ED R+  VHRD+   NVL+    + KI+DFGLAKL   E+K + +      I
Sbjct: 127 AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            +MA E  +    T ++DV+S+GV   E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 111/225 (49%), Gaps = 16/225 (7%)
Query: 627 LYTLRQIKAATNNFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQGNR- 679
           +Y   + + A      + ++G+G FG VY    KG++ D   T +A+K ++  +    R 
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 67
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
           EF+NE  ++      ++V+L G   +G   L++ E M    L   +     + E    L 
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 738 WPTRKKICI---GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYE 793
            P+  K+      IA G+AYL+ +   K VHRD+   N ++ +D   KI DFG+ + +YE
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 184
Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            D      +    + +M+PE    G  T+ +DV+SFGVV  EI +
Sbjct: 185 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 12/208 (5%)
Query: 638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 694
            NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    HP
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GLA+
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H     +++HRD+K  N+L++ +   K++DFGLA+ +        T    T+ Y APE 
Sbjct: 126 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEI 181
Query: 815 AMR-GYLTSKADVYSFGVVTLEIVSGKS 841
            +   Y ++  D++S G +  E+V+ ++
Sbjct: 182 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 209

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 12/208 (5%)
Query: 638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 694
            NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GLA+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H     +++HRD+K  N+L++ +   K++DFGLA+ +        T    T+ Y APE 
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEI 173
Query: 815 AMR-GYLTSKADVYSFGVVTLEIVSGKS 841
            +   Y ++  D++S G +  E+V+ ++
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 117
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +        T    T+ Y AP
Sbjct: 118 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAP 173
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 116/219 (52%), Gaps = 16/219 (7%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           + ++G G FG+VYKG       + + ++   + +  + F NE+ ++   +H N++   G 
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL--KLDWPTRKKICIGIARGLAYLHEDSR 760
             + N L +V ++ + + L + +  ++T++++   +D      I    A+G+ YLH  + 
Sbjct: 101 MTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMFQLID------IARQTAQGMDYLHAKN- 152
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE-DKTHISTRIAGTIGYMAPEYAM--- 816
             I+HRD+K++N+ L + L  KI DFGLA +      +    +  G++ +MAPE      
Sbjct: 153 --IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQD 210
Query: 817 RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 855
               + ++DVYS+G+V  E+++G+   ++  N D +  +
Sbjct: 211 NNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM 249

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 111/225 (49%), Gaps = 16/225 (7%)
Query: 627 LYTLRQIKAATNNFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQGNR- 679
           +Y   + + A      + ++G+G FG VY    KG++ D   T +A+K ++  +    R 
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
           EF+NE  ++      ++V+L G   +G   L++ E M    L   +     + E    L 
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 738 WPTRKKICI---GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYE 793
            P+  K+      IA G+AYL+ +   K VHRD+   N ++ +D   KI DFG+ + +YE
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            D      +    + +M+PE    G  T+ +DV+SFGVV  EI +
Sbjct: 184 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 12/208 (5%)
Query: 638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 694
            NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GLA+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H     +++HRD+K  N+L++ +   K++DFGLA+ +        T    T+ Y APE 
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEI 174
Query: 815 AMR-GYLTSKADVYSFGVVTLEIVSGKS 841
            +   Y ++  D++S G +  E+V+ ++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 12/208 (5%)
Query: 638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 694
            NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GLA+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H     +++HRD+K  N+L++ +   K++DFGLA+ +        T    T+ Y APE 
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEI 173
Query: 815 AMR-GYLTSKADVYSFGVVTLEIVSGKS 841
            +   Y ++  D++S G +  E+V+ ++
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 66  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 12/208 (5%)
Query: 638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 694
            NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    HP
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GLA+
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H     +++HRD+K  N+L++ +   K++DFGLA+ +        T    T+ Y APE 
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEI 178
Query: 815 AMR-GYLTSKADVYSFGVVTLEIVSGKS 841
            +   Y ++  D++S G +  E+V+ ++
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 206

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 12/208 (5%)
Query: 638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 694
            NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GLA+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H     +++HRD+K  N+L++ +   K++DFGLA+ +        T    T+ Y APE 
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEI 174
Query: 815 AMR-GYLTSKADVYSFGVVTLEIVSGKS 841
            +   Y ++  D++S G +  E+V+ ++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 65  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 111/225 (49%), Gaps = 16/225 (7%)
Query: 627 LYTLRQIKAATNNFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQGNR- 679
           +Y   + + A      + ++G+G FG VY    KG++ D   T +A+K ++  +    R 
Sbjct: 36  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 95
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
           EF+NE  ++      ++V+L G   +G   L++ E M    L   +     + E    L 
Sbjct: 96  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 738 WPTRKKICI---GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYE 793
            P+  K+      IA G+AYL+ +   K VHRD+   N ++ +D   KI DFG+ + +YE
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 212
Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            D      +    + +M+PE    G  T+ +DV+SFGVV  EI +
Sbjct: 213 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 66  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 66  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 65  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 65  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 65  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 65  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 64  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 119 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 65  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 65  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 66  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 65  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 65  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 98/194 (50%), Gaps = 8/194 (4%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           K+G G FG V+    +  T +AVK +   S      F+ E  ++   QH  LVKL+   V
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLH-AVV 252
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
               + ++ E+M    L    F K  E   K   P        IA G+A++ + + I   
Sbjct: 253 TKEPIYIITEFMAKGSLLD--FLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNYI--- 306
Query: 765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 824
           HRD++ +N+L+   L  KI+DFGLA++ E+++          I + APE    G  T K+
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 825 DVYSFGVVTLEIVS 838
           DV+SFG++ +EIV+
Sbjct: 367 DVWSFGILLMEIVT 380

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 116
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 172
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  +  +      D      +  P  K     + +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFM----DASALTGIPLPLIKSYLFQLLQGL 119
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 175
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 120
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 121 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 176
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 206

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 119
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 175
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 118
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 174
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 66  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 66  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 66  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 65  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 118
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 119 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 174
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 118
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 174
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG +G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 65  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 116
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 172
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 645 KVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLV 697
           ++G+G FG VY+G   D       T +AVK ++  +    R EF+NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRK---KICIGIARGL 752
           +L G   +G   L+V E M +  L   +     + E       PT +   ++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMA 811
           AYL+     K VHRD+   N ++  D   KI DFG+ + +YE D      +    + +MA
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVS 838
           PE    G  T+ +D++SFGVV  EI S
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 116
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 172
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 117
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 118 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 173
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 117
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 118 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 173
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 119
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 175
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 12/208 (5%)
Query: 638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 694
            NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GLA+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y APE 
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEI 173
Query: 815 AMR-GYLTSKADVYSFGVVTLEIVSGKS 841
            +   Y ++  D++S G +  E+V+ ++
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 12/208 (5%)
Query: 638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 694
            NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GLA+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y APE 
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEI 173
Query: 815 AMR-GYLTSKADVYSFGVVTLEIVSGKS 841
            +   Y ++  D++S G +  E+V+ ++
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 12/208 (5%)
Query: 638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 694
            NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VKL       N+L LV+E++  +  +      D      +  P  K     + +GLA+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDLKTFM----DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H     +++HRD+K  N+L++ +   K++DFGLA+ +        T    T+ Y APE 
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEI 173
Query: 815 AMR-GYLTSKADVYSFGVVTLEIVSGKS 841
            +   Y ++  D++S G +  E+V+ ++
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQ 691
           +     +    KVGEG +G VYK   S G ++A+K+  L ++        + EI ++   
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
            HPN+V L         L LV+E+M+ + L + +     E +  L     K     + RG
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL----DENKTGLQDSQIKIYLYQLLRG 131
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           +A+ H+    +I+HRD+K  N+L++ D   K++DFGLA+ +       +  +  T+ Y A
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRA 187
Query: 812 PEYAM--RGYLTSKADVYSFGVVTLEIVSGK 840
           P+  M  + Y TS  D++S G +  E+++GK
Sbjct: 188 PDVLMGSKKYSTS-VDIWSIGCIFAEMITGK 217

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 12/208 (5%)
Query: 638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 694
            NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    HP
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GLA+
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y APE 
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEI 175
Query: 815 AMR-GYLTSKADVYSFGVVTLEIVSGKS 841
            +   Y ++  D++S G +  E+V+ ++
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 16/218 (7%)
Query: 634 KAATNNFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQGNR-EFVNEIG 686
           + A      + ++G+G FG VY    KG++ D   T +A+K ++  +    R EF+NE  
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 71
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKI 744
           ++      ++V+L G   +G   L++ E M    L   +     + E    L  P+  K+
Sbjct: 72  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 131
Query: 745 CI---GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIS 800
                 IA G+AYL+ +   K VHRD+   N ++ +D   KI DFG+ + +YE D     
Sbjct: 132 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 188
Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            +    + +M+PE    G  T+ +DV+SFGVV  EI +
Sbjct: 189 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 16/218 (7%)
Query: 634 KAATNNFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQGNR-EFVNEIG 686
           + A      + ++G+G FG VY    KG++ D   T +A+K ++  +    R EF+NE  
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKI 744
           ++      ++V+L G   +G   L++ E M    L   +     + E    L  P+  K+
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 745 CI---GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIS 800
                 IA G+AYL+ +   K VHRD+   N ++ +D   KI DFG+ + +YE D     
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            +    + +M+PE    G  T+ +DV+SFGVV  EI +
Sbjct: 185 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 116
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 172
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQ 691
           +     +    KVGEG +G VYK   S G ++A+K+  L ++        + EI ++   
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
            HPN+V L         L LV+E+M+ + L + +     E +  L     K     + RG
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL----DENKTGLQDSQIKIYLYQLLRG 131
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           +A+ H+    +I+HRD+K  N+L++ D   K++DFGLA+ +       +  +  T+ Y A
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRA 187
Query: 812 PEYAM--RGYLTSKADVYSFGVVTLEIVSGK 840
           P+  M  + Y TS  D++S G +  E+++GK
Sbjct: 188 PDVLMGSKKYSTS-VDIWSIGCIFAEMITGK 217

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 645 KVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLV 697
           ++G+G FG VY+G   D       T +AVK ++  +    R EF+NE  ++      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRK---KICIGIARGL 752
           +L G   +G   L+V E M +  L   +     + E       PT +   ++   IA G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMA 811
           AYL+     K VHRD+   N ++  D   KI DFG+ + +YE D      +    + +MA
Sbjct: 143 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 199
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVS 838
           PE    G  T+ +D++SFGVV  EI S
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  +         D      +  P  K     + +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFM----DASALTGIPLPLIKSYLFQLLQGL 116
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 117 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 172
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 12/208 (5%)
Query: 638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 694
            NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL++
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGLSF 118
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H     +++HRD+K  N+L++ +   K++DFGLA+ +        T    T+ Y APE 
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEI 174
Query: 815 AMR-GYLTSKADVYSFGVVTLEIVSGKS 841
            +   Y ++  D++S G +  E+V+ ++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 110/225 (48%), Gaps = 16/225 (7%)
Query: 627 LYTLRQIKAATNNFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQGNR- 679
           +Y   + + A      + ++G+G FG VY    KG++ D   T +A+K ++  +    R 
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 60
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
           EF+NE  ++      ++V+L G   +G   L++ E M    L   +     + E    L 
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 738 WPTRKKICI---GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYE 793
            P+  K+      IA G+AYL+ +   K VHRD+   N  + +D   KI DFG+ + +YE
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYE 177
Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            D      +    + +M+PE    G  T+ +DV+SFGVV  EI +
Sbjct: 178 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLV 697
           F    K+G+G FG V+KGI +    V+A+K +   ++     +   EI ++S    P + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           K YG  ++  +L ++ EY+            D      LD      I   I +GL YLH 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS------ALDLLEPGPLDETQIATILREILKGLDYLHS 122
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
           + +I   HRDIK +NVLL +    K++DFG+A    + +   +T   GT  +MAPE   +
Sbjct: 123 EKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQ 178
Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
               SKAD++S G+  +E+  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 12/203 (5%)
Query: 640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLV 697
           F    K+G+G FG V+KGI +    V+A+K +   ++     +   EI ++S    P + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           K YG  ++  +L ++ EY+            D      LD      I   I +GL YLH 
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGS------ALDLLEPGPLDETQIATILREILKGLDYLHS 142
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
           + +I   HRDIK +NVLL +    K++DFG+A    + +   +T + GT  +MAPE   +
Sbjct: 143 EKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 198
Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
               SKAD++S G+  +E+  G+
Sbjct: 199 SAYDSKADIWSLGITAIELARGE 221

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 119
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 120 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 175
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 117
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 118 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 173
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 110/225 (48%), Gaps = 16/225 (7%)
Query: 627 LYTLRQIKAATNNFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQGNR- 679
           +Y   + + A      + ++G+G FG VY    KG++ D   T +A+K ++  +    R 
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 67
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
           EF+NE  ++      ++V+L G   +G   L++ E M    L   +     + E    L 
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 738 WPTRKKICI---GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYE 793
            P+  K+      IA G+AYL+ +   K VHRD+   N ++ +D   KI DFG+ + + E
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 184
Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            D      +    + +M+PE    G  T+ +DV+SFGVV  EI +
Sbjct: 185 TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  +         D      +  P  K     + +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFM----DASALTGIPLPLIKSYLFQLLQGL 119
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 175
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 12/208 (5%)
Query: 638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 694
            NF    K+GEG +G VYK      G V+A+   +L +++       + EI ++    HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GLA+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H     +++HRD+K  N+L++ +   K++DFGLA+ +        T    T+ Y APE 
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEI 174
Query: 815 AMR-GYLTSKADVYSFGVVTLEIVSGKS 841
            +   Y ++  D++S G +  E+V+ ++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 695
           F    ++G G FG+VY    + +  V+A+K++S   +Q N   ++ + E+  +   +HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
            ++  GC +  +   LV EY    CL  A    +  ++  L       +  G  +GLAYL
Sbjct: 116 TIQYRGCYLREHTAWLVMEY----CLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYL 170
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
           H  +   ++HRD+K  N+LL +    K+ DFG A +        +    GT  +MAPE  
Sbjct: 171 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANXFVGTPYWMAPEVI 222
Query: 816 M---RGYLTSKADVYSFGVVTLEIVSGK 840
           +    G    K DV+S G+  +E+   K
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERK 250

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 12/208 (5%)
Query: 638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 694
            NF    K+GEG +G VYK      G V+A+   +L +++       + EI ++    HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GLA+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H     +++HRD+K  N+L++ +   K++DFGLA+ +        T    T+ Y APE 
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEI 173
Query: 815 AMR-GYLTSKADVYSFGVVTLEIVSGKS 841
            +   Y ++  D++S G +  E+V+ ++
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  + L + +   D      +  P  K     + +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 119
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 175
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQ 692
           +  NF    K+GEG +G VYK      G V+A+K  +L +++       + EI ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+VKL       N+L LV+E++  +         D      +  P  K     + +GL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFM----DASALTGIPLPLIKSYLFQLLQGL 118
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           A+ H     +++HRD+K  N+L++ +   K++DFGLA+ +          +  T+ Y AP
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 174
Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +   Y ++  D++S G +  E+V+ ++
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 113/232 (48%), Gaps = 29/232 (12%)
Query: 624 QTGLYTL--RQIKAATNNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGNRE 680
           QTG  T+  ++ +A  N+ +   ++G G  G V+K      G VIAVKQ+    R GN+E
Sbjct: 9   QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKE 65
Query: 681 FVNEIGM-----ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK 735
               I M     + +   P +V+ +G  +    + +  E M   C  +       + R++
Sbjct: 66  ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEK------LKKRMQ 118
Query: 736 LDWPTR--KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 793
              P R   K+ + I + L YL E  +  ++HRD+K SN+LLD+    K+ DFG++    
Sbjct: 119 GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176
Query: 794 EDKTHISTRIAGTIGYMAPEY-----AMRGYLTSKADVYSFGVVTLEIVSGK 840
           +DK     R AG   YMAPE        +     +ADV+S G+  +E+ +G+
Sbjct: 177 DDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 695
           F    ++G G FG+VY    + +  V+A+K++S   +Q N   ++ + E+  +   +HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
            ++  GC +  +   LV EY    CL  A    +  ++  L       +  G  +GLAYL
Sbjct: 77  TIQYRGCYLREHTAWLVMEY----CLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYL 131
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
           H  +   ++HRD+K  N+LL +    K+ DFG A +        +    GT  +MAPE  
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANXFVGTPYWMAPEVI 183
Query: 816 M---RGYLTSKADVYSFGVVTLEIVSGK 840
           +    G    K DV+S G+  +E+   K
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERK 211

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 645 KVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLV 697
           ++G+G FG VY+G   D       T +AVK ++  +    R EF+NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRK---KICIGIARGL 752
           +L G   +G   L+V E M +  L   +     + E       PT +   ++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMA 811
           AYL+     K VHRD+   N ++  D   KI DFG+ + + E D      +    + +MA
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVS 838
           PE    G  T+ +D++SFGVV  EI S
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 645 KVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLV 697
           ++G+G FG VY+G   D       T +AVK ++  +    R EF+NE  ++      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRK---KICIGIARGL 752
           +L G   +G   L+V E M +  L   +     + E       PT +   ++   IA G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMA 811
           AYL+     K VHR++   N ++  D   KI DFG+ + +YE D      +    + +MA
Sbjct: 145 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 201
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVS 838
           PE    G  T+ +D++SFGVV  EI S
Sbjct: 202 PESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHP 694
             ++D    +GEG  G V   +       +AVK +  K      E +  EI +     H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+VK YG   EGN   L  EY    C    +F +  E  + +  P  ++    +  G+ Y
Sbjct: 65  NVVKFYGHRREGNIQYLFLEY----CSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE 813
           LH    I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 814 -YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               R +     DV+S G+V   +++G+
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 645 KVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLV 697
           ++G+G FG VY+G   D       T +AVK ++  +    R EF+NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRK---KICIGIARGL 752
           +L G   +G   L+V E M +  L   +     + E       PT +   ++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMA 811
           AYL+     K VHR++   N ++  D   KI DFG+ + +YE D      +    + +MA
Sbjct: 144 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVS 838
           PE    G  T+ +D++SFGVV  EI S
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 645 KVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLV 697
           ++G+G FG VY+G   D       T +AVK ++  +    R EF+NE  ++      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRK---KICIGIARGL 752
           +L G   +G   L+V E M +  L   +     + E       PT +   ++   IA G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMA 811
           AYL+     K VHRD+   N ++  D   KI DFG+ + + E D      +    + +MA
Sbjct: 141 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVS 838
           PE    G  T+ +D++SFGVV  EI S
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 645 KVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLV 697
           ++G+G FG VY+G   D       T +AVK ++  +    R EF+NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRK---KICIGIARGL 752
           +L G   +G   L+V E M +  L   +     + E       PT +   ++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMA 811
           AYL+     K VHRD+   N ++  D   KI DFG+ + + E D      +    + +MA
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVS 838
           PE    G  T+ +D++SFGVV  EI S
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 16/218 (7%)
Query: 634 KAATNNFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQGNR-EFVNEIG 686
           + A      + ++G+G FG VY    KG++ D   T +A+K ++  +    R EF+NE  
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKI 744
           ++      ++V+L G   +G   L++ E M    L   +     + E    L  P+  K+
Sbjct: 66  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 745 CI---GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIS 800
                 IA G+AYL+ +   K VHRD+   N ++ +D   KI DFG+ + + E D     
Sbjct: 126 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 182
Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            +    + +M+PE    G  T+ +DV+SFGVV  EI +
Sbjct: 183 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 640 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLV 697
           F    K+G+G FG V+KGI +    V+A+K +   ++     +   EI ++S    P + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           K YG  ++  +L ++ EY+            D      LD      I   I +GL YLH 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS------ALDLLEPGPLDETQIATILREILKGLDYLHS 122
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
           + +I   HRDIK +NVLL +    K++DFG+A    + +        GT  +MAPE   +
Sbjct: 123 EKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNXFVGTPFWMAPEVIKQ 178
Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
               SKAD++S G+  +E+  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 110/239 (46%), Gaps = 28/239 (11%)
Query: 618 LRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLS-S 672
            +G+ +  G+Y  ++      ++    K+G G +G V     K   S+  +  +K+    
Sbjct: 16  FQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFD 75
Query: 673 KSRQGN---------REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSR 723
           K R  +          E  NEI ++ +  HPN++KL+    +     LV E+ +   L  
Sbjct: 76  KGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE 135
Query: 724 AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LN 780
            I       R K D      I   I  G+ YLH+ +   IVHRDIK  N+LL+     LN
Sbjct: 136 QIIN-----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187
Query: 781 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            KI DFGL+  + +D   +  R+ GT  Y+APE   + Y   K DV+S GV+   ++ G
Sbjct: 188 IKIVDFGLSSFFSKD-YKLRDRL-GTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCG 243

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/236 (31%), Positives = 119/236 (50%), Gaps = 20/236 (8%)
Query: 646 VGEGGFGSVYKGIL--SDGTV--IAVK--QLSSKSRQGNREFVNEIGMISAQQHPNLVKL 699
           +GEG FGSV +G L   DGT   +AVK  +L + S++   EF++E   +    HPN+++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 700 YGCCVEGN-----QLLLVYEYMKNNCLSRAIFGKDTEYRLK-LDWPTRKKICIGIARGLA 753
            G C+E +     + +++  +MK   L   +     E   K +   T  K  + IA G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAP 812
           YL   S    +HRD+   N +L  D+   ++DFGL+K       +   RIA   + ++A 
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY---RPNEDFVYLLDWAYVLQEEE 865
           E       TSK+DV++FGV   EI + +  T Y   + +E + YLL    + Q E+
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIAT-RGMTPYPGVQNHEMYDYLLHGHRLKQPED 273

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 110/225 (48%), Gaps = 16/225 (7%)
Query: 627 LYTLRQIKAATNNFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQGNR- 679
           +Y   + + A      + ++G+G FG VY    KG++ D   T +A+K ++  +    R 
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKL 736
           EF+NE  ++      ++V+L G   +G   L++ E M    L    R++        +  
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 737 DWPTRKKICIG--IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYE 793
                K I +   IA G+AYL+ +   K VHRD+   N ++ +D   KI DFG+ + +YE
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            D      +    + +M+PE    G  T+ +DV+SFGVV  EI +
Sbjct: 191 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 9/213 (4%)
Query: 633 IKAATNNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLS--SKSRQGNREFVNEIGMIS 689
           + +   +++    +G G +G   K    SDG ++  K+L   S +    +  V+E+ ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 690 AQQHPNLVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 747
             +HPN+V+ Y   ++     L +V EY +   L+ ++  K T+ R  LD     ++   
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLA-SVITKGTKERQYLDEEFVLRVMTQ 119
Query: 748 IARGLAYLHE--DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
           +   L   H   D    ++HRD+K +NV LD   N K+ DFGLA++   D T  +    G
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKTFVG 178
Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           T  YM+PE   R     K+D++S G +  E+ +
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 9/213 (4%)
Query: 633 IKAATNNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLS--SKSRQGNREFVNEIGMIS 689
           + +   +++    +G G +G   K    SDG ++  K+L   S +    +  V+E+ ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 690 AQQHPNLVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 747
             +HPN+V+ Y   ++     L +V EY +   L+ ++  K T+ R  LD     ++   
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLA-SVITKGTKERQYLDEEFVLRVMTQ 119
Query: 748 IARGLAYLHE--DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
           +   L   H   D    ++HRD+K +NV LD   N K+ DFGLA++   D T  +    G
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVG 178
Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           T  YM+PE   R     K+D++S G +  E+ +
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 110/225 (48%), Gaps = 16/225 (7%)
Query: 627 LYTLRQIKAATNNFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQGNR- 679
           +Y   + + A      + ++G+G FG VY    KG++ D   T +A+K ++  +    R 
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 63
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKL 736
           EF+NE  ++      ++V+L G   +G   L++ E M    L    R++        +  
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 737 DWPTRKKICIG--IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYE 793
                K I +   IA G+AYL+ +   K VHRD+   N ++ +D   KI DFG+ + +YE
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 180
Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            D      +    + +M+PE    G  T+ +DV+SFGVV  EI +
Sbjct: 181 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 645 KVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLV 697
           ++G+G FG VY+G   D       T +AVK ++  +    R EF+NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRK---KICIGIARGL 752
           +L G   +G   L+V E M +  L   +     + E       PT +   ++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMA 811
           AYL+     K VHRD+   N ++  D   KI DFG+ + +YE        +    + +MA
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMA 200
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVS 838
           PE    G  T+ +D++SFGVV  EI S
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/232 (31%), Positives = 112/232 (48%), Gaps = 28/232 (12%)
Query: 640 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 697
           ++   ++G GGFG V + I  D G  +A+KQ   +    NRE +  EI ++    HPN+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 698 KLYGCC-----VEGNQL-LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
                      +  N L LL  EY +   L + +   +    LK + P R  +   I+  
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK-EGPIRT-LLSDISSA 133
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
           L YLHE+   +I+HRD+K  N++L    + L  KI D G AK  E D+  + T   GT+ 
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQ 188
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYV 860
           Y+APE   +   T   D +SFG +  E ++G     +RP     +L +W  V
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITG-----FRP-----FLPNWQPV 230

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/232 (31%), Positives = 112/232 (48%), Gaps = 28/232 (12%)
Query: 640 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 697
           ++   ++G GGFG V + I  D G  +A+KQ   +    NRE +  EI ++    HPN+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 698 KLYGCC-----VEGNQL-LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
                      +  N L LL  EY +   L + +   +    LK + P R  +   I+  
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK-EGPIRT-LLSDISSA 134
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
           L YLHE+   +I+HRD+K  N++L    + L  KI D G AK  E D+  + T   GT+ 
Sbjct: 135 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQ 189
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYV 860
           Y+APE   +   T   D +SFG +  E ++G     +RP     +L +W  V
Sbjct: 190 YLAPELLEQKKYTVTVDYWSFGTLAFECITG-----FRP-----FLPNWQPV 231

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 108/224 (48%), Gaps = 28/224 (12%)
Query: 631 RQIKAATNNFDP------ANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN 683
           R+ +    + DP        ++G+G FG VYK    + G + A K + +KS +   +++ 
Sbjct: 6   REYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV 65
Query: 684 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 743
           EI +++   HP +VKL G      +L ++ E+    C   A+     E    L  P  + 
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEF----CPGGAVDAIMLELDRGLTEPQIQV 121
Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA----KLYEEDKTHI 799
           +C  +   L +LH     +I+HRD+K  NVL+  + + +++DFG++    K  ++  + I
Sbjct: 122 VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI 178
Query: 800 STRIAGTIGYMAPEYAMRGYLTS-----KADVYSFGVVTLEIVS 838
                GT  +MAPE  M   +       KAD++S G+  +E+  
Sbjct: 179 -----GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ 217

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 98/193 (50%), Gaps = 14/193 (7%)
Query: 665 IAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC--- 720
           +A+K+++  K +    E + EI  +S   HPN+V  Y   V  ++L LV + +       
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 97
Query: 721 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 780
           + + I  K       LD  T   I   +  GL YLH++ +I   HRD+K  N+LL +D +
Sbjct: 98  IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGS 154
Query: 781 AKISDFGLAKLY----EEDKTHISTRIAGTIGYMAPEY--AMRGYLTSKADVYSFGVVTL 834
            +I+DFG++       +  +  +     GT  +MAPE    +RGY   KAD++SFG+  +
Sbjct: 155 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAI 213
Query: 835 EIVSGKSNTNYRP 847
           E+ +G +  +  P
Sbjct: 214 ELATGAAPYHKYP 226

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 9/213 (4%)
Query: 633 IKAATNNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLS--SKSRQGNREFVNEIGMIS 689
           + +   +++    +G G +G   K    SDG ++  K+L   S +    +  V+E+ ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 690 AQQHPNLVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 747
             +HPN+V+ Y   ++     L +V EY +   L+ ++  K T+ R  LD     ++   
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLA-SVITKGTKERQYLDEEFVLRVMTQ 119
Query: 748 IARGLAYLHE--DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
           +   L   H   D    ++HRD+K +NV LD   N K+ DFGLA++   D+   +    G
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED-FAKEFVG 178
Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           T  YM+PE   R     K+D++S G +  E+ +
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 98/193 (50%), Gaps = 14/193 (7%)
Query: 665 IAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC--- 720
           +A+K+++  K +    E + EI  +S   HPN+V  Y   V  ++L LV + +       
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 721 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 780
           + + I  K       LD  T   I   +  GL YLH++ +I   HRD+K  N+LL +D +
Sbjct: 103 IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGS 159
Query: 781 AKISDFGLAKLY----EEDKTHISTRIAGTIGYMAPEY--AMRGYLTSKADVYSFGVVTL 834
            +I+DFG++       +  +  +     GT  +MAPE    +RGY   KAD++SFG+  +
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAI 218
Query: 835 EIVSGKSNTNYRP 847
           E+ +G +  +  P
Sbjct: 219 ELATGAAPYHKYP 231

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGILSDGTV----IAVKQLSSKSRQGN---REFVNEIG 686
           K     +   +K+G GG  +VY   L++ T+    +A+K +    R+     + F  E+ 
Sbjct: 7   KIINERYKIVDKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVH 63
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 746
             S   H N+V +     E +   LV EY++   LS  I     E    L   T      
Sbjct: 64  NSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDTAINFTN 118
Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 806
            I  G+ + H+   ++IVHRDIK  N+L+D +   KI DFG+AK   E     +  + GT
Sbjct: 119 QILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGT 175
Query: 807 IGYMAPEYAMRGYLTSK-ADVYSFGVVTLEIVSGK 840
           + Y +PE A +G  T +  D+YS G+V  E++ G+
Sbjct: 176 VQYFSPEQA-KGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 104/221 (47%), Gaps = 43/221 (19%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQHPNLVKLY--- 700
           +G G +G+VYKG L D   +AVK  S  +RQ    F+NE  I  +   +H N+ +     
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIVGD 76
Query: 701 -GCCVEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH-- 756
                +G  + LLV EY  N  L + +    +      DW +  ++   + RGLAYLH  
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS------DWVSSCRLAHSVTRGLAYLHTE 130
Query: 757 ----EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA---------KLYEEDKTHISTRI 803
               +  +  I HRD+ + NVL+  D    ISDFGL+         +  EED   IS   
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE-- 188
Query: 804 AGTIGYMAPEYAMRGYLT--------SKADVYSFGVVTLEI 836
            GTI YMAPE  + G +          + D+Y+ G++  EI
Sbjct: 189 VGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 19/226 (8%)
Query: 622 DLQT--GLYTLRQIKAATNNFDPANKVGEGGFGSVY---KGILSDGTVIAVKQLSSKSRQ 676
           DLQ   G++   +    +  +    K+G G +G V      +      I + + +S S  
Sbjct: 19  DLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS 78
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKL 736
            N + + E+ ++    HPN++KLY    +     LV E  K   L   I      +R+K 
Sbjct: 79  SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII-----HRMKF 133
Query: 737 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYE 793
           +      I   +  G+ YLH+ +   IVHRD+K  N+LL   +KD   KI DFGL+ ++E
Sbjct: 134 NEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190
Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             K  +  R+ GT  Y+APE   + Y   K DV+S GV+   +++G
Sbjct: 191 NQKK-MKERL-GTAYYIAPEVLRKKY-DEKCDVWSIGVILFILLAG 233

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 110/214 (51%), Gaps = 16/214 (7%)
Query: 633 IKAATNNFDPANKVGEGGFGSVYKG-ILSDGTVIAVKQLSSKS--RQGNREFV-NEIGMI 688
           I     +F   N +G+G F  VY+   +  G  +A+K +  K+  + G  + V NE+ + 
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 689 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-LDWPTRKKICIG 747
              +HP++++LY    + N + LV E   N  ++R +     + R+K       +     
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL-----KNRVKPFSENEARHFMHQ 120
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGT 806
           I  G+ YLH      I+HRD+  SN+LL +++N KI+DFGLA +L    + H +  + GT
Sbjct: 121 IITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGT 175
Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
             Y++PE A R     ++DV+S G +   ++ G+
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 645 KVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           ++G+G FG VYK    + G + A K + +KS +   +++ EI +++   HP +VKL G  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
               +L ++ E+    C   A+     E    L  P  + +C  +   L +LH     +I
Sbjct: 78  YHDGKLWIMIEF----CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RI 130
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLA----KLYEEDKTHISTRIAGTIGYMAPEYAMRGY 819
           +HRD+K  NVL+  + + +++DFG++    K  ++  + I     GT  +MAPE  M   
Sbjct: 131 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCET 185
Query: 820 LTS-----KADVYSFGVVTLEIVS 838
           +       KAD++S G+  +E+  
Sbjct: 186 MKDTPYDYKADIWSLGITLIEMAQ 209

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 17/215 (7%)
Query: 638 NNFDPANKVGEGGFGSVYK----GILSDGTV--IAVKQLSSKSRQGNRE-FVNEIGMISA 690
           NN      +G G FG V +    G+  +  V  +AVK L S +    +E  ++E+ ++S 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 691 -QQHPNLVKLYGCCVEGNQLLLVYEY-----MKNNCLSRAIFGKDTEYRLKLDWPTRKKI 744
             QH N+V L G C  G  +L++ EY     + N    +A    D E    L+       
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 745 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA 804
              +A+G+A+L   +    +HRD+   NVLL     AKI DFGLA+    D  +I    A
Sbjct: 158 SSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 805 G-TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
              + +MAPE       T ++DV+S+G++  EI S
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 17/214 (7%)
Query: 640 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLV 697
           F   +++G+G FG VYKGI +    V+A+K +   ++     +   EI ++S    P + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           + +G  ++  +L ++ EY+            D      L+      I   I +GL YLH 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGS------ALDLLKPGPLEETYIATILREILKGLDYLHS 134
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
           + +I   HRDIK +NVLL +  + K++DFG+A    + +        GT  +MAPE   +
Sbjct: 135 ERKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-RNXFVGTPFWMAPEVIKQ 190
Query: 818 GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF 851
                KAD++S G+  +E+  G+      PN D 
Sbjct: 191 SAYDFKADIWSLGITAIELAKGEP-----PNSDL 219

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 107/222 (48%), Gaps = 31/222 (13%)
Query: 636 ATNNFDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNREF--VNEIGMI--- 688
           A   ++   ++GEG +G V+K   + + G  +A+K++  ++ +       + E+ ++   
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 689 SAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWP---- 739
              +HPN+V+L+  C         +L LV+E++  +          T Y  K+  P    
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL---------TTYLDKVPEPGVPT 119
Query: 740 -TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 798
            T K +   + RGL +LH     ++VHRD+K  N+L+      K++DFGLA++Y      
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA- 175
Query: 799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
             T +  T+ Y APE  ++    +  D++S G +  E+   K
Sbjct: 176 -LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 635 AATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK-----SRQGNREFVNEIGMI 688
           A   N+     +GEG FG V      + G  +A+K ++ K       QG  E   EI  +
Sbjct: 1   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYL 58
Query: 689 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 748
              +HP+++KLY      +++++V EY  N      +       R K+     ++    I
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV------QRDKMSEQEARRFFQQI 112
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
              + Y H   R KIVHRD+K  N+LLD+ LN KI+DFGL+ +   D   + T   G+  
Sbjct: 113 ISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS-CGSPN 167
Query: 809 YMAPEY-AMRGYLTSKADVYSFGVV 832
           Y APE  + + Y   + DV+S GV+
Sbjct: 168 YAAPEVISGKLYAGPEVDVWSCGVI 192

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 107/222 (48%), Gaps = 31/222 (13%)
Query: 636 ATNNFDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNREF--VNEIGMI--- 688
           A   ++   ++GEG +G V+K   + + G  +A+K++  ++ +       + E+ ++   
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 689 SAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWP---- 739
              +HPN+V+L+  C         +L LV+E++  +          T Y  K+  P    
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL---------TTYLDKVPEPGVPT 119
Query: 740 -TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 798
            T K +   + RGL +LH     ++VHRD+K  N+L+      K++DFGLA++Y      
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA- 175
Query: 799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
             T +  T+ Y APE  ++    +  D++S G +  E+   K
Sbjct: 176 -LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 107/222 (48%), Gaps = 31/222 (13%)
Query: 636 ATNNFDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNREF--VNEIGMI--- 688
           A   ++   ++GEG +G V+K   + + G  +A+K++  ++ +       + E+ ++   
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 689 SAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWP---- 739
              +HPN+V+L+  C         +L LV+E++  +          T Y  K+  P    
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL---------TTYLDKVPEPGVPT 119
Query: 740 -TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 798
            T K +   + RGL +LH     ++VHRD+K  N+L+      K++DFGLA++Y      
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA- 175
Query: 799 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
             T +  T+ Y APE  ++    +  D++S G +  E+   K
Sbjct: 176 -LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 635 AATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK-----SRQGNREFVNEIGMI 688
           A   N+     +GEG FG V      + G  +A+K ++ K       QG  E   EI  +
Sbjct: 11  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYL 68
Query: 689 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 748
              +HP+++KLY      +++++V EY  N      +       R K+     ++    I
Sbjct: 69  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV------QRDKMSEQEARRFFQQI 122
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
              + Y H   R KIVHRD+K  N+LLD+ LN KI+DFGL+ +   D   + T   G+  
Sbjct: 123 ISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS-CGSPN 177
Query: 809 YMAPEY-AMRGYLTSKADVYSFGVV 832
           Y APE  + + Y   + DV+S GV+
Sbjct: 178 YAAPEVISGKLYAGPEVDVWSCGVI 202

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 635 AATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK-----SRQGNREFVNEIGMI 688
           A   N+     +GEG FG V      + G  +A+K ++ K       QG  E   EI  +
Sbjct: 5   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYL 62
Query: 689 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 748
              +HP+++KLY      +++++V EY  N      +       R K+     ++    I
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV------QRDKMSEQEARRFFQQI 116
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
              + Y H   R KIVHRD+K  N+LLD+ LN KI+DFGL+ +   D   + T   G+  
Sbjct: 117 ISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS-CGSPN 171
Query: 809 YMAPEY-AMRGYLTSKADVYSFGVV 832
           Y APE  + + Y   + DV+S GV+
Sbjct: 172 YAAPEVISGKLYAGPEVDVWSCGVI 196

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 108/223 (48%), Gaps = 29/223 (13%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 705
           +G+G FG V  G    G  +AVK +  K+    + F+ E  +++  +H NLV+L G  VE
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 706 -GNQLLLVYEYMKNNCL-------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
               L +V EYM    L        R++ G D   +  LD          +   + YL  
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD----------VCEAMEYLEG 126
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
           ++    VHRD+   NVL+ +D  AK+SDFGL K  E   T  + ++   + + APE    
Sbjct: 127 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALRE 179
Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAY 859
              ++K+DV+SFG++  EI S G+      P +D V  ++  Y
Sbjct: 180 AAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 222

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 635 AATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK-----SRQGNREFVNEIGMI 688
           A   N+     +GEG FG V      + G  +A+K ++ K       QG  E   EI  +
Sbjct: 10  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYL 67
Query: 689 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 748
              +HP+++KLY      +++++V EY  N      +       R K+     ++    I
Sbjct: 68  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV------QRDKMSEQEARRFFQQI 121
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
              + Y H   R KIVHRD+K  N+LLD+ LN KI+DFGL+ +   D   + T   G+  
Sbjct: 122 ISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS-CGSPN 176
Query: 809 YMAPEY-AMRGYLTSKADVYSFGVV 832
           Y APE  + + Y   + DV+S GV+
Sbjct: 177 YAAPEVISGKLYAGPEVDVWSCGVI 201

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 17/215 (7%)
Query: 638 NNFDPANKVGEGGFGSVYK----GILSDGTV--IAVKQLSSKSRQGNRE-FVNEIGMISA 690
           NN      +G G FG V +    G+  +  V  +AVK L S +    +E  ++E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 691 -QQHPNLVKLYGCCVEGNQLLLVYEY-----MKNNCLSRAIFGKDTEYRLKLDWPTRKKI 744
             QH N+V L G C  G  +L++ EY     + N    +A    D E    L+       
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 745 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA 804
              +A+G+A+L   +    +HRD+   NVLL     AKI DFGLA+    D  +I    A
Sbjct: 166 SSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 805 G-TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
              + +MAPE       T ++DV+S+G++  EI S
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 106/201 (52%), Gaps = 18/201 (8%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLS-SKSRQG-NREFVNEIGMISAQQHPNLVKLYGC 702
           K+GEG +G VYK   + G   A+K++   K  +G     + EI ++   +H N+VKLY  
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 703 CVEGNQLLLVYEYMKNNC--LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
                +L+LV+E++  +   L     G        L+  T K   + +  G+AY H+   
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGG-------LESVTAKSFLLQLLNGIAYCHDR-- 119
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM--RG 818
            +++HRD+K  N+L++++   KI+DFGLA+ +       +  I  T+ Y AP+  M  + 
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKK 177
Query: 819 YLTSKADVYSFGVVTLEIVSG 839
           Y T+  D++S G +  E+V+G
Sbjct: 178 YSTT-IDIWSVGCIFAEMVNG 197

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/242 (30%), Positives = 115/242 (47%), Gaps = 27/242 (11%)
Query: 612 VSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL 670
           +++D   R LD +  L  LR        F+    VG G +G VYKG  +  G + A+K +
Sbjct: 2   MASDSPARSLD-EIDLSALRD---PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM 57
Query: 671 SSKSRQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGN------QLLLVYEYMKNNCLSR 723
                +   E   EI M+     H N+   YG  ++ N      QL LV E+     ++ 
Sbjct: 58  DVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 724 AIFGKDTE-YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 782
            I  K+T+   LK +W     IC  I RGL++LH+    K++HRDIK  NVLL ++   K
Sbjct: 117 LI--KNTKGNTLKEEWIAY--ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 169
Query: 783 ISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIV 837
           + DFG++   +      +T I GT  +MAPE              K+D++S G+  +E+ 
Sbjct: 170 LVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
Query: 838 SG 839
            G
Sbjct: 229 EG 230

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 23/219 (10%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF-----VNEIGMI- 688
           AT+ ++P  ++G G +G+VYK      G  +A+K +   +  G         V E+ ++ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 689 --SAQQHPNLVKLYGCCVEGN-----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 741
              A +HPN+V+L   C         ++ LV+E++  +   R    K     L  +  T 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL--RTYLDKAPPPGLPAE--TI 122
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
           K +     RGL +LH +    IVHRD+K  N+L+      K++DFGLA++Y        T
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LT 177
Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            +  T+ Y APE  ++    +  D++S G +  E+   K
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF--VNEIGMI---S 689
           AT+ ++P  ++G G +G+VYK      G  +A+K +   + +       V E+ ++    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 690 AQQHPNLVKLYGCCVEGN-----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI 744
           A +HPN+V+L   C         ++ LV+E++  +   R    K     L  +  T K +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL--RTYLDKAPPPGLPAE--TIKDL 117
Query: 745 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA 804
                RGL +LH +    IVHRD+K  N+L+      K++DFGLA++Y          + 
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV- 173
Query: 805 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            T+ Y APE  ++    +  D++S G +  E+   K
Sbjct: 174 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 645 KVGEGGFGSVYKGIL---SDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLY 700
           ++G G FGSV +G+         +A+K L   + + +  E + E  ++    +P +V+L 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G C +   L+LV E      L + + GK    R ++      ++   ++ G+ YL E + 
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN- 130
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAMRG 818
              VHRD+   NVLL     AKISDFGL+K    D ++ + R AG   + + APE     
Sbjct: 131 --FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 819 YLTSKADVYSFGVVTLEIVS 838
             +S++DV+S+GV   E +S
Sbjct: 189 KFSSRSDVWSYGVTMWEALS 208

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G FG VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R ++       +   I+  + YL +
Sbjct: 76  CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 128 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 185 NKFSIKSDVWAFGVLLWEIAT 205

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF--VNEIGMI---S 689
           AT+ ++P  ++G G +G+VYK      G  +A+K +   + +       V E+ ++    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 690 AQQHPNLVKLYGCCVEGN-----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI 744
           A +HPN+V+L   C         ++ LV+E++  +   R    K     L  +  T K +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL--RTYLDKAPPPGLPAE--TIKDL 117
Query: 745 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA 804
                RGL +LH +    IVHRD+K  N+L+      K++DFGLA++Y          + 
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV- 173
Query: 805 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            T+ Y APE  ++    +  D++S G +  E+   K
Sbjct: 174 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 18/201 (8%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLS-SKSRQG-NREFVNEIGMISAQQHPNLVKLYGC 702
           K+GEG +G VYK   + G   A+K++   K  +G     + EI ++   +H N+VKLY  
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 703 CVEGNQLLLVYEYMKNNC--LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
                +L+LV+E++  +   L     G        L+  T K   + +  G+AY H+   
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGG-------LESVTAKSFLLQLLNGIAYCHDR-- 119
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM--RG 818
            +++HRD+K  N+L++++   KI+DFGLA+ +       +  +  T+ Y AP+  M  + 
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKK 177
Query: 819 YLTSKADVYSFGVVTLEIVSG 839
           Y T+  D++S G +  E+V+G
Sbjct: 178 YSTT-IDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 18/201 (8%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLS-SKSRQG-NREFVNEIGMISAQQHPNLVKLYGC 702
           K+GEG +G VYK   + G   A+K++   K  +G     + EI ++   +H N+VKLY  
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 703 CVEGNQLLLVYEYMKNNC--LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
                +L+LV+E++  +   L     G        L+  T K   + +  G+AY H+   
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGG-------LESVTAKSFLLQLLNGIAYCHDR-- 119
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM--RG 818
            +++HRD+K  N+L++++   KI+DFGLA+ +       +  +  T+ Y AP+  M  + 
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKK 177
Query: 819 YLTSKADVYSFGVVTLEIVSG 839
           Y T+  D++S G +  E+V+G
Sbjct: 178 YSTT-IDIWSVGCIFAEMVNG 197

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 28/201 (13%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 705
           +G+G FG V  G    G  +AVK +  K+    + F+ E  +++  +H NLV+L G  VE
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 706 -GNQLLLVYEYMKNNCL-------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
               L +V EYM    L        R++ G D   +  LD          +   + YL  
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD----------VCEAMEYLEG 307
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
           ++    VHRD+   NVL+ +D  AK+SDFGL K  E   T  + ++   + + APE    
Sbjct: 308 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALRE 360
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              ++K+DV+SFG++  EI S
Sbjct: 361 KKFSTKSDVWSFGILLWEIYS 381

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 36/213 (16%)
Query: 644 NKVGEGGFGSVYKGIL----SDGTVIAVKQ-----LSSKSRQGNREFVNEIGMISAQQHP 694
            K+GEG FG   K IL     DG    +K+     +SSK R+ +R    E+ +++  +HP
Sbjct: 30  QKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESR---REVAVLANMKHP 83
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-------FGKDTEYRLKLDWPTRKKICIG 747
           N+V+      E   L +V +Y +   L + I       F +D      LDW    +IC+ 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQ----ILDWFV--QICLA 137
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
               L ++H+    KI+HRDIK+ N+ L KD   ++ DFG+A++       ++    GT 
Sbjct: 138 ----LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACIGTP 189
Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            Y++PE        +K+D+++ G V  E+ + K
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 28/201 (13%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 705
           +G+G FG V  G    G  +AVK +  K+    + F+ E  +++  +H NLV+L G  VE
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 706 -GNQLLLVYEYMKNNCL-------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
               L +V EYM    L        R++ G D   +  LD          +   + YL  
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD----------VCEAMEYLEG 120
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
           ++    VHRD+   NVL+ +D  AK+SDFGL K  E   T  + ++   + + APE    
Sbjct: 121 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALRE 173
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              ++K+DV+SFG++  EI S
Sbjct: 174 KKFSTKSDVWSFGILLWEIYS 194

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 28/201 (13%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 705
           +G+G FG V  G    G  +AVK +  K+    + F+ E  +++  +H NLV+L G  VE
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 706 -GNQLLLVYEYMKNNCL-------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
               L +V EYM    L        R++ G D   +  LD          +   + YL  
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD----------VCEAMEYLEG 135
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
           ++    VHRD+   NVL+ +D  AK+SDFGL K  E   T  + ++   + + APE    
Sbjct: 136 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALRE 188
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              ++K+DV+SFG++  EI S
Sbjct: 189 KKFSTKSDVWSFGILLWEIYS 209

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R +++      +   I+  + YL +
Sbjct: 79  CTREPPFYIIIEFM--------TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 131 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 187
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 188 NKFSIKSDVWAFGVLLWEIAT 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R +++      +   I+  + YL +
Sbjct: 83  CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 135 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 191
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF--VNEIGMI---S 689
           AT+ ++P  ++G G +G+VYK      G  +A+K +   + +       V E+ ++    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 690 AQQHPNLVKLYGCCVEGN-----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI 744
           A +HPN+V+L   C         ++ LV+E++  +   R    K     L  +  T K +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL--RTYLDKAPPPGLPAE--TIKDL 117
Query: 745 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA 804
                RGL +LH +    IVHRD+K  N+L+      K++DFGLA++Y          + 
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LDPVV 172
Query: 805 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            T+ Y APE  ++    +  D++S G +  E+   K
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 82
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R +++      +   I+  + YL +
Sbjct: 83  CTREPPFYIIIEFM--------TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 135 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 82
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R +++      +   I+  + YL +
Sbjct: 83  CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 135 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 645 KVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
           ++G G FGSV +G+        D  +  +KQ + K+     E + E  ++    +P +V+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVR 400
Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
           L G C +   L+LV E      L + + GK  E  +        ++   ++ G+ YL E 
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS----NVAELLHQVSMGMKYLEEK 455
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG--TIGYMAPEYAM 816
           +    VHR++   NVLL     AKISDFGL+K    D ++ + R AG   + + APE   
Sbjct: 456 N---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512
Query: 817 RGYLTSKADVYSFGVVTLEIVS 838
               +S++DV+S+GV   E +S
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALS 534

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 27/206 (13%)
Query: 646 VGEGGFGSVYKGI-LSDGTVI----AVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 699
           +G G FG+V+KG+ + +G  I     +K +  KS RQ  +   + +  I +  H ++V+L
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 700 YGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
            G C  G+ L LV +Y+    L       R   G     +L L+W       + IA+G+ 
Sbjct: 99  LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGP----QLLLNW------GVQIAKGMY 147
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIGYMAP 812
           YL E     +VHR++   NVLL      +++DFG+A L   +DK  + +     I +MA 
Sbjct: 148 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVS 838
           E    G  T ++DV+S+GV   E+++
Sbjct: 205 ESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 18/195 (9%)
Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
            K+G G FG V+    +  T +AVK +   S      F+ E  ++   QH  LVKL+   
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV- 245
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           V    + ++ E+M    L    F K  E   K   P        IA G+A++ + + I  
Sbjct: 246 VTKEPIYIITEFMAKGSLLD--FLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNYI-- 300
Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
            HRD++ +N+L+   L  KI+DFGLA+        +  +    I + APE    G  T K
Sbjct: 301 -HRDLRAANILVSASLVCKIADFGLAR--------VGAKFP--IKWTAPEAINFGSFTIK 349
Query: 824 ADVYSFGVVTLEIVS 838
           +DV+SFG++ +EIV+
Sbjct: 350 SDVWSFGILLMEIVT 364

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 77
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R +++      +   I+  + YL +
Sbjct: 78  CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R +++      +   I+  + YL +
Sbjct: 82  CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 133
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 134 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 77
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R +++      +   I+  + YL +
Sbjct: 78  CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R +++      +   I+  + YL +
Sbjct: 79  CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 131 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAY 187
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 188 NKFSIKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R +++      +   I+  + YL +
Sbjct: 80  CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 132 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAY 188
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 189 NKFSIKSDVWAFGVLLWEIAT 209

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R ++       +   I+  + YL +
Sbjct: 76  CTREPPFYIIIEFM--------TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 128 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 185 NKFSIKSDVWAFGVLLWEIAT 205

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 646 VGEGGFGSVYK---GILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +G+G FG V K    I      + V   +S   +     + E+ ++    HPN++KL+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             + +   +V E      L   I       R +       +I   +  G+ Y+H+ +   
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 763 IVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY 819
           IVHRD+K  N+LL   +KD + KI DFGL+  ++++ T +  RI GT  Y+APE  +RG 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VLRGT 198
Query: 820 LTSKADVYSFGVVTLEIVSG 839
              K DV+S GV+   ++SG
Sbjct: 199 YDEKCDVWSAGVILYILLSG 218

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R +++      +   I+  + YL +
Sbjct: 91  CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 142
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 143 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 199
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 200 NKFSIKSDVWAFGVLLWEIAT 220

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R +++      +   I+  + YL +
Sbjct: 80  CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 132 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 188
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 189 NKFSIKSDVWAFGVLLWEIAT 209

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 27/206 (13%)
Query: 646 VGEGGFGSVYKGI-LSDGTVI----AVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 699
           +G G FG+V+KG+ + +G  I     +K +  KS RQ  +   + +  I +  H ++V+L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 700 YGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
            G C  G+ L LV +Y+    L       R   G     +L L+W       + IA+G+ 
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGP----QLLLNW------GVQIAKGMY 129
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIGYMAP 812
           YL E     +VHR++   NVLL      +++DFG+A L   +DK  + +     I +MA 
Sbjct: 130 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVS 838
           E    G  T ++DV+S+GV   E+++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R +++      +   I+  + YL +
Sbjct: 80  CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 132 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 188
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 189 NKFSIKSDVWAFGVLLWEIAT 209

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R +++      +   I+  + YL +
Sbjct: 83  CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 135 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 646 VGEGGFGSVYK---GILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +G+G FG V K    I      + V   +S   +     + E+ ++    HPN++KL+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             + +   +V E      L   I       R +       +I   +  G+ Y+H+ +   
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 763 IVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY 819
           IVHRD+K  N+LL   +KD + KI DFGL+  ++++ T +  RI GT  Y+APE  +RG 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VLRGT 198
Query: 820 LTSKADVYSFGVVTLEIVSG 839
              K DV+S GV+   ++SG
Sbjct: 199 YDEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 646 VGEGGFGSVYK---GILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +G+G FG V K    I      + V   +S   +     + E+ ++    HPN++KL+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             + +   +V E      L   I       R +       +I   +  G+ Y+H+ +   
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 763 IVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY 819
           IVHRD+K  N+LL   +KD + KI DFGL+  ++++ T +  RI GT  Y+APE  +RG 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VLRGT 198
Query: 820 LTSKADVYSFGVVTLEIVSG 839
              K DV+S GV+   ++SG
Sbjct: 199 YDEKCDVWSAGVILYILLSG 218

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 31/253 (12%)
Query: 613 SADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYK----GILSDGTVI--A 666
           S+D E   +D +   Y L+  +    N +    +G G FG V      GI   G  I  A
Sbjct: 21  SSDNEYFYVDFREYEYDLKW-EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVA 79
Query: 667 VKQLSSKSRQGNRE-FVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRA 724
           VK L  K+    RE  ++E+ M++    H N+V L G C     + L++EY     L   
Sbjct: 80  VKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNY 139
Query: 725 IFGKDTEY-RLKLDWPTRKKI---------------CIG--IARGLAYLHEDSRIKIVHR 766
           +  K  ++   ++++  +K++               C    +A+G+ +L   S    VHR
Sbjct: 140 LRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196
Query: 767 DIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAMRGYLTSKAD 825
           D+   NVL+      KI DFGLA+    D  ++    A   + +MAPE    G  T K+D
Sbjct: 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD 256
Query: 826 VYSFGVVTLEIVS 838
           V+S+G++  EI S
Sbjct: 257 VWSYGILLWEIFS 269

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R ++       +   I+  + YL +
Sbjct: 78  CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R ++       +   I+  + YL +
Sbjct: 78  CTREPPFYIIIEFM--------TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R ++       +   I+  + YL +
Sbjct: 78  CTREPPFYIIIEFM--------TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R ++       +   I+  + YL +
Sbjct: 83  CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 134
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 135 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R ++       +   I+  + YL +
Sbjct: 78  CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 21/228 (9%)
Query: 620 GLDLQT-GLY--TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSR 675
           G+DL T  LY  ++ + +    +    +K+G G +G VY G+    ++ +AVK L   + 
Sbjct: 11  GVDLGTENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM 70
Query: 676 QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY--- 732
           +   EF+ E  ++   +HPNLV+L G C       +V EYM         +G   +Y   
Sbjct: 71  E-VEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMP--------YGNLLDYLRE 121
Query: 733 --RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 790
             R ++       +   I+  + YL + +    +HRD+   N L+ ++   K++DFGL++
Sbjct: 122 CNREEVTAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHVVKVADFGLSR 178
Query: 791 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           L   D           I + APE       + K+DV++FGV+  EI +
Sbjct: 179 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R ++       +   I+  + YL +
Sbjct: 76  CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HRD+   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 128 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAY 184
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 185 NKFSIKSDVWAFGVLLWEIAT 205

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 634 KAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNREF 681
           K +  +F     +G G FG V+              +L    V+ +KQ+   +       
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN------- 54
Query: 682 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 741
            +E  M+S   HP +++++G   +  Q+ ++ +Y++   L   +         +   P  
Sbjct: 55  -DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVA 108
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
           K     +   L YLH      I++RD+K  N+LLDK+ + KI+DFG AK Y  D T+   
Sbjct: 109 KFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-YVPDVTY--- 161
Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            + GT  Y+APE           D +SFG++  E+++G
Sbjct: 162 XLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 112/236 (47%), Gaps = 32/236 (13%)
Query: 646 VGEGGFGSVYKGILSDG-----------TVIAVKQLSSKSRQGN-REFVNEIGMISA-QQ 692
           +GEG FG V   +L++            T +AVK L S + + +  + ++E+ M+    +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT---EYRLKLDWPTRKKI----- 744
           H N++ L G C +   L ++ EY     L   +  ++    EY         +++     
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 745 ---CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIS 800
                 +ARG+ YL   +  K +HRD+   NVL+ +D   KI+DFGLA+ ++  D    +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
           T     + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 24/224 (10%)
Query: 626 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSS---KSRQGN 678
           G++        ++ +     +G+G FG V   IL      G   AVK +S    K +   
Sbjct: 20  GMFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDK 76
Query: 679 REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW 738
              + E+ ++    HPN++KLY    +     LV E      L   I       R +   
Sbjct: 77  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-----RKRFSE 131
Query: 739 PTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEED 795
               +I   +  G+ Y+H++   KIVHRD+K  N+LL+   KD N +I DFGL+  +E  
Sbjct: 132 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 188
Query: 796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           K  +  +I GT  Y+APE  + G    K DV+S GV+   ++SG
Sbjct: 189 KK-MKDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 25/219 (11%)
Query: 638 NNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA- 690
           N+    + +GEG FG V K      G+  D  +  +K+ +SK    +R+F  E+ ++   
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKL 72
Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWP 739
             HPN++ L G C     L L  EY  +  L      SR +     F         L   
Sbjct: 73  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 132
Query: 740 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 799
                   +ARG+ YL   S+ + +HRD+   N+L+ ++  AKI+DFGL++  E      
Sbjct: 133 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 189
Query: 800 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             R+   + +MA E       T+ +DV+S+GV+  EIVS
Sbjct: 190 MGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 646 VGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNR--EFVNEIGMISAQQHPNLVK 698
           +GEG FG V          + G  +AVK L  +S  GN   +   EI ++    H N+VK
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVK 75
Query: 699 LYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C E  GN + L+ E++ +  L   +     +  LK     + K  + I +G+ YL 
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLK----QQLKYAVQICKGMDYL- 130
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--IAGTIGYMAPEY 814
             SR + VHRD+   NVL++ +   KI DFGL K  E DK   + +      + + APE 
Sbjct: 131 -GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 188
Query: 815 AMRGYLTSKADVYSFGVVTLEIVS 838
            M+      +DV+SFGV   E+++
Sbjct: 189 LMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 21/219 (9%)
Query: 638 NNFDPANKVGEGGFGSVYK----GILSDGTV--IAVKQLSSKSRQGNRE-FVNEIGMISA 690
           NN      +G G FG V +    G+  +  V  +AVK L S +    +E  ++E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 691 -QQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRA--IFGKDTEYRLKLDWPTRKK 743
             QH N+V L G C  G  +L++ EY       N L R   +   D  + +     + + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 744 I---CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 800
           +      +A+G+A+L   +    +HRD+   NVLL     AKI DFGLA+    D  +I 
Sbjct: 166 LLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 801 TRIAG-TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
              A   + +MAPE       T ++DV+S+G++  EI S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 108/236 (45%), Gaps = 32/236 (13%)
Query: 646 VGEGGFGSVYKGILSDG-----------TVIAVKQLSSKSRQGN-REFVNEIGMISA-QQ 692
           +GEG FG V   +L++            T +AVK L S + + +  + ++E+ M+    +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-----------FGKDTEYRLKLDWPTR 741
           H N++ L G C +   L ++ EY     L   +           F        +L     
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIS 800
                 +ARG+ YL   +  K +HRD+   NVL+ +D   KI+DFGLA+ ++  D    +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209
Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
           T     + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 114/217 (52%), Gaps = 21/217 (9%)
Query: 634 KAATNNFDPANK---VGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGNREFVNEIGMIS 689
           + A N+F   +K   +G G FG V+K    + G  +A K + ++  +   E  NEI +++
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-KLDWPT-RKKICIG 747
              H NL++LY      N ++LV EY+    L   I   D  Y L +LD     K+IC  
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII--DESYNLTELDTILFMKQIC-- 197
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVL-LDKDLNA-KISDFGLAKLYE-EDKTHISTRIA 804
              G+ ++H+   + I+H D+K  N+L +++D    KI DFGLA+ Y+  +K  ++    
Sbjct: 198 --EGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--- 249
Query: 805 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           GT  ++APE     +++   D++S GV+   ++SG S
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 646 VGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNR--EFVNEIGMISAQQHPNLVK 698
           +GEG FG V          + G  +AVK L  +S  GN   +   EI ++    H N+VK
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVK 87
Query: 699 LYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C E  GN + L+ E++ +  L   +     + + K++   + K  + I +G+ YL 
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMDYL- 142
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--IAGTIGYMAPEY 814
             SR + VHRD+   NVL++ +   KI DFGL K  E DK   + +      + + APE 
Sbjct: 143 -GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 200
Query: 815 AMRGYLTSKADVYSFGVVTLEIVS 838
            M+      +DV+SFGV   E+++
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 646 VGEGGFGSV---YKGILSDGT--VIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKL 699
           +GEG FG V        +DGT  ++AVK L + +   +R  +  EI ++    H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 700 YGCCVEGN--QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
            GCC +     L LV EY+    L      +D   R  +           I  G+AYLH 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSL------RDYLPRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG--TIGYMAPEYA 815
              I   HRD+   NVLLD D   KI DFGLAK   E       R  G   + + APE  
Sbjct: 153 QHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL 209
Query: 816 MRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 855
                   +DV+SFGV   E+++   +++  P   F+ L+
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELI 248

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 26/233 (11%)
Query: 646 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V      GI  D       +AVK L   + + +  + V+E+ M+    +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICI------ 746
           ++ L G C +   L ++ EY     L    RA      EY   ++    +++        
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 747 --GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL   +  K +HRD+   NVL+ ++   KI+DFGLA+ +   D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 25/219 (11%)
Query: 638 NNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA- 690
           N+    + +GEG FG V K      G+  D  +  +K+ +SK    +R+F  E+ ++   
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKL 82
Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWP 739
             HPN++ L G C     L L  EY  +  L      SR +     F         L   
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 740 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 799
                   +ARG+ YL   S+ + +HRD+   N+L+ ++  AKI+DFGL++  E      
Sbjct: 143 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 199
Query: 800 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             R+   + +MA E       T+ +DV+S+GV+  EIVS
Sbjct: 200 MGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 22/223 (9%)
Query: 626 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSD---GTVIAVKQLSS---KSRQGNR 679
           G++        ++ +     +G+G FG V   +  D   G   AVK +S    K +    
Sbjct: 14  GMFVQHSTAIFSDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKE 71
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWP 739
             + E+ ++    HPN++KLY    +     LV E      L   I       R +    
Sbjct: 72  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEV 126
Query: 740 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDK 796
              +I   +  G+ Y+H++   KIVHRD+K  N+LL+   KD N +I DFGL+  +E  K
Sbjct: 127 DAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183
Query: 797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  +I GT  Y+APE  + G    K DV+S GV+   ++SG
Sbjct: 184 K-MKDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R +++      +   I+  + YL +
Sbjct: 324 CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 375
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HR++   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 376 KN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 432
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 433 NKFSIKSDVWAFGVLLWEIAT 453

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 112/233 (48%), Gaps = 26/233 (11%)
Query: 646 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V      GI  D       +AVK L   + + +  + V+E+ M+    +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 696 LVKLYGCCVEGNQLLLVYEY-----MKNNCLSRAIFGKDTEY---RLKLDWPTRKKIC-- 745
           ++ L G C +   L ++ EY     ++    +R   G +  Y   R+  +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 746 -IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL   +  K +HRD+   NVL+ ++   KI+DFGLA+ +   D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           +G+G +G VY G  LS+   IA+K++  +  + ++    EI +    +H N+V+  G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 705 EGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
           E   + +  E +    LS   R+ +G   +    + + T++     I  GL YLH++   
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLHDN--- 141
Query: 762 KIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY---AMR 817
           +IVHRDIK  NVL++      KISDFG +K          T   GT+ YMAPE      R
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPR 200
Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
           GY    AD++S G   +E+ +GK
Sbjct: 201 GY-GKAADIWSLGCTIIEMATGK 222

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 105/219 (47%), Gaps = 21/219 (9%)
Query: 638 NNFDPANKVGEGGFGSVYK----GILSDGTV--IAVKQLSSKSRQGNRE-FVNEIGMISA 690
           NN      +G G FG V +    G+  +  V  +AVK L S +    +E  ++E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 691 -QQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKL---DWPTRK 742
             QH N+V L G C  G  +L++ EY       N L R     +T+    +      TR 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 743 KICIG--IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 800
            +     +A+G+A+L   +    +HRD+   NVLL     AKI DFGLA+    D  +I 
Sbjct: 166 LLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 801 TRIAG-TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
              A   + +MAPE       T ++DV+S+G++  EI S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 638 NNFDPANKVGEGGFGSVYK----GILSDGTV--IAVKQLSSKSRQGNRE-FVNEIGMISA 690
           NN      +G G FG V +    G+  +  V  +AVK L S +    +E  ++E+ ++S 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 691 -QQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSR---AIFGK-----------DTE 731
             QH N+V L G C  G  +L++ EY       N L R   A+ G            D E
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 732 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 791
               L+          +A+G+A+L   +    +HRD+   NVLL     AKI DFGLA+ 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 792 YEEDKTHISTRIAG-TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
              D  +I    A   + +MAPE       T ++DV+S+G++  EI S
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 23/216 (10%)
Query: 634 KAATNNFDPANKVGEGGFGSVY---KGILSDGTVIAVKQLSSKSRQGNREFVN---EIGM 687
           KA  + F+    +G+G FG V+   K   SD   +   ++  K+    R+ V    E  +
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 688 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKK 743
           +    HP +VKL+       +L L+ ++++       LS+ +   + + +  L       
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL------- 132
Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 803
               +A  L +LH    + I++RD+K  N+LLD++ + K++DFGL+K    D    +   
Sbjct: 133 --AELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSF 186
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            GT+ YMAPE   R   T  AD +SFGV+  E+++G
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY    +  +L     Y KN CL + I    +      D    +     I   L 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGS-----FDETCTRFYTAEIVSALE 146
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 203
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E       +  +D+++ G +  ++V+G
Sbjct: 204 ELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 22/223 (9%)
Query: 626 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSD---GTVIAVKQLSS---KSRQGNR 679
           G++        ++ +     +G+G FG V   +  D   G   AVK +S    K +    
Sbjct: 37  GMFVQHSTAIFSDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKE 94
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWP 739
             + E+ ++    HPN++KLY    +     LV E      L   I       R +    
Sbjct: 95  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEV 149
Query: 740 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDK 796
              +I   +  G+ Y+H++   KIVHRD+K  N+LL+   KD N +I DFGL+  +E  K
Sbjct: 150 DAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 206
Query: 797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  +I GT  Y+APE  + G    K DV+S GV+   ++SG
Sbjct: 207 K-MKDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           +G+G +G VY G  LS+   IA+K++  +  + ++    EI +    +H N+V+  G   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 705 EGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
           E   + +  E +    LS   R+ +G   +    + + T++     I  GL YLH++   
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLHDN--- 127
Query: 762 KIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY---AMR 817
           +IVHRDIK  NVL++      KISDFG +K          T   GT+ YMAPE      R
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPR 186
Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
           GY    AD++S G   +E+ +GK
Sbjct: 187 GY-GKAADIWSLGCTIIEMATGK 208

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 32/236 (13%)
Query: 646 VGEGGFGSVYKGILSDG-----------TVIAVKQLSSKSRQGN-REFVNEIGMISA-QQ 692
           +GEG FG V   +L++            T +AVK L S + + +  + ++E+ M+    +
Sbjct: 77  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT---EYRLKLDWPTRKKI----- 744
           H N++ L G C +   L ++ EY     L   +  +     EY         +++     
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 745 ---CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIS 800
                 +ARG+ YL   +  K +HRD+   NVL+ +D   KI+DFGLA+ ++  D    +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
           T     + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 22/223 (9%)
Query: 626 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSD---GTVIAVKQLSS---KSRQGNR 679
           G++        ++ +     +G+G FG V   +  D   G   AVK +S    K +    
Sbjct: 38  GMFVQHSTAIFSDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKE 95
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWP 739
             + E+ ++    HPN++KLY    +     LV E      L   I       R +    
Sbjct: 96  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEV 150
Query: 740 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDK 796
              +I   +  G+ Y+H++   KIVHRD+K  N+LL+   KD N +I DFGL+  +E  K
Sbjct: 151 DAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 207
Query: 797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  +I GT  Y+APE  + G    K DV+S GV+   ++SG
Sbjct: 208 K-MKDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 34/214 (15%)
Query: 647 GEGGFGSVYKG-ILSDGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
             G FG V+K  +++D   + +  L  K S Q  RE  +  GM    +H NL++      
Sbjct: 24  ARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGM----KHENLLQFIAAEK 79
Query: 705 EGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-- 758
            G+    +L L+  +     L+  + G        + W     +   ++RGL+YLHED  
Sbjct: 80  RGSNLEVELWLITAFHDKGSLTDYLKGN------IITWNELCHVAETMSRGLSYLHEDVP 133
Query: 759 ------SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIGYMA 811
                  +  I HRD K+ NVLL  DL A ++DFGLA  +E  K    T    GT  YMA
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMA 193
Query: 812 PE-------YAMRGYLTSKADVYSFGVVTLEIVS 838
           PE       +    +L  + D+Y+ G+V  E+VS
Sbjct: 194 PEVLEGAINFQRDAFL--RIDMYAMGLVLWELVS 225

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 112/225 (49%), Gaps = 21/225 (9%)
Query: 638 NNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 695
           ++F+  +++G G  G V+K      G V+A K +  + +   R + + E+ ++     P 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLA 753
           +V  YG      ++ +  E+M    L + +   G+  E  L        K+ I + +GL 
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-------KVSIAVIKGLT 121
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAP 812
           YL E  + KI+HRD+K SN+L++     K+ DFG++ +L +E    ++    GT  YM+P
Sbjct: 122 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSP 175
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDW 857
           E     + + ++D++S G+  +E+  G+     RP      LLD+
Sbjct: 176 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP---RPPMAIFELLDY 217

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 32/236 (13%)
Query: 646 VGEGGFGSVYKGILSDG-----------TVIAVKQLSSKSRQGN-REFVNEIGMISA-QQ 692
           +GEG FG V   +L++            T +AVK L S + + +  + ++E+ M+    +
Sbjct: 29  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT---EYRLKLDWPTRKKI----- 744
           H N++ L G C +   L ++ EY     L   +  +     EY         +++     
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 745 ---CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIS 800
                 +ARG+ YL   +  K +HRD+   NVL+ +D   KI+DFGLA+ ++  D    +
Sbjct: 146 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202
Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
           T     + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 203 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 258

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           +K+G G +G VY+G+    ++ +AVK L   + +   EF+ E  ++   +HPNLV+L G 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY-----RLKLDWPTRKKICIGIARGLAYLHE 757
           C       ++ E+M         +G   +Y     R ++       +   I+  + YL +
Sbjct: 285 CTREPPFYIITEFM--------TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +    +HR++   N L+ ++   K++DFGL++L   D           I + APE    
Sbjct: 337 KN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 818 GYLTSKADVYSFGVVTLEIVS 838
              + K+DV++FGV+  EI +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 631 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGT----VIAVKQLSSKSRQGNR-EFVNEI 685
           +Q +   + +D  + +G G F  V   IL++      ++A+K ++ K+ +G      NEI
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEI 67
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            ++   +HPN+V L      G  L L+ + +    L   I  K   +  + D     ++ 
Sbjct: 68  AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERD---ASRLI 122
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVL---LDKDLNAKISDFGLAKLYEEDKTHISTR 802
             +   + YLH+   + IVHRD+K  N+L   LD+D    ISDFGL+K+  ED   + + 
Sbjct: 123 FQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLST 177
Query: 803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             GT GY+APE   +   +   D +S GV+   ++ G
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 32/236 (13%)
Query: 646 VGEGGFGSVYKGILSDG-----------TVIAVKQLSSKSRQGN-REFVNEIGMISA-QQ 692
           +GEG FG V   +L++            T +AVK L S + + +  + ++E+ M+    +
Sbjct: 25  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT---EYRLKLDWPTRKKI----- 744
           H N++ L G C +   L ++ EY     L   +  +     EY         +++     
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 745 ---CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIS 800
                 +ARG+ YL   +  K +HRD+   NVL+ +D   KI+DFGLA+ ++  D    +
Sbjct: 142 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198
Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
           T     + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 199 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 254

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 32/236 (13%)
Query: 646 VGEGGFGSVYKGILSDG-----------TVIAVKQLSSKSRQGN-REFVNEIGMISA-QQ 692
           +GEG FG V   +L++            T +AVK L S + + +  + ++E+ M+    +
Sbjct: 28  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT---EYRLKLDWPTRKKI----- 744
           H N++ L G C +   L ++ EY     L   +  +     EY         +++     
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 745 ---CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIS 800
                 +ARG+ YL   +  K +HRD+   NVL+ +D   KI+DFGLA+ ++  D    +
Sbjct: 145 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201
Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
           T     + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 202 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 257

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 32/236 (13%)
Query: 646 VGEGGFGSVYKGILSDG-----------TVIAVKQLSSKSRQGN-REFVNEIGMISA-QQ 692
           +GEG FG V   +L++            T +AVK L S + + +  + ++E+ M+    +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT---EYRLKLDWPTRKKI----- 744
           H N++ L G C +   L ++ EY     L   +  +     EY         +++     
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 745 ---CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIS 800
                 +ARG+ YL   +  K +HRD+   NVL+ +D   KI+DFGLA+ ++  D    +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
           T     + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY       R    K+ +   K D          +A  
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYA-----PRGEVYKELQKLSKFDEQRTATYITELANA 125
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 179
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 23/216 (10%)
Query: 634 KAATNNFDPANKVGEGGFGSVY---KGILSDGTVIAVKQLSSKSRQGNREFVN---EIGM 687
           KA  + F+    +G+G FG V+   K   SD   +   ++  K+    R+ V    E  +
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 688 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKK 743
           +    HP +VKL+       +L L+ ++++       LS+ +   + + +  L       
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL------- 132
Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 803
               +A  L +LH    + I++RD+K  N+LLD++ + K++DFGL+K    D    +   
Sbjct: 133 --AELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSF 186
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            GT+ YMAPE   R   T  AD +SFGV+  E+++G
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 23/216 (10%)
Query: 634 KAATNNFDPANKVGEGGFGSVY---KGILSDGTVIAVKQLSSKSRQGNREFVN---EIGM 687
           KA  + F+    +G+G FG V+   K   SD   +   ++  K+    R+ V    E  +
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 688 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKK 743
           +    HP +VKL+       +L L+ ++++       LS+ +   + + +  L       
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL------- 133
Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 803
               +A  L +LH    + I++RD+K  N+LLD++ + K++DFGL+K    D    +   
Sbjct: 134 --AELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSF 187
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            GT+ YMAPE   R   T  AD +SFGV+  E+++G
Sbjct: 188 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 120
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTELCGTLDYLP 174
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 643 ANKVGEGGFGSVYKGIL-SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 700
             ++G G FG V+ G L +D T++AVK    +       +F+ E  ++    HPN+V+L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G C +   + +V E ++       +  +    R+K    T  ++    A G+ YL     
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK----TLLQMVGDAAAGMEYLESKC- 233
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG----TIGYMAPEYAM 816
              +HRD+   N L+ +    KISDFG+++   E+   +     G     + + APE   
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVXAASGGLRQVPVKWTAPEALN 288
Query: 817 RGYLTSKADVYSFGVVTLEIVS 838
            G  +S++DV+SFG++  E  S
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 110/236 (46%), Gaps = 32/236 (13%)
Query: 646 VGEGGFGSVYKGILSDG-----------TVIAVKQLSSKSRQGN-REFVNEIGMISA-QQ 692
           +GEG FG V   +L++            T +AVK L S + + +  + ++E+ M+    +
Sbjct: 21  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT---EY--------RLKLDWPTR 741
           H N++ L G C +   L ++ EY     L   +  +     EY          +L     
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIS 800
                 +ARG+ YL   +  K +HRD+   NVL+ +D   KI+DFGLA+ ++  D    +
Sbjct: 138 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
           T     + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 102/223 (45%), Gaps = 20/223 (8%)
Query: 646 VGEGGFGSVYKGIL---SDGT--VIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKL 699
           +GEG FG V        +DGT  ++AVK L +     +R  +  EI ++    H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 700 YGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
            GCC +  +  L LV EY+    L      +D   R  +           I  G+AYLH 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSL------RDYLPRHSIGLAQLLLFAQQICEGMAYLHS 135
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG--TIGYMAPEYA 815
              I   HR++   NVLLD D   KI DFGLAK   E   +   R  G   + + APE  
Sbjct: 136 QHYI---HRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 816 MRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA 858
                   +DV+SFGV   E+++   +++  P   F+ L+  A
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIA 234

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 13/197 (6%)
Query: 646 VGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
           +GEG FG V++GI     +    +A+K   + +    RE F+ E   +    HP++VKL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G   E N + ++ E     C    +       +  LD  +       ++  LAYL     
Sbjct: 78  GVITE-NPVWIIMEL----CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK-- 130
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
            + VHRDI   NVL+  +   K+ DFGL++  E+     +++    I +MAPE       
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 821 TSKADVYSFGVVTLEIV 837
           TS +DV+ FGV   EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 120
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTXLCGTLDYLP 174
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 646 VGEGGFGSVYKGIL---SDGT--VIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKL 699
           +GEG FG V        +DGT  ++AVK L +     +R  +  EI ++    H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 700 YGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
            GCC +  +  L LV EY+    L      +D   R  +           I  G+AYLH 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSL------RDYLPRHSIGLAQLLLFAQQICEGMAYLHA 135
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG--TIGYMAPEYA 815
              I   HR++   NVLLD D   KI DFGLAK   E   +   R  G   + + APE  
Sbjct: 136 QHYI---HRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 816 MRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 855
                   +DV+SFGV   E+++   +++  P   F+ L+
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELI 231

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 26/233 (11%)
Query: 646 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V      GI  D       +AVK L   + + +  + V+E+ M+    +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICI------ 746
           ++ L G C +   L ++ EY     L    RA      EY   ++    +++        
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 747 --GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL   +  K +HRD+   NVL+ ++   KI+DFGLA+ +   D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 120
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 174
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 119
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 120 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 173
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 174 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 121
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T ++GT+ Y+ 
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR---RTTLSGTLDYLP 175
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 110/236 (46%), Gaps = 32/236 (13%)
Query: 646 VGEGGFGSVYKGILSDG-----------TVIAVKQLSSKSRQGN-REFVNEIGMISA-QQ 692
           +GEG FG V   +L++            T +AVK L S + + +  + ++E+ M+    +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT---EY--------RLKLDWPTR 741
           H N++ L G C +   L ++ EY     L   +  +     EY          +L     
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIS 800
                 +ARG+ YL   +  K +HRD+   NVL+ +D   KI+DFGLA+ ++  D    +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
           T     + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 110/223 (49%), Gaps = 28/223 (12%)
Query: 632 QIKAATNNFDPAN-----KVGEGGFGSVY---KGILSDGTVIAVKQLSSKSRQGNREFVN 683
            +KA +   DP++      +G+G FG V+   K    D   +   ++  K+    R+ V 
Sbjct: 17  HVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVR 76
Query: 684 ---EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKL 736
              E  +++   HP +VKL+       +L L+ ++++       LS+ +   + + +  L
Sbjct: 77  TKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 136
Query: 737 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 796
                      +A GL +LH    + I++RD+K  N+LLD++ + K++DFGL+K    D 
Sbjct: 137 ---------AELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-EAIDH 183
Query: 797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
              +    GT+ YMAPE   R   +  AD +S+GV+  E+++G
Sbjct: 184 EKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 643 ANKVGEGGFGSVYKGIL-SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 700
             ++G G FG V+ G L +D T++AVK    +       +F+ E  ++    HPN+V+L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G C +   + +V E ++       +  +    R+K    T  ++    A G+ YL     
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK----TLLQMVGDAAAGMEYLESKC- 233
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG----TIGYMAPEYAM 816
              +HRD+   N L+ +    KISDFG+++   E+   +     G     + + APE   
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 817 RGYLTSKADVYSFGVVTLEIVS 838
            G  +S++DV+SFG++  E  S
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 646 VGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
           +GEG FG V++GI     +    +A+K   + +    RE F+ E   +    HP++VKL 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G   E N + ++ E     C    +       +  LD  +       ++  LAYL     
Sbjct: 458 GVITE-NPVWIIMEL----CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK-- 510
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
            + VHRDI   NVL+  +   K+ DFGL++  E+   + +++    I +MAPE       
Sbjct: 511 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 821 TSKADVYSFGVVTLEIV 837
           TS +DV+ FGV   EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 626 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREF 681
           G +  ++ + A  +F+    +G+G FG+VY         ++A+K L     +      + 
Sbjct: 1   GSHMSKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 60
Query: 682 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 741
             E+ + S  +HPN+++LYG   +  ++ L+ EY     + R +     +   K D    
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRT 115
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
                 +A  L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T
Sbjct: 116 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RT 169
Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            + GT+ Y+ PE         K D++S GV+  E + GK
Sbjct: 170 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 123
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 177
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 646 VGEGGFGSVYK----GILSDGT--VIAVKQLSSKSRQG-NREFVNEIG-MISAQQHPNLV 697
           +G G FG V +    GI    T   +AVK L   +    +R  ++E+  +I    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 698 KLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKK-IC--IGIA 749
            L G C + G  L+++ E+ K   LS  +  K  E+     L  D+ T +  IC    +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG-TIG 808
           +G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D  ++    A   + 
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MAPE       T ++DV+SFGV+  EI S
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 639 NFDPANKVGEGGFGSV--YKGILSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISAQ 691
           N+     +G+G F  V   + IL+ G  +AVK     QL+S S Q   +   E+ ++   
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVL 63
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GI 748
            HPN+VKL+        L LV EY        A  G+  +Y +   W   K+       I
Sbjct: 64  NHPNIVKLFEVIETEKTLYLVMEY--------ASGGEVFDYLVAHGWMKEKEARAKFRQI 115
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
              + Y H+     IVHRD+K  N+LLD D+N KI+DFG +  +      + T   G+  
Sbjct: 116 VSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT-FCGSPP 170
Query: 809 YMAPE-YAMRGYLTSKADVYSFGVVTLEIVSG 839
           Y APE +  + Y   + DV+S GV+   +VSG
Sbjct: 171 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQL--SSKSRQG-NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L  +   + G   +   E+ + S  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 146
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 147 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 200
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 201 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 124
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 125 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 178
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 26/233 (11%)
Query: 646 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V      GI  D       +AVK L   + + +  + V+E+ M+    +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICI------ 746
           ++ L G C +   L ++ EY     L    RA      EY   ++    +++        
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 747 --GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL   +  K +HRD+   NVL+ ++   KI+DFGLA+ +   D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 26/233 (11%)
Query: 646 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V      GI  D       +AVK L   + + +  + V+E+ M+    +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICI------ 746
           ++ L G C +   L ++ EY     L    RA      EY   ++    +++        
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 747 --GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL   +  K +HRD+   NVL+ ++   KI+DFGLA+ +   D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 123
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 177
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 646 VGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
           +GEG FG V++GI     +    +A+K   + +    RE F+ E   +    HP++VKL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G   E N + ++ E      L    F +  +Y   LD  +       ++  LAYL     
Sbjct: 78  GVITE-NPVWIIMELCTLGELRS--FLQVRKY--SLDLASLILYAYQLSTALAYLESK-- 130
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
            + VHRDI   NVL+  +   K+ DFGL++  E+   + +++    I +MAPE       
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 821 TSKADVYSFGVVTLEIV 837
           TS +DV+ FGV   EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 26/233 (11%)
Query: 646 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V      GI  D       +AVK L   + + +  + V+E+ M+    +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICI------ 746
           ++ L G C +   L ++ EY     L    RA      EY   ++    +++        
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 747 --GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL   +  K +HRD+   NVL+ ++   KI+DFGLA+ +   D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 120
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLP 174
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 646 VGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
           +GEG FG V++GI     +    +A+K   + +    RE F+ E   +    HP++VKL 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G   E N + ++ E     C    +       +  LD  +       ++  LAYL     
Sbjct: 106 GVITE-NPVWIIMEL----CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-- 158
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
            + VHRDI   NVL+  +   K+ DFGL++  E+   + +++    I +MAPE       
Sbjct: 159 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 217
Query: 821 TSKADVYSFGVVTLEIV 837
           TS +DV+ FGV   EI+
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 121
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLP 175
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 125
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 179
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 25/219 (11%)
Query: 638 NNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA- 690
           N+    + +GEG FG V K      G+  D  +  +K+ +SK    +R+F  E+ ++   
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKL 79
Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWP 739
             HPN++ L G C     L L  EY  +  L      SR +     F         L   
Sbjct: 80  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 139
Query: 740 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 799
                   +ARG+ YL   S+ + +HR++   N+L+ ++  AKI+DFGL++  E      
Sbjct: 140 QLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKT 196
Query: 800 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             R+   + +MA E       T+ +DV+S+GV+  EIVS
Sbjct: 197 MGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 631 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGT----VIAVKQLSSKSRQGNR-EFVNEI 685
           +Q +   + +D  + +G G F  V   IL++      ++A+K ++ ++ +G      NEI
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEI 67
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            ++   +HPN+V L      G  L L+ + +    L   I  K   +  + D     ++ 
Sbjct: 68  AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERD---ASRLI 122
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVL---LDKDLNAKISDFGLAKLYEEDKTHISTR 802
             +   + YLH+   + IVHRD+K  N+L   LD+D    ISDFGL+K+  ED   + + 
Sbjct: 123 FQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLST 177
Query: 803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             GT GY+APE   +   +   D +S GV+   ++ G
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 125
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 179
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 180 PEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 13/197 (6%)
Query: 646 VGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
           +GEG FG V++GI     +    +A+K   + +    RE F+ E   +    HP++VKL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G   E N + ++ E     C    +       +  LD  +       ++  LAYL     
Sbjct: 78  GVITE-NPVWIIMEL----CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK-- 130
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
            + VHRDI   NVL+      K+ DFGL++  E+   + +++    I +MAPE       
Sbjct: 131 -RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 821 TSKADVYSFGVVTLEIV 837
           TS +DV+ FGV   EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 120
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLP 174
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 646 VGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
           +GEG FG V++GI     +    +A+K   + +    RE F+ E   +    HP++VKL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G   E N + ++ E      L    F +  +Y   LD  +       ++  LAYL     
Sbjct: 78  GVITE-NPVWIIMELCTLGELRS--FLQVRKY--SLDLASLILYAYQLSTALAYLESK-- 130
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
            + VHRDI   NVL+  +   K+ DFGL++  E+   + +++    I +MAPE       
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 821 TSKADVYSFGVVTLEIV 837
           TS +DV+ FGV   EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 646 VGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
           +GEG FG V++GI     +    +A+K   + +    RE F+ E   +    HP++VKL 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G   E N + ++ E      L    F +  +Y   LD  +       ++  LAYL     
Sbjct: 83  GVITE-NPVWIIMELCTLGELRS--FLQVRKY--SLDLASLILYAYQLSTALAYLESK-- 135
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
            + VHRDI   NVL+  +   K+ DFGL++  E+   + +++    I +MAPE       
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 821 TSKADVYSFGVVTLEIV 837
           TS +DV+ FGV   EI+
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 137
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 138 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 191
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 192 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 117
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 118 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 171
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 172 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 638 NNFDPANKVGEGGFGSVYK----GILSDGTV--IAVKQLSSKSRQGNRE-FVNEIGMISA 690
           NN      +G G FG V +    G+  +  V  +AVK L S +    +E  ++E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 691 -QQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAI-----FGKDTEYRLKLDWPT 740
             QH N+V L G C  G  +L++ EY       N L R       +  +  +  +    +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 741 RKKICIG--IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 798
           R  +     +A+G+A+L   +    +HRD+   NVLL     AKI DFGLA+    D  +
Sbjct: 166 RDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 799 ISTRIAG-TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           I    A   + +MAPE       T ++DV+S+G++  EI S
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 631 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGT----VIAVKQLSSKSRQGNR-EFVNEI 685
           +Q +   + +D  + +G G F  V   IL++      ++A+K ++ ++ +G      NEI
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEI 67
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            ++   +HPN+V L      G  L L+ + +    L   I  K   +  + D     ++ 
Sbjct: 68  AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERD---ASRLI 122
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVL---LDKDLNAKISDFGLAKLYEEDKTHISTR 802
             +   + YLH+   + IVHRD+K  N+L   LD+D    ISDFGL+K+  ED   + + 
Sbjct: 123 FQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLST 177
Query: 803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             GT GY+APE   +   +   D +S GV+   ++ G
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 26/233 (11%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNRE----FVNEIG 686
           QIK    +F+    +G+G FG V+           A+K L       + +     V +  
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRK 742
           +  A +HP L  ++        L  V EY+          G D  Y +    K D     
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLN---------GGDLMYHIQSCHKFDLSRAT 122
Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHIS 800
                I  GL +LH      IV+RD+K  N+LLDKD + KI+DFG+ K  +  + KT   
Sbjct: 123 FYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--- 176
Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 853
               GT  Y+APE  +        D +SFGV+  E++ G+S  + +  E+  +
Sbjct: 177 NEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 229

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 20/210 (9%)
Query: 646 VGEGGFGSVYK----GILSDGT--VIAVKQLSSKSRQG-NREFVNEIG-MISAQQHPNLV 697
           +G G FG V +    GI    T   +AVK L   +    +R  ++E+  +I    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 698 KLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKIC---IGIA 749
            L G C + G  L+++ E+ K   LS  +  K  E+     L  D+ T + +      +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG-TIG 808
           +G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D  ++    A   + 
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +MAPE       T ++DV+SFGV+  EI S
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 646 VGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
           +GEG FG V++GI     +    +A+K   + +    RE F+ E   +    HP++VKL 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G   E N + ++ E      L    F +  +Y   LD  +       ++  LAYL     
Sbjct: 75  GVITE-NPVWIIMELCTLGELRS--FLQVRKY--SLDLASLILYAYQLSTALAYLESK-- 127
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
            + VHRDI   NVL+  +   K+ DFGL++  E+   + +++    I +MAPE       
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 821 TSKADVYSFGVVTLEIV 837
           TS +DV+ FGV   EI+
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 14/217 (6%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
           +GEG FG VY+G+ +    +   +AVK         N+E F++E  ++    HP++VKL 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G  +E     ++ E      L   +       ++     T     + I + +AYL     
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVL----TLVLYSLQICKAMAYLES--- 127
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
           I  VHRDI   N+L+      K+ DFGL++  E++  + ++     I +M+PE       
Sbjct: 128 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 187
Query: 821 TSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLD 856
           T+ +DV+ F V   EI+S GK    +  N+D + +L+
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 224

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 631 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGT----VIAVKQLSSKSRQGNR-EFVNEI 685
           +Q +   + +D  + +G G F  V   IL++      ++A+K ++ ++ +G      NEI
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEI 67
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            ++   +HPN+V L      G  L L+ + +    L   I  K   +  + D     ++ 
Sbjct: 68  AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERD---ASRLI 122
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVL---LDKDLNAKISDFGLAKLYEEDKTHISTR 802
             +   + YLH+   + IVHRD+K  N+L   LD+D    ISDFGL+K+  ED   + + 
Sbjct: 123 FQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLST 177
Query: 803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             GT GY+APE   +   +   D +S GV+   ++ G
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 111/231 (48%), Gaps = 23/231 (9%)
Query: 638 NNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 695
           ++F+  +++G G  G V+K      G V+A K +  + +   R + + E+ ++     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLA 753
           +V  YG      ++ +  E+M    L + +   G+  E  L        K+ I + +GL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-------KVSIAVIKGLT 118
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YL E  + KI+HRD+K SN+L++     K+ DFG++    +    ++    GT  YM+PE
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPE 173
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGK-------SNTNYRPNEDFVYLLDW 857
                + + ++D++S G+  +E+  G+       +  + RP      LLD+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDY 224

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 26/233 (11%)
Query: 646 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V      GI  D       +AVK L   + + +  + V+E+ M+    +H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICI------ 746
           ++ L G C +   L ++ EY     L    RA      EY   ++    +++        
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 747 --GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL   +  K +HRD+   NVL+ ++   KI+DFGLA+ +   D    +T  
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 646 VGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
           +GEG FG V++GI     +    +A+K   + +    RE F+ E   +    HP++VKL 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G   E N + ++ E     C    +       +  LD  +       ++  LAYL     
Sbjct: 80  GVITE-NPVWIIMEL----CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-- 132
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
            + VHRDI   NVL+  +   K+ DFGL++  E+   + +++    I +MAPE       
Sbjct: 133 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 821 TSKADVYSFGVVTLEIV 837
           TS +DV+ FGV   EI+
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 646 VGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
           +GEG FG V++GI     +    +A+K   + +    RE F+ E   +    HP++VKL 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G   E N + ++ E     C    +       +  LD  +       ++  LAYL     
Sbjct: 81  GVITE-NPVWIIMEL----CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-- 133
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
            + VHRDI   NVL+  +   K+ DFGL++  E+   + +++    I +MAPE       
Sbjct: 134 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 821 TSKADVYSFGVVTLEIV 837
           TS +DV+ FGV   EI+
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY C  +  +L     Y KN  L + I    +      D    +     I   L 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALE 151
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 152 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 208
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E          +D+++ G +  ++V+G
Sbjct: 209 ELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 26/233 (11%)
Query: 646 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V      GI  D       +AVK L   + + +  + V+E+ M+    +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICI------ 746
           ++ L G C +   L ++ EY     L    RA      EY   ++    +++        
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 747 --GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL   +  K +HRD+   NVL+ ++   +I+DFGLA+ +   D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 14/217 (6%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
           +GEG FG VY+G+ +    +   +AVK         N+E F++E  ++    HP++VKL 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G  +E     ++ E      L   +       ++     T     + I + +AYL     
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVL----TLVLYSLQICKAMAYLES--- 143
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
           I  VHRDI   N+L+      K+ DFGL++  E++  + ++     I +M+PE       
Sbjct: 144 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 203
Query: 821 TSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLD 856
           T+ +DV+ F V   EI+S GK    +  N+D + +L+
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 240

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY     +   ++A+K L     +      +   E+ + S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 120
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     K++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ 
Sbjct: 121 LSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLP 174
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 13/197 (6%)
Query: 646 VGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
           +GEG FG V++GI     +    +A+K   + +    RE F+ E   +    HP++VKL 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G   E N + ++ E     C    +       +  LD  +       ++  LAYL     
Sbjct: 458 GVITE-NPVWIIMEL----CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK-- 510
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
            + VHRDI   NVL+      K+ DFGL++  E+   + +++    I +MAPE       
Sbjct: 511 -RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 821 TSKADVYSFGVVTLEIV 837
           TS +DV+ FGV   EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 26/233 (11%)
Query: 646 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V      GI  D       +AVK L   + + +  + V+E+ M+    +H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICI------ 746
           ++ L G C +   L ++ EY     L    RA      EY   ++    +++        
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 747 --GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL   +  K +HRD+   NVL+ ++   KI+DFGLA+ +   D    +T  
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 259

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 14/217 (6%)
Query: 646 VGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
           +GEG FG VY+G+ +    +   +AVK         N+E F++E  ++    HP++VKL 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G  +E     ++ E      L   +       ++     T     + I + +AYL     
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVL----TLVLYSLQICKAMAYLES--- 131
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
           I  VHRDI   N+L+      K+ DFGL++  E++  + ++     I +M+PE       
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 821 TSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLD 856
           T+ +DV+ F V   EI+S GK    +  N+D + +L+
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 26/233 (11%)
Query: 646 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V      GI  D       +AVK L   + + +  + V+E+ M+    +H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICI------ 746
           ++ L G C +   L ++ EY     L    RA      EY   ++    +++        
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 747 --GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL   +  K +HRD+   NVL+ ++   KI+DFGLA+ +   D    +T  
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 261

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQL--SSKSRQG-NREFVNEIGMISAQQH 693
            +FD    +G+G FG+VY         ++A+K L  +   + G   +   E+ + S  +H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           PN+++LYG   +  ++ L+ EY     + R +     +   + D          +A  L+
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSRFDEQRTATYITELANALS 126
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           Y H     +++HRDIK  N+LL  +   KI+DFG +      +    T + GT+ Y+ PE
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE 180
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSG 839
                    K D++S GV+  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 26/233 (11%)
Query: 646 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V      GI  D       +AVK L   + + +  + V+E+ M+    +H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICI------ 746
           ++ L G C +   L ++ EY     L    RA      EY   ++    +++        
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 747 --GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL   +  K +HRD+   NVL+ ++   KI+DFGLA+ +   D    +T  
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 264

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQL--SSKSRQG-NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L  +   + G   +   E+ + S  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY       R    K+ +   K D          +A  
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYA-----PRGEVYKELQKLSKFDEQRTATYITELANA 125
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ 
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLXGTLDYLP 179
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  L   + G D    LK    +   IC     I RGL Y+H  
Sbjct: 107 ---NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 163
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 164 N---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 221 NSKGY-TKSIDIWSVGCILAEMLSNR 245

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 643 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR------EFVNEIGMISAQQHPN 695
            + +G G FG V  G     G  +AVK L+   RQ  R      +   EI  +   +HP+
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILN---RQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           ++KLY      + + +V EY+    L   I         +LD    +++   I  G+ Y 
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-----RLDEKESRRLFQQILSGVDYC 132
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
           H   R  +VHRD+K  NVLLD  +NAKI+DFGL+ +  + +        G+  Y APE  
Sbjct: 133 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRXSCGSPNYAAPEVI 187
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
           + R Y   + D++S GV+   ++ G
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 110/214 (51%), Gaps = 20/214 (9%)
Query: 633 IKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLS----SKSRQG-NREFVNEIG 686
           +K+    ++  + +GEG F +VYK    +   ++A+K++     S+++ G NR  + EI 
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR-KKIC 745
           ++    HPN++ L       + + LV+++M+ +     +  KD    L    P+  K   
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDL---EVIIKDNSLVLT---PSHIKAYM 118
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
           +   +GL YLH+     I+HRD+K +N+LLD++   K++DFGLAK +         ++  
Sbjct: 119 LMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV- 174
Query: 806 TIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIV 837
           T  Y APE  +  R Y     D+++ G +  E++
Sbjct: 175 TRWYRAPELLFGARMYGVG-VDMWAVGCILAELL 207

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 645 KVGEGGFGSVYKGILS-DGTVIAVKQL-SSKSRQGNREFVNEIGMI-SAQQHPNLVKLYG 701
           ++G G +GSV K +    G ++AVK++ S+   +  ++ + ++ ++  +   P +V+ YG
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-----LDWPTRKKICIGIARGLAYLH 756
                    +  E M  +      F K  +Y        +      KI +   + L +L 
Sbjct: 89  ALFREGDCWICMELMSTS------FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY-- 814
           E+  +KI+HRDIK SN+LLD+  N K+ DFG++    +  +   TR AG   YMAPE   
Sbjct: 143 EN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPERID 198
Query: 815 --AMRGYLTSKADVYSFGVVTLEIVSGK 840
             A R     ++DV+S G+   E+ +G+
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 124/309 (40%), Gaps = 57/309 (18%)
Query: 3   KKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALK 62
           K+AL QI + LG           +   +W  ++D        V CD  + T  V  + L 
Sbjct: 8   KQALLQIKKDLGNP---------TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLS 58
Query: 63  AQNLTGT--LPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 120
             NL     +P+ L+ L YL  L +      G                  N L GP P  
Sbjct: 59  GLNLPKPYPIPSSLANLPYLNFLYI------GGI----------------NNLVGPIPPA 96
Query: 121 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 180
           +  +T L  L I     +G+IP  + ++  L  L  S N+ +G LP  ++ L NL  +  
Sbjct: 97  IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156
Query: 181 SDNNFSGKIPEFIGKWKKI-QKLHIQGSSLEGPIPASISALT-SLTDLRISDLKGSESAF 238
             N  SG IP+  G + K+   + I  + L G IP + + L  +  DL  + L+G  S  
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVL 216
Query: 239 PKLDK----------------------MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 276
              DK                       NL  L L    I+G +P  +  +  L ++++S
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276
Query: 277 FNNLTGGIP 285
           FNNL G IP
Sbjct: 277 FNNLCGEIP 285

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 63/143 (44%), Gaps = 26/143 (18%)
Query: 170 TKLTNLNDLRISDNNFSGK--IPEFIGKWKKIQKLHIQG-SSLEGPIPASISALTSLTDL 226
           T+   +N+L +S  N      IP  +     +  L+I G ++L GPIP +I+ LT L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 227 RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT 286
            I                       T   + G IPD++  +  L  +D S+N L+G +P 
Sbjct: 107 YI-----------------------THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP 143
Query: 287 TFEKLAKTNFMYLTGNKLTGPVP 309
           +   L     +   GN+++G +P
Sbjct: 144 SISSLPNLVGITFDGNRISGAIP 166

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 23/213 (10%)
Query: 646 VGEGGFGSVYK----GILSDGTV--IAVKQLSSKSRQG-NREFVNEIG-MISAQQHPNLV 697
           +G G FG V +    GI    T   +AVK L   +    +R  ++E+  +I    H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 698 KLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEY-------RLKLDWPTRKK-IC--I 746
            L G C + G  L+++ E+ K   LS  +  K  E+        L  D+ T +  IC   
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG- 805
            +A+G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D   +    A  
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 639 NFDPANKVGEGGFGSV--YKGILSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISAQ 691
           N+     +G+G F  V   + IL+ G  +AVK     QL+S S Q   +   E+ ++   
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVL 70
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG----KDTEYRLKLDWPTRKKICIG 747
            HPN+VKL+        L LV EY     +   +      K+ E R K            
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ--------- 121
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I   + Y H+     IVHRD+K  N+LLD D+N KI+DFG +  +      + T   G+ 
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT-FCGSP 176
Query: 808 GYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSG 839
            Y APE +  + Y   + DV+S GV+   +VSG
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 646 VGEGGFGSVYK----GILSDGTV--IAVKQLSSKSRQG-NREFVNEIG-MISAQQHPNLV 697
           +G G FG V +    GI    T   +AVK L   +    +R  ++E+  +I    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 698 KLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEY--------RLKLDWPTRKK-IC-- 745
            L G C + G  L+++ E+ K   LS  +  K  E+         L  D+ T +  IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +A+G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D  ++    A 
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 806 -TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 639 NFDPANKVGEGGFGSV--YKGILSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISAQ 691
           N+     +G+G F  V   + IL+ G  +AVK     QL+S S Q   +   E+ ++   
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVL 70
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG----KDTEYRLKLDWPTRKKICIG 747
            HPN+VKL+        L LV EY     +   +      K+ E R K            
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ--------- 121
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I   + Y H+     IVHRD+K  N+LLD D+N KI+DFG +  +      + T   G+ 
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT-FCGSP 176
Query: 808 GYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSG 839
            Y APE +  + Y   + DV+S GV+   +VSG
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 101/249 (40%), Gaps = 38/249 (15%)
Query: 607 CLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS------ 660
           C  GK S+  +L+              +    N      +G G FG VY+G +S      
Sbjct: 28  CFAGKTSSISDLK--------------EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP 73
Query: 661 DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 719
               +AVK L    S Q   +F+ E  +IS   H N+V+  G  ++     ++ E M   
Sbjct: 74  SPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGG 133
Query: 720 CLSRAIFGKDTEYRLKLDWPTRK------KICIGIARGLAYLHEDSRIKIVHRDIKTSNV 773
            L   +     E R +   P+         +   IA G  YL E+     +HRDI   N 
Sbjct: 134 DLKSFL----RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC 186
Query: 774 LLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSF 829
           LL        AKI DFG+A+ +Y              + +M PE  M G  TSK D +SF
Sbjct: 187 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 246
Query: 830 GVVTLEIVS 838
           GV+  EI S
Sbjct: 247 GVLLWEIFS 255

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 646 VGEGGFGSVYK----GILSDGTV--IAVKQLSSKSRQG-NREFVNEIG-MISAQQHPNLV 697
           +G G FG V +    GI    T   +AVK L   +    +R  ++E+  +I    H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 698 KLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEY--------RLKLDWPTRKK-IC-- 745
            L G C + G  L+++ E+ K   LS  +  K  E+         L  D+ T +  IC  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +A+G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D  ++    A 
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 806 -TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++ A +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 89  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 146 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 203 NSKGY-TKSIDIWSVGCILAEMLSNR 227

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 103/221 (46%), Gaps = 27/221 (12%)
Query: 633 IKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNE---I 685
           I    N+F     +G GGFG VY    +D G + A+K L  K    +QG    +NE   +
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTR 741
            ++S    P +V +       ++L  + + M          G D  Y L           
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN---------GGDLHYHLSQHGVFSEADM 294
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
           +     I  GL ++H  +R  +V+RD+K +N+LLD+  + +ISD GLA  + + K H S 
Sbjct: 295 RFYAAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 351
Query: 802 RIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKS 841
              GT GYMAPE   +G    S AD +S G +  +++ G S
Sbjct: 352 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 103/221 (46%), Gaps = 27/221 (12%)
Query: 633 IKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNE---I 685
           I    N+F     +G GGFG VY    +D G + A+K L  K    +QG    +NE   +
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTR 741
            ++S    P +V +       ++L  + + M          G D  Y L           
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN---------GGDLHYHLSQHGVFSEADM 294
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
           +     I  GL ++H  +R  +V+RD+K +N+LLD+  + +ISD GLA  + + K H S 
Sbjct: 295 RFYAAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 351
Query: 802 RIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKS 841
              GT GYMAPE   +G    S AD +S G +  +++ G S
Sbjct: 352 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 103/221 (46%), Gaps = 27/221 (12%)
Query: 633 IKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNE---I 685
           I    N+F     +G GGFG VY    +D G + A+K L  K    +QG    +NE   +
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTR 741
            ++S    P +V +       ++L  + + M          G D  Y L           
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN---------GGDLHYHLSQHGVFSEADM 294
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
           +     I  GL ++H  +R  +V+RD+K +N+LLD+  + +ISD GLA  + + K H S 
Sbjct: 295 RFYAAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 351
Query: 802 RIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKS 841
              GT GYMAPE   +G    S AD +S G +  +++ G S
Sbjct: 352 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 101/249 (40%), Gaps = 38/249 (15%)
Query: 607 CLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS------ 660
           C  GK S+  +L+              +    N      +G G FG VY+G +S      
Sbjct: 13  CFAGKTSSISDLK--------------EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP 58
Query: 661 DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 719
               +AVK L    S Q   +F+ E  +IS   H N+V+  G  ++     ++ E M   
Sbjct: 59  SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGG 118
Query: 720 CLSRAIFGKDTEYRLKLDWPTRK------KICIGIARGLAYLHEDSRIKIVHRDIKTSNV 773
            L   +     E R +   P+         +   IA G  YL E+     +HRDI   N 
Sbjct: 119 DLKSFL----RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC 171
Query: 774 LLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSF 829
           LL        AKI DFG+A+ +Y              + +M PE  M G  TSK D +SF
Sbjct: 172 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 231
Query: 830 GVVTLEIVS 838
           GV+  EI S
Sbjct: 232 GVLLWEIFS 240

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 101/249 (40%), Gaps = 38/249 (15%)
Query: 607 CLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS------ 660
           C  GK S+  +L+              +    N      +G G FG VY+G +S      
Sbjct: 28  CFAGKTSSISDLK--------------EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP 73
Query: 661 DGTVIAVKQLSS-KSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 719
               +AVK L    S Q   +F+ E  +IS   H N+V+  G  ++     ++ E M   
Sbjct: 74  SPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 133
Query: 720 CLSRAIFGKDTEYRLKLDWPTRK------KICIGIARGLAYLHEDSRIKIVHRDIKTSNV 773
            L   +     E R +   P+         +   IA G  YL E+     +HRDI   N 
Sbjct: 134 DLKSFL----RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC 186
Query: 774 LLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSF 829
           LL        AKI DFG+A+ +Y              + +M PE  M G  TSK D +SF
Sbjct: 187 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 246
Query: 830 GVVTLEIVS 838
           GV+  EI S
Sbjct: 247 GVLLWEIFS 255

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 101/249 (40%), Gaps = 38/249 (15%)
Query: 607 CLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS------ 660
           C  GK S+  +L+              +    N      +G G FG VY+G +S      
Sbjct: 5   CFAGKTSSISDLK--------------EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP 50
Query: 661 DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 719
               +AVK L    S Q   +F+ E  +IS   H N+V+  G  ++     ++ E M   
Sbjct: 51  SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 110
Query: 720 CLSRAIFGKDTEYRLKLDWPTRK------KICIGIARGLAYLHEDSRIKIVHRDIKTSNV 773
            L   +     E R +   P+         +   IA G  YL E+     +HRDI   N 
Sbjct: 111 DLKSFL----RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC 163
Query: 774 LLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSF 829
           LL        AKI DFG+A+ +Y              + +M PE  M G  TSK D +SF
Sbjct: 164 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 223
Query: 830 GVVTLEIVS 838
           GV+  EI S
Sbjct: 224 GVLLWEIFS 232

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 120
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLP 174
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 101/249 (40%), Gaps = 38/249 (15%)
Query: 607 CLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS------ 660
           C  GK S+  +L+              +    N      +G G FG VY+G +S      
Sbjct: 13  CFAGKTSSISDLK--------------EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP 58
Query: 661 DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 719
               +AVK L    S Q   +F+ E  +IS   H N+V+  G  ++     ++ E M   
Sbjct: 59  SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 118
Query: 720 CLSRAIFGKDTEYRLKLDWPTRK------KICIGIARGLAYLHEDSRIKIVHRDIKTSNV 773
            L   +     E R +   P+         +   IA G  YL E+     +HRDI   N 
Sbjct: 119 DLKSFL----RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC 171
Query: 774 LLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSF 829
           LL        AKI DFG+A+ +Y              + +M PE  M G  TSK D +SF
Sbjct: 172 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 231
Query: 830 GVVTLEIVS 838
           GV+  EI S
Sbjct: 232 GVLLWEIFS 240

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 103/221 (46%), Gaps = 27/221 (12%)
Query: 633 IKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNE---I 685
           I    N+F     +G GGFG VY    +D G + A+K L  K    +QG    +NE   +
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTR 741
            ++S    P +V +       ++L  + + M          G D  Y L           
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN---------GGDLHYHLSQHGVFSEADM 293
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
           +     I  GL ++H  +R  +V+RD+K +N+LLD+  + +ISD GLA  + + K H S 
Sbjct: 294 RFYAAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 350
Query: 802 RIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKS 841
              GT GYMAPE   +G    S AD +S G +  +++ G S
Sbjct: 351 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 388

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 120
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLP 174
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 102/230 (44%), Gaps = 40/230 (17%)
Query: 646 VGEGGFGSVYKGIL---SDGT--VIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKL 699
           +GEG FG V        +DGT  ++AVK L        R  +  EI ++    H ++VK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 700 YGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR------- 750
            GCC +  +  + LV EY+    L               D+  R   C+G+A+       
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLR--------------DYLPRH--CVGLAQLLLFAQQ 120
Query: 751 ---GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG-- 805
              G+AYLH    I   HR +   NVLLD D   KI DFGLAK   E   +   R  G  
Sbjct: 121 ICEGMAYLHAQHYI---HRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 177
Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 855
            + + APE          +DV+SFGV   E+++   ++N  P+  F  L+
Sbjct: 178 PVFWYAPECLKECKFYYASDVWSFGVTLYELLT-YCDSNQSPHTKFTELI 226

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 646 VGEGGFGSVYK----GILSDGTV--IAVKQLSSKSRQG-NREFVNEIG-MISAQQHPNLV 697
           +G G FG V +    GI    T   +AVK L   +    +R  ++E+  +I    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 698 KLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEY--------RLKLDWPTRKK-IC-- 745
            L G C + G  L+++ E+ K   LS  +  K  E+         L  D+ T +  IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +A+G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D   +    A 
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 806 -TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 646 VGEGGFGSVYK----GILSDGTV--IAVKQLSSKSRQG-NREFVNEIG-MISAQQHPNLV 697
           +G G FG V +    GI    T   +AVK L   +    +R  ++E+  +I    H N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 698 KLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEY--------RLKLDWPTRKK-IC-- 745
            L G C + G  L+++ E+ K   LS  +  K  E+         L  D+ T +  IC  
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +A+G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D  ++    A 
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 806 -TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 101/249 (40%), Gaps = 38/249 (15%)
Query: 607 CLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS------ 660
           C  GK S+  +L+              +    N      +G G FG VY+G +S      
Sbjct: 30  CFAGKTSSISDLK--------------EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP 75
Query: 661 DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 719
               +AVK L    S Q   +F+ E  +IS   H N+V+  G  ++     ++ E M   
Sbjct: 76  SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 135
Query: 720 CLSRAIFGKDTEYRLKLDWPTRK------KICIGIARGLAYLHEDSRIKIVHRDIKTSNV 773
            L   +     E R +   P+         +   IA G  YL E+     +HRDI   N 
Sbjct: 136 DLKSFL----RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC 188
Query: 774 LLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSF 829
           LL        AKI DFG+A+ +Y              + +M PE  M G  TSK D +SF
Sbjct: 189 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 248
Query: 830 GVVTLEIVS 838
           GV+  EI S
Sbjct: 249 GVLLWEIFS 257

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 101/249 (40%), Gaps = 38/249 (15%)
Query: 607 CLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS------ 660
           C  GK S+  +L+              +    N      +G G FG VY+G +S      
Sbjct: 28  CFAGKTSSISDLK--------------EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP 73
Query: 661 DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 719
               +AVK L    S Q   +F+ E  +IS   H N+V+  G  ++     ++ E M   
Sbjct: 74  SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGG 133
Query: 720 CLSRAIFGKDTEYRLKLDWPTRK------KICIGIARGLAYLHEDSRIKIVHRDIKTSNV 773
            L   +     E R +   P+         +   IA G  YL E+     +HRDI   N 
Sbjct: 134 DLKSFL----RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC 186
Query: 774 LLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSF 829
           LL        AKI DFG+A+ +Y              + +M PE  M G  TSK D +SF
Sbjct: 187 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 246
Query: 830 GVVTLEIVS 838
           GV+  EI S
Sbjct: 247 GVLLWEIFS 255

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 102/230 (44%), Gaps = 40/230 (17%)
Query: 646 VGEGGFGSVYKGIL---SDGT--VIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKL 699
           +GEG FG V        +DGT  ++AVK L        R  +  EI ++    H ++VK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 700 YGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR------- 750
            GCC +  +  + LV EY+    L               D+  R   C+G+A+       
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLR--------------DYLPRH--CVGLAQLLLFAQQ 119
Query: 751 ---GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG-- 805
              G+AYLH    I   HR +   NVLLD D   KI DFGLAK   E   +   R  G  
Sbjct: 120 ICEGMAYLHAQHYI---HRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 176
Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 855
            + + APE          +DV+SFGV   E+++   ++N  P+  F  L+
Sbjct: 177 PVFWYAPECLKECKFYYASDVWSFGVTLYELLT-YCDSNQSPHTKFTELI 225

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 123
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI++FG +      +    T + GT+ Y+ 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGTLDYLP 177
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 101/249 (40%), Gaps = 38/249 (15%)
Query: 607 CLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS------ 660
           C  GK S+  +L+              +    N      +G G FG VY+G +S      
Sbjct: 54  CFAGKTSSISDLK--------------EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP 99
Query: 661 DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 719
               +AVK L    S Q   +F+ E  +IS   H N+V+  G  ++     ++ E M   
Sbjct: 100 SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 159
Query: 720 CLSRAIFGKDTEYRLKLDWPTRK------KICIGIARGLAYLHEDSRIKIVHRDIKTSNV 773
            L   +     E R +   P+         +   IA G  YL E+     +HRDI   N 
Sbjct: 160 DLKSFL----RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC 212
Query: 774 LLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSF 829
           LL        AKI DFG+A+ +Y              + +M PE  M G  TSK D +SF
Sbjct: 213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 272
Query: 830 GVVTLEIVS 838
           GV+  EI S
Sbjct: 273 GVLLWEIFS 281

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 123
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLP 177
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 639 NFDPANKVGEGGFGSV--YKGILSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISAQ 691
           N+     +G+G F  V   + IL+ G  +AV+     QL+S S Q   +   E+ ++   
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQ---KLFREVRIMKVL 70
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG----KDTEYRLKLDWPTRKKICIG 747
            HPN+VKL+        L LV EY     +   +      K+ E R K            
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ--------- 121
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I   + Y H+     IVHRD+K  N+LLD D+N KI+DFG +   E    +      G+ 
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDEFCGSP 176
Query: 808 GYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSG 839
            Y APE +  + Y   + DV+S GV+   +VSG
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 122
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ 
Sbjct: 123 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLP 176
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 646 VGEGGFGSVYK----GILSDGTV--IAVKQLSSKSRQG-NREFVNEIG-MISAQQHPNLV 697
           +G G FG V +    GI    T   +AVK L   +    +R  ++E+  +I    H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 698 KLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEY--------RLKLDWPTRKK-IC-- 745
            L G C + G  L+++ E+ K   LS  +  K  E+         L  D+ T +  IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +A+G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D  ++    A 
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 806 -TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 646 VGEGGFGSVYK----GILSDGT--VIAVKQLSSKSRQG-NREFVNEIG-MISAQQHPNLV 697
           +G G FG V +    GI    T   +AVK L   +    +R  ++E+  +I    H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 698 KLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEY------RLKLDWPTRKKI---CIG 747
            L G C + G  L+++ E+ K   LS  +  K  E+       L  D+ T + +      
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG-T 806
           +A+G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D   +    A   
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKS---RQGNREFVN-EIGMISAQQHPNLVKLYG 701
           +G+GGF   ++   +D   +   ++  KS   +   RE ++ EI +  +  H ++V  +G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              + + + +V E     C  R++  +  + R  L  P  +     I  G  YLH   R 
Sbjct: 89  FFEDNDFVFVVLEL----CRRRSLL-ELHKRRKALTEPEARYYLRQIVLGCQYLH---RN 140
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
           +++HRD+K  N+ L++DL  KI DFGLA   E D     T + GT  Y+APE   +   +
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 199
Query: 822 SKADVYSFGVVTLEIVSGK 840
            + DV+S G +   ++ GK
Sbjct: 200 FEVDVWSIGCIMYTLLVGK 218

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 646 VGEGGFGSV-----YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           +GEG FG V     YK           +QL  KS    R    EI  +   +HP+++KLY
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKLY 75
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR---KKICIGIARGLAYLHE 757
                   +++V EY         +  K    R+  D   R   + IC      + Y H 
Sbjct: 76  DVITTPTDIVMVIEYAGGELFDYIVEKK----RMTEDEGRRFFQQIIC-----AIEYCH- 125
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
             R KIVHRD+K  N+LLD +LN KI+DFGL+ +   D   + T   G+  Y APE  + 
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTS-CGSPNYAAPE-VIN 180
Query: 818 G--YLTSKADVYSFGVVTLEIVSGK 840
           G  Y   + DV+S G+V   ++ G+
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 31/210 (14%)
Query: 649 GGFGSVYKGILSDGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGN 707
           G FG V+K  L +   +AVK    + +Q    E+  E+  +   +H N+++  G    G 
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKRGT 91
Query: 708 ----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED----- 758
                L L+  + +   LS  +          + W     I   +ARGLAYLHED     
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 759 --SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIGYMAPE-- 813
              +  I HRDIK+ NVLL  +L A I+DFGLA  +E  K+   T    GT  YMAPE  
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205
Query: 814 -----YAMRGYLTSKADVYSFGVVTLEIVS 838
                +    +L  + D+Y+ G+V  E+ S
Sbjct: 206 EGAINFQRDAFL--RIDMYAMGLVLWELAS 233

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 646 VGEGGFGSVYK----GILSDGTV--IAVKQLSSKSRQG-NREFVNEIG-MISAQQHPNLV 697
           +G G FG V +    GI    T   +AVK L   +    +R  ++E+  +I    H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 698 KLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEY--------RLKLDWPTRKK-IC-- 745
            L G C + G  L+++ E+ K   LS  +  K  E+         L  D+ T +  IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +A+G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D  ++    A 
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 806 -TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 646 VGEGGFGSVYK----GILSDGTV--IAVKQLSSKSRQG-NREFVNEIG-MISAQQHPNLV 697
           +G G FG V +    GI    T   +AVK L   +    +R  ++E+  +I    H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 698 KLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEY--------RLKLDWPTRKK-IC-- 745
            L G C + G  L+++ E+ K   LS  +  K  E+         L  D+ T +  IC  
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +A+G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D   +    A 
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 806 -TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQL--SSKSRQG-NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L  +   + G   +   E+ + S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 123
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLP 177
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 121
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ 
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT---LCGTLDYLP 175
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 646 VGEGGFGSVYKGILS------DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVK 698
           +G G FG VY+G +S          +AVK L    S Q   +F+ E  +IS   H N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK------KICIGIARGL 752
             G  ++     ++ E M    L   +     E R +   P+         +   IA G 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARDIACGC 160
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGTIG 808
            YL E+     +HRDI   N LL        AKI DFG+A+ +Y              + 
Sbjct: 161 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 217
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +M PE  M G  TSK D +SFGV+  EI S
Sbjct: 218 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKS---RQGNREFVN-EIGMISAQQHPNLVKLYG 701
           +G+GGF   ++   +D   +   ++  KS   +   RE ++ EI +  +  H ++V  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              + + + +V E     C  R++  +  + R  L  P  +     I  G  YLH   R 
Sbjct: 85  FFEDNDFVFVVLEL----CRRRSLL-ELHKRRKALTEPEARYYLRQIVLGCQYLH---RN 136
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
           +++HRD+K  N+ L++DL  KI DFGLA   E D     T + GT  Y+APE   +   +
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 195
Query: 822 SKADVYSFGVVTLEIVSGK 840
            + DV+S G +   ++ GK
Sbjct: 196 FEVDVWSIGCIMYTLLVGK 214

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 646 VGEGGFGSVYKGILS------DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVK 698
           +G G FG VY+G +S          +AVK L    S Q   +F+ E  +IS   H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK------KICIGIARGL 752
             G  ++     ++ E M    L   +     E R +   P+         +   IA G 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGTIG 808
            YL E+     +HRDI   N LL        AKI DFG+A+ +Y              + 
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 211
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +M PE  M G  TSK D +SFGV+  EI S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKS---RQGNREFVN-EIGMISAQQHPNLVKLYG 701
           +G+GGF   ++   +D   +   ++  KS   +   RE ++ EI +  +  H ++V  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              + + + +V E     C  R++  +  + R  L  P  +     I  G  YLH   R 
Sbjct: 85  FFEDNDFVFVVLEL----CRRRSLL-ELHKRRKALTEPEARYYLRQIVLGCQYLH---RN 136
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
           +++HRD+K  N+ L++DL  KI DFGLA   E D     T + GT  Y+APE   +   +
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 195
Query: 822 SKADVYSFGVVTLEIVSGK 840
            + DV+S G +   ++ GK
Sbjct: 196 FEVDVWSIGCIMYTLLVGK 214

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 122
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI++FG +      +    T + GT+ Y+ 
Sbjct: 123 LSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGTLDYLP 176
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 15/209 (7%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQG---NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L     +      +   E+ + S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 123
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L+Y H     +++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDDLCGTLDYLP 177
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE         K D++S GV+  E + GK
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 639 NFDPANKVGEGGFGSV--YKGILSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISAQ 691
           N+     +G+G F  V   + IL+ G  +AVK     QL+S S Q   +   E+ ++   
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVL 70
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG----KDTEYRLKLDWPTRKKICIG 747
            HPN+VKL+        L LV EY     +   +      K+ E R K            
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ--------- 121
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I   + Y H+     IVHRD+K  N+LLD D+N KI+DFG +   E    +      G  
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDAFCGAP 176
Query: 808 GYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSG 839
            Y APE +  + Y   + DV+S GV+   +VSG
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 101/249 (40%), Gaps = 38/249 (15%)
Query: 607 CLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS------ 660
           C  GK S+  +L+              +    N      +G G FG VY+G +S      
Sbjct: 31  CFAGKTSSISDLK--------------EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP 76
Query: 661 DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 719
               +AVK L    S Q   +F+ E  +IS   H N+V+  G  ++     ++ E M   
Sbjct: 77  SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 136
Query: 720 CLSRAIFGKDTEYRLKLDWPTRK------KICIGIARGLAYLHEDSRIKIVHRDIKTSNV 773
            L   +     E R +   P+         +   IA G  YL E+     +HRDI   N 
Sbjct: 137 DLKSFL----RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC 189
Query: 774 LLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSF 829
           LL        AKI DFG+A+ +Y              + +M PE  M G  TSK D +SF
Sbjct: 190 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 249
Query: 830 GVVTLEIVS 838
           GV+  EI S
Sbjct: 250 GVLLWEIFS 258

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 639 NFDPANKVGEGGFGSV--YKGILSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISAQ 691
           N+     +G+G F  V   + IL+ G  +AV+     QL+S S Q   +   E+ ++   
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQ---KLFREVRIMKVL 70
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG----KDTEYRLKLDWPTRKKICIG 747
            HPN+VKL+        L LV EY     +   +      K+ E R K            
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ--------- 121
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I   + Y H+     IVHRD+K  N+LLD D+N KI+DFG +  +      + T   G+ 
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT-FCGSP 176
Query: 808 GYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSG 839
            Y APE +  + Y   + DV+S GV+   +VSG
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 26/233 (11%)
Query: 646 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V      GI  D       +AVK L   + + +  + V+E+ M+    +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICI------ 746
           ++ L G C +   L ++  Y     L    RA      EY   ++    +++        
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 747 --GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL   +  K +HRD+   NVL+ ++   KI+DFGLA+ +   D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 646 VGEGGFGSVYKGILS------DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVK 698
           +G G FG VY+G +S          +AVK L    S Q   +F+ E  +IS   H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK------KICIGIARGL 752
             G  ++     ++ E M    L   +     E R +   P+         +   IA G 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGTIG 808
            YL E+     +HRDI   N LL        AKI DFG+A+ +Y              + 
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 211
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +M PE  M G  TSK D +SFGV+  EI S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQL--SSKSRQG-NREFVNEIGMISAQ 691
           A  +F+    +G+G FG+VY         ++A+K L  +   + G   +   E+ + S  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +HPN+++LYG   +  ++ L+ EY     + R +     +   K D          +A  
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 146
Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI-STR---IAGTI 807
           L+Y H     +++HRDIK  N+LL      KI+DFG +        H  S+R   + GT+
Sbjct: 147 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTL 196
Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            Y+ PE         K D++S GV+  E + GK
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 646 VGEGGFGSVYK----GILSDGTV--IAVKQLSSKSRQG-NREFVNEIG-MISAQQHPNLV 697
           +G G FG V +    GI    T   +AVK L   +    +R  ++E+  +I    H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 698 KLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEY--------RLKLDWPTRKK-IC-- 745
            L G C + G  L+++ E+ K   LS  +  K  E+         L  D+ T +  IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +A+G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D   +    A 
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 806 -TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 99/233 (42%), Gaps = 26/233 (11%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNRE----FVNEIG 686
           QIK    +F     +G+G FG V+           A+K L       + +     V +  
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRK 742
           +  A +HP L  ++        L  V EY+          G D  Y +    K D     
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLN---------GGDLMYHIQSCHKFDLSRAT 121
Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHIS 800
                I  GL +LH      IV+RD+K  N+LLDKD + KI+DFG+ K  +  + KT   
Sbjct: 122 FYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--- 175
Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 853
               GT  Y+APE  +        D +SFGV+  E++ G+S  + +  E+  +
Sbjct: 176 NXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 646 VGEGGFGSVYKGILSD---GTVIAVKQLSS---KSRQGNREFVNEIGMISAQQHPNLVKL 699
           +G+G FG V   +  D   G   AVK +S    K +      + E+ ++    HPN+ KL
Sbjct: 34  LGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
           Y    +     LV E      L   I       R +       +I   +  G+ Y H++ 
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYXHKN- 145
Query: 760 RIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
             KIVHRD+K  N+LL+   KD N +I DFGL+  +E  K        GT  Y+APE  +
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK--IGTAYYIAPE-VL 200
Query: 817 RGYLTSKADVYSFGVVTLEIVSG 839
            G    K DV+S GV+   ++SG
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSG 223

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 646 VGEGGFGSVYK----GILSDGTV--IAVKQLSSKSRQG-NREFVNEIG-MISAQQHPNLV 697
           +G G FG V +    GI    T   +AVK L   +    +R  ++E+  +I    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 698 KLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEY--------RLKLDWPTRKK-IC-- 745
            L G C + G  L+++ E+ K   LS  +  K  E+         L  D+ T +  IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +A+G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D   +    A 
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 806 -TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 646 VGEGGFGSVYKGILSDGTV----IAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
           +G+G FG VY G   D        A+K LS  +     E F+ E  ++    HPN++ L 
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 701 GCCV--EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGLAYL 755
           G  +  EG   +L+  YM +  L + I             PT K +    + +ARG+ YL
Sbjct: 89  GIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRN-------PTVKDLISFGLQVARGMEYL 140
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-----KLYEEDKTHISTRIAGTIGYM 810
            E    K VHRD+   N +LD+    K++DFGLA     + Y   + H   R+   + + 
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP--VKWT 195
Query: 811 APEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF 851
           A E       T+K+DV+SFGV+  E+++ +    YR  + F
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLT-RGAPPYRHIDPF 235

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++ A +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 89  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 146 N---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 203 NSKGY-TKSIDIWSVGCILAEMLSNR 227

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 646 VGEGGFGSVYKGILS------DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVK 698
           +G G FG VY+G +S          +AVK L    S Q   +F+ E  +IS   H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK------KICIGIARGL 752
             G  ++     ++ E M    L   +     E R +   P+         +   IA G 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGTIG 808
            YL E+     +HRDI   N LL        AKI DFG+A+ +Y              + 
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK 211
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +M PE  M G  TSK D +SFGV+  EI S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 646 VGEGGFGSVYKGILS------DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVK 698
           +G G FG VY+G +S          +AVK L    S Q   +F+ E  +IS   H N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK------KICIGIARGL 752
             G  ++     ++ E M    L   +     E R +   P+         +   IA G 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFL----RETRPRPSQPSSLAMLDLLHVARDIACGC 180
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGTIG 808
            YL E+     +HRDI   N LL        AKI DFG+A+ +Y              + 
Sbjct: 181 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 237
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +M PE  M G  TSK D +SFGV+  EI S
Sbjct: 238 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 26/233 (11%)
Query: 646 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 695
           +GEG FG V      GI  D       +AVK L   + + +  + V+E+ M+    +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICI------ 746
           ++ L G C +   L ++  Y     L    RA      EY   ++    +++        
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 747 --GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 803
              +ARG+ YL   +  K +HRD+   NVL+ ++   KI+DFGLA+ +   D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 855
              + +MAPE       T ++DV+SFGV+  EI + G S     P E+   LL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 104/205 (50%), Gaps = 12/205 (5%)
Query: 638 NNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 695
           ++F+  +++G G  G V K      G ++A K +  + +   R + + E+ ++     P 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           +V  YG      ++ +  E+M    L + +  K+ +   ++      K+ I + RGLAYL
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAK---RIPEEILGKVSIAVLRGLAYL 130
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
            E  + +I+HRD+K SN+L++     K+ DFG++    +    ++    GT  YMAPE  
Sbjct: 131 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMAPERL 185
Query: 816 MRGYLTSKADVYSFGVVTLEIVSGK 840
              + + ++D++S G+  +E+  G+
Sbjct: 186 QGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNL 696
           +F+P   +G GGFG V++     D    A+K++   +R+  RE V  E+  ++  +HP +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 697 VKLYGCCVEGNQLLL-------VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK---KICI 746
           V+ +   +E N           VY Y++     +         R  ++   R     I +
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST----- 801
            IA  + +LH      ++HRD+K SN+    D   K+ DFGL    ++D+   +      
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 802 ---RIAGTIG---YMAPEYAMRGYLTSKADVYSFGVVTLEIV 837
              R  G +G   YM+PE       + K D++S G++  E++
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 638 NNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 695
           ++F+  +++G G  G V+K      G V+A K +  + +   R + + E+ ++     P 
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLA 753
           +V  YG      ++ +  E+M    L + +   G+  E  L        K+ I + +GL 
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-------KVSIAVIKGLT 180
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YL E  + KI+HRD+K SN+L++     K+ DFG++    +    ++    GT  YM+PE
Sbjct: 181 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPE 235
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                + + ++D++S G+  +E+  G+
Sbjct: 236 RLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 638 NNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 695
           ++F+  +++G G  G V+K      G V+A K +  + +   R + + E+ ++     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLA 753
           +V  YG      ++ +  E+M    L + +   G+  E  L        K+ I + +GL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-------KVSIAVIKGLT 118
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YL E  + KI+HRD+K SN+L++     K+ DFG++    +    ++    GT  YM+PE
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPE 173
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                + + ++D++S G+  +E+  G+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 13/211 (6%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMIS 689
           K    +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
              HP  VKLY    +  +L     Y KN  L + I    +      D    +     I 
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIV 120
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIG 808
             L YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  
Sbjct: 121 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           Y++PE          +D+++ G +  ++V+G
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 13/211 (6%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMIS 689
           K    +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
              HP  VKLY    +  +L     Y KN  L + I    +      D    +     I 
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIV 117
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIG 808
             L YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  
Sbjct: 118 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           Y++PE          +D+++ G +  ++V+G
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 638 NNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 695
           ++F+  +++G G  G V+K      G V+A K +  + +   R + + E+ ++     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLA 753
           +V  YG      ++ +  E+M    L + +   G+  E  L        K+ I + +GL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-------KVSIAVIKGLT 118
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YL E  + KI+HRD+K SN+L++     K+ DFG++    +    ++    GT  YM+PE
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPE 173
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                + + ++D++S G+  +E+  G+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQL--SSKSRQG-NREFVNEIGMISAQQH 693
            +FD    +G+G FG+VY         ++A+K L  +   + G   +   E+ + S  +H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           PN+++LYG   +  ++ L+ EY     + R +     +   + D          +A  L+
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSRFDEQRTATYITELANALS 126
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           Y H     +++HRDIK  N+LL  +   KI+DFG +      +      + GT+ Y+ PE
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT---LCGTLDYLPPE 180
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSG 839
                    K D++S GV+  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 13/211 (6%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMIS 689
           K    +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
              HP  VKLY    +  +L     Y KN  L + I    +      D    +     I 
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIV 119
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIG 808
             L YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  
Sbjct: 120 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           Y++PE          +D+++ G +  ++V+G
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 13/211 (6%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMIS 689
           K    +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
              HP  VKLY    +  +L     Y KN  L + I    +      D    +     I 
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIV 118
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIG 808
             L YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  
Sbjct: 119 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           Y++PE          +D+++ G +  ++V+G
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 638 NNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 695
           ++F+  +++G G  G V+K      G V+A K +  + +   R + + E+ ++     P 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLA 753
           +V  YG      ++ +  E+M    L + +   G+  E  L        K+ I + +GL 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-------KVSIAVIKGLT 145
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YL E  + KI+HRD+K SN+L++     K+ DFG++    +    ++    GT  YM+PE
Sbjct: 146 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPE 200
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                + + ++D++S G+  +E+  G+
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 638 NNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 695
           ++F+  +++G G  G V+K      G V+A K +  + +   R + + E+ ++     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLA 753
           +V  YG      ++ +  E+M    L + +   G+  E  L        K+ I + +GL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-------KVSIAVIKGLT 118
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YL E  + KI+HRD+K SN+L++     K+ DFG++    +    ++    GT  YM+PE
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPE 173
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                + + ++D++S G+  +E+  G+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 638 NNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 695
           ++F+  +++G G  G V+K      G V+A K +  + +   R + + E+ ++     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLA 753
           +V  YG      ++ +  E+M    L + +   G+  E  L        K+ I + +GL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-------KVSIAVIKGLT 118
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YL E  + KI+HRD+K SN+L++     K+ DFG++    +    ++    GT  YM+PE
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPE 173
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                + + ++D++S G+  +E+  G+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKS---RQGNREFVN-EIGMISAQQHPNLVKLYG 701
           +G+GGF   ++   +D   +   ++  KS   +   RE ++ EI +  +  H ++V  +G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              + + + +V E     C  R++  +  + R  L  P  +     I  G  YLH   R 
Sbjct: 109 FFEDNDFVFVVLEL----CRRRSLL-ELHKRRKALTEPEARYYLRQIVLGCQYLH---RN 160
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
           +++HRD+K  N+ L++DL  KI DFGLA   E D       + GT  Y+APE   +   +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 219
Query: 822 SKADVYSFGVVTLEIVSGK 840
            + DV+S G +   ++ GK
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKS---RQGNREFVN-EIGMISAQQHPNLVKLYG 701
           +G+GGF   ++   +D   +   ++  KS   +   RE ++ EI +  +  H ++V  +G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              + + + +V E     C  R++  +  + R  L  P  +     I  G  YLH   R 
Sbjct: 107 FFEDNDFVFVVLEL----CRRRSLL-ELHKRRKALTEPEARYYLRQIVLGCQYLH---RN 158
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
           +++HRD+K  N+ L++DL  KI DFGLA   E D       + GT  Y+APE   +   +
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 217
Query: 822 SKADVYSFGVVTLEIVSGK 840
            + DV+S G +   ++ GK
Sbjct: 218 FEVDVWSIGCIMYTLLVGK 236

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 144 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 201 NSKGY-TKSIDIWSVGCILAEMLSNR 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 148 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 205 NSKGY-TKSIDIWSVGCILAEMLSNR 229

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGI---- 90
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 148 N---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 205 NSKGY-TKSIDIWSVGCILAEMLSNR 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 144 N---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 201 NSKGY-TKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 88
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 89  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 146 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 203 NSKGY-TKSIDIWSVGCILAEMLSNR 227

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHEDSR 760
                     E MK+  + + +   D    LK    +   IC     I RGL Y+H  + 
Sbjct: 91  RAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 144
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM-- 816
             ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +  
Sbjct: 145 --VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 817 RGYLTSKADVYSFGVVTLEIVSGK 840
           +GY T   D++S G +  E++S +
Sbjct: 203 KGY-TKSIDIWSVGCILAEMLSNR 225

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 94
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 95  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 151
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 152 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 209 NSKGY-TKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 144 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 201 NSKGY-TKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 144 N---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 201 NSKGY-TKSIDIWSVGCILAEMLSNR 225

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 644 NKVGEGGFGSVY-KGILSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLVKLYG 701
            K+G G FG V+     S G    +K ++    Q   E +  EI ++ +  HPN++K++ 
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              + + + +V E  +   L   I       +  L      ++   +   LAY H     
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMKQMMNALAYFHSQ--- 143
Query: 762 KIVHRDIKTSNVLLDKDLNA----KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
            +VH+D+K  N+L  +D +     KI DFGLA+L++ D+   ST  AGT  YMAPE   R
Sbjct: 144 HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPEVFKR 200
Query: 818 GYLTSKADVYSFGVVTLEIVSG 839
             +T K D++S GVV   +++G
Sbjct: 201 D-VTFKCDIWSAGVVMYFLLTG 221

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 85  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 141
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 142 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 199 NSKGY-TKSIDIWSVGCILAEMLSNR 223

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 85  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 141
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 142 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 199 NSKGY-TKSIDIWSVGCILAEMLSNR 223

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 107 ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 163
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 164 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 221 NSKGY-TKSIDIWSVGCILAEMLSNR 245

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 639 NFDPANKVGEGGFGSV--YKGILSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISAQ 691
           N+     +G+G F  V   + +L+ G  +AVK     QL+  S Q   +   E+ ++   
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQ---KLFREVRIMKIL 71
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG----KDTEYRLKLDWPTRKKICIG 747
            HPN+VKL+        L LV EY     +   +      K+ E R K            
Sbjct: 72  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ--------- 122
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I   + Y H+     IVHRD+K  N+LLD D+N KI+DFG +  +      + T   G+ 
Sbjct: 123 IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVG-NKLDT-FCGSP 177
Query: 808 GYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSG 839
            Y APE +  + Y   + DV+S GV+   +VSG
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 638 NNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 695
           ++F+  +++G G  G V+K      G V+A K +  + +   R + + E+ ++     P 
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLA 753
           +V  YG      ++ +  E+M    L + +   G+  E  L        K+ I + +GL 
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-------KVSIAVIKGLT 137
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YL E  + KI+HRD+K SN+L++     K+ DFG++    +    ++    GT  YM+PE
Sbjct: 138 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPE 192
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                + + ++D++S G+  +E+  G+
Sbjct: 193 RLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKS---RQGNREFVN-EIGMISAQQHPNLVKLYG 701
           +G+GGF   ++   +D   +   ++  KS   +   RE ++ EI +  +  H ++V  +G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              + + + +V E     C  R++  +  + R  L  P  +     I  G  YLH   R 
Sbjct: 83  FFEDNDFVFVVLEL----CRRRSLL-ELHKRRKALTEPEARYYLRQIVLGCQYLH---RN 134
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
           +++HRD+K  N+ L++DL  KI DFGLA   E D       + GT  Y+APE   +   +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 193
Query: 822 SKADVYSFGVVTLEIVSGK 840
            + DV+S G +   ++ GK
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 92  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 148
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 149 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 206 NSKGY-TKSIDIWSVGCILAEMLSNR 230

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 148 N---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 205 NSKGY-TKSIDIWSVGCILAEMLSNR 229

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 92
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 93  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 149
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 150 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 207 NSKGY-TKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 83
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 84  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 140
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 141 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 198 NSKGY-TKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 148 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 205 NSKGY-TKSIDIWSVGCILAEMLSNR 229

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY    +  +L     Y KN  L + I    +      D    +     I   L 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALE 146
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E          +D+++ G +  ++V+G
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY    +  +L     Y KN  L + I    +      D    +     I   L 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALE 144
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E          +D+++ G +  ++V+G
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY    +  +L     Y KN  L + I    +      D    +     I   L 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALE 143
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 144 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 200
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E          +D+++ G +  ++V+G
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY    +  +L     Y KN  L + I    +      D    +     I   L 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALE 128
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 129 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 185
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E          +D+++ G +  ++V+G
Sbjct: 186 ELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY    +  +L     Y KN  L + I    +      D    +     I   L 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALE 143
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 144 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 200
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E          +D+++ G +  ++V+G
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY    +  +L     Y KN  L + I    +      D    +     I   L 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALE 147
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 148 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 204
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E          +D+++ G +  ++V+G
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY    +  +L     Y KN  L + I    +      D    +     I   L 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALE 144
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E          +D+++ G +  ++V+G
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY    +  +L     Y KN  L + I    +      D    +     I   L 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALE 147
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 148 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 204
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E          +D+++ G +  ++V+G
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 639 NFDPANKVGEGGFGSV--YKGILSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISAQ 691
           N+     +G+G F  V   + IL+ G  +A+K     QL+  S Q   +   E+ ++   
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQ---KLFREVRIMKIL 68
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG----KDTEYRLKLDWPTRKKICIG 747
            HPN+VKL+        L L+ EY     +   +      K+ E R K            
Sbjct: 69  NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ--------- 119
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I   + Y H+    +IVHRD+K  N+LLD D+N KI+DFG +  +      + T   G+ 
Sbjct: 120 IVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDT-FCGSP 174
Query: 808 GYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSG 839
            Y APE +  + Y   + DV+S GV+   +VSG
Sbjct: 175 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 645 KVGEGGFGSVYKGILSDGTV-IAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYG 701
           ++G G F +VYKG+ ++ TV +A  +L  +  ++   + F  E   +   QHPN+V+ Y 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 702 ---CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKL--DWPTRKKICIGIARGLAYLH 756
                V+G + +++   +  +   +    +    ++K+   W      C  I +GL +LH
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW------CRQILKGLQFLH 146
Query: 757 EDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
             +   I+HRD+K  N+ +     + KI D GLA L    +   +  + GT  + APE  
Sbjct: 147 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFXAPEXY 202
Query: 816 MRGYLTSKADVYSFGVVTLEIVSGK 840
              Y  S  DVY+FG   LE  + +
Sbjct: 203 EEKYDES-VDVYAFGXCXLEXATSE 226

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY    +  +L     Y KN  L + I    +      D    +     I   L 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALE 146
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E          +D+++ G +  ++V+G
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY    +  +L     Y KN  L + I    +      D    +     I   L 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALE 149
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 150 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 206
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E          +D+++ G +  ++V+G
Sbjct: 207 ELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 639 NFDPANKVGEGGFGSV--YKGILSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISAQ 691
           N+     +G+G F  V   + IL+ G  +AVK     QL+S S Q   +   E+ +    
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQ---KLFREVRIXKVL 70
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG----KDTEYRLKLDWPTRKKICIG 747
            HPN+VKL+        L LV EY     +   +      K+ E R K            
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQ--------- 121
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I   + Y H+     IVHRD+K  N+LLD D N KI+DFG +   E    +      G  
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSN--EFTFGNKLDAFCGAP 176
Query: 808 GYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSG 839
            Y APE +  + Y   + DV+S GV+   +VSG
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY    +  +L     Y KN  L + I    +      D    +     I   L 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALE 146
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E          +D+++ G +  ++V+G
Sbjct: 204 ELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 640 FDPANKVGEGGFGSVYK----GILSDGTVIAVKQLSS----KSRQGNREFVNEIGMISAQ 691
           F+    +G+GG+G V++       + G + A+K L      ++ +       E  ++   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRLKLDWPTRKKICI 746
           +HP +V L      G +L L+ EY+    L        IF +DT              C 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT-------------ACF 125
Query: 747 GIAR---GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 803
            +A     L +LH+     I++RD+K  N++L+   + K++DFGL K    D T ++   
Sbjct: 126 YLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXF 181
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            GTI YMAPE  MR       D +S G +  ++++G
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 640 FDPANKVGEGGFGSVYK----GILSDGTVIAVKQLSS----KSRQGNREFVNEIGMISAQ 691
           F+    +G+GG+G V++       + G + A+K L      ++ +       E  ++   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRLKLDWPTRKKICI 746
           +HP +V L      G +L L+ EY+    L        IF +DT              C 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT-------------ACF 125
Query: 747 GIAR---GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 803
            +A     L +LH+     I++RD+K  N++L+   + K++DFGL K    D T ++   
Sbjct: 126 YLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTF 181
Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            GTI YMAPE  MR       D +S G +  ++++G
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY    +  +L     Y KN  L + I    +      D    +     I   L 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALE 146
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E          +D+++ G +  ++V+G
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY    +  +L     Y KN  L + I    +      D    +     I   L 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALE 144
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSP 201
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E          +D+++ G +  ++V+G
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F +V     L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY    +  +L     Y KN  L + I    +      D    +     I   L 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALE 146
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E          +D+++ G +  ++V+G
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 638 NNFDPANKVGEGGFGS-VYKGILSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQH 693
            +F     +GEG F + V    L+     A+K L  +   ++    +V  E  ++S   H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P  VKLY    +  +L     Y KN  L + I    +      D    +     I   L 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALE 144
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 812
           YLH      I+HRD+K  N+LL++D++ +I+DFG AK L  E K   +    GT  Y++P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSG 839
           E          +D+++ G +  ++V+G
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 639 NFDPANKVGEGGFGSV--YKGILSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISAQ 691
           N+     +G+G F  V   + IL+ G  +A+K     QL+  S Q   +   E+ ++   
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQ---KLFREVRIMKIL 71
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG----KDTEYRLKLDWPTRKKICIG 747
            HPN+VKL+        L L+ EY     +   +      K+ E R K            
Sbjct: 72  NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ--------- 122
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I   + Y H+    +IVHRD+K  N+LLD D+N KI+DFG +     ++  +  ++    
Sbjct: 123 IVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFS-----NEFTVGGKLDAFC 174
Query: 808 G---YMAPE-YAMRGYLTSKADVYSFGVVTLEIVSG 839
           G   Y APE +  + Y   + DV+S GV+   +VSG
Sbjct: 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           VGEG +G V K    D G ++A+K+   S   +   +  + EI ++   +H NLV L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTE-YRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
           C +  +  LV+E++ +  L       D E +   LD+   +K    I  G+ + H  +  
Sbjct: 93  CKKKKRWYLVFEFVDHTILD------DLELFPNGLDYQVVQKYLFQIINGIGFCHSHN-- 144
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
            I+HRDIK  N+L+ +    K+ DFG A+            +A T  Y APE  +     
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVKY 202
Query: 822 SKA-DVYSFGVVTLEIVSGK 840
            KA DV++ G +  E+  G+
Sbjct: 203 GKAVDVWAIGCLVTEMFMGE 222

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A++++S    Q   +  + EI ++   +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y APE  +
Sbjct: 148 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 205 NSKGY-TKSIDIWSVGCILAEMLSNR 229

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 640 FDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHP 694
           F+    +G G F  V   +L++    G + AVK +  K+ +G    + NEI ++   +H 
Sbjct: 24  FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+V L       N L LV + +    L   I  K   +  + D  T   +   +   + Y
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKG--FYTEKDAST---LIRQVLDAVYY 135
Query: 755 LHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           LH   R+ IVHRD+K  N+L    D++    ISDFGL+K+  E K  + +   GT GY+A
Sbjct: 136 LH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTACGTPGYVA 190
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           PE   +   +   D +S GV+   ++ G
Sbjct: 191 PEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 110/240 (45%), Gaps = 37/240 (15%)
Query: 622 DLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY---------------KGILSDGTVIA 666
           +L+T   T    K    NF+    +G G +G V+                 +L   T++ 
Sbjct: 38  ELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ 97
Query: 667 VKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF 726
             + +  +R   R+ +  I     +Q P LV L+       +L L+ +Y+    L   + 
Sbjct: 98  KAKTTEHTRT-ERQVLEHI-----RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS 151
Query: 727 GKD--TEYRLKLDWPTRKKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 783
            ++  TE+ ++        I +G I   L +LH   ++ I++RDIK  N+LLD + +  +
Sbjct: 152 QRERFTEHEVQ--------IYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVL 200
Query: 784 SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY--LTSKADVYSFGVVTLEIVSGKS 841
           +DFGL+K +  D+T  +    GTI YMAP+    G        D +S GV+  E+++G S
Sbjct: 201 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 13/199 (6%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSR----QGNREFVNEIGMISAQQHPNLVKLYG 701
           +G+GGF   Y+    D   +   ++  KS         +   EI +  +  +P++V  +G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              + + + +V E     C  R++  +  + R  +  P  +       +G+ YLH +   
Sbjct: 110 FFEDDDFVYVVLEI----CRRRSLL-ELHKRRKAVTEPEARYFMRQTIQGVQYLHNN--- 161
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
           +++HRD+K  N+ L+ D++ KI DFGLA   E D     T + GT  Y+APE   +   +
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAPEVLCKKGHS 220
Query: 822 SKADVYSFGVVTLEIVSGK 840
            + D++S G +   ++ GK
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 13/222 (5%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHP 694
             ++   K+GEG +G V+K    D G ++A+K+   S       +  + EI M+   +HP
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           NLV L        +L LV+EY  +  L          Y+  +     K I     + + +
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHEL-----DRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H+ +    +HRD+K  N+L+ K    K+ DFG A+L      +    +A T  Y +PE 
Sbjct: 118 CHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPEL 173
Query: 815 AM-RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 855
            +         DV++ G V  E++SG      + + D +YL+
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI 215

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 27/221 (12%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 693
           ++F+    +G+G FG V     +D   + A+K ++ +    R   R    E+ ++   +H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTRKKICIGIA 749
           P LV L+    +   + +V +          + G D  Y L+        T K     + 
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVD---------LLLGGDLRYHLQQNVHFKEETVKLFICELV 125
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
             L YL      +I+HRD+K  N+LLD+  +  I+DF +A +   + T I+T +AGT  Y
Sbjct: 126 MALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITT-MAGTKPY 180
Query: 810 MAPE-YAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNYR 846
           MAPE ++ R   GY +   D +S GV   E++ G+   + R
Sbjct: 181 MAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIR 220

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H         T  Y APE  +
Sbjct: 148 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 205 NSKGY-TKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 646 VGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCC 703
           +GEG +G V     +   V +A+K++S    Q   +  + EI ++   +H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 704 VEGNQLLLV--YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
              N ++     E MK+  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 92  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 148
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H         T  Y APE  +
Sbjct: 149 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 206 NSKGY-TKSIDIWSVGCILAEMLSNR 230

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 646 VGEGGFG---SVYKGILSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYG 701
           +GEG +G   S Y  +    T +A+K++S    Q   +  + EI ++   +H N++ +  
Sbjct: 51  IGEGAYGMVSSAYDHVRK--TRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRD 108
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 758
                       E M++  + + +   D    LK    +   IC     I RGL Y+H  
Sbjct: 109 ILRAST-----LEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSA 163
Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY--EEDKTHISTRIAGTIGYMAPEYAM 816
           +   ++HRD+K SN+L++   + KI DFGLA++   E D T   T    T  Y APE  +
Sbjct: 164 N---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 817 --RGYLTSKADVYSFGVVTLEIVSGK 840
             +GY T   D++S G +  E++S +
Sbjct: 221 NSKGY-TKSIDIWSVGCILAEMLSNR 245

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 12  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 124
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 125 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 181
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 182 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 13  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 69
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 70  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 125
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 126 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 182
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 183 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 218

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 14  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 70
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 71  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 126
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 127 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 183
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 184 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 219

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 12  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 124
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 125 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 181
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 182 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 21  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 133
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 134 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVAT 190
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 191 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 13  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 69
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 70  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 125
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 126 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 182
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 183 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 218

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 21  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 133
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 134 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 190
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 191 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 18  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 130
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 131 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 187
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 188 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 21  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 133
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 134 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 190
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 191 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 28  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYREL 84
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 140
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 141 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 197
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 198 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 15  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 71
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 72  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 127
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 128 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 184
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 185 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 696
           +++D   ++G G FG V++    + G   A K + +           EI  +S  +HP L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           V L+    + N+++++YE+M    L    F K  +   K+      +    + +GL ++H
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 757 EDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGL-AKLYEEDKTHISTRIAGTIGYMAPE 813
           E++    VH D+K  N++    +    K+ DFGL A L  +    ++T   GT  + APE
Sbjct: 167 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPE 220
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGKS 841
            A    +    D++S GV++  ++SG S
Sbjct: 221 VAEGKPVGYYTDMWSVGVLSYILLSGLS 248

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 83
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +  +VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 84  SSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 140
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMR 817
             I HRDIK  N+LLD D    K+ DFG AK     + ++S   +    Y APE  +   
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YRAPELIFGAT 198
Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
            Y TS  DV+S G V  E++ G+
Sbjct: 199 DY-TSSIDVWSAGCVLAELLLGQ 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 23  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 135
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 136 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 192
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 193 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 696
           +++D   ++G G FG V++    + G   A K + +           EI  +S  +HP L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           V L+    + N+++++YE+M    L    F K  +   K+      +    + +GL ++H
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 757 EDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGL-AKLYEEDKTHISTRIAGTIGYMAPE 813
           E++    VH D+K  N++    +    K+ DFGL A L  +    ++T   GT  + APE
Sbjct: 273 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPE 326
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGKS 841
            A    +    D++S GV++  ++SG S
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSGLS 354

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 18  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 130
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 131 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 187
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 188 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 18  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 130
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 131 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 187
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 188 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 644 NKVGEGGFGSVYKGI--LSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 700
           +K+GEG + +VYKG   L+D  ++A+K++  +  +G     + E+ ++   +H N+V L+
Sbjct: 8   DKLGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-----LDWPTRKKICIGIARGLAYL 755
                   L LV+EY+           KD +  L      ++    K     + RGLAY 
Sbjct: 67  DIIHTEKSLTLVFEYL----------DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
           H   R K++HRD+K  N+L+++    K++DFGLA+            +  T+ Y  P+  
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDIL 172
Query: 816 MRGY-LTSKADVYSFGVVTLEIVSGK 840
           +     +++ D++  G +  E+ +G+
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 637 TNNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA 690
           ++N+D   ++G+G F  V +      G+     +I  K+LS++  Q   +   E  +   
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 61
Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG-IA 749
            QHPN+V+L+    E +   LV++ +    L   I  +  E+  + D       CI  I 
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEAD----ASHCIQQIL 115
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKTHISTRIAGT 806
             +AY H +    IVHR++K  N+LL    K    K++DFGLA   E + +      AGT
Sbjct: 116 ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGT 170
Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            GY++PE   +   +   D+++ GV+   ++ G
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 28  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 84
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 140
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 141 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 197
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 198 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 28  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 84
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 140
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 141 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 197
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 198 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 22  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 134
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 135 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 191
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 192 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 22  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 134
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 135 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 191
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 192 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 35  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 91
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 92  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 147
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 148 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 204
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 205 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 240

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 27  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 83
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 84  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 139
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 140 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVAT 196
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 197 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 36  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 92
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 148
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 149 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 205
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 206 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 22  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 134
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 135 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 191
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 192 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 637 TNNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA 690
           ++N+D   ++G+G F  V +      G+     +I  K+LS++  Q   +   E  +   
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 84
Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG-IA 749
            QHPN+V+L+    E +   LV++ +    L   I  +  E+  + D       CI  I 
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEAD----ASHCIQQIL 138
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKTHISTRIAGT 806
             +AY H +    IVHR++K  N+LL    K    K++DFGLA   E + +      AGT
Sbjct: 139 ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGT 193
Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            GY++PE   +   +   D+++ GV+   ++ G
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 27  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 83
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 84  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 139
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 140 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 196
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 197 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 232

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 39  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 95
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 96  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 151
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 152 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 208
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 209 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 244

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSR----QGNREFVNEIGMISAQQHPNLVKLYG 701
           +G+GGF   Y+    D   +   ++  KS         +   EI +  +  +P++V  +G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              + + + +V E     C  R++  +  + R  +  P  +       +G+ YLH +   
Sbjct: 110 FFEDDDFVYVVLEI----CRRRSLL-ELHKRRKAVTEPEARYFMRQTIQGVQYLHNN--- 161
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
           +++HRD+K  N+ L+ D++ KI DFGLA   E D       + GT  Y+APE   +   +
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKXLCGTPNYIAPEVLCKKGHS 220
Query: 822 SKADVYSFGVVTLEIVSGK 840
            + D++S G +   ++ GK
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 36  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 92
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 148
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 149 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 205
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 206 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSR----QGNREFVNEIGMISAQQHPNLVKLYG 701
           +G+GGF   Y+    D   +   ++  KS         +   EI +  +  +P++V  +G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              + + + +V E     C  R++  +  + R  +  P  +       +G+ YLH +   
Sbjct: 94  FFEDDDFVYVVLEI----CRRRSLL-ELHKRRKAVTEPEARYFMRQTIQGVQYLHNN--- 145
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
           +++HRD+K  N+ L+ D++ KI DFGLA   E D       + GT  Y+APE   +   +
Sbjct: 146 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAPEVLCKKGHS 204
Query: 822 SKADVYSFGVVTLEIVSGK 840
            + D++S G +   ++ GK
Sbjct: 205 FEVDIWSLGCILYTLLVGK 223

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 12  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQ 124
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 125 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 181
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 182 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 35  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 91
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 92  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 147
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 148 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 204
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 205 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 240

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 96
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 97  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 153
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLY---EEDKTHISTRIAGTIGYMAPE--Y 814
             I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R      Y APE  +
Sbjct: 154 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 208
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
               Y TS  DV+S G V  E++ G+
Sbjct: 209 GATDY-TSSIDVWSAGCVLAELLLGQ 233

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 637 TNNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA 690
           ++N+D   ++G+G F  V +      G+     +I  K+LS++  Q   +   E  +   
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 60
Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG-IA 749
            QHPN+V+L+    E +   LV++ +    L   I  +  E+  + D       CI  I 
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEAD----ASHCIQQIL 114
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKTHISTRIAGT 806
             +AY H +    IVHR++K  N+LL    K    K++DFGLA   E + +      AGT
Sbjct: 115 ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGT 169
Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            GY++PE   +   +   D+++ GV+   ++ G
Sbjct: 170 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   +G G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 21  TIWEVPERYQNLSP---IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 133
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 134 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVAT 190
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 191 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 637 TNNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA 690
           ++N+D   ++G+G F  V +      G+     +I  K+LS++  Q   +   E  +   
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 61
Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG-IA 749
            QHPN+V+L+    E +   LV++ +    L   I  +  E+  + D       CI  I 
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEAD----ASHCIQQIL 115
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKTHISTRIAGT 806
             +AY H +    IVHR++K  N+LL    K    K++DFGLA   E + +      AGT
Sbjct: 116 ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGT 170
Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            GY++PE   +   +   D+++ GV+   ++ G
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/242 (30%), Positives = 112/242 (46%), Gaps = 22/242 (9%)
Query: 609 GGKVSADKELRGLDLQTGLYTLRQ--IKAATNNFDPANKVGEGGFGSVYKGILSD-GTVI 665
           G KVS DK+  G  + T + T  Q   +    ++     +G G FG VY+  L D G ++
Sbjct: 3   GSKVSRDKD--GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELV 60
Query: 666 AVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCCVEGNQLLLVYEYMKNNCLSRA 724
           A+K++    R  NRE    + ++    H N+V+L Y     G +   VY  +  + +   
Sbjct: 61  AIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET 116
Query: 725 IFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 781
           ++     Y R K   P    K     + R LAY+H      I HRDIK  N+LLD D   
Sbjct: 117 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAV 173
Query: 782 -KISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVS 838
            K+ DFG AK     + ++S   +    Y APE  +    Y TS  DV+S G V  E++ 
Sbjct: 174 LKLCDFGSAKQLVRGEPNVSXICSRY--YRAPELIFGATDY-TSSIDVWSAGCVLAELLL 230
Query: 839 GK 840
           G+
Sbjct: 231 GQ 232

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 12  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 124
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+       H    
Sbjct: 125 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDE 174
Query: 803 IAGTIG---YMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           +AG +    Y APE  +   +     D++S G +  E+++G++
Sbjct: 175 MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 18  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 130
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 131 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVAT 187
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 188 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 88
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 89  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 145
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLY---EEDKTHISTRIAGTIGYMAPE--Y 814
             I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R      Y APE  +
Sbjct: 146 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 200
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
               Y TS  DV+S G V  E++ G+
Sbjct: 201 GATDY-TSSIDVWSAGCVLAELLLGQ 225

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 111
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 112 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 168
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLY---EEDKTHISTRIAGTIGYMAPE--Y 814
             I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R      Y APE  +
Sbjct: 169 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 223
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
               Y TS  DV+S G V  E++ G+
Sbjct: 224 GATDY-TSSIDVWSAGCVLAELLLGQ 248

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 83
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 140
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLY---EEDKTHISTRIAGTIGYMAPE--Y 814
             I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R      Y APE  +
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 195
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
               Y TS  DV+S G V  E++ G+
Sbjct: 196 GATDY-TSSIDVWSAGCVLAELLLGQ 220

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSR----QGNREFVNEIGMISAQQHPNLVKLYG 701
           +G+GGF   Y+    D   +   ++  KS         +   EI +  +  +P++V  +G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              + + + +V E     C  R++  +  + R  +  P  +       +G+ YLH +   
Sbjct: 110 FFEDDDFVYVVLEI----CRRRSLL-ELHKRRKAVTEPEARYFMRQTIQGVQYLHNN--- 161
Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
           +++HRD+K  N+ L+ D++ KI DFGLA   E D       + GT  Y+APE   +   +
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAPEVLCKKGHS 220
Query: 822 SKADVYSFGVVTLEIVSGK 840
            + D++S G +   ++ GK
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+       H    
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDE 178
Query: 803 IAGTIG---YMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           +AG +    Y APE  +   +     D++S G +  E+++G++
Sbjct: 179 MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 22  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 134
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 135 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVAT 191
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 192 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 26  TIWEVPERYQNLAP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 82
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 83  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 138
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++T
Sbjct: 139 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 195
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 196 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 231

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+       H    
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDE 178
Query: 803 IAGTIG---YMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           +AG +    Y APE  +   +     D++S G +  E+++G++
Sbjct: 179 MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 117
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 174
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLY---EEDKTHISTRIAGTIGYMAPE--Y 814
             I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R      Y APE  +
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 229
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
               Y TS  DV+S G V  E++ G+
Sbjct: 230 GATDY-TSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 121
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 122 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 178
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLY---EEDKTHISTRIAGTIGYMAPE--Y 814
             I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R      Y APE  +
Sbjct: 179 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 233
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
               Y TS  DV+S G V  E++ G+
Sbjct: 234 GATDY-TSSIDVWSAGCVLAELLLGQ 258

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 162
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 163 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 219
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLY---EEDKTHISTRIAGTIGYMAPE--Y 814
             I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R      Y APE  +
Sbjct: 220 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 274
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
               Y TS  DV+S G V  E++ G+
Sbjct: 275 GATDY-TSSIDVWSAGCVLAELLLGQ 299

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 119
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 120 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 176
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLY---EEDKTHISTRIAGTIGYMAPE--Y 814
             I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R      Y APE  +
Sbjct: 177 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 231
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
               Y TS  DV+S G V  E++ G+
Sbjct: 232 GATDY-TSSIDVWSAGCVLAELLLGQ 256

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 106/227 (46%), Gaps = 36/227 (15%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCV 704
           VG+G +G V++G L  G  +AVK  SS+  Q   RE   EI      +H N++      +
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRE--TEIYNTVLLRHDNILGFIASDM 72
Query: 705 ----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-- 758
                  QL L+  Y ++  L   +  +  E  L L      ++ +  A GLA+LH +  
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLAL------RLAVSAACGLAHLHVEIF 126
Query: 759 ---SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI----STRIAGTIGYMA 811
               +  I HRD K+ NVL+  +L   I+D GLA ++ +   ++    + R+ GT  YMA
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTKRYMA 185
Query: 812 PEYAMRGYLTS------KADVYSFGVVTLE-----IVSGKSNTNYRP 847
           PE       T         D+++FG+V  E     IV+G    +YRP
Sbjct: 186 PEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVE-DYRP 231

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 18/230 (7%)
Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGIL--SDGTVI--AVKQLSSK--SRQGNREFVN 683
           L  +      F     +G+G FGSV +  L   DG+ +  AVK L +   +     EF+ 
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 684 EIGMISAQQHPNLVKLYGCCVEGNQL------LLVYEYMKNNCLSRAIFGKDT-EYRLKL 736
           E   +    HP++ KL G  +           +++  +MK+  L   +      E    L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 737 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 795
              T  +  + IA G+ YL   S    +HRD+   N +L +D+   ++DFGL+ K+Y  D
Sbjct: 135 PLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 845
                      + ++A E       T  +DV++FGV   EI++ +  T Y
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT-RGQTPY 240

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T  ++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 23  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 135
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+   ++ T +++T
Sbjct: 136 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT 192
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 193 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 23  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 135
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+   ++ T +++T
Sbjct: 136 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT 192
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 193 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 23  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 135
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+   ++ T +++T
Sbjct: 136 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT 192
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 193 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 109/239 (45%), Gaps = 19/239 (7%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREF---VNEIGMIS 689
           +   +NF+    +G+G FG V    + + G + AVK L       + +    + E  ++S
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 690 -AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 748
            A+ HP L +L+ C    ++L  V E++    L   I     +   + D    +     I
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI-----QKSRRFDEARARFYAAEI 133
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
              L +LH+     I++RD+K  NVLLD + + K++DFG+ K    +    +T   GT  
Sbjct: 134 ISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPD 189
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIY 867
           Y+APE           D ++ GV+  E++ G +      NED ++      +L +E +Y
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE-NEDDLF----EAILNDEVVY 243

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           VG G +GSV     +  G  IAVK+LS   +S    +    E+ ++   +H N++ L   
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI---CIGIARGLAYLHEDS 759
                 L    E   +  L   + G D    +K    T   +      I RGL Y+H   
Sbjct: 119 FTPATSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 172
Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRG 818
              I+HRD+K SN+ +++D   KI DFGLA+  +++ T +++TR      Y APE  +  
Sbjct: 173 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 226
Query: 819 -YLTSKADVYSFGVVTLEIVSGKS 841
            +     D++S G +  E+++G++
Sbjct: 227 MHYNMTVDIWSVGCIMAELLTGRT 250

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
           +D   ++G G FG V++ +  + G V   K +++          NEI +++   HP L+ 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
           L+    +  +++L+ E++    L   I  +D +          ++ C     GL ++HE 
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC----EGLKHMHEH 168
Query: 759 SRIKIVHRDIKTSNVLLD--KDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAPEYA 815
           S   IVH DIK  N++ +  K  + KI DFGLA KL  ++   ++T    T  + APE  
Sbjct: 169 S---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIV 222
Query: 816 MRGYLTSKADVYSFGVVTLEIVSGKS 841
            R  +    D+++ GV+   ++SG S
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLS 248

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/250 (22%), Positives = 105/250 (42%), Gaps = 32/250 (12%)
Query: 624 QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVN 683
           QT ++ L++        +    +G+G FG VY G       I +  +   +    + F  
Sbjct: 20  QTSIF-LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKR 78
Query: 684 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 743
           E+      +H N+V   G C+    L ++       C  R ++    + ++ LD    ++
Sbjct: 79  EVMAYRQTRHENVVLFMGACMSPPHLAIITSL----CKGRTLYSVVRDAKIVLDVNKTRQ 134
Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK--ISDFGLAKL-------YEE 794
           I   I +G+ YLH      I+H+D+K+ NV  D   N K  I+DFGL  +         E
Sbjct: 135 IAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRRE 188
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGY---------LTSKADVYSFGVVTLEIVSGKSNTNY 845
           DK  I     G + ++APE   +            +  +DV++ G +  E+ + +     
Sbjct: 189 DKLRIQN---GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
Query: 846 RPNEDFVYLL 855
           +P E  ++ +
Sbjct: 246 QPAEAIIWQM 255

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI D+GLA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 638 NNFDPANKVGEGGFGSV-----YKGILSDGTV-IAVKQLSSKSRQGNRE-FVNEIGMIS- 689
           N       +G G FG V     Y  I SD  + +AVK L   +    RE  ++E+ ++S 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT--------- 740
              H N+V L G C  G   L++ EY     L   +  K   +      P          
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 741 ----RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 796
                      +A+G+A+L   +    +HRD+   N+LL      KI DFGLA+  + D 
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKNDS 222
Query: 797 THISTRIAG-TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            ++    A   + +MAPE       T ++DV+S+G+   E+ S
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 638 NNFDPANKVGEGGFGSV-----YKGILSDGTV-IAVKQLSSKSRQGNRE-FVNEIGMIS- 689
           N       +G G FG V     Y  I SD  + +AVK L   +    RE  ++E+ ++S 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT--------- 740
              H N+V L G C  G   L++ EY     L   +  K   +      P          
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 741 ----RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 796
                      +A+G+A+L   +    +HRD+   N+LL      KI DFGLA+  + D 
Sbjct: 159 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 215
Query: 797 THISTRIAG-TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            ++    A   + +MAPE       T ++DV+S+G+   E+ S
Sbjct: 216 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR------EFVNEIG 686
           +    ++   + +G G FG V  G     G  +AVK L+   RQ  R      +   EI 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN---RQKIRSLDVVGKIKREIQ 63
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 746
            +   +HP+++KLY          +V EY+    L   I         +++    +++  
Sbjct: 64  NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-----RVEEMEARRLFQ 118
Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 806
            I   + Y H   R  +VHRD+K  NVLLD  +NAKI+DFGL+ +   D   + T   G+
Sbjct: 119 QILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTS-CGS 173
Query: 807 IGYMAPEY-AMRGYLTSKADVYSFGVVTLEIVSG 839
             Y APE  + R Y   + D++S GV+   ++ G
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 83
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 140
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMR 817
             I HRDIK  N+LLD D    K+ DFG AK     + ++S   +    Y APE  +   
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YRAPELIFGAT 198
Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
            Y TS  DV+S G V  E++ G+
Sbjct: 199 DY-TSSIDVWSAGCVLAELLLGQ 220

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 638 NNFDPANKVGEGGFGSV-----YKGILSDGTV-IAVKQLSSKSRQGNRE-FVNEIGMIS- 689
           N       +G G FG V     Y  I SD  + +AVK L   +    RE  ++E+ ++S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT--------- 740
              H N+V L G C  G   L++ EY     L   +  K   +      P          
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 741 ----RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 796
                      +A+G+A+L   +    +HRD+   N+LL      KI DFGLA+  + D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 797 THISTRIAG-TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            ++    A   + +MAPE       T ++DV+S+G+   E+ S
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 669 QLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL---SRAI 725
           ++S KS+    +F NE+ +I+  ++   +   G     +++ ++YEYM+N+ +       
Sbjct: 80  KISIKSKYD--DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYF 137
Query: 726 FGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 785
           F  D  Y   +     K I   +    +Y+H +  I   HRD+K SN+L+DK+   K+SD
Sbjct: 138 FVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVKLSD 195
Query: 786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGV 831
           FG ++ Y  DK    +R  GT  +M PE+      Y  +K D++S G+
Sbjct: 196 FGESE-YMVDKKIKGSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 83
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 140
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMR 817
             I HRDIK  N+LLD D    K+ DFG AK     + ++S   +    Y APE  +   
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YRAPELIFGAT 198
Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
            Y TS  DV+S G V  E++ G+
Sbjct: 199 DY-TSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 95
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 152
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMR 817
             I HRDIK  N+LLD D    K+ DFG AK     + ++S   +    Y APE  +   
Sbjct: 153 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YRAPELIFGAT 210
Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
            Y TS  DV+S G V  E++ G+
Sbjct: 211 DY-TSSIDVWSAGCVLAELLLGQ 232

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 29/219 (13%)
Query: 633 IKAATNNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSS--KSRQGNREFVNEIGMIS 689
           ++   ++ +P  ++G G +G V K   +  G ++AVK++ +   S++  R  ++    + 
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD------WPTRKK 743
               P  V  YG       + +  E M  +         D  Y+  +D           K
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMDTSL--------DKFYKQVIDKGQTIPEDILGK 113
Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 803
           I + I + L +LH  S++ ++HRD+K SNVL++     K+ DFG++    +D   ++  I
Sbjct: 114 IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDI 168
Query: 804 -AGTIGYMAPEYA-----MRGYLTSKADVYSFGVVTLEI 836
            AG   YMAPE        +GY + K+D++S G+  +E+
Sbjct: 169 DAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIEL 206

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 84
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 85  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 141
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMR 817
             I HRDIK  N+LLD D    K+ DFG AK     + ++S   +    Y APE  +   
Sbjct: 142 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YRAPELIFGAT 199
Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
            Y TS  DV+S G V  E++ G+
Sbjct: 200 DY-TSSIDVWSAGCVLAELLLGQ 221

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 102
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 103 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 159
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMR 817
             I HRDIK  N+LLD D    K+ DFG AK     + ++S   +    Y APE  +   
Sbjct: 160 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YRAPELIFGAT 217
Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
            Y TS  DV+S G V  E++ G+
Sbjct: 218 DY-TSSIDVWSAGCVLAELLLGQ 239

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 633 IKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 688
            +  ++ +    K+G G +G V     K   ++  +  +K+ S  +   +   ++E+ ++
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVL 75
Query: 689 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 748
               HPN++KLY    +     LV E  +   L   I       R K        I   +
Sbjct: 76  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMKQV 130
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             G  YLH+ +   IVHRD+K  N+LL+   +D   KI DFGL+  +E     +  R+ G
Sbjct: 131 LSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG-GKMKERL-G 185
Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           T  Y+APE  +R     K DV+S GV+   ++ G
Sbjct: 186 TAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 87
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 88  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 144
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMR 817
             I HRDIK  N+LLD D    K+ DFG AK     + ++S   +    Y APE  +   
Sbjct: 145 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YRAPELIFGAT 202
Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
            Y TS  DV+S G V  E++ G+
Sbjct: 203 DY-TSSIDVWSAGCVLAELLLGQ 224

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 91
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 92  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 148
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMR 817
             I HRDIK  N+LLD D    K+ DFG AK     + ++S   +    Y APE  +   
Sbjct: 149 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YRAPELIFGAT 206
Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
            Y TS  DV+S G V  E++ G+
Sbjct: 207 DY-TSSIDVWSAGCVLAELLLGQ 228

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N+V+L Y   
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 117
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 174
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLY---EEDKTHISTRIAGTIGYMAPE--Y 814
             I HRDIK  N+LLD D    K+ DFG AK     E + + I +R      Y APE  +
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELIF 229
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
               Y TS  DV+S G V  E++ G+
Sbjct: 230 GATDY-TSSIDVWSAGCVLAELLLGQ 254

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 638 NNFDPANKVGEGGFGSV-----YKGILSDGTV-IAVKQLSSKSRQGNRE-FVNEIGMIS- 689
           N       +G G FG V     Y  I SD  + +AVK L   +    RE  ++E+ ++S 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT--------- 740
              H N+V L G C  G   L++ EY     L   +  K   +      P          
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 741 ----RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 796
                      +A+G+A+L   +    +HRD+   N+LL      KI DFGLA+  + D 
Sbjct: 161 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 217
Query: 797 THISTRIAG-TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            ++    A   + +MAPE       T ++DV+S+G+   E+ S
Sbjct: 218 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-----EFVNEIGMISAQQHPNLVKL 699
           ++G G FG+V KG      V+    +     + N      E + E  ++    +P +V++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 700 YGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
            G C E    +LV E  +    N  L +    KD             ++   ++ G+ YL
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK---------NIIELVHQVSMGMKYL 143
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPE 813
            E +    VHRD+   NVLL     AKISDFGL+K    D+ +   +  G   + + APE
Sbjct: 144 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVS 838
                  +SK+DV+SFGV+  E  S
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-----EFVNEIGMISAQQHPNLVKL 699
           ++G G FG+V KG      V+    +     + N      E + E  ++    +P +V++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 700 YGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
            G C E    +LV E  +    N  L +    KD             ++   ++ G+ YL
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK---------NIIELVHQVSMGMKYL 143
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPE 813
            E +    VHRD+   NVLL     AKISDFGL+K    D+ +   +  G   + + APE
Sbjct: 144 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVS 838
                  +SK+DV+SFGV+  E  S
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 110/251 (43%), Gaps = 30/251 (11%)
Query: 602 MRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATN----NFDPANKVGEGGFGSVYKG 657
           + ++G +G  +  +KE         + T    KA+++    +FD    +G G +  V   
Sbjct: 20  LYFQGAMGSGIEEEKE--------AMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLV 71
Query: 658 ILSDGTVIAVKQLSSKSRQGNREFVNEIG-----MISAQQHPNLVKLYGCCVEGNQLLLV 712
            L     I   ++  K    + E ++ +         A  HP LV L+ C    ++L  V
Sbjct: 72  RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131
Query: 713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 772
            EY+    L   +     + + KL     +     I+  L YLHE     I++RD+K  N
Sbjct: 132 IEYVNGGDLMFHM-----QRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDN 183
Query: 773 VLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFG 830
           VLLD + + K++D+G+ K  L   D T   +   GT  Y+APE           D ++ G
Sbjct: 184 VLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGEDYGFSVDWWALG 240
Query: 831 VVTLEIVSGKS 841
           V+  E+++G+S
Sbjct: 241 VLMFEMMAGRS 251

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 638 NNFDPANKVGEGGFGSV-----YKGILSDGTV-IAVKQLSSKSRQGNRE-FVNEIGMIS- 689
           N       +G G FG V     Y  I SD  + +AVK L   +    RE  ++E+ ++S 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT--------- 740
              H N+V L G C  G   L++ EY     L   +  K   +      P          
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 741 ----RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 796
                      +A+G+A+L   +    +HRD+   N+LL      KI DFGLA+  + D 
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 222
Query: 797 THISTRIAG-TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            ++    A   + +MAPE       T ++DV+S+G+   E+ S
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-----EFVNEIGMISAQQHPNLVKL 699
           ++G G FG+V KG      V+    +     + N      E + E  ++    +P +V++
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 700 YGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
            G C E    +LV E  +    N  L +    KD             ++   ++ G+ YL
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK---------NIIELVHQVSMGMKYL 141
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPE 813
            E +    VHRD+   NVLL     AKISDFGL+K    D+ +   +  G   + + APE
Sbjct: 142 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 198
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVS 838
                  +SK+DV+SFGV+  E  S
Sbjct: 199 CINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 108/227 (47%), Gaps = 22/227 (9%)
Query: 626 GLYTLRQIKAATNNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNR 679
           G+ T RQ +   ++++   ++G G F  V K      G       I  ++LSS  R  +R
Sbjct: 1   GMSTFRQ-EDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSR 59
Query: 680 EFVN-EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW 738
           E +  E+ ++   +HPN++ L+        ++L+ E +    L   +  K++   L  D 
Sbjct: 60  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDE 116
Query: 739 PTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYEE 794
            T  +    I  G+ YLH     +I H D+K  N+ LLDK++     K+ DFG+A   E 
Sbjct: 117 AT--QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 171
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
                   I GT  ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 172 GNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 637 TNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ 692
           ++ +    K+G G +G V     K   ++  +  +K+ S  +   +   ++E+ ++    
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++KLY    +     LV E  +   L   I       R K        I   +  G 
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMKQVLSGT 117
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            YLH+ +   IVHRD+K  N+LL+   +D   KI DFGL+  +E     +  R+ GT  Y
Sbjct: 118 TYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG-GKMKERL-GTAYY 172
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           +APE   + Y   K DV+S GV+   ++ G
Sbjct: 173 IAPEVLRKKY-DEKCDVWSCGVILYILLCG 201

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR------EFVNEIG 686
           +    ++   + +G G FG V  G     G  +AVK L+   RQ  R      +   EI 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN---RQKIRSLDVVGKIKREIQ 63
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 746
            +   +HP+++KLY          +V EY+    L   I         +++    +++  
Sbjct: 64  NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-----RVEEMEARRLFQ 118
Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 806
            I   + Y H   R  +VHRD+K  NVLLD  +NAKI+DFGL+ +  + +    +   G+
Sbjct: 119 QILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS--CGS 173
Query: 807 IGYMAPEY-AMRGYLTSKADVYSFGVVTLEIVSG 839
             Y APE  + R Y   + D++S GV+   ++ G
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-----EFVNEIGMISAQQHPNLVKL 699
           ++G G FG+V KG      V+    +     + N      E + E  ++    +P +V++
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 700 YGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
            G C E    +LV E  +    N  L +    KD             ++   ++ G+ YL
Sbjct: 436 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI---------IELVHQVSMGMKYL 485
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPE 813
            E +    VHRD+   NVLL     AKISDFGL+K    D+ +   +  G   + + APE
Sbjct: 486 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 542
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVS 838
                  +SK+DV+SFGV+  E  S
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 24/205 (11%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-----EFVNEIGMISAQQHPNLVKL 699
           ++G G FG+V KG      V+    +     + N      E + E  ++    +P +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI----GIARGLAYL 755
            G C E    +LV E         A  G   +Y L+ +   + K  I     ++ G+ YL
Sbjct: 84  IGIC-EAESWMLVME--------MAELGPLNKY-LQQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPE 813
            E +    VHRD+   NVLL     AKISDFGL+K    D+ +   +  G   + + APE
Sbjct: 134 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVS 838
                  +SK+DV+SFGV+  E  S
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 39  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 95
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 96  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 151
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++   +++T
Sbjct: 152 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVAT 208
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 209 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 244

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 36  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 92
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 148
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGLA+       H    
Sbjct: 149 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDE 198
Query: 803 IAGTIG---YMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           + G +    Y APE  +   +     D++S G +  E+++G++
Sbjct: 199 MXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 36/229 (15%)
Query: 637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 695
            ++F+    +G+G FG V K   + D    A+K++     + +   ++E+ ++++  H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQY 63
Query: 696 LVKLYGCCVE-------------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
           +V+ Y   +E              + L +  EY +N  L   I  ++   +    W   +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-------LYEED 795
           +I       L+Y+H      I+HRD+K  N+ +D+  N KI DFGLAK       + + D
Sbjct: 124 QIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 796 KTHIS------TRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIV 837
             ++       T   GT  Y+A E     G+   K D+YS G++  E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 705
           +G G FG V++  L +   +A+K++    R  NR    E+ ++   +HPN+V L      
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYS 103
Query: 706 GNQ------LLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPTR--KKICIGIARGLAYLH 756
                    L LV EY     +   ++     Y +LK   P    K     + R LAY+H
Sbjct: 104 NGDKKDEVFLNLVLEY-----VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLY---EEDKTHISTRIAGTIGYMAP 812
               I I HRDIK  N+LLD      K+ DFG AK+    E + + I +R      Y AP
Sbjct: 159 S---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-----YRAP 210
Query: 813 E--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
           E  +    Y T+  D++S G V  E++ G+
Sbjct: 211 ELIFGATNY-TTNIDIWSTGCVMAELMQGQ 239

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-----EFVNEIGMISAQQHPNLVKL 699
           ++G G FG+V KG      V+    +     + N      E + E  ++    +P +V++
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 700 YGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
            G C E    +LV E  +    N  L +    KD             ++   ++ G+ YL
Sbjct: 437 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI---------IELVHQVSMGMKYL 486
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPE 813
            E +    VHRD+   NVLL     AKISDFGL+K    D+ +   +  G   + + APE
Sbjct: 487 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 543
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVS 838
                  +SK+DV+SFGV+  E  S
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 97/221 (43%), Gaps = 29/221 (13%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREF---VNE 684
           + K   N+FD    +G+G FG V   IL    + G   A+K L  +      E    V E
Sbjct: 2   RAKVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 58
Query: 685 IGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN----CLSRA-IFGKDTEYRLKLDWP 739
             ++   +HP L  L       ++L  V EY         LSR  +F   TE R +    
Sbjct: 59  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARF--- 112
Query: 740 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 799
                   I   L YLH  SR  +V+RDIK  N++LDKD + KI+DFGL K    D   +
Sbjct: 113 ----YGAEIVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 165
Query: 800 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            T   GT  Y+APE           D +  GVV  E++ G+
Sbjct: 166 KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 24/205 (11%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-----EFVNEIGMISAQQHPNLVKL 699
           ++G G FG+V KG      V+    +     + N      E + E  ++    +P +V++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI----GIARGLAYL 755
            G C E    +LV E         A  G   +Y L+ +   + K  I     ++ G+ YL
Sbjct: 74  IGIC-EAESWMLVMEM--------AELGPLNKY-LQQNRHVKDKNIIELVHQVSMGMKYL 123
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPE 813
            E +    VHRD+   NVLL     AKISDFGL+K    D+ +   +  G   + + APE
Sbjct: 124 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVS 838
                  +SK+DV+SFGV+  E  S
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 24/205 (11%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-----EFVNEIGMISAQQHPNLVKL 699
           ++G G FG+V KG      V+    +     + N      E + E  ++    +P +V++
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI----GIARGLAYL 755
            G C E    +LV E         A  G   +Y L+ +   + K  I     ++ G+ YL
Sbjct: 72  IGIC-EAESWMLVMEM--------AELGPLNKY-LQQNRHVKDKNIIELVHQVSMGMKYL 121
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPE 813
            E +    VHRD+   NVLL     AKISDFGL+K    D+ +   +  G   + + APE
Sbjct: 122 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 178
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVS 838
                  +SK+DV+SFGV+  E  S
Sbjct: 179 CINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 24/205 (11%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-----EFVNEIGMISAQQHPNLVKL 699
           ++G G FG+V KG      V+    +     + N      E + E  ++    +P +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI----GIARGLAYL 755
            G C E    +LV E         A  G   +Y L+ +   + K  I     ++ G+ YL
Sbjct: 78  IGIC-EAESWMLVMEM--------AELGPLNKY-LQQNRHVKDKNIIELVHQVSMGMKYL 127
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPE 813
            E +    VHRD+   NVLL     AKISDFGL+K    D+ +   +  G   + + APE
Sbjct: 128 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 184
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVS 838
                  +SK+DV+SFGV+  E  S
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREF---VNEIG 686
           K   N+FD    +G+G FG V   IL    + G   A+K L  +      E    V E  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN----CLSRA-IFGKDTEYRLKLDWPTR 741
           ++   +HP L  L       ++L  V EY         LSR  +F   TE R +      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARF----- 109
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
                 I   L YLH  SR  +V+RDIK  N++LDKD + KI+DFGL K    D   + T
Sbjct: 110 --YGAEIVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
              GT  Y+APE           D +  GVV  E++ G+
Sbjct: 165 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREF---VNEIG 686
           K   N+FD    +G+G FG V   IL    + G   A+K L  +      E    V E  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN----CLSRA-IFGKDTEYRLKLDWPTR 741
           ++   +HP L  L       ++L  V EY         LSR  +F   TE R +      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARF----- 109
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
                 I   L YLH  SR  +V+RDIK  N++LDKD + KI+DFGL K    D   + T
Sbjct: 110 --YGAEIVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
              GT  Y+APE           D +  GVV  E++ G+
Sbjct: 165 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 17/220 (7%)
Query: 625 TGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQL--SSKSRQG-NRE 680
           T L  + + K   ++FD    +G+G FG+VY         ++A+K L  S   ++G   +
Sbjct: 2   TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 61
Query: 681 FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 740
              EI + S  +HPN++++Y    +  ++ L+ E+       R    K+ +   + D   
Sbjct: 62  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFA-----PRGELYKELQKHGRFDEQR 116
Query: 741 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 800
                  +A  L Y HE    K++HRDIK  N+L+      KI+DFG    +      + 
Sbjct: 117 SATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLR 169
Query: 801 TR-IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            R + GT+ Y+ PE         K D++  GV+  E + G
Sbjct: 170 RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 36/229 (15%)
Query: 637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 695
            ++F+    +G+G FG V K   + D    A+K++   + +     ++E+ ++++  H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 696 LVKLYGCCVE-------------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
           +V+ Y   +E              + L +  EY +N  L   I  ++   +    W   +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-------LYEED 795
           +I       L+Y+H      I+HRD+K  N+ +D+  N KI DFGLAK       + + D
Sbjct: 124 QIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 796 KTHIS------TRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIV 837
             ++       T   GT  Y+A E     G+   K D+YS G++  E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           VG G +GSV   I    G  +A+K+LS   +S    +    E+ ++   QH N++ L   
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 703 CVEGNQL------LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
               + L       LV  +M+ +   + I G      LK      + +   + +GL Y+H
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDL--QKIMG------LKFSEEKIQYLVYQMLKGLKYIH 143
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYA 815
                 +VHRD+K  N+ +++D   KI DFGLA+  + + T ++ TR      Y APE  
Sbjct: 144 SAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVI 195
Query: 816 MRG-YLTSKADVYSFGVVTLEIVSGKS 841
           +   +     D++S G +  E+++GK+
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 17/220 (7%)
Query: 625 TGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQL--SSKSRQG-NRE 680
           T L  + + K   ++FD    +G+G FG+VY         ++A+K L  S   ++G   +
Sbjct: 1   TALAEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 681 FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 740
              EI + S  +HPN++++Y    +  ++ L+ E+       R    K+ +   + D   
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFA-----PRGELYKELQKHGRFDEQR 115
Query: 741 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 800
                  +A  L Y HE    K++HRDIK  N+L+      KI+DFG    +      + 
Sbjct: 116 SATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLR 168
Query: 801 TR-IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            R + GT+ Y+ PE         K D++  GV+  E + G
Sbjct: 169 RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 640 FDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQ 692
           +D   ++G G F  V K      G+      I  ++  S  R  +RE +  E+ ++   Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++ L+        ++L+ E +    L   +  K++     L      +    I  G+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGV 127
Query: 753 AYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            YLH    ++I H D+K  N+ LLD+++     KI DFGLA  ++ D  +    I GT  
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFKNIFGTPA 182
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           VG G +GSV   I    G  +A+K+LS   +S    +    E+ ++   QH N++ L   
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK--KICIGIARGLAYLHEDSR 760
               + L   Y++     L       D +  + +++   K   +   + +GL Y+H    
Sbjct: 110 FTPASSLRNFYDFY----LVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG- 164
Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRG- 818
             +VHRD+K  N+ +++D   KI DFGLA+  + + T ++ TR      Y APE  +   
Sbjct: 165 --VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWM 217
Query: 819 YLTSKADVYSFGVVTLEIVSGKS 841
           +     D++S G +  E+++GK+
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGKT 240

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 42/229 (18%)
Query: 639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
           +F     +G GGFG V+K     DG    ++++   + +  RE    +  ++   H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIV 68
Query: 698 KLYGC-------------CVEGNQ----------------LLLVYEYMKNNCLSRAIFGK 728
              GC              +E +                 L +  E+     L + I  +
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 729 DTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 788
             E   KLD     ++   I +G+ Y+H     K++HRD+K SN+ L      KI DFGL
Sbjct: 129 RGE---KLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGL 182
Query: 789 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV 837
               + D     TR  GT+ YM+PE         + D+Y+ G++  E++
Sbjct: 183 VTSLKNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DFGL +  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 29/215 (13%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLY---- 700
           +G GG G V+  + +D    +A+K++     Q  +  + EI +I    H N+VK++    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 701 ----------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 750
                     G   E N + +V EYM+ +  +    G   E   +L           + R
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-------FMYQLLR 131
Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIG- 808
           GL Y+H  +   ++HRD+K +N+ ++ +DL  KI DFGLA++ +   +H      G +  
Sbjct: 132 GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 809 -YMAPEYAMRGYLTSKA-DVYSFGVVTLEIVSGKS 841
            Y +P   +     +KA D+++ G +  E+++GK+
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 640 FDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQ 692
           +D   ++G G F  V K      G+      I  ++  S  R  +RE +  E+ ++   Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++ L+        ++L+ E +    L   +  K++     L      +    I  G+
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGV 126
Query: 753 AYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            YLH    ++I H D+K  N+ LLD+++     KI DFGLA  ++ D  +    I GT  
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFKNIFGTPE 181
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 214

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI  FGLA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 640 FDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQ 692
           +D   ++G G F  V K      G+      I  ++  S  R  +RE +  E+ ++   Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++ L+        ++L+ E +    L   +  K++     L      +    I  G+
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGV 126
Query: 753 AYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            YLH    ++I H D+K  N+ LLD+++     KI DFGLA  ++ D  +    I GT  
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFKNIFGTPE 181
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 214

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 640 FDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQ 692
           +D   ++G G F  V K      G+      I  ++  S  R  +RE +  E+ ++   Q
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++ L+        ++L+ E +    L   +  K++     L      +    I  G+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGV 127
Query: 753 AYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            YLH    ++I H D+K  N+ LLD+++     KI DFGLA  ++ D  +    I GT  
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFKNIFGTPE 182
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 640 FDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQ 692
           +D   ++G G F  V K      G+      I  ++  S  R  +RE +  E+ ++   Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++ L+        ++L+ E +    L   +  K++     L      +    I  G+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGV 127
Query: 753 AYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            YLH    ++I H D+K  N+ LLD+++     KI DFGLA  ++ D  +    I GT  
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFKNIFGTPE 182
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 29/219 (13%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSS--KSRQGNREFVNEIGMI 688
           ++KA  ++ +P  ++G G +G V K   +  G ++AVK++ +   S++  R  ++    +
Sbjct: 47  EVKA--DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 104
Query: 689 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD------WPTRK 742
                P  V  YG       + +  E M  +         D  Y+  +D           
Sbjct: 105 RTVDCPFTVTFYGALFREGDVWICMELMDTSL--------DKFYKQVIDKGQTIPEDILG 156
Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
           KI + I + L +LH  S++ ++HRD+K SNVL++     K+ DFG++  Y  D     T 
Sbjct: 157 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDSV-AKTI 212
Query: 803 IAGTIGYMAPEYA-----MRGYLTSKADVYSFGVVTLEI 836
            AG   YMAPE        +GY + K+D++S G+  +E+
Sbjct: 213 DAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIEL 250

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI DF LA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS---SKSRQGNREFVNEIGMISAQQHPN 695
           ++   K+G+G +G V+K I    G V+AVK++      S    R F   + +     H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 696 LVKLYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI-GIARGL 752
           +V L       N   + LV++YM+ +    A+       R  +  P  K+  +  + + +
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETDL--HAVI------RANILEPVHKQYVVYQLIKVI 122
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE------------------- 793
            YLH      ++HRD+K SN+LL+ + + K++DFGL++ +                    
Sbjct: 123 KYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 794 -EDKTHISTRIAGTIGYMAPEYAMRGYLTSKA-DVYSFGVVTLEIVSGK 840
            +D   I T    T  Y APE  +     +K  D++S G +  EI+ GK
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/99 (40%), Positives = 56/99 (56%), Gaps = 5/99 (5%)
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I  GL  LH   R +IV+RD+K  N+LLD   + +ISD GLA    E +T I  R+ GT+
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTV 349
Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 846
           GYMAPE       T   D ++ G +  E+++G+S    R
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 640 FDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQ 692
           +D   ++G G F  V K      G+      I  ++  S  R  +RE +  E+ ++   Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++ L+        ++L+ E +    L   +  K++     L      +    I  G+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGV 127
Query: 753 AYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            YLH    ++I H D+K  N+ LLD+++     KI DFGLA  ++ D  +    I GT  
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFKNIFGTPE 182
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 640 FDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQ 692
           +D   ++G G F  V K      G+      I  ++  S  R  +RE +  E+ ++   Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++ L+        ++L+ E +    L   +  K++     L      +    I  G+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGV 127
Query: 753 AYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            YLH    ++I H D+K  N+ LLD+++     KI DFGLA  ++ D  +    I GT  
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFKNIFGTPE 182
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 29/216 (13%)
Query: 639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
           +F     +G GGFG V+K     DG    +K++   + +  RE    +  ++   H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIV 67
Query: 698 KLYGCC----------------VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 741
              GC                  +   L +  E+     L + I  +  E   KLD    
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE---KLDKVLA 124
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
            ++   I +G+ Y+H     K+++RD+K SN+ L      KI DFGL    + D      
Sbjct: 125 LELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--X 179
Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV 837
           R  GT+ YM+PE         + D+Y+ G++  E++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI D GLA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 640 FDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQ 692
           +D   ++G G F  V K      G+      I  ++  S  R  +RE +  E+ ++   Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++ L+        ++L+ E +    L   +  K++     L      +    I  G+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGV 127
Query: 753 AYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            YLH    ++I H D+K  N+ LLD+++     KI DFGLA  ++ D  +    I GT  
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFKNIFGTPE 182
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 14/210 (6%)
Query: 635 AATNNFDPANKVGEGGFGSVYKGILSDGTVI-AVKQLSSKS---RQGNREFVNEIG-MIS 689
           A  ++F     +G+G FG V         V  AVK L  K+   ++  +  ++E   ++ 
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
             +HP LV L+      ++L  V +Y+    L    F      R  L+ P  +     IA
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLE-PRARFYAAEIA 149
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
             L YLH    + IV+RD+K  N+LLD   +  ++DFGL K   E  +  ST   GT  Y
Sbjct: 150 SALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEY 205
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           +APE   +       D +  G V  E++ G
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIG-----MISAQQ 692
            +FD    +G G +  V    L     I   ++  K    + E ++ +         A  
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HP LV L+ C    ++L  V EY+    L   +     + + KL     +     I+  L
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM-----QRQRKLPEEHARFYSAEISLAL 119
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYM 810
            YLHE     I++RD+K  NVLLD + + K++D+G+ K  L   D T   +   GT  Y+
Sbjct: 120 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYI 173
Query: 811 APEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           APE           D ++ GV+  E+++G+S
Sbjct: 174 APEILRGEDYGFSVDWWALGVLMFEMMAGRS 204

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 640 FDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQ 692
           +D   ++G G F  V K      G+      I  ++  S  R  +RE +  E+ ++   Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++ L+        ++L+ E +    L   +  K++     L      +    I  G+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGV 127
Query: 753 AYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            YLH    ++I H D+K  N+ LLD+++     KI DFGLA  ++ D  +    I GT  
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFKNIFGTPE 182
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-----EFVNEIGMISAQQHPNLVKL 699
           ++G G FG+V KG      V+    +     + N      E + E  ++    +P +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI----GIARGLAYL 755
            G C E    +LV E         A  G   +Y L+ +   + K  I     ++ G+ YL
Sbjct: 78  IGIC-EAESWMLVMEM--------AELGPLNKY-LQQNRHVKDKNIIELVHQVSMGMKYL 127
Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPE 813
            E +    VHRD+   NVLL     AKISDFGL+K    D+     +  G   + + APE
Sbjct: 128 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPE 184
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVS 838
                  +SK+DV+SFGV+  E  S
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIG-----MISAQQ 692
            +FD    +G G +  V    L     I   ++  K    + E ++ +         A  
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HP LV L+ C    ++L  V EY+    L   +     + + KL     +     I+  L
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM-----QRQRKLPEEHARFYSAEISLAL 123
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYM 810
            YLHE     I++RD+K  NVLLD + + K++D+G+ K  L   D T   +   GT  Y+
Sbjct: 124 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYI 177
Query: 811 APEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           APE           D ++ GV+  E+++G+S
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRS 208

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 640 FDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQ 692
           +D   ++G G F  V K      G+      I  ++  S  R  +RE +  E+ ++   Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++ L+        ++L+ E +    L   +  K++     L      +    I  G+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGV 127
Query: 753 AYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            YLH    ++I H D+K  N+ LLD+++     KI DFGLA  ++ D  +    I GT  
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFKNIFGTPE 182
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI D GLA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/99 (40%), Positives = 56/99 (56%), Gaps = 5/99 (5%)
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I  GL  LH   R +IV+RD+K  N+LLD   + +ISD GLA    E +T I  R+ GT+
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTV 349
Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 846
           GYMAPE       T   D ++ G +  E+++G+S    R
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 640 FDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQ 692
           +D   ++G G F  V K      G+      I  ++  S  R  +RE +  E+ ++   Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++ L+        ++L+ E +    L   +  K++     L      +    I  G+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGV 127
Query: 753 AYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            YLH    ++I H D+K  N+ LLD+++     KI DFGLA  ++ D  +    I GT  
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFKNIFGTPE 182
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 19/221 (8%)
Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK----SRQGNREFVNEI 685
           +R ++    ++D    +G G FG V          +   +L SK     R  +  F  E 
Sbjct: 67  IRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEER 126
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            +++    P +V+L+    +   L +V EYM    L   +    + Y +   W   K   
Sbjct: 127 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM----SNYDVPEKWA--KFYT 180
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIA 804
             +   L  +H    + ++HRD+K  N+LLDK  + K++DFG   K+ E    H  T + 
Sbjct: 181 AEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV- 236
Query: 805 GTIGYMAPEY----AMRGYLTSKADVYSFGVVTLEIVSGKS 841
           GT  Y++PE        GY   + D +S GV   E++ G +
Sbjct: 237 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT 277

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 640 FDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQ 692
           +D   ++G G F  V K      G+      I  ++  S  R  +RE +  E+ ++   Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++ L+        ++L+ E +    L   +  K++     L      +    I  G+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGV 127
Query: 753 AYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            YLH    ++I H D+K  N+ LLD+++     KI DFGLA  ++ D  +    I GT  
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFKNIFGTPE 182
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++       NRE    + ++    H N+V+L Y   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIVRLRYFFY 83
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 140
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLY---EEDKTHISTRIAGTIGYMAPE--Y 814
             I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R      Y APE  +
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 195
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
               Y TS  DV+S G V  E++ G+
Sbjct: 196 GATDY-TSSIDVWSAGCVLAELLLGQ 220

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 640 FDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQ 692
           +D   ++G G F  V K      G+      I  ++  S  R  +RE +  E+ ++   Q
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++ L+        ++L+ E +    L   +  K++     L      +    I  G+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGV 127
Query: 753 AYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            YLH    ++I H D+K  N+ LLD+++     KI DFGLA  ++ D  +    I GT  
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFKNIFGTPE 182
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           +G+G FG V++G    G  +AVK  SS+  R   RE   EI      +H N++       
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 106
Query: 705 EGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-- 758
           + N    QL LV +Y ++  L    F     Y + ++     K+ +  A GLA+LH +  
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVE--GMIKLALSTASGLAHLHMEIV 160
Query: 759 ---SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS---TRIAGTIGYMAP 812
               +  I HRD+K+ N+L+ K+    I+D GLA  ++     I        GT  YMAP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 813 EYA-----MRGYLT-SKADVYSFGVVTLEIV 837
           E       M+ + +  +AD+Y+ G+V  EI 
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++       NRE    + ++    H N+V+L Y   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIVRLRYFFY 83
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 140
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLY---EEDKTHISTRIAGTIGYMAPE--Y 814
             I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R      Y APE  +
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 195
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
               Y TS  DV+S G V  E++ G+
Sbjct: 196 GATDY-TSSIDVWSAGCVLAELLLGQ 220

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T+ ++     N  P   VG G +GSV        G  +AVK+LS   +S    +    E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 744
            ++   +H N++ L         L    E   +  L   + G D    +K    T   + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 745 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 801
                I RGL Y+H      I+HRD+K SN+ +++D   KI D GLA+  +++ T +++T
Sbjct: 129 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVAT 185
Query: 802 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 841
           R      Y APE  +   +     D++S G +  E+++G++
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREF---VNEIG 686
           K   N+FD    +G+G FG V   IL    + G   A+K L  +      E    V E  
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 62
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN----CLSRA-IFGKDTEYRLKLDWPTR 741
           ++   +HP L  L       ++L  V EY         LSR  +F   TE R +      
Sbjct: 63  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARF----- 114
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
                 I   L YLH  SR  +V+RDIK  N++LDKD + KI+DFGL K    D   +  
Sbjct: 115 --YGAEIVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX 169
Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
              GT  Y+APE           D +  GVV  E++ G+
Sbjct: 170 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 646 VGEGGFGSV---YKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G +GSV   Y   L     +AVK+LS   +S    R    E+ ++   +H N++ L 
Sbjct: 28  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI---CIGIARGLAYLHE 757
                   +    E      L   + G D    +K    + + +      + RGL Y+H 
Sbjct: 86  DVFTPATSI----EDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAM 816
                I+HRD+K SNV +++D   +I DFGLA+  +E+ T +++TR      Y APE  +
Sbjct: 142 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WYRAPEIML 193
Query: 817 RG-YLTSKADVYSFGVVTLEIVSGKS 841
              +     D++S G +  E++ GK+
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLQGKA 219

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           +G+G FG V++G    G  +AVK  SS+  R   RE   EI      +H N++       
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 93
Query: 705 EGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-- 758
           + N    QL LV +Y ++  L    F     Y + ++     K+ +  A GLA+LH +  
Sbjct: 94  KDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVE--GMIKLALSTASGLAHLHMEIV 147
Query: 759 ---SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS---TRIAGTIGYMAP 812
               +  I HRD+K+ N+L+ K+    I+D GLA  ++     I        GT  YMAP
Sbjct: 148 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 207
Query: 813 EYA-----MRGYLT-SKADVYSFGVVTLEIV 837
           E       M+ + +  +AD+Y+ G+V  EI 
Sbjct: 208 EVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           +G+G FG V++G    G  +AVK  SS+  R   RE   EI      +H N++       
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 68
Query: 705 EGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-- 758
           + N    QL LV +Y ++  L    F     Y + ++     K+ +  A GLA+LH +  
Sbjct: 69  KDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVE--GMIKLALSTASGLAHLHMEIV 122
Query: 759 ---SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS---TRIAGTIGYMAP 812
               +  I HRD+K+ N+L+ K+    I+D GLA  ++     I        GT  YMAP
Sbjct: 123 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 182
Query: 813 EYA-----MRGYLT-SKADVYSFGVVTLEIV 837
           E       M+ + +  +AD+Y+ G+V  EI 
Sbjct: 183 EVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREF---VNEIG 686
           K   N+FD    +G+G FG V   IL    + G   A+K L  +      E    V E  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN----CLSRA-IFGKDTEYRLKLDWPTR 741
           ++   +HP L  L       ++L  V EY         LSR  +F   TE R +      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARF----- 109
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
                 I   L YLH  SR  +V+RDIK  N++LDKD + KI+DFGL K    D   +  
Sbjct: 110 --YGAEIVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX 164
Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
              GT  Y+APE           D +  GVV  E++ G+
Sbjct: 165 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIG-----MISAQQ 692
            +FD    +G G +  V    L     I   ++  K    + E ++ +         A  
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HP LV L+ C    ++L  V EY+    L   +     + + KL     +     I+  L
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM-----QRQRKLPEEHARFYSAEISLAL 134
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYM 810
            YLHE     I++RD+K  NVLLD + + K++D+G+ K  L   D T   +   GT  Y+
Sbjct: 135 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYI 188
Query: 811 APEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           APE           D ++ GV+  E+++G+S
Sbjct: 189 APEILRGEDYGFSVDWWALGVLMFEMMAGRS 219

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 106/243 (43%), Gaps = 58/243 (23%)
Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGN---------------- 678
           N +   +++G+G +G V      +D T  A+K LS K   RQ                  
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 679 --------REFVNEIGMISAQQHPNLVKLYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGK 728
                    +   EI ++    HPN+VKL     + N+  L +V+E +    +       
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV------- 125
Query: 729 DTEYRLKLDWPTRKKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 780
                  ++ PT K +    AR        G+ YLH     KI+HRDIK SN+L+ +D +
Sbjct: 126 -------MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGH 175
Query: 781 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMRGYLTSKA-DVYSFGVVTLEIV 837
            KI+DFG++  ++     +S  + GT  +MAPE     R   + KA DV++ GV     V
Sbjct: 176 IKIADFGVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234
Query: 838 SGK 840
            G+
Sbjct: 235 FGQ 237

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 24/228 (10%)
Query: 626 GLYTLRQIKAATNNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQG-- 677
           G+ T +Q K   + +D   ++G G F  V K      G+      I  +Q S  SR+G  
Sbjct: 1   GMETFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQ-SRASRRGVC 58
Query: 678 NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD 737
             E   E+ ++    HPN++ L+        ++L+ E +    L   +  K++     L 
Sbjct: 59  REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-----LS 113
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYE 793
                     I  G+ YLH     KI H D+K  N+ LLDK++   + K+ DFGLA   E
Sbjct: 114 EEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
            D       I GT  ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 171 -DGVEFKN-IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 640 FDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQ 692
           +D   ++G G F  V K      G+      I  ++  S  R  +RE +  E+ ++   Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++ L+        ++L+ E +    L   +  K++     L      +    I  G+
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGV 127
Query: 753 AYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            YLH    ++I H D+K  N+ LLD+++     KI DFGLA  ++ D  +    I GT  
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFKNIFGTPE 182
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           +G+G FG V++G    G  +AVK  SS+  R   RE   EI      +H N++       
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 67
Query: 705 EGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-- 758
           + N    QL LV +Y ++  L    F     Y + ++     K+ +  A GLA+LH +  
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVE--GMIKLALSTASGLAHLHMEIV 121
Query: 759 ---SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS---TRIAGTIGYMAP 812
               +  I HRD+K+ N+L+ K+    I+D GLA  ++     I        GT  YMAP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 813 EYA-----MRGYLT-SKADVYSFGVVTLEIV 837
           E       M+ + +  +AD+Y+ G+V  EI 
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 106/235 (45%), Gaps = 35/235 (14%)
Query: 643 ANKVGEGGFGSVYKGILSDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
             ++G+G +G V+ G    G  +AVK   +++     RE   EI      +H N++    
Sbjct: 42  VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIA 98
Query: 702 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
             ++G     QL L+ +Y +N  L       D      LD  +  K+      GL +LH 
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLY------DYLKSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 758 D-----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI----STRIAGTIG 808
           +      +  I HRD+K+ N+L+ K+    I+D GLA  +  D   +    +TR+ GT  
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKR 211
Query: 809 YMAPEY----AMRGYLTS--KADVYSFGVVTLEI----VSGKSNTNYR-PNEDFV 852
           YM PE       R +  S   AD+YSFG++  E+    VSG     Y+ P  D V
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           +G+G FG V++G    G  +AVK  SS+  R   RE   EI      +H N++       
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 73
Query: 705 EGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-- 758
           + N    QL LV +Y ++  L    F     Y + ++     K+ +  A GLA+LH +  
Sbjct: 74  KDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVE--GMIKLALSTASGLAHLHMEIV 127
Query: 759 ---SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS---TRIAGTIGYMAP 812
               +  I HRD+K+ N+L+ K+    I+D GLA  ++     I        GT  YMAP
Sbjct: 128 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 187
Query: 813 EYA-----MRGYLT-SKADVYSFGVVTLEIV 837
           E       M+ + +  +AD+Y+ G+V  EI 
Sbjct: 188 EVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREF---VNEIG 686
           K   N+FD    +G+G FG V   IL    + G   A+K L  +      E    V E  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN----CLSRA-IFGKDTEYRLKLDWPTR 741
           ++   +HP L  L       ++L  V EY         LSR  +F   TE R +      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARF----- 109
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
                 I   L YLH  SR  +V+RDIK  N++LDKD + KI+DFGL K    D   +  
Sbjct: 110 --YGAEIVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX 164
Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
              GT  Y+APE           D +  GVV  E++ G+
Sbjct: 165 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           +G+G FG V++G    G  +AVK  SS+  R   RE   EI      +H N++       
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 70
Query: 705 EGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-- 758
           + N    QL LV +Y ++  L    F     Y + ++     K+ +  A GLA+LH +  
Sbjct: 71  KDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVE--GMIKLALSTASGLAHLHMEIV 124
Query: 759 ---SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS---TRIAGTIGYMAP 812
               +  I HRD+K+ N+L+ K+    I+D GLA  ++     I        GT  YMAP
Sbjct: 125 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 184
Query: 813 EYA-----MRGYLT-SKADVYSFGVVTLEIV 837
           E       M+ + +  +AD+Y+ G+V  EI 
Sbjct: 185 EVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 14/208 (6%)
Query: 635 AATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHP 694
           A ++ F+  +++G G    VY+     GT         K     +    EIG++    HP
Sbjct: 50  ALSDFFEVESELGRGATSIVYR-CKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHP 108
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N++KL        ++ LV E +    L   I  K   Y  + D     K    I   +AY
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVK---QILEAVAY 163
Query: 755 LHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           LHE+    IVHRD+K  N+L      D   KI+DFGL+K+ E     +   + GT GY A
Sbjct: 164 LHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCA 218
Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           PE         + D++S G++T  ++ G
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREF---VNEIG 686
           K   N+FD    +G+G FG V   IL    + G   A+K L  +      E    V E  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN----CLSRA-IFGKDTEYRLKLDWPTR 741
           ++   +HP L  L       ++L  V EY         LSR  +F   TE R +      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARF----- 109
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
                 I   L YLH  SR  +V+RDIK  N++LDKD + KI+DFGL K    D   +  
Sbjct: 110 --YGAEIVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX 164
Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
              GT  Y+APE           D +  GVV  E++ G+
Sbjct: 165 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 104/240 (43%), Gaps = 36/240 (15%)
Query: 637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 695
            ++F+    +G+G FG V K   + D    A+K++   + +     ++E+ ++++  H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVXLLASLNHQY 63
Query: 696 LVKLYGCCVE-------------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
           +V+ Y   +E              + L +  EY +N  L   I  ++   +    W   +
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-------LYEED 795
           +I       L+Y+H      I+HR++K  N+ +D+  N KI DFGLAK       + + D
Sbjct: 124 QIL----EALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 796 KTHIS------TRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 848
             ++       T   GT  Y+A E     G+   K D YS G++  E +   S    R N
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVN 236

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 646 VGEGGFGSV---YKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G +GSV   Y   L     +AVK+LS   +S    R    E+ ++   +H N++ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI---CIGIARGLAYLHE 757
                   +    E      L   + G D    +K    + + +      + RGL Y+H 
Sbjct: 94  DVFTPATSI----EDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAM 816
                I+HRD+K SNV +++D   +I DFGLA+  +E+ T +++TR      Y APE  +
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIML 201
Query: 817 RG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFV 852
              +     D++S G +  E++ GK+     P  D++
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGKA---LFPGSDYI 235

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ 692
           K     +DP + +G G    V + +  + G   AVK +   + + + E + E+   + ++
Sbjct: 90  KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149
Query: 693 ---------HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 743
                    HP+++ L       + + LV++ M+       +F   TE ++ L     + 
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG----ELFDYLTE-KVALSEKETRS 204
Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 803
           I   +   +++LH ++   IVHRD+K  N+LLD ++  ++SDFG +   E  +      +
Sbjct: 205 IMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LREL 259
Query: 804 AGTIGYMAPEY-------AMRGYLTSKADVYSFGVVTLEIVSG 839
            GT GY+APE           GY   + D+++ GV+   +++G
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAG 301

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQL--SSKSRQG-NREFVNEIGMISAQQH 693
           ++F+    +G+G FG+VY         ++A+K L  S   ++G   +   EI + +   H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           PN+++LY    +  ++ L+ EY       R    K+ +     D      I   +A  L 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYA-----PRGELYKELQKSCTFDEQRTATIMEELADALM 137
Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST----RIAGTIGY 809
           Y H     K++HRDIK  N+LL      KI+DFG +        H  +     + GT+ Y
Sbjct: 138 YCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS-------VHAPSLRRKTMCGTLDY 187
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           + PE         K D++  GV+  E++ G
Sbjct: 188 LPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 15/199 (7%)
Query: 646 VGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           +GEG F    K +        AVK +S +     ++ +  + +   + HPN+VKL+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKL--CEGHPNIVKLHEVFH 76
Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           +     LV E +    L   I  K      +  +  RK     +   ++++H+   + +V
Sbjct: 77  DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK-----LVSAVSHMHD---VGVV 128
Query: 765 HRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
           HRD+K  N+L    + +L  KI DFG A+L   D   + T    T+ Y APE   +    
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAPELLNQNGYD 187
Query: 822 SKADVYSFGVVTLEIVSGK 840
              D++S GV+   ++SG+
Sbjct: 188 ESCDLWSLGVILYTMLSGQ 206

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYGC 702
           VG+G +G V++G    G  +AVK  SS+  +      E  N + +    +H N++     
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 99
Query: 703 CV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH-- 756
            +       QL L+  Y +   L       D      LD  +  +I + IA GLA+LH  
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSL------YDYLQLTTLDTVSCLRIVLSIASGLAHLHIE 153
Query: 757 ---EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST----RIAGTIGY 809
                 +  I HRD+K+ N+L+ K+    I+D GLA ++ +    +      R+ GT  Y
Sbjct: 154 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRY 212
Query: 810 MAPEYAMRGYLTS------KADVYSFGVVTLEI----VSGKSNTNYRP 847
           MAPE               + D+++FG+V  E+    VS     +Y+P
Sbjct: 213 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 260

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 646 VGEGGFGSV---YKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLY 700
           VG G +GSV   Y   L     +AVK+LS   +S    R    E+ ++   +H N++ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI---CIGIARGLAYLHE 757
                   +    E      L   + G D    +K    + + +      + RGL Y+H 
Sbjct: 94  DVFTPATSI----EDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAM 816
                I+HRD+K SNV +++D   +I DFGLA+  +E+ T +++TR      Y APE  +
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIML 201
Query: 817 RG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFV 852
              +     D++S G +  E++ GK+     P  D++
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGKA---LFPGSDYI 235

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCC 703
           +G G FG VY+  L D G ++A+K++       NRE    + ++    H N+V+L Y   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIVRLRYFFY 83
Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEY-RLKLDWPT--RKKICIGIARGLAYLHEDSR 760
             G +   VY  +  + +   ++     Y R K   P    K     + R LAY+H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 140
Query: 761 IKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMR 817
             I HRDIK  N+LLD D    K+ DFG AK     + ++S   +    Y APE  +   
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YRAPELIFGAT 198
Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
            Y TS  DV+S G V  E++ G+
Sbjct: 199 DY-TSSIDVWSAGCVLAELLLGQ 220

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYGC 702
           VG+G +G V++G    G  +AVK  SS+  +      E  N + +    +H N++     
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 703 CV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH-- 756
            +       QL L+  Y +   L       D      LD  +  +I + IA GLA+LH  
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLY------DYLQLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 757 ---EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST----RIAGTIGY 809
                 +  I HRD+K+ N+L+ K+    I+D GLA ++ +    +      R+ GT  Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRY 183
Query: 810 MAPEYAMRGYLTS------KADVYSFGVVTLEI----VSGKSNTNYRP 847
           MAPE               + D+++FG+V  E+    VS     +Y+P
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 646 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYGC 702
           VG+G +G V++G    G  +AVK  SS+  +      E  N + +    +H N++     
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 703 CV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH-- 756
            +       QL L+  Y +   L       D      LD  +  +I + IA GLA+LH  
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLY------DYLQLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 757 ---EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST----RIAGTIGY 809
                 +  I HRD+K+ N+L+ K+    I+D GLA ++ +    +      R+ GT  Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRY 183
Query: 810 MAPEYAMRGYLTS------KADVYSFGVVTLEI----VSGKSNTNYRP 847
           MAPE               + D+++FG+V  E+    VS     +Y+P
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 88
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E   
Sbjct: 89  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--- 140
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 141 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  +AGT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 194 R----TWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 13/206 (6%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 694
             ++   K+GEG +G+V+K    +   ++A+K+  L           + EI ++   +H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+V+L+       +L LV+E+   + L +     + +    LD    K     + +GL +
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGD----LDPEIVKSFLFQLLKGLGF 116
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H  +   ++HRD+K  N+L++++   K++DFGLA+ +       S  +  T+ Y  P+ 
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDV 172
Query: 815 AMRGYLTSKA-DVYSFGVVTLEIVSG 839
                L S + D++S G +  E+ + 
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANA 198

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 638 NNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVN-EIGMISA 690
           ++++   ++G G F  V K      G       I  ++LSS  R  +RE +  E+ ++  
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 750
            +HPN++ L+        ++L+ E +    L   +  K++   L  D  T  +    I  
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEAT--QFLKQILD 119
Query: 751 GLAYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYEEDKTHISTRIAGT 806
           G+ YLH     +I H D+K  N+ LLDK++     K+ DFG+A   E         I GT
Sbjct: 120 GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGT 174
Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
             ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 88
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EYM    +   +   G+ +E      
Sbjct: 89  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSE------ 140
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    K++DFG AK  +    
Sbjct: 141 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-- 194
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 195 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREFVN---EIG 686
           +   N F+    +G+G FG V   IL    + G   A+K L  +      E  +   E  
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 203
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN----CLSRA-IFGKDTEYRLKLDWPTR 741
           ++   +HP L  L       ++L  V EY         LSR  +F +D   R +      
Sbjct: 204 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARF----- 255
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
                 I   L YLH  S   +V+RD+K  N++LDKD + KI+DFGL K   +D   + T
Sbjct: 256 --YGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 311
Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
              GT  Y+APE           D +  GVV  E++ G+
Sbjct: 312 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 88
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EYM    +   +   G+ +E      
Sbjct: 89  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSE------ 140
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    K++DFG AK  +    
Sbjct: 141 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-- 194
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 195 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREFVN---EIG 686
           +   N F+    +G+G FG V   IL    + G   A+K L  +      E  +   E  
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN----CLSRA-IFGKDTEYRLKLDWPTR 741
           ++   +HP L  L       ++L  V EY         LSR  +F +D   R +      
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARF----- 252
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
                 I   L YLH  S   +V+RD+K  N++LDKD + KI+DFGL K   +D   + T
Sbjct: 253 --YGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
              GT  Y+APE           D +  GVV  E++ G+
Sbjct: 309 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTV--IAVK--------QLSSKSRQGNREF-VNEIG 686
            N++P   +G G   SV +  +   T    AVK          S++  Q  RE  + E+ 
Sbjct: 4   ENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 62
Query: 687 MI-SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
           ++     HPN+++L           LV++ MK       +F   TE ++ L     +KI 
Sbjct: 63  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTE-KVTLSEKETRKIM 117
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +   +  LH   ++ IVHRD+K  N+LLD D+N K++DFG +   + D       + G
Sbjct: 118 RALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLREVCG 172
Query: 806 TIGYMAPEYA-------MRGYLTSKADVYSFGVVTLEIVSG 839
           T  Y+APE           GY   + D++S GV+   +++G
Sbjct: 173 TPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAG 212

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR---EFVNEIGMISAQQHPNLVKLYG 701
           +G GG   V+    L D   +AVK L +   +       F  E    +A  HP +V +Y 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 702 C----CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA-RGLAYLH 756
                   G    +V EY+    L      +D  +      P R    I  A + L + H
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTL------RDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI--STRIAGTIGYMAPEY 814
           ++    I+HRD+K +N+L+      K+ DFG+A+   +    +  +  + GT  Y++PE 
Sbjct: 134 QNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQ 190
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
           A    + +++DVYS G V  E+++G+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 646 VGEGGFGSVY--KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           +G G F  V+  K  L+ G + A+K +       +    NEI ++   +H N+V L    
Sbjct: 17  LGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 704 VEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
                  LV + +    L   I   G  TE    L       +   +   + YLHE+   
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-------VIQQVLSAVKYLHENG-- 126
Query: 762 KIVHRDIKTSNVL-LDKDLNAKI--SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 818
            IVHRD+K  N+L L  + N+KI  +DFGL+K+   ++  I +   GT GY+APE   + 
Sbjct: 127 -IVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYVAPEVLAQK 182
Query: 819 YLTSKADVYSFGVVTLEIVSG 839
             +   D +S GV+T  ++ G
Sbjct: 183 PYSKAVDCWSIGVITYILLCG 203

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTV--IAVK--------QLSSKSRQGNREF-VNEIG 686
            N++P   +G G   SV +  +   T    AVK          S++  Q  RE  + E+ 
Sbjct: 17  ENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 687 MI-SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
           ++     HPN+++L           LV++ MK       +F   TE ++ L     +KI 
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTE-KVTLSEKETRKIM 130
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +   +  LH   ++ IVHRD+K  N+LLD D+N K++DFG +   + D       + G
Sbjct: 131 RALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLREVCG 185
Query: 806 TIGYMAPEYA-------MRGYLTSKADVYSFGVVTLEIVSG 839
           T  Y+APE           GY   + D++S GV+   +++G
Sbjct: 186 TPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAG 225

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 107/232 (46%), Gaps = 33/232 (14%)
Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN----------- 678
           + ++ A  + +     +  G +G+V  G+ S+G  +A+K++ +    G            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 679 REFVNEIGMISAQQHPNLVKLYGCCVE-----GNQLLLVYEYMKNNCLSRAIFGKDTEYR 733
           +  + EI +++   HPN++ L    V       ++L LV E M+ + L++ I  +    R
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQ----R 128
Query: 734 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--L 791
           + +     +     I  GL  LHE     +VHRD+   N+LL  + +  I DF LA+   
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDT 185
Query: 792 YEEDKTHISTRIAGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGKS 841
            + +KTH  T       Y APE  M  +G+ T   D++S G V  E+ + K+
Sbjct: 186 ADANKTHYVTH----RWYRAPELVMQFKGF-TKLVDMWSAGCVMAEMFNRKA 232

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 107/232 (46%), Gaps = 33/232 (14%)
Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN----------- 678
           + ++ A  + +     +  G +G+V  G+ S+G  +A+K++ +    G            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 679 REFVNEIGMISAQQHPNLVKLYGCCVE-----GNQLLLVYEYMKNNCLSRAIFGKDTEYR 733
           +  + EI +++   HPN++ L    V       ++L LV E M+ + L++ I  +    R
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQ----R 128
Query: 734 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--L 791
           + +     +     I  GL  LHE     +VHRD+   N+LL  + +  I DF LA+   
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDT 185
Query: 792 YEEDKTHISTRIAGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGKS 841
            + +KTH  T       Y APE  M  +G+ T   D++S G V  E+ + K+
Sbjct: 186 ADANKTHYVTH----RWYRAPELVMQFKGF-TKLVDMWSAGCVMAEMFNRKA 232

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 19/152 (12%)
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIA 749
           P L +L+ C    ++L  V EY+          G D  Y +    K   P        I+
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVN---------GGDLMYHIQQVGKFKEPQAVFYAAEIS 130
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIG 808
            GL +LH+     I++RD+K  NV+LD + + KI+DFG+ K +  D   ++TR   GT  
Sbjct: 131 IGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG--VTTREFCGTPD 185
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           Y+APE           D +++GV+  E+++G+
Sbjct: 186 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR---EFVNEIGMISAQQHPNLVKLYG 701
           +G GG   V+    L D   +AVK L +   +       F  E    +A  HP +V +Y 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 702 C----CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA-RGLAYLH 756
                   G    +V EY+    L      +D  +      P R    I  A + L + H
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTL------RDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA--GTIGYMAPEY 814
           ++    I+HRD+K +N+++      K+ DFG+A+   +    ++   A  GT  Y++PE 
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
           A    + +++DVYS G V  E+++G+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTVI--AVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
           N +G G +G V K  +  GT I  A K++     +    F  EI ++ +  HPN+++LY 
Sbjct: 15  NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              +   + LV E     C    +F +    R+  +     +I   +   +AY H   ++
Sbjct: 74  TFEDNTDIYLVMEL----CTGGELFERVVHKRVFRE-SDAARIMKDVLSAVAYCH---KL 125
Query: 762 KIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 818
            + HRD+K  N L      D   K+ DFGLA  ++  K  + T++ GT  Y++P+  + G
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTPYYVSPQ-VLEG 182
Query: 819 YLTSKADVYSFGVVTLEIVSG 839
               + D +S GV+   ++ G
Sbjct: 183 LYGPECDEWSAGVMMYVLLCG 203

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR---EFVNEIGMISAQQHPNLVKLYG 701
           +G GG   V+    L D   +AVK L +   +       F  E    +A  HP +V +Y 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 702 C----CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA-RGLAYLH 756
                   G    +V EY+    L      +D  +      P R    I  A + L + H
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTL------RDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA--GTIGYMAPEY 814
           ++    I+HRD+K +N+++      K+ DFG+A+   +    ++   A  GT  Y++PE 
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
           A    + +++DVYS G V  E+++G+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 644 NKVGEGGFGSVYKGILSDGTVI--AVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
           N +G G +G V K  +  GT I  A K++     +    F  EI ++ +  HPN+++LY 
Sbjct: 32  NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 90
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              +   + LV E     C    +F +    R+  +     +I   +   +AY H   ++
Sbjct: 91  TFEDNTDIYLVMEL----CTGGELFERVVHKRVFRE-SDAARIMKDVLSAVAYCH---KL 142
Query: 762 KIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 818
            + HRD+K  N L      D   K+ DFGLA  ++  K  + T++ GT  Y++P+  + G
Sbjct: 143 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTPYYVSPQ-VLEG 199
Query: 819 YLTSKADVYSFGVVTLEIVSG 839
               + D +S GV+   ++ G
Sbjct: 200 LYGPECDEWSAGVMMYVLLCG 220

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 25/234 (10%)
Query: 620 GLDLQT-GLYTLRQIKAATNNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSS 672
           G+DL T  LY    ++   ++++   ++G G F  V K      G       I  ++L S
Sbjct: 10  GVDLGTENLYFQSMVE---DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXS 66
Query: 673 KSRQGNREFVN-EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTE 731
             R  +RE +  E+ ++   +HPN++ L+        ++L+ E +    L   +  K++ 
Sbjct: 67  SRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES- 125
Query: 732 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFG 787
             L  D  T  +    I  G+ YLH     +I H D+K  N+ LLDK++     K+ DFG
Sbjct: 126 --LTEDEAT--QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 178
Query: 788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           +A   E         I GT  ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 179 IAHKIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 230

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTV--IAVK--------QLSSKSRQGNREF-VNEIG 686
            N++P   +G G   SV +  +   T    AVK          S++  Q  RE  + E+ 
Sbjct: 17  ENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 687 MI-SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
           ++     HPN+++L           LV++ MK       +F   TE ++ L     +KI 
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTE-KVTLSEKETRKIM 130
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +   +  LH   ++ IVHRD+K  N+LLD D+N K++DFG +   + D       + G
Sbjct: 131 RALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLRSVCG 185
Query: 806 TIGYMAPEYA-------MRGYLTSKADVYSFGVVTLEIVSG 839
           T  Y+APE           GY   + D++S GV+   +++G
Sbjct: 186 TPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAG 225

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 4/99 (4%)
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I  GL +LH+ +   I++RD+K  NVLLD D N +ISD GLA   +  +T  +   AGT 
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTP 353
Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 846
           G+MAPE  +        D ++ GV   E+++ +     R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 644 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNRE--FVNEIGMISAQQHPNLVKLY 700
            K+GEG +G VYK I +     +A+K++  +  +       + E+ ++   QH N+++L 
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
                 ++L L++EY +N+         D   R+       K     +  G+ + H  SR
Sbjct: 100 SVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVI------KSFLYQLINGVNFCH--SR 151
Query: 761 IKIVHRDIKTSNVLLD-KDLNA----KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
            + +HRD+K  N+LL   D +     KI DFGLA+ +       +  I  T+ Y  PE  
Sbjct: 152 -RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEIL 209
Query: 816 M--RGYLTSKADVYSFGVVTLEIV 837
           +  R Y TS  D++S   +  E++
Sbjct: 210 LGSRHYSTS-VDIWSIACIWAEML 232

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 4/99 (4%)
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I  GL +LH+ +   I++RD+K  NVLLD D N +ISD GLA   +  +T  +   AGT 
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTP 353
Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 846
           G+MAPE  +        D ++ GV   E+++ +     R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 4/99 (4%)
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I  GL +LH+ +   I++RD+K  NVLLD D N +ISD GLA   +  +T  +   AGT 
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTP 353
Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 846
           G+MAPE  +        D ++ GV   E+++ +     R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 681 FVNEIGMISAQQHPNLVKLYGC----CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKL 736
           F  E    +A  HP +V +Y         G    +V EY+    L      +D  +    
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTL------RDIVHTEGP 112
Query: 737 DWPTRKKICIGIA-RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 795
             P R    I  A + L + H++    I+HRD+K +N+++      K+ DFG+A+   + 
Sbjct: 113 MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 796 KTHISTRIA--GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
              ++   A  GT  Y++PE A    + +++DVYS G V  E+++G+
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 4/99 (4%)
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I  GL +LH+ +   I++RD+K  NVLLD D N +ISD GLA   +  +T  +   AGT 
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTP 353
Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 846
           G+MAPE  +        D ++ GV   E+++ +     R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 14/148 (9%)
Query: 637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ---- 691
           T  F    K+G G FGSV+K +   DG + A+K+ S K   G+ +  N +  + A     
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 64
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK--LDWPTRKKICIGIA 749
           QH ++V+ +    E + +L+  EY     L+ AI      YR+         K + + + 
Sbjct: 65  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI---SENYRIMSYFKEAELKDLLLQVG 121
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDK 777
           RGL Y+H    + +VH DIK SN+ + +
Sbjct: 122 RGLRYIHS---MSLVHMDIKPSNIFISR 146

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 14/148 (9%)
Query: 637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ---- 691
           T  F    K+G G FGSV+K +   DG + A+K+ S K   G+ +  N +  + A     
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK--LDWPTRKKICIGIA 749
           QH ++V+ +    E + +L+  EY     L+ AI      YR+         K + + + 
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI---SENYRIMSYFKEAELKDLLLQVG 123
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDK 777
           RGL Y+H    + +VH DIK SN+ + +
Sbjct: 124 RGLRYIHS---MSLVHMDIKPSNIFISR 148

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 14/148 (9%)
Query: 637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ---- 691
           T  F    K+G G FGSV+K +   DG + A+K+ S K   G+ +  N +  + A     
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK--LDWPTRKKICIGIA 749
           QH ++V+ +    E + +L+  EY     L+ AI      YR+         K + + + 
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI---SENYRIMSYFKEAELKDLLLQVG 123
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDK 777
           RGL Y+H    + +VH DIK SN+ + +
Sbjct: 124 RGLRYIHS---MSLVHMDIKPSNIFISR 148

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 14/148 (9%)
Query: 637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ---- 691
           T  F    K+G G FGSV+K +   DG + A+K+ S K   G+ +  N +  + A     
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 68
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK--LDWPTRKKICIGIA 749
           QH ++V+ +    E + +L+  EY     L+ AI      YR+         K + + + 
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI---SENYRIMSYFKEAELKDLLLQVG 125
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDK 777
           RGL Y+H    + +VH DIK SN+ + +
Sbjct: 126 RGLRYIHS---MSLVHMDIKPSNIFISR 150

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 19  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 75
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E   
Sbjct: 76  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--- 127
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 128 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG 180
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 181 R----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 88
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E   
Sbjct: 89  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--- 140
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 141 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 194 R----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 88
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E   
Sbjct: 89  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--- 140
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 141 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 194 R----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 637 TNNFDPANKVGEGGFGSVYKGILSDGT------VIAVKQLSSKSRQGNREFVNEIGMISA 690
           T+++    ++G+G F  V + +    T      +I  K+LS++  Q   +   E  +   
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ---KLEREARICRL 86
Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI-GIA 749
            +HPN+V+L+    E     LV++ +    L   I  +  EY  + D       CI  I 
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEAD----ASHCIHQIL 140
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKTHISTRIAGT 806
             + ++H+     IVHRD+K  N+LL    K    K++DFGLA +  + +       AGT
Sbjct: 141 ESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGT 196
Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            GY++PE   +       D+++ GV+   ++ G
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 53  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 109
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E   
Sbjct: 110 -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--- 161
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 162 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK- 213
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 214 ---GATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 88
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E   
Sbjct: 89  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--- 140
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 141 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 194 R----TWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 33  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 89
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E   
Sbjct: 90  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--- 141
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 142 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 195 R----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 21/222 (9%)
Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGT--VIAVKQLSSKS---RQGNREFVNE 684
           +R ++    +++    +G G FG V + +    T  V A+K LS      R  +  F  E
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 685 IGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI 744
             +++    P +V+L+    +   L +V EYM    L   +    + Y +   W   +  
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWA--RFY 173
Query: 745 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRI 803
              +   L  +H    +  +HRD+K  N+LLDK  + K++DFG   K+ +E      T +
Sbjct: 174 TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 804 AGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKS 841
            GT  Y++PE        GY   + D +S GV   E++ G +
Sbjct: 231 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 88
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E   
Sbjct: 89  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--- 140
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 141 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 194 R----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 88
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E   
Sbjct: 89  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--- 140
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 141 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 194 R----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 638 NNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ---- 691
            +F   +++G G +G V+K + S  DG + AVK+  S  R G ++   ++  + +     
Sbjct: 57  QSFQRLSRLGHGSYGEVFK-VRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVG 114
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEY----MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 747
           QHP  V+L     EG  L L  E     ++ +C +      + +      W   +   + 
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQV-----WGYLRDTLLA 169
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
               LA+LH      +VH D+K +N+ L      K+ DFGL  L E           G  
Sbjct: 170 ----LAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDP 220
Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIV 837
            YMAPE  ++G   + ADV+S G+  LE+ 
Sbjct: 221 RYMAPEL-LQGSYGTAADVFSLGLTILEVA 249

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 88
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E   
Sbjct: 89  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--- 140
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 141 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 194 R----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF--VNEIGMISAQQH 693
            + ++   K+G+G FG V+K      G  +A+K++  ++ +       + EI ++   +H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 694 PNLVKLYGCCVEG--------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            N+V L   C             + LV+++ +++     + G  +   +K      K++ 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-----LAGLLSNVLVKFTLSEIKRVM 131
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +  GL Y+H   R KI+HRD+K +NVL+ +D   K++DFGLA+ +   K     R   
Sbjct: 132 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 806 ---TIGYMAPEYAM--RGYLTSKADVYSFGVVTLEI 836
              T+ Y  PE  +  R Y     D++  G +  E+
Sbjct: 189 RVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEM 223

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 100/251 (39%), Gaps = 39/251 (15%)
Query: 606 GCLGGKVSADKELRGL---DLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY------- 655
            C G +  + KE       D      T  Q  A  + FD    +G G FG V        
Sbjct: 6   ACKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKES 65
Query: 656 -----KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 710
                  IL    V+ +KQ+           +NE  ++ A   P LVKL     + + L 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 711 LVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI 768
           +V EY+    +   +   G+  E       P  +     I     YLH    + +++RD+
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFXE-------PHARFYAAQIVLTFEYLHS---LDLIYRDL 167
Query: 769 KTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYS 828
           K  N+L+D+    +++DFG AK  +      +  + GT  Y+APE  +        D ++
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 829 FGVVTLEIVSG 839
            GV+  E+ +G
Sbjct: 224 LGVLIYEMAAG 234

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 21/222 (9%)
Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGT--VIAVKQLSSKS---RQGNREFVNE 684
           +R ++    +++    +G G FG V + +    T  V A+K LS      R  +  F  E
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 685 IGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI 744
             +++    P +V+L+    +   L +V EYM    L   +    + Y +   W   +  
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWA--RFY 178
Query: 745 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRI 803
              +   L  +H    +  +HRD+K  N+LLDK  + K++DFG   K+ +E      T +
Sbjct: 179 TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 804 AGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKS 841
            GT  Y++PE        GY   + D +S GV   E++ G +
Sbjct: 236 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 276

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 17/204 (8%)
Query: 644 NKVGEGGFGSVYKG---ILSDGTV-IAVKQLSS---KSRQGNREFVNEIGMISAQQHPNL 696
            K+G+G FG V +G     S  TV +AVK L        +   +F+ E+  + +  H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++LYG  +    + +V E      L   +      + L     T  +  + +A G+ YL 
Sbjct: 84  IRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLG----TLSRYAVQVAEGMGYLE 138
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI--GYMAPEY 814
                + +HRD+   N+LL      KI DFGL +   ++  H   +    +   + APE 
Sbjct: 139 SK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPES 195
Query: 815 AMRGYLTSKADVYSFGVVTLEIVS 838
                 +  +D + FGV   E+ +
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 21/222 (9%)
Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGT--VIAVKQLSSKS---RQGNREFVNE 684
           +R ++    +++    +G G FG V + +    T  V A+K LS      R  +  F  E
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 685 IGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI 744
             +++    P +V+L+    +   L +V EYM    L   +    + Y +   W   +  
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWA--RFY 178
Query: 745 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRI 803
              +   L  +H    +  +HRD+K  N+LLDK  + K++DFG   K+ +E      T +
Sbjct: 179 TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 804 AGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKS 841
            GT  Y++PE        GY   + D +S GV   E++ G +
Sbjct: 236 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 276

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 644 NKVGEGGFGSVYKG---ILSDGTV-IAVKQLSS---KSRQGNREFVNEIGMISAQQHPNL 696
            K+G+G FG V +G     S  TV +AVK L        +   +F+ E+  + +  H NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++LYG  V    + +V E      L   +      + L     T  +  + +A G+ YL 
Sbjct: 78  IRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG----TLSRYAVQVAEGMGYLE 132
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH--ISTRIAGTIGYMAPEY 814
                + +HRD+   N+LL      KI DFGL +   ++  H  +         + APE 
Sbjct: 133 SK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 189
Query: 815 AMRGYLTSKADVYSFGVVTLEIVS 838
                 +  +D + FGV   E+ +
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF--VNEIGMISAQQH 693
            + ++   K+G+G FG V+K      G  +A+K++  ++ +       + EI ++   +H
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 694 PNLVKLYGCCVEG--------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            N+V L   C             + LV+++ +++     + G  +   +K      K++ 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-----LAGLLSNVLVKFTLSEIKRVM 130
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +  GL Y+H   R KI+HRD+K +NVL+ +D   K++DFGLA+ +   K     R   
Sbjct: 131 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 187
Query: 806 ---TIGYMAPEYAM--RGYLTSKADVYSFGVVTLEI 836
              T+ Y  PE  +  R Y     D++  G +  E+
Sbjct: 188 RVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEM 222

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF--VNEIGMISAQQH 693
            + ++   K+G+G FG V+K      G  +A+K++  ++ +       + EI ++   +H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 694 PNLVKLYGCCVEG--------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            N+V L   C             + LV+++ +++     + G  +   +K      K++ 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-----LAGLLSNVLVKFTLSEIKRVM 131
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +  GL Y+H   R KI+HRD+K +NVL+ +D   K++DFGLA+ +   K     R   
Sbjct: 132 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 806 ---TIGYMAPEYAM--RGYLTSKADVYSFGVVTLEI 836
              T+ Y  PE  +  R Y     D++  G +  E+
Sbjct: 189 RVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEM 223

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 644 NKVGEGGFGSVYKG---ILSDGTV-IAVKQLSS---KSRQGNREFVNEIGMISAQQHPNL 696
            K+G+G FG V +G     S  TV +AVK L        +   +F+ E+  + +  H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++LYG  +    + +V E      L   +      + L     T  +  + +A G+ YL 
Sbjct: 84  IRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLG----TLSRYAVQVAEGMGYLE 138
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH--ISTRIAGTIGYMAPEY 814
                + +HRD+   N+LL      KI DFGL +   ++  H  +         + APE 
Sbjct: 139 SK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 815 AMRGYLTSKADVYSFGVVTLEIVS 838
                 +  +D + FGV   E+ +
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 681 FVNEIGMISAQQHPNLVKLYGC----CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKL 736
           F  E    +A  HP +V +Y         G    +V EY+    L      +D  +    
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL------RDIVHTEGP 112
Query: 737 DWPTRKKICIGIA-RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 795
             P R    I  A + L + H++    I+HRD+K +N+++      K+ DFG+A+   + 
Sbjct: 113 MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 796 KTHISTRIA--GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
              ++   A  GT  Y++PE A    + +++DVYS G V  E+++G+
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 640 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNL 696
           ++   K+GEG +G+V+K    +   ++A+K+  L           + EI ++   +H N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           V+L+       +L LV+E+   + L +     + +    LD    K     + +GL + H
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGD----LDPEIVKSFLFQLLKGLGFCH 118
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
             +   ++HRD+K  N+L++++   K+++FGLA+ +       S  +  T+ Y  P+   
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 174
Query: 817 RGYLTSKA-DVYSFGVVTLEIVSG 839
              L S + D++S G +  E+ + 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANA 198

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 88
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E      
Sbjct: 89  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE------ 140
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    K++DFG AK  +    
Sbjct: 141 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-- 194
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 195 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 27  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 83
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+  E   
Sbjct: 84  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE--- 135
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 136 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 188
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 189 R----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 88
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+  E   
Sbjct: 89  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAE--- 140
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 141 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 194 R----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF--VNEIGMISAQQH 693
            + ++   K+G+G FG V+K      G  +A+K++  ++ +       + EI ++   +H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 694 PNLVKLYGCCVEGNQ--------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            N+V L   C             + LV+++ +++     + G  +   +K      K++ 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEHD-----LAGLLSNVLVKFTLSEIKRVM 131
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +  GL Y+H   R KI+HRD+K +NVL+ +D   K++DFGLA+ +   K     R   
Sbjct: 132 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 806 ---TIGYMAPEYAM--RGYLTSKADVYSFGVVTLEI 836
              T+ Y  PE  +  R Y     D++  G +  E+
Sbjct: 189 RVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEM 223

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 83/199 (41%), Gaps = 25/199 (12%)
Query: 602 MRWKGCLGGKVSADK-ELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-L 659
           M   G LGG    D+ +  G  ++ G   LR  +           + EGGF  VY+   +
Sbjct: 1   MAGPGSLGGASGRDQSDFVGQTVELGELRLRVRRV----------LAEGGFAFVYEAQDV 50
Query: 660 SDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQ--------LL 710
             G   A+K+L S   + NR  + E+  M     HPN+V+       G +         L
Sbjct: 51  GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL 110
Query: 711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKT 770
           L+ E  K   +    F K  E R  L   T  KI     R + ++H   +  I+HRD+K 
Sbjct: 111 LLTELCKGQLVE---FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKV 166
Query: 771 SNVLLDKDLNAKISDFGLA 789
            N+LL      K+ DFG A
Sbjct: 167 ENLLLSNQGTIKLCDFGSA 185

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 88
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+  E   
Sbjct: 89  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE--- 140
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 141 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 194 R----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 88
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+  E   
Sbjct: 89  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE--- 140
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 141 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 194 R----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 53  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 109
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+  E   
Sbjct: 110 -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE--- 161
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 162 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 214
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 215 R----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 86/203 (42%), Gaps = 14/203 (6%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVK-----QLSSKSRQGNREFVNEIGMISAQQHPNLVKL 699
           +G+G F  V + I  + G   AVK     + +S       +   E  +    +HP++V+L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
                    L +V+E+M    L   I  K  +                I   L Y H+++
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIV-KRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 760 RIKIVHRDIKTSNVLLDKDLNA---KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
              I+HRD+K  NVLL    N+   K+ DFG+A    E       R+ GT  +MAPE   
Sbjct: 151 ---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV-GTPHFMAPEVVK 206
Query: 817 RGYLTSKADVYSFGVVTLEIVSG 839
           R       DV+  GV+   ++SG
Sbjct: 207 REPYGKPVDVWGCGVILFILLSG 229

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 681 FVNEIGMISAQQHPNLVKLYGC----CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKL 736
           F  E    +A  HP +V +Y         G    +V EY+    L      +D  +    
Sbjct: 76  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL------RDIVHTEGP 129
Query: 737 DWPTRKKICIGIA-RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 795
             P R    I  A + L + H++    I+HRD+K +N+++      K+ DFG+A+   + 
Sbjct: 130 MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 186
Query: 796 KTHISTRIA--GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
              ++   A  GT  Y++PE A    + +++DVYS G V  E+++G+
Sbjct: 187 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREFVN---EIG 686
           +   N F+    +G+G FG V   IL    + G   A+K L  +      E  +   E  
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 62
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN----CLSRA-IFGKDTEYRLKLDWPTR 741
           ++   +HP L  L       ++L  V EY         LSR  +F +D            
Sbjct: 63  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA---------- 112
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
           +     I   L YLH  S   +V+RD+K  N++LDKD + KI+DFGL K   +D   +  
Sbjct: 113 RFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX 170
Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
              GT  Y+APE           D +  GVV  E++ G+
Sbjct: 171 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREFVN---EIG 686
           +   N F+    +G+G FG V   IL    + G   A+K L  +      E  +   E  
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 60
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN----CLSRA-IFGKDTEYRLKLDWPTR 741
           ++   +HP L  L       ++L  V EY         LSR  +F +D            
Sbjct: 61  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA---------- 110
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
           +     I   L YLH  S   +V+RD+K  N++LDKD + KI+DFGL K   +D   +  
Sbjct: 111 RFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX 168
Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
              GT  Y+APE           D +  GVV  E++ G+
Sbjct: 169 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREFVN---EIG 686
           +   N F+    +G+G FG V   IL    + G   A+K L  +      E  +   E  
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 61
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN----CLSRA-IFGKDTEYRLKLDWPTR 741
           ++   +HP L  L       ++L  V EY         LSR  +F +D            
Sbjct: 62  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA---------- 111
Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
           +     I   L YLH  S   +V+RD+K  N++LDKD + KI+DFGL K   +D   +  
Sbjct: 112 RFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX 169
Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
              GT  Y+APE           D +  GVV  E++ G+
Sbjct: 170 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 31/214 (14%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS------SKSRQGNREFVNEIGMISAQ 691
            N  P     +G   + Y  IL     +A+K+LS      + +++  RE V    ++   
Sbjct: 27  QNLKPIGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV----LMKVV 80
Query: 692 QHPNLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            H N++ L           E   + +V E M  N LS+ I       +++LD      + 
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LSQVI-------QMELDHERMSYLL 132
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +  G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    
Sbjct: 133 YQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVV 187
Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           T  Y APE  +        D++S GV+  E++ G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 639 NFDPANKVGEGGFGS-VYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
           +F P + +G G  G+ VY+G+  +  V   + L       +RE      +  + +HPN++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQL---LRESDEHPNVI 81
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           + Y C  +  Q   +   +    L   +  KD  + L L+  T   +      GLA+LH 
Sbjct: 82  R-YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAH-LGLEPIT---LLQQTTSGLAHLHS 136
Query: 758 DSRIKIVHRDIKTSNVLLDK-----DLNAKISDFGLAKLYEEDKTHISTR--IAGTIGYM 810
              + IVHRD+K  N+L+        + A ISDFGL K     +   S R  + GT G++
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 811 APEYA---MRGYLTSKADVYSFGVVTLEIVSGKSN 842
           APE      +   T   D++S G V   ++S  S+
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 31/214 (14%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS------SKSRQGNREFVNEIGMISAQ 691
            N  P     +G   + Y  IL     +A+K+LS      + +++  RE V    ++   
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV----LMKVV 80
Query: 692 QHPNLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            H N++ L           E   + +V E M  N LS+ I       +++LD      + 
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LSQVI-------QMELDHERMSYLL 132
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +  G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    
Sbjct: 133 YQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVV 187
Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           T  Y APE  +        D++S GV+  E++ G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 88
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E   
Sbjct: 89  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--- 140
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 141 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+APE  +        D ++ GV+  ++ +G
Sbjct: 194 R----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 105/214 (49%), Gaps = 19/214 (8%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL-SSKSRQGNREFVNEIGM-I 688
           ++KA  ++ +P  ++G G +G V K   +  G + AVK++ ++ + Q  +  + ++ +  
Sbjct: 30  EVKA--DDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISX 87
Query: 689 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 748
                P  V  YG       + +  E + +  L +  + +  +    +      KI + I
Sbjct: 88  RTVDCPFTVTFYGALFREGDVWICXE-LXDTSLDK-FYKQVIDKGQTIPEDILGKIAVSI 145
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI-AGTI 807
            + L +LH  S++ ++HRD+K SNVL++     K  DFG++    +D   ++  I AG  
Sbjct: 146 VKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDD---VAKDIDAGCK 200
Query: 808 GYMAPEYA-----MRGYLTSKADVYSFGVVTLEI 836
            Y APE        +GY + K+D++S G+  +E+
Sbjct: 201 PYXAPERINPELNQKGY-SVKSDIWSLGITXIEL 233

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 88
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E   
Sbjct: 89  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--- 140
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+++D+    +++DFG AK  + 
Sbjct: 141 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG 193
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 194 R----TWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY-KGILSDGTVIAVKQLSSKSRQGNREF---VNEIGM 687
           Q  A  + F+    +G G FG V     +  G   A+K L  +     +E    +NE  +
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRI 94
Query: 688 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKIC 745
           + A   P LVKL     + + L +V EY     +   +   G+ +E       P  +   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-------PHARFYA 147
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             I     YLH    + +++RD+K  N+++D+    K++DFGLAK  +      +  + G
Sbjct: 148 AQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLCG 200
Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           T  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 21  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 74
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E      
Sbjct: 75  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE------ 126
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 127 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 180
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 181 --TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 28  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT------ 81
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E      
Sbjct: 82  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE------ 133
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 134 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 187
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 188 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 111/264 (42%), Gaps = 31/264 (11%)
Query: 608 LGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAV 667
           +G K   D +   +++    +T+ +      N  P     +G   + Y  +L     +A+
Sbjct: 1   MGSKSKVDNQFYSVEVGDSTFTVLK---RYQNLKPIGSGAQGIVCAAYDAVLDRN--VAI 55
Query: 668 KQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLYGCCV------EGNQLLLVYEYMKNN 719
           K+LS   +++   +    E+ ++    H N++ L           E   + LV E M  N
Sbjct: 56  KKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN 115
Query: 720 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 779
            L + I       +++LD      +   +  G+ +LH      I+HRD+K SN+++  D 
Sbjct: 116 -LCQVI-------QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 164
Query: 780 NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             KI DFGLA+      + + T    T  Y APE  +        D++S G +  E+V  
Sbjct: 165 TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 222
Query: 840 KSNTNYRPNEDFVYLLDWAYVLQE 863
           K      P  D  Y+  W  V+++
Sbjct: 223 KI---LFPGRD--YIDQWNKVIEQ 241

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 62/109 (56%), Gaps = 10/109 (9%)
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIA 804
           +ARG+ +L   S  K +HRD+   N+LL ++   KI DFGLA+   ++  ++    TR+ 
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 805 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSNTNYRPNEDF 851
             + +MAPE       ++K+DV+S+GV+  EI S  G      + +EDF
Sbjct: 265 --LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDF 311

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 89
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E      
Sbjct: 90  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE------ 141
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 142 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 195
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 196 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 626 GLYTLRQIKAATNNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQG-- 677
           G+   +Q K   + +D   ++G G F  V K      G+      I  +Q S  SR+G  
Sbjct: 1   GMEPFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQ-SRASRRGVS 58
Query: 678 NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD 737
             E   E+ ++    H N++ L+        ++L+ E +    L   +  K++     L 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-----LS 113
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYE 793
                     I  G+ YLH     KI H D+K  N+ LLDK++   + K+ DFGLA   E
Sbjct: 114 EEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           +        I GT  ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 171 DGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 88
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E      
Sbjct: 89  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE------ 140
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 141 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 195 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT------ 89
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E      
Sbjct: 90  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE------ 141
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 142 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 195
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 196 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT------ 89
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E      
Sbjct: 90  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE------ 141
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 142 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 195
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 196 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 626 GLYTLRQIKAATNNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQG-- 677
           G+   +Q K   + +D   ++G G F  V K      G+      I  +Q S  SR+G  
Sbjct: 1   GMEPFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQ-SRASRRGVS 58
Query: 678 NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD 737
             E   E+ ++    H N++ L+        ++L+ E +    L   +  K++     L 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-----LS 113
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYE 793
                     I  G+ YLH     KI H D+K  N+ LLDK++   + K+ DFGLA   E
Sbjct: 114 EEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           +        I GT  ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 171 DGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT------ 89
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E      
Sbjct: 90  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE------ 141
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 142 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 195
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 196 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 637 TNNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA 690
           T  +    ++G+G F  V +      G      +I  K+LS++  Q   +   E  +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---KLEREARICRL 66
Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG-IA 749
            +HPN+V+L+    E     L+++ +    L   I  +  EY  + D       CI  I 
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEAD----ASHCIQQIL 120
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKISDFGLAKLYEEDKTHISTRIAGT 806
             + + H+   + +VHR++K  N+LL   L     K++DFGLA +  E +       AGT
Sbjct: 121 EAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGT 176
Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            GY++PE   +       D+++ GV+   ++ G
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 88
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E      
Sbjct: 89  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE------ 140
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 141 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 195 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 644 NKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
            ++G+G F  V +      G      +I  K+LS++  Q   +   E  +    +HPN+V
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKHPNIV 84
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG-IARGLAYLH 756
           +L+    E     L+++ +    L   I  +  EY  + D       CI  I   + + H
Sbjct: 85  RLHDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEAD----ASHCIQQILEAVLHCH 138
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA---KISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           +   + +VHRD+K  N+LL   L     K++DFGLA +  E +       AGT GY++PE
Sbjct: 139 Q---MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE 194
Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSG 839
              +       D+++ GV+   ++ G
Sbjct: 195 VLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 88
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E      
Sbjct: 89  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE------ 140
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 141 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 195 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 626 GLYTLRQIKAATNNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQG-- 677
           G+   +Q K   + +D   ++G G F  V K      G+      I  +Q S  SR+G  
Sbjct: 1   GMEPFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQ-SRASRRGVS 58
Query: 678 NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD 737
             E   E+ ++    H N++ L+        ++L+ E +    L   +  K++     L 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-----LS 113
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYE 793
                     I  G+ YLH     KI H D+K  N+ LLDK++   + K+ DFGLA   E
Sbjct: 114 EEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           +        I GT  ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 171 DGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 88
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E      
Sbjct: 89  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE------ 140
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 141 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 195 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 89
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E      
Sbjct: 90  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE------ 141
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 142 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 195
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 196 --TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT------ 88
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E      
Sbjct: 89  --LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE------ 140
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 141 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 195 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 25/204 (12%)
Query: 645 KVGEGGFGSVYKGILSD---GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
           ++G G FG V++  + D   G   AVK++  +  +   E +   G+ S    P +V LYG
Sbjct: 100 RLGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFRAE-ELMACAGLTS----PRIVPLYG 152
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA-RGLAYLHEDSR 760
              EG  + +  E ++   L + +  +     L  D   R    +G A  GL YLH  SR
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQGC---LPED---RALYYLGQALEGLEYLH--SR 204
Query: 761 IKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHIS----TRIAGTIGYMAPEYA 815
            +I+H D+K  NVLL  D  +A + DFG A   + D    S      I GT  +MAPE  
Sbjct: 205 -RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVV 263
Query: 816 MRGYLTSKADVYSFGVVTLEIVSG 839
           +     +K DV+S   + L +++G
Sbjct: 264 LGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 56  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT------ 109
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E      
Sbjct: 110 --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE------ 161
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 162 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 215
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 216 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT------ 88
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E      
Sbjct: 89  --LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE------ 140
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 141 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 195 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 88
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY     +   +   G+ +E      
Sbjct: 89  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE------ 140
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+++D+    K++DFG AK  +    
Sbjct: 141 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-- 194
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 195 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT------ 88
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E      
Sbjct: 89  --LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE------ 140
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 141 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 195 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT------ 89
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY     +   +   G+ +E      
Sbjct: 90  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE------ 141
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+++D+    K++DFG AK  +    
Sbjct: 142 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-- 195
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 196 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 88
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E   
Sbjct: 89  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--- 140
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 141 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT  Y+AP   +        D ++ GV+  E+ +G
Sbjct: 194 R----TWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 29/224 (12%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSS--KSRQGNREFVNEI 685
           T  +++A   +  P   VG G +G+V   +    G  +A+K+L    +S    +    E+
Sbjct: 19  TAWEVRAVYRDLQP---VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 75
Query: 686 GMISAQQHPNLVKLYGCCVEGNQL------LLVYEYMKNNCLSRAIFGKDTEYRLKLDWP 739
            ++   +H N++ L         L       LV  +M  +        K  E R++    
Sbjct: 76  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF--- 132
Query: 740 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTH 798
               +   + +GL Y+H      I+HRD+K  N+ +++D   KI DFGLA+  + E    
Sbjct: 133 ----LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGX 185
Query: 799 ISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKS 841
           + TR      Y APE  +     T   D++S G +  E+++GK+
Sbjct: 186 VVTR-----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 645 KVGEGGFGSVYKGILSD---GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
           +VG G FG V++  + D   G   AVK++  +  +     V E+   +    P +V LYG
Sbjct: 65  RVGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYG 117
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA-RGLAYLHEDSR 760
              EG  + +  E ++   L + I       ++      R    +G A  GL YLH    
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLI------KQMGCLPEDRALYYLGQALEGLEYLHTR-- 169
Query: 761 IKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHIS----TRIAGTIGYMAPEYA 815
            +I+H D+K  NVLL  D   A + DFG A   + D    S      I GT  +MAPE  
Sbjct: 170 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 816 MRGYLTSKADVYSFGVVTLEIVSG 839
           M     +K D++S   + L +++G
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 626 GLYTLRQIKAATNNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQG-- 677
           G+   +Q K   + +D   ++G G F  V K      G+      I  +Q S  SR+G  
Sbjct: 1   GMEPFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQ-SRASRRGVS 58
Query: 678 NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD 737
             E   E+ ++    H N++ L+        ++L+ E +    L   +  K++     L 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-----LS 113
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYE 793
                     I  G+ YLH     KI H D+K  N+ LLDK++   + K+ DFGLA   E
Sbjct: 114 EEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           +        I GT  ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 171 DGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 626 GLYTLRQIKAATNNFDPANKVGEGGFGSVYK------GILSDGTVIAVKQLSSKSRQG-- 677
           G+   +Q K   + +D   ++G G F  V K      G+      I  +Q S  SR+G  
Sbjct: 1   GMEPFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQ-SRASRRGVS 58
Query: 678 NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD 737
             E   E+ ++    H N++ L+        ++L+ E +    L   +  K++     L 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-----LS 113
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV-LLDKDL---NAKISDFGLAKLYE 793
                     I  G+ YLH     KI H D+K  N+ LLDK++   + K+ DFGLA   E
Sbjct: 114 EEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           +        I GT  ++APE      L  +AD++S GV+T  ++SG S
Sbjct: 171 DGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 28  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT------ 81
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+  E      
Sbjct: 82  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE------ 133
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 134 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 187
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 188 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 19/153 (12%)
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIA 749
           P L +L+ C    ++L  V EY+          G D  Y +    +   P        IA
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVN---------GGDLMYHIQQVGRFKEPHAVFYAAEIA 131
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIG 808
            GL +L       I++RD+K  NV+LD + + KI+DFG+ K  E     ++T+   GT  
Sbjct: 132 IGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPD 186
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           Y+APE           D ++FGV+  E+++G++
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 645 KVGEGGFGSVYKGILSD---GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
           +VG G FG V++  + D   G   AVK++  +  +     V E+   +    P +V LYG
Sbjct: 81  RVGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYG 133
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA-RGLAYLHEDSR 760
              EG  + +  E ++   L + I       ++      R    +G A  GL YLH    
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLI------KQMGCLPEDRALYYLGQALEGLEYLHTR-- 185
Query: 761 IKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHIS----TRIAGTIGYMAPEYA 815
            +I+H D+K  NVLL  D   A + DFG A   + D    S      I GT  +MAPE  
Sbjct: 186 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 244
Query: 816 MRGYLTSKADVYSFGVVTLEIVSG 839
           M     +K D++S   + L +++G
Sbjct: 245 MGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQH 693
           T+ +    ++G+G F  V + + +  G   A K +++K  S + +++   E  +    +H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG-IARGL 752
           PN+V+L+    E     LV++ +    L   I  +  EY  + D       CI  I   +
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEAD----ASHCIQQILESV 116
Query: 753 AYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            + H +    IVHRD+K  N+LL    K    K++DFGLA   + D+       AGT GY
Sbjct: 117 NHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGY 172
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           ++PE   +       D+++ GV+   ++ G
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQH 693
           T+ +    ++G+G F  V + + +  G   A K +++K  S + +++   E  +    +H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG-IARGL 752
           PN+V+L+    E     LV++ +    L   I  +  EY  + D       CI  I   +
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEAD----ASHCIQQILESV 116
Query: 753 AYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            + H +    IVHRD+K  N+LL    K    K++DFGLA   + D+       AGT GY
Sbjct: 117 NHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGY 172
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           ++PE   +       D+++ GV+   ++ G
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY-KGILSDGTVIAVKQLSSKSRQGNREF---VNEIGM 687
           Q  A  + F+    +G G FG V     +  G   A+K L  +     +E    +NE  +
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRI 94
Query: 688 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKIC 745
           + A   P LVKL     + + L +V EY     +   +   G+ +E       P  +   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-------PHARFYA 147
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             I     YLH    + +++RD+K  N+++D+    +++DFGLAK  +      +  + G
Sbjct: 148 AQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLCG 200
Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           T  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 88
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+  E      
Sbjct: 89  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE------ 140
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 141 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 195 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 89
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+  E      
Sbjct: 90  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE------ 141
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 142 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 195
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 196 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 19/153 (12%)
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIA 749
           P L +L+ C    ++L  V EY+          G D  Y +    +   P        IA
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVN---------GGDLMYHIQQVGRFKEPHAVFYAAEIA 452
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIG 808
            GL +L       I++RD+K  NV+LD + + KI+DFG+ K  E     ++T+   GT  
Sbjct: 453 IGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPD 507
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           Y+APE           D ++FGV+  E+++G++
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 88
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+  E      
Sbjct: 89  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE------ 140
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  +    
Sbjct: 141 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 195 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 31/214 (14%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS------SKSRQGNREFVNEIGMISAQ 691
            N  P     +G   + Y  IL     +A+K+LS      + +++  RE V    ++   
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV----LMKVV 80
Query: 692 QHPNLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            H N++ L           E   + +V E M  N LS+ I       +++LD      + 
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LSQVI-------QMELDHERMSYLL 132
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +  G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    
Sbjct: 133 YQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVV 187
Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           T  Y APE  +        D++S G +  E++ G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 35/217 (16%)
Query: 637 TNNFDPANKVGEGGFGSVYKGILSDG---TVIAVKQL---SSKSRQGNREFVNEIGMISA 690
           ++ +D    +G G FG     ++ D     ++AVK +   ++      RE +N   +   
Sbjct: 19  SDRYDFVKDIGSGNFG--VARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL--- 73
Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGI 748
            +HPN+V+     +    L ++ EY     L   I   G+ +E   +  +         +
Sbjct: 74  -RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ-------L 125
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLNAKISDFGLAK---LYEEDKTHISTRI 803
             G++Y H    ++I HRD+K  N LLD       KI DFG +K   L+ + K+ +    
Sbjct: 126 LSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---- 178
Query: 804 AGTIGYMAPEYAMRGYLTSK-ADVYSFGVVTLEIVSG 839
            GT  Y+APE  +R     K ADV+S GV    ++ G
Sbjct: 179 -GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 94/232 (40%), Gaps = 29/232 (12%)
Query: 617 ELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ 676
           EL GL    G Y+          +   + +G G FG V+  +  +     V +   K + 
Sbjct: 11  ELEGLAACEGEYS--------QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKV 62
Query: 677 GNREFVN---------EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 727
               ++          EI ++S  +H N++K+           LV E   +     A   
Sbjct: 63  LEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID 122
Query: 728 KDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK-IVHRDIKTSNVLLDKDLNAKISDF 786
           +      +LD P    I   +   + YL    R+K I+HRDIK  N+++ +D   K+ DF
Sbjct: 123 RHP----RLDEPLASYIFRQLVSAVGYL----RLKDIIHRDIKDENIVIAEDFTIKLIDF 174
Query: 787 GLAKLYEEDKTHISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIV 837
           G A   E  K   +    GTI Y APE  M   Y   + +++S GV    +V
Sbjct: 175 GSAAYLERGKLFYT--FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 88
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY     +   +   G+  E      
Sbjct: 89  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE------ 140
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+++D+    K++DFG AK  +    
Sbjct: 141 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-- 194
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 195 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 28/217 (12%)
Query: 644 NKVGEGGFGSV--YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
            K+GEGGF  V   +G L DG   A+K++    +Q   E   E  M     HPN+++L  
Sbjct: 35  QKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 702 CCVE----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI---CIGIARGLAY 754
            C+      ++  L+  + K   L   I       + K ++ T  +I    +GI RGL  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEI----ERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG---LAKLYEEDKTHIST-----RIAGT 806
           +H        HRD+K +N+LL  +    + D G    A ++ E      T         T
Sbjct: 150 IHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 807 IGYMAPE-YAMRGY--LTSKADVYSFGVVTLEIVSGK 840
           I Y APE ++++ +  +  + DV+S G V   ++ G+
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 645 KVGEGGFGSVYKGILSD---GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
           ++G G FG V++  + D   G   AVK++  +  +   E +   G+ S    P +V LYG
Sbjct: 81  RLGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFRAE-ELMACAGLTS----PRIVPLYG 133
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA-RGLAYLHEDSR 760
              EG  + +  E ++   L + +  +     L  D   R    +G A  GL YLH  SR
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQGC---LPED---RALYYLGQALEGLEYLH--SR 185
Query: 761 IKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTH----ISTRIAGTIGYMAPEYA 815
            +I+H D+K  NVLL  D  +A + DFG A   + D           I GT  +MAPE  
Sbjct: 186 -RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVV 244
Query: 816 MRGYLTSKADVYSFGVVTLEIVSG 839
           +     +K DV+S   + L +++G
Sbjct: 245 LGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  IL     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + +V E M  N LS+ I       +++LD      +   + 
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LSQVI-------QMELDHERMSYLLYQML 136
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            APE  +        D++S G +  E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 36/225 (16%)
Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQ 676
           T  Q  A  + FD    +G G FG V               IL    V+ +KQ+      
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--- 88
Query: 677 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRL 734
                +NE  ++ A   P LVKL     + + L +V EY+    +   +   G+ +E   
Sbjct: 89  -----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--- 140
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
               P  +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK  + 
Sbjct: 141 ----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
                +  + GT   +APE  +        D ++ GV+  E+ +G
Sbjct: 194 R----TWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 645 KVGEGGFGSVYKGILSD---GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
           ++G G FG V++  + D   G   AVK++  +  +     V E+   +    P +V LYG
Sbjct: 79  RLGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYG 131
Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA-RGLAYLHEDSR 760
              EG  + +  E ++   L + I       ++      R    +G A  GL YLH    
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLI------KQMGCLPEDRALYYLGQALEGLEYLHTR-- 183
Query: 761 IKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHIS----TRIAGTIGYMAPEYA 815
            +I+H D+K  NVLL  D   A + DFG A   + D    S      I GT  +MAPE  
Sbjct: 184 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 242
Query: 816 MRGYLTSKADVYSFGVVTLEIVSG 839
           M     +K D++S   + L +++G
Sbjct: 243 MGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 36  QNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT------ 89
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  +  A   P LVKL     + + L +V EY     +   +   G+ +E      
Sbjct: 90  --LNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSE------ 141
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+L+D+    K++DFG AK  +    
Sbjct: 142 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-- 195
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 196 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  +L     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + LV E M  N L + I       +++LD      +   + 
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVI-------QMELDHERMSYLLYQML 129
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 130 XGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 184
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            APE  +        D++S G +  E+V  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 88
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P LVKL     + + L +V EY     +   +   G+ +E      
Sbjct: 89  --LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE------ 140
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+++D+    +++DFG AK  +    
Sbjct: 141 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR-- 194
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 195 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQH 693
           T+ +     +G+G F  V + + L  G   A K +++K  S + +++   E  +    +H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG-IARGL 752
            N+V+L+    E     LV++ +    L   I  +  EY  + D       CI  I   +
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEAD----ASHCIQQILEAV 116
Query: 753 AYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            + H+   + +VHRD+K  N+LL    K    K++DFGLA   + D+       AGT GY
Sbjct: 117 LHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGY 172
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           ++PE   +       D+++ GV+   ++ G
Sbjct: 173 LSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 31/214 (14%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS------SKSRQGNREFVNEIGMISAQ 691
            N  P     +G   + Y  IL     +A+K+LS      + +++  RE V    ++   
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV----LMKVV 80
Query: 692 QHPNLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            H N++ L           E   + +V E M  N LS+ I       +++LD      + 
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LSQVI-------QMELDHERMSYLL 132
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +  G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    
Sbjct: 133 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVV 187
Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           T  Y APE  +        D++S G +  E++ G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  IL     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + +V E M  N LS+ I       +++LD      +   + 
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LSQVI-------QMELDHERMSYLLYQML 136
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            APE  +        D++S G +  E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 43/220 (19%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  IL     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + +V E M  N L + I       +++LD      +   + 
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 136
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA            R AGT   
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGTSFM 181
Query: 810 MAPEYAMRGYLTSK----------ADVYSFGVVTLEIVSG 839
           M PE   R Y   +           D++S G +  E++ G
Sbjct: 182 MTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  +L     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + LV E M  N L + I       +++LD      +   + 
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVI-------QMELDHERMSYLLYQML 136
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 XGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            APE  +        D++S G +  E+V  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 110/264 (41%), Gaps = 31/264 (11%)
Query: 608 LGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAV 667
           +  K   D +   +++    +T+ +      N  P     +G   + Y  +L     +A+
Sbjct: 1   MASKSKVDNQFYSVEVGDSTFTVLK---RYQNLKPIGSGAQGIVCAAYDAVLDRN--VAI 55
Query: 668 KQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLYGCCV------EGNQLLLVYEYMKNN 719
           K+LS   +++   +    E+ ++    H N++ L           E   + LV E M  N
Sbjct: 56  KKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN 115
Query: 720 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 779
            L + I       +++LD      +   +  G+ +LH      I+HRD+K SN+++  D 
Sbjct: 116 -LCQVI-------QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 164
Query: 780 NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             KI DFGLA+      + + T    T  Y APE  +        D++S G +  E+V  
Sbjct: 165 TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 222
Query: 840 KSNTNYRPNEDFVYLLDWAYVLQE 863
           K      P  D  Y+  W  V+++
Sbjct: 223 KI---LFPGRD--YIDQWNKVIEQ 241

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 89
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P L KL     + + L +V EY     +   +   G+ +E      
Sbjct: 90  --LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE------ 141
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+++D+    K++DFG AK  +    
Sbjct: 142 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-- 195
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 196 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  +L     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + LV E M  N L + I       +++LD      +   + 
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVI-------QMELDHERMSYLLYQML 136
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 XGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            APE  +        D++S G +  E+V  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 89
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P L KL     + + L +V EY     +   +   G+ +E      
Sbjct: 90  --LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE------ 141
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+++D+    K++DFG AK  +    
Sbjct: 142 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-- 195
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 196 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 645 KVGEGGFGSVYKG---ILSDGTV-IAVKQLSS---KSRQGNREFVNEIGMISAQQHPNLV 697
           K+G+G FG V +G     S  TV +AVK L        +   +F+ E+  + +  H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           +LYG  V    + +V E      L   +      + L     T  +  + +A G+ YL  
Sbjct: 75  RLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG----TLSRYAVQVAEGMGYLES 129
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI--GYMAPEYA 815
               + +HRD+   N+LL      KI DFGL +   ++  H   +    +   + APE  
Sbjct: 130 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 186
Query: 816 MRGYLTSKADVYSFGVVTLEIVS 838
                +  +D + FGV   E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 28/234 (11%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  +L     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 65  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + LV E M  N L + I       +++LD      +   + 
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 174
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 229
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQE 863
            APE  +        D++S G +  E+V  K      P  D  Y+  W  V+++
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKI---LFPGRD--YIDQWNKVIEQ 278

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 645 KVGEGGFGSVYKG---ILSDGTV-IAVKQLSS---KSRQGNREFVNEIGMISAQQHPNLV 697
           K+G+G FG V +G     S  TV +AVK L        +   +F+ E+  + +  H NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           +LYG  V    + +V E      L   +      + L     T  +  + +A G+ YL  
Sbjct: 79  RLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG----TLSRYAVQVAEGMGYLES 133
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI--GYMAPEYA 815
               + +HRD+   N+LL      KI DFGL +   ++  H   +    +   + APE  
Sbjct: 134 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 816 MRGYLTSKADVYSFGVVTLEIVS 838
                +  +D + FGV   E+ +
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 645 KVGEGGFGSVYKG---ILSDGTV-IAVKQLSS---KSRQGNREFVNEIGMISAQQHPNLV 697
           K+G+G FG V +G     S  TV +AVK L        +   +F+ E+  + +  H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           +LYG  V    + +V E      L   +      + L     T  +  + +A G+ YL  
Sbjct: 75  RLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG----TLSRYAVQVAEGMGYLES 129
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI--GYMAPEYA 815
               + +HRD+   N+LL      KI DFGL +   ++  H   +    +   + APE  
Sbjct: 130 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 816 MRGYLTSKADVYSFGVVTLEIVS 838
                +  +D + FGV   E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 645 KVGEGGFGSVYKG---ILSDGTV-IAVKQLSS---KSRQGNREFVNEIGMISAQQHPNLV 697
           K+G+G FG V +G     S  TV +AVK L        +   +F+ E+  + +  H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           +LYG  V    + +V E      L   +      + L     T  +  + +A G+ YL  
Sbjct: 75  RLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG----TLSRYAVQVAEGMGYLES 129
Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI--GYMAPEYA 815
               + +HRD+   N+LL      KI DFGL +   ++  H   +    +   + APE  
Sbjct: 130 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 816 MRGYLTSKADVYSFGVVTLEIVS 838
                +  +D + FGV   E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  +L     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + LV E M  N L + I       +++LD      +   + 
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 129
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 184
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            APE  +        D++S G +  E+V  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  +L     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 21  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + LV E M  N L + I       +++LD      +   + 
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 130
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 131 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 185
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            APE  +        D++S G +  E+V  K
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  +L     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 21  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + LV E M  N L + I       +++LD      +   + 
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 130
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 131 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 185
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            APE  +        D++S G +  E+V  K
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 637 TNNFDPANKVGEGGFGSVYKGILSDGTVI--AVKQLSSKSRQGNREFVNEIGMISAQQHP 694
           T+ ++    +G G + SV K  +   T +  AVK +    R    E   EI ++   QHP
Sbjct: 21  TDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKIIDKSKRDPTEEI--EI-LLRYGQHP 76
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK--ICIGIARGL 752
           N++ L     +G  + +V E MK   L   I       R K  +  R+   +   I + +
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKIL------RQKF-FSEREASAVLFTITKTV 129
Query: 753 AYLHEDSRIKIVHRDIKTSNVL-LDKDLNA---KISDFGLAKLYEEDKTHISTRIAGTIG 808
            YLH      +VHRD+K SN+L +D+  N    +I DFG AK    +   + T    T  
Sbjct: 130 EYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY-TAN 185
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           ++APE   R    +  D++S GV+   +++G
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 28/234 (11%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  +L     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 65  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + LV E M  N L + I       +++LD      +   + 
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 174
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 229
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQE 863
            APE  +        D++S G +  E+V  K      P  D  Y+  W  V+++
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKI---LFPGRD--YIDQWNKVIEQ 278

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  +L     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 26  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 83
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + LV E M  N L + I       +++LD      +   + 
Sbjct: 84  IISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 135
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 136 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 190
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            APE  +        D++S G +  E+V  K
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 26/222 (11%)
Query: 634 KAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ 692
           +   + F      G+G FG+V  G   S G  +A+K++    R  NRE +  +  ++   
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLH 77
Query: 693 HPNLVKL---YGCCVEGNQ----LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR--KK 743
           HPN+V+L   +    E ++    L +V EY+ +  L R        YR ++  P    K 
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCC---RNYYRRQVAPPPILIKV 133
Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLY---EEDKTHI 799
               + R +  LH  S + + HRDIK  NVL+++ D   K+ DFG AK     E +  +I
Sbjct: 134 FLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 800 STRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK 840
            +R      Y APE      + T+  D++S G +  E++ G+
Sbjct: 193 CSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  +L     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + LV E M  N L + I       +++LD      +   + 
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 136
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            APE  +        D++S G +  E+V  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  +L     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + LV E M  N L + I       +++LD      +   + 
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 136
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            APE  +        D++S G +  E+V  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 28/234 (11%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  +L     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + LV E M  N L + I       +++LD      +   + 
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 136
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQE 863
            APE  +        D++S G +  E+V  K      P  D  Y+  W  V+++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKI---LFPGRD--YIDQWNKVIEQ 240

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 608 LGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAV 667
           +G +   D     +++    +T+ +      N  P     +G   + Y  IL     +A+
Sbjct: 1   MGSRSKRDNNFYSVEIGDSTFTVLK---RYQNLKPIGSGAQGIVCAAYDAILERN--VAI 55
Query: 668 KQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLYGCCV------EGNQLLLVYEYMKNN 719
           K+LS   +++   +    E+ ++    H N++ L           E   + +V E M  N
Sbjct: 56  KKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN 115
Query: 720 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 779
            L + I       +++LD      +   +  G+ +LH      I+HRD+K SN+++  D 
Sbjct: 116 -LCQVI-------QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 164
Query: 780 NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             KI DFGLA+      + + T    T  Y APE  +        D++S G +  E++ G
Sbjct: 165 TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 28/234 (11%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  +L     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + LV E M  N L + I       +++LD      +   + 
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVI-------QMELDHERMSYLLYQML 136
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQE 863
            APE  +        D++S G +  E+V  K      P  D  Y+  W  V+++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKI---LFPGRD--YIDQWNKVIEQ 240

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 48/244 (19%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  IL     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + +V E M  N L + I       +++LD      +   + 
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 136
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA            R AGT   
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGTSFM 181
Query: 810 MAPEYAMRGYLTSK----------ADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAY 859
           M PE   R Y   +           D++S G +  E+V  K      P  D  Y+  W  
Sbjct: 182 MEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKI---LFPGRD--YIDQWNK 236
Query: 860 VLQE 863
           V+++
Sbjct: 237 VIEQ 240

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 36/222 (16%)
Query: 632 QIKAATNNFDPANKVGEGGFGSVY------------KGILSDGTVIAVKQLSSKSRQGNR 679
           Q  A  + F+    +G G FG V               IL    V+ +KQ+         
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------ 89
Query: 680 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLD 737
             +NE  ++ A   P L KL     + + L +V EY     +   +   G+  E      
Sbjct: 90  --LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE------ 141
Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
            P  +     I     YLH    + +++RD+K  N+++D+    K++DFG AK  +    
Sbjct: 142 -PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-- 195
Query: 798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
             +  + GT  Y+APE  +        D ++ GV+  E+ +G
Sbjct: 196 --TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 23/210 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  IL     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + +V E M  N L + I       +++LD      +   + 
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 136
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            APE  +        D++S G +  E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 23/210 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  IL     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + +V E M  N L + I       +++LD      +   + 
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 136
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            APE  +        D++S G +  E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 43/221 (19%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  IL     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + +V E M  N L + I       +++LD      +   + 
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 136
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA            R AGT   
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGTSFM 181
Query: 810 MAPEYAMRGYLTSK----------ADVYSFGVVTLEIVSGK 840
           M PE   R Y   +           D++S G +  E+V  K
Sbjct: 182 MEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 76/163 (46%), Gaps = 19/163 (11%)
Query: 684 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 743
           EI ++    HP ++K+     +     +V E M+   L   + G       +L   T K 
Sbjct: 204 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKL 257
Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHIS 800
               +   + YLHE+    I+HRD+K  NVLL   ++D   KI+DFG +K+  E  T + 
Sbjct: 258 YFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLM 312
Query: 801 TRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSG 839
             + GT  Y+APE  +     GY     D +S GV+    +SG
Sbjct: 313 RTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSG 354

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG-T 806
           +A+G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D  ++    A   
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG-T 806
           +A+G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D  ++    A   
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG-T 806
           +A+G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D  ++    A   
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 76/163 (46%), Gaps = 19/163 (11%)
Query: 684 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 743
           EI ++    HP ++K+     +     +V E M+   L   + G       +L   T K 
Sbjct: 190 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKL 243
Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHIS 800
               +   + YLHE+    I+HRD+K  NVLL   ++D   KI+DFG +K+  E  T + 
Sbjct: 244 YFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLM 298
Query: 801 TRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSG 839
             + GT  Y+APE  +     GY     D +S GV+    +SG
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSG 340

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG-T 806
           +A+G+ +L   +  K +HRD+   N+LL +    KI DFGLA+   +D  ++    A   
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
            EI ++    HP ++K+     +     +V E M+   L   + G       +L   T K
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCK 117
Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHI 799
                +   + YLHE+    I+HRD+K  NVLL   ++D   KI+DFG +K+  E  T +
Sbjct: 118 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 172
Query: 800 STRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSG 839
              + GT  Y+APE  +     GY     D +S GV+    +SG
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
            EI ++    HP ++K+     +     +V E M+   L   + G       +L   T K
Sbjct: 63  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCK 116
Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHI 799
                +   + YLHE+    I+HRD+K  NVLL   ++D   KI+DFG +K+  E  T +
Sbjct: 117 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 171
Query: 800 STRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSG 839
              + GT  Y+APE  +     GY     D +S GV+    +SG
Sbjct: 172 MRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSG 214

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 28/234 (11%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  IL     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 32  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 89
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + +V E M  N L + I       +++LD      +   + 
Sbjct: 90  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 141
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 142 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 196
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQE 863
            APE  +        D++S G +  E+V  K      P  D  Y+  W  V+++
Sbjct: 197 RAPEVILGMGYKENVDLWSVGCIMGEMVCHKI---LFPGRD--YIDQWNKVIEQ 245

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  IL     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 21  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + +V E M  N L + I       +++LD      +   + 
Sbjct: 79  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 130
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 131 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 185
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            APE  +        D++S G +  E+V  K
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
            EI ++    HP ++K+     +     +V E M+   L   + G       +L   T K
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCK 117
Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHI 799
                +   + YLHE+    I+HRD+K  NVLL   ++D   KI+DFG +K+  E  T +
Sbjct: 118 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 172
Query: 800 STRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSG 839
              + GT  Y+APE  +     GY     D +S GV+    +SG
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSG 215

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
            EI ++    HP ++K+     +     +V E M+   L   + G       +L   T K
Sbjct: 70  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCK 123
Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHI 799
                +   + YLHE+    I+HRD+K  NVLL   ++D   KI+DFG +K+  E  T +
Sbjct: 124 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 178
Query: 800 STRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSG 839
              + GT  Y+APE  +     GY     D +S GV+    +SG
Sbjct: 179 MRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSG 221

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 35/217 (16%)
Query: 637 TNNFDPANKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSR---QGNREFVNEIGMISA 690
           ++ ++    +G G FG     ++ D     ++AVK +    +      RE +N   +   
Sbjct: 18  SDRYELVKDIGAGNFGVAR--LMRDKQANELVAVKYIERGEKIDENVKREIINHRSL--- 72
Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGI 748
            +HPN+V+     +    L +V EY     L   I   G+ +E   +  +         +
Sbjct: 73  -RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ-------L 124
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLNAKISDFGLAK---LYEEDKTHISTRI 803
             G++Y H    +++ HRD+K  N LLD       KI+DFG +K   L+ + K+ +    
Sbjct: 125 ISGVSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV---- 177
Query: 804 AGTIGYMAPEYAMRGYLTSK-ADVYSFGVVTLEIVSG 839
            GT  Y+APE  ++     K ADV+S GV    ++ G
Sbjct: 178 -GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 23/210 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
               P     +G   + +  +L  G  +AVK+LS   +++   +    E+ ++    H N
Sbjct: 27  QQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 84
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + LV E M  N L + I        ++LD      +   + 
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-------HMELDHERMSYLLYQML 136
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+        + T    T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYY 191
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            APE  +     +  D++S G +  E+V G
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 23/210 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
               P     +G   + +  +L  G  +AVK+LS   +++   +    E+ ++    H N
Sbjct: 25  QQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 82
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + LV E M  N         D E   ++ +   + +C    
Sbjct: 83  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHE---RMSYLLYQMLC---- 135
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+        + T    T  Y
Sbjct: 136 -GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TASTNFMMTPYVVTRYY 189
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            APE  +        D++S G +  E+V G
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
            EI ++    HP ++K+     +     +V E M+   L   + G       +L   T K
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCK 117
Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHI 799
                +   + YLHE+    I+HRD+K  NVLL   ++D   KI+DFG +K+  E  T +
Sbjct: 118 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 172
Query: 800 STRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSG 839
              + GT  Y+APE  +     GY     D +S GV+    +SG
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSG 215

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 97/242 (40%), Gaps = 51/242 (21%)
Query: 646 VGEGGFGSVYKGILSDGTVI-AVKQLS-SKSRQGNREFVN----EIGMISAQQHPNLVKL 699
           +G+G +G V   I +    I A+K ++ +K RQ N + V     E+ ++    HPN+ +L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 700 YGCCVEGNQLLLVYEYMKN-------------------------------NCLSRAIFGK 728
           Y    +   + LV E                                    C   AI G 
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 729 DTEYRLKLDWPTRKKICIGIAR----GLAYLHEDSRIKIVHRDIKTSNVLL--DKDLNAK 782
              +R  LD+  R+K+   I R     L YLH      I HRDIK  N L   +K    K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 783 ISDFGLAKLY---EEDKTHISTRIAGTIGYMAPEY--AMRGYLTSKADVYSFGVVTLEIV 837
           + DFGL+K +      + +  T  AGT  ++APE           K D +S GV+   ++
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 838 SG 839
            G
Sbjct: 271 MG 272

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 23/210 (10%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
            N  P     +G   + Y  IL     +A+K+LS   +++   +    E+ ++    H N
Sbjct: 29  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 86
Query: 696 LVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
           ++ L           E   + +V E M  N L + I       +++LD      +   + 
Sbjct: 87  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI-------QMELDHERMSYLLYQML 138
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            G+ +LH      I+HRD+K SN+++  D   KI DFGLA+      + +      T  Y
Sbjct: 139 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMVPFVVTRYY 193
Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            APE  +        D++S G +  E++ G
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 37/215 (17%)
Query: 657 GILSDGTVIAVKQLSSKSRQGNREFVN-------EIGMIS-AQQHPNLVKLYGCCVEGNQ 708
           G  S GTV+       +     R  ++       EI +++ +  HPN+++ Y C    ++
Sbjct: 24  GYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY-CSETTDR 82
Query: 709 LLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRK-KICIGIARGLAYLHEDSRIKIVHR 766
            L +   + N  L   +  K+ ++  LKL        +   IA G+A+LH    +KI+HR
Sbjct: 83  FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHR 139
Query: 767 DIKTSNVLLD-------------KDLNAKISDFGLAKLYEEDKTHISTRI---AGTIGYM 810
           D+K  N+L+              ++L   ISDFGL K  +  ++   T +   +GT G+ 
Sbjct: 140 DLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWR 199
Query: 811 APE-------YAMRGYLTSKADVYSFGVVTLEIVS 838
           APE          +  LT   D++S G V   I+S
Sbjct: 200 APELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 646 VGEGGFGSVYKG-ILSDGTVIAVKQLSSKSRQGNREFVN------EIGMI----SAQQHP 694
           +G+GGFG+V+ G  L+D   +A+K +      G     +      E+ ++    +   HP
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
            +++L          +LV E       ++ +F   TE     + P+R   C       A 
Sbjct: 99  GVIRLLDWFETQEGFMLVLE---RPLPAQDLFDYITEKGPLGEGPSR---CFFGQVVAAI 152
Query: 755 LHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
            H  SR  +VHRDIK  N+L+D +   AK+ DFG   L  ++     T   GT  Y  PE
Sbjct: 153 QHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY---TDFDGTRVYSPPE 208
Query: 814 YAMR-GYLTSKADVYSFGVVTLEIVSG 839
           +  R  Y    A V+S G++  ++V G
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 81/182 (44%), Gaps = 24/182 (13%)
Query: 666 AVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL---- 721
           AVK +    R  + E   EI ++   QHPN++ L     +G  + LV E M+   L    
Sbjct: 56  AVKVIDKSKRDPSEEI--EI-LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI 112
Query: 722 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL-LDKDLN 780
            R  F  + E    L           I + + YLH      +VHRD+K SN+L +D+  N
Sbjct: 113 LRQKFFSEREASFVLH---------TIGKTVEYLHSQG---VVHRDLKPSNILYVDESGN 160
Query: 781 A---KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV 837
               +I DFG AK    +   + T    T  ++APE   R       D++S G++   ++
Sbjct: 161 PECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTML 219
Query: 838 SG 839
           +G
Sbjct: 220 AG 221

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 81/182 (44%), Gaps = 24/182 (13%)
Query: 666 AVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL---- 721
           AVK +    R  + E   EI ++   QHPN++ L     +G  + LV E M+   L    
Sbjct: 56  AVKVIDKSKRDPSEEI--EI-LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI 112
Query: 722 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL-LDKDLN 780
            R  F  + E    L           I + + YLH      +VHRD+K SN+L +D+  N
Sbjct: 113 LRQKFFSEREASFVLH---------TIGKTVEYLHSQG---VVHRDLKPSNILYVDESGN 160
Query: 781 A---KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV 837
               +I DFG AK    +   + T    T  ++APE   R       D++S G++   ++
Sbjct: 161 PECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTML 219
Query: 838 SG 839
           +G
Sbjct: 220 AG 221

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 637 TNNFDPANKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSRQG---NREFVNEIGMISA 690
           ++ ++    +G G FG     ++ D     ++AVK +    +      RE +N   +   
Sbjct: 18  SDRYELVKDIGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIAANVKREIINHRSL--- 72
Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGI 748
            +HPN+V+     +    L +V EY     L   I   G+ +E   +  +         +
Sbjct: 73  -RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ-------L 124
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLNAKISDFGLAK---LYEEDKTHISTRI 803
             G++Y H    +++ HRD+K  N LLD       KI DFG +K   L+ + K+ +    
Sbjct: 125 ISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---- 177
Query: 804 AGTIGYMAPEYAMRGYLTSK-ADVYSFGVVTLEIVSG 839
            GT  Y+APE  ++     K ADV+S GV    ++ G
Sbjct: 178 -GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 33/211 (15%)
Query: 657 GILSDGTVIAVKQLSSKSRQGNREFVN-------EIGMIS-AQQHPNLVKLYGCCVEGNQ 708
           G  S GTV+       +     R  ++       EI +++ +  HPN+++ Y C    ++
Sbjct: 42  GYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY-CSETTDR 100
Query: 709 LLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRK-KICIGIARGLAYLHEDSRIKIVHR 766
            L +   + N  L   +  K+ ++  LKL        +   IA G+A+LH    +KI+HR
Sbjct: 101 FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHR 157
Query: 767 DIKTSNVLLD-------------KDLNAKISDFGLAKLYEEDKTHISTRI---AGTIGYM 810
           D+K  N+L+              ++L   ISDFGL K  +  +      +   +GT G+ 
Sbjct: 158 DLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWR 217
Query: 811 APEY---AMRGYLTSKADVYSFGVVTLEIVS 838
           APE    + +  LT   D++S G V   I+S
Sbjct: 218 APELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 657 GILSDGTVIAVKQLSSKSRQGNREFVN-------EIGMIS-AQQHPNLVKLYGCCVEGNQ 708
           G  S GTV+       +     R  ++       EI +++ +  HPN+++ Y C    ++
Sbjct: 42  GYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY-CSETTDR 100
Query: 709 LLLVYEYMKNNCLSRAIFGK---DTEYRLKLDW-PTRKKICIGIARGLAYLHEDSRIKIV 764
            L +   + N  L   +  K   D   +L+ ++ P    +   IA G+A+LH    +KI+
Sbjct: 101 FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI--SLLRQIASGVAHLHS---LKII 155
Query: 765 HRDIKTSNVLLD-------------KDLNAKISDFGLAKLYEEDKTHISTRI---AGTIG 808
           HRD+K  N+L+              ++L   ISDFGL K  +  +      +   +GT G
Sbjct: 156 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSG 215
Query: 809 YMAPEY---AMRGYLTSKADVYSFGVVTLEIVS 838
           + APE    + +  LT   D++S G V   I+S
Sbjct: 216 WRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 637 TNNFDPANKVGEGGFGSVYKGILSDGT--VIAVKQLSSKSRQGNREFVNEIGMISAQQHP 694
           T+ ++    +G G + SV K  +   T    AVK +    R    E   EI ++   QHP
Sbjct: 21  TDGYEVKEDIGVGSY-SVCKRCIHKATNXEFAVKIIDKSKRDPTEEI--EI-LLRYGQHP 76
Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK--ICIGIARGL 752
           N++ L     +G  + +V E  K   L   I       R K  +  R+   +   I + +
Sbjct: 77  NIITLKDVYDDGKYVYVVTELXKGGELLDKIL------RQKF-FSEREASAVLFTITKTV 129
Query: 753 AYLHEDSRIKIVHRDIKTSNVL-LDKDLNA---KISDFGLAKLYEEDKTHISTRIAGTIG 808
            YLH      +VHRD+K SN+L +D+  N    +I DFG AK    +   + T    T  
Sbjct: 130 EYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TAN 185
Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
           ++APE   R    +  D++S GV+    ++G
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 100/223 (44%), Gaps = 27/223 (12%)
Query: 631 RQIKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ-GNREFVNEIGMI 688
           R +   +++F   + +GEG +G V        G ++A+K++    +       + EI ++
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKIL 63
Query: 689 SAQQHPNLVKLYGCCVEG-----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 743
              +H N++ ++           N++ ++ E M+ + L R I  +       L     + 
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-LHRVISTQ------MLSDDHIQY 116
Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--- 800
                 R +  LH  +   ++HRD+K SN+L++ + + K+ DFGLA++ +E     S   
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 801 ------TRIAGTIGYMAPEYAMRGYLTSKA-DVYSFGVVTLEI 836
                 T    T  Y APE  +     S+A DV+S G +  E+
Sbjct: 174 GQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 637 TNNFDPANKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSR---QGNREFVNEIGMISA 690
           ++ ++    +G G FG     ++ D     ++AVK +    +      RE +N   +   
Sbjct: 17  SDRYELVKDIGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL--- 71
Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGI 748
            +HPN+V+     +    L +V EY     L   I   G+ +E   +  +         +
Sbjct: 72  -RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ-------L 123
Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKD--LNAKISDFGLAK---LYEEDKTHISTRI 803
             G++Y H    +++ HRD+K  N LLD       KI DFG +K   L+ + K+ +    
Sbjct: 124 ISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---- 176
Query: 804 AGTIGYMAPEYAMRGYLTSK-ADVYSFGVVTLEIVSG 839
            GT  Y+APE  ++     K ADV+S GV    ++ G
Sbjct: 177 -GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 100/223 (44%), Gaps = 27/223 (12%)
Query: 631 RQIKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ-GNREFVNEIGMI 688
           R +   +++F   + +GEG +G V        G ++A+K++    +       + EI ++
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKIL 63
Query: 689 SAQQHPNLVKLYGCCVEG-----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 743
              +H N++ ++           N++ ++ E M+ + L R I  +       L     + 
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-LHRVISTQ------MLSDDHIQY 116
Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--- 800
                 R +  LH  +   ++HRD+K SN+L++ + + K+ DFGLA++ +E     S   
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 801 ------TRIAGTIGYMAPEYAMRGYLTSKA-DVYSFGVVTLEI 836
                 T    T  Y APE  +     S+A DV+S G +  E+
Sbjct: 174 GQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 97/221 (43%), Gaps = 16/221 (7%)
Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE----FVNEI 685
           ++Q++    +F+    +G G FG V    L +   +   ++ +K     R     F  E 
Sbjct: 66  VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER 125
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            ++       +  L+    + N L LV +Y     L   +    +++  +L     +   
Sbjct: 126 DVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL----SKFEDRLPEEMARFYL 181
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +   +  +H+   +  VHRDIK  N+L+D + + +++DFG      ED T  S+   G
Sbjct: 182 AEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG 238
Query: 806 TIGYMAPE--YAM---RGYLTSKADVYSFGVVTLEIVSGKS 841
           T  Y++PE   AM   +G    + D +S GV   E++ G++
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 84/203 (41%), Gaps = 14/203 (6%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVK-----QLSSKSRQGNREFVNEIGMISAQQHPNLVKL 699
           +G+G F  V + I  + G   AVK     + +S       +   E  +    +HP++V+L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
                    L +V+E+M    L   I  K  +                I   L Y H+++
Sbjct: 94  LETYSSDGMLYMVFEFMDGADLCFEIV-KRADAGFVYSEAVASHYMRQILEALRYCHDNN 152
Query: 760 RIKIVHRDIKTSNVLLDKDLNA---KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
              I+HRD+K   VLL    N+   K+  FG+A    E       R+ GT  +MAPE   
Sbjct: 153 ---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVK 208
Query: 817 RGYLTSKADVYSFGVVTLEIVSG 839
           R       DV+  GV+   ++SG
Sbjct: 209 REPYGKPVDVWGCGVILFILLSG 231

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 84/203 (41%), Gaps = 14/203 (6%)
Query: 646 VGEGGFGSVYKGILSD-GTVIAVK-----QLSSKSRQGNREFVNEIGMISAQQHPNLVKL 699
           +G+G F  V + I  + G   AVK     + +S       +   E  +    +HP++V+L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
                    L +V+E+M    L   I  K  +                I   L Y H+++
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIV-KRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 760 RIKIVHRDIKTSNVLLDKDLNA---KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
              I+HRD+K   VLL    N+   K+  FG+A    E       R+ GT  +MAPE   
Sbjct: 151 ---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVK 206
Query: 817 RGYLTSKADVYSFGVVTLEIVSG 839
           R       DV+  GV+   ++SG
Sbjct: 207 REPYGKPVDVWGCGVILFILLSG 229

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 54/114 (47%), Gaps = 14/114 (12%)
Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY---EEDKTHIS 800
           I I IA  + +LH      ++HRD+K SN+    D   K+ DFGL       EE++T ++
Sbjct: 169 IFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 801 TRIA--------GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 846
              A        GT  YM+PE       + K D++S G++  E++   S    R
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER 279

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 631 RQIKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ-GNREFVNEIGMI 688
           R +   +++F   + +GEG +G V        G ++A+K++    +       + EI ++
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKIL 63
Query: 689 SAQQHPNLVKLYGCCVEG-----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 743
              +H N++ ++           N++ ++ E M+ + L R I  +       L     + 
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-LHRVISTQ------MLSDDHIQY 116
Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE---DKTHIS 800
                 R +  LH  +   ++HRD+K SN+L++ + + K+ DFGLA++ +E   D +  +
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 801 TRIAGTIG------YMAPEYAMRGYLTSKA-DVYSFGVVTLEI 836
            + +G +       Y APE  +     S+A DV+S G +  E+
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCC 703
           KVG G +G VYK    DG       L      G +     EI ++   +HPN++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 704 VE--GNQLLLVYEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
           +     ++ L+++Y +++      F    K  +  ++L     K +   I  G+ YLH +
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 759 SRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAP 812
               ++HRD+K +N+L+     +    KI+D G A+L+      ++    +  T  Y AP
Sbjct: 148 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 813 EYAMRGYLTSKA-DVYSFGVVTLEIVSGK 840
           E  +     +KA D+++ G +  E+++ +
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 108/232 (46%), Gaps = 20/232 (8%)
Query: 620 GLDLQTGLYTLRQIKAATNNFDPANK-VGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR-Q 676
           G+DL T     + ++   N +   +K +G G F  V + I  S G   A K L  + R Q
Sbjct: 10  GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69
Query: 677 GNR-EFVNEIGMIS-AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL 734
             R E ++EI ++  A+  P ++ L+      ++++L+ EY     +      +  E   
Sbjct: 70  DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS 129
Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKISDFGLAKL 791
           + D     ++   I  G+ YLH+++   IVH D+K  N+LL       + KI DFG+++ 
Sbjct: 130 ENDVI---RLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR- 182
Query: 792 YEEDKTHIST--RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
                 H      I GT  Y+APE      +T+  D+++ G++   +++  S
Sbjct: 183 ---KIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTS 231

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 657 GILSDGTVIAVKQLSSKSRQGNREFVN-------EIGMIS-AQQHPNLVKLYGCCVEGNQ 708
           G  S GTV+       +     R  ++       EI +++ +  HPN+++ Y C    ++
Sbjct: 24  GYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY-CSETTDR 82
Query: 709 LLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRK-KICIGIARGLAYLHEDSRIKIVHR 766
            L +   + N  L   +  K+ ++  LKL        +   IA G+A+LH    +KI+HR
Sbjct: 83  FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHR 139
Query: 767 DIKTSNVLLD-------------KDLNAKISDFGLAKLYEEDKTHISTRI---AGTIGYM 810
           D+K  N+L+              ++L   ISDFGL K  +  +      +   +GT G+ 
Sbjct: 140 DLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWR 199
Query: 811 APE-------YAMRGYLTSKADVYSFGVVTLEIVS 838
           APE          +  LT   D++S G V   I+S
Sbjct: 200 APELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 61/110 (55%), Gaps = 10/110 (9%)
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK---LYEEDKTHISTRIAGT 806
           RGL Y+H     +++HRD+K SN+L++++   KI DFG+A+       +  +  T    T
Sbjct: 170 RGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 807 IGYMAPEYAMRGYLTSKA-DVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 855
             Y APE  +  +  ++A D++S G +  E+++ +      P +++V+ L
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR---QLFPGKNYVHQL 273

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 53/118 (44%), Gaps = 1/118 (0%)
Query: 723 RAIFGKDTEYRLKLDWPTRKKICIGIARGL-AYLHEDSRIKIVHRDIKTSNVLLDKDLNA 781
           R I G D    L+   P      + I R + + L         HRD+K  N+L+  D  A
Sbjct: 114 RLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFA 173
Query: 782 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            + DFG+A    ++K        GT+ Y APE     + T +AD+Y+   V  E ++G
Sbjct: 174 YLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECLTG 231

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 61/110 (55%), Gaps = 10/110 (9%)
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK---LYEEDKTHISTRIAGT 806
           RGL Y+H     +++HRD+K SN+L++++   KI DFG+A+       +  +  T    T
Sbjct: 169 RGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 807 IGYMAPEYAMRGYLTSKA-DVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 855
             Y APE  +  +  ++A D++S G +  E+++ +      P +++V+ L
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR---QLFPGKNYVHQL 272

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 35/221 (15%)
Query: 633 IKAATNNFDPANKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSR---QGNREFVNEIG 686
           I   ++ ++    +G G FG     ++ D     ++AVK +    +      RE +N   
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIDENVKREIINHRS 71
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKI 744
           +    +HPN+V+     +    L +V EY     L   I   G+ +E   +  +      
Sbjct: 72  L----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ---- 123
Query: 745 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLNAKISDFGLAK---LYEEDKTHI 799
              +  G++Y H    +++ HRD+K  N LLD       KI  FG +K   L+ + K+ +
Sbjct: 124 ---LISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV 177
Query: 800 STRIAGTIGYMAPEYAMRGYLTSK-ADVYSFGVVTLEIVSG 839
                GT  Y+APE  ++     K ADV+S GV    ++ G
Sbjct: 178 -----GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 16/221 (7%)
Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE----FVNEI 685
           +++++    +F+    +G G FG V    + +   I   ++ +K     R     F  E 
Sbjct: 66  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREER 125
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            ++       +  L+    + N L LV +Y     L   +    +++  KL     +   
Sbjct: 126 DVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL----SKFEDKLPEDMARFYI 181
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +   +  +H+   +  VHRDIK  NVLLD + + +++DFG      +D T  S+   G
Sbjct: 182 GEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVG 238
Query: 806 TIGYMAPEY--AMR---GYLTSKADVYSFGVVTLEIVSGKS 841
           T  Y++PE   AM    G    + D +S GV   E++ G++
Sbjct: 239 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 279

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 16/221 (7%)
Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE----FVNEI 685
           +++++    +F+    +G G FG V    + +   I   ++ +K     R     F  E 
Sbjct: 82  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREER 141
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            ++       +  L+    + N L LV +Y     L   +    +++  KL     +   
Sbjct: 142 DVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL----SKFEDKLPEDMARFYI 197
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             +   +  +H+   +  VHRDIK  NVLLD + + +++DFG      +D T  S+   G
Sbjct: 198 GEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVG 254
Query: 806 TIGYMAPE--YAMR---GYLTSKADVYSFGVVTLEIVSGKS 841
           T  Y++PE   AM    G    + D +S GV   E++ G++
Sbjct: 255 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 295

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 35/221 (15%)
Query: 633 IKAATNNFDPANKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSR---QGNREFVNEIG 686
           I   ++ ++    +G G FG     ++ D     ++AVK +    +      RE +N   
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIDENVKREIINHRS 71
Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKI 744
           +    +HPN+V+     +    L +V EY     L   I   G+ +E   +  +      
Sbjct: 72  L----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ---- 123
Query: 745 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLNAKISDFGLAK---LYEEDKTHI 799
              +  G++Y H    +++ HRD+K  N LLD       KI  FG +K   L+ + K  +
Sbjct: 124 ---LISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV 177
Query: 800 STRIAGTIGYMAPEYAMRGYLTSK-ADVYSFGVVTLEIVSG 839
                GT  Y+APE  ++     K ADV+S GV    ++ G
Sbjct: 178 -----GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E M+     + +F   TE R  L     +     +   + + H
Sbjct: 76  IRLLDWFERPDSFVLILERMEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 131
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 132 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 185
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 28/239 (11%)
Query: 620 GLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVK--QLSSKSRQG 677
           G+DL T     + +      +    ++G GG   V++ +     + A+K   L     Q 
Sbjct: 10  GVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT 69
Query: 678 NREFVNEIGMISA-QQHPN-LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK 735
              + NEI  ++  QQH + +++LY   +    + +V E   N  L+  +  K +     
Sbjct: 70  LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKS----- 123
Query: 736 LDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 795
           +D   RK     +   +  +H+     IVH D+K +N L+  D   K+ DFG+A   + D
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPD 179
Query: 796 KTH-ISTRIAGTIGYMAPEYAMRGYLTSKA------------DVYSFGVVTLEIVSGKS 841
            T  +     GT+ YM PE A++   +S+             DV+S G +   +  GK+
Sbjct: 180 TTSVVKDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 20/164 (12%)
Query: 706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVH 765
           G  +++V+E +  N L+     K  E+R  +     K+I   +  GL Y+H   R  I+H
Sbjct: 102 GVHVVMVFEVLGENLLA---LIKKYEHR-GIPLIYVKQISKQLLLGLDYMHR--RCGIIH 155
Query: 766 RDIKTSNVLL------DKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRG 818
            DIK  NVL+      +  +  KI+D G A  Y+E  T+ I TR      Y +PE  +  
Sbjct: 156 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR-----EYRSPEVLLGA 210
Query: 819 YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQ 862
                AD++S   +  E+++G  +  + P+E   Y  D  ++ Q
Sbjct: 211 PWGCGADIWSTACLIFELITG--DFLFEPDEGHSYTKDDDHIAQ 252

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 43/229 (18%)
Query: 640 FDPANKVGEGGFGSVYKGI--LSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPN 695
           ++  + +GEG FG V + +     G  +A+K + +  K ++  R  +N +  I+ +   N
Sbjct: 35  YEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDN 94
Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTR--KKICIGIA 749
                  CV   Q+   ++Y  + C+S  + G  T   LK    L +P    + +   + 
Sbjct: 95  K----NLCV---QMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLC 147
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLN----------------AKISDFGLAK 790
           + + +LH++   K+ H D+K  N+L    D +L                  ++ DFG A 
Sbjct: 148 QAVKFLHDN---KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT 204
Query: 791 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
               D  H ST I  T  Y APE  +    +   DV+S G +  E   G
Sbjct: 205 F---DHEHHST-IVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVG 249

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 20/164 (12%)
Query: 706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVH 765
           G  +++V+E +  N L+     K  E+R  +     K+I   +  GL Y+H   R  I+H
Sbjct: 102 GVHVVMVFEVLGENLLA---LIKKYEHR-GIPLIYVKQISKQLLLGLDYMHR--RCGIIH 155
Query: 766 RDIKTSNVLL------DKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRG 818
            DIK  NVL+      +  +  KI+D G A  Y+E  T+ I TR      Y +PE  +  
Sbjct: 156 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR-----EYRSPEVLLGA 210
Query: 819 YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQ 862
                AD++S   +  E+++G  +  + P+E   Y  D  ++ Q
Sbjct: 211 PWGCGADIWSTACLIFELITG--DFLFEPDEGHSYTKDDDHIAQ 252

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 25/253 (9%)
Query: 602 MRWKGCLGGKVSADKELRGL---DLQ-TGLYTLRQIKAATNNFDPANKVGEGGFGSVYKG 657
           + ++G L  K+++   LR     DL  T L   ++ +   + +     +G GGFGSVY G
Sbjct: 11  LYFQGSLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 70
Query: 658 I-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNLVKLYGCCVEGNQ 708
           I +SD   +A+K +         E  N      E+ ++   +     +++L       + 
Sbjct: 71  IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 130
Query: 709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI 768
            +L+ E  +     + +F   TE R  L     +     +   + + H      ++HRDI
Sbjct: 131 FVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDI 183
Query: 769 KTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY-AMRGYLTSKADV 826
           K  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+     Y    A V
Sbjct: 184 KDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAV 240
Query: 827 YSFGVVTLEIVSG 839
           +S G++  ++V G
Sbjct: 241 WSLGILLYDMVCG 253

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/246 (21%), Positives = 108/246 (43%), Gaps = 53/246 (21%)
Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQ--GNREFVNEIGMISAQQHP 694
           +N++  + +G G +G VY     +    +A+K+++         +  + EI +++  +  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 695 NLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
            +++L+   +     + ++L +V E      ++ +   K  +  + L     K I   + 
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLE------IADSDLKKLFKTPIFLTEQHVKTILYNLL 141
Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK------------- 796
            G  ++HE     I+HRD+K +N LL++D + KI DFGLA+    DK             
Sbjct: 142 LGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEE 198
Query: 797 ----------------THISTRIAGTIGYMAPEYA-MRGYLTSKADVYSFGVVTLEIVS- 838
                           +H+ TR      Y APE   ++   T+  D++S G +  E+++ 
Sbjct: 199 NEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTNSIDIWSTGCIFAELLNM 253
Query: 839 GKSNTN 844
            KS+ N
Sbjct: 254 MKSHIN 259

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 102/239 (42%), Gaps = 28/239 (11%)
Query: 620 GLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVK--QLSSKSRQG 677
           G+DL T     + +      +    ++G GG   V++ +     + A+K   L     Q 
Sbjct: 10  GVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT 69
Query: 678 NREFVNEIGMISA-QQHPN-LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK 735
              + NEI  ++  QQH + +++LY   +    + +V E   N  L+  +  K +     
Sbjct: 70  LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKS----- 123
Query: 736 LDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 795
           +D   RK     +   +  +H+     IVH D+K +N L+  D   K+ DFG+A   + D
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPD 179
Query: 796 KTH-ISTRIAGTIGYMAPEYAMRGYLTSKA------------DVYSFGVVTLEIVSGKS 841
               +     GT+ YM PE A++   +S+             DV+S G +   +  GK+
Sbjct: 180 XXXVVKDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/256 (24%), Positives = 107/256 (41%), Gaps = 56/256 (21%)
Query: 637 TNNFDPANKVGEGGFGSVYKGI----LSDGTVIAVKQLSSKSRQGNREFVNEIGMIS-AQ 691
           +N F   +K+GEG F SVY       +     IA+K L   S         E+  ++ A 
Sbjct: 20  SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIR--IAAELQCLTVAG 77
Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKICIG 747
              N++ +  C  + + +++   Y+++    + L+   F +  EY L L           
Sbjct: 78  GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNL----------- 126
Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRI--- 803
             + L  +H+     IVHRD+K SN L ++ L    + DFGLA+   + K  +   +   
Sbjct: 127 -FKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSE 182
Query: 804 ------------------------AGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVS 838
                                   AGT G+ APE   +    T+  D++S GV+ L ++S
Sbjct: 183 AQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242
Query: 839 GKSNTNYRPNEDFVYL 854
           G+    Y+ ++D   L
Sbjct: 243 GRY-PFYKASDDLTAL 257

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 107/251 (42%), Gaps = 25/251 (9%)
Query: 604 WKGCLGGKVSADKELRGL---DLQ-TGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI- 658
           ++G L  K+++   LR     DL  T L   ++ +   + +     +G GGFGSVY GI 
Sbjct: 13  FQGPLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIR 72
Query: 659 LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNLVKLYGCCVEGNQLL 710
           +SD   +A+K +         E  N      E+ ++   +     +++L       +  +
Sbjct: 73  VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 132
Query: 711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKT 770
           L+ E  +     + +F   TE R  L     +     +   + + H      ++HRDIK 
Sbjct: 133 LILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKD 185
Query: 771 SNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY-AMRGYLTSKADVYS 828
            N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+     Y    A V+S
Sbjct: 186 ENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWS 242
Query: 829 FGVVTLEIVSG 839
            G++  ++V G
Sbjct: 243 LGILLYDMVCG 253

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 18/223 (8%)
Query: 630 LRQIKAATNNFDPANKVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNRE---FVNEI 685
           L++++   ++F+    +G G F  V    +   G V A+K ++        E   F  E 
Sbjct: 53  LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREER 112
Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            ++       + +L+    + N L LV EY     L   +    +++  ++     +   
Sbjct: 113 DVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL----SKFGERIPAEMARFYL 168
Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
             I   +  +H   R+  VHRDIK  N+LLD+  + +++DFG       D T  S    G
Sbjct: 169 AEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVG 225
Query: 806 TIGYMAPE-------YAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           T  Y++PE           G    + D ++ GV   E+  G++
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 91  IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 146
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 147 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 200
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 92  IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 147
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 148 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 201
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 92  IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 147
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 148 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 201
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 104 IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 159
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 160 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 213
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 105 IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 160
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 161 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 214
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 105 IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 160
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 161 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 214
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 105 IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 160
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 161 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 214
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 104 IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 159
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 160 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 213
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 166
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 167 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 220
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 104 IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 159
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 160 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 213
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 105 IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 160
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 161 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 214
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 91  IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 146
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 147 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 200
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 104 IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 159
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 160 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 213
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 92  IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 147
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 148 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 201
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 77  IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 132
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 133 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 186
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 77  IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 132
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 133 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 186
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN------EIGMIS--AQQHPNL 696
           +G GGFGSVY GI +SD   +A+K +         E  N      E+ ++   +     +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 76  IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 131
Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L    K  + T   GT  Y  PE+ 
Sbjct: 132 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 185
Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y    A V+S G++  ++V G
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCG 210
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	869
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-157
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-141
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-139
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-76
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-63
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-60
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-53
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-43
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-58
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-57
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-57
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-56
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-55
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-54
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-53
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-46
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-43
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-56
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-54
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-53
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-53
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-51
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-45
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-40
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-36
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-45
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-45
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-44
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-43
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-43
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-43
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-43
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-43
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-43
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-42
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-42
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-42
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-42
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-42
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-42
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-42
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-41
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-41
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-41
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-41
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-41
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-41
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-41
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-41
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-41
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-41
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-40
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-40
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-40
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-40
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-40
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-40
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-38
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-37
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-34
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-34
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-40
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-40
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-40
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-40
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-40
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-40
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-40
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-39
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-39
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-39
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-39
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-39
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-39
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-39
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-39
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-39
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-39
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	1e-38
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-38
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-38
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-38
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-37
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-32
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-30
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-29
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-26
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-37
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-36
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-36
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-36
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-36
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-35
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-34
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-34
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-34
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-34
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-33
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-33
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-33
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-32
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-30
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-25
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-08
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-32
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-32
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-32
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-30
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-30
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-08
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-31
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-30
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-30
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-30
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-24
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-19
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-30
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-28
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-27
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-24
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-22
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-16
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-30
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-30
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-16
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-29
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-17
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-15
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-28
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-28
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-28
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-28
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-27
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-27
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-25
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-24
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-22
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-20
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-27
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-27
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-27
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-26
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-26
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-20
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-11
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-26
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-26
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-25
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-24
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-09
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-26
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-26
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-26
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-26
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-25
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-25
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-25
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-25
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-25
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-24
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-22
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-09
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-24
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-24
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-22
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-22
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-16
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-04
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-24
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-24
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-24
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-24
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-24
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-22
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-21
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-17
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-16
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-15
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-24
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-23
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-22
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-22
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-19
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-19
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-14
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-21
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-15
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-11
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-21
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-21
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-19
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-19
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-21
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-21
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-20
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-16
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-05
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-21
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-21
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-20
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-12
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-06
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-20
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-19
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-19
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-11
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-19
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-19
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-18
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-08
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-18
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-18
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-18
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-09
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-10
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-16
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-16
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-08
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-09
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-14
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-08
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-14
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	9e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-09
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	7e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	9e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	9e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	1e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  462 bits (1190), Expect = e-157
 Identities = 109/255 (42%), Positives = 163/255 (63%), Gaps = 5/255 (1%)

Query: 614 ADKELRGLDL-QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS 672
             +E   + L Q   ++LR+++ A++NF   N +G GGFG VYKG L+DGT++AVK+L  
Sbjct: 5   PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE 64

Query: 673 KSRQGN-REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTE 731
           +  QG   +F  E+ MIS   H NL++L G C+   + LLVY YM N  ++  +  +  E
Sbjct: 65  ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP-E 123

Query: 732 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 791
            +  LDWP R++I +G ARGLAYLH+    KI+HRD+K +N+LLD++  A + DFGLAKL
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183

Query: 792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR--PNE 849
            +   TH++T + GTIG++APEY   G  + K DV+ +GV+ LE+++G+   +     N+
Sbjct: 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243

Query: 850 DFVYLLDWAYVLQEE 864
           D V LLDW   L +E
Sbjct: 244 DDVMLLDWVKGLLKE 258

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  420 bits (1081), Expect = e-141
 Identities = 105/238 (44%), Positives = 151/238 (63%), Gaps = 5/238 (2%)

Query: 628 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM 687
             L  ++ ATNNFD    +G G FG VYKG+L DG  +A+K+ + +S QG  EF  EI  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 688 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 747
           +S  +HP+LV L G C E N+++L+Y+YM+N  L R ++G D    + + W  R +ICIG
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIG 147

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGT 806
            ARGL YLH  +   I+HRD+K+ N+LLD++   KI+DFG++K   E D+TH+ST + GT
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 864
           +GY+ PEY ++G LT K+DVYSFGVV  E++  +S        + V L +WA      
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  415 bits (1069), Expect = e-139
 Identities = 106/262 (40%), Positives = 153/262 (58%), Gaps = 20/262 (7%)

Query: 615 DKELRGLDLQTGLYTLRQIKAATNNFDP------ANKVGEGGFGSVYKGILSDGTVIAVK 668
           +K L   D +   ++  ++K  TNNFD        NK+GEGGFG VYKG + + T +AVK
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60

Query: 669 QLSS----KSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRA 724
           +L++     + +  ++F  EI +++  QH NLV+L G   +G+ L LVY YM N  L   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120

Query: 725 IFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 784
           +   D      L W  R KI  G A G+ +LHE+  I   HRDIK++N+LLD+   AKIS
Sbjct: 121 LSCLD--GTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKIS 175

Query: 785 DFGLAKLY-EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 843
           DFGLA+   +  +T +++RI GT  YMAPE  +RG +T K+D+YSFGVV LEI++G    
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234

Query: 844 NYRPNEDFVYLLDWAYVLQEEE 865
           +         LLD    +++EE
Sbjct: 235 DEHREPQ--LLLDIKEEIEDEE 254

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  249 bits (638), Expect = 5e-76
 Identities = 65/246 (26%), Positives = 101/246 (41%), Gaps = 25/246 (10%)

Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 688
               +   +           G FG V+K  L     +AVK    + +Q   +   E+  +
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYSL 72

Query: 689 SAQQHPNLVKLYGCCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI 744
              +H N+++  G    G      L L+  + +   LS  +          + W     I
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHI 126

Query: 745 CIGIARGLAYLHED-------SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
              +ARGLAYLHED        +  I HRDIK+ NVLL  +L A I+DFGLA  +E  K+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 798 HI-STRIAGTIGYMAPEYAMRGYLTS-----KADVYSFGVVTLEIVSGKSNTNYRPNEDF 851
              +    GT  YMAPE              + D+Y+ G+V  E+ S  +  +   +E  
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 852 VYLLDW 857
           +   + 
Sbjct: 247 LPFEEE 252

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  215 bits (550), Expect = 2e-63
 Identities = 68/242 (28%), Positives = 102/242 (42%), Gaps = 39/242 (16%)

Query: 636 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQH 693
             +N      +G G +G+VYKG L D   +AVK  S  +RQ    F+NE  I  +   +H
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEH 66

Query: 694 PNLVKLYGCCVEGN-----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 748
            N+ +              + LLV EY  N  L + +           DW +  ++   +
Sbjct: 67  DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSV 120

Query: 749 ARGLAYLHED------SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK------ 796
            RGLAYLH +       +  I HRD+ + NVL+  D    ISDFGL+     ++      
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180

Query: 797 -THISTRIAGTIGYMAPEYAM-------RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 848
             + +    GTI YMAPE                + D+Y+ G++  EI      T+  P 
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--TDLFPG 238

Query: 849 ED 850
           E 
Sbjct: 239 ES 240

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  207 bits (528), Expect = 2e-60
 Identities = 70/299 (23%), Positives = 110/299 (36%), Gaps = 43/299 (14%)

Query: 17  DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGT--LPTEL 74
            W    D C+    W             V CD  + T  V  + L   NL     +P+ L
Sbjct: 26  SWLPTTDCCN--RTW-----------LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 75  SKLRYLKQLDLS-RNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 132
           + L YL  L +   N L G   P  A L  L  L +    +SG  P  L+ I TL  L  
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 133 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNL-NDLRISDNNFSGKIPE 191
             N  +G++PP I  L NL  +    N  +G +P      + L   + IS N  +GKIP 
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192

Query: 192 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLIL 251
                  +  + +  + LEG       +  +                          + L
Sbjct: 193 TFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQ-----------------------KIHL 228

Query: 252 TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK 310
            K  +  ++   +G    L  +DL  N + G +P    +L   + + ++ N L G +P+
Sbjct: 229 AKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  188 bits (479), Expect = 1e-53
 Identities = 65/270 (24%), Positives = 106/270 (39%), Gaps = 32/270 (11%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 124
              G L    ++   +  LDLS   L                         P P  L N+
Sbjct: 37  TWLGVLCDTDTQTYRVNNLDLSGLNLPKP---------------------YPIPSSLANL 75

Query: 125 TTLKNLSIEG-NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 183
             L  L I G N   G IPP I KL  L  L ++  + +G +P  L+++  L  L  S N
Sbjct: 76  PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135

Query: 184 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL-TDLRISD--LKGSESAFPK 240
             SG +P  I     +  +   G+ + G IP S  + + L T + IS   L G     P 
Sbjct: 136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK---IPP 192

Query: 241 -LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 299
               +NL  + L++ ++ G+     G     + I L+ N+L   +          N + L
Sbjct: 193 TFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDL 251

Query: 300 TGNKLTGPVPKYIFNSN--KNVDISLNNFT 327
             N++ G +P+ +       ++++S NN  
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  157 bits (400), Expect = 6e-43
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 28/223 (12%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 123
           N++G +P  LS+++ L  LD S N L+G+  P  +SL  LV ++  GNR+SG  P    +
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171

Query: 124 ITTL-KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 182
            + L  +++I  N  TG IPP    L NL  + LS N   G+         N   + ++ 
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230

Query: 183 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLD 242
           N+ +  + + +G  K +  L ++ + + G +P  ++ L  L  L +S             
Sbjct: 231 NSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF------------ 277

Query: 243 KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 285
             N          + GEIP   G++ +      + N    G P
Sbjct: 278 --NN---------LCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  201 bits (514), Expect = 1e-58
 Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 9/200 (4%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 701
            K+G G FG+V++     G+ +AVK L  +        EF+ E+ ++   +HPN+V   G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              +   L +V EY+    L R +    +  R +LD   R  +   +A+G+ YLH     
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLL--HKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYL 820
            IVHR++K+ N+L+DK    K+ DFGL++L +      S   AGT  +MAPE        
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPS- 216

Query: 821 TSKADVYSFGVVTLEIVSGK 840
             K+DVYSFGV+  E+ + +
Sbjct: 217 NEKSDVYSFGVILWELATLQ 236

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  199 bits (507), Expect = 1e-57
 Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 12/198 (6%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
             VG G FG V K        +A+KQ+ S+S +  + F+ E+  +S   HPN+VKLYG C
Sbjct: 14  EVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
           +  N + LV EY +   L   + G +               C+  ++G+AYLH      +
Sbjct: 71  L--NPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126

Query: 764 VHRDIKTSNVLLDKDLN-AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
           +HRD+K  N+LL       KI DFG A     D     T   G+  +MAPE       + 
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182

Query: 823 KADVYSFGVVTLEIVSGK 840
           K DV+S+G++  E+++ +
Sbjct: 183 KCDVFSWGIILWEVITRR 200

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  210 bits (537), Expect = 1e-57
 Identities = 74/276 (26%), Positives = 122/276 (44%), Gaps = 19/276 (6%)

Query: 65  NLTGTLPTEL---SKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVL 121
           +++G              LK L +S N ++G        + L  L V  N  S   P  L
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDV-DVSRCVNLEFLDVSSNNFSTGIP-FL 219

Query: 122 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 181
            + + L++L I GN  +G     I     L+ L +SSN F G +P     L +L  L ++
Sbjct: 220 GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLA 277

Query: 182 DNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS--ES 236
           +N F+G+IP+F+ G    +  L + G+   G +P    + + L  L +S     G     
Sbjct: 278 ENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD 337

Query: 237 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMT-KLKNIDLSFNNLTGGIPTTFEKLAKTN 295
              K+    LK L L+     GE+P+ + +++  L  +DLS NN +G I     +  K  
Sbjct: 338 TLLKMR--GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395

Query: 296 --FMYLTGNKLTGPVPKYIFN-SN-KNVDISLNNFT 327
              +YL  N  TG +P  + N S   ++ +S N  +
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS 431

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  206 bits (527), Expect = 2e-56
 Identities = 79/279 (28%), Positives = 125/279 (44%), Gaps = 24/279 (8%)

Query: 65  NLTGTLPTE-LSKLRYLKQLDLSRNCLTGSFSPQWASL----QLVELSVMGNRLSGPFPK 119
            L          KL  L+ LDLS N ++G+    W       +L  L++ GN++SG    
Sbjct: 137 TLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD- 195

Query: 120 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 179
            ++    L+ L +  N F+  IP  +     LQ L +S N  +G+    ++  T L  L 
Sbjct: 196 -VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLN 253

Query: 180 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISA-LTSLTDLRISD--LKGSES 236
           IS N F G IP      K +Q L +  +   G IP  +S    +LT L +S     G+  
Sbjct: 254 ISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA-- 309

Query: 237 AFPK-LDKM-NLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 293
             P        L++L L+     GE+P D +  M  LK +DLSFN  +G +P +   L+ 
Sbjct: 310 -VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA 368

Query: 294 T-NFMYLTGNKLTGPVPKYIFNSNKN----VDISLNNFT 327
           +   + L+ N  +GP+   +  + KN    + +  N FT
Sbjct: 369 SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  203 bits (518), Expect = 5e-55
 Identities = 73/272 (26%), Positives = 125/272 (45%), Gaps = 14/272 (5%)

Query: 65  NLTGTLPTELSK--LRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVL 121
           N +G +   L +     L++L L  N  TG   P  ++  +LV L +  N LSG  P  L
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438

Query: 122 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 181
            +++ L++L +  N+  G IP ++  +  L+ LIL  N  TGE+P+ L+  TNLN + +S
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 498

Query: 182 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFP 239
           +N  +G+IP++IG+ + +  L +  +S  G IPA +    SL  L ++     G+    P
Sbjct: 499 NNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT---IP 555

Query: 240 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN--NLTGGIPTTFEKLAKTNFM 297
               M  ++  +    I G+   YI +    K    + N     G       +L+  N  
Sbjct: 556 A--AMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC 613

Query: 298 YLTGNKLTGPVPKYIFNSNK--NVDISLNNFT 327
            +T     G       N+     +D+S N  +
Sbjct: 614 NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS 645

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  199 bits (508), Expect = 8e-54
 Identities = 73/270 (27%), Positives = 127/270 (47%), Gaps = 12/270 (4%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 123
            L G +P EL  ++ L+ L L  N LTG      ++   L  +S+  NRL+G  PK +  
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512

Query: 124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 183
           +  L  L +  N F+G+IP ++    +L  L L++N F G +PA + K +      I+ N
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAAN 568

Query: 184 NFSGKIPEFIGKWKKIQKLHIQGS--SLEGPIPASISALTSLTDLRISD--LKGSESAFP 239
             +GK   +I      ++ H  G+    +G     ++ L++     I+     G  S   
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628

Query: 240 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 299
             +  ++  L ++  ++ G IP  IG M  L  ++L  N+++G IP     L   N + L
Sbjct: 629 DNNG-SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDL 687

Query: 300 TGNKLTGPVPKYI--FNSNKNVDISLNNFT 327
           + NKL G +P+ +        +D+S NN +
Sbjct: 688 SSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  198 bits (505), Expect = 2e-53
 Identities = 78/323 (24%), Positives = 127/323 (39%), Gaps = 59/323 (18%)

Query: 17  DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLT---GTLPTE 73
           DW+   +PC+    ++       G    VTC        V +I L ++ L      + + 
Sbjct: 32  DWSSNKNPCT----FD-------G----VTCR----DDKVTSIDLSSKPLNVGFSAVSSS 72

Query: 74  LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV--LTNITTLKNLS 131
           L  L  L+ L LS + + GS S    S  L  L +  N LSGP   +  L + + LK L+
Sbjct: 73  LLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLN 132

Query: 132 IEGNLFTGSIP-PDIRKLINLQKLILSSNSFTGELPAELT---KLTNLNDLRISDNNFSG 187
           +  N            KL +L+ L LS+NS +G              L  L IS N  SG
Sbjct: 133 VSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISG 192

Query: 188 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLK 247
            +   + +   ++ L +  ++    IP  +   ++L  L IS                  
Sbjct: 193 DVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISG----------------- 232

Query: 248 TLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP 307
                   + G+    I   T+LK +++S N   G IP     L    ++ L  NK TG 
Sbjct: 233 ------NKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGE 284

Query: 308 VPKYIFNSNKN---VDISLNNFT 327
           +P ++  +      +D+S N+F 
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFY 307

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  175 bits (447), Expect = 7e-46
 Identities = 60/248 (24%), Positives = 93/248 (37%), Gaps = 30/248 (12%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 123
            LTG +P  + +L  L  L LS N  +G+   +      L+ L +  N  +G  P  +  
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560

Query: 124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN--SFTGELPAELTKLTNLNDLRIS 181
            +      I  N   G     I+     ++   + N   F G    +L +L+  N   I+
Sbjct: 561 QSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT 616

Query: 182 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 241
              + G           +  L +  + L G IP  I ++  L  L +             
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG------------ 664

Query: 242 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 301
              N          I G IPD +GD+  L  +DLS N L G IP     L     + L+ 
Sbjct: 665 --HND---------ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713

Query: 302 NKLTGPVP 309
           N L+GP+P
Sbjct: 714 NNLSGPIP 721

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  166 bits (423), Expect = 7e-43
 Identities = 57/225 (25%), Positives = 85/225 (37%), Gaps = 28/225 (12%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 124
           + +G +P EL   R L  LDL+ N   G+              +  N ++G     + N 
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG---KIAANFIAGKRYVYIKND 581

Query: 125 TTLKNLSIEGNL--FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 182
              K     GNL  F G     + +L       ++S  + G          ++  L +S 
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY 641

Query: 183 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLD 242
           N  SG IP+ IG    +  L++  + + G IP  +  L  L  L +S             
Sbjct: 642 NMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSS------------ 689

Query: 243 KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 287
             N     L      G IP  +  +T L  IDLS NNL+G IP  
Sbjct: 690 --NK----LD-----GRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  194 bits (496), Expect = 2e-56
 Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 26/212 (12%)

Query: 644 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-------REFVNEIGMISAQQHPN 695
            ++G+GGFG V+KG  + D +V+A+K L     +G        +EF  E+ ++S   HPN
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           +VKLYG     N   +V E++    L   +  K       + W  + ++ + IA G+ Y+
Sbjct: 85  IVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGIEYM 138

Query: 756 HEDSRIKIVHRDIKTSNVLLDK-----DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 810
             +    IVHRD+++ N+ L        + AK++DFGL++       H  + + G   +M
Sbjct: 139 Q-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWM 193

Query: 811 APE-YAMRGYL-TSKADVYSFGVVTLEIVSGK 840
           APE         T KAD YSF ++   I++G+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGE 225

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  195 bits (498), Expect = 3e-56
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 21/211 (9%)

Query: 644 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
             +G+G FG   K      G V+ +K+L     +  R F+ E+ ++   +HPN++K  G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
             +  +L  + EY+K   L   I   D+    +  W  R      IA G+AYLH    + 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIASGMAYLHS---MN 128

Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH-------------ISTRIAGTIGY 809
           I+HRD+ + N L+ ++ N  ++DFGLA+L  ++KT                  + G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           MAPE         K DV+SFG+V  EI+   
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  192 bits (491), Expect = 7e-56
 Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 22/209 (10%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQL----SSKSRQGNREFVNEIGMISAQQHPNLVKL 699
             +G GGFG VY+     G  +AVK           Q       E  + +  +HPN++ L
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
            G C++   L LV E+ +   L+R + GK      ++         + IARG+ YLH+++
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEA 125

Query: 760 RIKIVHRDIKTSNVLLDKDL--------NAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
            + I+HRD+K+SN+L+ + +          KI+DFGLA+  E  +T   +  AG   +MA
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSA-AGAYAWMA 182

Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE       +  +DV+S+GV+  E+++G+
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  188 bits (480), Expect = 3e-54
 Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 20/205 (9%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 701
            K+ E   G ++KG    G  I VK L  +       R+F  E   +    HPN++ + G
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 702 CCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
            C         L+  +M    L   +          +D     K  + +ARG+A+LH   
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLH-TL 130

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG- 818
              I    + + +V++D+D+ A+IS   +   ++      S        ++APE A++  
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE-ALQKK 183

Query: 819 ---YLTSKADVYSFGVVTLEIVSGK 840
                   AD++SF V+  E+V+ +
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTRE 208

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  187 bits (478), Expect = 7e-54
 Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 18/204 (8%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 701
            ++G G FG+VYKG    G V AVK L+  +      + F NE+G++   +H N++   G
Sbjct: 30  QRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
                  L +V ++ + + L   +   +T    K +      I    ARG+ YLH     
Sbjct: 88  YSTAPQ-LAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLH---AK 139

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKL-YEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
            I+HRD+K++N+ L +D   KI DFGLA        +H   +++G+I +MAPE  +R   
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQD 198

Query: 821 ----TSKADVYSFGVVTLEIVSGK 840
               + ++DVY+FG+V  E+++G+
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ 222

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  186 bits (475), Expect = 2e-53
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 30/216 (13%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQHPNLVKLYG 701
             VG+G +G V++G    G  +AVK  SS   +  + +  E  +      +H N++    
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 702 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
             +       QL L+  Y +   L   +          LD  +  +I + IA GLA+LH 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 758 D-----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIAGTIGY 809
           +      +  I HRD+K+ N+L+ K+    I+D GLA ++ +    +   +    GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 810 MAPE------YAMRGYLTSKADVYSFGVVTLEIVSG 839
           MAPE               + D+++FG+V  E+   
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  186 bits (475), Expect = 7e-53
 Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 30/230 (13%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQHPNLVKLYG 701
            ++G+G +G V+ G    G  +AVK   +        +  E  I      +H N++    
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98

Query: 702 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
             ++G     QL L+ +Y +N  L   +          LD  +  K+      GL +LH 
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL------KSTTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 758 D-----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIAGTIGY 809
           +      +  I HRD+K+ N+L+ K+    I+D GLA  +  D   +        GT  Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 810 MAPE------YAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 853
           M PE                AD+YSFG++  E+     +          Y
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  181 bits (462), Expect = 2e-51
 Identities = 48/212 (22%), Positives = 86/212 (40%), Gaps = 25/212 (11%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 701
             +G+G FG VY G    G V A++ +  +    +  + F  E+      +H N+V   G
Sbjct: 39  ELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
            C+    L ++    K   L   +          LD    ++I   I +G+ YLH     
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKI----VLDVNKTRQIAQEIVKGMGYLH---AK 149

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKL----YEEDKTHISTRIAGTIGYMAPE---- 813
            I+H+D+K+ NV  D      I+DFGL  +        +        G + ++APE    
Sbjct: 150 GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208

Query: 814 -----YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                   +   +  +DV++ G +  E+ + +
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  182 bits (463), Expect = 3e-51
 Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 32/231 (13%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQHPNLVKLYG 701
             +G+G FG V++G    G  +AVK  SS   +  R +  E  I      +H N++    
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103

Query: 702 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
              + N    QL LV +Y ++  L   +       R  +      K+ +  A GLA+LH 
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHM 157

Query: 758 D-----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIAGTIGY 809
           +      +  I HRD+K+ N+L+ K+    I+D GLA  ++     I        GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 810 MAPEYAMRGYL-------TSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 853
           MAPE  +   +         +AD+Y+ G+V  EI    S      +    Y
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  172 bits (438), Expect = 2e-45
 Identities = 51/342 (14%), Positives = 108/342 (31%), Gaps = 51/342 (14%)

Query: 5   ALKQIGRKLGKKDWNFGVDPCSQKGNWELSSD-DKKGFESNVTCDCSSATCHVVTIALKA 63
           ALK+I   L  K+W+          NW  + + D  G +  V+ + +     V  ++L+ 
Sbjct: 34  ALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNG---RVTGLSLEG 90

Query: 64  QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS-----LQLVELSVMGNRLSGPFP 118
              +G +P  + +L  L+ L L  +    +            +   +   M       F 
Sbjct: 91  FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150

Query: 119 KVLT--NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLN 176
                 + + L    I  +    SI    R  +   ++   SN+ T  +   + +LT L 
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLR 209

Query: 177 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES 236
              + ++ F  +      + +  +                   L  LTD+ + +      
Sbjct: 210 QFYMGNSPFVAENICEAWENENSEYA-----QQYKTEDLKWDNLKDLTDVEVYN------ 258

Query: 237 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG--------IPTTF 288
                            C    ++P ++  + +++ I+++ N    G             
Sbjct: 259 -----------------CPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADA 301

Query: 289 EKLAKTNFMYLTGNKL-TGPVPKYIFN-SN-KNVDISLNNFT 327
               K   +Y+  N L T PV   +        ++   N   
Sbjct: 302 PVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  156 bits (397), Expect = 4e-40
 Identities = 40/285 (14%), Positives = 83/285 (29%), Gaps = 31/285 (10%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--QLVELSVMGNRLSG-PFPKVL 121
            L G LP        L  L+L+ N +T      +     Q+  LS   N+L   P     
Sbjct: 341 QLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDA 398

Query: 122 TNITTLKNLSIEGNLFTG-------SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 174
            +++ +  +    N            + P   K IN+  + LS+N  +       +  + 
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458

Query: 175 LNDLRISDNNFSG-------KIPEFIGKWKKIQKLHIQGSSLEGPIPASISA--LTSLTD 225
           L+ + +  N  +           E       +  + ++ + L   +     A  L  L  
Sbjct: 459 LSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVG 517

Query: 226 LRISD--LKG-SESAF--PKLDKMNLKT-LILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 279
           + +S                L    ++            E P+ I     L  + +  N+
Sbjct: 518 IDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577

Query: 280 LTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 324
           +          +   + + +  N        Y+    +     L 
Sbjct: 578 IRKVNEKITPNI---SVLDIKDNPNISIDLSYVCPYIEAGMYMLF 619

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  143 bits (363), Expect = 8e-36
 Identities = 42/290 (14%), Positives = 95/290 (32%), Gaps = 32/290 (11%)

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPK 119
           + +     ++           Q+    N +T   S     L  L +  +  +        
Sbjct: 166 INSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENIC 224

Query: 120 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 179
                   +           +       L +L  + + +     +LP  L  L  +  + 
Sbjct: 225 EAWENENSEYAQ-----QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279

Query: 180 ISDNNF--------SGKIPEFIGKWKKIQKLHIQGSSL-EGPIPASISALTSLTDLRISD 230
           ++ N            +        +KIQ ++I  ++L   P+  S+  +  L  L    
Sbjct: 280 VACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLY 339

Query: 231 --LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF 288
             L+G   AF     + L +L L    I     ++ G   +++N+  + N L   IP  F
Sbjct: 340 NQLEGKLPAFGSE--IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIF 396

Query: 289 E--KLAKTNFMYLTGNKLTG-------PVPKYIFNSNK--NVDISLNNFT 327
           +   ++  + +  + N++         P+    F      ++++S N  +
Sbjct: 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS 446

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  164 bits (418), Expect = 3e-45
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 27/223 (12%)

Query: 644 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
            ++GEG FG V+     +        ++AVK L   S    ++F  E  +++  QH ++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCL----------SRAIFGKDTEYRLKLDWPTRKKICIG 747
           + +G C EG  LL+V+EYM++  L          ++ + G +      L       +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT 806
           +A G+ YL   + +  VHRD+ T N L+ + L  KI DFG+++ +Y  D   +  R    
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-------GKSN 842
           I +M PE  +    T+++DV+SFGVV  EI +         SN
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  163 bits (415), Expect = 3e-45
 Identities = 68/225 (30%), Positives = 109/225 (48%), Gaps = 28/225 (12%)

Query: 644 NKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
            ++GEG FG V+           D  ++AVK L   +    ++F  E  +++  QH ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCL-----------SRAIFGKDTEYRLKLDWPTRKKICI 746
           K YG C +G+ L++V+EYMK+  L              + G+  + + +L       I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAG 805
            IA G+ YL   +    VHRD+ T N L+  +L  KI DFG+++ +Y  D   +      
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197

Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-------GKSNT 843
            I +M PE  M    T+++DV+SFGV+  EI +         SNT
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  163 bits (414), Expect = 4e-44
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 16/200 (8%)

Query: 645 KVGEGGFGSVYKGILSDGTV-IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           ++G G FG V+ G L      +AVK    +       +F+ E  ++    HPN+V+L G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
           C +   + +V E ++        F +    RL++   T  ++    A G+ YL       
Sbjct: 181 CTQKQPIYIVMELVQGGDFLT--FLRTEGARLRV--KTLLQMVGDAAAGMEYLES---KC 233

Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT----IGYMAPEYAMRG 818
            +HRD+   N L+ +    KISDFG+++   +    +     G     + + APE    G
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAPEALNYG 290

Query: 819 YLTSKADVYSFGVVTLEIVS 838
             +S++DV+SFG++  E  S
Sbjct: 291 RYSSESDVWSFGILLWETFS 310

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  159 bits (404), Expect = 1e-43
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 20/206 (9%)

Query: 644 NKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV          + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAY 754
             G C    +  L L+ EY+    L      +D   +++ ++D     +    I +G+ Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSL------RDYLQKHKERIDHIKLLQYTSQICKGMEY 129

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAP 812
           L      + +HRD+ T N+L++ +   KI DFGL K+  +DK     +  G   I + AP
Sbjct: 130 LGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186

Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVS 838
           E       +  +DV+SFGVV  E+ +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  159 bits (403), Expect = 2e-43
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 17/205 (8%)

Query: 644 NKVGEGGFGSVYKGIL-----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 697
             +GEG FG V          + G  +AVK L          +   EI ++    H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 698 KLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           K  G C E  GN + L+ E++ +  L    +    + ++ L    + K  + I +G+ YL
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNKINL--KQQLKYAVQICKGMDYL 142

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPE 813
                 + VHRD+   NVL++ +   KI DFGL K  E DK + + +      + + APE
Sbjct: 143 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVS 838
             M+      +DV+SFGV   E+++
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  159 bits (404), Expect = 2e-43
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 18/209 (8%)

Query: 644 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNL 696
            ++G+G FG VY+G+          T +A+K ++  +    R EF+NE  ++      ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK---KICIGIAR 750
           V+L G   +G   L++ E M    L    R++          L  P+     ++   IA 
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGY 809
           G+AYL+     K VHRD+   N ++ +D   KI DFG+   +YE D      +    + +
Sbjct: 150 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206

Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           M+PE    G  T+ +DV+SFGVV  EI +
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  159 bits (404), Expect = 2e-43
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 16/204 (7%)

Query: 644 NKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
            ++G+G FGSV          + G V+AVK+L   + +  R+F  EI ++ + QH N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             G C    +  L L+ EY+    L    + +  + R+        +    I +G+ YL 
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDH--IKLLQYTSQICKGMEYLG 162

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                + +HRD+ T N+L++ +   KI DFGL K+  +DK +   +  G   I + APE 
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219

Query: 815 AMRGYLTSKADVYSFGVVTLEIVS 838
                 +  +DV+SFGVV  E+ +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  157 bits (399), Expect = 5e-43
 Identities = 67/216 (31%), Positives = 100/216 (46%), Gaps = 26/216 (12%)

Query: 644 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 696
            ++GE  FG VYKG L           +A+K L  K       EF +E  + +  QHPN+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCL-----------SRAIFGKDTEYRLKLDWPTRKKIC 745
           V L G   +   L +++ Y  +  L                  D   +  L+ P    + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHISTR 802
             IA G+ YL   S   +VH+D+ T NVL+   LN KISD GL  ++Y  D  K   ++ 
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           +   I +MAPE  M G  +  +D++S+GVV  E+ S
Sbjct: 192 LP--IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  156 bits (396), Expect = 8e-43
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
            ++G G FG V  G       +A+K +   S S     EF+ E  ++    H  LV+LYG
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYG 86

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
            C +   + ++ EYM N CL    + ++  +R +       ++C  +   + YL      
Sbjct: 87  VCTKQRPIFIITEYMANGCLLN--YLREMRHRFQT--QQLLEMCKDVCEAMEYL---ESK 139

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT---IGYMAPEYAMRG 818
           + +HRD+   N L++     K+SDFGL++   +D     T   G+   + +  PE  M  
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWSPPEVLMYS 196

Query: 819 YLTSKADVYSFGVVTLEIVS 838
             +SK+D+++FGV+  EI S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  156 bits (396), Expect = 1e-42
 Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 16/200 (8%)

Query: 644 NKVGEGGFGSVYKGILSDGTV-IAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           +K+G G +G VY+G+    ++ +AVK L   +   +   EF+ E  ++   +HPNLV+L 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 75

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G C       ++ E+M    L    + ++   R ++       +   I+  + YL    +
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLD--YLRECN-RQEVSAVVLLYMATQISSAMEYL---EK 129

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGYMAPEYAMRG 818
              +HRD+   N L+ ++   K++DFGL++L   D    H   +    I + APE     
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN 187

Query: 819 YLTSKADVYSFGVVTLEIVS 838
             + K+DV++FGV+  EI +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  157 bits (398), Expect = 1e-42
 Identities = 63/207 (30%), Positives = 88/207 (42%), Gaps = 23/207 (11%)

Query: 644 NKVGEGGFGSVYKGIL-----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 697
             +GEG FG V            G ++AVK L +    Q    +  EI ++    H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 698 KLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEY--RLKLDWPTRKKICIGIARGLA 753
           K  GCC +     L LV EY+    L         +Y  R  +           I  G+A
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLR--------DYLPRHSIGLAQLLLFAQQICEGMA 148

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMA 811
           YLH       +HRD+   NVLLD D   KI DFGLAK   E   +   R  G   + + A
Sbjct: 149 YLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 205

Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVS 838
           PE          +DV+SFGV   E+++
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  155 bits (393), Expect = 2e-42
 Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 16/199 (8%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
            ++G G FG V+ G   +   +A+K +   + S +   +F+ E  ++    HP LV+LYG
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYG 70

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
            C+E   + LV E+M++ CLS   + +           T   +C+ +  G+AYL      
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSD--YLRTQRGLFAA--ETLLGMCLDVCEGMAYL---EEA 123

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGYMAPEYAMRGY 819
            ++HRD+   N L+ ++   K+SDFG+ +   +D   +   T+    + + +PE      
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFSR 181

Query: 820 LTSKADVYSFGVVTLEIVS 838
            +SK+DV+SFGV+  E+ S
Sbjct: 182 YSSKSDVWSFGVLMWEVFS 200

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  156 bits (397), Expect = 2e-42
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)

Query: 644 NKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 698
           +++G+G FGSV          + G ++AVKQL        R+F  EI ++ A     +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 699 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAY 754
             G      +  L LV EY+ + CL      +D    +R +LD          I +G+ Y
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCL------RDFLQRHRARLDASRLLLYSSQICKGMEY 142

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAP 812
           L      + VHRD+   N+L++ + + KI+DFGLAKL   DK +   R  G   I + AP
Sbjct: 143 LGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199

Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVS 838
           E       + ++DV+SFGVV  E+ +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  156 bits (397), Expect = 2e-42
 Identities = 68/248 (27%), Positives = 111/248 (44%), Gaps = 31/248 (12%)

Query: 644 NKVGEGGFGSVYKGILSDG---TVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPNLVK 698
           + +GEG FG V K  +         A+K++    S+  +R+F  E+  +     HPN++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK--------KICIG 747
           L G C     L L  EY  +  L    R     +T+    +   T               
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           +ARG+ YL   S+ + +HRD+   N+L+ ++  AKI+DFGL++  E        R+   +
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--V 205

Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY--RPNEDFVYLLDWAYVLQE- 863
            +MA E       T+ +DV+S+GV+  EIVS G   T Y      +    L   Y L++ 
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--TPYCGMTCAELYEKLPQGYRLEKP 263

Query: 864 ----EEIY 867
               +E+Y
Sbjct: 264 LNCDDEVY 271

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  153 bits (389), Expect = 5e-42
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 26/203 (12%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
           ++G G FG V  G       +AVK +   S S     EF  E   +    HP LVK YG 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71

Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLAYLHED 758
           C +   + +V EY+ N CL          Y       L+     ++C  +  G+A+L   
Sbjct: 72  CSKEYPIYIVTEYISNGCLL--------NYLRSHGKGLEPSQLLEMCYDVCEGMAFL--- 120

Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT---IGYMAPEYA 815
              + +HRD+   N L+D+DL  K+SDFG+ +   +D+        GT   + + APE  
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVF 177

Query: 816 MRGYLTSKADVYSFGVVTLEIVS 838
                +SK+DV++FG++  E+ S
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFS 200

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  155 bits (393), Expect = 7e-42
 Identities = 57/202 (28%), Positives = 105/202 (51%), Gaps = 15/202 (7%)

Query: 644 NKVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 697
             +G G FG+VYKG+           +A+K+L  + S + N+E ++E  ++++  +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           +L G C+  + + L+ + M   CL   +     E++  +        C+ IA+G+ YL  
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYL-- 133

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAM 816
               ++VHRD+   NVL+    + KI+DFGLAKL   ++           I +MA E  +
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 817 RGYLTSKADVYSFGVVTLEIVS 838
               T ++DV+S+GV   E+++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMT 214

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  152 bits (387), Expect = 2e-41
 Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 18/203 (8%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
           +G+G +G VY G  LS+   IA+K++  +  + ++    EI +    +H N+V+  G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 705 EGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
           E   + +  E +    LS   R+ +G      LK +  T       I  GL YLH++   
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWG-----PLKDNEQTIGFYTKQILEGLKYLHDN--- 141

Query: 762 KIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE---YAMR 817
           +IVHRDIK  NVL++      KISDFG +K          T   GT+ YMAPE      R
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPR 200

Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
           GY    AD++S G   +E+ +GK
Sbjct: 201 GY-GKAADIWSLGCTIIEMATGK 222

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  153 bits (390), Expect = 2e-41
 Identities = 63/249 (25%), Positives = 102/249 (40%), Gaps = 28/249 (11%)

Query: 644 NKVGEGGFGSVYKGILSD------GTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 695
             +G G FG V +              +AVK L S+         ++E+  M    QH N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRK---KICI 746
           +V L G C  G  +L++ EY     L         +   D  + +     + +       
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAG 805
            +A+G+A+L   +    +HRD+   NVLL     AKI DFGLA  +  +    +      
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228

Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSN-TNYRPNEDFVYLLDWAYVLQE 863
            + +MAPE       T ++DV+S+G++  EI S G +       N  F  L+   Y + +
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ 288

Query: 864 -----EEIY 867
                + IY
Sbjct: 289 PAFAPKNIY 297

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  153 bits (389), Expect = 3e-41
 Identities = 61/202 (30%), Positives = 108/202 (53%), Gaps = 15/202 (7%)

Query: 645 KVGEGGFGSVYKGILSDGTV-----IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 698
            +G G FG VYKG+L   +      +A+K L +  + +   +F+ E G++    H N+++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
           L G   +   ++++ EYM+N  L +  F ++ +    +       +  GIA G+ YL   
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSV--LQLVGMLRGIAAGMKYL--- 163

Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAM 816
           + +  VHRD+   N+L++ +L  K+SDFGL+++ E+D     T   G   I + APE   
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 817 RGYLTSKADVYSFGVVTLEIVS 838
               TS +DV+SFG+V  E+++
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMT 245

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  157 bits (399), Expect = 3e-41
 Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 13/222 (5%)

Query: 644 NKVGEGGFGSVYKGIL-SDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           +K+G G +G VY+G+       +AVK L   +   +   EF+ E  ++   +HPNLV+L 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 282

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G C       ++ E+M    L    + ++   R ++       +   I+  + YL    +
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLD--YLRECN-RQEVSAVVLLYMATQISSAMEYL---EK 336

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
              +HR++   N L+ ++   K++DFGL++L   D           I + APE       
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396

Query: 821 TSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
           + K+DV++FGV+  EI + G S            LL+  Y +
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 438

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  152 bits (385), Expect = 4e-41
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 16/204 (7%)

Query: 644 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 698
             +G+G FG VY G   D        A+K L      Q    F+ E  ++    HPN++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 699 LYGCCVEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           L G  +       ++  YM +  L +  F +  +    +         + +ARG+ YL  
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTV--KDLISFGLQVARGMEYL-- 140

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT--IGYMAPEY 814
            +  K VHRD+   N +LD+    K++DFGLA+ + + +   +         + + A E 
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199

Query: 815 AMRGYLTSKADVYSFGVVTLEIVS 838
                 T+K+DV+SFGV+  E+++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  152 bits (386), Expect = 4e-41
 Identities = 77/261 (29%), Positives = 117/261 (44%), Gaps = 44/261 (16%)

Query: 644 NKVGEGGFGSVYKGILSDG------TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNL 696
             +GEG FG V K            T +AVK L  + S    R+ ++E  ++    HP++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRK-------- 742
           +KLYG C +   LLL+ EY K   L      SR +           +  +          
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 743 -----KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED- 795
                     I++G+ YL   + +K+VHRD+   N+L+ +    KISDFGL+  +YEED 
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 796 -KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY--RPNEDF 851
                  RI   + +MA E       T+++DV+SFGV+  EIV+ G     Y   P E  
Sbjct: 206 YVKRSQGRIP--VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG--NPYPGIPPERL 261

Query: 852 VYLLDWAYVLQE-----EEIY 867
             LL   + ++      EE+Y
Sbjct: 262 FNLLKTGHRMERPDNCSEEMY 282

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  151 bits (384), Expect = 4e-41
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 18/204 (8%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
           ++G G F +VYKG+       +A  +      ++   + F  E  M+   QHPN+V+ Y 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 702 CCV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
                      ++LV E M +  L   +      ++  +     +  C  I +GL +LH 
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFK-VMKIKVLRSWCRQILKGLQFLHT 147

Query: 758 DSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
            +   I+HRD+K  N+ +     + KI D GLA L           + GT  +MAPE   
Sbjct: 148 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYE 203

Query: 817 RGYLTSKADVYSFGVVTLEIVSGK 840
             Y     DVY+FG+  LE+ + +
Sbjct: 204 EKY-DESVDVYAFGMCMLEMATSE 226

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  151 bits (383), Expect = 5e-41
 Identities = 62/196 (31%), Positives = 94/196 (47%), Gaps = 14/196 (7%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
             +G+G FG V  G      V AVK +  K+    + F+ E  +++  +H NLV+L G  
Sbjct: 27  QTIGKGEFGDVMLGDYRGNKV-AVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 704 VEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
           VE    L +V EYM    L    + +    R  L      K  + +   + YL       
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVD--YLRSRG-RSVLGGDCLLKFSLDVCEAMEYL---EGNN 137

Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 822
            VHRD+   NVL+ +D  AK+SDFGL K  E   T  + ++   + + APE       ++
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFST 193

Query: 823 KADVYSFGVVTLEIVS 838
           K+DV+SFG++  EI S
Sbjct: 194 KSDVWSFGILLWEIYS 209

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  152 bits (385), Expect = 5e-41
 Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 30/243 (12%)

Query: 644 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 698
             +G G FG VY G L D        AVK L          +F+ E  ++    HPN++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 699 LYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLA 753
           L G C+      L+V  YMK+  L          +                 + +A+G+ 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDL--------RNFIRNETHNPTVKDLIGFGLQVAKGMK 142

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT--IGYM 810
           YL      K VHRD+   N +LD+    K++DFGLA+ +Y+++   +  +      + +M
Sbjct: 143 YLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199

Query: 811 APEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQE-----E 864
           A E       T+K+DV+SFGV+  E+++ G          D    L     L +     +
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 259

Query: 865 EIY 867
            +Y
Sbjct: 260 PLY 262

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  151 bits (383), Expect = 5e-41
 Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 18/200 (9%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
            ++G G FG V+ G  +  T +AVK L   S S      F+ E  ++   QH  LV+LY 
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYA 75

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              +   + ++ EYM+N  L    F K     +KL       +   IA G+A++      
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVD--FLKTPS-GIKLTINKLLDMAAQIAEGMAFI---EER 128

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT---IGYMAPEYAMRG 818
             +HRD++ +N+L+   L+ KI+DFGLA+L E++     T   G    I + APE    G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYG 185

Query: 819 YLTSKADVYSFGVVTLEIVS 838
             T K+DV+SFG++  EIV+
Sbjct: 186 TFTIKSDVWSFGILLTEIVT 205

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  152 bits (386), Expect = 6e-41
 Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 14/202 (6%)

Query: 644 NKVGEGGFGSVYKGIL----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 698
             +G G  G V  G L         +A+K L +  + +  R+F++E  ++    HPN+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
           L G    G   ++V EYM+N  L    F +  + +  +       +  G+  G+ YL   
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTI--MQLVGMLRGVGAGMRYL--- 167

Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAM 816
           S +  VHRD+   NVL+D +L  K+SDFGL+++ E+D     T   G   I + APE   
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 817 RGYLTSKADVYSFGVVTLEIVS 838
               +S +DV+SFGVV  E+++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  152 bits (387), Expect = 7e-41
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 34/224 (15%)

Query: 644 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 696
             +GEG FG V++            T++AVK L  + S     +F  E  +++   +PN+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCL-----------SRAIFGKDTEYRLKLDWPTRK--- 742
           VKL G C  G  + L++EYM    L             ++   D   R ++  P      
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 743 -----KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED- 795
                 I   +A G+AYL   S  K VHRD+ T N L+ +++  KI+DFGL+  +Y  D 
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 796 -KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            K   +  I   I +M PE       T+++DV+++GVV  EI S
Sbjct: 230 YKADGNDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  151 bits (383), Expect = 1e-40
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 28/218 (12%)

Query: 644 NKVGEGGFGSVYKGIL------SDGTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 695
             +G G FG V +         +    +AVK L    +   +R  ++E+  +I    H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 696 LVKLYGCC-VEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK--------K 743
           +V L G C   G  L+++ E+ K   LS   R+   +   Y++  +   +          
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHIS 800
               +A+G+ +L   +  K +HRD+   N+LL +    KI DFGLA  +Y++        
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209

Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
            R+   + +MAPE       T ++DV+SFGV+  EI S
Sbjct: 210 ARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  151 bits (384), Expect = 1e-40
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 29/219 (13%)

Query: 644 NKVGEGGFGSVYKGILSD--------GTVIAVKQLSSK-SRQGNREFVNEIG-MISAQQH 693
             +GEG FG V                  +AVK L    + +   + V+E+  M    +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK-------- 742
            N++ L G C +   L ++ EY     L    RA      EY   ++    +        
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHI 799
                +ARG+ YL   +  K +HRD+   NVL+ ++   KI+DFGLA  +   D  K   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217

Query: 800 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           + R+   + +MAPE       T ++DV+SFGV+  EI +
Sbjct: 218 NGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  151 bits (383), Expect = 1e-40
 Identities = 64/250 (25%), Positives = 111/250 (44%), Gaps = 35/250 (14%)

Query: 644 NKVGEGGFGSVYKGILSDG----TVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLV 697
             +G+G FGSV +  L         +AVK L     +     EF+ E   +    HP++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 698 KLYGCCVEG------NQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGI 748
           KL G  +           +++  +MK+  L     A    +  + L L   T  +  + I
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL--QTLVRFMVDI 146

Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHISTRIAG 805
           A G+ YL   S    +HRD+   N +L +D+   ++DFGL+ K+Y  D  +   ++++  
Sbjct: 147 ACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP- 202

Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY--RPNEDFVYLLDWAYVLQ 862
            + ++A E       T  +DV++FGV   EI++ G+  T Y    N +    L     L+
Sbjct: 203 -VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ--TPYAGIENAEIYNYLIGGNRLK 259

Query: 863 E-----EEIY 867
           +     EE+Y
Sbjct: 260 QPPECMEEVY 269

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  151 bits (383), Expect = 1e-40
 Identities = 66/220 (30%), Positives = 91/220 (41%), Gaps = 25/220 (11%)

Query: 644 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 696
             +G G FG VY+G +S          +AVK L    S Q   +F+ E  +IS   H N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           V+  G  ++     ++ E M    L    R    + ++    L       +   IA G  
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQ 154

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAK-LYEEDKTHISTRIAGTIGY 809
           YL        +HRDI   N LL        AKI DFG+A+ +Y              + +
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211

Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVS-------GKSN 842
           M PE  M G  TSK D +SFGV+  EI S        KSN
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  150 bits (380), Expect = 2e-40
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 14/200 (7%)

Query: 645 KVGEGGFGSVYKGILSDG---TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           ++G G FGSV +G+         +A+K L     +    E + E  ++    +P +V+L 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G C +   L+LV E      L + + GK      ++      ++   ++ G+ YL     
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYL---EE 128

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAMRG 818
              VHRD+   NVLL     AKISDFGL+K    D ++ + R AG   + + APE     
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188

Query: 819 YLTSKADVYSFGVVTLEIVS 838
             +S++DV+S+GV   E +S
Sbjct: 189 KFSSRSDVWSYGVTMWEALS 208

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  150 bits (381), Expect = 2e-40
 Identities = 68/249 (27%), Positives = 116/249 (46%), Gaps = 34/249 (13%)

Query: 644 NKVGEGGFGSVYKGILSDG----TVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLV 697
             +GEG FGSV +G L         +AVK +   + S++   EF++E   +    HPN++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 698 KLYGCCVEGN-----QLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIA 749
           +L G C+E +     + +++  +MK   L         +     + L   T  K  + IA
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL--QTLLKFMVDIA 157

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED--KTHISTRIAGT 806
            G+ YL   S    +HRD+   N +L  D+   ++DFGL+K +Y  D  +     ++   
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP-- 212

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY--RPNEDFVYLLDWAYVLQE 863
           + ++A E       TSK+DV++FGV   EI + G   T Y    N +    L   + L++
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM--TPYPGVQNHEMYDYLLHGHRLKQ 270

Query: 864 -----EEIY 867
                +E+Y
Sbjct: 271 PEDCLDELY 279

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  154 bits (390), Expect = 2e-40
 Identities = 65/219 (29%), Positives = 112/219 (51%), Gaps = 9/219 (4%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
            K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
            E   + +V EYM    L   + G+       L  P    +   IA G+AY+    R+  
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYV---ERMNY 301

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           VHRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

Query: 824 ADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
           +DV+SFG++  E+ + G+       N + +  ++  Y +
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 400

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  158 bits (401), Expect = 2e-40
 Identities = 53/270 (19%), Positives = 96/270 (35%), Gaps = 9/270 (3%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 123
            L        ++   L  LD+  N ++         L  L  L++  N LS    K    
Sbjct: 36  QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95

Query: 124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 183
            T L  L +  N           K  NL  L LS N  +        +L NL +L +S+N
Sbjct: 96  CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155

Query: 184 NFSGKIPEFIG--KWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA---- 237
                  E +       ++KL +  + ++   P    A+  L  L +++++   S     
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215

Query: 238 FPKLDKMNLKTLILTKCLIHGEIPDYIGDM--TKLKNIDLSFNNLTGGIPTTFEKLAKTN 295
             +L   +++ L L+   +          +  T L  +DLS+NNL      +F  L +  
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275

Query: 296 FMYLTGNKLTGPVPKYIFNSNKNVDISLNN 325
           + +L  N +       +        ++L  
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  152 bits (387), Expect = 1e-38
 Identities = 53/293 (18%), Positives = 90/293 (30%), Gaps = 25/293 (8%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGS----FSPQWASLQLVELSVMGNRLSGPFPKV 120
            +    P     +  L  L L+   L  S       + A+  +  LS+  ++LS      
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241

Query: 121 LTN--ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDL 178
                 T L  L +  N            L  L+   L  N+        L  L N+  L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301

Query: 179 R---------ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL--- 226
                     IS  +            K ++ L+++ + + G      + L +L  L   
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361

Query: 227 --RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 284
               S    +   F  L    L  L LTK  I     D    +  L+ +DL  N +   +
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421

Query: 285 P-TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFTWESSDP 333
               +  L     +YL+ NK    + +  F    +   + +         S P
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQ-LTRNSFALVPSLQRLMLRRVALKNVDSSP 473

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  149 bits (378), Expect = 2e-37
 Identities = 50/283 (17%), Positives = 94/283 (33%), Gaps = 20/283 (7%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSP-----QWASLQLVELSVMGNRLSGPFPK 119
           ++ G      + L  LK L LS +  +            A   L  L++  N++S     
Sbjct: 340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399

Query: 120 VLTNITTLKNLSIEGNLFTGSIPPD-IRKLINLQKLILSSNSFTGELPAELTKLTNLNDL 178
             + +  L+ L +  N     +     R L N+ ++ LS N +          + +L  L
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459

Query: 179 RISDNNFSG--KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDL 231
            +           P      + +  L +  +++       +  L  L  L      ++ L
Sbjct: 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL 519

Query: 232 KGSESAFPKLDKM----NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 287
               +    +  +    +L  L L          +   D+ +LK IDL  NNL     + 
Sbjct: 520 WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579

Query: 288 FEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 327
           F        + L  N +T    K    + +N   +D+  N F 
Sbjct: 580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  140 bits (355), Expect = 1e-34
 Identities = 55/289 (19%), Positives = 108/289 (37%), Gaps = 25/289 (8%)

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPK 119
           +   +L          L+ L+ L++  N + G  S  +  L  L  LS+  +  S     
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371

Query: 120 VLT----NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA-ELTKLTN 174
             T      + L  L++  N  +         L +L+ L L  N    EL   E   L N
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431

Query: 175 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG--PIPASISALTSLTDLRISD-- 230
           + ++ +S N +             +Q+L ++  +L+     P+    L +LT L +S+  
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491

Query: 231 LKG-SESAFPKLDKMNLKTLILTKCLIH--------GEIPDYIGDMTKLKNIDLSFNNLT 281
           +   ++     L+   L+ L L    +         G    ++  ++ L  ++L  N   
Sbjct: 492 IANINDDMLEGLE--KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD 549

Query: 282 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 327
                 F+ L +   + L  N L   +P  +FN+  +   +++  N  T
Sbjct: 550 EIPVEVFKDLFELKIIDLGLNNLNT-LPASVFNNQVSLKSLNLQKNLIT 597

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  138 bits (349), Expect = 6e-34
 Identities = 50/262 (19%), Positives = 85/262 (32%), Gaps = 18/262 (6%)

Query: 79  YLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFT 138
             +  D S   LT    P      +  L++  N+L        T  + L +L +  N  +
Sbjct: 5   SHEVADCSHLKLTQV--PDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62

Query: 139 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 198
              P   +KL  L+ L L  N  +          TNL +L +  N+          K K 
Sbjct: 63  KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122

Query: 199 IQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTK 253
           +  L +  + L      +   L +L +L     +I  L             +LK L L+ 
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL--KSEELDIFANSSLKKLELSS 180

Query: 254 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF---EKLAKTNFMYLTGNKLTGPVPK 310
             I    P     + +L  + L+   L   +               + L+ ++L+     
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST-TSN 239

Query: 311 YIFNSNKNV-----DISLNNFT 327
             F   K       D+S NN  
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLN 261

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 86.2 bits (214), Expect = 2e-17
 Identities = 38/207 (18%), Positives = 71/207 (34%), Gaps = 18/207 (8%)

Query: 65  NLTG--TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLS------- 114
            L    + P+    LR L  LDLS N +          L +L  L +  N L+       
Sbjct: 465 ALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHAN 524

Query: 115 -GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 173
            G     L  ++ L  L++E N F        + L  L+ + L  N+      +      
Sbjct: 525 PGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQV 584

Query: 174 NLNDLRISDNNFSGKIPE-FIGKWKKIQKLHIQGSSLEGPIPASISALTS---LTDLRIS 229
           +L  L +  N  +    + F   ++ + +L ++ +  +     SI+   +    T   I 
Sbjct: 585 SLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE-SIAWFVNWINETHTNIP 643

Query: 230 DLKGS-ESAFP-KLDKMNLKTLILTKC 254
           +L        P       ++    + C
Sbjct: 644 ELSSHYLCNTPPHYHGFPVRLFDTSSC 670

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  150 bits (382), Expect = 2e-40
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 15/202 (7%)

Query: 644 NKVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 697
             +G G FG+V+KG+           + +K +     RQ  +   + +  I +  H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           +L G C  G+ L LV +Y+    L      +     L           + IA+G+ YL  
Sbjct: 79  RLLGLC-PGSSLQLVTQYLPLGSLLD--HVRQHRGALGP--QLLLNWGVQIAKGMYYL-- 131

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAM 816
                +VHR++   NVLL      +++DFG+A L   D   +    A T I +MA E   
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 817 RGYLTSKADVYSFGVVTLEIVS 838
            G  T ++DV+S+GV   E+++
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  152 bits (385), Expect = 2e-40
 Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 14/202 (6%)

Query: 644 NKVGEGGFGSVYKGIL----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 698
             VG G FG V  G L         +A+K L    + +  R+F+ E  ++    HPN+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
           L G   +   +++V EYM+N  L    F +  + +  +       +  GIA G+ YL   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTV--IQLVGMLRGIASGMKYL--- 163

Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAM 816
           S +  VHRD+   N+L++ +L  K+SDFGL ++ E+D     T   G   I + +PE   
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 817 RGYLTSKADVYSFGVVTLEIVS 838
               TS +DV+S+G+V  E++S
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  153 bits (388), Expect = 4e-40
 Identities = 63/199 (31%), Positives = 94/199 (47%), Gaps = 20/199 (10%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
             +G+G FG V  G      V AVK +  K+    + F+ E  +++  +H NLV+L G  
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKV-AVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 704 VEGN-QLLLVYEYMKNNCLSRAIFGKD---TEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
           VE    L +V EYM    L       D   +  R  L      K  + +   + YL    
Sbjct: 256 VEEKGGLYIVTEYMAKGSL------VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---E 306

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY 819
               VHRD+   NVL+ +D  AK+SDFGL K  E   T  + ++   + + APE      
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKK 362

Query: 820 LTSKADVYSFGVVTLEIVS 838
            ++K+DV+SFG++  EI S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  149 bits (379), Expect = 4e-40
 Identities = 52/217 (23%), Positives = 84/217 (38%), Gaps = 25/217 (11%)

Query: 644 NKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIG-MISAQQHPN 695
             +G G FG V +              +AVK L   +    R   ++E+  +     H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRK------- 742
           +V L G C  G   L++ EY     L       R  F         ++            
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIST 801
                +A+G+A+L   +    +HRD+   N+LL      KI DFGLA  +  +    +  
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
                + +MAPE       T ++DV+S+G+   E+ S
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  151 bits (383), Expect = 4e-40
 Identities = 69/256 (26%), Positives = 110/256 (42%), Gaps = 39/256 (15%)

Query: 644 NKVGEGGFGSVYKGILSD--------GTVIAVKQLSSK-SRQGNREFVNEIG-MISAQQH 693
             +GEG FG V                  +AVK L    + +   + V+E+  M    +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK-------- 742
            N++ L G C +   L ++ EY     L    RA      EY   ++    +        
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHI 799
                +ARG+ YL   +  K +HRD+   NVL+ ++   KI+DFGLA  +   D  K   
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263

Query: 800 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY--RPNEDFVYLLD 856
           + R+   + +MAPE       T ++DV+SFGV+  EI + G   + Y   P E+   LL 
Sbjct: 264 NGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEELFKLLK 319

Query: 857 WAYVLQE-----EEIY 867
             + + +      E+Y
Sbjct: 320 EGHRMDKPANCTNELY 335

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  149 bits (379), Expect = 6e-40
 Identities = 57/202 (28%), Positives = 105/202 (51%), Gaps = 15/202 (7%)

Query: 644 NKVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 697
             +G G FG+VYKG+           +A+K+L  + S + N+E ++E  ++++  +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           +L G C+  + + L+ + M   CL   +     E++  +        C+ IA+G+ YL  
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYL-- 133

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAM 816
               ++VHRD+   NVL+    + KI+DFGLAKL   ++           I +MA E  +
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 817 RGYLTSKADVYSFGVVTLEIVS 838
               T ++DV+S+GV   E+++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMT 214

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  148 bits (375), Expect = 6e-40
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 13/199 (6%)

Query: 645 KVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 699
            +GEG FG V++GI          +A+K   +  S     +F+ E   +    HP++VKL
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
            G   E N + ++ E      L    F +  +Y L L   +       ++  LAYL    
Sbjct: 82  IGVITE-NPVWIIMELCTLGELRS--FLQVRKYSLDL--ASLILYAYQLSTALAYL---E 133

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY 819
             + VHRDI   NVL+  +   K+ DFGL++  E+   + +++    I +MAPE      
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193

Query: 820 LTSKADVYSFGVVTLEIVS 838
            TS +DV+ FGV   EI+ 
Sbjct: 194 FTSASDVWMFGVCMWEILM 212

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  154 bits (390), Expect = 7e-40
 Identities = 66/222 (29%), Positives = 111/222 (50%), Gaps = 15/222 (6%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
            K+G+G FG V+ G  +  T +A+K L   +      F+ E  ++   +H  LV+LY   
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKD---TEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
            E   + +V EYM    L       D    E    L  P    +   IA G+AY+    R
Sbjct: 332 SE-EPIYIVTEYMSKGSL------LDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ER 381

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 820
           +  VHRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ G  
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441

Query: 821 TSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
           T K+DV+SFG++  E+ + G+       N + +  ++  Y +
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 483

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  147 bits (374), Expect = 8e-40
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)

Query: 645 KVGEGGFGSVYKGIL----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 699
            +GEG FG VY+G+      +   +AVK      +     +F++E  ++    HP++VKL
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
            G   E     ++ E      L    + +  +  LK+   T     + I + +AYL    
Sbjct: 79  IGII-EEEPTWIIMELYPYGELGH--YLERNKNSLKV--LTLVLYSLQICKAMAYL---E 130

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT---IGYMAPEYAM 816
            I  VHRDI   N+L+      K+ DFGL++  E++      + + T   I +M+PE   
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESIN 187

Query: 817 RGYLTSKADVYSFGVVTLEIVS 838
               T+ +DV+ F V   EI+S
Sbjct: 188 FRRFTTASDVWMFAVCMWEILS 209

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  147 bits (374), Expect = 1e-39
 Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 29/211 (13%)

Query: 645 KVGEGGFGSVYKGIL--------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 696
            +G+G F  ++KG+            T + +K L    R  +  F     M+S   H +L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           V  YG CV G++ +LV E++K   L    + K  +  + +    + ++   +A  + +L 
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNCINI--LWKLEVAKQLAAAMHFL- 129

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLN--------AKISDFGLAKLYEEDKTHISTRIAGTIG 808
                 ++H ++   N+LL ++ +         K+SD G++            +    I 
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---ILQER--IP 182

Query: 809 YMAPE-YAMRGYLTSKADVYSFGVVTLEIVS 838
           ++ PE       L    D +SFG    EI S
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  150 bits (380), Expect = 1e-39
 Identities = 62/243 (25%), Positives = 103/243 (42%), Gaps = 30/243 (12%)

Query: 644 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 698
             +G G FG VY G L D        AVK L          +F+ E  ++    HPN++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 699 LYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLA 753
           L G C+      L+V  YMK+  L          +                 + +A+G+ 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLR--------NFIRNETHNPTVKDLIGFGLQVAKGMK 206

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT--IGYM 810
           +L   +  K VHRD+   N +LD+    K++DFGLA+ +Y+++   +  +      + +M
Sbjct: 207 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263

Query: 811 APEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQE-----E 864
           A E       T+K+DV+SFGV+  E+++ G          D    L     L +     +
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 323

Query: 865 EIY 867
            +Y
Sbjct: 324 PLY 326

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  149 bits (379), Expect = 1e-39
 Identities = 66/236 (27%), Positives = 94/236 (39%), Gaps = 23/236 (9%)

Query: 644 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 696
             +G G FG VY+G +S          +AVK L    S Q   +F+ E  +IS   H N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           V+  G  ++     ++ E M    L    R            L       +   IA G  
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAK-LYEEDKTHISTRIAGTIGY 809
           YL        +HRDI   N LL        AKI DFG+A+ +Y              + +
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252

Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY--RPNEDFVYLLDWAYVLQ 862
           M PE  M G  TSK D +SFGV+  EI S G     Y  + N++ +  +     + 
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY--MPYPSKSNQEVLEFVTSGGRMD 306

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  148 bits (375), Expect = 1e-39
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 21/213 (9%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL------SSKSRQGNREFVNEIGMISA 690
            NF    K+G G F  VY+   L DG  +A+K++       +K+R    + + EI ++  
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQ 88

Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGI 748
             HPN++K Y   +E N+L +V E      LSR I  F K       +   T  K  + +
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL---IPERTVWKYFVQL 145

Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
              L ++H     +++HRDIK +NV +      K+ D GL + +    T   + + GT  
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 201

Query: 809 YMAPE-YAMRGYLTSKADVYSFGVVTLEIVSGK 840
           YM+PE     GY   K+D++S G +  E+ + +
Sbjct: 202 YMSPERIHENGY-NFKSDIWSLGCLLYEMAALQ 233

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  147 bits (374), Expect = 1e-39
 Identities = 57/211 (27%), Positives = 83/211 (39%), Gaps = 23/211 (10%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQ-QH 693
           +F   +++G G +G V+K     DG + AVK+ S    +G ++    + E+G      QH
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNC---LSRAIFGKDTEYRLKLDWPTRKKICIGIAR 750
           P  V+L     EG  L L  E     C   L +        +   L              
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL----CGPSLQQHC----EAWGASLPEAQVWGYLRDTLL 168

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 810
            LA+LH      +VH D+K +N+ L      K+ DFGL                G   YM
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYM 223

Query: 811 APEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           APE     Y  + ADV+S G+  LE+     
Sbjct: 224 APELLQGSY-GTAADVFSLGLTILEVACNME 253

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  148 bits (375), Expect = 3e-39
 Identities = 55/222 (24%), Positives = 82/222 (36%), Gaps = 30/222 (13%)

Query: 644 NKVGEGGFGSVYKGILSDG------TVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 695
             +G G FG V                +AVK L            ++E+  M     H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRK------- 742
           +V L G C     + L++EY     L       R  F +D            +       
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 743 -----KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDK 796
                     +A+G+ +L        VHRD+   NVL+      KI DFGLA  +  +  
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
             +       + +MAPE    G  T K+DV+S+G++  EI S
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  146 bits (371), Expect = 3e-39
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 22/204 (10%)

Query: 645 KVGEGGFGSVYKGIL---SDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKL 699
           ++G G FG+V KG          +AVK L   +       E + E  ++    +P +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY---RLKLDWPTRKKICIGIARGLAYLH 756
            G C E    +LV E  +   L+        +Y      +      ++   ++ G+ YL 
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLN--------KYLQQNRHVKDKNIIELVHQVSMGMKYL- 133

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 814
                  VHRD+   NVLL     AKISDFGL+K    D+ +   +  G   + + APE 
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191

Query: 815 AMRGYLTSKADVYSFGVVTLEIVS 838
                 +SK+DV+SFGV+  E  S
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  149 bits (377), Expect = 3e-39
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 29/219 (13%)

Query: 644 NKVGEGGFGSVYKGIL--------SDGTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQH 693
             +GEG FG V             +  T +AVK L S  + +   + ++E+  M    +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIG--- 747
            N++ L G C +   L ++ EY     L    +A      EY         +++      
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 748 -----IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHI 799
                +ARG+ YL   +  K +HRD+   NVL+ +D   KI+DFGLA  ++  D  K   
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251

Query: 800 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           + R+   + +MAPE       T ++DV+SFGV+  EI +
Sbjct: 252 NGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  150 bits (381), Expect = 4e-39
 Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 8/195 (4%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
            K+G G FG V+    +  T +AVK +   S      F+ E  ++   QH  LVKL+   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
            +   + ++ E+M    L    F K  E   K   P        IA G+A++    +   
Sbjct: 253 TK-EPIYIITEFMAKGSLLD--FLKSDEGS-KQPLPKLIDFSAQIAEGMAFI---EQRNY 305

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 823
           +HRD++ +N+L+   L  KI+DFGLA++ E+++          I + APE    G  T K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365

Query: 824 ADVYSFGVVTLEIVS 838
           +DV+SFG++ +EIV+
Sbjct: 366 SDVWSFGILLMEIVT 380

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  146 bits (370), Expect = 4e-39
 Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 17/203 (8%)

Query: 645 KVGEGGFGSVYKGIL----SDGTVIAVKQL---SSKSRQGNREFVNEIGMISAQQHPNLV 697
           K+G+G FG V +G           +AVK L        +   +F+ E+  + +  H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           +LYG  +    + +V E      L      +  +    L   T  +  + +A G+ YL  
Sbjct: 85  RLYGVVLT-PPMKMVTELAPLGSLLD--RLRKHQGHFLL--GTLSRYAVQVAEGMGYL-- 137

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYA 815
               + +HRD+   N+LL      KI DFGL +   ++  H   +        + APE  
Sbjct: 138 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196

Query: 816 MRGYLTSKADVYSFGVVTLEIVS 838
                +  +D + FGV   E+ +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  147 bits (373), Expect = 5e-39
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 12/207 (5%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 694
             +    K+GEG FG         DG    +K+  +S  S +   E   E+ +++  +HP
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+V+      E   L +V +Y +   L + I  +                 + I   L +
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL---FQEDQILDWFVQICLALKH 140

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE- 813
           +H+    KI+HRDIK+ N+ L KD   ++ DFG+A++           I GT  Y++PE 
Sbjct: 141 VHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEI 196

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGK 840
              + Y  +K+D+++ G V  E+ + K
Sbjct: 197 CENKPY-NNKSDIWALGCVLYELCTLK 222

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  152 bits (386), Expect = 7e-39
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)

Query: 645 KVGEGGFGSVYKGIL--SDGTV-IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 700
           ++G G FGSV +G+       + +A+K L     +    E + E  ++    +P +V+L 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 701 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
           G C +   L+LV E      L + +       R ++      ++   ++ G+ YL     
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYL---EE 454

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAMRG 818
              VHR++   NVLL     AKISDFGL+K    D ++ + R AG   + + APE     
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514

Query: 819 YLTSKADVYSFGVVTLEIVS 838
             +S++DV+S+GV   E +S
Sbjct: 515 KFSSRSDVWSYGVTMWEALS 534

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174

 Score =  140 bits (355), Expect = 1e-38
 Identities = 36/207 (17%), Positives = 63/207 (30%), Gaps = 40/207 (19%)

Query: 371 ADQYHYTLHINCGGAKIN-TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLD 429
           AD+  +   +N GG          Y  D       +    G+   +      +  + +  
Sbjct: 3   ADKVIW--AVNAGGESHVDVHGIHYRKD------PLEGRVGRASDYGMKLPILRSNPE-- 52

Query: 430 NYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTF 489
                           D  LY+T R +  S  Y       G Y + L FAE        F
Sbjct: 53  ----------------DQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFAE------VYF 90

Query: 490 NSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHL---YWAGRG 546
               +++FD+ +    V KD +I D  G       +  P  +    L +      + G+ 
Sbjct: 91  AQSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGEVSTFTGKL 149

Query: 547 TTGIPLRGTYGPLISAISVKSNFKPPV 573
           +          P + A+ +    K   
Sbjct: 150 SVEFVKGYYDNPKVCALFI---MKGTA 173

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  145 bits (367), Expect = 1e-38
 Identities = 59/218 (27%), Positives = 112/218 (51%), Gaps = 17/218 (7%)

Query: 630 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 682
           L ++++  +  DP        K+G+G  G+VY  + ++ G  +A++Q++ + +      +
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65

Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
           NEI ++   ++PN+V      + G++L +V EY+    L+      D      +D     
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIA 119

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
            +C    + L +LH +  I   HRDIK+ N+LL  D + K++DFG       +++  ST 
Sbjct: 120 AVCRECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176

Query: 803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           + GT  +MAPE   R     K D++S G++ +E++ G+
Sbjct: 177 V-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  145 bits (368), Expect = 2e-38
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 29/208 (13%)

Query: 644 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
            +VG G FG V++      G   AVK++  +  +     V E+   +    P +V LYG 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118

Query: 703 CVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
             EG  + +  E ++       + +   G   E                   GL YLH  
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQ--MGCLPE-------DRALYYLGQALEGLEYLHTR 169

Query: 759 SRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTR----IAGTIGYMAPE 813
              +I+H D+K  NVLL  D   A + DFG A   + D    S      I GT  +MAPE
Sbjct: 170 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226

Query: 814 YAM-RGYLTSKADVYSFGVVTLEIVSGK 840
             M +    +K D++S   + L +++G 
Sbjct: 227 VVMGKPC-DAKVDIWSSCCMMLHMLNGC 253

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  144 bits (366), Expect = 2e-38
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 17/218 (7%)

Query: 630 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 682
              ++   +  DP        K+GEG  G V        G  +AVK +  + +Q      
Sbjct: 31  KAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF 90

Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
           NE+ ++   QH N+V++Y   + G +L ++ E+++   L+      D   +++L+     
Sbjct: 91  NEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT------DIVSQVRLNEEQIA 144

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
            +C  + + LAYLH    I   HRDIK+ ++LL  D   K+SDFG      +D     + 
Sbjct: 145 TVCEAVLQALAYLHAQGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201

Query: 803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           + GT  +MAPE   R    ++ D++S G++ +E+V G+
Sbjct: 202 V-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  149 bits (377), Expect = 1e-37
 Identities = 47/272 (17%), Positives = 95/272 (34%), Gaps = 17/272 (6%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV-LTN 123
            +        S     + L+L          P      L  L+   N+    F +V L +
Sbjct: 293 TIERVKD--FSYNFGWQHLELVNCKFGQF--PTLKLKSLKRLTFTSNKGGNAFSEVDLPS 348

Query: 124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 183
           +  L +LS  G  F G          +L+ L LS N     + +    L  L  L    +
Sbjct: 349 LEFL-DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS 406

Query: 184 NFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS--ESAF 238
           N             + +  L I  +          + L+SL  L+++    + +     F
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466

Query: 239 PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 298
            +L   NL  L L++C +    P     ++ L+ +++S NN        ++ L     + 
Sbjct: 467 TELR--NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 524

Query: 299 LTGNKLTGPVPKYIFNSNKN---VDISLNNFT 327
            + N +     + + +   +   ++++ N+F 
Sbjct: 525 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  133 bits (336), Expect = 2e-32
 Identities = 46/270 (17%), Positives = 95/270 (35%), Gaps = 15/270 (5%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLT--GSFSPQWASL-QLVELSVMGNRLSGPFPKVL 121
           +  G        L  L+ LDLSRN L+  G  S        L  L +  N +        
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 392

Query: 122 TNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 180
             +  L++L  + +         +   L NL  L +S              L++L  L++
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452

Query: 181 SDNNFSGKI-PEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG-SES 236
           + N+F     P+   + + +  L +    LE   P + ++L+SL  L +S          
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512

Query: 237 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDM-TKLKNIDLSFNNLTGGIPTT--FEKLAK 293
            +  L+  +L+ L  +   I       +    + L  ++L+ N+           + +  
Sbjct: 513 PYKCLN--SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKD 570

Query: 294 TNFMYLTGNKLTGPVPKYIFNSN-KNVDIS 322
              + +   ++    P         +++I+
Sbjct: 571 QRQLLVEVERMECATPSDKQGMPVLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  125 bits (315), Expect = 6e-30
 Identities = 40/214 (18%), Positives = 73/214 (34%), Gaps = 14/214 (6%)

Query: 125 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 184
            + KNL +  N               LQ L LS              L++L+ L ++ N 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 185 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSE--SAFPK 240
                         +QKL    ++L       I  L +L +L ++   ++  +    F  
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 241 LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKN----IDLSFNNLTGGIPTTFEKLAKTNF 296
           L   NL+ L L+   I       +  + ++      +DLS N +    P  F+++ + + 
Sbjct: 148 LT--NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHK 204

Query: 297 MYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 327
           + L  N  +  V K             + L  F 
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  124 bits (313), Expect = 1e-29
 Identities = 52/296 (17%), Positives = 91/296 (30%), Gaps = 51/296 (17%)

Query: 44  NVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQL 103
           N+T  C               N    +P  L      K LDLS                 
Sbjct: 9   NITYQCME------------LNFY-KIPDNLP--FSTKNLDLS----------------- 36

Query: 104 VELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTG 163
                  N L         +   L+ L +             + L +L  LIL+ N    
Sbjct: 37  ------FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90

Query: 164 ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTS 222
                 + L++L  L   + N +      IG  K +++L++  + ++   +P   S LT+
Sbjct: 91  LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150

Query: 223 LTDLRISD--LKG-SESAFPKLDKMNLK--TLILTKCLIHGEIPDYIGDMTKLKNIDLSF 277
           L  L +S   ++    +    L +M L   +L L+   ++  I        +L  + L  
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRN 209

Query: 278 NNLTGGIP-TTFEKLAKTNFMYLTGNKLTG-----PVPKYIFNSNKNVDISLNNFT 327
           N  +  +  T  + LA      L   +           K       N+ I      
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  114 bits (288), Expect = 1e-26
 Identities = 50/277 (18%), Positives = 84/277 (30%), Gaps = 44/277 (15%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQW----ASLQLVELSVMGNRLSGPFPKV 120
            +    P    ++R L +L L  N  + +         A L++  L +   R  G   K 
Sbjct: 188 PMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246

Query: 121 -LTNITTLKNLSIEGN------LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 173
             + +  L NL+IE         +   I      L N+    L S +         +   
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNF 304

Query: 174 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 233
               L + +  F       +   K++     +G         S   L SL  L +S    
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG-----NAFSEVDLPSLEFLDLSR--- 356

Query: 234 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 293
                                   G         T LK +DLSFN +   + + F  L +
Sbjct: 357 ------------------NGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ 397

Query: 294 TNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 327
              +    + L       +F S +N   +DIS  +  
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  149 bits (378), Expect = 1e-37
 Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 13/199 (6%)

Query: 645 KVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 699
            +GEG FG V++GI          +A+K   +  S     +F+ E   +    HP++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
            G   E N + ++ E      L    F +  ++ L L   +       ++  LAYL    
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRS--FLQVRKFSLDL--ASLILYAYQLSTALAYL---E 508

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY 819
             + VHRDI   NVL+  +   K+ DFGL++  E+   + +++    I +MAPE      
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568

Query: 820 LTSKADVYSFGVVTLEIVS 838
            TS +DV+ FGV   EI+ 
Sbjct: 569 FTSASDVWMFGVCMWEILM 587

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  139 bits (353), Expect = 5e-37
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 11/211 (5%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 694
            +++    +G G +G   K    SDG ++  K+    S +    +  V+E+ ++   +HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 695 NLVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           N+V+ Y   ++     L +V EY +   L+  I  K T+ R  LD     ++   +   L
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-TKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 753 AYLHE--DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 810
              H   D    ++HRD+K +NV LD   N K+ DFGLA++   D +   T + GT  YM
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYM 183

Query: 811 APE-YAMRGYLTSKADVYSFGVVTLEIVSGK 840
           +PE      Y   K+D++S G +  E+ +  
Sbjct: 184 SPEQMNRMSY-NEKSDIWSLGCLLYELCALM 213

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  138 bits (350), Expect = 1e-36
 Identities = 49/229 (21%), Positives = 86/229 (37%), Gaps = 35/229 (15%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQ-Q 692
           T  F    K+G G FGSV+K +   DG + A+K+           +  + E+   +   Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           H ++V+ +    E + +L+  EY     L+ AI                K + + + RGL
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY-FKEAELKDLLLQVGRGL 128

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKD-------------------LNAKISDFGLAKLYE 793
            Y+H      +VH DIK SN+ + +                    +  KI D G      
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 794 EDKTHISTRIAGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 840
             +        G   ++A E       +L  KAD+++  +  +     +
Sbjct: 186 SPQVEE-----GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAE 228

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  138 bits (349), Expect = 2e-36
 Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 31/222 (13%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 696
            +F     +G GGFG V+K     DG    +K++    +  N +   E+  ++   H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66

Query: 697 VKLYGCCVE----------------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 740
           V   GC                      L +  E+     L + I  +  E    LD   
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK---LDKVL 123

Query: 741 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 800
             ++   I +G+ Y+H     K+++RD+K SN+ L      KI DFGL    + D     
Sbjct: 124 ALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178

Query: 801 TRIAGTIGYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           TR  GT+ YM+PE  + + Y   + D+Y+ G++  E++    
Sbjct: 179 TRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCD 219

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  138 bits (350), Expect = 3e-36
 Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 17/218 (7%)

Query: 630 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 682
           L+++   +    P        K+GEG +GSVYK I    G ++A+KQ+  +S    +E +
Sbjct: 15  LKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEII 72

Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
            EI ++     P++VK YG   +   L +V EY     +S  I  +     L  D     
Sbjct: 73  KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIAT- 129

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
            I     +GL YLH   +I   HRDIK  N+LL+ + +AK++DFG+A    +     +T 
Sbjct: 130 -ILQSTLKGLEYLHFMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV 185

Query: 803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           I GT  +MAPE          AD++S G+  +E+  GK
Sbjct: 186 I-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  141 bits (356), Expect = 5e-36
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 27/235 (11%)

Query: 616 KELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR 675
            E    D +T +  + +I      F P + +G G  G++    + D   +AVK++  +  
Sbjct: 7   LEQDDGDEETSVVIVGKIS-----FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF 61

Query: 676 QGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL 734
                   E+  +  + +HPN+++ +    +     +  E      L   +  KD  +  
Sbjct: 62  SFAD---REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAAT-LQEYVEQKDFAHLG 117

Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-----DKDLNAKISDFGLA 789
                    +      GLA+LH    + IVHRD+K  N+L+        + A ISDFGL 
Sbjct: 118 LE----PITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170

Query: 790 KLYEEDKTHISTR--IAGTIGYMAPEY---AMRGYLTSKADVYSFGVVTLEIVSG 839
           K     +   S R  + GT G++APE      +   T   D++S G V   ++S 
Sbjct: 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  137 bits (346), Expect = 6e-36
 Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 36/231 (15%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 695
            ++F+    +G+G FG V K     D    A+K++   + +     ++E+ ++++  H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63

Query: 696 LVKLYGCCVEGNQ-------------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
           +V+ Y   +E                L +  EY +N  L   I        L        
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYW 119

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS-- 800
           ++   I   L+Y+H      I+HRD+K  N+ +D+  N KI DFGLAK        +   
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 801 -----------TRIAGTIGYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSG 839
                      T   GT  Y+A E     G+   K D+YS G++  E++  
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  137 bits (346), Expect = 6e-36
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 22/224 (9%)

Query: 630 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 682
            R+ +    + DP        ++G+G FG VYK      G + A K + +KS +   +++
Sbjct: 5   SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI 64

Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
            EI +++   HP +VKL G      +L ++ E+     +   +     E    L  P  +
Sbjct: 65  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM----LELDRGLTEPQIQ 120

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
            +C  +   L +LH    I   HRD+K  NVL+  + + +++DFG++    +      + 
Sbjct: 121 VVCRQMLEALNFLHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF 177

Query: 803 IAGTIGYMAPEYAMR------GYLTSKADVYSFGVVTLEIVSGK 840
           I GT  +MAPE  M        Y   KAD++S G+  +E+   +
Sbjct: 178 I-GTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIE 219

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  135 bits (342), Expect = 5e-35
 Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 14/211 (6%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL-SSKSRQGNREFVNEIGMI-SAQQHP 694
            +     ++G G +GSV K +    G ++AVK++ S+   +  ++ + ++ ++  +   P
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
            +V+ YG         +  E M +    +      +     +      KI +   + L +
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE- 813
           L E+   KI+HRDIK SN+LLD+  N K+ DFG++   +   +   TR AG   YMAPE 
Sbjct: 141 LKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTRDAGCRPYMAPER 196

Query: 814 ----YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                + +GY   ++DV+S G+   E+ +G+
Sbjct: 197 IDPSASRQGY-DVRSDVWSLGITLYELATGR 226

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  133 bits (337), Expect = 1e-34
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 15/214 (7%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPN 695
           ++++    +G G    V           +A+K+++ +  Q + +  + EI  +S   HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           +V  Y   V  ++L LV + +    +    + I  K       LD  T   I   +  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL-AKLYEE-DKTHISTR--IAGTIG 808
            YLH++ +I   HRD+K  N+LL +D + +I+DFG+ A L    D T    R    GT  
Sbjct: 135 EYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 809 YMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGK 840
           +MAPE   +  GY   KAD++SFG+  +E+ +G 
Sbjct: 192 WMAPEVMEQVRGY-DFKADIWSFGITAIELATGA 224

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  133 bits (336), Expect = 1e-34
 Identities = 51/211 (24%), Positives = 100/211 (47%), Gaps = 15/211 (7%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQ-QHP 694
           ++ +P  ++G G +G V K   +  G ++AVK++ ++ + Q  +  + ++ +       P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
             V  YG       + +  E M +  L +  + +  +    +      KI + I + L +
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDK-FYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE- 813
           LH  S++ ++HRD+K SNVL++     K+ DFG++              AG   YMAPE 
Sbjct: 125 LH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPER 180

Query: 814 ----YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                  +GY + K+D++S G+  +E+   +
Sbjct: 181 INPELNQKGY-SVKSDIWSLGITMIELAILR 210

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  133 bits (336), Expect = 2e-34
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 14/204 (6%)

Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 697
           F    K+G+G FG V+KGI      V+A+K +  +  +   E    EI ++S    P + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAI-FGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           K YG  ++  +L ++ EY+        +  G   E ++         I   I +GL YLH
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILKGLDYLH 136

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
            + +I   HRDIK +NVLL +    K++DFG+A    + +   +T + GT  +MAPE   
Sbjct: 137 SEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 192

Query: 817 RGYLTSKADVYSFGVVTLEIVSGK 840
           +    SKAD++S G+  +E+  G+
Sbjct: 193 QSAYDSKADIWSLGITAIELARGE 216

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  133 bits (336), Expect = 2e-34
 Identities = 53/227 (23%), Positives = 86/227 (37%), Gaps = 20/227 (8%)

Query: 631 RQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMIS 689
             +     ++    K+GEGGF  V     L DG   A+K++    +Q   E   E  M  
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81

Query: 690 AQQHPNLVKLYGCCVE----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
              HPN+++L   C+      ++  L+  + K   L   I  +  +    L       + 
Sbjct: 82  LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLL 140

Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA- 804
           +GI RGL  +H        HRD+K +N+LL  +    + D G               +  
Sbjct: 141 LGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 805 -------GTIGYMAPE---YAMRGYLTSKADVYSFGVVTLEIVSGKS 841
                   TI Y APE         +  + DV+S G V   ++ G+ 
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  132 bits (335), Expect = 2e-34
 Identities = 53/237 (22%), Positives = 97/237 (40%), Gaps = 26/237 (10%)

Query: 620 GLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQG 677
           G+DL T     + +      +    ++G GG   V++ +     + A+K   L     Q 
Sbjct: 10  GVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT 69

Query: 678 NREFVNEIGMISAQQHPNL--VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK 735
              + NEI  ++  Q  +   ++LY   +    + +V E   N  L+  +     + +  
Sbjct: 70  LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-----KKKKS 123

Query: 736 LDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 795
           +D   RK     +   +  +H+     IVH D+K +N L+      K+ DFG+A   + D
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPD 179

Query: 796 KTHISTR-IAGTIGYMAPE-----------YAMRGYLTSKADVYSFGVVTLEIVSGK 840
            T +      GT+ YM PE              +  ++ K+DV+S G +   +  GK
Sbjct: 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  132 bits (335), Expect = 5e-34
 Identities = 61/233 (26%), Positives = 101/233 (43%), Gaps = 32/233 (13%)

Query: 624 QTGLYTLRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQ 676
           + G      +       DP        ++G G FG+VY    + +  V+A+K++S   +Q
Sbjct: 34  RAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ 93

Query: 677 GNREF---VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC--LSRAIFGKDTE 731
            N ++   + E+  +   +HPN ++  GC +  +   LV EY   +   L         E
Sbjct: 94  SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE 153

Query: 732 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 791
             +         +  G  +GLAYLH  + I   HRD+K  N+LL +    K+ DFG A +
Sbjct: 154 VEIAA-------VTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASI 203

Query: 792 YEEDKTHISTRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGK 840
                + +     GT  +MAPE  +      Y   K DV+S G+  +E+   K
Sbjct: 204 MAPANSFV-----GTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERK 250

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  131 bits (331), Expect = 6e-34
 Identities = 52/225 (23%), Positives = 96/225 (42%), Gaps = 32/225 (14%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPN 695
            +F+P   +G GGFG V++     D    A+K++   +R+  RE  + E+  ++  +HP 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 696 LVKLYGCCVEGNQ------------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 743
           +V+ +   +E N             L +  +  +   L   +         + +      
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSVCLH 122

Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 803
           I + IA  + +LH      ++HRD+K SN+    D   K+ DFGL    ++D+   +   
Sbjct: 123 IFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 804 A-----------GTIGYMAPE-YAMRGYLTSKADVYSFGVVTLEI 836
                       GT  YM+PE      Y + K D++S G++  E+
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFEL 223

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  133 bits (335), Expect = 7e-34
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 20/209 (9%)

Query: 638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPN 695
           ++F+  +++G G  G V+K      G V+A K +  + +     + + E+ ++     P 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLA 753
           +V  YG      ++ +  E+M    L + +   G+  E  L        K+ I + +GL 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-------KVSIAVIKGLT 145

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGYMA 811
           YL E    KI+HRD+K SN+L++     K+ DFG++    +    + +     GT  YM+
Sbjct: 146 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMS 198

Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE     + + ++D++S G+  +E+  G+
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  132 bits (333), Expect = 9e-34
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 26/213 (12%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNL--VKL 699
            ++G GG   V++ +     + A+K   L     Q    + NEI  ++  Q  +   ++L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
           Y   +    + +V E   N  L+  +     + +  +D   RK     +   +  +H+  
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQH- 127

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIGYMAPE----- 813
              IVH D+K +N L+      K+ DFG+A   + D T +      GT+ YM PE     
Sbjct: 128 --GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 814 ------YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                    +  ++ K+DV+S G +   +  GK
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  133 bits (335), Expect = 1e-33
 Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 26/213 (12%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNL--VKL 699
            ++G GG   V++ +     + A+K   L     Q    + NEI  ++  Q  +   ++L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 759
           Y   +    + +V E   N  L+  +     + +  +D   RK     +   +  +H+  
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQH- 174

Query: 760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIGYMAPE----- 813
              IVH D+K +N L+      K+ DFG+A   + D T +      G + YM PE     
Sbjct: 175 --GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 814 ------YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                    +  ++ K+DV+S G +   +  GK
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  131 bits (331), Expect = 3e-33
 Identities = 41/218 (18%), Positives = 84/218 (38%), Gaps = 21/218 (9%)

Query: 637 TNNFDPANKVGEG--GFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQ 691
              ++    +G+G     +V        G  + V++  L + S +       E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
            HPN+V      +  N+L +V  +M        I    T +   ++      I  G+ + 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKA 140

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG-LAKLYEEDK-----THISTRIAG 805
           L Y+H    +   HR +K S++L+  D    +S       +    +              
Sbjct: 141 LDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 806 TIGYMAPE---YAMRGYLTSKADVYSFGVVTLEIVSGK 840
            + +++PE     ++GY  +K+D+YS G+   E+ +G 
Sbjct: 198 VLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGH 234

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  134 bits (340), Expect = 5e-33
 Identities = 46/272 (16%), Positives = 96/272 (35%), Gaps = 12/272 (4%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 123
            +             L  L L+ N L        +  + L  L  +   +S      L N
Sbjct: 68  QIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN 127

Query: 124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS-D 182
             TL++L +  N  +    P       L+ L   +N+       +++ L    +L ++ +
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLN 187

Query: 183 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASIS--ALTSLTDLRISDLKG---SESA 237
            N    I          Q L+  G+     I   +    + SL      D+     S + 
Sbjct: 188 GNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247

Query: 238 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 297
           F  L +M+++++ L K        +     + L+ +DL+  +L+  +P+    L+    +
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKL 306

Query: 298 YLTGNKLTGPVPKYIFNSNKNV---DISLNNF 326
            L+ NK    + +   ++  ++    I  N  
Sbjct: 307 VLSANKFEN-LCQISASNFPSLTHLSIKGNTK 337

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  131 bits (332), Expect = 5e-32
 Identities = 54/272 (19%), Positives = 96/272 (35%), Gaps = 16/272 (5%)

Query: 69  TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGP-FPKVLTNITT 126
            LP+ L  L  LK+L LS N          ++   L  LS+ GN          L N+  
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351

Query: 127 LKNLSIEGNLFTGS--IPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 184
           L+ L +  +    S      +R L +LQ L LS N           +   L  L ++   
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411

Query: 185 FSGKIPE-FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD------LKGSESA 237
              K  +        ++ L++  S L+         L +L  L +             ++
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471

Query: 238 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 297
              L    L+ L+L+ C +          +  + ++DLS N LT         L    ++
Sbjct: 472 LQTLG--RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YL 528

Query: 298 YLTGNKLTGPVPK--YIFNSNKNVDISLNNFT 327
            L  N ++  +P    I +  + +++  N   
Sbjct: 529 NLASNHISIILPSLLPILSQQRTINLRQNPLD 560

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  125 bits (317), Expect = 4e-30
 Identities = 40/279 (14%), Positives = 93/279 (33%), Gaps = 15/279 (5%)

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 120
                  G   + +  L      D+    ++ +       + +  +++  +         
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273

Query: 121 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 180
               + L+ L +     +  +P  +  L  L+KL+LS+N F        +   +L  L I
Sbjct: 274 FHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI 332

Query: 181 SDNNFSGKI-PEFIGKWKKIQKLHIQGSSLE--GPIPASISALTSLTDLRISD--LKGSE 235
             N    ++    +   + +++L +    +E        +  L+ L  L +S       +
Sbjct: 333 KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLK 392

Query: 236 S-AFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAK 293
           + AF +     L+ L L    +  +       ++  LK ++LS + L       F+ L  
Sbjct: 393 TEAFKECP--QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPA 450

Query: 294 TNFMYLTGNKLTG--PVPKYIFNSNKNV---DISLNNFT 327
              + L GN              +   +    +S  + +
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  112 bits (281), Expect = 1e-25
 Identities = 43/229 (18%), Positives = 77/229 (33%), Gaps = 14/229 (6%)

Query: 65  NLTGTLPTE-LSKLRYLKQLDLSRNCLTGS--FSPQWASL-QLVELSVMGNRLSGPFPKV 120
                L T  L  L  L++LDLS + +  S   + Q  +L  L  L++  N       + 
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395

Query: 121 LTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 179
                 L+ L +              + L  L+ L LS +            L  L  L 
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455

Query: 180 ISDNNFSGKI---PEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG- 233
           +  N+F          +    +++ L +    L      + ++L  +  + +S   L   
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515

Query: 234 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 282
           S  A   L       L L    I   +P  +  +++ + I+L  N L  
Sbjct: 516 SIEALSHL---KGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  106 bits (266), Expect = 8e-24
 Identities = 39/297 (13%), Positives = 80/297 (26%), Gaps = 43/297 (14%)

Query: 42  ESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL 101
            S+  C          T   +   L   +P  L      + L+ S               
Sbjct: 3   SSDQKCIEKEVN---KTYNCENLGLN-EIPGTLP--NSTECLEFS--------------- 41

Query: 102 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSF 161
                    N L        + +  L  L +             +    L  L+L++N  
Sbjct: 42  --------FNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93

Query: 162 TGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALT 221
                  L+    L  L       S      +   K ++ L++  + +            
Sbjct: 94  IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153

Query: 222 SLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 276
            L  L      I  L  S+     L +    +L L    I   I     D    ++++  
Sbjct: 154 KLKVLDFQNNAIHYL--SKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFG 210

Query: 277 FNNLTGGIP-----TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSN-KNVDISLNNFT 327
                  I      +T + L    F  +    ++  V + +   + +++++  + F 
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF 267

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 55.8 bits (135), Expect = 4e-08
 Identities = 21/122 (17%), Positives = 45/122 (36%), Gaps = 4/122 (3%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 124
           +L+       + L+ +  +DLS N LT S     + L+ + L++  N +S   P +L  +
Sbjct: 487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPIL 546

Query: 125 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 184
           +  + +++  N    +        +       +                 L  +R+SD  
Sbjct: 547 SQQRTINLRQNPLDCT--CSNIYFLEW--YKENMQKLEDTEDTLCENPPLLRGVRLSDVT 602

Query: 185 FS 186
            S
Sbjct: 603 LS 604

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  128 bits (323), Expect = 1e-32
 Identities = 63/243 (25%), Positives = 109/243 (44%), Gaps = 29/243 (11%)

Query: 610 GKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK 668
           G   +  +  G     G    ++ +A  N+ +   ++G G  G V+K      G VIAVK
Sbjct: 1   GSSGSSGKQTGYLTIGG----QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK 56

Query: 669 QL-SSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS---R 723
           Q+  S +++ N+  + ++ ++      P +V+ +G  +    + +  E M   C     +
Sbjct: 57  QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKK 115

Query: 724 AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 783
            + G   E  L        K+ + I + L YL E     ++HRD+K SN+LLD+    K+
Sbjct: 116 RMQGPIPERILG-------KMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKL 166

Query: 784 SDFGLAKLYEEDKTHISTRIAGTIGYMAPE------YAMRGYLTSKADVYSFGVVTLEIV 837
            DFG++            R AG   YMAPE           Y   +ADV+S G+  +E+ 
Sbjct: 167 CDFGISG--RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELA 223

Query: 838 SGK 840
           +G+
Sbjct: 224 TGQ 226

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  127 bits (321), Expect = 1e-32
 Identities = 61/203 (30%), Positives = 91/203 (44%), Gaps = 18/203 (8%)

Query: 645 KVGEGGFGSVYKG---ILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQQHPNLV 697
           K+G GG  +VY     IL     +A+K +     +   E +     E+   S   H N+V
Sbjct: 18  KLGGGGMSTVYLAEDTIL--NIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
            +     E +   LV EY++   LS  I     E    L   T       I  G+ + H 
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDTAINFTNQILDGIKHAH- 128

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
              ++IVHRDIK  N+L+D +   KI DFG+AK   E     +  + GT+ Y +PE A  
Sbjct: 129 --DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186

Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
                  D+YS G+V  E++ G+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGE 209

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  130 bits (328), Expect = 2e-32
 Identities = 57/228 (25%), Positives = 89/228 (39%), Gaps = 33/228 (14%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNL 696
           N       +G G  G+V       G  +AVK++           + EI  +  +  HPN+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           ++ Y        L +  E    N L   +       E            +   IA G+A+
Sbjct: 72  IRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 755 LHEDSRIKIVHRDIKTSNVLLD-------------KDLNAKISDFGLAKLYEEDKTHIST 801
           LH    +KI+HRD+K  N+L+              ++L   ISDFGL K  +  ++   T
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 802 R---IAGTIGYMAPE-------YAMRGYLTSKADVYSFGVVTLEIVSG 839
                +GT G+ APE          +  LT   D++S G V   I+S 
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  133 bits (337), Expect = 3e-32
 Identities = 57/346 (16%), Positives = 111/346 (32%), Gaps = 55/346 (15%)

Query: 5   ALKQIGRKLGKKDWNF---GVDPCSQKGNWELSSD-DKKGFESNVTCDCSSATCHVVTIA 60
           ALK I   L  K+W +    ++      NW  + + D  G +  V  D +     V  ++
Sbjct: 273 ALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNG---RVTGLS 329

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSP-QWASLQLVELSVMGNRLSGPFPK 119
           L      G +P  + +L  LK L    +  T S        L         +R+   + K
Sbjct: 330 LAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK 389

Query: 120 -VLTNITTLKNLSIEGNLFT-----GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 173
             L     L    +  +          I  D R  +   ++   +N  T  +   + +LT
Sbjct: 390 MFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLT 448

Query: 174 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 233
            L  +  +++ F+             +  +   +        S S L  LTD+ + +   
Sbjct: 449 KLQIIYFANSPFTYDNIAVDW-----EDANSDYAKQYENEELSWSNLKDLTDVELYN--- 500

Query: 234 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG---------GI 284
                               C    ++PD++ D+ +L++++++ N              +
Sbjct: 501 --------------------CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540

Query: 285 PTTFEKLAKTNFMYLTGNKLTG-PVPKYIFNSNK--NVDISLNNFT 327
               +   K    Y+  N L   P    +    K   +D   N   
Sbjct: 541 ADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR 586

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  128 bits (324), Expect = 1e-30
 Identities = 55/304 (18%), Positives = 97/304 (31%), Gaps = 47/304 (15%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 124
            +       L+    L+        +         SL+  ++  + NR++    K +  +
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRL 447

Query: 125 TTLKNLSIEGNLFTG-------------------SIPPDIRKLINLQKLILSSNSFTGEL 165
           T L+ +    + FT                    +       L +L  + L +     +L
Sbjct: 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507

Query: 166 PAELTKLTNLNDLRISDNNFSG---------KIPEFIGKWKKIQKLHIQGSSLEG-PIPA 215
           P  L  L  L  L I+ N             ++ +      KIQ  ++  ++LE  P  A
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASA 567

Query: 216 SISALTSLTDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIPDYIG-DMTKLKNI 273
           S+  +  L  L     K     AF       L  L L    I  EIP+       +++ +
Sbjct: 568 SLQKMVKLGLLDCVHNKVRHLEAFGTNV--KLTDLKLDYNQIE-EIPEDFCAFTDQVEGL 624

Query: 274 DLSFNNLTGGIPTTFE--KLAKTNFMYLTGNKLTGPVPKYIFNSNKN--------VDISL 323
             S N L   IP  F    +     +  + NK+     + I  S  +        V +S 
Sbjct: 625 GFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSY 682

Query: 324 NNFT 327
           N   
Sbjct: 683 NEIQ 686

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  126 bits (317), Expect = 8e-30
 Identities = 37/293 (12%), Positives = 78/293 (26%), Gaps = 38/293 (12%)

Query: 69  TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--QLVELSVMGNRLSG-PFPKVLTNIT 125
                      L  L L  N +       + +   Q+  L    N+L   P      ++ 
Sbjct: 586 RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVY 644

Query: 126 TLKNLSIEGNLFTG-----SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 180
            + ++    N         S   D  K IN   + LS N             + ++ + +
Sbjct: 645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIIL 704

Query: 181 SDNNFS-------GKIPEFIGKWKKIQKLHIQGSSLEGPIPASI--SALTSLTDL----- 226
           S+N  +                   +  + ++ + L   +      + L  L+++     
Sbjct: 705 SNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYN 763

Query: 227 RISDLKGSESAFPKLDKMNL-KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 285
             S          +L    +          I  + P  I     L  + +  N++     
Sbjct: 764 CFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDE 823

Query: 286 TTFEKLAKTNFMYLTGNKLT-GPVP---------KYIFNSNKNVDISLNNFTW 328
               +L     + +  N      V           Y+   +K  DI   +   
Sbjct: 824 KLTPQL---YILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALG 873

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 86.9 bits (215), Expect = 1e-17
 Identities = 35/145 (24%), Positives = 49/145 (33%), Gaps = 15/145 (10%)

Query: 64  QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVM---GNRLSGPFPKV 120
           +N              L  +DL  N LT S S  + +  L  LS M    N  S  FP  
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQ 771

Query: 121 LTNITTLKNLSIEGNL------FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 174
             N + LK   I               P  I    +L +L + SN    ++  +L     
Sbjct: 772 PLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQ 828

Query: 175 LNDLRISDN-NFSGKIPEFIGKWKK 198
           L  L I+DN N S  +       + 
Sbjct: 829 LYILDIADNPNISIDVTSVCPYIEA 853

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 57.2 bits (138), Expect = 2e-08
 Identities = 35/244 (14%), Positives = 68/244 (27%), Gaps = 43/244 (17%)

Query: 124 ITTLKNLSIEGNLFTGSIPPDIRKLINL-QKLILSSNSFTGELPAELTKLTNLNDLRISD 182
           +T   N+ I+       I  D + L  + + L   +  +            N N  +   
Sbjct: 251 LTKDANVPIQLKETAEYIK-DYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNK-EL 308

Query: 183 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAF-- 238
           + +  +    +    ++  L + G   +G +P +I  LT L  L         S   F  
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 239 ---------------------------PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLK 271
                                       +L+  +L    + +      I        K  
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428

Query: 272 NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK--------YIFNSNKNVDISL 323
            I    N +T  I    ++L K   +Y   +  T                   +N ++S 
Sbjct: 429 QIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSW 487

Query: 324 NNFT 327
           +N  
Sbjct: 488 SNLK 491

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  123 bits (311), Expect = 4e-31
 Identities = 45/212 (21%), Positives = 85/212 (40%), Gaps = 23/212 (10%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGC 702
            +G+G   +V++G     G + A+K  ++ S     +  + E  ++    H N+VKL+  
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 703 --CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
                    +L+ E+     L   +  ++      L       +   +  G+ +L E   
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNHLRE--- 130

Query: 761 IKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--- 813
             IVHR+IK  N++     D     K++DFG A+  E+D     +   GT  Y+ P+   
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYE 188

Query: 814 -----YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                   +    +  D++S GV      +G 
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  123 bits (311), Expect = 6e-31
 Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)

Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLV 697
           F+    VG G +G VYKG  +  G + A+K +         E   EI M+     H N+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84

Query: 698 KLYGC------CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
             YG           +QL LV E+     ++  I  K+T+    L       IC  I RG
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGN-TLKEEWIAYICREILRG 141

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           L++LH+    K++HRDIK  NVLL ++   K+ DFG++   +      +T I GT  +MA
Sbjct: 142 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMA 197

Query: 812 PEYAMR------GYLTSKADVYSFGVVTLEIVSGK 840
           PE           Y   K+D++S G+  +E+  G 
Sbjct: 198 PEVIACDENPDATY-DFKSDLWSLGITAIEMAEGA 231

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  122 bits (307), Expect = 2e-30
 Identities = 61/264 (23%), Positives = 96/264 (36%), Gaps = 37/264 (14%)

Query: 602 MRWKGCLGGKVSADK-ELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-L 659
           M   G LGG    D+ +  G  ++ G   LR  +           + EGGF  VY+   +
Sbjct: 1   MAGPGSLGGASGRDQSDFVGQTVELGELRLRVRR----------VLAEGGFAFVYEAQDV 50

Query: 660 SDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNLVKLYGCCV-------EGNQLLL 711
             G   A+K+L S   + NR  + E+  M     HPN+V+              G    L
Sbjct: 51  GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL 110

Query: 712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTS 771
           +   +    L   +  K  E R  L   T  KI     R + ++H   +  I+HRD+K  
Sbjct: 111 LLTELCKGQLVEFL--KKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVE 167

Query: 772 NVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA-----------GTIGYMAPE---YAMR 817
           N+LL      K+ DFG A        +  +               T  Y  PE       
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227

Query: 818 GYLTSKADVYSFGVVTLEIVSGKS 841
             +  K D+++ G +   +   + 
Sbjct: 228 FPIGEKQDIWALGCILYLLCFRQH 251

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  121 bits (306), Expect = 2e-30
 Identities = 49/244 (20%), Positives = 87/244 (35%), Gaps = 23/244 (9%)

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPK 119
           L++  L    P +  +L +L+ + +    L             L  L++  N L    P 
Sbjct: 88  LRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPA 144

Query: 120 VLTNITTLKNLSIEGNLFTGSIPPDI---------RKLINLQKLILSSNSFTGELPAELT 170
            + ++  L+ LSI        +P  +         + L+NLQ L L        LPA + 
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA 203

Query: 171 KLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 230
            L NL  L+I ++  S  +   I    K+++L ++G +     P        L  L + D
Sbjct: 204 NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKD 262

Query: 231 LKGSES---AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN---NLTGGI 284
                +      +L    L+ L L  C+    +P  I  +     I +  +    L    
Sbjct: 263 CSNLLTLPLDIHRLT--QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320

Query: 285 PTTF 288
           P   
Sbjct: 321 PVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  121 bits (305), Expect = 3e-30
 Identities = 53/253 (20%), Positives = 91/253 (35%), Gaps = 24/253 (9%)

Query: 69  TLPTELSKLRY--LKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNIT 125
                L          L+L    L   F  Q   L  L  +++    L    P  +    
Sbjct: 70  ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFA 127

Query: 126 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL---------TKLTNLN 176
            L+ L++  N    ++P  I  L  L++L + +     ELP  L           L NL 
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186

Query: 177 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES 236
            LR+        +P  I   + ++ L I+ S L   +  +I  L  L +L +       +
Sbjct: 187 SLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRN 244

Query: 237 AFPK-LDKM-NLKTLILTKC--LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 292
            +P        LK LIL  C  L+   +P  I  +T+L+ +DL        +P+   +L 
Sbjct: 245 -YPPIFGGRAPLKRLILKDCSNLL--TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLP 301

Query: 293 KTNFMYLTGNKLT 305
               + +  +   
Sbjct: 302 ANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  102 bits (257), Expect = 7e-24
 Identities = 42/244 (17%), Positives = 81/244 (33%), Gaps = 38/244 (15%)

Query: 103 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG-------------------SIPP 143
              L   G+    P+  VL+      N                             +   
Sbjct: 14  RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATAD 73

Query: 144 DIRKL--INLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 201
            +          L L S     + P +  +L++L  + I       ++P+ + ++  ++ 
Sbjct: 74  LLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLET 131

Query: 202 LHIQGSSLEGPIPASISALTSLTDLRISDLK---------GSESAFPKLDKM-NLKTLIL 251
           L +  + L   +PASI++L  L +L I              S  A  +   + NL++L L
Sbjct: 132 LTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190

Query: 252 TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG-NKLTGPVPK 310
               I   +P  I ++  LK++ +  + L+  +      L K   + L G   L    P 
Sbjct: 191 EWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRN-YPP 247

Query: 311 YIFN 314
               
Sbjct: 248 IFGG 251

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 89.2 bits (222), Expect = 2e-19
 Identities = 34/156 (21%), Positives = 59/156 (37%), Gaps = 6/156 (3%)

Query: 69  TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTL 127
               E   L  L+ L L    +  S     A+LQ L  L +  + LS      + ++  L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231

Query: 128 KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 187
           + L + G     + PP       L++LIL   S    LP ++ +LT L  L +       
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291

Query: 188 KIPEFIGKWKKIQKLHI---QGSSLEGPIPASISAL 220
           ++P  I +      + +     + L+   P +  A 
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 19/167 (11%), Positives = 44/167 (26%), Gaps = 28/167 (16%)

Query: 139 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 198
           GS           + L    ++        L++     +   +  + + +          
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN------- 54

Query: 199 IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHG 258
                              S    +       LK +        +     L L    +  
Sbjct: 55  -------------------SNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP- 94

Query: 259 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 305
           + PD    ++ L+++ +    L   +P T ++ A    + L  N L 
Sbjct: 95  QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  125 bits (316), Expect = 5e-30
 Identities = 49/293 (16%), Positives = 99/293 (33%), Gaps = 36/293 (12%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL----------------QLV 104
           N       +   L  +  + L+   +          +W SL                 L 
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLK 331

Query: 105 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFT--GSIPPDIRKLINLQKLILSSNSFT 162
            L++  N+ S  F      + +L  L +  N  +  G          +L+ L LS N   
Sbjct: 332 SLTLTMNKGSISFK--KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389

Query: 163 GELPAELTKLTNLNDLRISDNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIPASISALT 221
             + A    L  L  L    +              +K+  L I  ++ +         LT
Sbjct: 390 -IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448

Query: 222 SLTDLRISD--LKGS--ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSF 277
           SL  L+++    K +   + F      NL  L L+KC +          + +L+ +++S 
Sbjct: 449 SLNTLKMAGNSFKDNTLSNVFANTT--NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH 506

Query: 278 NNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 327
           NNL     + + +L   + +  + N++       + +  K+    +++ N+  
Sbjct: 507 NNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  118 bits (299), Expect = 6e-28
 Identities = 48/303 (15%), Positives = 91/303 (30%), Gaps = 39/303 (12%)

Query: 47  CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVE 105
           C         +T     Q L+  +P ++      K +DLS N L    S  +++  +L  
Sbjct: 7   CIEV---VPNITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQW 60

Query: 106 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGEL 165
           L +    +     K    +  L NL + GN      P     L +L+ L+          
Sbjct: 61  LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE 120

Query: 166 PAELTKLTNLNDLRISDNNFSG-KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT 224
              + +L  L  L ++ N     K+P +      +  + +  + ++      +  L    
Sbjct: 121 SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENP 180

Query: 225 DLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 284
            +                     +L ++   I   I D      KL  + L  N  +  I
Sbjct: 181 QV-------------------NLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNI 220

Query: 285 P-TTFEKLAKTNFMYLTGNKLTGPVPKYIFN----------SNKNVDISLNNFTWESSDP 333
             T  + LA  +   L   +        IF           +     ++  N   +    
Sbjct: 221 MKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK 280

Query: 334 IEC 336
             C
Sbjct: 281 FHC 283

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  117 bits (295), Expect = 2e-27
 Identities = 53/279 (18%), Positives = 90/279 (32%), Gaps = 17/279 (6%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 123
            L        S    L+ LDLSR  +       W  L  L  L + GN +    P   + 
Sbjct: 43  PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102

Query: 124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISD 182
           +T+L+NL              I +LI L+KL ++ N     +LPA  + LTNL  + +S 
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162

Query: 183 NNFSGKIPEFIGKWKK----IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF 238
           N         +   ++       L +  + ++  I         L +L +     S +  
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIM 221

Query: 239 PKLDKM--NLKTLILTKCLIHGEI------PDYIGDMTKL--KNIDLSFNNLTGGIPTTF 288
               +    L    L       E       P  +  +  +      L++ N        F
Sbjct: 222 KTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF 281

Query: 289 EKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 327
             LA  + M L G  +            +++ I      
Sbjct: 282 HCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK 320

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  106 bits (266), Expect = 7e-24
 Identities = 46/286 (16%), Positives = 83/286 (29%), Gaps = 26/286 (9%)

Query: 64  QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQ---------WASLQLVELSVMGNRLS 114
            N +  + T L  L  L    L         + +            + + E  +      
Sbjct: 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDF 274

Query: 115 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 174
                    +  +  +S+ G         D+ K    Q L +       + P     L  
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPTL--DLPF 329

Query: 175 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE--GPIPASISALTSLTDLRISD-- 230
           L  L ++ N  S    + +     +  L +  ++L   G    S     SL  L +S   
Sbjct: 330 LKSLTLTMNKGSI-SFKKVA-LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNG 387

Query: 231 LKGSESAFPKLDKMNLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFE 289
                + F  L+   L+ L      +           + KL  +D+S+ N        F 
Sbjct: 388 AIIMSANFMGLE--ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL 445

Query: 290 KLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFTWESSD 332
            L   N + + GN         +F +  N+   D+S       S  
Sbjct: 446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  102 bits (257), Expect = 1e-22
 Identities = 45/257 (17%), Positives = 86/257 (33%), Gaps = 32/257 (12%)

Query: 92  GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI-TTLKNLSIEGNLFTGSIPPDIRKLIN 150
           GS +P    +  +    M  +LS    KV  +I ++ KN+ +  N               
Sbjct: 2   GSLNPCIEVVPNITYQCMDQKLS----KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSE 57

Query: 151 LQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 210
           LQ L LS              L +L++L ++ N      P        ++ L    + L 
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 211 GPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKL 270
                 I  L +L  L ++               N         +   ++P Y  ++T L
Sbjct: 118 SLESFPIGQLITLKKLNVAH--------------NF--------IHSCKLPAYFSNLTNL 155

Query: 271 KNIDLSFNNLTGGIPTTFEKLAKTNFM----YLTGNKLTGPVPKYIFNSNKNVDISLNNF 326
            ++DLS+N +        + L +   +     ++ N +   +    F   K  +++L   
Sbjct: 156 VHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGN 214

Query: 327 TWESSDPIECPRGSVNL 343
              S+    C +    L
Sbjct: 215 FNSSNIMKTCLQNLAGL 231

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 83.5 bits (207), Expect = 1e-16
 Identities = 25/170 (14%), Positives = 53/170 (31%), Gaps = 5/170 (2%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--QLVELSVMGNRLSGPFPKVLT 122
           N           L  L  L ++ N    +      +    L  L +   +L      V  
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494

Query: 123 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 182
            +  L+ L++  N           +L +L  L  S N              +L    +++
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554

Query: 183 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL--TSLTDLRISD 230
           N+ +  I E     + +++      ++E    A+   +  + + D   S 
Sbjct: 555 NSVA-CICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDFNNST 603

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  122 bits (307), Expect = 6e-30
 Identities = 46/212 (21%), Positives = 84/212 (39%), Gaps = 23/212 (10%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGC 702
            +G+G   +V++G     G + A+K  ++ S     +  + E  ++    H N+VKL+  
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 703 --CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
                    +L+ E+     L   +      Y L         +   +  G+ +L E   
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--EFLIVLRDVVGGMNHLRE--- 130

Query: 761 IKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--- 813
             IVHR+IK  N++     D     K++DFG A+  E+D     +   GT  Y+ P+   
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYE 188

Query: 814 -----YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                   +    +  D++S GV      +G 
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  120 bits (302), Expect = 7e-30
 Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 26/210 (12%)

Query: 645 KVGEGGFGSVYKG---ILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQQHPNLV 697
            +G GG   V+            +AVK L +     +  F      E    +A  HP +V
Sbjct: 19  ILGFGGMSEVHLARDLRD--HRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 698 KLY--GCCVEGNQLLLVY---EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
            +Y  G   E     L Y   EY+    L   +          +      ++     + L
Sbjct: 76  AVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIADACQAL 129

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI--STRIAGTIGYM 810
            + H   +  I+HRD+K +N+++      K+ DFG+A+   +    +  +  + GT  Y+
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 811 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           +PE A    + +++DVYS G V  E+++G+
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  125 bits (314), Expect = 7e-30
 Identities = 61/284 (21%), Positives = 99/284 (34%), Gaps = 40/284 (14%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 124
            LT +LP     L  L         L    S       L +L + GN+L+   P +    
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPALPS------GLCKLWIFGNQLTS-LPVLPPG- 142

Query: 125 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 184
             L+ LS+  N    S+P        L KL   +N  T  LP   + L  L+   +SDN 
Sbjct: 143 --LQELSVSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPSGLQELS---VSDNQ 192

Query: 185 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT--DLRISDLKGSESAFPKLD 242
            +  +P    +  K+   + + +SL    PA  S L  L     R++ L    S      
Sbjct: 193 LA-SLPTLPSELYKLWAYNNRLTSL----PALPSGLKELIVSGNRLTSLPVLPS------ 241

Query: 243 KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 302
              LK L+++   +   +P        L ++ +  N LT  +P +   L+    + L GN
Sbjct: 242 --ELKELMVSGNRL-TSLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294

Query: 303 KLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVES 346
            L+            +                  PR +  L  +
Sbjct: 295 PLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA 337

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 83.0 bits (205), Expect = 1e-16
 Identities = 34/181 (18%), Positives = 67/181 (37%), Gaps = 26/181 (14%)

Query: 125 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 184
                L++  +  T ++P  +    ++  L++  N+ T  LPA   +L  L    +S N 
Sbjct: 40  NGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQ 92

Query: 185 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM 244
            +  +P       ++       + L    PA  S L  L  +  + L       P     
Sbjct: 93  LT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKL-WIFGNQLTSLPVLPP----- 141

Query: 245 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 304
            L+ L ++   +   +P    ++ KL       N LT  +P     L +   + ++ N+L
Sbjct: 142 GLQELSVSDNQL-ASLPALPSELCKL---WAYNNQLT-SLPMLPSGLQE---LSVSDNQL 193

Query: 305 T 305
            
Sbjct: 194 A 194

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  119 bits (301), Expect = 7e-30
 Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 20/204 (9%)

Query: 645 KVGEGGFGSVYKG---ILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQQHPNLV 697
            VG GG G VY+    +     ++A+K +S  +   +  F      E       Q P++V
Sbjct: 41  LVGRGGMGDVYEAEDTVR--ERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
            ++       QL +    +    L+  +     +  L         I   I   L   H 
Sbjct: 98  PIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVA--IVRQIGSALDAAHA 152

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK-THISTRIAGTIGYMAPEYAM 816
                  HRD+K  N+L+  D  A + DFG+A    ++K T +   + GT+ YMAPE   
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFS 208

Query: 817 RGYLTSKADVYSFGVVTLEIVSGK 840
             + T +AD+Y+   V  E ++G 
Sbjct: 209 ESHATYRADIYALTCVLYECLTGS 232

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  125 bits (314), Expect = 1e-29
 Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 20/206 (9%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLY---- 700
           G GGFG V + I    G  +A+KQ   +    NRE    EI ++    HPN+V       
Sbjct: 23  GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82

Query: 701 --GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
                   +  LL  EY +   L + +   +    LK      + +   I+  L YLHE 
Sbjct: 83  GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG--PIRTLLSDISSALRYLHE- 139

Query: 759 SRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-Y 814
              +I+HRD+K  N++L    + L  KI D G AK  ++    + T   GT+ Y+APE  
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQYLAPELL 195

Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
             + Y T   D +SFG +  E ++G 
Sbjct: 196 EQKKY-TVTVDYWSFGTLAFECITGF 220

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  118 bits (297), Expect = 1e-29
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 17/208 (8%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQ 692
            +F+    +G+G FG+VY         ++A+K L      K+   ++    E+ + S  +
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN+++LYG   +  ++ L+ EY     +    + +  +   K D          +A  L
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLS-KFDEQRTATYITELANAL 122

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           +Y H     +++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ P
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPP 176

Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           E         K D++S GV+  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  122 bits (308), Expect = 1e-29
 Identities = 63/248 (25%), Positives = 97/248 (39%), Gaps = 23/248 (9%)

Query: 602 MRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LS 660
           M                  L    G++   +    +  +    K+G G +G V       
Sbjct: 1   MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60

Query: 661 DGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 717
                A+K +  K+          + E+ ++    HPN++KLY    +     LV E  K
Sbjct: 61  THVERAIKIIR-KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119

Query: 718 NNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 775
              L   I  +    E            I   +  G+ YLH+     IVHRD+K  N+LL
Sbjct: 120 GGELFDEIIHRMKFNEV-------DAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLL 169

Query: 776 ---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVV 832
              +KD   KI DFGL+ ++E  K        GT  Y+APE   + Y   K DV+S GV+
Sbjct: 170 ESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPEVLRKKY-DEKCDVWSIGVI 226

Query: 833 TLEIVSGK 840
              +++G 
Sbjct: 227 LFILLAGY 234

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  118 bits (298), Expect = 2e-29
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 15/199 (7%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
           G+GGF   ++        V A K +      K  Q  +    EI +  +  H ++V  +G
Sbjct: 24  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHG 82

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              + + + +V E  +   L         + R  L  P  +     I  G  YLH   R 
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLH---RN 134

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
           +++HRD+K  N+ L++DL  KI DFGLA   E D       + GT  Y+APE   +   +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 193

Query: 822 SKADVYSFGVVTLEIVSGK 840
            + DV+S G +   ++ GK
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  120 bits (301), Expect = 2e-29
 Identities = 29/237 (12%), Positives = 65/237 (27%), Gaps = 51/237 (21%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE------------------------- 680
           G+    +  +      G    V       R  +                           
Sbjct: 82  GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141

Query: 681 ---FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY---RL 734
              F+    ++   Q   ++++     +   L   + Y +     +        +     
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201

Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
            L    R ++ + + R LA LH      +VH  ++  +++LD+     ++ F        
Sbjct: 202 SLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258

Query: 795 DKTHISTRIAGTIGYMAPEY-----------AMRGYLTSKADVYSFGVVTLEIVSGK 840
                    + + G+  PE              R  +T   D ++ G+V   I    
Sbjct: 259 RVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  119 bits (299), Expect = 3e-29
 Identities = 21/227 (9%), Positives = 46/227 (20%), Gaps = 40/227 (17%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYGC 702
             G    V+    +      A+K  +  +     E           +     +  +    
Sbjct: 71  RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130

Query: 703 C--------------------------VEGNQLLLVYEYMK-NNCLSRAIFGKDTEYRLK 735
                                            LL+      +  L  +       +R  
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD 190

Query: 736 LDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 795
                   +   + R  A L       +VH      N+ +  D    + D          
Sbjct: 191 EGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT- 246

Query: 796 KTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGK 840
                   +  + Y   E+        T   + +  G+    +    
Sbjct: 247 ---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  118 bits (298), Expect = 4e-29
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 15/199 (7%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
           G+GGF   ++        V A K +      K  Q  +    EI +  +  H ++V  +G
Sbjct: 50  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHG 108

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              + + + +V E  +   L         + R  L  P  +     I  G  YLH   R 
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLH---RN 160

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
           +++HRD+K  N+ L++DL  KI DFGLA   E D       + GT  Y+APE   +   +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 219

Query: 822 SKADVYSFGVVTLEIVSGK 840
            + DV+S G +   ++ GK
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  121 bits (305), Expect = 4e-29
 Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 24/229 (10%)

Query: 621 LDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR 679
           L    G++        ++ +     +G+G FG V        G   AVK +S K +   +
Sbjct: 9   LHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS-KRQVKQK 67

Query: 680 EFV----NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYR 733
                   E+ ++    HPN++KLY    +     LV E      L   I  +   +E  
Sbjct: 68  TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD 127

Query: 734 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAK 790
                    +I   +  G+ Y+H+    KIVHRD+K  N+LL    KD N +I DFGL+ 
Sbjct: 128 A-------ARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177

Query: 791 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 839
            +E  K        GT  Y+APE     Y   K DV+S GV+   ++SG
Sbjct: 178 HFEASKKM--KDKIGTAYYIAPEVLHGTY-DEKCDVWSTGVILYILLSG 223

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  118 bits (298), Expect = 5e-29
 Identities = 52/244 (21%), Positives = 100/244 (40%), Gaps = 36/244 (14%)

Query: 611 KVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ 669
           K + +   + +  +  L      K     +DP + +G G    V + +  + G   AVK 
Sbjct: 67  KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126

Query: 670 LSSKSRQGNREFV--------NEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 720
           +   + + + E +         E   +     HP+++ L       + + LV++ M+   
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186

Query: 721 LSRAIF--GKDTEYRLKLDWPTRK--KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD 776
           L   +      +E         ++   I   +   +++LH      IVHRD+K  N+LLD
Sbjct: 187 LFDYLTEKVALSE---------KETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLD 234

Query: 777 KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-------YAMRGYLTSKADVYSF 829
            ++  ++SDFG +   E  +      + GT GY+APE           GY   + D+++ 
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWAC 291

Query: 830 GVVT 833
           GV+ 
Sbjct: 292 GVIL 295

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  117 bits (296), Expect = 7e-29
 Identities = 51/225 (22%), Positives = 94/225 (41%), Gaps = 28/225 (12%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFV--------------- 682
           N++     + +G F  +      D    A+K+      +  R+F                
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 683 --NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL---SRAIFGKDTEYRLKLD 737
             NE+ +I+  ++   +   G     +++ ++YEYM+N+ +       F  D  Y   + 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
               K I   +    +Y+H  +   I HRD+K SN+L+DK+   K+SDFG ++   + K 
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207

Query: 798 HISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGK 840
             S    GT  +M PE+      Y  +K D++S G+    +    
Sbjct: 208 KGS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  118 bits (296), Expect = 7e-29
 Identities = 38/246 (15%), Positives = 72/246 (29%), Gaps = 29/246 (11%)

Query: 631 RQIKAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNREFVNE 684
            + +  +      + +GEG F  VY+    D           +K     +          
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 685 IGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI 744
           +  +        +K Y   +  N  +LV E      L  AI          +        
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 745 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-----------DKDLNAKISDFGLAK-LY 792
            + +   +  +H+    +I+H DIK  N +L           D      + D G +  + 
Sbjct: 178 AMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 793 EEDKTHISTRIAGTIGYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSGK------SNTNY 845
              K  I T    T G+   E  + + +   + D +        ++ G            
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293

Query: 846 RPNEDF 851
           +P   F
Sbjct: 294 KPEGLF 299

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  119 bits (301), Expect = 1e-28
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 23/205 (11%)

Query: 644 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKL 699
             +G+G FG V K          AVK ++ K+   N++    + E+ ++    HPN++KL
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAYLHE 757
           +    + +   +V E      L   I  +   +E+          +I   +  G+ Y+H+
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-------ARIIKQVFSGITYMHK 139

Query: 758 DSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
                IVHRD+K  N+LL   +KD + KI DFGL+  ++++         GT  Y+APE 
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEV 194

Query: 815 AMRGYLTSKADVYSFGVVTLEIVSG 839
               Y   K DV+S GV+   ++SG
Sbjct: 195 LRGTY-DEKCDVWSAGVILYILLSG 218

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  115 bits (290), Expect = 1e-28
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 23/206 (11%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQ 692
              ++    +G+G FG V K          AVK ++ K+   N++    + E+ ++    
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLD 79

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIAR 750
           HPN++KL+    + +   +V E      L   I    + +E+          +I   +  
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFS 132

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           G+ Y+H+     IVHRD+K  N+LL   +KD + KI DFGL+  ++++         GT 
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTA 187

Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVT 833
            Y+APE     Y   K DV+S GV+ 
Sbjct: 188 YYIAPEVLRGTY-DEKCDVWSAGVIL 212

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  116 bits (292), Expect = 1e-28
 Identities = 44/279 (15%), Positives = 96/279 (34%), Gaps = 26/279 (9%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 123
           +L   L +       +K+LDLS N L+   +   A   +L  L++  N L       L +
Sbjct: 21  SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LES 78

Query: 124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 183
           ++TL+ L +  N        ++    +++ L  ++N+ +  +           ++ +++N
Sbjct: 79  LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANN 130

Query: 184 NFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDL-----RISDLKGSESA 237
             +       G   ++Q L ++ + ++        ++  +L  L      I D+      
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQV 188

Query: 238 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 297
                   LKTL L+   +   +         +  I L  N L   I             
Sbjct: 189 VFA----KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242

Query: 298 YLTGNKLT-GPVPKYIFNSNKNVDISLNNFTWESSDPIE 335
            L GN    G +  +   + +   ++       +    E
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  112 bits (283), Expect = 2e-27
 Identities = 54/289 (18%), Positives = 108/289 (37%), Gaps = 22/289 (7%)

Query: 70  LPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK 128
           +          K   ++ + L  + +    S   + EL + GN LS      L   T L+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 129 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 188
            L++  N+       D+  L  L+ L L++N        EL    ++  L  ++NN S +
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113

Query: 189 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM--NL 246
           +     + +  + +++  + +           + +  L +   +     F +L      L
Sbjct: 114 VSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 247 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 306
           + L L    I+ ++   +    KLK +DLS N L   +   F+  A   ++ L  NKL  
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL 228

Query: 307 PVPKYIFNSN--KNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNK 353
            + K +  S   ++ D+  N F       +         V++ +    K
Sbjct: 229 -IEKALRFSQNLEHFDLRGNGF---HCGTLRDFFSKNQRVQTVAKQTVK 273

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  117 bits (295), Expect = 2e-28
 Identities = 26/234 (11%), Positives = 62/234 (26%), Gaps = 42/234 (17%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE------------------------ 680
           +G+    +  +      G    V       R  +                          
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 681 ----FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC----LSRAIFGKDTEY 732
               F+    ++   Q   ++++     +   L   + Y +           +    + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 733 RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 792
           +  L    R ++ + + R LA LH      +VH  ++  +++LD+     ++ F      
Sbjct: 206 K-SLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 793 EEDKTHISTRIAGTIGYMAPE-----YAMRGYLTSKADVYSFGVVTLEIVSGKS 841
                    R        A             +T   D ++ G+    I     
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  115 bits (289), Expect = 2e-28
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLYGC 702
           K+G G FG V+     S G    +K ++    Q   E +  EI ++ +  HPN++K++  
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 703 CVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             + + + +V E  +   L      ++A     +E  +        ++   +   LAY H
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-------ELMKQMMNALAYFH 141

Query: 757 EDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
                 +VH+D+K  N+L          KI DFGLA+L++ D+    T  AGT  YMAPE
Sbjct: 142 S---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPE 196

Query: 814 YAMRGYLTSKADVYSFGVVT 833
              R   T K D++S GVV 
Sbjct: 197 VFKRDV-TFKCDIWSAGVVM 215

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  121 bits (304), Expect = 2e-28
 Identities = 43/205 (20%), Positives = 77/205 (37%), Gaps = 27/205 (13%)

Query: 645 KVGEGGFGSVYKG---ILSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 700
            +  GG G +Y      ++   V  +K L        +   + E   ++   HP++V+++
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPV-VLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 701 GCCVEGNQLL-----LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
                 ++       +V EY+    L R+   K       L         + I   L+YL
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-------LPVAEAIAYLLEILPALSYL 198

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
           H    I +V+ D+K  N++L ++   K+ D G               + GT G+ APE  
Sbjct: 199 H---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSFGY-LYGTPGFQAPEIV 249

Query: 816 MRGYLTSKADVYSFGVVTLEIVSGK 840
            R   T   D+Y+ G     +    
Sbjct: 250 -RTGPTVATDIYTVGRTLAALTLDL 273

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  119 bits (299), Expect = 2e-28
 Identities = 66/248 (26%), Positives = 107/248 (43%), Gaps = 32/248 (12%)

Query: 611 KVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ 669
               +   +G+ +  G+Y  ++      ++    K+G G +G V      +  +  A+K 
Sbjct: 9   SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68

Query: 670 LS------------SKSRQGNREFV-NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 716
           +             +K+ +   E + NEI ++ +  HPN++KL+    +     LV E+ 
Sbjct: 69  IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128

Query: 717 KNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 774
           +   L   I    K  E            I   I  G+ YLH+     IVHRDIK  N+L
Sbjct: 129 EGGELFEQIINRHKFDECDA-------ANIMKQILSGICYLHK---HNIVHRDIKPENIL 178

Query: 775 L---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGV 831
           L   +  LN KI DFGL+  + +D         GT  Y+APE   + Y   K DV+S GV
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPEVLKKKY-NEKCDVWSCGV 235

Query: 832 VTLEIVSG 839
           +   ++ G
Sbjct: 236 IMYILLCG 243

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  114 bits (287), Expect = 3e-28
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 19/209 (9%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQQ 692
           ++FD    +G+G FG+VY      +  ++A+K L  KS+            EI + S  +
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF-KSQLEKEGVEHQLRREIEIQSHLR 72

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HPN++++Y    +  ++ L+ E+     L    + +  ++  + D          +A  L
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHG-RFDEQRSATFMEELADAL 127

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
            Y H     K++HRDIK  N+L+      KI+DFG +      +    T + GT+ Y+ P
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPP 181

Query: 813 EYAM-RGYLTSKADVYSFGVVTLEIVSGK 840
           E    + +   K D++  GV+  E + G 
Sbjct: 182 EMIEGKTH-DEKVDLWCAGVLCYEFLVGM 209

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  114 bits (288), Expect = 3e-28
 Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 33/223 (14%)

Query: 631 RQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK--------QLSSKSRQGNREF 681
                   N++P   +G G    V + I        AVK          S++  Q  RE 
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 682 V-NEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLD 737
              E+  +     HPN+++L           LV++ MK   L   +      +E      
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE------ 123

Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
               +KI   +   +  LH+   + IVHRD+K  N+LLD D+N K++DFG +   +  + 
Sbjct: 124 -KETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179

Query: 798 HISTRIAGTIGYMAPE-------YAMRGYLTSKADVYSFGVVT 833
                + GT  Y+APE           GY   + D++S GV+ 
Sbjct: 180 L--REVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIM 219

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  113 bits (286), Expect = 4e-28
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
           G+G F  VY+   +  G  +A+K +      K+    R   NE+ +    +HP++++LY 
Sbjct: 20  GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELYN 78

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
              + N + LV E   N  ++R +  K+       +   R  +   I  G+ YLH     
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFS-ENEARHFM-HQIITGMLYLH---SH 131

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
            I+HRD+  SN+LL +++N KI+DFGLA   +       T + GT  Y++PE A R    
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHG 190

Query: 822 SKADVYSFGVVTLEIVSGK 840
            ++DV+S G +   ++ G+
Sbjct: 191 LESDVWSLGCMFYTLLIGR 209

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  114 bits (288), Expect = 1e-27
 Identities = 53/243 (21%), Positives = 98/243 (40%), Gaps = 23/243 (9%)

Query: 69  TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 128
           T  + L  L  L++L L+ + ++   SP     ++  L++  N         L+N+T L 
Sbjct: 101 TDISALQNLTNLRELYLNEDNIS-DISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLN 158

Query: 129 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 188
            L++  +      P  I  L +L  L L+ N      P  L  LT+L+      N  +  
Sbjct: 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI 214

Query: 189 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDK 243
            P  +    ++  L I  + +    P  ++ L+ LT L     +ISD+    +A   L  
Sbjct: 215 TP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI----NAVKDLT- 265

Query: 244 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 303
             LK L +    I       + ++++L ++ L+ N L          L     ++L+ N 
Sbjct: 266 -KLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322

Query: 304 LTG 306
           +T 
Sbjct: 323 ITD 325

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  112 bits (282), Expect = 5e-27
 Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 23/238 (9%)

Query: 73  ELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSI 132
            L+ L  +  L+L  N      SP      L  L+V  +++    P  + N+T L +LS+
Sbjct: 127 PLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL 184

Query: 133 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEF 192
             N      P  +  L +L       N  T   P  +  +T LN L+I +N  +   P  
Sbjct: 185 NYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238

Query: 193 IGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLK 247
           +    ++  L I  + +       +  LT L  L     +ISD+    S    L    L 
Sbjct: 239 LANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISDI----SVLNNLS--QLN 290

Query: 248 TLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 305
           +L L    +  E  + IG +T L  + LS N++T   P     L+K +        + 
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  107 bits (270), Expect = 2e-25
 Identities = 52/283 (18%), Positives = 112/283 (39%), Gaps = 37/283 (13%)

Query: 55  HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSP--QWASLQLVELSVMGNR 112
             +   L+  ++T  +     +L  + +L ++   +  S        +L+ + L+  GN+
Sbjct: 23  EGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQGIEYLTNLEYLNLN--GNQ 77

Query: 113 LSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL 172
           ++   P  L+N+  L NL I  N  T      ++ L NL++L L+ ++ +    + L  L
Sbjct: 78  ITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANL 131

Query: 173 TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----R 227
           T +  L +  N+        +     +  L +  S ++   P  I+ LT L  L     +
Sbjct: 132 TKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ 188

Query: 228 ISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 287
           I D+    S    L   +L         I    P  + +MT+L ++ +  N +T   P  
Sbjct: 189 IEDI----SPLASLT--SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238

Query: 288 FEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 327
              L++  ++ +  N+++                +++  N  +
Sbjct: 239 LANLSQLTWLEIGTNQISDINA---VKDLTKLKMLNVGSNQIS 278

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  104 bits (263), Expect = 2e-24
 Identities = 49/236 (20%), Positives = 99/236 (41%), Gaps = 17/236 (7%)

Query: 72  TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 131
              + L    +  L +  +T   + +     + +L V G +++    + +  +T L+ L+
Sbjct: 16  FPDADLAEGIRAVLQKASVTDVVTQEELE-SITKLVVAGEKVAS--IQGIEYLTNLEYLN 72

Query: 132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 191
           + GN  T   P  +  L+ L  L + +N  T    + L  LTNL +L ++++N S   P 
Sbjct: 73  LNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISP- 127

Query: 192 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKMNLKTLI 250
            +    K+  L++  +       + +S +T L  L +++ K  + +    L   +L +L 
Sbjct: 128 -LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLT--DLYSLS 183

Query: 251 LTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 306
           L    I    P  +  +T L       N +T   P     + + N + +  NK+T 
Sbjct: 184 LNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 96.8 bits (242), Expect = 8e-22
 Identities = 44/250 (17%), Positives = 88/250 (35%), Gaps = 19/250 (7%)

Query: 80  LKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG 139
              L      +     P     + +   +    ++         + ++  L + G     
Sbjct: 2   AATLATLPAPIN-QIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA- 57

Query: 140 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 199
           SI   I  L NL+ L L+ N  T   P  L+ L  L +L I  N  +      +     +
Sbjct: 58  SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNL 112

Query: 200 QKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKMNLKTLILTKCLIH 257
           ++L++   ++    P  ++ LT +  L +         S    +    L  L +T+  + 
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMT--GLNYLTVTESKVK 168

Query: 258 GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK 317
              P  I ++T L ++ L++N +    P     L   ++     N++T   P        
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVANMTRLN 224

Query: 318 NVDISLNNFT 327
           ++ I  N  T
Sbjct: 225 SLKIGNNKIT 234

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 93.0 bits (232), Expect = 2e-20
 Identities = 34/159 (21%), Positives = 68/159 (42%), Gaps = 9/159 (5%)

Query: 72  TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 131
           + L+ L  L       N +T   +P     +L  L +  N+++   P  L N++ L  L 
Sbjct: 193 SPLASLTSLHYFTAYVNQIT-DITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLE 249

Query: 132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 191
           I  N  +  I   ++ L  L+ L + SN  +    + L  L+ LN L +++N    +  E
Sbjct: 250 IGTNQIS-DINA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305

Query: 192 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 230
            IG    +  L +  + +    P  +++L+ +     ++
Sbjct: 306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFAN 342

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  112 bits (283), Expect = 1e-27
 Identities = 46/195 (23%), Positives = 77/195 (39%), Gaps = 19/195 (9%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
            +G G +G V   +        A K++     +    F  EI ++ +  HPN+++LY   
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 704 VEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
            +   + LV E      L   +       E           +I   +   +AY H+   +
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-------RIMKDVLSAVAYCHK---L 125

Query: 762 KIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 818
            + HRD+K  N L      D   K+ DFGLA  ++  K        GT  Y++P+     
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVLEGL 183

Query: 819 YLTSKADVYSFGVVT 833
           Y   + D +S GV+ 
Sbjct: 184 Y-GPECDEWSAGVMM 197

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  113 bits (286), Expect = 1e-27
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 27/207 (13%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 695
           T+ ++    +G G +    + I  +     AVK +    R    E   EI ++   QHPN
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI-LLRYGQHPN 77

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRK--KICIGIARG 751
           ++ L     +G  + +V E MK   L   I  +   +E         R+   +   I + 
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE---------REASAVLFTITKT 128

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLL-DKDLNA---KISDFGLAKLYEEDKTHISTRIAGTI 807
           + YLH      +VHRD+K SN+L  D+  N    +I DFG AK    +   + T    T 
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTA 184

Query: 808 GYMAPE-YAMRGYLTSKADVYSFGVVT 833
            ++APE    +GY  +  D++S GV+ 
Sbjct: 185 NFVAPEVLERQGY-DAACDIWSLGVLL 210

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  113 bits (285), Expect = 2e-27
 Identities = 53/253 (20%), Positives = 86/253 (33%), Gaps = 53/253 (20%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISA 690
              +     +G+G +G V   I      + A+K     ++   + +       E+ ++  
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTR------- 741
             HPN+ +LY    +   + LV E      L   +  F  D+  +  +D           
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 742 --------------------------KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 775
                                       I   I   L YLH      I HRDIK  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201

Query: 776 DKDLNA--KISDFGLAKLYEEDKTHISTR---IAGTIGYMAPE---YAMRGYLTSKADVY 827
             + +   K+ DFGL+K + +            AGT  ++APE        Y   K D +
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAW 260

Query: 828 SFGVVTLEIVSGK 840
           S GV+   ++ G 
Sbjct: 261 SAGVLLHLLLMGA 273

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  116 bits (291), Expect = 2e-27
 Identities = 46/279 (16%), Positives = 96/279 (34%), Gaps = 26/279 (9%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 123
           +L   L +       +K+LDLS N L+   +   A   +L  L++  N L       L +
Sbjct: 21  SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LES 78

Query: 124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 183
           ++TL+ L +  N     +        +++ L  ++N+ +  +           ++ +++N
Sbjct: 79  LSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANN 130

Query: 184 NFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDL-----RISDLKGSESA 237
             +       G   ++Q L ++ + ++        ++  +L  L      I D+      
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQV 188

Query: 238 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 297
                   LKTL L+   +   +         +  I L  N L   I             
Sbjct: 189 VFA----KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242

Query: 298 YLTGNKLTGPVPKYIFNSNKNV-DISLNNFTWESSDPIE 335
            L GN       +  F+ N+ V  ++       +    E
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  112 bits (282), Expect = 3e-26
 Identities = 52/259 (20%), Positives = 102/259 (39%), Gaps = 19/259 (7%)

Query: 77  LRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 135
               K   ++ + L  + +    S   + EL + GN LS      L   T L+ L++  N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 136 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGK 195
           +       D+  L  L+ L L++N        EL    ++  L  ++NN S ++     +
Sbjct: 69  VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC--SR 118

Query: 196 WKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM--NLKTLILTK 253
            +  + +++  + +           + +  L +   +     F +L      L+ L L  
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178

Query: 254 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 313
             I+ ++   +    KLK +DLS N L   +   F+  A   ++ L  NKL   + K + 
Sbjct: 179 NFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALR 234

Query: 314 NSN--KNVDISLNNFTWES 330
            S   ++ D+  N F   +
Sbjct: 235 FSQNLEHFDLRGNGFHCGT 253

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  111 bits (278), Expect = 9e-26
 Identities = 35/270 (12%), Positives = 76/270 (28%), Gaps = 17/270 (6%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKV 120
            +T     +      ++ LDL  N +        +    +L+   L++  N +       
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE--HLNLQYNFIYD-VKG- 186

Query: 121 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 180
                 LK L +  N     + P+ +    +  + L +N     +   L    NL    +
Sbjct: 187 QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDL 244

Query: 181 SDNNFS-GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 239
             N F  G + +F  K +++Q +  Q              + +L        +   + F 
Sbjct: 245 RGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304

Query: 240 ----KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 295
                L +     L          +     +  + + ID         I     +     
Sbjct: 305 DRLIALKRKEHALLSGQGSET-ERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKI 363

Query: 296 FMYLTGNKLTGPVPKYIFNSNKNVDISLNN 325
            +      L          ++  +D +L  
Sbjct: 364 TLEQKKKALD-EQVSNGRRAHAELDGTLQQ 392

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 95.3 bits (237), Expect = 1e-20
 Identities = 35/216 (16%), Positives = 71/216 (32%), Gaps = 22/216 (10%)

Query: 120 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 179
           +  N    K   +  +    ++    +   N+++L LS N  +    A+L   T L  L 
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64

Query: 180 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGS 234
           +S N       +       ++ L +  + ++      +    S+  L      IS +  S
Sbjct: 65  LSSNVLYE-TLDL-ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV--S 115

Query: 235 ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG-GIPTTFEKLAK 293
            S          K + L    I        G  ++++ +DL  N +              
Sbjct: 116 CSRGQ-----GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 294 TNFMYLTGNKLTGPVPKYIFNSN-KNVDISLNNFTW 328
              + L  N +   V   +  +  K +D+S N   +
Sbjct: 171 LEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLAF 205

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 64.9 bits (158), Expect = 5e-11
 Identities = 27/218 (12%), Positives = 59/218 (27%), Gaps = 5/218 (2%)

Query: 69  TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 128
            +   L   + L+  DL  N         + S      +V    +     +     T   
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287

Query: 129 NLSIEGNLFTGSIPPDIRKLINLQKLILS----SNSFTGELPAELTKLTNLNDLRISDNN 184
                         P   +LI L++   +      S T  L  E        ++      
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347

Query: 185 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM 244
           +   I +   + +    L  +  +L+  +     A   L       +   E      ++ 
Sbjct: 348 YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQS 407

Query: 245 NLKTLI-LTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 281
            L+ L  + K      +         +++ D+  +  T
Sbjct: 408 PLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  114 bits (286), Expect = 2e-27
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 20/202 (9%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
                  +G G FG V+K    + G  +A K + ++  +   E  NEI +++   H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----GLA 753
           +LY      N ++LV EY+    L   I  +           T     I   +    G+ 
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNL-------TELD-TILFMKQICEGIR 201

Query: 754 YLHEDSRIKIVHRDIKTSNVLL-DKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           ++H+   + I+H D+K  N+L  ++D    KI DFGLA+ Y+  +        GT  ++A
Sbjct: 202 HMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLA 256

Query: 812 PEYAMRGYLTSKADVYSFGVVT 833
           PE     +++   D++S GV+ 
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIA 278

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  111 bits (281), Expect = 3e-27
 Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 25/198 (12%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLYGC 702
            +G G F  V+       G + A+K +  KS       + NEI ++   +H N+V L   
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74

Query: 703 CVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRK--KICIGIARGLAYLHED 758
                   LV + +    L   I   G  TE         +    +   +   + YLHE 
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGVYTE---------KDASLVIQQVLSAVKYLHE- 124

Query: 759 SRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
               IVHRD+K  N+L    +++    I+DFGL+K+ +       +   GT GY+APE  
Sbjct: 125 --NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEVL 179

Query: 816 MRGYLTSKADVYSFGVVT 833
            +   +   D +S GV+T
Sbjct: 180 AQKPYSKAVDCWSIGVIT 197

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  112 bits (283), Expect = 1e-26
 Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 28/205 (13%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLS--------SKSRQGNREFVNEIGMISAQQHPN 695
            +G G  G V           +A++ +S        ++          EI ++    HP 
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           ++K+     +     +V E M+   L   + G       +L   T K     +   + YL
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYL 255

Query: 756 HEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           HE     I+HRD+K  NVLL   ++D   KI+DFG +K+  E    +   + GT  Y+AP
Sbjct: 256 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAP 310

Query: 813 E----YAMRGYLTSKADVYSFGVVT 833
           E        GY     D +S GV+ 
Sbjct: 311 EVLVSVGTAGY-NRAVDCWSLGVIL 334

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  110 bits (277), Expect = 1e-26
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 22/215 (10%)

Query: 634 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN-REFVN-----EIGM 687
           +     +    KVGEG +G VYK   S G ++A+K    + R     E +      EI +
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALK----RIRLDAEDEGIPSTAIREISL 72

Query: 688 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 747
           +    HPN+V L         L LV+E+M+ + L + +     E +  L     K     
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL----DENKTGLQDSQIKIYLYQ 127

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           + RG+A+ H+    +I+HRD+K  N+L++ D   K++DFGLA+ +       +  +  T+
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TL 183

Query: 808 GYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
            Y AP+     + Y TS  D++S G +  E+++GK
Sbjct: 184 WYRAPDVLMGSKKYSTS-VDIWSIGCIFAEMITGK 217

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  112 bits (283), Expect = 2e-26
 Identities = 57/262 (21%), Positives = 103/262 (39%), Gaps = 20/262 (7%)

Query: 69  TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 128
           +  + L+KL  L+ L  + N ++   +P      L ELS+ GN+L       L ++T L 
Sbjct: 190 SDISVLAKLTNLESLIATNNQIS-DITPLGILTNLDELSLNGNQLKDI--GTLASLTNLT 246

Query: 129 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 188
           +L +  N  +   P  +  L  L +L L +N  +   P  L  LT L +L +++N     
Sbjct: 247 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI 302

Query: 189 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKM-N 245
            P  I   K +  L +  +++    P  +S+LT L  L   +  +         L  + N
Sbjct: 303 SP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD----VSSLANLTN 354

Query: 246 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 305
           +  L      I    P  + ++T++  + L+    T         ++  N +      L 
Sbjct: 355 INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI 412

Query: 306 GPVPKYIFNSNKNVDISLNNFT 327
            P       S    DI+ N  +
Sbjct: 413 APATISDGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  110 bits (276), Expect = 2e-25
 Identities = 42/254 (16%), Positives = 93/254 (36%), Gaps = 17/254 (6%)

Query: 74  LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 133
            + L    +  L +  +T +   Q    Q+  L      +       +  +  L  ++  
Sbjct: 20  DTALAEKMKTVLGKTNVTDT-VSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 76

Query: 134 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI 193
            N  T   P  ++ L  L  +++++N         L  LTNL  L + +N  +   P  +
Sbjct: 77  NNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--L 130

Query: 194 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTK 253
                + +L +  +++       +S LTSL  L   +          L    L+ L ++ 
Sbjct: 131 KNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQVTDLKPLANLT--TLERLDISS 186

Query: 254 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 313
             +       +  +T L+++  + N ++   P     L   + + L GN+L         
Sbjct: 187 NKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASL 242

Query: 314 NSNKNVDISLNNFT 327
            +  ++D++ N  +
Sbjct: 243 TNLTDLDLANNQIS 256

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  107 bits (270), Expect = 1e-24
 Identities = 69/274 (25%), Positives = 110/274 (40%), Gaps = 21/274 (7%)

Query: 55  HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 114
             +   L   N+T T+    + L  +  L   R  +  S         L +++   N+L+
Sbjct: 25  EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLT 81

Query: 115 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 174
              P  L N+T L ++ +  N      P  +  L NL  L L +N  T   P  L  LTN
Sbjct: 82  DITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTN 135

Query: 175 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 234
           LN L +S N  S      +     +Q+L   G+ +    P  ++ LT+L  L IS  K S
Sbjct: 136 LNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVS 190

Query: 235 ESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 293
           +     L K+ NL++LI T   I    P  +G +T L  + L+ N L      T   L  
Sbjct: 191 D--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTN 244

Query: 294 TNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 327
              + L  N+++   P         + +  N  +
Sbjct: 245 LTDLDLANNQISNLAPLSGLTKLTELKLGANQIS 278

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 78.9 bits (195), Expect = 2e-15
 Identities = 34/186 (18%), Positives = 67/186 (36%), Gaps = 17/186 (9%)

Query: 126 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 185
            L + +I  +     I  D   L    K +L   + T  +    T L  +  L+      
Sbjct: 2   PLGSATITQDTPINQIFTDT-ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58

Query: 186 SGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDK 243
                + +     + +++   + L    P  +  LT L D+ +++  +    +    L  
Sbjct: 59  K--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-TPLANLT- 112

Query: 244 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 303
            NL  L L    I    P  + ++T L  ++LS N ++    +    L     +   GN+
Sbjct: 113 -NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQ 166

Query: 304 LTGPVP 309
           +T   P
Sbjct: 167 VTDLKP 172

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 66.9 bits (164), Expect = 1e-11
 Identities = 27/141 (19%), Positives = 51/141 (36%), Gaps = 7/141 (4%)

Query: 72  TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 131
           + +S L+ L  L L  N ++   SP  +  +L  L    N++S      L N+T +  LS
Sbjct: 303 SPISNLKNLTYLTLYFNNIS-DISPVSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLS 359

Query: 132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 191
              N  +   P  +  L  + +L L+  ++T         ++  N ++          P 
Sbjct: 360 AGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APA 415

Query: 192 FIGKWKKIQKLHIQGSSLEGP 212
            I       +  I  +     
Sbjct: 416 TISDGGSYTEPDITWNLPSYT 436

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 61.1 bits (149), Expect = 7e-10
 Identities = 25/154 (16%), Positives = 56/154 (36%), Gaps = 10/154 (6%)

Query: 175 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 234
           L    I+ +    +I        +  K  +  +++   +    + L  +T L+   L   
Sbjct: 3   LGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59

Query: 235 E-SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 293
                  L+  NL  +  +   +    P  + ++TKL +I ++ N +    P     L  
Sbjct: 60  SIDGVEYLN--NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTN 113

Query: 294 TNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 327
              + L  N++T   P     +   +++S N  +
Sbjct: 114 LTGLTLFNNQITDIDPLKNLTNLNRLELSSNTIS 147

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 58.4 bits (142), Expect = 6e-09
 Identities = 24/142 (16%), Positives = 51/142 (35%), Gaps = 28/142 (19%)

Query: 72  TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 131
           + +S L  L++L    N ++   S       +  LS   N++S   P  L N+T +  L 
Sbjct: 325 SPVSSLTKLQRLFFYNNKVS-DVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 381

Query: 132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN-------- 183
           +    +T + P + +  +++   + +        PA ++   +  +  I+ N        
Sbjct: 382 LNDQAWT-NAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSYTNEV 439

Query: 184 ---------------NFSGKIP 190
                           FSG + 
Sbjct: 440 SYTFSQPVTIGKGTTTFSGTVT 461

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  110 bits (277), Expect = 2e-26
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 32/222 (14%)

Query: 637 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 695
            + F      G+G FG+V  G     G  +A+K++    R  NRE +  +  ++   HPN
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80

Query: 696 LVKLYGCCVEGNQ-------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR--KKICI 746
           +V+L        +       L +V EY+ +  L R        YR ++  P    K    
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCC---RNYYRRQVAPPPILIKVFLF 136

Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAKLYEEDKTHIS--- 800
            + R +  LH  S   + HRDIK  NVL+++    L  K+ DFG AK     + +++   
Sbjct: 137 QLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSEPNVAYIC 193

Query: 801 TRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
           +R      Y APE  +  + Y T+  D++S G +  E++ G+
Sbjct: 194 SRY-----YRAPELIFGNQHY-TTAVDIWSVGCIFAEMMLGE 229

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  109 bits (275), Expect = 3e-26
 Identities = 64/215 (29%), Positives = 114/215 (53%), Gaps = 19/215 (8%)

Query: 635 AATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIGMI 688
           ++++ F    K+G G + +VYKG+  + G  +A+K    + +  + E        EI ++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK----EVKLDSEEGTPSTAIREISLM 57

Query: 689 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-LDWPTRKKICIG 747
              +H N+V+LY      N+L LV+E+M N+ L + +  +      + L+    K     
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQ 116

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           + +GLA+ HE+   KI+HRD+K  N+L++K    K+ DFGLA+ +       S+ +  T+
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TL 172

Query: 808 GYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
            Y AP+     R Y TS  D++S G +  E+++GK
Sbjct: 173 WYRAPDVLMGSRTYSTS-IDIWSCGCILAEMITGK 206

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  108 bits (273), Expect = 3e-26
 Identities = 48/211 (22%), Positives = 84/211 (39%), Gaps = 33/211 (15%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMI-----------SAQQHP 694
           G+GGFG+V+ G  L+D   +A+K +  ++R      +++               +   HP
Sbjct: 40  GKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRKKICIGIAR 750
            +++L          +LV E             +D       +  L     +     +  
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLP--------AQDLFDYITEKGPLGEGPSRCFFGQVVA 150

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
            + + H      +VHRDIK  N+L+D     AK+ DFG   L  ++         GT  Y
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVY 204

Query: 810 MAPEY-AMRGYLTSKADVYSFGVVTLEIVSG 839
             PE+ +   Y    A V+S G++  ++V G
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  109 bits (275), Expect = 4e-26
 Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 18/216 (8%)

Query: 633 IKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIG 686
           +K+    ++  + +GEG F +VYK    +   ++A+K++    R   ++ +N     EI 
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64

Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 746
           ++    HPN++ L       + + LV+++M+ + L   I  KD    L L     K   +
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVII--KDN--SLVLTPSHIKAYML 119

Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 806
              +GL YLH+     I+HRD+K +N+LLD++   K++DFGLAK +       + ++  T
Sbjct: 120 MTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-T 175

Query: 807 IGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
             Y APE  +  R Y     D+++ G +  E++   
Sbjct: 176 RWYRAPELLFGARMYGVG-VDMWAVGCILAELLLRV 210

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  108 bits (271), Expect = 4e-26
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 20/205 (9%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFV-NEIGMISAQQH 693
           ++N+D   ++G+G F  V + +  + G   A K ++  K    + + +  E  +    QH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARG 751
           PN+V+L+    E +   LV++ +    L   I      +E                I   
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD-------ASHCIQQILES 117

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
           +AY H      IVHR++K  N+LL    K    K++DFGLA    + +       AGT G
Sbjct: 118 IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPG 172

Query: 809 YMAPEYAMRGYLTSKADVYSFGVVT 833
           Y++PE   +   +   D+++ GV+ 
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVIL 197

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  108 bits (272), Expect = 4e-26
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISAQ 691
             +    K+GEG +G VYK   + G   A+K    K R     E +      EI ++   
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALK----KIRLEKEDEGIPSTTIREISILKEL 57

Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +H N+VKLY       +L+LV+E++  + L + +          L+  T K   + +  G
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL----DVCEGGLESVTAKSFLLQLLNG 112

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           +AY H+    +++HRD+K  N+L++++   KI+DFGLA+ +       +  I  T+ Y A
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRA 168

Query: 812 PE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
           P+     + Y T+  D++S G +  E+V+G 
Sbjct: 169 PDVLMGSKKYSTT-IDIWSVGCIFAEMVNGT 198

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  110 bits (276), Expect = 5e-26
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 20/204 (9%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 695
            + +D   ++G G FG V++ +  + G V   K +++          NEI +++   HP 
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----G 751
           L+ L+    +  +++L+ E++    L   I  +D +        +  +  I   R    G
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM-------SEAE-VINYMRQACEG 161

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 809
           L ++HE     IVH DIK  N++    K  + KI DFGLA     D+         T  +
Sbjct: 162 LKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEF 216

Query: 810 MAPEYAMRGYLTSKADVYSFGVVT 833
            APE   R  +    D+++ GV+ 
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLG 240

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  108 bits (273), Expect = 5e-26
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 28/213 (13%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--------SKSRQGNREFVNEIGM 687
            + +  +  +G G  G V           +A+K +S        ++          EI +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 688 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 747
           +    HP ++K+     +     +V E M+   L   + G       +L   T K     
Sbjct: 69  LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQ 122

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIA 804
           +   + YLHE     I+HRD+K  NVLL   ++D   KI+DFG +K+  E    + T + 
Sbjct: 123 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRT-LC 177

Query: 805 GTIGYMAPE----YAMRGYLTSKADVYSFGVVT 833
           GT  Y+APE        GY     D +S GV+ 
Sbjct: 178 GTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVIL 209

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  108 bits (273), Expect = 7e-26
 Identities = 50/203 (24%), Positives = 77/203 (37%), Gaps = 14/203 (6%)

Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISAQQH 693
           ++    +G+G F  V + I    G   AVK     + +S       +   E  +    +H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P++V+L         L +V+E+M    L   I  +                   I   L 
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF-VYSEAVASHYMRQILEALR 144

Query: 754 YLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 810
           Y H+     I+HRD+K   VLL   +     K+  FG+A    E       R+ GT  +M
Sbjct: 145 YCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFM 200

Query: 811 APEYAMRGYLTSKADVYSFGVVT 833
           APE   R       DV+  GV+ 
Sbjct: 201 APEVVKREPYGKPVDVWGCGVIL 223

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  108 bits (272), Expect = 7e-26
 Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 25/198 (12%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNLVKLYGC 702
            +GEG F    K +        AVK +S +     +    EI  +   + HPN+VKL+  
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLHEV 74

Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRK--KICIGIARGLAYLHED 758
             +     LV E +    L   I  K   +E          +   I   +   ++++H+ 
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSE---------TEASYIMRKLVSAVSHMHD- 124

Query: 759 SRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
             + +VHRD+K  N+L    + +L  KI DFG A+L   D   + T    T+ Y APE  
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELL 181

Query: 816 MRGYLTSKADVYSFGVVT 833
            +       D++S GV+ 
Sbjct: 182 NQNGYDESCDLWSLGVIL 199

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  107 bits (270), Expect = 8e-26
 Identities = 57/228 (25%), Positives = 89/228 (39%), Gaps = 62/228 (27%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQ--------- 692
           G+G +G V      +D T  A+K LS     +     R         +            
Sbjct: 22  GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81

Query: 693 -------------HPNLVKLYGCCV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK 735
                        HPN+VKL    V      + L +V+E +    +              
Sbjct: 82  QVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPV-------------- 125

Query: 736 LDWPTRKKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 787
           ++ PT K +    AR        G+ YLH     KI+HRDIK SN+L+ +D + KI+DFG
Sbjct: 126 MEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 788 LAKLYEEDKTHISTRIAGTIGYMAPE---YAMRGYLTSKADVYSFGVV 832
           ++  ++     +S    GT  +MAPE      + +     DV++ GV 
Sbjct: 183 VSNEFKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  106 bits (268), Expect = 1e-25
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 31/213 (14%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFV-NEIGMIS 689
            ++++   ++G G F  V K      G   A K     +LSS  R  +RE +  E+ ++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMK-----NNCLSRAIFGKDTEYRLKLDWPTRKKI 744
             +HPN++ L+        ++L+ E +      +    +      TE           + 
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL---TE-------DEATQF 113

Query: 745 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHIS 800
              I  G+ YLH     +I H D+K  N++L      +   K+ DFG+A   E       
Sbjct: 114 LKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-- 168

Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 833
             I GT  ++APE      L  +AD++S GV+T
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  107 bits (269), Expect = 1e-25
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 23/212 (10%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 690
             ++   K+GEG +G V+K      G ++A+K    K  +      +      EI M+  
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQ 58

Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 750
            +HPNLV L        +L LV+EY  +  +   +      Y+  +     K I     +
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHEL----DRYQRGVPEHLVKSITWQTLQ 113

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 810
            + + H+      +HRD+K  N+L+ K    K+ DFG A+L      +    +A T  Y 
Sbjct: 114 AVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYR 169

Query: 811 APE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
           +PE       Y     DV++ G V  E++SG 
Sbjct: 170 SPELLVGDTQYGPP-VDVWAIGCVFAELLSGV 200

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  107 bits (270), Expect = 1e-25
 Identities = 39/205 (19%), Positives = 81/205 (39%), Gaps = 23/205 (11%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHP 694
              +  A  +G G FG V++ +  S       K +  K    ++  V  EI +++  +H 
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHR 61

Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR---- 750
           N++ L+       +L++++E++    +   I     E          ++  +        
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFEL-------NERE-IVSYVHQVCE 113

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
            L +LH  +   I H DI+  N++    +    KI +FG A+  +         +     
Sbjct: 114 ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPE 168

Query: 809 YMAPEYAMRGYLTSKADVYSFGVVT 833
           Y APE      +++  D++S G + 
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLV 193

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  107 bits (270), Expect = 1e-25
 Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 34/231 (14%)

Query: 620 GLDLQTGLYTLRQIKAATNNFDPANKV-GEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQ 676
           G+DL T     + ++   N +   +K  G G F  V + I  S G   A K L   +  Q
Sbjct: 10  GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69

Query: 677 GNREFV-NEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMK-----NNCLSRAIFGKD 729
             R  + +EI  +  A+  P ++ L+      ++++L+ EY       + CL        
Sbjct: 70  DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL-AEMV 128

Query: 730 TEYRLKLDWPTRKKICIGIAR----GLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAK 782
           +E              I + +    G+ YLH+     IVH D+K  N+LL       + K
Sbjct: 129 SE-----------NDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIK 174

Query: 783 ISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 833
           I DFG+++            I GT  Y+APE      +T+  D+++ G++ 
Sbjct: 175 IVDFGMSRKIGHACEL--REIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  108 bits (271), Expect = 2e-25
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 26/221 (11%)

Query: 626 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNR 679
           G+ T +Q +   + +D   ++G G F  V K    S G   A K     Q  +  R   R
Sbjct: 1   GMETFKQ-QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR 59

Query: 680 EFV-NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKL 736
           E +  E+ ++    HPN++ L+        ++L+ E +    L   +  K+  +E     
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-- 117

Query: 737 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLY 792
                      I  G+ YLH     KI H D+K  N++L        + K+ DFGLA   
Sbjct: 118 -----TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169

Query: 793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 833
           E+        I GT  ++APE      L  +AD++S GV+T
Sbjct: 170 EDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  111 bits (278), Expect = 2e-25
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 22/213 (10%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHP 694
            +++D   ++G G FG V++    + G   A K +     + ++E V  EI  +S  +HP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHP 214

Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR---- 750
            LV L+    + N+++++YE+M    L   +  +  +        +  +  +   R    
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM-------SEDE-AVEYMRQVCK 266

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLL-DKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIG 808
           GL ++HE      VH D+K  N++   K  N  K+ DFGL    +  ++       GT  
Sbjct: 267 GLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAE 321

Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           + APE A    +    D++S GV++  ++SG S
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 354

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  107 bits (269), Expect = 2e-25
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 23/212 (10%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 690
             ++    VGEG +G V K      G ++A+K    K  + +  + V      EI ++  
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----KFLESDDDKMVKKIAMREIKLLKQ 80

Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 750
            +H NLV L   C +  +  LV+E++ +  +   +      +   LD+   +K    I  
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDL----ELFPNGLDYQVVQKYLFQIIN 135

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 810
           G+ + H      I+HRDIK  N+L+ +    K+ DFG A+            +A T  Y 
Sbjct: 136 GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYR 191

Query: 811 APE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
           APE       Y  +  DV++ G +  E+  G+
Sbjct: 192 APELLVGDVKYGKA-VDVWAIGCLVTEMFMGE 222

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  106 bits (268), Expect = 2e-25
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 25/210 (11%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFV-NEIGMIS 689
            + +D   ++G G F  V K    S G   A K     Q  +  R  +RE +  E+ ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIG 747
              H N++ L+        ++L+ E +    L   +  K+  +E                
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-------TSFIKQ 123

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLL-DKDLNA---KISDFGLAKLYEEDKTHISTRI 803
           I  G+ YLH     KI H D+K  N++L DK++     K+ DFGLA   E+        I
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNI 178

Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVT 833
            GT  ++APE      L  +AD++S GV+T
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  106 bits (267), Expect = 3e-25
 Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 22/211 (10%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIGMISAQ 691
             +   +K+GEG + +VYKG       ++A+K    + R  + E        E+ ++   
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKDL 57

Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +H N+V L+        L LV+EY+  + L + +     +    ++    K     + RG
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYL----DDCGNIINMHNVKLFLFQLLRG 112

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
           LAY H     K++HRD+K  N+L+++    K++DFGLA+            +  T+ Y  
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRP 168

Query: 812 PE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
           P+       Y T   D++  G +  E+ +G+
Sbjct: 169 PDILLGSTDYSTQ-IDMWGVGCIFYEMATGR 198

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  106 bits (267), Expect = 3e-25
 Identities = 53/208 (25%), Positives = 82/208 (39%), Gaps = 29/208 (13%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIGMISAQQHPNL 696
           G G FG V+  +       + VK +  K +     ++          EI ++S  +H N+
Sbjct: 33  GSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRKKICIGIARGL 752
           +K+           LV E   +        G D     +   +LD P    I   +   +
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGS--------GLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
            YL       I+HRDIK  N+++ +D   K+ DFG A   E  K    T   GTI Y AP
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT-FCGTIEYCAP 198

Query: 813 E-YAMRGYLTSKADVYSFGVVTLEIVSG 839
           E      Y   + +++S GV    +V  
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFE 226

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  108 bits (272), Expect = 4e-25
 Identities = 46/207 (22%), Positives = 87/207 (42%), Gaps = 23/207 (11%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFV-NEIGMISAQQH 693
           T  +    ++G+G F  V + + +  G   A   ++  K    + + +  E  +    +H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRK--KICIGIA 749
           PN+V+L+    E     L+++ +    L   I      +E                  I 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE---------ADASHCIQQIL 120

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 806
             + + H+   + +VHR++K  N+LL    K    K++DFGLA   E ++       AGT
Sbjct: 121 EAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGT 176

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVT 833
            GY++PE   +       D+++ GV+ 
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVIL 203

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  106 bits (266), Expect = 4e-25
 Identities = 48/208 (23%), Positives = 76/208 (36%), Gaps = 34/208 (16%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNLVKLYGCCV 704
           GEG    V   I L      AVK +  +          E+  +   Q H N+++L     
Sbjct: 22  GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81

Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRK--KICIGIARGLAYLHEDSR 760
           E ++  LV+E M+   +   I  +    E          +   +   +A  L +LH    
Sbjct: 82  EEDRFYLVFEKMRGGSILSHIHKRRHFNE---------LEASVVVQDVASALDFLHN--- 129

Query: 761 IKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTR------IAGTIGYMA 811
             I HRD+K  N+L    ++    KI DF L    + +               G+  YMA
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 812 PE------YAMRGYLTSKADVYSFGVVT 833
           PE           Y   + D++S GV+ 
Sbjct: 190 PEVVEAFSEEASIY-DKRCDLWSLGVIL 216

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  106 bits (266), Expect = 4e-25
 Identities = 50/276 (18%), Positives = 92/276 (33%), Gaps = 65/276 (23%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPN 695
            +F+P   +G GGFG V++     D    A+K++   +R+  RE V  E+  ++  +HP 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI----------- 744
           +V+ +   +E        E  +      +     +          + +            
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 745 -----------------CIG------IARGLAYLHEDSRI------------------KI 763
                            C        + R  +    +  +                   +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEED-----------KTHISTRIAGTIGYMAP 812
           +HRD+K SN+    D   K+ DFGL    ++D                T   GT  YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 848
           E       + K D++S G++  E++   S    R  
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR 281

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  105 bits (265), Expect = 4e-25
 Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)

Query: 636 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIG--- 686
           AT+ ++P  ++G G +G+VYK      G  +A+K +   +  G    +      E+    
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 687 MISAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 741
            + A +HPN+V+L   C         ++ LV+E++  + L   +   D      L   T 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL---DKAPPPGLPAETI 122

Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
           K +     RGL +LH +    IVHRD+K  N+L+      K++DFGLA++Y        T
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--T 177

Query: 802 RIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK 840
            +  T+ Y APE  +   Y T   D++S G +  E+   K
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRK 216

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  105 bits (265), Expect = 5e-25
 Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 39/225 (17%)

Query: 629 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFV 682
           T+ + +   + +D   ++G G F  V K    S G   A K     +  S  R  +RE +
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61

Query: 683 -NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK-----NNCLSRAIFGKDTEYRLKL 736
             E+ ++   QHPN++ L+        ++L+ E +      +    +      TE     
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TE----- 113

Query: 737 DWPTRKKICIGIAR----GLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGL 788
                 +      +    G+ YLH    ++I H D+K  N++L          KI DFGL
Sbjct: 114 ------EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164

Query: 789 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 833
           A   +         I GT  ++APE      L  +AD++S GV+T
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  107 bits (269), Expect = 6e-25
 Identities = 64/218 (29%), Positives = 95/218 (43%), Gaps = 31/218 (14%)

Query: 637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 696
              +     +G G FG V++  L +   +A+K++    R  NR    E+ ++   +HPN+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94

Query: 697 VKLYGCCVEGNQ------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR--KKICIGI 748
           V L               L LV EY+    + RA        +LK   P    K     +
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRAS---RHYAKLKQTMPMLLIKLYMYQL 150

Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDK--TH-ISTRIA 804
            R LAY+H    I I HRDIK  N+LLD      K+ DFG AK+    +     I +R  
Sbjct: 151 LRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY- 206

Query: 805 GTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
               Y APE  +    Y T+  D++S G V  E++ G+
Sbjct: 207 ----YRAPELIFGATNY-TTNIDIWSTGCVMAELMQGQ 239

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  105 bits (264), Expect = 7e-25
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 23/206 (11%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-------EIGMISAQQH--PNL 696
           G GGFGSVY GI +SD   +A+K +  K R  +   +        E+ ++         +
Sbjct: 52  GSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           ++L       +  +L+ E  +     + +F   TE R  L     +     +   + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 166

Query: 757 EDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 814
                 ++HRDIK  N+L+D +    K+ DFG   L ++          GT  Y  PE+ 
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWI 220

Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
               Y    A V+S G++  ++V G 
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGD 246

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  104 bits (262), Expect = 8e-25
 Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 23/210 (10%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 690
             ++   K+GEG +G+V+K        ++A+K    + R  +  E V      EI ++  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALK----RVRLDDDDEGVPSSALREICLLKE 57

Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 750
            +H N+V+L+       +L LV+E+   + L +            LD    K     + +
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYF----DSCNGDLDPEIVKSFLFQLLK 112

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 810
           GL + H      ++HRD+K  N+L++++   K+++FGLA+ +       S  +  T+ Y 
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYR 168

Query: 811 APE--YAMRGYLTSKADVYSFGVVTLEIVS 838
            P+  +  + Y TS  D++S G +  E+ +
Sbjct: 169 PPDVLFGAKLYSTS-IDMWSAGCIFAELAN 197

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  107 bits (269), Expect = 1e-24
 Identities = 63/312 (20%), Positives = 120/312 (38%), Gaps = 40/312 (12%)

Query: 47  CDCSSATCHV------------------VTIALKAQNLTGTLPTELSKLRYLKQLDLSRN 88
           C+CS+    V                    + L    +      E +   +L++L+L+ N
Sbjct: 7   CECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66

Query: 89  CLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPD 144
            ++    G+F+    +L+ + L    NRL      V T ++ L  L I  N     +   
Sbjct: 67  IVSAVEPGAFNNL-FNLRTLGLR--SNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDY 122

Query: 145 I-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPE--FIGKWKKIQ 200
           + + L NL+ L +  N     +     + L +L  L +   N +  IP          + 
Sbjct: 123 MFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSH-LHGLI 179

Query: 201 KLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK-LDKMNLKTLILTKCLIHGE 259
            L ++  ++      S   L  L  L IS     ++  P  L  +NL +L +T C +   
Sbjct: 180 VLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-A 238

Query: 260 IPDY-IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 318
           +P   +  +  L+ ++LS+N ++    +   +L +   + L G +L   V  Y F     
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAV-VEPYAFRGLNY 297

Query: 319 V---DISLNNFT 327
           +   ++S N  T
Sbjct: 298 LRVLNVSGNQLT 309

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  100 bits (252), Expect = 2e-22
 Identities = 51/249 (20%), Positives = 87/249 (34%), Gaps = 23/249 (9%)

Query: 69  TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 123
            +P    + L  L +LD+S N +       F        L  L V  N L     +  + 
Sbjct: 94  LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDL---YNLKSLEVGDNDLVYISHRAFSG 150

Query: 124 ITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRIS 181
           + +L+ L++E    T SIP +    L  L  L L   +    +      +L  L  L IS
Sbjct: 151 LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEIS 208

Query: 182 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSES 236
              +   +         +  L I   +L      ++  L  L  L      IS +    S
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTI--EGS 266

Query: 237 AFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 295
              +L    L+ + L    +   +  Y    +  L+ +++S N LT    + F  +    
Sbjct: 267 MLHELL--RLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLE 323

Query: 296 FMYLTGNKL 304
            + L  N L
Sbjct: 324 TLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 26/135 (19%), Positives = 47/135 (34%), Gaps = 11/135 (8%)

Query: 58  TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRL 113
            + +       T+         L  L ++   LT     +       L+ + LS   N +
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHL-VYLRFLNLS--YNPI 260

Query: 114 SGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TK 171
           S     +L  +  L+ + + G      + P   R L  L+ L +S N  T  L   +   
Sbjct: 261 STIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318

Query: 172 LTNLNDLRISDNNFS 186
           + NL  L +  N  +
Sbjct: 319 VGNLETLILDSNPLA 333

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  105 bits (263), Expect = 1e-24
 Identities = 57/197 (28%), Positives = 82/197 (41%), Gaps = 24/197 (12%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           ++G G    VY+          A+K L     +       EIG++    HPN++KL    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPNIIKLKEIF 117

Query: 704 VEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRK--KICIGIARGLAYLHEDS 759
               ++ LV E +    L   I   G  +E         R        I   +AYLHE  
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSE---------RDAADAVKQILEAVAYLHE-- 166

Query: 760 RIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
              IVHRD+K  N+L      D   KI+DFGL+K+ E         + GT GY APE   
Sbjct: 167 -NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILR 223

Query: 817 RGYLTSKADVYSFGVVT 833
                 + D++S G++T
Sbjct: 224 GCAYGPEVDMWSVGIIT 240

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  104 bits (262), Expect = 2e-24
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 14/198 (7%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFVN-EIGMISAQQHPNLVKLYGCC 703
           G+G F  V     +  G  +A+K +  ++    + + +  E+ ++    HPN+VKL+   
Sbjct: 24  GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
                L L+ EY     +   +         ++     +     I   + Y H   + +I
Sbjct: 84  ETEKTLYLIMEYASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCH---QKRI 135

Query: 764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYLTS 822
           VHRD+K  N+LLD D+N KI+DFG +  +      +     G   Y APE +  + Y   
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAF-CGAPPYAAPELFQGKKYDGP 193

Query: 823 KADVYSFGVVTLEIVSGK 840
           + DV+S GV+   +VSG 
Sbjct: 194 EVDVWSLGVILYTLVSGS 211

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  105 bits (264), Expect = 2e-24
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 26/208 (12%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQ 692
           ++N+D   ++G+G F  V + +  + G   A K ++   +   R+      E  +    Q
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQ 86

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRK--KICIGI 748
           HPN+V+L+    E +   LV++ +    L   I      +E                  I
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE---------ADASHCIQQI 137

Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
              +AY H      IVHR++K  N+LL    K    K++DFGLA    + +       AG
Sbjct: 138 LESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAG 192

Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVT 833
           T GY++PE   +   +   D+++ GV+ 
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  102 bits (257), Expect = 3e-24
 Identities = 62/194 (31%), Positives = 88/194 (45%), Gaps = 20/194 (10%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLVKLYGCCV 704
           GEG +G V   +       +AVK +  K      E +  EI +     H N+VK YG   
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75

Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK----ICIGIARGLAYLHEDSR 760
           EGN   L  EY     L   I        +      ++     +      G+ YLH    
Sbjct: 76  EGNIQYLFLEYCSGGELFDRIEPDI---GMPEP-DAQRFFHQLMA-----GVVYLH---G 123

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE-YAMRG 818
           I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE    R 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 819 YLTSKADVYSFGVV 832
           +     DV+S G+V
Sbjct: 184 FHAEPVDVWSCGIV 197

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  107 bits (269), Expect = 3e-24
 Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 29/224 (12%)

Query: 631 RQIKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNE-- 684
             I    N+F     +G GGFG VY    +D G + A+K L  K    +QG    +NE  
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241

Query: 685 -IGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWP 739
            + ++S    P +V +       ++L  + + M          G D  Y L         
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN---------GGDLHYHLSQHGVFSEA 292

Query: 740 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 799
             +     I  GL ++H      +V+RD+K +N+LLD+  + +ISD GLA  + + K H 
Sbjct: 293 DMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH- 348

Query: 800 STRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKS 841
                GT GYMAPE   +   Y  S AD +S G +  +++ G S
Sbjct: 349 -AS-VGTHGYMAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGHS 389

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  105 bits (265), Expect = 4e-24
 Identities = 45/240 (18%), Positives = 81/240 (33%), Gaps = 39/240 (16%)

Query: 69  TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTL 127
            LP     L ++       N L     P+  +L  L  +    N L    P +  +   L
Sbjct: 167 KLPDLPPSLEFI---AAGNNQLE--ELPELQNLPFLTAIYADNNSLKK-LPDLPLS---L 217

Query: 128 KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 187
           +++    N+      P+++ L  L  +   +N     LP     L  LN   + DN  + 
Sbjct: 218 ESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN---VRDNYLT- 270

Query: 188 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT--DLRISDLKGSESAFPKLDKMN 245
            +PE       +       S L          L  L      I  L             +
Sbjct: 271 DLPELPQSLTFLDVSENIFSGL----SELPPNLYYLNASSNEIRSLCDLPP--------S 318

Query: 246 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 305
           L+ L ++   +  E+P       +L+ +  SFN+L   +P   + L +   +++  N L 
Sbjct: 319 LEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLKQ---LHVEYNPLR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 99.7 bits (249), Expect = 3e-22
 Identities = 50/251 (19%), Positives = 95/251 (37%), Gaps = 39/251 (15%)

Query: 69  TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 128
               EL  L +L  +    N L  +      SL+   L+V  N L+   P++  ++T L 
Sbjct: 228 EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE--ALNVRDNYLTD-LPELPQSLTFLD 283

Query: 129 NLSIEGNLFTGSIPPDIRKLI--------------NLQKLILSSNSFTGELPAELTKLTN 174
                 +  +  +PP++  L               +L++L +S+N    ELPA   +L  
Sbjct: 284 VSENIFSGLS-ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER 341

Query: 175 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 234
           L     S N+ + ++PE       +++LH++ + L    P       S+ DLR++     
Sbjct: 342 LI---ASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPDIPE---SVEDLRMNSHLAE 390

Query: 235 ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 294
               P+    NLK L +    +  E PD       ++++ ++   +        E   K 
Sbjct: 391 VPELPQ----NLKQLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKL 442

Query: 295 NFMYLTGNKLT 305
                  +   
Sbjct: 443 EDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 99.7 bits (249), Expect = 4e-22
 Identities = 47/273 (17%), Positives = 98/273 (35%), Gaps = 56/273 (20%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--------------QLVELSVMG 110
           NLT  +P E   ++   +   + +    +  P                   Q  EL +  
Sbjct: 22  NLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNN 80

Query: 111 NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELT 170
             LS   P++  +   L++L    N  T  +P   + L +L     +  + + +LP  L 
Sbjct: 81  LGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-DLPPLLE 134

Query: 171 KL----------------TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 214
            L                + L  + + +N+   K+P+       ++ +    + LE  +P
Sbjct: 135 YLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLEE-LP 189

Query: 215 ASISALTSLTDLRISDLKGSESAFPKLDKM--NLKTLILTKCLIHGEIPDYIGDMTKLKN 272
             +  L  LT +   +         KL  +  +L++++    ++  E+P+ + ++  L  
Sbjct: 190 -ELQNLPFLTAIYADNNS-----LKKLPDLPLSLESIVAGNNILE-ELPE-LQNLPFLTT 241

Query: 273 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 305
           I    N L   +P     L     + +  N LT
Sbjct: 242 IYADNNLLK-TLPDLPPSLEA---LNVRDNYLT 270

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 80.4 bits (199), Expect = 6e-16
 Identities = 32/196 (16%), Positives = 71/196 (36%), Gaps = 35/196 (17%)

Query: 125 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL------------ 172
           T L+      +  T  +P +   + +  +   + + +    P    +             
Sbjct: 11  TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69

Query: 173 -TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT--DLRIS 229
               ++L +++   S  +PE       ++ L    +SL   +P    +L SL   +  + 
Sbjct: 70  DRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 124

Query: 230 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 289
            L    S  P      L+ L ++   +  ++P+ + + + LK ID+  N+L   +P    
Sbjct: 125 AL----SDLPP----LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPP 173

Query: 290 KLAKTNFMYLTGNKLT 305
            L     +    N+L 
Sbjct: 174 SLEF---IAAGNNQLE 186

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 42.7 bits (101), Expect = 5e-04
 Identities = 15/78 (19%), Positives = 28/78 (35%), Gaps = 6/78 (7%)

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 120
           L+  +    +P        LKQL +  N L   F     S++  +L +   R+  P+   
Sbjct: 382 LRMNSHLAEVPELPQN---LKQLHVETNPLR-EFPDIPESVE--DLRMNSERVVDPYEFA 435

Query: 121 LTNITTLKNLSIEGNLFT 138
                 L++   E +   
Sbjct: 436 HETTDKLEDDVFEHHHHH 453

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  103 bits (259), Expect = 4e-24
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 29/217 (13%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 690
           + +    K+GEG +G VYK I       +A+K    + R  +  E V      E+ ++  
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIK----RIRLEHEEEGVPGTAIREVSLLKE 89

Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 750
            QH N+++L       ++L L++EY +N+ L + +     +    +     K     +  
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYM-----DKNPDVSMRVIKSFLYQLIN 143

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-----KISDFGLAKLYEEDKTHISTRIAG 805
           G+ + H     + +HRD+K  N+LL     +     KI DFGLA+ +       +  I  
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII- 199

Query: 806 TIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 840
           T+ Y  PE  +  R Y TS  D++S   +  E++   
Sbjct: 200 TLWYRPPEILLGSRHYSTS-VDIWSIACIWAEMLMKT 235

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  104 bits (262), Expect = 5e-24
 Identities = 66/219 (30%), Positives = 95/219 (43%), Gaps = 32/219 (14%)

Query: 637 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 695
             ++     +G G FG VY+  L D G ++A+K++    R  NRE    + ++    H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCN 108

Query: 696 LVKLYGCCVEGNQ------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR--KKICIG 747
           +V+L        +      L LV +Y+    + R         R K   P    K     
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVA---RHYSRAKQTLPVIYVKLYMYQ 164

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDK--TH-ISTRI 803
           + R LAY+H      I HRDIK  N+LLD D    K+ DFG AK     +     I +R 
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221

Query: 804 AGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                Y APE  +    Y TS  DV+S G V  E++ G+
Sbjct: 222 -----YRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 254

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  103 bits (258), Expect = 6e-24
 Identities = 52/202 (25%), Positives = 80/202 (39%), Gaps = 35/202 (17%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-- 703
           G G  G V +      G   A+K L   S +  +E   +     A   P++V +      
Sbjct: 38  GLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEV--DH-HWQASGGPHIVCILDVYEN 93

Query: 704 --VEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRK--KICIGIARGLAYL 755
                  LL++ E M+   L   I  +     TE         R+  +I   I   + +L
Sbjct: 94  MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE---------REAAEIMRDIGTAIQFL 144

Query: 756 HEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           H      I HRD+K  N+L    +KD   K++DFG AK   ++   + T    T  Y+AP
Sbjct: 145 HS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT-PCYTPYYVAP 198

Query: 813 E-YAMRGYLTSKADVYSFGVVT 833
           E      Y     D++S GV+ 
Sbjct: 199 EVLGPEKY-DKSCDMWSLGVIM 219

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  102 bits (257), Expect = 6e-24
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 33/221 (14%)

Query: 638 NNFDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGN----------REFVNEI 685
             ++   ++GEG +G V+K   + + G  +A+K    + R             RE V  +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALK----RVRVQTGEEGMPLSTIRE-VAVL 65

Query: 686 GMISAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 740
             +   +HPN+V+L+  C         +L LV+E++  + L+  +   D      +   T
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL---DKVPEPGVPTET 121

Query: 741 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 800
            K +   + RGL +LH     ++VHRD+K  N+L+      K++DFGLA++Y        
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 176

Query: 801 TRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK 840
           T +  T+ Y APE  +   Y T   D++S G +  E+   K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRK 216

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  102 bits (256), Expect = 7e-24
 Identities = 62/194 (31%), Positives = 88/194 (45%), Gaps = 20/194 (10%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLVKLYGCCV 704
           GEG +G V   +       +AVK +  K      E +  EI +     H N+VK YG   
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75

Query: 705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK----ICIGIARGLAYLHEDSR 760
           EGN   L  EY     L   I        +      ++     +      G+ YLH    
Sbjct: 76  EGNIQYLFLEYCSGGELFDRIEPDI---GMPEP-DAQRFFHQLMA-----GVVYLH---G 123

Query: 761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE-YAMRG 818
           I I HRDIK  N+LLD+  N KISDFGLA ++   ++  +  ++ GT+ Y+APE    R 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 819 YLTSKADVYSFGVV 832
           +     DV+S G+V
Sbjct: 184 FHAEPVDVWSCGIV 197

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  106 bits (267), Expect = 8e-24
 Identities = 55/299 (18%), Positives = 99/299 (33%), Gaps = 34/299 (11%)

Query: 61  LKAQNLTGTLPTE-LSKLRYLKQLDLSRNCLTGSFSPQW-ASLQ-LVELSVMGNRLSGPF 117
           L +Q    T+  E    L  L+ LDL  + +     P     L  L EL +    LS   
Sbjct: 55  LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAV 113

Query: 118 --PKVLTNITTLKNLSIEGNLFTG-SIPPDIRKLINLQKLILSSNSFTGELPAELTKLT- 173
                  N+  L  L +  N      + P   KL +L+ +  SSN        EL  L  
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173

Query: 174 -NLNDLRISDNNFSGKIPEFIGKWKK------IQKLHIQGSSLEGPIPA---------SI 217
             L+   ++ N+   ++    GK         ++ L + G+     I             
Sbjct: 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQA 233

Query: 218 SALTSLTDLRISDLKG------SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLK 271
            +L     +  +           ++ F  L + +++ L L+   +          +  LK
Sbjct: 234 FSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLK 293

Query: 272 NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 327
            ++L++N +       F  L     + L+ N L   +    F     V   D+  N+  
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE-LYSSNFYGLPKVAYIDLQKNHIA 351

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  102 bits (255), Expect = 2e-22
 Identities = 47/275 (17%), Positives = 96/275 (34%), Gaps = 24/275 (8%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 123
            +          L+ LK L+L+ N +       +  L  L  L++  N L   +      
Sbjct: 277 FVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYG 336

Query: 124 ITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 182
           +  +  + ++ N     I     + L  LQ L L  N+ T      +  + ++ D+ +S 
Sbjct: 337 LPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSG 390

Query: 183 NNFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDLRISDLK----GSESA 237
           N                  +H+  + LE   I   +  +  L  L ++  +      +  
Sbjct: 391 NKLV----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQT 446

Query: 238 FPKLDKMNLKTLILTKCLIHGEIPDYI-----GDMTKLKNIDLSFNNLTGGIPTTFEKLA 292
             +    +L+ L L + ++       +       ++ L+ + L+ N L    P  F  L 
Sbjct: 447 PSENP--SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLT 504

Query: 293 KTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 327
               + L  N+LT      +  + + +DIS N   
Sbjct: 505 ALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLL 539

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 97.2 bits (242), Expect = 9e-21
 Identities = 41/276 (14%), Positives = 89/276 (32%), Gaps = 20/276 (7%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQW-ASL-QLVELSVMGNRLSGPFPKVLT 122
            +     +    L  L+ L+L       +   +   +L  L  L +  +++    P    
Sbjct: 35  YIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94

Query: 123 NITTLKNLSIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLR 179
            +  L  L +     + ++  D   R L  L +L LS N      L     KL +L  + 
Sbjct: 95  GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID 154

Query: 180 ISDNNFSGKIPE-FIG-KWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISDLKGSES 236
            S N             + K +    +  +SL   +       +    ++ +  L  S +
Sbjct: 155 FSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214

Query: 237 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN- 295
            +      N          I       +     +      F+N+      TF  LA+++ 
Sbjct: 215 GWTVDITGNFSN------AISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSV 268

Query: 296 -FMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 327
             + L+   +   +   +F + K++   +++ N   
Sbjct: 269 RHLDLSHGFVFS-LNSRVFETLKDLKVLNLAYNKIN 303

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 88.7 bits (220), Expect = 4e-18
 Identities = 47/272 (17%), Positives = 91/272 (33%), Gaps = 45/272 (16%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 123
            +          L  L+ L+LS N L   +S  +  L ++  + +  N ++    +    
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360

Query: 124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE--------------- 168
           +  L+ L +  N  T      I  + ++  + LS N     LP                 
Sbjct: 361 LEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLE 414

Query: 169 -------LTKLTNLNDLRISDNNFSGKIPEFIGKW-KKIQKLHIQGSSLEGPIPASI--S 218
                  L ++ +L  L ++ N FS    +        +++L +  + L+      +   
Sbjct: 415 NLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474

Query: 219 ALTSLTDLRISDLKG------SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKN 272
               L+ L++  L            F  L    L+ L L    +   +         L+ 
Sbjct: 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLT--ALRGLSLNSNRLT-VLSHND-LPANLEI 530

Query: 273 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 304
           +D+S N L    P  F  L   + + +T NK 
Sbjct: 531 LDISRNQLLAPNPDVFVSL---SVLDITHNKF 559

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 84.5 bits (209), Expect = 7e-17
 Identities = 51/297 (17%), Positives = 89/297 (29%), Gaps = 51/297 (17%)

Query: 46  TCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVE 105
           +C              +  NLT  +P  L+    L    LS N              +  
Sbjct: 1   SCSFDGRIAF-----YRFCNLT-QVPQVLNTTERL---LLSFN-------------YIRT 38

Query: 106 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGE 164
           ++                +  L+ L +       +I  +  R L NL+ L L S+     
Sbjct: 39  VT----------ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-F 87

Query: 165 LPAE-LTKLTNLNDLRISDNNFSGKI--PEFIGKWKKIQKLHIQGSSLEG-PIPASISAL 220
           L  +    L +L +LR+     S  +    +    K + +L +  + +    +  S   L
Sbjct: 88  LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL 147

Query: 221 TSLTDLRISDLK---GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTK------LK 271
            SL  +  S  +     E     L    L    L    ++  +    G          L+
Sbjct: 148 NSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207

Query: 272 NIDLSFNNLTGGIPTTFEK-LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 327
            +D+S N  T  I   F   ++K+    L             F  +   D   N F 
Sbjct: 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGA---GFGFHNIKDPDQNTFA 261

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 81.8 bits (202), Expect = 5e-16
 Identities = 43/210 (20%), Positives = 68/210 (32%), Gaps = 22/210 (10%)

Query: 140 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKI-PEFIGKWKK 198
            +P  +      ++L+LS N       +    L  L  L +        I  E       
Sbjct: 18  QVPQVLN---TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74

Query: 199 IQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTK 253
           ++ L +  S +    P +   L  L +L      +SD    +  F  L    L  L L+K
Sbjct: 75  LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK--ALTRLDLSK 132

Query: 254 CLIHG-EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN--FMYLTGNKLTGPVPK 310
             I    +    G +  LK+ID S N +        E L      F  L  N L   V  
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSV 192

Query: 311 YIFNSNKN--------VDISLNNFTWESSD 332
                           +D+S N +T + + 
Sbjct: 193 DWGKCMNPFRNMVLEILDVSGNGWTVDITG 222

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 80.6 bits (199), Expect = 1e-15
 Identities = 43/298 (14%), Positives = 98/298 (32%), Gaps = 44/298 (14%)

Query: 73  ELSKLRYLKQLDLSRNCLT----GSFSPQWASLQ---------LVELSVMGNRLSGPFPK 119
              +   L+ LD+S N  T    G+FS   +  Q         ++      + +  P   
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258

Query: 120 VLTNI--TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLN 176
               +  +++++L +       S+   +   L +L+ L L+ N            L NL 
Sbjct: 259 TFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ 317

Query: 177 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDL 231
            L +S N              K+  + +Q + +      +   L  L  L      ++ +
Sbjct: 318 VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI 377

Query: 232 KGSES------------AFPKLDKMNLKTLILTKCLIHG-EIPDYIGDMTKLKNIDLSFN 278
               S              PK++ +    + L++  +   +I  ++  +  L+ + L+ N
Sbjct: 378 HFIPSIPDIFLSGNKLVTLPKIN-LTANLIHLSENRLENLDILYFLLRVPHLQILILNQN 436

Query: 279 NLTGGIPT-TFEKLAKTNFMYLTGNKLTGP----VPKYIFNSNKNV---DISLNNFTW 328
             +      T  +      ++L  N L       +   +F    ++    ++ N    
Sbjct: 437 RFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS 494

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 69.4 bits (170), Expect = 4e-12
 Identities = 40/197 (20%), Positives = 73/197 (37%), Gaps = 17/197 (8%)

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSG-PFPK 119
           L+  +L     T +  +  +  + LS N L  +      +  L+ LS   NRL       
Sbjct: 364 LQTLDLRDNALTTIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLS--ENRLENLDILY 420

Query: 120 VLTNITTLKNLSIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTGELPAELTK-----L 172
            L  +  L+ L +  N F+ S   D    +  +L++L L  N        EL       L
Sbjct: 421 FLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGL 479

Query: 173 TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD-- 230
           ++L  L ++ N  +   P        ++ L +  + L   +  +     +L  L IS   
Sbjct: 480 SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV-LSHN-DLPANLEILDISRNQ 537

Query: 231 -LKGSESAFPKLDKMNL 246
            L  +   F  L  +++
Sbjct: 538 LLAPNPDVFVSLSVLDI 554

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 43.6 bits (103), Expect = 3e-04
 Identities = 29/125 (23%), Positives = 48/125 (38%), Gaps = 7/125 (5%)

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPK 119
           L+    T         L +L+ L L+ N L       ++ L  L  LS+  NRL+     
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHN 522

Query: 120 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDL 178
            L     L+ L I  N    +  PD+   ++L  L ++ N F  E   +      N  ++
Sbjct: 523 DLP--ANLEILDISRNQLL-APNPDV--FVSLSVLDITHNKFICECELSTFINWLNHTNV 577

Query: 179 RISDN 183
            I+  
Sbjct: 578 TIAGP 582

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  104 bits (261), Expect = 9e-24
 Identities = 55/298 (18%), Positives = 102/298 (34%), Gaps = 51/298 (17%)

Query: 47  CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQ 102
           C CS+    V+      +NL   +P  +S     + L+L  N +      SF        
Sbjct: 39  CSCSNQFSKVI---CVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLR---H 89

Query: 103 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 161
           L  L +  N +          +  L  L +  N  T +IP      L  L++L L +N  
Sbjct: 90  LEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI 148

Query: 162 TGELPAEL-TKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 220
              +P+    ++ +L  L + +               ++   +I   + EG        L
Sbjct: 149 E-SIPSYAFNRIPSLRRLDLGELK-------------RLS--YISEGAFEG--------L 184

Query: 221 TSLTDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 279
           ++L  L ++     E      L    L  L L+   +    P     +  L+ + +  + 
Sbjct: 185 SNLRYLNLAMCNLREIPNLTPLI--KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242

Query: 280 LTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN-VDISLNNFTWESSDPIEC 336
           +       F+ L     + L  N LT  +P  +F    +   I L++      +P  C
Sbjct: 243 IQVIERNAFDNLQSLVEINLAHNNLTL-LPHDLFTPLHHLERIHLHH------NPWNC 293

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  102 bits (255), Expect = 4e-23
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)

Query: 645 KVGEGGFGSVYKGI---LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 701
           KVG G +G VYK       D    A+KQ+       +     EI ++   +HPN++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85

Query: 702 CCVE--GNQLLLVYEYMKN---NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
             +     ++ L+++Y ++   + +      K  +  ++L     K +   I  G+ YLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNA----KISDFGLAKLY---EEDKTHISTRIAGTIGY 809
            +    ++HRD+K +N+L+  +       KI+D G A+L+    +    +   +  T  Y
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201

Query: 810 MAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 840
            APE  +  R Y T   D+++ G +  E+++ +
Sbjct: 202 RAPELLLGARHY-TKAIDIWAIGCIFAELLTSE 233

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  100 bits (250), Expect = 4e-23
 Identities = 51/211 (24%), Positives = 76/211 (36%), Gaps = 31/211 (14%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-----------QHP 694
           GEG +G V + +        AVK L        ++ +  I    A            +H 
Sbjct: 14  GEGSYGKVKEVLDSETLCRRAVKIL-------KKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 695 NLVKLYG--CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           N+++L       E  ++ +V EY         +     E R           C  +  GL
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFP-VCQAHGYFC-QLIDGL 122

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMA 811
            YLH      IVH+DIK  N+LL      KIS  G+A+               G+  +  
Sbjct: 123 EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 812 PEYAM--RGYLTSKADVYSFGVVTLEIVSGK 840
           PE A     +   K D++S GV    I +G 
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  101 bits (254), Expect = 7e-23
 Identities = 53/298 (17%), Positives = 105/298 (35%), Gaps = 51/298 (17%)

Query: 47  CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQ 102
           C CS+    VV      + L+  +P  +      + L+L  N +      +F        
Sbjct: 50  CSCSNQFSKVV---CTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLH---H 100

Query: 103 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 161
           L  L +  N +          + +L  L +  N  T  IP      L  L++L L +N  
Sbjct: 101 LEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI 159

Query: 162 TGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 220
              +P+    ++ +L  L + +               K++  +I   + EG        L
Sbjct: 160 E-SIPSYAFNRVPSLMRLDLGELK-------------KLE--YISEGAFEG--------L 195

Query: 221 TSLTDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 279
            +L  L +      +      L    L+ L ++        P     ++ LK + +  + 
Sbjct: 196 FNLKYLNLGMCNIKDMPNLTPLV--GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253

Query: 280 LTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN-VDISLNNFTWESSDPIEC 336
           ++      F+ LA    + L  N L+  +P  +F   +  V++ L++      +P  C
Sbjct: 254 VSLIERNAFDGLASLVELNLAHNNLSS-LPHDLFTPLRYLVELHLHH------NPWNC 304

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 98.0 bits (245), Expect = 9e-23
 Identities = 58/192 (30%), Positives = 93/192 (48%), Gaps = 17/192 (8%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHPNLVKLYG 701
           G G FG V  G     G  +AVK L+ + +  + + V     EI  +   +HP+++KLY 
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
                    +V EY+    L   I         +++    +++   I   + Y H   R 
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCH---RH 130

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYL 820
            +VHRD+K  NVLLD  +NAKI+DFGL+ +  + +  + T   G+  Y APE  + R Y 
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTS-CGSPNYAAPEVISGRLYA 188

Query: 821 TSKADVYSFGVV 832
             + D++S GV+
Sbjct: 189 GPEVDIWSCGVI 200

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 99.2 bits (248), Expect = 1e-22
 Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 690
           + ++   K+G+G FG V+K      G  +A+K    K    N +E        EI ++  
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQL 72

Query: 691 QQHPNLVKLYGCCVE--------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 742
            +H N+V L   C             + LV+++ +++ L+  +    +   +K      K
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL----SNVLVKFTLSEIK 127

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
           ++   +  GL Y+H +   KI+HRD+K +NVL+ +D   K++DFGLA+ +   K     R
Sbjct: 128 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 803 IAG---TIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 840
                 T+ Y  PE  +  R Y     D++  G +  E+ +  
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPP-IDLWGAGCIMAEMWTRS 226

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  100 bits (250), Expect = 1e-22
 Identities = 55/201 (27%), Positives = 78/201 (38%), Gaps = 32/201 (15%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG---- 701
           G G  G V +          A+K L     +  RE   E+    A Q P++V++      
Sbjct: 71  GLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYEN 126

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRK--KICIGIARGLAYL 755
                  LL+V E +    L   I  +     TE         R+  +I   I   + YL
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE---------REASEIMKSIGEAIQYL 177

Query: 756 HEDSRIKIVHRDIKTSNVLL-DKDLNA--KISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           H    I I HRD+K  N+L   K  NA  K++DFG AK      +   T    T  Y+AP
Sbjct: 178 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAP 232

Query: 813 EYAMRGYLTSKADVYSFGVVT 833
           E           D++S GV+ 
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIM 253

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  100 bits (250), Expect = 4e-22
 Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 25/216 (11%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 693
           + F     +G GGFG V+   +   G + A K+L+ K    R+G +  + E  +++    
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR--- 750
             +V L         L LV   M          G D  Y +              A    
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMN---------GGDIRYHIYNVDEDNPGFQEPRAIFYT 295

Query: 751 -----GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 805
                GL +LH+     I++RD+K  NVLLD D N +ISD GLA   +  +T      AG
Sbjct: 296 AQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AG 351

Query: 806 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           T G+MAPE  +        D ++ GV   E+++ + 
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 95.8 bits (239), Expect = 6e-22
 Identities = 53/268 (19%), Positives = 85/268 (31%), Gaps = 50/268 (18%)

Query: 47  CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQ 102
           C C +      +     Q L   +P  +      +++ L  N ++     SF        
Sbjct: 6   CVCYNEPKVTTS--CPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRAC---RN 57

Query: 103 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 161
           L  L +  N L+       T +  L+ L +  N    S+ P     L  L  L L     
Sbjct: 58  LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117

Query: 162 TGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 220
             EL       L  L  L + DN                    +   +           L
Sbjct: 118 Q-ELGPGLFRGLAALQYLYLQDNALQ----------------ALPDDTFRD--------L 152

Query: 221 TSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNID 274
            +LT L     RIS +   E AF  L   +L  L+L +  +   +  +   D+ +L  + 
Sbjct: 153 GNLTHLFLHGNRISSV--PERAFRGLH--SLDRLLLHQNRVA-HVHPHAFRDLGRLMTLY 207

Query: 275 LSFNNLTGGIPTTFEKLAKTNFMYLTGN 302
           L  NNL+         L    ++ L  N
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 50/220 (22%), Positives = 82/220 (37%), Gaps = 23/220 (10%)

Query: 121 LTNI-----TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLT 173
           L  +        + + + GN  +  +P    R   NL  L L SN     + A   T L 
Sbjct: 23  LQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLA 80

Query: 174 NLNDLRISDNNFSGKIPE--FIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD 230
            L  L +SDN     +    F G   ++  LH+    L+  +   +   L +L  L + D
Sbjct: 81  LLEQLDLSDNAQLRSVDPATFHG-LGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQD 138

Query: 231 --LKG-SESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPT 286
             L+   +  F  L   NL  L L    I   +P+     +  L  + L  N +    P 
Sbjct: 139 NALQALPDDTFRDL--GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPH 195

Query: 287 TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV-DISLNN 325
            F  L +   +YL  N L+  +P       + +  + LN+
Sbjct: 196 AFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLND 234

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 34/119 (28%), Positives = 49/119 (41%), Gaps = 13/119 (10%)

Query: 74  LSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK 128
              L  L+ L L  N L      +F      L  L  L + GNR+S    +    + +L 
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFR----DLGNLTHLFLHGNRISSVPERAFRGLHSLD 180

Query: 129 NLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNF 185
            L +  N     + P   R L  L  L L +N+ +  LP E L  L  L  LR++DN +
Sbjct: 181 RLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 97.4 bits (243), Expect = 9e-22
 Identities = 45/244 (18%), Positives = 98/244 (40%), Gaps = 24/244 (9%)

Query: 69  TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 123
            LP   L   R ++ L+L+   +      +F+    ++Q + +    N +    P V  N
Sbjct: 59  KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYA-HTIQKLYMG--FNAIRYLPPHVFQN 115

Query: 124 ITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRIS 181
           +  L  L +E N  + S+P  I      L  L +S+N+    +  +     T+L +L++S
Sbjct: 116 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 173

Query: 182 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 241
            N  +  +   +     +   ++  + L      +++   ++ +L  S    +       
Sbjct: 174 SNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV--VRGP 223

Query: 242 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 301
             + L  L L    +  +    + +   L  +DLS+N L   +   F K+ +   +Y++ 
Sbjct: 224 VNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 281

Query: 302 NKLT 305
           N+L 
Sbjct: 282 NRLV 285

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 90.9 bits (226), Expect = 1e-19
 Identities = 50/281 (17%), Positives = 94/281 (33%), Gaps = 39/281 (13%)

Query: 69  TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 123
            LP      +  L  L L RN L+    G F       +L  LS+  N L          
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNT---PKLTTLSMSNNNLERIEDDTFQA 163

Query: 124 ITTLKNLSIEGNLFTGSIPPD-----------------IRKLINLQKLILSSNSFTGELP 166
            T+L+NL +  N  T  +                    +   I +++L  S NS    + 
Sbjct: 164 TTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVR 221

Query: 167 AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL 226
             +     L  L++  NN +      +  +  + ++ +  + LE  +      +  L  L
Sbjct: 222 GPV--NVELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNELEKIMYHPFVKMQRLERL 277

Query: 227 RISD--LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 284
            IS+  L         +    LK L L+   +   +        +L+N+ L  N++    
Sbjct: 278 YISNNRLVALNLYGQPIP--TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK 334

Query: 285 PTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNN 325
            +T   L     + L+ N       + +F +     +   +
Sbjct: 335 LSTHHTLKN---LTLSHNDWDCNSLRALFRNVARPAVDDAD 372

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 90.1 bits (224), Expect = 3e-19
 Identities = 49/284 (17%), Positives = 101/284 (35%), Gaps = 31/284 (10%)

Query: 42  ESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQ 97
           +SN+  DC     + V I ++ Q++      E   L   K +    + +           
Sbjct: 14  DSNLQYDC---VFYDVHIDMQTQDVYFGF--EDITLNNQKIVTFKNSTMRKLPAALLDSF 68

Query: 98  WASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLIL 156
              ++L+ L+    ++            T++ L +  N     +PP + + +  L  L+L
Sbjct: 69  -RQVELLNLN--DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL 124

Query: 157 SSNSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPEFIGKW-KKIQKLHIQGSSLEGPIP 214
             N  +  LP  +      L  L +S+NN   +I +   +    +Q L +  + L   + 
Sbjct: 125 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VD 181

Query: 215 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNID 274
             +S + SL    +S    S         + ++ L  +   I+  +        +L  + 
Sbjct: 182 --LSLIPSLFHANVSYNLLST--LAIP--IAVEELDASHNSIN-VVRG--PVNVELTILK 232

Query: 275 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 318
           L  NNLT               + L+ N+L   +  + F   + 
Sbjct: 233 LQHNNLTD--TAWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQR 273

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 80.9 bits (200), Expect = 3e-16
 Identities = 33/171 (19%), Positives = 71/171 (41%), Gaps = 11/171 (6%)

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 120
           L   N++  L + L+    +++LD S N +         +++L  L +  N L+      
Sbjct: 188 LFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGP-VNVELTILKLQHNNLTD--TAW 243

Query: 121 LTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 179
           L N   L  + +  N     I      K+  L++L +S+N     L      +  L  L 
Sbjct: 244 LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLD 301

Query: 180 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 230
           +S N+    +     ++ +++ L++  +S+   +   +S   +L +L +S 
Sbjct: 302 LSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSH 348

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 74.7 bits (184), Expect = 3e-14
 Identities = 41/236 (17%), Positives = 78/236 (33%), Gaps = 36/236 (15%)

Query: 118 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLN 176
              L       ++ I+          +   L N + +   +++   +LPA  L     + 
Sbjct: 14  DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 72

Query: 177 DLRISDNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDL-----RIS 229
            L ++D     +I  +       IQKL++  +++   +P  +   +  LT L      +S
Sbjct: 73  LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 130

Query: 230 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIP--- 285
            L      F       L TL ++   +   I D      T L+N+ LS N LT  +    
Sbjct: 131 SL--PRGIFHNTP--KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL 184

Query: 286 --------------TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 327
                         +T         +  + N +   V   +      + +  NN T
Sbjct: 185 IPSLFHANVSYNLLSTLAIPIAVEELDASHNSINV-VRGPVNVELTILKLQHNNLT 239

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 98.5 bits (245), Expect = 2e-21
 Identities = 52/271 (19%), Positives = 91/271 (33%), Gaps = 43/271 (15%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 124
           NL+ +LP  L     +  L++++N L  S     ASL+   L    NRLS   P++  + 
Sbjct: 70  NLS-SLPDNLPPQ--ITVLEITQNALI-SLPELPASLE--YLDACDNRLST-LPELPAS- 121

Query: 125 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 184
             LK+L ++ N  T  +P        L+ +   +N  T  LP   T L  L+   + +N 
Sbjct: 122 --LKHLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTSLEVLS---VRNNQ 171

Query: 185 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM 244
            +  +PE       ++ L +  + LE  +PA         +  I                
Sbjct: 172 LT-FLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEETEIF--------------- 211

Query: 245 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 304
                   +  I   IP+ I  +     I L  N L+  I  +  +       +      
Sbjct: 212 ----FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266

Query: 305 TGPVPKYIFNSNKNVDISLNNFTWESSDPIE 335
           +    +         D     F       + 
Sbjct: 267 SMSDGQQNTLHRPLADAVTAWFPENKQSDVS 297

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 78.9 bits (194), Expect = 3e-15
 Identities = 43/278 (15%), Positives = 87/278 (31%), Gaps = 43/278 (15%)

Query: 111 NRLSGPFPKVLTNITTLKNLSIEGNLFTG--SIPPDIRKLINLQKLILSSNSFTGELPAE 168
           N +SG +    +     +  ++ G       S+  +   +    +L L+  + +  LP  
Sbjct: 20  NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC-LINQFSELQLNRLNLS-SLPDN 77

Query: 169 LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL----- 223
           L     +  L I+ N     +PE       ++ L    + L   +P   ++L  L     
Sbjct: 78  L--PPQITVLEITQNALI-SLPELPA---SLEYLDACDNRLST-LPELPASLKHLDVDNN 130

Query: 224 ---------TDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNI 273
                      L   +   ++ +  P+L   +L+ L +    +   +P+    +  L   
Sbjct: 131 QLTMLPELPALLEYINADNNQLTMLPELPT-SLEVLSVRNNQL-TFLPELPESLEAL--- 185

Query: 274 DLSFNNLTGGIPTTFEKLAK----TNFMYLTGNKLTGPVPKYIFN--SNKNVDISLNNFT 327
           D+S N L   +P    +         F     N++T  +P+ I +      + +  N   
Sbjct: 186 DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPL- 242

Query: 328 WESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNF 365
              S  I            Y  PR              
Sbjct: 243 ---SSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 67.3 bits (164), Expect = 1e-11
 Identities = 36/246 (14%), Positives = 69/246 (28%), Gaps = 18/246 (7%)

Query: 64  QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 123
            N    LP   + L  L    +  N LT        SL+   L V  N L    P V   
Sbjct: 149 NNQLTMLPELPTSLEVL---SVRNNQLT-FLPELPESLE--ALDVSTNLLES-LPAVPVR 201

Query: 124 ITTLKN----LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 179
               +          N  T  IP +I  L     +IL  N  +  +   L++ T   D  
Sbjct: 202 NHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYH 260

Query: 180 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 239
                FS    +     + +       +       + +S +           + + +   
Sbjct: 261 GPRIYFSMSDGQQNTLHRPLA--DAVTAWFPENKQSDVSQIWH----AFEHEEHANTFSA 314

Query: 240 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 299
            LD+++             ++  ++  ++    +      +      + E      +  L
Sbjct: 315 FLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNL 374

Query: 300 TGNKLT 305
               L 
Sbjct: 375 RKTLLV 380

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 98.1 bits (244), Expect = 3e-21
 Identities = 50/269 (18%), Positives = 107/269 (39%), Gaps = 27/269 (10%)

Query: 69  TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 123
            LP   L   R ++ L+L+   +      +F+    ++Q + +    N +    P V  N
Sbjct: 65  KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYA-HTIQKLYMG--FNAIRYLPPHVFQN 121

Query: 124 ITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRIS 181
           +  L  L +E N  + S+P  I      L  L +S+N+    +  +     T+L +L++S
Sbjct: 122 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 179

Query: 182 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 241
            N  +  +   +     +   ++  + L      +++   ++ +L  S      +     
Sbjct: 180 SNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS--INVVRGP 229

Query: 242 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 301
             + L  L L    +  +    + +   L  +DLS+N L   +   F K+ +   +Y++ 
Sbjct: 230 VNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287

Query: 302 NKLTGPVPKYIFNSN--KNVDISLNNFTW 328
           N+L   +  Y       K +D+S N+   
Sbjct: 288 NRLVA-LNLYGQPIPTLKVLDLSHNHLLH 315

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 91.5 bits (227), Expect = 3e-19
 Identities = 53/313 (16%), Positives = 104/313 (33%), Gaps = 45/313 (14%)

Query: 69  TLPTEL-SKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 123
            LP  +   +  L  L L RN L+    G F       +L  LS+  N L          
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTP---KLTTLSMSNNNLERIEDDTFQA 169

Query: 124 ITTLKNLSIEGNLFTGSIPPD-----------------IRKLINLQKLILSSNSFTGELP 166
            T+L+NL +  N  T  +                    +   I +++L  S NS    + 
Sbjct: 170 TTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVR 227

Query: 167 AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL 226
             +     L  L++  NN +      +  +  + ++ +  + LE  +      +  L  L
Sbjct: 228 GPV--NVELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNELEKIMYHPFVKMQRLERL 283

Query: 227 RISD--LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 284
            IS+  L         +    LK L L+   +   +        +L+N+ L  N++    
Sbjct: 284 YISNNRLVALNLYGQPIP--TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK 340

Query: 285 PTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLV 344
            +T   L     + L+ N       + +F +     +   +         +      + +
Sbjct: 341 LSTHHTLKN---LTLSHNDWDCNSLRALFRNVARPAVDDADQH------CKIDYQLEHGL 391

Query: 345 ESYSSPRNKLDKV 357
               S +  LD++
Sbjct: 392 CCKESDKPYLDRL 404

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 91.1 bits (226), Expect = 4e-19
 Identities = 49/284 (17%), Positives = 101/284 (35%), Gaps = 31/284 (10%)

Query: 42  ESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQ 97
           +SN+  DC     + V I ++ Q++      E   L   K +    + +           
Sbjct: 20  DSNLQYDC---VFYDVHIDMQTQDVYFGF--EDITLNNQKIVTFKNSTMRKLPAALLDSF 74

Query: 98  WASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLIL 156
              ++L+ L+    ++            T++ L +  N     +PP + + +  L  L+L
Sbjct: 75  -RQVELLNLN--DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL 130

Query: 157 SSNSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPEFIGKW-KKIQKLHIQGSSLEGPIP 214
             N  +  LP  +      L  L +S+NN   +I +   +    +Q L +  + L   + 
Sbjct: 131 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VD 187

Query: 215 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNID 274
             +S + SL    +S    S         + ++ L  +   I+  +        +L  + 
Sbjct: 188 --LSLIPSLFHANVSYNLLST--LAIP--IAVEELDASHNSIN-VVRG--PVNVELTILK 238

Query: 275 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 318
           L  NNLT               + L+ N+L   +  + F   + 
Sbjct: 239 LQHNNLTD--TAWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQR 279

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 75.7 bits (186), Expect = 3e-14
 Identities = 43/235 (18%), Positives = 78/235 (33%), Gaps = 34/235 (14%)

Query: 118 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLN 176
              L       ++ I+          +   L N + +   +++   +LPA  L     + 
Sbjct: 20  DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 78

Query: 177 DLRISDNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDL-----RIS 229
            L ++D     +I  +       IQKL++  +++   +P  +   +  LT L      +S
Sbjct: 79  LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 136

Query: 230 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTF 288
            L      F       L TL ++   +   I D      T L+N+ LS N LT    +  
Sbjct: 137 SL--PRGIFHNTP--KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLI 191

Query: 289 EKLAKTNFMY----------------LTGNKLTGPVPKYIFNSNKNVDISLNNFT 327
             L   N  Y                 + N +   V   +      + +  NN T
Sbjct: 192 PSLFHANVSYNLLSTLAIPIAVEELDASHNSINV-VRGPVNVELTILKLQHNNLT 245

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 96.8 bits (241), Expect = 3e-21
 Identities = 61/192 (31%), Positives = 96/192 (50%), Gaps = 17/192 (8%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHPNLVKLYG 701
           G G FG V  G     G  +AVK L+ + +  + + V     EI  +   +HP+++KLY 
Sbjct: 25  GVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
                + + +V EY+    L   I         +LD    +++   I  G+ Y H   R 
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNG-----RLDEKESRRLFQQILSGVDYCH---RH 135

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYL 820
            +VHRD+K  NVLLD  +NAKI+DFGL+ +  + +  + T   G+  Y APE  + R Y 
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTS-CGSPNYAAPEVISGRLYA 193

Query: 821 TSKADVYSFGVV 832
             + D++S GV+
Sbjct: 194 GPEVDIWSSGVI 205

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 97.5 bits (243), Expect = 4e-21
 Identities = 54/271 (19%), Positives = 93/271 (34%), Gaps = 28/271 (10%)

Query: 70  LPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNIT 125
           +    + L  +    L    +      S++  W  L+LV       +      K L  +T
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF--GQFPTLKLKSLKRLT 331

Query: 126 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDN 183
              N                  L +L+ L LS N  +  G         T+L  L +S N
Sbjct: 332 FTSNKGGNAFSEVD--------LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383

Query: 184 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISDLKGS---ESAFP 239
                +       ++++ L  Q S+L+     S+  +L +L  L IS           F 
Sbjct: 384 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442

Query: 240 KLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 298
            L   +L+ L +            I  ++  L  +DLS   L    PT F  L+    + 
Sbjct: 443 GL--SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500

Query: 299 LTGNKLTGPVPKYIFNSNKN---VDISLNNF 326
           +  N+L   VP  IF+   +   + +  N +
Sbjct: 501 MASNQLKS-VPDGIFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 95.9 bits (239), Expect = 1e-20
 Identities = 61/352 (17%), Positives = 108/352 (30%), Gaps = 68/352 (19%)

Query: 23  DPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQ 82
           +PC +                N+T  C               N    +P  L      K 
Sbjct: 1   EPCVEVVP-------------NITYQCME------------LNFY-KIPDNLP--FSTKN 32

Query: 83  LDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIP 142
           LDLS N              L  L                +   L+ L +       +I 
Sbjct: 33  LDLSFN-------------PLRHLG----------SYSFFSFPELQVLDLSRCEIQ-TIE 68

Query: 143 PD-IRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 201
               + L +L  LIL+ N          + L++L  L   + N +      IG  K +++
Sbjct: 69  DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128

Query: 202 LHIQGSSL-EGPIPASISALTSLTDLRISD--LKG-SESAFPKLDKMNLK--TLILTKCL 255
           L++  + +    +P   S LT+L  L +S   ++    +    L +M L   +L L+   
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188

Query: 256 IHGEIPDYIGDMTKLKNIDLSFNNLTGGIP-TTFEKLAKTNFMYLTGNKLTG-----PVP 309
           ++  I        +L  + L  N  +  +  T  + LA      L   +           
Sbjct: 189 MN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247

Query: 310 KYIFNSNKNVDISLNNFTWESSDPIECPRGSVNL--VESYSSPRNKLDKVHP 359
           K       N+ I      +      +       L  V S+S     +++V  
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 81.7 bits (202), Expect = 4e-16
 Identities = 46/283 (16%), Positives = 85/283 (30%), Gaps = 29/283 (10%)

Query: 64  QNLTGTLPTELSKLRYLKQLDLSRNC---------LTGSFSPQWASLQLVELSVMGNRLS 114
            +    + T +  L  L+   L                S      +L + E  +      
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270

Query: 115 G-PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 173
                 +   +T + + S+           D       Q L L +  F  + P    KL 
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFG-QFPTL--KLK 325

Query: 174 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE--GPIPASISALTSLTDLRISD- 230
           +L  L  + N         +     ++ L +  + L   G    S    TSL  L +S  
Sbjct: 326 SLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383

Query: 231 -LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI--GDMTKLKNIDLSFNNLTGGIPTT 287
            +    S F  L    L+ L      +  ++ ++     +  L  +D+S  +        
Sbjct: 384 GVITMSSNFLGL--EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440

Query: 288 FEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 327
           F  L+    + + GN         IF   +N+   D+S     
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 69.4 bits (170), Expect = 3e-12
 Identities = 33/140 (23%), Positives = 55/140 (39%), Gaps = 8/140 (5%)

Query: 74  LSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPK-VLTNITTLKNLS 131
              LR L  LD+S      +F+  +  L  L  L + GN     F   + T +  L  L 
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476

Query: 132 IEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKI 189
           +        + P     L +LQ L ++SN     +P     +LT+L  + +  N +    
Sbjct: 477 LSQCQLE-QLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 534

Query: 190 P--EFIGKWKKIQKLHIQGS 207
           P  +++ +W        QGS
Sbjct: 535 PRIDYLSRWLNKNSQKEQGS 554

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 45.5 bits (108), Expect = 7e-05
 Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 3/88 (3%)

Query: 65  NLTGTLPTE-LSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLT 122
           +       +  ++LR L  LDLS+  L       + SL  L  L++  N+L      +  
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD 515

Query: 123 NITTLKNLSIEGNLFTGSIPPDIRKLIN 150
            +T+L+ + +  N +  S  P I  L  
Sbjct: 516 RLTSLQKIWLHTNPWDCS-CPRIDYLSR 542

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 97.2 bits (242), Expect = 5e-21
 Identities = 65/215 (30%), Positives = 95/215 (44%), Gaps = 26/215 (12%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 693
           N F     +G+GGFG V    +   G + A K+L  K    R+G    +NE  ++     
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT-----RKKICIG- 747
             +V L       + L LV   M          G D ++ +           R       
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMN---------GGDLKFHIYHMGQAGFPEARAVFYAAE 294

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           I  GL  LH +   +IV+RD+K  N+LLD   + +ISD GLA    E +T I  R  GT+
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGR-VGTV 349

Query: 808 GYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           GYMAPE      Y T   D ++ G +  E+++G+S
Sbjct: 350 GYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQS 383

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 93.9 bits (234), Expect = 6e-21
 Identities = 54/276 (19%), Positives = 100/276 (36%), Gaps = 36/276 (13%)

Query: 71  PTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITT 126
             +   L++L  L L  N ++     +FSP     +L +L +  N L    P + ++   
Sbjct: 71  KDDFKGLQHLYALVLVNNKISKIHEKAFSPL---RKLQKLYISKNHLVEIPPNLPSS--- 124

Query: 127 LKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFT-GELPAELTKLTNLNDLRISDNN 184
           L  L I  N     +P  +   L N+  + +  N                LN LRIS+  
Sbjct: 125 LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183

Query: 185 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA-SISALTSLTDL-----RISDLKGSESAF 238
            +  IP+     + + +LH+  + ++  I    +   + L  L     +I  +     + 
Sbjct: 184 LT-GIPK--DLPETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIRMI--ENGSL 237

Query: 239 PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT---- 294
             L    L+ L L    +   +P  + D+  L+ + L  NN+T      F  +       
Sbjct: 238 SFLP--TLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRA 294

Query: 295 --NFMYLTGNKLT-GPVPKYIFNSNKN-VDISLNNF 326
             N + L  N +    V    F    + + I   N+
Sbjct: 295 YYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 58/273 (21%), Positives = 96/273 (35%), Gaps = 32/273 (11%)

Query: 53  TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELS 107
            CH+  +      L   +P E+S       LDL  N ++      F      L  L  L 
Sbjct: 32  HCHLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFK----GLQHLYALV 84

Query: 108 VMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA 167
           ++ N++S    K  + +  L+ L I  N     IPP++    +L +L +  N        
Sbjct: 85  LVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKG 141

Query: 168 ELTKLTNLNDLRISDNNF-SGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL 226
             + L N+N + +  N   +           K+  L I  + L G IP       +L +L
Sbjct: 142 VFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPK--DLPETLNEL 198

Query: 227 -----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNL 280
                +I  +        +     L  L L    I   I +     +  L+ + L  N L
Sbjct: 199 HLDHNKIQAI--ELEDLLRYS--KLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKL 253

Query: 281 TGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 313
           +  +P     L     +YL  N +T  V    F
Sbjct: 254 S-RVPAGLPDLKLLQVVYLHTNNITK-VGVNDF 284

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 25/188 (13%)

Query: 140 SIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPE--FIGKW 196
           ++P +I    +   L L +N  + EL  +    L +L  L + +N  S KI E  F    
Sbjct: 47  AVPKEISP--DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSP-L 101

Query: 197 KKIQKLHIQGSSLEGPIPASISALTSLTDLR-----ISDLKGSESAFPKLDKMNLKTLIL 251
           +K+QKL+I  + L   IP   +  +SL +LR     I  +   +  F  L   N+  + +
Sbjct: 102 RKLQKLYISKNHLVE-IPP--NLPSSLVELRIHDNRIRKV--PKGVFSGLR--NMNCIEM 154

Query: 252 TK-CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK 310
               L +        D  KL  + +S   LTG      E L   N ++L  NK+   +  
Sbjct: 155 GGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETL---NELHLDHNKIQA-IEL 210

Query: 311 YIFNSNKN 318
                   
Sbjct: 211 EDLLRYSK 218

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 94.4 bits (235), Expect = 7e-21
 Identities = 51/291 (17%), Positives = 101/291 (34%), Gaps = 36/291 (12%)

Query: 43  SNVTCDCSSA---------TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT-- 91
            N  C  SS          T  V ++ L    +T    ++L +   L+ L L+ N +   
Sbjct: 32  RNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTI 91

Query: 92  --GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI--RK 147
              SFS       L  L +  N LS         +++L  L++ GN +  ++        
Sbjct: 92  EEDSFSSLG---SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSH 147

Query: 148 LINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPE--FIGKWKKIQKLHI 204
           L  LQ L + +     ++  +    LT L +L I  ++                +  L +
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQ-NVSHLIL 205

Query: 205 QGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL---------DKMNLKTLILTKCL 255
                   +   +   +S+  L + D       F +L          K   + + +T   
Sbjct: 206 HMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDES 265

Query: 256 IHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLTGNKLT 305
           +  ++   +  ++ L  ++ S N L   +P   F++L     ++L  N   
Sbjct: 266 LF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 66.7 bits (163), Expect = 8e-12
 Identities = 39/211 (18%), Positives = 77/211 (36%), Gaps = 41/211 (19%)

Query: 121 LTNI-----TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLT 173
           L +I       +K+L +  N  T  I     ++ +NLQ L+L+SN     +  +  + L 
Sbjct: 43  LNSIPSGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLG 100

Query: 174 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--L 231
           +L  L +S N               +  L            +    L+SLT L +     
Sbjct: 101 SLEHLDLSYN--------------YLSNLS----------SSWFKPLSSLTFLNLLGNPY 136

Query: 232 K--GSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTF 288
           K  G  S F  L    L+ L +       +I       +T L+ +++  ++L    P + 
Sbjct: 137 KTLGETSLFSHL--TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSL 194

Query: 289 EKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV 319
           + +   + + L   +    + +   +   +V
Sbjct: 195 KSIQNVSHLILHMKQHIL-LLEIFVDVTSSV 224

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 93.2 bits (232), Expect = 7e-21
 Identities = 56/281 (19%), Positives = 99/281 (35%), Gaps = 56/281 (19%)

Query: 47  CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL- 101
           C CS            ++ LT ++PT +       +L+L  N L     G F      L 
Sbjct: 5   CSCSGTEIR-----CNSKGLT-SVPTGIPS--SATRLELESNKLQSLPHGVFD----KLT 52

Query: 102 QLVELSVMGNRLS--GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN 159
           QL +LS+  N LS  G   +     T+LK L +  N    ++  +   L  L+ L    +
Sbjct: 53  QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 111

Query: 160 SFTGELPAE--LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI 217
           +   ++        L NL  L IS  +                          G      
Sbjct: 112 NLK-QMSEFSVFLSLRNLIYLDISHTHTR----------------VAFNGIFNG------ 148

Query: 218 SALTSLTDLRISDLKGSES----AFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKN 272
             L+SL  L+++     E+     F +L   NL  L L++C +  ++       ++ L+ 
Sbjct: 149 --LSSLEVLKMAGNSFQENFLPDIFTELR--NLTFLDLSQCQLE-QLSPTAFNSLSSLQV 203

Query: 273 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 313
           +++S NN        ++ L     +  + N +     K   
Sbjct: 204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQEL 243

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 78.5 bits (194), Expect = 7e-16
 Identities = 38/168 (22%), Positives = 62/168 (36%), Gaps = 8/168 (4%)

Query: 69  TLPTELSKLRYLKQLDLSRNCLTGSFSPQW-ASL-QLVELSVMGNRLSGPFPKVLTNITT 126
           T+ +    L  L+ LD   + L          SL  L+ L +        F  +   +++
Sbjct: 92  TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 151

Query: 127 LKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNN 184
           L+ L + GN F  +  PDI  +L NL  L LS      +L       L++L  L +S NN
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNN 210

Query: 185 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI--SALTSLTDLRISD 230
           F             +Q L    + +             +SL  L ++ 
Sbjct: 211 FFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPSSLAFLNLTQ 257

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 93.0 bits (231), Expect = 9e-21
 Identities = 49/249 (19%), Positives = 80/249 (32%), Gaps = 41/249 (16%)

Query: 73  ELSKLRYLKQLDLSRNCLTGSFSPQWASL---QLVELSVMGNRLSGPFPKVLTNI----- 124
            +  +  L++L L    +TG+  P         L  L++     +      L  +     
Sbjct: 90  RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLK 148

Query: 125 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELT----KLTNLNDLRI 180
             LK LSI            +R    L  L LS N   GE          K   L  L +
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208

Query: 181 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRIS--DLKGSESAF 238
            +                         +  G   A  +A   L  L +S   L+ +  A 
Sbjct: 209 RNAGM---------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247

Query: 239 PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 298
                  L +L L+   +  ++P  +    KL  +DLS+N L    P + ++L +   + 
Sbjct: 248 SCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNP-SPDELPQVGNLS 302

Query: 299 LTGNKLTGP 307
           L GN     
Sbjct: 303 LKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 69.5 bits (170), Expect = 6e-13
 Identities = 49/296 (16%), Positives = 84/296 (28%), Gaps = 57/296 (19%)

Query: 48  DCSSATCHVVTIALKAQNLTGTLPTELSK-LRYLKQLDLSRNCLTGSFSPQWA--SLQLV 104
            CS            A N  G    EL    R L+ L    +             SL L 
Sbjct: 12  SCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLK 71

Query: 105 ELSVMGNRLSGPFPK---VLTNITTLKNLSIEGNLFTGSIPPDIRKLI--NLQKLILSSN 159
            L+V   R+          +  I+ L+ L++E    TG+ PP + +    +L  L L + 
Sbjct: 72  RLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131

Query: 160 SFTGELPAELTKL-----TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 214
           S+     A L +L       L  L I+  +      E +  +  +  L +  +   G   
Sbjct: 132 SWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190

Query: 215 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNID 274
              +                   FP L  + L+   +      G          +L+ +D
Sbjct: 191 LISALC--------------PLKFPTLQVLALRNAGMET--PSGVCSALAAARVQLQGLD 234

Query: 275 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 327
           LS N+L                                 +    +   ++S     
Sbjct: 235 LSHNSL------------------------RDAAGAPSCDWPSQLNSLNLSFTGLK 266

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 27/246 (10%), Positives = 63/246 (25%), Gaps = 51/246 (20%)

Query: 130 LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL---TNLNDLRISDNNFS 186
           L             DI K ++L++L + +      +     ++   + L +L + +   +
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 187 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNL 246
           G  P  + +                           L  L + ++               
Sbjct: 109 GTAPPPLLEAT----------------------GPDLNILNLRNVS-------------- 132

Query: 247 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 306
                T+     E+  ++     LK + ++  +               + + L+ N   G
Sbjct: 133 ---WATRDAWLAELQQWL--KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187

Query: 307 PVP------KYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 360
                       F + + + +        S          V L     S  N L      
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLS-HNSLRDAAGA 246

Query: 361 LRQNFP 366
              ++P
Sbjct: 247 PSCDWP 252

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 94.0 bits (234), Expect = 9e-21
 Identities = 52/194 (26%), Positives = 76/194 (39%), Gaps = 23/194 (11%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 705
           G G FG            ++AVK +  +    +     EI    + +HPN+V+     + 
Sbjct: 29  GSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87

Query: 706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK----ICIGIARGLAYLHEDSRI 761
              L ++ EY     L   I       R   D   R      +      G++Y H    +
Sbjct: 88  PTHLAIIMEYASGGELYERICNAG---RFSED-EARFFFQQLLS-----GVSYCH---SM 135

Query: 762 KIVHRDIKTSNVLLDKD--LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRG 818
           +I HRD+K  N LLD       KI DFG +K          + + GT  Y+APE    + 
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV-GTPAYIAPEVLLRQE 193

Query: 819 YLTSKADVYSFGVV 832
           Y    ADV+S GV 
Sbjct: 194 YDGKIADVWSCGVT 207

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 93.5 bits (233), Expect = 1e-20
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 37/221 (16%)

Query: 638 NNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFV----NEIGMIS 689
           ++F+    +G+G FG V             + A+K ++ K +   R  V     E+ ++ 
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMN-KQKCVERNEVRNVFKELQIMQ 70

Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKIC 745
             +HP LV L+    +   + +V + +        L +       E  +KL +     IC
Sbjct: 71  GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKL-F-----IC 122

Query: 746 -IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA 804
            + +A  L YL      +I+HRD+K  N+LLD+  +  I+DF +A +   +    +  +A
Sbjct: 123 ELVMA--LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MA 175

Query: 805 GTIGYMAPE----YAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           GT  YMAPE        GY +   D +S GV   E++ G+ 
Sbjct: 176 GTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRR 215

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 92.7 bits (231), Expect = 2e-20
 Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 18/200 (9%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHPNLVKLYG 701
           GEG FG V           +A+K +S +      +       EI  +   +HP+++KLY 
Sbjct: 18  GEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 761
                  +++V EY         +F    E + ++     ++    I   + Y H   R 
Sbjct: 77  VITTPTDIVMVIEYAGGE-----LFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RH 127

Query: 762 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYL 820
           KIVHRD+K  N+LLD +LN KI+DFGL+ +  +    + T   G+  Y APE    + Y 
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTS-CGSPNYAAPEVINGKLYA 185

Query: 821 TSKADVYSFGVVTLEIVSGK 840
             + DV+S G+V   ++ G+
Sbjct: 186 GPEVDVWSCGIVLYVMLVGR 205

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 91.9 bits (228), Expect = 5e-20
 Identities = 66/301 (21%), Positives = 111/301 (36%), Gaps = 79/301 (26%)

Query: 644 NKVGEGGFGSVYKGIL------SDGTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 695
             +G G FG V +         +    +AVK L    +   +R  ++E+  +I    H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 696 LVKLYGCC-VEGNQLLLVYEYMKNNCLS--------------------------RAIFGK 728
           +V L G C   G  L+++ E+ K   LS                                
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147

Query: 729 DTEYRLKLDWPTRKKICIGI--ARGLAYLHEDSRIKIVHRDIKTSNVLLD---------- 776
           D + RL     ++     G    + L+ + E+   + +++D  T   L+           
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207

Query: 777 ---------KDLNA-----------KISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYA 815
                    +DL A           KI DFGLA+   +D  ++    A   + +MAPE  
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 267

Query: 816 MRGYLTSKADVYSFGVVTLEIVS-GKSNTNY---RPNEDFVYLLDWAYVLQE-----EEI 866
                T ++DV+SFGV+  EI S G   + Y   + +E+F   L     ++       E+
Sbjct: 268 FDRVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM 325

Query: 867 Y 867
           Y
Sbjct: 326 Y 326

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 92.5 bits (230), Expect = 1e-19
 Identities = 47/276 (17%), Positives = 95/276 (34%), Gaps = 29/276 (10%)

Query: 69  TLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS---------LQLVELSVMGNRLSGPFPK 119
            L   + +L  ++  D + N L      +            + +  L +    L      
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304

Query: 120 VLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGEL---PAELTKLTNL 175
           V + +  +K +++E +     +P    + L +L+ L LS N    E     A      +L
Sbjct: 305 VYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363

Query: 176 NDLRISDNNFS--GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 233
             L +S N+     K  E +   K +  L I  ++   P+P S      +  L +S    
Sbjct: 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI 422

Query: 234 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 293
                       L+ L ++   +          + +L+ + +S N L      +      
Sbjct: 423 RV--VKTCIPQTLEVLDVSNNNL-DSFSL---FLPRLQELYISRNKLKTLPDASL--FPV 474

Query: 294 TNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNF 326
              M ++ N+L   VP  IF+   +   + +  N +
Sbjct: 475 LLVMKISRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 92.1 bits (229), Expect = 2e-19
 Identities = 41/262 (15%), Positives = 92/262 (35%), Gaps = 27/262 (10%)

Query: 69  TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 123
           +L +     L  LK L+L  N        S  P   +LQ + +  +    S         
Sbjct: 88  SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNV-ETFSEIRRIDFAG 146

Query: 124 ITTLKNLSIEGNLFTGSIPP-DIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 182
           +T+L  L I+      +     ++ + ++  L L  +     L      L+++  L + D
Sbjct: 147 LTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205

Query: 183 NN---FSGKIPEFIGKWKKIQKLHIQGSSLE----GPIPASISALTSLTDLRISDLKGSE 235
            N   F             ++KL  +GS L       +   +  +  L+++   D   + 
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265

Query: 236 ------------SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG 283
                       S   K++ + ++ L + +  +  ++      + K+K I +  + +   
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325

Query: 284 IPTTFEKLAKTNFMYLTGNKLT 305
             +  + L    F+ L+ N + 
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMV 347

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 89.8 bits (223), Expect = 1e-18
 Identities = 50/299 (16%), Positives = 112/299 (37%), Gaps = 29/299 (9%)

Query: 55  HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRL 113
            +  + +KA +L       L  +R +  L L  +            L  +  L +    L
Sbjct: 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208

Query: 114 SGPFP---KVLTNITTLKNLSIEGNLFT----GSIPPDIRKLINLQKLILSSNSFTG--- 163
           +        V    + +K L+  G++ T      +   +R ++ L ++     +  G   
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268

Query: 164 ------ELPAELTKL--TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA 215
                 ++ +EL K+    +  L I        +       +K++++ ++ S +     +
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCS 328

Query: 216 SISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIH--GEIPDYIGDMT 268
               L SL  L      + +     SA  K    +L+TL+L++  +    +  + +  + 
Sbjct: 329 FSQHLKSLEFLDLSENLMVEEYLKNSAC-KGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387

Query: 269 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 327
            L ++D+S N     +P + +   K  F+ L+   +   V   I  + + +D+S NN  
Sbjct: 388 NLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRV-VKTCIPQTLEVLDVSNNNLD 444

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 86.7 bits (215), Expect = 1e-17
 Identities = 53/341 (15%), Positives = 107/341 (31%), Gaps = 77/341 (22%)

Query: 42  ESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL 101
           +++  CD  S            ++ T ++P+ L+    +K LDLS N +T         +
Sbjct: 5   DASGVCDGRS------------RSFT-SIPSGLT--AAMKSLDLSFNKIT--------YI 41

Query: 102 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNS 160
                              L     L+ L ++ +    +I  D    L +L+ L LS N 
Sbjct: 42  G---------------HGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNH 85

Query: 161 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 220
            +    +    L++L  L +  N +                           + +    L
Sbjct: 86  LSSLSSSWFGPLSSLKYLNLMGNPYQ-----------------------TLGVTSLFPNL 122

Query: 221 TSLTDLRISDLKG----SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 276
           T+L  LRI +++         F  L   +L  L +    +       +  +  + ++ L 
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLT--SLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180

Query: 277 FNNLTGGIPTTFEKLAKTNFMYLTGNKLTG-----PVPKYIFNSNKNVDISLNNFTWESS 331
            +     +    + L+   ++ L    L            + +  K +    +  T ES 
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240

Query: 332 DPI-ECPRGSVNL--VESYSSPRNKLDKVHPCLRQNFPCSA 369
           + + +  R  + L  VE      N L   +P          
Sbjct: 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 74.8 bits (184), Expect = 5e-14
 Identities = 30/173 (17%), Positives = 55/173 (31%), Gaps = 19/173 (10%)

Query: 64  QNLTGTLPTELSKLRYLKQLDLSRNCLT------GSFSPQWASLQLVELSVMGNRLSGPF 117
                           L+ L LS+N L               +L  +++S   N    P 
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL-TLKNLTSLDIS--RNTFH-PM 402

Query: 118 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLND 177
           P        ++ L++        +   I     L+ L +S+N+        L +L  L  
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQELY- 457

Query: 178 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 230
             IS N     +P+    +  +  + I  + L+         LTSL  + +  
Sbjct: 458 --ISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 65.5 bits (160), Expect = 4e-11
 Identities = 27/146 (18%), Positives = 54/146 (36%), Gaps = 10/146 (6%)

Query: 64  QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 123
           +N    +P        ++ L+LS   +    +    +L+++++S   N L   F   L  
Sbjct: 396 RNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVS--NNNLDS-FSLFLPR 452

Query: 124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 183
              L+ L I  N    ++P        L  + +S N           +LT+L  + +  N
Sbjct: 453 ---LQELYISRNKLK-TLPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507

Query: 184 NFSG--KIPEFIGKWKKIQKLHIQGS 207
            +       +++ +W        QGS
Sbjct: 508 PWDCSCPRIDYLSRWLNKNSQKEQGS 533

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 89.2 bits (222), Expect = 2e-19
 Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 27/230 (11%)

Query: 623 LQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKS--RQ 676
           LQ      +  K    +F     +GEG F +V         +     A+K L  +   ++
Sbjct: 15  LQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKE 71

Query: 677 GNREFVN-EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTE 731
               +V  E  ++S   HP  VKLY    +  +L     Y KN      + +   G   E
Sbjct: 72  NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDE 129

Query: 732 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 791
              +            I   L YLH      I+HRD+K  N+LL++D++ +I+DFG AK+
Sbjct: 130 TCTRF-------YTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 179

Query: 792 YEEDKTHISTR-IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
              +          GT  Y++PE          +D+++ G +  ++V+G 
Sbjct: 180 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 89.4 bits (222), Expect = 7e-19
 Identities = 46/266 (17%), Positives = 86/266 (32%), Gaps = 23/266 (8%)

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 120
           L           +++    L  LD S N +T     Q   L    L+   N ++      
Sbjct: 153 LDCHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLN--RLNCDTNNITKL---D 207

Query: 121 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 180
           L     L  L    N  T  I  D+  L  L     S N  T EL   ++ L+ L  L  
Sbjct: 208 LNQNIQLTFLDCSSNKLT-EI--DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHC 261

Query: 181 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK 240
              +   +I   +    ++     +G      +   ++  T L  L       +E    +
Sbjct: 262 IQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITELDLSQ 316

Query: 241 LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLT 300
                L  L L    +  E+   +   TKLK++     ++      +  K+   N  +  
Sbjct: 317 N--PKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEA 369

Query: 301 GNKLTGPVPKYIFNSNKNVDISLNNF 326
             +      + + N++  + +S +  
Sbjct: 370 EGQTITMPKETLTNNSLTIAVSPDLL 395

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 87.1 bits (216), Expect = 4e-18
 Identities = 47/263 (17%), Positives = 91/263 (34%), Gaps = 24/263 (9%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 124
            +  T      +L  L  LD   + +T   +       L +L    N ++      L+  
Sbjct: 29  EMQATDTISEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLICTSNNITT-LD--LSQN 84

Query: 125 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 184
           T L  L+ + N  T ++   +  L  L  L   +N  T +L   +++   L  L  + N 
Sbjct: 85  TNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNT 138

Query: 185 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM 244
            + +I   +    ++ +L    +     +   ++  T LT L  S  K +E    +    
Sbjct: 139 LT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELDVSQNK-- 191

Query: 245 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 304
            L  L      I  ++   +    +L  +D S N LT  I      L +  +   + N L
Sbjct: 192 LLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPL 245

Query: 305 TGPVPKYIFNSNKNVDISLNNFT 327
           T  +     +    +     +  
Sbjct: 246 T-ELDVSTLSKLTTLHCIQTDLL 267

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 82.4 bits (204), Expect = 1e-16
 Identities = 44/261 (16%), Positives = 81/261 (31%), Gaps = 26/261 (9%)

Query: 73  ELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 131
           ++S+ + L +L+   N +T           QL  L    N+L+      +T +T L    
Sbjct: 186 DVSQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFD 239

Query: 132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 191
              N  T  +   +  L  L  L         E+   LT  T L   +        ++  
Sbjct: 240 CSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD- 292

Query: 192 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKMNLKTL 249
            +    ++  L  Q + +   +   +S    L  L +++  L    +         LK+L
Sbjct: 293 -VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL----TELDVSHNTKLKSL 344

Query: 250 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 309
                 I  +    +G +  L N   +          T    + T  +        G   
Sbjct: 345 SCVNAHI-QDFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPM 402

Query: 310 KYIFNSNKNVDISLNNFTWES 330
                     D + N  TWE+
Sbjct: 403 NIEPGDGGVYDQATNTITWEN 423

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 64.3 bits (157), Expect = 7e-11
 Identities = 31/179 (17%), Positives = 62/179 (34%), Gaps = 15/179 (8%)

Query: 127 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS 186
             +          +      +L  L  L   ++S T ++   + KLT L  L  + NN +
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77

Query: 187 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNL 246
             +   + +   +  L    + L   +   ++ LT LT L     K ++    +     L
Sbjct: 78  -TLD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTKLDVSQNP--LL 129

Query: 247 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 305
             L   +  +  EI   +   T+L  +D   N     +        +   +  + NK+T
Sbjct: 130 TYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 27/178 (15%), Positives = 55/178 (30%), Gaps = 13/178 (7%)

Query: 150 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 209
           N    + ++            +L  L  L   +++ +  +   I K   + KL    +++
Sbjct: 19  NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNI 76

Query: 210 EGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTK 269
              +   +S  T+LT L     K +      L    L  L      +  ++   +     
Sbjct: 77  TT-LD--LSQNTNLTYLACDSNKLTNLDVTPLT--KLTYLNCDTNKLT-KLD--VSQNPL 128

Query: 270 LKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 327
           L  ++ + N LT           +   +    NK    +          +D S N  T
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT 183

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 88.6 bits (220), Expect = 7e-19
 Identities = 54/251 (21%), Positives = 92/251 (36%), Gaps = 64/251 (25%)

Query: 637 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 695
           +  +     +G G FG V +    + G   A+K++    R  NRE    + ++    H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61

Query: 696 LVKLYGC--------------------------------------CVEGNQLLLVYEYMK 717
           ++KL                                           +   L ++ EY+ 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 718 NNCLSRAIFGKDTEYRLKLDWPTR--KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 775
           +  L + +    +  R     P          + R + ++H    + I HRDIK  N+L+
Sbjct: 122 DT-LHKVL---KSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLV 174

Query: 776 D-KDLNAKISDFGLAKLYEEDKTHIS---TRIAGTIGYMAPE--YAMRGYLTSKADVYSF 829
           + KD   K+ DFG AK     +  ++   +R      Y APE       Y T   D++S 
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY-TPSIDLWSI 228

Query: 830 GVVTLEIVSGK 840
           G V  E++ GK
Sbjct: 229 GCVFGELILGK 239

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 88.7 bits (220), Expect = 1e-18
 Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 48/237 (20%)

Query: 630 LRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKS--RQGNREFVN 683
           ++Q++    +F+    +G G FG V     K       V A+K L+     ++       
Sbjct: 66  VKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFR 122

Query: 684 -EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDW 738
            E  ++       +  L+    + N L LV +Y         LS+       E RL  + 
Sbjct: 123 EERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF------EDRLPEEM 176

Query: 739 PTRKKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 790
                     AR         +  +H+   +  VHRDIK  N+L+D + + +++DFG   
Sbjct: 177 ----------ARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCL 223

Query: 791 LYEEDKTHISTRIAGTIGYMAPE------YAMRGYLTSKADVYSFGVVTLEIVSGKS 841
              ED T  S+   GT  Y++PE           Y   + D +S GV   E++ G++
Sbjct: 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGET 279

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 56/280 (20%), Positives = 103/280 (36%), Gaps = 25/280 (8%)

Query: 55  HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 114
           + + IA    N+T T+    + L  +  L      +T +         L+ L +  N+++
Sbjct: 20  NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQIT 76

Query: 115 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 174
              P  L N+T +  L + GN    ++   I  L +++ L L+S   T   P  L  L+N
Sbjct: 77  DLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSN 130

Query: 175 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 234
           L  L +  N  +  I   +     +Q L I  + +       ++ L +L+ L       +
Sbjct: 131 LQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-----DLTPLANLSKLTTLKADDN 183

Query: 235 E-SAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 292
           + S    L  + NL  + L    I    P  + + + L  + L+   +T         L 
Sbjct: 184 KISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLV 241

Query: 293 KTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSD 332
             N +           P  I +   N   +  N TW  + 
Sbjct: 242 VPNVVKGPSGAPI--APATISD---NGTYASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 30/167 (17%), Positives = 64/167 (38%), Gaps = 16/167 (9%)

Query: 141 IPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ 200
           I PD   L N  K+    ++ T  +      L  +  L       +  I E +     + 
Sbjct: 12  IFPD-PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLI 66

Query: 201 KLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTLILTKCLIHG 258
            L ++ + +       ++ L +LT +   +L G+       +  + ++KTL LT   I  
Sbjct: 67  GLELKDNQIT-----DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD 121

Query: 259 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 305
             P  +  ++ L+ + L  N +T   P     L    ++ +   +++
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS 164

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 43/223 (19%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 686
              +     VG G +GSV   I    G  +A+K+LS       R F +         E+ 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75

Query: 687 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 740
           ++   QH N++ L                 LV  +M+ + L + +        LK     
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-LQKIM-------GLKFSEEK 127

Query: 741 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH-I 799
            + +   + +GL Y+H      +VHRD+K  N+ +++D   KI DFGLA+  + + T  +
Sbjct: 128 IQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV 184

Query: 800 STRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
            TR      Y APE   +   Y     D++S G +  E+++GK
Sbjct: 185 VTRW-----YRAPEVILSWMHY-NQTVDIWSVGCIMAEMLTGK 221

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 88.4 bits (219), Expect = 2e-18
 Identities = 42/261 (16%), Positives = 91/261 (34%), Gaps = 19/261 (7%)

Query: 79  YLKQLDLSRNCLTGSFSPQWAS----LQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 134
            L  ++ + N         W +      +  + + G      F    T++  L    +  
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285

Query: 135 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG 194
           ++F            N+     + +          +K++    L  S+N  +  + E  G
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345

Query: 195 KWKKIQKLHIQGSSLE--GPIPASISALTSLTDLRISD----LKGSESAFPKLDKMNLKT 248
              +++ L +Q + L+    I    + + SL  L IS         +         +L +
Sbjct: 346 HLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK--SLLS 403

Query: 249 LILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPV 308
           L ++  ++   I   +    ++K +DL  N +   IP    KL     + +  N+L   V
Sbjct: 404 LNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-V 459

Query: 309 PKYIFNSNKN---VDISLNNF 326
           P  IF+   +   + +  N +
Sbjct: 460 PDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 70.3 bits (172), Expect = 1e-12
 Identities = 37/170 (21%), Positives = 64/170 (37%), Gaps = 7/170 (4%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLS--GPFPKVL 121
                     SK+     LD S N LT +       L +L  L +  N+L       ++ 
Sbjct: 311 GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMT 370

Query: 122 TNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 180
           T + +L+ L I  N  +            +L  L +SSN  T  +   L     +  L +
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDL 428

Query: 181 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 230
             N     IP+ + K + +Q+L++  + L+         LTSL  + +  
Sbjct: 429 HSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT 477

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 67.2 bits (164), Expect = 1e-11
 Identities = 44/304 (14%), Positives = 90/304 (29%), Gaps = 34/304 (11%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSG-PFPK 119
            ++    +++  L  L+ L +S N +       F       +L  L +  N+L       
Sbjct: 32  YISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQ---ELEYLDLSHNKLVKISCHP 88

Query: 120 VLTNITTLKNLSIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTGELPAELTKLTNLND 177
              N   LK+L +  N F  ++P       +  L+ L LS+          +  L     
Sbjct: 89  -TVN---LKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKV 143

Query: 178 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA 237
           L +    +  K      +    + LHI   + +        ++ ++ +L +S++K     
Sbjct: 144 LLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLED 203

Query: 238 ----------FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNI-DLSFNNLT----- 281
                             L  L L            I  +     +   S +N+      
Sbjct: 204 NKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQL 263

Query: 282 --GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRG 339
                  +   L   +   +  +    P   YI+    N++I     +      + CP  
Sbjct: 264 DFRDFDYSGTSLKALSIHQVVSDVFGFP-QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSK 322

Query: 340 SVNL 343
               
Sbjct: 323 ISPF 326

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 61.8 bits (150), Expect = 6e-10
 Identities = 35/209 (16%), Positives = 67/209 (32%), Gaps = 7/209 (3%)

Query: 125 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDN 183
                L+I  N  +     DI  L  L+ LI+S N     L          L  L +S N
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHN 79

Query: 184 NFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDLRISDLKGSESAFPKLD 242
               KI         ++ L +  ++ +  PI      ++ L  L +S     +S+   + 
Sbjct: 80  KLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136

Query: 243 KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 302
            +N+  ++L     +GE  D    +       L     T         ++      L  +
Sbjct: 137 HLNISKVLLVLGETYGEKED-PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195

Query: 303 KLTGPVPKYIFNSNKNVDISLNNFTWESS 331
            +   +     +   ++   L      S+
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSN 224

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 55.6 bits (134), Expect = 5e-08
 Identities = 39/245 (15%), Positives = 72/245 (29%), Gaps = 31/245 (12%)

Query: 140 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 199
            +P D+        L +S N  +    +++  L+ L  L IS N              +I
Sbjct: 14  HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHN--------------RI 57

Query: 200 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 259
           Q L            +       L  L +S  K  + +      +NLK L L+       
Sbjct: 58  QYLD----------ISVFKFNQELEYLDLSHNKLVKISCHPT--VNLKHLDLSFNAFD-A 104

Query: 260 IPD--YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK 317
           +P     G+M++LK + LS  +L          L  +  + + G                
Sbjct: 105 LPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164

Query: 318 NVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYT 377
              + +   T +    I             S+ +  L+        +       +     
Sbjct: 165 TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSN 224

Query: 378 LHINC 382
           L +N 
Sbjct: 225 LTLNN 229

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 86.2 bits (214), Expect = 3e-18
 Identities = 54/286 (18%), Positives = 102/286 (35%), Gaps = 50/286 (17%)

Query: 53  TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELS 107
            CH+  +      L   +P +L        LDL  N +T    G F     +L  L  L 
Sbjct: 30  QCHLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFK----NLKNLHTLI 82

Query: 108 VMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA 167
           ++ N++S   P     +  L+ L +  N     +P  +     LQ+L +  N  T    +
Sbjct: 83  LINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKS 139

Query: 168 ELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR 227
               L  +  + +  N               ++   I+  + +G        +  L+ +R
Sbjct: 140 VFNGLNQMIVVELGTN--------------PLKSSGIENGAFQG--------MKKLSYIR 177

Query: 228 ISD--LKG-SESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGG 283
           I+D  +    +   P     +L  L L    I  ++       +  L  + LSFN+++  
Sbjct: 178 IADTNITTIPQGLPP-----SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAV 231

Query: 284 IPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSN--KNVDISLNNFT 327
              +         ++L  NKL   VP  + +    + V +  NN +
Sbjct: 232 DNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS 276

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 85.1 bits (211), Expect = 5e-18
 Identities = 43/249 (17%), Positives = 84/249 (33%), Gaps = 33/249 (13%)

Query: 74  LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKN 129
            + L  L++L LS+N L                L EL V  N ++     V   +  +  
Sbjct: 96  FAPLVKLERLYLSKNQLKELPEKMPK------TLQELRVHENEITKVRKSVFNGLNQMIV 149

Query: 130 LSIEGN-LFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 187
           + +  N L +  I     + +  L  + ++  + T  +P  L    +L +L +  N  + 
Sbjct: 150 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT- 205

Query: 188 KIPE--FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDK 243
           K+      G    + KL +  +S+      S++    L +L +++  L            
Sbjct: 206 KVDAASLKGL-NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH-- 262

Query: 244 MNLKTLILTKCLIHGEIPD-------YIGDMTKLKNIDLSFNNLTGGI--PTTFEKLAKT 294
             ++ + L    I   I         Y         + L  N +      P+TF  +   
Sbjct: 263 KYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 321

Query: 295 NFMYLTGNK 303
             + L   K
Sbjct: 322 AAVQLGNYK 330

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 86.3 bits (214), Expect = 4e-18
 Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 36/220 (16%)

Query: 637 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN---------EIG 686
              +     +G G  G V     +     +A+K+LS       R F N         E+ 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76

Query: 687 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 740
           ++    H N++ L           E   + +V E M  N L + I       +++LD   
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI-------QMELDHER 128

Query: 741 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 800
              +   +  G+ +LH      I+HRD+K SN+++  D   KI DFGLA+        + 
Sbjct: 129 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMM 183

Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           T    T  Y APE  +        D++S G +  E++ G 
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 85.8 bits (213), Expect = 5e-18
 Identities = 65/253 (25%), Positives = 109/253 (43%), Gaps = 37/253 (14%)

Query: 609 GGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY---KGILSD-GTV 664
           GG           +L+T   T    K    NF+    +G G +G V+   K    D G +
Sbjct: 25  GGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKL 84

Query: 665 IAVKQLSSKSRQGNREFV------NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 718
            A+K L   +     +         ++ +   +Q P LV L+       +L L+ +Y+  
Sbjct: 85  YAMKVLKKATIVQKAKTTEHTRTERQV-LEHIRQSPFLVTLHYAFQTETKLHLILDYIN- 142

Query: 719 NCLSRAIFGKD------TEYRLKLDWPTRKKICIG-IARGLAYLHEDSRIKIVHRDIKTS 771
                   G +         R         +I +G I   L +LH+   + I++RDIK  
Sbjct: 143 --------GGELFTHLSQRERFTEH---EVQIYVGEIVLALEHLHK---LGIIYRDIKLE 188

Query: 772 NVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE---YAMRGYLTSKADVYS 828
           N+LLD + +  ++DFGL+K +  D+T  +    GTI YMAP+       G+  +  D +S
Sbjct: 189 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKA-VDWWS 247

Query: 829 FGVVTLEIVSGKS 841
            GV+  E+++G S
Sbjct: 248 LGVLMYELLTGAS 260

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 85.8 bits (213), Expect = 5e-18
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 37/226 (16%)

Query: 637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS--SKSRQGNREFVN---------EI 685
            + +     +  G +G+V  G+ S+G  +A+K++       +      +         EI
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 686 GMISAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 740
            +++   HPN++ L    V       ++L LV E M+ + L++ I   D    +      
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVI--HDQRIVISPQ--- 134

Query: 741 RKKICI-GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-- 797
             +  +  I  GL  LHE     +VHRD+   N+LL  + +  I DF LA+    D    
Sbjct: 135 HIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT 191

Query: 798 -HISTRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
            +++ R      Y APE     +G+ T   D++S G V  E+ + K
Sbjct: 192 HYVTHRW-----YRAPELVMQFKGF-TKLVDMWSAGCVMAEMFNRK 231

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 84.9 bits (209), Expect = 6e-18
 Identities = 45/236 (19%), Positives = 71/236 (30%), Gaps = 48/236 (20%)

Query: 624 QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQL--------SSKSR 675
           Q G          T       K+GEG FG V++ I  D T +A+K +        +   +
Sbjct: 7   QKGPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQ 64

Query: 676 QGNREFVNEIGM---------ISAQQHPNLVKLYGC-CVEGN---QLLLVYEYMKNNCLS 722
           +   E + EI +             +    + L    CV+G+    LL  +++  +   S
Sbjct: 65  KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124

Query: 723 ----RAIFGKDTEYRL----------------KLDWPTRKKICIGIARGLAYLHEDSRIK 762
                  F  D  + +                     T K I   +   LA       ++
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLR 182

Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 818
             HRD+   NVLL K    K+      K                I Y        G
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSS---TIPSCGLQVSIIDYTLSRLERDG 235

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 55/274 (20%), Positives = 84/274 (30%), Gaps = 60/274 (21%)

Query: 46  TCDCSSAT--CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWA 99
                + T  C          N    +P  L      K LDLS N L      SF     
Sbjct: 4   VEVVPNITYQCM-------ELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFF---- 49

Query: 100 SL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILS 157
           S  +L  L +    +         +++ L  L + GN    S+       L +LQKL+  
Sbjct: 50  SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAV 108

Query: 158 SNSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPAS 216
             +    L       L  L +L ++ N               IQ            +P  
Sbjct: 109 ETNLA-SLENFPIGHLKTLKELNVAHN--------------LIQSF---------KLPEY 144

Query: 217 ISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIH---GEIPDYIGDMT 268
            S LT+L  L     +I  +    +    L    +  L L+  L       I        
Sbjct: 145 FSNLTNLEHLDLSSNKIQSI--YCTDLRVLH--QMPLLNLSLDLSLNPMNFIQPGAFKEI 200

Query: 269 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 302
           +LK + L  N L       F++L     ++L  N
Sbjct: 201 RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 56.9 bits (138), Expect = 7e-09
 Identities = 36/218 (16%), Positives = 70/218 (32%), Gaps = 63/218 (28%)

Query: 122 TNI-TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDL 178
            N+  + KNL +  N     +          LQ L LS       +       L++L+ L
Sbjct: 24  DNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTL 81

Query: 179 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF 238
            ++ N                                    + SL          +  AF
Sbjct: 82  ILTGNP-----------------------------------IQSL----------ALGAF 96

Query: 239 PKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNF 296
             L   +L+ L+  +  +   + ++  G +  LK ++++ N +    +P  F  L     
Sbjct: 97  SGL--SSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH 153

Query: 297 MYLTGNKLTGPVPKYIFNS-------NKNVDISLNNFT 327
           + L+ NK+   +              N ++D+SLN   
Sbjct: 154 LDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMN 190

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 19/202 (9%), Positives = 48/202 (23%), Gaps = 46/202 (22%)

Query: 645 KVGEGGFGSVYKGILSD---GTVIAVKQL---SSKSRQGNREFVNEIGMISAQQHPNLVK 698
             G       ++ +  D      +A+  +           +E ++    +S    P + +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
           +          L+V E+++   L                     +    +A      H  
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA-------DTSPSPVGAIRAMQSLAAAADAAH-- 146

Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 818
            R  +       S V +  D +  ++                         M        
Sbjct: 147 -RAGVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA----- 179

Query: 819 YLTSKADVYSFGVVTLEIVSGK 840
               + D+   G     ++  +
Sbjct: 180 --NPQDDIRGIGASLYALLVNR 199

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 83.7 bits (208), Expect = 2e-17
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)

Query: 634 KAATNNFDPANKVGEGGFGSVY---KGILSD-GTVIAVKQLSSKSRQGNREFV----NEI 685
           K     F+    +G+GG+G V+   K   ++ G + A+K L       N +       E 
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72

Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------TEYRLKLDWP 739
            ++   +HP +V L      G +L L+ EY+          G +       E     D  
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLS---------GGELFMQLEREGIFMED-- 121

Query: 740 TRKKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDK 796
                 +  I+  L +LH+     I++RD+K  N++L+   + K++DFGL K  +++   
Sbjct: 122 -TACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV 177

Query: 797 THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           TH  T   GTI YMAPE  MR G+     D +S G +  ++++G  
Sbjct: 178 TH--T-FCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAP 219

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 83.0 bits (206), Expect = 3e-17
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 37/225 (16%)

Query: 634 KAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVN---EIG 686
           KA  + F+    +G+G FG V+            + A+K L  K+    R+ V    E  
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-KATLKVRDRVRTKMERD 78

Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------TEYRLKLDWPT 740
           ++    HP +VKL+       +L L+ ++++         G D       E     +   
Sbjct: 79  ILVEVNHPFIVKLHYAFQTEGKLYLILDFLR---------GGDLFTRLSKEVMFTEE--- 126

Query: 741 RKKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKT 797
             K  +  +A  L +LH    + I++RD+K  N+LLD++ + K++DFGL+K  +  E K 
Sbjct: 127 DVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183

Query: 798 HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           +  +   GT+ YMAPE   R G+ T  AD +SFGV+  E+++G  
Sbjct: 184 Y--S-FCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTL 224

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 84.5 bits (209), Expect = 3e-17
 Identities = 56/220 (25%), Positives = 87/220 (39%), Gaps = 36/220 (16%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 686
              +     +G G  G V           +A+K+LS       R F N         E+ 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113

Query: 687 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 740
           ++    H N++ L           E   + LV E M  N L + I       +++LD   
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-------QMELDHER 165

Query: 741 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 800
              +   +  G+ +LH  S   I+HRD+K SN+++  D   KI DFGLA+        + 
Sbjct: 166 MSYLLYQMLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMM 220

Query: 801 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           T    T  Y APE  +        D++S G +  E+V  K
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 84.4 bits (209), Expect = 3e-17
 Identities = 60/219 (27%), Positives = 89/219 (40%), Gaps = 26/219 (11%)

Query: 634 KAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREF---VNEIG 686
           +   N F+    +G+G FG V     K     G   A+K L  +      E    + E  
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENR 200

Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRK 742
           ++   +HP L  L       ++L  V EY           G +  + L           +
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYAN---------GGELFFHLSRERVFSEDRAR 251

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
                I   L YLH  S   +V+RD+K  N++LDKD + KI+DFGL K   +D   + T 
Sbjct: 252 FYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT- 308

Query: 803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
             GT  Y+APE           D +  GVV  E++ G+ 
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 83.1 bits (206), Expect = 4e-17
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 42/223 (18%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 686
              +     VG G +G+V   +    G  +A+K+L        R F +         E+ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76

Query: 687 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 740
           ++   +H N++ L           +     LV  +M  + L + +         KL    
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-LGKLM------KHEKLGEDR 129

Query: 741 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HI 799
            + +   + +GL Y+H      I+HRD+K  N+ +++D   KI DFGLA+  + + T ++
Sbjct: 130 IQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV 186

Query: 800 STRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
            TR      Y APE       Y T   D++S G +  E+++GK
Sbjct: 187 VTRW-----YRAPEVILNWMRY-TQTVDIWSVGCIMAEMITGK 223

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 27/166 (16%), Positives = 64/166 (38%), Gaps = 6/166 (3%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 124
             + T     +++  L  + L+   +T   +    +  + +L++     +   P  ++ +
Sbjct: 31  GQSSTANITEAQMNSLTYITLANINVT-DLTGIEYAHNIKDLTINNIHATNYNP--ISGL 87

Query: 125 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 184
           + L+ L I G   T    P++  L +L  L +S ++    +  ++  L  +N + +S N 
Sbjct: 88  SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147

Query: 185 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 230
               I   +    +++ L+IQ   +       I     L  L    
Sbjct: 148 AITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 77.3 bits (191), Expect = 3e-16
 Identities = 31/168 (18%), Positives = 62/168 (36%), Gaps = 20/168 (11%)

Query: 122 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 181
             + +L  +++     T  +   I    N++ L +++   T   P  ++ L+NL  LRI 
Sbjct: 41  AQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIM 96

Query: 182 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL------RISDLKGSE 235
             + +      +     +  L I  S+ +  I   I+ L  +  +       I+D+    
Sbjct: 97  GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-- 154

Query: 236 SAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 282
                L  +  LK+L +    +H      I D  KL  +      + G
Sbjct: 155 -----LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 29/163 (17%), Positives = 56/163 (34%), Gaps = 33/163 (20%)

Query: 143 PDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL 202
           PD          +L  +S      A++  LT +    +++ N +                
Sbjct: 18  PD-STFKAYLNGLLGQSSTANITEAQMNSLTYIT---LANINVT---------------- 57

Query: 203 HIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIP 261
                 L G     I    ++ DL I+++  +  +    L   NL+ L +    +  +  
Sbjct: 58  -----DLTG-----IEYAHNIKDLTINNIHATNYNPISGLS--NLERLRIMGKDVTSDKI 105

Query: 262 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 304
             +  +T L  +D+S +     I T    L K N + L+ N  
Sbjct: 106 PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 81.6 bits (202), Expect = 1e-16
 Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 36/222 (16%)

Query: 634 KAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFV----NEI 685
            A  + FD    +G G FG V     K     G   A+K L  K +    + +    NE 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILD-KQKVVKLKQIEHTLNEK 92

Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTR 741
            ++ A   P LVKL     + + L +V EY+      + L R   G+ +E          
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPH-------- 142

Query: 742 KKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 800
            +     I     YLH    + +++RD+K  N+L+D+    +++DFG AK   + +T   
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTW-- 196

Query: 801 TRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKS 841
           T + GT   +APE  + +GY  +  D ++ GV+  E+ +G  
Sbjct: 197 T-LCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYP 236

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 44/224 (19%)

Query: 637 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN---------EIG 686
              +   + VG G +GSV     +  G  +AVK+LS       R F +         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80

Query: 687 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWP 739
           ++   +H N++ L           E N + LV   M  + L+  +  +  T+  ++    
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQF--- 136

Query: 740 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-H 798
               +   I RGL Y+H  S   I+HRD+K SN+ +++D   KI DFGLA+   ++ T +
Sbjct: 137 ----LIYQILRGLKYIH--SA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189

Query: 799 ISTRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
           ++TR      Y APE       Y     D++S G +  E+++G+
Sbjct: 190 VATRW-----YRAPEIMLNWMHY-NQTVDIWSVGCIMAELLTGR 227

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 82.8 bits (204), Expect = 2e-16
 Identities = 44/257 (17%), Positives = 87/257 (33%), Gaps = 18/257 (7%)

Query: 74  LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 133
                   + +L +  +T     Q     + ++    + +       +  +  +  L + 
Sbjct: 17  DDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 73

Query: 134 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI 193
           GN  T  I P +  L NL  L L  N    +L + L  L  L  L +  N  S  I   +
Sbjct: 74  GNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGL 127

Query: 194 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTLIL 251
               +++ L++  + +       I+ L+ LT L    L+ ++ S    L  +  L+ L L
Sbjct: 128 VHLPQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYL 182

Query: 252 TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY 311
           +K  I       +  +  L  ++L               L   N +  T   L  P    
Sbjct: 183 SKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240

Query: 312 IFNSNKNVDISLNNFTW 328
                +  ++  +   +
Sbjct: 241 DDGDYEKPNVKWHLPEF 257

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 79.0 bits (194), Expect = 2e-15
 Identities = 47/300 (15%), Positives = 103/300 (34%), Gaps = 19/300 (6%)

Query: 55  HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 114
             +   LK +++T  +    ++L  + Q+  + + +  S         + +L + GN+L+
Sbjct: 22  ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNKLT 78

Query: 115 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 174
              P  LTN+  L  L ++ N     +   ++ L  L+ L L  N  + ++   L  L  
Sbjct: 79  DIKP--LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQ 132

Query: 175 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 234
           L  L + +N  +      + +  K+  L ++ + +       I  L  LT L+   L  +
Sbjct: 133 LESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-----DIVPLAGLTKLQNLYLSKN 185

Query: 235 E-SAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 292
             S    L  + NL  L L       +  ++  ++     +  +  +L        +   
Sbjct: 186 HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV-TPEIISDDGD 244

Query: 293 KTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRN 352
                             +IF     +  +   F    + P++        V+       
Sbjct: 245 YEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTK 304

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 55.1 bits (132), Expect = 7e-08
 Identities = 44/275 (16%), Positives = 83/275 (30%), Gaps = 17/275 (6%)

Query: 74  LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 133
           L  L  L+ L L  N +T   +      +L  LS+  N++S   P  L  +T L+NL + 
Sbjct: 127 LVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 183

Query: 134 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI 193
            N  +  +   +  L NL  L L S     +     + L   N ++ +D +     PE I
Sbjct: 184 KNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEII 239

Query: 194 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTK 253
                 +K +++    E     S         + I   K             + T+    
Sbjct: 240 SDDGDYEKPNVKWHLPEFTNEVS---FIFYQPVTIGKAKARFHGRVTQPLKEVYTVS--- 293

Query: 254 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 313
                ++   +          ++           F+            N  T  +    F
Sbjct: 294 ----YDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDF 349

Query: 314 NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYS 348
                        T   +  ++  RG+  + +   
Sbjct: 350 TLYAVFKAETTEKTVNLTRYVKYIRGNAGIYKLPR 384

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 79.9 bits (198), Expect = 3e-16
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 32/218 (14%)

Query: 634 KAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKS--RQGNREFV-NEIG 686
           K +  +F     +G G FG V+    +    +G   A+K L  +   R    E   +E  
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERL 58

Query: 687 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRK 742
           M+S   HP +++++G   +  Q+ ++ +Y++     + L ++   +      K       
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKF------ 110

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
                +   L YLH      I++RD+K  N+LLDK+ + KI+DFG AK Y  D T+  T 
Sbjct: 111 -YAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-YVPDVTY--T- 162

Query: 803 IAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSG 839
           + GT  Y+APE      Y  S  D +SFG++  E+++G
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAG 199

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 80.9 bits (200), Expect = 3e-16
 Identities = 54/239 (22%), Positives = 89/239 (37%), Gaps = 50/239 (20%)

Query: 630 LRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNRE----F 681
           L++++   ++F+    +G G F  V     K     G V A+K ++ K     R     F
Sbjct: 53  LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMN-KWDMLKRGEVSCF 108

Query: 682 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLD 737
             E  ++       + +L+    + N L LV EY         LS+         R+  +
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF------GERIPAE 162

Query: 738 WPTRKKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 789
                      AR         +  +H    +  VHRDIK  N+LLD+  + +++DFG  
Sbjct: 163 M----------ARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSC 209

Query: 790 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVY-------SFGVVTLEIVSGKS 841
                D T  S    GT  Y++PE             Y       + GV   E+  G++
Sbjct: 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 82.4 bits (203), Expect = 3e-16
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 36/224 (16%)

Query: 634 KAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM-- 687
           +    +F+    +G+G FG V     KG      + AVK L  K      + V    +  
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILK-KDVVIQDDDVECTMVEK 392

Query: 688 ---ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPT 740
                  + P L +L+ C    ++L  V EY+          G D  Y +    +   P 
Sbjct: 393 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN---------GGDLMYHIQQVGRFKEPH 443

Query: 741 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTH 798
                  IA GL +L       I++RD+K  NV+LD + + KI+DFG+ K  +++   T 
Sbjct: 444 AVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT- 499

Query: 799 ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
             T   GT  Y+APE      Y     D ++FGV+  E+++G++
Sbjct: 500 -KT-FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQA 540

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 80.9 bits (200), Expect = 3e-16
 Identities = 56/232 (24%), Positives = 91/232 (39%), Gaps = 41/232 (17%)

Query: 630 LRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNRE----F 681
           +R ++    +++    +G G FG V     K       V A+K LS K     R     F
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLS-KFEMIKRSDSAFF 116

Query: 682 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 741
             E  +++    P +V+L+    +   L +V EYM          G D    +       
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP---------GGDLVNLMS-----N 162

Query: 742 KKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 793
             +    AR         L  +H    +  +HRD+K  N+LLDK  + K++DFG      
Sbjct: 163 YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219

Query: 794 EDKTHISTRIAGTIGYMAPE----YAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           ++         GT  Y++PE        GY   + D +S GV   E++ G +
Sbjct: 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 80.4 bits (199), Expect = 3e-16
 Identities = 60/219 (27%), Positives = 89/219 (40%), Gaps = 50/219 (22%)

Query: 646 VGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIG----MISAQQHPNLV 697
           +G+G FG V     K    +    AVK L  K+    +E  + +     ++   +HP LV
Sbjct: 46  IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 698 KLYGCCVEGNQLLLVYEYM----------KNNCLS--RAIFGKDTEYRLKLDWPTRKKIC 745
            L+      ++L  V +Y+          +  C    RA F     Y             
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-----Y------------A 145

Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRI 803
             IA  L YLH    + IV+RD+K  N+LLD   +  ++DFGL K  +     T  ST  
Sbjct: 146 AEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--ST-F 199

Query: 804 AGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
            GT  Y+APE   +  Y     D +  G V  E++ G  
Sbjct: 200 CGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLP 237

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 79.6 bits (197), Expect = 4e-16
 Identities = 68/227 (29%), Positives = 97/227 (42%), Gaps = 36/227 (15%)

Query: 631 RQIKAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSSKSRQGNREFVNEIG 686
            QIK    +F     +G+G FG V    +K         A+K L  K      + V    
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALK-KDVVLMDDDVECTM 65

Query: 687 M-----ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLD 737
           +       A +HP L  ++        L  V EY+          G D  Y +    K D
Sbjct: 66  VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN---------GGDLMYHIQSCHKFD 116

Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEED 795
                     I  GL +LH      IV+RD+K  N+LLDKD + KI+DFG+ K  +  + 
Sbjct: 117 LSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173

Query: 796 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           KT  +T   GT  Y+APE  +   Y     D +SFGV+  E++ G+S
Sbjct: 174 KT--NT-FCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQS 216

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 79.2 bits (196), Expect = 6e-16
 Identities = 63/223 (28%), Positives = 90/223 (40%), Gaps = 35/223 (15%)

Query: 634 KAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSSKSRQGNREFVN----EI 685
           K   N+FD    +G+G FG V     K     G   A+K L  K     ++ V     E 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILR-KEVIIAKDEVAHTVTES 56

Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTR 741
            ++   +HP L  L       ++L  V EY           G +  + L           
Sbjct: 57  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN---------GGELFFHLSRERVFTEERA 107

Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHI 799
           +     I   L YLH      +V+RDIK  N++LDKD + KI+DFGL K  + +      
Sbjct: 108 RFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-- 162

Query: 800 STRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
            T   GT  Y+APE      Y     D +  GVV  E++ G+ 
Sbjct: 163 KT-FCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRL 203

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 78.1 bits (193), Expect = 7e-16
 Identities = 50/201 (24%), Positives = 71/201 (35%), Gaps = 53/201 (26%)

Query: 647 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-- 703
           G G  G V +          A+K L     +  RE   E+    A Q P++V++      
Sbjct: 27  GLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYEN 82

Query: 704 --VEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRK--KICIGIARGLAYL 755
                  LL+V E +    L   I  +     TE         R+  +I   I   + YL
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE---------REASEIMKSIGEAIQYL 133

Query: 756 HEDSRIKIVHRDIKTSNVLL-DKDLNA--KISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           H    I I HRD+K  N+L   K  NA  K++DFG                       A 
Sbjct: 134 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------------AK 168

Query: 813 EYAMRGYLTSKADVYSFGVVT 833
           E     Y     D++S GV+ 
Sbjct: 169 ETTGEKY-DKSCDMWSLGVIM 188

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 26/217 (11%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQH 693
              +   + +GEG +G V       +   +A+K++S         R    EI ++   +H
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 84

Query: 694 PNLVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRKKICIG 747
            N++ +          +   + +V + M+ + L + +  +  +   +             
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICY-------FLYQ 136

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAG 805
           I RGL Y+H  +   ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 806 TIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 840
           T  Y APE  +  +GY T   D++S G +  E++S +
Sbjct: 194 TRWYRAPEIMLNSKGY-TKSIDIWSVGCILAEMLSNR 229

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 78.4 bits (194), Expect = 1e-15
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 50/235 (21%)

Query: 646 VGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIG-----MISAQQHPNL 696
           +G G +  V     K       + A+K +  K    + E ++ +         A  HP L
Sbjct: 17  IGRGSYAKVLLVRLKK---TDRIYAMKVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFL 72

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------TEYRLKLDWPTRKKICIG-IA 749
           V L+ C    ++L  V EY+          G D       + +L  +     +     I+
Sbjct: 73  VGLHSCFQTESRLFFVIEYVN---------GGDLMFHMQRQRKLPEE---HARFYSAEIS 120

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTI 807
             L YLHE     I++RD+K  NVLLD + + K++D+G+ K  L   D T   T   GT 
Sbjct: 121 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FCGTP 174

Query: 808 GYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS--------NTNYRPNEDFVY 853
            Y+APE      Y     D ++ GV+  E+++G+S        +   +  ED+++
Sbjct: 175 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 228

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 59/235 (25%), Positives = 100/235 (42%), Gaps = 50/235 (21%)

Query: 646 VGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIG-----MISAQQHPNL 696
           +G G +  V     K       + A++ +  K    + E ++ +         A  HP L
Sbjct: 60  IGRGSYAKVLLVRLKK---TDRIYAMRVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFL 115

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------TEYRLKLDWPTRKKICIG-IA 749
           V L+ C    ++L  V EY+          G D       + +L  +     +     I+
Sbjct: 116 VGLHSCFQTESRLFFVIEYVN---------GGDLMFHMQRQRKLPEE---HARFYSAEIS 163

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTI 807
             L YLHE     I++RD+K  NVLLD + + K++D+G+ K  L   D T   T   GT 
Sbjct: 164 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FCGTP 217

Query: 808 GYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS--------NTNYRPNEDFVY 853
            Y+APE      Y     D ++ GV+  E+++G+S        +   +  ED+++
Sbjct: 218 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 271

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 78.0 bits (193), Expect = 2e-15
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 36/212 (16%)

Query: 646 VGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIGM-----ISAQQHPNL 696
           +G+G FG V     K     G + AVK L  K      + V            A+ HP L
Sbjct: 31  LGKGSFGKVMLARVKE---TGDLYAVKVLK-KDVILQDDDVECTMTEKRILSLARNHPFL 86

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIARGL 752
            +L+ C    ++L  V E++          G D  + +    + D    +     I   L
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVN---------GGDLMFHIQKSRRFDEARARFYAAEIISAL 137

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYM 810
            +LH+     I++RD+K  NVLLD + + K++DFG+ K  +     T  +T   GT  Y+
Sbjct: 138 MFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--AT-FCGTPDYI 191

Query: 811 APEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           APE      Y     D ++ GV+  E++ G +
Sbjct: 192 APEILQEMLY-GPAVDWWAMGVLLYEMLCGHA 222

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 78.0 bits (193), Expect = 2e-15
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 34/211 (16%)

Query: 646 VGEGGFGSV----YKGILSDGTVIAVKQLSSKSRQGNREFVNEIG----MISAQQHPNLV 697
           +G+G FG V     KG      + AVK L       + +    +     +    + P L 
Sbjct: 28  LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIARGLA 753
           +L+ C    ++L  V EY+          G D  Y +    +   P        IA GL 
Sbjct: 85  QLHSCFQTMDRLYFVMEYVN---------GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMA 811
           +L       I++RD+K  NV+LD + + KI+DFG+ K  +++   T   T   GT  Y+A
Sbjct: 136 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK--T-FCGTPDYIA 189

Query: 812 PEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           PE      Y     D ++FGV+  E+++G++
Sbjct: 190 PEIIAYQPY-GKSVDWWAFGVLLYEMLAGQA 219

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 44/254 (17%), Positives = 88/254 (34%), Gaps = 18/254 (7%)

Query: 74  LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 133
                   + +L +  +T     Q     + ++    + +       +  +  +  L + 
Sbjct: 20  DDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76

Query: 134 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI 193
           GN  T  I P +  L NL  L L  N    +L + L  L  L  L +  N  S  I   +
Sbjct: 77  GNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGL 130

Query: 194 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTLIL 251
               +++ L++  + +       I+ L+ LT L    L+ ++ S    L  +  L+ L L
Sbjct: 131 VHLPQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYL 185

Query: 252 TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY 311
           +K  I  ++   +  +  L  ++L               L   N +  T   L  P    
Sbjct: 186 SKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 243

Query: 312 IFNSNKNVDISLNN 325
                +  ++  + 
Sbjct: 244 DDGDYEKPNVKWHL 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 76.8 bits (189), Expect = 4e-15
 Identities = 64/272 (23%), Positives = 99/272 (36%), Gaps = 38/272 (13%)

Query: 47  CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL- 101
           C CS+          +   +T  +P++L   R   +L      L     G+FS       
Sbjct: 7   CHCSNRVFL-----CQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFS----GFG 54

Query: 102 QLVELSVMGNR-LSGPFPKVLTNITTLKNLSIE-GNLFTGSIPPDI-RKLINLQKLILSS 158
            L ++ +  N  L      V +N+  L  + IE  N     I P+  + L NLQ L++S+
Sbjct: 55  DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISN 113

Query: 159 NSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPE--FIGKWKKIQKLHIQGSSLEGPIPA 215
                 LP            L I DN     I    F+G   +   L +  + ++  I  
Sbjct: 114 TGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHN 171

Query: 216 SISALTSLTDLRISDLKG----SESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKL 270
           S    T L +L +SD           F          L +++  IH  +P Y   ++ KL
Sbjct: 172 SAFNGTQLDELNLSDNNNLEELPNDVFHGAS--GPVILDISRTRIH-SLPSYGLENLKKL 228

Query: 271 KNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 302
           +    S  NL   +P T EKL       LT  
Sbjct: 229 RA--RSTYNLK-KLP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 32/213 (15%), Positives = 62/213 (29%), Gaps = 37/213 (17%)

Query: 125 TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISD 182
                L          I         +L+K+ +S N     + A+  + L  L+++RI  
Sbjct: 30  RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88

Query: 183 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG-SESAFP 239
            N              +  ++          P +   L +L  L IS+  +K   +    
Sbjct: 89  AN-------------NLLYIN----------PEAFQNLPNLQYLLISNTGIKHLPDVHKI 125

Query: 240 KLDKMNLKTLILTKCLIHGEIPDYI--GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 297
               +    L +   +    I      G   +   + L+ N +     + F         
Sbjct: 126 HS--LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELN 183

Query: 298 YLTGNKLTGPVPKYIF---NSNKNVDISLNNFT 327
               N L   +P  +F   +    +DIS     
Sbjct: 184 LSDNNNLEE-LPNDVFHGASGPVILDISRTRIH 215

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 76.5 bits (189), Expect = 4e-15
 Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 34/216 (15%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS-KSRQGNREFVNEIGMISA---- 690
            +++    K+G G +  V++ I +++   + VK L   K ++  RE       I      
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-------IKILENL 87

Query: 691 QQHPNLVKLYGCCV---EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 747
           +  PN++ L    V         LV+E++ NN   + ++   T+Y ++            
Sbjct: 88  RGGPNIITLA-DIVKDPVSRTPALVFEHV-NNTDFKQLYQTLTDYDIR-------FYMYE 138

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGT 806
           I + L Y H  S   I+HRD+K  NV++D +    ++ D+GLA+ Y   + + + R+A +
Sbjct: 139 ILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-S 193

Query: 807 IGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
             +  PE     + Y  S  D++S G +   ++  K
Sbjct: 194 RYFKGPELLVDYQMYDYS-LDMWSLGCMLASMIFRK 228

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 75.8 bits (187), Expect = 6e-15
 Identities = 56/225 (24%), Positives = 104/225 (46%), Gaps = 33/225 (14%)

Query: 637 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 695
            + +     +G GG G V+  + +D    +A+K++     Q  +  + EI +I    H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 696 LVKLY--------------GCCVEGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPT 740
           +VK++              G   E N + +V EYM+ + L+  +      E   +L    
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVLEQGPLLEEHARL---- 124

Query: 741 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHI 799
                  + RGL Y+H  +   ++HRD+K +N+ ++ +DL  KI DFGLA++ +   +H 
Sbjct: 125 ---FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178

Query: 800 S--TRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
              +    T  Y +P    +   Y T   D+++ G +  E+++GK
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGK 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 75.7 bits (187), Expect = 8e-15
 Identities = 50/224 (22%), Positives = 98/224 (43%), Gaps = 33/224 (14%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQH 693
           +++F   + +GEG +G V        G ++A+K++    K     R    EI ++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKH 68

Query: 694 PNLVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRKKICIG 747
            N++ ++           N++ ++ E M+ + L R I  +  ++  ++            
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTD-LHRVISTQMLSDDHIQY-------FIYQ 120

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
             R +  LH  +   ++HRD+K SN+L++ + + K+ DFGLA++ +E     S       
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 808 G---------YMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 840
           G         Y APE       Y +   DV+S G +  E+   +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKY-SRAMDVWSCGCILAELFLRR 220

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 76.7 bits (189), Expect = 8e-15
 Identities = 35/249 (14%), Positives = 75/249 (30%), Gaps = 29/249 (11%)

Query: 103 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 161
           +  + +  N ++       + +  L+ L +E       I  +  R L +L  L L  N F
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 162 TGELPAE-LTKLTNLNDLRISDNNF-SGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASI- 217
             +L       L NL  L ++  N     +          ++ L ++ ++++   PAS  
Sbjct: 92  L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 218 SALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKN 272
             +     L     ++  +   E         +   L L                + +  
Sbjct: 151 LNMRRFHVLDLTFNKVKSIC--EEDLLNFQGKHFTLLRL----------------SSITL 192

Query: 273 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSD 332
            D++   L         K      + L+GN     + K  F++     I     +   + 
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252

Query: 333 PIECPRGSV 341
                  + 
Sbjct: 253 GSSFGHTNF 261

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 74.8 bits (184), Expect = 4e-14
 Identities = 51/293 (17%), Positives = 99/293 (33%), Gaps = 54/293 (18%)

Query: 76  KLRYLKQLDLSRNCLT-----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTL--- 127
            L  L+ L L  N +        F        +++L+   N++     + L N       
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLN-MRRFHVLDLT--FNKVKSICEEDLLNFQGKHFT 183

Query: 128 -------KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR- 179
                      +           +  K  ++  L LS N F   +            ++ 
Sbjct: 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243

Query: 180 ------------ISDNNFSGKIPE--FIG-KWKKIQKLHIQGSSLEGPIPASI-SALTSL 223
                           NF        F G +   ++   +  S +   +  S+ S  T L
Sbjct: 244 LILSNSYNMGSSFGHTNFK-DPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDL 301

Query: 224 TDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSF 277
             L      I+ +   ++AF  L   +L  L L++  + G I   + + + KL+ +DLS+
Sbjct: 302 EQLTLAQNEINKI--DDNAFWGLT--HLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSY 356

Query: 278 NNLTGGIPT-TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNF 326
           N++   +   +F  L     + L  N+L   VP  IF+   +   + +  N +
Sbjct: 357 NHIRA-LGDQSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 71.3 bits (175), Expect = 5e-13
 Identities = 54/280 (19%), Positives = 93/280 (33%), Gaps = 40/280 (14%)

Query: 69  TLPTE-LSKLRYLKQLDLSRNCLTGSFSPQ--WASL-QLVELSVMGNRLSGPFPK-VLTN 123
            L T   + L  L+ L L++  L G+      +  L  L  L +  N +    P     N
Sbjct: 93  QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152

Query: 124 ITTLKNLSIEGNLFTGSIPPDI-----------RKLINLQKLILSSNSFTGELPAELTKL 172
           +     L +  N    SI  +             +L ++    ++      E      K 
Sbjct: 153 MRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211

Query: 173 TNLNDLRISDNNFSGKIPEFIGKWKKIQKL--------HIQGSSLEGPIPASISALT--- 221
           T++  L +S N F   + +         K+        +  GSS            T   
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271

Query: 222 -SLTDLRISDLKG------SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNI 273
              + ++  DL         +S F      +L+ L L +  I+ +I D     +T L  +
Sbjct: 272 LEASGVKTCDLSKSKIFALLKSVFSHFT--DLEQLTLAQNEIN-KIDDNAFWGLTHLLKL 328

Query: 274 DLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 313
           +LS N L       FE L K   + L+ N +   +    F
Sbjct: 329 NLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSF 367

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 65.5 bits (160), Expect = 3e-11
 Identities = 35/258 (13%), Positives = 78/258 (30%), Gaps = 46/258 (17%)

Query: 125 TTLKNLSIEGNLFTGSIPP-DIRKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLRISD 182
             +  + +  N     +      +L +LQ L +   +    +       L++L  L++  
Sbjct: 30  AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88

Query: 183 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS---ESA 237
           N              +  +L             + + L +L  L ++   L G+    + 
Sbjct: 89  N--------------QFLQLE----------TGAFNGLANLEVLTLTQCNLDGAVLSGNF 124

Query: 238 FPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNF 296
           F  L   +L+ L+L    I    P      M +   +DL+FN +              +F
Sbjct: 125 FKPLT--SLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHF 182

Query: 297 --MYLTGNKLT-------GPVPKYIFNSNKNVDI-SLNNFTWESSDPIECPRGSVNLVES 346
             + L+   L        G         N ++    L+   ++ S   +    ++   + 
Sbjct: 183 TLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKES-MAKRFFDAIAGTKI 241

Query: 347 YSSPRNKLDKVHPCLRQN 364
            S   +    +       
Sbjct: 242 QSLILSNSYNMGSSFGHT 259

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 59.4 bits (144), Expect = 3e-09
 Identities = 43/260 (16%), Positives = 80/260 (30%), Gaps = 37/260 (14%)

Query: 75  SKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMG-----------NRLSGPFPKVLTN 123
             +R    LDL+ N +         + Q    +++              L          
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210

Query: 124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLI-------------LSSNSFTGELPAELT 170
            T++  L + GN F  S+       I   K+                  +F         
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270

Query: 171 KL--TNLNDLRISDNNFSGKIPEFIGKW-KKIQKLHIQGSSLEGPIPASI-SALTSLTDL 226
            L  + +    +S +     + + +      +++L +  + +   I  +    LT L  L
Sbjct: 271 GLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKL 328

Query: 227 RISD--LKG-SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTG 282
            +S   L       F  LD   L+ L L+   I   + D     +  LK + L  N L  
Sbjct: 329 NLSQNFLGSIDSRMFENLD--KLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKS 385

Query: 283 GIPTTFEKLAKTNFMYLTGN 302
                F++L     ++L  N
Sbjct: 386 VPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 57.4 bits (139), Expect = 1e-08
 Identities = 26/129 (20%), Positives = 54/129 (41%), Gaps = 16/129 (12%)

Query: 64  QNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFP 118
             L  ++ +  + L  L    L++N +      +F      L  L++L++  N L     
Sbjct: 288 FALLKSVFSHFTDLEQL---TLAQNEINKIDDNAF----WGLTHLLKLNLSQNFLGSIDS 340

Query: 119 KVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLN 176
           ++  N+  L+ L +  N    ++       L NL++L L +N     +P     +LT+L 
Sbjct: 341 RMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQ 398

Query: 177 DLRISDNNF 185
            + +  N +
Sbjct: 399 KIWLHTNPW 407

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 44/173 (25%), Positives = 64/173 (36%), Gaps = 9/173 (5%)

Query: 61  LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 120
           L    L       L     L QL+L R  LT           L  L +  N+L    P +
Sbjct: 38  LSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQS-LPLL 95

Query: 121 LTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDL 178
              +  L  L +  N  T S+P    R L  LQ+L L  N     LP  L T    L  L
Sbjct: 96  GQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKL 153

Query: 179 RISDNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 230
            +++NN + ++P  +    + +  L +Q +SL   IP        L    +  
Sbjct: 154 SLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHG 204

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 46/195 (23%), Positives = 73/195 (37%), Gaps = 17/195 (8%)

Query: 140 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 199
           ++PPD+    +   L LS N       A L   T L  L +     + K+    G    +
Sbjct: 24  ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVL 79

Query: 200 QKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKC 254
             L +  + L+  +P     L +LT L     R++ L     A   L    L+ L L   
Sbjct: 80  GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSL--PLGALRGLG--ELQELYLKGN 134

Query: 255 LIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 313
            +   +P  +     KL+ + L+ NNLT         L   + + L  N L   +PK  F
Sbjct: 135 ELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFF 192

Query: 314 NSNKNVDISLNNFTW 328
            S+      L+   W
Sbjct: 193 GSHLLPFAFLHGNPW 207

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 75.2 bits (185), Expect = 3e-14
 Identities = 38/181 (20%), Positives = 79/181 (43%), Gaps = 31/181 (17%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 686
            + ++  + +G G +G V +     +  V+A+K++        R F +         EI 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104

Query: 687 MISAQQHPNLVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 741
           +++   H ++VK+          + ++L +V E   ++   +      T   L       
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD-FKKLF---RTPVYLTEL--HI 158

Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
           K +   +  G+ Y+H      I+HRD+K +N L+++D + K+ DFGLA+  +  +   S 
Sbjct: 159 KTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 802 R 802
            
Sbjct: 216 L 216

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 73.0 bits (179), Expect = 2e-13
 Identities = 48/302 (15%), Positives = 97/302 (32%), Gaps = 22/302 (7%)

Query: 17  DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSK 76
             N  V+         +  +D+            +    ++ + L+    T     +L +
Sbjct: 212 QVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQ 271

Query: 77  L---RYLKQLDLSRNCLTGSF---SPQWASLQLVELSVM---GNRLSGPFPKVLTNITTL 127
               R ++ L++    +T         ++   L  L +              + +    +
Sbjct: 272 FFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEM 331

Query: 128 K--NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 185
               LSI    F   + P      +   L  + N FT  +    + L  L  L +  N  
Sbjct: 332 NIKMLSISDTPFIHMVCPPS--PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389

Query: 186 SGKIPEFIGKWKKIQKLHIQGSSL----EGPIPASISALTSLTDLRISDLKGSESAFPKL 241
                +     K +  L     SL          + +   S+  L +S    + S F  L
Sbjct: 390 K-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448

Query: 242 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLT 300
               +K L L    I   IP  +  +  L+ ++++ N L   +P   F++L    +++L 
Sbjct: 449 -PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH 505

Query: 301 GN 302
            N
Sbjct: 506 DN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 72.2 bits (177), Expect = 3e-13
 Identities = 41/257 (15%), Positives = 95/257 (36%), Gaps = 17/257 (6%)

Query: 80  LKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGP-----FPKVLTNITTLKNLSIEG 134
           L+ ++ +  C    F   W    +  L++    ++       F    T + +L    ++ 
Sbjct: 256 LQHIETTWKCSVKLFQFFWPR-PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKN 314

Query: 135 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG 194
            +F  S          +   +LS +             ++   L  + N F+  + +   
Sbjct: 315 QVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCS 374

Query: 195 KWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG---SESAFPKL--DKMNLKTL 249
             K++Q L +Q + L+           +++ L   D+     +  A+ +      ++  L
Sbjct: 375 TLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL 433

Query: 250 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 309
            L+  ++ G +   +    K+K +DL  N +   IP     L     + +  N+L   VP
Sbjct: 434 NLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKS-VP 489

Query: 310 KYIFNSNKNV-DISLNN 325
             +F+   ++  I L++
Sbjct: 490 DGVFDRLTSLQYIWLHD 506

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 61.8 bits (150), Expect = 5e-10
 Identities = 35/191 (18%), Positives = 64/191 (33%), Gaps = 10/191 (5%)

Query: 120 VLTNI-TTLKNLSIEGNLFTGSIPP-DIRKLINLQKLILSSNSFTGELPAEL-TKLTNLN 176
           V  ++    K LS+  N  +  +   DI  L  L+ L LS N     L   +     +L 
Sbjct: 46  VPKDLPPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLE 103

Query: 177 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDLRISDLKGSE 235
            L +S N     I         ++ L +  +  +  P+      LT LT L +S  K  +
Sbjct: 104 YLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160

Query: 236 SAFPKLDKMNLKTLIL-TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 294
                +  ++L  ++L                +     + L F+  +         +   
Sbjct: 161 LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNAL 220

Query: 295 NFMYLTGNKLT 305
             + L+  KL 
Sbjct: 221 GHLQLSNIKLN 231

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 61.4 bits (149), Expect = 7e-10
 Identities = 52/333 (15%), Positives = 107/333 (32%), Gaps = 39/333 (11%)

Query: 42  ESNVTCDCSSATCHVV--TIALKAQNL-------TGTLPTELSKLRYLKQLDLSRNCLT- 91
           E     D S+     V   +  + + L       +     ++S L  L+ L LS N +  
Sbjct: 31  ELESMVDYSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS 90

Query: 92  ---GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPP--DIR 146
                F        L  L V  NRL       + +   L++L +  N F   +P   +  
Sbjct: 91  LDFHVFLFNQ---DLEYLDVSHNRLQNISCCPMAS---LRHLDLSFNDFD-VLPVCKEFG 143

Query: 147 KLINLQKLILSSNSFTGELPAELTKL-TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQ 205
            L  L  L LS+  F       +  L  +   L +   +  G   E +        LH+ 
Sbjct: 144 NLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQI-PNTTVLHLV 202

Query: 206 GSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM------NLKTLILTKCLIHGE 259
                        ++ +L  L++S++K ++    +L             L +T   I   
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262

Query: 260 IPDYIGDM-----TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPV----PK 310
               +          ++ +++    +T  I       ++T    L    +   V     +
Sbjct: 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322

Query: 311 YIFNSNKNVDISLNNFTWESSDPIECPRGSVNL 343
            +++    ++I + + +      + CP    + 
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSF 355

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 51.8 bits (124), Expect = 7e-07
 Identities = 32/116 (27%), Positives = 55/116 (47%), Gaps = 9/116 (7%)

Query: 74  LSKLRYLKQLDLSRNCLT-GSFSP--QWASLQLVELSVMGNRLSGPFPKVLTNITTLKNL 130
              +  L+ LD+S N L   ++     WA   ++ L++  N L+G   + L     +K L
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAE-SILVLNLSSNMLTGSVFRCLP--PKVKVL 455

Query: 131 SIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNF 185
            +  N    SIP D+  L  LQ+L ++SN     +P     +LT+L  + + DN +
Sbjct: 456 DLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 33/233 (14%), Positives = 71/233 (30%), Gaps = 35/233 (15%)

Query: 103 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 161
              L ++   L        +N+  +  + +  ++    +       L  +  + + +   
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92

Query: 162 TGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 220
              +  + L +L  L  L I +                ++           P    + + 
Sbjct: 93  LTYIDPDALKELPLLKFLGIFNT--------------GLKMF---------PDLTKVYST 129

Query: 221 TSLTDLRISDLKG----SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 276
                L I+D         +AF  L      TL L        +  Y  + TKL  + L+
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNE-TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187

Query: 277 FNNLTGGIPT-TFEKLAKT-NFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 327
            N     I    F  +    + + ++   +T  +P       K + I+ N +T
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSKGLEHLKEL-IARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 39/195 (20%), Positives = 67/195 (34%), Gaps = 43/195 (22%)

Query: 140 SIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKWKK 198
           S+PP      + Q L L        +P+   + L N++ + +S +               
Sbjct: 28  SLPP------STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDV-------------T 67

Query: 199 IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG----SESAFPKLDKMNLKTLILTKC 254
           +Q+L             S   L+ +T + I + +        A  +L    LK L +   
Sbjct: 68  LQQLE----------SHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP--LLKFLGIFNT 115

Query: 255 LIHGEIPDY--IGDMTKLKNIDLSFNNLTGGIPT-TFEKLAK-TNFMYLTGNKLTGPVPK 310
            +    PD   +        ++++ N     IP   F+ L   T  + L  N  T  V  
Sbjct: 116 GLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQG 173

Query: 311 YIFNSNKNVDISLNN 325
           Y FN  K   + LN 
Sbjct: 174 YAFNGTKLDAVYLNK 188

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 70.9 bits (174), Expect = 6e-13
 Identities = 45/203 (22%), Positives = 88/203 (43%), Gaps = 36/203 (17%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 686
            +N+   + +G G +G VY     +    +A+K+++       R F +         EI 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77

Query: 687 MISAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWP 739
           +++  +   +++LY   +     + ++L +V E   ++ L +        TE  +K    
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD-LKKLFKTPIFLTEEHIKT--- 133

Query: 740 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTH 798
               I   +  G  ++HE     I+HRD+K +N LL++D + K+ DFGLA  +  E  T+
Sbjct: 134 ----ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186

Query: 799 ISTRIAGTIGYMAPEYAMRGYLT 821
           I   +            ++  LT
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLT 209

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 69.7 bits (171), Expect = 1e-12
 Identities = 45/199 (22%), Positives = 83/199 (41%), Gaps = 32/199 (16%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 686
              ++   K+G+G +G V+K I    G V+AVK++          F N         EI 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60

Query: 687 MISA-QQHPNLVKLYGCCV--EGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRK 742
           +++    H N+V L           + LV++YM+ + L   I          +       
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD-LHAVIRANILEPVHKQY------ 113

Query: 743 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 802
            +   + + + YLH  S   ++HRD+K SN+LL+ + + K++DFGL++ +   +   +  
Sbjct: 114 -VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169

Query: 803 IAGTIGYMAPEYAMRGYLT 821
                         +  LT
Sbjct: 170 PLSINENTENFDDDQPILT 188

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 33/218 (15%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR---QGNRE-----FVNEIGMI--SAQQH 693
           K+G G F +V+    + + T +A+K +            E      VN+       +   
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 694 PNLVKLYGC----CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
            +++KL          G  +++V+E +  N L+     K  E+R  +     K+I   + 
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA---LIKKYEHR-GIPLIYVKQISKQLL 141

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLD------KDLNAKISDFGLAKLYEEDKT-HISTR 802
            GL Y+H   R  I+H DIK  NVL++        +  KI+D G A  Y+E  T  I TR
Sbjct: 142 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199

Query: 803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
                 Y +PE  +       AD++S   +  E+++G 
Sbjct: 200 E-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 56/216 (25%), Positives = 87/216 (40%), Gaps = 40/216 (18%)

Query: 122 TNI-TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDL 178
           +NI    K L ++ N  + S+P     +L  L+ L L+ N     LPA +  +L NL  L
Sbjct: 33  SNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETL 90

Query: 179 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD--LKG-S 234
            ++DN              K+Q L           P  +   L +L +LR+    LK   
Sbjct: 91  WVTDN--------------KLQAL-----------PIGVFDQLVNLAELRLDRNQLKSLP 125

Query: 235 ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAK 293
              F  L    L  L L    +   +P  + D +T LK + L  N L       F+KL +
Sbjct: 126 PRVFDSL--TKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTE 182

Query: 294 TNFMYLTGNKLTGPVPKYIFNSNKNV-DISLNNFTW 328
              + L  N+L   VP+  F+S + +  + L    W
Sbjct: 183 LKTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQENPW 217

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 45/175 (25%), Positives = 73/175 (41%), Gaps = 17/175 (9%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPK 119
            L+        +L  L+ L L+ N L     G F      L  L  L V  N+L      
Sbjct: 48  KLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFK----ELKNLETLWVTDNKLQALPIG 103

Query: 120 VLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLND 177
           V   +  L  L ++ N    S+PP +   L  L  L L  N     LP  +  KLT+L +
Sbjct: 104 VFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKE 161

Query: 178 LRISDNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD 230
           LR+ +N    ++PE    K  +++ L +  + L+  +P     +L  L  L++ +
Sbjct: 162 LRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQE 214

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 66.6 bits (163), Expect = 6e-12
 Identities = 48/192 (25%), Positives = 70/192 (36%), Gaps = 35/192 (18%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 696
            NF    K+G G FG +  G  L     +A+K    KSR                    +
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-YKQLGSGDGI 67

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK---KICIGIA---- 749
            ++Y     G    +V E +          G   E     D   R    K  + IA    
Sbjct: 68  PQVYYFGPCGKYNAMVLELL----------GPSLED--LFDLCDRTFSLKTVLMIAIQLI 115

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK-----ISDFGLAKLYEEDKT--HISTR 802
             + Y+H  +   +++RD+K  N L+ +  N       I DF LAK Y + +T  HI  R
Sbjct: 116 SRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172

Query: 803 ----IAGTIGYM 810
               + GT  YM
Sbjct: 173 EHKSLTGTARYM 184

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 45/182 (24%), Positives = 71/182 (39%), Gaps = 31/182 (17%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGC 702
           K+G G FG +Y G  ++ G  +A+K    K++        E  +    Q    +  +  C
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73

Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-----KLDWPTRKKICIGIARGLAYLHE 757
             EG+  ++V E +          G   E        K    T   +   +   + Y+H 
Sbjct: 74  GAEGDYNVMVMELL----------GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAK---ISDFGLAKLYEEDKT--HISTR----IAGTIG 808
            +    +HRD+K  N L+          I DFGLAK Y + +T  HI  R    + GT  
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180

Query: 809 YM 810
           Y 
Sbjct: 181 YA 182

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 63.6 bits (155), Expect = 7e-11
 Identities = 27/203 (13%), Positives = 63/203 (31%), Gaps = 39/203 (19%)

Query: 638 NNFDPANKVGEGGFGSVYKGI---------LSDGTVIAVKQLSSKSRQGNREFVNEIGMI 688
             +   +       G +Y+                  ++K L +K  +   E        
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 689 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI----FGKDTEYRLKLDWPTRKK- 743
              Q     KLY   +    +     +  +    R +     G+  +    LD   +   
Sbjct: 101 KPLQVNKWKKLYSTPLLA--IPTCMGFGVHQDKYRFLVLPSLGRSLQS--ALDVSPKHVL 156

Query: 744 -----ICIG---IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI--SDFGLAKLYE 793
                + +    +   L +LHE+     VH ++   N+ +D +  +++  + +G A  Y 
Sbjct: 157 SERSVLQVACRLLDA-LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212

Query: 794 EDKTHISTR------IAGTIGYM 810
               H++          G + ++
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFI 235

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 63.1 bits (154), Expect = 8e-11
 Identities = 46/185 (24%), Positives = 72/185 (38%), Gaps = 35/185 (18%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           ++GEG FG +++G  L +   +A+K    +S                     +  +Y   
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YKLLAGCTGIPNVYYFG 75

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK---KICIGIA----RGLAYLH 756
            EG   +LV + +          G   E    LD   RK   K     A      +  +H
Sbjct: 76  QEGLHNVLVIDLL----------GPSLED--LLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAK-----ISDFGLAKLYEEDKT--HISTR----IAG 805
           E S   +V+RDIK  N L+ +  +       + DFG+ K Y +  T  HI  R    ++G
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180

Query: 806 TIGYM 810
           T  YM
Sbjct: 181 TARYM 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 41/259 (15%), Positives = 83/259 (32%), Gaps = 20/259 (7%)

Query: 72  TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 131
                L    + +L +  +T     Q     +   +   + +       +   T LK L 
Sbjct: 13  FPDPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELH 69

Query: 132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 191
           +  N  +  + P ++ L  L++L ++ N            L+ L    + +N       +
Sbjct: 70  LSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNELRD--TD 122

Query: 192 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTL 249
            +   K ++ L I+ + L+     SI  L  L+ L + DL G+E +    L ++  +  +
Sbjct: 123 SLIHLKNLEILSIRNNKLK-----SIVMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWI 177

Query: 250 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG-PV 308
            LT      E   Y  ++     +           P             +          
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPVYTDE 235

Query: 309 PKYIFNSNKNVDISLNNFT 327
             Y F+   NV  +   F 
Sbjct: 236 VSYKFSEYINVGETEAIFD 254

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 47/182 (25%), Positives = 74/182 (40%), Gaps = 31/182 (17%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGC 702
           K+G G FG +Y G  +     +A+K  + K++  + + + E  +    Q    +  +   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWF 71

Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-----KLDWPTRKKICIGIARGLAYLHE 757
            VEG+  +LV + +          G   E        KL   T   +   +   + ++H 
Sbjct: 72  GVEGDYNVLVMDLL----------GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAK---ISDFGLAKLYEEDKT--HISTR----IAGTIG 808
            S    +HRDIK  N L+     A    I DFGLAK Y +  T  HI  R    + GT  
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178

Query: 809 YM 810
           Y 
Sbjct: 179 YA 180

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 32/142 (22%), Positives = 50/142 (35%), Gaps = 16/142 (11%)

Query: 74  LSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK 128
            ++L  L  L LS N L      +F      +  L  L +  N L      + +++  L+
Sbjct: 60  PTRLTNLHSLLLSHNHLNFISSEAFV----PVPNLRYLDLSSNHLHTLDEFLFSDLQALE 115

Query: 129 NLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE----LTKLTNLNDLRISDN 183
            L +  N     +  +    +  LQKL LS N  +   P E      KL  L  L +S N
Sbjct: 116 VLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSN 173

Query: 184 NFSGKIPEFIGKWKKIQKLHIQ 205
                    + K     K  + 
Sbjct: 174 KLKKLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 60.2 bits (146), Expect = 9e-10
 Identities = 43/198 (21%), Positives = 71/198 (35%), Gaps = 43/198 (21%)

Query: 140 SIPPDIRKLINLQKLILSSNSFTGELPAE--LTKLTNLNDLRISDNNFSGKIPEFIGKWK 197
           ++P  +        L LS N+ +  L AE   T+LTNL+ L +S N              
Sbjct: 32  NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHN-------------- 74

Query: 198 KIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG-SESAFPKLDKMNLKTLILTKC 254
            +  +             +   + +L  L +S   L    E  F  L    L+ L+L   
Sbjct: 75  HLNFIS----------SEAFVPVPNLRYLDLSSNHLHTLDEFLFSDL--QALEVLLLYNN 122

Query: 255 LIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTF---EKLAKTNFMYLTGNKLTGPVPK 310
            I   +      DM +L+ + LS N ++           KL K   + L+ NKL   +P 
Sbjct: 123 HIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK-LPL 180

Query: 311 YIFN---SNKNVDISLNN 325
                  +     + L+N
Sbjct: 181 TDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 31/123 (25%), Positives = 45/123 (36%), Gaps = 16/123 (13%)

Query: 74  LSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK 128
              +  L+ LDLS N L       FS     L  L  L +  N +         ++  L+
Sbjct: 84  FVPVPNLRYLDLSSNHLHTLDEFLFS----DLQALEVLLLYNNHIVVVDRNAFEDMAQLQ 139

Query: 129 NLSIEGNLFTGSIPPDI----RKLINLQKLILSSNSFTGELPAELTKLTNL--NDLRISD 182
            L +  N  +   P ++     KL  L  L LSSN        +L KL     N L + +
Sbjct: 140 KLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

Query: 183 NNF 185
           N  
Sbjct: 199 NPL 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 60.6 bits (147), Expect = 8e-10
 Identities = 37/198 (18%), Positives = 68/198 (34%), Gaps = 43/198 (21%)

Query: 645 KVGEGGFGSVYKGILSDGTVI------AVKQLSSKSRQ-----------GNREFVNEIGM 687
            +G+GGFG +Y   ++    +       VK   S +                E + +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 688 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK----- 742
               ++  + K +G  +                +    FG D +     +   ++     
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKN------GKSYRFMIMDRFGSDLQK--IYEANAKRFSRKT 153

Query: 743 --KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI--SDFGLAKLYEEDKT- 797
             ++ + I   L Y+HE      VH DIK SN+LL+     ++   D+GLA  Y  +   
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210

Query: 798 -HISTR----IAGTIGYM 810
              +        GTI + 
Sbjct: 211 KAYAADPKRCHDGTIEFT 228

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 25/206 (12%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHP---NLVK 698
           +G+G FG V K         +A+K + ++ R   Q   E +  +  +  Q      N++ 
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKDNTMNVIH 163

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
           +       N + + +E +  N        K  +++     P  +K    I + L  LH  
Sbjct: 164 MLENFTFRNHICMTFELLSMNLYE---LIKKNKFQ-GFSLPLVRKFAHSILQCLDALH-- 217

Query: 759 SRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKLYEEDK--THISTRIAGTIGYMAPEY 814
            + +I+H D+K  N+LL        K+ DFG +  YE  +  T+I +R      Y APE 
Sbjct: 218 -KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC-YEHQRVYTYIQSRF-----YRAPEV 270

Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
            +        D++S G +  E+++G 
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGY 296

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 31/160 (19%), Positives = 58/160 (36%), Gaps = 25/160 (15%)

Query: 47  CDCSSAT--CH--------------VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCL 90
           C CS+    C               +  I L+   +    P   S  + L+++DLS N +
Sbjct: 9   CTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI 68

Query: 91  T----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI- 145
           +     +F        L  L + GN+++     +   + +L+ L +  N     +  D  
Sbjct: 69  SELAPDAFQGL---RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAF 124

Query: 146 RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 185
           + L NL  L L  N          + L  +  + ++ N F
Sbjct: 125 QDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 41/247 (16%), Positives = 82/247 (33%), Gaps = 62/247 (25%)

Query: 140 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 199
            IP ++     + ++ L  N+     P   +    L  + +S+N              +I
Sbjct: 25  EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNN--------------QI 68

Query: 200 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 259
            +L                               +  AF  L   +L +L+L    I  E
Sbjct: 69  SEL-------------------------------APDAFQGL--RSLNSLVLYGNKIT-E 94

Query: 260 IPDYIGD-MTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK 317
           +P  + + +  L+ + L+ N +   +    F+ L   N + L  NKL   + K  F+  +
Sbjct: 95  LPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQT-IAKGTFSPLR 152

Query: 318 NV-DISLNNFTWES-------SDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSA 369
            +  + L    +         +D +       +     S  R    ++     + F CSA
Sbjct: 153 AIQTMHLAQNPFICDCHLKWLADYLHTNPIETSGARCTSPRRLANKRIGQIKSKKFRCSA 212

Query: 370 PADQYHY 376
            A  +H+
Sbjct: 213 AAHHHHH 219

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 41/193 (21%), Positives = 60/193 (31%), Gaps = 60/193 (31%)

Query: 119 KVLTNI-----TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TK 171
           K LT I      T+  + +E N     IPP        L+++ LS+N  + EL  +    
Sbjct: 21  KGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQG 78

Query: 172 LTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD 230
           L +LN L +  N              KI +L           P S+   L SL  L    
Sbjct: 79  LRSLNSLVLYGN--------------KITEL-----------PKSLFEGLFSLQLL---- 109

Query: 231 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFE 289
                     L+   +             +       +  L  + L  N L      TF 
Sbjct: 110 ---------LLNANKINC-----------LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149

Query: 290 KLAKTNFMYLTGN 302
            L     M+L  N
Sbjct: 150 PLRAIQTMHLAQN 162

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 56/260 (21%), Positives = 96/260 (36%), Gaps = 75/260 (28%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMI-----SAQQHPN--- 695
           K+G G F +V+    +     +A+K + S         ++EI ++     S    PN   
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102

Query: 696 LVKLYGC----CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +V+L        V G  + +V+E + ++ L    +   + Y+  L  P  KKI   + +G
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLK---WIIKSNYQG-LPLPCVKKIIQQVLQG 158

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLL------------------------------------ 775
           L YLH  ++ +I+H DIK  N+LL                                    
Sbjct: 159 LDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 776 -------------DKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLT 821
                         + L  KI+D G A    +  T  I TR      Y + E  +     
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYN 271

Query: 822 SKADVYSFGVVTLEIVSGKS 841
           + AD++S   +  E+ +G  
Sbjct: 272 TPADIWSTACMAFELATGDY 291

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 34/193 (17%), Positives = 65/193 (33%), Gaps = 36/193 (18%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQ--------------GNREFVNEIGMIS 689
           K+G GGFG +Y     +     A   +  + ++                ++ + +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKIC 745
              +  +   YG  +   +            +     G D +            T  ++ 
Sbjct: 104 QLDYLGIPLFYGSGLTEFK------GRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157

Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI--SDFGLAKLYEEDKTHI---- 799
           I +   L Y+HE+     VH DIK +N+LL      ++  +D+GL+  Y  +  H     
Sbjct: 158 IRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214

Query: 800 --STRIAGTIGYM 810
                  GTI + 
Sbjct: 215 NPRKGHNGTIEFT 227

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 37/161 (22%), Positives = 58/161 (36%), Gaps = 26/161 (16%)

Query: 47  CDCSSAT--CH--------------VVTIALKAQNLTGTLPT-ELSKLRYLKQLDLSRNC 89
           C C   T  C                  + L     T    T    KL  L++++ S N 
Sbjct: 9   CRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNK 68

Query: 90  LT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI 145
           +T    G+F        + E+ +  NRL     K+   + +LK L +  N  T  +  D 
Sbjct: 69  ITDIEEGAFEGA---SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDS 124

Query: 146 -RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 185
              L +++ L L  N  T   P     L +L+ L +  N F
Sbjct: 125 FIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 33/168 (19%), Positives = 61/168 (36%), Gaps = 34/168 (20%)

Query: 140 SIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 198
            IP  I       +L L++N FT  E      KL  L  +  S+N              K
Sbjct: 25  KIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNN--------------K 68

Query: 199 IQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG-SESAFPKLDKMNLKTLILTKCL 255
           I  +             +    + + ++ ++   L+      F  L+  +LKTL+L    
Sbjct: 69  ITDIE----------EGAFEGASGVNEILLTSNRLENVQHKMFKGLE--SLKTLMLRSNR 116

Query: 256 IHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 302
           I   + +     ++ ++ + L  N +T   P  F+ L   + + L  N
Sbjct: 117 IT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 60.3 bits (145), Expect = 3e-09
 Identities = 90/562 (16%), Positives = 151/562 (26%), Gaps = 196/562 (34%)

Query: 60  ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSP-------QWASLQ--LVELSV-- 108
            +K +    ++ T      Y++Q D   N     F+         +  L+  L+EL    
Sbjct: 97  PIKTEQRQPSMMTR----MYIEQRDRLYND-NQVFAKYNVSRLQPYLKLRQALLELRPAK 151

Query: 109 ------MGNRLSGPFPK-VLTNITTLKNLSIEGNLFTG---------SIPPDIRKLINLQ 152
                 +    SG   K  +  +    +  ++  +            + P  +  L  LQ
Sbjct: 152 NVLIDGVLG--SG---KTWVA-LDVCLSYKVQCKMDFKIFWLNLKNCNSPETV--LEMLQ 203

Query: 153 KL---------ILSSNSFTGELPAELTK--LTNL-------NDLRISDN----------N 184
           KL           S +S   +L     +  L  L       N L +  N          N
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFN 263

Query: 185 FSGKI---------PEFIG--KWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 233
            S KI          +F+       I   H   +          S L    D R  DL  
Sbjct: 264 LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP---DEVKSLLLKYLDCRPQDLP- 319

Query: 234 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIG--------DMTKLKN-IDLSFNNLTGGI 284
                       L T      +I   I D +         +  KL   I+ S N L    
Sbjct: 320 -REV--------LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE--- 367

Query: 285 PTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT--WESSDPIECPRGSVN 342
           P  + K+    F  L+           +F    +  I     +  W            VN
Sbjct: 368 PAEYRKM----FDRLS-----------VFP--PSAHIPTILLSLIWFDVIK-SDVMVVVN 409

Query: 343 LVESYS---------------------SPRNKLDKVH---------PCLRQNFPCSAP-A 371
            +  YS                             +H         P    +     P  
Sbjct: 410 KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYL 469

Query: 372 DQYHYTLHINCGGAKINTGHTKYEADMEARGASMF---Y-----------SSGQYWAFSS 417
           DQY Y+ HI         GH     +   R  ++F   +                W  ++
Sbjct: 470 DQYFYS-HI---------GHHLKNIEHPER-MTLFRMVFLDFRFLEQKIRHDSTAW--NA 516

Query: 418 TGKFMDDDTDLDNY---IRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTV 474
           +G  ++    L  Y   I  N     ++    +  +         L      L    YT 
Sbjct: 517 SGSILNTLQQLKFYKPYICDNDPKYERLVN-AILDF---------LPKIEENLICSKYTD 566

Query: 475 RLHFAEIIFKNDSTFNSLGKRI 496
            L  A ++ ++++ F    K++
Sbjct: 567 LLRIA-LMAEDEAIFEEAHKQV 587

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.3 bits (114), Expect = 1e-05
 Identities = 57/341 (16%), Positives = 98/341 (28%), Gaps = 103/341 (30%)

Query: 494 KRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTS-----HTLKI--------HL 540
           K I  ++        +F+ +D         V++ P  + S     H +           L
Sbjct: 19  KDILSVFEDA--FVDNFDCKD---------VQDMPKSILSKEEIDHIIMSKDAVSGTLRL 67

Query: 541 YWA--GRGTTGI------PLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASV 592
           +W    +    +       LR  Y  L+S I  +   +P    S    + I       + 
Sbjct: 68  FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR-QP----SMMTRMYIEQRDRLYND 122

Query: 593 LLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKV---GEG 649
             V     + R +               L L+  L  LR          PA  V   G  
Sbjct: 123 NQVFAKYNVSRLQ-----PY--------LKLRQALLELR----------PAKNVLIDGVL 159

Query: 650 GFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 709
           G G   K      T +A+    S   Q   +   +I  ++             C     +
Sbjct: 160 GSG---K------TWVALDVCLSYKVQ--CKMDFKIFWLN----------LKNCNSPETV 198

Query: 710 L-----LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 764
           L     L+Y+   N   SR+    + + R+               R L          +V
Sbjct: 199 LEMLQKLLYQIDPNWT-SRSDHSSNIKLRIH-SIQAEL-------RRLLKSKPYENCLLV 249

Query: 765 HRDIKTSNVLLDKDLNAKI----SDFGLA-KLYEEDKTHIS 800
             +++ +      +L+ KI        +   L     THIS
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 59.4 bits (143), Expect = 4e-09
 Identities = 27/159 (16%), Positives = 57/159 (35%), Gaps = 9/159 (5%)

Query: 72  TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 131
             +  +R     DL    L  +   +     +  L +    L+      L  +  + +L 
Sbjct: 412 KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLD 469

Query: 132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG-KIP 190
           +  N    ++PP +  L  L+ L  S N+    +   +  L  L +L + +N        
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAI 526

Query: 191 EFIGKWKKIQKLHIQG---SSLEGPIPASISALTSLTDL 226
           + +    ++  L++QG      EG        L S++ +
Sbjct: 527 QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 55.1 bits (132), Expect = 6e-08
 Identities = 50/310 (16%), Positives = 95/310 (30%), Gaps = 31/310 (10%)

Query: 17  DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSK 76
            ++  +   S+ G   L  D+        T D  +   HV    L A +L   LP    +
Sbjct: 260 CFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFR 319

Query: 77  LRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGP----FPKVLTNITTLKNLSI 132
           + +          L       W      +  +    LS          L +   L+ L  
Sbjct: 320 VIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEP 379

Query: 133 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD-----NNFSG 187
           E      +I   +R L  L            E     + L  ++ +R +      + F  
Sbjct: 380 ENKWCLLTIILLMRALDPLLYEK--------ETLQYFSTLKAVDPMRAAYLDDLRSKFLL 431

Query: 188 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKMN 245
           +      ++  ++ LH+    L   +   +  L  +T L +S   L+    A   L    
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALR--C 487

Query: 246 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN---FMYLTGN 302
           L+ L  +   +   +   + ++ +L+ + L  N L        + L        + L GN
Sbjct: 488 LEVLQASDNAL-ENVDG-VANLPRLQELLLCNNRLQQ--SAAIQPLVSCPRLVLLNLQGN 543

Query: 303 KLTGPVPKYI 312
            L        
Sbjct: 544 SLCQE-EGIQ 552

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 51.3 bits (122), Expect = 1e-06
 Identities = 22/84 (26%), Positives = 34/84 (40%), Gaps = 3/84 (3%)

Query: 69  TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSG-PFPKVLTNITTL 127
            LP  L+ LR L+ L  S N L  +        +L EL +  NRL      + L +   L
Sbjct: 477 ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535

Query: 128 KNLSIEGNLFTGSIPPDIRKLINL 151
             L+++GN           +L  +
Sbjct: 536 VLLNLQGNSLC-QEEGIQERLAEM 558

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 58.4 bits (142), Expect = 6e-09
 Identities = 56/306 (18%), Positives = 106/306 (34%), Gaps = 53/306 (17%)

Query: 50  SSATCHVVTIALKAQNLTGT----LPTELSKLRYLKQLDLSRNCLTGSFSPQWASL---- 101
            + +C +  ++L+   LTG     L + L  L  L++L LS N L  +            
Sbjct: 81  QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDP 140

Query: 102 --QLVELSVMGNRLS----GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL------- 148
             +L +L +    LS     P   VL      K L++  N    +    +R L       
Sbjct: 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEA---GVRVLCQGLKDS 197

Query: 149 -INLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGKIPEFIGKW-----KK 198
              L+ L L S   T +    L   +    +L +L +  N         +         +
Sbjct: 198 PCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSR 257

Query: 199 IQKLHIQGSSL--EG--PIPASISALTSLTDLRISDLK-GSESA---FPKLDKMN--LKT 248
           ++ L I    +  +G   +   + A  SL +L ++  + G E A      L +    L++
Sbjct: 258 LRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES 317

Query: 249 LILTKCLIHGEIPDYIGDM----TKLKNIDLSFNNLT-GGIPTTFEKLAKTN----FMYL 299
           L +  C        +   +      L  + +S N L   G+    + L +       ++L
Sbjct: 318 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWL 377

Query: 300 TGNKLT 305
               ++
Sbjct: 378 ADCDVS 383

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 57.3 bits (139), Expect = 1e-08
 Identities = 50/281 (17%), Positives = 95/281 (33%), Gaps = 55/281 (19%)

Query: 74  LSKLRYLKQLDLSRNCLTGSFSPQWA------SLQLVELSVMGNRLS----GPFPKVLTN 123
           L     L +L+L  N L               S ++ +LS+    L+    G     L  
Sbjct: 52  LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111

Query: 124 ITTLKNLSIEGNLFTGSIPPDIRKLI--------NLQKLILSSNSFTGE----LPAELTK 171
           + TL+ L +  NL   +    ++ L          L+KL L   S +      L + L  
Sbjct: 112 LPTLQELHLSDNLLGDA---GLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRA 168

Query: 172 LTNLNDLRISDNNFSGKIPEFIGK-----WKKIQKLHIQGSSLEGPIPASISAL------ 220
             +  +L +S+N+ +      + +       +++ L ++   +      +   L      
Sbjct: 169 KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT---SDNCRDLCGIVAS 225

Query: 221 -TSLTDLRISD----LKGSESAFPKLDKMN--LKTLILTKCLIHGEIPDYIGDM----TK 269
             SL +L +        G     P L   +  L+TL + +C I  +    +  +      
Sbjct: 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKES 285

Query: 270 LKNIDLSFNNLTG-GIPTTFEKLAKTNFM----YLTGNKLT 305
           LK + L+ N L   G     E L +        ++     T
Sbjct: 286 LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 53.0 bits (128), Expect = 2e-07
 Identities = 44/242 (18%), Positives = 85/242 (35%), Gaps = 46/242 (19%)

Query: 80  LKQLDLSRNCLTGSFSPQWASL-----QLVELSVMGNRLS----GPFPKVLTNITTLKNL 130
           ++ LD+    L+     +WA L     Q   + +    L+          L     L  L
Sbjct: 5   IQSLDIQCEELS---DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61

Query: 131 SIEGNLFTGSIPPDIRKL--------INLQKLILSSNSFTGE----LPAELTKLTNLNDL 178
           ++  N         +  +          +QKL L +   TG     L + L  L  L +L
Sbjct: 62  NLRSNELGDV---GVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118

Query: 179 RISDNNFSGKIPEFIGK-----WKKIQKLHIQGSSL--EG--PIPASISALTSLTDLRIS 229
            +SDN       + + +       +++KL ++  SL      P+ + + A     +L +S
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178

Query: 230 DLKGSESAFPKLDKM------NLKTLILTKCLIHGEIPDYIGDM----TKLKNIDLSFNN 279
           +   +E+    L +        L+ L L  C +  +    +  +      L+ + L  N 
Sbjct: 179 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238

Query: 280 LT 281
           L 
Sbjct: 239 LG 240

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 52/232 (22%), Positives = 98/232 (42%), Gaps = 23/232 (9%)

Query: 620 GLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--- 675
           G D     Y ++  +   + ++  + +G+G FG V K     +   +A+K + +K     
Sbjct: 36  GYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN 95

Query: 676 QGNRE--FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR 733
           Q   E   +  +     +    +V L    +  N L LV+E +  N L   +  ++T +R
Sbjct: 96  QAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLL--RNTNFR 152

Query: 734 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKL 791
             +     +K    +   L +L     + I+H D+K  N+LL   K    KI DFG +  
Sbjct: 153 -GVSLNLTRKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-C 209

Query: 792 YEEDK--THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGK 840
               +   +I +R      Y +PE  +   Y     D++S G + +E+ +G+
Sbjct: 210 QLGQRIYQYIQSRF-----YRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGE 255

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 39/152 (25%), Positives = 63/152 (41%), Gaps = 9/152 (5%)

Query: 81  KQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG 139
           ++LDL    L       +  L +L  L++  N+L      V  ++T L  L +  N    
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96

Query: 140 SIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPE--FIGK 195
           S+P  +   L  L KL L  N     LP+ +  +LT L +LR++ N     IP   F  K
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF-DK 153

Query: 196 WKKIQKLHIQGSSLEGPIPASISALTSLTDLR 227
              +Q L +  + L+     +   L  L  + 
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTIT 185

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 45/190 (23%), Positives = 65/190 (34%), Gaps = 36/190 (18%)

Query: 120 VLTNI-TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL-TKLTNLND 177
           V + I    + L ++            R L  L  L L  N     L A +   LT L  
Sbjct: 29  VPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGT 87

Query: 178 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD--LKG- 233
           L +++N              ++  L           P  +   LT L  L +    LK  
Sbjct: 88  LGLANN--------------QLASL-----------PLGVFDHLTQLDKLYLGGNQLKSL 122

Query: 234 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLA 292
               F +L    LK L L    +   IP    D +T L+ + LS N L       F++L 
Sbjct: 123 PSGVFDRL--TKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLG 179

Query: 293 KTNFMYLTGN 302
           K   + L GN
Sbjct: 180 KLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 37/116 (31%), Positives = 47/116 (40%), Gaps = 11/116 (9%)

Query: 76  KLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNL 130
            L  L  L L+ N L     G F      L QL +L + GN+L      V   +T LK L
Sbjct: 81  DLTELGTLGLANNQLASLPLGVFD----HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKEL 136

Query: 131 SIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 185
            +  N    SIP     KL NLQ L LS+N           +L  L  + +  N F
Sbjct: 137 RLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 39/282 (13%), Positives = 85/282 (30%), Gaps = 71/282 (25%)

Query: 74  LSKLRYLKQLDLSRNCLTGSFSPQWASLQ-----------LVELSVMGNRLSG----PFP 118
           ++  + L+  + S             +L+           L  + +  N        P  
Sbjct: 56  IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115

Query: 119 KVLTNITTLKNLSIEGN-------------LFTGSIPPDIRKLINLQKLILSSNSFTGE- 164
             L+  T L++L +  N             L   ++    +    L+ +I   N      
Sbjct: 116 DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGS 175

Query: 165 ---LPAELTKLTNLNDLRISDNNFSGK-----IPEFIGKWKKIQKLHIQGSSLEGPIPAS 216
                        L+ +++  N    +     + E +   ++++ L +Q ++    + +S
Sbjct: 176 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF-THLGSS 234

Query: 217 I--SALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDM------T 268
               AL S                      NL+ L L  CL+       + D        
Sbjct: 235 ALAIALKSWP--------------------NLRELGLNDCLLSARGAAAVVDAFSKLENI 274

Query: 269 KLKNIDLSFNNLTGGIPTTFEKLAKTN-----FMYLTGNKLT 305
            L+ + L +N +      T + +         F+ L GN+ +
Sbjct: 275 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 48.2 bits (115), Expect = 7e-06
 Identities = 36/235 (15%), Positives = 76/235 (32%), Gaps = 43/235 (18%)

Query: 103 LVELSVMGNRLSG----PFPKVLTNITTLKNLSIEGNLFTG----SIPPDIRKLINLQKL 154
           +   S+  + ++         VL    ++K + + GN         +  +I    +L+  
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 155 ILSSNSFTGELPAE-----------LTKLTNLNDLRISDNNFSGK----IPEFIGKWKKI 199
             S   FTG +  E           L K   L+ +R+SDN F       + +F+ K   +
Sbjct: 66  EFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124

Query: 200 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 259
           + L++  + L    P + + +          L+         +   L+++I  +  +   
Sbjct: 125 EHLYLHNNGLG---PQAGAKIARA-------LQELAVNKKAKNAPPLRSIICGRNRLENG 174

Query: 260 IPDYIGDM----TKLKNIDLSFNNLTG-GIPTTFEKLAKTN----FMYLTGNKLT 305
                         L  + +  N +   GI     +          + L  N  T
Sbjct: 175 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.5 bits (120), Expect = 1e-06
 Identities = 19/114 (16%), Positives = 38/114 (33%), Gaps = 7/114 (6%)

Query: 53  TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL----QLVELSV 108
             H  +     ++        L     L +L +           +   L    +L  L++
Sbjct: 6   CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHL--ELRDLRGLGELRNLTI 63

Query: 109 MGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT 162
           + + L    P        L  L++  N    S+     + ++LQ+L+LS N   
Sbjct: 64  VKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.8 bits (113), Expect = 9e-06
 Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 9/98 (9%)

Query: 213 IPASISALTSLTDLRISDLKGSES----AFPKLDKMNLKTLILTKCLIHGEIPDYI-GDM 267
               +    +LT+L I + +  +         L    L+ L + K  +   +        
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLG--ELRNLTIVKSGLR-FVAPDAFHFT 79

Query: 268 TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 305
            +L  ++LSFN L      T + L+    + L+GN L 
Sbjct: 80  PRLSRLNLSFNALESLSWKTVQGLSLQE-LVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 43.6 bits (102), Expect = 2e-04
 Identities = 17/94 (18%), Positives = 34/94 (36%), Gaps = 6/94 (6%)

Query: 140 SIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPE--FIGKW 196
                +    NL +L + +      L    L  L  L +L I  +     +    F    
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFT- 79

Query: 197 KKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 230
            ++ +L++  ++LE  +        SL +L +S 
Sbjct: 80  PRLSRLNLSFNALES-LSWKTVQGLSLQELVLSG 112

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 4/105 (3%)

Query: 81  KQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG 139
           + L L  N +T      + SL  L EL +  N+L      V  ++T L  L +  N  T 
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101

Query: 140 SIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 183
            +P  +  +L++L++L +  N  T ELP  + +LT+L  L +  N
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 40.8 bits (96), Expect = 8e-04
 Identities = 42/192 (21%), Positives = 61/192 (31%), Gaps = 56/192 (29%)

Query: 140 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 199
           S+P  I    N Q L L  N  T   P     L NL +L +  N              ++
Sbjct: 33  SVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN--------------QL 76

Query: 200 QKLHIQGSSLEGPIPASI-SALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHG 258
             L           P  +  +LT LT L              L    L  L         
Sbjct: 77  GAL-----------PVGVFDSLTQLTVLD-------------LGTNQLTVL--------- 103

Query: 259 EIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK 317
             P  + D +  LK + +  N LT  +P   E+L     + L  N+L   +P   F+   
Sbjct: 104 --PSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLS 159

Query: 318 NV-DISLNNFTW 328
           ++    L    W
Sbjct: 160 SLTHAYLFGNPW 171

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 48.5 bits (116), Expect = 4e-06
 Identities = 39/115 (33%), Positives = 52/115 (45%), Gaps = 13/115 (11%)

Query: 76  KLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNL 130
           +L  L  L L+ N L     G F      L  L EL ++ N+L      V   +T L  L
Sbjct: 83  ELTNLTYLILTGNQLQSLPNGVF----DKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL 138

Query: 131 SIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLRISDN 183
           ++  N    S+P  +  KL NL +L LS N     LP  +  KLT L DLR+  N
Sbjct: 139 NLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQN 191

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 35/192 (18%), Positives = 75/192 (39%), Gaps = 34/192 (17%)

Query: 125 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 184
                 +++    T        +L ++ ++I +++     +   +  L N+  L +  N 
Sbjct: 19  AETIKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNK 74

Query: 185 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISDLKGSESAFPKLDK 243
               I     +   +  L + G+ L+  +P  +   LT+L +L              L +
Sbjct: 75  LH-DISAL-KELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELV-------------LVE 118

Query: 244 MNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 302
             L++L           PD + D +T L  ++L+ N L       F+KL     + L+ N
Sbjct: 119 NQLQSL-----------PDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYN 167

Query: 303 KLTGPVPKYIFN 314
           +L   +P+ +F+
Sbjct: 168 QLQS-LPEGVFD 178

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 47.0 bits (112), Expect = 7e-06
 Identities = 39/140 (27%), Positives = 61/140 (43%), Gaps = 13/140 (9%)

Query: 47  CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVE 105
           C CS  T    +    +  +   +P +         LDL  N L    +  +  L  L +
Sbjct: 5   CSCSGTTVECYSQGRTS--VPTGIPAQT------TYLDLETNSLKSLPNGVFDELTSLTQ 56

Query: 106 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGE 164
           L + GN+L      V   +T+L  L++  N    S+P  +  KL  L++L L++N     
Sbjct: 57  LYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-S 114

Query: 165 LPAEL-TKLTNLNDLRISDN 183
           LP  +  KLT L DLR+  N
Sbjct: 115 LPDGVFDKLTQLKDLRLYQN 134

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 36/116 (31%), Positives = 52/116 (44%), Gaps = 7/116 (6%)

Query: 70  LPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKN 129
           +   LS L+  K L LS N +    S       L  LS+  N +      +     TL+ 
Sbjct: 40  MDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIKK-IENLDAVADTLEE 97

Query: 130 LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDN 183
           L I  N    S+   I KL+NL+ L +S+N  T  GE+  +L  L  L DL ++ N
Sbjct: 98  LWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 6/89 (6%)

Query: 105 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTG 163
           EL + GN+ +   PK L+N   L  + +  N  + ++       +  L  LILS N    
Sbjct: 35  ELYLDGNQFTLV-PKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR- 91

Query: 164 ELPAELT-KLTNLNDLRISDNNFSGKIPE 191
            +P      L +L  L +  N+ S  +PE
Sbjct: 92  CIPPRTFDGLKSLRLLSLHGNDIS-VVPE 119

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 45.0 bits (107), Expect = 7e-05
 Identities = 42/233 (18%), Positives = 80/233 (34%), Gaps = 59/233 (25%)

Query: 645 KVGEGGFGSVYKGI--LSDGTVIAVKQLSSKSR---QGNRE--FVNEIGMISAQQHPNLV 697
            +GEG FG V + +      + +A+K + +  +       E   + +I     +     V
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85

Query: 698 KLYGCCVEGNQLLLV--------YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
            +         + +         +E++K N            Y L       + +   + 
Sbjct: 86  LMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQP--------YPLPH----VRHMAYQLC 133

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-------------------KISDFGLAK 790
             L +LHE    ++ H D+K  N+L                          +++DFG A 
Sbjct: 134 HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189

Query: 791 LYEEDK--THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGK 840
            ++ +   T ++TR      Y  PE  +  G+     DV+S G +  E   G 
Sbjct: 190 TFDHEHHTTIVATRH-----YRPPEVILELGWAQP-CDVWSIGCILFEYYRGF 236

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 44.9 bits (106), Expect = 9e-05
 Identities = 31/235 (13%), Positives = 76/235 (32%), Gaps = 30/235 (12%)

Query: 74  LSKLRYLKQLDLSRNCLT-------GSFSPQWASLQLVELSVMGNRLSGP--FPKVLTNI 124
           ++  R +K L +  +  +          +    SL+++   +       P     +  N 
Sbjct: 160 VTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219

Query: 125 TTLKNLSIEG--NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 182
            +L ++ +     L           L       L+ +    E    L     L  L +S 
Sbjct: 220 RSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSY 279

Query: 183 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG--SESAFPK 240
              +  +P       +I+KL +  + LE       + +    +L + + +    +     
Sbjct: 280 MGPNE-MPILFPFAAQIRKLDLLYALLETE--DHCTLIQKCPNLEVLETRNVIGDRGLEV 336

Query: 241 LDKM--NLKTLILTKCLIHGEIPDYIGDMT------------KLKNIDLSFNNLT 281
           L +    LK L + +      + D  G ++            +L+ + +  +++T
Sbjct: 337 LAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDIT 391

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.8 bits (101), Expect = 9e-05
 Identities = 30/129 (23%), Positives = 54/129 (41%), Gaps = 12/129 (9%)

Query: 64  QNLTGTLPTELSKLRYLKQLDLSRNCLTG-SFSPQWASLQLVELSVMGNRLSGPFPKVLT 122
           ++  G +    ++   L+ L L    L   S  P+   L+ +ELS   NR+ G    +  
Sbjct: 35  KSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELS--ENRIFGGLDMLAE 92

Query: 123 NITTLKNLSIEGNLFT--GSIPPDIRKLINLQKLILSSNSFTGE------LPAELTKLTN 174
            +  L +L++ GN      ++ P ++KL  L+ L L +   T        +   L +LT 
Sbjct: 93  KLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTY 151

Query: 175 LNDLRISDN 183
           L+     D 
Sbjct: 152 LDGYDREDQ 160

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 39/261 (14%), Positives = 99/261 (37%), Gaps = 18/261 (6%)

Query: 81  KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG-NLFTG 139
           + LDL+   L    + +  S  ++      + +  P  +  +    ++++ +    +   
Sbjct: 50  QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVS 108

Query: 140 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD-NNFSGKIPEFIGK-WK 197
           ++   + +   LQ L L     +  +   L K +NL  L +S  + FS    + +     
Sbjct: 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 168

Query: 198 KIQKLHIQGSSL---EGPIPASISALTSLTDLRISDLKG--SESAFPKLDKM--NLKTLI 250
           ++ +L++        +    A      ++T L +S  +    +S    L +   NL  L 
Sbjct: 169 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228

Query: 251 LTKC-LIHGEIPDYIGDMTKLKNIDLSF-NNLTGGIPTTFEKLAK-TNFMYLT-GNKLTG 306
           L+   ++  +       +  L+++ LS   ++    P T  +L +      L     +  
Sbjct: 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII---PETLLELGEIPTLKTLQVFGIVPD 285

Query: 307 PVPKYIFNSNKNVDISLNNFT 327
              + +  +  ++ I+ ++FT
Sbjct: 286 GTLQLLKEALPHLQINCSHFT 306

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 30/166 (18%), Positives = 53/166 (31%), Gaps = 13/166 (7%)

Query: 74  LSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMG------NRLSGPFPKVLTNITT 126
           +++   LK L L+R       +       QL EL   G        +       L+    
Sbjct: 207 VTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKE 266

Query: 127 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE-LPAELTKLTNLNDLRISDNNF 185
           L+ LS   +     +P        L  L LS  +     L   L +   L  L + D   
Sbjct: 267 LRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIE 326

Query: 186 SGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDL 231
              +       K +++L +  S      P  +    +LT+  +  +
Sbjct: 327 DAGLEVLASTCKDLRELRVFPSE-----PFVMEPNVALTEQGLVSV 367

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 24/117 (20%), Positives = 42/117 (35%), Gaps = 11/117 (9%)

Query: 72  TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 131
            + +     ++LDL    +    +      Q   +    N +     + L     L+ L 
Sbjct: 13  AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEI-----RKLDGFPLLRRLK 67

Query: 132 ---IEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDN 183
              +  N          + L +L +LIL++NS    G+L   L  L +L  L I  N
Sbjct: 68  TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 26/86 (30%), Positives = 37/86 (43%), Gaps = 3/86 (3%)

Query: 102 QLVELSVMGNRLS-GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 160
            + EL +  +R + G    +      L+ LS      T SI  ++ KL  L+KL LS N 
Sbjct: 18  DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNR 75

Query: 161 FTGELPAELTKLTNLNDLRISDNNFS 186
            +G L     K  NL  L +S N   
Sbjct: 76  VSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 26/112 (23%), Positives = 48/112 (42%), Gaps = 5/112 (4%)

Query: 123 NITTLKNLSIEGNLFT-GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 181
             + +K L ++ +    G +     +   L+ L   +   T  + A L KL  L  L +S
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 182 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 233
           DN  SG +     K   +  L++ G+ ++    ++I  L  L +L+  DL  
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFN 122

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 25/122 (20%), Positives = 38/122 (31%), Gaps = 28/122 (22%)

Query: 64  QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 123
           ++  G L     +   L+ L      LT                     ++      L  
Sbjct: 28  RSNEGKLEGLTDEFEELEFLSTINVGLT--------------------SIAN-----LPK 62

Query: 124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRIS 181
           +  LK L +  N  +G +     K  NL  L LS N       +   L KL NL  L + 
Sbjct: 63  LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLF 121

Query: 182 DN 183
           + 
Sbjct: 122 NC 123

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 20/82 (24%), Positives = 33/82 (40%), Gaps = 5/82 (6%)

Query: 105 ELSVMGNRLSG-PFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFT 162
           EL +  N L       +   +  L  L ++ N  T  I P+      ++Q+L L  N   
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91

Query: 163 GELPAEL-TKLTNLNDLRISDN 183
            E+  ++   L  L  L + DN
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDN 112

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 42.3 bits (100), Expect = 5e-04
 Identities = 53/237 (22%), Positives = 90/237 (37%), Gaps = 67/237 (28%)

Query: 645 KVGEGGFGSVYKGI--LSDGTVIAVKQLSSKSR---QGNREFVNEIGMIS--AQQHP--- 694
            +GEG FG V + I   + G  +AVK + +  R          +EI ++       P   
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76

Query: 695 -NLVKLYGCCVEGNQLLLV--------YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
              V++         + +V        Y+++K N            +RL       +K+ 
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLP--------FRLDH----IRKMA 124

Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-------------------KISDF 786
             I + + +LH     K+ H D+K  N+L  +                       K+ DF
Sbjct: 125 YQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181

Query: 787 GLAKLYEEDK--THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGK 840
           G A  Y+++   T +STR      Y APE  +  G+ +   DV+S G + +E   G 
Sbjct: 182 GSA-TYDDEHHSTLVSTRH-----YRAPEVILALGW-SQPCDVWSIGCILIEYYLGF 231

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 41.5 bits (98), Expect = 7e-04
 Identities = 53/241 (21%), Positives = 91/241 (37%), Gaps = 71/241 (29%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR---QGNREFVNEIGMIS--AQQHP---N 695
           K+G+G FG V     + +    AVK + +  +           E  ++           N
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97

Query: 696 LVKLYGCCVEGNQLLLV--------YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 747
           +VK +G  +  + + L+        YE +  N  +         + ++      K  CI 
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNG--------FHIED----IKLYCIE 145

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-------------------------K 782
           I + L YL +   + + H D+K  N+LLD                              K
Sbjct: 146 ILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202

Query: 783 ISDFGLAKLYEEDK--THISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSG 839
           + DFG A  ++ D   + I+TR      Y APE  +  G+    +D++SFG V  E+ +G
Sbjct: 203 LIDFGCA-TFKSDYHGSIINTRQ-----YRAPEVILNLGW-DVSSDMWSFGCVLAELYTG 255

Query: 840 K 840
            
Sbjct: 256 S 256

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	869
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.98
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.98
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.98
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.98
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.98
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.98
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.98
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.98
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.98
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.98
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.98
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.98
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.98
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.98
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.98
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.98
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.98
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.98
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.98
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.98
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.98
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.98
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.98
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.98
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.98
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.98
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.98
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.98
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.98
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.98
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.98
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.97
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.97
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.97
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.97
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.97
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.97
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.97
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.97
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.97
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.97
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.97
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.97
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.97
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.97
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.97
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.96
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.96
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.96
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.96
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.96
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.96
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.96
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.96
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.96
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.96
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.96
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.96
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.96
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.96
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.95
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.95
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.95
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.95
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.95
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.95
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.94
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.94
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.94
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.94
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.94
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.94
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.94
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.93
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.92
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.92
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.92
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.91
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.91
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.89
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.89
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.89
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.89
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.88
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.88
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.88
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.87
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.87
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.87
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.86
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.86
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.86
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.85
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.84
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	99.83
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.83
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.83
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.83
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.81
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.81
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.8
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.8
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.8
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.79
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.79
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.78
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.78
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.78
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.77
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.77
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.75
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.72
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.72
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.72
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.71
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.71
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.67
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.67
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.66
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.65
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.65
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.64
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.63
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.6
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.59
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.59
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.58
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.58
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.58
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.57
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.54
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.52
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.52
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.52
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.51
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.48
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.47
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.42
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.42
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.31
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.26
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.23
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.09
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.98
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.94
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	98.93
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.9
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	98.87
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.87
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	98.84
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	98.71
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.62
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.53
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.41
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.4
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.39
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.39
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.37
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.25
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.25
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.17
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.08
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.0
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.83
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.8
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.74
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.71
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.54
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.53
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.44
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.26
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.22
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.05
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.95
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.94
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.92
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.89
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.75
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.61
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.43
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.27
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.73
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.64
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.66
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.88
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	87.53

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.9e-45  Score=396.21  Aligned_cols=205  Identities=33%  Similarity=0.543  Sum_probs=179.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46778899999999999999874      467899999987777777899999999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCc--------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEE
Q 002899          712 VYEYMKNNCLSRAIFGKDT--------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI  783 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl  783 (869)
                      |||||++|+|.++|+....        .....++|.+++.|+.|||+||+|||+++   ||||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            9999999999999976431        22347999999999999999999999987   999999999999999999999


Q ss_pred             eecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          784 SDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       784 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      +|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~  233 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ  233 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            99999987654332 22334578999999999999999999999999999999999 8999964

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-44  Score=395.13  Aligned_cols=198  Identities=27%  Similarity=0.519  Sum_probs=180.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      +.|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46888999999999999999975 68999999997665555677899999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++|+|.+++...      .+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+....
T Consensus       154 ~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          154 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             CCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            999999988643      5899999999999999999999998   9999999999999999999999999998776543


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .. ....+||+.|||||++.+..|+.++|||||||++|||++|+.||..
T Consensus       225 ~~-~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~  272 (346)
T 4fih_A          225 PR-RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN  272 (346)
T ss_dssp             CC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             Cc-ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            32 3356899999999999999999999999999999999999999964

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=395.94  Aligned_cols=205  Identities=31%  Similarity=0.517  Sum_probs=173.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45667789999999999999874      478899999987777777899999999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcE
Q 002899          712 VYEYMKNNCLSRAIFGKDTE----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA  781 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~  781 (869)
                      |||||++|+|.++++.....          ...+++|.+++.|+.|||+||+|||+++   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            99999999999999765321          1246999999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCceeecCCC-ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          782 KISDFGLAKLYEEDK-THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       782 kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ||+|||+++...... ........||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~  263 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ  263 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC
Confidence            999999998765433 223344679999999999999999999999999999999999 8999964

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.5e-44  Score=391.03  Aligned_cols=215  Identities=29%  Similarity=0.428  Sum_probs=181.1

Q ss_pred             CCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ++++.++||+|+||+||+|++.      +++.||||+++.... ...++|.+|++++++++|||||+++|+|.+++..+|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3456789999999999999973      467899999976543 335789999999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 002899          712 VYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN  780 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~  780 (869)
                      |||||++|+|.++|+....           .....++|.++.+|+.|||+||+|||+++   ||||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence            9999999999999975431           12346999999999999999999999987   999999999999999999


Q ss_pred             EEEeecCCceeecCCC-ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcchhhHHHHH
Q 002899          781 AKISDFGLAKLYEEDK-THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWA  858 (869)
Q Consensus       781 ~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~w~  858 (869)
                      +||+|||+|+...... ........||++|||||++.++.++.++|||||||++|||+| |+.||...   ...++++.+
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~---~~~~~~~~i  260 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY---SNQDVVEMI  260 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC---CHHHHHHHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC---CHHHHHHHH
Confidence            9999999998764432 222344679999999999999999999999999999999998 89999643   334555555


Q ss_pred             H
Q 002899          859 Y  859 (869)
Q Consensus       859 ~  859 (869)
                      .
T Consensus       261 ~  261 (308)
T 4gt4_A          261 R  261 (308)
T ss_dssp             H
T ss_pred             H
Confidence            3

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.7e-44  Score=387.95  Aligned_cols=200  Identities=27%  Similarity=0.419  Sum_probs=179.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.++||+|+||+||+|+.. +++.||||++....   ....+.+.+|++++++++|||||++++++++++.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46889999999999999999975 68999999986532   233567899999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++...+     .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus       112 Ey~~gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence            9999999999996543     6899999999999999999999998   9999999999999999999999999999875


Q ss_pred             CCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .... ......+||+.|||||++.+..++.++||||+||++|||++|+.||..
T Consensus       184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~  236 (311)
T 4aw0_A          184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA  236 (311)
T ss_dssp             TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            4332 233457899999999999999999999999999999999999999964

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-44  Score=394.74  Aligned_cols=201  Identities=25%  Similarity=0.422  Sum_probs=173.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++...  .....+.|.+|++++++++|||||++++++.+++.+|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            67999999999999999999975 6899999998654  23345679999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++|+|.+++...+.   ..+++.+++.++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+....
T Consensus       104 y~~gg~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             CCTTCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             CCCCCcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            9999999999975432   25789999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .. ......+||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus       178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~  227 (350)
T 4b9d_A          178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA  227 (350)
T ss_dssp             HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            22 122346799999999999999999999999999999999999999964

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=386.19  Aligned_cols=199  Identities=28%  Similarity=0.505  Sum_probs=168.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .+++.+.++||+|+||+||+|++.+  .||||+++..  .....++|.+|++++++++|||||+++|++.+ +..+||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            3567788999999999999998753  5899998654  33446789999999999999999999998865 56899999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      ||++|+|.++|+...    ..++|.++..|+.|||+||+|||+++   ||||||||+||||++++.+||+|||+|+....
T Consensus       112 y~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          112 WCEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             CCSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             cCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            999999999997653    26899999999999999999999987   99999999999999999999999999987654


Q ss_pred             CC-ccccccccccccccchhhccc---CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DK-THISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .. .......+||+.|||||++..   ..++.++|||||||++|||+||+.||..
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~  239 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH  239 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence            32 222344689999999999864   4689999999999999999999999964

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=396.87  Aligned_cols=198  Identities=27%  Similarity=0.519  Sum_probs=180.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      +.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+++|+.++|||||++++++.+++.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56889999999999999999975 68999999997766666678999999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++|+|.+++...      .+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+....
T Consensus       231 ~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          231 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             CCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            999999998643      5899999999999999999999998   9999999999999999999999999998776543


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .. ....+||+.|||||++.+..|+.++|||||||++|||++|+.||..
T Consensus       302 ~~-~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~  349 (423)
T 4fie_A          302 PR-RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN  349 (423)
T ss_dssp             CC-BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cc-ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            32 3356899999999999999999999999999999999999999964

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.5e-43  Score=375.90  Aligned_cols=195  Identities=28%  Similarity=0.485  Sum_probs=168.8

Q ss_pred             CCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEee----CceEEEEE
Q 002899          641 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVY  713 (869)
Q Consensus       641 ~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~  713 (869)
                      ++.++||+|+||+||+|... +++.||+|++...  .....+.|.+|++++++++|||||++++++.+    ++.+||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999975 6889999998654  23345679999999999999999999999875    35689999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-CCCcEEEeecCCceee
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLY  792 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~-~~~~~kl~DFGla~~~  792 (869)
                      |||++|+|.+++....     .+++..+..++.||++||+|||+++ ++||||||||+||||+ .++.+||+|||+|+..
T Consensus       109 Ey~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            9999999999997543     6899999999999999999999985 3599999999999997 4799999999999764


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...   .....+||+.|||||++.+ .++.++|||||||++|||+||+.||..
T Consensus       183 ~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~  231 (290)
T 3fpq_A          183 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            332   2334689999999998865 699999999999999999999999954

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.6e-43  Score=383.35  Aligned_cols=196  Identities=29%  Similarity=0.336  Sum_probs=170.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      +.|.+.++||+|+||.||+|+.. +|+.||||+++...     .+.+|++++++++|||||++++++.+++.+|||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            45777889999999999999975 68999999997542     2246999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-cEEEeecCCceeecCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLYEED  795 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~~  795 (869)
                      ++|+|.+++...+     .+++..+..++.||+.||+|||+++   ||||||||+||||+.++ ++||+|||+|+.+...
T Consensus       133 ~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          133 EGGSLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             TTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            9999999996543     6899999999999999999999998   99999999999999987 6999999999987543


Q ss_pred             Ccc----ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          796 KTH----ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       796 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ...    ....++||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~  259 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY  259 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence            221    122357999999999999999999999999999999999999999653

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.1e-44  Score=382.71  Aligned_cols=199  Identities=27%  Similarity=0.375  Sum_probs=169.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~----~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ++|++.+.||+|+||+||+|+..    .++.||||+++...  .....++.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999862    46899999986542  2234568899999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+|+.
T Consensus       104 vmEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEcCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            999999999999996543     6899999999999999999999998   99999999999999999999999999986


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...... .....+||+.|||||++.+..++.++||||+||++|||++|+.||..
T Consensus       176 ~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~  228 (304)
T 3ubd_A          176 SIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG  228 (304)
T ss_dssp             -----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence            543322 22346899999999999999999999999999999999999999964

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.2e-43  Score=370.21  Aligned_cols=197  Identities=29%  Similarity=0.499  Sum_probs=161.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....   ......+.+|++++++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999964 68999999986542   233467899999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+ +|+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+...
T Consensus        93 Ey~-~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  163 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMT  163 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred             eCC-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecC
Confidence            999 578998886543     6899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccccccchhhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...  .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||..
T Consensus       164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~  214 (275)
T 3hyh_A          164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD  214 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence            432  2234689999999999988765 6899999999999999999999964

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.6e-42  Score=372.88  Aligned_cols=197  Identities=30%  Similarity=0.430  Sum_probs=162.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHH--HHHHHHHhcCCCceeeEEeEEeeCc----eEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFV--NEIGMISAQQHPNLVKLYGCCVEGN----QLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~--~E~~~l~~l~H~nIv~l~~~~~~~~----~~~l  711 (869)
                      ++|.+.++||+|+||+||+|++ +|+.||||+++...   .+++.  .|+..+.+++|||||++++++.+++    .++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            3566788999999999999998 58999999996532   23344  4555567889999999999998754    5799


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-----SRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                      |||||++|+|.++++..      .++|+.+.+++.|+|+||+|||++     +.++||||||||+||||+.++++||+||
T Consensus        79 V~Ey~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF  152 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EecCCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence            99999999999999754      589999999999999999999986     2345999999999999999999999999


Q ss_pred             CCceeecCCCccc---cccccccccccchhhcccC------CCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          787 GLAKLYEEDKTHI---STRIAGTIGYMAPEYAMRG------YLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       787 Gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      |+|+.........   ....+||+.|||||++.+.      .++.++|||||||++|||+||++|+.
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~  219 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence            9998876543322   2235799999999998754      46789999999999999999988764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.7e-42  Score=379.88  Aligned_cols=215  Identities=27%  Similarity=0.403  Sum_probs=182.6

Q ss_pred             cHHHHHHHhcCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEecccCc-hhhHHHHHHHHHHHhcCC-CceeeEE
Q 002899          629 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQH-PNLVKLY  700 (869)
Q Consensus       629 ~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~~------g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H-~nIv~l~  700 (869)
                      ...+++...++|++.++||+|+||+||+|.+..      ++.||||+++.... ...++|.+|++++.+++| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            344555567889999999999999999999642      36899999976543 345779999999999965 8999999


Q ss_pred             eEEeeC-ceEEEEEEeccCCchhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC
Q 002899          701 GCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI  768 (869)
Q Consensus       701 ~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl  768 (869)
                      |+|.+. +.+++|||||++|+|.++|+.....           ....++|.++..++.|||+||+|||+++   ||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence            999764 5689999999999999999764321           1235899999999999999999999997   999999


Q ss_pred             CCCCEEEcCCCcEEEeecCCceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          769 KTSNVLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       769 k~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      ||+|||+++++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876544332 2334678999999999999999999999999999999998 99999653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.9e-41  Score=364.11  Aligned_cols=199  Identities=26%  Similarity=0.484  Sum_probs=162.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc--------
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--------  707 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~--------  707 (869)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35889999999999999999975 689999999865443 34567899999999999999999999987644        


Q ss_pred             ----eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEE
Q 002899          708 ----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI  783 (869)
Q Consensus       708 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl  783 (869)
                          .+|+||||+++|+|.+++.....  ....++..++.++.||++||+|||+++   |+||||||+|||++.++.+||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence                36999999999999999976542  224677889999999999999999998   999999999999999999999


Q ss_pred             eecCCceeecCCCcc-----------ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          784 SDFGLAKLYEEDKTH-----------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       784 ~DFGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      +|||+|+........           ..+..+||+.|||||++.+..++.++|||||||++|||++   ||.
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~  228 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS  228 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence            999999877543211           1123579999999999999999999999999999999996   664

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-40  Score=368.11  Aligned_cols=200  Identities=22%  Similarity=0.379  Sum_probs=171.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEee------Cce
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE------GNQ  708 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~------~~~  708 (869)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...  ....+.+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57899999999999999999975 78999999997543  2335678899999999999999999998764      357


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      +|||||||+ |+|.+++....     .+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEeCCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence            899999996 67999886543     6899999999999999999999998   99999999999999999999999999


Q ss_pred             ceeecCCC---ccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          789 AKLYEEDK---THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       789 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |+.+....   .......+||+.|||||++.+. .++.++||||+||++|||++|++||...
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~  266 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK  266 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence            98764322   1223346899999999998765 5799999999999999999999999654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.1e-39  Score=359.03  Aligned_cols=199  Identities=26%  Similarity=0.418  Sum_probs=171.4

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCce
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~~----~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~  708 (869)
                      ....++|++.++||+|+||+||+|+.+    .++.||||++....  ...++.+|++++..+ +|||||++++++.+.+.
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            345688999999999999999999853    46789999986543  345688999999988 69999999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-CcEEEeecC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFG  787 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~-~~~kl~DFG  787 (869)
                      .|+||||+++|+|.+++.        .+++.+++.++.|++.||+|||+++   |+||||||+|||++.+ +.+||+|||
T Consensus        95 ~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            999999999999999882        4789999999999999999999998   9999999999999877 799999999


Q ss_pred             CceeecCCCcc---------------------------ccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcC
Q 002899          788 LAKLYEEDKTH---------------------------ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSG  839 (869)
Q Consensus       788 la~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG  839 (869)
                      +|+........                           .....+||+.|+|||++.+. .++.++||||+||++|||++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            99866432211                           11235799999999999775 589999999999999999999


Q ss_pred             CCCCCC
Q 002899          840 KSNTNY  845 (869)
Q Consensus       840 ~~p~~~  845 (869)
                      +.||..
T Consensus       244 ~~Pf~~  249 (361)
T 4f9c_A          244 RYPFYK  249 (361)
T ss_dssp             CSSSSC
T ss_pred             CCCCCC
Confidence            999954

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.6e-39  Score=378.83  Aligned_cols=207  Identities=28%  Similarity=0.399  Sum_probs=175.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHH---HHHHHHHhcCCCceeeEEeEEeeCceEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFV---NEIGMISAQQHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~---~E~~~l~~l~H~nIv~l~~~~~~~~~~~  710 (869)
                      ++|++.++||+|+||.||+|+.. +|+.||||++....   ......+.   .++.+++.++|||||++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57899999999999999999976 68999999986432   11122233   3456677789999999999999999999


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      +||||+++|+|.++|....     .+++..++.++.||+.||+|||+++   ||||||||+||||+.+|++||+|||+|+
T Consensus       269 lVmEy~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence            9999999999999996543     6899999999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHH
Q 002899          791 LYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL  855 (869)
Q Consensus       791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~  855 (869)
                      .+.....   ...+||+.|||||++.. ..++.++||||+||++|||++|++||......+...+.
T Consensus       341 ~~~~~~~---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~  403 (689)
T 3v5w_A          341 DFSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID  403 (689)
T ss_dssp             ECSSCCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH
T ss_pred             ecCCCCC---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            7754332   34689999999999975 57999999999999999999999999754333333333

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=6.7e-39  Score=349.87  Aligned_cols=285  Identities=27%  Similarity=0.451  Sum_probs=251.1

Q ss_pred             cHHHHHHHHHHhCC----CCCCCCCCCCCCCCCccccCCCCCCCCcceEecCCCCcceEEEEeccCCCccc--cCCcccc
Q 002899            2 PKKALKQIGRKLGK----KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTG--TLPTELS   75 (869)
Q Consensus         2 ~~~~l~~~~~~l~~----~~W~~~~d~C~~~g~w~~~~~~~~~~~~~v~C~~~~~~~~v~~L~l~~~~l~~--~~p~~l~   75 (869)
                      +++||+++|+.+++    .+|..+.|||.  +.|.           ||+|+......+|+.|+|+++++++  .+|..|.
T Consensus         7 ~~~aL~~~k~~~~~~~~l~~W~~~~~~C~--~~w~-----------gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~   73 (313)
T 1ogq_A            7 DKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTWL-----------GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA   73 (313)
T ss_dssp             HHHHHHHHHHHTTCCGGGTTCCTTSCTTT--TCST-----------TEEECCSSSCCCEEEEEEECCCCSSCEECCGGGG
T ss_pred             HHHHHHHHHHhcCCcccccCCCCCCCCCc--CCCc-----------ceEeCCCCCCceEEEEECCCCCccCCcccChhHh
Confidence            46899999999976    47988889996  1243           5999865545799999999999999  9999999


Q ss_pred             CCCCCCEEEeec-CcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccE
Q 002899           76 KLRYLKQLDLSR-NCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK  153 (869)
Q Consensus        76 ~l~~L~~L~Ls~-N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  153 (869)
                      ++++|++|+|++ |.+.+.+|..|..+ +|++|+|++|++++.+|..|..+++|++|+|++|.+++.+|..|..+++|++
T Consensus        74 ~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  153 (313)
T 1ogq_A           74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG  153 (313)
T ss_dssp             GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred             CCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCe
Confidence            999999999995 99999999988888 8999999999999999999999999999999999999999999999999999


Q ss_pred             EEeecccccccCCccccCCC-CCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCC
Q 002899          154 LILSSNSFTGELPAELTKLT-NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK  232 (869)
Q Consensus       154 L~Ls~N~i~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~  232 (869)
                      |+|++|++++.+|..+..++ +|++|+|++|++++.+|..|..++ |+.|+|++|.+++..|..+..+++|+.|+|++  
T Consensus       154 L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~--  230 (313)
T 1ogq_A          154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK--  230 (313)
T ss_dssp             EECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCS--
T ss_pred             EECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCC--
Confidence            99999999999999999998 999999999999999999999987 99999999999998999999988888777764  


Q ss_pred             CCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh
Q 002899          233 GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI  312 (869)
Q Consensus       233 ~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  312 (869)
                                           |++++.+|. +..+++|++|+|++|+|++.+|..|..+++|+.|+|++|+++|.+|..-
T Consensus       231 ---------------------N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~  288 (313)
T 1ogq_A          231 ---------------------NSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             ---------------------SEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             ---------------------CceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence                                 555544444 6678889999999999988888889899999999999999988888754


Q ss_pred             -hccCCceeeecc
Q 002899          313 -FNSNKNVDISLN  324 (869)
Q Consensus       313 -~~~l~~l~ls~N  324 (869)
                       +..++.+++++|
T Consensus       289 ~l~~L~~l~l~~N  301 (313)
T 1ogq_A          289 NLQRFDVSAYANN  301 (313)
T ss_dssp             TGGGSCGGGTCSS
T ss_pred             cccccChHHhcCC
Confidence             567888888888

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.1e-38  Score=372.17  Aligned_cols=200  Identities=25%  Similarity=0.408  Sum_probs=180.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+++|+.++|||||++++++.+++.+|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            368999999999999999999975 6899999999776666667889999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC--CcEEEeecCCceeec
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD--LNAKISDFGLAKLYE  793 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~--~~~kl~DFGla~~~~  793 (869)
                      |++|+|.+++....    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+|+.+.
T Consensus       236 ~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          236 MSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             CCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             cCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            99999999886543    25899999999999999999999998   9999999999999854  899999999999876


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....  ....+||+.|||||++.+..++.++||||+||++|||++|++||..
T Consensus       309 ~~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~  358 (573)
T 3uto_A          309 PKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG  358 (573)
T ss_dssp             TTSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CCCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            4432  2345799999999999999999999999999999999999999964

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.7e-37  Score=352.92  Aligned_cols=210  Identities=25%  Similarity=0.341  Sum_probs=183.4

Q ss_pred             cHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEe
Q 002899          629 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCV  704 (869)
Q Consensus       629 ~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~  704 (869)
                      .++++...+++|++.++||+|+||+||+|+.. +++.||||+++...   ......+.+|++++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            34555566789999999999999999999986 47899999986532   222345889999999999999999999999


Q ss_pred             eCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEe
Q 002899          705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS  784 (869)
Q Consensus       705 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~  784 (869)
                      +++..++||||+++|+|.+++....    ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~  217 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA  217 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEc
Confidence            9999999999999999999997632    26899999999999999999999998   9999999999999999999999


Q ss_pred             ecCCceeecCCCccccccccccccccchhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          785 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       785 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |||+++.............+||+.|+|||++.     ...++.++|||||||++|||++|+.||..
T Consensus       218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~  283 (437)
T 4aw2_A          218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA  283 (437)
T ss_dssp             CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence            99999877654444444568999999999987     56789999999999999999999999965

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.6e-37  Score=335.92  Aligned_cols=227  Identities=46%  Similarity=0.814  Sum_probs=196.5

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceE
Q 002899          630 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       630 ~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~  709 (869)
                      +.++..++++|++.+.||+|+||.||+|...+++.||||++........+.+.+|+++++.++||||+++++++.+.+..
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            33445578899999999999999999999888999999998877666678899999999999999999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||+++|+|.+++..... ....++|..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999999999999866532 2336899999999999999999999997   999999999999999999999999999


Q ss_pred             eeecCCC-ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHHH
Q 002899          790 KLYEEDK-THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYV  860 (869)
Q Consensus       790 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~~  860 (869)
                      ....... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+...+.+|...
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  258 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE  258 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHH
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhh
Confidence            8754322 2223345689999999999988999999999999999999999999976555556666777643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.8e-37  Score=335.40  Aligned_cols=235  Identities=44%  Similarity=0.807  Sum_probs=199.2

Q ss_pred             CcccHHHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeEEe
Q 002899          626 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCV  704 (869)
Q Consensus       626 ~~~~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~  704 (869)
                      ..++++++..++++|++.+.||+|+||.||+|...+++.||||++...... ....+.+|+++++.++||||+++++++.
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence            467889999999999999999999999999999888999999998765332 3447899999999999999999999999


Q ss_pred             eCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEe
Q 002899          705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS  784 (869)
Q Consensus       705 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~  784 (869)
                      ..+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+...++|+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999976532 33469999999999999999999999832239999999999999999999999


Q ss_pred             ecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--CCcchhhHHHHHHHh
Q 002899          785 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR--PNEDFVYLLDWAYVL  861 (869)
Q Consensus       785 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~--~~~~~~~l~~w~~~~  861 (869)
                      |||++...............||+.|+|||++.+..++.++||||||+++|||++|+.||...  ...+...+.+|+...
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            99999887655444445567999999999998888999999999999999999999999631  123344455565443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=352.06  Aligned_cols=310  Identities=18%  Similarity=0.202  Sum_probs=250.8

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      ..+++.|+|++|++++..+..|.++++|++|+|++|.|++..+..|..+ +|++|+|++|+++.+.+..|.++++|++|+
T Consensus        31 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  110 (477)
T 2id5_A           31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLD  110 (477)
T ss_dssp             CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEE
T ss_pred             CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEE
Confidence            4578999999999999889999999999999999999999999999888 899999999999988888899999999999


Q ss_pred             ccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCC
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG  211 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  211 (869)
                      |++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+.+
T Consensus       111 Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~  190 (477)
T 2id5_A          111 ISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA  190 (477)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCE
T ss_pred             CCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcE
Confidence            99999998888899999999999999999998888899999999999999999998877889999999999999999988


Q ss_pred             CchHhhhcCCCCCEEEcCCCC------------------------CCCCcccccc-cccceEEEcccccCccCCCcccCC
Q 002899          212 PIPASISALTSLTDLRISDLK------------------------GSESAFPKLD-KMNLKTLILTKCLIHGEIPDYIGD  266 (869)
Q Consensus       212 ~~~~~l~~l~~L~~L~L~~n~------------------------~~~~~~~~~~-~~~L~~L~Ls~N~i~~~~p~~~~~  266 (869)
                      ..+..|..+++|+.|+|++|.                        ++..+...+. ..+|+.|+|++|.|++..+..|..
T Consensus       191 ~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  270 (477)
T 2id5_A          191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHE  270 (477)
T ss_dssp             ECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTT
T ss_pred             eChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccc
Confidence            777778777777777776654                        3333222222 236777777777777777777777


Q ss_pred             CCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh--hccCCceeeeccCccCCCCCCCCCCCCCccce
Q 002899          267 MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSVNLV  344 (869)
Q Consensus       267 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~~~  344 (869)
                      +++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+  ...++.|+|++|        ||.|||.+.|+.
T Consensus       271 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N--------~l~c~c~~~~~~  342 (477)
T 2id5_A          271 LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN--------PLACDCRLLWVF  342 (477)
T ss_dssp             CTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS--------CEECSGGGHHHH
T ss_pred             cccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC--------CccCccchHhHH
Confidence            7777777777777777777777777777777777777776555444  456777777777        999999999988


Q ss_pred             eccCCCCCCCCCCcCccCCCCCCCCCccccccee
Q 002899          345 ESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTL  378 (869)
Q Consensus       345 ~~l~~~~~~~~~~~~~~~~~~~C~~p~~~~~~~~  378 (869)
                      .|.....  .      ......|+.|...++..+
T Consensus       343 ~~~~~~~--~------~~~~~~C~~p~~~~g~~l  368 (477)
T 2id5_A          343 RRRWRLN--F------NRQQPTCATPEFVQGKEF  368 (477)
T ss_dssp             TTTTSSC--C------TTCCCBEEESGGGTTCBG
T ss_pred             hhhhccc--c------CccCceeCCchHHcCCch
Confidence            7753211  1      113457888887777654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1e-36  Score=343.99  Aligned_cols=207  Identities=24%  Similarity=0.345  Sum_probs=181.0

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEee
Q 002899          630 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVE  705 (869)
Q Consensus       630 ~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~  705 (869)
                      ++++....++|++.++||+|+||.||+|+.. +++.||+|+++...   ......+.+|+++++.++|||||++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3445556789999999999999999999976 58899999986532   2234468899999999999999999999999


Q ss_pred             CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002899          706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD  785 (869)
Q Consensus       706 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~D  785 (869)
                      ++..++||||+++|+|.+++...      .+++..+..++.||+.||+|||+++   |+||||||+|||++.++++||+|
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~D  211 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD  211 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEec
Confidence            99999999999999999988643      4799999999999999999999998   99999999999999999999999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcccCC----CCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY----LTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ||+++.............+||+.|+|||++....    ++.++|||||||++|||++|+.||..
T Consensus       212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  275 (410)
T 3v8s_A          212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  275 (410)
T ss_dssp             CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence            9999877654433334568999999999997654    78999999999999999999999964

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.2e-36  Score=323.01  Aligned_cols=199  Identities=26%  Similarity=0.530  Sum_probs=179.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      .++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999996 46899999998766655667889999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++|+|.+++...      .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        99 ~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           99 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             CTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            9999999998653      4899999999999999999999998   999999999999999999999999999877544


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       170 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  218 (297)
T 3fxz_A          170 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN  218 (297)
T ss_dssp             TCC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            332 2345799999999999999999999999999999999999999964

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.2e-35  Score=325.41  Aligned_cols=214  Identities=30%  Similarity=0.506  Sum_probs=186.8

Q ss_pred             cccCCcccHHHHHHHhcC----------CCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHh
Q 002899          622 DLQTGLYTLRQIKAATNN----------FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISA  690 (869)
Q Consensus       622 ~~~~~~~~~~~i~~~t~~----------f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~  690 (869)
                      ..+.+.++.++++.+++.          |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++
T Consensus        19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~   98 (321)
T 2c30_A           19 YFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD   98 (321)
T ss_dssp             ------CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTT
T ss_pred             eecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHh
Confidence            334567888888888765          667789999999999999986 789999999987666667789999999999


Q ss_pred             cCCCceeeEEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCC
Q 002899          691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKT  770 (869)
Q Consensus       691 l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~  770 (869)
                      ++||||+++++++...+..++||||+++|+|.+++...      .+++..+..++.|+++||+|||+.+   |+||||||
T Consensus        99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp  169 (321)
T 2c30_A           99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKS  169 (321)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence            99999999999999999999999999999999988543      5899999999999999999999997   99999999


Q ss_pred             CCEEEcCCCcEEEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          771 SNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       771 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +|||++.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~  243 (321)
T 2c30_A          170 DSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS  243 (321)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             HHEEECCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999876543322 2345799999999999999999999999999999999999999964

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.9e-36  Score=362.34  Aligned_cols=321  Identities=19%  Similarity=0.265  Sum_probs=262.1

Q ss_pred             cHHHHHHHHHHhCCCCCCCCCCCCCCCCCccccCCCCCCC--CcceEecCCCCcceEEEEeccCCCccccCCccccCCCC
Q 002899            2 PKKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGF--ESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRY   79 (869)
Q Consensus         2 ~~~~l~~~~~~l~~~~W~~~~d~C~~~g~w~~~~~~~~~~--~~~v~C~~~~~~~~v~~L~l~~~~l~~~~p~~l~~l~~   79 (869)
                      +++||..|+..++...|....++|.....|... .+.+.|  +.||+|+..   +||+.|+|++++++|.+|++|+++++
T Consensus        31 d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~---~~V~~L~L~~~~l~g~lp~~l~~L~~  106 (636)
T 4eco_A           31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSN---GRVTGLSLEGFGASGRVPDAIGQLTE  106 (636)
T ss_dssp             HHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTT---CCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred             HHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCC---CCEEEEEecCcccCCcCChHHhcCcc
Confidence            468999999999999998877777665568743 333333  278999754   79999999999999999999999999


Q ss_pred             CCEEEeecCcC---------------------------------------------------------------------
Q 002899           80 LKQLDLSRNCL---------------------------------------------------------------------   90 (869)
Q Consensus        80 L~~L~Ls~N~i---------------------------------------------------------------------   90 (869)
                      |++|+|++|.+                                                                     
T Consensus       107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l  186 (636)
T 4eco_A          107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT  186 (636)
T ss_dssp             CCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTT
T ss_pred             ceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhh
Confidence            99999999944                                                                     


Q ss_pred             ---------CCCCchhhccc-cceEEEeecccCCCC-----------------Cchhhc--CccccccccccccccCCCC
Q 002899           91 ---------TGSFSPQWASL-QLVELSVMGNRLSGP-----------------FPKVLT--NITTLKNLSIEGNLFTGSI  141 (869)
Q Consensus        91 ---------~~~~~~~~~~l-~L~~L~Ls~N~l~~~-----------------~~~~~~--~l~~L~~L~Ls~N~l~~~~  141 (869)
                               ++ +|..+..+ +|++|+|++|++++.                 +|..++  ++++|++|+|++|++.+.+
T Consensus       187 ~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~  265 (636)
T 4eco_A          187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL  265 (636)
T ss_dssp             TTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSC
T ss_pred             hhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccC
Confidence                     34 56667776 899999999999985                 888888  9999999999999999999


Q ss_pred             CccccCCCCccEEEeeccc-ccc-cCCccccCC------CCCCeEeccCCcCCCCCcc--ccCCCCcccEEEccCCcCCC
Q 002899          142 PPDIRKLINLQKLILSSNS-FTG-ELPAELTKL------TNLNDLRISDNNFSGKIPE--FIGKWKKIQKLHIQGSSLEG  211 (869)
Q Consensus       142 ~~~~~~l~~L~~L~Ls~N~-i~~-~~p~~~~~l------~~L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~  211 (869)
                      |..|.++++|++|+|++|+ +++ .+|..+..+      ++|++|+|++|+++ .+|.  .|+++++|+.|+|++|+++|
T Consensus       266 p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g  344 (636)
T 4eco_A          266 PTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEG  344 (636)
T ss_dssp             CTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEE
T ss_pred             hHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCcc
Confidence            9999999999999999998 988 788888776      89999999999998 7787  89999999999999999998


Q ss_pred             CchHhhhcCCCCCEEEcCCCCCCCCccccccccc-ceEEEcccccCccCCCcccCCCC--CcCEEeccCCCCCCCCchhh
Q 002899          212 PIPASISALTSLTDLRISDLKGSESAFPKLDKMN-LKTLILTKCLIHGEIPDYIGDMT--KLKNIDLSFNNLTGGIPTTF  288 (869)
Q Consensus       212 ~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~-L~~L~Ls~N~i~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~  288 (869)
                      .+| .+..+++|+.|+|++|.++..+.......+ |+.|+|++|+++ .+|..+..++  +|+.|+|++|++++.+|..+
T Consensus       345 ~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l  422 (636)
T 4eco_A          345 KLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF  422 (636)
T ss_dssp             ECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSS
T ss_pred             chh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhh
Confidence            788 888888888888888888755544444446 888888888888 6777776654  78888888888888888877


Q ss_pred             h-------cCCCCCEEEeeCCcCCCCCchhh---hccCCceeeeccCccCCCC
Q 002899          289 E-------KLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISLNNFTWESS  331 (869)
Q Consensus       289 ~-------~l~~L~~L~Ls~N~l~~~~p~~~---~~~l~~l~ls~N~~~~~~~  331 (869)
                      .       .+++|+.|+|++|+++ .+|..+   +..++.|+|++|.++..+.
T Consensus       423 ~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~~i~~  474 (636)
T 4eco_A          423 DPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLTEIPK  474 (636)
T ss_dssp             CTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCSBCCS
T ss_pred             cccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCCCcCH
Confidence            7       7778888888888888 566555   3567888888888875543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-36  Score=341.96  Aligned_cols=211  Identities=24%  Similarity=0.318  Sum_probs=183.0

Q ss_pred             cHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEe
Q 002899          629 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCV  704 (869)
Q Consensus       629 ~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~  704 (869)
                      .+++.....++|++.++||+|+||.||+|+.. +++.||||++....   ......+.+|.+++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34455556789999999999999999999985 68999999986532   223345889999999999999999999999


Q ss_pred             eCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEe
Q 002899          705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS  784 (869)
Q Consensus       705 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~  784 (869)
                      +.+..|+||||+++|+|.+++...+    ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++++||+
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEe
Confidence            9999999999999999999996532    26899999999999999999999998   9999999999999999999999


Q ss_pred             ecCCceeecCCCccccccccccccccchhhcc-------cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          785 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM-------RGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       785 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |||+++.............+||+.|+|||++.       ...++.++|||||||++|||++|+.||...
T Consensus       205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  273 (412)
T 2vd5_A          205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD  273 (412)
T ss_dssp             CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence            99999877654433334468999999999987       356899999999999999999999999653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.3e-36  Score=328.83  Aligned_cols=199  Identities=29%  Similarity=0.374  Sum_probs=176.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++..   .......+.+|+++++.++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57889999999999999999976 6899999998654   2233567889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        85 E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           85 EYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            9999999999886542     6899999999999999999999998   9999999999999999999999999998643


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       157 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  207 (337)
T 1o6l_A          157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  207 (337)
T ss_dssp             CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC
Confidence            3222 22346799999999999998999999999999999999999999964

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.3e-36  Score=327.36  Aligned_cols=199  Identities=26%  Similarity=0.440  Sum_probs=176.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++...  .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45788999999999999999997 47899999998654  2334567889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        94 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             CCCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             ECCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            9999999999986543     5899999999999999999999998   9999999999999999999999999997665


Q ss_pred             CCCccccccccccccccchhhcccCCCC-chhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLT-SKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...  ......||+.|+|||++.+..+. +++||||+||++|||++|+.||..
T Consensus       166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  216 (328)
T 3fe3_A          166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG  216 (328)
T ss_dssp             SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence            432  23346799999999999877764 899999999999999999999964

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-35  Score=320.91  Aligned_cols=202  Identities=31%  Similarity=0.530  Sum_probs=178.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      .++|.+.++||+|+||.||+|... +++.||+|++........+.|.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            356788999999999999999975 6899999998776667778899999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++|+|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        89 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           89 IKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             CTTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             cCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            99999999997643    26899999999999999999999998   999999999999999999999999999876543


Q ss_pred             Cccc-------------cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHI-------------STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....             .....||+.|+|||++.+..++.++||||||+++|||++|..|+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~  224 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD  224 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence            2211             1135799999999999999999999999999999999999998864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.7e-36  Score=331.29  Aligned_cols=200  Identities=27%  Similarity=0.433  Sum_probs=172.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  711 (869)
                      .++|++.++||+|+||.||+|+.. +++.||||+++...   ......+..|.+++..+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            468999999999999999999976 58999999987542   23345678899999987 79999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++.
T Consensus       102 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence            999999999999986543     6899999999999999999999998   99999999999999999999999999975


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  226 (353)
T 3txo_A          174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA  226 (353)
T ss_dssp             SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence            43322 223346799999999999988899999999999999999999999964

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.6e-35  Score=360.95  Aligned_cols=318  Identities=19%  Similarity=0.249  Sum_probs=259.4

Q ss_pred             cHHHHHHHHHHhCCCCCCCCC-----CC--CCCCCCcccc-CCCCCCCCcceEecCCCCcceEEEEeccCCCccccCCcc
Q 002899            2 PKKALKQIGRKLGKKDWNFGV-----DP--CSQKGNWELS-SDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTE   73 (869)
Q Consensus         2 ~~~~l~~~~~~l~~~~W~~~~-----d~--C~~~g~w~~~-~~~~~~~~~~v~C~~~~~~~~v~~L~l~~~~l~~~~p~~   73 (869)
                      +++||++||+.++.++|+.+.     +|  |.    |... ..+.++...||+|++   .+||+.|+|++++++|.+|++
T Consensus       270 d~~ALl~~k~~l~~~~W~~~~~~~~~~~~~C~----W~~~~~~~~w~~~~GV~C~~---~~~V~~L~Ls~~~L~G~ip~~  342 (876)
T 4ecn_A          270 DYKALKAIWEALDGKNWRYYSGTINNTIHSLN----WNFNKELDMWGDQPGVDLDN---NGRVTGLSLAGFGAKGRVPDA  342 (876)
T ss_dssp             HHHHHHHHHHHTTGGGCCCCCSSCSSCCCCCS----CCCSSCGGGTTCCTTEEECT---TSCEEEEECTTTCCEEEECGG
T ss_pred             HHHHHHHHHHHcCCCCCCcCCCcccccCCccc----cccccccccccCcCceEecC---CCCEEEEECccCCCCCcCchH
Confidence            468999999999999998765     67  75    4221 223344457899986   479999999999999999999


Q ss_pred             ccCCCCCCEEEe-ecCcCCCC-----------------------------------------------------------
Q 002899           74 LSKLRYLKQLDL-SRNCLTGS-----------------------------------------------------------   93 (869)
Q Consensus        74 l~~l~~L~~L~L-s~N~i~~~-----------------------------------------------------------   93 (869)
                      |++|++|+.|+| ++|.+.+.                                                           
T Consensus       343 l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~  422 (876)
T 4ecn_A          343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR  422 (876)
T ss_dssp             GGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCC
T ss_pred             HhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccc
Confidence            999999999999 77754332                                                           


Q ss_pred             -----------------Cchhhccc-cceEEEeecccCCC-----------------CCchhhc--Cccccccccccccc
Q 002899           94 -----------------FSPQWASL-QLVELSVMGNRLSG-----------------PFPKVLT--NITTLKNLSIEGNL  136 (869)
Q Consensus        94 -----------------~~~~~~~l-~L~~L~Ls~N~l~~-----------------~~~~~~~--~l~~L~~L~Ls~N~  136 (869)
                                       +|..+..+ +|+.|+|++|++++                 .+|..++  ++++|++|+|++|+
T Consensus       423 l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~  502 (876)
T 4ecn_A          423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP  502 (876)
T ss_dssp             CCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCT
T ss_pred             cchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCC
Confidence                             56667776 89999999999998                 2787877  99999999999999


Q ss_pred             cCCCCCccccCCCCccEEEeeccc-ccc-cCCccccCCC-------CCCeEeccCCcCCCCCcc--ccCCCCcccEEEcc
Q 002899          137 FTGSIPPDIRKLINLQKLILSSNS-FTG-ELPAELTKLT-------NLNDLRISDNNFSGKIPE--FIGKWKKIQKLHIQ  205 (869)
Q Consensus       137 l~~~~~~~~~~l~~L~~L~Ls~N~-i~~-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~L~  205 (869)
                      +.+.+|..|.++++|++|+|++|+ +++ .+|..+..++       +|++|+|++|+++ .+|.  .|.++++|+.|+|+
T Consensus       503 l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls  581 (876)
T 4ecn_A          503 NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCV  581 (876)
T ss_dssp             TCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECT
T ss_pred             CCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECC
Confidence            999999999999999999999998 887 7787665554       9999999999998 7777  89999999999999


Q ss_pred             CCcCCCCchHhhhcCCCCCEEEcCCCCCCCCccccccccc-ceEEEcccccCccCCCcccCCCCC--cCEEeccCCCCCC
Q 002899          206 GSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMN-LKTLILTKCLIHGEIPDYIGDMTK--LKNIDLSFNNLTG  282 (869)
Q Consensus       206 ~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~-L~~L~Ls~N~i~~~~p~~~~~l~~--L~~L~Ls~N~l~~  282 (869)
                      +|+++ .+| .|..+++|+.|+|++|.+...+.......+ |+.|+|++|+|+ .+|..+..++.  |+.|+|++|+|++
T Consensus       582 ~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g  658 (876)
T 4ecn_A          582 HNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS  658 (876)
T ss_dssp             TSCCC-BCC-CCCTTSEESEEECCSSCCSCCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTT
T ss_pred             CCCcc-cch-hhcCCCcceEEECcCCccccchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCC
Confidence            99998 677 889999999999999998855544444556 999999999998 67777776654  9999999999987


Q ss_pred             CCchhh---h--cCCCCCEEEeeCCcCCCCCchhhh---ccCCceeeeccCccCCCC
Q 002899          283 GIPTTF---E--KLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWESS  331 (869)
Q Consensus       283 ~~p~~~---~--~l~~L~~L~Ls~N~l~~~~p~~~~---~~l~~l~ls~N~~~~~~~  331 (869)
                      .+|...   .  .+++|+.|+|++|+++ .+|..++   ..++.|+|++|+++..+.
T Consensus       659 ~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip~  714 (876)
T 4ecn_A          659 EGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIPE  714 (876)
T ss_dssp             TSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSCCCT
T ss_pred             ccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCccCh
Confidence            666322   2  3458889999999998 6777664   578889999998885543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.7e-35  Score=319.95  Aligned_cols=201  Identities=29%  Similarity=0.426  Sum_probs=172.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.|.+|++++++++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467889999999999999999965 68899999885432   23356789999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++++|.+++....     ++++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        90 ~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred             EeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence            99999999999986542     6899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ............||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  214 (294)
T 4eqm_A          162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG  214 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            54433333446799999999999999999999999999999999999999964

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=1e-35  Score=342.14  Aligned_cols=294  Identities=18%  Similarity=0.220  Sum_probs=227.1

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCC-Cchhhccc-cceEEEeecccCCCCCchhhcCccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS-FSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNL  130 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~-~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  130 (869)
                      ..+++.|+|++|.+++..|..|.++++|++|+|++|.+.+. .+..|..+ +|++|+|++|++++..|..|.++++|++|
T Consensus        29 ~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  108 (455)
T 3v47_A           29 PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVL  108 (455)
T ss_dssp             CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEE
T ss_pred             CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEE
Confidence            36799999999999998899999999999999999999854 46678877 89999999999999989999999999999


Q ss_pred             cccccccCCCCCcc--ccCCCCccEEEeecccccccCCcc-ccCCCCCCeEeccCCcCCCCCccccCCC-----------
Q 002899          131 SIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKW-----------  196 (869)
Q Consensus       131 ~Ls~N~l~~~~~~~--~~~l~~L~~L~Ls~N~i~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-----------  196 (869)
                      +|++|++++..+..  |..+++|++|+|++|++++..|.. +.++++|++|+|++|++++..+..+..+           
T Consensus       109 ~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~  188 (455)
T 3v47_A          109 TLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS  188 (455)
T ss_dssp             ECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECT
T ss_pred             eCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccc
Confidence            99999999755554  899999999999999999887876 8899999999999999998777665443           


Q ss_pred             -----------------------CcccEEEccCCcCCC------------------------------------------
Q 002899          197 -----------------------KKIQKLHIQGSSLEG------------------------------------------  211 (869)
Q Consensus       197 -----------------------~~L~~L~L~~N~l~~------------------------------------------  211 (869)
                                             ++|+.|+|++|++++                                          
T Consensus       189 ~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~  268 (455)
T 3v47_A          189 SITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT  268 (455)
T ss_dssp             TCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTT
T ss_pred             cCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccc
Confidence                                   456666666665543                                          


Q ss_pred             ---------------------CchHhhhcCCCCCEEEcCCCCCCCCccccccc-ccceEEEcccccCccCCCcccCCCCC
Q 002899          212 ---------------------PIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTK  269 (869)
Q Consensus       212 ---------------------~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~  269 (869)
                                           ..|..+..+++|+.|+|++|.+.......+.. .+|+.|+|++|+|++..|..|..+++
T Consensus       269 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  348 (455)
T 3v47_A          269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDK  348 (455)
T ss_dssp             TGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTT
T ss_pred             cccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCccc
Confidence                                 34555666667777777777766554444332 36777777777777666777777777


Q ss_pred             cCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh--hccCCceeeeccCccCCCCCCCCCCCC-Cccceec
Q 002899          270 LKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRG-SVNLVES  346 (869)
Q Consensus       270 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~~~~~p~~C~c~-~~~~~~~  346 (869)
                      |+.|+|++|++++..|..|..+++|++|+|++|+|++..+..+  ...++.|++++|        ||.|+|+ +.++..|
T Consensus       349 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N--------~l~~~~~~~~~l~~~  420 (455)
T 3v47_A          349 LEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN--------PWDCSCPRIDYLSRW  420 (455)
T ss_dssp             CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS--------CBCCCTTTTHHHHHH
T ss_pred             CCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCC--------CcccCCCcchHHHHH
Confidence            7777777777776667777777777777777777775444333  346677777777        8999998 5667789


Q ss_pred             cCCCCCCC
Q 002899          347 YSSPRNKL  354 (869)
Q Consensus       347 l~~~~~~~  354 (869)
                      +.....+.
T Consensus       421 l~~~~~~~  428 (455)
T 3v47_A          421 LNKNSQKE  428 (455)
T ss_dssp             HHHTTTTE
T ss_pred             HHhCccce
Confidence            87654443

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.6e-35  Score=332.28  Aligned_cols=200  Identities=26%  Similarity=0.392  Sum_probs=174.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  711 (869)
                      .++|++.++||+|+||.||+|+.. +++.||+|+++...   ......+..|..++.++ +|||||++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            357889999999999999999976 57899999987542   22345678899998876 89999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|..++....     .+++..++.++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++.
T Consensus       131 V~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEcCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence            999999999999886543     6899999999999999999999998   99999999999999999999999999986


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       203 ~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          203 GLRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             CCCTTC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             cccCCC-ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            432222 23346799999999999999999999999999999999999999964

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.2e-35  Score=328.75  Aligned_cols=208  Identities=25%  Similarity=0.415  Sum_probs=179.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56889999999999999999976 57899999986532   233567889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        95 e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             CCCTTEEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            9999999999997643     5899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccccccchhhccc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHH
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL  855 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~  855 (869)
                      ...  ......||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+.
T Consensus       167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~  229 (384)
T 4fr4_A          167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV  229 (384)
T ss_dssp             TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH
T ss_pred             CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH
Confidence            432  2234679999999999864   45899999999999999999999999765444443333

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.4e-35  Score=324.88  Aligned_cols=200  Identities=27%  Similarity=0.378  Sum_probs=177.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch------hhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~------~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~  708 (869)
                      ..++|++.+.||+|+||.||+|... +|+.||+|+++.....      ....+.+|+++++.++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3567899999999999999999976 6899999998764322      24678999999999999999999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC----cEEEe
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKIS  784 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~----~~kl~  784 (869)
                      .++||||+++|+|.+++....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++    .+||+
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~  161 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI  161 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEE
Confidence            999999999999999996542     6899999999999999999999998   99999999999998877    79999


Q ss_pred             ecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          785 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       785 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |||++........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       162 DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~  220 (361)
T 2yab_A          162 DFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  220 (361)
T ss_dssp             CCSSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             ecCCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            9999987654322  2345799999999999988999999999999999999999999964

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.5e-35  Score=325.57  Aligned_cols=203  Identities=29%  Similarity=0.431  Sum_probs=176.3

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCce
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~  708 (869)
                      ....++|.+.++||+|+||.||+|+.. +++.||||+++...   ......+..|.+++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            445678999999999999999999986 68899999987542   23345678889998876 99999999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .++||||+++|+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~  164 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM  164 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChh
Confidence            999999999999999986532     5899999999999999999999998   99999999999999999999999999


Q ss_pred             ceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       165 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  220 (345)
T 1xjd_A          165 CKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG  220 (345)
T ss_dssp             CBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             hhhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence            976433222 23346799999999999998999999999999999999999999964

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=331.27  Aligned_cols=203  Identities=18%  Similarity=0.177  Sum_probs=174.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEE------EcCCcEEEEEEecccCchhhHHHHHHHHHHHhcC---CCceeeEEeEEeeC
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGI------LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEG  706 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~------~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~---H~nIv~l~~~~~~~  706 (869)
                      ..++|.+.++||+|+||.||+|.      ..+++.||||+++...   ..++..|++++..++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            45678899999999999999994      4468899999997543   457778888888876   99999999999999


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---------
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---------  777 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~---------  777 (869)
                      +..++||||+++|+|.+++..........+++..++.++.||++||+|||+.+   |+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            99999999999999999997532222346999999999999999999999987   999999999999998         


Q ss_pred             --CCcEEEeecCCceeecCC-CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          778 --DLNAKISDFGLAKLYEED-KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       778 --~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                        ++.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  286 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV  286 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence              899999999999876422 2223344679999999999999999999999999999999999999984

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-35  Score=320.79  Aligned_cols=196  Identities=27%  Similarity=0.450  Sum_probs=175.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56888999999999999999975 68999999986542   223456788999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             CCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            9999999999997543     5899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..    .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  205 (318)
T 1fot_A          158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD  205 (318)
T ss_dssp             SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence            32    2245799999999999998999999999999999999999999964

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=2.4e-35  Score=360.80  Aligned_cols=305  Identities=30%  Similarity=0.420  Sum_probs=241.6

Q ss_pred             cHHHHHHHHHHhCC----CCCCCCCCCCCCCCCccccCCCCCCCCcceEecCCCCcceEEEEeccCCCcccc---CC---
Q 002899            2 PKKALKQIGRKLGK----KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGT---LP---   71 (869)
Q Consensus         2 ~~~~l~~~~~~l~~----~~W~~~~d~C~~~g~w~~~~~~~~~~~~~v~C~~~~~~~~v~~L~l~~~~l~~~---~p---   71 (869)
                      +++||+++|+.+.+    .+|..+.|||.|.|               |+|+    .+||+.|+|+++++.|.   +|   
T Consensus        13 ~~~all~~k~~~~~~~~l~~W~~~~~~C~w~g---------------v~C~----~~~v~~L~L~~~~l~g~~~~l~~~l   73 (768)
T 3rgz_A           13 EIHQLISFKDVLPDKNLLPDWSSNKNPCTFDG---------------VTCR----DDKVTSIDLSSKPLNVGFSAVSSSL   73 (768)
T ss_dssp             HHHHHHHHHTTCSCTTSSTTCCTTSCGGGSTT---------------EEEE----TTEEEEEECTTSCCCEEHHHHHHHT
T ss_pred             HHHHHHHHHhhCCCcccccCCCCCCCCcCCcc---------------eEEC----CCcEEEEECCCCCcCCccCccChhH
Confidence            47899999999875    57988889998665               9997    47999999999999886   54   


Q ss_pred             --------------------ccccCCCCCCEEEeecCcCCCCCch--hhccc-cceEEEeecccCCCCCchhh-cCcccc
Q 002899           72 --------------------TELSKLRYLKQLDLSRNCLTGSFSP--QWASL-QLVELSVMGNRLSGPFPKVL-TNITTL  127 (869)
Q Consensus        72 --------------------~~l~~l~~L~~L~Ls~N~i~~~~~~--~~~~l-~L~~L~Ls~N~l~~~~~~~~-~~l~~L  127 (869)
                                          ..|.++++|++|+|++|.+++.+|.  .+..+ +|++|+|++|.+++..|..+ .++++|
T Consensus        74 ~~L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L  153 (768)
T 3rgz_A           74 LSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSL  153 (768)
T ss_dssp             TTCTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTC
T ss_pred             hccCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCC
Confidence                                4566677777777777777766665  56665 67777777777776666554 667777


Q ss_pred             ccccccccccCCCCCcc---ccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEc
Q 002899          128 KNLSIEGNLFTGSIPPD---IRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHI  204 (869)
Q Consensus       128 ~~L~Ls~N~l~~~~~~~---~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  204 (869)
                      ++|+|++|++++..|..   +.++++|++|+|++|++++..|  +..+++|++|+|++|++++.+|. ++++++|++|+|
T Consensus       154 ~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~L  230 (768)
T 3rgz_A          154 EVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDI  230 (768)
T ss_dssp             SEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB--CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEEC
T ss_pred             CEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCC--cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEEC
Confidence            77777777777666655   6777777777777777776544  37788999999999999887777 999999999999


Q ss_pred             cCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCC-CCcCEEeccCCCCCCC
Q 002899          205 QGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDM-TKLKNIDLSFNNLTGG  283 (869)
Q Consensus       205 ~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l-~~L~~L~Ls~N~l~~~  283 (869)
                      ++|.+++.+|..+.++++|+.|+|++|.+....... ...+|++|+|++|++++.+|..+..+ ++|++|+|++|++++.
T Consensus       231 s~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~-~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~  309 (768)
T 3rgz_A          231 SGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA  309 (768)
T ss_dssp             CSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC-CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEEC
T ss_pred             cCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc-ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCc
Confidence            999999999999999999999999999887544333 45578888888888888888877664 8888888888888888


Q ss_pred             CchhhhcCCCCCEEEeeCCcCCCCCchh-h--hccCCceeeeccCccCC
Q 002899          284 IPTTFEKLAKTNFMYLTGNKLTGPVPKY-I--FNSNKNVDISLNNFTWE  329 (869)
Q Consensus       284 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~--~~~l~~l~ls~N~~~~~  329 (869)
                      +|..|..+++|+.|+|++|+++|.+|.. +  ...++.|++++|.+++.
T Consensus       310 ~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~  358 (768)
T 3rgz_A          310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE  358 (768)
T ss_dssp             CCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEEC
T ss_pred             cchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCcc
Confidence            8888888888888888888888888866 3  45677888888877643

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=3.4e-35  Score=351.63  Aligned_cols=318  Identities=19%  Similarity=0.221  Sum_probs=247.3

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      +..++.|+|++|+|++..+.+|.++++|++|+|++|+|+++++.+|..+ +|++|+|++|+|++..+..|.++++|++|+
T Consensus        51 p~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~  130 (635)
T 4g8a_A           51 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV  130 (635)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred             CcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence            4578999999999998888899999999999999999999999999988 899999999999988889999999999999


Q ss_pred             ccccccCCCCCccccCCCCccEEEeecccccc-cCCccccCCCCCCeEeccCCcCCCCCccccC----------------
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIG----------------  194 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~----------------  194 (869)
                      |++|+|++..+..|+++++|++|+|++|++++ ..|..+..+++|++|+|++|+|++..+..|.                
T Consensus       131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~  210 (635)
T 4g8a_A          131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL  210 (635)
T ss_dssp             CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred             CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhccc
Confidence            99999998777789999999999999999986 4578889999999999999987644322110                


Q ss_pred             --------------------------------------------------------------------------------
Q 002899          195 --------------------------------------------------------------------------------  194 (869)
Q Consensus       195 --------------------------------------------------------------------------------  194 (869)
                                                                                                      
T Consensus       211 n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~  290 (635)
T 4g8a_A          211 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY  290 (635)
T ss_dssp             CCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred             CcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence                                                                                            


Q ss_pred             ------------------------------------------------------------------------------CC
Q 002899          195 ------------------------------------------------------------------------------KW  196 (869)
Q Consensus       195 ------------------------------------------------------------------------------~l  196 (869)
                                                                                                    .+
T Consensus       291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l  370 (635)
T 4g8a_A          291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL  370 (635)
T ss_dssp             CCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBC
T ss_pred             hcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccc
Confidence                                                                                          12


Q ss_pred             CcccEEEccCCcCCCC--------------------------------------------------chHhhhcCCCCCEE
Q 002899          197 KKIQKLHIQGSSLEGP--------------------------------------------------IPASISALTSLTDL  226 (869)
Q Consensus       197 ~~L~~L~L~~N~l~~~--------------------------------------------------~~~~l~~l~~L~~L  226 (869)
                      ++|+.|++++|.+...                                                  .+..+..+++|+.+
T Consensus       371 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l  450 (635)
T 4g8a_A          371 PSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL  450 (635)
T ss_dssp             TTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEE
T ss_pred             cccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccc
Confidence            2344444444433210                                                  00112233344444


Q ss_pred             EcCCCCCCCCc-------------------------ccccc-cccceEEEcccccCccCCCcccCCCCCcCEEeccCCCC
Q 002899          227 RISDLKGSESA-------------------------FPKLD-KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNL  280 (869)
Q Consensus       227 ~L~~n~~~~~~-------------------------~~~~~-~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l  280 (869)
                      +++.|.+....                         ...+. ..+|+.|+|++|+|++..|..|.++++|+.|+|++|+|
T Consensus       451 ~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l  530 (635)
T 4g8a_A          451 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF  530 (635)
T ss_dssp             ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             cccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcC
Confidence            44444432211                         11111 23789999999999988899999999999999999999


Q ss_pred             CCCCchhhhcCCCCCEEEeeCCcCCCCCchhhh---ccCCceeeeccCccCCCCCCCCCCCCCccceeccCCCCCCCCCC
Q 002899          281 TGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKV  357 (869)
Q Consensus       281 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~~l~~l~ls~N~~~~~~~~p~~C~c~~~~~~~~l~~~~~~~~~~  357 (869)
                      ++..|..|.++++|+.|+|++|+|++..|..+.   ..++.|+|++|        ||.|||++.||+.|++.....+.. 
T Consensus       531 ~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~N--------p~~C~C~~~~~~~wl~~~~~~~~~-  601 (635)
T 4g8a_A          531 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN--------DFACTCEHQSFLQWIKDQRQLLVE-  601 (635)
T ss_dssp             CBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTC--------CBCCSGGGHHHHHHHHHTTTTBSC-
T ss_pred             CCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCC--------CCcccCCcHHHHHHHHhCCCccCC-
Confidence            988888899999999999999999988887763   46888999998        999999999999999765544322 


Q ss_pred             cCccCCCCCCCCCcccccceee---eecC
Q 002899          358 HPCLRQNFPCSAPADQYHYTLH---INCG  383 (869)
Q Consensus       358 ~~~~~~~~~C~~p~~~~~~~~~---~~c~  383 (869)
                          ....+|+.|+..+|+.+.   +.|.
T Consensus       602 ----~~~~~C~~P~~~~g~~l~~~~~~C~  626 (635)
T 4g8a_A          602 ----VERMECATPSDKQGMPVLSLNITCQ  626 (635)
T ss_dssp             ----GGGCBBCSSTTTTTCBGGGCCCCC-
T ss_pred             ----CCCceeCCchHHCCCEeeeeccCCC
Confidence                245789999999886544   4563

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6e-35  Score=326.23  Aligned_cols=207  Identities=27%  Similarity=0.436  Sum_probs=177.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc--------CCcEEEEEEecccCc-hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG  706 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~--------~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~  706 (869)
                      .++|.+.+.||+|+||.||+|+..        ++..||||+++.... ...+++.+|+++++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467888999999999999999862        346799999976533 3456799999999999 899999999999999


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL  775 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  775 (869)
                      +..++||||+++|+|.+++......           ....+++..+..++.||++||+|||+++   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            9999999999999999999765321           1235899999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEeecCCceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          776 DKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       776 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      +.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~  309 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  309 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999876543221 2223457889999999999999999999999999999999 99999653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.2e-35  Score=323.36  Aligned_cols=199  Identities=27%  Similarity=0.397  Sum_probs=175.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|.+++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56888999999999999999976 58899999987542   23345678899999887 899999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++|+|.+++....     .+++..++.++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++..
T Consensus        89 ~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            99999999999886542     5899999999999999999999998   999999999999999999999999999764


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       161 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          161 LRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             CCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cCCCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            32222 23346799999999999998999999999999999999999999964

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.5e-34  Score=315.33  Aligned_cols=202  Identities=29%  Similarity=0.447  Sum_probs=173.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++|++.+.||+|+||+||+|+..+++.||+|++.....  .....+.+|++++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            467889999999999999999998899999999865432  224678899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++ +|.+.+....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       100 ~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A          100 FMEK-DLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             CCSE-EHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             CCCC-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            9985 7877775543    25899999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      .... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       172 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  224 (311)
T 3niz_A          172 PVRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT  224 (311)
T ss_dssp             CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             Cccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence            3222 233568999999999876 568999999999999999999999997643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.6e-35  Score=318.23  Aligned_cols=205  Identities=32%  Similarity=0.525  Sum_probs=169.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ..++|++.+.||+|+||.||+|+. +++.||||++....  ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            356788899999999999999987 57889999987653  333567899999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++.....  ...+++..+..++.|+++||+|||+.+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus       114 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             ECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             ecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            99999999999976532  224899999999999999999999985 349999999999999999999999999997654


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       191 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~  241 (309)
T 3p86_A          191 STFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN  241 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             cccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            3321 22345789999999999999999999999999999999999999964

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.5e-35  Score=318.51  Aligned_cols=202  Identities=31%  Similarity=0.481  Sum_probs=174.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            367889999999999999999976 789999999865432 234678899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+..
T Consensus        86 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             CCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             cCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            999999999886543     5899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCc-cccccccccccccchhhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          795 DKT-HISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       795 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  211 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  211 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence            322 22234679999999999987664 78999999999999999999999754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.6e-35  Score=324.42  Aligned_cols=201  Identities=27%  Similarity=0.378  Sum_probs=175.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~  710 (869)
                      ..++|++.++||+|+||.||+|+.. +++.||||+++...   ......+..|.+++..+ +||||+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3568999999999999999999986 47899999987542   23345678899999887 8999999999999999999


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      +||||+++|+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++
T Consensus        98 lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~  169 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  169 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence            9999999999999986542     5899999999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          791 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       170 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  223 (353)
T 2i0e_A          170 ENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  223 (353)
T ss_dssp             CCCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence            6432222 23346799999999999998999999999999999999999999964

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-34  Score=317.27  Aligned_cols=199  Identities=20%  Similarity=0.317  Sum_probs=176.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      .++|++.+.||+|+||.||+|... +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            467889999999999999999976 5789999998754 33456788999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC--CCcEEEeecCCceeec
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK--DLNAKISDFGLAKLYE  793 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~--~~~~kl~DFGla~~~~  793 (869)
                      +++|+|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.  ++.+||+|||++....
T Consensus        83 ~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           83 ISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             CCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            99999999986542    25899999999999999999999998   999999999999987  7899999999998775


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....  .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  205 (321)
T 1tki_A          156 PGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA  205 (321)
T ss_dssp             TTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CCCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence            4332  2345789999999999988899999999999999999999999965

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.3e-35  Score=311.63  Aligned_cols=201  Identities=30%  Similarity=0.545  Sum_probs=177.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .++|++.+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+++..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            356888999999999999999998889999999975433 3567999999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           88 EHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             TTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            9999999996543    25899999999999999999999998   9999999999999999999999999998665433


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ........+|+.|+|||++....++.++||||+|+++|||++ |+.||..
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~  210 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN  210 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC
Confidence            222333456788999999998999999999999999999999 9999865

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8e-35  Score=322.41  Aligned_cols=196  Identities=25%  Similarity=0.366  Sum_probs=175.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57888999999999999999976 68999999986542   233467889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       121 e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence            9999999999986542     5899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..    .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  240 (350)
T 1rdq_E          193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA  240 (350)
T ss_dssp             SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC
Confidence            32    2245799999999999998999999999999999999999999964

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.7e-35  Score=319.82  Aligned_cols=200  Identities=27%  Similarity=0.421  Sum_probs=166.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE----cCCcEEEEEEecccC----chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~----~~g~~VAvK~~~~~~----~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~  708 (869)
                      .++|++.+.||+|+||.||+|+.    .+++.||+|+++...    ......+.+|+++++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46788999999999999999997    478999999987642    2234567889999999999999999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .++||||+++|+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCc
Confidence            999999999999999986542     5889999999999999999999998   99999999999999999999999999


Q ss_pred             ceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       168 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  223 (327)
T 3a62_A          168 CKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG  223 (327)
T ss_dssp             C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence            876433222 22345799999999999988899999999999999999999999964

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-34  Score=316.48  Aligned_cols=199  Identities=27%  Similarity=0.380  Sum_probs=176.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch------hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~------~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~  709 (869)
                      .++|++.+.||+|+||.||+|... +++.||+|+++.....      ....+.+|++++++++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            456889999999999999999976 6899999998654321      356789999999999999999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC----cEEEee
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISD  785 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~----~~kl~D  785 (869)
                      ++||||+++|+|.+++....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++    .+||+|
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D  161 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID  161 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEEcCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence            99999999999999986542     6899999999999999999999998   99999999999999887    899999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ||++........  .....||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus       162 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  219 (326)
T 2y0a_A          162 FGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  219 (326)
T ss_dssp             CTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence            999987754322  2345799999999999988999999999999999999999999964

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.4e-34  Score=322.19  Aligned_cols=201  Identities=25%  Similarity=0.413  Sum_probs=176.7

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ...++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34568999999999999999999975 68999999986543  3345678899999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC---CcEEEeecCC
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKISDFGL  788 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~---~~~kl~DFGl  788 (869)
                      ||||+++|+|.+.+....     .+++..+..++.||++||+|||+++   |+||||||+|||++.+   +.+||+|||+
T Consensus       106 v~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EECCCCSCBHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            999999999999886543     5899999999999999999999998   9999999999999865   4599999999


Q ss_pred             ceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       178 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~  232 (362)
T 2bdw_A          178 AIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  232 (362)
T ss_dssp             CBCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ceEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            987653322  2345799999999999998999999999999999999999999954

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=9.3e-35  Score=318.91  Aligned_cols=201  Identities=30%  Similarity=0.499  Sum_probs=172.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEeccc-CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~----~g~~VAvK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ++|++.+.||+|+||.||+|.+.    .+..||||+++.. .....++|.+|++++++++||||+++++++.+++..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56788899999999999999974    3456999999765 334456799999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++|+|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       129 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             eeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999996543    26899999999999999999999998   999999999999999999999999999877


Q ss_pred             cCCCcc--ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          793 EEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       793 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ......  ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~  257 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN  257 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc
Confidence            543321  1222346778999999998899999999999999999999 9999854

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.1e-34  Score=308.93  Aligned_cols=201  Identities=30%  Similarity=0.513  Sum_probs=178.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .++|++.+.||+|+||.||+|...++..||||+++.... ..+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            467888999999999999999998888999999975433 3567899999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           86 SNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             TTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             CCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            9999999986542    25899999999999999999999998   9999999999999999999999999998776544


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  208 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL  208 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc
Confidence            333333456778999999998889999999999999999999 9999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-34  Score=322.69  Aligned_cols=200  Identities=27%  Similarity=0.399  Sum_probs=178.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      .++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467899999999999999999975 6889999999776655667899999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC--CCcEEEeecCCceeec
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK--DLNAKISDFGLAKLYE  793 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~--~~~~kl~DFGla~~~~  793 (869)
                      +++|+|.+++....    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.  ++.+||+|||++....
T Consensus       130 ~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          130 LSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             CCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             CCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence            99999999886542    25899999999999999999999998   999999999999974  5789999999998775


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....  .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  252 (387)
T 1kob_A          203 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG  252 (387)
T ss_dssp             TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence            4332  2234689999999999998999999999999999999999999964

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.3e-34  Score=321.28  Aligned_cols=204  Identities=25%  Similarity=0.379  Sum_probs=175.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-----chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  710 (869)
                      .++|++.+.||+|+||.||+|... +++.||||++....     ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            457889999999999999999975 68999999985431     123567899999999999999999999999999999


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc---EEEeecC
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKISDFG  787 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~---~kl~DFG  787 (869)
                      +||||+++|+|.+.+.... .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.   +||+|||
T Consensus       103 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEeCCCCCCHHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999988775432 12235899999999999999999999998   999999999999987654   9999999


Q ss_pred             CceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  235 (351)
T 3c0i_A          179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG  235 (351)
T ss_dssp             TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence            9987764332 22345799999999999988899999999999999999999999964

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.7e-34  Score=309.18  Aligned_cols=215  Identities=44%  Similarity=0.707  Sum_probs=186.8

Q ss_pred             CCcccHHHHHHHhcCCCCC------CeeeccCceEEEEEEEcCCcEEEEEEecccC----chhhHHHHHHHHHHHhcCCC
Q 002899          625 TGLYTLRQIKAATNNFDPA------NKVGEGGFGSVYKGILSDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQHP  694 (869)
Q Consensus       625 ~~~~~~~~i~~~t~~f~~~------~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~----~~~~~~f~~E~~~l~~l~H~  694 (869)
                      ...+++.++..++++|+..      +.||+|+||.||+|.. +++.||||++....    ....+.+.+|++++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3578999999999999888      8999999999999987 57899999986532    23356789999999999999


Q ss_pred             ceeeEEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 002899          695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL  774 (869)
Q Consensus       695 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIL  774 (869)
                      ||+++++++.+.+..++||||+++|+|.+++....  ....+++..+..++.|+++||+|||+.+   |+||||||+||+
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil  165 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL  165 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence            99999999999999999999999999999986532  2236899999999999999999999998   999999999999


Q ss_pred             EcCCCcEEEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          775 LDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       775 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ++.++.+||+|||++........ .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~  237 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH  237 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccC
Confidence            99999999999999987654322 22234578999999998765 5789999999999999999999999753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.8e-34  Score=315.79  Aligned_cols=205  Identities=22%  Similarity=0.290  Sum_probs=177.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++|++.+.||+|+||.||+|.. .+++.||||++.....  ...+..|+++++++ +||||+++++++..++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46788999999999999999996 4789999999865432  35688999999999 99999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc-----EEEeecCCc
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-----AKISDFGLA  789 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~-----~kl~DFGla  789 (869)
                      |+ +++|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.     +||+|||++
T Consensus        86 ~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           86 LL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred             eC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence            99 899999987542    26899999999999999999999998   999999999999998887     999999999


Q ss_pred             eeecCCCcc------ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcch
Q 002899          790 KLYEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF  851 (869)
Q Consensus       790 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~  851 (869)
                      +.+......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....++.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~  225 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL  225 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH
Confidence            876543321      12346799999999999999999999999999999999999999976544433

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.9e-34  Score=334.20  Aligned_cols=202  Identities=31%  Similarity=0.419  Sum_probs=178.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .++|++.++||+|+||.||+|+.. +|+.||||++....   ......+.+|+++++.++|||||++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467889999999999999999975 68999999986532   23345688999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++|+|.+++.....   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++..
T Consensus       263 mEy~~gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEcCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence            999999999999876432   25899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .....  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       337 ~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~  388 (576)
T 2acx_A          337 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR  388 (576)
T ss_dssp             CTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred             ccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence            54322  22357999999999999988999999999999999999999999764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2e-34  Score=328.84  Aligned_cols=202  Identities=23%  Similarity=0.360  Sum_probs=176.0

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ...++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+++++.++|||||++++++.+++..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            34577999999999999999999865 68999999987543  2335678899999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc---CCCcEEEeecCC
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGL  788 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~---~~~~~kl~DFGl  788 (869)
                      ||||+++|+|.+.+....     .+++..+..++.||+.||+|||+++   |+||||||+|||++   .++.+||+|||+
T Consensus        88 v~E~~~gg~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~  159 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGL  159 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred             EEEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCce
Confidence            999999999999887653     5899999999999999999999998   99999999999998   568899999999


Q ss_pred             ceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +........ ......||+.|+|||++.+..++.++||||+||++|||++|++||..
T Consensus       160 a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~  215 (444)
T 3soa_A          160 AIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD  215 (444)
T ss_dssp             CBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             eEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence            987654332 22346799999999999998999999999999999999999999954

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=100.00  E-value=3.7e-34  Score=327.76  Aligned_cols=321  Identities=16%  Similarity=0.183  Sum_probs=227.7

Q ss_pred             cceEecCCCCcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhh
Q 002899           43 SNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVL  121 (869)
Q Consensus        43 ~~v~C~~~~~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~  121 (869)
                      |+..|.|...   ...+++.+.+++ .+|..+.  ++|+.|+|++|+|+.+.+..|..+ +|++|+|++|+++++.+..|
T Consensus        35 Cp~~C~C~~~---~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~  108 (440)
T 3zyj_A           35 CPSVCSCSNQ---FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAF  108 (440)
T ss_dssp             CCSSSEECTT---SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGG
T ss_pred             CCCCCEeCCC---CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhc
Confidence            3445666543   346788889998 6777665  689999999999998888888877 78888888888888888888


Q ss_pred             cCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccC-CcCCCCCccccCCCCccc
Q 002899          122 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD-NNFSGKIPEFIGKWKKIQ  200 (869)
Q Consensus       122 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~  200 (869)
                      .++++|++|+|++|+|+...+..|..+++|++|+|++|+|+...+..|.++++|++|+|++ |.+....+..|.++++|+
T Consensus       109 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~  188 (440)
T 3zyj_A          109 NGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLR  188 (440)
T ss_dssp             TTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCC
T ss_pred             cCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccC
Confidence            8888888888888888866666788888888888888888876677788888888888888 445544455678888888


Q ss_pred             EEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCC
Q 002899          201 KLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNL  280 (869)
Q Consensus       201 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l  280 (869)
                      .|+|++|.++.. | .+..+++|+.|                       +|++|+|++..|..|.++++|+.|+|++|+|
T Consensus       189 ~L~L~~n~l~~~-~-~~~~l~~L~~L-----------------------~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l  243 (440)
T 3zyj_A          189 YLNLAMCNLREI-P-NLTPLIKLDEL-----------------------DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI  243 (440)
T ss_dssp             EEECTTSCCSSC-C-CCTTCSSCCEE-----------------------ECTTSCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             eecCCCCcCccc-c-ccCCCcccCEE-----------------------ECCCCccCccChhhhccCccCCEEECCCCce
Confidence            888888887733 3 24555555555                       5556666666666666677777777777777


Q ss_pred             CCCCchhhhcCCCCCEEEeeCCcCCCCCchhh--hccCCceeeeccCccCCCCCCCCCCCCCccceeccCCCCCCCCCCc
Q 002899          281 TGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH  358 (869)
Q Consensus       281 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~~~~~l~~~~~~~~~~~  358 (869)
                      ++..+..|.++++|+.|+|++|+|++..+..+  +..++.|+|++|        ||.|||++.|+..|++......    
T Consensus       244 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N--------p~~CdC~l~~l~~~~~~~~~~~----  311 (440)
T 3zyj_A          244 QVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN--------PWNCNCDILWLSWWIKDMAPSN----  311 (440)
T ss_dssp             CEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSS--------CEECSSTTHHHHHHHHTTSCSS----
T ss_pred             eEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCC--------CccCCCCchHHHHHHHhccccC----
Confidence            66666666667777777777777765444433  345666777766        9999999999999987642211    


Q ss_pred             CccCCCCCCCCCcccccceee------eecCCcceecCCceeccCccCccccccccc
Q 002899          359 PCLRQNFPCSAPADQYHYTLH------INCGGAKINTGHTKYEADMEARGASMFYSS  409 (869)
Q Consensus       359 ~~~~~~~~C~~p~~~~~~~~~------~~c~~~~~~~~~~~~~~d~~~~~~~~~~~~  409 (869)
                        ......|+.|+..+|+.+.      ..|..|.+...+..... .++......|..
T Consensus       312 --~~~~~~C~~P~~l~g~~l~~l~~~~~~C~~P~i~~~~~~~~v-~~G~~v~L~C~~  365 (440)
T 3zyj_A          312 --TACCARCNTPPNLKGRYIGELDQNYFTCYAPVIVEPPADLNV-TEGMAAELKCRA  365 (440)
T ss_dssp             --CSCCCBEEESTTTTTCBCC----CCSCCCCCCEEECCCCEEE-CTTSCCEECCEE
T ss_pred             --CccccCCCChhHhcCccHhHhhhhhccCCCCcccccccceee-ccCceEEEEeec
Confidence              1124579999988887654      46888777654433322 234444445543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.2e-34  Score=324.03  Aligned_cols=202  Identities=30%  Similarity=0.510  Sum_probs=164.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~----~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      .++|++.+.||+|+||.||+|+..    ++..||||+++... ....++|.+|++++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357889999999999999999865    46789999997653 3345689999999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+++....    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       124 v~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            999999999999997543    26899999999999999999999997   99999999999999999999999999987


Q ss_pred             ecCCCccc--cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          792 YEEDKTHI--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ........  .....+++.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~  253 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE  253 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence            65432211  112235678999999999999999999999999999998 9999854

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8e-35  Score=319.02  Aligned_cols=199  Identities=32%  Similarity=0.469  Sum_probs=170.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc----eEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----QLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lV  712 (869)
                      .++|++.++||+|+||.||+|+.. ++.||||++.... .....+..|+.++.+++|||||++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            467889999999999999999876 7899999996543 23445667888999999999999999998744    47999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEEcCCCCCCEEEcCCCcEE
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED----------SRIKIVHRDIKTSNVLLDKDLNAK  782 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~iiH~Dlk~~NILl~~~~~~k  782 (869)
                      |||+++|+|.+++...      .+++..+..++.|+++||+|||+.          +   |+||||||+|||++.++.+|
T Consensus       101 ~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred             EecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence            9999999999999653      489999999999999999999988          6   99999999999999999999


Q ss_pred             EeecCCceeecCCCcc-ccccccccccccchhhcccC-----CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          783 ISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRG-----YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       783 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |+|||+++........ ......||+.|+|||++.+.     .++.++|||||||++|||++|+.||...
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  241 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP  241 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence            9999999877543322 22335789999999998763     4567889999999999999999999653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.5e-34  Score=313.17  Aligned_cols=205  Identities=29%  Similarity=0.481  Sum_probs=161.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++|++.+.||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467899999999999999999965 689999999875432 234678899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          715 YMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      |++ |+|.+++..... .....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 589888754321 11235899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  212 (317)
T 2pmi_A          160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT  212 (317)
T ss_dssp             SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            3322 1223568999999999876 46899999999999999999999999653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8.6e-35  Score=324.58  Aligned_cols=200  Identities=27%  Similarity=0.393  Sum_probs=167.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHH-HHhcCCCceeeEEeEEeeCceEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGM-ISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      .++|++.++||+|+||.||+|+.. +++.||||+++....   .....+..|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357889999999999999999976 578999999875432   223456667665 567899999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+++....     .+++..++.++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++.
T Consensus       117 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            999999999999986542     5889999999999999999999998   99999999999999999999999999976


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       189 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  241 (373)
T 2r5t_A          189 NIEHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  241 (373)
T ss_dssp             GBCCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cccCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            433222 23346799999999999999999999999999999999999999964

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.5e-34  Score=310.48  Aligned_cols=201  Identities=27%  Similarity=0.489  Sum_probs=174.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .++|++.+.||+|+||.||+|.+.++..||||+++.... ..+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            457888999999999999999999888999999976533 3567999999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++....    ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++.......
T Consensus       102 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A          102 ANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             TTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             CCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            9999999996532    25899999999999999999999998   9999999999999999999999999998665432


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ........+|+.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~  224 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER  224 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            222233456788999999998899999999999999999998 9999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.7e-34  Score=317.66  Aligned_cols=197  Identities=27%  Similarity=0.452  Sum_probs=172.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|.+.+.||+|+||.||+|.. .+++.||||++....   ......+.+|+++++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5788999999999999999997 478999999986432   222457889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+ +|+|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        89 E~~-~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             CCC-CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             ECC-CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            999 678888886542     6899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccccccchhhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...  ......||+.|+|||++.+..+ ++++|||||||++|||++|+.||..
T Consensus       160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~  210 (336)
T 3h4j_B          160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD  210 (336)
T ss_dssp             TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred             CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence            432  2234579999999999987765 7899999999999999999999964

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.3e-34  Score=306.71  Aligned_cols=198  Identities=22%  Similarity=0.396  Sum_probs=169.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ++|++.+.||+|+||+||+|... +++.||||++.....  .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888999999999999999975 688999999875432  334678899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++ ++.+.+....    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~~-~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSE-EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             cCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            9986 4555443322    26899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccccccccccccccchhhcccCC-CCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      ... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.|+.
T Consensus       154 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~  203 (292)
T 3o0g_A          154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             ccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence            322 223456899999999997765 7999999999999999999998864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.7e-34  Score=314.33  Aligned_cols=202  Identities=25%  Similarity=0.450  Sum_probs=171.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc-------
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-------  707 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~-------  707 (869)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457889999999999999999986 78999999987543 334578999999999999999999999986643       


Q ss_pred             --------------------------------------------------eEEEEEEeccCCchhhhhhcCCcccccCCC
Q 002899          708 --------------------------------------------------QLLLVYEYMKNNCLSRAIFGKDTEYRLKLD  737 (869)
Q Consensus       708 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~  737 (869)
                                                                        ..++||||+++|+|.+++.....  ....+
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~  162 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDRE  162 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSC
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchh
Confidence                                                              27999999999999999976543  23567


Q ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc-----------ccccccccc
Q 002899          738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-----------HISTRIAGT  806 (869)
Q Consensus       738 ~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt  806 (869)
                      +..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.......           .......||
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            8889999999999999999998   99999999999999999999999999987765421           112235699


Q ss_pred             ccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 002899          807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       807 ~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~  843 (869)
                      +.|+|||++.+..++.++||||||+++|||++|..|+
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred             cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence            9999999999999999999999999999999998765

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=4.5e-34  Score=340.73  Aligned_cols=322  Identities=20%  Similarity=0.214  Sum_probs=210.2

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      ..+++.|+|++|.+++..+..|.++++|++|+|++|.|+++.+..|..+ +|++|+|++|++++..|..|+++++|++|+
T Consensus        31 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~  110 (606)
T 3vq2_A           31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV  110 (606)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred             CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence            4567888888888887777788888888888888888887777777776 788888888888877777788888888888


Q ss_pred             ccccccCCCCCccccCCCCccEEEeecccccc-cCCccccCCCCCCeEeccCCcCCCCCcccc-----------------
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFI-----------------  193 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-----------------  193 (869)
                      |++|.+++..+..|+++++|++|+|++|++++ .+|..|.++++|++|+|++|++++..+..|                 
T Consensus       111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~  190 (606)
T 3vq2_A          111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL  190 (606)
T ss_dssp             CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred             ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence            88887776665667777777777777777765 456667777777777777666554322211                 


Q ss_pred             --------------------------------------------------------------------------------
Q 002899          194 --------------------------------------------------------------------------------  193 (869)
Q Consensus       194 --------------------------------------------------------------------------------  193 (869)
                                                                                                      
T Consensus       191 n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~  270 (606)
T 3vq2_A          191 NPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY  270 (606)
T ss_dssp             CCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECC
T ss_pred             CCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccc
Confidence                                                                                            


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q 002899          194 ----------------------------------------------------------------------------GKWK  197 (869)
Q Consensus       194 ----------------------------------------------------------------------------~~l~  197 (869)
                                                                                                  ..++
T Consensus       271 ~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~  350 (606)
T 3vq2_A          271 TNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALP  350 (606)
T ss_dssp             CTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCT
T ss_pred             cccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccCC
Confidence                                                                                        0112


Q ss_pred             cccEEEccCCcCC-------------------------------------------------CCch-HhhhcCCCCCEEE
Q 002899          198 KIQKLHIQGSSLE-------------------------------------------------GPIP-ASISALTSLTDLR  227 (869)
Q Consensus       198 ~L~~L~L~~N~l~-------------------------------------------------~~~~-~~l~~l~~L~~L~  227 (869)
                      +|+.|+|++|.++                                                 +..+ ..+..+++|+.|+
T Consensus       351 ~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~  430 (606)
T 3vq2_A          351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLD  430 (606)
T ss_dssp             TCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEE
T ss_pred             CCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEE
Confidence            2333333333322                                                 2222 2333344444444


Q ss_pred             cCCCCCCCCcccccc-cccceEEEcccccCcc-CCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCC
Q 002899          228 ISDLKGSESAFPKLD-KMNLKTLILTKCLIHG-EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT  305 (869)
Q Consensus       228 L~~n~~~~~~~~~~~-~~~L~~L~Ls~N~i~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  305 (869)
                      +++|.+.......+. ..+|+.|+|++|++++ .+|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+++
T Consensus       431 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  510 (606)
T 3vq2_A          431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL  510 (606)
T ss_dssp             CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             CcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCC
Confidence            444444332222222 2267777777777776 36777777888888888888888777777888888888888888888


Q ss_pred             CCCchhh--hccCCceeeeccCcc----------------CCCCCCCCCCCCCccceeccCCCCCCCCCCcCccCCCCCC
Q 002899          306 GPVPKYI--FNSNKNVDISLNNFT----------------WESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPC  367 (869)
Q Consensus       306 ~~~p~~~--~~~l~~l~ls~N~~~----------------~~~~~p~~C~c~~~~~~~~l~~~~~~~~~~~~~~~~~~~C  367 (869)
                      +..|..+  +..++.|+|++|+++                .+..|||.|+|++.|++.|++........     .....|
T Consensus       511 ~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~~~~~l~~~~~~~~~-----~~~~~C  585 (606)
T 3vq2_A          511 FLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWVKEQKQFLVN-----VEQMTC  585 (606)
T ss_dssp             CEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTTHHHHTTTTTSSSSBSS-----GGGCCC
T ss_pred             CcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCccHHHHHHHHcCcccccC-----Ccccee
Confidence            7777766  456778888888764                23467999999999999999765443322     245789


Q ss_pred             CCCcccccceee
Q 002899          368 SAPADQYHYTLH  379 (869)
Q Consensus       368 ~~p~~~~~~~~~  379 (869)
                      +.|+...++.+.
T Consensus       586 ~~p~~~~~~~l~  597 (606)
T 3vq2_A          586 ATPVEMNTSLVL  597 (606)
T ss_dssp             C-----------
T ss_pred             CCChHhCCCEee
Confidence            888877766543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.1e-34  Score=309.62  Aligned_cols=199  Identities=28%  Similarity=0.406  Sum_probs=167.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--------------------------hhhHHHHHHHHHHH
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------------------------QGNREFVNEIGMIS  689 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--------------------------~~~~~f~~E~~~l~  689 (869)
                      .++|++.+.||+|+||.||+|... +++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            357889999999999999999975 688999999865421                          11356889999999


Q ss_pred             hcCCCceeeEEeEEee--CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcC
Q 002899          690 AQQHPNLVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRD  767 (869)
Q Consensus       690 ~l~H~nIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~D  767 (869)
                      +++||||+++++++.+  .+..++||||+++++|.+++..      ..+++..+..++.|+++||+|||+++   |+|||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D  162 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRD  162 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence            9999999999999986  5688999999999999876532      26899999999999999999999998   99999


Q ss_pred             CCCCCEEEcCCCcEEEeecCCceeecCCCccccccccccccccchhhcccCC---CCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          768 IKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY---LTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       768 lk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      |||+|||++.++.+||+|||++......... .....||+.|+|||++....   .+.++||||||+++|||++|+.||.
T Consensus       163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCHHHEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            9999999999999999999999876543322 23457999999999987654   4789999999999999999999995


Q ss_pred             C
Q 002899          845 Y  845 (869)
Q Consensus       845 ~  845 (869)
                      .
T Consensus       242 ~  242 (298)
T 2zv2_A          242 D  242 (298)
T ss_dssp             C
T ss_pred             C
Confidence            4

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-34  Score=312.05  Aligned_cols=202  Identities=23%  Similarity=0.338  Sum_probs=174.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc--eEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~  713 (869)
                      ++|.+.++||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56888999999999999999976 58999999987543 233567889999999999999999999998765  789999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE----cCCCcEEEeecCCc
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLA  789 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl----~~~~~~kl~DFGla  789 (869)
                      ||+++|+|.+++.....  ...+++..+..++.|+++||+|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        89 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             ECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             eCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            99999999999976432  224899999999999999999999998   9999999999999    77888999999999


Q ss_pred             eeecCCCccccccccccccccchhhcc--------cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          790 KLYEEDKTHISTRIAGTIGYMAPEYAM--------RGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       790 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +.......  .....||+.|+|||++.        ...++.++|||||||++|||++|+.||...
T Consensus       164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  226 (319)
T 4euu_A          164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF  226 (319)
T ss_dssp             EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred             eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            87754432  22356899999999986        467899999999999999999999999653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.5e-34  Score=309.82  Aligned_cols=200  Identities=28%  Similarity=0.447  Sum_probs=170.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|++.+.||+|+||.||+|+..+++.||+|++.....  .....+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46888999999999999999998899999999865432  2246788999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++ +|.+++....    ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             CSE-EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             cCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            985 8888886542    25899999999999999999999998   999999999999999999999999999766432


Q ss_pred             Cccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (288)
T 1ob3_A          154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (288)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            22 1223468999999999875 45899999999999999999999999653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.9e-34  Score=330.32  Aligned_cols=205  Identities=29%  Similarity=0.421  Sum_probs=179.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .++|.+.++||+|+||.||+|+.. +|+.||+|++....   ......+..|++++++++||||+++++++...+..++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            357888899999999999999985 68999999986542   22346788999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++|+|.+++..... ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++..
T Consensus       264 mE~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             ECCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            999999999999876432 2236899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       340 ~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~  392 (543)
T 3c4z_A          340 KAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR  392 (543)
T ss_dssp             CTTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred             cCCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence            543322 23357999999999999999999999999999999999999999754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.9e-35  Score=333.81  Aligned_cols=200  Identities=28%  Similarity=0.363  Sum_probs=166.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .++|++.+.||+|+||.||+|... +++.||||+++..   .......+.+|+++++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            357889999999999999999975 6899999998753   233346678899999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      |||+++|+|.+++....     .+++..+..++.||++||+|||+ .+   |+||||||+|||++.++.+||+|||+++.
T Consensus       227 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EeeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            99999999999886543     68999999999999999999998 76   99999999999999999999999999975


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       299 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  351 (446)
T 4ejn_A          299 GIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  351 (446)
T ss_dssp             TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence            433222 22346799999999999999999999999999999999999999964

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1e-34  Score=316.43  Aligned_cols=201  Identities=23%  Similarity=0.399  Sum_probs=167.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce----
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ----  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~----  708 (869)
                      .++|++.+.||+|+||.||+|+. .+++.||||+++....   .....|.+|++++.+++||||+++++++...+.    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46788999999999999999997 4789999999976532   234578899999999999999999999876543    


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .++||||+++++|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  162 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI  162 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred             cEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence            499999999999999986542     6899999999999999999999998   99999999999999999999999999


Q ss_pred             ceeecCCCcc--ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          789 AKLYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       789 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +.........  ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  221 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG  221 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            9876543221  22235689999999999999999999999999999999999999964

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1e-34  Score=325.43  Aligned_cols=202  Identities=27%  Similarity=0.445  Sum_probs=175.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++|.+.+.||+|+||.||+|.+. +++.||||.++.... ....+|.+|++++++++||||+++++++..++..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467888999999999999999986 789999999876533 334578999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++|+|.+++....    ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       193 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             cCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            999999999986532    25899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcccc-ccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          795 DKTHIS-TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       795 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ...... ....+++.|+|||++....++.++|||||||++|||++ |+.||..
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~  318 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN  318 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            221111 11235778999999998899999999999999999998 9999864

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=3.6e-34  Score=350.37  Aligned_cols=277  Identities=30%  Similarity=0.496  Sum_probs=230.6

Q ss_pred             eEEEEeccCCCccccCCccccC--CCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           55 HVVTIALKAQNLTGTLPTELSK--LRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        55 ~v~~L~l~~~~l~~~~p~~l~~--l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      +++.|++++|.+++.+|..+..  +++|++|+|++|.+++.+|..+..+ +|+.|+|++|++++.+|..+..+++|+.|+
T Consensus       369 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  448 (768)
T 3rgz_A          369 SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK  448 (768)
T ss_dssp             TCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred             CCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEE
Confidence            3555555555555555555555  6677777777777777777777776 788888888888888888888888888888


Q ss_pred             ccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCC
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG  211 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  211 (869)
                      |++|.+++.+|..+..+++|++|+|++|++++.+|..+.++++|++|+|++|++++.+|..|+.+++|+.|+|++|++++
T Consensus       449 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  528 (768)
T 3rgz_A          449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG  528 (768)
T ss_dssp             CCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEE
T ss_pred             CCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccC
Confidence            88888888888888888889999999998888888888888899999999999988888888889999999999999988


Q ss_pred             CchHhhhcCCCCCEEEcCCCCCCCCccccc--------------------------------------------------
Q 002899          212 PIPASISALTSLTDLRISDLKGSESAFPKL--------------------------------------------------  241 (869)
Q Consensus       212 ~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~--------------------------------------------------  241 (869)
                      .+|..+..+++|+.|+|++|++....+..+                                                  
T Consensus       529 ~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  608 (768)
T 3rgz_A          529 NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS  608 (768)
T ss_dssp             ECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGG
T ss_pred             cCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccc
Confidence            888889999999999998887653221110                                                  


Q ss_pred             ---------------------ccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEee
Q 002899          242 ---------------------DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLT  300 (869)
Q Consensus       242 ---------------------~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  300 (869)
                                           ...+|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..|+++++|+.|||+
T Consensus       609 ~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs  688 (768)
T 3rgz_A          609 TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS  688 (768)
T ss_dssp             GTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred             cccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECC
Confidence                                 01368899999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCCCCCchhh--hccCCceeeeccCccCCCC
Q 002899          301 GNKLTGPVPKYI--FNSNKNVDISLNNFTWESS  331 (869)
Q Consensus       301 ~N~l~~~~p~~~--~~~l~~l~ls~N~~~~~~~  331 (869)
                      +|+++|.+|..+  +..++.|||++|++++..+
T Consensus       689 ~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP  721 (768)
T 3rgz_A          689 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP  721 (768)
T ss_dssp             SSCCEECCCGGGGGCCCCSEEECCSSEEEEECC
T ss_pred             CCcccCcCChHHhCCCCCCEEECcCCcccccCC
Confidence            999999999988  5578999999999987544

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.5e-34  Score=320.21  Aligned_cols=194  Identities=28%  Similarity=0.424  Sum_probs=168.5

Q ss_pred             CCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCch
Q 002899          643 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL  721 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL  721 (869)
                      .+.||+|+||.||+|... +|+.||+|+++.......+++.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            567999999999999975 6899999999876666677899999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE--cCCCcEEEeecCCceeecCCCccc
Q 002899          722 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKLYEEDKTHI  799 (869)
Q Consensus       722 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl--~~~~~~kl~DFGla~~~~~~~~~~  799 (869)
                      .+++....    ..+++..+..++.||++||+|||+.+   |+||||||+|||+  +.++.+||+|||+++.......  
T Consensus       174 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--  244 (373)
T 2x4f_A          174 FDRIIDES----YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--  244 (373)
T ss_dssp             HHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred             HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence            99886542    25899999999999999999999998   9999999999999  5678999999999987754332  


Q ss_pred             cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          800 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       800 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .....||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  290 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG  290 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            2234699999999999988999999999999999999999999964

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-34  Score=332.85  Aligned_cols=204  Identities=28%  Similarity=0.476  Sum_probs=177.2

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      +...++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|++++++++|||||++++++. .+..++||
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence            34456788899999999999999999888999999997643 34678999999999999999999999986 56789999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       262 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             CCCTTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             eecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            9999999999997542   225789999999999999999999997   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ...........+++.|+|||++....++.++|||||||++|||++ |+.||..
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~  388 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG  388 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence            322222223446789999999998999999999999999999999 9999964

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2e-34  Score=311.49  Aligned_cols=202  Identities=30%  Similarity=0.495  Sum_probs=172.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-----cCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-----~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~--~~~  709 (869)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.|.+|++++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            35788899999999999999985     25789999999877666678899999999999999999999998654  458


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||+++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             EEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence            99999999999999997653    25899999999999999999999997   999999999999999999999999999


Q ss_pred             eeecCCCc--cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKT--HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ........  .......++..|+|||++.+..++.++||||||+++|||++|+.|+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  219 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  219 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence            87654322  112234567789999999999999999999999999999999998753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4e-34  Score=317.01  Aligned_cols=198  Identities=29%  Similarity=0.420  Sum_probs=160.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++...  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4577899999999999999999986 57899999987543  34678899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCcEEEeecCCcee
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAKL  791 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~---~~~~kl~DFGla~~  791 (869)
                      |+++|+|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+|||++.   ++.+||+|||+++.
T Consensus       129 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG-----YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             CCCSCBHHHHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             eCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            999999999986543     5899999999999999999999998   999999999999975   89999999999986


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       201 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  252 (349)
T 2w4o_A          201 VEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD  252 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            64322  22345789999999999998999999999999999999999999964

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=8.6e-34  Score=303.52  Aligned_cols=199  Identities=24%  Similarity=0.372  Sum_probs=176.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ..++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            3467889999999999999999976 467899999987666667889999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE---cCCCcEEEeecCCcee
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKL  791 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl---~~~~~~kl~DFGla~~  791 (869)
                      |+++++|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||+   +.++.+||+|||++..
T Consensus        87 ~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           87 LCTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             CCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ccCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            999999999886542     5899999999999999999999998   9999999999999   7889999999999987


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......  .....||+.|+|||++.+. ++.++||||||+++|||++|+.||..
T Consensus       159 ~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~  209 (277)
T 3f3z_A          159 FKPGKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA  209 (277)
T ss_dssp             CCTTSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCC
Confidence            654332  2345689999999988654 89999999999999999999999965

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.8e-34  Score=344.12  Aligned_cols=309  Identities=21%  Similarity=0.292  Sum_probs=206.6

Q ss_pred             EEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCc-hhhcCcccccccccc
Q 002899           56 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFP-KVLTNITTLKNLSIE  133 (869)
Q Consensus        56 v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls  133 (869)
                      ++.|++++|.++ .+|..+.++++|++|+|++|.+++..+..+..+ +|++|+|++|.+.+.++ ..+..+++|++|+|+
T Consensus       280 L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~  358 (606)
T 3t6q_A          280 LQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLS  358 (606)
T ss_dssp             CSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECC
T ss_pred             CCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECC
Confidence            444444444444 344444444445555555554444444444444 45555555555443332 235555555555565


Q ss_pred             ccccCCCC--CccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCcc-ccCCCCcccEEEccCCcCC
Q 002899          134 GNLFTGSI--PPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE-FIGKWKKIQKLHIQGSSLE  210 (869)
Q Consensus       134 ~N~l~~~~--~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~  210 (869)
                      +|.+++..  +..+..+++|++|+|++|++.+..|..|..+++|++|+|++|++++..+. .|..+++|+.|+|++|.++
T Consensus       359 ~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~  438 (606)
T 3t6q_A          359 HDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD  438 (606)
T ss_dssp             SSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCB
T ss_pred             CCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccC
Confidence            55555443  44566666666666666666666666666777777777777777655443 3677777777777777777


Q ss_pred             CCchHhhhcCCCCCEEEcCCCCCCCCcc---ccc-ccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCch
Q 002899          211 GPIPASISALTSLTDLRISDLKGSESAF---PKL-DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT  286 (869)
Q Consensus       211 ~~~~~~l~~l~~L~~L~L~~n~~~~~~~---~~~-~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  286 (869)
                      +..|..+..+++|+.|+|++|++.....   ..+ ...+|+.|+|++|++++..|..|..+++|+.|+|++|++++..|.
T Consensus       439 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  518 (606)
T 3t6q_A          439 ISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE  518 (606)
T ss_dssp             TTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGG
T ss_pred             CcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChh
Confidence            7777777777888888888877765322   122 233788888888888888888888888888888888888888888


Q ss_pred             hhhcCCCCCEEEeeCCcCCCCCchhh--hccCCceeeeccCccCCCCCCCCCCCCCccceeccCCCCCCCCCCcCccCCC
Q 002899          287 TFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN  364 (869)
Q Consensus       287 ~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~~~~~l~~~~~~~~~~~~~~~~~  364 (869)
                      .+..+++| .|+|++|++++..|..+  +..++.+++++|        ||.|+|...|++.|++.....+..     ...
T Consensus       519 ~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N--------~~~c~c~~~~~~~w~~~~~~~~~~-----~~~  584 (606)
T 3t6q_A          519 ALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQN--------PLDCTCSNIYFLEWYKENMQKLED-----TED  584 (606)
T ss_dssp             GGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTC--------CEECSGGGHHHHHHHHHCGGGEEC-----GGG
T ss_pred             HhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCC--------CccccCCcHHHHHHHHhCcccccC-----CCC
Confidence            88888888 88888888887777665  567888888888        999999999999999765433321     245


Q ss_pred             CCCCCCcccccceee
Q 002899          365 FPCSAPADQYHYTLH  379 (869)
Q Consensus       365 ~~C~~p~~~~~~~~~  379 (869)
                      ..|+.|+..+|+.+.
T Consensus       585 ~~C~~p~~~~g~~l~  599 (606)
T 3t6q_A          585 TLCENPPLLRGVRLS  599 (606)
T ss_dssp             CBEEESGGGTTCBGG
T ss_pred             CeeCCchHhCCCeee
Confidence            689999888776544

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.1e-34  Score=332.77  Aligned_cols=204  Identities=26%  Similarity=0.452  Sum_probs=178.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~~-g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ..++|++.+.||+|+||.||+|.+.. +..||||+++... ...++|.+|++++++++|||||++++++...+..++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            34568888999999999999999874 7899999997643 346789999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++|+|.+++.....   ..+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       297 ~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          297 FMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             CCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             ccCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            9999999999975432   25899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      ..........+++.|+|||++....++.++|||||||++|||++ |+.||...
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~  423 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI  423 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence            33322233456789999999998899999999999999999999 99998653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2e-34  Score=320.60  Aligned_cols=217  Identities=27%  Similarity=0.406  Sum_probs=182.3

Q ss_pred             cccHHHHHHHhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCc-hhhHHHHHHHHHHHhc-CCCceee
Q 002899          627 LYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVK  698 (869)
Q Consensus       627 ~~~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~  698 (869)
                      .+...+++...++|.+.+.||+|+||.||+|.+.      +++.||||+++.... ...+.+.+|++++.++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            3455666677889999999999999999999842      457899999976533 3456799999999999 8999999


Q ss_pred             EEeEEeeCce-EEEEEEeccCCchhhhhhcCCccc---------------------------------------------
Q 002899          699 LYGCCVEGNQ-LLLVYEYMKNNCLSRAIFGKDTEY---------------------------------------------  732 (869)
Q Consensus       699 l~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~~---------------------------------------------  732 (869)
                      +++++.+.+. .++||||+++|+|.+++.......                                             
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999987654 899999999999999997654210                                             


Q ss_pred             ----------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          733 ----------------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       733 ----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                                      ...+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            112899999999999999999999998   9999999999999999999999999998664332


Q ss_pred             c-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          797 T-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       797 ~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      . .......||+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  299 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  299 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence            2 22334568899999999999999999999999999999998 99999653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-33  Score=318.02  Aligned_cols=204  Identities=18%  Similarity=0.276  Sum_probs=176.4

Q ss_pred             hcCCCCCCeeecc--CceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          637 TNNFDPANKVGEG--GFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G--~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      .++|++.++||+|  +||.||+|+.. +++.||||++....  ....+.+.+|+++++.++|||||++++++.+++..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4578899999999  99999999986 68999999987543  3335678889999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+++.....   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||.+..
T Consensus       104 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence            9999999999999876422   25899999999999999999999998   99999999999999999999999999875


Q ss_pred             ecCCCc------cccccccccccccchhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          792 YEEDKT------HISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       792 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ......      .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence            532211      11122468999999999987  57899999999999999999999999653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.9e-34  Score=319.97  Aligned_cols=202  Identities=28%  Similarity=0.470  Sum_probs=164.0

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCc--e
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN--Q  708 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~--~  708 (869)
                      ...++|++.+.||+|+||.||+|... +++.||||++...  .....+++.+|+.++..+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34678999999999999999999975 6899999998643  3344567889999999997 999999999997644  6


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .|+||||++ |+|.+.+...      .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~  155 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGL  155 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcc
Confidence            899999998 5888888653      5899999999999999999999998   99999999999999999999999999


Q ss_pred             ceeecCCC--------------------ccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          789 AKLYEEDK--------------------THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       789 a~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ++......                    .......+||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence            98753211                    111233579999999999876 67899999999999999999999999654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-34  Score=318.02  Aligned_cols=202  Identities=27%  Similarity=0.385  Sum_probs=174.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE----cCCcEEEEEEecccC----chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCc
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN  707 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~----~~g~~VAvK~~~~~~----~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~  707 (869)
                      .++|++.+.||+|+||.||+|+.    .+++.||||+++...    ......+.+|++++..+ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            35788999999999999999997    368999999986542    22345677899999999 6999999999999999


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                      ..++||||+++|+|.+++....     .+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCC
Confidence            9999999999999999986542     5899999999999999999999998   9999999999999999999999999


Q ss_pred             CceeecCCCccccccccccccccchhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +++..............||+.|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  265 (355)
T 1vzo_A          205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  265 (355)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence            998765443333445679999999999985  35789999999999999999999999753

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.8e-34  Score=311.11  Aligned_cols=191  Identities=27%  Similarity=0.380  Sum_probs=151.7

Q ss_pred             CCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceEEEEEEeccCCc
Q 002899          643 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYMKNNC  720 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~~~~gs  720 (869)
                      .+.||+|+||.||+|... +++.||||++...   ....+.+|++++..+. ||||+++++++.+++..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999975 6899999998643   3467788999999997 9999999999999999999999999999


Q ss_pred             hhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC---cEEEeecCCceeecCCCc
Q 002899          721 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       721 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~---~~kl~DFGla~~~~~~~~  797 (869)
                      |.+++....     .+++..+..++.|+++||+|||+++   |+||||||+|||++.++   .+||+|||+++.......
T Consensus        93 L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  164 (325)
T 3kn6_A           93 LFERIKKKK-----HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ  164 (325)
T ss_dssp             HHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred             HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence            999997643     6899999999999999999999998   99999999999998765   899999999987654332


Q ss_pred             cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      . .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       165 ~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  211 (325)
T 3kn6_A          165 P-LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS  211 (325)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred             c-ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence            2 2335689999999999999999999999999999999999999965

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.4e-34  Score=316.81  Aligned_cols=209  Identities=26%  Similarity=0.344  Sum_probs=180.8

Q ss_pred             CcccHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcC-----CCceeeE
Q 002899          626 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----HPNLVKL  699 (869)
Q Consensus       626 ~~~~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~-----H~nIv~l  699 (869)
                      ..++.++.....++|.+.++||+|+||.||+|+.. +++.||||+++.. ....+.+..|++++..++     ||||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            34455555566789999999999999999999974 6889999998643 334567788999999886     9999999


Q ss_pred             EeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC--
Q 002899          700 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK--  777 (869)
Q Consensus       700 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~--  777 (869)
                      ++++...+..++||||+ +++|.+++.....   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.  
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY  174 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence            99999999999999999 8999999876532   25899999999999999999999998   999999999999975  


Q ss_pred             -----------------------CCcEEEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHH
Q 002899          778 -----------------------DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTL  834 (869)
Q Consensus       778 -----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~  834 (869)
                                             ++.+||+|||++.......    ....||+.|+|||++.+..++.++|||||||++|
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  250 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA  250 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence                                   7899999999998654322    2457899999999999999999999999999999


Q ss_pred             HHHcCCCCCCCC
Q 002899          835 EIVSGKSNTNYR  846 (869)
Q Consensus       835 elltG~~p~~~~  846 (869)
                      ||++|+.||...
T Consensus       251 ell~g~~pf~~~  262 (360)
T 3llt_A          251 ELYTGSLLFRTH  262 (360)
T ss_dssp             HHHHSSCSCCCS
T ss_pred             HHHHCCCCCCCC
Confidence            999999999653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.2e-34  Score=309.00  Aligned_cols=197  Identities=28%  Similarity=0.355  Sum_probs=165.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .++|++.++||+|+||+||+|+.. +++.||||++.....  ....++..|+..+.++ +||||+++++++.+++..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            467999999999999999999986 789999999865432  2334555666555554 999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+ +++|.+++....    ..++|..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       136 ~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             Eecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            9999 668888876543    26899999999999999999999997   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      ....  ......||+.|+|||++.+ .++.++|||||||++|||++|+.|+.
T Consensus       208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~  256 (311)
T 3p1a_A          208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH  256 (311)
T ss_dssp             C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred             ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            5432  2234568999999998875 78999999999999999999977663

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-33  Score=306.49  Aligned_cols=201  Identities=26%  Similarity=0.394  Sum_probs=170.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ++|++.+.||+|+||.||+|... +++.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57889999999999999999986 589999998865433  234668899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++++|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~~~~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           83 YCDHTVLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             CCSEEHHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eCCCchHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            999999988876543     5899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      .... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus       155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  207 (311)
T 4agu_A          155 PSDY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS  207 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            3222 233568999999999876 578999999999999999999999996543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-34  Score=315.40  Aligned_cols=208  Identities=31%  Similarity=0.479  Sum_probs=177.3

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN  707 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~  707 (869)
                      ...++|++.+.||+|+||.||+|+..      +++.||||+++.... ...+.|.+|++++++++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34678999999999999999999975      347899999976533 33567999999999999999999999999999


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcc-------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTE-------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI  768 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl  768 (869)
                      ..++||||+++|+|.+++......                   ....+++..++.++.||++||+|||+++   |+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            999999999999999998764211                   1146899999999999999999999998   999999


Q ss_pred             CCCCEEEcCCCcEEEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          769 KTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       769 k~~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ||+|||++.++.+||+|||++........ .......+|+.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            99999999999999999999976543221 12223567889999999998899999999999999999999 9999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.9e-34  Score=305.14  Aligned_cols=202  Identities=28%  Similarity=0.402  Sum_probs=162.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC----CcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~----g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      .++|++.+.||+|+||.||+|....    +..||+|+++... ....+.|.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4578889999999999999999743    4579999987643 334567899999999999999999999984 567899


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        93 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence            999999999999996543    25899999999999999999999998   99999999999999999999999999987


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      .............+++.|+|||++....++.++||||||+++|||++ |+.||...
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~  221 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV  221 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence            75443322333456789999999998899999999999999999997 99999653

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=100.00  E-value=6.3e-34  Score=326.97  Aligned_cols=305  Identities=15%  Similarity=0.176  Sum_probs=213.1

Q ss_pred             cceEecCCCCcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhh
Q 002899           43 SNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVL  121 (869)
Q Consensus        43 ~~v~C~~~~~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~  121 (869)
                      |+-.|.|...   ...+++.+.+++ .+|..+.  ++|+.|+|++|+|+++.+..|..+ +|++|+|++|+++++.+..|
T Consensus        46 Cp~~C~C~~~---~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~  119 (452)
T 3zyi_A           46 CPSVCSCSNQ---FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAF  119 (452)
T ss_dssp             CCTTSEECSS---SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTT
T ss_pred             CCCCCEECCC---CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhc
Confidence            4445666432   345778888888 5676654  688888888888887777777766 67777777777777777777


Q ss_pred             cCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccC-CcCCCCCccccCCCCccc
Q 002899          122 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD-NNFSGKIPEFIGKWKKIQ  200 (869)
Q Consensus       122 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~  200 (869)
                      .++++|++|+|++|+|+...+..|..+++|++|+|++|+|+...+..|.++++|+.|+|++ |.+....+..|.++++|+
T Consensus       120 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~  199 (452)
T 3zyi_A          120 NGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLK  199 (452)
T ss_dssp             TTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCC
T ss_pred             cCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCC
Confidence            7777777777777777766556677777777777777777765556677777777777776 444444444566677777


Q ss_pred             EEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCC
Q 002899          201 KLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNL  280 (869)
Q Consensus       201 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l  280 (869)
                      .|+|++|++++. | .+..++                       +|+.|+|++|+|++..|..|..+++|+.|+|++|+|
T Consensus       200 ~L~L~~n~l~~~-~-~~~~l~-----------------------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l  254 (452)
T 3zyi_A          200 YLNLGMCNIKDM-P-NLTPLV-----------------------GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV  254 (452)
T ss_dssp             EEECTTSCCSSC-C-CCTTCT-----------------------TCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCC
T ss_pred             EEECCCCccccc-c-cccccc-----------------------cccEEECcCCcCcccCcccccCccCCCEEEeCCCcC
Confidence            777777766643 2 234444                       455556667777777777788888888888888888


Q ss_pred             CCCCchhhhcCCCCCEEEeeCCcCCCCCchhh--hccCCceeeeccCccCCCCCCCCCCCCCccceeccCCCCCCCCCCc
Q 002899          281 TGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH  358 (869)
Q Consensus       281 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~~~~~l~~~~~~~~~~~  358 (869)
                      ++..|..|..+++|+.|+|++|+|++..+..+  +..++.|+|++|        ||.|||++.|+..|++......    
T Consensus       255 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N--------p~~CdC~~~~l~~~l~~~~~~~----  322 (452)
T 3zyi_A          255 SLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN--------PWNCDCDILWLAWWLREYIPTN----  322 (452)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSS--------CEECSTTTHHHHHHHHHHC-------
T ss_pred             ceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCC--------CcCCCCCchHHHHHHHHhCccC----
Confidence            87777778888888888888888875555444  456777888888        9999999999999987532111    


Q ss_pred             CccCCCCCCCCCcccccceee------eecCCcceecCCc
Q 002899          359 PCLRQNFPCSAPADQYHYTLH------INCGGAKINTGHT  392 (869)
Q Consensus       359 ~~~~~~~~C~~p~~~~~~~~~------~~c~~~~~~~~~~  392 (869)
                        ......|+.|...+++.+.      ..|..|.+.....
T Consensus       323 --~~~~~~C~~P~~l~g~~l~~~~~~~~~C~~P~i~~~~~  360 (452)
T 3zyi_A          323 --STCCGRCHAPMHMRGRYLVEVDQASFQCSAPFIMDAPR  360 (452)
T ss_dssp             --CCSSCBEEESTTTTTCBTTSCCGGGCCCCCCCCSBCCC
T ss_pred             --CccCcEeCCchHhccchhhccchhhhcccCcccccccc
Confidence              1123579899888876543      4688777654433

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.5e-34  Score=313.67  Aligned_cols=209  Identities=25%  Similarity=0.409  Sum_probs=175.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ..++|++.+.||+|+||.||+|... +++.||||+++....    .+.+|++++.++ +||||+++++++.+++..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4567999999999999999999976 688999999965432    345688888877 7999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC----CcEEEeecCCc
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD----LNAKISDFGLA  789 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~----~~~kl~DFGla  789 (869)
                      ||+++|+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||+..+    +.+||+|||++
T Consensus        96 E~~~gg~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK-----FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             CCCCSCBHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            9999999999986643     5899999999999999999999998   9999999999998543    35999999999


Q ss_pred             eeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHH
Q 002899          790 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDW  857 (869)
Q Consensus       790 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w  857 (869)
                      ........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....+....+.+.
T Consensus       168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~  234 (342)
T 2qr7_A          168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR  234 (342)
T ss_dssp             EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH
T ss_pred             ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH
Confidence            87654332 22345789999999999888889999999999999999999999975443344444333

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.3e-34  Score=303.18  Aligned_cols=201  Identities=30%  Similarity=0.534  Sum_probs=176.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .++|++.+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            356788899999999999999998889999999976543 3467899999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++....    ..+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           86 EHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             TTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc
Confidence            9999999996543    25899999999999999999999998   9999999999999999999999999998664322


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ........+++.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  208 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN  208 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence            222233457789999999998899999999999999999999 8999864

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.3e-33  Score=302.09  Aligned_cols=201  Identities=21%  Similarity=0.304  Sum_probs=175.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....  ....+.+|++++..+ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            45788999999999999999996 478999999986432  345688999999998 89999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc-----EEEeecCCc
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-----AKISDFGLA  789 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~-----~kl~DFGla  789 (869)
                      |+ +++|.+++....    ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.     +||+|||++
T Consensus        87 ~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           87 LL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             ec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            99 999999997543    25899999999999999999999987   999999999999988776     999999999


Q ss_pred             eeecCCCcc------ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          790 KLYEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       790 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      .........      ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  222 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  222 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence            877543321      1234579999999999999899999999999999999999999997644

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-33  Score=308.63  Aligned_cols=207  Identities=30%  Similarity=0.470  Sum_probs=177.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE------cCCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~------~~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~  709 (869)
                      .++|.+.+.||+|+||.||+|..      .+++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            56788899999999999999986      235789999997653 34457789999999999999999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCcc-------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCC
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTE-------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKT  770 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~  770 (869)
                      ++||||+++|+|.+++......                   ....+++..+..++.||++||+|||+++   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            9999999999999999764321                   1124899999999999999999999998   99999999


Q ss_pred             CCEEEcCCCcEEEeecCCceeecCCCccc-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          771 SNVLLDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       771 ~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      +|||++.++.+||+|||++.......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999998765433221 223456789999999998889999999999999999999 99999654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.7e-33  Score=322.92  Aligned_cols=198  Identities=30%  Similarity=0.480  Sum_probs=172.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc-eEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-QLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~E~  715 (869)
                      .++|++.+.||+|+||.||+|.+. ++.||||+++...  ..+.|.+|++++++++|||||++++++.+.+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            457888899999999999999985 7899999997643  4678999999999999999999999987765 78999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++|+|.+++.....   ..+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       269 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             CTTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             cCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            999999999975432   24799999999999999999999998   999999999999999999999999999855322


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP  847 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~  847 (869)
                      .    ....+++.|+|||++....++.++|||||||++|||++ |+.||....
T Consensus       343 ~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~  391 (450)
T 1k9a_A          343 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  391 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred             c----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            1    12356889999999999999999999999999999998 999996543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-33  Score=317.89  Aligned_cols=206  Identities=29%  Similarity=0.431  Sum_probs=177.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc--------CCcEEEEEEecccCc-hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG  706 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~--------~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~  706 (869)
                      .++|.+.+.||+|+||.||+|+..        .+..||||+++.... ...+++.+|+++++++ +||||+++++++..+
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            467888999999999999999862        235799999976533 3457789999999999 999999999999999


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL  775 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  775 (869)
                      +..++||||+++|+|.+++......           ....+++..+..++.||++||+|||+.+   |+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            9999999999999999999765321           1235899999999999999999999997   9999999999999


Q ss_pred             cCCCcEEEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          776 DKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       776 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~  296 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  296 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999987654322 22233457889999999999999999999999999999999 9999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-33  Score=307.59  Aligned_cols=203  Identities=29%  Similarity=0.468  Sum_probs=169.1

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCc-----hhhHHHHHHHHHHHhc---CCCceeeEEeEEee
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR-----QGNREFVNEIGMISAQ---QHPNLVKLYGCCVE  705 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~-----~~~~~f~~E~~~l~~l---~H~nIv~l~~~~~~  705 (869)
                      ..+++|++.+.||+|+||+||+|+. .+++.||||++.....     .....+.+|+++++++   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3467899999999999999999996 4689999999864321     1234566777776665   59999999999987


Q ss_pred             Cc-----eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 002899          706 GN-----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN  780 (869)
Q Consensus       706 ~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~  780 (869)
                      ..     ..++||||++ |+|.+++.....   ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSC
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCC
Confidence            55     5799999998 599998876532   24899999999999999999999998   999999999999999999


Q ss_pred             EEEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          781 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       781 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +||+|||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       159 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  222 (308)
T 3g33_A          159 VKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  222 (308)
T ss_dssp             EEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred             EEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999998664332  223457899999999999999999999999999999999999999653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.9e-34  Score=312.81  Aligned_cols=202  Identities=29%  Similarity=0.538  Sum_probs=167.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~----~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  710 (869)
                      .++|++.++||+|+||.||+|++. +++    +||+|.+.... ....++|.+|++++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            356888999999999999999964 343    46888876443 344678999999999999999999999998764 78


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      +|+||+++|+|.+++....    ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        93 ~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             EEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCccee
Confidence            9999999999999997643    26899999999999999999999997   9999999999999999999999999998


Q ss_pred             eecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          791 LYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       791 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      ........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  223 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI  223 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence            76543322 1223456889999999999999999999999999999999 99999654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.7e-34  Score=309.15  Aligned_cols=205  Identities=26%  Similarity=0.445  Sum_probs=180.4

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ...++|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            34667889999999999999999986 4788999998754 334678999999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++++|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        89 e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             ECCTTEEHHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             EcCCCCcHHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            99999999999976432   36899999999999999999999998   9999999999999999999999999998776


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      ...........+|+.|+|||++....++.++||||||+++|||++ |+.||...
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~  216 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI  216 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            544333344567889999999998999999999999999999999 99998653

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.8e-33  Score=308.16  Aligned_cols=199  Identities=27%  Similarity=0.368  Sum_probs=176.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch------hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~------~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~  709 (869)
                      .++|++.+.||+|+||.||+|... +++.||||++......      ...++.+|+++++.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467889999999999999999976 6899999998654322      256789999999999999999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC----cEEEee
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISD  785 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~----~~kl~D  785 (869)
                      ++||||+++++|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++    .+||+|
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence            99999999999999996543     5789999999999999999999998   99999999999999887    799999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ||++........  .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       163 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  220 (321)
T 2a2a_A          163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  220 (321)
T ss_dssp             CTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence            999987654322  2345689999999999988999999999999999999999999964

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-34  Score=321.37  Aligned_cols=206  Identities=31%  Similarity=0.406  Sum_probs=174.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccc-CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~  709 (869)
                      .++|++.+.||+|+||.||+|++.      +++.||||+++.. ......++.+|+.++++++||||+++++++...+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            356888999999999999999953      4678999999754 344456789999999999999999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCc--ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC---cEEEe
Q 002899          710 LLVYEYMKNNCLSRAIFGKDT--EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKIS  784 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~---~~kl~  784 (869)
                      ++||||+++|+|.+++.....  .....+++..++.++.||++||+|||+++   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999875432  12235899999999999999999999998   99999999999999555   59999


Q ss_pred             ecCCceeecCCC-ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          785 DFGLAKLYEEDK-THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       785 DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      |||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~  289 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS  289 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999997653222 122223567899999999999999999999999999999998 9999964

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.3e-34  Score=314.26  Aligned_cols=210  Identities=24%  Similarity=0.323  Sum_probs=173.4

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc-----CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC
Q 002899          633 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG  706 (869)
Q Consensus       633 i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~-----~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~  706 (869)
                      +....++|++.+.||+|+||.||+|... +++.||+|++...     .....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            3556788999999999999999999975 6789999998643     234457899999999999999999999999999


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCc-----------------------------------ccccCCCHHHHHHHHHHHHHH
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDT-----------------------------------EYRLKLDWPTRKKICIGIARG  751 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~-----------------------------------~~~~~l~~~~~~~i~~~ia~g  751 (869)
                      +..++||||+++|+|.+++.....                                   .....+++..+..++.||++|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999998852100                                   001134677888999999999


Q ss_pred             HHHHHhcCCCCeEEcCCCCCCEEEcCCC--cEEEeecCCceeecCCCc---cccccccccccccchhhccc--CCCCchh
Q 002899          752 LAYLHEDSRIKIVHRDIKTSNVLLDKDL--NAKISDFGLAKLYEEDKT---HISTRIAGTIGYMAPEYAMR--GYLTSKA  824 (869)
Q Consensus       752 L~yLH~~~~~~iiH~Dlk~~NILl~~~~--~~kl~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~k~  824 (869)
                      |+|||+.+   |+||||||+|||++.++  .+||+|||++..+.....   .......||+.|+|||++..  ..++.++
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999998   99999999999998776  899999999987643221   12234578999999999875  6789999


Q ss_pred             HHHHHHHHHHHHHcCCCCCCC
Q 002899          825 DVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       825 DvwSlGvil~elltG~~p~~~  845 (869)
                      ||||||+++|||++|+.||..
T Consensus       258 DiwslG~il~el~~g~~pf~~  278 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPG  278 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHHHHHHHHHHHHCCCCCCC
Confidence            999999999999999999964

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.6e-33  Score=305.05  Aligned_cols=196  Identities=29%  Similarity=0.457  Sum_probs=166.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHh--cCCCceeeEEeEEee----CceEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVE----GNQLL  710 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~--l~H~nIv~l~~~~~~----~~~~~  710 (869)
                      .++|++.+.||+|+||.||+|+. +++.||||++...   ....+..|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            56789999999999999999988 6899999998643   34566677777766  799999999998765    34689


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEcCCCCCCEEEcCCCcEE
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH--------EDSRIKIVHRDIKTSNVLLDKDLNAK  782 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiH~Dlk~~NILl~~~~~~k  782 (869)
                      +||||+++|+|.+++...      .+++..+..++.|+++||+|||        +.+   |+||||||+|||++.++.+|
T Consensus        83 lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred             EehhhccCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence            999999999999999543      5899999999999999999999        665   99999999999999999999


Q ss_pred             EeecCCceeecCCCccc---cccccccccccchhhcccC------CCCchhHHHHHHHHHHHHHcC----------CCCC
Q 002899          783 ISDFGLAKLYEEDKTHI---STRIAGTIGYMAPEYAMRG------YLTSKADVYSFGVVTLEIVSG----------KSNT  843 (869)
Q Consensus       783 l~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlGvil~elltG----------~~p~  843 (869)
                      |+|||+++.........   .....||+.|+|||++.+.      .+++++||||||+++|||++|          +.||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            99999998765443321   2234799999999999876      455799999999999999999          8888


Q ss_pred             CC
Q 002899          844 NY  845 (869)
Q Consensus       844 ~~  845 (869)
                      ..
T Consensus       234 ~~  235 (301)
T 3q4u_A          234 YD  235 (301)
T ss_dssp             TT
T ss_pred             cc
Confidence            54

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.5e-33  Score=300.93  Aligned_cols=199  Identities=26%  Similarity=0.424  Sum_probs=175.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            578899999999999999999975 58899999986543  334567889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc---EEEeecCCce
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKISDFGLAK  790 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~---~kl~DFGla~  790 (869)
                      ||+++++|.+.+....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||++.
T Consensus        85 e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             ecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            9999999988886542     5899999999999999999999998   999999999999986655   9999999998


Q ss_pred             eecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          791 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .......  .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  209 (284)
T 3kk8_A          157 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  209 (284)
T ss_dssp             ECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC
Confidence            7654332  2335789999999999999999999999999999999999999954

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.3e-33  Score=314.43  Aligned_cols=199  Identities=26%  Similarity=0.370  Sum_probs=165.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467889999999999999999976 78999999987543 2346788999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc--EEEeecCCceeec
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN--AKISDFGLAKLYE  793 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~--~kl~DFGla~~~~  793 (869)
                      +++|+|.+++....     .+++..+..++.|+++||+|||+++   |+||||||+|||++.++.  +||+|||+++...
T Consensus        98 ~~~~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           98 ASGGELYERICNAG-----RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            99999999886543     5899999999999999999999998   999999999999987765  9999999987543


Q ss_pred             CCCccccccccccccccchhhcccCCCCch-hHHHHHHHHHHHHHcCCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSK-ADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ...  ......||+.|+|||++.+..+..+ +|||||||++|||++|+.||...
T Consensus       170 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  221 (361)
T 3uc3_A          170 LHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP  221 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred             ccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence            222  1233569999999999988777665 89999999999999999999753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-33  Score=301.68  Aligned_cols=198  Identities=31%  Similarity=0.566  Sum_probs=163.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCc----hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR----QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~----~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|... ++.||||+++....    ...+.+.+|+++++.++||||+++++++.+++..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57888999999999999999975 88999999865432    22467889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC--------CCcEEEee
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK--------DLNAKISD  785 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~--------~~~~kl~D  785 (869)
                      ||+++++|.+++...      .+++..+..++.|+++||+|||+++..+|+||||||+|||++.        ++.+||+|
T Consensus        86 e~~~~~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           86 EFARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             ECCTTEEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EcCCCCCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            999999999988543      5899999999999999999999987556899999999999986        77899999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ||++........   ....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  216 (271)
T 3dtc_A          160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG  216 (271)
T ss_dssp             CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999986654322   234689999999999999999999999999999999999999964

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4e-34  Score=328.24  Aligned_cols=202  Identities=31%  Similarity=0.524  Sum_probs=170.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ..++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|++++++++||||+++++++.+ +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            456788899999999999999999888889999997643 335689999999999999999999999876 678999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++|+|.+++....   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       260 ~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          260 MSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             CTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             hcCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            99999999996432   225899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .........+++.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~  384 (452)
T 1fmk_A          334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  384 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence            3222233456789999999998999999999999999999999 9999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-33  Score=324.07  Aligned_cols=198  Identities=29%  Similarity=0.478  Sum_probs=175.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|.+.+.||+|+||.||+|+.. +|+.||||++.....   .....+.+|+++++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56888999999999999999976 789999999865421   23457889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        96 E~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           96 EYVSGGELFDYICKNG-----RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             ECCSSEEHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            9999999999986543     6899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccccccchhhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...  ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||..
T Consensus       168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~  218 (476)
T 2y94_A          168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD  218 (476)
T ss_dssp             TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence            432  2234579999999999987654 7899999999999999999999964

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-33  Score=302.18  Aligned_cols=201  Identities=31%  Similarity=0.533  Sum_probs=175.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .++|++.+.||+|+||.||+|...+++.||||.++... ...+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            45788899999999999999999888899999987543 335789999999999999999999999864 5689999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++++|.+++....   ...+++..+..++.|++.||+|||+++   |+||||||+||++++++.+||+|||++.......
T Consensus        90 ~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           90 ENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             TTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             CCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            9999999986432   226899999999999999999999998   9999999999999999999999999998776543


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ........+++.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  213 (279)
T 1qpc_A          164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG  213 (279)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence            333333457789999999998889999999999999999999 9999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=9.8e-34  Score=339.60  Aligned_cols=201  Identities=27%  Similarity=0.380  Sum_probs=176.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~  710 (869)
                      ..++|++.++||+|+||.||+|+.. +++.||||+++..   .......+..|.+++..+ +||+|+++++++.+.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3568999999999999999999976 5789999998753   223356678899999887 7999999999999999999


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      +||||+++|+|.+++....     .+++..++.++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++
T Consensus       419 lV~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             EEEeCcCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence            9999999999999997543     6899999999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          791 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       491 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~  544 (674)
T 3pfq_A          491 ENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  544 (674)
T ss_dssp             ECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC
Confidence            6443222 23346799999999999999999999999999999999999999965

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.7e-34  Score=310.80  Aligned_cols=202  Identities=29%  Similarity=0.465  Sum_probs=170.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~----~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ++|++.+.||+|+||.||+|.+. +++    +||+|.+.... ......+.+|+.++++++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            56788999999999999999965 344    37888875443 333467889999999999999999999986 457899


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        92 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence            999999999999997642    25889999999999999999999998   99999999999999999999999999987


Q ss_pred             ecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 002899          792 YEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP  847 (869)
Q Consensus       792 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~  847 (869)
                      ....... ......||+.|+|||++....++.++||||||+++|||++ |+.||....
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  222 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR  222 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence            6543322 2234567889999999998999999999999999999999 999997543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.2e-34  Score=311.71  Aligned_cols=200  Identities=24%  Similarity=0.415  Sum_probs=165.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|.+.+.||+|+||.||+|... +++.||||++...... ....+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888999999999999999976 6899999998654322 223566799999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      ++ |+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           82 LD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             CS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            98 58888876543    25899999999999999999999998   999999999999999999999999999865433


Q ss_pred             Cccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (324)
T 3mtl_A          154 TKT-YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS  204 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccc-cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            222 223468999999999876 56899999999999999999999999654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.3e-34  Score=326.13  Aligned_cols=197  Identities=26%  Similarity=0.354  Sum_probs=165.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------c
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------N  707 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~------~  707 (869)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .....+++.+|+++++.++|||||++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            467899999999999999999965 6889999998754  334456788999999999999999999999754      4


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                      ..++||||++++ +.+.+..       .+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             eEEEEEeCCCCC-HHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEE
Confidence            579999999865 5555532       4789999999999999999999998   9999999999999999999999999


Q ss_pred             CceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +++......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~  266 (464)
T 3ttj_A          210 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  266 (464)
T ss_dssp             CC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            998765432  233467999999999999999999999999999999999999999653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.8e-33  Score=315.90  Aligned_cols=196  Identities=24%  Similarity=0.307  Sum_probs=162.0

Q ss_pred             cCCCCC-CeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHH-hcCCCceeeEEeEEee----CceEE
Q 002899          638 NNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMIS-AQQHPNLVKLYGCCVE----GNQLL  710 (869)
Q Consensus       638 ~~f~~~-~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~-~l~H~nIv~l~~~~~~----~~~~~  710 (869)
                      ++|.+. ++||+|+||.||+|... +++.||||++..     ...+.+|++++. ..+||||+++++++..    .+..+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456565 68999999999999975 688999999863     245677888764 5689999999999876    56789


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCcEEEeecC
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFG  787 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~---~~~~kl~DFG  787 (869)
                      +||||+++|+|.+++.....   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||
T Consensus       136 lv~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence            99999999999999976432   25899999999999999999999998   999999999999997   7899999999


Q ss_pred             CceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +++......  ......||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus       210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  266 (400)
T 1nxk_A          210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_dssp             TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence            998765322  123457899999999999999999999999999999999999999653

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=8.3e-34  Score=312.64  Aligned_cols=199  Identities=26%  Similarity=0.378  Sum_probs=174.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--------hhhHHHHHHHHHHHhcCCCceeeEEeEEeeC
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEG  706 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--------~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~  706 (869)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++.....        .....+.+|++++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3568999999999999999999964 688999999876431        1334678899999999999999999999999


Q ss_pred             ceEEEEEEeccCC-chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002899          707 NQLLLVYEYMKNN-CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD  785 (869)
Q Consensus       707 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~D  785 (869)
                      +..++||||+..| +|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D  173 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLID  173 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEee
Confidence            9999999999777 9999886543     5899999999999999999999998   99999999999999999999999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcccCCC-CchhHHHHHHHHHHHHHcCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      ||++........  .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.
T Consensus       174 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  231 (335)
T 3dls_A          174 FGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC  231 (335)
T ss_dssp             CTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred             cccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence            999987754332  233578999999999987766 889999999999999999999985

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.8e-33  Score=305.57  Aligned_cols=202  Identities=24%  Similarity=0.364  Sum_probs=169.3

Q ss_pred             hcCCCCC-CeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHh-cCCCceeeEEeEEeeCceEEEEE
Q 002899          637 TNNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       637 t~~f~~~-~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      .+.|.+. +.||+|+||.||+|... +++.||||++..........+.+|++++.+ .+||||+++++++.+++..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3567774 78999999999999964 689999999977655556789999999988 47999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc---EEEeecCCce
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKISDFGLAK  790 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~---~kl~DFGla~  790 (869)
                      ||+++|+|.+++....     .+++..+..++.|+++||+|||+++   |+||||||+|||++.++.   +||+|||++.
T Consensus        91 e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR-----HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             ECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            9999999999986542     6899999999999999999999998   999999999999998776   9999999987


Q ss_pred             eecCCCc------cccccccccccccchhhccc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          791 LYEEDKT------HISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       791 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .......      .......||+.|+|||++..     ..++.++|||||||++|||++|+.||...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  229 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR  229 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence            6542211      11123458999999999875     45789999999999999999999999754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-33  Score=314.35  Aligned_cols=202  Identities=20%  Similarity=0.285  Sum_probs=167.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEecccCchh-----------hHHHHHHHHHHHhcCCCceee
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQG-----------NREFVNEIGMISAQQHPNLVK  698 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~~------g~~VAvK~~~~~~~~~-----------~~~f~~E~~~l~~l~H~nIv~  698 (869)
                      ..++|.+.+.||+|+||.||+|.+..      ++.||||++.......           ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34578899999999999999999764      4789999986553221           122345566677788999999


Q ss_pred             EEeEEeeC----ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 002899          699 LYGCCVEG----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL  774 (869)
Q Consensus       699 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIL  774 (869)
                      +++++...    ...++||||+ +++|.+++....    ..+++..+..++.||+.||+|||+.+   |+||||||+|||
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nil  184 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLL  184 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEE
Confidence            99998875    4589999999 999999986542    26899999999999999999999997   999999999999


Q ss_pred             Ec--CCCcEEEeecCCceeecCCCccc------cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          775 LD--KDLNAKISDFGLAKLYEEDKTHI------STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       775 l~--~~~~~kl~DFGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ++  .++.+||+|||+++.+.......      .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            99  88999999999998765432111      1234599999999999999999999999999999999999999974

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.2e-33  Score=309.61  Aligned_cols=209  Identities=25%  Similarity=0.431  Sum_probs=161.6

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEcC-C---cEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILSD-G---TVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~~-g---~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~  708 (869)
                      ...++|++.+.||+|+||.||+|.... +   ..||||+++..  .....+++.+|++++++++||||+++++++...+.
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345689999999999999999999653 2   27999998765  34456789999999999999999999999987765


Q ss_pred             E------EEEEEeccCCchhhhhhcCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcE
Q 002899          709 L------LLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA  781 (869)
Q Consensus       709 ~------~lV~E~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~  781 (869)
                      .      ++||||+++|+|.+++..... .....+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence            5      999999999999998864321 12235899999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          782 KISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       782 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      ||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~  243 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI  243 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence            9999999987644322 11223456789999999999999999999999999999999 99998653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.6e-33  Score=311.83  Aligned_cols=195  Identities=29%  Similarity=0.499  Sum_probs=169.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      +.|+..+.||+|+||.||+|+. .+++.||||++.....   ...+++.+|++++++++||||+++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4477889999999999999996 4789999999865432   23457899999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||++ |+|.+.+....    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       134 e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             ECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             ecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            9998 67877775432    26899999999999999999999998   9999999999999999999999999997654


Q ss_pred             CCCccccccccccccccchhhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..     ....||+.|+|||++.   ...++.++|||||||++|||++|+.||..
T Consensus       206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  255 (348)
T 1u5q_A          206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  255 (348)
T ss_dssp             SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            32     2346899999999984   56789999999999999999999999854

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-33  Score=309.96  Aligned_cols=209  Identities=29%  Similarity=0.445  Sum_probs=175.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEE------cCCcEEEEEEecccC-chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCc
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN  707 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~------~~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~  707 (869)
                      ..++|++.+.||+|+||.||+|..      .+++.||||++.... ....+.+.+|++++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            356788999999999999999996      245689999997543 33456799999999999 8999999999999999


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcc------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCC
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTE------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK  769 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk  769 (869)
                      ..++||||+++|+|.+++......                  ....+++..+..++.||++||+|||+.+   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999999999999999999765321                  0124899999999999999999999998   9999999


Q ss_pred             CCCEEEcCCCcEEEeecCCceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 002899          770 TSNVLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP  847 (869)
Q Consensus       770 ~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~  847 (869)
                      |+|||++.++.+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999999999999999999876543322 2233567889999999998999999999999999999998 999996543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.3e-33  Score=300.34  Aligned_cols=200  Identities=28%  Similarity=0.485  Sum_probs=155.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|+. .+++.||||++.....   ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5688899999999999999997 4789999999865421   22467889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++++|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        91 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             ECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            9999999999987542    26899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       164 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  214 (278)
T 3cok_A          164 MPHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT  214 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            33221 2235689999999999988899999999999999999999999964

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.7e-33  Score=301.64  Aligned_cols=199  Identities=28%  Similarity=0.479  Sum_probs=172.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      +.++|++.+.||+|+||.||+|... +++.||||++....   ......+.+|++++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3567889999999999999999976 56789999986532   2224678899999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+.+....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        87 v~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~  158 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH  158 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred             EEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecccccc
Confidence            999999999999886542     5899999999999999999999987   99999999999999999999999998865


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .....   .....|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  209 (279)
T 3fdn_A          159 APSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA  209 (279)
T ss_dssp             C-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC
Confidence            43322   2235689999999999999999999999999999999999999964

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-33  Score=311.58  Aligned_cols=199  Identities=25%  Similarity=0.400  Sum_probs=167.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccC--chhhHHHHHHHHHHHhcCC--CceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQH--PNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV  712 (869)
                      .++|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|++++.+++|  |||+++++++..++..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            45688999999999999999998889999999986542  3345678999999999987  9999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      || +.+++|.+++....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++ ++.+||+|||+++..
T Consensus        88 ~e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             Ee-CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            99 56789999997643     6899999999999999999999998   99999999999997 678999999999876


Q ss_pred             cCCCcc-ccccccccccccchhhccc-----------CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTH-ISTRIAGTIGYMAPEYAMR-----------GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...... ......||+.|+|||++..           ..++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence            543322 2234579999999999864           6789999999999999999999999964

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.8e-33  Score=306.41  Aligned_cols=201  Identities=25%  Similarity=0.317  Sum_probs=165.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      -++|++.+.||+|+||.||+|... +++.||+|++.....   ...+.+.+|++++++++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            468899999999999999999975 688999999875432   2246788999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++++|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       113 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EECCCCEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            99999999999986542     6899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ............|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  237 (309)
T 2h34_A          185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG  237 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred             cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence            54333333345689999999999988999999999999999999999999964

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.3e-33  Score=298.26  Aligned_cols=199  Identities=26%  Similarity=0.384  Sum_probs=172.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc------hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~------~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~  709 (869)
                      .++|++.+.||+|+||.||+|... +++.||+|.++....      ...+.+.+|++++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            356888999999999999999986 689999999865422      1356789999999999999999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC----cEEEee
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISD  785 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~----~~kl~D  785 (869)
                      ++||||+++++|.+++....     .+++..+..++.|+++||+|||+.+   ++||||||+||+++.++    .+||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~d  155 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLID  155 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEeecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEe
Confidence            99999999999999986532     6899999999999999999999998   99999999999998877    899999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ||++........  .....|++.|+|||++....++.++||||||+++|||++|+.||..
T Consensus       156 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  213 (283)
T 3bhy_A          156 FGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  213 (283)
T ss_dssp             CTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence            999987654322  2235689999999999988999999999999999999999999965

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=6e-33  Score=335.60  Aligned_cols=314  Identities=18%  Similarity=0.222  Sum_probs=251.7

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCC--CCchhhccc---cceEEEeecccCCCCCchhhcCccccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTG--SFSPQWASL---QLVELSVMGNRLSGPFPKVLTNITTLK  128 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~--~~~~~~~~l---~L~~L~Ls~N~l~~~~~~~~~~l~~L~  128 (869)
                      .+++.|++++|.+++..+..|.++++|++|+|++|.+..  .....|..+   +|+.|+|++|+++++.|..|..+++|+
T Consensus       329 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~  408 (680)
T 1ziw_A          329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLE  408 (680)
T ss_dssp             TTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             CCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCC
Confidence            467888888888888888888888999999998887543  333344433   789999999999999899999999999


Q ss_pred             cccccccccCCCCC-ccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCC--CCCccccCCCCcccEEEcc
Q 002899          129 NLSIEGNLFTGSIP-PDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS--GKIPEFIGKWKKIQKLHIQ  205 (869)
Q Consensus       129 ~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~  205 (869)
                      .|+|++|.+++.+| ..|.++++|++|+|++|++.+..+..|..+++|+.|++++|.++  +..|..|..+++|+.|+|+
T Consensus       409 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls  488 (680)
T 1ziw_A          409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLS  488 (680)
T ss_dssp             EEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECC
T ss_pred             EEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECC
Confidence            99999999987665 68899999999999999999888889999999999999999987  5688999999999999999


Q ss_pred             CCcCCCCchHhhhcCCCCCEEEcCCCCCCCCccc---------ccccccceEEEcccccCccCCCcccCCCCCcCEEecc
Q 002899          206 GSSLEGPIPASISALTSLTDLRISDLKGSESAFP---------KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS  276 (869)
Q Consensus       206 ~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~---------~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls  276 (869)
                      +|++++..+..|..+++|+.|+|++|+++.....         .....+|+.|+|++|+|+...+..|.++++|+.|+|+
T Consensus       489 ~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls  568 (680)
T 1ziw_A          489 NNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG  568 (680)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECC
Confidence            9999988888999999999999999998765322         1223489999999999997777789999999999999


Q ss_pred             CCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh---hccCCceeeeccCccCCCCCCCCCCCCC-ccceeccCCCCC
Q 002899          277 FNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISLNNFTWESSDPIECPRGS-VNLVESYSSPRN  352 (869)
Q Consensus       277 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~~l~~l~ls~N~~~~~~~~p~~C~c~~-~~~~~~l~~~~~  352 (869)
                      +|+|++..+..|..+++|+.|+|++|+|++..|..+   +..++.+++++|        ||.|+|+. .||..|+.....
T Consensus       569 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N--------~~~c~c~~~~~~~~~~~~~~~  640 (680)
T 1ziw_A          569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN--------PFDCTCESIAWFVNWINETHT  640 (680)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTC--------CCCBCCCCCSSEECCSSCC--
T ss_pred             CCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCC--------CcccCCccHHHHHHHHHhcCc
Confidence            999998888889999999999999999998877754   578999999999        99999996 999999876544


Q ss_pred             CCCCCcCccCCCCCCCCCcccccceee
Q 002899          353 KLDKVHPCLRQNFPCSAPADQYHYTLH  379 (869)
Q Consensus       353 ~~~~~~~~~~~~~~C~~p~~~~~~~~~  379 (869)
                      ....    ......|+.|+..+|+.+.
T Consensus       641 ~~~~----~~~~~~C~~p~~~~g~~l~  663 (680)
T 1ziw_A          641 NIPE----LSSHYLCNTPPHYHGFPVR  663 (680)
T ss_dssp             ---------------------------
T ss_pred             cccc----ccCCcEECCchHHCCCccc
Confidence            3321    1245689999988887665

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-33  Score=301.66  Aligned_cols=202  Identities=28%  Similarity=0.400  Sum_probs=170.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            356889999999999999999975 68899999986553 3345788999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE---cCCCcEEEeecCCcee
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKL  791 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl---~~~~~~kl~DFGla~~  791 (869)
                      |+++|+|.+.+.... .....+++..+..++.|+++||+|||+.+   |+||||||+|||+   +.++.+||+|||++..
T Consensus       101 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          101 TCEGGELLERIVSAQ-ARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCSCCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             eCCCCcHHHHHHhhh-hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            999999999885432 11236899999999999999999999998   9999999999999   4568899999999987


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......  .....||+.|+|||++. ..++.++||||||+++|||++|+.||..
T Consensus       177 ~~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~  227 (285)
T 3is5_A          177 FKSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG  227 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence            654322  23456899999999886 5689999999999999999999999964

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6e-33  Score=299.75  Aligned_cols=200  Identities=26%  Similarity=0.395  Sum_probs=176.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            356888999999999999999976 57899999986542   23456788999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++++|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        94 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  165 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV  165 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceec
Confidence            99999999999875432     6899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  217 (294)
T 2rku_A          166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET  217 (294)
T ss_dssp             CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            53322 22335689999999999988899999999999999999999999965

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.9e-33  Score=307.31  Aligned_cols=217  Identities=23%  Similarity=0.351  Sum_probs=179.0

Q ss_pred             ccccCCcccHHHHHHHhcCCCCC-CeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhc-CCCc
Q 002899          621 LDLQTGLYTLRQIKAATNNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQ-QHPN  695 (869)
Q Consensus       621 ~~~~~~~~~~~~i~~~t~~f~~~-~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l-~H~n  695 (869)
                      .+...+-..++..+...+.|.+. +.||+|+||.||+|... +++.||+|++....  .....++.+|++++..+ +|||
T Consensus        11 ~~~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   90 (327)
T 3lm5_A           11 VDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR   90 (327)
T ss_dssp             -----CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTT
T ss_pred             ccccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCC
Confidence            33344444555566777788887 88999999999999976 68999999987543  23357889999999998 5699


Q ss_pred             eeeEEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE
Q 002899          696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL  775 (869)
Q Consensus       696 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  775 (869)
                      |+++++++...+..++||||+++|+|.+++....   ...+++..+..++.|++.||+|||+++   |+||||||+|||+
T Consensus        91 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~  164 (327)
T 3lm5_A           91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILL  164 (327)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             EEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEE
Confidence            9999999999999999999999999999885432   236899999999999999999999998   9999999999999


Q ss_pred             cC---CCcEEEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          776 DK---DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       776 ~~---~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +.   ++.+||+|||++........  .....||+.|+|||++....++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  235 (327)
T 3lm5_A          165 SSIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG  235 (327)
T ss_dssp             SCBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ecCCCCCcEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            87   78999999999987654322  2335789999999999999999999999999999999999999954

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.7e-33  Score=305.00  Aligned_cols=208  Identities=28%  Similarity=0.439  Sum_probs=178.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEE------cCCcEEEEEEecccCc-hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCc
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN  707 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~------~~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~  707 (869)
                      ..++|.+.+.||+|+||.||+|..      .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++..++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346788899999999999999985      2467899999976543 3456789999999999 9999999999999999


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcc-------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTE-------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL  774 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIL  774 (869)
                      ..++||||+++|+|.+++......             ....+++..+..++.|+++||+|||+.+   |+||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence            999999999999999998765321             1225899999999999999999999998   999999999999


Q ss_pred             EcCCCcEEEeecCCceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          775 LDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       775 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      ++.++.+||+|||++......... ......+|+.|+|||++....++.++||||||+++|||++ |+.||...
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            999999999999999876544322 2223457889999999999999999999999999999999 99998654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.5e-33  Score=296.88  Aligned_cols=203  Identities=31%  Similarity=0.477  Sum_probs=176.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467889999999999999999976 68999999986543 3345678999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++++|.+++....     .+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        86 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           86 YCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             CCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             ecCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            999999999885432     5899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCc-cccccccccccccchhhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          795 DKT-HISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       795 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      ... .......|++.|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  212 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS  212 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred             CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence            322 12234578999999999987654 789999999999999999999997543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.3e-33  Score=308.31  Aligned_cols=201  Identities=25%  Similarity=0.420  Sum_probs=170.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEee--------C
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVE--------G  706 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~--------~  706 (869)
                      ++|++.+.||+|+||.||+|+.. +++.||||++.....  .....+.+|+++++.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            57889999999999999999974 789999999865432  234578899999999999999999999987        4


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                      +..++||||+++ +|.+.+....    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence            468999999985 6777665442    25899999999999999999999998   999999999999999999999999


Q ss_pred             CCceeecCCCc---cccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          787 GLAKLYEEDKT---HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       787 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |+++.......   .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  232 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  232 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99987653221   12234568999999998875 46899999999999999999999999753

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.1e-33  Score=307.02  Aligned_cols=208  Identities=27%  Similarity=0.439  Sum_probs=176.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc--------CCcEEEEEEecccC-chhhHHHHHHHHHHHhc-CCCceeeEEeEEee
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE  705 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~--------~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~  705 (869)
                      ..++|.+.+.||+|+||.||+|...        +++.||||++.... ....+++.+|+++++++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3567889999999999999999863        46789999997653 33456789999999999 99999999999999


Q ss_pred             CceEEEEEEeccCCchhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 002899          706 GNQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL  774 (869)
Q Consensus       706 ~~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIL  774 (869)
                      .+..++||||+++|+|.+++......           ....+++..+..++.||++||+|||+.+   |+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            99999999999999999999765321           1124899999999999999999999998   999999999999


Q ss_pred             EcCCCcEEEeecCCceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          775 LDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       775 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      ++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            999999999999999876543321 1223456789999999998889999999999999999999 99999653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.1e-33  Score=305.80  Aligned_cols=200  Identities=26%  Similarity=0.395  Sum_probs=176.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .++|.+.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            356888999999999999999976 57899999986542   23456788999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++++|.+++....     .+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus       120 ~e~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EecCCCCCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceec
Confidence            99999999999885432     6899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  243 (335)
T 2owb_A          192 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET  243 (335)
T ss_dssp             CSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence            53322 22345689999999999988899999999999999999999999965

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.2e-33  Score=299.84  Aligned_cols=202  Identities=27%  Similarity=0.401  Sum_probs=170.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC----CcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~----g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      .++|.+.+.||+|+||.||+|...+    +..||+|.+.... ....+.|.+|++++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4678889999999999999998643    3469999987653 3446779999999999999999999999865 45789


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++++|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        90 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence            999999999999986532    25899999999999999999999998   99999999999999999999999999987


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      .............+++.|+|||++....++.++||||||+++|||++ |+.||...
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~  218 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL  218 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence            65433322333457889999999998899999999999999999998 99999643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.7e-33  Score=318.12  Aligned_cols=200  Identities=26%  Similarity=0.414  Sum_probs=163.9

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--------chhhHHHHHHHHHHHhcCCCceeeEEeEEee
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--------RQGNREFVNEIGMISAQQHPNLVKLYGCCVE  705 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--------~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~  705 (869)
                      ...++|.+.+.||+|+||.||+|... +++.||||++....        ......+.+|++++++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            45688999999999999999999975 57899999986532        112335889999999999999999999975 


Q ss_pred             CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC---CcEE
Q 002899          706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAK  782 (869)
Q Consensus       706 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~---~~~k  782 (869)
                      .+..++||||+++|+|.+++....     .+++..+..++.|+++||+|||+++   |+||||||+|||++.+   ..+|
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEE
T ss_pred             cCceEEEEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEE
Confidence            456899999999999999886543     6899999999999999999999998   9999999999999754   4599


Q ss_pred             EeecCCceeecCCCccccccccccccccchhhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          783 ISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       783 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |+|||+++......  ......||+.|+|||++.   ...++.++|||||||++|||++|+.||..
T Consensus       283 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~  346 (419)
T 3i6u_A          283 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE  346 (419)
T ss_dssp             ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99999998765322  223467999999999985   35788899999999999999999999965

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.9e-33  Score=317.38  Aligned_cols=198  Identities=25%  Similarity=0.393  Sum_probs=166.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC-----ce
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~-----~~  708 (869)
                      .++|.+.+.||+|+||.||+|... +++.||||++...  .....+++.+|+++++.++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            568899999999999999999975 5789999999754  233457889999999999999999999999876     57


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .|+||||++ |+|.+++....     .+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEecCC-cCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCC
Confidence            899999987 59999886542     5899999999999999999999998   99999999999999999999999999


Q ss_pred             ceeecCCCcc---------------------ccccccccccccchhhc-ccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 002899          789 AKLYEEDKTH---------------------ISTRIAGTIGYMAPEYA-MRGYLTSKADVYSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       789 a~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~k~DvwSlGvil~elltG~~p~  843 (869)
                      ++........                     .....+||+.|+|||++ ....++.++||||+||++|||++|..|+
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            9876543211                     12446789999999986 5567999999999999999999865544

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-33  Score=298.08  Aligned_cols=201  Identities=30%  Similarity=0.483  Sum_probs=172.1

Q ss_pred             cCCCCCC-eeeccCceEEEEEEEc---CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          638 NNFDPAN-KVGEGGFGSVYKGILS---DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       638 ~~f~~~~-~IG~G~fG~Vyka~~~---~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ++|.+.+ .||+|+||.||+|...   +++.||||+++... ....+++.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4455555 8999999999999864   57889999997653 34467799999999999999999999999 55678999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++++|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        88 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEeCCCCCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence            99999999999986442    25899999999999999999999998   999999999999999999999999999877


Q ss_pred             cCCCccc--cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          793 EEDKTHI--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       793 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      .......  .....+|+.|+|||++....++.++||||||+++|||++ |+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  217 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM  217 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            5433221  122346889999999998889999999999999999998 99999653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.3e-33  Score=302.00  Aligned_cols=195  Identities=25%  Similarity=0.433  Sum_probs=170.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC-C-------cEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD-G-------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~-g-------~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~  708 (869)
                      .++|.+.+.||+|+||.||+|.... +       +.||+|++........+.+.+|++++++++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3568889999999999999998653 3       4799999977666667889999999999999999999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc--------
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN--------  780 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~--------  780 (869)
                      .++||||+++|+|.+++....    ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.        
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             CEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccce
Confidence            999999999999999997643    24899999999999999999999998   999999999999998887        


Q ss_pred             EEEeecCCceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCC
Q 002899          781 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       781 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~  843 (869)
                      +||+|||++......     ....||+.|+|||++.+ ..++.++||||||+++|||++|+.|+
T Consensus       160 ~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~  218 (289)
T 4fvq_A          160 IKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP  218 (289)
T ss_dssp             EEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence            999999998654321     22457889999999987 67999999999999999999965554

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-33  Score=321.75  Aligned_cols=193  Identities=24%  Similarity=0.404  Sum_probs=154.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC-----ce
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~-----~~  708 (869)
                      .++|++.++||+|+||.||+|... +++.||||++...  .....+++.+|+++++.++|||||++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            467999999999999999999965 6899999998654  233457789999999999999999999998543     56


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .|+||||++ |+|.+++....     .+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEeccc-cchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeeccccc
Confidence            899999885 68988886542     6899999999999999999999998   99999999999999999999999999


Q ss_pred             ceeecCCCc--------------------------cccccccccccccchhhc-ccCCCCchhHHHHHHHHHHHHHc
Q 002899          789 AKLYEEDKT--------------------------HISTRIAGTIGYMAPEYA-MRGYLTSKADVYSFGVVTLEIVS  838 (869)
Q Consensus       789 a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DvwSlGvil~ellt  838 (869)
                      ++.......                          ......+||+.|+|||++ ....++.++|||||||++|||++
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            987643211                          112335789999999976 46679999999999999999999

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.2e-33  Score=308.42  Aligned_cols=207  Identities=24%  Similarity=0.419  Sum_probs=178.6

Q ss_pred             cHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--------hhhHHHHHHHHHHHhc-CCCceee
Q 002899          629 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQ-QHPNLVK  698 (869)
Q Consensus       629 ~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--------~~~~~f~~E~~~l~~l-~H~nIv~  698 (869)
                      .........++|++.+.||+|+||.||+|... +|+.||||++.....        ...+.+.+|++++.++ +||||++
T Consensus        85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~  164 (365)
T 2y7j_A           85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT  164 (365)
T ss_dssp             HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            34445566778999999999999999999986 789999999865431        1134678899999998 8999999


Q ss_pred             EEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC
Q 002899          699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD  778 (869)
Q Consensus       699 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~  778 (869)
                      +++++...+..++||||+++++|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.+
T Consensus       165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~  236 (365)
T 2y7j_A          165 LIDSYESSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDN  236 (365)
T ss_dssp             EEEEEEBSSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred             EEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence            999999999999999999999999998643     26899999999999999999999998   9999999999999999


Q ss_pred             CcEEEeecCCceeecCCCccccccccccccccchhhccc------CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          779 LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR------GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       779 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +.+||+|||++........  .....||+.|+|||++.+      ..++.++|||||||++|||++|+.||..
T Consensus       237 ~~ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  307 (365)
T 2y7j_A          237 MQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH  307 (365)
T ss_dssp             CCEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCEEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence            9999999999987654322  234579999999999863      3578899999999999999999999964

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.5e-33  Score=314.16  Aligned_cols=198  Identities=25%  Similarity=0.398  Sum_probs=167.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccC--chhhHHHHHHHHHHHhcC--CCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQ--HPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|...+++.||||++....  ......+.+|++++.+++  ||||+++++++..++..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4588999999999999999998889999999986542  334577899999999996  599999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      | +.+++|.+++....     .+++..+..++.||++||+|||+.+   |+||||||+|||++ ++.+||+|||+++.+.
T Consensus       136 E-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             e-cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            9 67889999987643     6789999999999999999999997   99999999999995 5899999999998765


Q ss_pred             CCCcc-ccccccccccccchhhccc-----------CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTH-ISTRIAGTIGYMAPEYAMR-----------GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..... ......||+.|+|||++..           ..++.++|||||||++|||++|+.||..
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~  269 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  269 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence            43322 2234579999999999865           3689999999999999999999999964

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6e-33  Score=298.21  Aligned_cols=198  Identities=25%  Similarity=0.440  Sum_probs=175.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            357889999999999999999976 57889999986532   22246788999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++|+|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        93 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-----RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            99999999999886542     5899999999999999999999997   999999999999999999999999998765


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....   .....|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  214 (284)
T 2vgo_A          165 PSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS  214 (284)
T ss_dssp             SSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC
Confidence            4322   2235689999999999998899999999999999999999999964

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2e-33  Score=312.84  Aligned_cols=199  Identities=24%  Similarity=0.442  Sum_probs=175.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357889999999999999999976 68999999987653 3345678999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      |+++++|.+++....     .+++..+..++.|++.||+|||+. +   |+||||||+|||++.++.+||+|||++....
T Consensus       112 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             CCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             CCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999986543     589999999999999999999985 6   9999999999999999999999999987553


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ...   .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       184 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          184 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             HHC-------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             ccc---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            221   22357899999999999999999999999999999999999999653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.4e-33  Score=310.23  Aligned_cols=209  Identities=26%  Similarity=0.383  Sum_probs=171.5

Q ss_pred             ccHHHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCch-----------hhHHHHHHHHHHHhcCCCce
Q 002899          628 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ-----------GNREFVNEIGMISAQQHPNL  696 (869)
Q Consensus       628 ~~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~-----------~~~~f~~E~~~l~~l~H~nI  696 (869)
                      ...+++....++|.+.+.||+|+||.||+|...+++.||||++......           ..+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            3456778889999999999999999999999888999999998653221           13678999999999999999


Q ss_pred             eeEEeEEee-----CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCC
Q 002899          697 VKLYGCCVE-----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTS  771 (869)
Q Consensus       697 v~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~  771 (869)
                      +++++++..     ....++||||++ |+|.+.+....    ..+++..+..++.||+.||+|||+++   |+||||||+
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~  163 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPG  163 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChH
Confidence            999999854     336899999998 58888776543    26899999999999999999999998   999999999


Q ss_pred             CEEEcCCCcEEEeecCCceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          772 NVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       772 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |||++.++.+||+|||++.......  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       164 NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          164 NILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             GEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             HEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999997554322  2234568999999999876 67899999999999999999999999653

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.1e-33  Score=302.70  Aligned_cols=199  Identities=25%  Similarity=0.393  Sum_probs=173.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ..++|.+.+.||+|+||.||+|+.. +++.||+|++..........+.+|++++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3467889999999999999999975 689999999986554455678899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE---cCCCcEEEeecCCcee
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKL  791 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl---~~~~~~kl~DFGla~~  791 (869)
                      |+++++|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||++..
T Consensus        87 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           87 LVSGGELFDRILERG-----VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             CCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             cCCCccHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            999999999886542     5899999999999999999999998   9999999999999   7889999999999876


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .....   .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  209 (304)
T 2jam_A          159 EQNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE  209 (304)
T ss_dssp             CCCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cCCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            54321   2234689999999999999999999999999999999999999854

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=9.7e-34  Score=331.65  Aligned_cols=202  Identities=31%  Similarity=0.524  Sum_probs=175.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ..++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|++++++++|||||++++++.+ +..++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            456788899999999999999999888889999997643 335689999999999999999999999876 678999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++|+|.+++....   ...+++..+..|+.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       343 ~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          343 MSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             CTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             hcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            99999999996432   125899999999999999999999998   999999999999999999999999999866532


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .........++..|+|||++....++.++|||||||++|||++ |+.||..
T Consensus       417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~  467 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  467 (535)
T ss_dssp             HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred             ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            2222223456789999999998999999999999999999999 9999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.6e-33  Score=307.96  Aligned_cols=201  Identities=23%  Similarity=0.388  Sum_probs=164.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch--hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~--~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ..++|++.+.||+|+||.||+|... +++.||||++......  ..+.+.+|++++++++||||+++++++.+++..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            3467889999999999999999965 6889999998754322  245678999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-----CCCcEEEeecC
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-----KDLNAKISDFG  787 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~-----~~~~~kl~DFG  787 (869)
                      |||++ |+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||++     .++.+||+|||
T Consensus       112 ~e~~~-~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EECCS-EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EecCC-CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            99998 48999886553     5899999999999999999999998   99999999999994     45569999999


Q ss_pred             CceeecCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       183 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  241 (329)
T 3gbz_A          183 LARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD  241 (329)
T ss_dssp             HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence            9987653322 22335689999999998864 5899999999999999999999999653

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-33  Score=315.92  Aligned_cols=202  Identities=23%  Similarity=0.349  Sum_probs=173.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc--eEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV  712 (869)
                      .++|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            356888999999999999999976 58999999987543 233567889999999999999999999998755  77999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE----cCCCcEEEeecCC
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGL  788 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl----~~~~~~kl~DFGl  788 (869)
                      |||+++|+|.+++.....  ...+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||+
T Consensus        88 ~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EecCCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            999999999999965432  224899999999999999999999998   9999999999999    7778899999999


Q ss_pred             ceeecCCCccccccccccccccchhhccc--------CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMR--------GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ++.......  .....||+.|+|||++..        ..++.++|||||||++|||++|+.||..
T Consensus       163 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~  225 (396)
T 4eut_A          163 ARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (396)
T ss_dssp             CEECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             ceEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            987654322  234568999999999865        4678899999999999999999999964

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.1e-33  Score=297.18  Aligned_cols=200  Identities=32%  Similarity=0.566  Sum_probs=169.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchh-------hHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG-------NREFVNEIGMISAQQHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~-------~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~  708 (869)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.......       .+++.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367888999999999999999975 78999999986543221       167899999999999999999999987655 


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc-----EEE
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-----AKI  783 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~-----~kl  783 (869)
                       ++||||+++|+|.+.+....    ..+++..+..++.|++.||+|||+.+ ++|+||||||+|||++.++.     +||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             -eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEe
Confidence             69999999999998886543    26899999999999999999999885 34999999999999988776     999


Q ss_pred             eecCCceeecCCCccccccccccccccchhhc--ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          784 SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA--MRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       784 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      +|||+++.....    .....||+.|+|||++  ....++.++||||||+++|||++|+.||....
T Consensus       171 ~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  232 (287)
T 4f0f_A          171 ADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS  232 (287)
T ss_dssp             CCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             CCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            999999754322    2335789999999998  34567899999999999999999999997543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.2e-33  Score=306.93  Aligned_cols=201  Identities=31%  Similarity=0.474  Sum_probs=176.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-----cCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEe--eCceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV--EGNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-----~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~--~~~~~  709 (869)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            35788899999999999999984     367899999998776666778999999999999999999999987  45678


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||+++++|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             EEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccc
Confidence            99999999999999986532    25899999999999999999999998   999999999999999999999999999


Q ss_pred             eeecCCCcc--ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          790 KLYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       790 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      .........  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~  231 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC  231 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            877543321  2233467888999999998889999999999999999999999984

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.5e-32  Score=297.92  Aligned_cols=199  Identities=30%  Similarity=0.514  Sum_probs=176.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .+.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356888999999999999999865 68899999987553 3345788999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++++|.+++...      .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus       101 ~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A          101 YLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             CCTTEEHHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             eCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCc
Confidence            99999999988542      5899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .... .....||+.|+|||++....++.++||||||+++|||++|+.||..
T Consensus       172 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  221 (303)
T 3a7i_A          172 TQIK-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE  221 (303)
T ss_dssp             TBCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccc-cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence            3322 2335689999999999988999999999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.6e-33  Score=302.56  Aligned_cols=199  Identities=30%  Similarity=0.478  Sum_probs=170.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEE-----cCCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceE
Q 002899          638 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL  709 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~-----~~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~--~~~  709 (869)
                      +.|++.+.||+|+||.||+|++     .+++.||||+++... ....+.+.+|++++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4577889999999999999984     368899999987543 33357789999999999999999999999876  668


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||+++|+|.+++....    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccc
Confidence            99999999999999985432    25899999999999999999999998   999999999999999999999999999


Q ss_pred             eeecCCCc--cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 002899          790 KLYEEDKT--HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       790 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~  843 (869)
                      ........  .......||..|+|||++.+..++.++||||||+++|||++|+.|+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  229 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD  229 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCC
Confidence            87765432  1223356788899999999988999999999999999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-33  Score=308.33  Aligned_cols=204  Identities=28%  Similarity=0.424  Sum_probs=167.5

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch-----hhHHHHHHHHHHHhcCCCceeeEEeEEeeCc
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-----GNREFVNEIGMISAQQHPNLVKLYGCCVEGN  707 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~-----~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~  707 (869)
                      ....++|++.+.||+|+||.||+|... +|+.||||++......     ..+.+.+|+++++.++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344578999999999999999999975 5899999998753221     1356889999999999999999999999999


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                      ..++||||+++ +|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             ceEEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecc
Confidence            99999999986 7888876542    25888999999999999999999998   9999999999999999999999999


Q ss_pred             CceeecCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +++....... ......||+.|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus       158 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~  216 (346)
T 1ua2_A          158 LAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  216 (346)
T ss_dssp             GGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            9987643322 22345789999999998754 5899999999999999999999998653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6e-33  Score=322.37  Aligned_cols=198  Identities=30%  Similarity=0.464  Sum_probs=169.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....  ......+.+|+++++.++|||||++++++.+.+..++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            456889999999999999999976 68899999987543  334577899999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCcEEEeecCCce
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAK  790 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~---~~~~kl~DFGla~  790 (869)
                      ||+++|+|.+.+....     .+++..+..++.||++||+|||+.+   |+||||||+|||++.   ++.+||+|||++.
T Consensus       116 e~~~~g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            9999999998886542     6899999999999999999999998   999999999999976   4559999999998


Q ss_pred             eecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          791 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......  ......||+.|+|||++. ..++.++||||+||++|||++|+.||..
T Consensus       188 ~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~  239 (494)
T 3lij_A          188 VFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG  239 (494)
T ss_dssp             ECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence            775432  223457999999999886 4689999999999999999999999965

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.2e-33  Score=309.33  Aligned_cols=214  Identities=26%  Similarity=0.422  Sum_probs=180.2

Q ss_pred             cHHHHHHHhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEe
Q 002899          629 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYG  701 (869)
Q Consensus       629 ~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~  701 (869)
                      ..++++...++|++.+.||+|+||.||+|...      +++.||||++..... ....+|.+|+++++.++||||+++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            33445556788999999999999999999864      367899999975533 34557899999999999999999999


Q ss_pred             EEeeCceEEEEEEeccCCchhhhhhcCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc
Q 002899          702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTE-----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD  776 (869)
Q Consensus       702 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~  776 (869)
                      ++.+.+..++||||+++|+|.+++......     ....+++..+..++.|++.||+|||+++   |+||||||+||+++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~  172 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA  172 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence            999999999999999999999988653211     1135799999999999999999999998   99999999999999


Q ss_pred             CCCcEEEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          777 KDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       777 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  243 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG  243 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence            999999999999986543322 11223457889999999998899999999999999999999 8888864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7e-33  Score=301.42  Aligned_cols=198  Identities=31%  Similarity=0.525  Sum_probs=164.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEecc
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      ++|++.+.||+|+||.||+|... ++.||||++...  ...+.|.+|++++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            46778899999999999999985 788999998643  34578999999999999999999999877  45789999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc-EEEeecCCceeecCCC
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-AKISDFGLAKLYEEDK  796 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~-~kl~DFGla~~~~~~~  796 (869)
                      +|+|.+++.....  ...+++..+..++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++.......
T Consensus        83 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~  160 (307)
T 2eva_A           83 GGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM  160 (307)
T ss_dssp             TCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc
Confidence            9999999976532  235789999999999999999999943234999999999999998886 7999999997654321


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                          ....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       161 ----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  206 (307)
T 2eva_A          161 ----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI  206 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred             ----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence                2346899999999999989999999999999999999999999653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.5e-33  Score=304.99  Aligned_cols=201  Identities=25%  Similarity=0.431  Sum_probs=169.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      .++|++.+.||+|+||.||+|... +++.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            356888999999999999999976 589999998865432  23456789999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++++|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       104 e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             ECCSEEHHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             ecCCcchHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            9999999988765432     5899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus       176 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  228 (331)
T 4aaa_A          176 APGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD  228 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            4322 22235689999999998765 7899999999999999999999999653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.4e-33  Score=304.02  Aligned_cols=202  Identities=29%  Similarity=0.539  Sum_probs=165.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEeccc-CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~----~VAvK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  710 (869)
                      .++|++.++||+|+||.||+|... +++    +||+|.+... .....+++.+|++++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            357889999999999999999964 344    3678877544 3345678999999999999999999999998764 78


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      +|+||+++|+|.+++....    ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        93 ~v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             EEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            9999999999999987643    25899999999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          791 LYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       791 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      ........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~  223 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI  223 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            76543221 1222456789999999999999999999999999999999 99999654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-33  Score=310.67  Aligned_cols=196  Identities=26%  Similarity=0.418  Sum_probs=165.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc------
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------  707 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~------  707 (869)
                      .++|++.+.||+|+||.||+|... +|+.||||++....  ....+++.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467889999999999999999974 68999999986532  233567889999999999999999999998653      


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                      ..++||||+ +++|.+++...      .+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             eEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeee
Confidence            469999999 78999988653      5899999999999999999999998   9999999999999999999999999


Q ss_pred             CceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +++.....    .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       174 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  229 (367)
T 1cm8_A          174 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  229 (367)
T ss_dssp             TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99876432    223568999999999876 67999999999999999999999999653

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.1e-33  Score=307.74  Aligned_cols=200  Identities=22%  Similarity=0.300  Sum_probs=165.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEecccCch-----------hhHHHHHHHHHHHhcCCCceeeEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQ-----------GNREFVNEIGMISAQQHPNLVKLYG  701 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~----~g~~VAvK~~~~~~~~-----------~~~~f~~E~~~l~~l~H~nIv~l~~  701 (869)
                      .++|.+.+.||+|+||.||+|...    ++..||||++......           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            356888999999999999999975    5678999998754321           1234677888999999999999999


Q ss_pred             EEee----CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC
Q 002899          702 CCVE----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK  777 (869)
Q Consensus       702 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~  777 (869)
                      ++..    ....++||||+ +++|.+++....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~  186 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGY  186 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEES
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEcc
Confidence            9988    77899999999 999999986543     6899999999999999999999997   999999999999998


Q ss_pred             CC--cEEEeecCCceeecCCCcc------ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          778 DL--NAKISDFGLAKLYEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       778 ~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ++  .+||+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            87  9999999999876432211      11335789999999999998999999999999999999999999954

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2e-32  Score=295.56  Aligned_cols=201  Identities=30%  Similarity=0.422  Sum_probs=170.7

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEecc
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      +|....+||+|+||.||+|... +++.||||.+........+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            3455669999999999999974 688999999987666667789999999999999999999999999999999999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCcEEEeecCCceeecCCC
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~-~~~~kl~DFGla~~~~~~~  796 (869)
                      +++|.+++.....  ...+++..+..++.|+++||+|||+.+   |+||||||+||+++. ++.+||+|||++.......
T Consensus       103 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          103 GGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             EEEHHHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCHHHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            9999999875432  235678999999999999999999998   999999999999987 8999999999998765432


Q ss_pred             ccccccccccccccchhhcccC--CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      . ......|++.|+|||++...  .++.++||||||+++|||++|+.||..
T Consensus       178 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  227 (295)
T 2clq_A          178 P-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE  227 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred             C-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence            2 12345689999999998764  388999999999999999999999954

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.8e-33  Score=296.19  Aligned_cols=197  Identities=23%  Similarity=0.375  Sum_probs=169.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|+.. ++.||||+++...  ....++|.+|++++++++||||+++++++.+.  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            56888999999999999999985 8889999987653  34456799999999999999999999999887  7889999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++.....   ..+++..+..++.|+++||+|||+.+ ++++||||||+||+++.++.++|+|||++....
T Consensus        89 e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             ECCTTCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             cccCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            99999999999976532   25899999999999999999999875 359999999999999999999999998865432


Q ss_pred             CCCccccccccccccccchhhcccCCCCc---hhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTS---KADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .      ....||+.|+|||++.+...+.   ++||||||+++|||++|+.||..
T Consensus       165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  213 (271)
T 3kmu_A          165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD  213 (271)
T ss_dssp             C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred             c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            2      1246889999999998654443   89999999999999999999964

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2e-32  Score=295.47  Aligned_cols=203  Identities=24%  Similarity=0.333  Sum_probs=168.5

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEE-eeCceEEEE
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-VEGNQLLLV  712 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lV  712 (869)
                      ...++|++.+.||+|+||.||+|+. .+++.||||++....  ...++..|++++..++|++++..++.+ ...+..++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            3457899999999999999999996 478899999875433  234688999999999988877665554 667788999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE---cCCCcEEEeecCCc
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLA  789 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl---~~~~~~kl~DFGla  789 (869)
                      |||+ +++|.+++....    ..+++..+..++.|++.||+|||+++   |+||||||+|||+   +.++.+||+|||++
T Consensus        84 ~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEcc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            9999 899999986432    25899999999999999999999998   9999999999999   78899999999999


Q ss_pred             eeecCCCcc------ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          790 KLYEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       790 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      +........      ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence            877543321      1224578999999999999999999999999999999999999997643

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=9.3e-33  Score=296.26  Aligned_cols=196  Identities=27%  Similarity=0.472  Sum_probs=172.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEee---------
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE---------  705 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~---------  705 (869)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....    ..+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4467889999999999999999986 78999999987543    467789999999999999999998864         


Q ss_pred             -------CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC
Q 002899          706 -------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD  778 (869)
Q Consensus       706 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~  778 (869)
                             ....++||||+++|+|.+++....   ...+++..+..++.|+++||+|||+.+   |+||||||+|||++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT  158 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence                   455899999999999999996542   236899999999999999999999998   9999999999999999


Q ss_pred             CcEEEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 002899          779 LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       779 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~  843 (869)
                      +.+||+|||++........  .....||+.|+|||++.+..++.++||||||+++|||++|+.|+
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~  221 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA  221 (284)
T ss_dssp             TEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred             CCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence            9999999999987654332  22346899999999999889999999999999999999999886

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.2e-33  Score=298.53  Aligned_cols=199  Identities=32%  Similarity=0.547  Sum_probs=160.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++|++.+.||+|+||.||+|+..  ..||||+++...  ....+.|.+|++++++++||||+++++++ ..+..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            467889999999999999999864  359999987543  33456799999999999999999999965 4557899999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++++|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       100 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A          100 WCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             CCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             ecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence            999999999986543    26899999999999999999999998   99999999999999999999999999976543


Q ss_pred             CC-ccccccccccccccchhhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DK-THISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .. ........||+.|+|||++.   ...++.++||||||+++|||++|+.||..
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  227 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN  227 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence            22 22223456899999999986   56788899999999999999999999965

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.6e-32  Score=319.51  Aligned_cols=200  Identities=30%  Similarity=0.467  Sum_probs=172.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-------------hhhHHHHHHHHHHHhcCCCceeeEEe
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-------------QGNREFVNEIGMISAQQHPNLVKLYG  701 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-------------~~~~~f~~E~~~l~~l~H~nIv~l~~  701 (869)
                      ..++|.+.++||+|+||+||+|... +++.||||++.....             ...+.+.+|++++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999976 578999999865421             23467889999999999999999999


Q ss_pred             EEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC--
Q 002899          702 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL--  779 (869)
Q Consensus       702 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~--  779 (869)
                      ++.+.+..++||||+++|+|.+.+....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++  
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~  185 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSL  185 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCC
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCC
Confidence            9999999999999999999999886542     6899999999999999999999998   99999999999998775  


Q ss_pred             -cEEEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          780 -NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       780 -~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                       .+||+|||++........  .....||+.|+|||++. ..++.++||||+||++|||++|+.||...
T Consensus       186 ~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~  250 (504)
T 3q5i_A          186 LNIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ  250 (504)
T ss_dssp             SSEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence             699999999987754322  23457999999999987 46899999999999999999999999653

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.7e-33  Score=303.56  Aligned_cols=216  Identities=27%  Similarity=0.418  Sum_probs=180.9

Q ss_pred             ccHHHHHHHhcCCCCCCeeeccCceEEEEEEE------cCCcEEEEEEecccCc-hhhHHHHHHHHHHHhc-CCCceeeE
Q 002899          628 YTLRQIKAATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKL  699 (869)
Q Consensus       628 ~~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~------~~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l  699 (869)
                      +...+.....++|++.+.||+|+||.||+|..      .+++.||||+++.... ...+.+.+|++++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            34445555678899999999999999999985      2468899999976543 3456789999999999 79999999


Q ss_pred             EeEEeeCc-eEEEEEEeccCCchhhhhhcCCccc-----------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcC
Q 002899          700 YGCCVEGN-QLLLVYEYMKNNCLSRAIFGKDTEY-----------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRD  767 (869)
Q Consensus       700 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~D  767 (869)
                      ++++...+ ..++||||+++|+|.+++.......           ...+++..+..++.|+++||+|||+.+   |+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99988755 5899999999999999997654321           123789999999999999999999998   99999


Q ss_pred             CCCCCEEEcCCCcEEEeecCCceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          768 IKTSNVLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       768 lk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      |||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999999999999876543322 2233567889999999999999999999999999999998 9999965


Q ss_pred             C
Q 002899          846 R  846 (869)
Q Consensus       846 ~  846 (869)
                      .
T Consensus       254 ~  254 (316)
T 2xir_A          254 V  254 (316)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.9e-33  Score=320.74  Aligned_cols=199  Identities=28%  Similarity=0.457  Sum_probs=172.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ..++|++.++||+|+||+||+|... +++.||||++....  ......+.+|++++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467999999999999999999976 68999999986432  23456789999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc---CCCcEEEeecCCc
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLA  789 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~---~~~~~kl~DFGla  789 (869)
                      |||+++|+|.+.+....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++   .++.+||+|||++
T Consensus       100 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  171 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred             EEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence            99999999998886543     6899999999999999999999998   99999999999995   5668999999999


Q ss_pred             eeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ........  .....||+.|+|||++.+ .++.++||||+||++|||++|+.||..
T Consensus       172 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~  224 (486)
T 3mwu_A          172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG  224 (486)
T ss_dssp             TTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eECCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            86654322  234579999999999875 589999999999999999999999964

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.4e-32  Score=295.20  Aligned_cols=200  Identities=25%  Similarity=0.405  Sum_probs=171.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ..++|++.+.||+|+||.||+|... +++.||||++...  ......++.+|+..+..+ +||||+++++++.+++..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3567889999999999999999986 7899999998754  233456788999999998 99999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-------------
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-------------  778 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~-------------  778 (869)
                      ||||+++++|.+++..... ....+++..+..++.||++||+|||+++   |+||||||+|||++.+             
T Consensus        89 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred             EEEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence            9999999999999865421 1236899999999999999999999998   9999999999999844             


Q ss_pred             ------CcEEEeecCCceeecCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          779 ------LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       779 ------~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                            ..+||+|||.+.......     ...||+.|+|||++.+. .+++++||||||+++|||++|++|+.
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  232 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR  232 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred             cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence                  479999999998765432     23589999999999765 56789999999999999999997753

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-32  Score=303.80  Aligned_cols=201  Identities=30%  Similarity=0.514  Sum_probs=166.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcC-----CcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~-----g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      ++|++.+.||+|+||.||+|....     +..||||.++.... ....++.+|++++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456678999999999999998653     24699999976533 345678999999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       124 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence            999999999999986542    26899999999999999999999998   99999999999999999999999999987


Q ss_pred             ecCCCcc--ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          792 YEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .......  ......+|+.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~  253 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE  253 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence            6543221  1122346788999999998899999999999999999999 9999954

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.4e-33  Score=328.91  Aligned_cols=194  Identities=29%  Similarity=0.482  Sum_probs=164.4

Q ss_pred             eeeccCceEEEEEEEc---CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccCCc
Q 002899          645 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC  720 (869)
Q Consensus       645 ~IG~G~fG~Vyka~~~---~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs  720 (869)
                      .||+|+||.||+|.+.   ++..||||+++... ....++|.+|++++++++|||||++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999874   45679999997653 3356789999999999999999999999976 56899999999999


Q ss_pred             hhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcccc
Q 002899          721 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS  800 (869)
Q Consensus       721 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  800 (869)
                      |.+++....    ..+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++..........
T Consensus       422 L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  494 (613)
T 2ozo_A          422 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  494 (613)
T ss_dssp             HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred             HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence            999996543    26899999999999999999999998   99999999999999999999999999987654322211


Q ss_pred             --ccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          801 --TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       801 --~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                        ....+++.|+|||++....++.++|||||||++|||++ |+.||...
T Consensus       495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~  543 (613)
T 2ozo_A          495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM  543 (613)
T ss_dssp             -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence              12345689999999998999999999999999999998 99999653

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=8e-33  Score=341.97  Aligned_cols=229  Identities=18%  Similarity=0.152  Sum_probs=155.4

Q ss_pred             cccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCC
Q 002899          144 DIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL  223 (869)
Q Consensus       144 ~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L  223 (869)
                      .|..+++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|++|.+....+..|..+++|
T Consensus       285 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  364 (844)
T 3j0a_A          285 VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKL  364 (844)
T ss_dssp             CSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCC
T ss_pred             hhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCC
Confidence            34455566666666666665556666666666666666666666666666666666666666666666666666667777


Q ss_pred             CEEEcCCCCCCCCccc-----------------------------------------ccccccceEEEcccccCccC---
Q 002899          224 TDLRISDLKGSESAFP-----------------------------------------KLDKMNLKTLILTKCLIHGE---  259 (869)
Q Consensus       224 ~~L~L~~n~~~~~~~~-----------------------------------------~~~~~~L~~L~Ls~N~i~~~---  259 (869)
                      +.|+|++|.++.....                                         .....+|+.|+|++|++++.   
T Consensus       365 ~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  444 (844)
T 3j0a_A          365 QTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGD  444 (844)
T ss_dssp             CEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSS
T ss_pred             CEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccc
Confidence            7777776665542210                                         00122455555555555422   


Q ss_pred             ---------------------------CCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh
Q 002899          260 ---------------------------IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI  312 (869)
Q Consensus       260 ---------------------------~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  312 (869)
                                                 .+..|..+++|+.|+|++|+|++.+|..|.++++|+.|+|++|+|++..|..+
T Consensus       445 ~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~  524 (844)
T 3j0a_A          445 QTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL  524 (844)
T ss_dssp             SSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCC
T ss_pred             cccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhh
Confidence                                       23446677888888888888888888889999999999999999998777777


Q ss_pred             hccCCceeeeccCccCCC-------------CCCCCCCCCCccceeccCCCCCCCCCCcCccCCCCCCCCCcccccc
Q 002899          313 FNSNKNVDISLNNFTWES-------------SDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHY  376 (869)
Q Consensus       313 ~~~l~~l~ls~N~~~~~~-------------~~p~~C~c~~~~~~~~l~~~~~~~~~~~~~~~~~~~C~~p~~~~~~  376 (869)
                      ...++.|+|++|+++...             .|||.|+|++.||..|+......+..    ......|+.|+...+.
T Consensus       525 ~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~~~f~~~~~~~~~~~~~----~~~~~~C~~p~~~~g~  597 (844)
T 3j0a_A          525 PANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAG----PPADIYCVYPDSFSGV  597 (844)
T ss_dssp             CSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSCCSHHHHHHHTTTTTCC----CGGGCCCSSCSSSCSC
T ss_pred             hccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccccccHHHHHHHHhcCccccc----ccccCccCCchhhCCC
Confidence            788999999999988654             47999999999999998754433321    1234567777665443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.1e-33  Score=321.65  Aligned_cols=198  Identities=30%  Similarity=0.488  Sum_probs=174.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .++|++.++||+|+||.||+|... +++.||||++....   ......+.+|++++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            457889999999999999999976 78999999986542   33467789999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE---cCCCcEEEeecCCc
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLA  789 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl---~~~~~~kl~DFGla  789 (869)
                      |||+.+|+|.+.+....     .+++..+..++.||+.||+|||+++   |+||||||+|||+   +.++.+||+|||++
T Consensus       105 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             EecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            99999999999886653     5899999999999999999999998   9999999999999   56789999999999


Q ss_pred             eeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ........  .....||+.|+|||++.+ .++.++||||+||++|||++|++||..
T Consensus       177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~  229 (484)
T 3nyv_A          177 THFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG  229 (484)
T ss_dssp             HHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence            87654332  233569999999999876 689999999999999999999999965

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.2e-32  Score=294.09  Aligned_cols=201  Identities=24%  Similarity=0.343  Sum_probs=171.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEE-eeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-VEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lV~E  714 (869)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....  ..++.+|++++..++|++++..+.++ .+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            56889999999999999999997 5789999999865432  35688999999999998866555544 66778899999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE---cCCCcEEEeecCCcee
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKL  791 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl---~~~~~~kl~DFGla~~  791 (869)
                      |+ +++|.+++....    ..+++..+..++.|++.||+|||+++   |+||||||+|||+   +.++.+||+|||++..
T Consensus        86 ~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            99 899999986432    26899999999999999999999998   9999999999999   4889999999999987


Q ss_pred             ecCCCcc------ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          792 YEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       792 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      .......      ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence            7654321      1234578999999999999999999999999999999999999997643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-32  Score=309.68  Aligned_cols=202  Identities=24%  Similarity=0.345  Sum_probs=165.8

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------  706 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~------  706 (869)
                      +...++|.+.+.||+|+||.||+|.. .+++.||||++....    ....+|+++++.++|||||++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            44567899999999999999999997 478999999986542    2234799999999999999999998543      


Q ss_pred             --------------------------------ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHH
Q 002899          707 --------------------------------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY  754 (869)
Q Consensus       707 --------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~y  754 (869)
                                                      ...++||||++ |+|.+.+.... .....+++..+..++.||++||+|
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            34889999998 57777665321 112368999999999999999999


Q ss_pred             HHhcCCCCeEEcCCCCCCEEEc-CCCcEEEeecCCceeecCCCccccccccccccccchhhcccC-CCCchhHHHHHHHH
Q 002899          755 LHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVV  832 (869)
Q Consensus       755 LH~~~~~~iiH~Dlk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvi  832 (869)
                      ||+.+   |+||||||+|||++ .++.+||+|||+++.......  .....||+.|+|||++.+. .++.++||||+||+
T Consensus       157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            99998   99999999999998 689999999999987654332  2345689999999998764 58999999999999


Q ss_pred             HHHHHcCCCCCCCC
Q 002899          833 TLEIVSGKSNTNYR  846 (869)
Q Consensus       833 l~elltG~~p~~~~  846 (869)
                      +|||++|+.||...
T Consensus       232 l~ell~g~~pf~~~  245 (383)
T 3eb0_A          232 FGELILGKPLFSGE  245 (383)
T ss_dssp             HHHHHHSSCSSCCS
T ss_pred             HHHHHhCCCCCCCC
Confidence            99999999999753

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.3e-32  Score=298.95  Aligned_cols=192  Identities=21%  Similarity=0.373  Sum_probs=169.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchhhHHHHHHHHHHHhcC-CCceeeEEeEEee--CceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVE--GNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~--~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|.. .+++.||||+++...   .+.+.+|++++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            6788999999999999999986 468999999987433   467899999999997 9999999999987  66789999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-cEEEeecCCceee
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLY  792 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~-~~kl~DFGla~~~  792 (869)
                      ||+++++|.+++.        .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++ .+||+|||+++..
T Consensus       113 e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             ECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             eccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            9999999988873        3788999999999999999999998   99999999999999776 8999999999876


Q ss_pred             cCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .....  .....|++.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus       182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            54332  223468999999999876 6789999999999999999999999954

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-32  Score=300.45  Aligned_cols=197  Identities=30%  Similarity=0.470  Sum_probs=171.1

Q ss_pred             CCCCCeeeccCceEEEEEEEc-----CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEee--CceEEE
Q 002899          640 FDPANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLL  711 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~~-----~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~l  711 (869)
                      |++.+.||+|+||.||++.+.     +++.||||+++.... ...+.+.+|++++++++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            378899999999999998753     578999999976533 345678999999999999999999999987  467899


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+++...      .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       113 v~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence            99999999999998654      4899999999999999999999998   99999999999999999999999999987


Q ss_pred             ecCCCcc--ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .......  ......+|+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~  239 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS  239 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence            7644321  22334578889999999988899999999999999999999999853

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.3e-32  Score=307.68  Aligned_cols=197  Identities=24%  Similarity=0.338  Sum_probs=162.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc------
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------  707 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~------  707 (869)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467889999999999999999975 6889999998653  2334567889999999999999999999998655      


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                      ..++||||+++ +|.+.+..       .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ceEEEEEcCCC-CHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEee
Confidence            78999999985 67777742       4789999999999999999999998   9999999999999999999999999


Q ss_pred             CceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       173 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  229 (371)
T 2xrw_A          173 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  229 (371)
T ss_dssp             C------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            998664322  223457899999999999989999999999999999999999999653

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2e-32  Score=305.35  Aligned_cols=201  Identities=25%  Similarity=0.393  Sum_probs=172.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC-----ceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~  709 (869)
                      .++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457889999999999999999975 68899999987543 33347789999999999999999999999765     368


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||++ |+|.+++...      .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       106 ~iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence            99999998 5898888543      5899999999999999999999998   999999999999999999999999999


Q ss_pred             eeecCCCccc--cccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          790 KLYEEDKTHI--STRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       790 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      ..........  .....||+.|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  236 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  236 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence            8775432221  234579999999998654 558999999999999999999999996543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.8e-32  Score=312.28  Aligned_cols=198  Identities=21%  Similarity=0.313  Sum_probs=171.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhc------CCCceeeEEeEEeeCceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ------QHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l------~H~nIv~l~~~~~~~~~~  709 (869)
                      ..+|++.++||+|+||.||+|... +++.||||++... ....+.+.+|++++..+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457889999999999999999875 5889999999753 33356677888888776      577999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc--EEEeecC
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN--AKISDFG  787 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~--~kl~DFG  787 (869)
                      ++||||++ ++|.+++.....   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.  +||+|||
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEeccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence            99999997 689888866532   25899999999999999999999998   999999999999999887  9999999


Q ss_pred             CceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ++.......    ....||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus       248 ~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          248 SSCYEHQRV----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             TCEETTCCC----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cceecCCcc----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            997654322    2357899999999999989999999999999999999999999653

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4e-33  Score=306.76  Aligned_cols=212  Identities=29%  Similarity=0.428  Sum_probs=178.5

Q ss_pred             HHHHHhcCCCCCCeeeccCceEEEEEEEcC-C-----cEEEEEEecccCc-hhhHHHHHHHHHHHhc-CCCceeeEEeEE
Q 002899          632 QIKAATNNFDPANKVGEGGFGSVYKGILSD-G-----TVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCC  703 (869)
Q Consensus       632 ~i~~~t~~f~~~~~IG~G~fG~Vyka~~~~-g-----~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~~~~  703 (869)
                      +++...++|++.+.||+|+||.||+|.... +     +.||+|.+..... ...+.+.+|+++++++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            344456789999999999999999999742 2     4799999976543 3456789999999999 899999999999


Q ss_pred             eeCceEEEEEEeccCCchhhhhhcCCcc---------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 002899          704 VEGNQLLLVYEYMKNNCLSRAIFGKDTE---------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL  774 (869)
Q Consensus       704 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIL  774 (869)
                      .+.+..++||||+++|+|.+++......         ....+++..+..++.|++.||+|||+++   |+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence            9999999999999999999988653210         1235799999999999999999999997   999999999999


Q ss_pred             EcCCCcEEEeecCCceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          775 LDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       775 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      ++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  270 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI  270 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence            999999999999999866443321 2223457889999999998899999999999999999999 99998653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.2e-32  Score=294.48  Aligned_cols=199  Identities=27%  Similarity=0.450  Sum_probs=166.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .++|.+.+.||+|+||.||+|... +++.||||++....   ......+.+|+++++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            357889999999999999999986 78999999986542   22345788999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++++|.+++....     .+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        90 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccccc
Confidence            99999999999986542     5899999999999999999999998   999999999999999999999999999776


Q ss_pred             cCCCccccccccccccccchhhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .....  .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus       162 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  213 (276)
T 2h6d_A          162 SDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD  213 (276)
T ss_dssp             CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            54321  223468999999999987655 6899999999999999999999964

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.3e-32  Score=294.40  Aligned_cols=200  Identities=26%  Similarity=0.413  Sum_probs=174.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---------chhhHHHHHHHHHHHhcC-CCceeeEEeEEe
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---------RQGNREFVNEIGMISAQQ-HPNLVKLYGCCV  704 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---------~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~  704 (869)
                      ..++|++.+.||+|+||.||+|... +++.||||++....         ....+.+.+|++++.++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3568899999999999999999985 68899999986542         122456789999999995 999999999999


Q ss_pred             eCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEe
Q 002899          705 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS  784 (869)
Q Consensus       705 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~  784 (869)
                      ..+..++||||+++++|.+++...     ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence            999999999999999999998653     26899999999999999999999998   9999999999999999999999


Q ss_pred             ecCCceeecCCCccccccccccccccchhhcc------cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          785 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM------RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       785 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |||++........  .....|++.|+|||++.      ...++.++||||||+++|||++|+.||..
T Consensus       167 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  231 (298)
T 1phk_A          167 DFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH  231 (298)
T ss_dssp             CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence            9999987654322  23356899999999885      45678999999999999999999999854

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.1e-33  Score=317.00  Aligned_cols=200  Identities=15%  Similarity=0.156  Sum_probs=163.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccc---CchhhHHHHHHH---HHHHhcCCCceeeEE-------eE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEI---GMISAQQHPNLVKLY-------GC  702 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~---~~~~~~~f~~E~---~~l~~l~H~nIv~l~-------~~  702 (869)
                      .++|.+.+.||+|+||.||+|+. .+|+.||||++...   .....+.|.+|+   +++++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46688899999999999999996 46899999998743   334457788999   455566899999998       66


Q ss_pred             EeeCc-----------------eEEEEEEeccCCchhhhhhcCCcc--cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 002899          703 CVEGN-----------------QLLLVYEYMKNNCLSRAIFGKDTE--YRLKLDWPTRKKICIGIARGLAYLHEDSRIKI  763 (869)
Q Consensus       703 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  763 (869)
                      +...+                 ..++||||+ +|+|.+++......  ....+++..+..|+.||++||+|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            65543                 278999999 58999998653211  1123456888999999999999999998   9


Q ss_pred             EEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccccccccccccccchhhcccC-----------CCCchhHHHHHHHH
Q 002899          764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-----------YLTSKADVYSFGVV  832 (869)
Q Consensus       764 iH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~DvwSlGvi  832 (869)
                      +||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999986432    2233567 999999999877           89999999999999


Q ss_pred             HHHHHcCCCCCCC
Q 002899          833 TLEIVSGKSNTNY  845 (869)
Q Consensus       833 l~elltG~~p~~~  845 (869)
                      +|||++|+.||..
T Consensus       303 l~elltg~~Pf~~  315 (377)
T 3byv_A          303 IYWIWCADLPITK  315 (377)
T ss_dssp             HHHHHHSSCCC--
T ss_pred             HHHHHHCCCCCcc
Confidence            9999999999964

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2e-32  Score=299.84  Aligned_cols=200  Identities=26%  Similarity=0.410  Sum_probs=168.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc--------hhhHHHHHHHHHHHhcCCCceeeEEeEEeeC
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEG  706 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~--------~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~  706 (869)
                      ..++|.+.+.||+|+||.||+|... +++.||||++.....        .....+.+|++++++++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4567899999999999999999975 578999999865321        1234688999999999999999999998765


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc---EEE
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKI  783 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~---~kl  783 (869)
                      + .++||||+++++|.+++....     .+++..+..++.||++||+|||+++   |+||||||+|||++.++.   +||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl  158 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI  158 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEE
T ss_pred             c-eEEEEecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEE
Confidence            5 899999999999999886543     6899999999999999999999998   999999999999987654   999


Q ss_pred             eecCCceeecCCCccccccccccccccchhhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          784 SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       784 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +|||++.......  ......||+.|+|||++.   ...++.++||||||+++|||++|+.||...
T Consensus       159 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  222 (322)
T 2ycf_A          159 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  222 (322)
T ss_dssp             CCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred             ccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            9999998765322  222356899999999874   467899999999999999999999999653

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-32  Score=299.54  Aligned_cols=199  Identities=27%  Similarity=0.460  Sum_probs=163.0

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHh--cCCCceeeEEeEEeeC--
Q 002899          631 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVEG--  706 (869)
Q Consensus       631 ~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~--l~H~nIv~l~~~~~~~--  706 (869)
                      ..-....++|++.+.||+|+||.||+|+.. ++.||||++...   ....+..|.+++..  ++||||+++++++...  
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            333455678999999999999999999985 899999998543   23445556666655  4999999999999887  


Q ss_pred             --ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEcCCCCCCEEEcCCC
Q 002899          707 --NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS-----RIKIVHRDIKTSNVLLDKDL  779 (869)
Q Consensus       707 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~Dlk~~NILl~~~~  779 (869)
                        ...++||||+++|+|.+++...      .+++..+..++.|++.||+|||+..     .++|+||||||+|||++.++
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence              7899999999999999999653      5899999999999999999999871     11299999999999999999


Q ss_pred             cEEEeecCCceeecCCCccc---cccccccccccchhhcccCCCCch------hHHHHHHHHHHHHHcC
Q 002899          780 NAKISDFGLAKLYEEDKTHI---STRIAGTIGYMAPEYAMRGYLTSK------ADVYSFGVVTLEIVSG  839 (869)
Q Consensus       780 ~~kl~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------~DvwSlGvil~elltG  839 (869)
                      .+||+|||++..........   .....||+.|+|||++.+.....+      +|||||||++|||++|
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            99999999998765433221   123578999999999987766554      9999999999999999

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.7e-32  Score=294.00  Aligned_cols=197  Identities=28%  Similarity=0.469  Sum_probs=168.8

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEee----CceEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLL  711 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~l  711 (869)
                      .|.+.+.||+|+||.||+|... ++..||+|++...  .....+.+.+|++++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3667789999999999999975 5788999998654  23445678999999999999999999999875    456899


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-CCCcEEEeecCCce
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAK  790 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~-~~~~~kl~DFGla~  790 (869)
                      ||||+++|+|.+++....     .+++..+..++.|++.||+|||+.+ .+|+||||||+|||++ .++.+||+|||++.
T Consensus       107 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEecCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            999999999999996532     5899999999999999999999875 3499999999999997 78999999999997


Q ss_pred             eecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          791 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ......   .....||+.|+|||++. +.++.++||||||+++|||++|+.||..
T Consensus       181 ~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~  231 (290)
T 1t4h_A          181 LKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             GCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence            554322   22356899999999876 4589999999999999999999999964

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.6e-33  Score=309.74  Aligned_cols=196  Identities=29%  Similarity=0.436  Sum_probs=154.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------c
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------N  707 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~------~  707 (869)
                      .++|++.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468889999999999999999964 6899999998654  233456788999999999999999999998754      5


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                      ..++||||+ +++|.+++...      .+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CCEEEEECC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred             eEEEEeccc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence            679999998 68898887542      5899999999999999999999998   9999999999999999999999999


Q ss_pred             CceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +++.....    .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  233 (367)
T 2fst_X          178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  233 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99865432    223578999999999876 67899999999999999999999999653

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-33  Score=308.83  Aligned_cols=200  Identities=30%  Similarity=0.453  Sum_probs=159.8

Q ss_pred             CCCCCCeeeccCceEEEEEEEc--CC--cEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEee-CceEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS--DG--TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLV  712 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~--~g--~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV  712 (869)
                      .|++.++||+|+||.||+|.+.  ++  ..||||.++... ....++|.+|++++++++||||+++++++.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3566789999999999999864  22  368999986543 3446789999999999999999999998764 5578999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++|+|.+++....    ..+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       170 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence            99999999999996543    25789999999999999999999998   999999999999999999999999999866


Q ss_pred             cCCCcc---ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          793 EEDKTH---ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       793 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ......   ......+|+.|+|||++....++.++||||||+++|||++ |++||..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~  299 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  299 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCC
Confidence            432211   1223457789999999999999999999999999999999 6777754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.1e-33  Score=297.12  Aligned_cols=207  Identities=27%  Similarity=0.451  Sum_probs=172.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEee--CceEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~l  711 (869)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++..  .+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467889999999999999999975 68999999987543  3345678999999999999999999998854  568899


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS--RIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ||||+++++|.+++.... .....+++..+..++.|++.||+|||+.+  ..+|+||||||+||+++.++.+||+|||++
T Consensus        85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEECCTTEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEeCCCCCCHHHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            999999999999986532 12235899999999999999999999875  133999999999999999999999999999


Q ss_pred             eeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ........ ......|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       164 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  218 (279)
T 2w5a_A          164 RILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA  218 (279)
T ss_dssp             HHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence            77654322 12234689999999999988999999999999999999999999965

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.98  E-value=2.8e-32  Score=296.91  Aligned_cols=203  Identities=28%  Similarity=0.443  Sum_probs=164.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|... +++.||||++...   ......++.+|++++++++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            46888999999999999999974 7899999998753   2334567899999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++++|.+++.... .....+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus       112 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             ECCCSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             ecCCCCCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999886421 11236899999999999999999999998   9999999999999999999999999988665


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .... ......|++.|+|||++....++.++||||||+++|||++|+.||..
T Consensus       188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  238 (310)
T 2wqm_A          188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  238 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred             CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            4322 12235689999999999998999999999999999999999999964

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.98  E-value=1.1e-32  Score=300.97  Aligned_cols=204  Identities=25%  Similarity=0.339  Sum_probs=171.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEee----CceEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~l  711 (869)
                      .++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+++++.++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46788999999999999999997 4789999999877666667789999999999999999999999873    447899


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+++..... ....+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            9999999999998865311 1236899999999999999999999997   99999999999999999999999999876


Q ss_pred             ecCCCcc--------ccccccccccccchhhcccCC---CCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          792 YEEDKTH--------ISTRIAGTIGYMAPEYAMRGY---LTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       792 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      .......        ......||+.|+|||++....   ++.++||||||+++|||++|+.||.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  247 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD  247 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence            5321110        011245799999999987543   6889999999999999999999984

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.98  E-value=1.3e-32  Score=302.03  Aligned_cols=201  Identities=30%  Similarity=0.496  Sum_probs=174.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-----cCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc--eE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-----~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~--~~  709 (869)
                      .++|++.+.||+|+||.||+|+.     .+++.||||++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            34678889999999999999984     368899999998776666778999999999999999999999987654  68


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||+++++|.+++....    ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence            99999999999999997643    25899999999999999999999997   999999999999999999999999999


Q ss_pred             eeecCCCcc--ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          790 KLYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       790 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      .........  ......++..|+|||++.+..++.++||||||+++|||++|+.|+.
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~  249 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK  249 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence            877544321  1223456778999999998889999999999999999999998875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.98  E-value=3.2e-32  Score=296.85  Aligned_cols=200  Identities=33%  Similarity=0.517  Sum_probs=171.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ..++|++.+.||+|+||.||+|... +|+.||||++....  ...++.+|++++++++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4567899999999999999999976 58999999987543  35678999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++++|.+++....    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus       105 ~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          105 YCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             CCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             cCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            999999999886322    26899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ... ......|++.|+|||++....++.++||||||+++|||++|+.||..
T Consensus       178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  227 (314)
T 3com_A          178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD  227 (314)
T ss_dssp             TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            322 12335689999999999988899999999999999999999999964

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.98  E-value=1.8e-32  Score=295.64  Aligned_cols=200  Identities=30%  Similarity=0.439  Sum_probs=169.3

Q ss_pred             hcCCCCCC-eeeccCceEEEEEEEc---CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEE
Q 002899          637 TNNFDPAN-KVGEGGFGSVYKGILS---DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       637 t~~f~~~~-~IG~G~fG~Vyka~~~---~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  710 (869)
                      .++|.+.+ .||+|+||.||+|...   +++.||||+++...  ....+++.+|+++++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35677777 9999999999999653   46789999987553  22356799999999999999999999999 567789


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      +||||+++++|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        94 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEeCCCCCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            9999999999999997643     5899999999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCccc--cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          791 LYEEDKTHI--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       791 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .........  .....+++.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  223 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG  223 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence            775443321  122346789999999998889999999999999999999 9999965

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.98  E-value=1.8e-32  Score=298.84  Aligned_cols=210  Identities=27%  Similarity=0.415  Sum_probs=164.8

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN  707 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~~----~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~  707 (869)
                      ....++|.+.+.||+|+||.||+|...    .++.||||+++...  ....+.+.+|++++++++||||+++++++.+.+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            334567888999999999999999864    34589999987543  334567899999999999999999999998755


Q ss_pred             e-----EEEEEEeccCCchhhhhhcCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcE
Q 002899          708 Q-----LLLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA  781 (869)
Q Consensus       708 ~-----~~lV~E~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~  781 (869)
                      .     .++||||+++|+|.+++..... .....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence            3     4999999999999998854321 12246899999999999999999999997   9999999999999999999


Q ss_pred             EEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          782 KISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       782 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      ||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  253 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV  253 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence            9999999987644322 11223457889999999999999999999999999999999 88888653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.98  E-value=8.1e-33  Score=299.79  Aligned_cols=201  Identities=26%  Similarity=0.488  Sum_probs=170.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      .++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+++++.++||||+++++++..++..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467889999999999999999986 5889999999876666678899999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++....    ..+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        98 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           98 CPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             CTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             CCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            99999998886532    25899999999999999999999998   999999999999999999999999987543221


Q ss_pred             Cccccccccccccccchhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      . .......||+.|+|||++.     ...++.++||||||+++|||++|+.||..
T Consensus       171 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  224 (302)
T 2j7t_A          171 L-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE  224 (302)
T ss_dssp             H-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             c-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc
Confidence            1 1112346899999999983     56789999999999999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.98  E-value=1.6e-32  Score=303.94  Aligned_cols=200  Identities=23%  Similarity=0.395  Sum_probs=174.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchh-----------------hHHHHHHHHHHHhcCCCceeeE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG-----------------NREFVNEIGMISAQQHPNLVKL  699 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~-----------------~~~f~~E~~~l~~l~H~nIv~l  699 (869)
                      .++|.+.+.||+|+||.||+|.. +++.||||++.......                 ...+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46788999999999999999999 89999999986542211                 1789999999999999999999


Q ss_pred             EeEEeeCceEEEEEEeccCCchhhh------hhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCC
Q 002899          700 YGCCVEGNQLLLVYEYMKNNCLSRA------IFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSN  772 (869)
Q Consensus       700 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~N  772 (869)
                      ++++.+.+..++||||+++|+|.++      +...   ....+++..+..++.|++.||+|||+ .+   |+||||||+|
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N  182 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN  182 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence            9999999999999999999999998      5432   12478999999999999999999998 77   9999999999


Q ss_pred             EEEcCCCcEEEeecCCceeecCCCccccccccccccccchhhcccC-CCCc-hhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          773 VLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTS-KADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       773 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |+++.++.+||+|||++......   ......|++.|+|||++.+. .++. ++||||||+++|||++|+.||...
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  255 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK  255 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999876543   22345689999999999876 5666 999999999999999999999753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.98  E-value=3.4e-32  Score=298.26  Aligned_cols=202  Identities=27%  Similarity=0.473  Sum_probs=171.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEE--cCCcEEEEEEecccCc--hhhHHHHHHHHHHHhc---CCCceeeEEeEEe----
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGIL--SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQ---QHPNLVKLYGCCV----  704 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~--~~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l---~H~nIv~l~~~~~----  704 (869)
                      +.++|++.+.||+|+||.||+|..  .+++.||+|++.....  .....+.+|+++++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999997  3678999999865432  2234567777777665   8999999999987    


Q ss_pred             -eCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEE
Q 002899          705 -EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI  783 (869)
Q Consensus       705 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl  783 (869)
                       .....++||||++ |+|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl  161 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKL  161 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEE
Confidence             5567899999998 699998865432   25899999999999999999999998   999999999999999999999


Q ss_pred             eecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          784 SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       784 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +|||++.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       162 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  222 (326)
T 1blx_A          162 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  222 (326)
T ss_dssp             CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence            9999998664322  223456899999999999889999999999999999999999999653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.98  E-value=1.3e-32  Score=327.70  Aligned_cols=194  Identities=30%  Similarity=0.444  Sum_probs=163.9

Q ss_pred             CeeeccCceEEEEEEEc---CCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~---~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      +.||+|+||.||+|.+.   .++.||||+++....  ...++|.+|++++++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999763   467899999976432  335789999999999999999999999864 568899999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|.+++....     .+++..+..|+.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+......
T Consensus       454 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          454 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             CCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            99999996543     6899999999999999999999998   999999999999999999999999999876543321


Q ss_pred             --ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          799 --ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       799 --~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                        ......+|+.|+|||++....++.++|||||||++|||++ |+.||...
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~  576 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM  576 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence              1223456789999999999999999999999999999998 99999653

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.98  E-value=2.7e-32  Score=295.15  Aligned_cols=201  Identities=30%  Similarity=0.447  Sum_probs=167.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcC----CcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEee-CceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~----g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~l  711 (869)
                      .+|++.++||+|+||.||+|...+    ...||+|.+.... ....+.+.+|++++++++||||+++++++.+ ++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457788999999999999998642    2368999987543 3345678999999999999999999998654 567899


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+++....    ..+++..+..++.|+++||+|||+++   |+||||||+||+++.++.+||+|||++..
T Consensus       105 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence            999999999999996543    25799999999999999999999998   99999999999999999999999999987


Q ss_pred             ecCCCc---cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          792 YEEDKT---HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       792 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ......   .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||..
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  235 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  235 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            644321   11223457889999999999999999999999999999999 5555543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.98  E-value=1.9e-32  Score=308.69  Aligned_cols=199  Identities=27%  Similarity=0.388  Sum_probs=164.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce------EE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ------LL  710 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~------~~  710 (869)
                      ..+|.+.++||+|+||.||+|+...+..||+|++.....    ...+|+++++.++||||+++++++...+.      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            346888999999999999999998777799998754322    22369999999999999999999965443      78


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-CCCcEEEeecCCc
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLA  789 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~-~~~~~kl~DFGla  789 (869)
                      +||||++++.+.......  .....+++..+..++.||++||+|||+.+   |+||||||+|||++ .++.+||+|||++
T Consensus       115 lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYA--KLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEECCSEEHHHHHHHHH--HTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEeeccCccHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            999999976444332211  11236899999999999999999999998   99999999999999 7999999999999


Q ss_pred             eeecCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          790 KLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       790 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +.......  .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       190 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  245 (394)
T 4e7w_A          190 KILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE  245 (394)
T ss_dssp             EECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            87754332  2345789999999998764 5899999999999999999999999753

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.98  E-value=3.4e-32  Score=309.21  Aligned_cols=209  Identities=28%  Similarity=0.361  Sum_probs=166.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------ceEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQLL  710 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~  710 (869)
                      .+|++.++||+|+||.||+|+.. +++.||||++....    +.+.+|+++++.++|||||++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            45788899999999999999985 58999999986432    2334799999999999999999998642      2367


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-CcEEEeecCCc
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLA  789 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~-~~~kl~DFGla  789 (869)
                      +||||+++ ++.+.+.... .....+++..+..++.||++||+|||+.+   |+||||||+|||++.+ +.+||+|||++
T Consensus       130 lv~e~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eehhcccc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence            99999986 5655543211 11236899999999999999999999987   9999999999999965 67899999999


Q ss_pred             eeecCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHH
Q 002899          790 KLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAY  859 (869)
Q Consensus       790 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~  859 (869)
                      +.......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....  +...+.+.+.
T Consensus       205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~--~~~~l~~i~~  271 (420)
T 1j1b_A          205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIK  271 (420)
T ss_dssp             EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH
T ss_pred             hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHH
Confidence            87654332  2235789999999998764 78999999999999999999999996532  3334444443

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.98  E-value=2.3e-32  Score=299.98  Aligned_cols=203  Identities=30%  Similarity=0.472  Sum_probs=169.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcE--EEEEEeccc-CchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTV--IAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~--VAvK~~~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ++|++.+.||+|+||.||+|+.. ++..  ||+|.++.. .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57888999999999999999965 5654  499988653 233456789999999999 999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcE
Q 002899          713 YEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA  781 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~  781 (869)
                      |||+++|+|.+++.....           .....+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            999999999999976531           12236899999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          782 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       782 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      ||+|||+++......  ......+++.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~  244 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  244 (327)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence            999999987433211  1122356789999999998889999999999999999998 9999954

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.98  E-value=9.2e-33  Score=306.54  Aligned_cols=197  Identities=16%  Similarity=0.237  Sum_probs=169.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcC---------CcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceee----------
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSD---------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK----------  698 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~---------g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~----------  698 (869)
                      ++|.+.+.||+|+||.||+|+...         ++.||||++...     ..+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578899999999999999999763         788999998643     46889999999999999987          


Q ss_pred             -----EEeEEee-CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCC
Q 002899          699 -----LYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN  772 (869)
Q Consensus       699 -----l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~N  772 (869)
                           +++++.. ++..++||||+ +++|.+++....   ...+++..+..++.||++||+|||+++   |+||||||+|
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N  189 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN  189 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence                 6777776 67889999999 999999997642   236899999999999999999999998   9999999999


Q ss_pred             EEEcCCC--cEEEeecCCceeecCCCcc------ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          773 VLLDKDL--NAKISDFGLAKLYEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       773 ILl~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      ||++.++  .+||+|||+++.+......      ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  8999999999876543211      1123578999999999999899999999999999999999999997


Q ss_pred             CC
Q 002899          845 YR  846 (869)
Q Consensus       845 ~~  846 (869)
                      ..
T Consensus       270 ~~  271 (352)
T 2jii_A          270 NC  271 (352)
T ss_dssp             GG
T ss_pred             cC
Confidence            53

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.98  E-value=2.7e-32  Score=297.88  Aligned_cols=200  Identities=26%  Similarity=0.396  Sum_probs=165.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEe-----------
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV-----------  704 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~-----------  704 (869)
                      .++|.+.+.||+|+||.||+|... +++.||||++........+++.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            367889999999999999999986 48999999998766666788999999999999999999999874           


Q ss_pred             ---eCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-CCCc
Q 002899          705 ---EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLN  780 (869)
Q Consensus       705 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~-~~~~  780 (869)
                         +.+..++||||++ |+|.+++...      .+++..+..++.|+++||+|||+++   |+||||||+|||++ +++.
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCe
Confidence               3467899999998 6999988542      5889999999999999999999998   99999999999997 5679


Q ss_pred             EEEeecCCceeecCCCc--cccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          781 AKISDFGLAKLYEEDKT--HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       781 ~kl~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +||+|||+++.......  .......+|+.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  228 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA  228 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence            99999999987643221  11223457889999998865 67899999999999999999999999653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.98  E-value=4e-32  Score=306.04  Aligned_cols=199  Identities=25%  Similarity=0.350  Sum_probs=168.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcC--------CCceeeEEeEEe---
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ--------HPNLVKLYGCCV---  704 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~--------H~nIv~l~~~~~---  704 (869)
                      .++|++.++||+|+||.||+|... +++.||||++... ....+.+.+|+++++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            467899999999999999999865 6889999999743 334567889999999885        788999999988   


Q ss_pred             -eCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEcCCCCCCEEEcCCC---
Q 002899          705 -EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDL---  779 (869)
Q Consensus       705 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NILl~~~~---  779 (869)
                       .....++||||+. +++.+.+.....   ..+++..++.++.||+.||+|||++ +   |+||||||+|||++.++   
T Consensus       115 ~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          115 VNGTHICMVFEVLG-HHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             TTEEEEEEEECCCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred             CCCceEEEEEeccC-ccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence             4567899999995 556555544321   2589999999999999999999998 7   99999999999999775   


Q ss_pred             ----------------------------------------------cEEEeecCCceeecCCCccccccccccccccchh
Q 002899          780 ----------------------------------------------NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE  813 (869)
Q Consensus       780 ----------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE  813 (869)
                                                                    .+||+|||++.......    ....||+.|+|||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~~y~aPE  263 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCGGGCCHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCCcccCCh
Confidence                                                          79999999998765332    2346899999999


Q ss_pred             hcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          814 YAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       814 ~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      ++.+..++.++|||||||++|||++|+.||....
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  297 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHS  297 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            9999899999999999999999999999997644

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=4.5e-32  Score=293.18  Aligned_cols=198  Identities=28%  Similarity=0.413  Sum_probs=167.5

Q ss_pred             CCCCCCeeeccCceEEEEEEEcC-C---cEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceE-EEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILSD-G---TVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL-LLV  712 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~~-g---~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~-~lV  712 (869)
                      .|+..++||+|+||.||+|.+.+ +   ..||+|.+..... ...+.|.+|++++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            34556899999999999998642 2   3799999875433 3457789999999999999999999999876665 999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+.+|+|.+++....    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       102 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             EecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            99999999999997643    25799999999999999999999998   999999999999999999999999999765


Q ss_pred             cCCCc---cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 002899          793 EEDKT---HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       793 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~  843 (869)
                      .....   .......+++.|+|||.+.+..++.++||||||+++|||++|+.|+
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~  228 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP  228 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred             cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence            43221   1122356788999999999999999999999999999999966664

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.98  E-value=7.1e-32  Score=292.79  Aligned_cols=202  Identities=25%  Similarity=0.329  Sum_probs=168.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC----chhhHHHHHHHHHHHhcCCCceeeEEeEEe--eCceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQHPNLVKLYGCCV--EGNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~----~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~--~~~~~  709 (869)
                      .++|.+.+.||+|+||.||+|... +++.||+|+++...    ......+.+|++++++++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999975 68899999987542    234567899999999999999999999984  45678


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||++++ |.+++....   ...+++..+..++.|+++||+|||+++   |+||||||+||+++.++.+||+|||++
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEehhccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence            9999999977 666665432   236899999999999999999999998   999999999999999999999999999


Q ss_pred             eeecCCC-ccccccccccccccchhhcccCC--CCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDK-THISTRIAGTIGYMAPEYAMRGY--LTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....... ........||+.|+|||++.+..  .+.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG  215 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            8765322 12223456899999999987643  47899999999999999999999964

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.98  E-value=1.6e-32  Score=294.00  Aligned_cols=197  Identities=30%  Similarity=0.478  Sum_probs=164.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC-ceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-NQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lV~E~  715 (869)
                      .++|++.+.||+|+||.||+|... ++.||||+++...  ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            457888999999999999999875 8899999987543  456789999999999999999999997654 478999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++++|.+++....   ...+++..+..++.|+++||+|||+++   ++||||||+||+++.++.+||+|||++......
T Consensus        97 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             CTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             CCCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            99999999986542   124789999999999999999999998   999999999999999999999999998765432


Q ss_pred             CccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      .    ....+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       171 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  218 (278)
T 1byg_A          171 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  218 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             c----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence            2    12357889999999998899999999999999999998 99998653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.98  E-value=9.8e-33  Score=308.63  Aligned_cols=198  Identities=11%  Similarity=0.042  Sum_probs=152.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHHHHhc--CCCceeeEE-------eEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQ--QHPNLVKLY-------GCC  703 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l--~H~nIv~l~-------~~~  703 (869)
                      ..+|.+.+.||+|+||.||+|... +++.||||++.....   ...+.+.+|+++++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345788999999999999999975 789999999977542   2345677785544444  699988855       444


Q ss_pred             eeC-----------------ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHH------HHHHHHHHHHHHHHHhcCC
Q 002899          704 VEG-----------------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR------KKICIGIARGLAYLHEDSR  760 (869)
Q Consensus       704 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~  760 (869)
                      ...                 ...++||||++ |+|.+++.....    .+.+..+      ..++.||++||+|||+++ 
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSKG-  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-
Confidence            432                 34899999999 899999975421    3455666      788899999999999998 


Q ss_pred             CCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCccccccccccccccchhhccc--CCCCchhHHHHHHHHHHHHHc
Q 002899          761 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVS  838 (869)
Q Consensus       761 ~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~ellt  838 (869)
                        |+||||||+|||++.++.+||+|||+++......    ....+|+.|+|||++.+  ..++.++|||||||++|||++
T Consensus       215 --ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          215 --LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             --EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             --CccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence              9999999999999999999999999998664321    13456799999999987  679999999999999999999


Q ss_pred             CCCCCCCC
Q 002899          839 GKSNTNYR  846 (869)
Q Consensus       839 G~~p~~~~  846 (869)
                      |+.||...
T Consensus       289 g~~Pf~~~  296 (371)
T 3q60_A          289 LFLPFGLV  296 (371)
T ss_dssp             SSCSTTBC
T ss_pred             CCCCCCCc
Confidence            99999654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.98  E-value=5.1e-32  Score=296.95  Aligned_cols=204  Identities=29%  Similarity=0.487  Sum_probs=168.8

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEee------
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE------  705 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~------  705 (869)
                      ....++|++.+.||+|+||.||+|... +++.||||++.... ....++.+|++++.++ +||||+++++++..      
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            345678899999999999999999974 68999999986543 3457889999999998 89999999999987      


Q ss_pred             CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002899          706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD  785 (869)
Q Consensus       706 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~D  785 (869)
                      .+..++||||+++|+|.+++....   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEee
Confidence            467899999999999999997643   236899999999999999999999998   99999999999999999999999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ||++........ ......||+.|+|||++.     ...++.++||||||+++|||++|+.||..
T Consensus       173 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  236 (326)
T 2x7f_A          173 FGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  236 (326)
T ss_dssp             CTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            999987643221 122356899999999986     56789999999999999999999999954

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.98  E-value=1.4e-31  Score=307.90  Aligned_cols=204  Identities=25%  Similarity=0.343  Sum_probs=173.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccCchhhHHHHHHHHHHHhcCC-CceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++|++.++||+|+||.||+|+. .+++.||||++.....  ..++..|++++..++| +++..+..++.+.+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46789999999999999999996 4689999998765432  3468899999999987 556677777788889999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE---cCCCcEEEeecCCcee
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKL  791 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl---~~~~~~kl~DFGla~~  791 (869)
                      |+ +++|.+++....    ..+++..++.|+.||+.||+|||+++   |+||||||+|||+   +.++.+||+|||+++.
T Consensus        84 ~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             CC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            99 899999986432    26899999999999999999999998   9999999999999   6889999999999988


Q ss_pred             ecCCCcc------ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcc
Q 002899          792 YEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED  850 (869)
Q Consensus       792 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~  850 (869)
                      +......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~  220 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT  220 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh
Confidence            7654321      1224679999999999999999999999999999999999999997644333

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.98  E-value=2.3e-32  Score=294.32  Aligned_cols=202  Identities=25%  Similarity=0.386  Sum_probs=157.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhh-HHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGN-REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~-~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      .++|++.+.||+|+||.||+|... +++.||||+++.... ... +.+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            467889999999999999999974 789999999876532 222 33445555678899999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      ||++ |+|.+++.... .....+++..+..++.|++.||+|||++ +   |+||||||+||+++.++.+||+|||++...
T Consensus        86 e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             ECCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             ehhc-cchHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            9998 48877664321 1123689999999999999999999998 7   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccccchhhc----ccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYA----MRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .....  .....||+.|+|||++    ....++.++||||||+++|||++|+.||..
T Consensus       161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (290)
T 3fme_A          161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS  215 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence            54322  2234689999999996    456789999999999999999999999964

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.98  E-value=8.3e-32  Score=297.27  Aligned_cols=204  Identities=28%  Similarity=0.415  Sum_probs=173.0

Q ss_pred             cHHHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHh--cCCCceeeEEeEEeeC
Q 002899          629 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVEG  706 (869)
Q Consensus       629 ~~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~--l~H~nIv~l~~~~~~~  706 (869)
                      ....-....++|.+.+.||+|+||.||+|+. +++.||||++...   ..+.+..|++++..  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3334455678899999999999999999998 5899999998643   34677889888887  7999999999999887


Q ss_pred             c----eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEcCCCCCCEE
Q 002899          707 N----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH--------EDSRIKIVHRDIKTSNVL  774 (869)
Q Consensus       707 ~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiH~Dlk~~NIL  774 (869)
                      +    ..++||||+++|+|.+++...      .+++..+..++.|++.||+|||        +.+   |+||||||+|||
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIl  179 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNIL  179 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEE
Confidence            6    789999999999999999653      5899999999999999999999        665   999999999999


Q ss_pred             EcCCCcEEEeecCCceeecCCCcc---ccccccccccccchhhcccCC------CCchhHHHHHHHHHHHHHcC------
Q 002899          775 LDKDLNAKISDFGLAKLYEEDKTH---ISTRIAGTIGYMAPEYAMRGY------LTSKADVYSFGVVTLEIVSG------  839 (869)
Q Consensus       775 l~~~~~~kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~k~DvwSlGvil~elltG------  839 (869)
                      ++.++.+||+|||++.........   ......||+.|+|||++....      ++.++||||||+++|||++|      
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            999999999999999877654322   123457899999999987652      33789999999999999999      


Q ss_pred             ----CCCCCC
Q 002899          840 ----KSNTNY  845 (869)
Q Consensus       840 ----~~p~~~  845 (869)
                          +.||..
T Consensus       260 ~~~~~~p~~~  269 (342)
T 1b6c_B          260 HEDYQLPYYD  269 (342)
T ss_dssp             CCCCCCTTTT
T ss_pred             ccccccCccc
Confidence                677754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.98  E-value=7.7e-32  Score=296.62  Aligned_cols=199  Identities=22%  Similarity=0.353  Sum_probs=172.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE-c-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCc------eeeEEeEEeeCce
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL-S-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN------LVKLYGCCVEGNQ  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~-~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~n------Iv~l~~~~~~~~~  708 (869)
                      .++|++.+.||+|+||.||+|.. . +++.||||+++.. ......+.+|+++++.++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46788999999999999999986 3 6889999998753 334567888999998887654      9999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-----------
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-----------  777 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~-----------  777 (869)
                      .++||||+ +++|.+++.....   .++++..+..++.|+++||+|||+++   |+||||||+|||++.           
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred             EEEEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence            99999999 7899998866532   26889999999999999999999998   999999999999987           


Q ss_pred             --------CCcEEEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          778 --------DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       778 --------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                              ++.+||+|||++.......    ....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             ccccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                    6689999999998654322    23578999999999998899999999999999999999999997543

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.98  E-value=7e-33  Score=301.21  Aligned_cols=281  Identities=20%  Similarity=0.258  Sum_probs=217.0

Q ss_pred             EEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCC--CchhhcCcccccccccc
Q 002899           57 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGP--FPKVLTNITTLKNLSIE  133 (869)
Q Consensus        57 ~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~Ls  133 (869)
                      +.+++++++++ .+|..+.  ++|++|+|++|+|+.+++..|..+ +|++|+|++|+++..  .+..+..+++|++|+|+
T Consensus        10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls   86 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS   86 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred             CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence            36788888888 5666554  689999999999998877777777 899999999988843  36677788999999999


Q ss_pred             ccccCCCCCccccCCCCccEEEeecccccccCC-ccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCC-
Q 002899          134 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG-  211 (869)
Q Consensus       134 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-  211 (869)
                      +|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|++|+|++|++++..+..|..+++|++|+|++|.+++ 
T Consensus        87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  165 (306)
T 2z66_A           87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN  165 (306)
T ss_dssp             SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred             CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence            99888 566778888899999999998886554 578888889999999998888888888888888888888888876 


Q ss_pred             CchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcC
Q 002899          212 PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL  291 (869)
Q Consensus       212 ~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  291 (869)
                      ..|..+..+++|+.|+|+                       +|+|++..|..|..+++|+.|+|++|++++..+..+..+
T Consensus       166 ~~~~~~~~l~~L~~L~Ls-----------------------~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  222 (306)
T 2z66_A          166 FLPDIFTELRNLTFLDLS-----------------------QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL  222 (306)
T ss_dssp             EECSCCTTCTTCCEEECT-----------------------TSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTC
T ss_pred             cchhHHhhCcCCCEEECC-----------------------CCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCc
Confidence            467777777777666665                       555555566667777777777777777776666677777


Q ss_pred             CCCCEEEeeCCcCCCCCchhhh---ccCCceeeeccCccCCCCCCCCCCCCCccceeccCCCCCCCCCCcCccCCCCCCC
Q 002899          292 AKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCS  368 (869)
Q Consensus       292 ~~L~~L~Ls~N~l~~~~p~~~~---~~l~~l~ls~N~~~~~~~~p~~C~c~~~~~~~~l~~~~~~~~~~~~~~~~~~~C~  368 (869)
                      ++|+.|+|++|++++..|..+.   ..++.|+|++|        ||.|+|.+.++..|++..+....     ......|+
T Consensus       223 ~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N--------~~~~~c~~~~~~~~l~~~~~~~~-----~~~~~~C~  289 (306)
T 2z66_A          223 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN--------DFACTCEHQSFLQWIKDQRQLLV-----EVERMECA  289 (306)
T ss_dssp             TTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTC--------CEECSGGGHHHHHHHHHTGGGBS-----CGGGCBEE
T ss_pred             ccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCC--------CeecccChHHHHHHHHhhhhhhc-----cccccccC
Confidence            7777777777777777666552   36677777777        88899999999999976543221     12456788


Q ss_pred             CCcccccce
Q 002899          369 APADQYHYT  377 (869)
Q Consensus       369 ~p~~~~~~~  377 (869)
                      .|+..+|+.
T Consensus       290 ~p~~~~g~~  298 (306)
T 2z66_A          290 TPSDKQGMP  298 (306)
T ss_dssp             ESGGGTTCB
T ss_pred             CchhhCCce
Confidence            888776654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.98  E-value=5e-32  Score=300.49  Aligned_cols=200  Identities=24%  Similarity=0.399  Sum_probs=170.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC-----ceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~  709 (869)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.... .....++.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467889999999999999999976 68999999986543 33356788999999999999999999988764     678


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||++ |+|.+++...      .+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        90 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence            99999998 5898888653      5899999999999999999999998   999999999999999999999999999


Q ss_pred             eeecCCCcc---------ccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          790 KLYEEDKTH---------ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       790 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .........         ......||+.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  226 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR  226 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            876532211         1123468999999998764 67899999999999999999999999653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.98  E-value=2e-32  Score=300.56  Aligned_cols=206  Identities=31%  Similarity=0.410  Sum_probs=170.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEE------cCCcEEEEEEeccc-CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~------~~g~~VAvK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~  709 (869)
                      .++|++.+.||+|+||.||+|+.      .+++.||||++... ......++.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46788999999999999999984      24678999999754 334456789999999999999999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCcc--cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCcEEEe
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTE--YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKIS  784 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~---~~~~kl~  784 (869)
                      ++||||+++|+|.+++......  ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            9999999999999999765321  1235899999999999999999999998   999999999999984   4569999


Q ss_pred             ecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          785 DFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       785 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      |||++........ .......||+.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  248 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS  248 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            9999876543221 12223467889999999998899999999999999999998 9999864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.98  E-value=1.7e-32  Score=302.03  Aligned_cols=195  Identities=32%  Similarity=0.524  Sum_probs=160.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHH--HHhcCCCceeeEEeEEee-----CceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM--ISAQQHPNLVKLYGCCVE-----GNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~--l~~l~H~nIv~l~~~~~~-----~~~~  709 (869)
                      .++|++.+.||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            36788899999999999999987 68999999986432   3445555555  445899999999986543     3367


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeEEcCCCCCCEEEcCCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED---------SRIKIVHRDIKTSNVLLDKDLN  780 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~iiH~Dlk~~NILl~~~~~  780 (869)
                      ++||||+++|+|.+++...      ..++..+..++.||++||+|||+.         +   |+||||||+|||++.++.
T Consensus        88 ~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred             EEEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence            8999999999999999654      358999999999999999999988         6   999999999999999999


Q ss_pred             EEEeecCCceeecCCCc-------cccccccccccccchhhccc-------CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          781 AKISDFGLAKLYEEDKT-------HISTRIAGTIGYMAPEYAMR-------GYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       781 ~kl~DFGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      +||+|||++..+.....       .......||+.|+|||++.+       ..++.++|||||||++|||++|+.|+.
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            99999999987653221       11223569999999999876       356678999999999999999977763

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.97  E-value=1.3e-32  Score=329.29  Aligned_cols=261  Identities=20%  Similarity=0.260  Sum_probs=234.2

Q ss_pred             CccccCCccccCCCCCCEEEeecCcCCCC-----------------Cchhhc--cc-cceEEEeecccCCCCCchhhcCc
Q 002899           65 NLTGTLPTELSKLRYLKQLDLSRNCLTGS-----------------FSPQWA--SL-QLVELSVMGNRLSGPFPKVLTNI  124 (869)
Q Consensus        65 ~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~-----------------~~~~~~--~l-~L~~L~Ls~N~l~~~~~~~~~~l  124 (869)
                      ++++ +|.+|+++++|++|+|++|.+++.                 +|..+.  .+ +|++|+|++|++.+.+|..|+++
T Consensus       194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l  272 (636)
T 4eco_A          194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL  272 (636)
T ss_dssp             EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred             CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence            4556 899999999999999999999995                 777776  66 89999999999999999999999


Q ss_pred             cccccccccccc-cCC-CCCccccCC------CCccEEEeecccccccCCc--cccCCCCCCeEeccCCcCCCCCccccC
Q 002899          125 TTLKNLSIEGNL-FTG-SIPPDIRKL------INLQKLILSSNSFTGELPA--ELTKLTNLNDLRISDNNFSGKIPEFIG  194 (869)
Q Consensus       125 ~~L~~L~Ls~N~-l~~-~~~~~~~~l------~~L~~L~Ls~N~i~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~  194 (869)
                      ++|++|+|++|+ +++ .+|..++.+      ++|++|+|++|+++ .+|.  .+.++++|++|+|++|+++|.+| .|.
T Consensus       273 ~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~  350 (636)
T 4eco_A          273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFG  350 (636)
T ss_dssp             SSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCE
T ss_pred             CCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhC
Confidence            999999999998 998 789888876      99999999999999 8888  89999999999999999998889 999


Q ss_pred             CCCcccEEEccCCcCCCCchHhhhcCCC-CCEEEcCCCCCCCCccccccc--ccceEEEcccccCccCCCcccC------
Q 002899          195 KWKKIQKLHIQGSSLEGPIPASISALTS-LTDLRISDLKGSESAFPKLDK--MNLKTLILTKCLIHGEIPDYIG------  265 (869)
Q Consensus       195 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~-L~~L~L~~n~~~~~~~~~~~~--~~L~~L~Ls~N~i~~~~p~~~~------  265 (869)
                      .+++|+.|+|++|+++ .+|..+..+++ |+.|+|++|.++..+......  .+|+.|+|++|++++.+|..|.      
T Consensus       351 ~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~  429 (636)
T 4eco_A          351 SEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP  429 (636)
T ss_dssp             EEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSC
T ss_pred             CCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccchhhhhcccCccCEEECcCCcCCCcchhhhccccccc
Confidence            9999999999999999 78888999999 999999999999655332222  2799999999999999999988      


Q ss_pred             -CCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhc----------cCCceeeeccCccCCC
Q 002899          266 -DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN----------SNKNVDISLNNFTWES  330 (869)
Q Consensus       266 -~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~----------~l~~l~ls~N~~~~~~  330 (869)
                       .+++|+.|+|++|+|+...+..+..+++|+.|+|++|+++ .+|...+.          .++.|+|++|+++..+
T Consensus       430 ~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp  504 (636)
T 4eco_A          430 FKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLS  504 (636)
T ss_dssp             CCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCCBCC
T ss_pred             ccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCCccC
Confidence             8899999999999999665566777999999999999999 78877654          8899999999998554

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.97  E-value=2.2e-32  Score=309.57  Aligned_cols=203  Identities=26%  Similarity=0.422  Sum_probs=154.8

Q ss_pred             cCCCC-CCeeeccCceEEEEEEEc---CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEee--CceEEE
Q 002899          638 NNFDP-ANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLL  711 (869)
Q Consensus       638 ~~f~~-~~~IG~G~fG~Vyka~~~---~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~l  711 (869)
                      +.|.+ .++||+|+||.||+|+..   +++.||||++....  ....+.+|++++++++|||||++++++..  ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34555 458999999999999975   47889999997543  23578899999999999999999999954  678999


Q ss_pred             EEEeccCCchhhhhhcCC----cccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE----cCCCcEEE
Q 002899          712 VYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKI  783 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl----~~~~~~kl  783 (869)
                      ||||+++ +|.+++....    ......+++..++.++.||+.||+|||+.+   |+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999985 7777664321    111225899999999999999999999998   9999999999999    67899999


Q ss_pred             eecCCceeecCCCc--cccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          784 SDFGLAKLYEEDKT--HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       784 ~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +|||+++.......  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            99999987654321  12234678999999999887 45899999999999999999999999653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.97  E-value=2.4e-32  Score=300.51  Aligned_cols=205  Identities=24%  Similarity=0.321  Sum_probs=158.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcC-CCceeeEEeEEe--------eC
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCV--------EG  706 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~--------~~  706 (869)
                      ..+|++.++||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457888999999999999999975 68999999987766666778999999999996 999999999994        34


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                      ...++||||++ |+|.+++....  ....+++..+..++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence            45899999996 78888875421  1226899999999999999999999875 34999999999999999999999999


Q ss_pred             CCceeecCCCccc-----------cccccccccccchhhc---ccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          787 GLAKLYEEDKTHI-----------STRIAGTIGYMAPEYA---MRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       787 Gla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |++..........           .....||+.|+|||++   ....++.++||||||+++|||++|+.||..
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            9998765432211           1134589999999998   566789999999999999999999999853

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.97  E-value=1.2e-32  Score=298.34  Aligned_cols=208  Identities=26%  Similarity=0.435  Sum_probs=157.5

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ...++|.+.+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34578999999999999999999854 68899999886543 33456788999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcC---CcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          713 YEYMKNNCLSRAIFGK---DTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      |||+++++|.+++...   .......+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            9999999999988531   1111236899999999999999999999998   999999999999999999999999998


Q ss_pred             eeecCCCc----cccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          790 KLYEEDKT----HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ........    .......||+.|+|||++.. ..++.++||||||+++|||++|+.||..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  229 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK  229 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            76543221    11223568999999999875 5689999999999999999999999965

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.97  E-value=8e-32  Score=299.67  Aligned_cols=209  Identities=24%  Similarity=0.334  Sum_probs=160.9

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002899          630 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       630 ~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~  708 (869)
                      ..+.....++|++.+.||+|+||.||+|... +++.||||++.... .....+.+|++.+..++||||+++++++...+.
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            3455677889999999999999999999975 68999999886532 234466788888999999999999999976443


Q ss_pred             -------EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEEcCCCCCCEEEcC-C
Q 002899          709 -------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH--EDSRIKIVHRDIKTSNVLLDK-D  778 (869)
Q Consensus       709 -------~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~iiH~Dlk~~NILl~~-~  778 (869)
                             .++||||++++ |.+.+.... .....+++..+..++.|++.||.|||  +.+   |+||||||+|||++. +
T Consensus        94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPDT-LHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             SCTTCEEEEEEEECCSCB-HHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTT
T ss_pred             ccccceeEEEEeeccccc-HHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCC
Confidence                   78999999864 444332210 11236899999999999999999999  776   999999999999997 8


Q ss_pred             CcEEEeecCCceeecCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          779 LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       779 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +.+||+|||++........  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  235 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD  235 (360)
T ss_dssp             TEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence            9999999999987654332  2345689999999998654 4899999999999999999999999753

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.97  E-value=9.5e-32  Score=302.70  Aligned_cols=281  Identities=17%  Similarity=0.179  Sum_probs=192.8

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI  132 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  132 (869)
                      .+++.|+++++.++...+..|..+++|++|+|++|.|++..+..|..+ +|++|+|++|++++..|..|.++++|++|+|
T Consensus        45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  124 (390)
T 3o6n_A           45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL  124 (390)
T ss_dssp             CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence            467888999988886555567889999999999999988888888877 8999999999999888888899999999999


Q ss_pred             cccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCC----------------
Q 002899          133 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKW----------------  196 (869)
Q Consensus       133 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l----------------  196 (869)
                      ++|+++...+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++.....+.++                
T Consensus       125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~  204 (390)
T 3o6n_A          125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIP  204 (390)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECC
T ss_pred             CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccCCC
Confidence            9999985555557889999999999999987778888889999999999999886543333222                


Q ss_pred             ---------------------CcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccc-cccceEEEcccc
Q 002899          197 ---------------------KKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLD-KMNLKTLILTKC  254 (869)
Q Consensus       197 ---------------------~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~-~~~L~~L~Ls~N  254 (869)
                                           ++|+.|+|++|.+++.  ..+..+++|+.|+|++|.+.......+. ..+|+.|+|++|
T Consensus       205 ~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  282 (390)
T 3o6n_A          205 IAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN  282 (390)
T ss_dssp             SSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSS
T ss_pred             CcceEEECCCCeeeeccccccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCC
Confidence                                 1344444444444432  3455556666666666655554333332 225666666666


Q ss_pred             cCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCCCCCCC
Q 002899          255 LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPI  334 (869)
Q Consensus       255 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~  334 (869)
                      ++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++. |...+..++.|++++|        ||
T Consensus       283 ~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~L~~L~l~~N--------~~  351 (390)
T 3o6n_A          283 RLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-KLSTHHTLKNLTLSHN--------DW  351 (390)
T ss_dssp             CCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-CCCTTCCCSEEECCSS--------CE
T ss_pred             cCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-CchhhccCCEEEcCCC--------Cc
Confidence            6654 2334455566666666666665 3444555566666666666666533 3333455566666666        89


Q ss_pred             CCCCCCccceecc
Q 002899          335 ECPRGSVNLVESY  347 (869)
Q Consensus       335 ~C~c~~~~~~~~l  347 (869)
                      .|+|...++..|.
T Consensus       352 ~~~~~~~~~~~~~  364 (390)
T 3o6n_A          352 DCNSLRALFRNVA  364 (390)
T ss_dssp             EHHHHHHHTTTCC
T ss_pred             cchhHHHHHHHHH
Confidence            9998665555443

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.97  E-value=1e-31  Score=314.18  Aligned_cols=183  Identities=21%  Similarity=0.298  Sum_probs=141.6

Q ss_pred             cCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCC--CchHhhhcCCCCCEEEcCCCCCCC-Ccccccc-ccc
Q 002899          170 TKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG--PIPASISALTSLTDLRISDLKGSE-SAFPKLD-KMN  245 (869)
Q Consensus       170 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~l~~l~~L~~L~L~~n~~~~-~~~~~~~-~~~  245 (869)
                      ..+++|++|+|++|++++..|..+..+++|+.|+|++|++++  .+|..+..+++|+.|+|++|.+.. .+...+. ..+
T Consensus       321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  400 (520)
T 2z7x_B          321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS  400 (520)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred             hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence            566778888888888887778888888888888888888886  456778888888888888888876 4443333 347


Q ss_pred             ceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchh-h--hccCCceeee
Q 002899          246 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY-I--FNSNKNVDIS  322 (869)
Q Consensus       246 L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~--~~~l~~l~ls  322 (869)
                      |+.|+|++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|.. +  +..++.|+++
T Consensus       401 L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~  476 (520)
T 2z7x_B          401 LLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLH  476 (520)
T ss_dssp             CCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred             CCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECc
Confidence            88888888888877776654  78899999999998 77777779999999999999998 45654 3  4578889999


Q ss_pred             ccCccCCCCCCCCCCCCCccc-eeccCCCCCCCCCCcCccCCCCCCCCCc
Q 002899          323 LNNFTWESSDPIECPRGSVNL-VESYSSPRNKLDKVHPCLRQNFPCSAPA  371 (869)
Q Consensus       323 ~N~~~~~~~~p~~C~c~~~~~-~~~l~~~~~~~~~~~~~~~~~~~C~~p~  371 (869)
                      +|        ||.|+|.+.|+ ..|+.......       ..+..|+.|.
T Consensus       477 ~N--------~~~c~c~~~~~~~~~~~~~~~~~-------~~~~~C~~p~  511 (520)
T 2z7x_B          477 TN--------PWDCSCPRIDYLSRWLNKNSQKE-------QGSAKCSGSG  511 (520)
T ss_dssp             SS--------CBCCCHHHHHHHHHHHHHTTTTE-------ESCCBBTTTC
T ss_pred             CC--------CCcccCCchHHHHHHHHhccccC-------CCCCCcCCcc
Confidence            98        99999999999 88987654332       2456777774

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.97  E-value=3.6e-32  Score=292.95  Aligned_cols=201  Identities=25%  Similarity=0.435  Sum_probs=163.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc--CCc--EEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS--DGT--VIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~--~g~--~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~  709 (869)
                      .++|++.+.||+|+||.||+|++.  +++  .||||+++..   .....+.+.+|++++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357888999999999999999864  233  6899988754   2334578899999999999999999999998765 8


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||+++++|.+++....    ..+++..+..++.|+++||+|||+++   |+||||||+||+++.++.+||+|||++
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~  168 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM  168 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             eeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccc
Confidence            89999999999999886532    25899999999999999999999998   999999999999999999999999999


Q ss_pred             eeecCCCcc--ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          790 KLYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .........  ......+|+.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  227 (291)
T 1u46_A          169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG  227 (291)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            877543322  1223457889999999998889999999999999999999 9999964

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.97  E-value=1.6e-31  Score=315.78  Aligned_cols=286  Identities=20%  Similarity=0.227  Sum_probs=180.3

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI  132 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  132 (869)
                      .+++.|+|++|.+++..|.+|.++++|++|+|++|.|++..|..|..+ +|++|+|++|+++. +|..  .+++|++|+|
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~L  128 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISCC--PMASLRHLDL  128 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE-ECSC--CCTTCSEEEC
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc-cCcc--ccccCCEEEC
Confidence            568888888888887777788888888888888888888877777776 67777777777763 3332  5666666666


Q ss_pred             cccccCCC-CCccccCCCCccEEEeeccccc-------------------------------------------------
Q 002899          133 EGNLFTGS-IPPDIRKLINLQKLILSSNSFT-------------------------------------------------  162 (869)
Q Consensus       133 s~N~l~~~-~~~~~~~l~~L~~L~Ls~N~i~-------------------------------------------------  162 (869)
                      ++|++++. +|..|.++++|++|+|++|+++                                                 
T Consensus       129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~  208 (562)
T 3a79_B          129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSL  208 (562)
T ss_dssp             CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSC
T ss_pred             CCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccc
Confidence            66666542 2345555555555555555443                                                 


Q ss_pred             --------------------------------------------------------------------------------
Q 002899          163 --------------------------------------------------------------------------------  162 (869)
Q Consensus       163 --------------------------------------------------------------------------------  162 (869)
                                                                                                      
T Consensus       209 ~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l  288 (562)
T 3a79_B          209 FSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI  288 (562)
T ss_dssp             CCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEE
T ss_pred             hhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEe
Confidence                                                                                            


Q ss_pred             -ccCCccc-----------------------------------------------------cCCCCCCeEeccCCcCCCC
Q 002899          163 -GELPAEL-----------------------------------------------------TKLTNLNDLRISDNNFSGK  188 (869)
Q Consensus       163 -~~~p~~~-----------------------------------------------------~~l~~L~~L~Ls~N~l~~~  188 (869)
                       +.+|..+                                                     ..+++|++|+|++|++++.
T Consensus       289 ~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~  368 (562)
T 3a79_B          289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDS  368 (562)
T ss_dssp             CSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTT
T ss_pred             eccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccccc
Confidence             2222222                                                     3445555555555555555


Q ss_pred             CccccCCCCcccEEEccCCcCCCC--chHhhhcCCCCCEEEcCCCCCCC-Ccccccc-cccceEEEcccccCccCCCccc
Q 002899          189 IPEFIGKWKKIQKLHIQGSSLEGP--IPASISALTSLTDLRISDLKGSE-SAFPKLD-KMNLKTLILTKCLIHGEIPDYI  264 (869)
Q Consensus       189 ~~~~~~~l~~L~~L~L~~N~l~~~--~~~~l~~l~~L~~L~L~~n~~~~-~~~~~~~-~~~L~~L~Ls~N~i~~~~p~~~  264 (869)
                      .|..|.++++|+.|+|++|++++.  +|..+.++++|+.|+|++|.++. .+...+. ..+|+.|+|++|+|++..|..+
T Consensus       369 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l  448 (562)
T 3a79_B          369 VFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL  448 (562)
T ss_dssp             TTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSC
T ss_pred             hhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhh
Confidence            555555556666666666665542  23445556666666666666554 3322222 2356666666666655544443


Q ss_pred             CCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchh-h--hccCCceeeeccCccCCCCCCCCCCCCCc
Q 002899          265 GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY-I--FNSNKNVDISLNNFTWESSDPIECPRGSV  341 (869)
Q Consensus       265 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~--~~~l~~l~ls~N~~~~~~~~p~~C~c~~~  341 (869)
                      .  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|.. +  +..++.|++++|        ||.|+|++.
T Consensus       449 ~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N--------~~~c~c~~~  516 (562)
T 3a79_B          449 P--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN--------PWDCTCPGI  516 (562)
T ss_dssp             C--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSC--------CBCCCHHHH
T ss_pred             c--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCC--------CcCCCcchH
Confidence            3  56777777777777 55555557777777777777777 45544 3  446677777777        999999999


Q ss_pred             ccee-ccCCCCCCC
Q 002899          342 NLVE-SYSSPRNKL  354 (869)
Q Consensus       342 ~~~~-~l~~~~~~~  354 (869)
                      |++. |.......+
T Consensus       517 ~~~~~~~~~~~~~~  530 (562)
T 3a79_B          517 RYLSEWINKHSGVV  530 (562)
T ss_dssp             HHHHHHHHHTTTTE
T ss_pred             HHHHHHHHhcCCcc
Confidence            9977 766544333

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=8.1e-32  Score=301.15  Aligned_cols=194  Identities=27%  Similarity=0.421  Sum_probs=165.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceE----
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL----  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~----  709 (869)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+++++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467889999999999999999975 68999999997643  23356788999999999999999999999877654    


Q ss_pred             --EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          710 --LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       710 --~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                        ++||||++ ++|.+.+..       .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             eEEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecC
Confidence              99999998 578777622       4899999999999999999999998   9999999999999999999999999


Q ss_pred             CceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +++.....    .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus       190 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  244 (371)
T 4exu_A          190 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  244 (371)
T ss_dssp             CC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            99865432    223568999999999877 6889999999999999999999999965

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.97  E-value=8.6e-32  Score=316.99  Aligned_cols=138  Identities=22%  Similarity=0.246  Sum_probs=104.4

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      ..+++.|+|++|++++..|.+|.++++|++|+|++|+|++.++..|..+ +|++|+|++|++++..+..|+++++|++|+
T Consensus        25 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  104 (549)
T 2z81_A           25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN  104 (549)
T ss_dssp             CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEE
T ss_pred             CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEE
Confidence            3478899999999998888889999999999999999988888888877 799999999999888888888889999999


Q ss_pred             ccccccCCC-CCccccCCCCccEEEeecccccccCC-ccccCCCCCCeEeccCCcCCCCCc
Q 002899          132 IEGNLFTGS-IPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDLRISDNNFSGKIP  190 (869)
Q Consensus       132 Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~  190 (869)
                      |++|.+++. .|..+.++++|++|+|++|++.+.+| ..|.++++|++|+|++|++++..|
T Consensus       105 Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  165 (549)
T 2z81_A          105 LMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS  165 (549)
T ss_dssp             CTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred             CCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccCh
Confidence            999888853 45567777777777777776333332 345555555555555555544333

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.97  E-value=1e-31  Score=301.54  Aligned_cols=204  Identities=21%  Similarity=0.285  Sum_probs=171.6

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcC-CC-----ceeeEEeEEee
Q 002899          633 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HP-----NLVKLYGCCVE  705 (869)
Q Consensus       633 i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~-H~-----nIv~l~~~~~~  705 (869)
                      .....++|++.+.||+|+||.||+|... +++.||||+++.. .....++..|++++..++ |+     +|+++++++..
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            3445688999999999999999999976 6789999999743 333566778888888775 54     49999999999


Q ss_pred             CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc--CCCcEEE
Q 002899          706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLNAKI  783 (869)
Q Consensus       706 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~--~~~~~kl  783 (869)
                      .+..++||||++ |+|.+++.....   ..+++..+..++.|++.||+|||.+ ..+|+||||||+|||++  .++.+||
T Consensus       128 ~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          128 RNHLCLVFEMLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             CCceEEEEecCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEE
Confidence            999999999997 599998876532   2589999999999999999999952 12399999999999994  5788999


Q ss_pred             eecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          784 SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       784 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +|||+++......    ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       203 ~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          203 VDFGSSCQLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CCCTTCEETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EeccCceeccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999998764322    2357899999999999999999999999999999999999999753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.97  E-value=1.4e-31  Score=287.97  Aligned_cols=201  Identities=26%  Similarity=0.440  Sum_probs=173.5

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEE
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  710 (869)
                      ....++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++||||+++++++.+.+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            344578999999999999999999976 68999999986542  234567899999999999999999999999999999


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC---CcEEEeecC
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKISDFG  787 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~---~~~kl~DFG  787 (869)
                      +||||+++++|.+.+....     .+++..+..++.|++.||+|||+.+   ++||||||+||+++.+   +.+||+|||
T Consensus        98 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg  169 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG  169 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred             EEEEccCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccC
Confidence            9999999999998886542     5899999999999999999999998   9999999999999754   479999999


Q ss_pred             CceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ++........  .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||..
T Consensus       170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (287)
T 2wei_A          170 LSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG  224 (287)
T ss_dssp             GGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence            9876643322  123458899999998875 489999999999999999999999964

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=1.1e-31  Score=294.73  Aligned_cols=203  Identities=27%  Similarity=0.445  Sum_probs=151.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHH-HHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      .++|++.+.||+|+||.||+|... +++.||||++..... ....++..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367888999999999999999985 689999999876532 33455666665 677789999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      ||+++ +|.+++..........+++..+..++.|+++||.|||+. +   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 777766431111123689999999999999999999998 7   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccccchhhc----ccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYA----MRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .....  .....||+.|+|||++    ....++.++||||||+++|||++|+.||..
T Consensus       177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (327)
T 3aln_A          177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK  231 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred             ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            53322  2234689999999998    456789999999999999999999999854

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.97  E-value=3.5e-32  Score=296.62  Aligned_cols=206  Identities=24%  Similarity=0.387  Sum_probs=169.8

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccC--chhhHHHHHHHHHHHhcC--CCceeeEEeEEee
Q 002899          630 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQ--HPNLVKLYGCCVE  705 (869)
Q Consensus       630 ~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~--H~nIv~l~~~~~~  705 (869)
                      ++.+....++|++.+.||+|+||.||+|...+++.||||++....  ......+.+|++++.+++  ||||+++++++..
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            333444567789999999999999999998889999999986542  334577899999999997  5999999999999


Q ss_pred             CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002899          706 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD  785 (869)
Q Consensus       706 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~D  785 (869)
                      ++..++||| +.+++|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+|||+++ +.+||+|
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D  169 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID  169 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred             CCEEEEEEe-cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence            999999999 67889999987543     6899999999999999999999997   999999999999964 8999999


Q ss_pred             cCCceeecCCCcc-ccccccccccccchhhccc-----------CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          786 FGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMR-----------GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       786 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ||++......... ......||+.|+|||++..           ..++.++||||||+++|||++|+.||..
T Consensus       170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (313)
T 3cek_A          170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  241 (313)
T ss_dssp             CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence            9999876543221 1223568999999999865           4688899999999999999999999964

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.97  E-value=9.6e-32  Score=321.36  Aligned_cols=203  Identities=28%  Similarity=0.406  Sum_probs=170.4

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEcC----CcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceE
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~~----g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~  709 (869)
                      ...++|++.+.||+|+||.||+|.+..    +..||||+++.... ...+.|.+|+.++++++||||+++++++. ++..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            345678889999999999999999742    46799999875433 33467999999999999999999999985 4578


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA  789 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla  789 (869)
                      ++||||+++|+|.+++....    ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             EEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence            99999999999999996543    25899999999999999999999998   999999999999999999999999999


Q ss_pred             eeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          790 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       790 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      +..............+|+.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  595 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG  595 (656)
T ss_dssp             CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC
Confidence            8765443333333457789999999998899999999999999999997 9999864

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.97  E-value=2e-31  Score=316.98  Aligned_cols=280  Identities=18%  Similarity=0.183  Sum_probs=192.9

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI  132 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  132 (869)
                      .+++.|+++++.++...+..|..+++|++|+|++|.|++.++..|..+ +|++|+|++|.+++..|..|+++++|++|+|
T Consensus        51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  130 (597)
T 3oja_B           51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL  130 (597)
T ss_dssp             CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence            356778888888886666678888999999999999988888888877 7999999999998888888888999999999


Q ss_pred             cccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCC----------------
Q 002899          133 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKW----------------  196 (869)
Q Consensus       133 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l----------------  196 (869)
                      ++|.|++..+..|..+++|++|+|++|.|++..|..|.++++|++|+|++|++++.....+.++                
T Consensus       131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~  210 (597)
T 3oja_B          131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIP  210 (597)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECC
T ss_pred             eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCC
Confidence            9999886666667888999999999999988888888888999999999998886543333222                


Q ss_pred             ---------------------CcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccc-cccceEEEcccc
Q 002899          197 ---------------------KKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLD-KMNLKTLILTKC  254 (869)
Q Consensus       197 ---------------------~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~-~~~L~~L~Ls~N  254 (869)
                                           ++|+.|+|++|.+++  +..+..+++|+.|+|++|.+....+..+. ..+|+.|+|++|
T Consensus       211 ~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  288 (597)
T 3oja_B          211 IAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN  288 (597)
T ss_dssp             TTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTS
T ss_pred             chhheeeccCCcccccccccCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCC
Confidence                                 124444444444443  24455566666666666666554433332 225666666666


Q ss_pred             cCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCCCCCCC
Q 002899          255 LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPI  334 (869)
Q Consensus       255 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~  334 (869)
                      .|++ +|..+..+++|+.|+|++|.|+ .+|..+..+++|+.|+|++|+|++. |...++.++.|+|++|        ||
T Consensus       289 ~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~L~~L~l~~N--------~~  357 (597)
T 3oja_B          289 RLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-KLSTHHTLKNLTLSHN--------DW  357 (597)
T ss_dssp             CCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-CCCTTCCCSEEECCSS--------CE
T ss_pred             CCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-ChhhcCCCCEEEeeCC--------CC
Confidence            6654 3444455666666666666666 4555556666666666666666533 3333455666666666        88


Q ss_pred             CCCCCCccceec
Q 002899          335 ECPRGSVNLVES  346 (869)
Q Consensus       335 ~C~c~~~~~~~~  346 (869)
                      .|+|...++..+
T Consensus       358 ~~~~~~~~~~~~  369 (597)
T 3oja_B          358 DCNSLRALFRNV  369 (597)
T ss_dssp             EHHHHHHHTTTC
T ss_pred             CChhHHHHHHHH
Confidence            899855544433

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=4.2e-32  Score=301.33  Aligned_cols=293  Identities=18%  Similarity=0.198  Sum_probs=176.0

Q ss_pred             eccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccccC
Q 002899           60 ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFT  138 (869)
Q Consensus        60 ~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  138 (869)
                      ++++++++ .+|..+.  ++|++|+|++|.|++.++..|..+ +|++|+|++|++++..+..|.++++|++|+|++|+++
T Consensus        37 ~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  113 (353)
T 2z80_A           37 KGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS  113 (353)
T ss_dssp             ECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             eCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCC
Confidence            33455555 4444443  356666666666665555555555 5666666666666555556666666666666666666


Q ss_pred             CCCCccccCCCCccEEEeecccccccCC-ccccCCCCCCeEeccCC-cCCCCCccccCCCCcccEEEccCCcCCCCchHh
Q 002899          139 GSIPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDLRISDN-NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPAS  216 (869)
Q Consensus       139 ~~~~~~~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  216 (869)
                      +..+..|.++++|++|+|++|++++..+ ..+.++++|++|++++| .++...+..|.++++|++|++++|.+++..|..
T Consensus       114 ~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  193 (353)
T 2z80_A          114 NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKS  193 (353)
T ss_dssp             SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTT
T ss_pred             cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHH
Confidence            4333335666666666666666663222 24556666666666666 355444555666666666666666666555666


Q ss_pred             hhcCCCCCEEEcCCCCCCCCcccccc-cccceEEEcccccCccCCCcccC---CCCCcCEEeccCCCCCC----CCchhh
Q 002899          217 ISALTSLTDLRISDLKGSESAFPKLD-KMNLKTLILTKCLIHGEIPDYIG---DMTKLKNIDLSFNNLTG----GIPTTF  288 (869)
Q Consensus       217 l~~l~~L~~L~L~~n~~~~~~~~~~~-~~~L~~L~Ls~N~i~~~~p~~~~---~l~~L~~L~Ls~N~l~~----~~p~~~  288 (869)
                      +..+++|+.|++++|.+...+...+. ..+|+.|+|++|.+++..+..+.   ..+.|+.++|++|.+++    .+|..+
T Consensus       194 l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l  273 (353)
T 2z80_A          194 LKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLL  273 (353)
T ss_dssp             TTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHH
T ss_pred             HhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHH
Confidence            66666666666666665444332222 23566666666666655444332   35567777777777764    356667


Q ss_pred             hcCCCCCEEEeeCCcCCCCCchhh---hccCCceeeeccCccCCCCCCCCCCCC-CccceeccCCCCCCCCCCcCccCCC
Q 002899          289 EKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISLNNFTWESSDPIECPRG-SVNLVESYSSPRNKLDKVHPCLRQN  364 (869)
Q Consensus       289 ~~l~~L~~L~Ls~N~l~~~~p~~~---~~~l~~l~ls~N~~~~~~~~p~~C~c~-~~~~~~~l~~~~~~~~~~~~~~~~~  364 (869)
                      ..+++|+.|+|++|+++ .+|..+   +..++.|++++|        ||.|+|+ +.++..|+........       ..
T Consensus       274 ~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N--------~~~~~~~~l~~l~~~~~~~~~~~~-------~~  337 (353)
T 2z80_A          274 NQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN--------PWDCSCPRIDYLSRWLNKNSQKEQ-------GS  337 (353)
T ss_dssp             HTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSS--------CBCCCHHHHHHHHHHHHHTTTTEE-------SC
T ss_pred             hcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCC--------CccCcCCCcHHHHHHHHhccccCC-------CC
Confidence            77777777777777777 455544   346677777777        8889996 7788888876554432       35


Q ss_pred             CCCCCCc
Q 002899          365 FPCSAPA  371 (869)
Q Consensus       365 ~~C~~p~  371 (869)
                      ..|+.|.
T Consensus       338 ~~C~~p~  344 (353)
T 2z80_A          338 AKCSGSG  344 (353)
T ss_dssp             CBBTTTC
T ss_pred             cccCCCC
Confidence            5677764

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.97  E-value=3.9e-31  Score=293.09  Aligned_cols=198  Identities=21%  Similarity=0.342  Sum_probs=169.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CC-cEEEEEEecccCchhhHHHHHHHHHHHhcCCCc------eeeEEeEEeeCce
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DG-TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN------LVKLYGCCVEGNQ  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g-~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~n------Iv~l~~~~~~~~~  708 (869)
                      .++|++.+.||+|+||.||+|... ++ +.||||+++.. ......+.+|++++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            568999999999999999999975 34 68999998753 334567888999999887766      8999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE-------------
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-------------  775 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl-------------  775 (869)
                      .++||||+ ++++.+.+.....   ..+++..+..++.||++||+|||+.+   |+||||||+|||+             
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             EEEEEecc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence            99999999 5566666654321   25899999999999999999999997   9999999999999             


Q ss_pred             ------cCCCcEEEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          776 ------DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       776 ------~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                            +.++.+||+|||++.......    ....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                  678899999999998654322    2357899999999999989999999999999999999999999754

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=2.3e-31  Score=287.92  Aligned_cols=195  Identities=28%  Similarity=0.473  Sum_probs=162.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEee---------
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE---------  705 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~---------  705 (869)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3567889999999999999999975 7899999998643 3345678999999999999999999998865         


Q ss_pred             ----CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcE
Q 002899          706 ----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA  781 (869)
Q Consensus       706 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~  781 (869)
                          .+..++||||+++|+|.+++....    ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~  155 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNV  155 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCE
Confidence                457899999999999999997543    25788999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCceeecCCC-------------ccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHc
Q 002899          782 KISDFGLAKLYEEDK-------------THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVS  838 (869)
Q Consensus       782 kl~DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~ellt  838 (869)
                      ||+|||++.......             ........||+.|+|||++.+. .++.++||||||+++|||++
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            999999997654321             1112235689999999998754 78999999999999999998

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.97  E-value=1e-31  Score=292.68  Aligned_cols=200  Identities=26%  Similarity=0.392  Sum_probs=163.3

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc------hhhHHHHHHHHHHHhc----CCCceeeEEeE
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR------QGNREFVNEIGMISAQ----QHPNLVKLYGC  702 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~------~~~~~f~~E~~~l~~l----~H~nIv~l~~~  702 (869)
                      ....++|++.+.||+|+||.||+|... +++.||||+++....      .....+..|++++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            445678999999999999999999864 688999999865432      1234566789998888    89999999999


Q ss_pred             EeeCceEEEEEEe-ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-CCCc
Q 002899          703 CVEGNQLLLVYEY-MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLN  780 (869)
Q Consensus       703 ~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~-~~~~  780 (869)
                      +...+..++|||| +.+++|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+||+++ .++.
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence            9999999999999 78999999986542     5899999999999999999999998   99999999999999 8899


Q ss_pred             EEEeecCCceeecCCCccccccccccccccchhhcccCCC-CchhHHHHHHHHHHHHHcCCCCCC
Q 002899          781 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       781 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      +||+|||++.......   .....|++.|+|||++....+ +.++||||||+++|||++|+.||.
T Consensus       179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  240 (312)
T 2iwi_A          179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE  240 (312)
T ss_dssp             EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence            9999999998775432   224568999999999876655 458999999999999999999985

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=1.8e-31  Score=296.29  Aligned_cols=195  Identities=27%  Similarity=0.422  Sum_probs=165.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce-----
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ-----  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~-----  708 (869)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467888999999999999999975 68999999986543  2335678899999999999999999999987654     


Q ss_pred             -EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          709 -LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       709 -~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                       .++||||++ ++|.+.+..       .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             eEEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecc
Confidence             499999998 588776632       4899999999999999999999998   9999999999999999999999999


Q ss_pred             CceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ++......    .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus       172 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  227 (353)
T 3coi_A          172 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  227 (353)
T ss_dssp             CTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred             cccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99765432    223468999999999876 67899999999999999999999999653

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.97  E-value=2.6e-31  Score=296.98  Aligned_cols=198  Identities=24%  Similarity=0.338  Sum_probs=167.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcC-----------CCceeeEEeEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----------HPNLVKLYGCCV  704 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~-----------H~nIv~l~~~~~  704 (869)
                      .++|.+.+.||+|+||.||+|... +++.||||++... ......+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            357889999999999999999974 6899999998743 334567888999988876           899999999998


Q ss_pred             eCc----eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEcCCCCCCEEEc---
Q 002899          705 EGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLD---  776 (869)
Q Consensus       705 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NILl~---  776 (869)
                      ..+    ..++||||+ +++|.+++.....   ..+++..+..++.||+.||+|||++ +   |+||||||+|||++   
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEE
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccC
Confidence            654    789999999 8899998865432   2589999999999999999999998 7   99999999999994   


Q ss_pred             ---CCCcEEEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          777 ---KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       777 ---~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                         ..+.+||+|||++.......    ....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  238 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  238 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             CCcCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence               34589999999998765322    2346899999999999999999999999999999999999999753

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.97  E-value=3.6e-31  Score=313.07  Aligned_cols=133  Identities=23%  Similarity=0.256  Sum_probs=82.2

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI  132 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  132 (869)
                      .+++.|+|++|++++..+.+|.++++|++|+|++|.|+++.+..|..+ +|++|+|++|++++..+..|.++++|++|+|
T Consensus        28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (570)
T 2z63_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (570)
T ss_dssp             SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence            356667777777666666666666677777777666666666666655 6666666666666665566666666666666


Q ss_pred             cccccCCCCCccccCCCCccEEEeecccccc-cCCccccCCCCCCeEeccCCcCC
Q 002899          133 EGNLFTGSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFS  186 (869)
Q Consensus       133 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~L~~L~Ls~N~l~  186 (869)
                      ++|++++..+..|+++++|++|+|++|.+++ .+|..|.++++|++|++++|+++
T Consensus       108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~  162 (570)
T 2z63_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ  162 (570)
T ss_dssp             TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred             cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccc
Confidence            6666664444445566666666666665554 24555555555555555555443

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=1.5e-31  Score=292.73  Aligned_cols=200  Identities=23%  Similarity=0.375  Sum_probs=171.7

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch------hhHHHHHHHHHHHhcC--CCceeeEEeEEe
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ------GNREFVNEIGMISAQQ--HPNLVKLYGCCV  704 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~------~~~~f~~E~~~l~~l~--H~nIv~l~~~~~  704 (869)
                      ....++|++.+.||+|+||.||+|... +++.||||++......      ....+..|++++++++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            344678999999999999999999964 6889999998654321      2356778999999996  599999999999


Q ss_pred             eCceEEEEEEeccC-CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-CCCcEE
Q 002899          705 EGNQLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAK  782 (869)
Q Consensus       705 ~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~-~~~~~k  782 (869)
                      ..+..++|||++.+ ++|.+++....     .+++..+..++.|+++||+|||+.+   |+||||||+|||++ +++.+|
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence            99999999999986 89999886532     6899999999999999999999998   99999999999999 789999


Q ss_pred             EeecCCceeecCCCccccccccccccccchhhcccCCC-CchhHHHHHHHHHHHHHcCCCCCC
Q 002899          783 ISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       783 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      |+|||++.......   .....||+.|+|||++....+ +.++||||||+++|||++|+.||.
T Consensus       191 L~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  250 (320)
T 3a99_A          191 LIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE  250 (320)
T ss_dssp             ECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence            99999998765432   223568999999999876655 788999999999999999999985

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=1.8e-31  Score=287.00  Aligned_cols=257  Identities=19%  Similarity=0.238  Sum_probs=186.6

Q ss_pred             EEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccccccc
Q 002899           57 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN  135 (869)
Q Consensus        57 ~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  135 (869)
                      +.+++++++++ .+|..+  .++|++|+|++|.|++..+..|..+ +|++|+|++|.+++..+..|..+++|++|+|++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            67888889988 556544  4688999999988887777666666 6777777777777666777777777777777777


Q ss_pred             c-cCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCch
Q 002899          136 L-FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP  214 (869)
Q Consensus       136 ~-l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  214 (869)
                      . ++...+..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|++++..+
T Consensus        91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  170 (285)
T 1ozn_A           91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE  170 (285)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence            5 665556667777777777777777776666667777777777777777776666666677777777777777665555


Q ss_pred             HhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCC
Q 002899          215 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT  294 (869)
Q Consensus       215 ~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  294 (869)
                      ..+..+++|+.|+|                       ++|.|++..|..|..+++|+.|+|++|++++..+..+..+++|
T Consensus       171 ~~~~~l~~L~~L~l-----------------------~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  227 (285)
T 1ozn_A          171 RAFRGLHSLDRLLL-----------------------HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL  227 (285)
T ss_dssp             TTTTTCTTCCEEEC-----------------------CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTC
T ss_pred             HHhcCccccCEEEC-----------------------CCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCccc
Confidence            55555555554444                       4666666677778888888888888888887777778888888


Q ss_pred             CEEEeeCCcCCCCCchhhhccCCceeeeccCccCCCCCCCCCCCCCccceeccCCCCCCCCCCcCccCCCCCCCCCcccc
Q 002899          295 NFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQY  374 (869)
Q Consensus       295 ~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~~~~~l~~~~~~~~~~~~~~~~~~~C~~p~~~~  374 (869)
                      +.|+|++|                              ||.|+|...++..|++.....        .....|+.|+..+
T Consensus       228 ~~L~l~~N------------------------------~~~c~~~~~~~~~~l~~~~~~--------~~~~~c~~p~~l~  269 (285)
T 1ozn_A          228 QYLRLNDN------------------------------PWVCDCRARPLWAWLQKFRGS--------SSEVPCSLPQRLA  269 (285)
T ss_dssp             CEEECCSS------------------------------CEECSGGGHHHHHHHHHCCSE--------ECCCBEEESGGGT
T ss_pred             CEEeccCC------------------------------CccCCCCcHHHHHHHHhcccc--------cCccccCCchHhC
Confidence            88888888                              777999999999998764422        2345688887776


Q ss_pred             cce
Q 002899          375 HYT  377 (869)
Q Consensus       375 ~~~  377 (869)
                      |..
T Consensus       270 g~~  272 (285)
T 1ozn_A          270 GRD  272 (285)
T ss_dssp             TCB
T ss_pred             CcC
Confidence            644

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.97  E-value=3.8e-31  Score=306.04  Aligned_cols=279  Identities=21%  Similarity=0.268  Sum_probs=216.9

Q ss_pred             eEecCCCCcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcC
Q 002899           45 VTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN  123 (869)
Q Consensus        45 v~C~~~~~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~  123 (869)
                      ..|.|...   .+.+++++++++ .+|..+.  ++|+.|+|++|+|++..+..|..+ +|++|+|++|.++++.|..|.+
T Consensus         5 ~~C~C~~~---~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~   78 (477)
T 2id5_A            5 PRCECSAQ---DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNN   78 (477)
T ss_dssp             TTCEEETT---TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred             CCCeECCC---CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhC
Confidence            34555432   235788888888 6777664  689999999999999999999888 8999999999999999999999


Q ss_pred             ccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEE
Q 002899          124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLH  203 (869)
Q Consensus       124 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  203 (869)
                      +++|++|+|++|+++...+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|+.|+
T Consensus        79 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  158 (477)
T 2id5_A           79 LFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLT  158 (477)
T ss_dssp             CTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEE
T ss_pred             CccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEE
Confidence            99999999999999977777789999999999999999988899999999999999999999998899999999999999


Q ss_pred             ccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccc-cc------------------------eEEEcccccCcc
Q 002899          204 IQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NL------------------------KTLILTKCLIHG  258 (869)
Q Consensus       204 L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~-~L------------------------~~L~Ls~N~i~~  258 (869)
                      |++|++++..+..+.++++|+.|+|++|.+.......+... +|                        +.|+|++|+|+.
T Consensus       159 l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~  238 (477)
T 2id5_A          159 LEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA  238 (477)
T ss_dssp             EESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCS
T ss_pred             CCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccc
Confidence            99999998888999999999999999999887654333222 44                        445555555554


Q ss_pred             CCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh--hccCCceeeeccCccCC
Q 002899          259 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWE  329 (869)
Q Consensus       259 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~~  329 (869)
                      ..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|..+  +..|+.|+|++|+++..
T Consensus       239 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  311 (477)
T 2id5_A          239 VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTL  311 (477)
T ss_dssp             CCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCC
T ss_pred             cCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCcee
Confidence            333445555555555555555555555555555555555555555555545444  34555555555555544

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=3.3e-31  Score=292.08  Aligned_cols=197  Identities=23%  Similarity=0.301  Sum_probs=146.9

Q ss_pred             HhcCCCCCC-eeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEee----CceE
Q 002899          636 ATNNFDPAN-KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQL  709 (869)
Q Consensus       636 ~t~~f~~~~-~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~----~~~~  709 (869)
                      ..++|.+.+ +||+|+||.||+|... +++.||||++....    ....+....+..++||||+++++++..    +...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            356788854 6999999999999986 68999999986431    122223344667899999999999876    4568


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCcEEEeec
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDF  786 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~---~~~~kl~DF  786 (869)
                      ++||||+++|+|.+++.....   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.   ++.+||+||
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence            999999999999999976532   36899999999999999999999998   999999999999976   455999999


Q ss_pred             CCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          787 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       787 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |++.......   .....||+.|+|||++....++.++||||||+++|||++|+.||..
T Consensus       176 g~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (336)
T 3fhr_A          176 GFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS  231 (336)
T ss_dssp             TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             ccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            9998665322   2235689999999999888899999999999999999999999954

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.97  E-value=1.1e-31  Score=293.23  Aligned_cols=201  Identities=23%  Similarity=0.403  Sum_probs=166.4

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ...++|++.+.||+|+||.||+|....  .||+|+++...  ....+.|.+|++++++++||||+++++++.+.+..++|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            345678899999999999999999754  48999886542  23345688899999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++++|.+++....    ..+++..+..++.|+++||+|||+++   |+||||||+|||++ ++.+||+|||++...
T Consensus       108 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             CBCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             eecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            99999999999996543    35899999999999999999999998   99999999999998 679999999998765


Q ss_pred             cCCC----ccccccccccccccchhhccc---------CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDK----THISTRIAGTIGYMAPEYAMR---------GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....    ........|++.|+|||++..         ..++.++||||||+++|||++|+.||..
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  245 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT  245 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            3211    111223458999999999864         3578999999999999999999999964

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=4e-31  Score=301.63  Aligned_cols=200  Identities=28%  Similarity=0.340  Sum_probs=156.6

Q ss_pred             CCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEEEecc
Q 002899          639 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      .|...++||+|+||+||.+...+|+.||||++...   ....+.+|++++.++ +|||||++++++.+++..++||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            34456889999999998776678999999998643   235678899999876 89999999999999999999999996


Q ss_pred             CCchhhhhhcCCcccc--cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-------------CcEE
Q 002899          718 NNCLSRAIFGKDTEYR--LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-------------LNAK  782 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~-------------~~~k  782 (869)
                       |+|.+++........  ....+..+..++.||+.||+|||+++   |+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             699999976532111  01234456789999999999999998   9999999999999754             4899


Q ss_pred             EeecCCceeecCCCccc---cccccccccccchhhccc-------CCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          783 ISDFGLAKLYEEDKTHI---STRIAGTIGYMAPEYAMR-------GYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       783 l~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      |+|||+++.........   .....||+.|+|||++.+       ..++.++|||||||++|||++ |+.||..
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  242 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD  242 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence            99999998876433221   223579999999999865       578999999999999999999 9999964

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=3.3e-32  Score=300.05  Aligned_cols=191  Identities=22%  Similarity=0.243  Sum_probs=161.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCc--------hhhHHHHHHHHHHHhcC---------CCceeeE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQ---------HPNLVKL  699 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~--------~~~~~f~~E~~~l~~l~---------H~nIv~l  699 (869)
                      .++|++.+.||+|+||.||+|+. +|+.||||++.....        ...+.+.+|+++++.++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35678899999999999999998 689999999875421        22367889999988875         8888888


Q ss_pred             EeEEe------------------------------eCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHH
Q 002899          700 YGCCV------------------------------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA  749 (869)
Q Consensus       700 ~~~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia  749 (869)
                      .+.+.                              ..+..++||||+++|++.+.+...      .+++..++.++.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~------~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK------LSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT------CCCHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc------CCCHHHHHHHHHHHH
Confidence            77643                              267899999999999877766432      579999999999999


Q ss_pred             HHHHHHH-hcCCCCeEEcCCCCCCEEEcCCC--------------------cEEEeecCCceeecCCCcccccccccccc
Q 002899          750 RGLAYLH-EDSRIKIVHRDIKTSNVLLDKDL--------------------NAKISDFGLAKLYEEDKTHISTRIAGTIG  808 (869)
Q Consensus       750 ~gL~yLH-~~~~~~iiH~Dlk~~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~  808 (869)
                      .||+||| +.+   |+||||||+|||++.++                    .+||+|||+|+.....      ...||+.
T Consensus       172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~  242 (336)
T 2vuw_A          172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred             HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence            9999999 887   99999999999999887                    8999999999876532      2478999


Q ss_pred             ccchhhcccCCCCchhHHHHHHHH-HHHHHcCCCCCC
Q 002899          809 YMAPEYAMRGYLTSKADVYSFGVV-TLEIVSGKSNTN  844 (869)
Q Consensus       809 y~aPE~~~~~~~~~k~DvwSlGvi-l~elltG~~p~~  844 (869)
                      |+|||++.+.. +.++||||++++ .+++++|..||.
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence            99999998766 899999998776 888999999883

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=5.1e-31  Score=317.88  Aligned_cols=192  Identities=22%  Similarity=0.377  Sum_probs=166.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc--CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce-----
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ-----  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~--~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~-----  708 (869)
                      .++|++.+.||+|+||.||+|...  +++.||||++.... ......|.+|++++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999975  58999999986543 3445678999999999999999999999987665     


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .|+||||+++++|.+++..       .+++..++.++.||++||+|||+++   |+||||||+|||++.+ .+||+|||+
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             eEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEeccc
Confidence            7999999999999876633       5899999999999999999999998   9999999999999986 899999999


Q ss_pred             ceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ++.....     ....||+.|+|||++.+.. +.++|||||||++|||++|.+|+..
T Consensus       228 a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          228 VSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             CEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             chhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence            9876543     2356999999999987665 8999999999999999999988753

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=7.4e-31  Score=298.80  Aligned_cols=198  Identities=26%  Similarity=0.355  Sum_probs=158.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ..+|.+.++||+|+||+||.....+++.||||++.....   ..+.+|+++++.+ +|||||++++++.+.+..++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            345778899999999987655556789999999865432   3466899999998 899999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-----CCcEEEeecCCce
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-----DLNAKISDFGLAK  790 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~-----~~~~kl~DFGla~  790 (869)
                      ++ |+|.+++.....    ...+..+..++.||++||+|||+.+   |+||||||+|||++.     ...+||+|||+++
T Consensus       100 ~~-g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A          100 CA-ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             CS-EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             CC-CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            97 599999876542    3445567899999999999999998   999999999999953     3468899999998


Q ss_pred             eecCCCc--cccccccccccccchhhcc---cCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          791 LYEEDKT--HISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       791 ~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .......  .......||+.|+|||++.   ...++.++|||||||++|||++ |+.||..
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~  232 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK  232 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence            7654321  1223457999999999987   4567889999999999999999 9999853

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=1.1e-30  Score=285.09  Aligned_cols=199  Identities=29%  Similarity=0.493  Sum_probs=149.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch-hh-HHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-GN-REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~-~~-~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      .++|++.+.||+|+||.||+|... +++.||||++...... .. +.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            356788899999999999999985 6899999998755322 22 33445556788889999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      ||+ ++.+..+....    ...+++..+..++.|+++||+|||+. +   |+||||||+||+++.++.+||+|||++...
T Consensus       104 e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             CCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             ecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            999 44554444321    23689999999999999999999985 7   999999999999999999999999999766


Q ss_pred             cCCCccccccccccccccchhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .....  .....||+.|+|||++.     ...++.++||||||+++|||++|+.||..
T Consensus       176 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (318)
T 2dyl_A          176 VDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN  231 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence            44322  22356899999999984     45788999999999999999999999964

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=8.8e-31  Score=287.44  Aligned_cols=269  Identities=20%  Similarity=0.310  Sum_probs=191.3

Q ss_pred             cHHHHHHHHHHhCCCCCCCCCCCCCCCCCccccC--CCCCCCCcceEecC------CCCcceEEEEeccCCCccccCCcc
Q 002899            2 PKKALKQIGRKLGKKDWNFGVDPCSQKGNWELSS--DDKKGFESNVTCDC------SSATCHVVTIALKAQNLTGTLPTE   73 (869)
Q Consensus         2 ~~~~l~~~~~~l~~~~W~~~~d~C~~~g~w~~~~--~~~~~~~~~v~C~~------~~~~~~v~~L~l~~~~l~~~~p~~   73 (869)
                      +++||+++|+.+..       |+|.|.+.|+...  ......|.|+.|+.      .....+|+.|+|++|+++ .+|+.
T Consensus        28 ~~~aLl~~k~~~~~-------~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~   99 (328)
T 4fcg_A           28 YHDVLSQWQRHYNA-------DRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ   99 (328)
T ss_dssp             HHHHHHHHHHHHHH-------CCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC
T ss_pred             HHHHHHHHHHhccC-------CchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh
Confidence            57899999998732       2233333332110  01111223466742      112357888999999888 77888


Q ss_pred             ccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccC-----
Q 002899           74 LSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRK-----  147 (869)
Q Consensus        74 l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----  147 (869)
                      +.++++|++|+|++|.|+ .+|..+..+ +|++|+|++|+++ .+|..+.++++|++|+|++|++.+.+|..+..     
T Consensus       100 l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~  177 (328)
T 4fcg_A          100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG  177 (328)
T ss_dssp             GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CC
T ss_pred             hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchh
Confidence            888999999999998888 556666665 7888888888888 66777888888888888888777777776654     


Q ss_pred             ----CCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCC
Q 002899          148 ----LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL  223 (869)
Q Consensus       148 ----l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L  223 (869)
                          +++|++|+|++|+|+ .+|..+.++++|++|+|++|++++ +|..+..+++|+.|+|++|.+.+.+|..+..+++|
T Consensus       178 ~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L  255 (328)
T 4fcg_A          178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL  255 (328)
T ss_dssp             CEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCC
T ss_pred             hhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCC
Confidence                777777777777777 666677777777777777777774 44456777777777777777776666666666655


Q ss_pred             CEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCc
Q 002899          224 TDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK  303 (869)
Q Consensus       224 ~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  303 (869)
                      +.|+|+                       +|.+.+.+|..+..+++|+.|+|++|++.+.+|..+..+++|+.+++..|.
T Consensus       256 ~~L~L~-----------------------~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~  312 (328)
T 4fcg_A          256 KRLILK-----------------------DCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL  312 (328)
T ss_dssp             CEEECT-----------------------TCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGG
T ss_pred             CEEECC-----------------------CCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHH
Confidence            555544                       566666777778888888888888888888888888888888888888776


Q ss_pred             CC
Q 002899          304 LT  305 (869)
Q Consensus       304 l~  305 (869)
                      +.
T Consensus       313 ~~  314 (328)
T 4fcg_A          313 QA  314 (328)
T ss_dssp             SC
T ss_pred             HH
Confidence            54

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.97  E-value=3.9e-30  Score=282.70  Aligned_cols=266  Identities=20%  Similarity=0.283  Sum_probs=229.7

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      .|+++.+++++++++ .+|..+.  ++|+.|+|++|.|++..+..|..+ +|++|+|++|++++..|..|.++++|++|+
T Consensus        30 ~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (330)
T 1xku_A           30 QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY  106 (330)
T ss_dssp             EEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             cCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence            346788999999998 5676664  689999999999999988888887 899999999999988899999999999999


Q ss_pred             ccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCC--CCccccCCCCcccEEEccCCcC
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG--KIPEFIGKWKKIQKLHIQGSSL  209 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l  209 (869)
                      |++|+++ .+|..+.  ++|++|++++|++++..+..|.++++|++|+|++|+++.  ..+..|.++++|+.|++++|.+
T Consensus       107 Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l  183 (330)
T 1xku_A          107 LSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI  183 (330)
T ss_dssp             CCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred             CCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence            9999999 5666554  799999999999998777789999999999999999964  6788899999999999999999


Q ss_pred             CCCchHhhhcCCCCCEEEcCCCCCCCCccccccc-ccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhh
Q 002899          210 EGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF  288 (869)
Q Consensus       210 ~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  288 (869)
                      +. +|..+.  ++|+.|+|++|.++......+.. .+|+.|+|++|.|++..+..|..+++|+.|+|++|+|+ .+|..+
T Consensus       184 ~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l  259 (330)
T 1xku_A          184 TT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL  259 (330)
T ss_dssp             CS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTT
T ss_pred             cc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhh
Confidence            85 444333  79999999999998876555544 48999999999999988889999999999999999999 788889


Q ss_pred             hcCCCCCEEEeeCCcCCCCCchhh--------hccCCceeeeccCccC
Q 002899          289 EKLAKTNFMYLTGNKLTGPVPKYI--------FNSNKNVDISLNNFTW  328 (869)
Q Consensus       289 ~~l~~L~~L~Ls~N~l~~~~p~~~--------~~~l~~l~ls~N~~~~  328 (869)
                      ..+++|++|+|++|+|++..+..+        ...++.+++++|.+..
T Consensus       260 ~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~  307 (330)
T 1xku_A          260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY  307 (330)
T ss_dssp             TTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred             ccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccc
Confidence            999999999999999997665554        2456789999997764

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.97  E-value=2.7e-30  Score=296.89  Aligned_cols=270  Identities=20%  Similarity=0.208  Sum_probs=214.4

Q ss_pred             EEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCC-CchhhcCcccccccccccc
Q 002899           58 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGP-FPKVLTNITTLKNLSIEGN  135 (869)
Q Consensus        58 ~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N  135 (869)
                      .+++.+++++ .+|. +.  ++|++|+|++|.|++..+..|..+ +|++|+|++|.+.+. .+..|.++++|++|+|++|
T Consensus        14 ~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n   89 (455)
T 3v47_A           14 NAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN   89 (455)
T ss_dssp             EEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred             ccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence            5777888888 5665 33  789999999999999989999888 899999999999754 4678999999999999999


Q ss_pred             ccCCCCCccccCCCCccEEEeecccccccCCcc--ccCCCCCCeEeccCCcCCCCCccc-cCCCCcccEEEccCCcCCCC
Q 002899          136 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAE--LTKLTNLNDLRISDNNFSGKIPEF-IGKWKKIQKLHIQGSSLEGP  212 (869)
Q Consensus       136 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~  212 (869)
                      ++++..|..|.++++|++|+|++|++++..+..  |..+++|++|+|++|++++..|.. |.++++|++|+|++|++++.
T Consensus        90 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~  169 (455)
T 3v47_A           90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSI  169 (455)
T ss_dssp             TTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCC
T ss_pred             ccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccccc
Confidence            999888999999999999999999999755554  899999999999999999887876 89999999999999999988


Q ss_pred             chHhhhcC----------------------------------CCCCEEEcCCCCCCCCccc-------------------
Q 002899          213 IPASISAL----------------------------------TSLTDLRISDLKGSESAFP-------------------  239 (869)
Q Consensus       213 ~~~~l~~l----------------------------------~~L~~L~L~~n~~~~~~~~-------------------  239 (869)
                      .+..+..+                                  ++|+.|+|++|.+......                   
T Consensus       170 ~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~  249 (455)
T 3v47_A          170 CEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS  249 (455)
T ss_dssp             CTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTC
T ss_pred             ChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccc
Confidence            77766554                                  5677778877766431110                   


Q ss_pred             ---------------------ccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEE
Q 002899          240 ---------------------KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY  298 (869)
Q Consensus       240 ---------------------~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  298 (869)
                                           .....+|+.|+|++|.+++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  329 (455)
T 3v47_A          250 YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLN  329 (455)
T ss_dssp             TTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             cccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEE
Confidence                                 01113577777777777777777777777777777777777776677777777777777


Q ss_pred             eeCCcCCCCCchhh--hccCCceeeeccCccCCCC
Q 002899          299 LTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESS  331 (869)
Q Consensus       299 Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~~~~  331 (869)
                      |++|++++..|..+  +..++.|+|++|+++...+
T Consensus       330 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  364 (455)
T 3v47_A          330 LSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGD  364 (455)
T ss_dssp             CCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECT
T ss_pred             CCCCccCCcChhHhcCcccCCEEECCCCcccccCh
Confidence            77777766656555  4566777777777765543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=4.7e-31  Score=310.16  Aligned_cols=201  Identities=28%  Similarity=0.446  Sum_probs=172.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc-CchhhHHHHHHHHHHHhcCCCceeeEEeEEee------Cce
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE------GNQ  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~------~~~  708 (869)
                      .++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999974 6889999998764 33445678999999999999999999998765      667


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc---EEEee
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKISD  785 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~---~kl~D  785 (869)
                      .++||||+++|+|.+++.....  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             EEEEEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcc
Confidence            8999999999999999976432  235889999999999999999999998   999999999999997665   99999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      ||++........  .....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       168 FG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~  224 (676)
T 3qa8_A          168 LGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL  224 (676)
T ss_dssp             CCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence            999987654322  234578999999999999999999999999999999999999985

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.96  E-value=1.6e-29  Score=271.87  Aligned_cols=172  Identities=10%  Similarity=0.043  Sum_probs=150.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      .++|++.+.||+|+||.||+|... +++.||||++.....   ...+.|.+|++++.+++||||+++++++.+++..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            356888999999999999999976 489999999976532   2347789999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++++|.+++...       ....++.+++.|++.||+|||+++   |+||||||+|||++.++.+||+++      
T Consensus       110 ~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~------  173 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP------  173 (286)
T ss_dssp             EECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC------
T ss_pred             EEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec------
Confidence            9999999999998432       245578899999999999999998   999999999999999999999844      


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                                     +|++|       ++.++||||||+++|||++|+.||...
T Consensus       174 ---------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~  205 (286)
T 3uqc_A          174 ---------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEA  205 (286)
T ss_dssp             ---------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCC
T ss_pred             ---------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                           33333       688999999999999999999999753

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.96  E-value=2.8e-29  Score=310.27  Aligned_cols=279  Identities=16%  Similarity=0.160  Sum_probs=211.3

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCC-Cchhhccc-cceEEEeecccCCCCCchhhcCccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS-FSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNL  130 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~-~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  130 (869)
                      ..+++.|+|++|.|++..|..|.++++|++|+|++|.+.+. .+..|..+ +|++|+|++|.+++..|..|.++++|++|
T Consensus        23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  102 (844)
T 3j0a_A           23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL  102 (844)
T ss_dssp             CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred             CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence            45789999999999999999999999999999999965544 47888888 89999999999999999999999999999


Q ss_pred             cccccccCCCCCcc--ccCCCCccEEEeecccccccCC-ccccCCCCCCeEeccCCcCCCCCccccCCC--CcccEEEcc
Q 002899          131 SIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTGELP-AELTKLTNLNDLRISDNNFSGKIPEFIGKW--KKIQKLHIQ  205 (869)
Q Consensus       131 ~Ls~N~l~~~~~~~--~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L~  205 (869)
                      +|++|.+++.+|..  |.++++|++|+|++|.+++..+ ..|.++++|++|+|++|++++..+..|..+  ++|+.|+|+
T Consensus       103 ~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~  182 (844)
T 3j0a_A          103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA  182 (844)
T ss_dssp             ECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEEC
T ss_pred             eCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECC
Confidence            99999999866665  9999999999999999997655 579999999999999999998888888776  777778887


Q ss_pred             CCcCCCCchHhhhcCCC------CCEEEcCCCCCCCCcccc---------------------------------------
Q 002899          206 GSSLEGPIPASISALTS------LTDLRISDLKGSESAFPK---------------------------------------  240 (869)
Q Consensus       206 ~N~l~~~~~~~l~~l~~------L~~L~L~~n~~~~~~~~~---------------------------------------  240 (869)
                      .|.+.+..|..+..+++      |+.|+|++|.++......                                       
T Consensus       183 ~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~  262 (844)
T 3j0a_A          183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG  262 (844)
T ss_dssp             CSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTT
T ss_pred             CCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhc
Confidence            77777766665555544      677777766543221110                                       


Q ss_pred             cccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh--hccCCc
Q 002899          241 LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKN  318 (869)
Q Consensus       241 ~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~l~~  318 (869)
                      +...+|+.|+|++|.+.+..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+  ...++.
T Consensus       263 l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  342 (844)
T 3j0a_A          263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY  342 (844)
T ss_dssp             TTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCE
T ss_pred             cccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCE
Confidence            001246666666666666666666666666666666666666666666666666666666666665555544  345566


Q ss_pred             eeeeccCccCCCC
Q 002899          319 VDISLNNFTWESS  331 (869)
Q Consensus       319 l~ls~N~~~~~~~  331 (869)
                      |++++|+++...+
T Consensus       343 L~L~~N~i~~~~~  355 (844)
T 3j0a_A          343 IDLQKNHIAIIQD  355 (844)
T ss_dssp             EECCSCCCCCCCS
T ss_pred             EECCCCCCCccCh
Confidence            6666666655443

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.96  E-value=3.9e-29  Score=297.99  Aligned_cols=275  Identities=20%  Similarity=0.204  Sum_probs=246.9

Q ss_pred             eEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccccc
Q 002899           55 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE  133 (869)
Q Consensus        55 ~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  133 (869)
                      .++.|++++|.+++..+..|.++++|++|+|++|.++.. |..+..+ +|++|+|++|++++..|..+..+++|++|+|+
T Consensus       255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~l-p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  333 (606)
T 3t6q_A          255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL-PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK  333 (606)
T ss_dssp             EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCC-CSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECC
T ss_pred             ceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCC-ChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECC
Confidence            799999999999988888899999999999999999955 4455655 89999999999999889999999999999999


Q ss_pred             ccccCCCCCc-cccCCCCccEEEeecccccccC--CccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCC
Q 002899          134 GNLFTGSIPP-DIRKLINLQKLILSSNSFTGEL--PAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE  210 (869)
Q Consensus       134 ~N~l~~~~~~-~~~~l~~L~~L~Ls~N~i~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  210 (869)
                      +|.+.+.++. .+..+++|++|++++|++++..  +..+..+++|++|+|++|++++..|..|..+++|+.|+|++|++.
T Consensus       334 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  413 (606)
T 3t6q_A          334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK  413 (606)
T ss_dssp             SCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEE
T ss_pred             CCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCC
Confidence            9999877665 4899999999999999999766  778999999999999999999999999999999999999999999


Q ss_pred             CCchH-hhhcCCCCCEEEcCCCCCCCCcccccc-cccceEEEcccccCccC---CCcccCCCCCcCEEeccCCCCCCCCc
Q 002899          211 GPIPA-SISALTSLTDLRISDLKGSESAFPKLD-KMNLKTLILTKCLIHGE---IPDYIGDMTKLKNIDLSFNNLTGGIP  285 (869)
Q Consensus       211 ~~~~~-~l~~l~~L~~L~L~~n~~~~~~~~~~~-~~~L~~L~Ls~N~i~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p  285 (869)
                      +..+. .+..+++|+.|+|++|.+.......+. ..+|++|+|++|++++.   .+..+..+++|+.|+|++|++++..|
T Consensus       414 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~  493 (606)
T 3t6q_A          414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ  493 (606)
T ss_dssp             CCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECT
T ss_pred             CcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccCh
Confidence            87654 599999999999999999887666554 34899999999999873   34678999999999999999999999


Q ss_pred             hhhhcCCCCCEEEeeCCcCCCCCchhh--hccCCceeeeccCccCCCC
Q 002899          286 TTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESS  331 (869)
Q Consensus       286 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~~~~  331 (869)
                      ..|..+++|+.|+|++|++++..|..+  ...+ .|++++|+++...+
T Consensus       494 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~  540 (606)
T 3t6q_A          494 HAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP  540 (606)
T ss_dssp             TTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCG
T ss_pred             hhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCH
Confidence            999999999999999999999888887  4567 89999999886543

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.96  E-value=1.7e-29  Score=277.83  Aligned_cols=264  Identities=22%  Similarity=0.315  Sum_probs=227.4

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      .|+++.+++++++++ .+|..+.  ++|+.|+|++|.|++..+..|..+ +|++|+|++|++++..|..|.++++|++|+
T Consensus        32 ~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  108 (332)
T 2ft3_A           32 HCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY  108 (332)
T ss_dssp             EEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred             cccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence            346788999999998 6777664  689999999999999888888887 899999999999998899999999999999


Q ss_pred             ccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCC--CCCccccCCCCcccEEEccCCcC
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS--GKIPEFIGKWKKIQKLHIQGSSL  209 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~l  209 (869)
                      |++|+++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|.++  +..+..|..+ +|+.|++++|++
T Consensus       109 L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l  184 (332)
T 2ft3_A          109 ISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL  184 (332)
T ss_dssp             CCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred             CCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence            9999999 5666555  79999999999999777777999999999999999996  4778888888 999999999999


Q ss_pred             CCCchHhhhcCCCCCEEEcCCCCCCCCccccccc-ccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhh
Q 002899          210 EGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF  288 (869)
Q Consensus       210 ~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  288 (869)
                      ++ +|..+.  ++|+.|+|++|.++......+.. .+|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+
T Consensus       185 ~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l  260 (332)
T 2ft3_A          185 TG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL  260 (332)
T ss_dssp             SS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTG
T ss_pred             Cc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhh
Confidence            96 444433  78999999999999877655543 48999999999999988889999999999999999999 788889


Q ss_pred             hcCCCCCEEEeeCCcCCCCCchhh--------hccCCceeeeccCcc
Q 002899          289 EKLAKTNFMYLTGNKLTGPVPKYI--------FNSNKNVDISLNNFT  327 (869)
Q Consensus       289 ~~l~~L~~L~Ls~N~l~~~~p~~~--------~~~l~~l~ls~N~~~  327 (869)
                      ..+++|+.|+|++|+|++..+..+        ...++.+++++|.++
T Consensus       261 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~  307 (332)
T 2ft3_A          261 PDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP  307 (332)
T ss_dssp             GGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred             hcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccc
Confidence            999999999999999997655544        234678999999655

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.96  E-value=5.3e-29  Score=303.70  Aligned_cols=268  Identities=18%  Similarity=0.243  Sum_probs=191.0

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCc-CCC-CCchhhccc--------cceEEEeecccCCCCCch--h
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNC-LTG-SFSPQWASL--------QLVELSVMGNRLSGPFPK--V  120 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~-i~~-~~~~~~~~l--------~L~~L~Ls~N~l~~~~~~--~  120 (869)
                      ..+++.|+|++|++.+.+|..|.++++|+.|+|++|+ +++ .+|..+..+        +|+.|+|++|+++ .+|.  .
T Consensus       490 L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~  568 (876)
T 4ecn_A          490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASAS  568 (876)
T ss_dssp             CTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHH
T ss_pred             CCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhh
Confidence            3568999999999999999999999999999999998 888 677766554        6999999999999 7777  8


Q ss_pred             hcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCC-CCeEeccCCcCCCCCccccCCCCc-
Q 002899          121 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN-LNDLRISDNNFSGKIPEFIGKWKK-  198 (869)
Q Consensus       121 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~-  198 (869)
                      |.++++|+.|+|++|+++ .+| .|..+++|+.|+|++|+++ .+|..+.++++ |+.|+|++|+|+ .+|..+..++. 
T Consensus       569 l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~  644 (876)
T 4ecn_A          569 LQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVY  644 (876)
T ss_dssp             HTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSS
T ss_pred             hhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccC
Confidence            999999999999999999 777 8999999999999999999 88888988988 999999999988 66766655543 


Q ss_pred             -ccEEEccCCcCCCCch-----------------------------HhhhcCCCCCEEEcCCCCCCCCcccccccc----
Q 002899          199 -IQKLHIQGSSLEGPIP-----------------------------ASISALTSLTDLRISDLKGSESAFPKLDKM----  244 (869)
Q Consensus       199 -L~~L~L~~N~l~~~~~-----------------------------~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~----  244 (869)
                       |+.|+|++|++.+.+|                             ..+..+++|+.|+|++|.+...+...+...    
T Consensus       645 ~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l  724 (876)
T 4ecn_A          645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNY  724 (876)
T ss_dssp             CEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCC
T ss_pred             CCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccc
Confidence             6666666665554332                             223345555555555555554443333322    


Q ss_pred             ----cceEEEcccccCccCCCcccC--CCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeC------CcCCCCCchhh
Q 002899          245 ----NLKTLILTKCLIHGEIPDYIG--DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG------NKLTGPVPKYI  312 (869)
Q Consensus       245 ----~L~~L~Ls~N~i~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~  312 (869)
                          +|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|..+..+++|+.|+|++      |++.+.+|..+
T Consensus       725 ~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l  802 (876)
T 4ecn_A          725 KNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI  802 (876)
T ss_dssp             TTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTG
T ss_pred             cccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHH
Confidence                4555556555555 4444444  55556666666665554 455555555566665544      55555555555


Q ss_pred             --hccCCceeeeccCcc
Q 002899          313 --FNSNKNVDISLNNFT  327 (869)
Q Consensus       313 --~~~l~~l~ls~N~~~  327 (869)
                        +..|+.|+|++|++.
T Consensus       803 ~~L~~L~~L~Ls~N~L~  819 (876)
T 4ecn_A          803 TTCPSLIQLQIGSNDIR  819 (876)
T ss_dssp             GGCSSCCEEECCSSCCC
T ss_pred             hcCCCCCEEECCCCCCC
Confidence              335555566655553

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.96  E-value=1.3e-29  Score=276.29  Aligned_cols=229  Identities=27%  Similarity=0.421  Sum_probs=157.6

Q ss_pred             CCCCEEEeecCcCCC--CCchhhccc-cceEEEeec-ccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccE
Q 002899           78 RYLKQLDLSRNCLTG--SFSPQWASL-QLVELSVMG-NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK  153 (869)
Q Consensus        78 ~~L~~L~Ls~N~i~~--~~~~~~~~l-~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  153 (869)
                      .+++.|+|++|.+++  .+|..+..+ +|++|+|++ |.+.+.+|..|.++++|++|+|++|++++.+|..|..+++|++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~  129 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence            356677777776665  555555554 555566553 5555555555555555555555555555555555555555555


Q ss_pred             EEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCC-cccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCC
Q 002899          154 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWK-KIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK  232 (869)
Q Consensus       154 L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~  232 (869)
                      |+|++|++++.+|..+..+++|++|+|++|++++.+|..+..++ +|+.|+|++|++++.+|..+..+            
T Consensus       130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l------------  197 (313)
T 1ogq_A          130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL------------  197 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC------------
T ss_pred             EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCC------------
Confidence            55555555555555555555555555555555555555555554 55555555555555555555444            


Q ss_pred             CCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh
Q 002899          233 GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI  312 (869)
Q Consensus       233 ~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  312 (869)
                                  +|+.|+|++|++++..|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+
T Consensus       198 ------------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l  264 (313)
T 1ogq_A          198 ------------NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL  264 (313)
T ss_dssp             ------------CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGG
T ss_pred             ------------cccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHH
Confidence                        456666778888888999999999999999999999977666 8899999999999999999999988


Q ss_pred             --hccCCceeeeccCccCCCC
Q 002899          313 --FNSNKNVDISLNNFTWESS  331 (869)
Q Consensus       313 --~~~l~~l~ls~N~~~~~~~  331 (869)
                        +..++.|+|++|++++..+
T Consensus       265 ~~l~~L~~L~Ls~N~l~~~ip  285 (313)
T 1ogq_A          265 TQLKFLHSLNVSFNNLCGEIP  285 (313)
T ss_dssp             GGCTTCCEEECCSSEEEEECC
T ss_pred             hcCcCCCEEECcCCcccccCC
Confidence              5689999999999985543

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.96  E-value=1.6e-28  Score=269.85  Aligned_cols=266  Identities=20%  Similarity=0.231  Sum_probs=228.4

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      ..+++.|+|++|++++..+..|.++++|++|+|++|.|++..|..|..+ +|++|+|++|+++.. |..+.  ++|++|+
T Consensus        51 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l-~~~~~--~~L~~L~  127 (330)
T 1xku_A           51 PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL-PEKMP--KTLQELR  127 (330)
T ss_dssp             CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBC-CSSCC--TTCCEEE
T ss_pred             CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCcc-Chhhc--ccccEEE
Confidence            4578999999999998888899999999999999999999999999888 899999999999954 44443  7999999


Q ss_pred             ccccccCCCCCccccCCCCccEEEeecccccc--cCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcC
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTG--ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL  209 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  209 (869)
                      |++|.+++..+..|.++++|++|+|++|++..  ..+..+.++++|++|++++|+++. +|..+.  ++|+.|+|++|.+
T Consensus       128 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l  204 (330)
T 1xku_A          128 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKI  204 (330)
T ss_dssp             CCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCC
T ss_pred             CCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcC
Confidence            99999998877789999999999999999964  678889999999999999999985 555443  8999999999999


Q ss_pred             CCCchHhhhcCCCCCEEEcCCCCCCCCccccccc-ccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhh
Q 002899          210 EGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF  288 (869)
Q Consensus       210 ~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  288 (869)
                      ++..+..+..+++|+.|+|++|.++......+.. .+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|
T Consensus       205 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f  283 (330)
T 1xku_A          205 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF  283 (330)
T ss_dssp             CEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred             CccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhc
Confidence            9888999999999999999999999877654443 48999999999999 778889999999999999999998888777


Q ss_pred             hcC------CCCCEEEeeCCcCCC--CCchhh--hccCCceeeeccC
Q 002899          289 EKL------AKTNFMYLTGNKLTG--PVPKYI--FNSNKNVDISLNN  325 (869)
Q Consensus       289 ~~l------~~L~~L~Ls~N~l~~--~~p~~~--~~~l~~l~ls~N~  325 (869)
                      ...      +.|+.|+|++|++..  ..|..+  ...++.++|++|+
T Consensus       284 ~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             SCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             CCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            643      789999999999974  344444  3467788988883

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.96  E-value=1.7e-28  Score=296.60  Aligned_cols=279  Identities=19%  Similarity=0.210  Sum_probs=224.7

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      ..+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|..+ +|++|+|++|+++++.+..|+++++|++|+
T Consensus        24 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  103 (680)
T 1ziw_A           24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH  103 (680)
T ss_dssp             CTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred             CCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence            4579999999999998877889999999999999999999999999888 899999999999988777899999999999


Q ss_pred             ccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccC--CCCcccEEEccCCcC
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG--KWKKIQKLHIQGSSL  209 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l  209 (869)
                      |++|++++..|..|.++++|++|+|++|++++..|..+.++++|++|+|++|++++..+..+.  .+++|+.|+|++|.+
T Consensus       104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l  183 (680)
T 1ziw_A          104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI  183 (680)
T ss_dssp             CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred             CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence            999999987778899999999999999999988888999999999999999999988877765  458999999999999


Q ss_pred             CCCchHhhhcCC---------------------------CCCEEEcCCCCCCCCccccccc---ccceEEEcccccCccC
Q 002899          210 EGPIPASISALT---------------------------SLTDLRISDLKGSESAFPKLDK---MNLKTLILTKCLIHGE  259 (869)
Q Consensus       210 ~~~~~~~l~~l~---------------------------~L~~L~L~~n~~~~~~~~~~~~---~~L~~L~Ls~N~i~~~  259 (869)
                      ++..|..+..++                           +|+.|++++|.+.......+..   .+|+.|+|++|++++.
T Consensus       184 ~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~  263 (680)
T 1ziw_A          184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV  263 (680)
T ss_dssp             CCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEE
T ss_pred             cccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCcc
Confidence            988888777664                           4555666666665544333332   2477777777777777


Q ss_pred             CCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCC-----Cch----hh--hccCCceeeeccCccC
Q 002899          260 IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP-----VPK----YI--FNSNKNVDISLNNFTW  328 (869)
Q Consensus       260 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~----~~--~~~l~~l~ls~N~~~~  328 (869)
                      .|..|+.+++|+.|+|++|++++..|..|.++++|+.|+|++|...+.     +|.    .+  ...++.|++++|+++.
T Consensus       264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~  343 (680)
T 1ziw_A          264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG  343 (680)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC
T ss_pred             CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC
Confidence            777777777777777777777777777777777777777776655432     221    12  3466777777777766


Q ss_pred             CCC
Q 002899          329 ESS  331 (869)
Q Consensus       329 ~~~  331 (869)
                      ..+
T Consensus       344 ~~~  346 (680)
T 1ziw_A          344 IKS  346 (680)
T ss_dssp             CCT
T ss_pred             CCh
Confidence            544

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.96  E-value=3.7e-29  Score=292.55  Aligned_cols=268  Identities=16%  Similarity=0.179  Sum_probs=191.6

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI  132 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  132 (869)
                      .+++.|+|++|.+++..|..|.++++|++|+|++|+|++..|..|..+ +|++|+|++|+++. +|..  .+++|++|+|
T Consensus        21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~L   97 (520)
T 2z7x_B           21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDL   97 (520)
T ss_dssp             TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCCCCSEEEC
T ss_pred             ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--ccCCccEEec
Confidence            468888888888887777788888888888888888888888888877 78888888888884 4444  7888888888


Q ss_pred             cccccCC-CCCccccCCCCccEEEeecccccccCCccccCCCCC--CeEeccCCcC--CCCCccccCCCC----------
Q 002899          133 EGNLFTG-SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNL--NDLRISDNNF--SGKIPEFIGKWK----------  197 (869)
Q Consensus       133 s~N~l~~-~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L--~~L~Ls~N~l--~~~~~~~~~~l~----------  197 (869)
                      ++|++++ .+|..|+++++|++|+|++|+|++   ..+..+++|  ++|+|++|++  .+..|..|..+.          
T Consensus        98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~  174 (520)
T 2z7x_B           98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT  174 (520)
T ss_dssp             CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred             cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence            8888886 367788888888888888888774   345555555  6666666666  444444444322          


Q ss_pred             -------------------------------------------------------------------------cccEEEc
Q 002899          198 -------------------------------------------------------------------------KIQKLHI  204 (869)
Q Consensus       198 -------------------------------------------------------------------------~L~~L~L  204 (869)
                                                                                               +|+.|++
T Consensus       175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l  254 (520)
T 2z7x_B          175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI  254 (520)
T ss_dssp             SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEE
T ss_pred             CcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEe
Confidence                                                                                     4555555


Q ss_pred             cCCcCCCCchHhh-----hcCCC--------------------------CCEEEcCCCCCCCCcccccccccceEEEccc
Q 002899          205 QGSSLEGPIPASI-----SALTS--------------------------LTDLRISDLKGSESAFPKLDKMNLKTLILTK  253 (869)
Q Consensus       205 ~~N~l~~~~~~~l-----~~l~~--------------------------L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~  253 (869)
                      ++|++++.+|..+     ..+++                          |+.|++++|.+...... ....+|++|+|++
T Consensus       255 ~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~l~~L~~L~Ls~  333 (520)
T 2z7x_B          255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP-SKISPFLHLDFSN  333 (520)
T ss_dssp             EEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCC-SSCCCCCEEECCS
T ss_pred             ecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccch-hhCCcccEEEeEC
Confidence            5555555555444     33333                          44444444444333221 2334788888888


Q ss_pred             ccCccCCCcccCCCCCcCEEeccCCCCCC--CCchhhhcCCCCCEEEeeCCcCCCCCchhh---hccCCceeeeccCccC
Q 002899          254 CLIHGEIPDYIGDMTKLKNIDLSFNNLTG--GIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISLNNFTW  328 (869)
Q Consensus       254 N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~~l~~l~ls~N~~~~  328 (869)
                      |++++..|..+..+++|+.|+|++|++++  .+|..+..+++|+.|+|++|++++.+|...   ...++.|++++|.++.
T Consensus       334 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~  413 (520)
T 2z7x_B          334 NLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD  413 (520)
T ss_dssp             SCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCG
T ss_pred             CccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCc
Confidence            88888888888888888888888888886  455778888888888888888887677653   3567888888887764

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.96  E-value=1.4e-28  Score=266.41  Aligned_cols=174  Identities=24%  Similarity=0.338  Sum_probs=150.0

Q ss_pred             cCCCCC-CeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHH-HhcCCCceeeEEeEEee----CceEE
Q 002899          638 NNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMI-SAQQHPNLVKLYGCCVE----GNQLL  710 (869)
Q Consensus       638 ~~f~~~-~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l-~~l~H~nIv~l~~~~~~----~~~~~  710 (869)
                      ++|.+. ++||+|+||.||+|... +++.||+|++..     ...+.+|++++ +..+||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456666 77999999999999974 689999999864     24567888887 56799999999999887    67789


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCcEEEeecC
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFG  787 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~---~~~~kl~DFG  787 (869)
                      +||||+++|+|.+++.....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.   ++.+||+|||
T Consensus        92 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            99999999999999976432   26899999999999999999999998   999999999999998   7899999999


Q ss_pred             CceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ++.....                       ..++.++||||||+++|||++|+.||..
T Consensus       166 ~a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~  200 (299)
T 3m2w_A          166 FAKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYS  200 (299)
T ss_dssp             TCEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            9865431                       3357789999999999999999999954

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=2.3e-29  Score=285.17  Aligned_cols=199  Identities=15%  Similarity=0.142  Sum_probs=152.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHHHHhcCC-Cce---------------e
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQH-PNL---------------V  697 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l~H-~nI---------------v  697 (869)
                      .+|...++||+|+||.||+|... +|+.||||++.....   ...+.|.+|+.++..++| +|.               +
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            45667789999999999999964 689999999874322   235778999999999987 221               1


Q ss_pred             e------EEeEEee-----CceEEEEEEeccCCchhhhhhcCC--cccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 002899          698 K------LYGCCVE-----GNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV  764 (869)
Q Consensus       698 ~------l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii  764 (869)
                      .      +..++..     ....+++|++ .+++|.+++....  ......+++..+..++.||++||+|||+++   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence            1      1111111     1235677775 4689988874110  011235788999999999999999999998   99


Q ss_pred             EcCCCCCCEEEcCCCcEEEeecCCceeecCCCccccccccccccccchhhc----------ccCCCCchhHHHHHHHHHH
Q 002899          765 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA----------MRGYLTSKADVYSFGVVTL  834 (869)
Q Consensus       765 H~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k~DvwSlGvil~  834 (869)
                      ||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          ....++.++|||||||++|
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            9999999999999999999999998865432    233567 999999999          5556888999999999999


Q ss_pred             HHHcCCCCCCC
Q 002899          835 EIVSGKSNTNY  845 (869)
Q Consensus       835 elltG~~p~~~  845 (869)
                      ||++|+.||..
T Consensus       309 elltg~~Pf~~  319 (413)
T 3dzo_A          309 WIWCADLPNTD  319 (413)
T ss_dssp             HHHHSSCCCCT
T ss_pred             HHHHCCCCCCC
Confidence            99999999965

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.96  E-value=2.8e-28  Score=274.40  Aligned_cols=250  Identities=16%  Similarity=0.110  Sum_probs=180.1

Q ss_pred             cCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccE
Q 002899           75 SKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK  153 (869)
Q Consensus        75 ~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  153 (869)
                      ..+++|+.|++++|.++.+++..|..+ +|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|..+++|++
T Consensus        42 ~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  121 (390)
T 3o6n_A           42 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV  121 (390)
T ss_dssp             GGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             cccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence            346899999999999999988888887 8999999999999888889999999999999999999888888999999999


Q ss_pred             EEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCC-
Q 002899          154 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK-  232 (869)
Q Consensus       154 L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~-  232 (869)
                      |+|++|+++...+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|++++....   .+++|+.|++++|. 
T Consensus       122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~---~l~~L~~L~l~~n~l  198 (390)
T 3o6n_A          122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLS---LIPSLFHANVSYNLL  198 (390)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGG---GCTTCSEEECCSSCC
T ss_pred             EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccc---cccccceeecccccc
Confidence            99999999955555579999999999999999988899999999999999999999976433   33444443333333 


Q ss_pred             ------------------CCCCccc--------------------ccccccceEEEcccccCccCCCcccCCCCCcCEEe
Q 002899          233 ------------------GSESAFP--------------------KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNID  274 (869)
Q Consensus       233 ------------------~~~~~~~--------------------~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~  274 (869)
                                        +...+..                    .....+|+.|+|++|.+++..|..|..+++|+.|+
T Consensus       199 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  278 (390)
T 3o6n_A          199 STLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY  278 (390)
T ss_dssp             SEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEE
T ss_pred             cccCCCCcceEEECCCCeeeeccccccccccEEECCCCCCcccHHHcCCCCccEEECCCCcCCCcChhHccccccCCEEE
Confidence                              3222111                    11112455555555555555555555555555555


Q ss_pred             ccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh--hccCCceeeeccCccCC
Q 002899          275 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWE  329 (869)
Q Consensus       275 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~~  329 (869)
                      |++|++++ +|..+..+++|+.|+|++|+++ .+|..+  +..++.|++++|+++..
T Consensus       279 L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~  333 (390)
T 3o6n_A          279 ISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL  333 (390)
T ss_dssp             CCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC
T ss_pred             CCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee
Confidence            55555552 3444445555555555555555 233333  34555555555555443

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.96  E-value=2e-28  Score=269.33  Aligned_cols=264  Identities=20%  Similarity=0.232  Sum_probs=228.8

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      ..+++.|++++|++++..|..|.++++|++|+|++|.|++..+..|..+ +|++|+|++|+++.. |..+.  ++|++|+
T Consensus        53 ~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l-~~~~~--~~L~~L~  129 (332)
T 2ft3_A           53 SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEI-PPNLP--SSLVELR  129 (332)
T ss_dssp             CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSC-CSSCC--TTCCEEE
T ss_pred             CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCcc-Ccccc--ccCCEEE
Confidence            3578999999999998888899999999999999999999999999888 899999999999954 44443  8999999


Q ss_pred             ccccccCCCCCccccCCCCccEEEeecccccc--cCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcC
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTG--ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL  209 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  209 (869)
                      |++|++++..+..|..+++|++|++++|.++.  ..+..+..+ +|++|++++|++++ +|..+.  ++|+.|+|++|.+
T Consensus       130 l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i  205 (332)
T 2ft3_A          130 IHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKI  205 (332)
T ss_dssp             CCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCC
T ss_pred             CCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcC
Confidence            99999997777789999999999999999963  677888888 99999999999996 555443  7999999999999


Q ss_pred             CCCchHhhhcCCCCCEEEcCCCCCCCCccccccc-ccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhh
Q 002899          210 EGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF  288 (869)
Q Consensus       210 ~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  288 (869)
                      ++..+..+..+++|+.|+|++|.+.......+.. .+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|
T Consensus       206 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~  284 (332)
T 2ft3_A          206 QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDF  284 (332)
T ss_dssp             CCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSS
T ss_pred             CccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHc
Confidence            9988899999999999999999999887655544 48999999999999 678889999999999999999998888877


Q ss_pred             hcC------CCCCEEEeeCCcCC--CCCchhh--hccCCceeeecc
Q 002899          289 EKL------AKTNFMYLTGNKLT--GPVPKYI--FNSNKNVDISLN  324 (869)
Q Consensus       289 ~~l------~~L~~L~Ls~N~l~--~~~p~~~--~~~l~~l~ls~N  324 (869)
                      ..+      ++|+.|++++|++.  +..|..+  ...++.+++++|
T Consensus       285 ~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n  330 (332)
T 2ft3_A          285 CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY  330 (332)
T ss_dssp             SCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred             cccccccccccccceEeecCcccccccCcccccccchhhhhhcccc
Confidence            764      67999999999998  5555555  457888999888

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.96  E-value=1.4e-28  Score=293.23  Aligned_cols=162  Identities=16%  Similarity=0.147  Sum_probs=135.2

Q ss_pred             cCCCCCCeEeccCCcCCCCCc-cccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCC-ccccc-ccccc
Q 002899          170 TKLTNLNDLRISDNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES-AFPKL-DKMNL  246 (869)
Q Consensus       170 ~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~-~~~~~-~~~~L  246 (869)
                      ..+++|+.|++++|++++..+ ..|..+++|+.|++++|.+.+..|..+..+++|+.|+|++|.+... ....+ ...+|
T Consensus       396 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L  475 (606)
T 3vq2_A          396 MGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL  475 (606)
T ss_dssp             TTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred             cCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCC
Confidence            344455555555555555555 5678889999999999999999999999999999999999998873 33333 34589


Q ss_pred             eEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhh---ccCCceeeec
Q 002899          247 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISL  323 (869)
Q Consensus       247 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~~l~~l~ls~  323 (869)
                      +.|+|++|++++..|..|..+++|+.|+|++|++++.+|..|..+++|+.|+|++|+|+ .+|..+.   ..++.+++++
T Consensus       476 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~  554 (606)
T 3vq2_A          476 TFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTN  554 (606)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCS
T ss_pred             CEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccC
Confidence            99999999999999999999999999999999999999999999999999999999999 6776663   2589999999


Q ss_pred             cCccCCCCC
Q 002899          324 NNFTWESSD  332 (869)
Q Consensus       324 N~~~~~~~~  332 (869)
                      |++....+.
T Consensus       555 N~~~c~c~~  563 (606)
T 3vq2_A          555 NSVACICEH  563 (606)
T ss_dssp             CCCCCSSTT
T ss_pred             CCcccCCcc
Confidence            999865554

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.96  E-value=1.9e-28  Score=289.28  Aligned_cols=263  Identities=20%  Similarity=0.175  Sum_probs=197.8

Q ss_pred             EEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccccccc
Q 002899           57 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN  135 (869)
Q Consensus        57 ~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  135 (869)
                      +.++++++++++ +|..+.  ++|++|+|++|.|++.++..|..+ +|++|+|++|++++..|+.|.++++|++|+|++|
T Consensus        34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            789999999995 777665  899999999999999999999988 8999999999999999999999999999999999


Q ss_pred             ccCCCCCccccCCCCccEEEeecccccc-cCCccccCCCCCCeEeccCCcCCCCCccccCCCCcc--cEEEccCCcC--C
Q 002899          136 LFTGSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI--QKLHIQGSSL--E  210 (869)
Q Consensus       136 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--~  210 (869)
                      +|+ .+|..  .+++|++|+|++|++++ ..|..|.++++|++|+|++|++++..   +..+++|  +.|+|++|.+  +
T Consensus       111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~---~~~l~~L~L~~L~L~~n~l~~~  184 (562)
T 3a79_B          111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLD---LLPVAHLHLSCILLDLVSYHIK  184 (562)
T ss_dssp             CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTT---TGGGTTSCEEEEEEEESSCCCC
T ss_pred             cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCc---hhhhhhceeeEEEeeccccccc
Confidence            999 56655  89999999999999997 34689999999999999999987532   3333444  7777777666  4


Q ss_pred             CCchHhhhcCC---------------------------------------------------------------------
Q 002899          211 GPIPASISALT---------------------------------------------------------------------  221 (869)
Q Consensus       211 ~~~~~~l~~l~---------------------------------------------------------------------  221 (869)
                      +..|..+..+.                                                                     
T Consensus       185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~  264 (562)
T 3a79_B          185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK  264 (562)
T ss_dssp             SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHH
T ss_pred             ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHH
Confidence            44333333322                                                                     


Q ss_pred             ------------CCCEEEcCCCCCCC-Ccccc------------------------------------------------
Q 002899          222 ------------SLTDLRISDLKGSE-SAFPK------------------------------------------------  240 (869)
Q Consensus       222 ------------~L~~L~L~~n~~~~-~~~~~------------------------------------------------  240 (869)
                                  +|++|++++|.+.. .+...                                                
T Consensus       265 ~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~  344 (562)
T 3a79_B          265 CSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFI  344 (562)
T ss_dssp             HHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCC
T ss_pred             HHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcc
Confidence                        34444444444331 11100                                                


Q ss_pred             -----cccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCC--chhhhcCCCCCEEEeeCCcCCCCCchhh-
Q 002899          241 -----LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI--PTTFEKLAKTNFMYLTGNKLTGPVPKYI-  312 (869)
Q Consensus       241 -----~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-  312 (869)
                           ....+|+.|+|++|++++..|..+..+++|+.|+|++|++++..  |..+..+++|+.|+|++|++++.+|... 
T Consensus       345 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  424 (562)
T 3a79_B          345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTC  424 (562)
T ss_dssp             CCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCC
T ss_pred             cccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhh
Confidence                 12236778888888888777777778888888888888887533  4557777888888888888877566553 


Q ss_pred             --hccCCceeeeccCccC
Q 002899          313 --FNSNKNVDISLNNFTW  328 (869)
Q Consensus       313 --~~~l~~l~ls~N~~~~  328 (869)
                        ...++.|++++|.++.
T Consensus       425 ~~l~~L~~L~l~~n~l~~  442 (562)
T 3a79_B          425 AWAESILVLNLSSNMLTG  442 (562)
T ss_dssp             CCCTTCCEEECCSSCCCG
T ss_pred             cCcccCCEEECCCCCCCc
Confidence              3456677777777654

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=8.4e-28  Score=285.67  Aligned_cols=244  Identities=18%  Similarity=0.193  Sum_probs=174.6

Q ss_pred             CCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEE
Q 002899           76 KLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKL  154 (869)
Q Consensus        76 ~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  154 (869)
                      .+++++.|++++|.++.+++..|..+ +|+.|+|++|.+++..+..|..+++|++|+|++|.|++..|..|+++++|++|
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  128 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence            46789999999999999999888887 89999999999999999999999999999999999999888889999999999


Q ss_pred             EeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCC
Q 002899          155 ILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS  234 (869)
Q Consensus       155 ~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~  234 (869)
                      +|++|.|++..+..|.++++|++|+|++|.+++..|..|..+++|+.|+|++|.+++..+.   .+++|+.|++++|.++
T Consensus       129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~---~l~~L~~L~l~~n~l~  205 (597)
T 3oja_B          129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLS---LIPSLFHANVSYNLLS  205 (597)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGG---GCTTCSEEECCSSCCS
T ss_pred             EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChh---hhhhhhhhhcccCccc
Confidence            9999999966666689999999999999999999999999999999999999999976433   3444444444443333


Q ss_pred             C-------------------CcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCC
Q 002899          235 E-------------------SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN  295 (869)
Q Consensus       235 ~-------------------~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  295 (869)
                      .                   .+...  ..+|+.|+|++|.+++  +..+..+++|+.|+|++|.|++.+|..|..+++|+
T Consensus       206 ~l~~~~~L~~L~ls~n~l~~~~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  281 (597)
T 3oja_B          206 TLAIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE  281 (597)
T ss_dssp             EEECCTTCSEEECCSSCCCEEECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCC
T ss_pred             cccCCchhheeeccCCccccccccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCC
Confidence            2                   21111  1134444444444443  23344445555555555555444444444444555


Q ss_pred             EEEeeCCcCCCCCchhh--hccCCceeeeccCcc
Q 002899          296 FMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFT  327 (869)
Q Consensus       296 ~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~  327 (869)
                      .|+|++|++++ +|..+  ++.|+.|+|++|.++
T Consensus       282 ~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~  314 (597)
T 3oja_B          282 RLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL  314 (597)
T ss_dssp             EEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC
T ss_pred             EEECCCCCCCC-CCcccccCCCCcEEECCCCCCC
Confidence            55555554443 22222  234444444444444

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.95  E-value=5.7e-28  Score=257.57  Aligned_cols=225  Identities=22%  Similarity=0.339  Sum_probs=151.0

Q ss_pred             ceEecCCCCcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcC
Q 002899           44 NVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTN  123 (869)
Q Consensus        44 ~v~C~~~~~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~  123 (869)
                      ++.|+|..   .++.+++++++++ .+|..+.  ++|++|+|++|+|++..                       +..|.+
T Consensus         9 ~~~C~c~~---~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~-----------------------~~~~~~   59 (270)
T 2o6q_A            9 GGVCSCNN---NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLP-----------------------SKAFHR   59 (270)
T ss_dssp             TCSBEEET---TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCC-----------------------TTSSSS
T ss_pred             CCCCEeCC---CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeC-----------------------HHHhcC
Confidence            36787753   2457888888888 4666554  46777777766665443                       344555


Q ss_pred             ccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEE
Q 002899          124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLH  203 (869)
Q Consensus       124 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  203 (869)
                      +++|++|+|++|.++...+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+
T Consensus        60 l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  139 (270)
T 2o6q_A           60 LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS  139 (270)
T ss_dssp             CTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence            66666666666666644444455666666666666666655455556666666666666666666666666666666666


Q ss_pred             ccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCC
Q 002899          204 IQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG  283 (869)
Q Consensus       204 L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~  283 (869)
                      |++|.+++..+..|..+++|+.|+|+                       +|+|++..+..|..+++|+.|+|++|+|++.
T Consensus       140 Ls~n~l~~~~~~~~~~l~~L~~L~L~-----------------------~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  196 (270)
T 2o6q_A          140 LGYNELQSLPKGVFDKLTSLKELRLY-----------------------NNQLKRVPEGAFDKLTELKTLKLDNNQLKRV  196 (270)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECC-----------------------SSCCSCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCCcCCccCHhHccCCcccceeEec-----------------------CCcCcEeChhHhccCCCcCEEECCCCcCCcC
Confidence            66666665555555666655555444                       4455555566677888888888888888877


Q ss_pred             CchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCCCCCCCCCCCC-CccceeccCCC
Q 002899          284 IPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRG-SVNLVESYSSP  350 (869)
Q Consensus       284 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~~C~c~-~~~~~~~l~~~  350 (869)
                      .+..|..+++|+.|+|++|                              ||.|+|. +.++..|+...
T Consensus       197 ~~~~~~~l~~L~~L~l~~N------------------------------~~~c~c~~~~~~~~~l~~~  234 (270)
T 2o6q_A          197 PEGAFDSLEKLKMLQLQEN------------------------------PWDCTCNGIIYMAKWLKKK  234 (270)
T ss_dssp             CTTTTTTCTTCCEEECCSS------------------------------CBCCSSSSSHHHHHHHHHH
T ss_pred             CHHHhccccCCCEEEecCC------------------------------CeeCCCccHHHHHHHHHhh
Confidence            7777888888888888888                              8889997 67888888653

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.95  E-value=4.8e-28  Score=260.76  Aligned_cols=220  Identities=21%  Similarity=0.182  Sum_probs=154.2

Q ss_pred             cccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCcc
Q 002899           73 ELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQ  152 (869)
Q Consensus        73 ~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  152 (869)
                      .+.++++|++|++++|.++.+++...  .+++.|+|++|++++..+..|..+++|++|+|++|.|++..+  ...+++|+
T Consensus         5 ~~~~l~~l~~l~~~~~~l~~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~   80 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG   80 (290)
T ss_dssp             EEECSTTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred             cccccCCccEEECCCCCCCcCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCC
Confidence            36677778888888888776554332  367777777777777777778888888888888888774433  26677777


Q ss_pred             EEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCC
Q 002899          153 KLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK  232 (869)
Q Consensus       153 ~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~  232 (869)
                      +|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|+   
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~---  156 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA---  156 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT---
T ss_pred             EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECC---
Confidence            8888777777 566667777777777777777776666677777777777777777776555555555555554444   


Q ss_pred             CCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh
Q 002899          233 GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI  312 (869)
Q Consensus       233 ~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  312 (869)
                                          +|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|          
T Consensus       157 --------------------~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~N----------  205 (290)
T 1p9a_G          157 --------------------NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN----------  205 (290)
T ss_dssp             --------------------TSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSC----------
T ss_pred             --------------------CCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCC----------
Confidence                                44454445555666777777777777777 55655666666666666666          


Q ss_pred             hccCCceeeeccCccCCCCCCCCCCCCCccceeccCCCC
Q 002899          313 FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPR  351 (869)
Q Consensus       313 ~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~~~~~l~~~~  351 (869)
                                          ||.|+|.+.++..|++...
T Consensus       206 --------------------p~~C~c~~~~l~~wl~~~~  224 (290)
T 1p9a_G          206 --------------------PWLCNCEILYFRRWLQDNA  224 (290)
T ss_dssp             --------------------CBCCSGGGHHHHHHHHHTG
T ss_pred             --------------------CccCcCccHHHHHHHHhCc
Confidence                                9999999999999987643

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.95  E-value=2.4e-27  Score=278.99  Aligned_cols=117  Identities=25%  Similarity=0.288  Sum_probs=88.8

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCC-CchhhcCccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGP-FPKVLTNITTLKNL  130 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L  130 (869)
                      ..+++.|+|++|.+++..|.+|.++++|++|+|++|.+++.++..|..+ +|++|+|++|++++. .|..+.++++|++|
T Consensus        49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L  128 (549)
T 2z81_A           49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL  128 (549)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred             CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence            3568899999999998888889999999999999999998888878777 799999999988863 45667778888888


Q ss_pred             cccccccCCCCC-ccccCCCCccEEEeecccccccCCccc
Q 002899          131 SIEGNLFTGSIP-PDIRKLINLQKLILSSNSFTGELPAEL  169 (869)
Q Consensus       131 ~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~p~~~  169 (869)
                      +|++|.+.+.+| ..|.++++|++|+|++|++++..|..+
T Consensus       129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l  168 (549)
T 2z81_A          129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSL  168 (549)
T ss_dssp             EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTT
T ss_pred             ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhh
Confidence            888777333333 456666666666666666665444433

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.95  E-value=4.5e-27  Score=259.97  Aligned_cols=260  Identities=21%  Similarity=0.286  Sum_probs=208.1

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      ..+++.|++++|.+++. +. +..+++|++|+|++|.++.. + .+..+ +|++|+|++|.+++..+  +..+++|++|+
T Consensus        65 ~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~-~-~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~  138 (347)
T 4fmz_A           65 LTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI-S-ALQNLTNLRELYLNEDNISDISP--LANLTKMYSLN  138 (347)
T ss_dssp             CTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEE
T ss_pred             cCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc-h-HHcCCCcCCEEECcCCcccCchh--hccCCceeEEE
Confidence            34689999999999854 44 99999999999999999875 3 46665 89999999999986544  88999999999


Q ss_pred             ccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCC
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG  211 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  211 (869)
                      |++|.....+ ..+..+++|++|++++|.+.+..+  +..+++|++|++++|++++..+  +..+++|+.|++++|.+.+
T Consensus       139 l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~  213 (347)
T 4fmz_A          139 LGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD  213 (347)
T ss_dssp             CTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred             CCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCC
Confidence            9999666444 458899999999999999885443  7888999999999999885444  7888888888888888886


Q ss_pred             CchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcC
Q 002899          212 PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL  291 (869)
Q Consensus       212 ~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  291 (869)
                      ..+  +..+++|+.|+|++|.++..+. .....+|++|+|++|.+++.  ..+..+++|+.|+|++|++++.  ..+..+
T Consensus       214 ~~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l  286 (347)
T 4fmz_A          214 ITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNL  286 (347)
T ss_dssp             CGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGC
T ss_pred             Cch--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCC
Confidence            555  7888888888888888877654 33344788888888888764  4577888888888888888854  457888


Q ss_pred             CCCCEEEeeCCcCCCCCchhh--hccCCceeeeccCccCCC
Q 002899          292 AKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWES  330 (869)
Q Consensus       292 ~~L~~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~~~  330 (869)
                      ++|+.|+|++|++++..|..+  ++.++.|++++|+++...
T Consensus       287 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~  327 (347)
T 4fmz_A          287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR  327 (347)
T ss_dssp             TTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCG
T ss_pred             CCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccccc
Confidence            888888888888887777766  457888888888777653

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=6.9e-29  Score=270.52  Aligned_cols=240  Identities=20%  Similarity=0.260  Sum_probs=115.5

Q ss_pred             EEEEeccCCCccccCCccccCCCCCCEEEeecCcCC-CCCchhhc--------cccceEEEeecccCCCCCchhh--cCc
Q 002899           56 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT-GSFSPQWA--------SLQLVELSVMGNRLSGPFPKVL--TNI  124 (869)
Q Consensus        56 v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~-~~~~~~~~--------~l~L~~L~Ls~N~l~~~~~~~~--~~l  124 (869)
                      ++.|++++|.+  .+|..+...  |+.|+|++|.++ ...+..+.        ..+|++|+|++|++++..|..+  ..+
T Consensus        45 L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l  120 (312)
T 1wwl_A           45 LEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATG  120 (312)
T ss_dssp             CTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCS
T ss_pred             ceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcC
Confidence            34445555555  444444433  555555555552 22232222        1245555555555555555443  555


Q ss_pred             cccccccccccccCCCCCccccCC-----CCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCC--Ccccc--CC
Q 002899          125 TTLKNLSIEGNLFTGSIPPDIRKL-----INLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK--IPEFI--GK  195 (869)
Q Consensus       125 ~~L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~~~~--~~  195 (869)
                      ++|++|+|++|++++. |..+..+     ++|++|+|++|+|++..|..|.++++|++|+|++|++.+.  .+..+  ..
T Consensus       121 ~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~  199 (312)
T 1wwl_A          121 PDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK  199 (312)
T ss_dssp             CCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTS
T ss_pred             CCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhcc
Confidence            5555555555555544 4444444     5555555555555544445555555555555555554432  12222  45


Q ss_pred             CCcccEEEccCCcCCC---CchHhhhcCCCCCEEEcCCCCCCCCc-ccccc-cccceEEEcccccCccCCCcccCCCCCc
Q 002899          196 WKKIQKLHIQGSSLEG---PIPASISALTSLTDLRISDLKGSESA-FPKLD-KMNLKTLILTKCLIHGEIPDYIGDMTKL  270 (869)
Q Consensus       196 l~~L~~L~L~~N~l~~---~~~~~l~~l~~L~~L~L~~n~~~~~~-~~~~~-~~~L~~L~Ls~N~i~~~~p~~~~~l~~L  270 (869)
                      +++|++|+|++|++++   .....+.++++|+.|+|++|.++... ...+. ..+|+.|+|++|+|+ .+|..+.  ++|
T Consensus       200 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L  276 (312)
T 1wwl_A          200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKL  276 (312)
T ss_dssp             CTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEE
T ss_pred             CCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCc
Confidence            5555555555555552   11123344555555555555554433 12111 224555555555555 3333333  455


Q ss_pred             CEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCC
Q 002899          271 KNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT  305 (869)
Q Consensus       271 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  305 (869)
                      +.|+|++|+|++. |. +..+++|+.|+|++|+++
T Consensus       277 ~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~  309 (312)
T 1wwl_A          277 SVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL  309 (312)
T ss_dssp             EEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred             eEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence            5555555555533 33 455555555555555554

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=1.2e-27  Score=255.95  Aligned_cols=254  Identities=20%  Similarity=0.257  Sum_probs=184.0

Q ss_pred             EEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccc
Q 002899           58 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL  136 (869)
Q Consensus        58 ~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  136 (869)
                      .+++.+.+++ .+|..+.  ++|++|+|++|.|++..+..|..+ +|++|+|++|++++..+..|.++++|++|+|++|.
T Consensus        11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~   87 (276)
T 2z62_A           11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP   87 (276)
T ss_dssp             EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence            3455666666 5666554  578999999998887777667666 78888888888777777777777888888888887


Q ss_pred             cCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCC-CccccCCCCcccEEEccCCcCCCCchH
Q 002899          137 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK-IPEFIGKWKKIQKLHIQGSSLEGPIPA  215 (869)
Q Consensus       137 l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~  215 (869)
                      +++..+..|.++++|++|++++|++++..+..+..+++|++|+|++|++++. +|..|..+++|+.|+|++|++++..+.
T Consensus        88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~  167 (276)
T 2z62_A           88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT  167 (276)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred             cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence            7766667777777788888887777766665677777777777777777753 477777777777777777777766666


Q ss_pred             hhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCC
Q 002899          216 SISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN  295 (869)
Q Consensus       216 ~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  295 (869)
                      .+..+++|+.|.+                   .|++++|.|++..+..+.. .+|+.|+|++|+|++..+..|..+++|+
T Consensus       168 ~~~~l~~L~~l~l-------------------~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~  227 (276)
T 2z62_A          168 DLRVLHQMPLLNL-------------------SLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQ  227 (276)
T ss_dssp             GGHHHHTCTTCCE-------------------EEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCC
T ss_pred             Hhhhhhhccccce-------------------eeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhccccccc
Confidence            6666555552211                   4666677777666665554 4899999999999987777788899999


Q ss_pred             EEEeeCCcCCCCCchhhhccCCceeeeccCccCCCCCCCCCCCC-CccceeccCCCCCCCCCCcCccCCCCCCCCCc
Q 002899          296 FMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRG-SVNLVESYSSPRNKLDKVHPCLRQNFPCSAPA  371 (869)
Q Consensus       296 ~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~~C~c~-~~~~~~~l~~~~~~~~~~~~~~~~~~~C~~p~  371 (869)
                      .|+|++|                              ||.|+|. +.++..|+........       ....|+.|.
T Consensus       228 ~L~l~~N------------------------------~~~c~c~~l~~l~~~~~~~~~~~~-------~~~~C~~~~  267 (276)
T 2z62_A          228 KIWLHTN------------------------------PWDCSCPRIDYLSRWLNKNSQKEQ-------GSAKCSGSG  267 (276)
T ss_dssp             EEECCSS------------------------------CBCCCTTTTHHHHHHHHHTGGGBC-------SCCBBTTTC
T ss_pred             EEEccCC------------------------------cccccCCchHHHHHHHHhcccccC-------CCceeeCCC
Confidence            9999988                              7779996 6667788765433322       234566654

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.95  E-value=9.6e-28  Score=260.59  Aligned_cols=234  Identities=19%  Similarity=0.204  Sum_probs=199.1

Q ss_pred             CcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCC--chhhccc-cceEEEeecccCCCCCchhhcCccccc
Q 002899           52 ATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSF--SPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK  128 (869)
Q Consensus        52 ~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~--~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~  128 (869)
                      ...+++.|+|++|+++...+..|.++++|++|+|++|.|+...  +..+..+ +|++|+|++|.++. +|..+..+++|+
T Consensus        26 ~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~  104 (306)
T 2z66_A           26 IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLE  104 (306)
T ss_dssp             CCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCC
T ss_pred             CCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCcccc-ChhhcCCCCCCC
Confidence            3457999999999999655556899999999999999998553  4444444 89999999999984 566799999999


Q ss_pred             cccccccccCCCCC-ccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCC-CCccccCCCCcccEEEccC
Q 002899          129 NLSIEGNLFTGSIP-PDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG-KIPEFIGKWKKIQKLHIQG  206 (869)
Q Consensus       129 ~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~  206 (869)
                      +|+|++|++++..+ ..+..+++|++|+|++|++.+..+..+.++++|++|+|++|++++ ..|..|..+++|+.|+|++
T Consensus       105 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~  184 (306)
T 2z66_A          105 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ  184 (306)
T ss_dssp             EEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred             EEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCC
Confidence            99999999997655 579999999999999999998889999999999999999999986 6889999999999999999


Q ss_pred             CcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCch
Q 002899          207 SSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT  286 (869)
Q Consensus       207 N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  286 (869)
                      |.+++..|..+..+++|+.|+|++                       |+|++..+..+..+++|+.|+|++|++++..|.
T Consensus       185 n~l~~~~~~~~~~l~~L~~L~L~~-----------------------N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  241 (306)
T 2z66_A          185 CQLEQLSPTAFNSLSSLQVLNMSH-----------------------NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ  241 (306)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECTT-----------------------SCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSS
T ss_pred             CCcCCcCHHHhcCCCCCCEEECCC-----------------------CccCccChhhccCcccCCEeECCCCCCcccCHH
Confidence            999988888999888888777764                       555555555677788888888888888888888


Q ss_pred             hhhcCC-CCCEEEeeCCcCCCCCc
Q 002899          287 TFEKLA-KTNFMYLTGNKLTGPVP  309 (869)
Q Consensus       287 ~~~~l~-~L~~L~Ls~N~l~~~~p  309 (869)
                      .+..++ +|+.|+|++|++++..+
T Consensus       242 ~~~~~~~~L~~L~L~~N~~~~~c~  265 (306)
T 2z66_A          242 ELQHFPSSLAFLNLTQNDFACTCE  265 (306)
T ss_dssp             SCCCCCTTCCEEECTTCCEECSGG
T ss_pred             HHHhhhccCCEEEccCCCeecccC
Confidence            888874 88888888888876543

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=5.3e-27  Score=257.32  Aligned_cols=224  Identities=21%  Similarity=0.286  Sum_probs=173.9

Q ss_pred             CCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEe
Q 002899           77 LRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLIL  156 (869)
Q Consensus        77 l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  156 (869)
                      .+.++.|+|++|.++.+++..+...+|++|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..+..+++|++|+|
T Consensus        80 ~~~l~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L  157 (328)
T 4fcg_A           80 QPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI  157 (328)
T ss_dssp             STTCCEEEEESSCCSSCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred             ccceeEEEccCCCchhcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence            46788888888888855444444337888888888887 66777788888888888888887 66777888888888888


Q ss_pred             ecccccccCCccccC---------CCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEE
Q 002899          157 SSNSFTGELPAELTK---------LTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR  227 (869)
Q Consensus       157 s~N~i~~~~p~~~~~---------l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~  227 (869)
                      ++|++.+.+|..+..         +++|++|+|++|+++ .+|..|..+++|++|+|++|.+++ +|..+..+++|+.| 
T Consensus       158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L-  234 (328)
T 4fcg_A          158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL-  234 (328)
T ss_dssp             EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEE-
T ss_pred             CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEE-
Confidence            887777777766543         677777777777776 566666777777777777777764 34456666655555 


Q ss_pred             cCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCC
Q 002899          228 ISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP  307 (869)
Q Consensus       228 L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  307 (869)
                                            +|++|.+.+.+|..|..+++|+.|+|++|++.+.+|..+..+++|+.|+|++|++.+.
T Consensus       235 ----------------------~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~  292 (328)
T 4fcg_A          235 ----------------------DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR  292 (328)
T ss_dssp             ----------------------ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCC
T ss_pred             ----------------------ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhh
Confidence                                  4557777778899999999999999999999999999999999999999999999999


Q ss_pred             Cchhh--hccCCceeeeccCcc
Q 002899          308 VPKYI--FNSNKNVDISLNNFT  327 (869)
Q Consensus       308 ~p~~~--~~~l~~l~ls~N~~~  327 (869)
                      +|..+  ...++.+++..|.+.
T Consensus       293 iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          293 LPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             CCGGGGGSCTTCEEECCGGGSC
T ss_pred             ccHHHhhccCceEEeCCHHHHH
Confidence            99998  457788888877554

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.95  E-value=1.4e-26  Score=255.95  Aligned_cols=259  Identities=18%  Similarity=0.285  Sum_probs=203.3

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI  132 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  132 (869)
                      .+++.|+++++.++. ++ .+..+++|++|+|++|.+++..+  +..+ +|++|+|++|.++..  +.+..+++|++|+|
T Consensus        44 ~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l  117 (347)
T 4fmz_A           44 ESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYL  117 (347)
T ss_dssp             TTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEEC
T ss_pred             ccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEEC
Confidence            357888898888874 44 48888999999999998887665  5555 899999999988864  35888899999999


Q ss_pred             cccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCC
Q 002899          133 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP  212 (869)
Q Consensus       133 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  212 (869)
                      ++|.+++. +. +..+++|++|++++|.....+ ..+..+++|++|++++|.+.+..+  +..+++|+.|++++|.+.+.
T Consensus       118 ~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~  192 (347)
T 4fmz_A          118 NEDNISDI-SP-LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI  192 (347)
T ss_dssp             TTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCC
T ss_pred             cCCcccCc-hh-hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccc
Confidence            99988854 33 888889999999998666443 348888899999999998885544  78888999999999988865


Q ss_pred             chHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCC
Q 002899          213 IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA  292 (869)
Q Consensus       213 ~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  292 (869)
                      .+  +..+++|+.|++++|.+..... .....+|+.|+|++|.+++..+  +..+++|+.|+|++|++++.  ..+..++
T Consensus       193 ~~--~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~  265 (347)
T 4fmz_A          193 SP--LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLT  265 (347)
T ss_dssp             GG--GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCT
T ss_pred             cc--ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCC
Confidence            44  8888899999999988887654 3334478999999998886555  78889999999999988854  4688888


Q ss_pred             CCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCCC
Q 002899          293 KTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWES  330 (869)
Q Consensus       293 ~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~  330 (869)
                      +|+.|++++|++++...-.-++.++.|++++|.++...
T Consensus       266 ~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~  303 (347)
T 4fmz_A          266 KLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNED  303 (347)
T ss_dssp             TCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCGGG
T ss_pred             CcCEEEccCCccCCChhhcCCCCCCEEECcCCcCCCcC
Confidence            99999999998886522222567888999999876543

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.95  E-value=6.9e-27  Score=279.54  Aligned_cols=153  Identities=20%  Similarity=0.250  Sum_probs=138.9

Q ss_pred             EEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccc
Q 002899           58 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL  136 (869)
Q Consensus        58 ~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  136 (869)
                      .+++++.+++ .+|..+.  +++++|||++|+|+++++..|..+ +|++|+|++|+|+++.+++|.++++|++|+|++|+
T Consensus        35 ~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~  111 (635)
T 4g8a_A           35 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP  111 (635)
T ss_dssp             EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc
Confidence            4688899999 6787664  479999999999999999999988 89999999999999999999999999999999999


Q ss_pred             cCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCC-CccccCCCCcccEEEccCCcCCCCc
Q 002899          137 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK-IPEFIGKWKKIQKLHIQGSSLEGPI  213 (869)
Q Consensus       137 l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~  213 (869)
                      |++..+..|.++++|++|+|++|+|++..+..|+++++|++|+|++|++++. .|..+..+++|++|+|++|+|++..
T Consensus       112 l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~  189 (635)
T 4g8a_A          112 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY  189 (635)
T ss_dssp             CCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEEC
T ss_pred             CCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccc
Confidence            9977778899999999999999999987777899999999999999999864 6788999999999999999886543

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.94  E-value=3.2e-26  Score=263.82  Aligned_cols=257  Identities=25%  Similarity=0.347  Sum_probs=151.0

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI  132 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  132 (869)
                      .+++.|+|++|.+++..+  +.++++|++|+|++|.+++..+  +..+ +|++|+|++|++++..+  +..+++|++|+|
T Consensus        68 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l  141 (466)
T 1o6v_A           68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLEL  141 (466)
T ss_dssp             TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEE
T ss_pred             cCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEEC
Confidence            468888888888886543  8888888888888888887766  5555 78888888888886543  888888888888


Q ss_pred             cccccCCCCCccccCCCC---------------------ccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCcc
Q 002899          133 EGNLFTGSIPPDIRKLIN---------------------LQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE  191 (869)
Q Consensus       133 s~N~l~~~~~~~~~~l~~---------------------L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~  191 (869)
                      ++|.+++. + .+..+++                     |++|++++|++++.  ..+..+++|++|++++|++++..+ 
T Consensus       142 ~~n~l~~~-~-~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-  216 (466)
T 1o6v_A          142 SSNTISDI-S-ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP-  216 (466)
T ss_dssp             EEEEECCC-G-GGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-
T ss_pred             CCCccCCC-h-hhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc-
Confidence            88888743 2 3444444                     44444444444421  124444444444444444443333 


Q ss_pred             ccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcC
Q 002899          192 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLK  271 (869)
Q Consensus       192 ~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~  271 (869)
                       ++.+++|+.|++++|.+++.  ..+..+++|+.|++++|.+..... .....+|+.|+|++|.+++..+  +..+++|+
T Consensus       217 -~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~  290 (466)
T 1o6v_A          217 -LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP--LAGLTALT  290 (466)
T ss_dssp             -GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCS
T ss_pred             -ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc--ccCCCccC
Confidence             34444555555555554432  234455555555555555544332 1222245555555555554333  55555566


Q ss_pred             EEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCC
Q 002899          272 NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWE  329 (869)
Q Consensus       272 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~  329 (869)
                      .|+|++|++++..+  +..+++|+.|+|++|++++..|..-+..++.|++++|.++..
T Consensus       291 ~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~  346 (466)
T 1o6v_A          291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV  346 (466)
T ss_dssp             EEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred             eEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc
Confidence            66666666554333  555566666666666666555533345556666666655543

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.94  E-value=1.9e-27  Score=263.72  Aligned_cols=257  Identities=19%  Similarity=0.230  Sum_probs=225.7

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      ..+++.|++++|++++..+..|.++++|++|+|++|.|++..+..|..+ +|++|+|++|++++..+..|.++++|++|+
T Consensus        51 ~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  130 (353)
T 2z80_A           51 TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLN  130 (353)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEE
T ss_pred             cccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEE
Confidence            3479999999999998777799999999999999999999988889887 899999999999988777899999999999


Q ss_pred             ccccccCCCCC-ccccCCCCccEEEeecc-cccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcC
Q 002899          132 IEGNLFTGSIP-PDIRKLINLQKLILSSN-SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL  209 (869)
Q Consensus       132 Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N-~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  209 (869)
                      |++|+++...+ ..|..+++|++|++++| .+....+..|.++++|++|++++|++++..|..|..+++|++|+|++|.+
T Consensus       131 L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l  210 (353)
T 2z80_A          131 LLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH  210 (353)
T ss_dssp             CTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCS
T ss_pred             CCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcc
Confidence            99999995444 47899999999999999 57767778899999999999999999998899999999999999999999


Q ss_pred             CCCchHhhhcCCCCCEEEcCCCCCCCCccccccc----ccceEEEcccccCcc----CCCcccCCCCCcCEEeccCCCCC
Q 002899          210 EGPIPASISALTSLTDLRISDLKGSESAFPKLDK----MNLKTLILTKCLIHG----EIPDYIGDMTKLKNIDLSFNNLT  281 (869)
Q Consensus       210 ~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~----~~L~~L~Ls~N~i~~----~~p~~~~~l~~L~~L~Ls~N~l~  281 (869)
                      .......+..+++|+.|+|++|.++...+..+..    ..++.++|+++.+.+    .+|..+..+++|+.|+|++|+|+
T Consensus       211 ~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~  290 (353)
T 2z80_A          211 ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK  290 (353)
T ss_dssp             TTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC
T ss_pred             ccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC
Confidence            8655566778999999999999998876554432    258888888888876    36778899999999999999999


Q ss_pred             CCCchhhhcCCCCCEEEeeCCcCCCCCc
Q 002899          282 GGIPTTFEKLAKTNFMYLTGNKLTGPVP  309 (869)
Q Consensus       282 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  309 (869)
                      ...+..|..+++|+.|+|++|++++..|
T Consensus       291 ~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          291 SVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            5544446999999999999999998876

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.94  E-value=1.6e-26  Score=265.32  Aligned_cols=230  Identities=18%  Similarity=0.200  Sum_probs=206.2

Q ss_pred             CcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccc
Q 002899           52 ATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNL  130 (869)
Q Consensus        52 ~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  130 (869)
                      ...+++.|+|++|+|++..+..|.++++|++|+|++|.|+++.+..|..+ +|++|+|++|+++.+.+..|..+++|++|
T Consensus        73 ~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  152 (452)
T 3zyi_A           73 IPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLREL  152 (452)
T ss_dssp             CCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEE
T ss_pred             CCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEE
Confidence            34579999999999999999999999999999999999999999999988 89999999999998888889999999999


Q ss_pred             cccccccCCCCCccccCCCCccEEEeec-ccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcC
Q 002899          131 SIEGNLFTGSIPPDIRKLINLQKLILSS-NSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL  209 (869)
Q Consensus       131 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~-N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  209 (869)
                      +|++|+|+...+..|..+++|++|+|++ |.+....+..|.++++|++|+|++|++++. | .+..+++|+.|+|++|.+
T Consensus       153 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l  230 (452)
T 3zyi_A          153 WLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHF  230 (452)
T ss_dssp             ECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCC
T ss_pred             ECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcC
Confidence            9999999977777899999999999999 455545555799999999999999999954 4 588999999999999999


Q ss_pred             CCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhh
Q 002899          210 EGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE  289 (869)
Q Consensus       210 ~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  289 (869)
                      ++..|..|.++++|+.|+|+                       +|+|++..+..|..+++|+.|+|++|+|++..+..|.
T Consensus       231 ~~~~~~~~~~l~~L~~L~L~-----------------------~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  287 (452)
T 3zyi_A          231 PEIRPGSFHGLSSLKKLWVM-----------------------NSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT  287 (452)
T ss_dssp             SEECGGGGTTCTTCCEEECT-----------------------TSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSST
T ss_pred             cccCcccccCccCCCEEEeC-----------------------CCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhc
Confidence            99889999999888877766                       5666667778888999999999999999988888889


Q ss_pred             cCCCCCEEEeeCCcCCC
Q 002899          290 KLAKTNFMYLTGNKLTG  306 (869)
Q Consensus       290 ~l~~L~~L~Ls~N~l~~  306 (869)
                      .+++|+.|+|++|++.-
T Consensus       288 ~l~~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          288 PLRYLVELHLHHNPWNC  304 (452)
T ss_dssp             TCTTCCEEECCSSCEEC
T ss_pred             cccCCCEEEccCCCcCC
Confidence            99999999999998864

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.94  E-value=4.5e-28  Score=264.66  Aligned_cols=257  Identities=17%  Similarity=0.140  Sum_probs=220.9

Q ss_pred             eEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccccc
Q 002899           55 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE  133 (869)
Q Consensus        55 ~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  133 (869)
                      +...++++.+++...+...+..+++|++|+|++|.|++..+..|..+ +|++|+|++|++++..+  +..+++|++|+|+
T Consensus        11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls   88 (317)
T 3o53_A           11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN   88 (317)
T ss_dssp             EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred             ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence            46778888999887777777888899999999999999999999888 89999999999997665  9999999999999


Q ss_pred             ccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCc
Q 002899          134 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI  213 (869)
Q Consensus       134 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  213 (869)
                      +|++++..     ..++|++|++++|+|++..+.   .+++|++|+|++|++++..+..|..+++|+.|+|++|.+++..
T Consensus        89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  160 (317)
T 3o53_A           89 NNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN  160 (317)
T ss_dssp             SSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred             CCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence            99998433     348999999999999966544   3678999999999999888889999999999999999999877


Q ss_pred             hHhh-hcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCC
Q 002899          214 PASI-SALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA  292 (869)
Q Consensus       214 ~~~l-~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  292 (869)
                      +..+ ..+++|+.|+|++|.++..+... ...+|+.|+|++|+|++..+. +..+++|+.|+|++|+|+ .+|..+..++
T Consensus       161 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~l~~L~~L~Ls~N~l~~l~~~-~~~l~~L~~L~L~~N~l~-~l~~~~~~l~  237 (317)
T 3o53_A          161 FAELAASSDTLEHLNLQYNFIYDVKGQV-VFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLV-LIEKALRFSQ  237 (317)
T ss_dssp             GGGGGGGTTTCCEEECTTSCCCEEECCC-CCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCC-EECTTCCCCT
T ss_pred             HHHHhhccCcCCEEECCCCcCccccccc-ccccCCEEECCCCcCCcchhh-hcccCcccEEECcCCccc-chhhHhhcCC
Confidence            7776 47999999999999998764332 355899999999999975554 889999999999999999 5788899999


Q ss_pred             CCCEEEeeCCcCC-CCCchhh--hccCCceeeecc
Q 002899          293 KTNFMYLTGNKLT-GPVPKYI--FNSNKNVDISLN  324 (869)
Q Consensus       293 ~L~~L~Ls~N~l~-~~~p~~~--~~~l~~l~ls~N  324 (869)
                      +|+.|+|++|+++ +.+|..+  .+.++.++++.|
T Consensus       238 ~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~  272 (317)
T 3o53_A          238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV  272 (317)
T ss_dssp             TCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHH
T ss_pred             CCCEEEccCCCccCcCHHHHHhccccceEEECCCc
Confidence            9999999999998 6666665  346677888744

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=5.8e-28  Score=283.43  Aligned_cols=185  Identities=19%  Similarity=0.146  Sum_probs=129.5

Q ss_pred             eeeccCceEEEEEE-EcCCcEEEEEEecccC----------chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEE
Q 002899          645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS----------RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       645 ~IG~G~fG~Vyka~-~~~g~~VAvK~~~~~~----------~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ..+.|++|.+..++ .-.|+.+|||.+....          ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35667777666554 2357889999986531          12245799999999999 799999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||++|++|.+.|....     +++..   +|+.||++||+|+|++|   ||||||||+|||+++++.+||+|||+|+..
T Consensus       321 MEyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~  389 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTT  389 (569)
T ss_dssp             EECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred             EecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence            99999999999997653     45543   58999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN  842 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p  842 (869)
                      ...... ....+||++|||||++.+ .+..++|+||+|+++++|.+|..|
T Consensus       390 ~~~~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          390 PQDCSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             C---CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCCCcc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            543322 234679999999999875 457789999999998877665443

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.94  E-value=6.4e-26  Score=261.31  Aligned_cols=261  Identities=25%  Similarity=0.330  Sum_probs=209.8

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCc-------------
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFP-------------  118 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~-------------  118 (869)
                      ..+++.|++++|.+++..+  +.++++|++|+|++|.+++..+  +..+ +|++|+|++|.+++...             
T Consensus        89 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~  164 (466)
T 1o6v_A           89 LTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFG  164 (466)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEE
T ss_pred             cccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCChhhccCCcccEeecC
Confidence            3578899999999986554  8899999999999999987754  5555 78899998888875321             


Q ss_pred             ------hhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccc
Q 002899          119 ------KVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEF  192 (869)
Q Consensus       119 ------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  192 (869)
                            ..+.++++|++|+|++|.+++.  ..+..+++|++|++++|++++..|  +..+++|++|+|++|++++.  ..
T Consensus       165 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~  238 (466)
T 1o6v_A          165 NQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GT  238 (466)
T ss_dssp             ESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GG
T ss_pred             CcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hh
Confidence                  2366778899999999998853  358889999999999999986555  77789999999999999853  46


Q ss_pred             cCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCE
Q 002899          193 IGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKN  272 (869)
Q Consensus       193 ~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~  272 (869)
                      +..+++|+.|++++|.+++..+  +..+++|+.|++++|.++..+. .....+|+.|+|++|++++..+  +..+++|+.
T Consensus       239 l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~  313 (466)
T 1o6v_A          239 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTY  313 (466)
T ss_dssp             GGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSE
T ss_pred             hhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCE
Confidence            7888999999999999987655  8889999999999998887654 3334479999999999987655  778899999


Q ss_pred             EeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCCC
Q 002899          273 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWES  330 (869)
Q Consensus       273 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~  330 (869)
                      |+|++|++++..|  +..+++|+.|++++|++++...-.-+..++.|++++|+++...
T Consensus       314 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~  369 (466)
T 1o6v_A          314 LTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLT  369 (466)
T ss_dssp             EECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBCG
T ss_pred             EECcCCcCCCchh--hccCccCCEeECCCCccCCchhhccCCCCCEEeCCCCccCccc
Confidence            9999999987666  7888999999999999987632222567888999999887654

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=1.2e-27  Score=276.82  Aligned_cols=266  Identities=17%  Similarity=0.152  Sum_probs=212.1

Q ss_pred             eccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccccC
Q 002899           60 ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFT  138 (869)
Q Consensus        60 ~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  138 (869)
                      ++...++...+......+++|+.|+|++|.|++.+|..|..+ +|++|+|++|.+++..|  |..+++|++|+|++|.|+
T Consensus        16 ~~~~~~l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~   93 (487)
T 3oja_A           16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ   93 (487)
T ss_dssp             SCCTTTHHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEE
T ss_pred             cCchhhhHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCC
Confidence            334444433333333444589999999999999988888887 89999999999987766  899999999999999999


Q ss_pred             CCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhh
Q 002899          139 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASIS  218 (869)
Q Consensus       139 ~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~  218 (869)
                      +..     ..++|++|+|++|.|++..+.   .+++|+.|+|++|+|++..|..|+.+++|+.|+|++|.+++.+|..+.
T Consensus        94 ~l~-----~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~  165 (487)
T 3oja_A           94 ELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA  165 (487)
T ss_dssp             EEE-----ECTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGG
T ss_pred             CCC-----CCCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHh
Confidence            543     238999999999999976554   458899999999999998899999999999999999999998888876


Q ss_pred             -cCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEE
Q 002899          219 -ALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM  297 (869)
Q Consensus       219 -~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  297 (869)
                       .+++|+.|+|++|.++..+... ...+|+.|+|++|.|++.+|. +..+++|+.|+|++|+|++ +|..+..+++|+.|
T Consensus       166 ~~l~~L~~L~Ls~N~l~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L  242 (487)
T 3oja_A          166 ASSDTLEHLNLQYNFIYDVKGQV-VFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHF  242 (487)
T ss_dssp             GGTTTCCEEECTTSCCCEEECCC-CCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEE
T ss_pred             hhCCcccEEecCCCccccccccc-cCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcc-cchhhccCCCCCEE
Confidence             8999999999999998764322 355899999999999976655 8899999999999999995 77789999999999


Q ss_pred             EeeCCcCC-CCCchhh--hccCCceeeeccCccCCCCCCCCCCCC
Q 002899          298 YLTGNKLT-GPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRG  339 (869)
Q Consensus       298 ~Ls~N~l~-~~~p~~~--~~~l~~l~ls~N~~~~~~~~p~~C~c~  339 (869)
                      +|++|+++ +.+|..+  ...++.++++.+.. ....+|+.|.|.
T Consensus       243 ~l~~N~l~c~~~~~~~~~l~~L~~l~~~~~~~-~~~~~~~~c~~~  286 (487)
T 3oja_A          243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK-LTGQNEEECTVP  286 (487)
T ss_dssp             ECTTCCBCHHHHHHHHTTCHHHHHHHHHHHHH-HTSSSSCCCSST
T ss_pred             EcCCCCCcCcchHHHHHhCCCCcEEecccccc-ccCCCcccccCC
Confidence            99999998 5566555  33455566652110 112336777664

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.94  E-value=2.7e-26  Score=262.43  Aligned_cols=229  Identities=22%  Similarity=0.248  Sum_probs=205.5

Q ss_pred             CcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccc
Q 002899           52 ATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNL  130 (869)
Q Consensus        52 ~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  130 (869)
                      ....++.|+|++|++++..+..|.++++|++|+|++|.|+++.+..|..+ +|++|+|++|+++.+.+..|..+++|++|
T Consensus        62 ~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  141 (440)
T 3zyj_A           62 ISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKEL  141 (440)
T ss_dssp             CCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEE
T ss_pred             CCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCcee
Confidence            34568999999999999889999999999999999999999999999988 89999999999998888899999999999


Q ss_pred             cccccccCCCCCccccCCCCccEEEeecc-cccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcC
Q 002899          131 SIEGNLFTGSIPPDIRKLINLQKLILSSN-SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL  209 (869)
Q Consensus       131 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  209 (869)
                      +|++|+|+...+..|..+++|++|+|++| .+....+..|.++++|++|+|++|+++. +| .+..+++|+.|+|++|++
T Consensus       142 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l  219 (440)
T 3zyj_A          142 WLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHL  219 (440)
T ss_dssp             ECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCC
T ss_pred             eCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCcc
Confidence            99999999877779999999999999995 5554555579999999999999999994 45 488999999999999999


Q ss_pred             CCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhh
Q 002899          210 EGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE  289 (869)
Q Consensus       210 ~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  289 (869)
                      ++..|..|.++++|+.|+|+                       +|+|++..+..|.++++|+.|+|++|+|++..+..|.
T Consensus       220 ~~~~~~~~~~l~~L~~L~L~-----------------------~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  276 (440)
T 3zyj_A          220 SAIRPGSFQGLMHLQKLWMI-----------------------QSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFT  276 (440)
T ss_dssp             CEECTTTTTTCTTCCEEECT-----------------------TCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTS
T ss_pred             CccChhhhccCccCCEEECC-----------------------CCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhc
Confidence            98889999999888777766                       5666667778888999999999999999988888889


Q ss_pred             cCCCCCEEEeeCCcCC
Q 002899          290 KLAKTNFMYLTGNKLT  305 (869)
Q Consensus       290 ~l~~L~~L~Ls~N~l~  305 (869)
                      .+++|+.|+|++|++.
T Consensus       277 ~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          277 PLHHLERIHLHHNPWN  292 (440)
T ss_dssp             SCTTCCEEECCSSCEE
T ss_pred             cccCCCEEEcCCCCcc
Confidence            9999999999999986

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.94  E-value=7.2e-28  Score=262.46  Aligned_cols=248  Identities=19%  Similarity=0.210  Sum_probs=208.7

Q ss_pred             cccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCC-CCCchhhc-------CccccccccccccccCCCCCcc
Q 002899           73 ELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS-GPFPKVLT-------NITTLKNLSIEGNLFTGSIPPD  144 (869)
Q Consensus        73 ~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~-~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~~~  144 (869)
                      .++..++|+.|++++|.+  .+|..+... |+.|+|++|+++ ..+|..+.       ++++|++|+|++|++++.+|..
T Consensus        38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~-L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI-IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEEECTTHHHHCCTT--CCCHHHHHH-HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EEccCCCceeEeeccccc--ccHHHHHHH-HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            456678899999999999  445544433 889999999994 45666665       7999999999999999999987


Q ss_pred             c--cCCCCccEEEeecccccccCCccccCC-----CCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCC--chH
Q 002899          145 I--RKLINLQKLILSSNSFTGELPAELTKL-----TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP--IPA  215 (869)
Q Consensus       145 ~--~~l~~L~~L~Ls~N~i~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~  215 (869)
                      +  ..+++|++|+|++|++++. |..+..+     ++|++|+|++|++++..+..|+.+++|++|+|++|++.+.  .+.
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  193 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS  193 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence            6  8999999999999999977 8888777     9999999999999998889999999999999999998865  344


Q ss_pred             hh--hcCCCCCEEEcCCCCCCCCcc---ccc-ccccceEEEcccccCccCCC-cccCCCCCcCEEeccCCCCCCCCchhh
Q 002899          216 SI--SALTSLTDLRISDLKGSESAF---PKL-DKMNLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTF  288 (869)
Q Consensus       216 ~l--~~l~~L~~L~L~~n~~~~~~~---~~~-~~~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~  288 (869)
                      .+  ..+++|+.|+|++|.++..+.   ..+ ...+|+.|+|++|+|++..| ..+..+++|+.|+|++|+|+ .+|..+
T Consensus       194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~  272 (312)
T 1wwl_A          194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL  272 (312)
T ss_dssp             HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred             HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence            55  899999999999999985332   111 22489999999999998875 55677899999999999999 777766


Q ss_pred             hcCCCCCEEEeeCCcCCCCCchh-hhccCCceeeeccCccC
Q 002899          289 EKLAKTNFMYLTGNKLTGPVPKY-IFNSNKNVDISLNNFTW  328 (869)
Q Consensus       289 ~~l~~L~~L~Ls~N~l~~~~p~~-~~~~l~~l~ls~N~~~~  328 (869)
                      .  ++|+.|+|++|+|++. |.. -++.++.|++++|+++.
T Consensus       273 ~--~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          273 P--AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             C--SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTTC
T ss_pred             c--CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCCC
Confidence            6  8999999999999977 551 25678899999997764

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.94  E-value=6.4e-27  Score=251.44  Aligned_cols=237  Identities=17%  Similarity=0.168  Sum_probs=204.3

Q ss_pred             CcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeeccc-CCCCCchhhcCcccccc
Q 002899           52 ATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNR-LSGPFPKVLTNITTLKN  129 (869)
Q Consensus        52 ~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~  129 (869)
                      ...+++.|++++|++++..+..|.++++|++|+|++|.+++..+..|..+ +|++|+|++|. ++...+..|..+++|++
T Consensus        30 ~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~  109 (285)
T 1ozn_A           30 IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHT  109 (285)
T ss_dssp             CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCE
T ss_pred             CCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCE
Confidence            34579999999999998888899999999999999999999989889887 89999999997 88888899999999999


Q ss_pred             ccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcC
Q 002899          130 LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL  209 (869)
Q Consensus       130 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  209 (869)
                      |+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+
T Consensus       110 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  189 (285)
T 1ozn_A          110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV  189 (285)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             EECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcc
Confidence            99999999988888999999999999999999977777899999999999999999987778899999999999999999


Q ss_pred             CCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhh
Q 002899          210 EGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE  289 (869)
Q Consensus       210 ~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  289 (869)
                      ++..|..+..+++|+.|+|+                       +|+|++..+..+..+++|+.|+|++|++....+.. .
T Consensus       190 ~~~~~~~~~~l~~L~~L~l~-----------------------~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~  245 (285)
T 1ozn_A          190 AHVHPHAFRDLGRLMTLYLF-----------------------ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-P  245 (285)
T ss_dssp             CEECTTTTTTCTTCCEEECC-----------------------SSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-H
T ss_pred             cccCHhHccCcccccEeeCC-----------------------CCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-H
Confidence            98889999988877777766                       55666566667888999999999999988544321 1


Q ss_pred             cCCCCCEEEeeCCcCCCCCchhh
Q 002899          290 KLAKTNFMYLTGNKLTGPVPKYI  312 (869)
Q Consensus       290 ~l~~L~~L~Ls~N~l~~~~p~~~  312 (869)
                      -+..|+.+..+.|.+....|..+
T Consensus       246 ~~~~l~~~~~~~~~~~c~~p~~l  268 (285)
T 1ozn_A          246 LWAWLQKFRGSSSEVPCSLPQRL  268 (285)
T ss_dssp             HHHHHHHCCSEECCCBEEESGGG
T ss_pred             HHHHHHhcccccCccccCCchHh
Confidence            12234444577788887777765

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.94  E-value=8.3e-26  Score=259.01  Aligned_cols=250  Identities=20%  Similarity=0.148  Sum_probs=209.3

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI  132 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  132 (869)
                      .+++.|++++|++++. | .+..+++|++|+|++|.|++..   +..+ +|++|+|++|++++. +  ++++++|++|+|
T Consensus        42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~~---~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L  113 (457)
T 3bz5_A           42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC  113 (457)
T ss_dssp             TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCCC---CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred             CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeEc---cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence            4689999999999964 5 7999999999999999999863   5555 899999999999975 3  889999999999


Q ss_pred             cccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCC
Q 002899          133 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP  212 (869)
Q Consensus       133 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  212 (869)
                      ++|++++ ++  +..+++|++|++++|++++.   .+..+++|++|++++|+..+.+  .+..+++|+.|++++|++++.
T Consensus       114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l  185 (457)
T 3bz5_A          114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL  185 (457)
T ss_dssp             CSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC
T ss_pred             CCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcccee
Confidence            9999996 44  88999999999999999964   3888999999999999655555  478899999999999999974


Q ss_pred             chHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCC
Q 002899          213 IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA  292 (869)
Q Consensus       213 ~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  292 (869)
                       |  +..+++|+.|++++|.++..++.  ...+|+.|+|++|+|++ +|  ++.+++|+.|+|++|++++..+..+..+.
T Consensus       186 -~--l~~l~~L~~L~l~~N~l~~~~l~--~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~  257 (457)
T 3bz5_A          186 -D--VSQNKLLNRLNCDTNNITKLDLN--QNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLT  257 (457)
T ss_dssp             -C--CTTCTTCCEEECCSSCCSCCCCT--TCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCC
T ss_pred             -c--cccCCCCCEEECcCCcCCeeccc--cCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCC
Confidence             4  88899999999999999887433  33489999999999997 45  78899999999999999987766666555


Q ss_pred             -------CCCEEEeeCCcCCCCCchhhhccCCceeeeccCcc
Q 002899          293 -------KTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT  327 (869)
Q Consensus       293 -------~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~  327 (869)
                             +|+.|++++|++.+.+|..-+..++.|++++|.+.
T Consensus       258 ~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~~l  299 (457)
T 3bz5_A          258 TLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQL  299 (457)
T ss_dssp             EEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTCTTC
T ss_pred             EEeccCCCCCEEECCCCccCCcccccccccCCEEECCCCccc
Confidence                   56677777777777777666678888999888654

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.93  E-value=4.9e-26  Score=269.01  Aligned_cols=266  Identities=18%  Similarity=0.196  Sum_probs=228.4

Q ss_pred             EEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccc
Q 002899           58 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL  136 (869)
Q Consensus        58 ~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  136 (869)
                      .+++++.+++ .+|..+.  ++|+.|+|++|.|+++.+..|..+ +|++|+|++|+++++.+..|.++++|++|+|++|+
T Consensus        11 ~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~   87 (570)
T 2z63_A           11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP   87 (570)
T ss_dssp             EEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             EEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCc
Confidence            4777788888 5676654  579999999999999999888888 89999999999999889999999999999999999


Q ss_pred             cCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCC-CCccccCCCCcccEEEccCCcCCCCchH
Q 002899          137 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG-KIPEFIGKWKKIQKLHIQGSSLEGPIPA  215 (869)
Q Consensus       137 l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~  215 (869)
                      +++..|..|.++++|++|+|++|++++..+..++++++|++|+|++|.+++ .+|..|+++++|++|++++|.+++..+.
T Consensus        88 l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~  167 (570)
T 2z63_A           88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT  167 (570)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGG
T ss_pred             CCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHH
Confidence            998888899999999999999999997666679999999999999999987 3699999999999999999999988888


Q ss_pred             hhhcCCCC----CEEEcCCCCCCCCcccccccccceEEEcccc-------------------------------------
Q 002899          216 SISALTSL----TDLRISDLKGSESAFPKLDKMNLKTLILTKC-------------------------------------  254 (869)
Q Consensus       216 ~l~~l~~L----~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N-------------------------------------  254 (869)
                      .+..+++|    +.|++++|.+.......+...+|+.|+|++|                                     
T Consensus       168 ~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~  247 (570)
T 2z63_A          168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD  247 (570)
T ss_dssp             GGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECC
T ss_pred             HccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcc
Confidence            89888888    8999999999887777666667888877776                                     


Q ss_pred             ---------------------cCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhh
Q 002899          255 ---------------------LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF  313 (869)
Q Consensus       255 ---------------------~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  313 (869)
                                           .+.+..|..+..+++|+.|++++|.++ .+|..+..+ +|+.|++++|+++ .+|...+
T Consensus       248 ~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~~~l  324 (570)
T 2z63_A          248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPTLKL  324 (570)
T ss_dssp             TTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCBCBC
T ss_pred             hhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCcccc
Confidence                                 444556677777888888888888888 577777777 8888888888887 6666667


Q ss_pred             ccCCceeeeccCccCC
Q 002899          314 NSNKNVDISLNNFTWE  329 (869)
Q Consensus       314 ~~l~~l~ls~N~~~~~  329 (869)
                      ..++.|++++|.+...
T Consensus       325 ~~L~~L~l~~n~~~~~  340 (570)
T 2z63_A          325 KSLKRLTFTSNKGGNA  340 (570)
T ss_dssp             SSCCEEEEESCBSCCB
T ss_pred             cccCEEeCcCCccccc
Confidence            7788888888866543

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.93  E-value=7.5e-25  Score=251.05  Aligned_cols=252  Identities=19%  Similarity=0.087  Sum_probs=196.5

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI  132 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  132 (869)
                      .+++.|+|++|++++. |  +..+++|++|+|++|.|++..   +..+ +|++|+|++|++++. +  ++.+++|++|+|
T Consensus        64 ~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~~---~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l  134 (457)
T 3bz5_A           64 TGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNLD---VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNC  134 (457)
T ss_dssp             TTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred             CCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCceee---cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEEC
Confidence            4689999999999974 4  899999999999999999863   5555 899999999999975 3  889999999999


Q ss_pred             cccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCC
Q 002899          133 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP  212 (869)
Q Consensus       133 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  212 (869)
                      ++|++++. +  +..+++|++|++++|+..+.+  .+..+++|++|+|++|++++. |  +..+++|+.|++++|++++.
T Consensus       135 ~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~  206 (457)
T 3bz5_A          135 ARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL  206 (457)
T ss_dssp             TTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee
Confidence            99999964 3  788899999999999655555  477888999999999999863 4  78888999999999998865


Q ss_pred             chHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCC-------CcCEEeccCCCCCCCCc
Q 002899          213 IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMT-------KLKNIDLSFNNLTGGIP  285 (869)
Q Consensus       213 ~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p  285 (869)
                         .+..+++|+.|+|++|+++..+  .....+|+.|+|++|++++..+..+..+.       +|+.|++++|.+.+.+|
T Consensus       207 ---~l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~  281 (457)
T 3bz5_A          207 ---DLNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ  281 (457)
T ss_dssp             ---CCTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE
T ss_pred             ---ccccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc
Confidence               3788889999999999888865  33334788999999988887655555544       45566666666655555


Q ss_pred             hhhhcCCCCCEEEeeCCcCCCCCchhh----------hccCCceeeeccCccCC
Q 002899          286 TTFEKLAKTNFMYLTGNKLTGPVPKYI----------FNSNKNVDISLNNFTWE  329 (869)
Q Consensus       286 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~----------~~~l~~l~ls~N~~~~~  329 (869)
                        +..+++|+.|+|++|++.+.+|...          .+.++.|++++|++++.
T Consensus       282 --~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l  333 (457)
T 3bz5_A          282 --AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL  333 (457)
T ss_dssp             --CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC
T ss_pred             --ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc
Confidence              4567778888888887766666432          23566777777777765

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.92  E-value=3e-26  Score=250.18  Aligned_cols=239  Identities=21%  Similarity=0.187  Sum_probs=204.5

Q ss_pred             CCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEee
Q 002899           79 YLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILS  157 (869)
Q Consensus        79 ~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  157 (869)
                      .++.++++.+.+...+...+... +|++|+|++|++++..|..|..+++|++|+|++|++++..+  +..+++|++|+|+
T Consensus        11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls   88 (317)
T 3o53_A           11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN   88 (317)
T ss_dssp             EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred             ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence            45667788888876666777666 89999999999999999999999999999999999996554  9999999999999


Q ss_pred             cccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCc
Q 002899          158 SNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA  237 (869)
Q Consensus       158 ~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~  237 (869)
                      +|+|++..     ..++|++|++++|++++..+..   +++|+.|+|++|++++..+..+..+++|+.|+|++|.++...
T Consensus        89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  160 (317)
T 3o53_A           89 NNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN  160 (317)
T ss_dssp             SSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred             CCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence            99998432     3489999999999999766554   678999999999999888889999999999999999999877


Q ss_pred             ccccc--cccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh--h
Q 002899          238 FPKLD--KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--F  313 (869)
Q Consensus       238 ~~~~~--~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~  313 (869)
                      +..+.  ..+|+.|+|++|.|++..+  ...+++|+.|+|++|+|++. |..+..+++|+.|+|++|+|+ .+|..+  .
T Consensus       161 ~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l  236 (317)
T 3o53_A          161 FAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFS  236 (317)
T ss_dssp             GGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCC
T ss_pred             HHHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcC
Confidence            66553  3589999999999997633  33589999999999999965 455999999999999999999 467666  5


Q ss_pred             ccCCceeeeccCccCCCCCCCCCCCC
Q 002899          314 NSNKNVDISLNNFTWESSDPIECPRG  339 (869)
Q Consensus       314 ~~l~~l~ls~N~~~~~~~~p~~C~c~  339 (869)
                      ..++.|++++|        +|.|+|.
T Consensus       237 ~~L~~L~l~~N--------~~~~~~~  254 (317)
T 3o53_A          237 QNLEHFDLRGN--------GFHCGTL  254 (317)
T ss_dssp             TTCCEEECTTC--------CCBHHHH
T ss_pred             CCCCEEEccCC--------CccCcCH
Confidence            68899999999        7777753

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.92  E-value=4.7e-25  Score=260.48  Aligned_cols=263  Identities=25%  Similarity=0.296  Sum_probs=164.9

Q ss_pred             CCCCCCCCCCCCCCCccccCCCCCCCCcceEecCCCCcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCc
Q 002899           16 KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFS   95 (869)
Q Consensus        16 ~~W~~~~d~C~~~g~w~~~~~~~~~~~~~v~C~~~~~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~   95 (869)
                      +.|....+||.|+|..+         .+...|.|.  ...++.|+|++|+|+ .+|..+.  ++|+.|+|++|.|+.+++
T Consensus        13 ~~W~~~~~~~~~~~r~~---------~~~~~~~c~--~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~   78 (622)
T 3g06_A           13 SAWRRAAPAEESRGRAA---------VVQKMRACL--NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA   78 (622)
T ss_dssp             HHHHHTCCGGGHHHHHH---------HHHHHHHHH--HHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC
T ss_pred             HHHHhcCCcchhccccc---------cCccccccc--CCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC
Confidence            34766677776543221         122334443  234889999999998 7787776  799999999999986655


Q ss_pred             hhhccccceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCC
Q 002899           96 PQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNL  175 (869)
Q Consensus        96 ~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L  175 (869)
                         ...+|++|+|++|+|+++ |.   .+++|++|+|++|+|++ +|.   .+++|++|+|++|+|+. +|..   +++|
T Consensus        79 ---~l~~L~~L~Ls~N~l~~l-p~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L  143 (622)
T 3g06_A           79 ---LPPELRTLEVSGNQLTSL-PV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGL  143 (622)
T ss_dssp             ---CCTTCCEEEECSCCCSCC-CC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTC
T ss_pred             ---cCCCCCEEEcCCCcCCcC-CC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCC
Confidence               234899999999999854 43   67899999999999985 444   56788888999888884 5543   4788


Q ss_pred             CeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEccccc
Q 002899          176 NDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCL  255 (869)
Q Consensus       176 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~  255 (869)
                      ++|+|++|++++ +|.   .+++|+.|+|++|.|++ +|   ..+++|+.|+|++|.++..+..   ..+|+.|++++|.
T Consensus       144 ~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~  212 (622)
T 3g06_A          144 QELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASLPTL---PSELYKLWAYNNR  212 (622)
T ss_dssp             CEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSC
T ss_pred             CEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCCCc---cchhhEEECcCCc
Confidence            888888888875 333   23566666666666664 23   3456666666666666553321   1245555555555


Q ss_pred             CccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccC
Q 002899          256 IHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW  328 (869)
Q Consensus       256 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~  328 (869)
                      |+. +|.   .+++|+.|+|++|+|++ +|   ..+++|+.|+|++|+|+ .+|. ....++.|+|++|+++.
T Consensus       213 l~~-l~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~-~~~~L~~L~Ls~N~L~~  275 (622)
T 3g06_A          213 LTS-LPA---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM-LPSGLLSLSVYRNQLTR  275 (622)
T ss_dssp             CSS-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC-CCTTCCEEECCSSCCCS
T ss_pred             ccc-cCC---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc-ccccCcEEeCCCCCCCc
Confidence            552 222   13455555555555553 33   33445555555555555 2333 33445555555555553

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.92  E-value=5.3e-26  Score=262.93  Aligned_cols=235  Identities=16%  Similarity=0.109  Sum_probs=208.6

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      ..+++.|+|++|++++..|..|..+++|++|+|++|.|++.++  +..+ +|++|+|++|.|++..+     .++|++|+
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~  105 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLH  105 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEE
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEE
Confidence            4479999999999999888999999999999999999998776  6666 89999999999986543     38999999


Q ss_pred             ccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccC-CCCcccEEEccCCcCC
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG-KWKKIQKLHIQGSSLE  210 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~  210 (869)
                      |++|.|++..+.   .+++|++|+|++|.|++..|..+..+++|++|+|++|.|++..|..+. .+++|+.|+|++|.|+
T Consensus       106 L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~  182 (487)
T 3oja_A          106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY  182 (487)
T ss_dssp             CCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred             CcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence            999999976554   468899999999999998898999999999999999999998888876 7999999999999999


Q ss_pred             CCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCC-CCCchhhh
Q 002899          211 GPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT-GGIPTTFE  289 (869)
Q Consensus       211 ~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~  289 (869)
                      +..+  +..+++|+.|+|++|.++..+.......+|+.|+|++|.|++ +|..+..+++|+.|+|++|.+. +.+|..+.
T Consensus       183 ~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~  259 (487)
T 3oja_A          183 DVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS  259 (487)
T ss_dssp             EEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred             cccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence            7633  446999999999999999877665556689999999999996 6777899999999999999998 77888899


Q ss_pred             cCCCCCEEEee
Q 002899          290 KLAKTNFMYLT  300 (869)
Q Consensus       290 ~l~~L~~L~Ls  300 (869)
                      .+++|+.|+++
T Consensus       260 ~l~~L~~l~~~  270 (487)
T 3oja_A          260 KNQRVQTVAKQ  270 (487)
T ss_dssp             TCHHHHHHHHH
T ss_pred             hCCCCcEEecc
Confidence            99999888886

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.92  E-value=6.4e-25  Score=251.43  Aligned_cols=250  Identities=20%  Similarity=0.236  Sum_probs=112.2

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-c-------------ceEEEeecccCCCCCch
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-Q-------------LVELSVMGNRLSGPFPK  119 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~-------------L~~L~Ls~N~l~~~~~~  119 (869)
                      .+++.|++++|++ +.+|++|+++++|++|+|++|.+++..|..+..+ +             +++|++++|++++.. .
T Consensus        11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp-~   88 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLP-E   88 (454)
T ss_dssp             ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCC-S
T ss_pred             ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCC-C
Confidence            4577788888888 6778888888888888888887777777666654 2             366777777766432 2


Q ss_pred             hhcCccccccccccccccCCCCCcccc----------------CC-CCccEEEeecccccccCCccccCCCCCCeEeccC
Q 002899          120 VLTNITTLKNLSIEGNLFTGSIPPDIR----------------KL-INLQKLILSSNSFTGELPAELTKLTNLNDLRISD  182 (869)
Q Consensus       120 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~----------------~l-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~  182 (869)
                         -.++|++|+|++|.+++ +|..+.                .+ ++|++|+|++|++++ +| .|.++++|++|++++
T Consensus        89 ---~~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~  162 (454)
T 1jl5_A           89 ---LPPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDN  162 (454)
T ss_dssp             ---CCTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred             ---CcCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCC
Confidence               12456666666666664 343210                01 344444444444443 33 344445555555555


Q ss_pred             CcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCc
Q 002899          183 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPD  262 (869)
Q Consensus       183 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~  262 (869)
                      |++++ +|..+   ++|++|++++|++++ +| .+.++++|+.|++++|.++..+...   .+|+.|++++|.++ .+|.
T Consensus       163 N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~~---~~L~~L~l~~n~l~-~lp~  232 (454)
T 1jl5_A          163 NSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDLP---LSLESIVAGNNILE-ELPE  232 (454)
T ss_dssp             SCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCCC---TTCCEEECCSSCCS-SCCC
T ss_pred             CcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCCc---CcccEEECcCCcCC-cccc
Confidence            55443 23221   244555555555543 22 3455555555555555544322110   24555555555554 3332


Q ss_pred             ccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccC
Q 002899          263 YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW  328 (869)
Q Consensus       263 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~  328 (869)
                       ++.+++|+.|+|++|++++ +|.   .+++|+.|++++|++++ +|.. ...++.|++++|.++.
T Consensus       233 -~~~l~~L~~L~l~~N~l~~-l~~---~~~~L~~L~l~~N~l~~-l~~~-~~~L~~L~ls~N~l~~  291 (454)
T 1jl5_A          233 -LQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTD-LPEL-PQSLTFLDVSENIFSG  291 (454)
T ss_dssp             -CTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSC-CCCC-CTTCCEEECCSSCCSE
T ss_pred             -cCCCCCCCEEECCCCcCCc-ccc---cccccCEEECCCCcccc-cCcc-cCcCCEEECcCCccCc
Confidence             4455555555555555553 222   12445555555555553 3322 2445555555555444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=3.6e-25  Score=258.27  Aligned_cols=184  Identities=18%  Similarity=0.210  Sum_probs=145.4

Q ss_pred             CCCCeeeccCceEEEEEEEcCCcEEEEEEecccCc--------hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          641 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       641 ~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~--------~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ...++||+|+||.||+|.. .++.+++|+......        ...++|.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3467899999999999954 467888887644321        1134589999999999999999776676777888999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++++|.+++..             +..++.|+++||+|||+++   |+||||||+|||++.  .+||+|||+++..
T Consensus       418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~  479 (540)
T 3en9_A          418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS  479 (540)
T ss_dssp             EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred             EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence            999999999998854             5689999999999999998   999999999999998  9999999999987


Q ss_pred             cCCCccc------cccccccccccchhhccc--CCCCchhHHHHHHHHHHHHHcCCCCC
Q 002899          793 EEDKTHI------STRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       793 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltG~~p~  843 (869)
                      .......      .....||+.|||||++..  ..|+..+|+|+..+-..+.+.++.++
T Consensus       480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            6432211      234679999999999976  56788899999999999988888766

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.91  E-value=2.4e-26  Score=252.94  Aligned_cols=287  Identities=18%  Similarity=0.257  Sum_probs=194.7

Q ss_pred             CcHHHHHHHHHHhCCCCCCCCCCCCCCCCCccccCCCCCCCCcceEecCCCCcceEEEEeccCCCccccCCccccCC--C
Q 002899            1 MPKKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKL--R   78 (869)
Q Consensus         1 ~~~~~l~~~~~~l~~~~W~~~~d~C~~~g~w~~~~~~~~~~~~~v~C~~~~~~~~v~~L~l~~~~l~~~~p~~l~~l--~   78 (869)
                      +|.+.|.+|+++++..+......+|.   .|.           .+.|+.    ..++.|+++++.+.   +..+..+  +
T Consensus        12 LP~eil~~If~~L~~~d~~~~~~vc~---~W~-----------~~~~~~----~~~~~l~l~~~~~~---~~~~~~~~~~   70 (336)
T 2ast_B           12 LPDELLLGIFSCLCLPELLKVSGVCK---RWY-----------RLASDE----SLWQTLDLTGKNLH---PDVTGRLLSQ   70 (336)
T ss_dssp             SCHHHHHHHHTTSCHHHHHHTTSSCH---HHH-----------HHHTCS----TTSSEEECTTCBCC---HHHHHHHHHT
T ss_pred             CCHHHHHHHHHhCCHHHHHHHHHHHH---HHH-----------HHhcCc----hhheeeccccccCC---HHHHHhhhhc
Confidence            69999999999999876555566775   365           233331    13567888888777   4566666  7


Q ss_pred             CCCEEEeecCcCCCCCchhhccccceEEEeecccCCCC-CchhhcCccccccccccccccCCCCCccccCCCCccEEEee
Q 002899           79 YLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGP-FPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILS  157 (869)
Q Consensus        79 ~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  157 (869)
                      +|+.|+|++|.+++..+..+...+|++|+|++|.+++. ++..+..+++|++|+|++|.+++..+..+..+++|++|+|+
T Consensus        71 ~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~  150 (336)
T 2ast_B           71 GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS  150 (336)
T ss_dssp             TCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred             cceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECC
Confidence            88889998888888777766555788888888887755 66777778888888888888776667777778888888888


Q ss_pred             cc-ccccc-CCccccCCCCCCeEeccCC-cCCCC-CccccCCCC-cccEEEccCC--cCC-CCchHhhhcCCCCCEEEcC
Q 002899          158 SN-SFTGE-LPAELTKLTNLNDLRISDN-NFSGK-IPEFIGKWK-KIQKLHIQGS--SLE-GPIPASISALTSLTDLRIS  229 (869)
Q Consensus       158 ~N-~i~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~-~~~~~~~l~-~L~~L~L~~N--~l~-~~~~~~l~~l~~L~~L~L~  229 (869)
                      +| .+++. ++..+.++++|++|+|++| .+++. ++..+..++ +|++|+|++|  .++ +.++..+..+++|+.|+|+
T Consensus       151 ~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~  230 (336)
T 2ast_B          151 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS  230 (336)
T ss_dssp             TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECT
T ss_pred             CCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCC
Confidence            87 56652 5555677778888888888 77643 456677777 7888888777  444 3456666777777777666


Q ss_pred             CCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCC-CCCCCchhhhcCCCCCEEEeeCCcCCCCC
Q 002899          230 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN-LTGGIPTTFEKLAKTNFMYLTGNKLTGPV  308 (869)
Q Consensus       230 ~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  308 (869)
                      +|..                      +++..+..+..+++|+.|+|++|. +.......+..+++|+.|+|++| ++...
T Consensus       231 ~~~~----------------------l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~~~  287 (336)
T 2ast_B          231 DSVM----------------------LKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGT  287 (336)
T ss_dssp             TCTT----------------------CCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTC
T ss_pred             CCCc----------------------CCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCHHH
Confidence            5541                      444445555666777777777774 22111124666777777777776 43333


Q ss_pred             chhhhccCCceeeeccCccCCCC
Q 002899          309 PKYIFNSNKNVDISLNNFTWESS  331 (869)
Q Consensus       309 p~~~~~~l~~l~ls~N~~~~~~~  331 (869)
                      -..+...++.|+++.|+++...+
T Consensus       288 ~~~l~~~l~~L~l~~n~l~~~~~  310 (336)
T 2ast_B          288 LQLLKEALPHLQINCSHFTTIAR  310 (336)
T ss_dssp             HHHHHHHSTTSEESCCCSCCTTC
T ss_pred             HHHHHhhCcceEEecccCccccC
Confidence            23333456667777776665544

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.91  E-value=2.3e-24  Score=230.27  Aligned_cols=208  Identities=20%  Similarity=0.201  Sum_probs=180.7

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      ..+++.|++++|++++..+..|.++++|++|+|++|.+++..+..|..+ +|++|+|++|++++..+..|.++++|++|+
T Consensus        27 ~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (276)
T 2z62_A           27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV  106 (276)
T ss_dssp             CTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEE
Confidence            3469999999999998888899999999999999999999888888887 899999999999999889999999999999


Q ss_pred             ccccccCCCCCccccCCCCccEEEeeccccccc-CCccccCCCCCCeEeccCCcCCCCCccccCCCCccc----EEEccC
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE-LPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ----KLHIQG  206 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~L~~  206 (869)
                      |++|++++..+..+..+++|++|+|++|++++. +|..+.++++|++|+|++|++++..+..|..+++|+    .|++++
T Consensus       107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~  186 (276)
T 2z62_A          107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL  186 (276)
T ss_dssp             CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCS
T ss_pred             CCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCC
Confidence            999999987777899999999999999999874 689999999999999999999988888887777776    666677


Q ss_pred             CcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCC
Q 002899          207 SSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI  284 (869)
Q Consensus       207 N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  284 (869)
                      |.+++..+.                        .+...+|+.|+|++|+|++..+..|..+++|+.|+|++|++++..
T Consensus       187 n~l~~~~~~------------------------~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  240 (276)
T 2z62_A          187 NPMNFIQPG------------------------AFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  240 (276)
T ss_dssp             SCCCEECTT------------------------SSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred             CcccccCcc------------------------ccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccC
Confidence            666643333                        222336777777888888887788899999999999999999644

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.91  E-value=1.3e-23  Score=240.57  Aligned_cols=241  Identities=23%  Similarity=0.295  Sum_probs=143.3

Q ss_pred             eEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccccc
Q 002899           55 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG  134 (869)
Q Consensus        55 ~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  134 (869)
                      +++.|++++|.+++ +| +|.++++|++|+|++|++++.+. .+  .+|++|+|++|++++ +| .+.++++|++|+|++
T Consensus       132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~-~~--~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~  204 (454)
T 1jl5_A          132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPD-LP--PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADN  204 (454)
T ss_dssp             TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred             CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCC-Cc--ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCC
Confidence            46666666666664 45 46666666666666666665322 11  266666666666665 33 466666666677766


Q ss_pred             cccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCch
Q 002899          135 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP  214 (869)
Q Consensus       135 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  214 (869)
                      |++++ +|...   ++|++|++++|+++ .+| .+..+++|++|++++|++++ +|..   +++|+.|++++|++++ +|
T Consensus       205 N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~  273 (454)
T 1jl5_A          205 NSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LP  273 (454)
T ss_dssp             SCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CC
T ss_pred             CcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cC
Confidence            66664 33222   36666666666666 455 36666677777777776664 3332   3566666666666664 22


Q ss_pred             HhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCC-CCcCEEeccCCCCCCCCchhhhcCCC
Q 002899          215 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDM-TKLKNIDLSFNNLTGGIPTTFEKLAK  293 (869)
Q Consensus       215 ~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~  293 (869)
                      ..   +++|+.|++++|.++..+..   ..+|+.|++++|++++.     ..+ ++|+.|+|++|++++ +|..   +++
T Consensus       274 ~~---~~~L~~L~ls~N~l~~l~~~---~~~L~~L~l~~N~l~~i-----~~~~~~L~~L~Ls~N~l~~-lp~~---~~~  338 (454)
T 1jl5_A          274 EL---PQSLTFLDVSENIFSGLSEL---PPNLYYLNASSNEIRSL-----CDLPPSLEELNVSNNKLIE-LPAL---PPR  338 (454)
T ss_dssp             CC---CTTCCEEECCSSCCSEESCC---CTTCCEEECCSSCCSEE-----CCCCTTCCEEECCSSCCSC-CCCC---CTT
T ss_pred             cc---cCcCCEEECcCCccCcccCc---CCcCCEEECcCCcCCcc-----cCCcCcCCEEECCCCcccc-cccc---CCc
Confidence            21   25666666666666542210   12555666666655531     122 467777777777775 4432   467


Q ss_pred             CCEEEeeCCcCCCCCchhhhccCCceeeeccCccCCC
Q 002899          294 TNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWES  330 (869)
Q Consensus       294 L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~  330 (869)
                      |+.|+|++|++++ +|. ....++.|++++|+++..+
T Consensus       339 L~~L~L~~N~l~~-lp~-~l~~L~~L~L~~N~l~~l~  373 (454)
T 1jl5_A          339 LERLIASFNHLAE-VPE-LPQNLKQLHVEYNPLREFP  373 (454)
T ss_dssp             CCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSSCC
T ss_pred             CCEEECCCCcccc-ccc-hhhhccEEECCCCCCCcCC
Confidence            7777777777773 555 5566777777777776643

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=4.5e-24  Score=224.76  Aligned_cols=174  Identities=21%  Similarity=0.285  Sum_probs=109.5

Q ss_pred             ccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEcc
Q 002899          126 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQ  205 (869)
Q Consensus       126 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  205 (869)
                      +|+.|+|++|.+++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus        36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  115 (251)
T 3m19_A           36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG  115 (251)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence            45555555555554444455555555555555555554444455555555555555555555555555555555555555


Q ss_pred             CCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCc
Q 002899          206 GSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP  285 (869)
Q Consensus       206 ~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  285 (869)
                      +|+|++..+..|..+++|+.|+|                       ++|+|++..+..|..+++|+.|+|++|+|++..+
T Consensus       116 ~N~l~~~~~~~~~~l~~L~~L~L-----------------------s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  172 (251)
T 3m19_A          116 GNQLKSLPSGVFDRLTKLKELRL-----------------------NTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH  172 (251)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEEC-----------------------CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CCcCCCcChhHhccCCcccEEEC-----------------------cCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence            55555444444555554444443                       3555555556667778888888888888887777


Q ss_pred             hhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCCCCCCCCCC-CCCccceeccCCCCC
Q 002899          286 TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECP-RGSVNLVESYSSPRN  352 (869)
Q Consensus       286 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~~C~-c~~~~~~~~l~~~~~  352 (869)
                      ..|..+++|+.|+|++|                              ||.|+ |.+.++..|+.....
T Consensus       173 ~~~~~l~~L~~L~l~~N------------------------------~~~c~~~~~~~l~~~~~~~~~  210 (251)
T 3m19_A          173 GAFDRLGKLQTITLFGN------------------------------QFDCSRCEILYLSQWIRENSN  210 (251)
T ss_dssp             TTTTTCTTCCEEECCSC------------------------------CBCTTSTTHHHHHHHHHHSGG
T ss_pred             HHHhCCCCCCEEEeeCC------------------------------ceeCCccccHHHHHHHHhccc
Confidence            77888888888888888                              67798 899999999875443

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.91  E-value=2e-26  Score=264.93  Aligned_cols=274  Identities=19%  Similarity=0.217  Sum_probs=218.9

Q ss_pred             eEEEEeccCCCccc----cCCccccCCCCCCEEEeecCcCCCCCchhhcc------ccceEEEeecccCCCCC----chh
Q 002899           55 HVVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS------LQLVELSVMGNRLSGPF----PKV  120 (869)
Q Consensus        55 ~v~~L~l~~~~l~~----~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~------l~L~~L~Ls~N~l~~~~----~~~  120 (869)
                      +++.|+|++|.++.    .++..+..+++|++|+|++|.+++..+..+..      .+|++|+|++|++++..    +..
T Consensus        86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~  165 (461)
T 1z7x_W           86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV  165 (461)
T ss_dssp             CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred             ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence            68999999999984    56888999999999999999988665544433      16999999999998744    566


Q ss_pred             hcCccccccccccccccCCCCCcccc-----CCCCccEEEeeccccccc----CCccccCCCCCCeEeccCCcCCCCC--
Q 002899          121 LTNITTLKNLSIEGNLFTGSIPPDIR-----KLINLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGKI--  189 (869)
Q Consensus       121 ~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~--  189 (869)
                      +..+++|++|+|++|.++...+..+.     .+++|++|+|++|.+++.    ++..+..+++|++|+|++|++++..  
T Consensus       166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~  245 (461)
T 1z7x_W          166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA  245 (461)
T ss_dssp             HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred             HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHH
Confidence            77789999999999998855444443     356899999999999863    4667788899999999999987543  


Q ss_pred             ---ccccCCCCcccEEEccCCcCCCC----chHhhhcCCCCCEEEcCCCCCCCCccccccc------ccceEEEcccccC
Q 002899          190 ---PEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPKLDK------MNLKTLILTKCLI  256 (869)
Q Consensus       190 ---~~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~------~~L~~L~Ls~N~i  256 (869)
                         +..+..+++|++|+|++|.++..    ++..+..+++|+.|+|++|.+.......+..      .+|+.|+|++|.+
T Consensus       246 ~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l  325 (461)
T 1z7x_W          246 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF  325 (461)
T ss_dssp             HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred             HHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCC
Confidence               33344689999999999999864    5778888999999999999887654433322      3899999999999


Q ss_pred             ccC----CCcccCCCCCcCEEeccCCCCCCCCchhhhc-----CCCCCEEEeeCCcCCC----CCchhh--hccCCceee
Q 002899          257 HGE----IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK-----LAKTNFMYLTGNKLTG----PVPKYI--FNSNKNVDI  321 (869)
Q Consensus       257 ~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~--~~~l~~l~l  321 (869)
                      ++.    ++..+..+++|+.|+|++|++++..+..+..     .++|+.|+|++|++++    .+|..+  .+.++.|++
T Consensus       326 ~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l  405 (461)
T 1z7x_W          326 TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL  405 (461)
T ss_dssp             BGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEEC
T ss_pred             chHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEEC
Confidence            876    4566777899999999999998766666654     6799999999999986    667666  568899999


Q ss_pred             eccCccC
Q 002899          322 SLNNFTW  328 (869)
Q Consensus       322 s~N~~~~  328 (869)
                      ++|+++.
T Consensus       406 ~~N~i~~  412 (461)
T 1z7x_W          406 SNNCLGD  412 (461)
T ss_dssp             CSSSCCH
T ss_pred             CCCCCCH
Confidence            9997763

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=8.6e-24  Score=220.81  Aligned_cols=204  Identities=17%  Similarity=0.163  Sum_probs=125.1

Q ss_pred             ccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeeccc-CCCCCchhhcCccccccccccc-cccCCCCC
Q 002899           66 LTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNR-LSGPFPKVLTNITTLKNLSIEG-NLFTGSIP  142 (869)
Q Consensus        66 l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~  142 (869)
                      ++ .+|. +.  ++|++|+|++|+|+++++..|..+ +|++|+|++|+ ++.+.+..|.++++|++|+|++ |++++..+
T Consensus        23 l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~   98 (239)
T 2xwt_C           23 IQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP   98 (239)
T ss_dssp             CS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECT
T ss_pred             cc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCH
Confidence            44 4555 43  378888888888776666566555 56666666665 6555555566666666666665 66664444


Q ss_pred             ccccCCCCccEEEeecccccccCCccccCCCCCC---eEeccCC-cCCCCCccccCCCCccc-EEEccCCcCCCCchHhh
Q 002899          143 PDIRKLINLQKLILSSNSFTGELPAELTKLTNLN---DLRISDN-NFSGKIPEFIGKWKKIQ-KLHIQGSSLEGPIPASI  217 (869)
Q Consensus       143 ~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~l  217 (869)
                      ..|.++++|++|+|++|++++ +|. |..+++|+   +|++++| ++++..+..|.++++|+ .|+|++|+++       
T Consensus        99 ~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-------  169 (239)
T 2xwt_C           99 DALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-------  169 (239)
T ss_dssp             TSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-------
T ss_pred             HHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-------
Confidence            555566666666666666653 443 55555555   5555555 55544444455555555 5555555544       


Q ss_pred             hcCCCCCEEEcCCCCCCCCcccccccccceEEEccccc-CccCCCcccCCC-CCcCEEeccCCCCCCCCchhhhcCCCCC
Q 002899          218 SALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCL-IHGEIPDYIGDM-TKLKNIDLSFNNLTGGIPTTFEKLAKTN  295 (869)
Q Consensus       218 ~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~-i~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  295 (869)
                                       ..+...+...+|+.|+|++|+ +++..+..|..+ ++|+.|+|++|+|++..+.   .+++|+
T Consensus       170 -----------------~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~  229 (239)
T 2xwt_C          170 -----------------SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLK  229 (239)
T ss_dssp             -----------------EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCS
T ss_pred             -----------------ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCc
Confidence                             333222333356677777774 776777778888 8888888888888854433   567788


Q ss_pred             EEEeeCC
Q 002899          296 FMYLTGN  302 (869)
Q Consensus       296 ~L~Ls~N  302 (869)
                      .|+++++
T Consensus       230 ~L~l~~~  236 (239)
T 2xwt_C          230 ELIARNT  236 (239)
T ss_dssp             EEECTTC
T ss_pred             eeeccCc
Confidence            8887766

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.90  E-value=5.1e-24  Score=227.19  Aligned_cols=195  Identities=19%  Similarity=0.293  Sum_probs=108.0

Q ss_pred             cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEecc
Q 002899          102 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS  181 (869)
Q Consensus       102 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls  181 (869)
                      +|+.|++++|.++..  ..+..+++|++|+|++|.+++.  ..+..+++|++|+|++|++++..+..|.++++|++|+|+
T Consensus        42 ~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  117 (272)
T 3rfs_A           42 SIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLV  117 (272)
T ss_dssp             TCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             ceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECC
Confidence            455555555554422  2355666666666666666642  356666666666666666665555556666666666666


Q ss_pred             CCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCC
Q 002899          182 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP  261 (869)
Q Consensus       182 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p  261 (869)
                      +|++++..+..|..+++|+.|+|++|.+++..+..+..+++|+.|+|++|++                       ++..+
T Consensus       118 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l-----------------------~~~~~  174 (272)
T 3rfs_A          118 ENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL-----------------------QSLPE  174 (272)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC-----------------------CCCCT
T ss_pred             CCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCc-----------------------CccCH
Confidence            6666666666666666666666666666666565566666666555554333                       33333


Q ss_pred             cccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccC
Q 002899          262 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW  328 (869)
Q Consensus       262 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~  328 (869)
                      ..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++..|     .++.++++.|.+++
T Consensus       175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~-----~l~~l~~~~n~~~g  236 (272)
T 3rfs_A          175 GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP-----GIRYLSEWINKHSG  236 (272)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT-----TTHHHHHHHHHTGG
T ss_pred             HHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc-----HHHHHHHHHHhCCC
Confidence            334444444555555554444444444444455555555554444332     23344444444443

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=5.2e-23  Score=223.73  Aligned_cols=223  Identities=20%  Similarity=0.241  Sum_probs=162.5

Q ss_pred             CCCCEEEeecCcCCCCCc----hhhccccceEEEeecccCCCCCchhh--cCccccccccccccccCCCCC----ccccC
Q 002899           78 RYLKQLDLSRNCLTGSFS----PQWASLQLVELSVMGNRLSGPFPKVL--TNITTLKNLSIEGNLFTGSIP----PDIRK  147 (869)
Q Consensus        78 ~~L~~L~Ls~N~i~~~~~----~~~~~l~L~~L~Ls~N~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~~----~~~~~  147 (869)
                      ..++.|.+.++.++....    ..+...+|++|+|++|++++..|..+  ..+++|++|+|++|.+++..+    ..+..
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~  143 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL  143 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence            457888888887763221    11222369999999999998888887  889999999999999987655    34567


Q ss_pred             CCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCC--C--ccccCCCCcccEEEccCCcCCCCch--H-hhhcC
Q 002899          148 LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK--I--PEFIGKWKKIQKLHIQGSSLEGPIP--A-SISAL  220 (869)
Q Consensus       148 l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~--~~~~~~l~~L~~L~L~~N~l~~~~~--~-~l~~l  220 (869)
                      +++|++|+|++|++++..+..|..+++|++|+|++|++.+.  +  +..+..+++|++|+|++|+++...+  . .+..+
T Consensus       144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l  223 (310)
T 4glp_A          144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAG  223 (310)
T ss_dssp             CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHT
T ss_pred             ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcC
Confidence            88999999999999888888888999999999999987642  2  2334778899999999999973221  1 35788


Q ss_pred             CCCCEEEcCCCCCCCCccccccc----ccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCE
Q 002899          221 TSLTDLRISDLKGSESAFPKLDK----MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNF  296 (869)
Q Consensus       221 ~~L~~L~L~~n~~~~~~~~~~~~----~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  296 (869)
                      ++|+.|+|++|.+....+..+..    .+|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|++. |. +..+++|+.
T Consensus       224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~  298 (310)
T 4glp_A          224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN  298 (310)
T ss_dssp             CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred             CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence            88888888888877763322222    36777777777777 4455443  6777777777777753 33 566777777


Q ss_pred             EEeeCCcCC
Q 002899          297 MYLTGNKLT  305 (869)
Q Consensus       297 L~Ls~N~l~  305 (869)
                      |+|++|+|+
T Consensus       299 L~L~~N~l~  307 (310)
T 4glp_A          299 LTLDGNPFL  307 (310)
T ss_dssp             EECSSTTTS
T ss_pred             EECcCCCCC
Confidence            777777775

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=3.2e-25  Score=246.75  Aligned_cols=263  Identities=17%  Similarity=0.244  Sum_probs=204.5

Q ss_pred             EEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCc----hhhccc--cceEEEeecccCCCCCchhhcCc-----cc
Q 002899           58 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFS----PQWASL--QLVELSVMGNRLSGPFPKVLTNI-----TT  126 (869)
Q Consensus        58 ~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~----~~~~~l--~L~~L~Ls~N~l~~~~~~~~~~l-----~~  126 (869)
                      ..+++.|++++.+|..+...++|++|+|++|.|++..+    ..+..+  +|++|+|++|++++..+..+..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            36788999999988888888889999999999998887    566655  69999999999998888888876     99


Q ss_pred             cccccccccccCCCCCccc----cCC-CCccEEEeecccccccCCccc----cC-CCCCCeEeccCCcCCCCCc----cc
Q 002899          127 LKNLSIEGNLFTGSIPPDI----RKL-INLQKLILSSNSFTGELPAEL----TK-LTNLNDLRISDNNFSGKIP----EF  192 (869)
Q Consensus       127 L~~L~Ls~N~l~~~~~~~~----~~l-~~L~~L~Ls~N~i~~~~p~~~----~~-l~~L~~L~Ls~N~l~~~~~----~~  192 (869)
                      |++|+|++|.+++..+..+    ..+ ++|++|+|++|+|++..+..+    .. .++|++|+|++|++++..+    ..
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~  161 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI  161 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence            9999999999997766644    444 899999999999987665544    33 3699999999999986444    34


Q ss_pred             cCCCC-cccEEEccCCcCCCCchHhhh----cC-CCCCEEEcCCCCCCCCcccccc------cccceEEEcccccCccCC
Q 002899          193 IGKWK-KIQKLHIQGSSLEGPIPASIS----AL-TSLTDLRISDLKGSESAFPKLD------KMNLKTLILTKCLIHGEI  260 (869)
Q Consensus       193 ~~~l~-~L~~L~L~~N~l~~~~~~~l~----~l-~~L~~L~L~~n~~~~~~~~~~~------~~~L~~L~Ls~N~i~~~~  260 (869)
                      +..++ +|++|+|++|++++..+..+.    .+ ++|+.|+|++|.+.......+.      ..+|+.|+|++|.|++..
T Consensus       162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~  241 (362)
T 3goz_A          162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS  241 (362)
T ss_dssp             HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred             HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence            45555 999999999999887765444    45 5999999999998875433221      137999999999998765


Q ss_pred             C----cccCCCCCcCEEeccCCCCCCCCch-------hhhcCCCCCEEEeeCCcCCCCCchhhhccCCcee
Q 002899          261 P----DYIGDMTKLKNIDLSFNNLTGGIPT-------TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVD  320 (869)
Q Consensus       261 p----~~~~~l~~L~~L~Ls~N~l~~~~p~-------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~  320 (869)
                      +    ..+..+++|+.|+|++|.+.+..+.       .+..+++|+.|||++|++.+..+..+...++.+.
T Consensus       242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~~~~l~~~~  312 (362)
T 3goz_A          242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELS  312 (362)
T ss_dssp             HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHHHHHHHHHCC
Confidence            5    3456778899999999986654443       4567778889999999988776666655544443

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.89  E-value=2.6e-23  Score=221.64  Aligned_cols=208  Identities=20%  Similarity=0.261  Sum_probs=147.8

Q ss_pred             ceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccC
Q 002899          103 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD  182 (869)
Q Consensus       103 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~  182 (869)
                      +..+++..+.+...  ..+..+++|+.|++++|.++. + ..+..+++|++|+|++|++++.  ..+..+++|++|+|++
T Consensus        21 l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~   94 (272)
T 3rfs_A           21 TIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTG   94 (272)
T ss_dssp             HHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTT
T ss_pred             HHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCC
Confidence            33444444444433  224556677777777776662 2 2466667777777777776642  3566667777777777


Q ss_pred             CcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCc
Q 002899          183 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPD  262 (869)
Q Consensus       183 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~  262 (869)
                      |++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+                       |++|+|++..+.
T Consensus        95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~-----------------------L~~n~l~~~~~~  151 (272)
T 3rfs_A           95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN-----------------------LAHNQLQSLPKG  151 (272)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE-----------------------CCSSCCCCCCTT
T ss_pred             CccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE-----------------------CCCCccCccCHH
Confidence            777666666666667777777777776666555566666555554                       557777777777


Q ss_pred             ccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh--hccCCceeeeccCccCCCCCCCCCCCCC
Q 002899          263 YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGS  340 (869)
Q Consensus       263 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~~~~~p~~C~c~~  340 (869)
                      .|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|..+  +..++.|++++|        ||.|+|..
T Consensus       152 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N--------~~~~~~~~  223 (272)
T 3rfs_A          152 VFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN--------PWDCTCPG  223 (272)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS--------CBCCCTTT
T ss_pred             HhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCC--------CccccCcH
Confidence            88999999999999999998888889999999999999999998777655  568999999999        88899974


Q ss_pred             -ccceecc
Q 002899          341 -VNLVESY  347 (869)
Q Consensus       341 -~~~~~~l  347 (869)
                       .++..|.
T Consensus       224 l~~l~~~~  231 (272)
T 3rfs_A          224 IRYLSEWI  231 (272)
T ss_dssp             THHHHHHH
T ss_pred             HHHHHHHH
Confidence             3444443

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.89  E-value=2.2e-23  Score=214.90  Aligned_cols=188  Identities=19%  Similarity=0.242  Sum_probs=127.5

Q ss_pred             ccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCC
Q 002899          128 KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS  207 (869)
Q Consensus       128 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  207 (869)
                      +.+++++|.++ .+|..+.  ++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            34555555555 3444333  45666666666666555556666666666666666666666666666666666666666


Q ss_pred             cCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchh
Q 002899          208 SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT  287 (869)
Q Consensus       208 ~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  287 (869)
                      +|+...+..|..+++|+.|+|+                       +|+|++..|..|..+++|+.|+|++|+|++..+..
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~-----------------------~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  147 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLN-----------------------ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGT  147 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECC-----------------------SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred             cCCccCHhHccCCCCCCEEECC-----------------------CCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHH
Confidence            6665555555555555544443                       55555566777778888888888888888777777


Q ss_pred             hhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCCCCCCCCCCCCCccceeccCCCCCCCCCCcCccCCCCCC
Q 002899          288 FEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPC  367 (869)
Q Consensus       288 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~~~~~l~~~~~~~~~~~~~~~~~~~C  367 (869)
                      |..+++|+.|+|++|                              ||.|+|.+.|+..|+......        .....|
T Consensus       148 ~~~l~~L~~L~L~~N------------------------------~~~c~c~l~~l~~~l~~~~~~--------~~~~~C  189 (220)
T 2v9t_B          148 FSPLRAIQTMHLAQN------------------------------PFICDCHLKWLADYLHTNPIE--------TSGARC  189 (220)
T ss_dssp             TTTCTTCCEEECCSS------------------------------CEECSGGGHHHHHHHHHCCCB--------CSCCBE
T ss_pred             HhCCCCCCEEEeCCC------------------------------CcCCCCccHHHHHHHHhCCCC--------ccCCCc
Confidence            888888888888887                              888999999999998753322        134679


Q ss_pred             CCCcccccceee
Q 002899          368 SAPADQYHYTLH  379 (869)
Q Consensus       368 ~~p~~~~~~~~~  379 (869)
                      +.|..++|+.+.
T Consensus       190 ~~P~~l~g~~l~  201 (220)
T 2v9t_B          190 TSPRRLANKRIG  201 (220)
T ss_dssp             EESGGGTTCBGG
T ss_pred             CCchHHcCCchh
Confidence            888888876544

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.89  E-value=2.5e-22  Score=237.17  Aligned_cols=236  Identities=27%  Similarity=0.303  Sum_probs=192.7

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCcccccccccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE  133 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  133 (869)
                      .+++.|+|++|+|+ .+|.   .+++|++|+|++|+|+.++.   ...+|++|+|++|++++..+    .+++|+.|+|+
T Consensus        61 ~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~l~~l~~----~l~~L~~L~L~  129 (622)
T 3g06_A           61 AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLPV---LPPGLLELSIFSNPLTHLPA----LPSGLCKLWIF  129 (622)
T ss_dssp             TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCCCC---CCTTCCEEEECSCCCCCCCC----CCTTCCEEECC
T ss_pred             CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcCCC---CCCCCCEEECcCCcCCCCCC----CCCCcCEEECC
Confidence            57999999999999 5665   57899999999999997655   33489999999999996544    67899999999


Q ss_pred             ccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCc
Q 002899          134 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI  213 (869)
Q Consensus       134 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  213 (869)
                      +|+|++ +|..   +++|++|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|   ..+++|+.|+|++|.|++. 
T Consensus       130 ~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l-  196 (622)
T 3g06_A          130 GNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASL-  196 (622)
T ss_dssp             SSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCC-
T ss_pred             CCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCC-
Confidence            999995 5543   4899999999999994 453   35789999999999985 45   4578999999999999863 


Q ss_pred             hHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCC
Q 002899          214 PASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK  293 (869)
Q Consensus       214 ~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  293 (869)
                      |.   .+++|+.|++++|.++..+..   ..+|+.|+|++|+|++ +|   ..+++|+.|+|++|+|+ .+|.   .+++
T Consensus       197 ~~---~~~~L~~L~L~~N~l~~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~  262 (622)
T 3g06_A          197 PT---LPSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSG  262 (622)
T ss_dssp             CC---CCTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTT
T ss_pred             CC---ccchhhEEECcCCcccccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---cccc
Confidence            32   357899999999998876532   2579999999999986 44   45688999999999999 4554   6788


Q ss_pred             CCEEEeeCCcCCCCCchhh--hccCCceeeeccCccC
Q 002899          294 TNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTW  328 (869)
Q Consensus       294 L~~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~  328 (869)
                      |+.|+|++|+|+ .+|..+  ++.++.|+|++|+++.
T Consensus       263 L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~  298 (622)
T 3g06_A          263 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE  298 (622)
T ss_dssp             CCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCH
T ss_pred             CcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCC
Confidence            999999999999 678776  4578889999997764

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.89  E-value=9.3e-23  Score=219.40  Aligned_cols=200  Identities=22%  Similarity=0.194  Sum_probs=174.5

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      ..+++.|++++++++ .+|..+.  ++|+.|+|++|.|++..+..|..+ +|++|+|++|++++..+.  ..+++|++|+
T Consensus         9 l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~   83 (290)
T 1p9a_G            9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLD   83 (290)
T ss_dssp             STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEE
T ss_pred             cCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEE
Confidence            346889999999999 6676665  789999999999999999889888 899999999999965443  7899999999


Q ss_pred             ccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCC
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG  211 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  211 (869)
                      |++|+|+ .+|..+..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|+.
T Consensus        84 Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  162 (290)
T 1p9a_G           84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE  162 (290)
T ss_dssp             CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred             CCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCc
Confidence            9999999 778889999999999999999998777889999999999999999998888889999999999999999998


Q ss_pred             CchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCC
Q 002899          212 PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG  282 (869)
Q Consensus       212 ~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~  282 (869)
                      ..+..|..+++|+.|+|++|++                       + .+|..+..+++|+.|+|++|.+..
T Consensus       163 l~~~~~~~l~~L~~L~L~~N~l-----------------------~-~ip~~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          163 LPAGLLNGLENLDTLLLQENSL-----------------------Y-TIPKGFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCC-----------------------C-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             cCHHHhcCcCCCCEEECCCCcC-----------------------C-ccChhhcccccCCeEEeCCCCccC
Confidence            7777888898888887775554                       4 345555667788889999888873

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.89  E-value=1.8e-25  Score=256.89  Aligned_cols=272  Identities=18%  Similarity=0.220  Sum_probs=124.4

Q ss_pred             EEEEeccCCCccc----cCCccccCCCCCCEEEeecCcCCCCCchhhc-cc-----cceEEEeecccCCC----CCchhh
Q 002899           56 VVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRNCLTGSFSPQWA-SL-----QLVELSVMGNRLSG----PFPKVL  121 (869)
Q Consensus        56 v~~L~l~~~~l~~----~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~-~l-----~L~~L~Ls~N~l~~----~~~~~~  121 (869)
                      ++.|+|++|+++.    .++..+..+++|++|+|++|.+++..+..+. .+     +|++|+|++|+++.    .++..+
T Consensus        30 L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l  109 (461)
T 1z7x_W           30 CQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTL  109 (461)
T ss_dssp             CSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHT
T ss_pred             ccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHH
Confidence            4455555555443    2334444455555555555555433222221 11     25555555555542    234445


Q ss_pred             cCccccccccccccccCCCCCccc-----cCCCCccEEEeecccccccC----CccccCCCCCCeEeccCCcCCCCCccc
Q 002899          122 TNITTLKNLSIEGNLFTGSIPPDI-----RKLINLQKLILSSNSFTGEL----PAELTKLTNLNDLRISDNNFSGKIPEF  192 (869)
Q Consensus       122 ~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~i~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~~~~  192 (869)
                      ..+++|++|+|++|.+++..+..+     ...++|++|+|++|++++..    +..+..+++|++|+|++|.++...+..
T Consensus       110 ~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~  189 (461)
T 1z7x_W          110 RTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRV  189 (461)
T ss_dssp             TSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHH
T ss_pred             ccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHH
Confidence            555555555555555443222211     11334555555555555322    333344455555555555554332322


Q ss_pred             cC-----CCCcccEEEccCCcCCCC----chHhhhcCCCCCEEEcCCCCCCCCccccc------ccccceEEEcccccCc
Q 002899          193 IG-----KWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPKL------DKMNLKTLILTKCLIH  257 (869)
Q Consensus       193 ~~-----~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~n~~~~~~~~~~------~~~~L~~L~Ls~N~i~  257 (869)
                      +.     .+++|++|+|++|.++..    ++..+..+++|+.|+|++|.+.......+      ...+|+.|+|++|.|+
T Consensus       190 l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~  269 (461)
T 1z7x_W          190 LCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGIT  269 (461)
T ss_dssp             HHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred             HHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCC
Confidence            22     133555555555555542    34445555555555555555443321111      1224555555555555


Q ss_pred             cC----CCcccCCCCCcCEEeccCCCCCCCCchhhhcC-----CCCCEEEeeCCcCCCCC----chhh--hccCCceeee
Q 002899          258 GE----IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL-----AKTNFMYLTGNKLTGPV----PKYI--FNSNKNVDIS  322 (869)
Q Consensus       258 ~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~----p~~~--~~~l~~l~ls  322 (869)
                      ..    ++..+..+++|+.|+|++|.+++..+..+...     ++|+.|+|++|++++..    |..+  .+.++.|+++
T Consensus       270 ~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls  349 (461)
T 1z7x_W          270 AKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQIS  349 (461)
T ss_dssp             HHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECC
T ss_pred             HHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEcc
Confidence            43    34444445555555555555543333333322     45555555555555432    2221  2345555555


Q ss_pred             ccCcc
Q 002899          323 LNNFT  327 (869)
Q Consensus       323 ~N~~~  327 (869)
                      +|.++
T Consensus       350 ~n~i~  354 (461)
T 1z7x_W          350 NNRLE  354 (461)
T ss_dssp             SSBCH
T ss_pred             CCccc
Confidence            55443

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.88  E-value=4e-23  Score=224.67  Aligned_cols=230  Identities=17%  Similarity=0.192  Sum_probs=187.0

Q ss_pred             hhhccccceEEEeecccCCCCCch---hhcCccccccccccccccCCCCCccc--cCCCCccEEEeecccccccCC----
Q 002899           96 PQWASLQLVELSVMGNRLSGPFPK---VLTNITTLKNLSIEGNLFTGSIPPDI--RKLINLQKLILSSNSFTGELP----  166 (869)
Q Consensus        96 ~~~~~l~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~--~~l~~L~~L~Ls~N~i~~~~p----  166 (869)
                      ..+...+++.|.+.++.++...-.   .+..+++|++|+|++|.+++..|..+  ..+++|++|+|++|++++..+    
T Consensus        59 ~~~~~~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~  138 (310)
T 4glp_A           59 DTVKALRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAE  138 (310)
T ss_dssp             GGGSSCCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHH
T ss_pred             HHhhhcceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHH
Confidence            344555789999999887632111   12345779999999999999999988  899999999999999997555    


Q ss_pred             ccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCC--c--hHhhhcCCCCCEEEcCCCCCCCCccc---
Q 002899          167 AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP--I--PASISALTSLTDLRISDLKGSESAFP---  239 (869)
Q Consensus       167 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~--~~~l~~l~~L~~L~L~~n~~~~~~~~---  239 (869)
                      ..+..+++|++|+|++|++++..+..|..+++|++|+|++|++.+.  +  +..+..+++|+.|+|++|.++..+..   
T Consensus       139 ~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~  218 (310)
T 4glp_A          139 LQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAA  218 (310)
T ss_dssp             HHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHH
T ss_pred             HHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHH
Confidence            3456799999999999999998999999999999999999998753  2  22347899999999999999754432   


Q ss_pred             cc-ccccceEEEcccccCccCCCcccCCC---CCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhcc
Q 002899          240 KL-DKMNLKTLILTKCLIHGEIPDYIGDM---TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNS  315 (869)
Q Consensus       240 ~~-~~~~L~~L~Ls~N~i~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~  315 (869)
                      .+ ...+|++|+|++|+|++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|+.|+|++|+|++.....-++.
T Consensus       219 l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~~~~l~~  295 (310)
T 4glp_A          219 LAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQPDELPE  295 (310)
T ss_dssp             HHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCCTTSCCC
T ss_pred             HHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCchhhhCCC
Confidence            11 23589999999999999888877776   79999999999999 6677664  899999999999997422233578


Q ss_pred             CCceeeeccCccC
Q 002899          316 NKNVDISLNNFTW  328 (869)
Q Consensus       316 l~~l~ls~N~~~~  328 (869)
                      ++.|+|++|+++.
T Consensus       296 L~~L~L~~N~l~~  308 (310)
T 4glp_A          296 VDNLTLDGNPFLV  308 (310)
T ss_dssp             CSCEECSSTTTSC
T ss_pred             ccEEECcCCCCCC
Confidence            9999999997764

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.88  E-value=8.6e-23  Score=213.22  Aligned_cols=197  Identities=16%  Similarity=0.141  Sum_probs=164.3

Q ss_pred             cceEEEeecccCCCCCchhhcCccccccccccccc-cCCCCCccccCCCCccEEEeec-ccccccCCccccCCCCCCeEe
Q 002899          102 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL-FTGSIPPDIRKLINLQKLILSS-NSFTGELPAELTKLTNLNDLR  179 (869)
Q Consensus       102 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~-N~i~~~~p~~~~~l~~L~~L~  179 (869)
                      +|++|+|++|+++++.+..|.++++|++|+|++|+ ++...+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            78999999999998888889999999999999997 8866667888999999999998 899877777888999999999


Q ss_pred             ccCCcCCCCCccccCCCCccc---EEEccCC-cCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEccccc
Q 002899          180 ISDNNFSGKIPEFIGKWKKIQ---KLHIQGS-SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCL  255 (869)
Q Consensus       180 Ls~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~  255 (869)
                      |++|++++ +|. |..+++|+   .|++++| .++...+..|..+++|+                      ..|+|++|+
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~----------------------~~L~l~~n~  167 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET----------------------LTLKLYNNG  167 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSE----------------------EEEECCSCC
T ss_pred             CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcce----------------------eEEEcCCCC
Confidence            99999986 555 78888887   8889888 88866666677666555                      045556889


Q ss_pred             CccCCCcccCCCCCcCEEeccCCC-CCCCCchhhhcC-CCCCEEEeeCCcCCCCCchhhhccCCceeeecc
Q 002899          256 IHGEIPDYIGDMTKLKNIDLSFNN-LTGGIPTTFEKL-AKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN  324 (869)
Q Consensus       256 i~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N  324 (869)
                      |+...+..|.. ++|+.|+|++|+ +++..+..|..+ ++|+.|+|++|+|+ .+|...+..++.|+++++
T Consensus       168 l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~~~~~L~~L~l~~~  236 (239)
T 2xwt_C          168 FTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT  236 (239)
T ss_dssp             CCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCTTCTTCSEEECTTC
T ss_pred             CcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChhHhccCceeeccCc
Confidence            98655566666 899999999995 998888889999 99999999999999 456667888999998876

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.88  E-value=2.9e-22  Score=213.27  Aligned_cols=183  Identities=20%  Similarity=0.249  Sum_probs=164.6

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      ...++.|+|++|++++..+..|.++++|++|+|++|.|+.+++..|..+ +|++|+|++|++++..+..|..+++|++|+
T Consensus        36 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  115 (270)
T 2o6q_A           36 PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELR  115 (270)
T ss_dssp             CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEE
T ss_pred             CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEE
Confidence            3468999999999998777899999999999999999999888888877 899999999999988888899999999999


Q ss_pred             ccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCC
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG  211 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  211 (869)
                      |++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++
T Consensus       116 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  195 (270)
T 2o6q_A          116 LDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR  195 (270)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCc
Confidence            99999998888889999999999999999997767778999999999999999998888889999999999999999998


Q ss_pred             CchHhhhcCCCCCEEEcCCCCCCC
Q 002899          212 PIPASISALTSLTDLRISDLKGSE  235 (869)
Q Consensus       212 ~~~~~l~~l~~L~~L~L~~n~~~~  235 (869)
                      ..+..+..+++|+.|+|++|++..
T Consensus       196 ~~~~~~~~l~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          196 VPEGAFDSLEKLKMLQLQENPWDC  219 (270)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CCHHHhccccCCCEEEecCCCeeC
Confidence            777788889988888888777543

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=3e-22  Score=217.46  Aligned_cols=207  Identities=24%  Similarity=0.321  Sum_probs=120.6

Q ss_pred             EeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccccccccc
Q 002899           59 IALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLF  137 (869)
Q Consensus        59 L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  137 (869)
                      +.+..+++++.++  +.++++|++|++++|.++...  .+..+ +|++|+|++|++++..+  +..+++|++|+|++|++
T Consensus        24 ~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~l~--~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l   97 (308)
T 1h6u_A           24 IAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL   97 (308)
T ss_dssp             HHTTCSSTTSEEC--HHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred             HHhCCCCcCceec--HHHcCCcCEEEeeCCCccCch--hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcC
Confidence            3444445544332  345566777777777666432  23333 56666666666654433  55566666666666665


Q ss_pred             CCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhh
Q 002899          138 TGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI  217 (869)
Q Consensus       138 ~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l  217 (869)
                      ++.  +.+..+++|++|+|++|++++. + .+..+++|++|+|++|++++..+  +..+++|+.|+|++|.+++..+  +
T Consensus        98 ~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l  169 (308)
T 1h6u_A           98 KNV--SAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--L  169 (308)
T ss_dssp             SCC--GGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--G
T ss_pred             CCc--hhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--h
Confidence            532  2455555566666666655532 2 25555555555555555554332  5555555555555555554322  4


Q ss_pred             hcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEE
Q 002899          218 SALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM  297 (869)
Q Consensus       218 ~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  297 (869)
                      ..+++|                       +.|+|++|+|++..+  +..+++|+.|+|++|++++..+  +..+++|+.|
T Consensus       170 ~~l~~L-----------------------~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L  222 (308)
T 1h6u_A          170 ANLSKL-----------------------TTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV  222 (308)
T ss_dssp             TTCTTC-----------------------CEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEE
T ss_pred             cCCCCC-----------------------CEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEE
Confidence            455544                       455555666654433  6678888888888888885543  7888888888


Q ss_pred             EeeCCcCCC
Q 002899          298 YLTGNKLTG  306 (869)
Q Consensus       298 ~Ls~N~l~~  306 (869)
                      +|++|++++
T Consensus       223 ~l~~N~i~~  231 (308)
T 1h6u_A          223 TLTNQTITN  231 (308)
T ss_dssp             EEEEEEEEC
T ss_pred             EccCCeeec
Confidence            888888875

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.88  E-value=1.1e-22  Score=209.70  Aligned_cols=187  Identities=20%  Similarity=0.206  Sum_probs=135.5

Q ss_pred             ccccccccccCCCCCccccCCCCccEEEeecccccccCC-ccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccC
Q 002899          128 KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQG  206 (869)
Q Consensus       128 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  206 (869)
                      +.|++++|.++ .+|..+.  ..+++|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus        14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            45666666666 3454443  245677777777775543 3466777777777777777766666777777777777777


Q ss_pred             CcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCch
Q 002899          207 SSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT  286 (869)
Q Consensus       207 N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  286 (869)
                      |.|++..+..|..+++|+.|+|+                       +|+|++..|..|..+++|+.|+|++|+|++..|.
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls-----------------------~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  147 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLR-----------------------SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG  147 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECT-----------------------TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred             CccCccCHhHhcCCcCCCEEECC-----------------------CCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence            77777666677777666655554                       5666666777888899999999999999988888


Q ss_pred             hhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCCCCCCCCCCCCCccceeccCCCCCCCCCCcCccCCCCC
Q 002899          287 TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFP  366 (869)
Q Consensus       287 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~~~~~l~~~~~~~~~~~~~~~~~~~  366 (869)
                      .|..+++|+.|+|++|                              ||.|+|.+.|+..|+......        .....
T Consensus       148 ~~~~l~~L~~L~L~~N------------------------------~l~c~c~l~~l~~~~~~~~~~--------~~~~~  189 (220)
T 2v70_A          148 AFDTLHSLSTLNLLAN------------------------------PFNCNCYLAWLGEWLRKKRIV--------TGNPR  189 (220)
T ss_dssp             TTTTCTTCCEEECCSC------------------------------CEECSGGGHHHHHHHHHSCCB--------CCCCE
T ss_pred             HhcCCCCCCEEEecCc------------------------------CCcCCCchHHHHHHHHhcCcc--------ccCCc
Confidence            9999999999988888                              788999999999998743321        13347


Q ss_pred             CCCCccccccee
Q 002899          367 CSAPADQYHYTL  378 (869)
Q Consensus       367 C~~p~~~~~~~~  378 (869)
                      |+.|..+++..+
T Consensus       190 C~~P~~l~g~~l  201 (220)
T 2v70_A          190 CQKPYFLKEIPI  201 (220)
T ss_dssp             EEESGGGTTEEG
T ss_pred             cCCChHHCCCCh
Confidence            888887776543

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=2.1e-24  Score=242.32  Aligned_cols=255  Identities=18%  Similarity=0.235  Sum_probs=180.7

Q ss_pred             cCCccccCCCCCCEEEeecCcCCCCCchh----hccc-cceEEEeeccc---CCCCCchhh-------cCcccccccccc
Q 002899           69 TLPTELSKLRYLKQLDLSRNCLTGSFSPQ----WASL-QLVELSVMGNR---LSGPFPKVL-------TNITTLKNLSIE  133 (869)
Q Consensus        69 ~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~----~~~l-~L~~L~Ls~N~---l~~~~~~~~-------~~l~~L~~L~Ls  133 (869)
                      .++..+..+++|+.|+|++|.|+...+..    +..+ +|++|+|++|.   +++.+|..+       ..+++|++|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            56677788888888888888887665444    3344 78888888854   444455444       677888888888


Q ss_pred             ccccCC----CCCccccCCCCccEEEeecccccccCCccc----cCC---------CCCCeEeccCCcCC-CCCc---cc
Q 002899          134 GNLFTG----SIPPDIRKLINLQKLILSSNSFTGELPAEL----TKL---------TNLNDLRISDNNFS-GKIP---EF  192 (869)
Q Consensus       134 ~N~l~~----~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~----~~l---------~~L~~L~Ls~N~l~-~~~~---~~  192 (869)
                      +|.+++    .++..+..+++|++|+|++|.|+...+..+    ..+         ++|++|+|++|+++ ..++   ..
T Consensus       103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~  182 (386)
T 2ca6_A          103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT  182 (386)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence            888886    356677788888888888888865433333    333         78888888888886 3344   45


Q ss_pred             cCCCCcccEEEccCCcCCC-----CchHhhhcCCCCCEEEcCCCCCCCC-----cccccccccceEEEcccccCccC---
Q 002899          193 IGKWKKIQKLHIQGSSLEG-----PIPASISALTSLTDLRISDLKGSES-----AFPKLDKMNLKTLILTKCLIHGE---  259 (869)
Q Consensus       193 ~~~l~~L~~L~L~~N~l~~-----~~~~~l~~l~~L~~L~L~~n~~~~~-----~~~~~~~~~L~~L~Ls~N~i~~~---  259 (869)
                      |..+++|+.|+|++|+++.     ..+..+..+++|+.|+|++|.++..     +.......+|+.|+|++|.|++.   
T Consensus       183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~  262 (386)
T 2ca6_A          183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA  262 (386)
T ss_dssp             HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred             HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence            6678888888888888873     2333777888888888888887521     11122234788888888888765   


Q ss_pred             -CCccc--CCCCCcCEEeccCCCCCC----CCchhh-hcCCCCCEEEeeCCcCCCCCc--hhh---hccCCceeeec
Q 002899          260 -IPDYI--GDMTKLKNIDLSFNNLTG----GIPTTF-EKLAKTNFMYLTGNKLTGPVP--KYI---FNSNKNVDISL  323 (869)
Q Consensus       260 -~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~~p--~~~---~~~l~~l~ls~  323 (869)
                       ++..+  +.+++|+.|+|++|+|++    .+|..+ .++++|+.|+|++|++++..|  ..+   ++.++.+++..
T Consensus       263 ~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~~~l~~~l~~~~~~~l~~  339 (386)
T 2ca6_A          263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDE  339 (386)
T ss_dssp             HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHHHHHHHHHHHHTCCEECC
T ss_pred             HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHHHHHHHHhhhcCcchhhh
Confidence             45566  348999999999999986    477777 668999999999999998775  333   33444455543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.87  E-value=1.2e-23  Score=234.01  Aligned_cols=247  Identities=16%  Similarity=0.164  Sum_probs=200.8

Q ss_pred             EEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCc----hhhcCcc-ccccccccccccCCCCCccccCC-----CC
Q 002899           82 QLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFP----KVLTNIT-TLKNLSIEGNLFTGSIPPDIRKL-----IN  150 (869)
Q Consensus        82 ~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~----~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l-----~~  150 (869)
                      .+.|+.|.+++.+|..+... +|++|+|++|.+++..+    ..|..++ +|++|+|++|.|++..+..+..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            47899999999999888877 59999999999998887    7888898 99999999999998877777765     99


Q ss_pred             ccEEEeecccccccCCccc----cCC-CCCCeEeccCCcCCCCCccccC----C-CCcccEEEccCCcCCCCc----hHh
Q 002899          151 LQKLILSSNSFTGELPAEL----TKL-TNLNDLRISDNNFSGKIPEFIG----K-WKKIQKLHIQGSSLEGPI----PAS  216 (869)
Q Consensus       151 L~~L~Ls~N~i~~~~p~~~----~~l-~~L~~L~Ls~N~l~~~~~~~~~----~-l~~L~~L~L~~N~l~~~~----~~~  216 (869)
                      |++|+|++|++++..+..+    ..+ ++|++|+|++|+|++..+..+.    . .++|++|+|++|.++...    +..
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~  161 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI  161 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence            9999999999997666644    444 8999999999999977776543    4 369999999999999644    445


Q ss_pred             hhcCC-CCCEEEcCCCCCCCCccccccc------ccceEEEcccccCccC----CCcccCC-CCCcCEEeccCCCCCCCC
Q 002899          217 ISALT-SLTDLRISDLKGSESAFPKLDK------MNLKTLILTKCLIHGE----IPDYIGD-MTKLKNIDLSFNNLTGGI  284 (869)
Q Consensus       217 l~~l~-~L~~L~L~~n~~~~~~~~~~~~------~~L~~L~Ls~N~i~~~----~p~~~~~-l~~L~~L~Ls~N~l~~~~  284 (869)
                      +..++ +|+.|+|++|.++......+..      .+|+.|+|++|.|++.    ++..+.. .++|+.|+|++|+|++..
T Consensus       162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~  241 (362)
T 3goz_A          162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS  241 (362)
T ss_dssp             HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred             HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence            56666 9999999999998776543322      3899999999999974    3444544 469999999999999876


Q ss_pred             chh----hhcCCCCCEEEeeCCcCCCCCchhh---------hccCCceeeeccCccC
Q 002899          285 PTT----FEKLAKTNFMYLTGNKLTGPVPKYI---------FNSNKNVDISLNNFTW  328 (869)
Q Consensus       285 p~~----~~~l~~L~~L~Ls~N~l~~~~p~~~---------~~~l~~l~ls~N~~~~  328 (869)
                      +..    +..+++|+.|+|++|++.+..+..+         ...++.||+++|++..
T Consensus       242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~  298 (362)
T 3goz_A          242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP  298 (362)
T ss_dssp             HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred             HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence            644    4567999999999999776655533         2356789999997653

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.87  E-value=4e-22  Score=209.80  Aligned_cols=177  Identities=19%  Similarity=0.250  Sum_probs=154.8

Q ss_pred             EEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccc
Q 002899           56 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG  134 (869)
Q Consensus        56 v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  134 (869)
                      .+.+++++++++ .+|..+.  ++|+.|+|++|.|++..+..|..+ +|++|+|++|++++..+..|..+++|++|+|++
T Consensus        16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~   92 (251)
T 3m19_A           16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN   92 (251)
T ss_dssp             GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence            457899999999 6777665  689999999999999988888887 899999999999988888899999999999999


Q ss_pred             cccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCch
Q 002899          135 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP  214 (869)
Q Consensus       135 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  214 (869)
                      |+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+
T Consensus        93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  172 (251)
T 3m19_A           93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH  172 (251)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence            99997777788999999999999999997777778889999999999999998777789999999999999999998888


Q ss_pred             HhhhcCCCCCEEEcCCCCCCC
Q 002899          215 ASISALTSLTDLRISDLKGSE  235 (869)
Q Consensus       215 ~~l~~l~~L~~L~L~~n~~~~  235 (869)
                      ..+..+++|+.|+|++|++..
T Consensus       173 ~~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          173 GAFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             TTTTTCTTCCEEECCSCCBCT
T ss_pred             HHHhCCCCCCEEEeeCCceeC
Confidence            888888888888888776644

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.87  E-value=1.4e-22  Score=224.24  Aligned_cols=243  Identities=15%  Similarity=0.116  Sum_probs=140.6

Q ss_pred             EEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCC-chhhcCcccccccccccc
Q 002899           58 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPF-PKVLTNITTLKNLSIEGN  135 (869)
Q Consensus        58 ~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N  135 (869)
                      .+++++++++ .+|..+.  ++|++|+|++|+|+.+++..|..+ +|++|+|++|++.+.+ +.+|.++++|++      
T Consensus        13 ~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~------   83 (350)
T 4ay9_X           13 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHE------   83 (350)
T ss_dssp             EEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCE------
T ss_pred             EEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhh------
Confidence            5788889998 6777663  577888888877775555555544 4555555555543322 233444444433      


Q ss_pred             ccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccC-CcCCCCch
Q 002899          136 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQG-SSLEGPIP  214 (869)
Q Consensus       136 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~  214 (869)
                                       .+.++.|+|+...|..|..+++|++|++++|+|+...+..+....++..|++.+ |++....+
T Consensus        84 -----------------~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~  146 (350)
T 4ay9_X           84 -----------------IRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER  146 (350)
T ss_dssp             -----------------EEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECT
T ss_pred             -----------------hhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccc
Confidence                             233344444444444445555555555555555444444444444455555533 34443334


Q ss_pred             HhhhcCC-CCCEEEcCCCCCCCCcccccccccceEEEccc-ccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCC
Q 002899          215 ASISALT-SLTDLRISDLKGSESAFPKLDKMNLKTLILTK-CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA  292 (869)
Q Consensus       215 ~~l~~l~-~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~-N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  292 (869)
                      ..|..+. .|+.|+|++|+++.++...+...+|++|++++ |.++.+.++.|..+++|+.|||++|+|+...+..   +.
T Consensus       147 ~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~---~~  223 (350)
T 4ay9_X          147 NSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG---LE  223 (350)
T ss_dssp             TSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS---CT
T ss_pred             cchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh---hc
Confidence            4444443 45556666666665555555555777777764 6677666677888899999999999998554444   44


Q ss_pred             CCCEEEeeCCcCCCCCch-hhhccCCceeeeccCccCCCCCCCCCCC
Q 002899          293 KTNFMYLTGNKLTGPVPK-YIFNSNKNVDISLNNFTWESSDPIECPR  338 (869)
Q Consensus       293 ~L~~L~Ls~N~l~~~~p~-~~~~~l~~l~ls~N~~~~~~~~p~~C~c  338 (869)
                      +|+.|.+.++.-...+|. .-+..|+.+++++         ||+|+|
T Consensus       224 ~L~~L~~l~~~~l~~lP~l~~l~~L~~l~l~~---------~~~c~~  261 (350)
T 4ay9_X          224 NLKKLRARSTYNLKKLPTLEKLVALMEASLTY---------PSHCCA  261 (350)
T ss_dssp             TCCEEECTTCTTCCCCCCTTTCCSCCEEECSC---------HHHHHH
T ss_pred             cchHhhhccCCCcCcCCCchhCcChhhCcCCC---------Cccccc
Confidence            555665555444445554 2256677777753         688865

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.86  E-value=1.6e-23  Score=235.11  Aligned_cols=233  Identities=16%  Similarity=0.163  Sum_probs=189.6

Q ss_pred             hhhccc-cceEEEeecccCCCCCc----hhhcCcccccccccccc---ccCCCCCccc-------cCCCCccEEEeeccc
Q 002899           96 PQWASL-QLVELSVMGNRLSGPFP----KVLTNITTLKNLSIEGN---LFTGSIPPDI-------RKLINLQKLILSSNS  160 (869)
Q Consensus        96 ~~~~~l-~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N---~l~~~~~~~~-------~~l~~L~~L~Ls~N~  160 (869)
                      ..+... +|++|+|++|+++...+    ..+..+++|++|+|++|   ++++.+|..+       ..+++|++|+|++|+
T Consensus        26 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~  105 (386)
T 2ca6_A           26 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA  105 (386)
T ss_dssp             HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred             HHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCc
Confidence            334433 79999999999997644    44778999999999996   4455556554       788999999999999


Q ss_pred             ccc----cCCccccCCCCCCeEeccCCcCCCCCccccC----CC---------CcccEEEccCCcCC-CCch---Hhhhc
Q 002899          161 FTG----ELPAELTKLTNLNDLRISDNNFSGKIPEFIG----KW---------KKIQKLHIQGSSLE-GPIP---ASISA  219 (869)
Q Consensus       161 i~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~----~l---------~~L~~L~L~~N~l~-~~~~---~~l~~  219 (869)
                      |++    .+|..+..+++|++|+|++|.++...+..+.    .+         ++|++|+|++|+++ ..++   ..+..
T Consensus       106 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~  185 (386)
T 2ca6_A          106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS  185 (386)
T ss_dssp             CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHh
Confidence            997    4777889999999999999999755444444    34         89999999999998 3444   57889


Q ss_pred             CCCCCEEEcCCCCCCCCc-----c-cccccccceEEEcccccCc----cCCCcccCCCCCcCEEeccCCCCCCC----Cc
Q 002899          220 LTSLTDLRISDLKGSESA-----F-PKLDKMNLKTLILTKCLIH----GEIPDYIGDMTKLKNIDLSFNNLTGG----IP  285 (869)
Q Consensus       220 l~~L~~L~L~~n~~~~~~-----~-~~~~~~~L~~L~Ls~N~i~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p  285 (869)
                      +++|+.|+|++|.+....     . ......+|+.|+|++|.|+    ..+|..+..+++|+.|+|++|+|++.    ++
T Consensus       186 ~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~  265 (386)
T 2ca6_A          186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV  265 (386)
T ss_dssp             CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred             CCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHH
Confidence            999999999999988432     1 2223348999999999996    56788899999999999999999976    56


Q ss_pred             hhhhc--CCCCCEEEeeCCcCCC----CCchhh---hccCCceeeeccCccC
Q 002899          286 TTFEK--LAKTNFMYLTGNKLTG----PVPKYI---FNSNKNVDISLNNFTW  328 (869)
Q Consensus       286 ~~~~~--l~~L~~L~Ls~N~l~~----~~p~~~---~~~l~~l~ls~N~~~~  328 (869)
                      ..+..  +++|+.|+|++|++++    .+|..+   ++.++.|++++|+++.
T Consensus       266 ~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~  317 (386)
T 2ca6_A          266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  317 (386)
T ss_dssp             HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             HHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence            66644  9999999999999998    588877   4789999999997663

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.86  E-value=1.3e-22  Score=225.46  Aligned_cols=191  Identities=20%  Similarity=0.199  Sum_probs=94.4

Q ss_pred             cccccccccccCCCCCcccc-CCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEcc
Q 002899          127 LKNLSIEGNLFTGSIPPDIR-KLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQ  205 (869)
Q Consensus       127 L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  205 (869)
                      |+.|+|++|+|++..+..|. .+++|++|+|++|+|++..+..|.++++|++|+|++|+|+...+..|.++++|+.|+|+
T Consensus        41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  120 (361)
T 2xot_A           41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY  120 (361)
T ss_dssp             CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence            34444444444433333343 44444444444444444444444445555555555555544444444444445555544


Q ss_pred             CCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCccc---CCCCCcCEEeccCCCCCC
Q 002899          206 GSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI---GDMTKLKNIDLSFNNLTG  282 (869)
Q Consensus       206 ~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~---~~l~~L~~L~Ls~N~l~~  282 (869)
                      +|+|+...+..|..+++|+.|+|++|.++                       +..+..|   ..+++|+.|+|++|+|++
T Consensus       121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-----------------------~l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A          121 NNHIVVVDRNAFEDMAQLQKLYLSQNQIS-----------------------RFPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCC-----------------------SCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             CCcccEECHHHhCCcccCCEEECCCCcCC-----------------------eeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            44444433444444444444433322222                       1122222   346677777777777776


Q ss_pred             CCchhhhcCCCC--CEEEeeCCcCCCCCchhhhccCCceeeeccCccCCCCCCCCCCCCCccc-eeccCCCCCCCCCCcC
Q 002899          283 GIPTTFEKLAKT--NFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNL-VESYSSPRNKLDKVHP  359 (869)
Q Consensus       283 ~~p~~~~~l~~L--~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~~-~~~l~~~~~~~~~~~~  359 (869)
                      ..+..+..++.+  +.|+|++|                              ||.|||++.|+ ..|+......+..   
T Consensus       178 l~~~~~~~l~~~~l~~l~l~~N------------------------------~~~C~C~l~~~~~~~~~~~~~~~~~---  224 (361)
T 2xot_A          178 LPLTDLQKLPAWVKNGLYLHNN------------------------------PLECDCKLYQLFSHWQYRQLSSVMD---  224 (361)
T ss_dssp             CCHHHHHHSCHHHHTTEECCSS------------------------------CEECCHHHHHHHHHHHHTTCHHHHT---
T ss_pred             cCHHHhhhccHhhcceEEecCC------------------------------CccCCcCcHHHHHHHHHhcCCchhc---
Confidence            555666666553  45555555                              89999999886 4565433211100   


Q ss_pred             ccCCCCCCCCCcccc
Q 002899          360 CLRQNFPCSAPADQY  374 (869)
Q Consensus       360 ~~~~~~~C~~p~~~~  374 (869)
                       ......|+.|....
T Consensus       225 -~~~~~~C~~p~~~~  238 (361)
T 2xot_A          225 -FQEDLYCMHSKKLH  238 (361)
T ss_dssp             -TGGGCEEESSSCCE
T ss_pred             -cCcCCEeCCChHHc
Confidence             11345677776543

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.86  E-value=3.7e-21  Score=208.90  Aligned_cols=194  Identities=20%  Similarity=0.248  Sum_probs=117.5

Q ss_pred             CccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEE
Q 002899          123 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL  202 (869)
Q Consensus       123 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  202 (869)
                      .+++|++|++++|.++. ++ .+..+++|++|+|++|++++..+  +..+++|++|+|++|++++.  ..+..+++|+.|
T Consensus        39 ~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L  112 (308)
T 1h6u_A           39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTL  112 (308)
T ss_dssp             HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEE
T ss_pred             HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEE
Confidence            34445555555554442 22 34444555555555555443222  44455555555555554432  234445555555


Q ss_pred             EccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCC
Q 002899          203 HIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG  282 (869)
Q Consensus       203 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~  282 (869)
                      +|++|++++..  .+..+++|+.|+|++|.++..+. .....+|+.|+|++|++++..+  +..+++|+.|+|++|++++
T Consensus       113 ~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~  187 (308)
T 1h6u_A          113 DLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD  187 (308)
T ss_dssp             ECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred             ECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCc
Confidence            55555554322  14455555555555555544332 1122256666666777775444  8899999999999999996


Q ss_pred             CCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCC
Q 002899          283 GIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWE  329 (869)
Q Consensus       283 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~  329 (869)
                      ..+  +..+++|+.|+|++|++++..|-.-++.++.|++++|.++..
T Consensus       188 ~~~--l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~l~~N~i~~~  232 (308)
T 1h6u_A          188 ISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITNQ  232 (308)
T ss_dssp             CGG--GGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEEEEEECC
T ss_pred             Chh--hcCCCCCCEEEccCCccCccccccCCCCCCEEEccCCeeecC
Confidence            554  899999999999999999777644467899999999977643

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=8e-22  Score=210.97  Aligned_cols=152  Identities=17%  Similarity=0.069  Sum_probs=120.8

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCc------------------hhhHHHHHHHHHHHhcC
Q 002899          631 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR------------------QGNREFVNEIGMISAQQ  692 (869)
Q Consensus       631 ~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~------------------~~~~~f~~E~~~l~~l~  692 (869)
                      ..+......|.+.+.||+|+||.||+|...+|+.||||.++....                  .....+.+|++++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344444556777799999999999999997799999999864321                  12456889999999998


Q ss_pred             CCceeeEEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCC
Q 002899          693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN  772 (869)
Q Consensus       693 H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~N  772 (869)
                        | +++.+++.. +..++||||+++|+|.+ +..           .....++.|+++||+|||+.+   |+||||||+|
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N  223 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN  223 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence              4 555554433 56799999999999988 421           124579999999999999998   9999999999


Q ss_pred             EEEcCCCcEEEeecCCceeecCCCccccccccccccccchhhcc
Q 002899          773 VLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM  816 (869)
Q Consensus       773 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~  816 (869)
                      ||++ ++.+||+|||+++.              +..|+|||++.
T Consensus       224 ILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             EEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             EEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            9999 99999999999863              23578999874

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.86  E-value=1.3e-21  Score=216.55  Aligned_cols=231  Identities=16%  Similarity=0.110  Sum_probs=173.4

Q ss_pred             ceEecCC-------CCcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCC-chhhccc-cce-EEEeecccC
Q 002899           44 NVTCDCS-------SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSF-SPQWASL-QLV-ELSVMGNRL  113 (869)
Q Consensus        44 ~v~C~~~-------~~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~-~~~~~~l-~L~-~L~Ls~N~l  113 (869)
                      .|.|+..       +...+++.|+|++|+|+...+.+|.++++|++|+|++|+|.+.+ +..|..+ +++ .+.+..|++
T Consensus        13 ~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l   92 (350)
T 4ay9_X           13 VFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL   92 (350)
T ss_dssp             EEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTC
T ss_pred             EEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcc
Confidence            4677542       23457899999999999666678999999999999999997654 5678877 555 577888999


Q ss_pred             CCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeec-ccccccCCccccCCC-CCCeEeccCCcCCCCCcc
Q 002899          114 SGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSS-NSFTGELPAELTKLT-NLNDLRISDNNFSGKIPE  191 (869)
Q Consensus       114 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~-N~i~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~  191 (869)
                      +.+.|..|..+++|++|++++|+|+...+..+....++..|++.+ |++....+..|..+. .|+.|+|++|+|+.+.+.
T Consensus        93 ~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~  172 (350)
T 4ay9_X           93 LYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNS  172 (350)
T ss_dssp             CEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTT
T ss_pred             cccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChh
Confidence            999999999999999999999999977777788888999999976 577766666777765 688999999999955444


Q ss_pred             ccCCCCcccEEEccC-CcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCc
Q 002899          192 FIGKWKKIQKLHIQG-SSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKL  270 (869)
Q Consensus       192 ~~~~l~~L~~L~L~~-N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L  270 (869)
                      .| ...+|+.|++++ |.++...+..|..+++|+.|+|++|+++.                       ..+..|.+   |
T Consensus       173 ~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~-----------------------lp~~~~~~---L  225 (350)
T 4ay9_X          173 AF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS-----------------------LPSYGLEN---L  225 (350)
T ss_dssp             SS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCC-----------------------CCSSSCTT---C
T ss_pred             hc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCc-----------------------cChhhhcc---c
Confidence            44 567899999975 67776666778888888888777555544                       33333333   3


Q ss_pred             CEEeccCC-CCCCCCchhhhcCCCCCEEEeeCCc
Q 002899          271 KNIDLSFN-NLTGGIPTTFEKLAKTNFMYLTGNK  303 (869)
Q Consensus       271 ~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~  303 (869)
                      +.|.+.++ .++ .+| .+..+++|+.++++++.
T Consensus       226 ~~L~~l~~~~l~-~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          226 KKLRARSTYNLK-KLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             CEEECTTCTTCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred             hHhhhccCCCcC-cCC-CchhCcChhhCcCCCCc
Confidence            34443333 344 455 36777788888876553

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.85  E-value=1.8e-21  Score=227.22  Aligned_cols=217  Identities=19%  Similarity=0.232  Sum_probs=112.7

Q ss_pred             CCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeec
Q 002899           79 YLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSS  158 (869)
Q Consensus        79 ~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  158 (869)
                      +|+.|+|++|.|+++++..+  .+|+.|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. +..  +|++|+|++
T Consensus        60 ~L~~L~Ls~n~L~~lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~  129 (571)
T 3cvr_A           60 QFSELQLNRLNLSSLPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDN  129 (571)
T ss_dssp             TCSEEECCSSCCSCCCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCS
T ss_pred             CccEEEeCCCCCCccCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCC
Confidence            56666666666665333222  34555555555555 233   234555555555555554 343 333  555555555


Q ss_pred             ccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcc
Q 002899          159 NSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF  238 (869)
Q Consensus       159 N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~  238 (869)
                      |+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|. |.  +                 
T Consensus       130 N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~-----------------  180 (571)
T 3cvr_A          130 NQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--E-----------------  180 (571)
T ss_dssp             SCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--T-----------------
T ss_pred             CcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--C-----------------
Confidence            55553 333   34555555555555553 332   34455555555555553 222 22  3                 


Q ss_pred             cccccccceEEEcccccCccCCCcccCCCCCc-------CEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchh
Q 002899          239 PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKL-------KNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY  311 (869)
Q Consensus       239 ~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  311 (869)
                            +|+.|+|++|+|+ .+|. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..
T Consensus       181 ------~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~  249 (571)
T 3cvr_A          181 ------SLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRES  249 (571)
T ss_dssp             ------TCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHH
T ss_pred             ------CCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHH
Confidence                  5555555566655 3333 332  45       77788887777 46666667777888888888887777776


Q ss_pred             hhccC---------CceeeeccCccCCCCCCCCCCCCCccceecc
Q 002899          312 IFNSN---------KNVDISLNNFTWESSDPIECPRGSVNLVESY  347 (869)
Q Consensus       312 ~~~~l---------~~l~ls~N~~~~~~~~p~~C~c~~~~~~~~l  347 (869)
                      +....         -.++++.|.+... .+| .|+|...|+..+.
T Consensus       250 l~~l~~~~~~~~~~~~~~l~~~~~~~~-~~p-~~~~~~~Wl~~~~  292 (571)
T 3cvr_A          250 LSQQTAQPDYHGPRIYFSMSDGQQNTL-HRP-LADAVTAWFPENK  292 (571)
T ss_dssp             HHHHHHSCC---CEEECCC-----------C-CSHHHHTTCC---
T ss_pred             HHHhhcCccccCCeeEEeecccccccc-ccc-chhhHHHHhhhhc
Confidence            62210         1234445544333 234 8999988876643

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.84  E-value=6.7e-21  Score=194.32  Aligned_cols=180  Identities=21%  Similarity=0.232  Sum_probs=93.6

Q ss_pred             EEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccccccc
Q 002899           57 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN  135 (869)
Q Consensus        57 ~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  135 (869)
                      +.+++++++++ .+|..+  .++|++|+|++|++++.++..|..+ +|++|+|++|+++++.+..|..+++|++|+|++|
T Consensus        10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n   86 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN   86 (208)
T ss_dssp             TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence            35667777777 455444  3577788887777775555444444 4555555555555444444444555555555555


Q ss_pred             ccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchH
Q 002899          136 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA  215 (869)
Q Consensus       136 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  215 (869)
                      +|++..+..                        |.++++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+.
T Consensus        87 ~l~~~~~~~------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  142 (208)
T 2o6s_A           87 QLQSLPNGV------------------------FDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDG  142 (208)
T ss_dssp             CCCCCCTTT------------------------TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred             cCCccCHhH------------------------hcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHH
Confidence            554333333                        44444555555555555444444444555555555555555544444


Q ss_pred             hhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCC
Q 002899          216 SISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTK  269 (869)
Q Consensus       216 ~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~  269 (869)
                      .+..+++|+.|+|++|.+...      ..+|+.|+++.|+++|.+|..++.++.
T Consensus       143 ~~~~l~~L~~L~l~~N~~~~~------~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          143 VFDRLTSLQYIWLHDNPWDCT------CPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             TTTTCTTCCEEECCSCCBCCC------TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             HhccCCCccEEEecCCCeecC------CCCHHHHHHHHHhCCceeeccCccccC
Confidence            445555555555544432211      013455555566666666665555443

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A*

Probab=99.83  E-value=4.4e-21  Score=188.85  Aligned_cols=158  Identities=22%  Similarity=0.297  Sum_probs=120.8

Q ss_pred             eeeeecCCccee-cCCceeccCccCc--ccccccccCcceeeeeccccccCCCCcccceecccccccccccchhhhhhhc
Q 002899          377 TLHINCGGAKIN-TGHTKYEADMEAR--GASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTA  453 (869)
Q Consensus       377 ~~~~~c~~~~~~-~~~~~~~~d~~~~--~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (869)
                      .+.++|||+..+ ....++++|..-.  |.+..+.+.          .                ......+.+++||+||
T Consensus         7 ~~~INcGg~~~~d~~gr~w~~D~~~~~~g~~~~~~~~----------~----------------~~~~~~~~~~~lY~Ta   60 (174)
T 2jwp_A            7 IWAVNAGGESHVDVHGIHYRKDPLEGRVGRASDYGMK----------L----------------PILRSNPEDQVLYQTE   60 (174)
T ss_dssp             EEEEEETSSSEEETTTEEECSSCSSTTCCCCCCCCTT----------S----------------CCSSSCHHHHHTTTCC
T ss_pred             EEEEECCCCCccCCCCCEEcCCcCcccCCcccccccc----------e----------------EecccCCCCchhhhhh
Confidence            467899998865 4567788875421  211100000          0                0011356788999999


Q ss_pred             ccccccceeeeeeccCceEEEEEEeEEEEecCCCcccccCceeeEEEecceecccccchhhhcCCCCcceEEeeceeecc
Q 002899          454 RVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTS  533 (869)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (869)
                      |+.|.+++|+..|..+|.|.|+||||||.++      ++|+|+|||||||+.++++|||.+++++ ..++.+.+...+++
T Consensus        61 R~~~~~~tY~f~v~~~G~Y~VrLhF~ei~~~------~~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~~~~~~~~~v~~  133 (174)
T 2jwp_A           61 RYNEDSFGYDIPIKEEGEYVLVLKFAEVYFA------QSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKK  133 (174)
T ss_dssp             CCCCSCEEEEEECCSCEEEEEEEEEECCSCC------CSSSSCEEEEETTEEEEEEECHHHHHSS-SSCEEEEEEEEEET
T ss_pred             ccCCCCeEEEEEeCCCeEEEEEEEEeccccC------CCCCeEeEEEECCEEeecCcCHHHhhCC-CeeEEEEEEEEEec
Confidence            9999999999999999999999999999765      3799999999999999999999999987 78999999999999


Q ss_pred             ceeEEEEEEc-CCCccccCCC--CCCCCccccccccc
Q 002899          534 HTLKIHLYWA-GRGTTGIPLR--GTYGPLISAISVKS  567 (869)
Q Consensus       534 ~~~~~~~~~~-g~~~~~~p~~--~~~~pl~s~~~~~~  567 (869)
                      ++|+||..|+ ++|+..+...  ..+.|.++++-+.+
T Consensus       134 ~~l~i~~~~~~~~g~L~I~f~p~~~~~a~inaIEI~~  170 (174)
T 2jwp_A          134 GKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMK  170 (174)
T ss_dssp             TEEEETTEEEECCSEEEEEEECSSSCSSSEEEEEEES
T ss_pred             CceeeeeeecccCCeEEEEEeccCCCCcEEEEEEEEe
Confidence            9999998886 5666554432  25678888776543

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.83  E-value=3.6e-22  Score=219.49  Aligned_cols=233  Identities=19%  Similarity=0.226  Sum_probs=189.6

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCC-Cchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS-FSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~-~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      .+++.|++++|.+++..+. +..+++|++|+|++|.+++. .+..+..+ +|++|+|++|.+++..+..++.+++|++|+
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~  148 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN  148 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence            4689999999999977665 66899999999999999865 67777777 899999999999988889999999999999


Q ss_pred             cccc-ccCCC-CCccccCCCCccEEEeecc-ccccc-CCccccCCC-CCCeEeccCC--cCC-CCCccccCCCCcccEEE
Q 002899          132 IEGN-LFTGS-IPPDIRKLINLQKLILSSN-SFTGE-LPAELTKLT-NLNDLRISDN--NFS-GKIPEFIGKWKKIQKLH  203 (869)
Q Consensus       132 Ls~N-~l~~~-~~~~~~~l~~L~~L~Ls~N-~i~~~-~p~~~~~l~-~L~~L~Ls~N--~l~-~~~~~~~~~l~~L~~L~  203 (869)
                      |++| .+++. ++..+..+++|++|+|++| .+++. ++..+..++ +|++|+|++|  .++ +.++..+..+++|+.|+
T Consensus       149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~  228 (336)
T 2ast_B          149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD  228 (336)
T ss_dssp             CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred             CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence            9999 67753 5666888999999999999 99864 577788899 9999999999  555 45677888999999999


Q ss_pred             ccCCc-CCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCC
Q 002899          204 IQGSS-LEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG  282 (869)
Q Consensus       204 L~~N~-l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~  282 (869)
                      |++|. +++..+..+..+++|+.|+|++|.                      .+.......+..+++|+.|+|++| ++.
T Consensus       229 l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~----------------------~~~~~~~~~l~~~~~L~~L~l~~~-i~~  285 (336)
T 2ast_B          229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCY----------------------DIIPETLLELGEIPTLKTLQVFGI-VPD  285 (336)
T ss_dssp             CTTCTTCCGGGGGGGGGCTTCCEEECTTCT----------------------TCCGGGGGGGGGCTTCCEEECTTS-SCT
T ss_pred             CCCCCcCCHHHHHHHhCCCCCCEeeCCCCC----------------------CCCHHHHHHHhcCCCCCEEeccCc-cCH
Confidence            99999 777778899999999988888664                      111111224667899999999999 543


Q ss_pred             CCchhhhcC-CCCCEEEeeCCcCCCCCchhhh
Q 002899          283 GIPTTFEKL-AKTNFMYLTGNKLTGPVPKYIF  313 (869)
Q Consensus       283 ~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~  313 (869)
                      ..   +..+ .+|..|++++|++++..|..+.
T Consensus       286 ~~---~~~l~~~l~~L~l~~n~l~~~~~~~~~  314 (336)
T 2ast_B          286 GT---LQLLKEALPHLQINCSHFTTIARPTIG  314 (336)
T ss_dssp             TC---HHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred             HH---HHHHHhhCcceEEecccCccccCCccc
Confidence            33   3333 2366677999999998887663

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.83  E-value=1.2e-20  Score=192.55  Aligned_cols=176  Identities=19%  Similarity=0.198  Sum_probs=136.6

Q ss_pred             eEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCC
Q 002899          104 VELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN  183 (869)
Q Consensus       104 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N  183 (869)
                      +.++++++.++.+ |..+  .++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus        10 ~~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n   86 (208)
T 2o6s_A           10 TTVECYSQGRTSV-PTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN   86 (208)
T ss_dssp             TEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCccCC-CCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence            3455666666533 3222  358889999999998776667889999999999999999776777889999999999999


Q ss_pred             cCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcc
Q 002899          184 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDY  263 (869)
Q Consensus       184 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~  263 (869)
                      ++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.                       |++..+..
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~-----------------------l~~~~~~~  143 (208)
T 2o6s_A           87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQ-----------------------LKSVPDGV  143 (208)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC-----------------------CSCCCTTT
T ss_pred             cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCc-----------------------cceeCHHH
Confidence            9998888889999999999999999998888889999988888777554                       44445555


Q ss_pred             cCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh
Q 002899          264 IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI  312 (869)
Q Consensus       264 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  312 (869)
                      |..+++|+.|+|++|.+.+       .+++|+.|+++.|+++|.+|..+
T Consensus       144 ~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~  185 (208)
T 2o6s_A          144 FDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSA  185 (208)
T ss_dssp             TTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTT
T ss_pred             hccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccC
Confidence            6667777777777776663       33466777777777777777655

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.83  E-value=2.3e-20  Score=193.41  Aligned_cols=167  Identities=23%  Similarity=0.300  Sum_probs=104.4

Q ss_pred             cccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccC
Q 002899          127 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQG  206 (869)
Q Consensus       127 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  206 (869)
                      .+.++++++.++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|+.|+|++
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            344555555555 3443332  4566666666666655555566666666666666666554445556666666666666


Q ss_pred             CcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCch
Q 002899          207 SSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT  286 (869)
Q Consensus       207 N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  286 (869)
                      |+|++..+..|..+++|+.|+|+                       +|+|+ .+|..+..+++|+.|+|++|+|++..+.
T Consensus        98 N~l~~l~~~~~~~l~~L~~L~Ls-----------------------~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~  153 (229)
T 3e6j_A           98 NQLTVLPSAVFDRLVHLKELFMC-----------------------CNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHG  153 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECC-----------------------SSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTT
T ss_pred             CcCCccChhHhCcchhhCeEecc-----------------------CCccc-ccCcccccCCCCCEEECCCCcCCccCHH
Confidence            66665555555555555555444                       33343 3455566777888888888888876667


Q ss_pred             hhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCCCCCCCCCCCC-CccceeccCCC
Q 002899          287 TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRG-SVNLVESYSSP  350 (869)
Q Consensus       287 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~~C~c~-~~~~~~~l~~~  350 (869)
                      .|..+++|+.|+|++|                              ||.|+|. +.++..|+...
T Consensus       154 ~~~~l~~L~~L~l~~N------------------------------~~~c~c~~~~~l~~~~~~~  188 (229)
T 3e6j_A          154 AFDRLSSLTHAYLFGN------------------------------PWDCECRDIMYLRNWVADH  188 (229)
T ss_dssp             TTTTCTTCCEEECTTS------------------------------CBCTTBGGGHHHHHHHHHC
T ss_pred             HHhCCCCCCEEEeeCC------------------------------CccCCcchhHHHHHHHHhC
Confidence            7777888888887777                              7889996 77888887653

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.81  E-value=8.3e-20  Score=213.12  Aligned_cols=219  Identities=23%  Similarity=0.332  Sum_probs=169.4

Q ss_pred             CCCCCCCCCCCCC-CccccCCCCCCCCcce-EecCCCCcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCC
Q 002899           17 DWNFGVDPCSQKG-NWELSSDDKKGFESNV-TCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSF   94 (869)
Q Consensus        17 ~W~~~~d~C~~~g-~w~~~~~~~~~~~~~v-~C~~~~~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~   94 (869)
                      +|....++|.... .|.           ++ .|.|.    +++.|+|++|+|++ +|..+.  ++|+.|+|++|.|+.++
T Consensus        35 ~W~~~~~~~~~~~~~~~-----------~l~~C~~~----~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~ip   96 (571)
T 3cvr_A           35 KWEKQALPGENRNEAVS-----------LLKECLIN----QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALISLP   96 (571)
T ss_dssp             HHHTTCCTTCCHHHHHH-----------HHHHHHHT----TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSCCC
T ss_pred             HHhccCCccccccchhh-----------hccccccC----CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcccc
Confidence            4766677774211 122           45 67653    69999999999997 777663  89999999999999654


Q ss_pred             chhhccccceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCC
Q 002899           95 SPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN  174 (869)
Q Consensus        95 ~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~  174 (869)
                       .  ...+|+.|+|++|+|++ +|. +..  +|++|+|++|+|++ +|.   .+++|++|+|++|+|++ +|.   .+++
T Consensus        97 -~--~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~  161 (571)
T 3cvr_A           97 -E--LPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTS  161 (571)
T ss_dssp             -C--CCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTT
T ss_pred             -c--ccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCC
Confidence             1  12389999999999997 555 665  99999999999996 665   68999999999999996 665   5789


Q ss_pred             CCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccc
Q 002899          175 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKC  254 (869)
Q Consensus       175 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N  254 (869)
                      |++|+|++|+|++ +|. |.  ++|+.|+|++|+|+ .+|. +..  +|.                .....|+.|+|++|
T Consensus       162 L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~----------------~~~~~L~~L~Ls~N  217 (571)
T 3cvr_A          162 LEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNH----------------HSEETEIFFRCREN  217 (571)
T ss_dssp             CCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC--------------------------CCEEEECCSS
T ss_pred             cCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhh----------------cccccceEEecCCC
Confidence            9999999999997 666 66  99999999999999 4444 332  220                00113577888888


Q ss_pred             cCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCC
Q 002899          255 LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK  293 (869)
Q Consensus       255 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  293 (869)
                      +|+ .+|..+..+++|+.|+|++|+|++.+|..+..+..
T Consensus       218 ~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          218 RIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             CCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             cce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence            888 46777777999999999999999999998887644

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.81  E-value=4.1e-20  Score=205.32  Aligned_cols=175  Identities=21%  Similarity=0.211  Sum_probs=147.1

Q ss_pred             EEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhc-cc-cceEEEeecccCCCCCchhhcCccccccccccc
Q 002899           57 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWA-SL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG  134 (869)
Q Consensus        57 ~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~-~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  134 (869)
                      ..+++++++|+ .+|..+.  +.|+.|+|++|+|+++.+..|. .+ +|+.|+|++|+|+++.+..|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            47899999999 5777665  4689999999999998888886 55 899999999999988888899999999999999


Q ss_pred             cccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCcccc---CCCCcccEEEccCCcCCC
Q 002899          135 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI---GKWKKIQKLHIQGSSLEG  211 (869)
Q Consensus       135 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~  211 (869)
                      |+|+...+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|   ..+++|+.|+|++|+|+.
T Consensus        98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            99997777788999999999999999998888889999999999999999997666666   568899999999999998


Q ss_pred             CchHhhhcCCCC--CEEEcCCCCCC
Q 002899          212 PIPASISALTSL--TDLRISDLKGS  234 (869)
Q Consensus       212 ~~~~~l~~l~~L--~~L~L~~n~~~  234 (869)
                      ..+..+..++.+  +.|+|++|++.
T Consensus       178 l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          178 LPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             cCHHHhhhccHhhcceEEecCCCcc
Confidence            777888888763  66666666543

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.80  E-value=7.4e-20  Score=188.37  Aligned_cols=151  Identities=21%  Similarity=0.314  Sum_probs=103.0

Q ss_pred             EEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccccccc
Q 002899           57 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN  135 (869)
Q Consensus        57 ~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  135 (869)
                      ..+++++++++ .+|..+.  ++|+.|+|++|+|+++.+..|..+ +|+.|+|++|+++++.|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            46888899988 5676654  678888888888887766666665 6777777777776666666666666777777776


Q ss_pred             ccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCC
Q 002899          136 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE  210 (869)
Q Consensus       136 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  210 (869)
                      +|+...+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            666544445566666666666666666665666666666666666666666555555666666666666666654

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.80  E-value=7.4e-20  Score=184.25  Aligned_cols=162  Identities=17%  Similarity=0.273  Sum_probs=103.8

Q ss_pred             EEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCC
Q 002899          153 KLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK  232 (869)
Q Consensus       153 ~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~  232 (869)
                      .+++++|+++ .+|..+.  ++|++|+|++|+|+ .+|..|.++++|+.|+|++|.|++..+..|.++++|+.|+|+   
T Consensus        14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls---   86 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILS---   86 (193)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC---
T ss_pred             EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECC---
Confidence            4455555554 3343332  35555555555555 344555555555555555555555555555555544444443   


Q ss_pred             CCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh
Q 002899          233 GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI  312 (869)
Q Consensus       233 ~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  312 (869)
                                          +|+|++..|..|..+++|+.|+|++|+|+...+..|..+++|+.|+|++|          
T Consensus        87 --------------------~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N----------  136 (193)
T 2wfh_A           87 --------------------YNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN----------  136 (193)
T ss_dssp             --------------------SSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSS----------
T ss_pred             --------------------CCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCC----------
Confidence                                45555556667778888888888888888766667888888888888887          


Q ss_pred             hccCCceeeeccCccCCCCCCCCCCCCCccceeccCCCCCCCCCCcCccCCCCCCCCCcccccceee
Q 002899          313 FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLH  379 (869)
Q Consensus       313 ~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~~~~~l~~~~~~~~~~~~~~~~~~~C~~p~~~~~~~~~  379 (869)
                                          ||.|||++.|+..|+......        .....|+.|+.++|+.+.
T Consensus       137 --------------------~~~C~c~l~~l~~~~~~~~~~--------~~~~~C~~P~~l~g~~l~  175 (193)
T 2wfh_A          137 --------------------PLYCDCNMQWLSDWVKSEYKE--------PGIARCAGPGEMADKLLL  175 (193)
T ss_dssp             --------------------CEECSGGGHHHHHHHHHSSCC--------CSCCBEEESGGGTTCBTT
T ss_pred             --------------------CeecCCcCHHHHHHHHhccCC--------CCCcCcCCchHHCCCCcc
Confidence                                888999999999998653211        134578888888776543

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.80  E-value=1.5e-19  Score=186.09  Aligned_cols=152  Identities=18%  Similarity=0.260  Sum_probs=111.3

Q ss_pred             EEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCc-hhhccc-cceEEEeecccCCCCCchhhcCccccccccccc
Q 002899           57 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFS-PQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG  134 (869)
Q Consensus        57 ~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~-~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  134 (869)
                      +.+++++|+++ .+|..+.  +.+++|+|++|+|++..+ ..|..+ +|+.|+|++|+|+++.+..|.++++|++|+|++
T Consensus        14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            37899999998 4676664  356889999998887744 445555 677777777777776666777777777777777


Q ss_pred             cccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCC
Q 002899          135 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG  211 (869)
Q Consensus       135 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  211 (869)
                      |+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|.+..
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence            77776666667777777777777777776667777777777777777777776667777777777777777777664

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.79  E-value=1.1e-19  Score=183.01  Aligned_cols=164  Identities=18%  Similarity=0.324  Sum_probs=109.0

Q ss_pred             cEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCcc-ccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCC
Q 002899          152 QKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE-FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD  230 (869)
Q Consensus       152 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~  230 (869)
                      ++|++++|+++ .+|..+.  .+|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|+.|+|+ 
T Consensus        11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls-   86 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG-   86 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC-
T ss_pred             CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC-
Confidence            44555555554 3444332  2555666666665544443 35556666666666666665555566665555555444 


Q ss_pred             CCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCch
Q 002899          231 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK  310 (869)
Q Consensus       231 n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  310 (869)
                                            +|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|        
T Consensus        87 ----------------------~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N--------  136 (192)
T 1w8a_A           87 ----------------------ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN--------  136 (192)
T ss_dssp             ----------------------SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTC--------
T ss_pred             ----------------------CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCC--------
Confidence                                  45555566667788888999999999998888888888889998888888        


Q ss_pred             hhhccCCceeeeccCccCCCCCCCCCCCCCccceeccCCCCCCCCCCcCccCCCCCCCCCcccccceee
Q 002899          311 YIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLH  379 (869)
Q Consensus       311 ~~~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~~~~~l~~~~~~~~~~~~~~~~~~~C~~p~~~~~~~~~  379 (869)
                                            ||.|+|++.|+..|+.......        ....|+.|...++..+.
T Consensus       137 ----------------------~l~c~c~l~~~~~~l~~~~~~~--------~~~~C~~P~~l~~~~l~  175 (192)
T 1w8a_A          137 ----------------------PFNCNCHLAWFAEWLRKKSLNG--------GAARCGAPSKVRDVQIK  175 (192)
T ss_dssp             ----------------------CBCCSGGGHHHHHHHHHHCCSG--------GGCBBCSSTTTTTSBGG
T ss_pred             ----------------------CccCcCcchHHHHHHHHcCCCC--------CCCCCCCChHHcCCChh
Confidence                                  7779999999999986532211        24578898888776544

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.79  E-value=2e-19  Score=193.45  Aligned_cols=172  Identities=22%  Similarity=0.313  Sum_probs=104.3

Q ss_pred             cCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccE
Q 002899          122 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK  201 (869)
Q Consensus       122 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  201 (869)
                      ..+++|+.|++++|.++.. + .+..+++|++|+|++|++++..+  +.++++|++|+|++|++++ + ..+..+++|+.
T Consensus        43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~  116 (291)
T 1h6t_A           43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-L-SSLKDLKKLKS  116 (291)
T ss_dssp             HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-G-GGGTTCTTCCE
T ss_pred             hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-C-hhhccCCCCCE
Confidence            4455566666666655532 2 35555666666666666654332  5556666666666666653 2 22556666666


Q ss_pred             EEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCC
Q 002899          202 LHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT  281 (869)
Q Consensus       202 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~  281 (869)
                      |+|++|++++.  ..+..+++|+.|+|++|.++.. .......+|+.|+|++|+|++..+  +..+++|+.|+|++|+|+
T Consensus       117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~  191 (291)
T 1h6t_A          117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS  191 (291)
T ss_dssp             EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence            66666666543  3455566666666666555544 111122256666666777776554  778888888888888888


Q ss_pred             CCCchhhhcCCCCCEEEeeCCcCCC
Q 002899          282 GGIPTTFEKLAKTNFMYLTGNKLTG  306 (869)
Q Consensus       282 ~~~p~~~~~l~~L~~L~Ls~N~l~~  306 (869)
                      + ++ .+..+++|+.|+|++|+++.
T Consensus       192 ~-l~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          192 D-LR-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             B-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred             C-Ch-hhccCCCCCEEECcCCcccC
Confidence            5 34 37888888888888888764

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.78  E-value=2.2e-19  Score=211.74  Aligned_cols=190  Identities=20%  Similarity=0.287  Sum_probs=133.5

Q ss_pred             ceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccC
Q 002899          103 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD  182 (869)
Q Consensus       103 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~  182 (869)
                      +..+.|..+.+....+  +..|++|+.|+|++|.|.. ++ .+..+++|+.|+|++|+|++..+  +..+++|+.|+|++
T Consensus        23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~   96 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE   96 (605)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred             HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence            4444555555554332  4566777777777777763 33 46777777777777777775443  67777777777777


Q ss_pred             CcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCc
Q 002899          183 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPD  262 (869)
Q Consensus       183 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~  262 (869)
                      |+|++ + ..|..+++|+.|+|++|.|.+.  ..+..+++|+.|+|++|.++.. .......+|+.|+|++|+|++..| 
T Consensus        97 N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~-  170 (605)
T 1m9s_A           97 NKIKD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-  170 (605)
T ss_dssp             SCCCC-C-TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG-
T ss_pred             CCCCC-C-hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh-
Confidence            77764 2 2567777777777777777753  3477777777777777777665 222233368888888888887766 


Q ss_pred             ccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCC
Q 002899          263 YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP  307 (869)
Q Consensus       263 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  307 (869)
                       +..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|++++.
T Consensus       171 -l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          171 -LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK  212 (605)
T ss_dssp             -GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred             -hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence             88899999999999999864  3588899999999999998854

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.78  E-value=4.2e-19  Score=209.38  Aligned_cols=167  Identities=22%  Similarity=0.355  Sum_probs=118.6

Q ss_pred             eEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccccc
Q 002899           55 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE  133 (869)
Q Consensus        55 ~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  133 (869)
                      .+..+.|..+.++..++  +..|++|+.|+|++|.|..+.  .+..+ +|+.|+|++|+|++..+  +..+++|+.|+|+
T Consensus        22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls   95 (605)
T 1m9s_A           22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD   95 (605)
T ss_dssp             HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred             HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence            34556666677765544  567778888888888887653  34545 78888888888876554  7778888888888


Q ss_pred             ccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCc
Q 002899          134 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI  213 (869)
Q Consensus       134 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  213 (869)
                      +|.|++ ++ .+..+++|++|+|++|+|++.  ..+..+++|+.|+|++|+|++.  ..|..+++|+.|+|++|.|.+..
T Consensus        96 ~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~  169 (605)
T 1m9s_A           96 ENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV  169 (605)
T ss_dssp             SSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCG
T ss_pred             CCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCch
Confidence            888774 33 677777888888888887742  3577777888888888887754  56777777888888888777665


Q ss_pred             hHhhhcCCCCCEEEcCCCCCCC
Q 002899          214 PASISALTSLTDLRISDLKGSE  235 (869)
Q Consensus       214 ~~~l~~l~~L~~L~L~~n~~~~  235 (869)
                      |  +..+++|+.|+|++|.++.
T Consensus       170 ~--l~~l~~L~~L~Ls~N~i~~  189 (605)
T 1m9s_A          170 P--LAGLTKLQNLYLSKNHISD  189 (605)
T ss_dssp             G--GTTCTTCCEEECCSSCCCB
T ss_pred             h--hccCCCCCEEECcCCCCCC
Confidence            5  7777777777776665544

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.78  E-value=3.2e-20  Score=224.28  Aligned_cols=261  Identities=21%  Similarity=0.208  Sum_probs=103.8

Q ss_pred             cHHHHHHHHHHhCCCCCCCCCCCCCCCCCccccCCCCCCCCcceEecCCCCcceEEEEeccCCCccccCCccccCCCCCC
Q 002899            2 PKKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLK   81 (869)
Q Consensus         2 ~~~~l~~~~~~l~~~~W~~~~d~C~~~g~w~~~~~~~~~~~~~v~C~~~~~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~   81 (869)
                      ++++|.++...+....|....       .|...+.+. ..+.++.+    ..++++.|+|.++++.. ++..     .|+
T Consensus       133 ~~~~l~~~~~~~~~~~~~~~~-------~~~~~~~~~-~~~~~~~~----s~~~~~~l~L~~n~~~~-~~~~-----~l~  194 (727)
T 4b8c_D          133 TKQALMEMADTLTDSKTAKKQ-------QPTGDSTPS-GTATNSAV----STPLTPKIELFANGKDE-ANQA-----LLQ  194 (727)
T ss_dssp             CCHHHHHHHHHHHHHHTTC-------------------------------------------------------------
T ss_pred             chhhhhhhhhhcccccCcccC-------CCcCCCCcc-ccCCCcee----cCCccceEEeeCCCCCc-chhh-----Hhh
Confidence            578999999888776664321       122111111 11222333    24679999999999885 3333     355


Q ss_pred             EEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccc
Q 002899           82 QLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSF  161 (869)
Q Consensus        82 ~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i  161 (869)
                      .++|+.|.|.             .++++.|++. ..++.+..++.|+.|+|++|.|. .+|..+..+++|++|+|++|+|
T Consensus       195 ~l~Ls~~~i~-------------~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l  259 (727)
T 4b8c_D          195 HKKLSQYSID-------------EDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSL  259 (727)
T ss_dssp             -----------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCC
T ss_pred             cCccCccccc-------------Ccccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcC
Confidence            6667766655             3345555555 55666666677777777777666 5555556666777777777776


Q ss_pred             cccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCccccc
Q 002899          162 TGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL  241 (869)
Q Consensus       162 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~  241 (869)
                      + .+|..|.+|++|++|+|++|+|+ .+|..|+.+++|++|+|++|.|+ .+|..|.++++|+.|+|++|.++......+
T Consensus       260 ~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~  336 (727)
T 4b8c_D          260 T-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKIL  336 (727)
T ss_dssp             S-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHH
T ss_pred             c-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHH
Confidence            6 66666666777777777777766 55666666777777777777665 445556666666666666666655444333


Q ss_pred             ccc--cceEEEcccccCccCCCcccCCCCCcCEEeccCC--------CCCCCCchhhhcCCCCCEEEeeCCcC
Q 002899          242 DKM--NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN--------NLTGGIPTTFEKLAKTNFMYLTGNKL  304 (869)
Q Consensus       242 ~~~--~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N--------~l~~~~p~~~~~l~~L~~L~Ls~N~l  304 (869)
                      ...  .+..|+|++|.+++.+|..      |+.|+++.|        .|.+..+..+..+.++....++.|-+
T Consensus       337 ~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil  403 (727)
T 4b8c_D          337 TEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTL  403 (727)
T ss_dssp             HHHHHHHHHHHHHHCCCCCCCCCC-----------------------------------------------CC
T ss_pred             hhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccceeeeecccc
Confidence            322  2234567788887766643      455666666        33333333444444555555555544

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.77  E-value=1.8e-20  Score=222.32  Aligned_cols=187  Identities=13%  Similarity=0.073  Sum_probs=107.9

Q ss_pred             ccccCCCCccEEEeecccccccCC-ccccCCCCCCeEeccC-----------------------------------CcCC
Q 002899          143 PDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDLRISD-----------------------------------NNFS  186 (869)
Q Consensus       143 ~~~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~Ls~-----------------------------------N~l~  186 (869)
                      ..+..+++|++|+|++|.+++... ..+..+++|++|+|++                                   |.++
T Consensus       287 ~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~  366 (592)
T 3ogk_B          287 ILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVS  366 (592)
T ss_dssp             GGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCC
T ss_pred             HHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccC
Confidence            344556678888888777654322 2234555555555542                                   3333


Q ss_pred             CCC-ccccCCCCcccEEEccCCcCCCCchHhhhc-CCCCCEEEcC----CCCCCCCccc------ccccccceEEEcccc
Q 002899          187 GKI-PEFIGKWKKIQKLHIQGSSLEGPIPASISA-LTSLTDLRIS----DLKGSESAFP------KLDKMNLKTLILTKC  254 (869)
Q Consensus       187 ~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~-l~~L~~L~L~----~n~~~~~~~~------~~~~~~L~~L~Ls~N  254 (869)
                      +.. +..+..+++|+.|+++.|.+++..+..+.. +++|+.|+|+    .|.++..+..      .....+|+.|+|+.|
T Consensus       367 ~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~  446 (592)
T 3ogk_B          367 QRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLR  446 (592)
T ss_dssp             HHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECC
T ss_pred             HHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecC
Confidence            211 111233555555555555555544444444 6666666664    4445443211      111236777777643


Q ss_pred             --cCccCCCcccC-CCCCcCEEeccCCCCCC-CCchhhhcCCCCCEEEeeCCcCCCCCchhh---hccCCceeeeccCcc
Q 002899          255 --LIHGEIPDYIG-DMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISLNNFT  327 (869)
Q Consensus       255 --~i~~~~p~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~~l~~l~ls~N~~~  327 (869)
                        .+++..+..+. .+++|+.|+|++|++++ .++..+..+++|+.|+|++|++++.....+   .+.++.|+|++|+++
T Consensus       447 ~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it  526 (592)
T 3ogk_B          447 QGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS  526 (592)
T ss_dssp             GGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCC
T ss_pred             CCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCC
Confidence              35544444443 47888888888888875 344556778888888888888765533333   457888888888776


Q ss_pred             CC
Q 002899          328 WE  329 (869)
Q Consensus       328 ~~  329 (869)
                      ..
T Consensus       527 ~~  528 (592)
T 3ogk_B          527 MT  528 (592)
T ss_dssp             TT
T ss_pred             HH
Confidence            43

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.77  E-value=1.2e-18  Score=187.51  Aligned_cols=193  Identities=16%  Similarity=0.226  Sum_probs=160.9

Q ss_pred             ccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEE
Q 002899          124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLH  203 (869)
Q Consensus       124 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  203 (869)
                      +.++..+.+..+.+++..  .+..+++|++|++++|.+... + .+..+++|++|+|++|++++..+  +..+++|+.|+
T Consensus        23 l~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~   96 (291)
T 1h6t_A           23 FAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF   96 (291)
T ss_dssp             HHHHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             HHHHHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEE
Confidence            455667778888877443  356789999999999999844 4 48889999999999999997655  99999999999


Q ss_pred             ccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCC
Q 002899          204 IQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG  283 (869)
Q Consensus       204 L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~  283 (869)
                      |++|.+++.  ..+..+++|+.|+|++|.++..+ ......+|+.|+|++|+|++.  ..+..+++|+.|+|++|+|++.
T Consensus        97 l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~  171 (291)
T 1h6t_A           97 LDENKVKDL--SSLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI  171 (291)
T ss_dssp             CCSSCCCCG--GGGTTCTTCCEEECTTSCCCCCG-GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC
T ss_pred             CCCCcCCCC--hhhccCCCCCEEECCCCcCCCCh-hhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccc
Confidence            999999863  34999999999999999998863 233344899999999999976  6789999999999999999976


Q ss_pred             CchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCC
Q 002899          284 IPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWE  329 (869)
Q Consensus       284 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~  329 (869)
                      .|  +..+++|+.|+|++|++++..+-.-+..++.|++++|+++..
T Consensus       172 ~~--l~~l~~L~~L~L~~N~i~~l~~l~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          172 VP--LAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             GG--GTTCTTCCEEECCSSCCCBCGGGTTCTTCSEEEEEEEEEECC
T ss_pred             hh--hcCCCccCEEECCCCcCCCChhhccCCCCCEEECcCCcccCC
Confidence            55  999999999999999999643222266889999999977653

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.77  E-value=1.8e-18  Score=179.11  Aligned_cols=151  Identities=22%  Similarity=0.304  Sum_probs=117.1

Q ss_pred             EEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccc
Q 002899           58 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL  136 (869)
Q Consensus        58 ~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  136 (869)
                      .+++++++++ .+|..+.  ++|++|+|++|.|++..+..|..+ +|++|+|++|+|+.+.+..|..+++|++|+|++|+
T Consensus        23 ~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~   99 (229)
T 3e6j_A           23 TVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ   99 (229)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence            4666777887 6666554  889999999999988877777776 78888888888877766777888888888888888


Q ss_pred             cCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCC
Q 002899          137 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP  212 (869)
Q Consensus       137 l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  212 (869)
                      |++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+...
T Consensus       100 l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  174 (229)
T 3e6j_A          100 LTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE  174 (229)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred             CCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence            88666666777888888888888887 6677777778888888888888766666777777777777777777653

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.75  E-value=4.5e-20  Score=216.34  Aligned_cols=189  Identities=18%  Similarity=0.205  Sum_probs=121.8

Q ss_pred             cCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeeccc-------------CCCCCchhhcCcccccccc-ccccccCC
Q 002899           75 SKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNR-------------LSGPFPKVLTNITTLKNLS-IEGNLFTG  139 (869)
Q Consensus        75 ~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~-------------l~~~~~~~~~~l~~L~~L~-Ls~N~l~~  139 (869)
                      ..+++|+.|+|++|.|+ .+|..+..+ +|+.|++++|.             +.+..|..++.+++|+.|+ ++.|.+. 
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-  423 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-  423 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence            45667777777777776 335555555 66666665553             4445566666666666666 5555432 


Q ss_pred             CCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhc
Q 002899          140 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISA  219 (869)
Q Consensus       140 ~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~  219 (869)
                                +|+.+.+++|.|+...+      ..|+.|+|++|+|++ +|. |+.+++|+.|+|++|.|+ .+|..++.
T Consensus       424 ----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~  484 (567)
T 1dce_A          424 ----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA  484 (567)
T ss_dssp             ----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred             ----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence                      45555566666653221      247888888888885 455 888888888888888888 66778888


Q ss_pred             CCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCC-chhhhcCCCCCEEE
Q 002899          220 LTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI-PTTFEKLAKTNFMY  298 (869)
Q Consensus       220 l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~  298 (869)
                      +++|+.|+|++|.++.                        +| .++.+++|+.|+|++|+|++.. |..|..+++|+.|+
T Consensus       485 l~~L~~L~Ls~N~l~~------------------------lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~  539 (567)
T 1dce_A          485 LRCLEVLQASDNALEN------------------------VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN  539 (567)
T ss_dssp             CTTCCEEECCSSCCCC------------------------CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred             CCCCCEEECCCCCCCC------------------------Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence            8877777776554443                        23 4556666666666666666554 66666666666666


Q ss_pred             eeCCcCCCCCc
Q 002899          299 LTGNKLTGPVP  309 (869)
Q Consensus       299 Ls~N~l~~~~p  309 (869)
                      |++|+|++..|
T Consensus       540 L~~N~l~~~~~  550 (567)
T 1dce_A          540 LQGNSLCQEEG  550 (567)
T ss_dssp             CTTSGGGGSSS
T ss_pred             ecCCcCCCCcc
Confidence            66666665544

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=8e-18  Score=169.96  Aligned_cols=154  Identities=18%  Similarity=0.270  Sum_probs=112.6

Q ss_pred             hcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCccc
Q 002899          121 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ  200 (869)
Q Consensus       121 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  200 (869)
                      ...+++|+.|+|++|.++ .+| .+..+++|++|++++|.++.  +..+..+++|++|+|++|++++..+..|..+++|+
T Consensus        40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~  115 (197)
T 4ezg_A           40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT  115 (197)
T ss_dssp             HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred             hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence            356777888888888777 445 57777888888888886652  33677788888888888888776777788888888


Q ss_pred             EEEccCCcCCCCchHhhhcCCCCCEEEcCCCC-CCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCC
Q 002899          201 KLHIQGSSLEGPIPASISALTSLTDLRISDLK-GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN  279 (869)
Q Consensus       201 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~-~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~  279 (869)
                      .|+|++|.+++..+..+..+++|+.|+|++|. +..                        +| .+..+++|+.|+|++|+
T Consensus       116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~------------------------~~-~l~~l~~L~~L~l~~n~  170 (197)
T 4ezg_A          116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD------------------------IM-PLKTLPELKSLNIQFDG  170 (197)
T ss_dssp             EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC------------------------CG-GGGGCSSCCEEECTTBC
T ss_pred             EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc------------------------cH-hhcCCCCCCEEECCCCC
Confidence            88888888887777788888877777776554 322                        22 46677888888888888


Q ss_pred             CCCCCchhhhcCCCCCEEEeeCCcCC
Q 002899          280 LTGGIPTTFEKLAKTNFMYLTGNKLT  305 (869)
Q Consensus       280 l~~~~p~~~~~l~~L~~L~Ls~N~l~  305 (869)
                      +++. + .+..+++|+.|++++|++.
T Consensus       171 i~~~-~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          171 VHDY-R-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             CCCC-T-TGGGCSSCCEEEECBC---
T ss_pred             CcCh-H-HhccCCCCCEEEeeCcccC
Confidence            8853 3 6788888888888888775

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=7.3e-18  Score=177.86  Aligned_cols=136  Identities=17%  Similarity=0.148  Sum_probs=105.4

Q ss_pred             CCCCCeeeccCceEEEEEEE-cCCcE--EEEEEecccCch------------------------hhHHHHHHHHHHHhcC
Q 002899          640 FDPANKVGEGGFGSVYKGIL-SDGTV--IAVKQLSSKSRQ------------------------GNREFVNEIGMISAQQ  692 (869)
Q Consensus       640 f~~~~~IG~G~fG~Vyka~~-~~g~~--VAvK~~~~~~~~------------------------~~~~f~~E~~~l~~l~  692 (869)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|++++.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999998 68888  999987543111                        1135788999999998


Q ss_pred             CCce--eeEEeEEeeCceEEEEEEeccC-C----chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeE
Q 002899          693 HPNL--VKLYGCCVEGNQLLLVYEYMKN-N----CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH-EDSRIKIV  764 (869)
Q Consensus       693 H~nI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ii  764 (869)
                      |+++  ..++++    +..++||||+.+ |    +|.+....        .++..+..++.|++.||.||| +.+   |+
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g---iv  193 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE---LV  193 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence            8764  344432    356899999953 4    55544321        124567889999999999999 887   99


Q ss_pred             EcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          765 HRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       765 H~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      ||||||+|||++.  .++|+|||+|...
T Consensus       194 HrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          194 HADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             eCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999998  9999999999754

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.72  E-value=5.8e-18  Score=179.18  Aligned_cols=168  Identities=21%  Similarity=0.324  Sum_probs=91.8

Q ss_pred             cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEecc
Q 002899          102 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS  181 (869)
Q Consensus       102 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls  181 (869)
                      ++..+++++|.+++..  .+..+++|++|+|++|.|+ .++ .+..+++|++|+|++|+|++..+  +..+++|++|+|+
T Consensus        20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~   93 (263)
T 1xeu_A           20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN   93 (263)
T ss_dssp             HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred             HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence            3444555555555332  3455555555555555555 233 45555555555555555553322  5555555555555


Q ss_pred             CCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCC
Q 002899          182 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP  261 (869)
Q Consensus       182 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p  261 (869)
                      +|++++. +.. .. ++|+.|+|++|++++.  ..+..+++|+.|                       +|++|+|++. +
T Consensus        94 ~N~l~~l-~~~-~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L-----------------------~Ls~N~i~~~-~  144 (263)
T 1xeu_A           94 RNRLKNL-NGI-PS-ACLSRLFLDNNELRDT--DSLIHLKNLEIL-----------------------SIRNNKLKSI-V  144 (263)
T ss_dssp             SSCCSCC-TTC-CC-SSCCEEECCSSCCSBS--GGGTTCTTCCEE-----------------------ECTTSCCCBC-G
T ss_pred             CCccCCc-Ccc-cc-CcccEEEccCCccCCC--hhhcCcccccEE-----------------------ECCCCcCCCC-h
Confidence            5555532 221 11 5555555555555532  124444444444                       4445555543 2


Q ss_pred             cccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCC
Q 002899          262 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP  307 (869)
Q Consensus       262 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  307 (869)
                       .+..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|++++.
T Consensus       145 -~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          145 -MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             -GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             -HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence             466777788888888887755  5577777788888888877643

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.72  E-value=5.4e-19  Score=209.63  Aligned_cols=175  Identities=10%  Similarity=0.132  Sum_probs=129.6

Q ss_pred             cCCCCccEEEee-----------cccccccCC-ccccCCCCCCeEeccCCcCCCCCccccCC-CCcccEEEcc----CCc
Q 002899          146 RKLINLQKLILS-----------SNSFTGELP-AELTKLTNLNDLRISDNNFSGKIPEFIGK-WKKIQKLHIQ----GSS  208 (869)
Q Consensus       146 ~~l~~L~~L~Ls-----------~N~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~----~N~  208 (869)
                      ..+++|++|+|+           .|.+++... ..+..+++|++|+++.|++++..+..+.. +++|+.|+|+    .|.
T Consensus       339 ~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~  418 (592)
T 3ogk_B          339 QYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREER  418 (592)
T ss_dssp             HHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSC
T ss_pred             HhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCcc
Confidence            345667777777           355553322 22356899999999999999877777766 8999999996    788


Q ss_pred             CCCC-----chHhhhcCCCCCEEEcCCCC--CCCCcccccc--cccceEEEcccccCccC-CCcccCCCCCcCEEeccCC
Q 002899          209 LEGP-----IPASISALTSLTDLRISDLK--GSESAFPKLD--KMNLKTLILTKCLIHGE-IPDYIGDMTKLKNIDLSFN  278 (869)
Q Consensus       209 l~~~-----~~~~l~~l~~L~~L~L~~n~--~~~~~~~~~~--~~~L~~L~Ls~N~i~~~-~p~~~~~l~~L~~L~Ls~N  278 (869)
                      +++.     ++..+.++++|+.|+|+.+.  ++...+..+.  ..+|+.|+|++|++++. ++..+..+++|+.|+|++|
T Consensus       419 l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n  498 (592)
T 3ogk_B          419 ITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGC  498 (592)
T ss_dssp             CSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESC
T ss_pred             ccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCC
Confidence            8864     55668889999999998644  4444333332  34799999999999863 4556688999999999999


Q ss_pred             CCCCC-CchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCcee
Q 002899          279 NLTGG-IPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVD  320 (869)
Q Consensus       279 ~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~  320 (869)
                      .+++. ++..+..+++|++|+|++|++++.....+...+..+.
T Consensus       499 ~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~  541 (592)
T 3ogk_B          499 CFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWN  541 (592)
T ss_dssp             CCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEE
T ss_pred             CCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcE
Confidence            98754 3444568999999999999999775555544444433

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.72  E-value=6.8e-20  Score=214.82  Aligned_cols=105  Identities=13%  Similarity=0.137  Sum_probs=82.8

Q ss_pred             CCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCC
Q 002899          223 LTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN  302 (869)
Q Consensus       223 L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  302 (869)
                      |+.|+|++|.++..+. .....+|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++ +| .+..+++|+.|+|++|
T Consensus       443 L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N  518 (567)
T 1dce_A          443 VRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN  518 (567)
T ss_dssp             CSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             ceEEEecCCCCCCCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCC
Confidence            5555555555554332 222235666667788888 678899999999999999999996 67 8999999999999999


Q ss_pred             cCCCCC-chhh--hccCCceeeeccCccCCCC
Q 002899          303 KLTGPV-PKYI--FNSNKNVDISLNNFTWESS  331 (869)
Q Consensus       303 ~l~~~~-p~~~--~~~l~~l~ls~N~~~~~~~  331 (869)
                      +|++.. |..+  +..|+.|+|++|+++..++
T Consensus       519 ~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          519 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             CCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            999887 8887  5689999999999987654

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.71  E-value=4.7e-17  Score=164.27  Aligned_cols=149  Identities=20%  Similarity=0.216  Sum_probs=105.2

Q ss_pred             cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEecc
Q 002899          102 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS  181 (869)
Q Consensus       102 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls  181 (869)
                      +|+.|+|++|.++ .+| .+..+++|++|+|++|.++  .+..+..+++|++|+|++|++++..+..+..+++|++|+|+
T Consensus        45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls  120 (197)
T 4ezg_A           45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS  120 (197)
T ss_dssp             TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred             CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence            5667777777776 333 4777788888888888665  23467778888888888888887677778888888888888


Q ss_pred             CCcCCCCCccccCCCCcccEEEccCCc-CCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCC
Q 002899          182 DNNFSGKIPEFIGKWKKIQKLHIQGSS-LEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEI  260 (869)
Q Consensus       182 ~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~  260 (869)
                      +|++++..+..|..+++|++|+|++|. ++ .++ .+..+++|+.|++++|.++..                        
T Consensus       121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~------------------------  174 (197)
T 4ezg_A          121 HSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY------------------------  174 (197)
T ss_dssp             SSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC------------------------
T ss_pred             CCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh------------------------
Confidence            888887777778888888888888887 55 344 577777777777665544331                        


Q ss_pred             CcccCCCCCcCEEeccCCCCC
Q 002899          261 PDYIGDMTKLKNIDLSFNNLT  281 (869)
Q Consensus       261 p~~~~~l~~L~~L~Ls~N~l~  281 (869)
                      + .+..+++|+.|++++|+|.
T Consensus       175 ~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          175 R-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             T-TGGGCSSCCEEEECBC---
T ss_pred             H-HhccCCCCCEEEeeCcccC
Confidence            1 3556677777777777765

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.71  E-value=7.5e-18  Score=178.34  Aligned_cols=170  Identities=17%  Similarity=0.238  Sum_probs=138.9

Q ss_pred             CCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEE
Q 002899           76 KLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKL  154 (869)
Q Consensus        76 ~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  154 (869)
                      ++.++..++|++|.+++..  .+..+ +|+.|+|++|+++.. + .+..+++|++|+|++|+|++..+  +..+++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            4667888999999998765  35555 899999999999954 4 68999999999999999996544  9999999999


Q ss_pred             EeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCC
Q 002899          155 ILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS  234 (869)
Q Consensus       155 ~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~  234 (869)
                      +|++|++++ +|. +.. ++|++|+|++|++++.  ..+..+++|+.|+|++|++++. + .+..+++|+.|+|++|+++
T Consensus        91 ~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~  163 (263)
T 1xeu_A           91 SVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT  163 (263)
T ss_dssp             ECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred             ECCCCccCC-cCc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence            999999995 443 333 8999999999999964  3699999999999999999965 3 6888888888877755544


Q ss_pred             CCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCC
Q 002899          235 ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG  283 (869)
Q Consensus       235 ~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~  283 (869)
                                             +.  ..+..+++|+.|+|++|++++.
T Consensus       164 -----------------------~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          164 -----------------------NT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             -----------------------BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             -----------------------ch--HHhccCCCCCEEeCCCCcccCC
Confidence                                   33  4466778888888888888754

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.67  E-value=7.1e-18  Score=200.00  Aligned_cols=149  Identities=19%  Similarity=0.192  Sum_probs=85.5

Q ss_pred             ceEEEEeccCC-Ccccc-CCccccCCCCCCEEEeecCcCCCCCchhhccc-----cceEEEeecccCCCCCchh----hc
Q 002899           54 CHVVTIALKAQ-NLTGT-LPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-----QLVELSVMGNRLSGPFPKV----LT  122 (869)
Q Consensus        54 ~~v~~L~l~~~-~l~~~-~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-----~L~~L~Ls~N~l~~~~~~~----~~  122 (869)
                      .+++.|+|.+| .++.. ++..+.++++|++|+|++|.+++..+..+..+     +|++|+|++|. .......    +.
T Consensus       130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~  208 (594)
T 2p1m_B          130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVT  208 (594)
T ss_dssp             TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHH
T ss_pred             CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHH
Confidence            46888888888 55543 34445578888888888888776555444322     67777777776 2121222    23


Q ss_pred             Ccccccccccccc-c-------------------------------------------------cCCC----CCccccCC
Q 002899          123 NITTLKNLSIEGN-L-------------------------------------------------FTGS----IPPDIRKL  148 (869)
Q Consensus       123 ~l~~L~~L~Ls~N-~-------------------------------------------------l~~~----~~~~~~~l  148 (869)
                      .+++|++|+|++| .                                                 +...    ++..+..+
T Consensus       209 ~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~  288 (594)
T 2p1m_B          209 RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVC  288 (594)
T ss_dssp             HCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHH
T ss_pred             hCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhh
Confidence            3466777777665 1                                                 1111    11112245


Q ss_pred             CCccEEEeecccccccCCc-cccCCCCCCeEeccCCcCCCC-CccccCCCCcccEEEc
Q 002899          149 INLQKLILSSNSFTGELPA-ELTKLTNLNDLRISDNNFSGK-IPEFIGKWKKIQKLHI  204 (869)
Q Consensus       149 ~~L~~L~Ls~N~i~~~~p~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L  204 (869)
                      ++|++|+|++|.+++.... .+..+++|++|++++| ++.. ++.....+++|++|+|
T Consensus       289 ~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L  345 (594)
T 2p1m_B          289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRV  345 (594)
T ss_dssp             TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEE
T ss_pred             CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEE
Confidence            7888888888886643222 2456777777777776 3311 1222223555666655

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.67  E-value=7.7e-17  Score=162.02  Aligned_cols=131  Identities=20%  Similarity=0.275  Sum_probs=83.6

Q ss_pred             EEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccccccc
Q 002899           57 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL  136 (869)
Q Consensus        57 ~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  136 (869)
                      +.|++++++++ .+|..+..  +|++|+|++|.|++..+.                      ..|..+++|++|+|++|+
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~----------------------~~~~~l~~L~~L~Ls~N~   65 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSD----------------------GLFGRLPHLVKLELKRNQ   65 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCS----------------------CSGGGCTTCCEEECCSSC
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCc----------------------cccccCCCCCEEECCCCC
Confidence            57888888886 56665543  677777777776654432                      135555666666666666


Q ss_pred             cCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCC
Q 002899          137 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP  212 (869)
Q Consensus       137 l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  212 (869)
                      |++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|.+.+.
T Consensus        66 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  141 (192)
T 1w8a_A           66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             CCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence            6655556666666666666666666655555566666666666666666666666666666666666666666654

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.66  E-value=1.9e-17  Score=200.07  Aligned_cols=202  Identities=19%  Similarity=0.208  Sum_probs=95.2

Q ss_pred             EEEEeccCCCccc---------cCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccc
Q 002899           56 VVTIALKAQNLTG---------TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITT  126 (869)
Q Consensus        56 v~~L~l~~~~l~~---------~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~  126 (869)
                      +..++|+.+.|.+         ..+..+..++.|+.|+|++|.|..+++..+...+|++|+|++|.|+ .+|..|.+|++
T Consensus       193 l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~  271 (727)
T 4b8c_D          193 LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSN  271 (727)
T ss_dssp             -----------------------------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTT
T ss_pred             hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCC
Confidence            4556666665543         3356677777777777777777755555554446777777777777 55666777777


Q ss_pred             cccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCc-ccEEEcc
Q 002899          127 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK-IQKLHIQ  205 (869)
Q Consensus       127 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~  205 (869)
                      |++|+|++|+|+ .+|..|..|++|++|+|++|.|+ .+|..|.++++|++|+|++|.|++.+|..+..+.. +..|+|+
T Consensus       272 L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~  349 (727)
T 4b8c_D          272 LRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLR  349 (727)
T ss_dssp             CCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHH
T ss_pred             CCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhc
Confidence            777777777777 56667777777777777777776 55666777777777777777777666666654422 2335667


Q ss_pred             CCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCC
Q 002899          206 GSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT  281 (869)
Q Consensus       206 ~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~  281 (869)
                      +|.+++.+|.      .|..|+++.|...               ....+.|.+..+..+.++..+....+++|-+.
T Consensus       350 ~N~l~~~~p~------~l~~l~l~~n~~~---------------~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          350 DNRPEIPLPH------ERRFIEINTDGEP---------------QREYDSLQQSTEHLATDLAKRTFTVLSYNTLC  404 (727)
T ss_dssp             HCCCCCCCCC------C--------------------------------------------------------CCC
T ss_pred             cCcccCcCcc------ccceeEeeccccc---------------ccccCCccccccchhhcccccceeeeeccccc
Confidence            7777665554      2334444433100               01122455555566667777888888888876

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.65  E-value=2.6e-16  Score=155.87  Aligned_cols=127  Identities=18%  Similarity=0.276  Sum_probs=78.0

Q ss_pred             cEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCC
Q 002899          152 QKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDL  231 (869)
Q Consensus       152 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n  231 (869)
                      +.+++++|+++ .+|..+.  ++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|+  
T Consensus        10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~--   84 (177)
T 2o6r_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH--   84 (177)
T ss_dssp             TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC--
T ss_pred             CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC--
Confidence            44555555555 3333222  455666666666655555555556666666666666655444445555554444443  


Q ss_pred             CCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcC
Q 002899          232 KGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL  304 (869)
Q Consensus       232 ~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  304 (869)
                                           +|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|++
T Consensus        85 ---------------------~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  136 (177)
T 2o6r_A           85 ---------------------ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW  136 (177)
T ss_dssp             ---------------------SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             ---------------------CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCe
Confidence                                 4555555556677788888888888888876666677888888888888833

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.65  E-value=1.4e-17  Score=197.42  Aligned_cols=221  Identities=18%  Similarity=0.179  Sum_probs=145.7

Q ss_pred             ceEEEEeccCCCccccCCcccc-CCCCCCEEEeecC-cCCCC-Cchhhccc-cceEEEeecccCCCCCchhhc----Ccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELS-KLRYLKQLDLSRN-CLTGS-FSPQWASL-QLVELSVMGNRLSGPFPKVLT----NIT  125 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~-~l~~L~~L~Ls~N-~i~~~-~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~----~l~  125 (869)
                      .+++.|+|+++.+++..+..+. .+++|++|+|++| .++.. .+..+..+ +|++|+|++|.+++..+..+.    .++
T Consensus       105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~  184 (594)
T 2p1m_B          105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT  184 (594)
T ss_dssp             TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred             CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence            4689999999999987777776 6899999999999 55543 33344344 899999999998876655554    567


Q ss_pred             ccccccccccccCCCCCcc----ccCCCCccEEEeeccc-c---------------------------------------
Q 002899          126 TLKNLSIEGNLFTGSIPPD----IRKLINLQKLILSSNS-F---------------------------------------  161 (869)
Q Consensus       126 ~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~Ls~N~-i---------------------------------------  161 (869)
                      +|++|+|++|. .......    +..+++|++|+|++|. +                                       
T Consensus       185 ~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~  263 (594)
T 2p1m_B          185 SLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSG  263 (594)
T ss_dssp             CCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHT
T ss_pred             cCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhc
Confidence            99999999997 2111122    2446888999888771 1                                       


Q ss_pred             ----------cc----cCCccccCCCCCCeEeccCCcCCCCC-ccccCCCCcccEEEccCCcCCC-CchHhhhcCCCCCE
Q 002899          162 ----------TG----ELPAELTKLTNLNDLRISDNNFSGKI-PEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTD  225 (869)
Q Consensus       162 ----------~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~  225 (869)
                                ..    .++..+..+++|++|+|++|.+++.. ...+..+++|+.|++++| +.. .++.....+++|+.
T Consensus       264 ~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~  342 (594)
T 2p1m_B          264 CKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRE  342 (594)
T ss_dssp             CTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCE
T ss_pred             CCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCE
Confidence                      10    01222235689999999999987443 334678999999999998 443 23334446888999


Q ss_pred             EEcC---------CCCCCCCcccccc--cccceEEEcccccCccCCCcccC-CCCCcCEEecc
Q 002899          226 LRIS---------DLKGSESAFPKLD--KMNLKTLILTKCLIHGEIPDYIG-DMTKLKNIDLS  276 (869)
Q Consensus       226 L~L~---------~n~~~~~~~~~~~--~~~L~~L~Ls~N~i~~~~p~~~~-~l~~L~~L~Ls  276 (869)
                      |+|.         .+.++......+.  ..+|+.|.+..|.+++..+..+. .+++|+.|+|+
T Consensus       343 L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~  405 (594)
T 2p1m_B          343 LRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLC  405 (594)
T ss_dssp             EEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEE
T ss_pred             EEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEee
Confidence            9883         3344433222211  23566666655555544443333 35555555555

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.64  E-value=1.5e-16  Score=174.30  Aligned_cols=243  Identities=15%  Similarity=0.103  Sum_probs=145.6

Q ss_pred             eEEEEeccCCCccccCCccccC-CCCCCEEEeecCcCC--CCCchhhccccceEEEeecccCCCCCchhhcC--------
Q 002899           55 HVVTIALKAQNLTGTLPTELSK-LRYLKQLDLSRNCLT--GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN--------  123 (869)
Q Consensus        55 ~v~~L~l~~~~l~~~~p~~l~~-l~~L~~L~Ls~N~i~--~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~--------  123 (869)
                      +++.|.++++ +...--..+.. +++|+.|||++|+|.  ......+..  +..+.+..|.   +.+.+|.+        
T Consensus        26 ~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~--~~~~~~~~~~---I~~~aF~~~~~~~~~g   99 (329)
T 3sb4_A           26 SITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPN--GKFYIYMANF---VPAYAFSNVVNGVTKG   99 (329)
T ss_dssp             HCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGG--GCCEEECTTE---ECTTTTEEEETTEEEE
T ss_pred             ceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccc--cccccccccc---cCHHHhcccccccccc
Confidence            4566666543 22111122333 677788888887776  222222222  3444444443   33456777        


Q ss_pred             ccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcC----CCCCccccCCCCcc
Q 002899          124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF----SGKIPEFIGKWKKI  199 (869)
Q Consensus       124 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l----~~~~~~~~~~l~~L  199 (869)
                      +++|+.|+|.+ .++.+.+.+|.++++|++|+|++|.+....+.+|.++.++..+.+..+..    .......|.++..|
T Consensus       100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L  178 (329)
T 3sb4_A          100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL  178 (329)
T ss_dssp             CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred             cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence            88888888888 77766667788888888888888888767777787777777666655321    11222233333333


Q ss_pred             c--------------------------EEEccCCcCCCCchHhh-hcCCCCCEEEcCCCCCCCCcccccccc-cceEEEc
Q 002899          200 Q--------------------------KLHIQGSSLEGPIPASI-SALTSLTDLRISDLKGSESAFPKLDKM-NLKTLIL  251 (869)
Q Consensus       200 ~--------------------------~L~L~~N~l~~~~~~~l-~~l~~L~~L~L~~n~~~~~~~~~~~~~-~L~~L~L  251 (869)
                      +                          .+.+.++-.. .....+ ..+++|+.|+|++|.++.++...+... +|+.|+|
T Consensus       179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l  257 (329)
T 3sb4_A          179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKL  257 (329)
T ss_dssp             EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred             ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence            3                          2222222111 111111 236777777777777776666655554 6777777


Q ss_pred             ccccCccCCCcccCCCCCcC-EEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCC
Q 002899          252 TKCLIHGEIPDYIGDMTKLK-NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP  307 (869)
Q Consensus       252 s~N~i~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  307 (869)
                      .+| ++.+.+.+|.++++|+ .|+|.+ +++.+.+.+|.++++|+.|+|++|+++..
T Consensus       258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I  312 (329)
T 3sb4_A          258 PHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTL  312 (329)
T ss_dssp             CTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEE
T ss_pred             Ccc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCcc
Confidence            776 6666677777777777 777777 66666667777777777777777777733

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.63  E-value=5.5e-16  Score=152.02  Aligned_cols=133  Identities=24%  Similarity=0.254  Sum_probs=85.0

Q ss_pred             cceEEEeecccCC-CCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEec
Q 002899          102 QLVELSVMGNRLS-GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI  180 (869)
Q Consensus       102 ~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L  180 (869)
                      +|+.|+|++|+++ +.+|..+..+++|++|+|++|.+++.  ..+..+++|++|+|++|++++.+|..+..+++|++|+|
T Consensus        25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  102 (168)
T 2ell_A           25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL  102 (168)
T ss_dssp             SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred             cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence            3444444445544 34455566666677777777766644  56666777777777777777556666666777777777


Q ss_pred             cCCcCCCCCc-cccCCCCcccEEEccCCcCCCCch---HhhhcCCCCCEEEcCCCCCCCC
Q 002899          181 SDNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIP---ASISALTSLTDLRISDLKGSES  236 (869)
Q Consensus       181 s~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~l~~l~~L~~L~L~~n~~~~~  236 (869)
                      ++|++++... ..+..+++|+.|+|++|.+++..+   ..+..+++|+.|++++|.+...
T Consensus       103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~  162 (168)
T 2ell_A          103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA  162 (168)
T ss_dssp             BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred             cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence            7777765422 566777777777777777775544   4677777777777766655443

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.63  E-value=5.9e-16  Score=155.63  Aligned_cols=128  Identities=23%  Similarity=0.271  Sum_probs=81.6

Q ss_pred             EEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccccccc
Q 002899           57 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL  136 (869)
Q Consensus        57 ~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  136 (869)
                      +.+++++++++ .+|..+.  ++|++|+|++|.|+.                        +|..|.++++|+.|+|++|+
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~------------------------ip~~~~~l~~L~~L~Ls~N~   65 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTL------------------------VPKELSNYKHLTLIDLSNNR   65 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCS------------------------CCGGGGGCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCch------------------------hHHHhhcccCCCEEECCCCc
Confidence            46788888887 5665543  467777777766652                        33455556666666666666


Q ss_pred             cCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCC
Q 002899          137 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG  211 (869)
Q Consensus       137 l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  211 (869)
                      |++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|+...+..|..+++|+.|+|++|.+..
T Consensus        66 i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           66 ISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            665555556666666666666666665555566666666666666666665555556666666666666666653

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.62  E-value=1.2e-15  Score=149.56  Aligned_cols=133  Identities=18%  Similarity=0.221  Sum_probs=75.5

Q ss_pred             CCccEEEeeccccc-ccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEE
Q 002899          149 INLQKLILSSNSFT-GELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR  227 (869)
Q Consensus       149 ~~L~~L~Ls~N~i~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~  227 (869)
                      ++|++|+|++|+++ +.+|..+..+++|++|+|++|++++.  ..|..+++|+.|+|++|++++.+|..+.++++|+.|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            44555555555555 44454555555555555555555543  4455556666666666666655555555566555555


Q ss_pred             cCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCc---hhhhcCCCCCEEEeeCCcC
Q 002899          228 ISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP---TTFEKLAKTNFMYLTGNKL  304 (869)
Q Consensus       228 L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l  304 (869)
                      |++|.++..+                      .+..+..+++|+.|+|++|++++..+   ..+..+++|+.|++++|.+
T Consensus       102 Ls~N~l~~~~----------------------~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~  159 (168)
T 2ell_A          102 LSGNKLKDIS----------------------TLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED  159 (168)
T ss_dssp             CBSSSCCSSG----------------------GGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred             ccCCccCcch----------------------hHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence            5543333211                      11445566667777777777665444   3666677777777777766


Q ss_pred             C
Q 002899          305 T  305 (869)
Q Consensus       305 ~  305 (869)
                      .
T Consensus       160 ~  160 (168)
T 2ell_A          160 Q  160 (168)
T ss_dssp             C
T ss_pred             h
Confidence            5

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.60  E-value=7.4e-16  Score=147.90  Aligned_cols=126  Identities=25%  Similarity=0.252  Sum_probs=100.8

Q ss_pred             cceEEEeecccCC-CCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEec
Q 002899          102 QLVELSVMGNRLS-GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI  180 (869)
Q Consensus       102 ~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L  180 (869)
                      +|+.|++++|.++ +.+|..+..+++|++|+|++|.+++.  ..+..+++|++|+|++|++++.+|..+..+++|++|+|
T Consensus        18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l   95 (149)
T 2je0_A           18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL   95 (149)
T ss_dssp             GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred             cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence            5667777777776 56677778888888888888888855  67888888888888888888767777777888888888


Q ss_pred             cCCcCCCC-CccccCCCCcccEEEccCCcCCCCch---HhhhcCCCCCEEEcC
Q 002899          181 SDNNFSGK-IPEFIGKWKKIQKLHIQGSSLEGPIP---ASISALTSLTDLRIS  229 (869)
Q Consensus       181 s~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~l~~l~~L~~L~L~  229 (869)
                      ++|++++. .+..+..+++|+.|++++|.+++..+   ..+..+++|+.|+++
T Consensus        96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            88888863 34778888888888888888887665   678888888888876

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.59  E-value=1.8e-15  Score=148.81  Aligned_cols=124  Identities=19%  Similarity=0.242  Sum_probs=83.2

Q ss_pred             CCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccc
Q 002899          175 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKC  254 (869)
Q Consensus       175 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N  254 (869)
                      .+.|++++|+++. +|..+  .++|+.|+|++|+|++..|..|..+++|+.|+|+                       +|
T Consensus        11 ~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls-----------------------~N   64 (170)
T 3g39_A           11 GTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLD-----------------------NN   64 (170)
T ss_dssp             TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECC-----------------------SS
T ss_pred             CCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECC-----------------------CC
Confidence            3455566666553 33333  2455666666666665555555555555554444                       44


Q ss_pred             cCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCCCCCCC
Q 002899          255 LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPI  334 (869)
Q Consensus       255 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~  334 (869)
                      +|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|                              ||
T Consensus        65 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N------------------------------~~  114 (170)
T 3g39_A           65 QLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNN------------------------------PW  114 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS------------------------------CB
T ss_pred             CcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCC------------------------------CC
Confidence            455455666777888888888888888777777888888888888888                              77


Q ss_pred             CCCCC-CccceeccCCCCCCC
Q 002899          335 ECPRG-SVNLVESYSSPRNKL  354 (869)
Q Consensus       335 ~C~c~-~~~~~~~l~~~~~~~  354 (869)
                      .|+|. +.++..|+.......
T Consensus       115 ~c~c~~l~~l~~~l~~~~~~~  135 (170)
T 3g39_A          115 DCACSDILYLSRWISQHPGLV  135 (170)
T ss_dssp             CTTBGGGHHHHHHHHHCGGGE
T ss_pred             CCCchhHHHHHHHHHhCccee
Confidence            89995 889999987655444

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.59  E-value=5.3e-15  Score=146.38  Aligned_cols=132  Identities=22%  Similarity=0.286  Sum_probs=75.8

Q ss_pred             EEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCcccccccccccc
Q 002899           56 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN  135 (869)
Q Consensus        56 v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  135 (869)
                      .+.+++++++++ .+|..+.  ++|+.|+|++|++++.++                       ..|..+++|++|+|++|
T Consensus         9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~-----------------------~~~~~l~~L~~L~l~~n   62 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPH-----------------------GVFDKLTQLTKLSLSQN   62 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCT-----------------------TTTTTCTTCSEEECCSS
T ss_pred             CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCH-----------------------HHhcCcccccEEECCCC
Confidence            456778888777 4454332  566777777666664444                       34455555555555555


Q ss_pred             ccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCc
Q 002899          136 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI  213 (869)
Q Consensus       136 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  213 (869)
                      +|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.+..
T Consensus        63 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A           63 QIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  140 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             cceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence            555444444555555555555555555444444555566666666666665544444555666666666666665443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.58  E-value=2.8e-15  Score=143.83  Aligned_cols=128  Identities=18%  Similarity=0.245  Sum_probs=76.2

Q ss_pred             CCccEEEeeccccc-ccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEE
Q 002899          149 INLQKLILSSNSFT-GELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR  227 (869)
Q Consensus       149 ~~L~~L~Ls~N~i~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~  227 (869)
                      ++|++|++++|.++ +.+|..+..+++|++|+|++|++++.  ..+..+++|+.|+|++|.+++.+|..+..+++|+.|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            45555666666555 45555555666666666666666544  5556666666666666666655666666666666665


Q ss_pred             cCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCc---hhhhcCCCCCEEEee
Q 002899          228 ISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP---TTFEKLAKTNFMYLT  300 (869)
Q Consensus       228 L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls  300 (869)
                      +++|.++..+                      .+..+..+++|+.|+|++|++++..+   ..+..+++|+.|+++
T Consensus        95 ls~N~i~~~~----------------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIKDLS----------------------TIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCCSHH----------------------HHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCCChH----------------------HHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            5544333211                      22445566677777777777765555   466777777777665

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.58  E-value=8.1e-16  Score=168.79  Aligned_cols=136  Identities=11%  Similarity=0.131  Sum_probs=99.9

Q ss_pred             CCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCch--------------hhHH--------HHHHHHHHHhcCCCce
Q 002899          639 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--------------GNRE--------FVNEIGMISAQQHPNL  696 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~--------------~~~~--------f~~E~~~l~~l~H~nI  696 (869)
                      -|.+.+.||+|+||.||+|...+|+.||||+++.....              ....        ...|...|.++.+..+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            38889999999999999999989999999987542110              0011        1245566666654443


Q ss_pred             e--eEEeEEeeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 002899          697 V--KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL  774 (869)
Q Consensus       697 v--~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIL  774 (869)
                      .  ..+++    ...+|||||+++++|.++...           +....++.|++.+|.|||+.+   ||||||||.|||
T Consensus       176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NIL  237 (397)
T 4gyi_A          176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNIL  237 (397)
T ss_dssp             SCCCEEEE----ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred             CCCeeeec----cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEE
Confidence            2  22222    234799999999888665421           134578899999999999998   999999999999


Q ss_pred             EcCCC----------cEEEeecCCceee
Q 002899          775 LDKDL----------NAKISDFGLAKLY  792 (869)
Q Consensus       775 l~~~~----------~~kl~DFGla~~~  792 (869)
                      +++++          .+.|+||+-+...
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EeCCCCcccccccccceEEEEeCCcccC
Confidence            98876          3899999977553

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.58  E-value=1.5e-14  Score=162.15  Aligned_cols=248  Identities=10%  Similarity=0.072  Sum_probs=173.7

Q ss_pred             ccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccc
Q 002899           66 LTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI  145 (869)
Q Consensus        66 l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  145 (869)
                      ++.+-..+|.+. +|+.++|..| ++.+...+|...+|+.+.|.. .++.+.+.+|.++++|+.++|++|+++......|
T Consensus       124 i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF  200 (401)
T 4fdw_A          124 VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNSTVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTF  200 (401)
T ss_dssp             CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTCCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTT
T ss_pred             cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCCCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhE
Confidence            333334566664 6888888766 777777888888888888875 6776777888888888888888888885555555


Q ss_pred             cCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCE
Q 002899          146 RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTD  225 (869)
Q Consensus       146 ~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~  225 (869)
                      . ..+|+.+.|.++ ++.....+|.++++|+.|+|..| ++.+...+|.+ .+|+.+.| .|.++.....+|.++++|+.
T Consensus       201 ~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~  275 (401)
T 4fdw_A          201 V-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAE  275 (401)
T ss_dssp             T-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCE
T ss_pred             e-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCE
Confidence            5 578888888754 66566778888888888888875 56566677777 78888888 45566566788888888888


Q ss_pred             EEcCCCCCC-----CCccccccc-ccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEe
Q 002899          226 LRISDLKGS-----ESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL  299 (869)
Q Consensus       226 L~L~~n~~~-----~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  299 (869)
                      +.+.+|.+.     .+....+.. .+|+.++|. +.++.+...+|.+|++|+.|+|..| ++.+...+|.++ +|+.|++
T Consensus       276 l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l  352 (401)
T 4fdw_A          276 VTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKV  352 (401)
T ss_dssp             EEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEE
T ss_pred             EEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEE
Confidence            888877665     233333333 267788877 4477677777888888888888544 665667777777 7888888


Q ss_pred             eCCcCCCCCchhhh---ccCCceeeecc
Q 002899          300 TGNKLTGPVPKYIF---NSNKNVDISLN  324 (869)
Q Consensus       300 s~N~l~~~~p~~~~---~~l~~l~ls~N  324 (869)
                      ++|.+....+..+.   ..+..|.+..|
T Consensus       353 ~~n~~~~l~~~~F~~~~~~l~~l~vp~~  380 (401)
T 4fdw_A          353 EGTTPPQVFEKVWYGFPDDITVIRVPAE  380 (401)
T ss_dssp             CCSSCCBCCCSSCCCSCTTCCEEEECGG
T ss_pred             cCCCCcccccccccCCCCCccEEEeCHH
Confidence            88776633333221   13344555444

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.57  E-value=2.1e-15  Score=165.00  Aligned_cols=257  Identities=14%  Similarity=0.078  Sum_probs=182.1

Q ss_pred             ccccCCccccCCCCCCEEEeecCcCCCCCchhhcc-c-cceEEEeecccCC--CCCchhhcCccccccccccccccCCCC
Q 002899           66 LTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS-L-QLVELSVMGNRLS--GPFPKVLTNITTLKNLSIEGNLFTGSI  141 (869)
Q Consensus        66 l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~-l-~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~  141 (869)
                      +.+.+++.  .+++|+.|.++++ +.......+.. + +|+.|||++|++.  .....   .++.++.+.+..|.|.   
T Consensus        15 l~~~l~~~--~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I~---   85 (329)
T 3sb4_A           15 LISMMTEE--EANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFVP---   85 (329)
T ss_dssp             GGGGSCHH--HHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEEC---
T ss_pred             HHhhccch--hhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccc---cccccccccccccccC---
Confidence            34444432  3668999999975 22222223333 3 7999999999998  22222   2333566666666544   


Q ss_pred             CccccC--------CCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCc----C
Q 002899          142 PPDIRK--------LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSS----L  209 (869)
Q Consensus       142 ~~~~~~--------l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~----l  209 (869)
                      +..|.+        +++|++|+|.+ +++.+.+.+|.++++|+.|+|++|.+..+.+.+|.++.++..|.+..+.    .
T Consensus        86 ~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~  164 (329)
T 3sb4_A           86 AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFK  164 (329)
T ss_dssp             TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTS
T ss_pred             HHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcc
Confidence            556777        99999999999 8887778889999999999999999988888899998888888776632    2


Q ss_pred             CCCchHhhhcCCCCC-EEEcCCCC------------------------CCCCccccc--ccccceEEEcccccCccCCCc
Q 002899          210 EGPIPASISALTSLT-DLRISDLK------------------------GSESAFPKL--DKMNLKTLILTKCLIHGEIPD  262 (869)
Q Consensus       210 ~~~~~~~l~~l~~L~-~L~L~~n~------------------------~~~~~~~~~--~~~~L~~L~Ls~N~i~~~~p~  262 (869)
                      .......|.++.+|+ .+.+....                        +....+..+  ...+|+.|+|++|+++.+.+.
T Consensus       165 ~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~  244 (329)
T 3sb4_A          165 NRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDF  244 (329)
T ss_dssp             TTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTT
T ss_pred             ccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHh
Confidence            223334455555555 33332111                        111111111  134899999999999988889


Q ss_pred             ccCCCCCcCEEeccCCCCCCCCchhhhcCCCCC-EEEeeCCcCCCCCchhh--hccCCceeeeccCccCCCCCCC
Q 002899          263 YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN-FMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPI  334 (869)
Q Consensus       263 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~~~~~p~  334 (869)
                      .|.++++|+.|+|.+| ++.+.+.+|.++++|+ .|+|.+ +++...+..+  ...|+.++++.|+++..+...+
T Consensus       245 aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF  317 (329)
T 3sb4_A          245 TFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELF  317 (329)
T ss_dssp             TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTT
T ss_pred             hhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhh
Confidence            9999999999999998 8878889999999999 999998 6774444444  3468899999999998877665

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.54  E-value=3.5e-14  Score=159.20  Aligned_cols=241  Identities=7%  Similarity=0.068  Sum_probs=200.4

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI  132 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  132 (869)
                      ++++.+.|..+ ++.+-..+|.+ .+|+.+.|.. .++.+....|..+ +|+.++|.+|+++.+...+|. ..+|+.+.|
T Consensus       135 ~~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~l  210 (401)
T 4fdw_A          135 SQIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLL  210 (401)
T ss_dssp             CCCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEEC
T ss_pred             CCccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEe
Confidence            45778888655 77666677888 4799999985 7888888899887 899999999999988778887 589999999


Q ss_pred             cccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCC--
Q 002899          133 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE--  210 (869)
Q Consensus       133 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--  210 (869)
                      ..+ ++.+...+|.++++|+.|+|..| ++.....+|.+ .+|+.+.| .|.++.+...+|.++++|+.+.+.+|.+.  
T Consensus       211 p~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~  286 (401)
T 4fdw_A          211 PVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDD  286 (401)
T ss_dssp             CTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCC
T ss_pred             CCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCC
Confidence            855 77677778999999999999975 66566777877 78999999 56677677889999999999999998875  


Q ss_pred             ---CCchHhhhcCCCCCEEEcCCCCCCCCccccccc-ccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCch
Q 002899          211 ---GPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT  286 (869)
Q Consensus       211 ---~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  286 (869)
                         ...+.+|.++++|+.+.|. +.++.+....+.. .+|+.|.|..| ++.+...+|.++ +|+.|++++|.+....+.
T Consensus       287 ~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~  363 (401)
T 4fdw_A          287 PEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEK  363 (401)
T ss_dssp             TTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCS
T ss_pred             cccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccc
Confidence               4567889999999999998 4577777666665 58999999655 887888999999 999999999999988888


Q ss_pred             hhhcCC-CCCEEEeeCCcCC
Q 002899          287 TFEKLA-KTNFMYLTGNKLT  305 (869)
Q Consensus       287 ~~~~l~-~L~~L~Ls~N~l~  305 (869)
                      .|.+++ +++.|++..|.+.
T Consensus       364 ~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          364 VWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             SCCCSCTTCCEEEECGGGHH
T ss_pred             cccCCCCCccEEEeCHHHHH
Confidence            898885 7899999888654

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.52  E-value=2.5e-16  Score=159.09  Aligned_cols=155  Identities=21%  Similarity=0.274  Sum_probs=107.1

Q ss_pred             hcCccccccccccccccCCCCCc------cccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccC
Q 002899          121 LTNITTLKNLSIEGNLFTGSIPP------DIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG  194 (869)
Q Consensus       121 ~~~l~~L~~L~Ls~N~l~~~~~~------~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  194 (869)
                      +.....++.++|+.+.+++..|.      .+..+++|++|+|++|+|++ +| .+.++++|++|+|++|+++ .+|..+.
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~   90 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA   90 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence            45566777778888877777666      67777778888888777774 55 6777777888888888777 4566666


Q ss_pred             CCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCC-cccCCCCCcCEE
Q 002899          195 KWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP-DYIGDMTKLKNI  273 (869)
Q Consensus       195 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L  273 (869)
                      .+++|+.|+|++|++++ +| .+..+++|+.|+|+                       +|+|++..+ ..+..+++|+.|
T Consensus        91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~-----------------------~N~i~~~~~~~~l~~l~~L~~L  145 (198)
T 1ds9_A           91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMS-----------------------NNKITNWGEIDKLAALDKLEDL  145 (198)
T ss_dssp             HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEES-----------------------EEECCCHHHHHHHTTTTTCSEE
T ss_pred             cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECC-----------------------CCcCCchhHHHHHhcCCCCCEE
Confidence            67777777777777775 33 46666655555544                       555543222 356677888888


Q ss_pred             eccCCCCCCCCch----------hhhcCCCCCEEEeeCCcCC
Q 002899          274 DLSFNNLTGGIPT----------TFEKLAKTNFMYLTGNKLT  305 (869)
Q Consensus       274 ~Ls~N~l~~~~p~----------~~~~l~~L~~L~Ls~N~l~  305 (869)
                      +|++|++++.+|.          .+..+++|+.||  +|.++
T Consensus       146 ~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          146 LLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             EECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             EecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            8888887765544          377788888776  67665

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.52  E-value=2.7e-14  Score=157.39  Aligned_cols=151  Identities=21%  Similarity=0.279  Sum_probs=86.0

Q ss_pred             eEeccCC-cCCCCCccccCCCCcccEEEccC-CcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccc
Q 002899          177 DLRISDN-NFSGKIPEFIGKWKKIQKLHIQG-SSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKC  254 (869)
Q Consensus       177 ~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N  254 (869)
                      .++++++ +|+. +|. |..+++|+.|+|++ |.|++..+..|.++++|+.|+|+                       +|
T Consensus        12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~-----------------------~N   66 (347)
T 2ifg_A           12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV-----------------------KS   66 (347)
T ss_dssp             CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECC-----------------------SS
T ss_pred             EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECC-----------------------CC
Confidence            3455554 5552 344 55555555555553 55554444444444444433333                       44


Q ss_pred             cCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCCCCCCC
Q 002899          255 LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPI  334 (869)
Q Consensus       255 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~  334 (869)
                      +|++..|..|.++++|+.|+|++|+|++..+..|..++ |+.|+|++|                              +|
T Consensus        67 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N------------------------------~~  115 (347)
T 2ifg_A           67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGN------------------------------PL  115 (347)
T ss_dssp             CCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSS------------------------------CC
T ss_pred             ccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCC------------------------------Cc
Confidence            44445555566666666666666666655555454444 666666665                              77


Q ss_pred             CCCCCCccceeccCCCCCCCCCCcCccCCCCCCCCCcccccceeeeecCCcceecC
Q 002899          335 ECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTG  390 (869)
Q Consensus       335 ~C~c~~~~~~~~l~~~~~~~~~~~~~~~~~~~C~~p~~~~~~~~~~~c~~~~~~~~  390 (869)
                      .|+|.+.||..|+......+.      .....|..|.....-.. ..|..|.+...
T Consensus       116 ~c~c~l~~~~~~~~~~~~~l~------~~~~~C~~~~~l~~l~~-~~c~~P~i~~~  164 (347)
T 2ifg_A          116 HCSCALRWLQRWEEEGLGGVP------EQKLQCHGQGPLAHMPN-ASCGVPTLKVQ  164 (347)
T ss_dssp             CCCGGGHHHHHHHHTTCSSCG------GGCCCCSSSSCSSCCCC-TTCCCCEEEEE
T ss_pred             cCCCccHHHHHHHHhCccccc------ccCCCCCCChHHhcCCc-ccCCCCceecc
Confidence            899999999999876544432      24567877774332222 46877776543

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.52  E-value=1.7e-14  Score=142.32  Aligned_cols=121  Identities=18%  Similarity=0.272  Sum_probs=78.3

Q ss_pred             CeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEccccc
Q 002899          176 NDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCL  255 (869)
Q Consensus       176 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~  255 (869)
                      +.+++++|+++ .+|..+.  ++|+.|+|++|+|++..|..|.++++|+.|+|+                       +|+
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls-----------------------~N~   68 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFN-----------------------SNK   68 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC-----------------------SSC
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECC-----------------------CCC
Confidence            45555555554 3333332  455555555555555555555555555444444                       444


Q ss_pred             CccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCCCCCCCC
Q 002899          256 IHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIE  335 (869)
Q Consensus       256 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~~  335 (869)
                      |++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|                              ||.
T Consensus        69 l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N------------------------------~~~  118 (174)
T 2r9u_A           69 LTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNN------------------------------PWD  118 (174)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSS------------------------------CBC
T ss_pred             CCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCC------------------------------Ccc
Confidence            44445555677888888888888888766666888888888888888                              777


Q ss_pred             CCCC-CccceeccCCCCC
Q 002899          336 CPRG-SVNLVESYSSPRN  352 (869)
Q Consensus       336 C~c~-~~~~~~~l~~~~~  352 (869)
                      |+|. +.++..|+.....
T Consensus       119 c~~~~~~~l~~~~~~~~~  136 (174)
T 2r9u_A          119 CECRDIMYLRNWVADHTS  136 (174)
T ss_dssp             TTBGGGHHHHHHHHHCGG
T ss_pred             cccccHHHHHHHHHhccc
Confidence            9996 7788888865433

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.51  E-value=7.1e-15  Score=145.35  Aligned_cols=105  Identities=14%  Similarity=0.173  Sum_probs=50.2

Q ss_pred             ccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCcc--ccCCCCcccEEE
Q 002899          126 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE--FIGKWKKIQKLH  203 (869)
Q Consensus       126 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~  203 (869)
                      +|++|+|++|.|++.  ..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|.  .+..+++|+.|+
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence            444444444444432  34444555555555555555332333345555555555555554 2332  445555555555


Q ss_pred             ccCCcCCCCchH---hhhcCCCCCEEEcCCCCC
Q 002899          204 IQGSSLEGPIPA---SISALTSLTDLRISDLKG  233 (869)
Q Consensus       204 L~~N~l~~~~~~---~l~~l~~L~~L~L~~n~~  233 (869)
                      |++|.+....+.   .+..+++|+.|+++.|.+
T Consensus       120 l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~  152 (176)
T 1a9n_A          120 ILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKL  152 (176)
T ss_dssp             CCSSGGGGSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred             ecCCCCCCcHhHHHHHHHHCCccceeCCCcCCH
Confidence            555555422211   355555555555555544

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.48  E-value=4.6e-16  Score=157.13  Aligned_cols=121  Identities=23%  Similarity=0.297  Sum_probs=61.0

Q ss_pred             cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEecc
Q 002899          102 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS  181 (869)
Q Consensus       102 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls  181 (869)
                      +|++|+|++|++++ +| .+..+++|++|+|++|.|+ .+|..+..+++|++|+|++|+|++ +| .+..+++|++|+|+
T Consensus        49 ~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~  123 (198)
T 1ds9_A           49 ACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMS  123 (198)
T ss_dssp             TCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEES
T ss_pred             CCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECC
Confidence            34444444444443 23 4455555555555555555 344444444555555555555553 22 34455555555555


Q ss_pred             CCcCCCCCc-cccCCCCcccEEEccCCcCCCCchH----------hhhcCCCCCEEE
Q 002899          182 DNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIPA----------SISALTSLTDLR  227 (869)
Q Consensus       182 ~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~----------~l~~l~~L~~L~  227 (869)
                      +|++++..+ ..+..+++|+.|++++|.+.+..|.          .+..+++|+.|+
T Consensus       124 ~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld  180 (198)
T 1ds9_A          124 NNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             EEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC
T ss_pred             CCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC
Confidence            555553222 3455555555555555555443332          366666666665

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.47  E-value=4.6e-14  Score=139.44  Aligned_cols=134  Identities=23%  Similarity=0.207  Sum_probs=105.4

Q ss_pred             ccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCC
Q 002899           72 TELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLIN  150 (869)
Q Consensus        72 ~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  150 (869)
                      ..+.++++|+.|+|++|.|+.+ +...... +|+.|+|++|++++.  ..|..+++|++|+|++|+|++..+..|..+++
T Consensus        13 ~~~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           13 AQYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             CEEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             HhcCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            3467788888899998888865 4444445 788889988888865  56888888888999888888655555688888


Q ss_pred             ccEEEeecccccccCCc--cccCCCCCCeEeccCCcCCCCCcc----ccCCCCcccEEEccCCcCC
Q 002899          151 LQKLILSSNSFTGELPA--ELTKLTNLNDLRISDNNFSGKIPE----FIGKWKKIQKLHIQGSSLE  210 (869)
Q Consensus       151 L~~L~Ls~N~i~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~  210 (869)
                      |++|+|++|+|+ .+|.  .+..+++|+.|+|++|.++. .|.    .+..+++|+.|+++.|.+.
T Consensus        90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence            889999888886 4554  77888888889998888874 454    4788888888888888876

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.42  E-value=1.5e-13  Score=134.93  Aligned_cols=106  Identities=23%  Similarity=0.296  Sum_probs=67.9

Q ss_pred             EEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCcccccccccccc
Q 002899           56 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN  135 (869)
Q Consensus        56 v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  135 (869)
                      .+.|++++|+++ .+|..+.  ++|++|+|++|.|++                       +.|..|.++++|++|+|++|
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~-----------------------~~~~~~~~l~~L~~L~Ls~N   64 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITK-----------------------LEPGVFDRLTQLTRLDLDNN   64 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCC-----------------------CCTTTTTTCTTCSEEECCSS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCc-----------------------cChhhhcCcccCCEEECCCC
Confidence            356788888887 4565553  566666666666654                       44555666666666666666


Q ss_pred             ccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCC
Q 002899          136 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG  187 (869)
Q Consensus       136 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~  187 (869)
                      +|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|.++.
T Consensus        65 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  116 (170)
T 3g39_A           65 QLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDC  116 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred             CcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence            6665555556666666666666666665555556666777777777776663

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.42  E-value=3e-13  Score=133.37  Aligned_cols=104  Identities=20%  Similarity=0.284  Sum_probs=66.8

Q ss_pred             EEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccccccc
Q 002899           57 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL  136 (869)
Q Consensus        57 ~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  136 (869)
                      +.+++++++++ .+|..+.  ++|++|+|++|+|++.                       .|..|.++++|++|+|++|+
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~-----------------------~~~~~~~l~~L~~L~Ls~N~   68 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKL-----------------------EPGVFDHLVNLQQLYFNSNK   68 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCC-----------------------CTTTTTTCTTCCEEECCSSC
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCcccc-----------------------CHHHhcCCcCCCEEECCCCC
Confidence            56788888876 5666554  6666666666666544                       44555666666666666666


Q ss_pred             cCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCC
Q 002899          137 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS  186 (869)
Q Consensus       137 l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~  186 (869)
                      |++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus        69 l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           69 LTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             CCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence            66544445566666666666666666544445666777777777777766

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.31  E-value=8.5e-14  Score=154.52  Aligned_cols=157  Identities=18%  Similarity=0.182  Sum_probs=79.3

Q ss_pred             CCCCEEEeecCcCCCCCchhhccc------cceEEEeecccCCCCCchhh-cCccccccccccccccCCCCCccc-----
Q 002899           78 RYLKQLDLSRNCLTGSFSPQWASL------QLVELSVMGNRLSGPFPKVL-TNITTLKNLSIEGNLFTGSIPPDI-----  145 (869)
Q Consensus        78 ~~L~~L~Ls~N~i~~~~~~~~~~l------~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~-----  145 (869)
                      +.|+.|+|++|.|+......+...      +|++|+|++|.++......+ ..+++|+.|+|++|.|+......+     
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            456667777766664433332221      56666666666653322222 234556666666666653322222     


Q ss_pred             cCCCCccEEEeecccccc----cCCccccCCCCCCeEeccCCcCCCC----CccccCCCCcccEEEccCCcCCCC----c
Q 002899          146 RKLINLQKLILSSNSFTG----ELPAELTKLTNLNDLRISDNNFSGK----IPEFIGKWKKIQKLHIQGSSLEGP----I  213 (869)
Q Consensus       146 ~~l~~L~~L~Ls~N~i~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~  213 (869)
                      ...++|++|+|++|.|+.    .++..+..+++|++|+|++|+|+..    ++..+...++|+.|+|++|.|+..    +
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l  231 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL  231 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence            234556666666666553    1223334555666666666665532    133444555566666666655532    2


Q ss_pred             hHhhhcCCCCCEEEcCCCCCC
Q 002899          214 PASISALTSLTDLRISDLKGS  234 (869)
Q Consensus       214 ~~~l~~l~~L~~L~L~~n~~~  234 (869)
                      +..+...++|+.|+|++|.++
T Consensus       232 ~~~L~~~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          232 ARAAREHPSLELLHLYFNELS  252 (372)
T ss_dssp             HHHHHHCSSCCEEECTTSSCC
T ss_pred             HHHHHhCCCCCEEeccCCCCC
Confidence            233344455555555544443

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.26  E-value=1e-13  Score=153.83  Aligned_cols=168  Identities=16%  Similarity=0.173  Sum_probs=130.1

Q ss_pred             ceEEEEeccCCCccccCCccccCC-----CCCCEEEeecCcCCCCCchhhcc-c-cceEEEeecccCCCCCchhh-----
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKL-----RYLKQLDLSRNCLTGSFSPQWAS-L-QLVELSVMGNRLSGPFPKVL-----  121 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l-----~~L~~L~Ls~N~i~~~~~~~~~~-l-~L~~L~Ls~N~l~~~~~~~~-----  121 (869)
                      .+++.|+|++|.|+......|...     ++|++|+|++|.|+......+.. + +|+.|+|++|.|+......+     
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            358899999999986544443333     79999999999998654444433 3 89999999999986555554     


Q ss_pred             cCccccccccccccccCCC----CCccccCCCCccEEEeeccccccc----CCccccCCCCCCeEeccCCcCCCC----C
Q 002899          122 TNITTLKNLSIEGNLFTGS----IPPDIRKLINLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGK----I  189 (869)
Q Consensus       122 ~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~  189 (869)
                      ...++|++|+|++|.|+..    ++..+..+++|++|+|++|+|+..    ++..+...++|++|+|++|.|+..    +
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l  231 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL  231 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence            3468899999999999742    334457789999999999999853    355677788999999999999853    3


Q ss_pred             ccccCCCCcccEEEccCCcCCCCchHhhhcCC
Q 002899          190 PEFIGKWKKIQKLHIQGSSLEGPIPASISALT  221 (869)
Q Consensus       190 ~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~  221 (869)
                      +..+...++|++|+|++|.|+......+..+.
T Consensus       232 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~  263 (372)
T 3un9_A          232 ARAAREHPSLELLHLYFNELSSEGRQVLRDLG  263 (372)
T ss_dssp             HHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC
T ss_pred             HHHHHhCCCCCEEeccCCCCCHHHHHHHHHHh
Confidence            34556679999999999999977666776654

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.23  E-value=7e-12  Score=137.95  Aligned_cols=103  Identities=21%  Similarity=0.191  Sum_probs=64.9

Q ss_pred             EEeccCC-CccccCCccccCCCCCCEEEeec-CcCCCCCchhhccccceEEEeecccCCCCCchhhcCcccccccccccc
Q 002899           58 TIALKAQ-NLTGTLPTELSKLRYLKQLDLSR-NCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN  135 (869)
Q Consensus        58 ~L~l~~~-~l~~~~p~~l~~l~~L~~L~Ls~-N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  135 (869)
                      .++++++ +|+ .+|. |..+++|+.|+|++ |.|+++++.                       .|.+|++|+.|+|++|
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~-----------------------~~~~l~~L~~L~l~~N   66 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELR-----------------------DLRGLGELRNLTIVKS   66 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGG-----------------------GSCSCCCCSEEECCSS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChh-----------------------HhccccCCCEEECCCC
Confidence            4577787 788 4777 88888888888885 777655444                       4555555555555555


Q ss_pred             ccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCC
Q 002899          136 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS  186 (869)
Q Consensus       136 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~  186 (869)
                      +|++..|..|.+|++|++|+|++|+|++..+..|..++ |+.|+|++|.+.
T Consensus        67 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             CCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             ccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            55555555555555566666666665544444444443 666666666665

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.20  E-value=6.9e-11  Score=124.48  Aligned_cols=148  Identities=14%  Similarity=0.073  Sum_probs=114.5

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceEEEE
Q 002899          634 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       634 ~~~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ...-+.|.+...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. |..+.++++++...+..|+|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            344467878888888888999999754 6789999986532233456889999999884 66777899999988899999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED----------------------------------  758 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------  758 (869)
                      |||++|.+|.+.+..          ......++.+++++|+.||+.                                  
T Consensus        89 ~e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           89 MSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            999999998765311          112457888999999999981                                  


Q ss_pred             ----------------------CCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          759 ----------------------SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       759 ----------------------~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                                            .+..++|+|++|.|||++++..+.|+||+.+...
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence                                  1134889999999999987666679999987643

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.09  E-value=5.9e-10  Score=124.81  Aligned_cols=76  Identities=16%  Similarity=0.134  Sum_probs=50.2

Q ss_pred             cceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhh---ccCCceee
Q 002899          245 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDI  321 (869)
Q Consensus       245 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~~l~~l~l  321 (869)
                      +|+.+.+..+ ++.+...+|.++++|+.++|..+ ++.+...+|.++.+|+.++|..| ++ .++...|   .+|+.+++
T Consensus       298 ~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~l  373 (394)
T 4fs7_A          298 SLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVEL  373 (394)
T ss_dssp             TCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEEE
T ss_pred             cccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEEE
Confidence            5777777654 66566677788888888888644 66566677888888888887766 55 3333332   25666776


Q ss_pred             ecc
Q 002899          322 SLN  324 (869)
Q Consensus       322 s~N  324 (869)
                      ..+
T Consensus       374 p~~  376 (394)
T 4fs7_A          374 PKR  376 (394)
T ss_dssp             EGG
T ss_pred             CCC
Confidence            554

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.05  E-value=2.8e-10  Score=119.28  Aligned_cols=138  Identities=16%  Similarity=0.120  Sum_probs=100.9

Q ss_pred             CCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCc--eeeEEeEEeeCceEEEEEEec
Q 002899          639 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN--LVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~E~~  716 (869)
                      ++.+..+.+.|..+.||++...+|+.+++|.....   ....+..|+++++.+.+.+  +.+++++...++..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            34443333455668999998777888999987643   2356788999998886545  446888888888899999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS-------------------------------------  759 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------  759 (869)
                      ++.++.  . ..       .+   ...++.++++.|..||+..                                     
T Consensus        98 ~G~~l~--~-~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           98 PGQDLL--S-SH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             SSEETT--T-SC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             CCcccC--c-Cc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            998884  2 11       11   2356777888888888642                                     


Q ss_pred             ------------------CCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          760 ------------------RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       760 ------------------~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                                        +..++|+|++|.|||++++..+.|+|||.+...
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                              122899999999999988766779999998654

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.98  E-value=1.7e-10  Score=127.03  Aligned_cols=153  Identities=22%  Similarity=0.254  Sum_probs=88.2

Q ss_pred             ccCCCCCCeEeccCCc-CCCCCccccCCCCcccEEEccCCcCCCCchHhhh--cCCCCCEEEcCC--CC-CCCCcc----
Q 002899          169 LTKLTNLNDLRISDNN-FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASIS--ALTSLTDLRISD--LK-GSESAF----  238 (869)
Q Consensus       169 ~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~--~l~~L~~L~L~~--n~-~~~~~~----  238 (869)
                      +..+|+|+.|+|++|. +.  ++. + .+++|+.|+|..|.+.......+.  .+++|+.|+|+.  |. ......    
T Consensus       168 l~~~P~L~~L~L~g~~~l~--l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~  243 (362)
T 2ra8_A          168 LDAMPLLNNLKIKGTNNLS--IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR  243 (362)
T ss_dssp             HHTCTTCCEEEEECCBTCB--CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTG
T ss_pred             HhcCCCCcEEEEeCCCCce--ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHH
Confidence            3444555555555542 11  111 2 245566666665555433333333  456666666542  11 111100    


Q ss_pred             ---cccccccceEEEcccccCccCCCccc---CCCCCcCEEeccCCCCCCCC----chhhhcCCCCCEEEeeCCcCCCCC
Q 002899          239 ---PKLDKMNLKTLILTKCLIHGEIPDYI---GDMTKLKNIDLSFNNLTGGI----PTTFEKLAKTNFMYLTGNKLTGPV  308 (869)
Q Consensus       239 ---~~~~~~~L~~L~Ls~N~i~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~  308 (869)
                         .....++|+.|+|.+|.+.+..+..+   ..+++|+.|+|+.|.|++..    +..+..+++|+.|+|++|.|+...
T Consensus       244 ~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~  323 (362)
T 2ra8_A          244 PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM  323 (362)
T ss_dssp             GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHH
T ss_pred             HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHH
Confidence               11112478888888888765443333   25789999999999998643    334466899999999999887555


Q ss_pred             chhhhc-cCCceeeeccC
Q 002899          309 PKYIFN-SNKNVDISLNN  325 (869)
Q Consensus       309 p~~~~~-~l~~l~ls~N~  325 (869)
                      -..+.. ....++++.|+
T Consensus       324 ~~~l~~alg~~~~~~~~~  341 (362)
T 2ra8_A          324 KKELQKSLPMKIDVSDSQ  341 (362)
T ss_dssp             HHHHHHHCCSEEECCSBC
T ss_pred             HHHHHHHcCCEEEecCCc
Confidence            444443 34668888885

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.94  E-value=1.9e-10  Score=126.58  Aligned_cols=36  Identities=11%  Similarity=0.040  Sum_probs=20.9

Q ss_pred             ceEEEEeccCCCccc-c-------CCccccCCCCCCEEEeecCc
Q 002899           54 CHVVTIALKAQNLTG-T-------LPTELSKLRYLKQLDLSRNC   89 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~-~-------~p~~l~~l~~L~~L~Ls~N~   89 (869)
                      .+|+.|.+......+ .       +..++.++++|+.|.|..+.
T Consensus       107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~  150 (362)
T 2ra8_A          107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDID  150 (362)
T ss_dssp             GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCC
T ss_pred             hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcc
Confidence            456666666554432 1       23345567788888886543

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=98.93  E-value=9.4e-10  Score=102.26  Aligned_cols=94  Identities=19%  Similarity=0.201  Sum_probs=72.6

Q ss_pred             EEEcccccCc-cCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCc
Q 002899          248 TLILTKCLIH-GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNF  326 (869)
Q Consensus       248 ~L~Ls~N~i~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~  326 (869)
                      .++.+++.++ ..+|..+.  ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|                        
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N------------------------   65 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGAN------------------------   65 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSS------------------------
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCC------------------------
Confidence            5667777776 24454322  46899999999999877888888999998888888                        


Q ss_pred             cCCCCCCCCCCCCCccceeccCCCCCCCCCCcCccCCCCCCCCCcccccceee
Q 002899          327 TWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLH  379 (869)
Q Consensus       327 ~~~~~~p~~C~c~~~~~~~~l~~~~~~~~~~~~~~~~~~~C~~p~~~~~~~~~  379 (869)
                            ||.|||.+.||..|+........      .....|+.|+.++|+.+.
T Consensus        66 ------P~~CdC~l~~l~~wl~~~~~~~~------~~~~~C~~P~~l~g~~l~  106 (130)
T 3rfe_A           66 ------PWRCDCRLVPLRAWLAGRPERAP------YRDLRCVAPPALRGRLLP  106 (130)
T ss_dssp             ------CCBCSGGGHHHHHHHHTSSCSGG------GTTCBCCBSTTTTTCBGG
T ss_pred             ------CeeccCccHHHHHHHHhCccccc------ccCcEeCcChHHcCCCcc
Confidence                  99999999999999986543321      246789999999887654

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.90  E-value=2e-09  Score=115.93  Aligned_cols=186  Identities=18%  Similarity=0.200  Sum_probs=122.5

Q ss_pred             CCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcC-CCc--eeeEEeEEeeCc---eEEEEEEec
Q 002899          643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPN--LVKLYGCCVEGN---QLLLVYEYM  716 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~-H~n--Iv~l~~~~~~~~---~~~lV~E~~  716 (869)
                      .+.++.|....||+..    ..+++|+....  .....+.+|+++++.+. +..  +.+++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4668999999999863    45888886432  33567889999998873 333  334554443333   348899999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED--------------------------------------  758 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------  758 (869)
                      +|.++......       .++..++..++.++++.++.||+.                                      
T Consensus        99 ~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           99 KGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             CCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            99888653321       356777888888888888888861                                      


Q ss_pred             -----------------CCCCeEEcCCCCCCEEEcC--CCcEEEeecCCceeecCCCcccccc-------------cccc
Q 002899          759 -----------------SRIKIVHRDIKTSNVLLDK--DLNAKISDFGLAKLYEEDKTHISTR-------------IAGT  806 (869)
Q Consensus       759 -----------------~~~~iiH~Dlk~~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~-------------~~gt  806 (869)
                                       .++.++|+|++|.||++++  +..+.|+||+.+........-....             ....
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence                             1234799999999999998  4567899999987653311100000             0000


Q ss_pred             ccccc-hhhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 002899          807 IGYMA-PEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       807 ~~y~a-PE~~~~~~~~~k~DvwSlGvil~elltG~~p~  843 (869)
                      .+... |+.....  ....+.|+++.++|++.+|+.++
T Consensus       252 Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence            11122 2322211  22368999999999999999776

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=98.87  E-value=1.8e-08  Score=112.65  Aligned_cols=247  Identities=12%  Similarity=0.136  Sum_probs=124.6

Q ss_pred             CccccCCC-CCCEEEeecCcCCCCCchhhccc-cceEEEeeccc---CCCCCchhhcCccccccccccccccCCCCCccc
Q 002899           71 PTELSKLR-YLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNR---LSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI  145 (869)
Q Consensus        71 p~~l~~l~-~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~---l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  145 (869)
                      ..+|.+.+ .|+.+.|-. .++.+...+|... +|+.+.+..|.   ++.+...+|.++.+|+.+.+..+ ++......|
T Consensus        56 ~~aF~~~~~~L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF  133 (394)
T 4gt6_A           56 DRVFCNYKYVLTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAF  133 (394)
T ss_dssp             TTTTTTCCSCCCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTT
T ss_pred             HhhccCCCCcCEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhh
Confidence            34555543 356666643 2555555556554 56666665543   44444555555556665555443 232334445


Q ss_pred             cCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCC----------------------CCccccCCCCcccEEE
Q 002899          146 RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG----------------------KIPEFIGKWKKIQKLH  203 (869)
Q Consensus       146 ~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~----------------------~~~~~~~~l~~L~~L~  203 (869)
                      ..+.+|+.+.+..+ +.......|..+.+|+.+.+..+ ++.                      ....+|..+.+|....
T Consensus       134 ~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~~~l~~i~ip~~~~~i~~~af~~c~~l~~~~  211 (394)
T 4gt6_A          134 HHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTGTALTQIHIPAKVTRIGTNAFSECFALSTIT  211 (394)
T ss_dssp             TTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCCCSEEEECTTCCEECTTTTTTCTTCCEEE
T ss_pred             hhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccccceeEEEECCcccccccchhhhccccceec
Confidence            55555555555432 22233334444444554444332 111                      2222333333333333


Q ss_pred             ccCCc------------------------------------CCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccce
Q 002899          204 IQGSS------------------------------------LEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLK  247 (869)
Q Consensus       204 L~~N~------------------------------------l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~  247 (869)
                      ...+.                                    ++.....+|.++.+|+.+.+.++.............+|+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~  291 (394)
T 4gt6_A          212 SDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVVSIGTGAFMNCPALQ  291 (394)
T ss_dssp             ECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCCEECTTTTTTCTTCC
T ss_pred             ccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccceecCcccccccccc
Confidence            22111                                    111123355666667766665443322222222223577


Q ss_pred             EEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhh---ccCCceeeecc
Q 002899          248 TLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLN  324 (869)
Q Consensus       248 ~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~~l~~l~ls~N  324 (869)
                      .+.+. +.++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.|..+ ++ .+....|   .+|+.+++.+|
T Consensus       292 ~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~  367 (394)
T 4gt6_A          292 DIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGS  367 (394)
T ss_dssp             EEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSC
T ss_pred             cccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCc
Confidence            77765 4455566667777777777777654 55556667777777777777544 54 3333332   35666777665


Q ss_pred             C
Q 002899          325 N  325 (869)
Q Consensus       325 ~  325 (869)
                      .
T Consensus       368 ~  368 (394)
T 4gt6_A          368 R  368 (394)
T ss_dssp             H
T ss_pred             e
Confidence            3

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.87  E-value=4.7e-09  Score=115.83  Aligned_cols=142  Identities=15%  Similarity=0.241  Sum_probs=105.9

Q ss_pred             CCeeeccCceEEEEEEEcCCcEEEEEEec--ccC-chhhHHHHHHHHHHHhcCC--CceeeEEeEEeeC---ceEEEEEE
Q 002899          643 ANKVGEGGFGSVYKGILSDGTVIAVKQLS--SKS-RQGNREFVNEIGMISAQQH--PNLVKLYGCCVEG---NQLLLVYE  714 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~~g~~VAvK~~~--~~~-~~~~~~f~~E~~~l~~l~H--~nIv~l~~~~~~~---~~~~lV~E  714 (869)
                      .+.|+.|.++.||+....+ ..+++|+..  ... ......+.+|+++++.+.+  ..+.++++++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            4678999999999988754 578888775  322 1224577889999998874  4577889888776   45899999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS-----------------------------------  759 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----------------------------------  759 (869)
                      |+++..+.+...       ..++...+..++.++++.|+.||+..                                   
T Consensus       122 ~v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          122 FVSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             CCCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             ecCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            999877743211       13678888999999999999999731                                   


Q ss_pred             --------------------CCCeEEcCCCCCCEEEcCCCc--EEEeecCCceee
Q 002899          760 --------------------RIKIVHRDIKTSNVLLDKDLN--AKISDFGLAKLY  792 (869)
Q Consensus       760 --------------------~~~iiH~Dlk~~NILl~~~~~--~kl~DFGla~~~  792 (869)
                                          +..++|||+++.|||++.++.  +.|+||+.+..-
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                245899999999999997753  689999998754

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=98.84  E-value=1.6e-08  Score=113.05  Aligned_cols=220  Identities=13%  Similarity=0.129  Sum_probs=157.4

Q ss_pred             CccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCC
Q 002899           71 PTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI  149 (869)
Q Consensus        71 p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  149 (869)
                      ..+|.++++|+.+.|.++ +..+....|... +|+.+.+..| ++.+...+|.++..|+.+.+..+...  +...+....
T Consensus       155 ~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~  230 (394)
T 4fs7_A          155 DEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKT  230 (394)
T ss_dssp             TTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTC
T ss_pred             hhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccC
Confidence            345777777777777644 344556666665 6777777655 55455666777777777777665433  223334446


Q ss_pred             CccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcC
Q 002899          150 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRIS  229 (869)
Q Consensus       150 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~  229 (869)
                      +|+.+.+..+ ++......|.++.+|+.+.+..+... .....|..+..|+.+.+..+.+.   ...|..+.+|+.+.+.
T Consensus       231 ~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~  305 (394)
T 4fs7_A          231 GVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLL  305 (394)
T ss_dssp             CCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEEC
T ss_pred             CCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccc
Confidence            7777777653 33344566778888888888877554 66677888888888887766543   4578888999999987


Q ss_pred             CCCCCCCccccccc-ccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCC
Q 002899          230 DLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN  302 (869)
Q Consensus       230 ~n~~~~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  302 (869)
                      ++ ++.+....+.. .+|+.++|..+ ++.+...+|.++++|+.++|..| ++.+...+|.++.+|+.++|..+
T Consensus       306 ~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          306 DS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             TT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             cc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence            64 55555555544 47999999754 77778889999999999999877 77778889999999999999765

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=98.71  E-value=1.3e-07  Score=105.74  Aligned_cols=242  Identities=11%  Similarity=0.138  Sum_probs=162.9

Q ss_pred             EEEEeccCCCccccCCccccCCCCCCEEEeecCc---CCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           56 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNC---LTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        56 v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~---i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      ++.+.+.. +++.+-..+|.++++|+.+.+..|.   ++.+...+|... +|+.+.+..+ ++.+...+|..+.+|+.+.
T Consensus        66 L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~  143 (394)
T 4gt6_A           66 LTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVT  143 (394)
T ss_dssp             CCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEE
T ss_pred             CEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccc
Confidence            67777764 4776667789999999999998764   666666777665 5666555433 4445555666666666666


Q ss_pred             ccccccCCCCCccccCCCCccEEEeeccc---------------------ccccCCccccCCCCCCeEeccCCc------
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNS---------------------FTGELPAELTKLTNLNDLRISDNN------  184 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~---------------------i~~~~p~~~~~l~~L~~L~Ls~N~------  184 (869)
                      |..+- .......|..+.+|+.+.+..+-                     +......+|.++.+|+......+.      
T Consensus       144 lp~~~-~~I~~~~F~~c~~L~~i~~~~~~~~I~~~aF~~~~l~~i~ip~~~~~i~~~af~~c~~l~~~~~~~~~~~~~~~  222 (394)
T 4gt6_A          144 IPEGV-TSVADGMFSYCYSLHTVTLPDSVTAIEERAFTGTALTQIHIPAKVTRIGTNAFSECFALSTITSDSESYPAIDN  222 (394)
T ss_dssp             CCTTC-CEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCCCSEEEECTTCCEECTTTTTTCTTCCEEEECCSSSCBSSS
T ss_pred             cccee-eeecccceecccccccccccceeeEeccccccccceeEEEECCcccccccchhhhccccceecccccccccccc
Confidence            65432 22333445555555555554321                     111223344444555444333221      


Q ss_pred             ------------------------------CCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCC
Q 002899          185 ------------------------------FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS  234 (869)
Q Consensus       185 ------------------------------l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~  234 (869)
                                                    ++.+...+|.++.+|+.+.+.++... ....+|.++++|+.+.+. +.++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~  300 (394)
T 4gt6_A          223 VLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRIT  300 (394)
T ss_dssp             CEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCC
T ss_pred             eeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-Cccc
Confidence                                          11122346788899999999766554 667789999999999996 4555


Q ss_pred             CCccccccc-ccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcC
Q 002899          235 ESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL  304 (869)
Q Consensus       235 ~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  304 (869)
                      .+....+.. .+|+.++|..+ ++.+...+|.+|.+|+.+.|..+ ++.+...+|.++.+|+.+++.+|..
T Consensus       301 ~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~  369 (394)
T 4gt6_A          301 ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS  369 (394)
T ss_dssp             EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred             ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence            555555554 48999999864 77777889999999999999755 7768888999999999999999854

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.62  E-value=3.1e-07  Score=101.90  Aligned_cols=267  Identities=13%  Similarity=0.113  Sum_probs=172.6

Q ss_pred             eEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccccc
Q 002899           55 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG  134 (869)
Q Consensus        55 ~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  134 (869)
                      +++.+.+. .+++.+-..+|.++++|+.++|.. .++.+...+|...+|+.+.+..+ ++.+...+|... +|+.+.|..
T Consensus        47 ~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~-~v~~Ig~~aF~~c~l~~i~~~~~-l~~I~~~aF~~~-~L~~i~lp~  122 (379)
T 4h09_A           47 RISEVRVN-SGITSIGEANFNSCYNMTKVTVAS-TVTSIGDGAFADTKLQSYTGMER-VKKFGDYVFQGT-DLDDFEFPG  122 (379)
T ss_dssp             GCSEEEEC-TTEEEECTTTTTTCTTCCEEEECT-TCCEECTTTTTTCCCCEEEECTT-CCEECTTTTTTC-CCSEEECCT
T ss_pred             CCEEEEeC-CCccChHHHHhhCCCCCCEEEeCC-cceEechhhhcCCCCceEECCce-eeEeccceeccC-CcccccCCC
Confidence            46677775 467766667899999999999975 48888888998888888888654 555666667654 788888876


Q ss_pred             cccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCC----------------------------
Q 002899          135 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS----------------------------  186 (869)
Q Consensus       135 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~----------------------------  186 (869)
                      +-.. .....|.+. +|+.+.+..+ ++......|..+.+|+.+.+..+...                            
T Consensus       123 ~~~~-i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (379)
T 4h09_A          123 ATTE-IGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEF  199 (379)
T ss_dssp             TCCE-ECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEE
T ss_pred             cccc-ccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceecccccccccccc
Confidence            5322 333344433 4555555443 33233445555555555554433211                            


Q ss_pred             -------CCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCccccccc-ccceEEEcccccCcc
Q 002899          187 -------GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHG  258 (869)
Q Consensus       187 -------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~-~~L~~L~Ls~N~i~~  258 (869)
                             ......+....+|+.+.+..+ +.......+.++.+|+.+.+..+ ++.+....+.. .+|+.+.+..+ ++.
T Consensus       200 ~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~  276 (379)
T 4h09_A          200 TIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKT  276 (379)
T ss_dssp             ECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSE
T ss_pred             ccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-cee
Confidence                   122334555667777777544 34355667888888888888765 44444333333 36888888643 665


Q ss_pred             CCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhh---ccCCceeeeccCccCCCCCCC
Q 002899          259 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWESSDPI  334 (869)
Q Consensus       259 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~~l~~l~ls~N~~~~~~~~p~  334 (869)
                      .....|.++++|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++ .+....|   .+|+.+.+..+ ++..+...+
T Consensus       277 i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF  352 (379)
T 4h09_A          277 VPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISYPKS-ITLIESGAF  352 (379)
T ss_dssp             ECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECTTTT
T ss_pred             ccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEECCc-cCEEchhHh
Confidence            66777888999999999888888777788888999999988755 55 3444333   35777777544 554444444

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.41  E-value=4.3e-08  Score=97.17  Aligned_cols=114  Identities=16%  Similarity=0.182  Sum_probs=60.3

Q ss_pred             hhcCcccccccccccc-ccCCC----CCccccCCCCccEEEeeccccccc----CCccccCCCCCCeEeccCCcCCCC--
Q 002899          120 VLTNITTLKNLSIEGN-LFTGS----IPPDIRKLINLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGK--  188 (869)
Q Consensus       120 ~~~~l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~--  188 (869)
                      .+...+.|++|+|++| .|...    +...+...++|++|+|++|+|...    +...+...++|++|+|++|.|+..  
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~  110 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI  110 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence            3444555555555555 54421    122334445566666666665532    223334445666666666666532  


Q ss_pred             --CccccCCCCcccEEEc--cCCcCCCC----chHhhhcCCCCCEEEcCCCCC
Q 002899          189 --IPEFIGKWKKIQKLHI--QGSSLEGP----IPASISALTSLTDLRISDLKG  233 (869)
Q Consensus       189 --~~~~~~~l~~L~~L~L--~~N~l~~~----~~~~l~~l~~L~~L~L~~n~~  233 (869)
                        +...+...++|++|+|  ++|.|...    +...+...++|+.|+|++|.+
T Consensus       111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i  163 (185)
T 1io0_A          111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  163 (185)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence              2344555566666666  56666542    234445556666666665554

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.40  E-value=4.8e-08  Score=102.00  Aligned_cols=104  Identities=23%  Similarity=0.268  Sum_probs=72.6

Q ss_pred             hcCcccccc--ccccccccCCCCCc----cccCCCCccEEEeecccccc--cCCccccCCCCCCeEeccCCcCCCCCccc
Q 002899          121 LTNITTLKN--LSIEGNLFTGSIPP----DIRKLINLQKLILSSNSFTG--ELPAELTKLTNLNDLRISDNNFSGKIPEF  192 (869)
Q Consensus       121 ~~~l~~L~~--L~Ls~N~l~~~~~~----~~~~l~~L~~L~Ls~N~i~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  192 (869)
                      |...+.|+.  ++++.|+.. .++.    ...++++|++|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..
T Consensus       137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~  213 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RE  213 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GG
T ss_pred             cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hh
Confidence            555556665  666777433 2222    22467888888888888886  4456677888899999999988854  33


Q ss_pred             cCCCC--cccEEEccCCcCCCCch-------HhhhcCCCCCEEE
Q 002899          193 IGKWK--KIQKLHIQGSSLEGPIP-------ASISALTSLTDLR  227 (869)
Q Consensus       193 ~~~l~--~L~~L~L~~N~l~~~~~-------~~l~~l~~L~~L~  227 (869)
                      +..+.  +|++|+|++|.+.+..|       ..+..+++|+.||
T Consensus       214 l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          214 LDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             GGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             hhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            34444  88999999999886443       4578888888886

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.39  E-value=7.5e-08  Score=95.46  Aligned_cols=121  Identities=14%  Similarity=0.132  Sum_probs=76.8

Q ss_pred             CccccCCCCCCeEeccCC-cCCCC----CccccCCCCcccEEEccCCcCCCC----chHhhhcCCCCCEEEcCCCCCCCC
Q 002899          166 PAELTKLTNLNDLRISDN-NFSGK----IPEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSES  236 (869)
Q Consensus       166 p~~~~~l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~n~~~~~  236 (869)
                      ...+...++|++|+|++| .|...    +...+...++|++|+|++|.|...    +...+...++|+.|+|++|.+...
T Consensus        29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~  108 (185)
T 1io0_A           29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS  108 (185)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred             HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence            344566778888888888 77632    334455667777777777777642    234445556666666665554432


Q ss_pred             cccccccccceEEEcccccCccCCCcccCCCCCcCEEec--cCCCCCCC----CchhhhcCCCCCEEEeeCCcCC
Q 002899          237 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDL--SFNNLTGG----IPTTFEKLAKTNFMYLTGNKLT  305 (869)
Q Consensus       237 ~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  305 (869)
                      ....                   +...+...++|++|+|  ++|.|+..    +...+...++|+.|+|++|.+.
T Consensus       109 g~~~-------------------l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          109 GILA-------------------LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHH-------------------HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHH-------------------HHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            2111                   2344556678888888  77888743    3345556688888888888775

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.37  E-value=2.9e-06  Score=93.98  Aligned_cols=241  Identities=14%  Similarity=0.080  Sum_probs=164.2

Q ss_pred             ceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCcccccccccc
Q 002899           54 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE  133 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  133 (869)
                      ..++.++|.. +++.+-..+|.+. +|+.+.+.. .++.+...+|...+|+.+.+..+ +..+...+|.+. +|+.+.+.
T Consensus        69 ~~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~-~l~~I~~~aF~~~~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~  143 (379)
T 4h09_A           69 YNMTKVTVAS-TVTSIGDGAFADT-KLQSYTGME-RVKKFGDYVFQGTDLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIP  143 (379)
T ss_dssp             TTCCEEEECT-TCCEECTTTTTTC-CCCEEEECT-TCCEECTTTTTTCCCSEEECCTT-CCEECTTTTTTC-CCCEEEEC
T ss_pred             CCCCEEEeCC-cceEechhhhcCC-CCceEECCc-eeeEeccceeccCCcccccCCCc-cccccccccccc-eeeeeecc
Confidence            3578888864 4775556677776 687877764 46666777777778888888654 332334444443 34444443


Q ss_pred             ccccCCCCCccccCCCCccEEEeecccc-----------------------------------cccCCccccCCCCCCeE
Q 002899          134 GNLFTGSIPPDIRKLINLQKLILSSNSF-----------------------------------TGELPAELTKLTNLNDL  178 (869)
Q Consensus       134 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~i-----------------------------------~~~~p~~~~~l~~L~~L  178 (869)
                      .+ ++......|....+|+.+.+..+..                                   .......+....+|+.+
T Consensus       144 ~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i  222 (379)
T 4h09_A          144 KS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYGFSYGKNLKKI  222 (379)
T ss_dssp             TT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTTTTTCSSCSEE
T ss_pred             ce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeEEeeccccccccccee
Confidence            32 2223333444455555444433211                                   11233455667788888


Q ss_pred             eccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCccccccc-ccceEEEcccccCc
Q 002899          179 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIH  257 (869)
Q Consensus       179 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~-~~L~~L~Ls~N~i~  257 (869)
                      .+..+ +..+...+|.++..|+.+.+..+ ++.....+|.++.+|+.+.+..+ +.......+.. .+|+.+.+.++.++
T Consensus       223 ~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~  299 (379)
T 4h09_A          223 TITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE  299 (379)
T ss_dssp             ECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC
T ss_pred             eeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccc
Confidence            88765 44466778889999999999876 66566788999999999998654 44444444443 47999999999999


Q ss_pred             cCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCC
Q 002899          258 GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT  305 (869)
Q Consensus       258 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  305 (869)
                      .+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+..+ ++
T Consensus       300 ~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~  345 (379)
T 4h09_A          300 TLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-IT  345 (379)
T ss_dssp             EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CC
T ss_pred             eehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cC
Confidence            888899999999999999765 77677788999999999998765 54

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.25  E-value=5.9e-06  Score=86.80  Aligned_cols=137  Identities=13%  Similarity=0.101  Sum_probs=95.0

Q ss_pred             eeeccCce-EEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCC-CceeeEEeEEeeCceEEEEEEeccCCch
Q 002899          645 KVGEGGFG-SVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYEYMKNNCL  721 (869)
Q Consensus       645 ~IG~G~fG-~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~E~~~~gsL  721 (869)
                      .+..|..| .||+.... ++..+++|+-...   ...++.+|.+.|+.+.. --+.++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45566665 69987765 4567888976432   34567889998887742 2355788999999999999999999887


Q ss_pred             hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 002899          722 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-------------------------------------------  758 (869)
Q Consensus       722 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------  758 (869)
                      .+.....         ......++.++++.|.-||..                                           
T Consensus       108 ~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          108 FQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             cccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            6544221         112234455555555555531                                           


Q ss_pred             ------------CCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          759 ------------SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       759 ------------~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                                  .++.++|+|+.+.|||++.++.+-|+||+.+....
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd  225 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD  225 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence                        12237899999999999988777899999986543

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.25  E-value=7.6e-06  Score=87.85  Aligned_cols=180  Identities=15%  Similarity=0.125  Sum_probs=111.0

Q ss_pred             CCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCC---ceeeEEeEEe-eCceEEEEEEeccC
Q 002899          643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHP---NLVKLYGCCV-EGNQLLLVYEYMKN  718 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~---nIv~l~~~~~-~~~~~~lV~E~~~~  718 (869)
                      .+.++.|....||+.    ++.+++|+..  .......+..|++++..+.+.   .+.+++.+.. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888888899987    4667888753  223356788999999998753   2456666664 34567899999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED----------------------------------------  758 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------  758 (869)
                      ..+......       .++...+..++.++++.|+.||+.                                        
T Consensus        98 ~~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           98 QILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             EECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             eECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            888653211       123344444445555544444432                                        


Q ss_pred             -----------------CCCCeEEcCCCCCCEEEcC---CCc-EEEeecCCceeecCCCccccccccccccccchhh---
Q 002899          759 -----------------SRIKIVHRDIKTSNVLLDK---DLN-AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY---  814 (869)
Q Consensus       759 -----------------~~~~iiH~Dlk~~NILl~~---~~~-~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~---  814 (869)
                                       .++.++|+|+++.||+++.   ++. +.|+||+.+..-.+...-...  .   ....|+.   
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~~~Dla~~--~---~~~~~~~~~~  245 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPDYDYVYL--L---EDCGELFTRQ  245 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECGGGGGHHH--H---HHTCHHHHHH
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCHHHHHHHH--H---HhcCHHHHHH
Confidence                             2334799999999999987   455 489999988765432211100  0   0011211   


Q ss_pred             -cccCC---C---CchhHHHHHHHHHHHHHcCC
Q 002899          815 -AMRGY---L---TSKADVYSFGVVTLEIVSGK  840 (869)
Q Consensus       815 -~~~~~---~---~~k~DvwSlGvil~elltG~  840 (869)
                       +....   .   ..+.++|++..++..++.|.
T Consensus       246 ~~~Y~~~~~~~~~~~r~~~~~~~~~l~~~~~~~  278 (306)
T 3tdw_A          246 VMAYRGEVDLDTHIRKVSLFVTFDQVSYLLEGL  278 (306)
T ss_dssp             HHHHTTCSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhcccccCCCHHHHHHHHHHHHHHHHHHHHH
Confidence             11110   0   34678899888777766554

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.17  E-value=2.5e-07  Score=96.62  Aligned_cols=30  Identities=23%  Similarity=0.164  Sum_probs=17.3

Q ss_pred             CcCEEeccCCCCCCCCc-------hhhhcCCCCCEEE
Q 002899          269 KLKNIDLSFNNLTGGIP-------TTFEKLAKTNFMY  298 (869)
Q Consensus       269 ~L~~L~Ls~N~l~~~~p-------~~~~~l~~L~~L~  298 (869)
                      +|+.|+|++|.+++..|       ..+..+++|+.||
T Consensus       221 ~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          221 KLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             CCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             CcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            56666666666655443       2355666666654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.00  E-value=1.1e-05  Score=88.61  Aligned_cols=79  Identities=6%  Similarity=0.011  Sum_probs=54.5

Q ss_pred             Cee-eccCceEEEEEEEc-------CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCC---CceeeEEeEEeeC---
Q 002899          644 NKV-GEGGFGSVYKGILS-------DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQH---PNLVKLYGCCVEG---  706 (869)
Q Consensus       644 ~~I-G~G~fG~Vyka~~~-------~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H---~nIv~l~~~~~~~---  706 (869)
                      +.| +.|....+|+....       +++.+++|+.....   ......+..|+++++.+..   -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            557 78888999998764       26678888865432   1112467788888887742   2456788877655   


Q ss_pred             ceEEEEEEeccCCchh
Q 002899          707 NQLLLVYEYMKNNCLS  722 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~  722 (869)
                      +..++||||+++..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999987654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.83  E-value=9.9e-06  Score=78.50  Aligned_cols=84  Identities=13%  Similarity=0.163  Sum_probs=56.5

Q ss_pred             CCccEEEeecccccccCCccccCCCCCCeEeccCCc-CCCCCccccCCC----CcccEEEccCCc-CCCCchHhhhcCCC
Q 002899          149 INLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN-FSGKIPEFIGKW----KKIQKLHIQGSS-LEGPIPASISALTS  222 (869)
Q Consensus       149 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~~~~l~~l~~  222 (869)
                      .+|++|||+++.|+..--..+.++++|++|+|++|. |+..--..++.+    ++|++|+|++|. |+...-..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            467777777777776555566777777777777774 554444445553    367888887764 66555566777777


Q ss_pred             CCEEEcCCCC
Q 002899          223 LTDLRISDLK  232 (869)
Q Consensus       223 L~~L~L~~n~  232 (869)
                      |+.|+|+++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            7777777654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.80  E-value=8.3e-05  Score=80.69  Aligned_cols=144  Identities=16%  Similarity=0.243  Sum_probs=80.4

Q ss_pred             CeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhc-----CCCceeeEE-e--EEeeCceEEEEEEe
Q 002899          644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-----QHPNLVKLY-G--CCVEGNQLLLVYEY  715 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l-----~H~nIv~l~-~--~~~~~~~~~lV~E~  715 (869)
                      +.|+.|..+.||+....+| .+++|+....    ..++..|.+++..+     ..|.++... |  +....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3466677889999987655 4889988652    12333444444433     234444311 1  12346678999999


Q ss_pred             ccCCchh--------------hhhhcCCccc---------ccCCCHHHH-------------------------------
Q 002899          716 MKNNCLS--------------RAIFGKDTEY---------RLKLDWPTR-------------------------------  741 (869)
Q Consensus       716 ~~~gsL~--------------~~l~~~~~~~---------~~~l~~~~~-------------------------------  741 (869)
                      +++..+.              ..+|......         ...-.|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              1122111000         001233221                               


Q ss_pred             HHHHHHHHHHHHHHHh----------cCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          742 KKICIGIARGLAYLHE----------DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       742 ~~i~~~ia~gL~yLH~----------~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      ..+...+.+++++|++          ..+..++|||+++.|||++.++.+.|+||+.+..-
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g  253 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD  253 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence            0111223446667763          12345999999999999988889999999987643

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.74  E-value=9.4e-06  Score=78.66  Aligned_cols=82  Identities=15%  Similarity=0.178  Sum_probs=37.9

Q ss_pred             cccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCC-CCCCcccccccc-----cceEEEcccc-cCccCCCcccCCCCCc
Q 002899          198 KIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK-GSESAFPKLDKM-----NLKTLILTKC-LIHGEIPDYIGDMTKL  270 (869)
Q Consensus       198 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~-~~~~~~~~~~~~-----~L~~L~Ls~N-~i~~~~p~~~~~l~~L  270 (869)
                      +|+.|+|+++.++......+..+++|+.|+|+++. +++.....+...     +|+.|+|++| +|++..-..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            34555555554444333444455555555554442 333332222221     3444455554 2544433444556666


Q ss_pred             CEEeccCCC
Q 002899          271 KNIDLSFNN  279 (869)
Q Consensus       271 ~~L~Ls~N~  279 (869)
                      ++|+|+++.
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            666666653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.71  E-value=0.00011  Score=81.89  Aligned_cols=75  Identities=15%  Similarity=0.214  Sum_probs=49.2

Q ss_pred             CCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-------hhhHHHHHHHHHHHhcCC--Cce-eeEEeEEeeCceEEE
Q 002899          643 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-------QGNREFVNEIGMISAQQH--PNL-VKLYGCCVEGNQLLL  711 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-------~~~~~f~~E~~~l~~l~H--~nI-v~l~~~~~~~~~~~l  711 (869)
                      .+.||.|.++.||++... +++.++||.......       ....++..|.+++..+..  +.. .+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999754 467899998654321       123456778888887632  333 355544  3445689


Q ss_pred             EEEeccCC
Q 002899          712 VYEYMKNN  719 (869)
Q Consensus       712 V~E~~~~g  719 (869)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.54  E-value=0.0003  Score=74.52  Aligned_cols=77  Identities=18%  Similarity=0.151  Sum_probs=56.7

Q ss_pred             CCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCC---ceeeEEeEEeeCceEEEEEEecc
Q 002899          641 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHP---NLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       641 ~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~---nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      ...+.+|.|..+.||+.++.+|+.|++|+...........|..|++.|+.+.-.   -+.+++++.    .-++||||++
T Consensus        18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~   93 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVD   93 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCC
T ss_pred             EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeec
Confidence            345779999999999999999999999987655444445688899999887422   234455442    3478999998


Q ss_pred             CCch
Q 002899          718 NNCL  721 (869)
Q Consensus       718 ~gsL  721 (869)
                      ++..
T Consensus        94 ~~~~   97 (288)
T 3f7w_A           94 ERPP   97 (288)
T ss_dssp             CCCC
T ss_pred             ccCC
Confidence            7654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.53  E-value=0.00042  Score=74.15  Aligned_cols=140  Identities=15%  Similarity=0.155  Sum_probs=92.5

Q ss_pred             CCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcC---CCceeeEEeEEeeCceEEEEEEeccCC
Q 002899          643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEGNQLLLVYEYMKNN  719 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~E~~~~g  719 (869)
                      .+.|+.|....+|+... +++.+++|+....   ....|..|++.|+.+.   ...+.+++++....+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            45689999999999876 4677889987532   2456888988888774   345778888888888899999999987


Q ss_pred             chh-----------hhhhcCCc--cccc---------------CCCHHHHH---HHHH----------------HHHH-H
Q 002899          720 CLS-----------RAIFGKDT--EYRL---------------KLDWPTRK---KICI----------------GIAR-G  751 (869)
Q Consensus       720 sL~-----------~~l~~~~~--~~~~---------------~l~~~~~~---~i~~----------------~ia~-g  751 (869)
                      .+.           ..||....  ....               .-+|....   ++..                .++. .
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            652           12343221  1100               12465322   1111                1111 1


Q ss_pred             HHHHHh-cCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          752 LAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       752 L~yLH~-~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                      ...|.. ..++.++|+|+.+.|++++.++ +.|.|+.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            233432 2346689999999999999887 8999984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.44  E-value=0.00032  Score=78.67  Aligned_cols=79  Identities=11%  Similarity=0.076  Sum_probs=49.8

Q ss_pred             CCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcccccccc-ccccccchhhcccC---CCCchhHHHHHHHHHHH
Q 002899          760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA-GTIGYMAPEYAMRG---YLTSKADVYSFGVVTLE  835 (869)
Q Consensus       760 ~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~-gt~~y~aPE~~~~~---~~~~k~DvwSlGvil~e  835 (869)
                      +..++|||+++.|||++.++ ++|+||+.+..-.....-.. ... -...|++|+.....   ......++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGA-YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHH-HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHH-HHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            44589999999999999876 99999999876532211000 000 01356666655321   11224566688888888


Q ss_pred             HHcCC
Q 002899          836 IVSGK  840 (869)
Q Consensus       836 lltG~  840 (869)
                      .++++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            88764

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.26  E-value=6.5e-05  Score=74.15  Aligned_cols=15  Identities=7%  Similarity=0.328  Sum_probs=6.7

Q ss_pred             CCCCCeEeccCCcCC
Q 002899          172 LTNLNDLRISDNNFS  186 (869)
Q Consensus       172 l~~L~~L~Ls~N~l~  186 (869)
                      -+.|+.|+|++|+|.
T Consensus        69 N~~L~~L~L~~n~ig   83 (197)
T 1pgv_A           69 SKHIEKFSLANTAIS   83 (197)
T ss_dssp             CSCCCEEECTTSCCB
T ss_pred             CCCcCEEEccCCCCC
Confidence            344444444444443

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.22  E-value=0.00013  Score=72.07  Aligned_cols=117  Identities=11%  Similarity=0.069  Sum_probs=66.6

Q ss_pred             ccCCCCCCeEeccCC-cCCCC----CccccCCCCcccEEEccCCcCCC----CchHhhhcCCCCCEEEcCCCCCCCCccc
Q 002899          169 LTKLTNLNDLRISDN-NFSGK----IPEFIGKWKKIQKLHIQGSSLEG----PIPASISALTSLTDLRISDLKGSESAFP  239 (869)
Q Consensus       169 ~~~l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~~~~l~~l~~L~~L~L~~n~~~~~~~~  239 (869)
                      +.+-+.|++|+|++| +|...    +.+++..-+.|+.|+|++|.|..    .+...+..-+.|+.|+|+.|.|......
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~  116 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA  116 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence            344566777777764 66421    33445555667777777777653    3344445555566666555554433222


Q ss_pred             ccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCC---CC----CCchhhhcCCCCCEEEeeCCcC
Q 002899          240 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNL---TG----GIPTTFEKLAKTNFMYLTGNKL  304 (869)
Q Consensus       240 ~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l---~~----~~p~~~~~l~~L~~L~Ls~N~l  304 (869)
                      .                   +...+..-+.|+.|+|++|..   ..    .+...+..-+.|+.|+|+.|.+
T Consensus       117 a-------------------la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          117 R-------------------LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             H-------------------HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             H-------------------HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence            1                   223445556688888876533   31    2334566677888888877754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.05  E-value=0.0016  Score=71.57  Aligned_cols=144  Identities=19%  Similarity=0.252  Sum_probs=84.7

Q ss_pred             CeeeccCceEEEEEEEc--------CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCce-eeEEeEEeeCceEEEEEE
Q 002899          644 NKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL-VKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~--------~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~E  714 (869)
                      +.+..|-...+|+....        +++.+++|+.... ........+|.++++.+.-..+ .++++++..    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            45766777889998864        2478899986432 2234556688888877643233 466766543    28999


Q ss_pred             eccCCchhh-----------------hhhcCCcccccCC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 002899          715 YMKNNCLSR-----------------AIFGKDTEYRLKL--DWPTRKKICIGIAR-------------------GLAYLH  756 (869)
Q Consensus       715 ~~~~gsL~~-----------------~l~~~~~~~~~~l--~~~~~~~i~~~ia~-------------------gL~yLH  756 (869)
                      |+++..+..                 .+|..+.......  -|.++.++..++..                   .++.|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            999866531                 1233221111122  24555555544322                   233332


Q ss_pred             ----hc-CCCCeEEcCCCCCCEEEcCC----CcEEEeecCCceee
Q 002899          757 ----ED-SRIKIVHRDIKTSNVLLDKD----LNAKISDFGLAKLY  792 (869)
Q Consensus       757 ----~~-~~~~iiH~Dlk~~NILl~~~----~~~kl~DFGla~~~  792 (869)
                          .. .+..++|+|+.+.|||++.+    +.+.|+||..+..-
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~  255 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN  255 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence                22 23347899999999999876    78999999988754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.95  E-value=0.011  Score=63.13  Aligned_cols=162  Identities=13%  Similarity=0.143  Sum_probs=88.1

Q ss_pred             ccHHHHHHHhcCCCCC-----CeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCc--eeeEE
Q 002899          628 YTLRQIKAATNNFDPA-----NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN--LVKLY  700 (869)
Q Consensus       628 ~~~~~i~~~t~~f~~~-----~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~n--Iv~l~  700 (869)
                      .+.+++...-..|.+.     +.|+.|....+|+....+| .+++|+.....  ...++..|++++..+....  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            3445555555556552     3466788889999987666 57889876521  1234455666666553212  22333


Q ss_pred             eE------EeeCceEEEEEEeccCCchhh--------------hhhcCCcccccC-------CCHHHHHH----------
Q 002899          701 GC------CVEGNQLLLVYEYMKNNCLSR--------------AIFGKDTEYRLK-------LDWPTRKK----------  743 (869)
Q Consensus       701 ~~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~~~~~~~-------l~~~~~~~----------  743 (869)
                      ..      ....+..+++|+|+++..+..              .+|........+       ..|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            11      123456789999999765421              122110000000       12332111          


Q ss_pred             --HHHHHHHHHHHHHhc----CCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          744 --ICIGIARGLAYLHED----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       744 --i~~~ia~gL~yLH~~----~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                        +...+.+.++++++.    .+..++|+|+.+.|||++.+..+.|+||+.+..-
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~g  218 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACND  218 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccCc
Confidence              011244456666532    2345899999999999998766689999987653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.94  E-value=0.005  Score=66.40  Aligned_cols=145  Identities=15%  Similarity=0.128  Sum_probs=73.4

Q ss_pred             CeeeccCceE-EEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCC--CceeeEEeEEeeCceEEEEEEeccCCc
Q 002899          644 NKVGEGGFGS-VYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH--PNLVKLYGCCVEGNQLLLVYEYMKNNC  720 (869)
Q Consensus       644 ~~IG~G~fG~-Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~E~~~~gs  720 (869)
                      +.|+.|+... +|+....+++.+++|.......   .++..|++++..+..  -.+.+++.+..+.+  +++||++++..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            3465565544 6677654467777776543321   233455666655532  22446666644443  68999998766


Q ss_pred             hhhhhhcCCc---------------------ccccCCCHHHHH--------------------HHHHHHHHHHHHHHh--
Q 002899          721 LSRAIFGKDT---------------------EYRLKLDWPTRK--------------------KICIGIARGLAYLHE--  757 (869)
Q Consensus       721 L~~~l~~~~~---------------------~~~~~l~~~~~~--------------------~i~~~ia~gL~yLH~--  757 (869)
                      +.+.+.+...                     .....++.....                    .....+.+.++.+.+  
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            6543322110                     000011111100                    000112222333321  


Q ss_pred             -cCCCCeEEcCCCCCCEEEcCC----CcEEEeecCCceeec
Q 002899          758 -DSRIKIVHRDIKTSNVLLDKD----LNAKISDFGLAKLYE  793 (869)
Q Consensus       758 -~~~~~iiH~Dlk~~NILl~~~----~~~kl~DFGla~~~~  793 (869)
                       ..+..++|||+.+.|||++.+    ..+.|+||+.+..-.
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence             224458999999999999875    689999999987654

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.92  E-value=0.0051  Score=66.04  Aligned_cols=145  Identities=12%  Similarity=0.053  Sum_probs=81.3

Q ss_pred             CeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCc--eeeEEeE-----EeeCceEEEEEEec
Q 002899          644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN--LVKLYGC-----CVEGNQLLLVYEYM  716 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~n--Iv~l~~~-----~~~~~~~~lV~E~~  716 (869)
                      ..++ |....||+....+|+.+++|....... ....+..|.+++..+....  +.+++..     ....+..++||||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3466 777899998877777899999864311 2345666777776653212  3344432     22345668899999


Q ss_pred             cCCchhh--------------hhhcC----CcccccCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 002899          717 KNNCLSR--------------AIFGK----DTEYRLKLDWPTR----KKI---------------CIGIARGLAYLHED-  758 (869)
Q Consensus       717 ~~gsL~~--------------~l~~~----~~~~~~~l~~~~~----~~i---------------~~~ia~gL~yLH~~-  758 (869)
                      ++..+..              .+|..    ........++...    ..+               ...+.+.++.+.+. 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8755420              11211    0000111222211    001               11111223333321 


Q ss_pred             ---CCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          759 ---SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       759 ---~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                         .+..++|||+++.|||++ + .+.|+||+.+..-
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence               234478999999999999 5 8999999987654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.89  E-value=0.003  Score=67.18  Aligned_cols=142  Identities=12%  Similarity=0.146  Sum_probs=76.5

Q ss_pred             CCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCce-eeEEeEEeeCceEEEEEEec-cCCc
Q 002899          643 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL-VKLYGCCVEGNQLLLVYEYM-KNNC  720 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~E~~-~~gs  720 (869)
                      .+.|+.|....+|+.     +.+++|+....... ......|+++++.+....+ .++++++  .+.-++|+||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            577999999999998     45888887653221 1233457777766543233 3555543  33346899999 5544


Q ss_pred             hhh------------------hhhcCCcccccCCC-HHHHHHHHH--------------HHHHHH----HHHHh-cCCCC
Q 002899          721 LSR------------------AIFGKDTEYRLKLD-WPTRKKICI--------------GIARGL----AYLHE-DSRIK  762 (869)
Q Consensus       721 L~~------------------~l~~~~~~~~~~l~-~~~~~~i~~--------------~ia~gL----~yLH~-~~~~~  762 (869)
                      +..                  .+|..........+ +.....+..              .+.+.+    +.+.. ..+..
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            421                  12222111100111 111111111              011111    12211 22344


Q ss_pred             eEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       763 iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ++|+|+.+.||+ ..++.+.++||..+..-.
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~  204 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGMND  204 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence            789999999999 667788999999887543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.75  E-value=0.0052  Score=68.84  Aligned_cols=73  Identities=18%  Similarity=0.221  Sum_probs=49.5

Q ss_pred             CCeeeccCceEEEEEEEcC--------CcEEEEEEecccCchhhHHHHHHHHHHHhcCCCce-eeEEeEEeeCceEEEEE
Q 002899          643 ANKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL-VKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~~--------g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~  713 (869)
                      .+.|+.|....+|+....+        ++.+++|+......  ...+..|..++..+...++ .++++.+..    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3567888889999998753        47899998844211  1455678888887743344 467766542    2899


Q ss_pred             EeccCCch
Q 002899          714 EYMKNNCL  721 (869)
Q Consensus       714 E~~~~gsL  721 (869)
                      ||+++.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986454

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.61  E-value=0.012  Score=66.25  Aligned_cols=74  Identities=14%  Similarity=0.046  Sum_probs=48.3

Q ss_pred             CCeeeccCceEEEEEEEcC-CcEEEEEEecccCchhhHHHHHHHHHHHhcCCCce-eeEEeEEeeCceEEEEEEeccCCc
Q 002899          643 ANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL-VKLYGCCVEGNQLLLVYEYMKNNC  720 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~~-g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~E~~~~gs  720 (869)
                      .+.|+.|-...+|+....+ +..+++|+...... ...+-..|..++..+...++ .++++.+. .   .+||||+++..
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCcc
Confidence            3568888889999998765 47788998754321 11222578888888865555 46777763 2   25999998755


Q ss_pred             h
Q 002899          721 L  721 (869)
Q Consensus       721 L  721 (869)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.43  E-value=0.0036  Score=57.54  Aligned_cols=56  Identities=14%  Similarity=0.325  Sum_probs=29.5

Q ss_pred             EEEeeccccc-ccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCC
Q 002899          153 KLILSSNSFT-GELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE  210 (869)
Q Consensus       153 ~L~Ls~N~i~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  210 (869)
                      .++.++++++ ..+|..+.  ++|++|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            4555555554 23333322  34566666666666555555555556666666655554

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.27  E-value=0.0089  Score=65.48  Aligned_cols=73  Identities=10%  Similarity=0.086  Sum_probs=43.1

Q ss_pred             CeeeccCceEEEEEEEcC---------CcEEEEEEecccCchhhHHHHHHHHHHHhcCCCce-eeEEeEEeeCceEEEEE
Q 002899          644 NKVGEGGFGSVYKGILSD---------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL-VKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~---------g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~  713 (869)
                      +.|+.|....+|+....+         ++.+++|+...... ...+...|.+++..+....+ .++++..  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            457778888999988754         26788888754322 12234567777776643333 3666544  2  26899


Q ss_pred             EeccCCch
Q 002899          714 EYMKNNCL  721 (869)
Q Consensus       714 E~~~~gsL  721 (869)
                      ||+++..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.64  E-value=0.041  Score=59.43  Aligned_cols=34  Identities=26%  Similarity=0.384  Sum_probs=29.0

Q ss_pred             CCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       760 ~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      +..++|+|+.+.||++++++.+.|+||+.+....
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            3458999999999999988889999999876543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.66  E-value=0.084  Score=58.65  Aligned_cols=143  Identities=10%  Similarity=0.093  Sum_probs=84.1

Q ss_pred             CeeeccCceEEEEEEEcC--------CcEEEEEEecccCchhhHHHHHHHHHHHhcCCCce-eeEEeEEeeCceEEEEEE
Q 002899          644 NKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL-VKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~--------g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~E  714 (869)
                      +.+..|-...+|+....+        ++.+++|+..... ....+-.+|.++++.+.-..+ .++++.+.    -++|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            456667778999988753        5788999865432 222234567777777643333 35565332    268999


Q ss_pred             eccCCchhh-----------------hhhcCCc-----c---cccCCCHHHHHHHHHHH-------------------HH
Q 002899          715 YMKNNCLSR-----------------AIFGKDT-----E---YRLKLDWPTRKKICIGI-------------------AR  750 (869)
Q Consensus       715 ~~~~gsL~~-----------------~l~~~~~-----~---~~~~l~~~~~~~i~~~i-------------------a~  750 (869)
                      |+++..+..                 .+|..+.     .   ...+.-|.++.++..++                   ..
T Consensus       151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  230 (424)
T 3mes_A          151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE  230 (424)
T ss_dssp             CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred             EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence            999866421                 1121111     0   11122344444443322                   22


Q ss_pred             HHHHHHh---------------------cCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          751 GLAYLHE---------------------DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       751 gL~yLH~---------------------~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      .+++|.+                     ..+..++|+|+.+.||+ +.++.+.|+||..+...
T Consensus       231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~  292 (424)
T 3mes_A          231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN  292 (424)
T ss_dssp             HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence            2333321                     12234789999999999 88889999999998754

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.88  E-value=0.28  Score=54.06  Aligned_cols=30  Identities=23%  Similarity=0.424  Sum_probs=25.3

Q ss_pred             eEEcCCCCCCEEE------cCCCcEEEeecCCceee
Q 002899          763 IVHRDIKTSNVLL------DKDLNAKISDFGLAKLY  792 (869)
Q Consensus       763 iiH~Dlk~~NILl------~~~~~~kl~DFGla~~~  792 (869)
                      ++|+|+.+.|||+      +++..++++||..|..-
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            4699999999999      34677999999998754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=87.53  E-value=1.8  Score=42.89  Aligned_cols=105  Identities=10%  Similarity=0.074  Sum_probs=67.0

Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      .-||.+.|...+    .++++++++.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.+.+.+ +.+.       
T Consensus        32 ~vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-------   97 (229)
T 2yle_A           32 ALSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-------   97 (229)
T ss_dssp             EEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred             cccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-------
Confidence            347888886554    389999999999999999877622110 1 1233446889999999888764 1110       


Q ss_pred             cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 002899          798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~  843 (869)
                            .....+.|||... ...+.+.=|||+|+++|.-+-=..|-
T Consensus        98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e  136 (229)
T 2yle_A           98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE  136 (229)
T ss_dssp             ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence                  0112566888653 35578889999999999988654443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	869
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-63
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-62
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-60
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-58
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-57
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-55
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-55
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-55
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-54
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-54
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-53
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-53
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-53
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-53
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-52
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-52
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-51
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-51
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-50
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-48
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-48
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-47
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-45
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-44
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-43
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-37
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-35
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-26
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-22
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-07
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-14
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-14
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-05
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-11
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-11
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-10
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-10
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.004
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	6e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (542), Expect = 7e-63
 Identities = 49/207 (23%), Positives = 97/207 (46%), Gaps = 12/207 (5%)

Query: 636 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQH 693
             ++F+  +++G G  G V+K      G V+A K +  + +   R   + E+ ++     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P +V  YG      ++ +  E+M    L + +         ++      K+ I + +GL 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLT 118

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YL    + KI+HRD+K SN+L++     K+ DFG++    +          GT  YM+PE
Sbjct: 119 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPE 173

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                + + ++D++S G+  +E+  G+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 4e-62
 Identities = 59/207 (28%), Positives = 108/207 (52%), Gaps = 12/207 (5%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
                  ++G G FG+VYKG       + +  +++ + Q  + F NE+G++   +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
              G      QL +V ++ + + L   +   +T    K +      I    A+G+ YLH 
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHA 122

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE-DKTHISTRIAGTIGYMAPEYAM 816
                I+HRD+K++N+ L +DL  KI DFGLA +      +H   +++G+I +MAPE   
Sbjct: 123 K---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 817 ---RGYLTSKADVYSFGVVTLEIVSGK 840
              +   + ++DVY+FG+V  E+++G+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 2e-60
 Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 9/229 (3%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
                  ++G G FG V+ G  +  T +AVK L  +       F+ E  ++   QH  LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           +LY    +   + ++ EYM+N  L   +        +KL       +   IA G+A++ E
Sbjct: 72  RLYAVVTQEP-IYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
                 +HRD++ +N+L+   L+ KI+DFGLA+L E+++          I + APE    
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEE 865
           G  T K+DV+SFG++  EIV+ G+       N + +  L+  Y +   +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 8e-60
 Identities = 64/231 (27%), Positives = 115/231 (49%), Gaps = 9/231 (3%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
           +      ++G G FG V+ G   +   +A+K +  +      +F+ E  ++    HP LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           +LYG C+E   + LV+E+M++ CLS  +  +   +       T   +C+ +  G+AYL E
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYLEE 119

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
                ++HRD+   N L+ ++   K+SDFG+ +   +D+   ST     + + +PE    
Sbjct: 120 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176

Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEEIY 867
              +SK+DV+SFGV+  E+ S GK     R N + V  +   + L +  + 
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 227

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-58
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 9/231 (3%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
            +     ++G G FG V  G       +A+K +  +      EF+ E  ++    H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           +LYG C +   + ++ EYM N CL   +       R +       ++C  +   + YL  
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
               + +HRD+   N L++     K+SDFGL++   +D+   S      + +  PE  M 
Sbjct: 119 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 818 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEEIY 867
              +SK+D+++FGV+  EI S GK       N +    +     L    + 
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 226

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 5e-57
 Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 8/203 (3%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
            +     K+G+G FG V+ G  +  T +A+K L          F+ E  ++   +H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
           +LY        + +V EYM    L   + G+  +Y      P    +   IA G+AY+  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL---RLPQLVDMAAQIASGMAYVE- 130

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
             R+  VHRD++ +N+L+ ++L  K++DFGLA+L E+++          I + APE A+ 
Sbjct: 131 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188

Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
           G  T K+DV+SFG++  E+ +  
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKG 211

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-55
 Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 12/221 (5%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPN 695
            ++D    +GEG +G V   +       +AVK +  K      E    EI +     H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           +VK YG   EGN   L  EY     L   I        + +  P  ++    +  G+ YL
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYL 119

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED-KTHISTRIAGTIGYMAPEY 814
           H    I I HRDIK  N+LLD+  N KISDFGLA ++  + +  +  ++ GT+ Y+APE 
Sbjct: 120 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 815 AMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYL 854
             R  +     DV+S G+V   +++G+   +   +    Y 
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-55
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 9/209 (4%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPN 695
           +++    +G G +G   K    SDG ++  K+L   S +    +  V+E+ ++   +HPN
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 696 LVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           +V+ Y   ++     L +V EY +   L+  I  K T+ R  LD     ++   +   L 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 754 YLHE--DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 811
             H   D    ++HRD+K +NV LD   N K+ DFGLA++   D T  +    GT  YM+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMS 182

Query: 812 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           PE   R     K+D++S G +  E+ +  
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM 211

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 6e-55
 Identities = 58/219 (26%), Positives = 114/219 (52%), Gaps = 17/219 (7%)

Query: 629 TLRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF 681
            L ++++  +  DP        K+G+G  G+VY  + ++ G  +A++Q++ + +      
Sbjct: 5   ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI 64

Query: 682 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 741
           +NEI ++   ++PN+V      + G++L +V EY+    L+      D      +D    
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQI 118

Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
             +C    + L +LH +   +++HRDIK+ N+LL  D + K++DFG       +++  ST
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175

Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            + GT  +MAPE   R     K D++S G++ +E++ G+
Sbjct: 176 MV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (484), Expect = 6e-55
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 20/237 (8%)

Query: 640 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 695
           F    ++G G FG+VY    + +  V+A+K++S   +Q N   ++ + E+  +   +HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
            ++  GC +  +   LV EY   +        K       L       +  G  +GLAYL
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYL 131

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
           H      ++HRD+K  N+LL +    K+ DFG A +     + +     GT  +MAPE  
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVI 183

Query: 816 M---RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIYWS 869
           +    G    K DV+S G+  +E+   K           +Y +        +  +WS
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  188 bits (479), Expect = 2e-54
 Identities = 66/257 (25%), Positives = 115/257 (44%), Gaps = 26/257 (10%)

Query: 628 YTLRQIKAATNNFDPA---------NKVGEGGFGSVYKGIL----SDGTVIAVKQL-SSK 673
           +T      A   F              +G G FG V  G L         +A+K L S  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 674 SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR 733
           + +  R+F++E  ++    HPN++ L G   +   ++++ E+M+N  L   +   D ++ 
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 734 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 793
                     +  GIA G+ YL     +  VHRD+   N+L++ +L  K+SDFGL++  E
Sbjct: 126 ---TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179

Query: 794 EDKTHISTR----IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPN 848
           +D +  +          I + APE       TS +DV+S+G+V  E++S G+       N
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239

Query: 849 EDFVYLLDWAYVLQEEE 865
           +D +  ++  Y L    
Sbjct: 240 QDVINAIEQDYRLPPPM 256

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 2e-54
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 14/203 (6%)

Query: 644 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 702
            ++G+G FG VYK        + A K + +KS +   +++ EI ++++  HPN+VKL   
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 703 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 762
               N L ++ E+     +   +     E    L     + +C      L YLH+    K
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVML----ELERPLTESQIQVVCKQTLDALNYLHD---NK 130

Query: 763 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM-----R 817
           I+HRD+K  N+L   D + K++DFG++           + I GT  +MAPE  M      
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKD 189

Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
                KADV+S G+  +E+   +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIE 212

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 1e-53
 Identities = 64/230 (27%), Positives = 103/230 (44%), Gaps = 15/230 (6%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
                   +G+G FG V  G    G  +AVK + + +    + F+ E  +++  +H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 698 KLYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           +L G  VE    L +V EYM    L   +  +    R  L      K  + +   + YL 
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
            +     VHRD+   NVL+ +D  AK+SDFGL K     +          + + APE   
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALR 173

Query: 817 RGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEE 865
               ++K+DV+SFG++  EI S G+      P +D V  ++  Y +   +
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 223

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  186 bits (472), Expect = 1e-53
 Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 8/217 (3%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 696
            +    +K+G G +G VY+G+       +AVK L   + +   EF+ E  ++   +HPNL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           V+L G C       ++ E+M    L   +   +   R ++       +   I+  + YL 
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLE 132

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 816
              +   +HRD+   N L+ ++   K++DFGL++L   D           I + APE   
Sbjct: 133 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189

Query: 817 RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 853
               + K+DV++FGV+  EI +   +     +   VY
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 2e-53
 Identities = 62/240 (25%), Positives = 113/240 (47%), Gaps = 16/240 (6%)

Query: 631 RQIKAATNNFDPAN-KVGEGGFGSVYKGIL---SDGTVIAVKQLSSKSRQGNRE-FVNEI 685
           +++    +N   A+ ++G G FGSV +G+         +A+K L   + + + E  + E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 686 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 745
            ++    +P +V+L G C +   L+LV E      L + + GK    R ++      ++ 
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELL 115

Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--I 803
             ++ G+ YL E      VHRD+   NVLL     AKISDFGL+K    D ++ + R   
Sbjct: 116 HQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 804 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQ 862
              + + APE       +S++DV+S+GV   E +S G+         + +  ++    ++
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 232

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 4e-53
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 18/205 (8%)

Query: 644 NKVGEGGFGSVYKGILSD-GTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLY 700
            ++G G F +VYKG+ ++    +A  +L  +  ++   + F  E  M+   QHPN+V+ Y
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 701 GCCVE----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
                       ++LV E M +  L   +          +     +  C  I +GL +LH
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 129

Query: 757 EDSRIKIVHRDIKTSNVLL-DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
             +   I+HRD+K  N+ +     + KI D GLA L           + GT  +MAPE  
Sbjct: 130 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMY 185

Query: 816 MRGYLTSKADVYSFGVVTLEIVSGK 840
              Y     DVY+FG+  LE+ + +
Sbjct: 186 EEKY-DESVDVYAFGMCMLEMATSE 209

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  184 bits (467), Expect = 8e-53
 Identities = 69/251 (27%), Positives = 112/251 (44%), Gaps = 30/251 (11%)

Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNR-EFV 682
           L  ++   NN +    +GEG FG V++            T++AVK L  ++    + +F 
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 683 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------------- 729
            E  +++   +PN+VKL G C  G  + L++EYM    L+  +                 
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 730 ------TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 783
                 +     L    +  I   +A G+AYL E    K VHRD+ T N L+ +++  KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181

Query: 784 SDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN 842
           +DFGL++ +Y  D        A  I +M PE       T+++DV+++GVV  EI S    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 843 TNYRPNEDFVY 853
             Y    + V 
Sbjct: 242 PYYGMAHEEVI 252

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 9e-53
 Identities = 63/241 (26%), Positives = 99/241 (41%), Gaps = 26/241 (10%)

Query: 645 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 704
            +G+G FG V++G    G  +AVK  SS+  + +     EI      +H N++       
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67

Query: 705 EGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-- 758
           + N    QL LV +Y ++  L   +       R  +      K+ +  A GLA+LH +  
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 759 ---SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS---TRIAGTIGYMAP 812
               +  I HRD+K+ N+L+ K+    I+D GLA  ++     I        GT  YMAP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 813 EY------AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEI 866
           E               +AD+Y+ G+V  EI    S      +    Y          EE+
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 867 Y 867
            
Sbjct: 242 R 242

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-52
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 15/207 (7%)

Query: 638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 693
            +F+    +G+G FG+VY         ++A+K L            +   E+ + S  +H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           PN+++LYG   +  ++ L+ EY     + R +         K D          +A  L+
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALS 120

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           Y H     +++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ PE
Sbjct: 121 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPE 174

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                    K D++S GV+  E + GK
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGK 201

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 7e-52
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 16/202 (7%)

Query: 644 NKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVK 698
            ++G G FG+V KG          +AVK L +++       E + E  ++    +P +V+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 699 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 758
           + G C E    +LV E  +   L++ +          +      ++   ++ G+ YL E 
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES 126

Query: 759 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--IAGTIGYMAPEYAM 816
                VHRD+   NVLL     AKISDFGL+K    D+ +   +      + + APE   
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 817 RGYLTSKADVYSFGVVTLEIVS 838
               +SK+DV+SFGV+  E  S
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFS 205

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 2e-51
 Identities = 59/230 (25%), Positives = 92/230 (40%), Gaps = 30/230 (13%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNRE-FVNEIGMISA 690
            N +    +G G FG V                +AVK L  K+    RE  ++E+ M++ 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 691 -QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK------------------DTE 731
              H N+V L G C     + L++EY     L   +  K                  + E
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 732 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK- 790
               L +         +A+G+ +L        VHRD+   NVL+      KI DFGLA+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 791 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           +  +    +       + +MAPE    G  T K+DV+S+G++  EI S  
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 6e-51
 Identities = 59/235 (25%), Positives = 93/235 (39%), Gaps = 25/235 (10%)

Query: 638 NNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISA 690
           N       +G G FG V +              +AVK L   +    RE  ++E+ ++S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 691 -QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK-------------DTEYRLKL 736
              H N+V L G C  G   L++ EY     L   +  K               +  L L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 737 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 795
           D          +A+G+A+L        +HRD+   N+LL      KI DFGLA+ +  + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 796 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 850
              +       + +MAPE       T ++DV+S+G+   E+ S  S+       D
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-50
 Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 15/224 (6%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSDGT-----VIAVKQLSSKSRQGNR-EFVNEIGMISAQ 691
           +       +G G FG VYKG+L   +      +A+K L +   +  R +F+ E G++   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 692 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
            H N+++L G   +   ++++ EYM+N  L + +  KD     +        +  GIA G
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAG 122

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGY 809
           + YL     +  VHRD+   N+L++ +L  K+SDFGL+++ E+D   T+ ++     I +
Sbjct: 123 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 853
            APE       TS +DV+SFG+V  E+++      +  +   V 
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM 223

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 2e-50
 Identities = 70/239 (29%), Positives = 109/239 (45%), Gaps = 20/239 (8%)

Query: 639 NFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISAQQH 693
           +F+    +G G FG VY G L D        AVK L+  +  G   +F+ E  ++    H
Sbjct: 30  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 694 PNLVKLYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           PN++ L G C+      L+V  YMK+  L   I  +                 + +A+G+
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGM 143

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY---EEDKTHISTRIAGTIGY 809
            +L      K VHRD+   N +LD+    K++DFGLA+     E D  H  T     + +
Sbjct: 144 KFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200

Query: 810 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS--NTNYRPNEDFVYLLDWAYVLQEEEI 866
           MA E       T+K+DV+SFGV+  E+++  +    +    +  VYLL    +LQ E  
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 259

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  178 bits (453), Expect = 3e-50
 Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 12/206 (5%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 696
           +++D   ++G G FG V++    + G   A K + +           EI  +S  +HP L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           V L+    + N+++++YE+M    L   +  +      K+      +    + +GL ++H
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 757 EDSRIKIVHRDIKTSNVLLDKDLN--AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
           E      VH D+K  N++     +   K+ DFGL    +  ++   T   GT  + APE 
Sbjct: 142 E---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEV 196

Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
           A    +    D++S GV++  ++SG 
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGL 222

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 3e-50
 Identities = 68/246 (27%), Positives = 121/246 (49%), Gaps = 18/246 (7%)

Query: 630 LRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTV----IAVKQLS-SKSRQGNREFVN 683
           LR +K     F     +G G FG+VYKG+ + +G      +A+K+L  + S + N+E ++
Sbjct: 3   LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60

Query: 684 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 743
           E  ++++  +P++ +L G C+    + L+ + M   CL   +                  
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNI----GSQYLLN 115

Query: 744 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTR 802
            C+ IA+G+ YL      ++VHRD+   NVL+    + KI+DFGLAK L  E+K + +  
Sbjct: 116 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172

Query: 803 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 861
               I +MA E  +    T ++DV+S+GV   E+++ G    +  P  +   +L+    L
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 232

Query: 862 QEEEIY 867
            +  I 
Sbjct: 233 PQPPIC 238

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 2e-49
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 21/219 (9%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSDG---TVIAVKQLS-SKSRQGNREFVNEIGMISA-QQ 692
           N+    + +GEG FG V K  +         A+K++    S+  +R+F  E+ ++     
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-----------FGKDTEYRLKLDWPTR 741
           HPN++ L G C     L L  EY  +  L   +           F         L     
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 742 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 801
                 +ARG+ YL +    + +HRD+   N+L+ ++  AKI+DFGL++  E       T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184

Query: 802 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
                + +MA E       T+ +DV+S+GV+  EIVS  
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 223

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  175 bits (445), Expect = 3e-49
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 12/206 (5%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 696
           + +D   ++G G FG V++ +  + G V   K +++          NEI +++   HP L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 697 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 756
           + L+    +  +++L+ E++    L   I  +D     K+              GL ++H
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMH 144

Query: 757 EDSRIKIVHRDIKTSNVLLD--KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
           E     IVH DIK  N++ +  K  + KI DFGLA     D+    T    T  + APE 
Sbjct: 145 E---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEI 199

Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGK 840
             R  +    D+++ GV+   ++SG 
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGL 225

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 9e-49
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 13/221 (5%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQ 692
              +    +GEG FG V++GI          +A+K   + +    RE F+ E   +    
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HP++VKL G   E N + ++ E      L   +  +       LD  +       ++  L
Sbjct: 67  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTAL 121

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           AYL      + VHRDI   NVL+  +   K+ DFGL++  E+   + +++    I +MAP
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 853
           E       TS +DV+ FGV   EI+            + V 
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-48
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 13/212 (6%)

Query: 634 KAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK---SRQGNREFVNEIGMIS 689
           K    +F     +GEG F +V     L+     A+K L  +             E  ++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 690 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
              HP  VKLY    +  +L     Y KN  L + I           D    +     I 
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIV 118

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 808
             L YLH      I+HRD+K  N+LL++D++ +I+DFG AK+   E K   +    GT  
Sbjct: 119 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175

Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           Y++PE          +D+++ G +  ++V+G 
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 8e-48
 Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)

Query: 638 NNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSK---SRQGNREFVNEIGMISA 690
            +     K+G+G FG V +G           +AVK L        +   +F+ E+  + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 750
             H NL++LYG  +    + +V E      L      +  +++      T  +  + +A 
Sbjct: 68  LDHRNLIRLYGVVLTPP-MKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAE 122

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH--ISTRIAGTIG 808
           G+ YL      + +HRD+   N+LL      KI DFGL +   ++  H  +         
Sbjct: 123 GMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179

Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 838
           + APE       +  +D + FGV   E+ +
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  171 bits (433), Expect = 2e-47
 Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 19/230 (8%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQ- 692
           N+F     +G GGFG VY    +D G + A+K L  K    +QG    +NE  M+S    
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 693 --HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 750
              P +V +       ++L  + + M    L   +                +     I  
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-----EADMRFYAAEIIL 118

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 810
           GL ++H      +V+RD+K +N+LLD+  + +ISD GLA  + + K H S    GT GYM
Sbjct: 119 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 172

Query: 811 APEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAY 859
           APE   +G    S AD +S G +  +++ G S       +D   +     
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 222

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-45
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 16/229 (6%)

Query: 638 NNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLS-SKSRQGNREFVNEIGMISA 690
                + ++G+G FG VY+G+          T +A+K ++ + S +   EF+NE  ++  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-----FGKDTEYRLKLDWPTRKKIC 745
               ++V+L G   +G   L++ E M    L   +        +             ++ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 746 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIA 804
             IA G+AYL+ +   K VHRD+   N ++ +D   KI DFG+ + +YE D      +  
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 805 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 853
             + +M+PE    G  T+ +DV+SFGVV  EI +         + + V 
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 6e-45
 Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 24/238 (10%)

Query: 638 NNFDPANKVGEGGFGSVYKGI------LSDGTVIAVKQLSSKSRQG-NREFVNEIGMISA 690
           +       +G G FG V +         +    +AVK L   +    +R  ++E+ ++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 691 QQH-PNLVKLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLD 737
             H  N+V L G C + G  L+++ E+ K   LS  +  K  E           Y+  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 738 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 797
                     +A+G+ +L      K +HRD+   N+LL +    KI DFGLA+   +D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 798 HI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYL 854
           ++        + +MAPE       T ++DV+SFGV+  EI S  ++       D  + 
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  161 bits (407), Expect = 2e-44
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 16/208 (7%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 693
            +F     +G G FG V+      +G   A+K L  +     +      +E  M+S   H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P +++++G   +  Q+ ++ +Y++   L   +         +   P  K     +   L 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALE 118

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YLH      I++RD+K  N+LLDK+ + KI+DFG AK   +        + GT  Y+APE
Sbjct: 119 YLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPE 171

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGKS 841
                      D +SFG++  E+++G +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (406), Expect = 2e-44
 Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 9/212 (4%)

Query: 631 RQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMI 688
           +Q +   + +D  + +G G F  V          ++A+K ++ K+ +G      NEI ++
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 689 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 748
              +HPN+V L      G  L L+ + +    L   I  K              ++   +
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQV 116

Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
              + YLH+   +    +        LD+D    ISDFGL+K+  ED   + +   GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPG 174

Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           Y+APE   +   +   D +S GV+   ++ G 
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 3e-44
 Identities = 64/251 (25%), Positives = 105/251 (41%), Gaps = 26/251 (10%)

Query: 638 NNFDPANKVGEGGFGSVYKGIL--------SDGTVIAVKQLSSKSRQGN-REFVNEIGMI 688
           +       +GEG FG V             +  T +AVK L S + + +  + ++E+ M+
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 689 SA-QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-----------FGKDTEYRLKL 736
               +H N++ L G C +   L ++ EY     L   +           +        +L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 737 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 796
                      +ARG+ YL      K +HRD+   NVL+ +D   KI+DFGLA+      
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 797 THIST-RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYL 854
            +  T      + +MAPE       T ++DV+SFGV+  EI + G S     P E+   L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

Query: 855 LDWAYVLQEEE 865
           L   + + +  
Sbjct: 250 LKEGHRMDKPS 260

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  157 bits (398), Expect = 1e-43
 Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 10/205 (4%)

Query: 638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPN 695
             +    K+GEG +G VYK   + G   A+K++    +        + EI ++   +H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           +VKLY       +L+LV+E++  +        +       L+  T K   + +  G+AY 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYC 116

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
           H+    +++HRD+K  N+L++++   KI+DFGLA+ +       +  I            
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173

Query: 816 MRGYLTSKADVYSFGVVTLEIVSGK 840
                ++  D++S G +  E+V+G 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 1e-43
 Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 10/209 (4%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHP 694
              +   + +GEG +G V       +   +A+K++S    Q   +  + EI ++   +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N++ +           +   Y+  + +   ++         L           I RGL Y
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY--KLLKTQHLSNDHICYFLYQILRGLKY 124

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAP 812
           +H      ++HRD+K SN+LL+   + KI DFGLA++ + D  H    T    T  Y AP
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 813 EYAMRG-YLTSKADVYSFGVVTLEIVSGK 840
           E  +     T   D++S G +  E++S +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 2e-43
 Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 10/205 (4%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPN 695
           NF    K+GEG +G VYK      G V+A+K++   +++       + EI ++    HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           +VKL       N+L LV+E++  +         D      +  P  K     + +GLA+ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKF----MDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 815
           H     +++HRD+K  N+L++ +   K++DFGLA+ +       +  +            
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 816 MRGYLTSKADVYSFGVVTLEIVSGK 840
              Y ++  D++S G +  E+V+ +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  156 bits (395), Expect = 3e-43
 Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 27/219 (12%)

Query: 639 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS---------SKSRQGNREFVNEIGMI 688
           N++P   +G G    V + I        AVK +           + ++     + E+ ++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 689 SA-QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 747
                HPN+++L           LV++ MK   L   +  K       L     +KI   
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRA 118

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           +   +  LH+   + IVHRD+K  N+LLD D+N K++DFG +   +  +      + GT 
Sbjct: 119 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTP 173

Query: 808 GYMAPEYAM------RGYLTSKADVYSFGVVTLEIVSGK 840
            Y+APE               + D++S GV+   +++G 
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 4e-43
 Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 14/209 (6%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQ-Q 692
            +F     +G+G FG V+           A+K L       + +    + E  ++S   +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 693 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 752
           HP L  ++        L  V EY+    L   I         K D          I  GL
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGL 116

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
            +LH      IV+RD+K  N+LLDKD + KI+DFG+ K         +T   GT  Y+AP
Sbjct: 117 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAP 172

Query: 813 EYAMRGYLTSKADVYSFGVVTLEIVSGKS 841
           E  +        D +SFGV+  E++ G+S
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQS 201

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 8e-43
 Identities = 39/199 (19%), Positives = 79/199 (39%), Gaps = 13/199 (6%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
            +G G FG V++ +  S       K +  K          EI +++  +H N++ L+   
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70

Query: 704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 763
               +L++++E++    +   I         +L+          +   L +LH      I
Sbjct: 71  ESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQFLHS---HNI 123

Query: 764 VHRDIKTSNVLLDKDLNA--KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 821
            H DI+  N++     ++  KI +FG A+  +               Y APE      ++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVS 181

Query: 822 SKADVYSFGVVTLEIVSGK 840
           +  D++S G +   ++SG 
Sbjct: 182 TATDMWSLGTLVYVLLSGI 200

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 9e-43
 Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 13/213 (6%)

Query: 636 ATNNFDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNRE-----FVNEIGMI 688
           A   ++   ++GEG +G V+K   + + G  +A+K++  ++ +          V  +  +
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 689 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG-KDTEYRLKLDWPTRKKICIG 747
              +HPN+V+L+  C            +    + + +    D      +   T K +   
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 748 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 807
           + RGL +LH     ++VHRD+K  N+L+      K++DFGLA++Y        T +  T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179

Query: 808 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
            Y APE  ++    +  D++S G +  E+   K
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  153 bits (387), Expect = 4e-42
 Identities = 48/214 (22%), Positives = 93/214 (43%), Gaps = 18/214 (8%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS---SKSRQGNREFVNEIGMISAQQ 692
           ++ ++    +G GG   V+    L     +AVK L    ++       F  E    +A  
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 693 HPNLVKLYGCCVE----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 748
           HP +V +Y         G    +V EY+    L   +  +       +      ++    
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADA 120

Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI--STRIAGT 806
            + L + H+     I+HRD+K +N+++      K+ DFG+A+   +    +  +  + GT
Sbjct: 121 CQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
             Y++PE A    + +++DVYS G V  E+++G+
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 9e-42
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 16/204 (7%)

Query: 644 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQG-----NREFVNEIGMISAQQHPNLV 697
           + +GEG F +VYK    +   ++A+K++    R       NR  + EI ++    HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 698 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 757
            L       + + LV+++M+ +           +  L L     K   +   +GL YLH+
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVI-----IKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118

Query: 758 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
                I+HRD+K +N+LLD++   K++DFGLAK +        T    T  Y APE    
Sbjct: 119 H---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFG 174

Query: 818 -GYLTSKADVYSFGVVTLEIVSGK 840
                   D+++ G +  E++   
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRV 198

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (375), Expect = 2e-40
 Identities = 49/231 (21%), Positives = 83/231 (35%), Gaps = 21/231 (9%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 696
           N +    K+G G FG +Y G  ++ G  +A+K    K++    +   E  +    Q    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64

Query: 697 VKLYG-CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           +     C  EG+  ++V E +  +      F        K    T   +   +   + Y+
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYI 119

Query: 756 HEDSRIKIVHRDIKTSNVL---LDKDLNAKISDFGLAKLYEEDKTHI------STRIAGT 806
           H       +HRD+K  N L     K     I DFGLAK Y + +TH       +  + GT
Sbjct: 120 HS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDW 857
             Y +    +    + + D+ S G V +    G                + 
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  147 bits (371), Expect = 6e-40
 Identities = 41/226 (18%), Positives = 81/226 (35%), Gaps = 23/226 (10%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMIS-AQQHPN 695
            ++    ++GEG FG +++G  L +   +A+K    +S     +  +E            
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           +  +Y    EG   +LV + +  +               K    T       +   +  +
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD-----LCGRKFSVKTVAMAAKQMLARVQSI 117

Query: 756 HEDSRIKIVHRDIKTSNVLLDKDLN-----AKISDFGLAKLYEEDKTHI------STRIA 804
           HE     +V+RDIK  N L+ +  +       + DFG+ K Y +  T           ++
Sbjct: 118 HE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 805 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 850
           GT  YM+    +    + + D+ + G V +  + G           
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 8e-40
 Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 21/214 (9%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR------EFVNEIGMISA 690
           + +D   ++G G F  V K    S G   A K +  +  + +R      +   E+ ++  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 691 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 750
            QHPN++ L+        ++L+ E +    L   +  K+      L      +    I  
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILN 124

Query: 751 GLAYLHEDSRIKIVHRDIKTSNVLLDKD----LNAKISDFGLAKLYEEDKTHISTRIAGT 806
           G+ YLH     +I H D+K  N++L          KI DFGLA   +         I GT
Sbjct: 125 GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGT 179

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
             ++APE      L  +AD++S GV+T  ++SG 
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 1e-39
 Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 18/210 (8%)

Query: 639 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 697
           ++     +G G FG VY+  L   G ++A+K++    R  NRE    + ++    H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76

Query: 698 KLYGCCVEGNQ------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 751
           +L        +      L LV +Y+       A      +  L       K     + R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL--PVIYVKLYMYQLFRS 134

Query: 752 LAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 810
           LAY+H      I HRDIK  N+LLD D    K+ DFG AK     + ++ + I       
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRA 190

Query: 811 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
                     TS  DV+S G V  E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-39
 Identities = 48/208 (23%), Positives = 82/208 (39%), Gaps = 21/208 (10%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE------FVNEIGMISA--QQHPN 695
            +G GGFGSVY GI +SD   +A+K +         E         E+ ++         
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 696 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 755
           +++L       +  +L+ E  +          +    R  L     +     +   + + 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHC 126

Query: 756 HEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
           H      ++HRDIK  N+L+D +    K+ DFG   L ++      T   GT  Y  PE+
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEW 180

Query: 815 AM-RGYLTSKADVYSFGVVTLEIVSGKS 841
                Y    A V+S G++  ++V G  
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDI 208

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 4e-39
 Identities = 51/218 (23%), Positives = 100/218 (45%), Gaps = 23/218 (10%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHP 694
           + ++   K+G+G FG V+K      G  +A+K++  ++ +       + EI ++   +H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 695 NLVKLYGCCVEG--------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 746
           N+V L   C             + LV+++ +++       G  +   +K      K++  
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-----GLLSNVLVKFTLSEIKRVMQ 124

Query: 747 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT---HISTRI 803
            +  GL Y+H +   KI+HRD+K +NVL+ +D   K++DFGLA+ +   K    +  T  
Sbjct: 125 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181

Query: 804 AGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGK 840
             T+ Y  PE  +         D++  G +  E+ +  
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 2e-38
 Identities = 58/207 (28%), Positives = 85/207 (41%), Gaps = 13/207 (6%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 693
           N+FD    +G+G FG V      + G   A+K L  +   ++      V E  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P L  L       ++L  V EY     L   +  +             +     I   L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALE 119

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YLH      +V+RDIK  N++LDKD + KI+DFGL K    D         GT  Y+APE
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPE 175

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGK 840
                      D +  GVV  E++ G+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 1e-37
 Identities = 39/207 (18%), Positives = 85/207 (41%), Gaps = 11/207 (5%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHP 694
             ++   K+GEG +G+V+K        ++A+K++             + EI ++   +H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 695 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 754
           N+V+L+       +L LV+E+   +                      K     + +GL +
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD-----PEIVKSFLFQLLKGLGF 116

Query: 755 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 814
            H      ++HRD+K  N+L++++   K+++FGLA+ +       S  +           
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 815 AMRGYLTSKADVYSFGVVTLEIVSGKS 841
                 ++  D++S G +  E+ +   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR 200

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (355), Expect = 3e-37
 Identities = 49/207 (23%), Positives = 86/207 (41%), Gaps = 16/207 (7%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQH 693
           + FD    +G G FG V        G   A+K L  +     ++    +NE  ++ A   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           P LVKL     + + L +V EY+    +   +         +   P  +     I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFE 155

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           YLH    + +++RD+K  N+L+D+    +++DFG AK  +     +     GT   +APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPE 208

Query: 814 YAMRGYLTSKADVYSFGVVTLEIVSGK 840
             +        D ++ GV+  E+ +G 
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGY 235

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 3e-37
 Identities = 49/203 (24%), Positives = 77/203 (37%), Gaps = 20/203 (9%)

Query: 646 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC- 703
           +G G  G V +          A+K L     +  RE   E+    A Q P++V++     
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYE 75

Query: 704 ---VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 760
                   LL+V E +    L   I  +  +           +I   I   + YLH    
Sbjct: 76  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHS--- 129

Query: 761 IKIVHRDIKTSNVLLDK---DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 817
           I I HRD+K  N+L      +   K++DFG AK      +  +     T  Y+APE    
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGP 187

Query: 818 GYLTSKADVYSFGVVTLEIVSGK 840
                  D++S GV+   ++ G 
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGY 210

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 5e-35
 Identities = 51/227 (22%), Positives = 93/227 (40%), Gaps = 28/227 (12%)

Query: 628 YTLRQIKAAT----NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNRE 680
           +  +++          +     VG G +G+V   +    G  +A+K+L    +S    + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 681 FVNEIGMISAQQHPNLVKLYGCCVEGNQL------LLVYEYMKNNCLSRAIFGKDTEYRL 734
              E+ ++   +H N++ L         L       LV  +M  +               
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE------- 116

Query: 735 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 794
           KL     + +   + +GL Y+H      I+HRD+K  N+ +++D   KI DFGLA+  + 
Sbjct: 117 KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173

Query: 795 DKTHISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK 840
           + T        T  Y APE  +     T   D++S G +  E+++GK
Sbjct: 174 EMTG----YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 3e-33
 Identities = 50/212 (23%), Positives = 82/212 (38%), Gaps = 22/212 (10%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQHP 694
             +     +G G  G V           +A+K+LS   +++   +    E+ ++    H 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 695 NLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 748
           N++ L           E   + LV E M  N             +++LD      +   +
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV--------IQMELDHERMSYLLYQM 128

Query: 749 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 808
             G+ +LH    I   HRD+K SN+++  D   KI DFGLA+          T    T  
Sbjct: 129 LCGIKHLHSAGII---HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 183

Query: 809 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 840
           Y APE  +        D++S G +  E+V  K
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  128 bits (321), Expect = 6e-33
 Identities = 41/210 (19%), Positives = 87/210 (41%), Gaps = 22/210 (10%)

Query: 638 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPN 695
           +++    K+G G +  V++ I +++   + VK L    ++   +   EI  + + +  PN
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91

Query: 696 LVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
           ++ L     +       LV+E++ N            +    L     +     I + L 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFK--------QLYQTLTDYDIRFYMYEILKALD 143

Query: 754 YLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 812
           Y H    + I+HRD+K  NV++D +    ++ D+GLA+ Y   + +       +  +  P
Sbjct: 144 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGP 198

Query: 813 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 841
           E  +         D++S G +   ++  K 
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-32
 Identities = 58/240 (24%), Positives = 103/240 (42%), Gaps = 24/240 (10%)

Query: 612 VSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAV 667
           ++   ELR  +L     T    K    NF+    +G G +G V+          G + A+
Sbjct: 3   LTVKHELRTANL-----TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAM 57

Query: 668 KQLS----SKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYEYMKNNCLS 722
           K L      +  +       E  ++   +  P LV L+       +L L+ +Y+    L 
Sbjct: 58  KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 117

Query: 723 RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 782
             +  ++          T  ++ I +   +  L    ++ I++RDIK  N+LLD + +  
Sbjct: 118 THLSQRE--------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 169

Query: 783 ISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGK 840
           ++DFGL+K +  D+T  +    GTI YMAP+    G        D +S GV+  E+++G 
Sbjct: 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 4e-31
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 12/208 (5%)

Query: 637 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQH 693
              +   + VG G +GSV        G  +AVK+LS   +S    +    E+ ++   +H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 694 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 753
            N++ L         L    +      L  A      + + KL     + +   I RGL 
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLK 135

Query: 754 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 813
           Y+H      I+HRD+K SN+ +++D   KI DFGLA+  +++ T        T  Y APE
Sbjct: 136 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 188

Query: 814 YAMR-GYLTSKADVYSFGVVTLEIVSGK 840
             +   +     D++S G +  E+++G+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (275), Expect = 1e-26
 Identities = 51/240 (21%), Positives = 94/240 (39%), Gaps = 27/240 (11%)

Query: 645 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 703
           K+G G F +V+    + + T +A+K +    +       +EI ++      +  K     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 704 VEG-NQLLLVYEYMKNNCLSRAIFGKDTEY----------RLKLDWPTRKKICIGIARGL 752
                +LL  + +   N +   +  +                 +     K+I   +  GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 753 AYLHEDSRIKIVHRDIKTSNVLLDKD------LNAKISDFGLAKLYEEDKTHISTRIAGT 806
            Y+H      I+H DIK  NVL++        +  KI+D G A  Y+E  T+       T
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI----QT 192

Query: 807 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEI 866
             Y +PE  +       AD++S   +  E+++G     + P+E   Y  D  ++ Q  E+
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDF--LFEPDEGHSYTKDDDHIAQIIEL 250

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 97.1 bits (240), Expect = 2e-22
 Identities = 74/314 (23%), Positives = 114/314 (36%), Gaps = 23/314 (7%)

Query: 3   KKALKQIGRKLGK----KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVT 58
           K+AL QI + LG       W    D C+    W             V CD  + T  V  
Sbjct: 8   KQALLQIKKDLGNPTTLSSWLPTTDCCN--RTWL-----------GVLCDTDTQTYRVNN 54

Query: 59  IALKAQNLTG--TLPTELSKLRYLKQLDLS--RNCLTGSFSPQWASLQLVELSVMGNRLS 114
           + L   NL     +P+ L+ L YL  L +    N +           QL  L +    +S
Sbjct: 55  LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114

Query: 115 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 174
           G  P  L+ I TL  L    N  +G++PP I  L NL  +    N  +G +P      + 
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174

Query: 175 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 234
           L        N              +  + +  + LEG       +  +   + ++    +
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234

Query: 235 ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 294
                     NL  L L    I+G +P  +  +  L ++++SFNNL G IP     L + 
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRF 293

Query: 295 NFMYLTGNK-LTGP 307
           +      NK L G 
Sbjct: 294 DVSAYANNKCLCGS 307

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 58.2 bits (139), Expect = 1e-09
 Identities = 20/62 (32%), Positives = 30/62 (48%), Gaps = 3/62 (4%)

Query: 156 LSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL--EGPI 213
           L +N   G LP  LT+L  L+ L +S NN  G+IP+  G  ++        +      P+
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPL 309

Query: 214 PA 215
           PA
Sbjct: 310 PA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 51.7 bits (122), Expect = 2e-07
 Identities = 19/58 (32%), Positives = 29/58 (50%), Gaps = 4/58 (6%)

Query: 65  NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRL--SGPFPK 119
            + GTLP  L++L++L  L++S N L G   PQ  +LQ     +   N+     P P 
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSPLPA 311

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 92.2 bits (228), Expect = 6e-22
 Identities = 28/161 (17%), Positives = 45/161 (27%), Gaps = 30/161 (18%)

Query: 644 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR----------QGNREFVNEIGMISAQQH 693
             +GEG   +V+           VK                  G+  F       +  + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 694 PNLVKLYGCCV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 749
             L KL G  V          ++ E +    L R                   ++   I 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------------RVENPDEVLDMIL 113

Query: 750 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 790
             +A  +      IVH D+   NVL+  +    I DF  + 
Sbjct: 114 EEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 79.7 bits (195), Expect = 8e-17
 Identities = 39/189 (20%), Positives = 69/189 (36%), Gaps = 5/189 (2%)

Query: 140 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 199
            +P D+    +   L L +N  T     +   L NL+ L + +N  S   P       K+
Sbjct: 24  KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 200 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 259
           ++L++  + L+         L  L        K  +S F  L++M +  L        G 
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 260 IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV 319
                  M KL  I ++  N+T         L +   ++L GNK+T      +   N   
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTE---LHLDGNKITKVDAASLKGLNNLA 198

Query: 320 DISLNNFTW 328
            + L+  + 
Sbjct: 199 KLGLSFNSI 207

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 77.0 bits (188), Expect = 7e-16
 Identities = 52/293 (17%), Positives = 101/293 (34%), Gaps = 28/293 (9%)

Query: 47  CDCSSATCH----------------VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCL 90
           C C                         + L+   +T     +   L+ L  L L  N +
Sbjct: 8   CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 91  TGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI 149
           +      +A L +L  L +  N+L     K+   +  L+    E      S+   + ++I
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127

Query: 150 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 209
            ++ L  +    +G        +  L+ +RI+D N +  IP+  G    + +LH+ G+ +
Sbjct: 128 VVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKI 183

Query: 210 EGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTK 269
                AS+  L +L  L +S    S      L        +        ++P  + D   
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 243

Query: 270 LKNIDLSFNNLTGGIPTTF------EKLAKTNFMYLTGNKLT-GPVPKYIFNS 315
           ++ + L  NN++      F       K A  + + L  N +    +    F  
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 74.7 bits (182), Expect = 4e-15
 Identities = 43/247 (17%), Positives = 88/247 (35%), Gaps = 15/247 (6%)

Query: 55  HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 114
           ++ T+ L    ++   P   + L  L++L LS+N L     P+     L EL V  N ++
Sbjct: 56  NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL--PEKMPKTLQELRVHENEIT 113

Query: 115 GPFPKVLTNIT--TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL 172
                V   +    +  L       +G      + +  L  + ++  + T  +P  L   
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--P 170

Query: 173 TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK 232
            +L +L +  N  +      +     + KL +  +S+      S++    L +L +++ K
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230

Query: 233 GSESAFPKLDKMNLKTLILTKCLIHG------EIPDYIGDMTKLKNIDLSFNNLTGG--I 284
             +      D   ++ + L    I          P Y         + L  N +      
Sbjct: 231 LVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290

Query: 285 PTTFEKL 291
           P+TF  +
Sbjct: 291 PSTFRCV 297

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 77.7 bits (190), Expect = 9e-16
 Identities = 39/195 (20%), Positives = 73/195 (37%), Gaps = 13/195 (6%)

Query: 130 LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKI 189
           L    N  +   P  I    NL +L L+ N         L  LTNL DL +++N  S   
Sbjct: 202 LIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 257

Query: 190 PEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTL 249
           P  +    K+ +L +  + +    P +     +  +L  +     E   P  +  NL  L
Sbjct: 258 P--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ---LEDISPISNLKNLTYL 312

Query: 250 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 309
            L    I    P  +  +TKL+ +  + N ++    ++   L   N++    N+++   P
Sbjct: 313 TLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368

Query: 310 KYIFNSNKNVDISLN 324
                    + ++  
Sbjct: 369 LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 74.3 bits (181), Expect = 1e-14
 Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 13/177 (7%)

Query: 54  CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRL 113
            ++  ++L    L       L+ L  L  LDL+ N ++   +P     +L EL +  N++
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI 275

Query: 114 SGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 173
           S   P  L  +T L NL +  N         I  L NL  L L  N+ +   P  ++ LT
Sbjct: 276 SNISP--LAGLTALTNLELNENQLE--DISPISNLKNLTYLTLYFNNISDISP--VSSLT 329

Query: 174 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 230
            L  L  ++N  S      +     I  L    + +    P  ++ LT +T L ++D
Sbjct: 330 KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 72.7 bits (177), Expect = 4e-14
 Identities = 39/198 (19%), Positives = 70/198 (35%), Gaps = 15/198 (7%)

Query: 105 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE 164
            L    N++S   P     +T L  LS+ GN         +  L NL  L L++N  +  
Sbjct: 201 SLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 256

Query: 165 LPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT 224
            P  L+ LT L +L++  N  S  I    G          +    +    +++  LT L 
Sbjct: 257 AP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISPISNLKNLTYL- 312

Query: 225 DLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 284
            L  +++    S    L    L+ L      +       + ++T +  +    N ++   
Sbjct: 313 TLYFNNISDI-SPVSSLT--KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367

Query: 285 PTTFEKLAKTNFMYLTGN 302
           P     L +   + L   
Sbjct: 368 P--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.5 bits (109), Expect = 9e-06
 Identities = 20/90 (22%), Positives = 38/90 (42%), Gaps = 7/90 (7%)

Query: 47  CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVE 105
               S   ++  + L   N++   P  +S L  L++L  + N ++       A+L  +  
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINW 355

Query: 106 LSVMGNRLSGPFPKVLTNITTLKNLSIEGN 135
           LS   N++S   P  L N+T +  L +   
Sbjct: 356 LSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.0 bits (105), Expect = 3e-05
 Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 9/157 (5%)

Query: 171 KLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 230
           KLTNL  L  ++N  S   P  I     + +L + G+ L+     ++++LT+LTDL +++
Sbjct: 195 KLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLAN 250

Query: 231 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 290
            + S  A P      L  L L    I    P  +  +T L N++L+ N L     +    
Sbjct: 251 NQISNLA-PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE--DISPISN 305

Query: 291 LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 327
           L    ++ L  N ++   P       + +  + N  +
Sbjct: 306 LKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVS 342

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.3 bits (152), Expect = 2e-11
 Identities = 30/177 (16%), Positives = 58/177 (32%), Gaps = 4/177 (2%)

Query: 140 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 199
           ++P  I      Q++ L  N  +    A      NL  L +  N  +            +
Sbjct: 25  AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 200 QKLHIQGSSLEGPI-PASISALTSLTDLRISDLKGSESAFP-KLDKMNLKTLILTKCLIH 257
           ++L +  ++    + PA+   L  L  L +      E           L+ L L    + 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 258 GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN 314
               D   D+  L ++ L  N ++      F  L   + + L  N++    P    +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.5 bits (150), Expect = 4e-11
 Identities = 36/287 (12%), Positives = 83/287 (28%), Gaps = 16/287 (5%)

Query: 47  CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVEL 106
           C C +     VT +   Q L   +P  +      +++ L  N ++   +  + + + + +
Sbjct: 6   CVCYNEP--KVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTI 60

Query: 107 SV--MGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE 164
                                  +    +        P     L  L  L L        
Sbjct: 61  LWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL 120

Query: 165 LPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT 224
            P     L  L  L + DN       +       +  L + G+ +      +   L SL 
Sbjct: 121 GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180

Query: 225 DLRI---SDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 281
            L +           AF  L ++    L            + +  +  L+ + L+ N   
Sbjct: 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL--PTEALAPLRALQYLRLNDNPWV 238

Query: 282 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV-DISLNNFT 327
                     A       + +++   +P+ +  + +++  ++ N+  
Sbjct: 239 CDCRAR-PLWAWLQKFRGSSSEVPCSLPQRL--AGRDLKRLAANDLQ 282

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.8 bits (143), Expect = 3e-10
 Identities = 42/254 (16%), Positives = 66/254 (25%), Gaps = 28/254 (11%)

Query: 30  NWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNC 89
           N  +                +               L    P     L  L  L L R  
Sbjct: 57  NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116

Query: 90  LTGSF-SPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL 148
           L             L  L +  N L         ++  L +L + GN  +       R L
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176

Query: 149 INLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSS 208
            +L +L+L  N      P     L  L  L +  NN S    E +   + +Q L +  + 
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236

Query: 209 LEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMT 268
                           D R   L              L+    +   +   +P  +    
Sbjct: 237 WVC-------------DCRARPLWA-----------WLQKFRGSSSEVPCSLPQRLAGRD 272

Query: 269 KLKNIDLSFNNLTG 282
                 L+ N+L G
Sbjct: 273 LK---RLAANDLQG 283

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.1 bits (144), Expect = 2e-10
 Identities = 30/257 (11%), Positives = 83/257 (32%), Gaps = 14/257 (5%)

Query: 83  LDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIP 142
           LDL+   L    + +  S  ++      + +  P  +  +    ++++ +  ++   S  
Sbjct: 5   LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVSTL 63

Query: 143 PDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE---------- 191
             I  +   LQ L L     +  +   L K +NL  L +S  +   +             
Sbjct: 64  HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123

Query: 192 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLIL 251
                        +   +     +      +L+  R +  K   S   +     +   + 
Sbjct: 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183

Query: 252 TKCLIHGEIPDYIGDMTKLKNIDLSF-NNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK 310
              ++  +       +  L+++ LS   ++         ++     + + G    G +  
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243

Query: 311 YIFNSNKNVDISLNNFT 327
            +  +  ++ I+ ++FT
Sbjct: 244 -LKEALPHLQINCSHFT 259

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.0 bits (110), Expect = 5e-06
 Identities = 38/258 (14%), Positives = 72/258 (27%), Gaps = 24/258 (9%)

Query: 63  AQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--QLVELSVMGNRLSGPFPKV 120
            ++       E      ++ +DLS + +  S      S   +L  LS+ G RLS P    
Sbjct: 31  PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90

Query: 121 LTNITTLKNLSIE--GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDL 178
           L   + L  L++         ++   +     L +                  L+   D 
Sbjct: 91  LAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE----------------LNLSWCFDF 134

Query: 179 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF 238
                  +            +          +              DL  S +  ++   
Sbjct: 135 TEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ 194

Query: 239 PKLDKMNLKTLILTKC-LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 297
                  L+ L L++C  I  E    +G++  LK + +      G +    E L      
Sbjct: 195 EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ-- 252

Query: 298 YLTGNKLTGPVPKYIFNS 315
            +  +  T      I N 
Sbjct: 253 -INCSHFTTIARPTIGNK 269

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.2 bits (114), Expect = 2e-07
 Identities = 24/113 (21%), Positives = 35/113 (30%), Gaps = 4/113 (3%)

Query: 69  TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 128
           T+   L +L  +  LDLS N L        A   L  L    N L               
Sbjct: 11  TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQEL 70

Query: 129 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE--LPAELTK-LTNLNDL 178
            L     L   +    +     L  L L  NS   E  +   L + L +++ +
Sbjct: 71  LLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.5 bits (107), Expect = 2e-06
 Identities = 22/118 (18%), Positives = 37/118 (31%), Gaps = 10/118 (8%)

Query: 81  KQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE-GNLFT 138
           + L L+   LT         L  +  L +  NRL    P     +  L+ L +   +   
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNA 54

Query: 139 GSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIGK 195
                 +  L  LQ+L+L +N          L     L  L +  N+          +
Sbjct: 55  LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQER 111

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.9 bits (90), Expect = 4e-04
 Identities = 20/143 (13%), Positives = 40/143 (27%), Gaps = 28/143 (19%)

Query: 152 QKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 211
           + L L+    T      L +L  +  L +S N      P             ++      
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALR------CLEVLQASD 52

Query: 212 PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLK 271
               ++  + +L  L+   L  +                    L        +    +L 
Sbjct: 53  NALENVDGVANLPRLQELLLCNN-------------------RLQQSAAIQPLVSCPRLV 93

Query: 272 NIDLSFNNLTGGIPTTFEKLAKT 294
            ++L  N+L        E+LA+ 
Sbjct: 94  LLNLQGNSLC-QEEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 35.8 bits (82), Expect = 0.004
 Identities = 19/110 (17%), Positives = 33/110 (30%), Gaps = 9/110 (8%)

Query: 200 QKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKMNLKTLILTKCLIH 257
           + LH+    L   +   +  L  +T L +S   L+    A   L    L+ L  +   + 
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAAL--RCLEVLQASDNALE 56

Query: 258 GEIPDYIGDMTKLKNIDLSFNNLTGG-IPTTFEKLAKTNFMYLTGNKLTG 306
                      +   + L  N L             +   + L GN L  
Sbjct: 57  NVDGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.5 bits (119), Expect = 3e-07
 Identities = 39/207 (18%), Positives = 68/207 (32%), Gaps = 6/207 (2%)

Query: 122 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 181
           + + +   ++ +    T ++PPD+ K  +   L LS N       A L   T L  L + 
Sbjct: 7   SKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 182 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 241
                    +  G    +  L +  + L+       +           +   S       
Sbjct: 64  --RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 242 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 301
               L+ L L    +    P  +    KL+ + L+ NNLT         L   + + L  
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 302 NKLTGPVPKYIFNSNKNVDISLNNFTW 328
           N L   +PK  F S+      L+   W
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.0 bits (110), Expect = 3e-06
 Identities = 48/240 (20%), Positives = 73/240 (30%), Gaps = 36/240 (15%)

Query: 44  NVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-Q 102
           +  C+ S    H+  +    +NLT  LP +L K      L LS N L            +
Sbjct: 1   HPICEVSKVASHL-EVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTR 56

Query: 103 LVELSVMGNRLSGPFPKVLTNITTLKNLSI--EGNLFTGSIPPDIRKLINLQKLILSSNS 160
           L +L      L       L    TL  L      +    S+P   + L  L  L +S N 
Sbjct: 57  LTQL-----NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNR 111

Query: 161 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 220
            T      L  L  L +L +  N      P  +    K++KL +  ++L       ++ L
Sbjct: 112 LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171

Query: 221 TSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNL 280
            +L  L + +                             IP        L    L  N  
Sbjct: 172 ENLDTLLLQENSLY------------------------TIPKGFFGSHLLPFAFLHGNPW 207

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (116), Expect = 1e-06
 Identities = 14/85 (16%), Positives = 33/85 (38%), Gaps = 9/85 (10%)

Query: 123 NITTLKNLSIEGNLFTG----SIPPDIRKLINLQKLILSSNSFTGELPAELTK-----LT 173
             + L+ L +     +     S+   +    +L++L LS+N        +L +       
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 174 NLNDLRISDNNFSGKIPEFIGKWKK 198
            L  L + D  +S ++ + +   +K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 14/90 (15%), Positives = 31/90 (34%), Gaps = 5/90 (5%)

Query: 127 LKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGE----LPAELTKLTNLNDLRIS 181
           +++L I+    + +   ++   L   Q + L     T      + + L     L +L + 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 182 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 211
            N         + +  +     IQ  SL+ 
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 15/89 (16%), Positives = 32/89 (35%), Gaps = 10/89 (11%)

Query: 102 QLVELSVMGNRLSG----PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI-----NLQ 152
            L  L +    +S          L    +L+ L +  N    +    + + +      L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 153 KLILSSNSFTGELPAELTKL-TNLNDLRI 180
           +L+L    ++ E+   L  L  +   LR+
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDKPSLRV 458

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 12/92 (13%), Positives = 31/92 (33%), Gaps = 10/92 (10%)

Query: 149 INLQKLILSSNSFTGELPAELTK-LTNLNDLRISDNNFSGK----IPEFIGKWKKIQKLH 203
           +++Q L +     +    AEL   L     +R+ D   +      I   +     + +L+
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 204 IQGSSLEGPIPASISAL-----TSLTDLRISD 230
           ++ + L       +          +  L + +
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 7e-05
 Identities = 17/167 (10%), Positives = 40/167 (23%), Gaps = 6/167 (3%)

Query: 222 SLTDLRISDLKGSESAFPKLDKM--NLKTLILTKCLIHGE----IPDYIGDMTKLKNIDL 275
            +  L I   + S++ + +L  +    + + L  C +       I   +     L  ++L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 276 SFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIE 335
             N L         +  +T    +    L             +  +       E      
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122

Query: 336 CPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINC 382
               +   +        +       L      +A  +     L    
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKP 169

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.1 bits (115), Expect = 1e-06
 Identities = 18/96 (18%), Positives = 34/96 (35%), Gaps = 12/96 (12%)

Query: 109 MGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE 168
             N  S     +     +L+ L++  N     +P        L++LI S N    E+P  
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPEL 322

Query: 169 LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHI 204
              L  L+   +  N    + P+       ++ L +
Sbjct: 323 PQNLKQLH---VEYNPLR-EFPDIPE---SVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.2 bits (105), Expect = 2e-05
 Identities = 21/135 (15%), Positives = 44/135 (32%), Gaps = 8/135 (5%)

Query: 18  WNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKL 77
            +            +L    +     +V+ +  S    +          +  + +     
Sbjct: 224 PSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLP 283

Query: 78  RYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLF 137
             L++L++S N L          L+ +  S   N L+   P++  N   LK L +E N  
Sbjct: 284 PSLEELNVSNNKLI-ELPALPPRLERLIAS--FNHLAE-VPELPQN---LKQLHVEYNPL 336

Query: 138 TGSIPPDIRKLINLQ 152
               P     + +L+
Sbjct: 337 R-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.002
 Identities = 13/65 (20%), Positives = 25/65 (38%), Gaps = 5/65 (7%)

Query: 150 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 209
              +L L++   +  LP     L +L     S N+ + ++PE     K +   +    +L
Sbjct: 39  QAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93

Query: 210 EGPIP 214
               P
Sbjct: 94  SDLPP 98

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (90), Expect = 6e-04
 Identities = 30/152 (19%), Positives = 56/152 (36%), Gaps = 5/152 (3%)

Query: 70  LPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKN 129
           L   +SK     Q  L    L     P   +  +  +    + ++     +  NI  L +
Sbjct: 12  LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLS 69

Query: 130 LSIEGNLFTG--SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 187
           L++  N       +   ++K  NL+ L LS N    E   +  K   L +L +  N+ S 
Sbjct: 70  LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129

Query: 188 KIPEFIGKWKKIQKLHIQGSSLEG-PIPASIS 218
              +       I++   +   L+G  +P  I+
Sbjct: 130 TFRDQSTYISAIRERFPKLLRLDGHELPPPIA 161

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (85), Expect = 0.003
 Identities = 28/190 (14%), Positives = 57/190 (30%), Gaps = 35/190 (18%)

Query: 124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 183
           +  LK   +E       +   + K  +  +  L           +L        L    +
Sbjct: 1   LNELKPEQVE------QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-S 51

Query: 184 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK 243
           + +  +        ++  L+                   L++ R+  L    S   K   
Sbjct: 52  SMAATLRIIEENIPELLSLN-------------------LSNNRLYRLDDMSSIVQKAP- 91

Query: 244 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT-----NFMY 298
            NLK L L+   +  E         KL+ + L  N+L+         ++         + 
Sbjct: 92  -NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLR 150

Query: 299 LTGNKLTGPV 308
           L G++L  P+
Sbjct: 151 LDGHELPPPI 160

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.9 bits (91), Expect = 0.001
 Identities = 13/92 (14%), Positives = 36/92 (39%), Gaps = 8/92 (8%)

Query: 126 TLKNLSIEGNLFTG----SIPPDIRKLINLQKLILSSNSFTGE----LPAELTKLTNLND 177
           +++  S++ +  T     S+   + +  ++++++LS N+   E    L   +    +L  
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 178 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 209
              SD        E     + + +  ++   L
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.8 bits (89), Expect = 0.001
 Identities = 32/203 (15%), Positives = 68/203 (33%), Gaps = 23/203 (11%)

Query: 118 PKVLTNITTLKNLS--IEGNLFTGSI--PPDIRKLINLQKLILSSNSFTGELPAELTKLT 173
           P  +  I +    +  I+ NL   S+       +L ++ ++I +++         +  L 
Sbjct: 11  PTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLP 68

Query: 174 NLNDLRISDNNFSGKIP---------------EFIGKWKKIQKLHIQGSSLEGPIPASIS 218
           N+  L ++ N  +   P               +            ++  SLE    + I+
Sbjct: 69  NVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN 128

Query: 219 ALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN 278
            L  L  L    L  ++     +     K   L+           +  +TKL+N+ LS N
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN 188

Query: 279 NLTGGIPTTFEKLAKTNFMYLTG 301
           +++         L   + + L  
Sbjct: 189 HISD--LRALAGLKNLDVLELFS 209

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 30/224 (13%), Positives = 68/224 (30%), Gaps = 25/224 (11%)

Query: 117 FPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLN 176
           FP     +     ++   +  T ++      L  +  L       T  +   +  L NL 
Sbjct: 13  FP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLI 66

Query: 177 DLRISDNNFSGK---------------IPEFIGKWKKIQKLHIQGSSLEGPIPASISALT 221
            L + DN  +                                I+   L       ++ L 
Sbjct: 67  GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126

Query: 222 SLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 281
            L++L++  L  ++               L+           + +++KL  +    N ++
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS 186

Query: 282 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNN 325
              P     L     ++L  N+++   P  + N++    ++L N
Sbjct: 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	869
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.96
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.96
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.93
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.9
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.9
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.9
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.88
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.86
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.84
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.77
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.76
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.75
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.75
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.74
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.71
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.71
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.7
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.67
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.66
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.61
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.59
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.58
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.58
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.54
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.51
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.48
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.48
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.46
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.45
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.44
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.43
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.3
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.26
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.25
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.47
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.36
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.29
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.9
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.74
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.68
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.32
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.21
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.04
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.53
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.11
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.15

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-43  Score=371.05  Aligned_cols=201  Identities=31%  Similarity=0.481  Sum_probs=175.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|++.++||+|+||+||+|+.. +|+.||||++.... ....+++.+|++++++++|||||++++++.+++..|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57889999999999999999975 68999999986543 23356799999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +++|+|.+++....     .+++..++.++.||++||+|||+++   |+||||||+|||+++++.+||+|||+|+.....
T Consensus        85 ~~gg~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          85 CSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             CTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCcHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            99999999986543     6899999999999999999999998   999999999999999999999999999877543


Q ss_pred             C-ccccccccccccccchhhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          796 K-THISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       796 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      . .......+||+.|||||++.+..+ +.++||||+||++|||++|+.||...
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~  209 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  209 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC
Confidence            3 223345689999999999987765 67899999999999999999999653

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=371.55  Aligned_cols=198  Identities=26%  Similarity=0.525  Sum_probs=179.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999964 68999999987665555678999999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++|+|.+++...      .+++..+..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+|+......
T Consensus       100 ~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1         100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             TTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            999999887543      5899999999999999999999998   9999999999999999999999999998875433


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      . .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~  218 (293)
T d1yhwa1         171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN  218 (293)
T ss_dssp             C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC
Confidence            2 23346799999999999999999999999999999999999999964

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-42  Score=366.30  Aligned_cols=197  Identities=28%  Similarity=0.482  Sum_probs=176.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....   ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            56889999999999999999985 68899999986432   233567889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+|....
T Consensus        86 Ey~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred             eecCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecC
Confidence            9999999999986543     6899999999999999999999998   9999999999999999999999999997664


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...   .....||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus       158 ~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  206 (263)
T d2j4za1         158 SSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA  206 (263)
T ss_dssp             CCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence            332   2345799999999999999999999999999999999999999964

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-42  Score=367.28  Aligned_cols=199  Identities=30%  Similarity=0.542  Sum_probs=166.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEecc
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      ++|++.+.||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5678889999999999999999888999999987543 345789999999999999999999999999999999999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      +|+|.+++....    ..++|..+..++.|||+||+|||+++   |+||||||+|||+++++.+||+|||+++.......
T Consensus        84 ~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          84 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             CCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            999999987653    26899999999999999999999997   99999999999999999999999999987765444


Q ss_pred             cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcC-CCCCC
Q 002899          798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG-KSNTN  844 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG-~~p~~  844 (869)
                      .......||+.|+|||++.+..++.++|||||||++|||+|+ ++|+.
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~  204 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE  204 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC
Confidence            334446789999999999999999999999999999999995 54443

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-42  Score=368.25  Aligned_cols=201  Identities=27%  Similarity=0.465  Sum_probs=178.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      +.|++.+.||+|+||+||+|+.. +++.||||+++.......+.|.+|++++++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46888999999999999999975 68999999998776677788999999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++|+|.+++....    ..+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+|+......
T Consensus        92 ~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~  164 (288)
T d2jfla1          92 AGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  164 (288)
T ss_dssp             TTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred             CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence            9999999875432    26899999999999999999999998   9999999999999999999999999998664322


Q ss_pred             ccccccccccccccchhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      . ......||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       165 ~-~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~  218 (288)
T d2jfla1         165 Q-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL  218 (288)
T ss_dssp             H-HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             c-cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence            2 223467999999999984     456899999999999999999999999653

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-42  Score=364.46  Aligned_cols=199  Identities=31%  Similarity=0.530  Sum_probs=175.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .++|++.+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            45788899999999999999999888999999997543 345789999999999999999999998764 5679999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++|+|.+++....   ...++|..+++|+.|||+||+|||+++   |+||||||+||||++++.+||+|||+|+......
T Consensus        90 ~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          90 ENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             TTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             CCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence            9999998875542   236899999999999999999999987   9999999999999999999999999999876554


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT  843 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~  843 (869)
                      ........||+.|+|||++....++.++|||||||++|||+||+.|+
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~  210 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP  210 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence            44444567899999999999999999999999999999999966555

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-41  Score=357.83  Aligned_cols=201  Identities=27%  Similarity=0.485  Sum_probs=181.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEecc
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK  717 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~  717 (869)
                      ++|++.++||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            6899999999999999999999888899999987643 345789999999999999999999999999999999999999


Q ss_pred             CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc
Q 002899          718 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT  797 (869)
Q Consensus       718 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~  797 (869)
                      +|+|..++....    ..+++..+.+++.|+|+||+|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus        83 ~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          83 NGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             TEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             CCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            999999876553    26899999999999999999999987   99999999999999999999999999987765544


Q ss_pred             cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          798 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       798 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      .......||+.|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~  205 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF  205 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC
Confidence            44444678999999999999999999999999999999998 89999653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-42  Score=370.43  Aligned_cols=218  Identities=24%  Similarity=0.416  Sum_probs=186.0

Q ss_pred             HHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEE
Q 002899          632 QIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       632 ~i~~~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  710 (869)
                      +++...++|++.+.||+|+||+||+|++. +++.||||+++... ...++|.+|++++++++|||||++++++.+++..+
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            33344567888999999999999999986 58899999987543 34678999999999999999999999999999999


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      +||||+++|+|.+++.....   ..+++..+..|+.|||+||+|||+++   |+||||||+|||+++++.+||+|||+|+
T Consensus        90 iv~E~~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~  163 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR  163 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred             EEeecccCcchHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccccee
Confidence            99999999999999875432   36899999999999999999999997   9999999999999999999999999998


Q ss_pred             eecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHH
Q 002899          791 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA  858 (869)
Q Consensus       791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~  858 (869)
                      ..............|++.|+|||++.+..++.++|||||||++|||++|+.|+...  .+...+.+.+
T Consensus       164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~--~~~~~~~~~i  229 (287)
T d1opja_         164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLSQVYELL  229 (287)
T ss_dssp             TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT--CCHHHHHHHH
T ss_pred             ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc--chHHHHHHHH
Confidence            77655444444456899999999999999999999999999999999987776432  2334444444

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-42  Score=363.19  Aligned_cols=199  Identities=32%  Similarity=0.546  Sum_probs=168.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++|.+.++||+|+||+||+|+++  ..||||+++..  .....++|.+|++++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467889999999999999999865  35999998654  34456789999999999999999999998764 56899999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++|+|.++++..+.    .+++..+..++.|||+||+|||+++   ||||||||+|||++.++.+||+|||+|+....
T Consensus        84 y~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          84 WCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             CCCEEEHHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             cCCCCCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            9999999999976532    5899999999999999999999987   99999999999999999999999999987654


Q ss_pred             CCc-cccccccccccccchhhccc---CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKT-HISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ... .......||+.|||||++..   ..++.++|||||||++|||+||+.||..
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~  211 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN  211 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence            322 22344679999999999864   3589999999999999999999999964

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=376.73  Aligned_cols=200  Identities=24%  Similarity=0.440  Sum_probs=177.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          636 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       636 ~t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ..++|++.++||+|+||+||+|+.. +|+.||+|+++... .....++.+|++++++++|||||++++++.+++..++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3578999999999999999999975 68999999987553 333567899999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      ||+++|+|.+++....     .+++..+..++.|+++||+|||+. +   |+||||||+|||++.++.+||+|||+|+..
T Consensus        84 Ey~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             ECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EcCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            9999999999996543     689999999999999999999974 6   999999999999999999999999999866


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ....   ....+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       156 ~~~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         156 IDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             HHHT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             CCCc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            4322   23468999999999999999999999999999999999999999654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-42  Score=366.61  Aligned_cols=200  Identities=27%  Similarity=0.419  Sum_probs=175.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.++||+|+||+||+|+.. +++.||||++....   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57899999999999999999975 68999999986432   233467899999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++...+     .+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+.
T Consensus        88 Ey~~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EccCCCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecc
Confidence            9999999999886543     6899999999999999999999998   9999999999999999999999999998875


Q ss_pred             CCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (288)
T d1uu3a_         160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA  212 (288)
T ss_dssp             ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence            4332 223346799999999999999999999999999999999999999964

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=366.34  Aligned_cols=206  Identities=27%  Similarity=0.452  Sum_probs=166.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEee--CceEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLV  712 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV  712 (869)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....  ....+.|.+|++++++++|||||++++++.+  .+.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            67899999999999999999975 68999999986543  3345678999999999999999999999865  4568999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCC--CCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR--IKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~--~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      |||+++|+|.+++.... .....+++..++.++.||+.||+|||+++.  .+|+||||||+|||++.++.+||+|||+|+
T Consensus        84 mEy~~~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          84 MEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EECCTTEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EecCCCCcHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999886432 123469999999999999999999998652  349999999999999999999999999998


Q ss_pred             eecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          791 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....... ......||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus       163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~  216 (269)
T d2java1         163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA  216 (269)
T ss_dssp             HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence            7654332 23346799999999999999999999999999999999999999964

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-41  Score=354.42  Aligned_cols=195  Identities=28%  Similarity=0.478  Sum_probs=167.9

Q ss_pred             CCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEee----CceEEEEE
Q 002899          641 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVY  713 (869)
Q Consensus       641 ~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~  713 (869)
                      ++.++||+|+||+||+|+.. +++.||+|++...  .....+.|.+|++++++++|||||++++++.+    +..+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45668999999999999975 6889999998654  33345678999999999999999999999875    35689999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-CCCcEEEeecCCceee
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLY  792 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~-~~~~~kl~DFGla~~~  792 (869)
                      ||+++|+|.+++....     .+++..++.++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+..
T Consensus        92 E~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eCCCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            9999999999986543     6899999999999999999999875 4599999999999996 5789999999999765


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....   ....+||+.|||||++.+ .++.++|||||||++|||++|+.||..
T Consensus       166 ~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~  214 (270)
T d1t4ha_         166 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE  214 (270)
T ss_dssp             CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence            4322   234679999999998865 589999999999999999999999954

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-41  Score=364.48  Aligned_cols=201  Identities=30%  Similarity=0.500  Sum_probs=163.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcC-C---cEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSD-G---TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~-g---~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ++|++.++||+|+||+||+|++.. +   ..||||++.... ....++|.+|++++++++|||||+++|++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            345667899999999999999752 3   368999886643 34457899999999999999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++|+|.+++....    ..++|.++..++.|||+||+|||+++   |+||||||+||||+.++++||+|||+++..
T Consensus       106 ~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEc
Confidence            99999999999886543    25899999999999999999999987   999999999999999999999999999877


Q ss_pred             cCCCccc----cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          793 EEDKTHI----STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .......    .....||+.|||||++....++.++|||||||++|||+| |+.||..
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~  236 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD  236 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence            5432211    112457899999999999999999999999999999998 8999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.5e-41  Score=367.56  Aligned_cols=200  Identities=25%  Similarity=0.413  Sum_probs=179.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      -++|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999975 6899999999876666677899999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc--CCCcEEEeecCCceeec
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLNAKISDFGLAKLYE  793 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~--~~~~~kl~DFGla~~~~  793 (869)
                      +++|+|.+++....    ..+++..+..++.||+.||+|||+++   |+||||||+|||++  .++.+||+|||+++...
T Consensus       105 ~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2         105 MSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             CCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             CCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            99999999986543    25899999999999999999999998   99999999999996  46789999999998776


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....  .....||+.|||||++.+..++.++||||+||++|||++|+.||..
T Consensus       178 ~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  227 (350)
T d1koaa2         178 PKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG  227 (350)
T ss_dssp             TTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence            4332  2345799999999999999999999999999999999999999964

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-41  Score=357.74  Aligned_cols=201  Identities=30%  Similarity=0.477  Sum_probs=172.5

Q ss_pred             cCCCCCC-eeeccCceEEEEEEEc---CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEE
Q 002899          638 NNFDPAN-KVGEGGFGSVYKGILS---DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       638 ~~f~~~~-~IG~G~fG~Vyka~~~---~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ++|.+.+ +||+|+||+||+|.++   ++..||||+++... ....++|.+|++++++++|||||+++|++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4555666 4999999999999864   35579999997654 3446789999999999999999999999865 568999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++|+|.+++...+    ..+++..+..++.|||+||+|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        87 mE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcc
Confidence            99999999999886543    26899999999999999999999987   999999999999999999999999999987


Q ss_pred             cCCCccc--cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          793 EEDKTHI--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       793 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      .......  .....||+.|+|||++....++.++|||||||++|||+| |+.||...
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~  216 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM  216 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence            6543221  223568999999999999999999999999999999998 99999653

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-41  Score=365.95  Aligned_cols=199  Identities=29%  Similarity=0.370  Sum_probs=178.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|+.. +|+.||||+++...   ....+.+.+|++++++++|||||++++++.+++.+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57899999999999999999974 78999999987542   234567889999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|.+++....     .+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+...
T Consensus        85 ey~~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          85 EYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eccCCCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence            9999999999987643     6899999999999999999999998   9999999999999999999999999998664


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .... .....+||+.|+|||++.+..++.++||||+||++|||++|++||..
T Consensus       157 ~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~  207 (337)
T d1o6la_         157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  207 (337)
T ss_dssp             CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC
Confidence            4322 23346899999999999999999999999999999999999999965

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.7e-41  Score=362.11  Aligned_cols=196  Identities=27%  Similarity=0.447  Sum_probs=176.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.++||+|+||+||+|+.. +|+.||||+++...   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56889999999999999999975 68999999986532   233567899999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+++|+|..++....     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus        84 E~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eecCCccccccccccc-----cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEec
Confidence            9999999998886654     5788999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...    ...+||+.|||||++.+..++.++||||+||++|||++|+.||..
T Consensus       156 ~~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~  203 (316)
T d1fota_         156 DVT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD  203 (316)
T ss_dssp             SCB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ccc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence            432    246799999999999999999999999999999999999999964

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-41  Score=362.89  Aligned_cols=199  Identities=27%  Similarity=0.418  Sum_probs=161.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .+.|++.++||+|+||+||+|+.. +++.||||++..... .....+.+|++++++++|||||++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            467899999999999999999975 689999999875432 334568899999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc---CCCcEEEeecCCcee
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKL  791 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~---~~~~~kl~DFGla~~  791 (869)
                      |+++|+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||+.   +++.+||+|||+|+.
T Consensus        88 ~~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          88 LVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             CCCSCBHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             ccCCCcHHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence            999999999997643     6899999999999999999999998   99999999999994   578999999999987


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .....  .....+||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus       160 ~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  211 (307)
T d1a06a_         160 EDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD  211 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence            65332  22346799999999999999999999999999999999999999964

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.2e-40  Score=365.06  Aligned_cols=200  Identities=27%  Similarity=0.404  Sum_probs=179.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      -++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++.+|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357899999999999999999974 7999999999876656667888999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc--CCCcEEEeecCCceeec
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLNAKISDFGLAKLYE  793 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~--~~~~~kl~DFGla~~~~  793 (869)
                      +++|+|.+.+....    .++++..+..|+.||+.||+|||+++   |+||||||+|||++  .++.+||+|||+|....
T Consensus       108 ~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         108 LSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             CCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             CCCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecC
Confidence            99999988775543    25899999999999999999999998   99999999999998  67899999999998876


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....  .....||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       181 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  230 (352)
T d1koba_         181 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG  230 (352)
T ss_dssp             TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CCCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence            5432  2345789999999999999999999999999999999999999964

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-41  Score=354.40  Aligned_cols=193  Identities=30%  Similarity=0.447  Sum_probs=165.6

Q ss_pred             CeeeccCceEEEEEEEcC---CcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEeccC
Q 002899          644 NKVGEGGFGSVYKGILSD---GTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN  718 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~---g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~  718 (869)
                      ++||+|+||+||+|.+++   ++.||||+++...  ....++|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            469999999999998753   4689999986542  3335689999999999999999999999865 467899999999


Q ss_pred             CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCCcc
Q 002899          719 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH  798 (869)
Q Consensus       719 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  798 (869)
                      |+|.+++....     .+++..+..++.|||+||+|||+++   |+||||||+|||++.++.+||+|||+++........
T Consensus        92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            99999987543     6899999999999999999999987   999999999999999999999999999877544332


Q ss_pred             c--cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          799 I--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       799 ~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      .  .....||+.|+|||++....++.++|||||||++|||++ |+.||..
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~  213 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG  213 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC
Confidence            2  223568999999999999999999999999999999998 8999964

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.3e-41  Score=360.01  Aligned_cols=194  Identities=29%  Similarity=0.501  Sum_probs=171.2

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .|+..+.||+|+||+||+|+.. +++.||||+++....   ...++|.+|++++++++|||||++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4888999999999999999965 688999999875432   234578999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+++|++..++....     ++++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|.....
T Consensus        96 ~~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             CCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            999999976664432     6899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCccccccccccccccchhhccc---CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .     ....||+.|||||++.+   ..++.++|||||||++|||++|+.||..
T Consensus       168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~  216 (309)
T d1u5ra_         168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (309)
T ss_dssp             B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC
Confidence            2     23579999999999863   4689999999999999999999999954

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-40  Score=354.05  Aligned_cols=199  Identities=27%  Similarity=0.375  Sum_probs=176.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc------hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~------~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~  709 (869)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++....      ...+.|.+|++++++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467999999999999999999975 689999999864321      2356799999999999999999999999999999


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC----cEEEee
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISD  785 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~----~~kl~D  785 (869)
                      ++||||+++|+|.+++....     .+++..++.++.|++.||+|||+++   |+||||||+|||++.++    .+|++|
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~D  160 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID  160 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEEcCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecc
Confidence            99999999999999986543     6899999999999999999999998   99999999999998776    499999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ||+|........  .....||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       161 fG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  218 (293)
T d1jksa_         161 FGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  218 (293)
T ss_dssp             CTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             hhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC
Confidence            999987754332  2345789999999999999999999999999999999999999964

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-41  Score=355.67  Aligned_cols=213  Identities=30%  Similarity=0.466  Sum_probs=173.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .++|++.+.||+|+||.||+|++++++.||||+++.. ....+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            3578899999999999999999988889999999754 3345789999999999999999999999854 5689999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++|+|..++....   ...++|.+++.++.|||.||+|||+++   |+||||||+|||++.++++||+|||+++......
T Consensus        94 ~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          94 SKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             TTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             CCCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            9999998886542   225899999999999999999999998   9999999999999999999999999998775444


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcchhhHHHHHH
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAY  859 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~~l~~w~~  859 (869)
                      ........||+.|+|||++..+.++.++|||||||++|||++|+.|+...  ....++..++.
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~--~~~~~~~~~i~  228 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVE  228 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHH
T ss_pred             ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC--CCHHHHHHHHH
Confidence            33344467899999999999999999999999999999999976665432  23344455543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-40  Score=352.40  Aligned_cols=201  Identities=30%  Similarity=0.515  Sum_probs=166.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCC-----cEEEEEEecccCc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDG-----TVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g-----~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      +.|+..++||+|+||.||+|.++..     ..||||++..... ....+|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4677889999999999999997642     4799999875533 335679999999999999999999999999999999


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+.+|++.+.+....    ..++|.++..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.
T Consensus        87 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          87 ITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999998876543    26899999999999999999999987   99999999999999999999999999987


Q ss_pred             ecCCCcc--ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          792 YEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       792 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      .......  ......||+.|+|||++....++.++|||||||++|||++|+.|+..
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~  215 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW  215 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence            6543322  22235689999999999999999999999999999999997666643

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-40  Score=359.33  Aligned_cols=207  Identities=29%  Similarity=0.436  Sum_probs=174.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC-C-----cEEEEEEeccc-CchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCce
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD-G-----TVIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~-g-----~~VAvK~~~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~  708 (869)
                      .++|++.++||+|+||+||+|++.. +     ..||||++... .......|.+|++++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3678899999999999999999743 2     36999998654 334456789999999988 89999999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcc------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTE------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKT  770 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~  770 (869)
                      .++||||+++|+|.++++.....                  ....+++..++.++.||++||+|||+++   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            99999999999999999765321                  1235899999999999999999999997   99999999


Q ss_pred             CCEEEcCCCcEEEeecCCceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          771 SNVLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       771 ~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      +|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999876544332 2234568999999999999999999999999999999998 89999653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.6e-40  Score=359.87  Aligned_cols=203  Identities=29%  Similarity=0.427  Sum_probs=173.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHH---HHHHHHhcCCCceeeEEeEEeeCceEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVN---EIGMISAQQHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~---E~~~l~~l~H~nIv~l~~~~~~~~~~~  710 (869)
                      ++|++.++||+|+||.||+|+.. +|+.||||++....   ......+.+   |+++++.++|||||++++++.+++..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57899999999999999999975 68999999986432   112233444   466777788999999999999999999


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      +||||+++|+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus        84 ivmE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceee
Confidence            9999999999999996543     6789999999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcch
Q 002899          791 LYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF  851 (869)
Q Consensus       791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~  851 (869)
                      .......   ....||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.
T Consensus       156 ~~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~  214 (364)
T d1omwa3         156 DFSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK  214 (364)
T ss_dssp             ECSSSCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH
T ss_pred             ecCCCcc---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            7754332   34579999999999875 5689999999999999999999999976444343

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.2e-40  Score=360.06  Aligned_cols=196  Identities=25%  Similarity=0.364  Sum_probs=176.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~  713 (869)
                      ++|++.+.||+|+||.||+|+.. +|+.||||+++...   ....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57899999999999999999975 68999999986432   233467899999999999999999999999999999999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeec
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE  793 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~  793 (869)
                      ||+.+|+|.+++....     .+++..++.++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+...
T Consensus       121 e~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~  192 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             ccccccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence            9999999999886543     6899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ...    ....||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus       193 ~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~  240 (350)
T d1rdqe_         193 GRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA  240 (350)
T ss_dssp             SCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccc----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC
Confidence            322    245799999999999999999999999999999999999999964

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-39  Score=352.07  Aligned_cols=199  Identities=30%  Similarity=0.439  Sum_probs=174.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHH-hcCCCceeeEEeEEeeCceEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMIS-AQQHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ++|.+.++||+|+||+||+|+.. +++.||||+++...   ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57889999999999999999975 68999999996432   233456677777665 68999999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          713 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      |||+++|+|.+++....     .+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++..
T Consensus        82 mEy~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~  153 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN  153 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EeecCCCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhc
Confidence            99999999999996543     5899999999999999999999998   999999999999999999999999999866


Q ss_pred             cCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~  205 (320)
T d1xjda_         154 MLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG  205 (320)
T ss_dssp             CCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC
Confidence            54332 23346799999999999999999999999999999999999999964

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.3e-39  Score=344.53  Aligned_cols=201  Identities=23%  Similarity=0.378  Sum_probs=168.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc----e
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----Q  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~----~  708 (869)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++...   ....+.|.+|+++++.++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999974 78999999997543   233457899999999999999999999988654    4


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .|+||||+++|+|.+++...+     .+++.+++.++.||++||+|||+++   |+||||||+|||++.++..+++|||.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~  157 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI  157 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTT
T ss_pred             EEEEEECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhh
Confidence            799999999999998886543     6899999999999999999999998   99999999999999999999999999


Q ss_pred             ceeecCCCc--cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          789 AKLYEEDKT--HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       789 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      +........  ......+||+.|+|||++.+..+++++||||+||++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  216 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG  216 (277)
T ss_dssp             CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence            876543322  223346799999999999999999999999999999999999999964

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-39  Score=345.03  Aligned_cols=202  Identities=28%  Similarity=0.403  Sum_probs=163.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC----CcEEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~----g~~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      .++|++.+.||+|+||.||+|++..    +..||||.++..... ..+.|.+|++++++++|||||++++++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3578889999999999999998742    357899998654433 3567999999999999999999999986 467899


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||||+++|+|.+++....    ..+++..++.++.||++||+|||+++   |+||||||+||+++.++.+||+|||+|+.
T Consensus        85 v~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence            999999999998876543    26899999999999999999999998   99999999999999999999999999987


Q ss_pred             ecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002899          792 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR  846 (869)
Q Consensus       792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~  846 (869)
                      .............||+.|+|||++....++.++|||||||++|||++ |++||...
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~  213 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV  213 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC
Confidence            76544444445678999999999999999999999999999999998 89888653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.1e-39  Score=341.37  Aligned_cols=199  Identities=27%  Similarity=0.409  Sum_probs=174.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCch---------hhHHHHHHHHHHHhcC-CCceeeEEeEEeeC
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ---------GNREFVNEIGMISAQQ-HPNLVKLYGCCVEG  706 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~---------~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~  706 (869)
                      ++|++.+.||+|+||+||+|+.. +++.||||+++.....         ..+.+.+|++++++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            67889999999999999999974 7899999998654211         1245889999999997 99999999999999


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                      +..|+||||+++|+|.+++..+.     .+++.+++.++.||++||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence            99999999999999999996543     6899999999999999999999998   999999999999999999999999


Q ss_pred             CCceeecCCCccccccccccccccchhhccc------CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          787 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMR------GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       787 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |+++.......  .....||+.|+|||++..      ..++.++||||+||++|||++|+.||...
T Consensus       155 G~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~  218 (277)
T d1phka_         155 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR  218 (277)
T ss_dssp             TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence            99987764332  234679999999999863      35688999999999999999999999643

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-39  Score=351.23  Aligned_cols=224  Identities=29%  Similarity=0.429  Sum_probs=183.6

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCch-hhHHHHHHHHHHHhcCCCceeeEEeE
Q 002899          630 LRQIKAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGC  702 (869)
Q Consensus       630 ~~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~  702 (869)
                      +.+++...++|++.+.||+|+||+||+|++.      +++.||||+++..... ..++|.+|++++++++||||++++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            3344555678999999999999999999964      3578999999765433 35679999999999999999999999


Q ss_pred             EeeCceEEEEEEeccCCchhhhhhcCCc-------------------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 002899          703 CVEGNQLLLVYEYMKNNCLSRAIFGKDT-------------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI  763 (869)
Q Consensus       703 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  763 (869)
                      +...+..++||||+++|+|.++++....                   .....+++..++.|+.|+|.||+|||+++   |
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence            9999999999999999999999865321                   11235899999999999999999999987   9


Q ss_pred             EEcCCCCCCEEEcCCCcEEEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCC-
Q 002899          764 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS-  841 (869)
Q Consensus       764 iH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~-  841 (869)
                      |||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|.. 
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            9999999999999999999999999986644322 22334578899999999999999999999999999999999964 


Q ss_pred             CCCCCCCcchhhHHHHHH
Q 002899          842 NTNYRPNEDFVYLLDWAY  859 (869)
Q Consensus       842 p~~~~~~~~~~~l~~w~~  859 (869)
                      ||...   +..++.+.+.
T Consensus       242 p~~~~---~~~e~~~~v~  256 (301)
T d1lufa_         242 PYYGM---AHEEVIYYVR  256 (301)
T ss_dssp             TTTTS---CHHHHHHHHH
T ss_pred             CCCCC---CHHHHHHHHH
Confidence            55432   3344444443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-39  Score=347.01  Aligned_cols=199  Identities=20%  Similarity=0.318  Sum_probs=176.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      -++|.+.+.||+|+||+||+|... +++.||||+++... .....+.+|+++|+.++|||||++++++.+++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            367889999999999999999975 68899999997653 3345688999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC--CcEEEeecCCceeec
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD--LNAKISDFGLAKLYE  793 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~--~~~kl~DFGla~~~~  793 (869)
                      +++|+|.+++....    ..+++.++..++.||+.||+|||+.+   |+||||||+|||++.+  ..+||+|||+++...
T Consensus        83 ~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          83 ISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             CCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccc
Confidence            99999999996543    25899999999999999999999998   9999999999999854  589999999998765


Q ss_pred             CCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          794 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ....  .....+|+.|+|||...+..++.++||||+||++|||++|+.||..
T Consensus       156 ~~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~  205 (321)
T d1tkia_         156 PGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA  205 (321)
T ss_dssp             TTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cCCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC
Confidence            4322  2335689999999999999999999999999999999999999965

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-39  Score=349.26  Aligned_cols=202  Identities=30%  Similarity=0.554  Sum_probs=168.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEeccc-CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~----~VAvK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  711 (869)
                      .+|++.++||+|+||+||+|.+. +|+    +||||+++.. .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46889999999999999999975 343    6899988654 344567899999999999999999999999865 5678


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ++||+.+|+|.+.+....    ..+++..+++++.|||+||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             EEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecccccee
Confidence            889999999998886543    36899999999999999999999987   99999999999999999999999999987


Q ss_pred             ecCCCccc-cccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 002899          792 YEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP  847 (869)
Q Consensus       792 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~  847 (869)
                      ........ .....||+.|+|||++.++.++.++|||||||++|||+| |++||....
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~  218 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  218 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence            75433322 233568999999999999999999999999999999998 788886543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-39  Score=340.46  Aligned_cols=207  Identities=29%  Similarity=0.443  Sum_probs=168.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEee-CceEEEEEEec
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVYEYM  716 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~E~~  716 (869)
                      ++|++.+.||+|+||.||+|+++ |+.||||+++..  ...++|.+|++++++++|||||+++|++.+ .+.+++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            46778899999999999999985 788999999654  345789999999999999999999999865 45689999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++|+|.++++...   ...++|..+++|+.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~  157 (262)
T d1byga_          84 AKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  157 (262)
T ss_dssp             TTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             CCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC
Confidence            9999999996542   225899999999999999999999987   9999999999999999999999999998654322


Q ss_pred             ccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcchhhHHHHHHH
Q 002899          797 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYV  860 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~w~~~  860 (869)
                          ....+|+.|+|||++.+..+++++|||||||++|||+| |++||...   ...++.+++..
T Consensus       158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~---~~~~~~~~i~~  215 (262)
T d1byga_         158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEK  215 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CGGGHHHHHTT
T ss_pred             ----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC---CHHHHHHHHHc
Confidence                22457889999999999999999999999999999998 67777542   44456666543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-39  Score=339.77  Aligned_cols=211  Identities=24%  Similarity=0.402  Sum_probs=167.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcC--C--cEEEEEEeccc---CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSD--G--TVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL  710 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~--g--~~VAvK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  710 (869)
                      ++|++.+.||+|+||.||+|++..  +  ..||||+++..   .....++|.+|++++++++|||||+++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            568889999999999999998642  2  36899988654   23345689999999999999999999999975 4678


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      +||||+++|++.+.+....    ..+++..+++++.|||+||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        87 lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhh
Confidence            9999999999998876542    25899999999999999999999987   9999999999999999999999999999


Q ss_pred             eecCCCcc--ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcchhhHHHHHH
Q 002899          791 LYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAY  859 (869)
Q Consensus       791 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~w~~  859 (869)
                      ........  ......|+..|+|||++.+..++.++|||||||++|||+| |+.||..   .+..+...++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~---~~~~~~~~~i~  228 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG---LNGSQILHKID  228 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHHHHHH
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC---cCHHHHHHHHH
Confidence            87544322  2223567889999999999999999999999999999998 8999853   23444555553

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-39  Score=344.22  Aligned_cols=195  Identities=28%  Similarity=0.400  Sum_probs=165.2

Q ss_pred             CCeeeccCceEEEEEEEc-CCcEEEEEEecccCch-----hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEec
Q 002899          643 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-----GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM  716 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~-----~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~  716 (869)
                      .++||+|+||+||+|+.. +|+.||||+++.....     ..+.+.+|++++++++|||||++++++..++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            478999999999999975 6899999998654322     1356889999999999999999999999999999999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      +++++..+....     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          83 ETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             SEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             cchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence            998777665433     26888999999999999999999998   9999999999999999999999999998765433


Q ss_pred             ccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          797 THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       797 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .. ....+||+.|+|||++... .++.++||||+||++|||++|++||...
T Consensus       155 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  204 (299)
T d1ua2a_         155 RA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  204 (299)
T ss_dssp             CC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence            22 2335799999999998754 6799999999999999999999999653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-38  Score=345.64  Aligned_cols=196  Identities=23%  Similarity=0.306  Sum_probs=168.8

Q ss_pred             hcCCCCCC-eeeccCceEEEEEEE-cCCcEEEEEEecccCchhhHHHHHHHHHHHh-cCCCceeeEEeEEee----CceE
Q 002899          637 TNNFDPAN-KVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGCCVE----GNQL  709 (869)
Q Consensus       637 t~~f~~~~-~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~-l~H~nIv~l~~~~~~----~~~~  709 (869)
                      .++|.+.. +||+|+||+||+|+. .+++.||||+++.     ...+.+|++++.+ .+|||||++++++.+    +..+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            35787764 699999999999997 4689999999864     2457789988665 589999999999875    4678


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCcEEEeec
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDF  786 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~---~~~~kl~DF  786 (869)
                      |+|||||++|+|.+++.....   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.   ++.+||+||
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEECCCCCcHHHHHHhcCC---CCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccc
Confidence            999999999999999976432   26899999999999999999999998   999999999999985   567999999


Q ss_pred             CCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          787 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       787 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      |+|+.......  .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~  215 (335)
T d2ozaa1         159 GFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS  215 (335)
T ss_dssp             TTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred             ceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence            99987764332  2345799999999999999999999999999999999999999954

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-38  Score=339.75  Aligned_cols=200  Identities=28%  Similarity=0.458  Sum_probs=169.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~-~~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++...  ......+.+|++++++++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5789999999999999999997 478999999986543  2235678999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      |+.++.+........    ..+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|+....
T Consensus        82 ~~~~~~~~~~~~~~~----~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          82 FLHQDLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             CCSEEHHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             ecCCchhhhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccC
Confidence            998765544333322    26899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccccccccccccccchhhcccCC-CCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ... ......||+.|+|||++.... ++.++||||+||++|||++|+.||..
T Consensus       155 ~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~  205 (298)
T d1gz8a_         155 PVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  205 (298)
T ss_dssp             CSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             Ccc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence            332 233457999999999877654 58899999999999999999999964

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-38  Score=340.32  Aligned_cols=212  Identities=27%  Similarity=0.400  Sum_probs=166.6

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccC-chhhHHHHHHHHHHHhc-CCCceeeEEeE
Q 002899          631 RQIKAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGC  702 (869)
Q Consensus       631 ~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~~~  702 (869)
                      .+++...++|++.++||+|+||.||+|++.      +++.||||+++... ....+++..|.+++.++ +|+|||+++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            333334578999999999999999999964      24689999987543 34456788888887776 78999999999


Q ss_pred             EeeC-ceEEEEEEeccCCchhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCC
Q 002899          703 CVEG-NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKT  770 (869)
Q Consensus       703 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~  770 (869)
                      +.+. +..++||||+++|+|.++++.....           ....+++..+..++.||++||+|||+++   |+||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence            8764 4689999999999999999764321           1235899999999999999999999997   99999999


Q ss_pred             CCEEEcCCCcEEEeecCCceeecCCCcc-ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCC-CCCCC
Q 002899          771 SNVLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK-SNTNY  845 (869)
Q Consensus       771 ~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~-~p~~~  845 (869)
                      +|||+++++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|. +||..
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999876543322 233467999999999999999999999999999999999975 56643

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-38  Score=338.99  Aligned_cols=214  Identities=29%  Similarity=0.421  Sum_probs=175.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCc--EEEEEEeccc-CchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGT--VIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV  712 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~--~VAvK~~~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV  712 (869)
                      ++|++.++||+|+||+||+|++. ++.  .||||+++.. .....++|.+|+++++++ +|||||+++|++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            57888899999999999999976 344  5788887644 334466899999999998 799999999999999999999


Q ss_pred             EEeccCCchhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcE
Q 002899          713 YEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA  781 (869)
Q Consensus       713 ~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~  781 (869)
                      |||+++|+|.++++....           .....++|..+..++.|||+||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            999999999999976521           12347999999999999999999999997   9999999999999999999


Q ss_pred             EEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCC-CCCCCCCcchhhHHHHHH
Q 002899          782 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS-NTNYRPNEDFVYLLDWAY  859 (869)
Q Consensus       782 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~-p~~~~~~~~~~~l~~w~~  859 (869)
                      ||+|||+++.......  .....||..|+|||.+....++.++|||||||++|||++|.. ||..   .+..++.+.+.
T Consensus       167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~---~~~~~~~~~i~  240 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG---MTCAELYEKLP  240 (309)
T ss_dssp             EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHHHHGG
T ss_pred             EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC---CCHHHHHHHHH
Confidence            9999999976543222  123468999999999999999999999999999999999765 5543   24455555553

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-38  Score=338.46  Aligned_cols=197  Identities=29%  Similarity=0.420  Sum_probs=162.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHH--HHHhcCCCceeeEEeEEeeCc----eEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIG--MISAQQHPNLVKLYGCCVEGN----QLLL  711 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~--~l~~l~H~nIv~l~~~~~~~~----~~~l  711 (869)
                      ++|.+.+.||+|+||.||+|++ +|+.||||+++...   .+++..|.+  .+..++|||||++++++.+++    .+++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            4566778999999999999997 58899999986432   334444544  455789999999999998754    6899


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-----SRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                      ||||+++|+|.++++..      .++|..+.+++.|+|.||+|||+.     +..+|+||||||+||||+.++.+||+||
T Consensus        79 v~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            99999999999999754      589999999999999999999974     1235999999999999999999999999


Q ss_pred             CCceeecCCCcc---ccccccccccccchhhcccC------CCCchhHHHHHHHHHHHHHcCCCCCC
Q 002899          787 GLAKLYEEDKTH---ISTRIAGTIGYMAPEYAMRG------YLTSKADVYSFGVVTLEIVSGKSNTN  844 (869)
Q Consensus       787 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlGvil~elltG~~p~~  844 (869)
                      |+++........   ......||+.|+|||++...      .++.++|||||||++|||+||..|+.
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence            999887654322   22346799999999998754      25779999999999999999998774

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7e-38  Score=334.66  Aligned_cols=200  Identities=28%  Similarity=0.436  Sum_probs=171.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|++.++||+|+||+||+|+.++|+.||||+++....  ...+.|.+|+.++++++|||||++++++..++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57889999999999999999999999999999866532  2356899999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCC
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED  795 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~  795 (869)
                      +.++.+.......     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+|++|||.+......
T Consensus        82 ~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          82 LDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             CSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             ehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            9987776665433     26899999999999999999999987   999999999999999999999999999876543


Q ss_pred             Cccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          796 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       796 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .. ......|++.|+|||.+.. ..++.++||||+||++|||++|+.||...
T Consensus       154 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~  204 (286)
T d1ob3a_         154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (286)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence            22 2233468999999999865 46799999999999999999999999643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-37  Score=334.98  Aligned_cols=196  Identities=29%  Similarity=0.452  Sum_probs=168.8

Q ss_pred             CCeeeccCceEEEEEEEcCC----cEEEEEEeccc-CchhhHHHHHHHHHHHhcCCCceeeEEeEEee-CceEEEEEEec
Q 002899          643 ANKVGEGGFGSVYKGILSDG----TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVYEYM  716 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~~g----~~VAvK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~E~~  716 (869)
                      .++||+|+||+||+|++.+.    ..||||+++.. .....++|.+|++++++++|||||+++|++.+ ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999997532    36899998754 44456789999999999999999999999876 46899999999


Q ss_pred             cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecCCC
Q 002899          717 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK  796 (869)
Q Consensus       717 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~  796 (869)
                      ++|+|.++++....    ..++..+++++.|+|+||.|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus       112 ~~g~l~~~~~~~~~----~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         112 KHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             TTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             ecCchhhhhccccc----cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            99999998876532    5788999999999999999999987   9999999999999999999999999998765433


Q ss_pred             cc---ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          797 TH---ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       797 ~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ..   ......||+.|+|||.+....++.++||||||+++|||++|+.||..
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~  236 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP  236 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence            22   22235689999999999999999999999999999999998888754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-38  Score=333.83  Aligned_cols=198  Identities=23%  Similarity=0.373  Sum_probs=168.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCc------hhhHHHHHHHHHHHhcC--CCceeeEEeEEeeCc
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQ--HPNLVKLYGCCVEGN  707 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~------~~~~~f~~E~~~l~~l~--H~nIv~l~~~~~~~~  707 (869)
                      .++|++.++||+|+||+||+|+.. +|+.||||++.....      ....++.+|++++++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            357889999999999999999975 789999999865321      12345778999999986  899999999999999


Q ss_pred             eEEEEEEeccC-CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-CcEEEee
Q 002899          708 QLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISD  785 (869)
Q Consensus       708 ~~~lV~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~-~~~kl~D  785 (869)
                      ..++||||+.+ +++.+++....     .+++..++.++.||++||+|||+++   |+||||||+|||++.+ +.+||+|
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~D  154 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID  154 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred             eEEEEEEeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECc
Confidence            99999999976 56777765432     6899999999999999999999998   9999999999999854 7999999


Q ss_pred             cCCceeecCCCccccccccccccccchhhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          786 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       786 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ||+|+......   .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||..
T Consensus       155 FG~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (273)
T d1xwsa_         155 FGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH  212 (273)
T ss_dssp             CTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             cccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence            99998764332   234679999999999987654 6779999999999999999999953

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-37  Score=337.12  Aligned_cols=206  Identities=28%  Similarity=0.445  Sum_probs=175.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccCc-hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCce
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~  708 (869)
                      .++|++.++||+|+||.||+|++.      +++.||||+++.... ....+|.+|+.+++++ +|||||++++++.+++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            467888999999999999999862      457899999976543 3455789999999998 69999999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCc-------------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDT-------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL  775 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  775 (869)
                      .++||||+++|+|.++++....             .....+++..+.+++.|||+||+|||+++   ++||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            9999999999999999875432             12336899999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 002899          776 DKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY  845 (869)
Q Consensus       776 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~  845 (869)
                      +.++.+|++|||+++....... .......||+.|+|||++....++.++|||||||++|||+| |++|+..
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~  250 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG  250 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC
Confidence            9999999999999987754333 23344678999999999999999999999999999999999 5555544

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-37  Score=336.00  Aligned_cols=201  Identities=26%  Similarity=0.457  Sum_probs=167.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-C-CcEEEEEEecccCc--hhhHHHHHHHHHHHhc---CCCceeeEEeEEee----
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-D-GTVIAVKQLSSKSR--QGNREFVNEIGMISAQ---QHPNLVKLYGCCVE----  705 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~-g~~VAvK~~~~~~~--~~~~~f~~E~~~l~~l---~H~nIv~l~~~~~~----  705 (869)
                      .++|++.++||+|+||+||+|+.. + ++.||||+++....  .....+.+|+++++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999974 4 66799999865422  2234566777766654   89999999999863    


Q ss_pred             -CceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEe
Q 002899          706 -GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS  784 (869)
Q Consensus       706 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~  784 (869)
                       ....+++|||++++++........    ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCceEEEEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeec
Confidence             346899999999887765543332    26899999999999999999999998   9999999999999999999999


Q ss_pred             ecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          785 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       785 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |||+++......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       159 dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~  218 (305)
T d1blxa_         159 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  218 (305)
T ss_dssp             SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             chhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence            999987654322  233467999999999999999999999999999999999999999654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-38  Score=336.09  Aligned_cols=217  Identities=28%  Similarity=0.403  Sum_probs=176.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEcC--------CcEEEEEEecccCc-hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG  706 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~~--------g~~VAvK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~  706 (869)
                      .++|.+.+.||+|+||.||+|+...        +..||||+++.... ....++.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4578888999999999999998532        24799999976544 3457888999888887 899999999999999


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL  775 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  775 (869)
                      +..++||||+++|+|.+++......           ....+++.++++++.|||+||+|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            9999999999999999999765321           1246899999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcchhh
Q 002899          776 DKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVY  853 (869)
Q Consensus       776 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~  853 (869)
                      +.++.+||+|||+++....... .......||+.|+|||.+..+.+++++|||||||++|||++ |++||...   ....
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~---~~~~  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---PVEE  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC---CHHH
Confidence            9999999999999987754332 22344678999999999999999999999999999999998 68777532   2334


Q ss_pred             HHHHHH
Q 002899          854 LLDWAY  859 (869)
Q Consensus       854 l~~w~~  859 (869)
                      +.+++.
T Consensus       246 ~~~~i~  251 (299)
T d1fgka_         246 LFKLLK  251 (299)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            445443

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-38  Score=339.56  Aligned_cols=207  Identities=27%  Similarity=0.431  Sum_probs=176.3

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc
Q 002899          635 AATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN  707 (869)
Q Consensus       635 ~~t~~f~~~~~IG~G~fG~Vyka~~~------~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~  707 (869)
                      ...++|.+.+.||+|+||+||+|.+.      +++.||||+++... ......|.+|++++++++|||||++++++..++
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            33577888999999999999999864      35789999997543 334457899999999999999999999999999


Q ss_pred             eEEEEEEeccCCchhhhhhcCCc-----ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEE
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDT-----EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK  782 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~k  782 (869)
                      ..++||||+++|+|.++++....     .....+++..+.+++.|+|+||.|||+++   |+||||||+|||+++++++|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEE
Confidence            99999999999999998864321     11235799999999999999999999987   99999999999999999999


Q ss_pred             EeecCCceeecCCCc-cccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCC-CCCC
Q 002899          783 ISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK-SNTN  844 (869)
Q Consensus       783 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~-~p~~  844 (869)
                      |+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+||+ +||.
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~  237 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ  237 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence            999999987654332 2233356899999999999999999999999999999999995 5664

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=5e-37  Score=332.51  Aligned_cols=287  Identities=27%  Similarity=0.451  Sum_probs=243.4

Q ss_pred             cHHHHHHHHHHhCC----CCCCCCCCCCCCCCCccccCCCCCCCCcceEecCCCCcceEEEEeccCCCccc--cCCcccc
Q 002899            2 PKKALKQIGRKLGK----KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTG--TLPTELS   75 (869)
Q Consensus         2 ~~~~l~~~~~~l~~----~~W~~~~d~C~~~g~w~~~~~~~~~~~~~v~C~~~~~~~~v~~L~l~~~~l~~--~~p~~l~   75 (869)
                      +++||++||+.+.+    ++|..++|||..  .|.           ||+|+..+...||+.|+|++++++|  .+|++|+
T Consensus         7 e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~--~w~-----------gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~   73 (313)
T d1ogqa_           7 DKQALLQIKKDLGNPTTLSSWLPTTDCCNR--TWL-----------GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA   73 (313)
T ss_dssp             HHHHHHHHHHHTTCCGGGTTCCTTSCTTTT--CST-----------TEEECCSSSCCCEEEEEEECCCCSSCEECCGGGG
T ss_pred             HHHHHHHHHHHCCCCCcCCCCCCCCCCCCC--cCC-----------CeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHh
Confidence            57999999999987    589999999951  243           5999987778899999999999998  5899999


Q ss_pred             CCCCCCEEEeec-CcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccE
Q 002899           76 KLRYLKQLDLSR-NCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK  153 (869)
Q Consensus        76 ~l~~L~~L~Ls~-N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  153 (869)
                      +|++|++|+|++ |++++.+|..+..+ +|++|+|++|++.+..+..+..+.+|+.|++++|.+.+.+|..+.++++|++
T Consensus        74 ~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~  153 (313)
T d1ogqa_          74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG  153 (313)
T ss_dssp             GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred             cCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccce
Confidence            999999999997 88998888888888 8999999999999988888999999999999999999899999999999999


Q ss_pred             EEeecccccccCCccccCCCCC-CeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCC
Q 002899          154 LILSSNSFTGELPAELTKLTNL-NDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK  232 (869)
Q Consensus       154 L~Ls~N~i~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~  232 (869)
                      +++++|.+.+.+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|.+.+.+|..+..+++|+.|+++   
T Consensus       154 l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~---  229 (313)
T d1ogqa_         154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLA---  229 (313)
T ss_dssp             EECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECC---
T ss_pred             eeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccc---
Confidence            9999999999999988888776 889999999998888888877655 69999999988888888888877777666   


Q ss_pred             CCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh
Q 002899          233 GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI  312 (869)
Q Consensus       233 ~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  312 (869)
                                          +|.+.+.+| .+..+++|+.|+|++|+|+|.+|..|.++++|++|+|++|+|+|.+|...
T Consensus       230 --------------------~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~  288 (313)
T d1ogqa_         230 --------------------KNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             --------------------SSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             --------------------ccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence                                555554443 46677888888888888888888888888888888888888888887643


Q ss_pred             -hccCCceeeeccCc
Q 002899          313 -FNSNKNVDISLNNF  326 (869)
Q Consensus       313 -~~~l~~l~ls~N~~  326 (869)
                       +..++.+++++|++
T Consensus       289 ~L~~L~~l~l~~N~~  303 (313)
T d1ogqa_         289 NLQRFDVSAYANNKC  303 (313)
T ss_dssp             TGGGSCGGGTCSSSE
T ss_pred             cCCCCCHHHhCCCcc
Confidence             56777788888854

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-36  Score=329.61  Aligned_cols=201  Identities=24%  Similarity=0.403  Sum_probs=166.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEee--------C
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--------G  706 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~--------~  706 (869)
                      ++|++.++||+|+||+||+|+.. +|+.||||++...  .....+++.+|++++++++||||+++++++..        +
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            67889999999999999999974 7899999998544  23345678999999999999999999998865        3


Q ss_pred             ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002899          707 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF  786 (869)
Q Consensus       707 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DF  786 (869)
                      +..++||||++++.+.......     ..++...++.++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence            4689999999988776554332     25788999999999999999999998   999999999999999999999999


Q ss_pred             CCceeecCCCcc---ccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          787 GLAKLYEEDKTH---ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       787 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      |+++........   .....+||+.|+|||++... .+++++||||+||++|||++|+.||...
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~  225 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  225 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence            999876543221   12235699999999998754 6899999999999999999999999653

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.1e-36  Score=321.58  Aligned_cols=202  Identities=21%  Similarity=0.299  Sum_probs=173.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCC-CceeeEEeEEeeCceEEEEEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      .++|++.++||+|+||+||+|+.. +|+.||||++....  ....+.+|++.++.++| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            357889999999999999999975 68999999875432  34567889999999875 899999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-----CCcEEEeecCCc
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-----DLNAKISDFGLA  789 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~-----~~~~kl~DFGla  789 (869)
                      |+ +++|.+++....    ..+++.++..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+|
T Consensus        82 ~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          82 LL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             ec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEccccee
Confidence            98 588988876543    25899999999999999999999998   999999999999974     578999999999


Q ss_pred             eeecCCCcc------ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 002899          790 KLYEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN  848 (869)
Q Consensus       790 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~  848 (869)
                      +.+......      ......||+.|||||++.+..++.++|||||||++|||++|+.||.....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~  218 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  218 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence            887543221      12346799999999999999999999999999999999999999976443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-36  Score=332.10  Aligned_cols=202  Identities=24%  Similarity=0.365  Sum_probs=168.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc----eEE
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----QLL  710 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~  710 (869)
                      +++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457889999999999999999964 79999999997543 334567899999999999999999999987643    234


Q ss_pred             EEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCce
Q 002899          711 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK  790 (869)
Q Consensus       711 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~  790 (869)
                      ++++|+.+|+|.+++...      .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus        87 ~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCcee
Confidence            555667899999998643      5899999999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCcc--ccccccccccccchhhcc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          791 LYEEDKTH--ISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       791 ~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      ........  ......||+.|+|||++. ...++.++||||+||++|||++|+.||....
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~  217 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  217 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence            76543221  223457899999999985 4567899999999999999999999996543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-36  Score=329.18  Aligned_cols=202  Identities=27%  Similarity=0.390  Sum_probs=174.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEecccC----chhhHHHHHHHHHHHhcCC-CceeeEEeEEeeCce
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQ  708 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~----~g~~VAvK~~~~~~----~~~~~~f~~E~~~l~~l~H-~nIv~l~~~~~~~~~  708 (869)
                      ++|++.+.||+|+||+||+|+..    +|+.||||+++...    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999852    47899999986542    2235678899999999976 899999999999999


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .++||||+.+|+|.+++....     .++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eeeeeecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccc
Confidence            999999999999999986654     5678899999999999999999987   99999999999999999999999999


Q ss_pred             ceeecCCCccccccccccccccchhhcccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      ++.+............|++.|+|||.+...  .++.++||||+||+||||++|+.||....
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~  236 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG  236 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred             hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            987765444444456799999999998754  57889999999999999999999996543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-36  Score=331.19  Aligned_cols=197  Identities=29%  Similarity=0.379  Sum_probs=163.2

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------ceEEE
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQLLL  711 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~l  711 (869)
                      +|+..++||+|+||+||+|+.. +|+.||||++.....    .+.+|++++++++|||||++++++...      ..+++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5777889999999999999975 689999999865432    234699999999999999999998653      24789


Q ss_pred             EEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-cEEEeecCCce
Q 002899          712 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAK  790 (869)
Q Consensus       712 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~-~~kl~DFGla~  790 (869)
                      ||||++++.+..+.+..  .....+++..++.++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||++.
T Consensus        97 v~Ey~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEECCSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEeccCCccHHHHHhhh--hccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchh
Confidence            99999876544433221  12236899999999999999999999988   99999999999999775 89999999998


Q ss_pred             eecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          791 LYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .......  .....||+.|+|||.+.+ ..++.++||||+||++|||++|++||...
T Consensus       172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~  226 (350)
T d1q5ka_         172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  226 (350)
T ss_dssp             ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence            7754332  233579999999998765 57899999999999999999999999653

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-36  Score=330.21  Aligned_cols=196  Identities=26%  Similarity=0.426  Sum_probs=163.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccc--CchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc------
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------  707 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~------  707 (869)
                      .++|++.++||+|+||+||+|... +|+.||||+++..  .....+.+.+|+++|+.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            467889999999999999999975 6899999999754  2334567899999999999999999999998655      


Q ss_pred             eEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002899          708 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG  787 (869)
Q Consensus       708 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFG  787 (869)
                      .+++||||+ +++|.+.....      .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+|++|||
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             eEEEEEecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccc
Confidence            579999999 45677666432      5899999999999999999999998   9999999999999999999999999


Q ss_pred             CceeecCCCccccccccccccccchhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          788 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       788 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +|+......    +...||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus       167 ~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~  222 (346)
T d1cm8a_         167 LARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  222 (346)
T ss_dssp             TCEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence            998765432    24578999999999875 46789999999999999999999999653

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-35  Score=315.02  Aligned_cols=199  Identities=22%  Similarity=0.379  Sum_probs=173.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceEEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E  714 (869)
                      ++|++.++||+|+||+||+|+.. +++.||||+++...  ......+.+|+.+++.++|||||++++++.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57889999999999999999975 78899999986543  2335788999999999999999999999999999999999


Q ss_pred             eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCCceeecC
Q 002899          715 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE  794 (869)
Q Consensus       715 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~~~  794 (869)
                      ++.++++..++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++....
T Consensus        82 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          82 FCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecccccccccccccc-----ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccC
Confidence            999999988776543     6789999999999999999999998   99999999999999999999999999987754


Q ss_pred             CCccccccccccccccchhhcccCC-CCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          795 DKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       795 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                      ... ......+++.|+|||.+.... ++.++||||+||++|||++|+.||..
T Consensus       154 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  204 (292)
T d1unla_         154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             CCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence            332 222345788999999887654 68999999999999999999999743

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-35  Score=316.13  Aligned_cols=200  Identities=25%  Similarity=0.332  Sum_probs=166.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCcee-eEEeEEeeCceEEEEEEe
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV-KLYGCCVEGNQLLLVYEY  715 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~E~  715 (869)
                      ++|++.++||+|+||.||+|+.. +|+.||||++....  ...++..|+++++.++|+|+| .+.++..+++..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            56889999999999999999974 68999999876543  235688999999999877655 556666778889999999


Q ss_pred             ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc---CCCcEEEeecCCceee
Q 002899          716 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLY  792 (869)
Q Consensus       716 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~---~~~~~kl~DFGla~~~  792 (869)
                      ++ +++.+.+....    ..+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+|+.+
T Consensus        85 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          85 LG-PSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             CC-CBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             cC-Cchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            96 45655554332    26899999999999999999999998   99999999999985   4567999999999987


Q ss_pred             cCCCcc------ccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 002899          793 EEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP  847 (869)
Q Consensus       793 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~  847 (869)
                      ......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~  217 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  217 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence            643321      2234679999999999999999999999999999999999999997543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8.6e-35  Score=316.89  Aligned_cols=193  Identities=21%  Similarity=0.361  Sum_probs=166.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcC-CCceeeEEeEEee--CceEEEEE
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVE--GNQLLLVY  713 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~--~~~~~lV~  713 (869)
                      ++|++.++||+|+||+||+|+.. +++.||||+++...   .+++.+|+++|++++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999974 78999999986532   467889999999985 9999999999975  35689999


Q ss_pred             EeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-cEEEeecCCceee
Q 002899          714 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLY  792 (869)
Q Consensus       714 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~-~~kl~DFGla~~~  792 (869)
                      ||+++++|....        ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+|+..
T Consensus       112 e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         112 EHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             ECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             eecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceec
Confidence            999999987653        15899999999999999999999998   99999999999998655 6899999999877


Q ss_pred             cCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          793 EEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       793 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      .....  .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus       181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~  233 (328)
T d3bqca1         181 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  233 (328)
T ss_dssp             CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             cCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence            54332  2345789999999998765 5799999999999999999999999654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-35  Score=320.09  Aligned_cols=196  Identities=26%  Similarity=0.332  Sum_probs=159.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEee------Cce
Q 002899          638 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE------GNQ  708 (869)
Q Consensus       638 ~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~------~~~  708 (869)
                      ++|++.++||+|+||+||+|+.. +|+.||||++....  .....++.+|+.++++++|||||++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999976 69999999997542  3345678899999999999999999999964      367


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .|+||||+.++.+ +.++.       .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+|++|||+
T Consensus        97 ~~iv~Ey~~~~l~-~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             EEEEEECCSEEHH-HHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             eEEEEeccchHHH-Hhhhc-------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence            8999999987655 44422       4789999999999999999999998   99999999999999999999999999


Q ss_pred             ceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      ++......  ......+|+.|+|||++.+..+++++||||+||+++||++|+.||...
T Consensus       166 ~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~  221 (355)
T d2b1pa1         166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence            87665432  223457899999999999999999999999999999999999999653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-35  Score=320.59  Aligned_cols=197  Identities=26%  Similarity=0.393  Sum_probs=165.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccC--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC-----ce
Q 002899          637 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ  708 (869)
Q Consensus       637 t~~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~-----~~  708 (869)
                      +++|++.++||+|+||+||+|+.. +|+.||||+++...  ....+++.+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            568999999999999999999964 79999999997543  33456788999999999999999999998643     34


Q ss_pred             EEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002899          709 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL  788 (869)
Q Consensus       709 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGl  788 (869)
                      .+++|||+.+|+|.+++..+      .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+|++|||+
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             eEEEEEeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccch
Confidence            46677888999999988543      5899999999999999999999998   99999999999999999999999999


Q ss_pred             ceeecCCCccccccccccccccchhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002899          789 AKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR  846 (869)
Q Consensus       789 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~  846 (869)
                      +......    .....||+.|+|||...+. .++.++||||+||++|||++|+.||...
T Consensus       168 a~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~  222 (348)
T d2gfsa1         168 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  222 (348)
T ss_dssp             --CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hcccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence            8765432    2335689999999987654 5689999999999999999999999653

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=9.4e-30  Score=280.78  Aligned_cols=197  Identities=24%  Similarity=0.277  Sum_probs=157.4

Q ss_pred             CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecccCchhhHHHHHHHHHHHhcC-----------CCceeeEEeEEeeC
Q 002899          639 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----------HPNLVKLYGCCVEG  706 (869)
Q Consensus       639 ~f~~~~~IG~G~fG~Vyka~~~-~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~-----------H~nIv~l~~~~~~~  706 (869)
                      +|++.++||+|+||+||+|+.. +|+.||||+++... .....+.+|+++++.++           |+|||++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            4889999999999999999974 78999999997543 23456778888887765           57899999888653


Q ss_pred             --ceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCEEEcCCC----
Q 002899          707 --NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDL----  779 (869)
Q Consensus       707 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NILl~~~~----  779 (869)
                        ...+++|+++..+.........  .....+++..+..++.||++||+|||+ .+   |+||||||+|||++.++    
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred             cccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence              4566777776655443322211  122367899999999999999999998 55   99999999999998665    


Q ss_pred             --cEEEeecCCceeecCCCccccccccccccccchhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 002899          780 --NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY  845 (869)
Q Consensus       780 --~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~  845 (869)
                        .++++|||.+.......    ...+||+.|+|||++....++.++||||+||+++||++|+.||..
T Consensus       168 ~~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~  231 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP  231 (362)
T ss_dssp             EEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             cceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence              38999999997654322    245799999999999999999999999999999999999999964

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.8e-30  Score=272.02  Aligned_cols=266  Identities=19%  Similarity=0.247  Sum_probs=198.2

Q ss_pred             EecCCCCcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCc
Q 002899           46 TCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNI  124 (869)
Q Consensus        46 ~C~~~~~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l  124 (869)
                      .|.|.....  ..+++++++++ .+|..+.  +.+++|+|++|+|+.+++..|..+ +|++|++++|++..+.+..+..+
T Consensus         5 ~C~C~~~~~--~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~   79 (284)
T d1ozna_           5 ACVCYNEPK--VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL   79 (284)
T ss_dssp             TCEEECSSS--CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred             CCEEcCCCC--eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccc
Confidence            466632221  34567888888 6777665  578999999999988777777777 68888888888887777777777


Q ss_pred             ccccccccc-ccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEE
Q 002899          125 TTLKNLSIE-GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLH  203 (869)
Q Consensus       125 ~~L~~L~Ls-~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  203 (869)
                      +.++.|... .|.++...+..|.++++|++|++++|.+....+..+..+++|+.+++++|+|+++.+..|..+++|+.|+
T Consensus        80 ~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~  159 (284)
T d1ozna_          80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF  159 (284)
T ss_dssp             TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             ccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcc
Confidence            777777654 4566666666777777888888888877766666677777778888888877766667777777777777


Q ss_pred             ccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCC
Q 002899          204 IQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG  283 (869)
Q Consensus       204 L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~  283 (869)
                      |++|+++...+..|.++++|+.|+++                       +|++++..|..|..+++|+.|++++|++++.
T Consensus       160 l~~N~l~~l~~~~f~~l~~L~~l~l~-----------------------~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~  216 (284)
T d1ozna_         160 LHGNRISSVPERAFRGLHSLDRLLLH-----------------------QNRVAHVHPHAFRDLGRLMTLYLFANNLSAL  216 (284)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECC-----------------------SSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             cccCcccccchhhhccccccchhhhh-----------------------hccccccChhHhhhhhhcccccccccccccc
Confidence            77777776666677777666655554                       6666667778888888888888888888888


Q ss_pred             CchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCCCCCCCCCCCCCccceeccCCCCCCCCCCcCccCC
Q 002899          284 IPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQ  363 (869)
Q Consensus       284 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~~~~~l~~~~~~~~~~~~~~~~  363 (869)
                      .+..|..+++|++|+|++|                              ||.|||++.|+..|++......        .
T Consensus       217 ~~~~~~~~~~L~~L~l~~N------------------------------~l~C~C~~~~l~~~l~~~~~~~--------~  258 (284)
T d1ozna_         217 PTEALAPLRALQYLRLNDN------------------------------PWVCDCRARPLWAWLQKFRGSS--------S  258 (284)
T ss_dssp             CHHHHTTCTTCCEEECCSS------------------------------CEECSGGGHHHHHHHHHCCSEE--------C
T ss_pred             cccccccccccCEEEecCC------------------------------CCCCCccchHHHHHHHhCcCCC--------C
Confidence            8888888888888888888                              8889999999999997543322        3


Q ss_pred             CCCCCCCcccccce
Q 002899          364 NFPCSAPADQYHYT  377 (869)
Q Consensus       364 ~~~C~~p~~~~~~~  377 (869)
                      +..|+.|....|+.
T Consensus       259 ~~~C~~p~~l~g~~  272 (284)
T d1ozna_         259 EVPCSLPQRLAGRD  272 (284)
T ss_dssp             CCBEEESGGGTTCB
T ss_pred             ceEeCCchHHcCCc
Confidence            55787777776543

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=8.1e-28  Score=253.22  Aligned_cols=221  Identities=24%  Similarity=0.283  Sum_probs=139.8

Q ss_pred             ecCCCCcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccc
Q 002899           47 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITT  126 (869)
Q Consensus        47 C~~~~~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~  126 (869)
                      |.|...... ..+++++++|+ .+|+.|.  ++|++|+|++|.|++++                       +..|.++++
T Consensus         4 C~~~~~~~~-~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~-----------------------~~~f~~l~~   56 (266)
T d1p9ag_           4 CEVSKVASH-LEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFS-----------------------LATLMPYTR   56 (266)
T ss_dssp             SEEECSTTC-CEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEE-----------------------GGGGTTCTT
T ss_pred             cEEcccCCC-eEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcC-----------------------HHHhhcccc
Confidence            555443333 33578888887 4666554  45666666666665433                       344555566


Q ss_pred             cccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccC
Q 002899          127 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQG  206 (869)
Q Consensus       127 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  206 (869)
                      |++|+|++|+|+. ++ .+..+++|++|+|++|+++ ..+..+.++++|+.|++++|.+....+..+..+.+|+.|++++
T Consensus        57 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~  133 (266)
T d1p9ag_          57 LTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG  133 (266)
T ss_dssp             CCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred             ccccccccccccc-cc-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccc
Confidence            6666666666552 22 2445666666666666666 3344566666666666666666655566666666666666666


Q ss_pred             CcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCch
Q 002899          207 SSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT  286 (869)
Q Consensus       207 N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  286 (869)
                      |.++...+..+..+++|+.|+++                       +|+|++..+..|..+++|++|+|++|+|+ .+|.
T Consensus       134 n~l~~l~~~~~~~l~~l~~l~l~-----------------------~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~  189 (266)
T d1p9ag_         134 NELKTLPPGLLTPTPKLEKLSLA-----------------------NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK  189 (266)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECT-----------------------TSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCT
T ss_pred             cccceeccccccccccchhcccc-----------------------cccccccCccccccccccceeecccCCCc-ccCh
Confidence            66665555555555544444433                       45555555666677777777777777777 6666


Q ss_pred             hhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCCCCCCCCCCCCCccceeccCCCC
Q 002899          287 TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPR  351 (869)
Q Consensus       287 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~~~~~l~~~~  351 (869)
                      .+..+++|+.|+|++|                              ||.|||++.||.+|++...
T Consensus       190 ~~~~~~~L~~L~L~~N------------------------------p~~CdC~~~~l~~wl~~~~  224 (266)
T d1p9ag_         190 GFFGSHLLPFAFLHGN------------------------------PWLCNCEILYFRRWLQDNA  224 (266)
T ss_dssp             TTTTTCCCSEEECCSC------------------------------CBCCSGGGHHHHHHHHHTG
T ss_pred             hHCCCCCCCEEEecCC------------------------------CCCCCcchHHHHHHHHhcc
Confidence            6667777777777777                              9999999999999997543

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=7.7e-26  Score=242.91  Aligned_cols=262  Identities=20%  Similarity=0.257  Sum_probs=221.3

Q ss_pred             eEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccccc
Q 002899           55 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE  133 (869)
Q Consensus        55 ~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  133 (869)
                      +.+.+++++++++ .+|..+.  ++|++|+|++|+|+.+++..|..+ +|++|++++|.+..+.|..|.++++|++|+|+
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            4567899999999 6777774  689999999999999998889887 89999999999998889999999999999999


Q ss_pred             ccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCC--CCCccccCCCCcccEEEccCCcCCC
Q 002899          134 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS--GKIPEFIGKWKKIQKLHIQGSSLEG  211 (869)
Q Consensus       134 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~  211 (869)
                      +|+|+ .+|..+  ...|+.|++.+|.+.+..+..+.....+..++...|...  ...+..|..+++|+.+++++|.+..
T Consensus        88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~  164 (305)
T d1xkua_          88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT  164 (305)
T ss_dssp             SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred             CCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc
Confidence            99999 455443  358999999999999777777888888999999998654  3445678899999999999999984


Q ss_pred             CchHhhhcCCCCCEEEcCCCCCCCCccccccc-ccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhc
Q 002899          212 PIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK  290 (869)
Q Consensus       212 ~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  290 (869)
                      . |..  .+++|+.|++++|.........+.. ..++.|++++|.+++..+..|.++++|++|+|++|+|+ .+|..|..
T Consensus       165 l-~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~  240 (305)
T d1xkua_         165 I-PQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD  240 (305)
T ss_dssp             C-CSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred             c-Ccc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccccc
Confidence            3 333  3679999999999988776655544 37999999999999999999999999999999999999 66889999


Q ss_pred             CCCCCEEEeeCCcCCCCCchhh--------hccCCceeeeccCc
Q 002899          291 LAKTNFMYLTGNKLTGPVPKYI--------FNSNKNVDISLNNF  326 (869)
Q Consensus       291 l~~L~~L~Ls~N~l~~~~p~~~--------~~~l~~l~ls~N~~  326 (869)
                      +++|++|+|++|+|+......+        ...++.|+|++|.+
T Consensus       241 l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~  284 (305)
T d1xkua_         241 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV  284 (305)
T ss_dssp             CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred             ccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcC
Confidence            9999999999999995433332        24577899999933

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.93  E-value=2.8e-26  Score=247.33  Aligned_cols=212  Identities=26%  Similarity=0.437  Sum_probs=159.4

Q ss_pred             CchhhcCccccccccccc-cccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCC
Q 002899          117 FPKVLTNITTLKNLSIEG-NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGK  195 (869)
Q Consensus       117 ~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  195 (869)
                      +|..+++|++|++|+|++ |+++|.+|..|+++++|++|+|++|+|.+..+..+..+.+|+.+++++|++.+.+|..|.+
T Consensus        68 lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~  147 (313)
T d1ogqa_          68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS  147 (313)
T ss_dssp             CCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGG
T ss_pred             CChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhcc
Confidence            455666666666666665 5666666666666666666666666666666666666666666666666666666666666


Q ss_pred             CCcccEEEccCCcCCCCchHhhhcCCCC-CEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEe
Q 002899          196 WKKIQKLHIQGSSLEGPIPASISALTSL-TDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNID  274 (869)
Q Consensus       196 l~~L~~L~L~~N~l~~~~~~~l~~l~~L-~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~  274 (869)
                      +++|+.+++++|.+.+.+|..+..+.++ +.++++.|+++......+....+..+++++|.+.+.+|..+..+++|+.|+
T Consensus       148 l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~  227 (313)
T d1ogqa_         148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH  227 (313)
T ss_dssp             CTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEE
T ss_pred             Ccccceeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            6666666666666666666666666654 666666666665555555555666788889999999999999999999999


Q ss_pred             ccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhh--hccCCceeeeccCccCC
Q 002899          275 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWE  329 (869)
Q Consensus       275 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~l~~l~ls~N~~~~~  329 (869)
                      +++|.+++.+| .+..+++|+.|+|++|+|+|.+|..+  +..|+.|+|++|++++.
T Consensus       228 ~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~  283 (313)
T d1ogqa_         228 LAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE  283 (313)
T ss_dssp             CCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred             ccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCccccc
Confidence            99999997655 68899999999999999999999998  56899999999999854

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.90  E-value=4.9e-23  Score=227.67  Aligned_cols=256  Identities=24%  Similarity=0.342  Sum_probs=165.3

Q ss_pred             eEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccccc
Q 002899           55 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE  133 (869)
Q Consensus        55 ~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  133 (869)
                      +++.|++++++|+. + +.+..+++|++|+|++|+|+++.+  +..+ +|++|+|++|++++..+  ++.+++|+.|+++
T Consensus        45 ~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~  118 (384)
T d2omza2          45 QVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF  118 (384)
T ss_dssp             TCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred             CCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc--ccCCcccccccccccccccccc--ccccccccccccc
Confidence            47888888888874 3 457788888888888888887654  6666 78888888888886543  7788888888888


Q ss_pred             ccccCCCC---------------------------------------------------------------CccccCCCC
Q 002899          134 GNLFTGSI---------------------------------------------------------------PPDIRKLIN  150 (869)
Q Consensus       134 ~N~l~~~~---------------------------------------------------------------~~~~~~l~~  150 (869)
                      +|.+++..                                                               ...+..+++
T Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  198 (384)
T d2omza2         119 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTN  198 (384)
T ss_dssp             SSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccc
Confidence            77765311                                                               123445577


Q ss_pred             ccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCC
Q 002899          151 LQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD  230 (869)
Q Consensus       151 L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~  230 (869)
                      ++.|++++|.+++..|  +...++|+.|++++|+++.  ...+..+++|+.|++++|.+++..+  +..+++|+.|++++
T Consensus       199 ~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~  272 (384)
T d2omza2         199 LESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA  272 (384)
T ss_dssp             CSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCS
T ss_pred             cceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC--cchhhcccccchhccccCccCCCCc--ccccccCCEeeccC
Confidence            8888888888875543  4556788888888888874  2356777888888888888876543  77778888888888


Q ss_pred             CCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCch
Q 002899          231 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK  310 (869)
Q Consensus       231 n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  310 (869)
                      +++..... ......++.+.++.|.+++.  ..+..+++|+.|+|++|++++..+  +..+++|+.|+|++|+|++ +| 
T Consensus       273 ~~l~~~~~-~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-  345 (384)
T d2omza2         273 NQISNISP-LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-  345 (384)
T ss_dssp             SCCCCCGG-GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-
T ss_pred             cccCCCCc-cccccccccccccccccccc--cccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-
Confidence            77765432 22222455555555555432  224445555555555555554322  4555555555555555553 22 


Q ss_pred             hh--hccCCceeeeccCccCC
Q 002899          311 YI--FNSNKNVDISLNNFTWE  329 (869)
Q Consensus       311 ~~--~~~l~~l~ls~N~~~~~  329 (869)
                      .+  .+.|+.|++++|+++..
T Consensus       346 ~l~~l~~L~~L~l~~N~l~~l  366 (384)
T d2omza2         346 SLANLTNINWLSAGHNQISDL  366 (384)
T ss_dssp             GGGGCTTCCEEECCSSCCCBC
T ss_pred             hHcCCCCCCEEECCCCcCCCC
Confidence            12  33455555555555543

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=3.6e-24  Score=227.32  Aligned_cols=250  Identities=16%  Similarity=0.161  Sum_probs=206.6

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEee-cccCCCCCchhhcCccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVM-GNRLSGPFPKVLTNITTLKNL  130 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls-~N~l~~~~~~~~~~l~~L~~L  130 (869)
                      ...++.|+|++|+|+...+.+|.++++|++|++++|.|..+.+..+... .++.|... .|.++.+.+..|.++++|++|
T Consensus        31 p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L  110 (284)
T d1ozna_          31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL  110 (284)
T ss_dssp             CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred             CCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEE
Confidence            3457899999999997777889999999999999999999999888877 77787654 678888889999999999999


Q ss_pred             cccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCC
Q 002899          131 SIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE  210 (869)
Q Consensus       131 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  210 (869)
                      +|++|.+....+..+....+|+.+++++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|+.|++++|+++
T Consensus       111 ~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~  190 (284)
T d1ozna_         111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA  190 (284)
T ss_dssp             ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             ecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccc
Confidence            99999999777888899999999999999999777888999999999999999999888999999999999999999999


Q ss_pred             CCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhc
Q 002899          211 GPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK  290 (869)
Q Consensus       211 ~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  290 (869)
                      +..|..|..+++|+.|+++                       +|++.+..+..|..+++|+.|+|++|.+...-+. ..-
T Consensus       191 ~i~~~~f~~l~~L~~L~l~-----------------------~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l  246 (284)
T d1ozna_         191 HVHPHAFRDLGRLMTLYLF-----------------------ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPL  246 (284)
T ss_dssp             EECTTTTTTCTTCCEEECC-----------------------SSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHH
T ss_pred             ccChhHhhhhhhccccccc-----------------------ccccccccccccccccccCEEEecCCCCCCCccc-hHH
Confidence            9889999999988877766                       6666667777888899999999999988854331 111


Q ss_pred             CCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCcc
Q 002899          291 LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT  327 (869)
Q Consensus       291 l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~  327 (869)
                      ...++.+....++++...|..+. ....++++.++++
T Consensus       247 ~~~l~~~~~~~~~~~C~~p~~l~-g~~l~~l~~~~l~  282 (284)
T d1ozna_         247 WAWLQKFRGSSSEVPCSLPQRLA-GRDLKRLAANDLQ  282 (284)
T ss_dssp             HHHHHHCCSEECCCBEEESGGGT-TCBGGGSCGGGSC
T ss_pred             HHHHHhCcCCCCceEeCCchHHc-CCccccCCHHHCC
Confidence            12244455566777766666653 3455666666554

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.90  E-value=7.2e-23  Score=219.43  Aligned_cols=257  Identities=21%  Similarity=0.228  Sum_probs=216.7

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS  131 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  131 (869)
                      ...++.|+|++|+|+...+.+|.++++|++|++++|.+..+.+..|..+ +|+.|+|++|+++.+...   ....|+.|+
T Consensus        30 ~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~---~~~~l~~L~  106 (305)
T d1xkua_          30 PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK---MPKTLQELR  106 (305)
T ss_dssp             CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSS---CCTTCCEEE
T ss_pred             CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCccc---hhhhhhhhh
Confidence            3568999999999996666689999999999999999999999999987 899999999999955432   246889999


Q ss_pred             ccccccCCCCCccccCCCCccEEEeeccccc--ccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcC
Q 002899          132 IEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL  209 (869)
Q Consensus       132 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  209 (869)
                      +.+|.+.+..+..+.....++.+++..|...  ...+..+..+++|+.+++++|+++. +|..+  +++|+.|++++|.+
T Consensus       107 ~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~  183 (305)
T d1xkua_         107 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKI  183 (305)
T ss_dssp             CCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCC
T ss_pred             ccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcC
Confidence            9999999777777888889999999988654  3446678899999999999999984 44433  57999999999999


Q ss_pred             CCCchHhhhcCCCCCEEEcCCCCCCCCccccccc-ccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhh
Q 002899          210 EGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF  288 (869)
Q Consensus       210 ~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  288 (869)
                      ....+..+.+++.++.|++++|.+.......+.. .+|++|+|++|+|+. +|..|.++++|++|+|++|+|+......|
T Consensus       184 ~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f  262 (305)
T d1xkua_         184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDF  262 (305)
T ss_dssp             CEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred             CCCChhHhhccccccccccccccccccccccccccccceeeecccccccc-cccccccccCCCEEECCCCccCccChhhc
Confidence            9999999999999999999999999876665544 489999999999994 57789999999999999999996654444


Q ss_pred             ------hcCCCCCEEEeeCCcCC-CCCchhhhccC
Q 002899          289 ------EKLAKTNFMYLTGNKLT-GPVPKYIFNSN  316 (869)
Q Consensus       289 ------~~l~~L~~L~Ls~N~l~-~~~p~~~~~~l  316 (869)
                            ..+.+|+.|+|++|+++ ..++...|..+
T Consensus       263 ~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~  297 (305)
T d1xkua_         263 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV  297 (305)
T ss_dssp             SCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTC
T ss_pred             cCcchhcccCCCCEEECCCCcCccCcCCHhHhccc
Confidence                  45788999999999986 45666655543

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=6.8e-23  Score=215.14  Aligned_cols=179  Identities=22%  Similarity=0.175  Sum_probs=123.7

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSI  132 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  132 (869)
                      ...++.|+|++|.|++..+.+|.++++|++|+|++|+|+.+.                         .++.+++|++|+|
T Consensus        30 p~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~-------------------------~~~~l~~L~~L~L   84 (266)
T d1p9ag_          30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ-------------------------VDGTLPVLGTLDL   84 (266)
T ss_dssp             CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE-------------------------CCSCCTTCCEEEC
T ss_pred             CcCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc-------------------------ccccccccccccc
Confidence            357899999999999877788999999999999999887332                         1234556666666


Q ss_pred             cccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCC
Q 002899          133 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP  212 (869)
Q Consensus       133 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  212 (869)
                      ++|+++ ..+..+..+++|+.|++++|.+....+..+..+.+|++|++++|.++...+..+..+++|+.|++++|+|++.
T Consensus        85 s~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~  163 (266)
T d1p9ag_          85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL  163 (266)
T ss_dssp             CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred             cccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccccc
Confidence            666666 3455566666666666666666655555666666777777777777666666666677777777777777766


Q ss_pred             chHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCC
Q 002899          213 IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT  281 (869)
Q Consensus       213 ~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~  281 (869)
                      .+..|..+++|+.|+|+                       +|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus       164 ~~~~~~~l~~L~~L~Ls-----------------------~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         164 PAGLLNGLENLDTLLLQ-----------------------ENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CTTTTTTCTTCCEEECC-----------------------SSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             Cccccccccccceeecc-----------------------cCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            66666666666655555                       34444 34445556777777888877776

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.86  E-value=6.2e-21  Score=210.52  Aligned_cols=256  Identities=25%  Similarity=0.311  Sum_probs=207.3

Q ss_pred             EEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccccc
Q 002899           58 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL  136 (869)
Q Consensus        58 ~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  136 (869)
                      ...+..+++++.++.  ..+.+|++|++++|.|+.+  ..+..+ +|++|+|++|+|++..+  ++++++|++|+|++|+
T Consensus        26 ~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~   99 (384)
T d2omza2          26 KTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ   99 (384)
T ss_dssp             HHHTTCSSTTSEECH--HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             HHHhCCCCCCCccCH--HHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc--ccCCcccccccccccc
Confidence            456777788876654  4677899999999999865  235555 89999999999997643  9999999999999999


Q ss_pred             cCCCCCccccCCCCccEEEeecccccccC---------------------------------------------------
Q 002899          137 FTGSIPPDIRKLINLQKLILSSNSFTGEL---------------------------------------------------  165 (869)
Q Consensus       137 l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~---------------------------------------------------  165 (869)
                      +.+..  .++.+++|+.|++++|.+++..                                                   
T Consensus       100 i~~i~--~l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (384)
T d2omza2         100 IADIT--PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTL  177 (384)
T ss_dssp             CCCCG--GGTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTC
T ss_pred             ccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccc
Confidence            99543  4889999999999998876311                                                   


Q ss_pred             ------------CccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCC
Q 002899          166 ------------PAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG  233 (869)
Q Consensus       166 ------------p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~  233 (869)
                                  ...+..+++++.|++++|.+++..|  +..+++|+.|++++|.++..  ..+..+++|+.|++++|.+
T Consensus       178 ~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l  253 (384)
T d2omza2         178 ERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQI  253 (384)
T ss_dssp             CEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred             ccccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCcc
Confidence                        1234556788999999999986654  45678999999999999853  3688899999999999998


Q ss_pred             CCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhh
Q 002899          234 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF  313 (869)
Q Consensus       234 ~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  313 (869)
                      +.... .....+|+.|++++|++++..+  +..++.++.++++.|++++  ...+..+++++.|+|++|++++..|-.-+
T Consensus       254 ~~~~~-~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~l~~l  328 (384)
T d2omza2         254 SNLAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISPVSSL  328 (384)
T ss_dssp             CCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGGGGGC
T ss_pred             CCCCc-ccccccCCEeeccCcccCCCCc--ccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCcccccC
Confidence            87543 2334489999999999986543  7788999999999999985  34589999999999999999987665557


Q ss_pred             ccCCceeeeccCccCCC
Q 002899          314 NSNKNVDISLNNFTWES  330 (869)
Q Consensus       314 ~~l~~l~ls~N~~~~~~  330 (869)
                      +.++.|++++|+++..+
T Consensus       329 ~~L~~L~L~~n~l~~l~  345 (384)
T d2omza2         329 TKLQRLFFANNKVSDVS  345 (384)
T ss_dssp             TTCCEEECCSSCCCCCG
T ss_pred             CCCCEEECCCCCCCCCh
Confidence            89999999999998764

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.84  E-value=8.5e-22  Score=195.80  Aligned_cols=161  Identities=19%  Similarity=0.140  Sum_probs=118.6

Q ss_pred             CCCeeeccCceEEEEEEEcCCcEEEEEEecccCc------------------hhhHHHHHHHHHHHhcCCCceeeEEeEE
Q 002899          642 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR------------------QGNREFVNEIGMISAQQHPNLVKLYGCC  703 (869)
Q Consensus       642 ~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~------------------~~~~~f~~E~~~l~~l~H~nIv~l~~~~  703 (869)
                      +.++||+|+||+||+|+..+|+.||||+++....                  .....+..|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            5678999999999999998999999998753211                  0122345678889999999999887653


Q ss_pred             eeCceEEEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCcEEE
Q 002899          704 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI  783 (869)
Q Consensus       704 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl~~~~~~kl  783 (869)
                          ..+++|||++++.+.+            ++......++.|++++++|||+++   |+||||||+|||++++ .++|
T Consensus        84 ----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred             ----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence                2379999998765432            334456789999999999999998   9999999999999965 5899


Q ss_pred             eecCCceeecCCCccccccccccccccc------hhhcccCCCCchhHHHHHHHH
Q 002899          784 SDFGLAKLYEEDKTHISTRIAGTIGYMA------PEYAMRGYLTSKADVYSFGVV  832 (869)
Q Consensus       784 ~DFGla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~k~DvwSlGvi  832 (869)
                      +|||+|.........         .|..      .|.. ...++.++|+||..--
T Consensus       144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         144 IDFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred             EECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence            999999765432211         1111      1111 2456778899997543

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=7.6e-19  Score=180.97  Aligned_cols=226  Identities=17%  Similarity=0.144  Sum_probs=128.7

Q ss_pred             EecCCCCcceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccc-cceEEEeecccCCCC-CchhhcC
Q 002899           46 TCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGP-FPKVLTN  123 (869)
Q Consensus        46 ~C~~~~~~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~-~~~~~~~  123 (869)
                      .|+|.+     +.+++++.+++ .+|+.+.  +++++|+|++|.|+.+++..|..+ +|++|+|++|.+... .+..|.+
T Consensus         5 ~C~C~~-----~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~   76 (242)
T d1xwdc1           5 ICHCSN-----RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN   76 (242)
T ss_dssp             SEEECS-----SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEES
T ss_pred             cCCCcC-----CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccc
Confidence            477754     36788888888 7776654  578888888888876655555554 566666666655432 2334555


Q ss_pred             ccccccccccc-cccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEE
Q 002899          124 ITTLKNLSIEG-NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL  202 (869)
Q Consensus       124 l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  202 (869)
                      ++++++|++.. |++....+..|.++++|++|++++|++....+..                       .+..+..+..+
T Consensus        77 l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~-----------------------~~~~l~~l~~~  133 (242)
T d1xwdc1          77 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH-----------------------KIHSLQKVLLD  133 (242)
T ss_dssp             CTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCT-----------------------TTCBSSCEEEE
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhccccccc-----------------------ccccccccccc
Confidence            55555555443 3444444444555555555555555554221111                       12223333333


Q ss_pred             EccCCcCCCCchHhhhcCC-CCCEEEcCCCCCCCCcccccccccceEE-EcccccCccCCCcccCCCCCcCEEeccCCCC
Q 002899          203 HIQGSSLEGPIPASISALT-SLTDLRISDLKGSESAFPKLDKMNLKTL-ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNL  280 (869)
Q Consensus       203 ~L~~N~l~~~~~~~l~~l~-~L~~L~L~~n~~~~~~~~~~~~~~L~~L-~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l  280 (869)
                      ...++.+....+..+..++ .++.|++++|+++......+...+++.+ ++++|+|+...+..|.++++|+.|+|++|+|
T Consensus       134 ~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l  213 (242)
T d1xwdc1         134 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI  213 (242)
T ss_dssp             EESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCC
T ss_pred             cccccccccccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcC
Confidence            3444444433333333332 4444455444444443333333344444 4567777766667788888888888888888


Q ss_pred             CCCCchhhhcCCCCCEEEeeCC
Q 002899          281 TGGIPTTFEKLAKTNFMYLTGN  302 (869)
Q Consensus       281 ~~~~p~~~~~l~~L~~L~Ls~N  302 (869)
                      +...+..|.++++|+.|++.+.
T Consensus       214 ~~l~~~~~~~l~~L~~l~~~~l  235 (242)
T d1xwdc1         214 HSLPSYGLENLKKLRARSTYNL  235 (242)
T ss_dssp             CCCCSSSCTTCCEEESSSEESS
T ss_pred             CccCHHHHcCCcccccCcCCCC
Confidence            8666666777777777666543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=3.3e-19  Score=176.94  Aligned_cols=162  Identities=18%  Similarity=0.323  Sum_probs=109.4

Q ss_pred             cEEEeecccccccCCccccCCCCCCeEeccCCcCCC-CCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCC
Q 002899          152 QKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG-KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD  230 (869)
Q Consensus       152 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~  230 (869)
                      ++++.++|+++ .+|..+.  +++++|+|++|+|++ ..+..|.++++|+.|+|++|.+....+..+..+++|+.|+|+ 
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls-   86 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG-   86 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC-
T ss_pred             CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec-
Confidence            34555555555 4444432  456666666666654 234445666666666666666665556666666655555444 


Q ss_pred             CCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCch
Q 002899          231 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK  310 (869)
Q Consensus       231 n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  310 (869)
                                            +|+|+.+.+..|.++++|++|+|++|+|++..|.+|..+++|++|+|++|        
T Consensus        87 ----------------------~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N--------  136 (192)
T d1w8aa_          87 ----------------------ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN--------  136 (192)
T ss_dssp             ----------------------SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTC--------
T ss_pred             ----------------------cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccc--------
Confidence                                  55566667778888999999999999999888888999999999998888        


Q ss_pred             hhhccCCceeeeccCccCCCCCCCCCCCCCccceeccCCCCCCCCCCcCccCCCCCCCCCcccccce
Q 002899          311 YIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYT  377 (869)
Q Consensus       311 ~~~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~~~~~l~~~~~~~~~~~~~~~~~~~C~~p~~~~~~~  377 (869)
                                            ||.|+|++.|+..|+......        ....+|+.|....+..
T Consensus       137 ----------------------~~~~~~~~~~~~~~l~~~~l~--------~~~~~c~~p~~l~~~~  173 (192)
T d1w8aa_         137 ----------------------PFNCNCHLAWFAEWLRKKSLN--------GGAARCGAPSKVRDVQ  173 (192)
T ss_dssp             ----------------------CBCCSGGGHHHHHHHHHHCCS--------GGGCBBCSSTTTTTSB
T ss_pred             ----------------------ccccccchHHHhhhhhhhccc--------CCCeEeCCChhhcCCE
Confidence                                  778999999998887643221        1345677777766543

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=1.1e-18  Score=179.82  Aligned_cols=202  Identities=15%  Similarity=0.080  Sum_probs=154.5

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCC-Cchhhccc-cceEEEeec-ccCCCCCchhhcCcccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS-FSPQWASL-QLVELSVMG-NRLSGPFPKVLTNITTLKN  129 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~-~~~~~~~l-~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~  129 (869)
                      ...++.|+|++|.|+...+.+|.++++|++|+|++|.+... .+..|..+ ++++|.+.. |.+....+..|.++++|++
T Consensus        28 ~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~  107 (242)
T d1xwdc1          28 PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQY  107 (242)
T ss_dssp             CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCE
T ss_pred             CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccc
Confidence            35789999999999976667899999999999999999875 45567777 789998764 7888888889999999999


Q ss_pred             ccccccccCCCCCc-cccCCCCccEEEeecccccccCCccccCCC-CCCeEeccCCcCCCCCccccCCCCcccEEEccCC
Q 002899          130 LSIEGNLFTGSIPP-DIRKLINLQKLILSSNSFTGELPAELTKLT-NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS  207 (869)
Q Consensus       130 L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  207 (869)
                      |++++|.+....+. .+..+..|..+...++++....+..|.+++ .++.|++++|+++...+..|.....++.+++++|
T Consensus       108 l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n  187 (242)
T d1xwdc1         108 LLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN  187 (242)
T ss_dssp             EEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCT
T ss_pred             cccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccccchhhhcccccccc
Confidence            99999999854332 345567777778888888876677777665 7889999999999655555544433444567888


Q ss_pred             cCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccC
Q 002899          208 SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSF  277 (869)
Q Consensus       208 ~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~  277 (869)
                      +++...+..|.++++|+.|+|++|+                       |+...+..|.++++|+.|++.+
T Consensus       188 ~l~~l~~~~f~~l~~L~~L~Ls~N~-----------------------l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         188 NLEELPNDVFHGASGPVILDISRTR-----------------------IHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             TCCCCCTTTTTTSCCCSEEECTTSC-----------------------CCCCCSSSCTTCCEEESSSEES
T ss_pred             ccccccHHHhcCCCCCCEEECCCCc-----------------------CCccCHHHHcCCcccccCcCCC
Confidence            8987667778888888888777554                       4434445566777777666543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.75  E-value=2.6e-19  Score=177.77  Aligned_cols=155  Identities=21%  Similarity=0.282  Sum_probs=112.9

Q ss_pred             EEEeccCCCccccCCccccCCCCCCEEEeecCcCCC-CCchhhccc-cceEEEeecccCCCCCchhhcCccccccccccc
Q 002899           57 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTG-SFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG  134 (869)
Q Consensus        57 ~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~-~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  134 (869)
                      +.+++++++++ .+|..+.  +++++|+|++|+|+. ..+..|..+ +|+.|+|++|++....+..|..+++|++|+|++
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            47899999999 6787764  689999999999976 445666666 788888888888877777788888888888888


Q ss_pred             cccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCch
Q 002899          135 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP  214 (869)
Q Consensus       135 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  214 (869)
                      |+|+...+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+...... ..-...|+.+.+..|.++...|
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSS
T ss_pred             ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCCC
Confidence            888877677777888888888888888877777777778888888888877643221 1112235555566666655444


Q ss_pred             H
Q 002899          215 A  215 (869)
Q Consensus       215 ~  215 (869)
                      .
T Consensus       167 ~  167 (192)
T d1w8aa_         167 S  167 (192)
T ss_dssp             T
T ss_pred             h
Confidence            3

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=7.7e-18  Score=171.65  Aligned_cols=184  Identities=17%  Similarity=0.245  Sum_probs=84.8

Q ss_pred             cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEecc
Q 002899          102 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS  181 (869)
Q Consensus       102 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls  181 (869)
                      +|+.|++.+|+|+.. + .+..+++|++|+|++|++++..  .+..+++|++|++++|.++. + ..+.++++|+.|+++
T Consensus        42 ~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l~l~  115 (227)
T d1h6ua2          42 GITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLKN-V-SAIAGLQSIKTLDLT  115 (227)
T ss_dssp             TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEECT
T ss_pred             CcCEEECCCCCCCcc-h-hHhcCCCCcEeecCCceeeccc--cccccccccccccccccccc-c-ccccccccccccccc
Confidence            344444444444432 1 2455555555555555555322  24555555555555555542 2 134455555555555


Q ss_pred             CCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCC
Q 002899          182 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP  261 (869)
Q Consensus       182 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p  261 (869)
                      +|...+.  ..+...+.++.+.++.+.+....  .+..+++|+.|++++|.+..... .....+|+.|+|++|++++.. 
T Consensus       116 ~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~Ls~n~l~~l~-  189 (227)
T d1h6ua2         116 STQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDIS-  189 (227)
T ss_dssp             TSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG-
T ss_pred             ccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccccchh-hcccccceecccCCCccCCCh-
Confidence            5554422  22344455555555555554322  24444555555554444432211 111123444444444444321 


Q ss_pred             cccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEee
Q 002899          262 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLT  300 (869)
Q Consensus       262 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  300 (869)
                       .++.+++|++|+|++|+|++..|  +.++++|+.|+|+
T Consensus       190 -~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls  225 (227)
T d1h6ua2         190 -PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT  225 (227)
T ss_dssp             -GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred             -hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence             24555555666666655553322  5555555555554

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.74  E-value=4.8e-18  Score=173.21  Aligned_cols=206  Identities=17%  Similarity=0.211  Sum_probs=168.2

Q ss_pred             ceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccC
Q 002899          103 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD  182 (869)
Q Consensus       103 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~  182 (869)
                      +..++++.+++++..  .+..+.+|+.|++.+|.|+. ++ .+..+++|++|+|++|+|++..  .+..+++|++|++++
T Consensus        21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~   94 (227)
T d1h6ua2          21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSG   94 (227)
T ss_dssp             HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCS
T ss_pred             HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeeccc--ccccccccccccccc
Confidence            344566777777543  46788999999999999995 43 5899999999999999998644  389999999999999


Q ss_pred             CcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCc
Q 002899          183 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPD  262 (869)
Q Consensus       183 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~  262 (869)
                      |.++. + ..+.++++|+.|.+++|...+.  ..+...+.+..+.++.+.+..... .....+|+.|++++|.+++..  
T Consensus        95 n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~L~~L~l~~n~~~~~~--  167 (227)
T d1h6ua2          95 NPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLT--  167 (227)
T ss_dssp             CCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCG--
T ss_pred             ccccc-c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchhhh-hccccccccccccccccccch--
Confidence            99984 3 3588999999999999998754  347788899999999988875432 334447999999999998543  


Q ss_pred             ccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeec
Q 002899          263 YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL  323 (869)
Q Consensus       263 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~  323 (869)
                      .++++++|+.|+|++|++++. + .++++++|++|+|++|+|++..|-.-++.|+.|++++
T Consensus       168 ~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         168 PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN  226 (227)
T ss_dssp             GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEE
T ss_pred             hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcccccCCCCCEEEeeC
Confidence            388999999999999999964 4 3899999999999999999765544477888999874

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.71  E-value=3.1e-17  Score=164.94  Aligned_cols=166  Identities=21%  Similarity=0.293  Sum_probs=100.1

Q ss_pred             CccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEE
Q 002899          123 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL  202 (869)
Q Consensus       123 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  202 (869)
                      .+.+|++|++++|.++...  .+..+++|++|+|++|+|++..  .+..+++|++|++++|+|++ ++ .+..+++|+.|
T Consensus        44 ~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L  117 (210)
T d1h6ta2          44 ELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL  117 (210)
T ss_dssp             HHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred             HhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccc
Confidence            3455566666666555322  2555566666666666665322  24556666666666666653 22 35556666666


Q ss_pred             EccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCC
Q 002899          203 HIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG  282 (869)
Q Consensus       203 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~  282 (869)
                      ++++|.+...  ..+..+++|+.++++.|.++.... .....+|+.+++++|++++..  .++++++|+.|+|++|+|+.
T Consensus       118 ~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~~~-~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~  192 (210)
T d1h6ta2         118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDITV-LSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD  192 (210)
T ss_dssp             ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB
T ss_pred             cccccccccc--cccccccccccccccccccccccc-ccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC
Confidence            6666665422  245566666666666666554321 112235666677777777543  27788889999999998884


Q ss_pred             CCchhhhcCCCCCEEEeeC
Q 002899          283 GIPTTFEKLAKTNFMYLTG  301 (869)
Q Consensus       283 ~~p~~~~~l~~L~~L~Ls~  301 (869)
                       +| .+.++++|++|+|++
T Consensus       193 -l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         193 -LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             -CG-GGTTCTTCSEEEEEE
T ss_pred             -Ch-hhcCCCCCCEEEccC
Confidence             44 588888888888874

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.71  E-value=3.1e-16  Score=169.84  Aligned_cols=252  Identities=20%  Similarity=0.200  Sum_probs=160.0

Q ss_pred             eEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccccc
Q 002899           55 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG  134 (869)
Q Consensus        55 ~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  134 (869)
                      +++.|+|++++++ .+|+.   .++|++|+|++|+|+.+ |..+  .+|+.|++++|+++.+ +. +  .+.|++|+|++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~l-p~~~--~~L~~L~l~~n~l~~l-~~-l--p~~L~~L~L~~  107 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTEL-PELP--QSLKSLLVDNNNLKAL-SD-L--PPLLEYLGVSN  107 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSC-CCCC--TTCCEEECCSSCCSCC-CS-C--CTTCCEEECCS
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCccc-ccch--hhhhhhhhhhcccchh-hh-h--ccccccccccc
Confidence            4779999999998 57764   47899999999999965 4332  2799999999999843 22 1  24699999999


Q ss_pred             cccCCCCCccccCCCCccEEEeecccccccCC------------------ccccCCCCCCeEeccCCcCCCCCc------
Q 002899          135 NLFTGSIPPDIRKLINLQKLILSSNSFTGELP------------------AELTKLTNLNDLRISDNNFSGKIP------  190 (869)
Q Consensus       135 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p------------------~~~~~l~~L~~L~Ls~N~l~~~~~------  190 (869)
                      |.+. .+| .++.+++|++|++++|.+.....                  ..+..++.++.|++++|.+.....      
T Consensus       108 n~l~-~lp-~~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~  185 (353)
T d1jl5a_         108 NQLE-KLP-ELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLE  185 (353)
T ss_dssp             SCCS-SCC-CCTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCC
T ss_pred             cccc-ccc-chhhhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccccccccc
Confidence            9999 555 36889999999999998873221                  123344556666666665542111      


Q ss_pred             ------------cccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCcc
Q 002899          191 ------------EFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHG  258 (869)
Q Consensus       191 ------------~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~  258 (869)
                                  ..+..++.|+.+++++|..... +   ....++..+.+.++.+......   ...+..+++..+.+.+
T Consensus       186 ~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~-~---~~~~~l~~~~~~~~~~~~~~~~---~~~l~~~~~~~~~~~~  258 (353)
T d1jl5a_         186 SIVAGNNILEELPELQNLPFLTTIYADNNLLKTL-P---DLPPSLEALNVRDNYLTDLPEL---PQSLTFLDVSENIFSG  258 (353)
T ss_dssp             EEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSC-C---SCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSE
T ss_pred             cccccccccccccccccccccccccccccccccc-c---cccccccccccccccccccccc---cccccccccccccccc
Confidence                        1123344555555555544421 1   1223444444444444322110   0022223332222211


Q ss_pred             ----------------CCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCceeee
Q 002899          259 ----------------EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDIS  322 (869)
Q Consensus       259 ----------------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls  322 (869)
                                      .++.....+++|++|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|. ...+++.|+++
T Consensus       259 l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~-~~~~L~~L~L~  332 (353)
T d1jl5a_         259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPE-LPQNLKQLHVE  332 (353)
T ss_dssp             ESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCC-CCTTCCEEECC
T ss_pred             cccccchhcccccccCccccccccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-cccc-ccCCCCEEECc
Confidence                            11122234678999999999998 5664   4678999999999998 5665 35679999999


Q ss_pred             ccCccCCCCC
Q 002899          323 LNNFTWESSD  332 (869)
Q Consensus       323 ~N~~~~~~~~  332 (869)
                      +|+++.++.-
T Consensus       333 ~N~L~~lp~~  342 (353)
T d1jl5a_         333 YNPLREFPDI  342 (353)
T ss_dssp             SSCCSSCCCC
T ss_pred             CCcCCCCCcc
Confidence            9988766543

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.70  E-value=6.2e-17  Score=161.28  Aligned_cols=162  Identities=20%  Similarity=0.295  Sum_probs=79.6

Q ss_pred             CccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEE
Q 002899          123 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL  202 (869)
Q Consensus       123 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  202 (869)
                      .+.+|++|++++|.++. + ..+..+++|++|+|++|+|++..+  +.++++|++|++++|.+... + .+.++++|+.|
T Consensus        38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L  111 (199)
T d2omxa2          38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGL  111 (199)
T ss_dssp             HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEE
T ss_pred             HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccccccc-c-ccccccccccc
Confidence            34444555555554442 1 124444555555555555543221  44555555555555554421 1 24445555555


Q ss_pred             EccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCC
Q 002899          203 HIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG  282 (869)
Q Consensus       203 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~  282 (869)
                      ++++|.+...  ..+..+++|+.|++++|++...+ ......+|+.|++++|++++..  .++++++|+.|+|++|+|++
T Consensus       112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~  186 (199)
T d2omxa2         112 TLFNNQITDI--DPLKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD  186 (199)
T ss_dssp             ECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred             cccccccccc--cccchhhhhHHhhhhhhhhcccc-cccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC
Confidence            5555544432  12444455555555544443322 1111224445555556555432  36677777777777777774


Q ss_pred             CCchhhhcCCCCCEE
Q 002899          283 GIPTTFEKLAKTNFM  297 (869)
Q Consensus       283 ~~p~~~~~l~~L~~L  297 (869)
                       ++ .++.+++|+.|
T Consensus       187 -i~-~l~~L~~L~~L  199 (199)
T d2omxa2         187 -IS-VLAKLTNLESL  199 (199)
T ss_dssp             -CG-GGGGCTTCSEE
T ss_pred             -Cc-cccCCCCCCcC
Confidence             33 46777777765

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.67  E-value=1.6e-16  Score=159.64  Aligned_cols=186  Identities=15%  Similarity=0.221  Sum_probs=149.3

Q ss_pred             ccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEE
Q 002899          124 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLH  203 (869)
Q Consensus       124 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  203 (869)
                      +.++...++..+.+++.++.  ..+.+|++|++++|.++.. + .+..+++|++|+|++|+|++..  .++.+++|+.|+
T Consensus        23 l~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~   96 (210)
T d1h6ta2          23 FAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLF   96 (210)
T ss_dssp             HHHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred             HHHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccc
Confidence            34455567888887765543  4577999999999999853 3 4788999999999999999644  368899999999


Q ss_pred             ccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCC
Q 002899          204 IQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG  283 (869)
Q Consensus       204 L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~  283 (869)
                      +++|++++ ++ .+..+++|+.|++++|.+.... ......+|+.+++++|.+++  +..+..+++|+.+++++|++++.
T Consensus        97 l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~~~-~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i  171 (210)
T d1h6ta2          97 LDENKVKD-LS-SLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI  171 (210)
T ss_dssp             CCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCCG-GGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC
T ss_pred             cccccccc-cc-cccccccccccccccccccccc-cccccccccccccccccccc--ccccccccccccccccccccccc
Confidence            99999985 34 5899999999999999987643 22333489999999999985  34577899999999999999964


Q ss_pred             CchhhhcCCCCCEEEeeCCcCCCCCch-hhhccCCceeeec
Q 002899          284 IPTTFEKLAKTNFMYLTGNKLTGPVPK-YIFNSNKNVDISL  323 (869)
Q Consensus       284 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~~l~~l~ls~  323 (869)
                       + .+.++++|+.|+|++|+|+. +|. .-+.+|+.|+|++
T Consensus       172 -~-~l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         172 -V-PLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFS  209 (210)
T ss_dssp             -G-GGTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEE
T ss_pred             -c-cccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEEccC
Confidence             3 38999999999999999985 453 2256788898874

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.66  E-value=2.6e-16  Score=156.63  Aligned_cols=171  Identities=16%  Similarity=0.236  Sum_probs=140.4

Q ss_pred             CccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEE
Q 002899          123 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL  202 (869)
Q Consensus       123 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  202 (869)
                      ++.++..+.++.+.+++.++  ...+.+|++|++++|.|+. + +.+..+++|++|+|++|++++..+  ++++++|+.|
T Consensus        16 ~l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L   89 (199)
T d2omxa2          16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI   89 (199)
T ss_dssp             HHHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HHHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccc
Confidence            34556667888888886543  3567899999999999984 3 358889999999999999996543  8999999999


Q ss_pred             EccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCC
Q 002899          203 HIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG  282 (869)
Q Consensus       203 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~  282 (869)
                      ++++|.+....  .+.++++|+.|+++++.+..... .....+|+.|++++|++...  ..+..+++|+.|++++|++++
T Consensus        90 ~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~  164 (199)
T d2omxa2          90 LMNNNQIADIT--PLANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTD  164 (199)
T ss_dssp             ECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC
T ss_pred             ccccccccccc--ccccccccccccccccccccccc-cchhhhhHHhhhhhhhhccc--ccccccccccccccccccccC
Confidence            99999998543  48899999999999998876542 22345899999999999743  358889999999999999996


Q ss_pred             CCchhhhcCCCCCEEEeeCCcCCC
Q 002899          283 GIPTTFEKLAKTNFMYLTGNKLTG  306 (869)
Q Consensus       283 ~~p~~~~~l~~L~~L~Ls~N~l~~  306 (869)
                      ..  .+.++++|+.|+|++|++++
T Consensus       165 l~--~l~~l~~L~~L~ls~N~i~~  186 (199)
T d2omxa2         165 LK--PLANLTTLERLDISSNKVSD  186 (199)
T ss_dssp             CG--GGTTCTTCCEEECCSSCCCC
T ss_pred             Cc--cccCCCCCCEEECCCCCCCC
Confidence            43  38999999999999999985

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.61  E-value=1.3e-16  Score=168.16  Aligned_cols=248  Identities=17%  Similarity=0.264  Sum_probs=122.4

Q ss_pred             EEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCC-CchhhcCccccccccccccc
Q 002899           58 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGP-FPKVLTNITTLKNLSIEGNL  136 (869)
Q Consensus        58 ~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~  136 (869)
                      .|||+++++.......+.. ..+..+.++...+.......+...+|++|+|+++.++.. +...+..+++|++|+|++|.
T Consensus         4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~   82 (284)
T d2astb2           4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR   82 (284)
T ss_dssp             EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCB
T ss_pred             EEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccC
Confidence            4566666654322222211 123445555544444433444444566666666655432 23345556666666666665


Q ss_pred             cCCCCCccccCCCCccEEEeecc-cccccC-CccccCCCCCCeEeccCC-cCCCC-CccccCC-CCcccEEEccCC--cC
Q 002899          137 FTGSIPPDIRKLINLQKLILSSN-SFTGEL-PAELTKLTNLNDLRISDN-NFSGK-IPEFIGK-WKKIQKLHIQGS--SL  209 (869)
Q Consensus       137 l~~~~~~~~~~l~~L~~L~Ls~N-~i~~~~-p~~~~~l~~L~~L~Ls~N-~l~~~-~~~~~~~-l~~L~~L~L~~N--~l  209 (869)
                      +++..+..+..+++|++|+|+++ .++... ..-+.++++|++|+|+++ .++.. +...+.. .++|+.|+++++  .+
T Consensus        83 l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i  162 (284)
T d2astb2          83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNL  162 (284)
T ss_dssp             CCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGS
T ss_pred             CCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccc
Confidence            55444455555566666666553 343211 111234555666666553 23211 1111222 245555555543  23


Q ss_pred             CCC-chHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCC-CCCCCCchh
Q 002899          210 EGP-IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN-NLTGGIPTT  287 (869)
Q Consensus       210 ~~~-~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~  287 (869)
                      +.. +...+.++++|++|+|++|.                      .+++.....+..+++|++|+|++| .+++.....
T Consensus       163 ~~~~l~~l~~~~~~L~~L~L~~~~----------------------~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~  220 (284)
T d2astb2         163 QKSDLSTLVRRCPNLVHLDLSDSV----------------------MLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLE  220 (284)
T ss_dssp             CHHHHHHHHHHCTTCSEEECTTCT----------------------TCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGG
T ss_pred             cccccccccccccccccccccccc----------------------CCCchhhhhhcccCcCCEEECCCCCCCChHHHHH
Confidence            221 22233445555555554322                      345455555666677777777774 566555556


Q ss_pred             hhcCCCCCEEEeeCCcCCCCCchhhhccCCceeeeccCccCC
Q 002899          288 FEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWE  329 (869)
Q Consensus       288 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l~ls~N~~~~~  329 (869)
                      ++++++|+.|+++++ ++...-..+...+..|++..++++..
T Consensus       221 L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L~i~~~~ls~~  261 (284)
T d2astb2         221 LGEIPTLKTLQVFGI-VPDGTLQLLKEALPHLQINCSHFTTI  261 (284)
T ss_dssp             GGGCTTCCEEECTTS-SCTTCHHHHHHHSTTSEESCCCSCCT
T ss_pred             HhcCCCCCEEeeeCC-CCHHHHHHHHHhCccccccCccCCCC
Confidence            666777777777766 33322233344556666666655543

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=4e-17  Score=183.42  Aligned_cols=155  Identities=15%  Similarity=0.222  Sum_probs=75.4

Q ss_pred             CCCCeEeccCCcCCC-----CCccccCCCCcccEEEccCCcCCCC----chHhhhcCCCCCEEEcCCCCCCCCccccc--
Q 002899          173 TNLNDLRISDNNFSG-----KIPEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPKL--  241 (869)
Q Consensus       173 ~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~n~~~~~~~~~~--  241 (869)
                      +.++.+++++|++..     .....+.....|+.|++++|.+...    ....+...+.++.+++++|.+.......+  
T Consensus       226 ~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~  305 (460)
T d1z7xw1         226 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE  305 (460)
T ss_dssp             TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred             ccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence            445555555554421     1122234456777888888777642    23345556677777777766643222211  


Q ss_pred             ----ccccceEEEcccccCccCCCcc----cCCCCCcCEEeccCCCCCCC----Cchhhh-cCCCCCEEEeeCCcCCCCC
Q 002899          242 ----DKMNLKTLILTKCLIHGEIPDY----IGDMTKLKNIDLSFNNLTGG----IPTTFE-KLAKTNFMYLTGNKLTGPV  308 (869)
Q Consensus       242 ----~~~~L~~L~Ls~N~i~~~~p~~----~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~~  308 (869)
                          ....|+.+++++|.++......    +...++|++|+|++|+|++.    ++..+. ..+.|+.|+|++|+|+...
T Consensus       306 ~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~  385 (460)
T d1z7xw1         306 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS  385 (460)
T ss_dssp             HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred             cccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHH
Confidence                1124556666666555432222    22344566666666665432    112222 2344666666666555321


Q ss_pred             ----chhh--hccCCceeeeccCcc
Q 002899          309 ----PKYI--FNSNKNVDISLNNFT  327 (869)
Q Consensus       309 ----p~~~--~~~l~~l~ls~N~~~  327 (869)
                          +..+  .+.++.|+|++|+++
T Consensus       386 ~~~l~~~l~~~~~L~~L~Ls~N~i~  410 (460)
T d1z7xw1         386 CSSLAATLLANHSLRELDLSNNCLG  410 (460)
T ss_dssp             HHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred             HHHHHHHHhcCCCCCEEECCCCcCC
Confidence                1122  234555666666554

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=2.2e-15  Score=143.36  Aligned_cols=98  Identities=17%  Similarity=0.194  Sum_probs=50.4

Q ss_pred             cCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhh--ccCCceeeeccCccCCCCCCCCCCCCCc
Q 002899          264 IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSDPIECPRGSV  341 (869)
Q Consensus       264 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~l~~l~ls~N~~~~~~~~p~~C~c~~~  341 (869)
                      |.++++|+.|+|++|+|+.+.|.+|..+++|++|+|++|+|+ .+|...+  ..++.|+|++|        ||+|||.+.
T Consensus        52 f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~N--------p~~C~C~~~  122 (156)
T d2ifga3          52 LRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN--------PLHCSCALR  122 (156)
T ss_dssp             SCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSS--------CCCCCGGGH
T ss_pred             hccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCC--------cccCCchHH
Confidence            333344444444444444333333444444444444444443 2222221  12334444444        999999999


Q ss_pred             cceeccCCCCCCCCCCcCccCCCCCCCCCcccccc
Q 002899          342 NLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHY  376 (869)
Q Consensus       342 ~~~~~l~~~~~~~~~~~~~~~~~~~C~~p~~~~~~  376 (869)
                      |+..|+......+.      ..+..|.+|..+++.
T Consensus       123 ~l~~~~~~~~~~~~------~~~~~C~~p~~l~~~  151 (156)
T d2ifga3         123 WLQRWEEEGLGGVP------EQKLQCHGQGPLAHM  151 (156)
T ss_dssp             HHHHHHHTTCSSCG------GGCCCCSSSSCSSCC
T ss_pred             HHHHHHHhccCccC------cCCcEECcChHHCcC
Confidence            99999876443331      245678888766543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.58  E-value=2.4e-14  Score=154.60  Aligned_cols=242  Identities=23%  Similarity=0.251  Sum_probs=169.1

Q ss_pred             cceEEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccc
Q 002899           53 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSI  132 (869)
Q Consensus        53 ~~~v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  132 (869)
                      .++++.|+|++|+|+ .+|..+   .+|+.|++++|+++.+.. .  ...|++|+|++|.+... |. ++.+++|+.|++
T Consensus        57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l~~-l--p~~L~~L~L~~n~l~~l-p~-~~~l~~L~~L~l  127 (353)
T d1jl5a_          57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKALSD-L--PPLLEYLGVSNNQLEKL-PE-LQNSSFLKIIDV  127 (353)
T ss_dssp             CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCCCS-C--CTTCCEEECCSSCCSSC-CC-CTTCTTCCEEEC
T ss_pred             CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchhhh-h--ccccccccccccccccc-cc-hhhhccceeecc
Confidence            347899999999999 677654   579999999999986531 1  12699999999999854 43 678999999999


Q ss_pred             cccccCCCCC------------------ccccCCCCccEEEeecccccccC------------------CccccCCCCCC
Q 002899          133 EGNLFTGSIP------------------PDIRKLINLQKLILSSNSFTGEL------------------PAELTKLTNLN  176 (869)
Q Consensus       133 s~N~l~~~~~------------------~~~~~l~~L~~L~Ls~N~i~~~~------------------p~~~~~l~~L~  176 (869)
                      ++|.+.....                  ..+..++.++.|++++|.+....                  ...+..++.|+
T Consensus       128 ~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~  207 (353)
T d1jl5a_         128 DNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLT  207 (353)
T ss_dssp             CSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCC
T ss_pred             ccccccccccccccccchhhccccccccccccccccceeccccccccccccccccccccccccccccccccccccccccc
Confidence            9998773322                  23566778899999888765311                  12345678999


Q ss_pred             eEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEEEcCCCCCCCCc---------------cccc
Q 002899          177 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA---------------FPKL  241 (869)
Q Consensus       177 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~---------------~~~~  241 (869)
                      .+++++|.... .+.   ...++..+.+..|.+.... .   ...++..+++..+.+....               ...+
T Consensus       208 ~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~~-~---~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~  279 (353)
T d1jl5a_         208 TIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDLP-E---LPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSL  279 (353)
T ss_dssp             EEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCCC-C---CCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEE
T ss_pred             ccccccccccc-ccc---ccccccccccccccccccc-c---ccccccccccccccccccccccchhcccccccCccccc
Confidence            99999998773 333   3456788888888876422 1   1233444444333222110               0000


Q ss_pred             --ccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCCchhhhcCCCCCEEEeeCCcCCCCCchhhhccCCce
Q 002899          242 --DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV  319 (869)
Q Consensus       242 --~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~l  319 (869)
                        ...+|++|+|++|+|+. +|.   .+++|+.|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|. +...++.|
T Consensus       280 ~~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~-~l~~---~~~~L~~L~L~~N~L~-~lp~-~~~~L~~L  349 (353)
T d1jl5a_         280 CDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPD-IPESVEDL  349 (353)
T ss_dssp             CCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-SCCC-CCTTCCEE
T ss_pred             cccCCCCCEEECCCCccCc-ccc---ccCCCCEEECCCCcCC-cccc---ccCCCCEEECcCCcCC-CCCc-cccccCee
Confidence              12379999999999984 554   3689999999999999 5664   3568999999999998 5664 34456665


Q ss_pred             ee
Q 002899          320 DI  321 (869)
Q Consensus       320 ~l  321 (869)
                      .+
T Consensus       350 ~~  351 (353)
T d1jl5a_         350 RM  351 (353)
T ss_dssp             EC
T ss_pred             EC
Confidence            54

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=7.2e-16  Score=162.41  Aligned_cols=231  Identities=20%  Similarity=0.211  Sum_probs=160.2

Q ss_pred             EEEEeccCCCccccCCccccCCCCCCEEEeecCcCCCCC-chhhccc-cceEEEeecccCCCCCchhhcCcccccccccc
Q 002899           56 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSF-SPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE  133 (869)
Q Consensus        56 v~~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~i~~~~-~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  133 (869)
                      +..+.+.+..+...+. .......|++|||++|.++... ...+... +|++|+|+++.+++..+..+..+++|++|+|+
T Consensus        25 ~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls  103 (284)
T d2astb2          25 VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS  103 (284)
T ss_dssp             CSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred             ceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence            3455666655553333 3345578999999999987543 4445555 89999999999998888889999999999999


Q ss_pred             cc-ccCCCC-CccccCCCCccEEEeecc-ccccc-CCcccc-CCCCCCeEeccCC--cCCCC-CccccCCCCcccEEEcc
Q 002899          134 GN-LFTGSI-PPDIRKLINLQKLILSSN-SFTGE-LPAELT-KLTNLNDLRISDN--NFSGK-IPEFIGKWKKIQKLHIQ  205 (869)
Q Consensus       134 ~N-~l~~~~-~~~~~~l~~L~~L~Ls~N-~i~~~-~p~~~~-~l~~L~~L~Ls~N--~l~~~-~~~~~~~l~~L~~L~L~  205 (869)
                      ++ .++... ...+..+++|++|+|+++ .++.. +...+. ..++|+.|+++++  .++.. +...+.++++|++|+|+
T Consensus       104 ~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~  183 (284)
T d2astb2         104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS  183 (284)
T ss_dssp             TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECT
T ss_pred             ccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccc
Confidence            95 565321 122457899999999996 45432 222333 3578999999975  34422 33345678999999999


Q ss_pred             CC-cCCCCchHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCC
Q 002899          206 GS-SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI  284 (869)
Q Consensus       206 ~N-~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  284 (869)
                      +| .+++.....+..+++|+.|+|+++.                      .|++.....++.+++|+.|+++++--.+..
T Consensus       184 ~~~~itd~~~~~l~~~~~L~~L~L~~C~----------------------~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l  241 (284)
T d2astb2         184 DSVMLKNDCFQEFFQLNYLQHLSLSRCY----------------------DIIPETLLELGEIPTLKTLQVFGIVPDGTL  241 (284)
T ss_dssp             TCTTCCGGGGGGGGGCTTCCEEECTTCT----------------------TCCGGGGGGGGGCTTCCEEECTTSSCTTCH
T ss_pred             cccCCCchhhhhhcccCcCCEEECCCCC----------------------CCChHHHHHHhcCCCCCEEeeeCCCCHHHH
Confidence            86 5777777888889988888887532                      333344445677899999999988322233


Q ss_pred             chhhhcCCCCCEEEeeCCcCCCCCchhh
Q 002899          285 PTTFEKLAKTNFMYLTGNKLTGPVPKYI  312 (869)
Q Consensus       285 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  312 (869)
                      +.....+++|+   +..++++...+..+
T Consensus       242 ~~l~~~lp~L~---i~~~~ls~~~~~~~  266 (284)
T d2astb2         242 QLLKEALPHLQ---INCSHFTTIARPTI  266 (284)
T ss_dssp             HHHHHHSTTSE---ESCCCSCCTTCSSC
T ss_pred             HHHHHhCcccc---ccCccCCCCCCCcc
Confidence            33334566654   68888886655554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.51  E-value=5e-16  Score=168.46  Aligned_cols=236  Identities=16%  Similarity=0.196  Sum_probs=124.0

Q ss_pred             CCccccCCCCCCEEEeecCcCCCCCchhhc----cc-cceEEEeecccCCCC----------CchhhcCccccccccccc
Q 002899           70 LPTELSKLRYLKQLDLSRNCLTGSFSPQWA----SL-QLVELSVMGNRLSGP----------FPKVLTNITTLKNLSIEG  134 (869)
Q Consensus        70 ~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~----~l-~L~~L~Ls~N~l~~~----------~~~~~~~l~~L~~L~Ls~  134 (869)
                      +..++.+.+.|+.|+|++|.|.......+.    .. +|+.|+++++.....          +...+..+++|+.|+|++
T Consensus        23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~  102 (344)
T d2ca6a1          23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  102 (344)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence            445567777888888888877654333332    22 577777776654321          123344556777777777


Q ss_pred             cccCCCCC----ccccCCCCccEEEeecccccccCCcc-------------ccCCCCCCeEeccCCcCCCCC----cccc
Q 002899          135 NLFTGSIP----PDIRKLINLQKLILSSNSFTGELPAE-------------LTKLTNLNDLRISDNNFSGKI----PEFI  193 (869)
Q Consensus       135 N~l~~~~~----~~~~~l~~L~~L~Ls~N~i~~~~p~~-------------~~~l~~L~~L~Ls~N~l~~~~----~~~~  193 (869)
                      |.++....    ..+...++|++|++++|.+.......             ....+.|+.|.+++|+++...    ...+
T Consensus       103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l  182 (344)
T d2ca6a1         103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF  182 (344)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred             cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence            77664322    22345566777777777664211100             124456677777777665322    2234


Q ss_pred             CCCCcccEEEccCCcCCCC-----chHhhhcCCCCCEEEcCCCCCCCCccccc-----ccccceEEEcccccCccCCCcc
Q 002899          194 GKWKKIQKLHIQGSSLEGP-----IPASISALTSLTDLRISDLKGSESAFPKL-----DKMNLKTLILTKCLIHGEIPDY  263 (869)
Q Consensus       194 ~~l~~L~~L~L~~N~l~~~-----~~~~l~~l~~L~~L~L~~n~~~~~~~~~~-----~~~~L~~L~Ls~N~i~~~~p~~  263 (869)
                      ...+.|+.|+|++|.+...     +...+..+++|+.|+|++|.++......+     ...+|++|+|++|.|++.....
T Consensus       183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~  262 (344)
T d2ca6a1         183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA  262 (344)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred             hhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHH
Confidence            4456667777776666531     22335556666666666666543221111     1124555555555555432222


Q ss_pred             c----C--CCCCcCEEeccCCCCCCC----Cchhhh-cCCCCCEEEeeCCcCC
Q 002899          264 I----G--DMTKLKNIDLSFNNLTGG----IPTTFE-KLAKTNFMYLTGNKLT  305 (869)
Q Consensus       264 ~----~--~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~  305 (869)
                      +    .  ..+.|++|+|++|+|+..    +...+. ++++|+.|+|++|++.
T Consensus       263 l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             HHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            2    1  124566666666665532    122222 3455666666666654

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.48  E-value=5.2e-14  Score=128.08  Aligned_cols=118  Identities=19%  Similarity=0.267  Sum_probs=81.0

Q ss_pred             eEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCC
Q 002899          104 VELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN  183 (869)
Q Consensus       104 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N  183 (869)
                      +.|+|++|+++.. + .+..+++|++|+|++|+|+ .+|..|..+++|++|++++|+|+. +| .+..+++|++|++++|
T Consensus         1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            3566666666633 3 3677777777777777777 556667777777888888777774 33 4777777888888888


Q ss_pred             cCCCCC-ccccCCCCcccEEEccCCcCCC---CchHhhhcCCCCCEE
Q 002899          184 NFSGKI-PEFIGKWKKIQKLHIQGSSLEG---PIPASISALTSLTDL  226 (869)
Q Consensus       184 ~l~~~~-~~~~~~l~~L~~L~L~~N~l~~---~~~~~l~~l~~L~~L  226 (869)
                      +|+... ...+..+++|+.|++++|+++.   ........+|+|+.|
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            777543 2457777778888888877763   234455667777665

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=2.1e-14  Score=137.40  Aligned_cols=123  Identities=14%  Similarity=0.152  Sum_probs=82.0

Q ss_pred             cceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEecc
Q 002899          102 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS  181 (869)
Q Consensus       102 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls  181 (869)
                      ++++|+|++|+|+.+ +..+..+++|+.|+|++|+|+. ++ .|..+++|++|+|++|+|+...+..+..+++|++|+|+
T Consensus        19 ~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~   95 (162)
T d1a9na_          19 RDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT   95 (162)
T ss_dssp             SCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred             cCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccccceec
Confidence            455555555555533 4445667777777777777773 32 46777777777777777775555555667778888888


Q ss_pred             CCcCCCCCc-cccCCCCcccEEEccCCcCCCCc---hHhhhcCCCCCEEE
Q 002899          182 DNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPI---PASISALTSLTDLR  227 (869)
Q Consensus       182 ~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~l~~L~~L~  227 (869)
                      +|+|+.... ..+..+++|++|++++|.++...   +..+..+++|+.||
T Consensus        96 ~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          96 NNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             SCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             cccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            887764322 45677788888888888776432   34677888888776

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=7.4e-16  Score=172.87  Aligned_cols=275  Identities=17%  Similarity=0.163  Sum_probs=182.2

Q ss_pred             ceEEEEeccCCCccccC-CccccCCCCCCEEEeecCcCCCCC----chhhccc-cceEEEeecccCCCCC----chhhc-
Q 002899           54 CHVVTIALKAQNLTGTL-PTELSKLRYLKQLDLSRNCLTGSF----SPQWASL-QLVELSVMGNRLSGPF----PKVLT-  122 (869)
Q Consensus        54 ~~v~~L~l~~~~l~~~~-p~~l~~l~~L~~L~Ls~N~i~~~~----~~~~~~l-~L~~L~Ls~N~l~~~~----~~~~~-  122 (869)
                      .+++.||++++++++.. .+-+..+++|++|+|++|.|+...    ...+... +|++|+|++|.|+...    ...+. 
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            36899999999998632 344677899999999999998533    2333344 7999999999986322    22222 


Q ss_pred             CccccccccccccccCCC----CCccccCCCCccEEEeecccccccCCc-------------------------------
Q 002899          123 NITTLKNLSIEGNLFTGS----IPPDIRKLINLQKLILSSNSFTGELPA-------------------------------  167 (869)
Q Consensus       123 ~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~~p~-------------------------------  167 (869)
                      ..++|++|+|++|++++.    ++..+..+++|++|+|++|.|+.....                               
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  161 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  161 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence            235899999999999854    345678899999999999987631000                               


Q ss_pred             --cccCCCCCCeEeccCCcCCC-----------------------------C----CccccCCCCcccEEEccCCcCCC-
Q 002899          168 --ELTKLTNLNDLRISDNNFSG-----------------------------K----IPEFIGKWKKIQKLHIQGSSLEG-  211 (869)
Q Consensus       168 --~~~~l~~L~~L~Ls~N~l~~-----------------------------~----~~~~~~~l~~L~~L~L~~N~l~~-  211 (869)
                        .+.....++.++++++.+..                             .    ....+...+.++.+++..|.+.. 
T Consensus       162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~  241 (460)
T d1z7xw1         162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV  241 (460)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence              01123455666665554321                             0    00122345677788888777643 


Q ss_pred             ----CchHhhhcCCCCCEEEcCCCCCCCCccccc-----ccccceEEEcccccCccCCCccc-----CCCCCcCEEeccC
Q 002899          212 ----PIPASISALTSLTDLRISDLKGSESAFPKL-----DKMNLKTLILTKCLIHGEIPDYI-----GDMTKLKNIDLSF  277 (869)
Q Consensus       212 ----~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~-----~~~~L~~L~Ls~N~i~~~~p~~~-----~~l~~L~~L~Ls~  277 (869)
                          ...........|+.|++++|.+........     ....++.+++++|.++......+     .....|+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~  321 (460)
T d1z7xw1         242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS  321 (460)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred             ccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccc
Confidence                123344456789999999988775443221     22368899999998864333222     2346799999999


Q ss_pred             CCCCCCCchh----hhcCCCCCEEEeeCCcCCCCC----chhhh---ccCCceeeeccCccC
Q 002899          278 NNLTGGIPTT----FEKLAKTNFMYLTGNKLTGPV----PKYIF---NSNKNVDISLNNFTW  328 (869)
Q Consensus       278 N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~~----p~~~~---~~l~~l~ls~N~~~~  328 (869)
                      |.++......    +...++|+.|+|++|+++...    ++.+.   ..++.|+|++|+++.
T Consensus       322 ~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~  383 (460)
T d1z7xw1         322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD  383 (460)
T ss_dssp             SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred             cchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCCh
Confidence            9888554333    345678999999999987532    23332   347889999998864

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=4.5e-14  Score=135.03  Aligned_cols=127  Identities=14%  Similarity=0.116  Sum_probs=57.8

Q ss_pred             CCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCCcCCCCchHhhhcCCCCCEE
Q 002899          147 KLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL  226 (869)
Q Consensus       147 ~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L  226 (869)
                      +..+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+..  +.|..+++|++|+|++|+++...+..+..+++|+.|
T Consensus        16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L   92 (162)
T d1a9na_          16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL   92 (162)
T ss_dssp             CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred             CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccccc
Confidence            3334444444444444 2233333444444444444444421  124444444444444444443333334444444444


Q ss_pred             EcCCCCCCCCcccccccccceEEEcccccCccCCCcccCCCCCcCEEeccCCCCCCCC---chhhhcCCCCCEEE
Q 002899          227 RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI---PTTFEKLAKTNFMY  298 (869)
Q Consensus       227 ~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~  298 (869)
                      +|++|++....                      ....+..+++|+.|+|++|.++...   +..+..+++|++||
T Consensus        93 ~L~~N~i~~~~----------------------~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          93 ILTNNSLVELG----------------------DLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             ECCSCCCCCGG----------------------GGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             eeccccccccc----------------------cccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            44433332211                      0123445666666666666665322   23466677777665

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.44  E-value=4.7e-15  Score=160.65  Aligned_cols=228  Identities=15%  Similarity=0.184  Sum_probs=170.2

Q ss_pred             eEEEEeccCCCccc----cCCccccCCCCCCEEEeecCcCCCCC---ch-------hhccc-cceEEEeecccCCCCC--
Q 002899           55 HVVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRNCLTGSF---SP-------QWASL-QLVELSVMGNRLSGPF--  117 (869)
Q Consensus        55 ~v~~L~l~~~~l~~----~~p~~l~~l~~L~~L~Ls~N~i~~~~---~~-------~~~~l-~L~~L~Ls~N~l~~~~--  117 (869)
                      .++.|+|++|.+..    .+...+...++|+.|+|+++.+....   +.       .+... +|+.|+|++|.++...  
T Consensus        32 ~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~  111 (344)
T d2ca6a1          32 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE  111 (344)
T ss_dssp             CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHH
T ss_pred             CCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccccccc
Confidence            47899999998854    34456788899999999988665332   11       12222 7999999999998653  


Q ss_pred             --chhhcCccccccccccccccCCCCCcc-------------ccCCCCccEEEeeccccccc----CCccccCCCCCCeE
Q 002899          118 --PKVLTNITTLKNLSIEGNLFTGSIPPD-------------IRKLINLQKLILSSNSFTGE----LPAELTKLTNLNDL  178 (869)
Q Consensus       118 --~~~~~~l~~L~~L~Ls~N~l~~~~~~~-------------~~~l~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L  178 (869)
                        ...+..+++|++|+|++|.+.......             ....+.|+.|++++|++...    +...+...++|+.|
T Consensus       112 ~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L  191 (344)
T d2ca6a1         112 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV  191 (344)
T ss_dssp             HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEE
T ss_pred             chhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccc
Confidence              344566899999999999876211111             13467899999999998743    23345677899999


Q ss_pred             eccCCcCCCC-----CccccCCCCcccEEEccCCcCCCC----chHhhhcCCCCCEEEcCCCCCCCCccccc-------c
Q 002899          179 RISDNNFSGK-----IPEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPKL-------D  242 (869)
Q Consensus       179 ~Ls~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~n~~~~~~~~~~-------~  242 (869)
                      +|++|+|+..     +...+..+++|+.|+|++|.++..    +...+..+++|++|+|++|.++......+       .
T Consensus       192 ~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~  271 (344)
T d2ca6a1         192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE  271 (344)
T ss_dssp             ECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCS
T ss_pred             ccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhcc
Confidence            9999998742     345577889999999999998743    45677899999999999999987544332       2


Q ss_pred             cccceEEEcccccCccCCC----cccC-CCCCcCEEeccCCCCCC
Q 002899          243 KMNLKTLILTKCLIHGEIP----DYIG-DMTKLKNIDLSFNNLTG  282 (869)
Q Consensus       243 ~~~L~~L~Ls~N~i~~~~p----~~~~-~l~~L~~L~Ls~N~l~~  282 (869)
                      ...|++|+|++|+|+....    ..+. ++++|+.|+|++|++..
T Consensus       272 ~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             SCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             CCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            3479999999999975432    3332 57899999999999984

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.43  E-value=2e-13  Score=124.07  Aligned_cols=103  Identities=20%  Similarity=0.261  Sum_probs=82.3

Q ss_pred             ccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCCCCcccEEEccCC
Q 002899          128 KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS  207 (869)
Q Consensus       128 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  207 (869)
                      |.|+|++|+|+ .++ .+..+++|++|++++|+|+ .+|..+..+++|+.|++++|+|+.. | .+..+++|+.|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence            57899999998 444 4888899999999999998 5677888899999999999999853 3 4888889999999999


Q ss_pred             cCCCCc-hHhhhcCCCCCEEEcCCCCCCC
Q 002899          208 SLEGPI-PASISALTSLTDLRISDLKGSE  235 (869)
Q Consensus       208 ~l~~~~-~~~l~~l~~L~~L~L~~n~~~~  235 (869)
                      +|+... ...+..+++|+.|++++|+++.
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            988643 3567888888888877666543

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.30  E-value=1.1e-12  Score=124.35  Aligned_cols=103  Identities=17%  Similarity=0.164  Sum_probs=70.6

Q ss_pred             EEeccCCCccccCCccccCCCCCCEEEeecC-cCCCCCchhhccc-cceEEEeecccCCCCCchhhcCcccccccccccc
Q 002899           58 TIALKAQNLTGTLPTELSKLRYLKQLDLSRN-CLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN  135 (869)
Q Consensus        58 ~L~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N-~i~~~~~~~~~~l-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  135 (869)
                      .+++.+++++ ..|..+..+++|++|+|++| .|+.+.+..|..+ +|+.|+|++|+|+.+.+.+|..+++|++|+|++|
T Consensus        12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence            3677788887 56778888999999999765 4776666666666 6777777777777666666777777777777777


Q ss_pred             ccCCCCCccccCCCCccEEEeeccccc
Q 002899          136 LFTGSIPPDIRKLINLQKLILSSNSFT  162 (869)
Q Consensus       136 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~  162 (869)
                      +|+...+..|. ..+|++|+|++|.+.
T Consensus        91 ~l~~l~~~~~~-~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          91 ALESLSWKTVQ-GLSLQELVLSGNPLH  116 (156)
T ss_dssp             CCSCCCSTTTC-SCCCCEEECCSSCCC
T ss_pred             CCcccChhhhc-cccccccccCCCccc
Confidence            77633333333 335666666666654

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.26  E-value=8.4e-14  Score=137.84  Aligned_cols=113  Identities=20%  Similarity=0.213  Sum_probs=77.4

Q ss_pred             CCchhhcCccccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCccccCC
Q 002899          116 PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGK  195 (869)
Q Consensus       116 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  195 (869)
                      .++..+..+++|++|+|++|+|+. ++ .+..+++|++|+|++|+|+ .+|..+..+++|+.|++++|+|+..  ..+..
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~  113 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEK  113 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHH
T ss_pred             hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccc
Confidence            345667777788888888887773 33 4777777888888888777 4454445556777888888877742  34667


Q ss_pred             CCcccEEEccCCcCCCCc-hHhhhcCCCCCEEEcCCCCC
Q 002899          196 WKKIQKLHIQGSSLEGPI-PASISALTSLTDLRISDLKG  233 (869)
Q Consensus       196 l~~L~~L~L~~N~l~~~~-~~~l~~l~~L~~L~L~~n~~  233 (869)
                      +++|+.|+|++|+|+... ...+..+++|+.|+|++|++
T Consensus       114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l  152 (198)
T d1m9la_         114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL  152 (198)
T ss_dssp             HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHH
T ss_pred             cccccccccccchhccccccccccCCCccceeecCCCcc
Confidence            777888888888777432 24677777777777765554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.25  E-value=1.2e-13  Score=136.74  Aligned_cols=130  Identities=25%  Similarity=0.310  Sum_probs=63.2

Q ss_pred             CCccccCCCCCCEEEeecCcCCCCCchhhccccceEEEeecccCCCCCchhhcCccccccccccccccCCCCCccccCCC
Q 002899           70 LPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI  149 (869)
Q Consensus        70 ~p~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  149 (869)
                      ++.+|..+++|++|+|++|+|+.+                        + .+..+++|+.|+|++|.|+ .++..+..++
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~~i------------------------~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~   93 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIEKI------------------------S-SLSGMENLRILSLGRNLIK-KIENLDAVAD   93 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEESCC------------------------C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHH
T ss_pred             hhhHHhcccccceeECcccCCCCc------------------------c-cccCCccccChhhcccccc-cccccccccc
Confidence            344555666666666666655533                        1 2444455555555555544 2333333334


Q ss_pred             CccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCCc-cccCCCCcccEEEccCCcCCCCch----------Hhhh
Q 002899          150 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIP----------ASIS  218 (869)
Q Consensus       150 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~----------~~l~  218 (869)
                      +|++|++++|+|+..  ..+..+++|+.|+|++|+|+.... ..|..+++|+.|+|++|++....+          ..+.
T Consensus        94 ~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~  171 (198)
T d1m9la_          94 TLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK  171 (198)
T ss_dssp             HCCEEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHH
T ss_pred             ccccccccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHH
Confidence            455555555555421  124444555555555555542211 234555555555555555432111          1256


Q ss_pred             cCCCCCEEE
Q 002899          219 ALTSLTDLR  227 (869)
Q Consensus       219 ~l~~L~~L~  227 (869)
                      .+++|+.||
T Consensus       172 ~lp~L~~LD  180 (198)
T d1m9la_         172 RLPNLKKLD  180 (198)
T ss_dssp             HCSSCCEES
T ss_pred             HCCCcCEeC
Confidence            777777765

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.47  E-value=5.1e-09  Score=99.18  Aligned_cols=106  Identities=21%  Similarity=0.141  Sum_probs=59.7

Q ss_pred             hcCccccccccccccccCCCCCccccCCCCccEEEeecccccccC--CccccCCCCCCeEeccCCcCCCCCccccCCCCc
Q 002899          121 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGEL--PAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK  198 (869)
Q Consensus       121 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  198 (869)
                      +..+..+..|++.++.+. .++..+..+++|++|+|++|+|+...  +..+..+++|+.|+|++|+|+...+-.+....+
T Consensus        38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~  116 (162)
T d1koha1          38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK  116 (162)
T ss_dssp             TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred             hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence            334444455555544433 33333445666777777777666432  234556677777777777776443333334446


Q ss_pred             ccEEEccCCcCCCCch-------HhhhcCCCCCEEE
Q 002899          199 IQKLHIQGSSLEGPIP-------ASISALTSLTDLR  227 (869)
Q Consensus       199 L~~L~L~~N~l~~~~~-------~~l~~l~~L~~L~  227 (869)
                      |+.|+|++|.+.....       ..+..+|+|+.||
T Consensus       117 L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1         117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             CSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             cceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            7777777777764322       3356677777764

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.36  E-value=1.6e-06  Score=88.25  Aligned_cols=151  Identities=14%  Similarity=0.113  Sum_probs=100.6

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceE
Q 002899          631 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQL  709 (869)
Q Consensus       631 ~~i~~~t~~f~~~~~IG~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~~~  709 (869)
                      +++...-..|++.+..+.++.+.||+... +++.+++|+...........+.+|..++..+. +--+.+++++...++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            45555566776666544445578998865 45667888876655444556778888887663 32345778888888899


Q ss_pred             EEEEEeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh--------------------------------
Q 002899          710 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE--------------------------------  757 (869)
Q Consensus       710 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~--------------------------------  757 (869)
                      ++||+++++..+.+......          ....++.++++.++.||+                                
T Consensus        86 ~lv~~~l~G~~~~~~~~~~~----------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDEQ----------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTCS----------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             EEEEEecccccccccccccc----------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            99999999887754332110          122234444455555553                                


Q ss_pred             ---------------------c---CCCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          758 ---------------------D---SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       758 ---------------------~---~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                                           .   .+..++|+|+.|.|||+++++.+-|+||+.+..-
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence                                 1   1122789999999999998776779999987643

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.29  E-value=4.9e-08  Score=92.20  Aligned_cols=104  Identities=17%  Similarity=0.122  Sum_probs=62.3

Q ss_pred             ccccccccccccCCCCCccccCCCCccEEEeecccccccCCccccCCCCCCeEeccCCcCCCCC--ccccCCCCcccEEE
Q 002899          126 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKI--PEFIGKWKKIQKLH  203 (869)
Q Consensus       126 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~  203 (869)
                      ..+.|+++++...    ..+..+..+..|...+|.+. .++..+..+++|++|+|++|+|+...  +..+..+++|+.|+
T Consensus        23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~   97 (162)
T d1koha1          23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN   97 (162)
T ss_dssp             SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred             hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence            4556666655432    23444455555555555444 44444566788888888888887543  34466677788888


Q ss_pred             ccCCcCCCCchHhhhcCCCCCEEEcCCCCCC
Q 002899          204 IQGSSLEGPIPASISALTSLTDLRISDLKGS  234 (869)
Q Consensus       204 L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~  234 (869)
                      |++|.|+...+-.+....+|+.|++++|++.
T Consensus        98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          98 LSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             cccCccccchhhhhhhccccceeecCCCCcC
Confidence            8888877544433334445666666655544

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.90  E-value=2.4e-05  Score=78.67  Aligned_cols=145  Identities=15%  Similarity=0.102  Sum_probs=86.9

Q ss_pred             eeeccCc-eEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCc--eeeEEeEEeeCceEEEEEEeccCCch
Q 002899          645 KVGEGGF-GSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN--LVKLYGCCVEGNQLLLVYEYMKNNCL  721 (869)
Q Consensus       645 ~IG~G~f-G~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~E~~~~gsL  721 (869)
                      .+..|.. +.||+....++..+++|......   ..++..|++.++.+....  +.+++++..+++..++||||+++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3455554 57999988778888899865443   335667777777664333  45778888888889999999987665


Q ss_pred             hhh-----------------hhcCCcccc-cCCCHHHHHHHHH--------------------HHHHHHHHHHhc----C
Q 002899          722 SRA-----------------IFGKDTEYR-LKLDWPTRKKICI--------------------GIARGLAYLHED----S  759 (869)
Q Consensus       722 ~~~-----------------l~~~~~~~~-~~l~~~~~~~i~~--------------------~ia~gL~yLH~~----~  759 (869)
                      ...                 ||....... ..-.+.....-..                    .....+..+.+.    .
T Consensus        94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  173 (255)
T d1nd4a_          94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE  173 (255)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred             ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence            321                 111110000 0001111100000                    011223333332    2


Q ss_pred             CCCeEEcCCCCCCEEEcCCCcEEEeecCCceee
Q 002899          760 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY  792 (869)
Q Consensus       760 ~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~~  792 (869)
                      ++.++|+|+.|.|||++++..+-|+||+.+...
T Consensus       174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g  206 (255)
T d1nd4a_         174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  206 (255)
T ss_dssp             CEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             CceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence            223789999999999998776789999987653

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.74  E-value=1.1e-05  Score=75.88  Aligned_cols=40  Identities=3%  Similarity=-0.193  Sum_probs=24.0

Q ss_pred             cCCCCCcCEEeccCCCCCCC-------CchhhhcCCCCCEEEeeCCc
Q 002899          264 IGDMTKLKNIDLSFNNLTGG-------IPTTFEKLAKTNFMYLTGNK  303 (869)
Q Consensus       264 ~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~  303 (869)
                      +...+.|++|+|++|++...       +...+...+.|+.|+++.+.
T Consensus        96 L~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          96 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence            44556677777777765532       23344456777777776653

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.68  E-value=6.8e-06  Score=77.40  Aligned_cols=87  Identities=13%  Similarity=0.066  Sum_probs=43.2

Q ss_pred             ccCCCCccEEEeecccccccC----CccccCCCCCCeEeccCCcCCCC----CccccCCCCcccEEEccCCcCCCC----
Q 002899          145 IRKLINLQKLILSSNSFTGEL----PAELTKLTNLNDLRISDNNFSGK----IPEFIGKWKKIQKLHIQGSSLEGP----  212 (869)
Q Consensus       145 ~~~l~~L~~L~Ls~N~i~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----  212 (869)
                      +...++|++|+|++|.+....    ...+...++|++|+|++|.|+..    +..++...+.|++|+|++|.+...    
T Consensus        40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~  119 (167)
T d1pgva_          40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV  119 (167)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred             HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHH
Confidence            334445555555555554211    12233445566666666665532    122344455566666666554421    


Q ss_pred             ---chHhhhcCCCCCEEEcCCC
Q 002899          213 ---IPASISALTSLTDLRISDL  231 (869)
Q Consensus       213 ---~~~~l~~l~~L~~L~L~~n  231 (869)
                         +...+...++|+.|+++.+
T Consensus       120 ~~~l~~~L~~n~sL~~l~l~~~  141 (167)
T d1pgva_         120 EMDMMMAIEENESLLRVGISFA  141 (167)
T ss_dssp             HHHHHHHHHHCSSCCEEECCCC
T ss_pred             HHHHHHHHHhCCCccEeeCcCC
Confidence               2344555566666666543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.32  E-value=0.00032  Score=75.20  Aligned_cols=77  Identities=13%  Similarity=0.162  Sum_probs=48.0

Q ss_pred             CCeeeccCceEEEEEEEcC-CcEEEEEEecccC-------chhhHHHHHHHHHHHhcC-C--CceeeEEeEEeeCceEEE
Q 002899          643 ANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS-------RQGNREFVNEIGMISAQQ-H--PNLVKLYGCCVEGNQLLL  711 (869)
Q Consensus       643 ~~~IG~G~fG~Vyka~~~~-g~~VAvK~~~~~~-------~~~~~~f~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~l  711 (869)
                      .+.||.|....||+....+ ++.|+||.-.+..       .....+...|.+.+..+. +  ..+.+++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3468999999999998654 6789999754321       112233456777776552 2  334556654  4455679


Q ss_pred             EEEeccCCch
Q 002899          712 VYEYMKNNCL  721 (869)
Q Consensus       712 V~E~~~~gsL  721 (869)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987554

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.21  E-value=4.7e-05  Score=71.28  Aligned_cols=15  Identities=13%  Similarity=-0.186  Sum_probs=7.4

Q ss_pred             hhcCCCCCEEEeeCC
Q 002899          288 FEKLAKTNFMYLTGN  302 (869)
Q Consensus       288 ~~~l~~L~~L~Ls~N  302 (869)
                      +...+.|+.|+++.|
T Consensus       128 L~~n~~L~~L~l~~~  142 (166)
T d1io0a_         128 LEKNTTLLKFGYHFT  142 (166)
T ss_dssp             HHHCSSCCEEECCCS
T ss_pred             HHhCCCcCEEeCcCC
Confidence            334455555555444

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.04  E-value=8.1e-05  Score=69.56  Aligned_cols=114  Identities=17%  Similarity=0.251  Sum_probs=63.6

Q ss_pred             cCCCCccEEEeec-cccccc----CCccccCCCCCCeEeccCCcCCCCC----ccccCCCCcccEEEccCCcCCCC----
Q 002899          146 RKLINLQKLILSS-NSFTGE----LPAELTKLTNLNDLRISDNNFSGKI----PEFIGKWKKIQKLHIQGSSLEGP----  212 (869)
Q Consensus       146 ~~l~~L~~L~Ls~-N~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~----  212 (869)
                      .+.++|++|+|++ +.|+..    +...+...++|++|+|++|.++...    ...+...+.|+.|++++|.+...    
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~   93 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA   93 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence            3456777777776 345431    2233445667777777777665322    22344456666666666666532    


Q ss_pred             chHhhhcCCCCCEEEcCCCCCCCCcccccccccceEEEcccccCcc----CCCcccCCCCCcCEEeccCCCC
Q 002899          213 IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHG----EIPDYIGDMTKLKNIDLSFNNL  280 (869)
Q Consensus       213 ~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~----~~p~~~~~l~~L~~L~Ls~N~l  280 (869)
                      +...+...++|+.++|+                     +++|.+..    .+...+...++|+.|+++.+..
T Consensus        94 l~~~l~~~~~L~~l~L~---------------------l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          94 LVEALQSNTSLIELRID---------------------NQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHGGGGCSSCCEEECC---------------------CCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHHhCccccEEeec---------------------cCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            22444555556555443                     22344432    2334455678899998887754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.53  E-value=0.0038  Score=64.62  Aligned_cols=137  Identities=12%  Similarity=0.063  Sum_probs=78.5

Q ss_pred             eEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCCCce--eeEE-----eEEeeCceEEEEEEeccCCchhh-
Q 002899          652 GSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL--VKLY-----GCCVEGNQLLLVYEYMKNNCLSR-  723 (869)
Q Consensus       652 G~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nI--v~l~-----~~~~~~~~~~lV~E~~~~gsL~~-  723 (869)
                      -.||++..++|+.+++|+..+... ...++.+|.+.+..+....+  +..+     .....++..+.++++++|..+.. 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            489999999999999999865422 34567778887776642222  1111     12344667889999998754410 


Q ss_pred             -------------hhh----cCCcccccCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCCCe
Q 002899          724 -------------AIF----GKDTEYRLKLDWP-------------------TRKKICIGIARGLAYLHE----DSRIKI  763 (869)
Q Consensus       724 -------------~l~----~~~~~~~~~l~~~-------------------~~~~i~~~ia~gL~yLH~----~~~~~i  763 (869)
                                   .+|    ......+...++.                   .+..+...+.+.++.+..    ..+..+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                         011    1111111112221                   111222223333344432    233457


Q ss_pred             EEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          764 VHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       764 iH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ||+|+.+.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            899999999999754  45899998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.11  E-value=0.0051  Score=65.47  Aligned_cols=72  Identities=18%  Similarity=0.216  Sum_probs=48.0

Q ss_pred             CeeeccCceEEEEEEEcCC--------cEEEEEEecccCchhhHHHHHHHHHHHhcCCCcee-eEEeEEeeCceEEEEEE
Q 002899          644 NKVGEGGFGSVYKGILSDG--------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV-KLYGCCVEGNQLLLVYE  714 (869)
Q Consensus       644 ~~IG~G~fG~Vyka~~~~g--------~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~E  714 (869)
                      +.|+.|-.-.+|++...++        +.|.+++.-..  .......+|.++++.+.-.+++ ++++++..    .+|||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            5677788889999987543        45677766532  2234455788888877433444 77777653    57999


Q ss_pred             eccCCch
Q 002899          715 YMKNNCL  721 (869)
Q Consensus       715 ~~~~gsL  721 (869)
                      |+++..+
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987655

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.15  E-value=0.068  Score=54.26  Aligned_cols=161  Identities=13%  Similarity=0.061  Sum_probs=82.6

Q ss_pred             ccHHHHHHHhcCCCCCCeee-----ccCceEEEEEEEcCCcEEEEEEecccCchhhHHHHHHHHHHHhcCC-----Ccee
Q 002899          628 YTLRQIKAATNNFDPANKVG-----EGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH-----PNLV  697 (869)
Q Consensus       628 ~~~~~i~~~t~~f~~~~~IG-----~G~fG~Vyka~~~~g~~VAvK~~~~~~~~~~~~f~~E~~~l~~l~H-----~nIv  697 (869)
                      .+.++++....+|.+.+...     .|---+.|+....+|+ +++|++.....  ..+...|++++..+..     |..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence            35677888888888765543     4555678999877665 89998864322  2334445555555432     2222


Q ss_pred             eEE---eEEeeCceEEEEEEeccCCchhh--------------hhhc--CCc--ccccCC------------------CH
Q 002899          698 KLY---GCCVEGNQLLLVYEYMKNNCLSR--------------AIFG--KDT--EYRLKL------------------DW  738 (869)
Q Consensus       698 ~l~---~~~~~~~~~~lV~E~~~~gsL~~--------------~l~~--~~~--~~~~~l------------------~~  738 (869)
                      ...   .+...++....++.+..+.....              .++.  ...  ......                  ..
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            110   01223445566677666543311              0000  000  000000                  00


Q ss_pred             HHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcee
Q 002899          739 PTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL  791 (869)
Q Consensus       739 ~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NILl~~~~~~kl~DFGla~~  791 (869)
                      ......+..+...+.-.+. .-+..+||+|+.+.||+++.+...-|.||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            1111222222222222221 2233489999999999999987778999998864